PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Orabi, AI; Shah, AU; Muili, K; Luo, YH; Mahmood, SM; Ahmad, A; Reed, A; Husain, SZ				Orabi, Abrahim I.; Shah, Ahsan U.; Muili, Kamaldeen; Luo, Yuhuan; Mahmood, Syeda Maham; Ahmad, Asim; Reed, Anamika; Husain, Sohail Z.			Ethanol Enhances Carbachol-induced Protease Activation and Accelerates Ca2+ Waves in Isolated Rat Pancreatic Acini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; CALCIUM-RELEASE CHANNELS; C-ALPHA PHOSPHORYLATION; RYANODINE RECEPTOR; KINASE-C; BASOLATERAL EXOCYTOSIS; ALCOHOLIC PANCREATITIS; ZYMOGEN ACTIVATION; ETHYL-ESTERS; ENZYME ACTIVATION	Alcohol abuse is a leading cause of pancreatitis, accounting for 30% of acute cases and 70-90% of chronic cases, yet the mechanisms leading to alcohol-associated pancreatic injury are unclear. An early and critical feature of pancreatitis is the aberrant signaling of Ca2+ within the pancreatic acinar cell. An important conductor of this Ca2+ is the basolaterally localized, intracellular Ca2+ channel ryanodine receptor (RYR). In this study, we examined the effect of ethanol on mediating both pathologic intra-acinar protease activation, a precursor to pancreatitis, as well as RYR Ca2+ signals. We hypothesized that ethanol sensitizes the acinar cell to protease activation by modulating RYR Ca2+. Acinar cells were freshly isolated from rat, pretreated with ethanol, and stimulated with the muscarinic agonist carbachol (1 mu M). Ethanol caused a doubling in the carbachol-induced activation of the proteases trypsin and chymotrypsin (p < 0.02). The RYR inhibitor dantrolene abrogated the enhancement of trypsin and chymotrypsin activity by ethanol (p < 0.005 for both proteases). Further, ethanol accelerated the speed of the apical to basolateral Ca2+ wave from 9 to 18 mu m/s (p < 0.0005; n = 18-22 cells/group); an increase in Ca2+ wave speed was also observed with a change from physiologic concentrations of carbachol (1 mu M) to a supraphysiologic concentration (1 mM) that leads to protease activation. Dantrolene abrogated the ethanol-induced acceleration of wave speed (p < 0.05; n = 10-16 cells/group). Our results suggest that the enhancement of pathologic protease activation by ethanol is dependent on the RYR and that a novel mechanism for this enhancement may involve RYR-mediated acceleration of Ca2+ waves.	[Orabi, Abrahim I.; Shah, Ahsan U.; Muili, Kamaldeen; Luo, Yuhuan; Mahmood, Syeda Maham; Ahmad, Asim; Reed, Anamika; Husain, Sohail Z.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Husain, SZ (corresponding author), Yale Child Hlth Res Ctr, 464 Congress Ave,Rm 222, New Haven, CT 06520 USA.	sohail.husain@yale.edu			National Institutes of Health [RO1 DK083327, R03 DK078707, K12 HD001401, DK34989]; American Gastroenterological Association; Children's Digestive Health and Nutrition Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090104, R01DK083327, P30DK034989, R03DK078707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; Children's Digestive Health and Nutrition Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK083327, R03 DK078707, K12 HD001401, and DK34989 (to S. Z. H.), an American Gastroenterological Association Fellowship to Faculty Transition Award (to A. R.), and a Children's Digestive Health and Nutrition Young Investigator Award (to S. Z. H.).	Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Best CA, 2003, FRONT BIOSCI-LANDMRK, V8, pE202, DOI 10.2741/931; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Cosen-Binker LI, 2007, GASTROENTEROLOGY, V132, P1527, DOI 10.1053/j.gastro.2007.01.042; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; Cosen-Binker LI, 2007, CAN J GASTROENTEROL, V21, P19, DOI 10.1155/2007/930424; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fernandez-Sanchez M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-77; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fitzsimmons TJ, 2000, BIOCHEM J, V351, P265, DOI 10.1042/0264-6021:3510265; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Gonzalez A, 1999, BIOCHEM BIOPH RES CO, V261, P726, DOI 10.1006/bbrc.1999.1106; Gonzalez A, 1998, AM J PHYSIOL-CELL PH, V275, pC810, DOI 10.1152/ajpcell.1998.275.3.C810; Gonzalez A, 2008, ALCOHOL, V42, P565, DOI 10.1016/j.alcohol.2008.06.005; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P106, DOI 10.1053/gast.2002.30302; HABER PS, 1993, J LAB CLIN MED, V121, P759; Haber PS, 1998, J LAB CLIN MED, V132, P294, DOI 10.1016/S0022-2143(98)90042-7; Husain SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG1594, DOI 10.1152/ajpgi.00500.2006; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; Ito K, 1999, J CELL BIOL, V146, P405, DOI 10.1083/jcb.146.2.405; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Katz M, 1996, AM J PHYSIOL-GASTR L, V270, pG171, DOI 10.1152/ajpgi.1996.270.1.G171; Lam PPL, 2007, TRAFFIC, V8, P605, DOI 10.1111/j.1600-0854.2007.00557.x; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; Lowenfels Albert B, 2005, Curr Gastroenterol Rep, V7, P90, DOI 10.1007/s11894-005-0045-6; Lu Z, 2002, AM J PHYSIOL-GASTR L, V282, pG501, DOI 10.1152/ajpgi.00388.2001; Lugea A, 2010, ALCOHOL CLIN EXP RES, V34, P1768, DOI 10.1111/j.1530-0277.2010.01264.x; NATHANSON MH, 1992, J BIOL CHEM, V267, P18118; NORDBACK IH, 1991, ANN SURG, V214, P671, DOI 10.1097/00000658-199112000-00006; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; OWYANG C, 1996, AM J PHYSIOL, V271, P1; Pandol SJ, 1999, GASTROENTEROLOGY, V117, P706, DOI 10.1016/S0016-5085(99)70465-8; Pfeiffer F, 1998, AM J PHYSIOL-CELL PH, V274, pC663; PONNAPPA BC, 1987, BIOCHEM PHARMACOL, V36, P69, DOI 10.1016/0006-2952(87)90383-2; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Satoh A, 2006, AM J PHYSIOL-GASTR L, V291, pG432, DOI 10.1152/ajpgi.00579.2005; Shah AU, 2008, AM J PHYSIOL-GASTR L, V294, pG1328, DOI 10.1152/ajpgi.00440.2007; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; STEINBERG W, 1994, NEW ENGL J MED, V330, P1198, DOI 10.1056/NEJM199404283301706; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; Virlos I, 2004, INTENS CARE MED, V30, P1645, DOI 10.1007/s00134-004-2328-z; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; Weber H, 2004, AM J PHYSIOL-GASTR L, V286, pG932, DOI 10.1152/ajpgi.00406.2003; Weber H, 2009, INT J EXP PATHOL, V90, P387, DOI 10.1111/j.1365-2613.2009.00638.x; Werner J, 1997, GASTROENTEROLOGY, V113, P286, DOI 10.1016/S0016-5085(97)70106-9; WILSON JS, 1990, J LAB CLIN MED, V115, P749; Zhou H, 2007, BIOCHEM BIOPH RES CO, V352, P277, DOI 10.1016/j.bbrc.2006.10.174	55	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14090	14097		10.1074/jbc.M110.196832	http://dx.doi.org/10.1074/jbc.M110.196832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372126	Green Published, hybrid			2022-12-25	WOS:000289556200032
J	Dunstan, AJ; Ward, PD; Marshall, NJ				Dunstan, Andrew J.; Ward, Peter D.; Marshall, N. Justin			Vertical Distribution and Migration Patterns of Nautilus pompilius	PLOS ONE			English	Article							LIVING NAUTILUS; PALAU; ISLANDS; BELAUENSIS; IMPLOSION; BEHAVIOR; MOVEMENT; BIOLOGY; FIJI	Vertical depth migrations into shallower waters at night by the chambered cephalopod Nautilus were first hypothesized early in the early 20(th) Century. Subsequent studies have supported the hypothesis that Nautilus spend daytime hours at depth and only ascend to around 200 m at night. Here we challenge this idea of a universal Nautilus behavior. Ultrasonic telemetry techniques were employed to track eleven specimens of Nautilus pompilius for variable times ranging from one to 78 days at Osprey Reef, Coral Sea, Australia. To supplement these observations, six remotely operated vehicle (ROV) dives were conducted at the same location to provide 29 hours of observations from 100 to 800 meter depths which sighted an additional 48 individuals, including five juveniles, all deeper than 489 m. The resulting data suggest virtually continuous, nightly movement between depths of 130 to 700 m, with daytime behavior split between either virtual stasis in the relatively shallow 160-225 m depths or active foraging in depths between 489 to 700 m. The findings also extend the known habitable depth range of Nautilus to 700 m, demonstrate juvenile distribution within the same habitat as adults and document daytime feeding behavior. These data support a hypothesis that, contrary to previously observed diurnal patterns of shallower at night than day, more complex vertical movement patterns may exist in at least this, and perhaps all other Nautilus populations. These are most likely dictated by optimal feeding substrate, avoidance of daytime visual predators, requirements for resting periods at 200 m to regain neutral buoyancy, upper temperature limits of around 25 degrees C and implosion depths of 800 m. The slope, terrain and biological community of the various geographically separated Nautilus populations may provide different permutations and combinations of the above factors resulting in preferred vertical movement strategies most suited for each population.	[Dunstan, Andrew J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Ward, Peter D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Washington; University of Washington Seattle; University of Queensland	Dunstan, AJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	andy.dunstan@gmail.com		Marshall, Justin/0000-0001-9006-6713	Undersea Explorer; University of Queensland; University of Washington; Andrew Dunstan; Australian Research Council [LP0775179]	Undersea Explorer; University of Queensland(University of Queensland); University of Washington(University of Washington); Andrew Dunstan; Australian Research Council(Australian Research Council)	Funding for this work was provided by Undersea Explorer, University of Queensland, University of Washington, Andrew Dunstan and Australian Research Council Linkage Projects: Project ID: LP0775179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutilier RG, 1996, NATURE, V382, P534, DOI 10.1038/382534a0; CARLSON BA, 1984, PAC SCI, V38, P183; CARLSON BA, 1979, PAC SCI, V33, P118; DUNSTAN A, 2010, FISHERIES R IN PRESS; DUNSTAN A, 2010, PLOS ONE IN PRESS; HAVEN N, 1977, MAR BIOL, V42, P177, DOI 10.1007/BF00391570; KANIE Y, 1980, PALEOBIOLOGY, V6, P44, DOI 10.1017/S0094837300012483; ODOR RK, 1993, NATURE, V362, P626, DOI 10.1038/362626a0; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1979, SCIENCE, V204, P1199, DOI 10.1126/science.204.4398.1199; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; Tanabe K., 1985, KAGOSHIMA U RES CTR, V4, P38; WARD P, 1980, LETHAIA, V13, P182, DOI 10.1111/j.1502-3931.1980.tb01050.x; WARD P, 1984, NATURE, V309, P248, DOI 10.1038/309248a0; WARD P, 1978, J EXP ZOOL, V205, P5, DOI 10.1002/jez.1402050103; WARD P, 1977, PALEOBIOLOGY, V3, P377, DOI 10.1017/S0094837300005534; Ward P. D., 1987, NATURAL HIST NAUTILU; WELLS MJ, 1992, J MAR BIOL ASSOC UK, V72, P313, DOI 10.1017/S0025315400037723; ZANN LP, 1984, VELIGER, V27, P19	19	41	43	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16311	10.1371/journal.pone.0016311	http://dx.doi.org/10.1371/journal.pone.0016311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364981	Green Published, gold			2022-12-25	WOS:000287656600005
J	Zandian, M; Mott, KR; Allen, SJ; Chen, SA; Arditi, M; Ghiasi, H				Zandian, Mandana; Mott, Kevin R.; Allen, Sariah J.; Chen, Shuang; Arditi, Moshe; Ghiasi, Homayon			IL-2 Suppression of IL-12p70 by a Recombinant HSV-1 Expressing IL-2 Induces T-Cell Auto-Reactivity and CNS Demyelination	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS PATIENTS; TRANSCRIPTION FACTOR FOXP3; MYELIN BASIC-PROTEIN; WILD-TYPE VIRUS; DENDRITIC CELLS; IN-VIVO; REGULATORY CELLS	To evaluate the role of cellular infiltrates in CNS demyelination in immunocompetent mice, we have used a model of multiple sclerosis (MS) in which different strains of mice are infected with a recombinant HSV-1 expressing IL-2. Histologic examination of the mice infected with HSV-IL-2 demonstrates that natural killer cells, dendritic cells, B cells, and CD25 (IL-2r alpha) do not play any role in the HSV-IL-2-induced demyelination. T cell depletion, T cell knockout and T cell adoptive transfer experiments suggest that both CD8(+) and CD4(+) T cells contribute to HSV-IL-2-induced CNS demyelination with CD8(+) T cells being the primary inducers. In the adoptive transfer studies, all of the transferred T cells irrespective of their CD25 status at the time of transfer were positive for expression of FoxP3 and depletion of FoxP3 blocked CNS demyelination by HSV-IL-2. The expression levels of IL-12p35 relative to IL-12p40 differed in BM-derived macrophages infected with HSV-IL-2 from those infected with wild-type HSV-1. HSV-IL-2-induced demyelination was blocked by injecting HSV-IL-2-infected mice with IL-12p70 DNA. This study demonstrates that suppression of the IL-12p70 function of macrophages by IL-2 causes T cells to become auto-aggressive. Interruption of this immunoregulatory axis results in demyelination of the optic nerve, the spinal cord and the brain by autoreactive T cells in the HSV-IL-2 mouse model of MS.	[Zandian, Mandana; Mott, Kevin R.; Allen, Sariah J.; Ghiasi, Homayon] Cedars Sinai Med Ctr, Dept Surg, Ctr Neurobiol & Vaccine Dev, Los Angeles, CA 90048 USA; [Chen, Shuang; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zandian, M (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Ctr Neurobiol & Vaccine Dev, Los Angeles, CA 90048 USA.	ghiasih@cshs.org			National Eye Institute [EY15557]; NATIONAL EYE INSTITUTE [R01EY015557] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This work was supported by Public Health Service grant EY15557 from the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1987, J VIROL, V61, P1571, DOI 10.1128/JVI.61.5.1571-1576.1987; Antony PA, 2005, J IMMUNOTHER, V28, P120, DOI 10.1097/01.cji.0000155049.26787.45; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Boman J, 2000, NEUROLOGY, V54, P265, DOI 10.1212/WNL.54.1.265; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; CHEN YH, 1995, J IMMUNOL, V155, P910; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Friedman JE, 1999, MULT SCLER, V5, P355, DOI 10.1177/135245859900500509; GALLO P, 1988, ANN NEUROL, V24, P795, DOI 10.1002/ana.410240618; GALLO P, 1989, J NEUROL SCI, V92, P9, DOI 10.1016/0022-510X(89)90171-8; Ghiasi H, 2002, J VIROL, V76, P9069, DOI 10.1128/JVI.76.18.9069-9078.2002; GHIASI H, 1995, J VIROL, V69, P334, DOI 10.1128/JVI.69.1.334-340.1995; Ghiasi H, 2000, ANTIVIR RES, V45, P33, DOI 10.1016/S0166-3542(99)00075-3; Ghiasi H, 2002, VIROLOGY, V302, P144, DOI 10.1006/viro.2002.1609; Ghiasi H, 2001, J VIROL, V75, P9029, DOI 10.1128/JVI.75.19.9029-9036.2001; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hemmer B, 2002, CURR OPIN NEUROL, V15, P227, DOI 10.1097/00019052-200206000-00001; Kang BY, 1999, INT J CANCER, V82, P569, DOI 10.1002/(SICI)1097-0215(19990812)82:4<569::AID-IJC16>3.0.CO;2-M; Karp CL, 2001, CURR OPIN NEUROL, V14, P361, DOI 10.1097/00019052-200106000-00016; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kohlmann WM, 2004, EXP DERMATOL, V13, P607, DOI 10.1111/j.0906-6705.2004.00195.x; Kriegel MA, 2004, J EXP MED, V199, P1285, DOI 10.1084/jem.20032158; Kuroda K, 1996, J IMMUNOL, V157, P1422; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; LU CZ, 1993, J NEUROL SCI, V120, P99, DOI 10.1016/0022-510X(93)90032-T; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Martin C, 1997, ACTA NEUROL SCAND, V95, P280, DOI 10.1111/j.1600-0404.1997.tb00210.x; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Mirandola P, 1999, NEUROLOGY, V53, P1367, DOI 10.1212/WNL.53.6.1367-a; Mott KR, 2008, J VIROL, V82, P9870, DOI 10.1128/JVI.00566-08; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2007, MOL VIS, V13, P1802; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; Osorio Y, 2005, EXP NEUROL, V193, P1, DOI 10.1016/j.expneurol.2004.12.004; Osorio Y, 2002, OCUL IMMUNOL INFLAMM, V10, P105, DOI 10.1076/ocii.10.2.105.13982; Peters JH, 1996, IMMUNOL TODAY, V17, P273, DOI 10.1016/0167-5699(96)80544-5; Petitto JM, 2000, NEUROSCI LETT, V285, P66, DOI 10.1016/S0304-3940(00)00996-4; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; PRINEAS JW, 1978, LAB INVEST, V38, P409; Putheti P, 2004, J CLIN IMMUNOL, V24, P155, DOI 10.1023/B:JOCI.0000019780.93817.82; Ramirez MC, 2004, TRENDS MICROBIOL, V12, P204, DOI 10.1016/j.tim.2004.03.008; Ramirez MC, 2002, J IMMUNOL, V169, P6733, DOI 10.4049/jimmunol.169.12.6733; Schwarz T, 1995, RES IMMUNOL, V146, P494, DOI 10.1016/0923-2494(96)83022-7; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Tran EH, 1998, J IMMUNOL, V161, P3767; TRAUGOTT U, 1983, J NEUROIMMUNOL, V4, P201, DOI 10.1016/0165-5728(83)90036-X; TROTTER JL, 1989, ANN NEUROL, V25, P172, DOI 10.1002/ana.410250211; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wu GF, 2000, J IMMUNOL, V165, P2278, DOI 10.4049/jimmunol.165.4.2278; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zandian M, 2009, INVEST OPHTH VIS SCI, V50, P3275, DOI 10.1167/iovs.08-3211; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	74	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16820	10.1371/journal.pone.0016820	http://dx.doi.org/10.1371/journal.pone.0016820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364747	gold, Green Published, Green Submitted			2022-12-25	WOS:000287482800016
J	Katz, SL; Hampton, SE; Izmest'eva, LR; Moore, MV				Katz, Stephen L.; Hampton, Stephanie E.; Izmest'eva, Lyubov R.; Moore, Marianne V.			Influence of Long-Distance Climate Teleconnection on Seasonality of Water Temperature in the World's Largest Lake - Lake Baikal, Siberia	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; ASIAN WINTER MONSOON; ENSO TELECONNECTIONS; SYNOPTIC CONDITIONS; ARCTIC OSCILLATION; DECEMBER 1974; EASTERN ASIA; COLD SURGES; VARIABILITY; PACIFIC	Large-scale climate change is superimposed on interacting patterns of climate variability that fluctuate on numerous temporal and spatial scales-elements of which, such as seasonal timing, may have important impacts on local and regional ecosystem forcing. Lake Baikal in Siberia is not only the world's largest and most biologically diverse lake, but it has exceptionally strong seasonal structure in ecosystem dynamics that may be dramatically affected by fluctuations in seasonal timing. We applied time-frequency analysis to a near-continuous, 58-year record of water temperature from Lake Baikal to examine how seasonality in the lake has fluctuated over the past half century and to infer underlying mechanisms. On decadal scales, the timing of seasonal onset strongly corresponds with deviation in the zonal wind intensity as described by length of day (LOD); on shorter scales, these temperature patterns shift in concert with the El Nino-Southern Oscillation (ENSO). Importantly, the connection between ENSO and Lake Baikal is gated by the cool and warm periods of the Pacific Decadal Oscillation (PDO). Large-scale climatic phenomena affecting Siberia are apparent in Lake Baikal surface water temperature data, dynamics resulting from jet stream and storm track variability in central Asia and across the Northern Hemisphere.	[Katz, Stephen L.] Natl Oceanog & Atmospher Adm, Santa Barbara, CA 93109 USA; [Hampton, Stephanie E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Izmest'eva, Lyubov R.] Irkutsk State Univ, Sci Res Inst Biol, Irkutsk 664003, Russia; [Moore, Marianne V.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Irkutsk State University; Wellesley College	Katz, SL (corresponding author), Natl Oceanog & Atmospher Adm, Santa Barbara, CA 93109 USA.	steve.katz@noaa.gov		Hampton, Stephanie/0000-0003-2389-4249	National Science Foundation [DEB-0072909, DEB-0528531]; Wellesley College	National Science Foundation(National Science Foundation (NSF)); Wellesley College	The National Center for Ecological Analysis and Synthesis, funded by the National Science Foundation (#DEB-0072909) on the University of California Santa Barbara campus, hosted the Lake Baikal Working Group. Wellesley College and NSF (#DEB-0528531) supported additional translation and technical help. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P516, DOI 10.1139/cjfas-56-3-516; Bond NA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018597; BOX GEP, 1971, J R STAT SOC SER A-G, V134, P229, DOI 10.2307/2343873; BOYLE JS, 1986, MON WEATHER REV, V114, P919, DOI 10.1175/1520-0493(1986)114<0919:COTSCI>2.0.CO;2; BOYLE JS, 1986, MON WEATHER REV, V114, P903, DOI 10.1175/1520-0493(1986)114<0903:COTSCI>2.0.CO;2; Branstator G, 2002, J CLIMATE, V15, P1893, DOI 10.1175/1520-0442(2002)015<1893:CTTJSW>2.0.CO;2; Chatfield C., 2016, ANAL TIME SERIES INT; Chen TC, 2004, J CLIMATE, V17, P401, DOI 10.1175/1520-0442(2004)017<0401:IVOTEA>2.0.CO;2; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; del Rio RA, 1999, ANN GEOPHYS-ATM HYDR, V17, P806, DOI 10.1007/s005850050809; Diaz HF, 2001, INT J CLIMATOL, V21, P1845, DOI 10.1002/joc.631; Gershunov A, 1998, B AM METEOROL SOC, V79, P2715, DOI 10.1175/1520-0477(1998)079<2715:IMOET>2.0.CO;2; GONG D, 2001, GEOPHYS RES LETT, V28, P4; Gross RS, 1996, GEOPHYS RES LETT, V23, P3373, DOI 10.1029/96GL03260; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Izmest'eva Lyubov R., 2006, LAKE BAIKAL PLANKTON; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McCabe GJ, 1999, INT J CLIMATOL, V19, P1399, DOI 10.1002/(SICI)1097-0088(19991115)19:13&lt;1399::AID-JOC457&gt;3.0.CO;2-A; McWilliams JC, 1994, CHAOS, V4, P305, DOI 10.1063/1.166010; Moore MV, 2009, BIOSCIENCE, V59, P405, DOI 10.1525/bio.2009.59.5.8; Munk W.H., 1960, ROTATION EARTH; Nakamura H, 2002, J CLIMATE, V15, P1855, DOI 10.1175/1520-0442(2002)015<1855:IADMRO>2.0.CO;2; *NAT RES COUNC PAN, 1998, DEC TO CENT SCAL CLI; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Qian S., 1996, JOINT TIME FREQUENCY; Rogers JC, 2002, CLIM DYNAM, V19, P599, DOI 10.1007/s00382-002-0247-7; Rosen RD, 2000, CLIM DYNAM, V16, P693, DOI 10.1007/s003820000076; SCHEMSKE DW, 1978, ECOLOGY, V59, P351, DOI 10.2307/1936379; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Schwing FB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016535; Seebens H, 2009, GLOBAL CHANGE BIOL, V15, P1394, DOI 10.1111/j.1365-2486.2008.01806.x; Shimaraev M. N., 1994, PHYS LIMNOLOGY LAKE; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stine AR, 2009, NATURE, V457, P435, DOI 10.1038/nature07675; Strong C, 2008, J CLIMATE, V21, P584, DOI 10.1175/2007JCLI1723.1; Strong C, 2010, J CLIMATE, V23, P1269, DOI 10.1175/2009JCLI2676.1; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI [10.1175/1520-0442(2000)013<1000:AMITEC>2.0.CO;2, 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2]; THOMSON DJ, 1995, SCIENCE, V268, P59, DOI 10.1126/science.268.5207.59; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2; 2008, GLOBAL CHANGE BIOL, V14, P1947, DOI DOI 10.1111/J.1365-2486.2008.01616.X	48	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14688	10.1371/journal.pone.0014688	http://dx.doi.org/10.1371/journal.pone.0014688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359207	Green Published, Green Submitted, gold			2022-12-25	WOS:000287392700005
J	Audouard, C; Le Masson, F; Charry, C; Li, ZH; Christians, ES				Audouard, Christophe; Le Masson, Florent; Charry, Colette; Li, Zihai; Christians, Elisabeth S.			Oocyte-Targeted Deletion Reveals That Hsp90b1 Is Needed for the Completion of First Mitosis in Mouse Zygotes	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; ENDOPLASMIC-RETICULUM; MITOTIC PROGRESSION; MAMMALIAN OOCYTES; GENE DISRUPTION; CRE RECOMBINASE; EXPRESSION; EMBRYOS; MICE; CELLS	Background: Hsp90b1 is an endoplasmic reticulum (ER) chaperone (also named Grp94, ERp99, gp96, Targ2, Tra-1, Tra1, Hspc4) (MGI:98817) contributing with Hspa5 (also named Grp78, BIP) (MGI:95835) to protein folding in ER compartment. Besides its high protein expression in mouse oocytes, little is known about Hsp90b1 during the transition from oocyte-to-embryo. Because the constitutive knockout of Hsp90b1 is responsible for peri-implantation embryonic lethality, it was not yet known whether Hsp90b1 is a functionally important maternal factor. Methodology/Findings: To circumvent embryonic lethality, we established an oocyte-specific conditional knockout line taking advantage of the more recently created floxed Hsp90b1 line (Hsp90b1(flox), MGI:3700023) in combination with the transgenic mouse line expressing the cre recombinase under the control of zona pellucida 3 (ZP3) promoter (Zp3-cre, MGI:2176187). Altered expression of Hsp90b1 in growing oocytes provoked a limited, albeit significant reduction of the zona pellucida thickness but no obvious anomalies in follicular growth, meiotic maturation or fertilization. Interestingly, mutant zygotes obtained from oocytes lacking Hsp90b1 were unable to reach the 2-cell stage. They exhibited either a G2/M block or, more frequently an abnormal mitotic spindle leading to developmental arrest. Despite the fact that Hspa5 displayed a similar profile of expression as Hsp90b1, we found that HSPA5 and HSP90B1 did not fully colocalize in zygotes suggesting distinct function for the two chaperones. Consequently, even if HSPA5 was overexpressed in Hsp90b1 mutant embryos, it did not compensate for HSP90B1 deficiency. Finally, further characterization of ER compartment and cytoskeleton revealed a defective organization of the cytoplasmic region surrounding the mutant zygotic spindle. Conclusions: Our findings demonstrate that the maternal contribution of Hsp90b1 is critical for the development of murine zygotes. All together our data indicate that Hsp90b1 is involved in unique and specific aspects of the first mitosis, which brings together the maternal and paternal genomes on a single spindle.	[Audouard, Christophe; Le Masson, Florent; Charry, Colette; Christians, Elisabeth S.] Univ Toulouse 3, Ctr Dev Biol, UPS, UMR 5547, F-31062 Toulouse, France; [Li, Zihai] Med Univ S Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Div Basic Sci, Charleston, SC 29425 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Medical University of South Carolina	Audouard, C (corresponding author), Univ Toulouse 3, Ctr Dev Biol, UPS, UMR 5547, F-31062 Toulouse, France.	Elisabeth.Christians@cict.fr			Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale et de la Recherche; Universite de Toulouse III; Fondation pour la Recherche Medicale (FRM); National Institutes of Health [R01AI070603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale et de la Recherche; Universite de Toulouse III; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work presented in this paper was supported by the Centre National de la Recherche Scientifique (CNRS), the Ministere de l'Education Nationale et de la Recherche (PhD fellowship to FLM), the Universite de Toulouse III (to FLM and ESC), the Fondation pour la Recherche Medicale (FRM) (to ESC), and National Institutes of Health grant R01AI070603 (to ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Bierkamp C, 2010, DEV BIOL, V339, P338, DOI 10.1016/j.ydbio.2009.12.037; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Christians E, 1997, MOL CELL BIOL, V17, P778, DOI 10.1128/MCB.17.2.778; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Duensing A, 2010, ADV EXP MED BIOL, V676, P93; FitzHarris G, 2003, MOL BIOL CELL, V14, P288, DOI 10.1091/mbc.E02-07-0431; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Hartshorn C, 2007, GENE REGUL SYST BIO, V1, P365; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Irelan JT, 2007, P NATL ACAD SCI USA, V104, P16940, DOI 10.1073/pnas.0706493104; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lin XQ, 2007, MOL CELL BIOL, V27, P4905, DOI 10.1128/MCB.02396-06; Mao CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010852; McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; MEZGER V, 1994, DEV BIOL, V165, P627, DOI 10.1006/dbio.1994.1281; MORANGE M, 1984, MOL CELL BIOL, V4, P730, DOI 10.1128/MCB.4.4.730; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; PAVELKA M, 1989, J HISTOCHEM CYTOCHEM, V37, P877, DOI 10.1177/37.6.2542394; Rankin T, 1999, DEVELOPMENT, V126, P3847; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voss AK, 2000, DEVELOPMENT, V127, P1; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069; Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538; Zhang P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-348; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	38	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17109	10.1371/journal.pone.0017109	http://dx.doi.org/10.1371/journal.pone.0017109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21358806	gold, Green Submitted, Green Published			2022-12-25	WOS:000287369200023
J	Verges, A; Vanderklift, MA; Doropoulos, C; Hyndes, GA				Verges, Adriana; Vanderklift, Mathew A.; Doropoulos, Christopher; Hyndes, Glenn A.			Spatial Patterns in Herbivory on a Coral Reef Are Influenced by Structural Complexity but Not by Algal Traits	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SEA-URCHIN; PHASE-SHIFTS; GRAZING OPTIMIZATION; COMMUNITY STRUCTURE; CHEMICAL DEFENSES; FRINGING-REEF; FISHES; PLANT; HETEROGENEITY	Background: Patterns of herbivory can alter the spatial structure of ecosystems, with important consequences for ecosystem functions and biodiversity. While the factors that drive spatial patterns in herbivory in terrestrial systems are well established, comparatively less is known about what influences the distribution of herbivory in coral reefs. Methodology and Principal Findings: We quantified spatial patterns of macroalgal consumption in a cross-section of Ningaloo Reef (Western Australia). We used a combination of descriptive and experimental approaches to assess the influence of multiple macroalgal traits and structural complexity in establishing the observed spatial patterns in macroalgal herbivory, and to identify potential feedback mechanisms between herbivory and macroalgal nutritional quality. Spatial patterns in macroalgal consumption were best explained by differences in structural complexity among habitats. The biomass of herbivorous fish, and rates of herbivory were always greater in the structurally-complex coral-dominated outer reef and reef flat habitats, which were also characterised by high biomass of herbivorous fish, low cover and biomass of macroalgae and the presence of unpalatable algae species. Macroalgal consumption decreased to undetectable levels within 75 m of structurally-complex reef habitat, and algae were most abundant in the structurally-simple lagoon habitats, which were also characterised by the presence of the most palatable algae species. In contrast to terrestrial ecosystems, herbivory patterns were not influenced by the distribution, productivity or nutritional quality of resources (macroalgae), and we found no evidence of a positive feedback between macroalgal consumption and the nitrogen content of algae. Significance: This study highlights the importance of seascape-scale patterns in structural complexity in determining spatial patterns of macroalgal consumption by fish. Given the importance of herbivory in maintaining the ability of coral reefs to reorganise and retain ecosystem functions following disturbance, structural complexity emerges as a critical feature that is essential for the healthy functioning of these ecosystems.	[Verges, Adriana] Univ New S Wales, Sydney Inst Marine Sci & Evolut, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Verges, Adriana] Univ New S Wales, Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Verges, Adriana; Vanderklift, Mathew A.; Hyndes, Glenn A.] Edith Cowan Univ, Sch Nat Sci, Ctr Marine Ecosyst Res, Joondalup, Australia; [Vanderklift, Mathew A.] CSIRO Wealth Oceans Flagship, Wembley, WA, Australia; [Doropoulos, Christopher] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Doropoulos, Christopher] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Edith Cowan University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Queensland	Verges, A (corresponding author), Univ New S Wales, Sydney Inst Marine Sci & Evolut, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	a.verges@unsw.edu.au	Verges, Adriana/B-8288-2013; Hyndes, G.a./AAB-6619-2019; Vanderklift, Mathew A/B-1003-2008; Doropoulos, Christopher/B-7249-2016	Verges, Adriana/0000-0002-3507-1234; Hyndes, G.a./0000-0002-3525-1665; Vanderklift, Mathew A/0000-0002-5170-7546; Doropoulos, Christopher/0000-0001-8038-2771	Western Australian Marine Science Institute (WAMSI)	Western Australian Marine Science Institute (WAMSI)	Funding: This study was funded by the Western Australian Marine Science Institute (WAMSI) under the Ningaloo Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Alcoverro T, 2005, BOT MAR, V48, P1, DOI 10.1515/BOT.2005.010; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; [Anonymous], 2008, PERMANOVA PRIMER; Aragones LV, 2006, OECOLOGIA, V149, P635, DOI 10.1007/s00442-006-0477-1; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 2003, ECOL APPL, V13, P1325, DOI 10.1890/02-5283; Augustine DJ, 2001, ECOLOGY, V82, P3149, DOI 10.1890/0012-9658(2001)082[3149:EOMGOS]2.0.CO;2; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Barile PJ, 2004, J EXP MAR BIOL ECOL, V303, P65, DOI 10.1016/j.jembe.2003.11.004; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bennett S, 2010, CORAL REEFS, V29, P471, DOI 10.1007/s00338-010-0594-5; Bennett S, MAR ECOL PR IN PRESS; Bittick SJ, 2010, MAR BIOL, V157, P317, DOI 10.1007/s00227-009-1319-6; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bolser RC, 1998, J CHEM ECOL, V24, P1639, DOI 10.1023/A:1020816511924; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Choat J.H., 1991, ECOLOGY FISHES CORAL; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COEN LD, 1989, MAR ECOL PROG SER, V54, P287, DOI 10.3354/meps054287; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; COUGHENOUR MB, 1991, J RANGE MANAGE, V44, P530, DOI 10.2307/4003033; De Mazancourt C, 1998, ECOLOGY, V79, P2242, DOI 10.1890/0012-9658(1998)079[2242:GOANCW]2.0.CO;2; Diaz-Pulido G, 2003, ECOLOGY, V84, P2026, DOI 10.1890/01-3127; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Fong P, 1997, J PHYCOL, V33, P353, DOI 10.1111/j.0022-3646.1997.00353.x; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Gorley RN, 2006, PRIMER V6; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; Hay M, 1992, HERBIVORES THEIR INT; Hay M.E., 1991, P96; HAY ME, 1981, AM NAT, V118, P520, DOI 10.1086/283845; HAY ME, 1983, OECOLOGIA, V58, P299, DOI 10.1007/BF00385227; HAY ME, 1981, AQUAT BOT, V11, P97, DOI 10.1016/0304-3770(81)90051-6; HAY ME, 1984, OECOLOGIA, V64, P396, DOI 10.1007/BF00379139; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hoey AS, 2010, MAR ECOL PROG SER, V411, P299, DOI 10.3354/meps08660; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hulme PE, 1996, J ECOL, V84, P609, DOI 10.2307/2261482; HUNTLY N, 1988, BIOSCIENCE, V38, P786, DOI 10.2307/1310788; Jones GP, 1998, AUST J ECOL, V23, P287, DOI 10.1111/j.1442-9993.1998.tb00733.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; LEWIS SM, 1985, OECOLOGIA, V65, P370, DOI 10.1007/BF00378911; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; McClanahan TR, 2001, CORAL REEFS, V19, P380, DOI 10.1007/s003380000133; MCCLANAHAN TR, 1994, J EXP MAR BIOL ECOL, V184, P237, DOI 10.1016/0022-0981(94)90007-8; McClanahan TR, 1999, ECOSYSTEMS, V2, P511, DOI 10.1007/s100219900099; McCook LJ, 1997, MAR BIOL, V129, P713, DOI 10.1007/s002270050214; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Munday PL, P NATL ACAD SCI US, V107, P12930; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; PASTOR J, 1993, ECOLOGY, V74, P467, DOI 10.2307/1939308; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; PICKETT STA, 1995, SCIENCE, V269, P331, DOI 10.1126/science.269.5222.331; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2009, R FDN STAT COMP; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; RUSS G, 1984, MAR ECOL PROG SER, V20, P35, DOI 10.3354/meps020035; Russ GR, 2003, CORAL REEFS, V22, P63, DOI 10.1007/s00338-003-0286-5; STEINBERG PD, 1990, MAR ECOL PROG SER, V58, P253; Stimson J, 2001, CORAL REEFS, V19, P343, DOI 10.1007/s003380000123; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Valentine JF, 2008, ECOL APPL, V18, P1501, DOI 10.1890/07-1720.1; Van Alstyne KL, 2009, J EXP MAR BIOL ECOL, V379, P85, DOI 10.1016/j.jembe.2009.08.002; Vanderklift MA, 2007, MAR ECOL PROG SER, V340, P235, DOI 10.3354/meps340235; Verges A, 2008, OECOLOGIA, V155, P751, DOI 10.1007/s00442-007-0943-4; Verges A, 2009, MAR ECOL PROG SER, V375, P1, DOI 10.3354/meps07778; VONWESTERNHAGEN H, 1974, AQUACULTURE, V3, P109, DOI 10.1016/0044-8486(74)90106-9; Westera, 2003, EFFECT RECREATIONAL; WILKINSON CR, 1983, MAR ECOL PROG SER, V13, P15, DOI 10.3354/meps013015; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; ZIEMAN JC, 1984, MAR ECOL PROG SER, V15, P151, DOI 10.3354/meps015151	96	71	71	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17115	10.1371/journal.pone.0017115	http://dx.doi.org/10.1371/journal.pone.0017115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347254	Green Published, gold			2022-12-25	WOS:000287364500029
J	Sabatel, C; Malvaux, L; Bovy, N; Deroanne, C; Lambert, V; Gonzalez, MLA; Colige, A; Rakic, JM; Noel, A; Martial, JA; Struman, I				Sabatel, Celine; Malvaux, Ludovic; Bovy, Nicolas; Deroanne, Christophe; Lambert, Vincent; Gonzalez, Maria-Luz Alvarez; Colige, Alain; Rakic, Jean-Marie; Noel, Agnes; Martial, Joseph A.; Struman, Ingrid			MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells	PLOS ONE			English	Article							ANTI-ANGIOGENIC THERAPY; HUMAN BREAST-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; VASCULAR INTEGRITY; LUNG-CANCER; OVEREXPRESSION; MIR-21; METASTASIS; INVASION	Background: MicroRNAs (miRNAs) are endogenously expressed small non-coding RNAs that regulate gene expression at post-transcriptional level. The recent discovery of the involvement of these RNAs in the control of angiogenesis renders them very attractive in the development of new approaches for restoring the angiogenic balance. Whereas miRNA-21 has been demonstrated to be highly expressed in endothelial cells, the potential function of this miRNA in angiogenesis has never been investigated. Methodology/Principal Findings: We first observed in endothelial cells a negative regulation of miR-21 expression by serum and bFGF, two pro-angiogenic factors. Then using in vitro angiogenic assays, we observed that miR-21 acts as a negative modulator of angiogenesis. miR-21 overexpression reduced endothelial cell proliferation, migration and the ability of these cells to form tubes whereas miR-21 inhibition using a LNA-anti-miR led to opposite effects. Expression of miR-21 in endothelial cells also led to a reduction in the organization of actin into stress fibers, which may explain the decrease in cell migration. Further mechanistic studies showed that miR-21 targets RhoB, as revealed by a decrease in RhoB expression and activity in miR-21 overexpressing cells. RhoB silencing impairs endothelial cell migration and tubulogenesis, thus providing a possible mechanism for miR-21 to inhibit angiogenesis. Finally, the therapeutic potential of miR-21 as an angiogenesis inhibitor was demonstrated in vivo in a mouse model of choroidal neovascularization. Conclusions/Significance: Our results identify miR-21 as a new angiogenesis inhibitor and suggest that inhibition of cell migration and tubulogenesis is mediated through repression of RhoB.	[Sabatel, Celine; Malvaux, Ludovic; Bovy, Nicolas; Martial, Joseph A.; Struman, Ingrid] Univ Liege, GIGA Res, Unit Mol Biol & Genet Engn, Liege, Belgium; [Deroanne, Christophe; Colige, Alain] Univ Liege, GIGA Res, Lab Connect Tissues, Liege, Belgium; [Lambert, Vincent; Gonzalez, Maria-Luz Alvarez; Noel, Agnes] Univ Liege, GIGA Res, Lab Tumor & Dev Biol, Liege, Belgium; [Lambert, Vincent; Rakic, Jean-Marie] Univ Hosp, Dept Ophthalmol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Sabatel, C (corresponding author), Univ Liege, GIGA Res, Unit Mol Biol & Genet Engn, Liege, Belgium.	I.Struman@ulg.ac.be		struman, ingrid/0000-0003-2550-3707; Noel, Agnes/0000-0002-7670-6179	FRIA (Fonds pour la Recherche industrielle et agricole); FNRS (Fond national de la recherche scientifique); Televie; Fonds Leon Fredericq; ULg (Mirage program); FP7-HEALTH-2007-A [201279]; Belgian Science Policy (Brussels, Belgium); Neoangio Program of the Walloon Region	FRIA (Fonds pour la Recherche industrielle et agricole)(Fonds de la Recherche Scientifique - FNRS); FNRS (Fond national de la recherche scientifique)(Fonds de la Recherche Scientifique - FNRS); Televie; Fonds Leon Fredericq; ULg (Mirage program); FP7-HEALTH-2007-A; Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); Neoangio Program of the Walloon Region	This study was supported by the FRIA (Fonds pour la Recherche industrielle et agricole), FNRS (Fond national de la recherche scientifique), Televie, le Fonds Leon Fredericq, ULg (Mirage program), FP7-HEALTH-2007-A, proposal No. 201279 "MICROENVIMET", the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium) and by the Neoangio Program of the Walloon Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Aepfelbacher M, 1997, ARTERIOSCL THROM VAS, V17, P1623, DOI 10.1161/01.ATV.17.9.1623; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Connolly EC, 2010, MOL CANCER RES, V8, P691, DOI 10.1158/1541-7786.MCR-09-0465; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; GORDON SR, 1982, CELL MOTIL CYTOSKEL, V2, P343, DOI 10.1002/cm.970020404; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lambert V, 2001, FASEB J, V15, P1021, DOI 10.1096/fj.00-0393com; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; MORIYAMA T, 2009, MOL CANC THER; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Noel A, 2007, TRENDS MOL MED, V13, P345, DOI 10.1016/j.molmed.2007.06.005; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Veeranna, 1998, J NEUROSCI, V18, P4008; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhang CX, 2010, J CARDIOVASC TRANSL, V3, P235, DOI 10.1007/s12265-010-9164-z; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	49	189	202	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16979	10.1371/journal.pone.0016979	http://dx.doi.org/10.1371/journal.pone.0016979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347332	Green Published, Green Submitted, gold			2022-12-25	WOS:000287363000027
J	Reveillaud, J; van Soest, R; Derycke, S; Picton, B; Rigaux, A; Vanreusel, A				Reveillaud, Julie; van Soest, Rob; Derycke, Sofie; Picton, Bernard; Rigaux, Annelien; Vanreusel, Ann			Phylogenetic Relationships among NE Atlantic Plocamionida Topsent (1927) (Porifera, Poecilosclerida): Under-Estimated Diversity in Reef Ecosystems	PLOS ONE			English	Article							BATHYAL CORAL-REEFS; OXIDASE SUBUNIT-I; INTEGRATIVE TAXONOMY; NORTHEAST ATLANTIC; SPONGE; MITOCHONDRIAL; DEEP; DNA; DEMOSPONGIAE; BANK	Background: Small and cryptic sponges associated with cold-water coral reefs are particularly numerous and challenging to identify, but their ecological and biochemical importance is likely to compete with megabenthic specimens. Methodology/Principal Findings: Here we use a combination of the standard M1M6 and I3M11 partitions of the COI fragment, partial rDNA 28S sequences and morphology to delineate small encrusting Plocamionida species. In total, 46 specimens were retrieved from seven shallow to deep-water coral locations, crossing 3,000 km along the European margins. Our work provides evidence that the Plocamionida ambigua f. tylotata and f. grandichelata can be considered valid species, whereas Plocamionida ambigua f. tornata corresponds to the species P. ambigua. Within the monophyletic group of Plocamionida, P. microcionides is shown as really divergent from the other taxa, and four putative new Plocamionida species are suggested. Conclusions/Significance: This study shows that the use of molecular and morphological information in an integrative approach is a powerful tool for the identification of sponge species, and suggests that an under-estimated biodiversity of sponges occurs in cold-water coral reefs.	[Reveillaud, Julie; Derycke, Sofie; Rigaux, Annelien; Vanreusel, Ann] Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium; [Reveillaud, Julie; Derycke, Sofie; Rigaux, Annelien; Vanreusel, Ann] Ctr Mol Phylogeny & Evolut, CeMoFE, Ghent, Belgium; [van Soest, Rob] Univ Amsterdam ZMA, Zool Museum, Amsterdam, Netherlands; [Picton, Bernard] Natl Museums No Ireland, Dept Nat Sci, Holywood, North Ireland	Ghent University	Reveillaud, J (corresponding author), Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium.	julie.reveillaud@ugent.be	Picton, Bernard/K-2482-2019	Picton, Bernard/0000-0002-1500-2215	European Community Research Infrastructure Action; European Community [FP7/2007-2013, 226354]; Ghent University; European Science Foundation [813.03.006/855.01.040]; Netherlands Organisation for Scientific Research [814.01.005/835.20.024]	European Community Research Infrastructure Action(European Commission); European Community(European Commission); Ghent University(Ghent University); European Science Foundation(European Science Foundation (ESF)European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The support of a SYNTHESYS Grant financed by European Community Research Infrastructure Action under the FP6 "Structuring the European Research Area" Program to visit to the Zoological Museum in Amsterdam (JR) is acknowledged. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the HERMIONE project, grant 517 agreement no 226354. JR had a Special Research Fund (BOF) from Ghent University. The study benefited from funding by the EUROMARGIN Programme of the European Science Foundation (Moundforce 2004 Project, 813.03.006/855.01.040) and the Netherlands Organisation for Scientific Research (BIOSYS project 814.01.005/835.20.024) to support sponge material collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alander H., 1942, THESIS U LUND H STRU, P1; Barthel D., 1991, P387; Blanquer A, 2007, MOL PHYLOGENET EVOL, V45, P392, DOI 10.1016/j.ympev.2007.03.004; Boury-Esnault Nicole, 1994, Memoires du Museum National d'Histoire Naturelle, V160, P1; Bowerbank JS., 1866, MONOGRAPH BRIT SPONG, VII; BRONDSTED HV, 1932, ZOOLOGY FAROES, V1, P1; Carter H.J., 1876, ANN MAGAZINE NATURAL, V18, P458, DOI DOI 10.1080/00222937608682035; Carter H.J, 1876, ANN MAGAZINE NATURAL, V18, p[105, 307], DOI [10.1080/00222937608682078, DOI 10.1080/00222937608682035]; Carter H.J., 1876, ANN MAGAZINE NATURAL, V18, P307, DOI DOI 10.1080/00222937608682035; Carter HJ, 1876, J NAT HIST, V18, P226, DOI [10.1080/00222937608682035, DOI 10.1080/00222937608682035]; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Faulkner DJ, 2000, NAT PROD REP, V17, P1, DOI 10.1039/a909113k; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Hilario A, 2010, DEEP-SEA RES PT I, V57, P143, DOI 10.1016/j.dsr.2009.10.004; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Klitgaard AB, 2004, PROG OCEANOGR, V61, P57, DOI 10.1016/j.pocean.2004.06.002; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Longo C, 2005, J MAR BIOL ASSOC UK, V85, P1341, DOI 10.1017/S0025315405012518; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; McCormack GP, 2002, J NAT HIST, V36, P1009, DOI 10.1080/00222930110040394; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; NYLANDER JAA, 2002, MRMODELTEST V 1 0 PR; Picton BE, 2007, J MAR BIOL ASSOC UK, V87, P1441, DOI 10.1017/S0025315407058122; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; RICE AL, 1990, PROG OCEANOGR, V24, P179, DOI 10.1016/0079-6611(90)90029-2; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROT C, 2006, BMC EVOLUTIONARY BIO; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; STEPHENS J, 1921, SCI INVESTIGATIONS F, P1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Topsent E., 1928, Resultats des Campagnes Scientifiques Albert I de Monaco Fasc, V74, P1; Vacelet J., 1969, Memoires du Museum Nationale d'Histoire Naturelle Paris (Ser A), V59, P145; van Soest RWM, 2007, CONTRIB ZOOL, V76, P121, DOI 10.1163/18759866-07602005; Van Soest RWM, 2005, MAR BIOL RES, V1, P338, DOI 10.1080/17451000500380322; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Wulff JL, 2006, BIOL BULL-US, V211, P83, DOI 10.2307/4134581; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004	49	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16533	10.1371/journal.pone.0016533	http://dx.doi.org/10.1371/journal.pone.0016533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347368	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700019
J	Thurber, AE; Douglas, G; Sturm, EC; Zabierowski, SE; Smit, DJ; Ramakrishnan, SN; Hacker, E; Leonard, JH; Herlyn, M; Sturm, RA				Thurber, A. E.; Douglas, G.; Sturm, E. C.; Zabierowski, S. E.; Smit, D. J.; Ramakrishnan, S. N.; Hacker, E.; Leonard, J. H.; Herlyn, M.; Sturm, R. A.			Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway	ONCOGENE			English	Article						cell adhesion; invasion; melanoma; metastasis; NOTCH; transcription factor	EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN MELANOCYTES; STEM-CELLS; IN-VITRO; PHENOTYPE; GENE; SUBPOPULATION; SIGNATURE; REVEALS; PROGRAM	The use of adherent monolayer cultures have produced many insights into melanoma cell growth and differentiation, but often novel therapeutics demonstrated to act on these cells are not active in vivo. It is imperative that new methods of growing melanoma cells that reflect growth in vivo are investigated. To this end, a range of human melanoma cell lines passaged as adherent cultures or induced to form melanoma spheres (melanospheres) in stem cell media have been studied to compare cellular characteristics and protein expression. Melanoma spheres and tumours grown from cell lines as mouse xenografts had increased heterogeneity when compared with adherent cells and 3D-spheroids in agar (aggregates). Furthermore, cells within the melanoma spheres and mouse xenografts each displayed a high level of reciprocal BRN2 or MITF expression, which matched more closely the pattern seen in human melanoma tumours in situ, rather than the propensity for co-expression of these important melanocytic transcription factors seen in adherent cells and 3D-spheroids. Notably, when the levels of the BRN2 and MITF proteins were each independently repressed using siRNA treatment of adherent melanoma cells, members of the NOTCH pathway responded by decreasing or increasing expression, respectively. This links BRN2 as an activator, and conversely, MITF as a repressor of the NOTCH pathway in melanoma cells. Loss of the BRN2-MITF axis in antisense-ablated cell lines decreased the melanoma sphere-forming capability, cell adhesion during 3D-spheroid formation and invasion through a collagen matrix. Combined, this evidence suggests that the melanoma sphere-culture system induces subpopulations of cells that may more accurately portray the in vivo disease, than the growth as adherent melanoma cells. Oncogene (2011) 30, 3036-3048; doi: 10.1038/onc.2011.33; published online 28 February 2011	[Thurber, A. E.; Douglas, G.; Sturm, E. C.; Smit, D. J.; Ramakrishnan, S. N.; Sturm, R. A.] Univ Queensland, Inst Mol Biosci, Melanogenix Grp, Brisbane, Qld 4072, Australia; [Zabierowski, S. E.; Herlyn, M.; Sturm, R. A.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Hacker, E.; Leonard, J. H.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; The Wistar Institute; QIMR Berghofer Medical Research Institute	Sturm, RA (corresponding author), Univ Queensland, Inst Mol Biosci, Melanogenix Grp, 306 Carmody Rd, Brisbane, Qld 4072, Australia.	R.Sturm@imb.uq.edu.au	Hacker, Elke/J-1265-2012; Sturm, Richard A/C-9943-2009; Leonard, Helen/F-2022-2013	Hacker, Elke/0000-0003-2759-8244; Sturm, Richard A/0000-0003-1301-0294; SMIT, Darren/0000-0002-3288-3659	University of Queensland; Cancer Council Queensland; NIH [CA-25874]; NATIONAL CANCER INSTITUTE [P01CA025874] Funding Source: NIH RePORTER	University of Queensland(University of Queensland); Cancer Council Queensland(Cancer Council Queensland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Professor N Hayward (QIMR) for providing some of the cell lines that were tested for melanoma sphere formation as part of this manuscript. RAS is a Senior Research Fellow of the Australian NHMRC, and in conducting part of this work, was supported by an SSP award from the University of Queensland. This work was supported by grants from the Cancer Council Queensland to RAS and JHL and NIH grant CA-25874 to MH.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; ANGUS J, 1995, ONCOGENE, V11, P691; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Cook AL, 2005, EXP CELL RES, V308, P222, DOI 10.1016/j.yexcr.2005.04.019; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Cook AL, 2008, PIGM CELL MELANOMA R, V21, P611, DOI 10.1111/j.1755-148X.2008.00510.x; Cook AL, 2006, FROM MELANOCYTES TO MELANOMA: THE PROGRESSION TO MALIGNANCY, P149, DOI 10.1007/978-1-59259-994-3_8; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mouriaux F, 2003, EXP EYE RES, V76, P653, DOI 10.1016/S0014-4835(03)00082-4; Na YR, 2009, TUMOR BIOL, V30, P300, DOI 10.1159/000261073; Na YR, 2009, CANCER SCI, V100, P1429, DOI 10.1111/j.1349-7006.2009.01218.x; Newton RA, 2007, J INVEST DERMATOL, V127, P2216, DOI 10.1038/sj.jid.5700840; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Pinnix CC, 2007, PIGM CELL RES, V20, P458, DOI 10.1111/j.1600-0749.2007.00410.x; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Richmond-Sinclair NM, 2008, MELANOMA RES, V18, P336, DOI 10.1097/CMR.0b013e32830d8329; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smit DJ, 2007, INT J CANCER, V121, P2653, DOI 10.1002/ijc.23039; Smith AG, 1998, MELANOMA RES, V8, P2, DOI 10.1097/00008390-199802000-00002	36	67	68	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	27					3036	3048		10.1038/onc.2011.33	http://dx.doi.org/10.1038/onc.2011.33			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	789IW	21358674	Green Submitted, Green Accepted			2022-12-25	WOS:000292510100004
J	Shin, MK; Jang, YH; Yoo, HJ; Kang, DW; Park, MH; Kim, MK; Song, JH; Kim, SD; Min, G; You, HK; Choi, KY; Bae, YS; Min, DS				Shin, Min Kyoung; Jang, Young Hoon; Yoo, Hyun Jung; Kang, Dong Woo; Park, Mi Hee; Kim, Mi Kyoung; Song, Ju Hyun; Kim, Sang Doo; Min, Gyesik; You, Hyung Keun; Choi, Kang-Yell; Bae, Yoe-Sik; Min, Do Sik			N-Formyl-Methionyl-Leucyl-Phenylalanine (fMLP) Promotes Osteoblast Differentiation via the N-Formyl Peptide Receptor 1-mediated Signaling Pathway in Human Mesenchymal Stem Cells from Bone Marrow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D; CYCLOSPORINE-H; PROTEIN-KINASE; STROMAL CELLS; EXPRESSION; OSTEOPOROSIS; NEUTROPHILS; FRACTURES; ZEBRAFISH; ANNEXIN-1	Binding of N-formyl-methionyl-leucyl-phenylalanine (fMLP) to its specific cell surface receptor, N-formyl peptide receptor (FPR), triggers different cascades of biochemical events, eventually leading to cellular activation. However, the physiological role of fMLP and FPR during differentiation of mesenchymal stem cells is unknown. In this study, we attempted to determine whether fMLP regulates differentiation of mesenchymal stem cells derived from bone marrow. Analysis by quantitative-PCR and flow cytometry showed significantly increased expression of FPR1, but not FPR2 and FPR3, during osteoblastic differentiation. fMLP, a specific ligand of FPR1, promotes osteoblastic commitment and suppresses adipogenic commitment under differentiation conditions. Remarkably, fMLP-stimulated osteogenesis is associated with increased expression of osteogenic markers and mineralization, which were blocked by cyclosporine H, a selective FPR1 antagonist. In addition, fMLP inhibited expression of peroxisome proliferator-activated receptor-gamma 1, a major regulator of adipocytic differentiation. fMLP-stimulated osteogenic differentiation was mediated via FPR1-phospholipase C/phospholipase D-Ca2+-calmodulin-dependent kinase II-ERK-CREB signaling pathways. Finally, fMLP promoted bone formation in zebrafish and rabbits, suggesting its physiological relevance in vivo. Collectively, our findings provide novel insight into the functional role of fMLP in bone biology, with important implications for its potential use as a therapeutic agent for treatment of bone-related disorders.	[Shin, Min Kyoung; Jang, Young Hoon; Yoo, Hyun Jung; Kang, Dong Woo; Park, Mi Hee; Kim, Mi Kyoung; Song, Ju Hyun; Min, Do Sik] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan 609735, South Korea; [Kim, Sang Doo; Bae, Yoe-Sik] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Min, Gyesik] Gyeongnam Natl Univ Sci & Technol, Dept Pharmaceut Engn, Jinju 660758, South Korea; [You, Hyung Keun] Wonkwang Univ, Coll Dent, Dept Periodontol, Iksan 570740, South Korea; [Choi, Kang-Yell; Min, Do Sik] Yonsei Univ, Translat Res Ctr Prot Funct Control, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Choi, Kang-Yell; Min, Do Sik] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Pusan National University; Sungkyunkwan University (SKKU); Gyeongnam National University of Science and Technology; Wonkwang University; Yonsei University; Yonsei University	Min, DS (corresponding author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, 30 Jangjeon Dong, Pusan 609735, South Korea.	minds@pusan.ac.kr		Jang, Younghoon/0000-0002-5705-4945	Korean Government; Translational Research Center for Protein Function Control, South Korea [NSF 2009-0092960]; PNU Tenure-track Faculty	Korean Government(Korean Government); Translational Research Center for Protein Function Control, South Korea; PNU Tenure-track Faculty	This work was supported by National Research Foundation Grant KRF-2008-313-C00698 funded by the Korean Government, Translational Research Center for Protein Function Control Grant NSF 2009-0092960, South Korea, and by Financial Supporting Project of Long Term Overseas Dispatch of the PNU Tenure-track Faculty, 2009.	CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Chan GK, 2002, GERONTOLOGY, V48, P62, DOI 10.1159/000048929; CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Fulfaro F, 1998, PAIN, V78, P157, DOI 10.1016/S0304-3959(98)00135-3; Gangji V, 1999, CLIN RHEUMATOL, V18, P266, DOI 10.1007/s100670050099; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Johnson EE, 2000, CLIN ORTHOP RELAT R, P61, DOI 10.1097/00003086-200002000-00008; Kim MK, 2007, FEBS LETT, V581, P1917, DOI 10.1016/j.febslet.2007.03.078; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Min DS, 2001, NEUROPHARMACOLOGY, V41, P384, DOI 10.1016/S0028-3908(01)00070-3; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; NOVIKOFF AB, 1980, J CELL BIOL, V87, P180, DOI 10.1083/jcb.87.1.180; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; PEREZALBUERNE ED, 1993, P NATL ACAD SCI USA, V90, P11960, DOI 10.1073/pnas.90.24.11960; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; RIGGS BL, 1992, NEW ENGL J MED, V327, P620; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Viswanathan A, 2007, STEM CELLS, V25, P1263, DOI 10.1634/stemcells.2006-0522; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; WENZELSEIFERT K, 1991, J IMMUNOL, V147, P1940; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681	42	28	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17133	17143		10.1074/jbc.M110.197772	http://dx.doi.org/10.1074/jbc.M110.197772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21372136	hybrid, Green Published			2022-12-25	WOS:000290301900063
J	Song, DS; Lee, FS				Song, Daisheng; Lee, Frank S.			Mouse Knock-out of IOP1 Protein Reveals Its Essential Role in Mammalian Cytosolic Iron-Sulfur Protein Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; SIGNALING PATHWAYS; HOMEOSTASIS; MECHANISMS; CELLS; DEGRADATION; MATURATION; APOPTOSIS; AUTOPHAGY; COMPONENT	Iron-sulfur proteins play an essential role in a variety of biologic processes and exist in multiple cellular compartments. The biogenesis of these proteins has been the subject of extensive investigation, and particular focus has been placed on the pathways that assemble iron-sulfur clusters in the different cellular compartments. Iron-only hydrogenase-like protein 1 (IOP1; also known as nuclear prelamin A recognition factor like protein, or NARFL) is a human protein that is homologous to Nar1, a protein in Saccharomyces cerevisiae that, in turn, is an essential component of the cytosolic iron-sulfur protein assembly pathway in yeast. Previous siRNA-induced knockdown studies using mammalian cells point to a similar role for IOP1 in mammals. In the present studies, we pursued this further by knocking out Iop1 in Mus musculus. We find that Iop1 knock-out results in embryonic lethality before embryonic day 10.5. Acute, inducible global knock-out of Iop1 in adult mice results in lethality and significantly diminished activity of cytosolic aconitase, an iron-sulfur protein, in liver extracts. Inducible knock-out of Iop1 in mouse embryonic fibroblasts results in diminished activity of cytosolic but not mitochondrial aconitase and loss of cell viability. Therefore, just as with knock-out of Nar1 in yeast, we find that knock-out of Iop1/Narfl in mice results in lethality and defective cytosolic iron-sulfur cluster assembly. The findings demonstrate an essential role for IOP1 in this pathway.	[Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, Philadelphia, PA 19104 USA	University of Pennsylvania	Lee, FS (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu		Lee, Frank/0000-0003-2511-1834	National Institutes of Health [R01-GM71459]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM71459 (to F. S. L.).	Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Li XP, 2010, BLOOD CELL MOL DIS, V45, P9, DOI 10.1016/j.bcmd.2010.03.003; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Thomson AM, 2000, J BIOL CHEM, V275, P31609, DOI 10.1074/jbc.M002354200; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; XU J, 2005, CURRENT PROTOCOLS MO; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	43	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201731	http://dx.doi.org/10.1074/jbc.M110.201731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21367862	Green Published, hybrid			2022-12-25	WOS:000290022800020
J	Ogwang, S; Nguyen, HT; Sherman, M; Bajaksouzian, S; Jacobs, MR; Boom, WH; Zhang, GF; Nguyen, L				Ogwang, Sam; Nguyen, Hoa T.; Sherman, Marissa; Bajaksouzian, Saralee; Jacobs, Michael R.; Boom, W. Henry; Zhang, Guo-Fang; Nguyen, Liem			Bacterial Conversion of Folinic Acid Is Required for Antifolate Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOPPORTUNISTIC INFECTION AGENTS; ESCHERICHIA-COLI; METHENYLTETRAHYDROFOLATE SYNTHETASE; MYCOBACTERIUM-TUBERCULOSIS; 5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE; 5-FORMYLTETRAHYDROFOLATE CYCLOLIGASE; SERINE HYDROXYMETHYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; FOLATE HOMEOSTASIS	Antifolates, which are among the first antimicrobial agents invented, inhibit cell growth by creating an intracellular state of folate deficiency. Clinical resistance to antifolates has been mainly attributed to mutations that alter structure or expression of enzymes involved in de novo folate synthesis. We identified a Mycobacterium smegmatis mutant, named FUEL (which stands for folate utilization enzyme for leucovorin), that is hypersusceptible to antifolates. Chemical complementation indicated that FUEL is unable to metabolize folinic acid (also known as leucovorin or 5-formyltetrahydrofolate), whose metabolic function remains unknown. Targeted mutagenesis, genetic complementation, and biochemical studies showed that FUEL lacks 5,10-methenyltetrahydrofolate synthase (MTHFS; also called 5-formyltetrahydrofolate cyclo-ligase; EC 6.3.3.2) activity responsible for the only ATP-dependent, irreversible conversion of folinic acid to 5,10-methenyltetrahydrofolate. In trans expression of active MTHFS proteins from bacteria or human restored both antifolate resistance and folinic acid utilization to FUEL. Absence of MTHFS resulted in marked cellular accumulation of polyglutamylated species of folinic acid. Importantly, MTHFS also affected M. smegmatis utilization of monoglutamylated 5-methyltetrahydrofolate exogenously added to the medium. Likewise, Escherichia coli mutants lacking MTHFS became susceptible to antifolates. These results indicate that folinic acid conversion by MTHFS is required for bacterial intrinsic antifolate resistance and folate homeostatic control. This novel mechanism of antimicrobial antifolate resistance might be targeted to sensitize bacterial pathogens to classical antifolates.	[Ogwang, Sam; Nguyen, Hoa T.; Sherman, Marissa; Nguyen, Liem] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bajaksouzian, Saralee; Jacobs, Michael R.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Boom, W. Henry] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Zhang, Guo-Fang] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Nguyen, L (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, W222,10900 Euclid Ave, Cleveland, OH 44106 USA.	liem.nguyen@case.edu		Nguyen, Liem/0000-0002-1523-1472	National Institutes of Health [R01AI087903]; Case/University Hospital Center for AIDS Research; AIDS International Training Hospital; Fogarty Center [TW000011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case/University Hospital Center for AIDS Research; AIDS International Training Hospital; Fogarty Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI087903 (to L. N.). This work was also supported by a Center for AIDS Research developmental award from the Case/University Hospital Center for AIDS Research (to L. N.).; Supported by the AIDS International Training Hospital Research Program, Fogarty Center Grant TW000011 at Case Western Reserve University. Present address: Joint Clinical Research Centre, Makerere University, Kampala, Uganda.	Akhtar TA, 2010, PLANT J, V64, P256, DOI 10.1111/j.1365-313X.2010.04330.x; Anguera MC, 2004, PROTEIN EXPRES PURIF, V35, P276, DOI 10.1016/j.pep.2004.02.010; Anguera MC, 2003, J BIOL CHEM, V278, P29856, DOI 10.1074/jbc.M302883200; Argyrou A, 2006, NAT STRUCT MOL BIOL, V13, P408, DOI 10.1038/nsmb1089; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Bertino JR, 1971, FOLATE ANTAGONISTS C; Blakley R.L., 1969, N HOLLAND RES MONOGR, P1; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Date AA, 2010, B WORLD HEALTH ORGAN, V88, P253, DOI 10.2471/BLT.09.066522; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAYAN A, 1995, GENE, V165, P307, DOI 10.1016/0378-1119(95)00321-V; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; DOULL J A, 1963, Int J Lepr, V31, P143; FASS RJ, 1979, ANTIMICROB AGENTS CH, V16, P622, DOI 10.1128/AAC.16.5.622; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Gangjee A, 2007, ANTI-CANCER AGENT ME, V7, P524, DOI 10.2174/187152007781668724; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; Gorlick R, 1996, NEW ENGL J MED, V335, P1041, DOI 10.1056/NEJM199610033351408; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; Green J. C., 1996, ESCHERICHIA COLI SAL, P665; Grim SA, 2005, PHARMACOTHERAPY, V25, P253, DOI 10.1592/phco.25.2.253.56956; HAMMES W, 1973, J BACTERIOL, V116, P1029, DOI 10.1128/JB.116.2.1029-1053.1973; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Holmes WB, 2002, J BIOL CHEM, V277, P20205, DOI 10.1074/jbc.M201242200; Jeanguenin L, 2010, J BIOL CHEM, V285, P41557, DOI 10.1074/jbc.M110.190504; Johnson JE, 2004, J BACTERIOL, V186, P2418, DOI 10.1128/JB.186.8.2418-2429.2004; Jolivet, 1996, Oncologist, V1, P248; Kamen B, 1997, SEMIN ONCOL, V24, P30; KLOPMAN G, 1993, ANTIMICROB AGENTS CH, V37, P1799, DOI 10.1128/AAC.37.9.1799; KRUSCHWITZ HL, 1994, J BIOL CHEM, V269, P28757; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Libecco JA, 2004, PEDIATR REV, V25, P375; Mwenya DM, 2010, ANTIMICROB AGENTS CH, V54, P3756, DOI 10.1128/AAC.01409-09; *NAT COMM CLIN LAB, 2003, M24A NAT COMM CLIN L, V23; Nguyen HT, 2010, J UROLOGY, V184, P305, DOI 10.1016/j.juro.2010.03.084; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Nguyen L, 2007, J BACTERIOL, V189, P7896, DOI 10.1128/JB.00726-07; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Ong W, 2010, ANTIMICROB AGENTS CH, V54, P2748, DOI 10.1128/AAC.00029-10; Proctor RA, 2008, CLIN INFECT DIS, V46, P584, DOI 10.1086/525536; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; Roje S, 2002, J BIOL CHEM, V277, P42748, DOI 10.1074/jbc.M205632200; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; SAUER H, 1977, BRIT J HAEMATOL, V36, P189, DOI 10.1111/j.1365-2141.1977.tb00639.x; Sedlaczek L, 1999, APPL MICROBIOL BIOT, V52, P563, DOI 10.1007/s002530051561; SHIN YS, 1975, CAN J BIOCHEM CELL B, V53, P338, DOI 10.1139/o75-047; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; STOVER P, 1990, J BIOL CHEM, V265, P14227; STOVER P, 1991, J BIOL CHEM, V266, P1543; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; Waites KB, 1998, J CLIN MICROBIOL, V36, P2052, DOI 10.1128/JCM.36.7.2052-2056.1998; WASHINGTON JA, 1972, APPL MICROBIOL, V24, P1013, DOI 10.1128/AEM.24.6.1013-1013.1972; Wolff KA, 2009, ANTIMICROB AGENTS CH, V53, P3515, DOI 10.1128/AAC.00012-09; Wright GD, 2000, CHEM BIOL, V7, pR127, DOI 10.1016/S1074-5521(00)00126-5; Wright GD, 2007, TRENDS MOL MED, V13, P260, DOI 10.1016/j.molmed.2007.04.004; Wu D, 2009, CANCER RES, V69, P7294, DOI 10.1158/0008-5472.CAN-09-1927; Young LS, 2009, ANTIMICROB AGENTS CH, V53, P4577, DOI 10.1128/AAC.00887-09; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang GF, 2005, J CHROMATOGR A, V1078, P59, DOI 10.1016/j.chroma.2005.04.085	64	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15377	15390		10.1074/jbc.M111.231076	http://dx.doi.org/10.1074/jbc.M111.231076			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372133	Green Published, hybrid			2022-12-25	WOS:000289788300068
J	Lu, SP; Lin, SJ				Lu, Shu-Ping; Lin, Su-Ju			Phosphate-responsive Signaling Pathway Is a Novel Component of NAD(+) Metabolism in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS; NICOTINAMIDE ADENINE-DINUCLEOTIDE; FUNCTIONAL-CHARACTERIZATION; CALORIE RESTRICTION; DIPHOSPHOPYRIDINE NUCLEOTIDE; ALKALINE-PHOSPHATASE; INORGANIC-PHOSPHATE; GENE DELETION; BIOSYNTHESIS	Nicotinamide adenine dinucleotide (NAD(+)) is an essential cofactor involved in various cellular biochemical reactions. To date the signaling pathways that regulate NAD(+) metabolism remain unclear due to the dynamic nature and complexity of the NAD(+) metabolic pathways and the difficulty of determining the levels of the interconvertible pyridine nucleotides. Nicotinamide riboside (NmR) is a key pyridine metabolite that is excreted and re-assimilated by yeast and plays important roles in the maintenance of NAD(+) pool. In this study we establish a NmR-specific reporter system and use it to identify yeast mutants with altered NmR/NAD(+) metabolism. We show that the phosphate-responsive signaling (PHO) pathway contributes to control NAD(+) metabolism. Yeast strains with activated PHO pathway show increases in both the release rate and internal concentration of NmR. We further identify Pho8, a PHO-regulated vacuolar phosphatase, as a potential NmR production factor. We also demonstrate that Fun26, a homolog of human ENT (equilibrative nucleoside transporter), localizes to the vacuolar membrane and establishes the size of the vacuolar and cytosolic NmR pools. In addition, the PHO pathway responds to depletion of cellular nicotinic acid mononucleotide (NaMN) and mediates nicotinamide mononucleotide (NMN) catabolism, thereby contributing to both NmR salvage and phosphate acquisition. Therefore, NaMN is a putative molecular link connecting the PHO signaling and NAD(+) metabolic pathways. Our findings may contribute to the understanding of the molecular basis and regulation of NAD(+) metabolism in higher eukaryotes.	[Lu, Shu-Ping; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			National Institutes of Health [AG24351]; NATIONAL INSTITUTE ON AGING [R01AG024351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG24351 (NIA).	Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; BISSON LF, 1982, GENETICS, V102, P341; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brachmann CB, 1998, YEAST, V14, P115; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; CLARK DW, 1982, J BACTERIOL, V152, P865; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Endo Y, 2007, CANCER SCI, V98, P1633, DOI 10.1111/j.1349-7006.2007.00581.x; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; Grubmeyer CT, 1999, METHOD ENZYMOL, V308, P28; Itoh Roichi, 2003, BMC Biochem, V4, P4, DOI 10.1186/1471-2091-4-4; KANEKO Y, 1987, GENE, V58, P137; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Lundh F, 2009, BIOCHEMISTRY-US, V48, P4497, DOI 10.1021/bi9001198; Mouillon JM, 2005, CURR GENET, V48, P226, DOI 10.1007/s00294-005-0019-0; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; RUBIN GM, 1973, J BIOL CHEM, V248, P3860; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sandmeier JJ, 2002, GENETICS, V160, P877; Shimoaraiso M, 2000, J BIOL CHEM, V275, P29623, DOI 10.1074/jbc.M910371199; Sporty J, 2009, YEAST, V26, P363, DOI 10.1002/yea.1671; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; TOHE A, 1976, BIOCHIM BIOPHYS ACTA, V428, P182, DOI 10.1016/0304-4165(76)90119-7; UEDA Y, 1975, MOL GEN GENET, V136, P255, DOI 10.1007/BF00334020; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200; Werner TP, 2005, ARCH MICROBIOL, V184, P129, DOI 10.1007/s00203-005-0031-2; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wykoff DD, 2001, GENETICS, V159, P1491; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	60	42	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14271	14281		10.1074/jbc.M110.217885	http://dx.doi.org/10.1074/jbc.M110.217885			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349851	Green Published, hybrid			2022-12-25	WOS:000289556200050
J	Parikh, RB; Bali, M; Akabas, MH				Parikh, Rishi B.; Bali, Moez; Akabas, Myles H.			Structure of the M2 Transmembrane Segment of GLIC, a Prokaryotic Cys Loop Receptor Homologue from Gloeobacter violaceus, Probed by Substituted Cysteine Accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; ANESTHETIC BINDING-SITE; MEMBRANE-SPANNING SEGMENT; GABA(A) RECEPTOR; SULFHYDRYL GROUPS; 5-HT3 RECEPTORS; LINING RESIDUES; PROTEIN PACKING; HIGH-RESOLUTION	GLIC is a homopentameric proton-gated, prokaryotic homologue of the Cys loop receptor family of neurotransmitter-gated ion channels. Recently, crystal structures of GLIC hypothesized to represent an open channel state were published. To explore the channel structure in functional GLIC channels, we tested the ability of p-chloromercuribenzenesulfonate to react with 30 individual cysteine substitution mutants in and flanking the M2 channel-lining segment in the closed state (pH 7.5) and in a submaximally activated state (pH 5.0). Nine mutants did not tolerate cysteine substitution and were not functional. From positions 10' to 27', p-chloromercuribenzenesulfonate significantly modified the currents at pH 7.5 and 5.0 in all mutants except H234C (11'), I235C (12'), V241C (18'), T243C (20'), L245C (22'), and Y250C (27'), which were not functional, except for 12'. Currents for P246C (23') and K247C (24') were only significantly altered at pH5.0. The reaction rates were all > 1000 M-1 s(-1). The reactive residues were more accessible in the activated than in the resting state. We infer that M2 is tightly associated with the adjacent transmembrane helices at the intracellular end but is more loosely packed from 10' to the extracellular end than the x-ray structures suggest. We infer that the charge selectivity filter is in the cytoplasmic half of the channel. We also show that below pH 5.0, GLIC desensitizes on a time scale of minutes and infer that the crystal structures may represent a desensitized state.	[Parikh, Rishi B.; Bali, Moez; Akabas, Myles H.] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Akabas, MH (corresponding author), Dept Physiol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	myles.akabas@einstein.yu.edu		Akabas, Myles/0000-0001-8781-7846	National Institutes of Health [NS030808, GM077660]; NIGMS MSTP [GM007288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, R01GM077660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS030808 and GM077660 (to M. H. A.). R. B. P. was supported in part by NIGMS MSTP training grant GM007288.	Akabas MH, 2004, INT REV NEUROBIOL, V62, P1, DOI 10.1016/S0074-7742(04)62001-0; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2007, J GEN PHYSIOL, V129, P145, DOI 10.1085/jgp.200609639; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2010, BBA-BIOMEMBRANES, V1798, P1608, DOI 10.1016/j.bbamem.2010.04.014; Braun T, 2003, MOL CANCER RES, V1, P186; Changeux JP, 2010, ANNU REV PHARMACOL, V50, P1, DOI 10.1146/annurev.pharmtox.010909.105741; Corringer P J, 1999, Novartis Found Symp, V225, P215; Cross TA, 2011, TRENDS BIOCHEM SCI, V36, P117, DOI 10.1016/j.tibs.2010.07.005; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Goren EN, 2004, J BIOL CHEM, V279, P11198, DOI 10.1074/jbc.M314050200; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; HALBACH S, 1985, ARCH TOXICOL, V57, P139, DOI 10.1007/BF00343125; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; HASINOFF BB, 1971, CAN J BIOCHEM CELL B, V49, P742, DOI 10.1139/o71-105; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 1998, MOL PHARMACOL, V53, P870; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lide D. R., 2000, HDB CHEM PHYS; Menard C, 2005, J BIOL CHEM, V280, P27502, DOI 10.1074/jbc.M501624200; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VANSTEVENINCK J, 1965, J GEN PHYSIOL, V48, P617, DOI 10.1085/jgp.48.4.617; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wiltfong RE, 2009, J NEUROSCI, V29, P1626, DOI 10.1523/JNEUROSCI.4121-08.2009; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	55	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14098	14109		10.1074/jbc.M111.221895	http://dx.doi.org/10.1074/jbc.M111.221895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362624	hybrid, Green Published			2022-12-25	WOS:000289556200033
J	Hudson, JJR; Bednarova, K; Kozakova, L; Liao, CY; Guerineau, M; Colnaghi, R; Vidot, S; Marek, J; Bathula, SR; Lehmann, AR; Palecek, J				Hudson, Jessica J. R.; Bednarova, Katerina; Kozakova, Lucie; Liao, Chunyan; Guerineau, Marc; Colnaghi, Rita; Vidot, Susanne; Marek, Jaromir; Bathula, Sreenivas R.; Lehmann, Alan R.; Palecek, Jan			Interactions between the Nse3 and Nse4 Components of the SMC5-6 Complex Identify Evolutionarily Conserved Interactions between MAGE and EID Families	PLOS ONE			English	Article							DNA-REPAIR; STATISTICAL-MODEL; SUMO LIGASE; PROTEIN; GENE; ROLES; IDENTIFICATION; RECOMBINATION; INHIBITOR	Background: The SMC5-6 protein complex is involved in the cellular response to DNA damage. It is composed of 6-8 polypeptides, of which Nse1, Nse3 and Nse4 form a tight sub-complex. MAGEG1, the mammalian ortholog of Nse3, is the founding member of the MAGE (melanoma-associated antigen) protein family and Nse4 is related to the EID (E1A-like inhibitor of differentiation) family of transcriptional repressors. Methodology/Principal Findings: Using site-directed mutagenesis, protein-protein interaction analyses and molecular modelling, we have identified a conserved hydrophobic surface on the C-terminal domain of Nse3 that interacts with Nse4 and identified residues in its N-terminal domain that are essential for interaction with Nse1. We show that these interactions are conserved in the human orthologs. Furthermore, interaction of MAGEG1, the mammalian ortholog of Nse3, with NSE4b, one of the mammalian orthologs of Nse4, results in transcriptional co-activation of the nuclear receptor, steroidogenic factor 1 (SF1). In an examination of the evolutionary conservation of the Nse3-Nse4 interactions, we find that several MAGE proteins can interact with at least one of the NSE4/EID proteins. Conclusions/Significance: We have found that, despite the evolutionary diversification of the MAGE family, the characteristic hydrophobic surface shared by all MAGE proteins from yeast to humans mediates its binding to NSE4/EID proteins. Our work provides new insights into the interactions, evolution and functions of the enigmatic MAGE proteins.	[Hudson, Jessica J. R.; Liao, Chunyan; Colnaghi, Rita; Vidot, Susanne; Lehmann, Alan R.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Bednarova, Katerina; Kozakova, Lucie; Marek, Jaromir; Palecek, Jan] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Bathula, Sreenivas R.] Masaryk Univ, Natl Ctr Biomol Res, Brno, Czech Republic	University of Sussex; Masaryk University Brno; Masaryk University Brno	Hudson, JJR (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	a.r.lehmann@sussex.ac.uk; jpalecek@sci.muni.cz	Zabrady, Katerina/D-9232-2012; Bathula, Sreenivas Reddy/D-9493-2012; Palecek, Jan/D-6864-2012; Marek, Jaromir/D-8825-2012; Bozděchová, Lucie/D-9149-2012; Guerineau, Marc/AAR-1167-2021	Zabrady, Katerina/0000-0003-1946-0851; Palecek, Jan/0000-0002-6223-5169; Bozděchová, Lucie/0000-0002-7113-4343; Guerineau, Marc/0000-0002-0546-3106; Marek, Jaromir/0000-0002-8881-2040	Grant Agency of the Czech Academy of Sciences [IAA501630902]; Grant Agency of the Czech Republic [204/08/H054]; MRC; Medical Research Council [G0801130B, G0901011, G0501450] Funding Source: researchfish; MRC [G0501450, G0901011] Funding Source: UKRI	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants to J.P. from the Grant Agency of the Czech Academy of Sciences (IAA501630902, http://www.gaav.cz/en/) and Institutional support was provided by Czech Ministry of Education, Youth and Sports (MSM0021622415, http://www.msmt.cz/eu-presidency-2009/events). M.G. was supported from Grant Agency of the Czech Republic (204/08/H054, http://www.gacr.cz/international.htm). Work from the ARL lab was funded by an MRC Programme Grant. The authors are grateful to the METACentrum (super) computing facilities at Masaryk University for access under the research intent MSM6383917201. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bavner A, 2005, NUCLEIC ACIDS RES, V33, P3561, DOI 10.1093/nar/gki667; Bush JR, 2008, DIFFERENTIATION, V76, P994, DOI 10.1111/j.1432-0436.2008.00281.x; Caballero OL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012773; Chomez P, 2001, CANCER RES, V61, P5544; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duan XY, 2009, MOL CELL, V35, P657, DOI 10.1016/j.molcel.2009.06.032; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lopez-Sanchez N, 2007, PHYSIOL GENOMICS, V30, P156, DOI 10.1152/physiolgenomics.00249.2006; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishimura I, 2007, GENE EXPR PATTERNS, V7, P244, DOI 10.1016/j.modgep.2006.09.008; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2008, MOL BIOL CELL, V19, P4099, DOI 10.1091/mbc.E08-02-0226; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schubert V, 2009, CYTOGENET GENOME RES, V124, P202, DOI 10.1159/000218126; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Wang XH, 2010, EMBO J, V29, P1389, DOI 10.1038/emboj.2010.34; Watson AT, 2008, GENE, V407, P63, DOI 10.1016/j.gene.2007.09.024; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	35	37	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17270	10.1371/journal.pone.0017270	http://dx.doi.org/10.1371/journal.pone.0017270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364888	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000287764100039
J	Santorelli, CJ; Schaffner, CM; Campbell, CJ; Notman, H; Pavelka, MS; Weghorst, JA; Aureli, F				Santorelli, Claire J.; Schaffner, Colleen M.; Campbell, Christina J.; Notman, Hugh; Pavelka, Mary S.; Weghorst, Jennifer A.; Aureli, Filippo			Traditions in Spider Monkeys Are Biased towards the Social Domain	PLOS ONE			English	Article							ATELES-GEOFFROYI; TOOL USE; CULTURAL TRANSMISSION; CAPUCHIN MONKEYS; EVOLUTION; BEHAVIOR; PRIMATES; PREFERENCES; AGGRESSION; DIFFUSION	Cross-site comparison studies of behavioral variation can provide evidence for traditions in wild species once ecological and genetic factors are excluded as causes for cross-site differences. These studies ensure behavior variants are considered within the context of a species' ecology and evolutionary adaptations. We examined wide-scale geographic variation in the behavior of spider monkeys (Ateles geoffroyi) across five long-term field sites in Central America using a well established ethnographic cross-site survey method. Spider monkeys possess a relatively rare social system with a high degree of fission-fusion dynamics, also typical of chimpanzees (Pan troglodytes) and humans (Homo sapiens). From the initial 62 behaviors surveyed 65% failed to meet the necessary criteria for traditions. The remaining 22 behaviors showed cross-site variation in occurrence ranging from absent through to customary, representing to our knowledge, the first documented cases of traditions in this taxon and only the second case of multiple traditions in a New World monkey species. Of the 22 behavioral variants recorded across all sites, on average 57% occurred in the social domain, 19% in food-related domains and 24% in other domains. This social bias contrasts with the food-related bias reported in great ape cross-site comparison studies and has implications for the evolution of human culture. No pattern of geographical radiation was found in relation to distance across sites. Our findings promote A. geoffroyi as a model species to investigate traditions with field and captive based experiments and emphasize the importance of the social domain for the study of animal traditions.	[Santorelli, Claire J.; Schaffner, Colleen M.] Univ Chester, Dept Psychol, Chester, Cheshire, England; [Campbell, Christina J.] Calif State Univ Northridge, Dept Anthropol, Northridge, CA 91330 USA; [Notman, Hugh] Athabasca Univ, Ctr Work & Community Studies, Athabasca, AB, Canada; [Pavelka, Mary S.] Univ Calgary, Dept Anthropol, Calgary, AB, Canada; [Weghorst, Jennifer A.] Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA; [Weghorst, Jennifer A.] Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Aureli, Filippo] Liverpool John Moores Univ, Res Ctr Evolutionary Anthropol & Palaeoecol, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England	University of Chester; California State University System; California State University Northridge; Athabasca University; University of Calgary; University of Kansas; University of Kansas; Liverpool John Moores University	Santorelli, CJ (corresponding author), Univ Chester, Dept Psychol, Chester, Cheshire, England.	c.santorelli@chester.ac.uk		Aureli, Filippo/0000-0002-0671-013X	National Science Foundation [SBR-9711161]; Leakey Foundation; Department of Anthropology, University of California, Berkeley; Smithsonian Tropical Research Institute; NSF [0233248, BSR 8315399]; Wenner-Gren Foundation; American Society of Primatologists; Washington University in St. Louis; WWF grant; Mellon Foundation through the Institute of Latin American Studies at UT Austin; British Academy; North of England Zoological Society; University of Chester; Santander University; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); Leakey Foundation; Department of Anthropology, University of California, Berkeley(University of California System); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); NSF(National Science Foundation (NSF)); Wenner-Gren Foundation; American Society of Primatologists; Washington University in St. Louis; WWF grant; Mellon Foundation through the Institute of Latin American Studies at UT Austin; British Academy; North of England Zoological Society; University of Chester; Santander University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Research at Barro Colorado Island was supported by grants from the National Science Foundation (SBR-9711161), the Leakey Foundation, the Department of Anthropology, University of California, Berkeley (www.berkeley.edu) and a Short-term Fellowship from the Smithsonian Tropical Research Institute (www.stri.org). Research at Corcovado National Park's Sirena Biological Station was supported by NSF award 0233248 (with R. Sussman), the Wenner-Gren Foundation, the Leakey Foundation, the American Society of Primatologists (www.asp.org), and Washington University in St. Louis (www.wustl.edu). Funds for Sirena's field lab facility were provided to L. E. Gilbert (Univ. of Texas at Austin) by NSF BSR 8315399 and a matching WWF grant, and funds for updating Sirena's trail system and installation of spatial reference system were provided by the Mellon Foundation through the Institute of Latin American Studies at UT Austin. Research at Santa Rosa and Punta Laguna was supported by The British Academy (www.britac.ac.uk), the Wenner-Gren Foundation (www.wennergren.org), the Leakey Foundation (www.leakeyfoundation.org) and the North of England Zoological Society (www.chesterzoo.org). CJS was supported by a Gladstone bursary from the University of Chester (www.chester.ac.uk) and by the Santander University Scheme (www.santander.co.uk). Research at Runaway Creek was supported by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio N, 2009, BEHAV ECOL SOCIOBIOL, V63, P649, DOI 10.1007/s00265-008-0699-9; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Aureli F, 2006, AM J PHYS ANTHROPOL, V131, P486, DOI 10.1002/ajpa.20451; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; AZIZ MA, 1986, PRIMATES, V27, P293, DOI 10.1007/BF02382073; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Borenstein E, 2008, EVOLUTION, V62, P586, DOI 10.1111/j.1558-5646.2007.00313.x; Boughman JW, 1998, ANIM BEHAV, V55, P1717, DOI 10.1006/anbe.1997.0721; Boyd R., 2005, ORIGIN EVOLUTION CUL; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Byrne RW, 2007, PHILOS T R SOC B, V362, P577, DOI 10.1098/rstb.2006.1996; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; Campbell CJ, 2003, INT J PRIMATOL, V24, P223, DOI 10.1023/A:1023036830192; Campbell CJ, 2000, AM J PRIMATOL, V51, P205, DOI 10.1002/1098-2345(200007)51:3<205::AID-AJP5>3.0.CO;2-L; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; CHAPMAN CA, 1991, FOLIA PRIMATOL, V56, P162, DOI 10.1159/000156542; Collins AC, 2008, CAM S BIO EVOL ANTHR, V55, P50; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Datta S, 2002, SIGNAL PROCESS, V82, P251, DOI 10.1016/S0165-1684(01)00184-0; de Waal F., 2001, APE SUSHI MASTER CUL; Di Fiore A, 2008, CAM S BIO EVOL ANTHR, V55, P81; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; ERIKSON G. E., 1963, SYMP ZOOL SOC LONDON, V10, P135; ESTRADA A, 1988, AM J PRIMATOL, V14, P315, DOI 10.1002/ajp.1350140402; Fragaszy DM., 2003, BIOL TRADITIONS MODE, P1, DOI DOI 10.1017/CBO9780511584022.002; Galef BG, 2004, LEARN BEHAV, V32, P53; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Heyes CM., 1996, SOCIAL LEARNING ANIM; Heymann EW, 2006, AM J PRIMATOL, V68, P650, DOI 10.1002/ajp.20258; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Humle T, 2008, ANIM BEHAV, V75, P267, DOI 10.1016/j.anbehav.2007.05.021; Humle Tatyana, 2010, P116; Klein L. L., 1972, THESIS U CALIFORNIA; Krutzen M, 2007, TRENDS ECOL EVOL, V22, P6, DOI 10.1016/j.tree.2006.10.011; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; Laland K., 2002, INT ENCY SOCIAL BEHA, P3164; Laland KN, 2008, CURR BIOL, V18, pR366, DOI 10.1016/j.cub.2008.02.049; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Laska M, 2007, PRIMATES, V48, P160, DOI 10.1007/s10329-006-0019-9; Leca JB, 2008, AM J PRIMATOL, V70, P803, DOI 10.1002/ajp.20551; Lindshield SM, 2009, PRIMATES, V50, P269, DOI 10.1007/s10329-009-0144-3; Link Andres, 2003, Neotropical Primates, V11, P104; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 1998, ANNU REV ANTHROPOL, V27, P301, DOI 10.1146/annurev.anthro.27.1.301; McGrew William, 2004, CULTURED CHIMPANZEE; Milton K, 2006, DEV PRIMATOL-PROG PR, P417, DOI 10.1007/0-387-25872-8_21; Milton K, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P375; Milton K., 2006, FEEDING ECOLOGY APES, P381; Nishida T., 1987, P165; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; POZO RWE, 2004, ANUAR INVESTIGACION, V2, P77; RAMOSFERNA N, 2003, NEOTROPICAL PRIMATES, V11, P115; RAMOSFERNA N, 2002, PRIMATES FRAGMENTS E, P191; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rocha OJ, 2001, AM J BOT, V88, P1607, DOI 10.2307/3558405; RODSETH L, 1991, CURR ANTHROPOL, V32, P221, DOI 10.1086/203952; Rosenberger AL, 2008, CAM S BIO EVOL ANTHR, V55, P19; SADER SA, 2001, STLOUIS MISS ASPRS 2; Schaffner CM, 2005, INT J PRIMATOL, V26, P1093, DOI 10.1007/s10764-005-6460-6; Shimooka Y, 2008, CAM S BIO EVOL ANTHR, V55, P329; Thornton A, 2008, ANIM BEHAV, V76, P1411, DOI 10.1016/j.anbehav.2008.07.007; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; van der Post DJ, 2009, ANIM BEHAV, V78, P155, DOI 10.1016/j.anbehav.2009.04.009; van Roosmalen M.G.M., 1988, P455; van Schaik C. P., 2009, QUESTION ANIMAL CULT, P70; Van Schaik Carel P., 2003, P297, DOI 10.1017/CBO9780511584022.012; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; van Schaik CP, 2002, INT J PRIMATOL, V23, P527, DOI 10.1023/A:1014965516127; Vick LG, 2008, CAM S BIO EVOL ANTHR, V55, P288; Watson CFI, 2009, INT J PRIMATOL, V30, P143, DOI 10.1007/s10764-009-9334-5; Weghorst JA, 2007, PRIMATES, V48, P108, DOI 10.1007/s10329-006-0025-y; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WHITEN A, 2006, SOCIAL INFORM TRANSM, P119; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031	84	35	35	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16863	10.1371/journal.pone.0016863	http://dx.doi.org/10.1371/journal.pone.0016863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373196	Green Published, gold			2022-12-25	WOS:000287657500020
J	Cortes-Bratti, X; Basseres, E; Herrera-Rodriguez, F; Botero-Kleiven, S; Coppotelli, G; Andersen, JB; Masucci, MG; Holmgren, A; Chaves-Olarte, E; Frisan, T; Avila-Carino, J				Cortes-Bratti, Ximena; Basseres, Eugenie; Herrera-Rodriguez, Fabiola; Botero-Kleiven, Silvia; Coppotelli, Giuseppe; Andersen, Jens B.; Masucci, Maria G.; Holmgren, Arne; Chaves-Olarte, Esteban; Frisan, Teresa; Avila-Carino, Javier			Thioredoxin 80-Activated-Monocytes (TAMs) Inhibit the Replication of Intracellular Pathogens	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CYTOTOXICITY-ENHANCING FACTOR; LISTERIA-MONOCYTOGENES; TRUNCATED THIOREDOXIN; MITOGENIC CYTOKINE; EXPRESSION; MONOCYTES; INFECTION; TRX80; BRUCELLA	Background: Thioredoxin 80 (Trx80) is an 80 amino acid natural cleavage product of Trx, produced primarily by monocytes. Trx80 induces differentiation of human monocytes into a novel cell type, named Trx80-activated-monocytes (TAMs). Principal Findings: In this investigation we present evidence for a role of TAMs in the control of intracellular bacterial infections. As model pathogens we have chosen Listeria monocytogenes and Brucella abortus which replicate in the cytosol and the endoplasmic reticulum respectively. Our data indicate that TAMs efficiently inhibit intracellular growth of both L. monocytogenes and B. abortus. Further analysis shows that Trx80 activation prevents the escape of GFP-tagged L. monocytogenes into the cytosol, and induces accumulation of the bacteria within the lysosomes. Inhibition of the lysosomal activity by chloroquine treatment resulted in higher replication of bacteria in TAMs compared to that observed in control cells 24 h post-infection, indicating that TAMs kill bacteria by preventing their escape from the endosomal compartments, which progress into a highly degradative phagolysosome. Significance: Our results show that Trx80 potentiates the bactericidal activities of professional phagocytes, and contributes to the first line of defense against intracellular bacteria.	[Cortes-Bratti, Ximena; Basseres, Eugenie; Coppotelli, Giuseppe; Masucci, Maria G.; Frisan, Teresa; Avila-Carino, Javier] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Herrera-Rodriguez, Fabiola; Chaves-Olarte, Esteban] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Botero-Kleiven, Silvia] Swedish Inst Infect Dis Control, Solna, Sweden; [Andersen, Jens B.] Natl Food Inst, Dept Microbiol & Risk Assessment, Soborg, Denmark; [Holmgren, Arne] Karolinska Inst, Dept Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet; Universidad Costa Rica; Swedish Institute for Infectious Disease Control; Technical University of Denmark; Karolinska Institutet	Cortes-Bratti, X (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	teresa.frisan@ki.se; javier.avila-carino@ki.se	Masucci, Maria/AAC-6666-2019; Andersen, Jens B/J-4256-2017; Frisan, Teresa/H-8444-2019	Masucci, Maria/0000-0002-5541-2809; Andersen, Jens B/0000-0003-1720-1581; Frisan, Teresa/0000-0002-1209-0942	Cancer and Allergy Foundation; Swedish Research Council; Swedish Cancer Society; Magnus Bergvall Foundation; Karolinska Institutet; Association for International Cancer Research; Edinburgh UK; European Community [LSHC-CT-2005-018683]	Cancer and Allergy Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Magnus Bergvall Foundation; Karolinska Institutet(Karolinska Institutet); Association for International Cancer Research; Edinburgh UK; European Community(European Commission)	Funding: This work was supported by the Cancer and Allergy Foundation (http://www.cancerochallergifonden.se/) to JAC; the Swedish Research Council (http://www.vr.se/inenglish. 4.12fff4451215cbd83e4800015152.html), the Swedish Cancer Society (http://www.cancerfonden.se/sv/Information-in-English/), the Magnus Bergvall Foundation (http://www.magnbergvallsstiftelse.nu/), and the Karolinska Institutet (http://ki.se/ki/jsp/polopoly.jsp?l = en&d = 20152) to JAC and TF; and the Association for International Cancer Research (http://www.aicr.org.uk/research.stm), Edinburgh UK and the European Community Network of Excellence RUBICON (http://www.rubicon-net.org/) Project No. LSHC-CT-2005-018683 to MGM. XCB is a NETROPICA (http://www.netropica.org/portal/) fellow. TF is supported by the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-86; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Bizzarri C, 2005, ANTIOXID REDOX SIGN, V7, P1189, DOI 10.1089/ars.2005.7.1189; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; DESSEIN AJ, 1984, CELL IMMUNOL, V85, P100, DOI 10.1016/0008-8749(84)90282-X; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Freitag NE, 1999, INFECT IMMUN, V67, P1844; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Lemarechal H, 2007, CLIN SCI, V113, P149, DOI 10.1042/CS20070067; LENZI HL, 1985, CELL IMMUNOL, V94, P333, DOI 10.1016/0008-8749(85)90257-6; NEWMAN GW, 1994, J EXP MED, V180, P359, DOI 10.1084/jem.180.1.359; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pekkari K, 2005, BLOOD, V105, P1598, DOI 10.1182/blood-2004-04-1577; Pekkari K, 2003, FEBS LETT, V539, P143, DOI 10.1016/S0014-5793(03)00214-X; Pekkari K, 2001, BLOOD, V97, P3184, DOI 10.1182/blood.V97.10.3184; Pekkari K, 2000, J BIOL CHEM, V275, P37474, DOI 10.1074/jbc.M001012200; Sahaf B, 1997, EXP CELL RES, V236, P181, DOI 10.1006/excr.1997.3699; Sahaf B, 2000, ANTIOXID REDOX SIGN, V2, P717, DOI 10.1089/ars.2000.2.4-717; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; SILBERSTEIN DS, 1989, J IMMUNOL, V143, P979; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16960	10.1371/journal.pone.0016960	http://dx.doi.org/10.1371/journal.pone.0016960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365006	Green Published, gold, Green Submitted			2022-12-25	WOS:000287482800023
J	Wozniak, KL; Hardison, SE; Kolls, JK; Wormley, FL				Wozniak, Karen L.; Hardison, Sarah E.; Kolls, Jay K.; Wormley, Floyd L., Jr.			Role of IL-17A on Resolution of Pulmonary C-neoformans Infection	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE INFECTION; CLASSICAL MACROPHAGE ACTIVATION; IL-17-PRODUCING T-CELLS; CRYPTOCOCCUS-NEOFORMANS; HOST-DEFENSE; IMMUNE-RESPONSE; NEUTROPHIL RECRUITMENT; INFLAMMATORY RESPONSE; VIRULENCE FACTOR; TH17 CELLS	The current studies evaluated the role of interleukin (IL)-17A in the induction of protective immunity against pulmonary cryptococcosis in mice. Protection against pulmonary infection with C. neoformans strain H99 gamma was associated with increased IL-17A production. Signaling through the IFN-gamma receptor (R) was required for increased IL-17A production, however, a Th17-type cytokine profile was not observed. Neutrophils were found to be the predominant leukocytic source of IL-17A, rather than T cells, suggesting that the IL-17A produced was not part of a T cell-mediated Th17-type immune response. Depletion of IL-17A in mice during pulmonary infection with C. neoformans strain H99 gamma resulted in an initial increase in pulmonary fungal burden, but had no effect on cryptococcal burden at later time points. Also, depletion of IL-17A did not affect the local production of other cytokines. IL-17RA(-/-) mice infected with C. neoformans strain H99 gamma survived the primary infection as well as a secondary challenge with wild-type cryptococci. However, dissemination of the wild-type strain to the brain was noted in the surviving IL-17RA(-/-) mice. Altogether, our results suggested that IL-17A may be important for optimal protective immune responsiveness during pulmonary C. neoformans infection, but protective Th1-type immune responses are sufficient for protection against cryptococcal infection.	[Wozniak, Karen L.; Hardison, Sarah E.; Wormley, Floyd L., Jr.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Wozniak, Karen L.; Hardison, Sarah E.; Wormley, Floyd L., Jr.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Kolls, Jay K.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wozniak, KL (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	Karen.Wozniak@utsa.edu	Kolls, Jay/AAH-1829-2019; Hardison, Sarah E./AAC-7510-2019; Hardison, Sarah/ABB-1606-2021	Kolls, Jay/0000-0001-5151-6304; Wozniak, Karen/0000-0003-1798-2146	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [RO1 AI071752-03, RO1 HL079142]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061271, R01HL079142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071752] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grant RO1 AI071752-03 (F.L.W. Jr.) and RO1 HL079142 (J.K.K.) from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) http://www.niaid.nih.gov. This content is solely the responsibility of the authors and does not reflect the official views of the NIAID or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007079; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BLASI E, 1994, INFECT IMMUN, V62, P3189, DOI 10.1128/IAI.62.8.3189-3196.1994; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Buchanan KL, 2000, INFECT IMMUN, V68, P456, DOI 10.1128/IAI.68.2.456-462.2000; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hardison SE, 2010, INFECT IMMUN, V78, P5341, DOI 10.1128/IAI.00845-10; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; HILL JO, 1991, J EXP MED, V173, P755, DOI 10.1084/jem.173.3.755; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; HUFFNAGLE GB, 1994, J LEUKOCYTE BIOL, V55, P35, DOI 10.1002/jlb.55.1.35; HUFFNAGLE GB, 1991, INFECT IMMUN, V59, P1423, DOI 10.1128/IAI.59.4.1423-1433.1991; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; Kish DD, 2009, J IMMUNOL, V182, P5949, DOI 10.4049/jimmunol.0802830; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LEVITZ SM, 1991, REV INFECT DIS, V13, P1163; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; MODY CH, 1990, J IMMUNOL, V144, P1472; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Romani L, 2008, J IMMUNOL, V180, P5157, DOI 10.4049/jimmunol.180.8.5157; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Siciliano NA, 2006, J IMMUNOL, V177, P7131, DOI 10.4049/jimmunol.177.10.7131; Singh N, 1997, CLIN TRANSPLANT, V11, P66; Singh N, 2008, CLIN INFECT DIS, V47, P1321, DOI 10.1086/592690; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Voelz K, 2009, INFECT IMMUN; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wozniak KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006854; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Young M, 2009, PROTEOMICS, V9, P2578, DOI 10.1002/pmic.200800713; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	54	77	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17204	10.1371/journal.pone.0017204	http://dx.doi.org/10.1371/journal.pone.0017204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359196	Green Published, gold, Green Submitted			2022-12-25	WOS:000287482300038
J	Riemer, J; Hansen, HG; Appenzeller-Herzog, C; Johansson, L; Ellgaard, L				Riemer, Jan; Hansen, Henning G.; Appenzeller-Herzog, Christian; Johansson, Linda; Ellgaard, Lars			Identification of the PDI-Family Member ERp90 as an Interaction Partner of ERFAD	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; ENDOPLASMIC-RETICULUM; BINDING SITE; REDUCTION; OXIDATION; MECHANISM	In the endoplasmic reticulum (ER), members of the protein disulfide isomerase (PDI) family perform critical functions during protein maturation. Herein, we identify the previously uncharacterized PDI-family member ERp90. In cultured human cells, we find ERp90 to be a soluble ER-luminal glycoprotein that comprises five potential thioredoxin (Trx)-like domains. Mature ERp90 contains 10 cysteine residues, of which at least some form intramolecular disulfides. While none of the Trx domains contain a canonical Cys-Xaa-Xaa-Cys active-site motif, other conserved cysteines could endow the protein with redox activity. Importantly, we show that ERp90 co-immunoprecipitates with ERFAD, a flavoprotein involved in ER-associated degradation (ERAD), through what is most likely a direct interaction. We propose that the function of ERp90 is related to substrate recruitment or delivery to the ERAD retrotranslocation machinery by ERFAD.	[Riemer, Jan; Hansen, Henning G.; Appenzeller-Herzog, Christian; Johansson, Linda; Ellgaard, Lars] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Riemer, J (corresponding author), Univ Kaiserslautern, Dept Cell Biol, Kaiserslautern, Germany.	lellgaard@bio.ku.dk	Appenzeller-Herzog, Christian/A-2894-2014; Riemer, Jan/B-3340-2012; Riemer, Jan/AAC-1072-2021; Ellgaard, Lars/I-9034-2014	Appenzeller-Herzog, Christian/0000-0001-7430-294X; Ellgaard, Lars/0000-0002-7018-0137; Riemer, Jan/0000-0002-7574-8457; Hansen, Henning Gram/0000-0002-2832-730X	Novo Nordisk Foundation; Lundbeckfonden; Augustinusfonden; Danish Natural Science Research Council; Novartis Stiftung	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeckfonden(Lundbeckfonden); Augustinusfonden; Danish Natural Science Research Council(Danish Natural Science Research Council); Novartis Stiftung	Funding was obtained from the Novo Nordisk Foundation, Lundbeckfonden, Augustinusfonden, the Danish Natural Science Research Council and the Novartis Stiftung. J.R. was a fellow of the Boehringer Ingelheim Fonds and is a recipient of an EMBO long-term fellowship. C.A.-H. was a fellow of the Swiss National Science Foundation and is a recipient of an Ambizione research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Hagiwara M, MOL CELL IN PRESS; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Raghava GPS, 2002, CASP5A132; Riemer J, 2009, P NATL ACAD SCI USA, V106, P14831, DOI 10.1073/pnas.0900742106; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Shim S, 2010, CELL MOL LIFE SCI; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200	27	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17037	10.1371/journal.pone.0017037	http://dx.doi.org/10.1371/journal.pone.0017037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359175	Green Published, gold			2022-12-25	WOS:000287392700037
J	Pandeeti, EVP; Pitchika, GK; Jotshi, J; Nilegaonkar, SS; Kanekar, PP; Siddavattam, D				Pandeeti, Emmanuel Vijay Paul; Pitchika, Gopi Krishna; Jotshi, Jyotsna; Nilegaonkar, Smita S.; Kanekar, Pradnya P.; Siddavattam, Dayananda			Enzymatic Depilation of Animal Hide: Identification of Elastase (LasB) from Pseudomonas aeruginosa MCM B-327 as a Depilating Protease	PLOS ONE			English	Article							ALKALINE PROTEASE; EXTRACELLULAR PROTEINS; ESCHERICHIA-COLI; KERATINASE; EXPRESSION; PURIFICATION; ACTIVATION; CLONING; OPTIMIZATION; MUTAGENESIS	Conventional leather processing involving depilation of animal hide by lime and sulphide treatment generates considerable amounts of chemical waste causing severe environmental pollution. Enzymatic depilation is an environmentally friendly process and has been considered to be a viable alternative to the chemical depilation process. We isolated an extracellular protease from Pseudomonas aeruginosa strain MCM B-327 with high depilation activity using buffalo hide as a substrate. This 33 kDa protease generated a peptide mass fingerprint and de novo sequence that matched perfectly with LasB (elastase), of Pseudomonas aeruginosa. In support of this data a lasB mutant of MCM B-327 strain lacked depilatory activity and failed to produce LasB. LasB heterologously over-produced and purified from Escherichia coli also exhibited high depilating activity. Moreover, reintroduction of the lasB gene to the P. aeruginosa lasB mutant via a knock-in strategy also successfully restored depilation activity thus confirming the role of LasB as the depilating enzyme.	[Pandeeti, Emmanuel Vijay Paul; Pitchika, Gopi Krishna; Siddavattam, Dayananda] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India; [Jotshi, Jyotsna; Nilegaonkar, Smita S.; Kanekar, Pradnya P.] MACS Agharkar Res Inst, Microbial Sci Div, Pune, Maharashtra, India	University of Hyderabad; Department of Science & Technology (India); Agharkar Research Institute (ARI)	Pandeeti, EVP (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	sdsl@uohyd.ernet.in		Pandeeti, Emmanuel/0000-0001-8244-7401	CSIR-NMITLI, New Delhi [5/258/13A/2005-NMITLI]	CSIR-NMITLI, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by CSIR-NMITLI, New Delhi through the grant 5/258/13A/2005-NMITLI to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbu P, 2005, ENZYME MICROB TECH, V36, P639, DOI 10.1016/j.enzmictec.2004.07.019; Anderson RM, 1999, J BACTERIOL, V181, P6264, DOI 10.1128/JB.181.20.6264-6270.1999; Bayoudh A, 2000, J IND MICROBIOL BIOT, V24, P291, DOI 10.1038/sj.jim.2900822; Brandelli A, 2008, FOOD BIOPROCESS TECH, V1, P105, DOI 10.1007/s11947-007-0025-y; Braun P, 2000, MICROBIOL-UK, V146, P2565, DOI 10.1099/00221287-146-10-2565; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Friedrich J, 2005, ENZYME MICROB TECH, V36, P455, DOI 10.1016/j.enzmictec.2004.09.015; Germann H.P., 1999, P 25 IULTCS C CHENN; Giongo JL, 2007, WORLD J MICROB BIOT, V23, P375, DOI 10.1007/s11274-006-9234-1; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hauser AR, 1998, INFECT IMMUN, V66, P1413, DOI 10.1128/IAI.66.4.1413-1420.1998; HOLDER IA, 1989, INFECT IMMUN, V57, P3345, DOI 10.1128/IAI.57.11.3345-3348.1989; Kanekar PP, 2002, BIORESOURCE TECHNOL, V85, P87, DOI 10.1016/S0960-8524(02)00018-4; KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lin HH, 2009, J AGR FOOD CHEM, V57, P5321, DOI 10.1021/jf900417t; Lin HH, 2009, J AGR FOOD CHEM, V57, P3506, DOI 10.1021/jf803752j; Lin XJ, 2009, PROTEIN EXPRES PURIF, V63, P69, DOI 10.1016/j.pep.2007.12.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDVIK J, 2000, USRAS921201151 UN NA; Macedo AJ, 2005, APPL ENVIRON MICROB, V71, P594, DOI 10.1128/AEM.71.1.594-596.2005; Marsal A, 1999, J SOC LEATH TECH CH, V83, P310; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Mukhopadhyay R. P., 1993, Indian Journal of Experimental Biology, V31, P557; Najafi MF, 2006, ENZYME MICROB TECH, V39, P1433, DOI 10.1016/j.enzmictec.2006.03.031; Nilegaonkar SS, 2007, BIORESOURCE TECHNOL, V98, P1238, DOI 10.1016/j.biortech.2006.05.003; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Nouwens AS, 2002, PROTEOMICS, V2, P1325, DOI 10.1002/1615-9861(200209)2:9<1325::AID-PROT1325>3.0.CO;2-4; Pandeeti EVP, 2009, LETT APPL MICROBIOL, V48, P566, DOI 10.1111/j.1472-765X.2009.02564.x; PANDEY JP, 2009, MOL BIOL REP, V34, P13; Puvanakrishnan R., 1988, ENZYMES DEHAIRING; Ramasami T, 1999, J SOC LEATH TECH CH, V83, P39; RAMASAMI T, 1998, BACKGROUND INFORMATI, P183; RUST L, 1996, J BACTERIOL, V179, P557; Sambrook J., 2002, MOL CLONING LAB MANU; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Sharma R, 2010, BIOTECHNOL LETT, V32, P1863, DOI 10.1007/s10529-010-0361-2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Wang HY, 2007, LETT APPL MICROBIOL, V44, P1, DOI 10.1111/j.1472-765X.2006.02039.x; Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YATES JR, 1968, AUST J BIOL SCI, V21, P361, DOI 10.1071/BI9680361; Yates JR, 1972, J SOC LEATHER TRADES, V56, P158; Zambare VP, 2007, WORLD J MICROB BIOT, V23, P1569, DOI 10.1007/s11274-007-9402-y; ZAMBARE VP, 2010, NEW BIOTECH IN PRESS	48	12	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16742	10.1371/journal.pone.0016742	http://dx.doi.org/10.1371/journal.pone.0016742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347249	gold, Green Published, Green Submitted			2022-12-25	WOS:000287364500004
J	Mihali, TK; Carmichael, WW; Neilan, BA				Mihali, Troco K.; Carmichael, Wayne W.; Neilan, Brett A.			A Putative Gene Cluster from a Lyngbya wollei Bloom that Encodes Paralytic Shellfish Toxin Biosynthesis	PLOS ONE			English	Article							CYANOBACTERIUM CYLINDROSPERMOPSIS-RACIBORSKII; DINOFLAGELLATE GYMNODINIUM-CATENATUM; POISONING TOXINS; 1ST EVIDENCE; SAXITOXIN; IDENTIFICATION; AUSTRALIA; TOXICITY; PROTEINS; WATERS	Saxitoxin and its analogs cause the paralytic shellfish-poisoning syndrome, adversely affecting human health and coastal shellfish industries worldwide. Here we report the isolation, sequencing, annotation, and predicted pathway of the saxitoxin biosynthetic gene cluster in the cyanobacterium Lyngbya wollei. The gene cluster spans 36 kb and encodes enzymes for the biosynthesis and export of the toxins. The Lyngbya wollei saxitoxin gene cluster differs from previously identified saxitoxin clusters as it contains genes that are unique to this cluster, whereby the carbamoyltransferase is truncated and replaced by an acyltransferase, explaining the unique toxin profile presented by Lyngbya wollei. These findings will enable the creation of toxin probes, for water monitoring purposes, as well as proof-of-concept for the combinatorial biosynthesis of these natural occurring alkaloids for the production of novel, biologically active compounds.	[Mihali, Troco K.; Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Carmichael, Wayne W.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Neilan, Brett A.] Univ New S Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia	University of New South Wales Sydney; University System of Ohio; Wright State University Dayton; University of New South Wales Sydney	Mihali, TK (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	b.neilan@unsw.edu.au	Neilan, Brett A/I-5767-2012	Neilan, Brett A/0000-0001-6113-772X	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. BAN is a fellow of the Australian Research Council. The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA O, 1994, TOXICON, V32, P175, DOI 10.1016/0041-0101(94)90106-6; Arakawa O, 1995, TOXICON, V33, P1577, DOI 10.1016/0041-0101(95)00106-9; BAKER PD, 1994, AUST J MAR FRESH RES, V45, P773; Beltran EC, 2000, APPL ENVIRON MICROB, V66, P4468, DOI 10.1128/AEM.66.10.4468-4474.2000; Carmichael WW, 1997, APPL ENVIRON MICROB, V63, P3104, DOI 10.1128/AEM.63.8.3104-3110.1997; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Hallegraeff G. M., 1995, MANUAL HARMFUL MARIN, V33, P1; HARADA T, 1982, AGR BIOL CHEM TOKYO, V46, P1861, DOI 10.1080/00021369.1982.10865327; Hawkins PR, 1997, TOXICON, V35, P341, DOI 10.1016/S0041-0101(96)00185-7; HUMPAGE AR, 1994, AUST J MAR FRESH RES, V45, P761, DOI 10.1071/MF9940761; Kao C., 1986, TETRODOTOXIN SAXITOX; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kellmann R, 2008, J MOL EVOL, V67, P526, DOI 10.1007/s00239-008-9169-2; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Kellmann R, 2007, J PHYCOL, V43, P497, DOI 10.1111/j.1529-8817.2007.00351.x; Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X; MAHMOOD NA, 1986, TOXICON, V24, P175, DOI 10.1016/0041-0101(86)90120-0; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; Messineo V, 2010, ENVIRON TOXICOL, V25, P18, DOI 10.1002/tox.20469; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Mihali TK, 2008, APPL ENVIRON MICROB, V74, P716, DOI 10.1128/AEM.01988-07; Moffitt MC, 2004, APPL ENVIRON MICROB, V70, P6353, DOI 10.1128/AEM.70.11.6353-6362.2004; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; Negri A, 2003, CHEM RES TOXICOL, V16, P1029, DOI 10.1021/tx034037j; Neilan BA, 2003, MOL ECOL, V12, P133, DOI 10.1046/j.1365-294X.2003.01709.x; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P2286, DOI 10.1128/AEM.61.6.2286-2291.1995; Onodera Hideyuki, 1997, Natural Toxins, V5, P146; OSHIMA Y, 1987, TOXICON, V25, P1105, DOI 10.1016/0041-0101(87)90267-4; OSHIMA Y, 1995, J AOAC INT, V78, P528; Pomati F, 2004, MICROBIOL-SGM, V150, P455, DOI 10.1099/mic.0.26350-0; Pomati F, 2000, J PHYCOL, V36, P553, DOI 10.1046/j.1529-8817.2000.99181.x; Seifert M, 2007, HARMFUL ALGAE, V6, P73, DOI 10.1016/j.hal.2006.07.001; SHIMIZU Y, 1993, CHEM REV, V93, P1685, DOI 10.1021/cr00021a002; SPEZIALE BJ, 1992, J PHYCOL, V28, P613; St-Pierre B, 1998, PLANT J, V14, P703, DOI 10.1046/j.1365-313x.1998.00174.x; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; SU Z, 2004, J PHARM EXPT THERAPE, V308; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Velzeboer RMA, 2000, PHYCOLOGIA, V39, P395, DOI 10.2216/i0031-8884-39-5-395.1; Wang JX, 2003, J GEN PHYSIOL, V121, P583, DOI 10.1085/jgp.200308812; Zaman L, 1998, TOXICON, V36, P627, DOI 10.1016/S0041-0101(97)00086-X	43	73	77	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e14657	10.1371/journal.pone.0014657	http://dx.doi.org/10.1371/journal.pone.0014657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347365	Green Published, gold, Green Submitted			2022-12-25	WOS:000287363000002
J	MacIntyre, DA; Sanchis, DM; Jimenez, B; Moreno, R; Stojkovic, M; Pineda-Lucena, A				MacIntyre, David A.; Melguizo Sanchis, Dario; Jimenez, Beatriz; Moreno, Ruben; Stojkovic, Miodrag; Pineda-Lucena, Antonio			Characterisation of Human Embryonic Stem Cells Conditioning Media by H-1-Nuclear Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; HUMAN-DIPLOID FIBROBLASTS; HUMAN FEEDERS; HUMAN BLASTOCYSTS; CULTURE-MEDIA; HUMAN-SERUM; IN-VITRO; URINE; LINES; METABONOMICS	Background: Cell culture media conditioned by human foreskin fibroblasts (HFFs) provide a complex supplement of protein and metabolic factors that support in vitro proliferation of human embryonic stem cells (hESCs). However, the conditioning process is variable with different media batches often exhibiting differing capacities to maintain hESCs in culture. While recent studies have examined the protein complement of conditioned culture media, detailed information regarding the metabolic component of this media is lacking. Methodology/Principal Findings: Using a H-1-Nuclear Magnetic Resonance (H-1-NMR) metabonomics approach, 32 metabolites and small compounds were identified and quantified in media conditioned by passage 11 HFFs (CMp11). A number of metabolites were secreted by HFFs with significantly higher concentration of lactate, alanine, and formate detected in CMp11 compared to non-conditioned media. In contrast, levels of tryptophan, folate and niacinamide were depleted in CMp11 indicating the utilisation of these metabolites by HFFs. Multivariate statistical analysis of the H-1-NMR data revealed marked age-related differences in the metabolic profile of CMp11 collected from HFFs every 24 h over 72 h. Additionally, the metabolic profile of CMp11 was altered following freezing at -20 degrees C for 2 weeks. CM derived from passage 18 HFFs (CMp18) was found to be ineffective at supporting hESCs in an undifferentiated state beyond 5 days culture. Multivariate statistical comparison of CMp11 and CMp18 metabolic profiles enabled rapid and clear discrimination between the two media with CMp18 containing lower concentrations of lactate and alanine as well as higher concentrations of glucose and glutamine. Conclusions/Significance: H-1-NMR-based metabonomics offers a rapid and accurate method of characterising hESC conditioning media and is a valuable tool for monitoring, controlling and optimising hESC culture media preparation.	[MacIntyre, David A.; Jimenez, Beatriz; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Struct Biochem Lab, Valencia, Spain; [Melguizo Sanchis, Dario; Moreno, Ruben; Stojkovic, Miodrag] Ctr Invest Principe Felipe, Cellular Reprogramming Lab, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center	MacIntyre, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod Dev Biol, Hammersmith Hosp Campus, London, England.	apineda@cipf.es	MacIntyre, David A/D-9267-2012; Pineda-Lucena, Antonio/B-1320-2014	Pineda-Lucena, Antonio/0000-0002-3532-8781; Stojkovic, Miodrag/0000-0001-7526-6573; MacIntyre, David/0000-0002-4186-5567; Melguizo Sanchis, Dario/0000-0002-5728-4345	Fondo de Investigacion Sanitario from Instituto de Salud Carlos III (ISCIII) [CD2006/00133]	Fondo de Investigacion Sanitario from Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III)	DAM is a Marie Curie International Incoming Fellow (PIIF-GA-2008-221484). BJ is supported by a Fondo de Investigacion Sanitario from Instituto de Salud Carlos III (ISCIII) Sara Borrell grant (CD2006/00133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; ANTHONY ML, 1994, MOL PHARMACOL, V46, P199; BALES JR, 1984, CLIN CHEM, V30, P426; Barton RH, 2008, INT J EPIDEMIOL, V37, P31, DOI 10.1093/ije/dym284; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Chin ACP, 2007, J BIOTECHNOL, V130, P320, DOI 10.1016/j.jbiotec.2007.04.013; Choo ABH, 2004, BIOTECHNOL BIOENG, V88, P321, DOI 10.1002/bit.20247; Cobo F, 2005, APPL MICROBIOL BIOT, V68, P456, DOI 10.1007/s00253-005-0062-2; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Jimenez B, 2010, J PROTEOME RES, V9, P5180, DOI 10.1021/pr100486e; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kettapeh-Wold S., 1999, INTRO MULTI MEGAVARI, P213; Lamers RJAN, 2003, J NUTR, V133, P3080, DOI 10.1093/jn/133.10.3080; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Lim JWE, 2002, PROTEOMICS, V2, P1187, DOI 10.1002/1615-9861(200209)2:9<1187::AID-PROT1187>3.0.CO;2-T; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Miccheli AT, 2006, BBA-GEN SUBJECTS, V1760, P1723, DOI 10.1016/j.bbagen.2006.09.009; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; NICHOLSON JK, 1983, BIOCHEM J, V211, P605, DOI 10.1042/bj2110605; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; PINE L, 1989, CAN J MICROBIOL, V35, P245, DOI 10.1139/m89-037; Prowse ABJ, 2007, J PROTEOME RES, V6, P3796, DOI 10.1021/pr0702262; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Sartipy P, 2007, DRUG DISCOV TODAY, V12, P688, DOI 10.1016/j.drudis.2007.07.005; SAUDE E, 2007, METABOLOMICS, V3, P1573; Seagle C, 2008, TISSUE ENG PART C-ME, V14, P107, DOI 10.1089/ten.tec.2007.0401; Shufaro Y, 2004, BEST PRACT RES CL OB, V18, P909, DOI 10.1016/j.bpobgyn.2004.07.002; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TRITSCH GL, 1962, EXP CELL RES, V28, P360, DOI 10.1016/0014-4827(62)90290-2; Willker W., 1996, J MAGN RESON ANAL, V2, P21; Wilson ID, 2005, J PROTEOME RES, V4, P591, DOI 10.1021/pr049769r; Xie CQ, 2004, BIOCHEM BIOPH RES CO, V315, P581, DOI 10.1016/j.bbrc.2004.01.089; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; ZIELKE HR, 1976, P NATL ACAD SCI USA, V73, P4110, DOI 10.1073/pnas.73.11.4110; ZIELKE HR, 1980, J CELL PHYSIOL, V104, P433, DOI 10.1002/jcp.1041040316	47	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16732	10.1371/journal.pone.0016732	http://dx.doi.org/10.1371/journal.pone.0016732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347425	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700030
J	Wang, FY; Tong, RJ; Shi, ZY; Xu, XF; He, XH				Wang, Fa Yuan; Tong, Rui Jian; Shi, Zhao Yong; Xu, Xiao Feng; He, Xin Hua			Inoculations with Arbuscular Mycorrhizal Fungi Increase Vegetable Yields and Decrease Phoxim Concentrations in Carrot and Green Onion and Their Soils	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDE-RESIDUES; POLYCYCLIC AROMATIC-HYDROCARBONS; MICROBIAL COMMUNITY STRUCTURE; PHOSPHATASE-ACTIVITY; NONIONIC SURFACTANT; SPIKED SOIL; DISSIPATION; RHIZOSPHERE; GROWTH; CHINA	Background: As one of the most widely used organophosphate insecticides in vegetable production, phoxim (C12H15N2O3PS) is often found as residues in crops and soils and thus poses a potential threat to public health and environment. Arbuscular mycorrhizal (AM) fungi may make a contribution to the decrease of organophosphate residues in crops and/or the degradation in soils, but such effects remain unknown. Methodology/Principal Findings: A greenhouse pot experiment studied the influence of AM fungi and phoxim application on the growth of carrot and green onion, and phoxim concentrations in the two vegetables and their soil media. Treatments included three AM fungal inoculations with Glomus intraradices BEG 141, G. mosseae BEG 167, and a nonmycorrhizal control, and four phoxim application rates (0, 200, 400, 800 mg l(-1), while 400 mg l(-1) rate is the recommended dose in the vegetable production system). Carrot and green onion were grown in a greenhouse for 130 d and 150 d. Phoxim solution (100 ml) was poured into each pot around the roots 14d before plant harvest. Results showed that mycorrhizal colonization was higher than 70%, and phoxim application inhibited AM colonization on carrot but not on green onion. Compared with the nonmycorrhizal controls, both shoot and root fresh weights of these two vegetables were significantly increased by AM inoculations irrespective of phoxim application rates. Phoxim concentrations in shoots, roots and soils were increased with the increase of phoxim application rate, but significantly decreased by the AM inoculations. Soil phosphatase activity was enhanced by both AM inocula, but not affected by phoxim application rate. In general, G. intraradices BEG 141 had more pronounced effects than G. mosseae BEG 167 on the increase of fresh weight production in both carrot and green onion, and the decrease of phoxim concentrations in plants and soils. Conclusions/Significance: Our results indicate a promising potential of AM fungi for enhancing vegetable production and reducing organophosphorus pesticide residues in plant tissues and their growth media, as well as for the phytoremediation of organophosphorus pesticide-contaminated soils.	[Wang, Fa Yuan; Shi, Zhao Yong; Xu, Xiao Feng] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Tong, Rui Jian] Luoyang Normal Univ, Dept Life Sci, Luoyang, Peoples R China; [He, Xin Hua] Edith Cowan Univ, Sch Nat Resources, Ctr Ecosyst Management, Joondalup, Australia; [He, Xin Hua] Univ Western Australia, State Ctr Excellence Ecohydrol, Crawley, Australia; [He, Xin Hua] Univ Western Australia, Sch Plant Biol, Crawley, Australia	Henan University of Science & Technology; Luoyang Normal University; Edith Cowan University; University of Western Australia; University of Western Australia	Wang, FY (corresponding author), Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China.	wfy1975@163.com	He, Xinhua/B-8047-2015; Wang, F./U-8471-2018	He, Xinhua/0000-0002-5570-3454; Wang, F./0000-0003-1345-256X	National Natural Science Foundation of China [40801120, 40971150]; China Postdoctoral Science Foundation [20080440373, 200902095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by the National Natural Science Foundation of China (grant numbers 40801120, 40971150) (http://www.nsfc.gov.cn/Portal0/default106.htm) and China Postdoctoral Science Foundation funded project (grant numbers 20080440373, 200902095) (http://www.chinapostdoctor.org.cn/new_english/main_en.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PC, 2009, J HAZARD MATER, V165, P1, DOI 10.1016/j.jhazmat.2008.10.061; Bai YH, 2006, FOOD CHEM, V98, P240, DOI 10.1016/j.foodchem.2005.05.070; Cabello MN, 1997, FEMS MICROBIOL ECOL, V22, P233, DOI 10.1016/S0168-6496(96)00094-3; Cairney JWG, 1999, ENVIRON POLLUT, V106, P169, DOI 10.1016/S0269-7491(99)00081-0; Chen C, 2009, FOOD ADDIT CONTAM A, V26, P340, DOI 10.1080/02652030802524516; Criquet S, 2000, BIOTECHNOL LETT, V22, P1733, DOI 10.1023/A:1005604719909; FAO, PEST RES FOOD 1983; Feng G, 2003, APPL SOIL ECOL, V22, P139, DOI 10.1016/S0929-1393(02)00133-6; Franco-Ramirez A, 2007, J BASIC MICROB, V47, P378, DOI 10.1002/jobm.200610293; *GEN ADM QUAL SUP, 2003, 145522003 GBT GEN AD; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez-Arroyo S, 2007, TOXICOL IN VITRO, V21, P950, DOI 10.1016/j.tiv.2007.01.027; HABTE M, 1988, BIOL FERT SOILS, V5, P313, DOI 10.1007/BF00262138; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Huang HL, 2007, ENVIRON POLLUT, V146, P452, DOI 10.1016/j.envpol.2006.07.001; Huang HL, 2009, SOIL BIOL BIOCHEM, V41, P726, DOI 10.1016/j.soilbio.2009.01.009; International Programme on Chemical Safety, 2010, WHO REC CLASS PEST H; Isoda Hiroko, 2005, Environ Sci, V12, P9; JIANG JD, 2004, CHINESE J APPL ECOL, V15, P1459; Jin F, 2010, J PESTIC SCI, V35, P138, DOI 10.1584/jpestics.G10-15; Joner EJ, 2000, MYCOL RES, V104, P81, DOI 10.1017/S0953756299001240; Joner EJ, 2001, MYCORRHIZA, V10, P155, DOI 10.1007/s005720000071; Joner EJ, 2003, ENVIRON SCI TECHNOL, V37, P2371, DOI 10.1021/es020196y; Joner EJ, 2001, ENVIRON SCI TECHNOL, V35, P2773, DOI 10.1021/es000288s; Joner Erik Jautris, 2003, Agronomie (Paris), V23, P495, DOI 10.1051/agro:2003021; Koide RT, 2000, NEW PHYTOL, V148, P511, DOI 10.1046/j.1469-8137.2000.00776.x; Kojima T, 1998, BIOL FERT SOILS, V26, P331, DOI 10.1007/s003740050384; [李芳 Li Fang], 2006, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V12, P104; LU ZR, 1984, ACTA U MED NANJING, V4, P29; Marin M, 2002, AGR FOOD SCI FINLAND, V11, P245, DOI 10.23986/afsci.5728; Menendez A, 1999, Int Microbiol, V2, P43; *MIN AGR CHIN, 2008, 7612008 NYT MIN AGR; NEMEC S, 1985, PLANT SOIL, V85, P543; *PAN PEST, PAN PEST DAT; Pattinson GS, 1997, MYCORRHIZA, V7, P155, DOI 10.1007/s005720050175; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Shen Yu-jia, 2007, Huanjing Kexue, V28, P2833; SREENIVASA MN, 1989, PLANT SOIL, V119, P127, DOI 10.1007/BF02370276; Sun J, 2000, Wei Sheng Yan Jiu, V29, P65; Sun XinGui, 2003, CHINESE J FOOD HYGIE, V15, P536; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; TARAFDAR JC, 1994, SOIL BIOL BIOCHEM, V26, P387, DOI 10.1016/0038-0717(94)90288-7; VEERASWAMY J, 1993, AGR ECOSYST ENVIRON, V43, P337, DOI 10.1016/0167-8809(93)90096-8; Wang J, 1999, CRIT REV PLANT SCI, V18, P403, DOI 10.1016/S0735-2689(99)00374-3; Wang LG, 2008, B ENVIRON CONTAM TOX, V81, P377, DOI 10.1007/s00128-008-9498-2; Whipps JM, 2004, CAN J BOT, V82, P1198, DOI [10.1139/B04-082, 10.1139/b04-082]; White JC, 2006, J HAZARD MATER, V137, P1750, DOI 10.1016/j.jhazmat.2006.05.012; WU JZ, 2006, CHIN J IND MED, V19, P94; Wu NY, 2008, SCI TOTAL ENVIRON, V394, P230, DOI 10.1016/j.scitotenv.2008.02.003; Wu NY, 2008, ENVIRON POLLUT, V151, P569, DOI 10.1016/j.envpol.2007.04.005; ZHAN N, 2000, J HYG RES, V29, P4; [张瑞福 Zhang Ruifu], 2003, [环境科学学报, Acta Scientiae Circumstantiae], V23, P411; ZHENG J, 1999, ANHUI J PREVENT MED, V5, P33	53	22	27	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16949	10.1371/journal.pone.0016949	http://dx.doi.org/10.1371/journal.pone.0016949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347374	gold, Green Published, Green Submitted			2022-12-25	WOS:000287361700055
J	Burghardt, TP				Burghardt, Thomas P.			Single Molecule Fluorescence Image Patterns Linked to Dipole Orientation and Axial Position: Application to Myosin Cross-Bridges in Muscle Fibers	PLOS ONE			English	Article							LEVER-ARM ORIENTATION; LOCALIZATION ANALYSIS; MICROSCOPY; EMISSION; FIELD; GFP; DIFFRACTION	Background: Photoactivatable fluorescent probes developed specifically for single molecule detection extend advantages of single molecule imaging to high probe density regions of cells and tissues. They perform in the native biomolecule environment and have been used to detect both probe position and orientation. Methods and Findings: Fluorescence emission from a single photoactivated probe captured in an oil immersion, high numerical aperture objective, produces a spatial pattern on the detector that is a linear combination of 6 independent and distinct spatial basis patterns with weighting coefficients specifying emission dipole orientation. Basis patterns are tabulated for single photoactivated probes labeling myosin cross-bridges in a permeabilized muscle fiber undergoing total internal reflection illumination. Emitter proximity to the glass/aqueous interface at the coverslip implies the dipole near-field and dipole power normalization are significant affecters of the basis patterns. Other characteristics of the basis patterns are contributed by field polarization rotation with transmission through the microscope optics and refraction by the filter set. Pattern recognition utilized the generalized linear model, maximum likelihood fitting, for Poisson distributed uncertainties. This fitting method is more appropriate for treating low signal level photon counting data than x 2 minimization. Conclusions: Results indicate that emission dipole orientation is measurable from the intensity image except for the ambiguity under dipole inversion. The advantage over an alternative method comparing two measured polarized emission intensities using an analyzing polarizer is that information in the intensity spatial distribution provides more constraints on fitted parameters and a single image provides all the information needed. Axial distance dependence in the emission pattern is also exploited to measure relative probe position near focus. Single molecule images from axial scanning fitted simultaneously boost orientation and axial resolution in simulation.	[Burghardt, Thomas P.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Burghardt, Thomas P.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Burghardt, TP (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	burghardt@mayo.edu			United States National Instutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR049277]; National Heart Lung Blood Institute (NHLBI) [R01HL095572]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049277] Funding Source: NIH RePORTER	United States National Instutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart Lung Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The research was supported by United States National Instutes of Health: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant R01AR049277, National Heart Lung Blood Institute (NHLBI) grant R01HL095572, and by the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio D, 2007, BIOPHYS J, V93, P232, DOI 10.1529/biophysj.106.102319; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Axelrod D, 2006, NAT REV MOL CELL BIO, V7, P944, DOI 10.1038/nrm2062; Bartko AP, 1999, J PHYS CHEM B, V103, P3053, DOI 10.1021/jp9846330; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; Bohmer M, 2003, J OPT SOC AM B, V20, P554, DOI 10.1364/JOSAB.20.000554; BORN M, 1975, PRINCIPLES OPTICS, pCH10; Burghardt TP, 2007, BIOPHYS J, V93, P2226, DOI 10.1529/biophysj.107.107433; Burghardt Thomas P, 2010, Biophys Rev, V2, P159, DOI 10.1007/s12551-010-0038-z; Burghardt TP, 2009, BIOCHEMISTRY-US, V48, P754, DOI 10.1021/bi8017703; BURGHARDT TP, 1984, OPT ENG, V23, P62, DOI 10.1117/12.7973254; HELLEN EH, 1987, J OPT SOC AM B, V4, P337, DOI 10.1364/JOSAB.4.000337; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Lieb MA, 2004, J OPT SOC AM B, V21, P1210, DOI 10.1364/JOSAB.21.001210; Mattheyses AL, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2052867; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/NMETH.1447, 10.1038/nmeth.1447]; RICHARDS B, 1959, PROC R SOC LON SER-A, V253, P358, DOI 10.1098/rspa.1959.0200; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Stoneking MR, 1997, REV SCI INSTRUM, V68, P914, DOI 10.1063/1.1147768; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X	22	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16772	10.1371/journal.pone.0016772	http://dx.doi.org/10.1371/journal.pone.0016772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347442	Green Submitted, Green Published, gold			2022-12-25	WOS:000287077600024
J	Uschakov, A; Grivel, J; Cvetkovic-Lopes, V; Bayer, L; Bernheim, L; Jones, BE; Muhlethaler, M; Serafin, M				Uschakov, Aaron; Grivel, Jeremy; Cvetkovic-Lopes, Vesna; Bayer, Laurence; Bernheim, Laurent; Jones, Barbara E.; Muehlethaler, Michel; Serafin, Mauro			Sleep-Deprivation Regulates alpha-2 Adrenergic Responses of Rat Hypocretin/Orexin Neurons	PLOS ONE			English	Article							OREXIN NEURONS; RGS PROTEINS; WAKEFULNESS; CHANNELS; CATECHOLAMINES; NORADRENALINE; TRAFFICKING; NARCOLEPSY; RECEPTORS; COMPLEX	We recently demonstrated, in rat brain slices, that the usual excitation by noradrenaline (NA) of hypocretin/orexin (hcrt/orx) neurons was changed to an inhibition following sleep deprivation (SD). Here we describe that in control condition (CC), i.e. following 2 hours of natural sleep in the morning, the alpha(2)-adrenergic receptor (alpha(2)-AR) agonist, clonidine, had no effect on hcrt/orx neurons, whereas following 2 hours of SD (SDC), it hyperpolarized the neurons by activating G-protein-gated inwardly rectifying potassium (GIRK) channels. Since concentrations of clonidine up to a thousand times (100 mu M) higher than those effective in SDC (100 nM), were completely ineffective in CC, a change in the availability of G-proteins is unlikely to explain the difference between the two conditions. To test whether the absence of effect of clonidine in CC could be due to a down-regulation of GIRK channels, we applied baclofen, a GABA(B) agonist known to also activate GIRK channels, and found that it hyperpolarized hcrt/orx neurons in that condition. Moreover, baclofen occluded the response to clonidine in SDC, indicating that absence of effect of clonidine in CC could not be attributed to down-regulation of GIRK channels. We finally tested whether alpha(2)-ARs were still available at the membrane in CC and found that clonidine could reduce calcium currents, indicating that alpha(2)-ARs associated with calcium channels remain available in that condition. Taken together, these results suggest that a pool of alpha(2)-ARs associated with GIRK channels is normally down-regulated (or desensitized) in hcrt/orx neurons to only become available for their inhibition following sleep deprivation.	[Uschakov, Aaron; Grivel, Jeremy; Cvetkovic-Lopes, Vesna; Bayer, Laurence; Bernheim, Laurent; Muehlethaler, Michel; Serafin, Mauro] Ctr Med Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland; [Jones, Barbara E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	University of Geneva; McGill University	Uschakov, A (corresponding author), Ctr Med Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland.	mauro.serafin@unige.ch	Jones, Barbara E/A-8033-2017		Swiss Fonds National [31003A-113996]	Swiss Fonds National	Swiss Fonds National 31003A-113996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; ALFOLDI P, 1990, AM J PHYSIOL, V258, pR634, DOI 10.1152/ajpregu.1990.258.3.R634; Andretic R, 2008, ANNU REV GENET, V42, P361, DOI 10.1146/annurev.genet.42.110807.091541; Bayer L, 2005, NEUROSCIENCE, V130, P807, DOI 10.1016/j.neuroscience.2004.10.032; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; Eggermann E, 2003, J NEUROSCI, V23, P1557; Grivel J, 2005, J NEUROSCI, V25, P4127, DOI 10.1523/JNEUROSCI.0666-05.2005; HANK PJ, 2008, EUROPEAN J NEUROSCIE, V27, P2433; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Jones BE, 2005, HYPOCRETINS: INTEGRATORS OF PHYSIOLOGICAL FUNCTIONS, P289; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Li Y, 2005, J NEUROSCI, V25, P173, DOI 10.1523/JNEUROSCI.4015-04.2005; Lomazzi M, 2008, TRENDS PHARMACOL SCI, V29, P544, DOI 10.1016/j.tips.2008.07.011; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Peyron C, 1998, J NEUROSCI, V18, P9996; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saunders C, 1999, PHARMACOL THERAPEUT, V84, P193, DOI 10.1016/S0163-7258(99)00032-7; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; TONONI G, 1994, BRAIN RES BULL, V35, P589, DOI 10.1016/0361-9230(94)90173-2; VEA V, 2004, EUR J NEURO IN PRESS; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yamanaka A, 2006, J NEUROPHYSIOL, V96, P284, DOI 10.1152/jn.01361.2005; Zeitzer JM, 2006, TRENDS PHARMACOL SCI, V27, P368, DOI 10.1016/j.tips.2006.05.006	33	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16672	10.1371/journal.pone.0016672	http://dx.doi.org/10.1371/journal.pone.0016672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347440	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600014
J	Michael, DR; Phillips, AO; Krupa, A; Martin, J; Redman, JE; Altaher, A; Neville, RD; Webber, J; Kim, MY; Bowen, T				Michael, Daryn R.; Phillips, Aled O.; Krupa, Aleksandra; Martin, John; Redman, James E.; Altaher, Abdalsamed; Neville, Rachel D.; Webber, Jason; Kim, Min-young; Bowen, Timothy			The Human Hyaluronan Synthase 2 (HAS2) Gene and Its Natural Antisense RNA Exhibit Coordinated Expression in the Renal Proximal Tubular Epithelial Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC-NEPHROPATHY; ACID RECEPTOR; FIBROSIS; TRANSCRIPTION; PROMOTER; DISEASE; CANCER; PROLIFERATION; BIOSYNTHESIS; INSIGHTS	Aberrant expression of the human hyaluronan synthase 2 (HAS2) gene has been implicated in the pathology of malignancy, pulmonary arterial hypertension, osteoarthritis, asthma, thyroid dysfunction, and large organ fibrosis. Renal fibrosis is associated with increased cortical synthesis of hyaluronan (HA), an extracellular matrix glycosaminoglycan, and we have shown that HA is a correlate of interstitial fibrosis in vivo. Our previous in vitro data have suggested that both HAS2 transcriptional induction and subsequent HAS2-driven HA synthesis may contribute to kidney fibrosis via phenotypic modulation of the renal proximal tubular epithelial cell (PTC). Post-transcriptional regulation of HAS2 mRNA synthesis by the natural antisense RNA HAS2-AS1 has recently been described in osteosarcoma cells, but the antisense transcript was not detected in kidney. In this study, PTC stimulation with IL-1 beta or TGF-beta 1 induced coordinated temporal profiles of HAS2-AS1 and HAS2 transcription. Constitutive activity of the putative HAS2-AS1 promoter was demonstrated, and transcription factor-binding sequence motifs were identified. Knockdown of Sp1/Sp3 expression by siRNA blunted IL-1 beta induction of both HAS2-AS1 and HAS2, and Smad2/Smad3 knockdown similarly attenuated TGF-beta 1 stimulation. Inhibition of IL-1 beta-stimulated HAS2-AS1 RNA induction using HAS2-AS1-specific siRNAs also suppressed up-regulation of HAS2 mRNA transcription. The thermodynamic feasibility of HAS2-AS1/HAS2 heterodimer formation was demonstrated in silico, and locus-specific cytoplasmic double-stranded RNA was detected in vitro. In summary, our data show that transcriptional induction of HAS2-AS1 and HAS2 occurs simultaneously in PTCs and suggest that transcription of the antisense RNA stabilizes or augments HAS2 mRNA expression in these cells via RNA/mRNA heteroduplex formation.	[Michael, Daryn R.; Phillips, Aled O.; Krupa, Aleksandra; Martin, John; Altaher, Abdalsamed; Neville, Rachel D.; Webber, Jason; Kim, Min-young; Bowen, Timothy] Cardiff Univ, Inst Nephrol, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Phillips, Aled O.; Martin, John; Neville, Rachel D.; Bowen, Timothy] Cardiff Medictr, Cardiff Inst Tissue Engn & Repair, Cardiff CF14 4UJ, S Glam, Wales; [Redman, James E.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Bowen, T (corresponding author), Cardiff Univ, Inst Nephrol, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	bowent@cf.ac.uk	Webber, Jason P/O-1960-2017; Redman, James/B-7175-2008	Webber, Jason P/0000-0003-4772-3014; Redman, James/0000-0001-5492-2869	Libyan Government; Cardiff University School of Medicine; St. John's College (Cardiff, United Kingdom)	Libyan Government; Cardiff University School of Medicine; St. John's College (Cardiff, United Kingdom)	Recipient of a research fellowship from the Libyan Government.; Recipient of a Ph.D. studentship from the Cardiff University School of Medicine.; Recipient of a Nuffield Science Bursary coordinated by the Techniquest Science Discovery Centre (Cardiff, United Kingdom) and supported by St. John's College (Cardiff, United Kingdom).	Andhare RA, 2009, OSTEOARTHR CARTILAGE, V17, P892; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Carninci P, 2008, CURR OPIN CELL BIOL, V20, P274, DOI 10.1016/j.ceb.2008.03.008; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200; Dallosso AR, 2007, RNA, V13, P2287, DOI 10.1261/rna.562907; El-Chemaly S, 2009, P NATL ACAD SCI USA, V106, P3958, DOI 10.1073/pnas.0813368106; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Gingeras TR, 2007, GENOME RES, V17, P682, DOI 10.1101/gr.6525007; Gressner OA, 2007, J CELL MOL MED, V11, P1031, DOI 10.1111/j.1582-4934.2007.00092.x; HOFACKER WF, 1994, MONATSHEFTE CHEM CHE, V125, P167; Hoogendoorn B, 2003, HUM MOL GENET, V12, P2249, DOI 10.1093/hmg/ddg246; Hurst SM, 2002, J IMMUNOL, V169, P5244, DOI 10.4049/jimmunol.169.9.5244; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo DD, 2009, NEPHROL DIAL TRANSPL, V24, P2655, DOI 10.1093/ndt/gfp208; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Monslow J, 2004, J BIOL CHEM, V279, P20576, DOI 10.1074/jbc.M312666200; Monslow J, 2003, INT J BIOCHEM CELL B, V35, P1272, DOI 10.1016/S1357-2725(03)00048-7; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Nobili V, 2009, GASTROENTEROLOGY, V136, P160, DOI 10.1053/j.gastro.2008.09.013; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; Sayo T, 2002, J INVEST DERMATOL, V118, P43, DOI 10.1046/j.0022-202x.2001.01613.x; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Soares LMM, 2006, EMBO J, V25, P923, DOI 10.1038/sj.emboj.7601023; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052	46	67	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19523	19532		10.1074/jbc.M111.233916	http://dx.doi.org/10.1074/jbc.M111.233916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21357421	Green Published, hybrid			2022-12-25	WOS:000291027700035
J	Dou, XW; Menkari, CE; Shanmugasundararaj, S; Miller, KW; Charness, ME				Dou, Xiaowei; Menkari, Carrie E.; Shanmugasundararaj, Sivananthaperumal; Miller, Keith W.; Charness, Michael E.			Two Alcohol Binding Residues Interact across a Domain Interface of the L1 Neural Cell Adhesion Molecule and Regulate Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOPHILIC ADHESION; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; ETHANOL; MUTATIONS; INHIBITION; MECHANISM; RECEPTOR; PROTEIN; CUTOFF	Ethanol may cause fetal alcohol spectrum disorders (FASD) in part by inhibiting cell adhesion mediated by the L1 neural cell adhesion molecule. Azialcohols photolabel Glu-33 and Tyr-418, two residues that are predicted by homology modeling to lie within 2.8 angstrom of each other at the interface between the Ig1 and Ig4 domains of L1 (Arevalo, E., Shanmugasundararaj, S., Wilkemeyer, M. F., Dou, X., Chen, S., Charness, M. E., and Miller, K. W. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 371-375). Using transient transfection of NIH/3T3 cells with wild type (WT-L1) and mutated L1, we found that cysteine substitution of both residues (E33C/Y418C-L1) significantly increased L1 adhesion above levels observed for WT-L1 or the single cysteine substitutions E33C-L1 or Y418C-L1. The reducing agent beta-mercaptoethanol (beta ME) reversibly decreased the adhesion of E33C/Y418C-L1, but had no effect on WT-L1, E33C-L1, or Y418C-L1. Thus, disulfide bond formation occurs between Cys-33 and Cys-418, confirming both the close proximity of these residues and the importance of Ig1-Ig4 interactions in L1 adhesion. Maximal ethanol inhibition of cell adhesion was significantly lower in cells expressing E33C/Y418C-L1 than in those expressing WT-L1, E33C-L1, or Y418C-L1. Moreover, the effects of beta ME and ethanol on E33C/Y418C-L1 adhesion were non-additive. The cutoff for alcohol inhibition of WT-L1 adhesion was between 1-butanol and 1-pentanol. Increasing the size of the alcohol binding pocket by mutating Glu-33 to Ala-33, increased the alcohol cutoff from 1-butanol to 1-decanol. These findings support the hypothesis that alcohol binding within a pocket bordered by Glu-33 and Tyr-418 inhibits L1 adhesion by disrupting the Ig1-Ig4 interaction.	[Dou, Xiaowei; Menkari, Carrie E.; Charness, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Vet Affairs Boston Healthcare Syst, W Roxbury, MA 02132 USA; [Shanmugasundararaj, Sivananthaperumal; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Charness, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Vet Affairs Boston Healthcare Syst, W Roxbury, MA 02132 USA.	mcharness@hms.harvard.edu	Dou, Xiaowei/ABC-8814-2021	Charness, Michael/0000-0002-3301-8966	NIAAA, National Institutes of Health [R37-AA12974]; NIAAA, as a component of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders [U24-AA014811]; Medical Research Service, Dept. of Veterans Affairs; Dept. of Anesthesia and Critical Care, MA General Hospital; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA014811, R37AA012974] Funding Source: NIH RePORTER	NIAAA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA, as a component of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Service, Dept. of Veterans Affairs(US Department of Veterans Affairs); Dept. of Anesthesia and Critical Care, MA General Hospital; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by NIAAA, National Institutes of Health Grant R37-AA12974 (to M. E. C.); NIAAA U24-AA014811, as a component of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (to M. E. C.); the Medical Research Service, Dept. of Veterans Affairs (to M. E. C.); and the Dept. of Anesthesia and Critical Care, MA General Hospital (to K. W. M.).	ABEL EL, 1986, LANCET, V2, P1222; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; Bateman A, 1996, EMBO J, V15, P6050, DOI 10.1002/j.1460-2075.1996.tb00993.x; Bearer CF, 1999, J BIOL CHEM, V274, P13264, DOI 10.1074/jbc.274.19.13264; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; CHARNESS ME, 1994, J BIOL CHEM, V269, P9304; Chen MM, 2010, MOL BIOL CELL, V21, P1671, DOI 10.1091/mbc.E09-10-0900; Chen SY, 2005, DEV NEUROSCI-BASEL, V27, P13, DOI 10.1159/000084528; Chen SY, 2001, FASEB J, V15, P1649, DOI 10.1096/fj.00-0862fje; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; FRANKS NP, 1985, NATURE, V316, P349, DOI 10.1038/316349a0; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Goodlett CR, 2001, ALCOHOL RES HEALTH, V25, P175; Gouveia RM, 2008, J BIOL CHEM, V283, P28038, DOI 10.1074/jbc.M804991200; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Parnell SE, 2007, ALCOHOL CLIN EXP RES, V31, P2059, DOI 10.1111/j.1530-0277.2007.00524.x; PRINGLE MJ, 1981, MOL PHARMACOL, V19, P49; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Spong CY, 2001, J PHARMACOL EXP THER, V297, P774; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Wilkemeyer MF, 2004, J PHARMACOL EXP THER, V309, P1183, DOI 10.1124/jpet.103.063818; Wilkemeyer MF, 1999, ALCOHOL CLIN EXP RES, V23, P1711, DOI 10.1097/00000374-199911000-00002; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Wilkemeyer MF, 2002, MOL PHARMACOL, V62, P1053, DOI 10.1124/mol.62.5.1053; Wilkemeyer MF, 2002, J PHARMACOL EXP THER, V303, P110, DOI 10.1124/jpet.102.036277; Wilkemeyer WF, 2000, P NATL ACAD SCI USA, V97, P3690, DOI 10.1073/pnas.97.7.3690; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; Yeaney NK, 2009, J NEUROCHEM, V110, P779, DOI 10.1111/j.1471-4159.2009.06143.x; Zhou FC, 2004, J MOL NEUROSCI, V24, P189, DOI 10.1385/JMN:24:2:189	44	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.209254	http://dx.doi.org/10.1074/jbc.M110.209254			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21367865	Green Published, hybrid			2022-12-25	WOS:000290022800053
J	Amano, Y; Yamashita, Y; Kojima, K; Yoshino, K; Tanaka, N; Sugamura, K; Takeshita, T				Amano, Yuji; Yamashita, Yuki; Kojima, Katsuhiko; Yoshino, Kazuhisa; Tanaka, Nobuyuki; Sugamura, Kazuo; Takeshita, Toshikazu			Hrs Recognizes a Hydrophobic Amino Acid Cluster in Cytokine Receptors during Ubiquitin-independent Endosomal Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCING ADAPTER MOLECULE; HUMAN IL-2 RECEPTOR; FACTOR-II RECEPTOR; ESCRT-III; PLASMA-MEMBRANE; GAMMA-CHAIN; TYROSINE PHOSPHORYLATION; RAPID INTERNALIZATION; MONOCLONAL-ANTIBODIES; CYTOPLASMIC TAIL	Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) is a component of the ESCRT-0 protein complex that captures ubiquitylated cargo proteins and sorts them to the lysosomal pathway. Although Hrs acts as a key transporter for ubiquitin-dependent endosomal sorting, we previously reported that Hrs is also involved in ubiquitin-independent endosomal sorting of interleukin-2 receptor beta (IL-2R beta). Here, we show direct interactions between bacterially expressed Hrs and interleukin-4 receptor alpha (IL-4R alpha), indicating that their binding is not required for ubiquitylation of the receptors, similar to the case for IL-2R beta. Examinations of the Hrs binding regions of the receptors reveal that a hydrophobic amino acid cluster in both IL-2R beta and IL-4R alpha is essential for the binding. Whereas the wild-type receptors are delivered to LAMP1-positive late endosomes, mutant receptors lacking the hydrophobic amino acid cluster are sorted to lysobisphosphatidic acid-positive late endosomes rather than LAMP1-positive late endosomes. We also show that the degradation of these mutant receptors is attenuated. Accordingly, Hrs functions during ubiquitin-independent endosomal sorting of the receptors by recognizing the hydrophobic amino acid cluster. These findings suggest the existence of a group of cargo proteins that have this hydrophobic amino acid cluster as a ubiquitin-independent sorting signal.	[Amano, Yuji; Yamashita, Yuki; Kojima, Katsuhiko; Yoshino, Kazuhisa; Takeshita, Toshikazu] Shinshu Univ, Sch Med, Dept Microbiol & Immunol, Nagano 3908621, Japan; [Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Tanaka, Nobuyuki] Div Immunol, Natori, Miyagi 9811293, Japan	Shinshu University; Miyagi Cancer Center	Takeshita, T (corresponding author), Shinshu Univ, Sch Med, Dept Microbiol & Immunol, 3-1-1 Asahi, Nagano 3908621, Japan.	takesit@shinshu-u.ac.jp	Takeshita, Toshikazu/AAL-1382-2021		 [C21590530]		This work was supported in part by a Grant-in-aid for Scientific Research C21590530 (to T. T.).	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; HARADA N, 1992, J BIOL CHEM, V267, P22752; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; ISHII N, 1994, INT IMMUNOL, V6, P1273, DOI 10.1093/intimm/6.8.1273; JADOT M, 1992, J BIOL CHEM, V267, P11069; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; OHBO K, 1991, J IMMUNOL METHODS, V142, P61, DOI 10.1016/0022-1759(91)90293-O; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Suzuki J, 1989, Int Immunol, V1, P373, DOI 10.1093/intimm/1.4.373; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; TANAKA Y, 1985, MICROBIOL IMMUNOL, V29, P959, DOI 10.1111/j.1348-0421.1985.tb02960.x; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yamashita Y, 2008, J CELL SCI, V121, P1727, DOI 10.1242/jcs.024455; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	52	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15458	15472		10.1074/jbc.M110.191924	http://dx.doi.org/10.1074/jbc.M110.191924			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21362618	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000289788300074
J	Spehr, J; Gelis, L; Osterloh, M; Oberland, S; Hatt, H; Spehr, M; Neuhaus, EM				Spehr, Jennifer; Gelis, Lian; Osterloh, Markus; Oberland, Sonja; Hatt, Hanns; Spehr, Marc; Neuhaus, Eva M.			G Protein-coupled Receptor Signaling via Src Kinase Induces Endogenous Human Transient Receptor Potential Vanilloid Type 6 (TRPV6) Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER EPITHELIAL-CELLS; HUMAN PROSTATE-CANCER; CA2+-PERMEABLE CATIONIC CHANNELS; OPERATED CA2+ CHANNELS; CALCIUM-CHANNEL; PORE PROPERTIES; 2-AMINOETHYLDIPHENYL BORATE; ADENYLATE-CYCLASE; MAST-CELLS; INHIBITION	Ca2+ homeostasis plays a critical role in a variety of cellular processes. We showed previously that stimulation of the prostate-specific G protein-coupled receptor (PSGR) enhances cytosolic Ca2+ and inhibits proliferation of prostate cells. Here, we analyzed the signaling mechanisms underlying the PSGR-mediated Ca2+ increase. Using complementary molecular, biochemical, electrophysiological, and live-cell imaging techniques, we found that endogenous Ca2+-selective transient receptor potential vanilloid type 6 (TRPV6) channels are critically involved in the PSGR-induced Ca2+ signal. Biophysical characterization of the current activated by PSGR stimulation revealed characteristic properties of TRPV6. The molecular identity of the involved channel was confirmed using RNA interference targeting TrpV6. TRPV6-mediated Ca2+ influx depended on Src kinase activity. Src kinase activation occurred independently of G protein activation, presumably by direct interaction with PSGR. Taken together, we report that endogenous TRPV6 channels are activated downstream of a G protein-coupled receptor and present the first physiological characterization of these channels in situ.	[Spehr, Jennifer; Spehr, Marc] RTWH Aachen Univ, Dept Chemosensat, D-52074 Aachen, Germany; [Spehr, Jennifer; Gelis, Lian; Osterloh, Markus; Hatt, Hanns] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany; [Oberland, Sonja; Neuhaus, Eva M.] Charite, NeuroSci Res Ctr, D-10117 Berlin, Germany	RWTH Aachen University; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spehr, J (corresponding author), Rhein Westfal TH Aachen, Dept Chemosensor, 42D,Worringer Weg 1, D-52074 Aachen, Germany.	j.spehr@sensorik.rwth-aachen.de	Spehr, Marc/B-3140-2011; Spehr, Marc/AAK-3162-2021; Neuhaus, Eva M./L-1428-2015	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Neuhaus, Eva M./0000-0003-3363-1231	Deutsche Forschungsgemeinschaft [SFB642, EXC257, SP724/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SFB642, EXC257, and SP724/2-1).	Avila G, 2007, J PHYSIOL-LONDON, V584, P47, DOI 10.1113/jphysiol.2007.137687; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bodding M, 2005, J BIOL CHEM, V280, P7022, DOI 10.1074/jbc.M410184200; Bodding M, 2003, J BIOL CHEM, V278, P50872, DOI 10.1074/jbc.M308800200; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cox ME, 2000, J BIOL CHEM, V275, P13812, DOI 10.1074/jbc.275.18.13812; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Garcia DE, 1998, J NEUROSCI, V18, P2834; GUELLAEN G, 1977, BIOCHIM BIOPHYS ACTA, V484, P465, DOI 10.1016/0005-2744(77)90102-4; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Kawasaki BT, 2006, P NATL ACAD SCI USA, V103, P335, DOI 10.1073/pnas.0508030102; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; MA JY, 1994, P NATL ACAD SCI USA, V91, P12351, DOI 10.1073/pnas.91.25.12351; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; Sanchez MG, 2005, EUR J PHARMACOL, V515, P20, DOI 10.1016/j.ejphar.2005.04.010; Schindl R, 2002, J BIOL CHEM, V277, P26950, DOI 10.1074/jbc.M203700200; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SHAH GV, 1994, ENDOCRINOLOGY, V134, P596, DOI 10.1210/en.134.2.596; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Sternfeld L, 2005, CELL SIGNAL, V17, P951, DOI 10.1016/j.cellsig.2004.11.012; Sternfeld L, 2007, CELL CALCIUM, V42, P91, DOI 10.1016/j.ceca.2006.11.008; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Sydorenko V, 2003, J PHYSIOL-LONDON, V548, P823, DOI 10.1113/jphysiol.2002.036772; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Thebault S, 2003, J CLIN INVEST, V111, P1691, DOI 10.1172/JCI200316293; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Vanden Abeele F, 2003, J BIOL CHEM, V278, P15381, DOI 10.1074/jbc.M212106200; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Vennekens R, 2001, J PHYSIOL-LONDON, V530, P183, DOI 10.1111/j.1469-7793.2001.0183l.x; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Wozny C, 2008, J NEUROSCI, V28, P14358, DOI 10.1523/JNEUROSCI.4973-08.2008; Xu LL, 2000, CANCER RES, V60, P6568; Yeh BI, 2003, J BIOL CHEM, V278, P51044, DOI 10.1074/jbc.M306326200; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Yun HM, 2007, J BIOL CHEM, V282, P5496, DOI 10.1074/jbc.M606215200; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	61	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13184	13192		10.1074/jbc.M110.183525	http://dx.doi.org/10.1074/jbc.M110.183525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349844	Green Published, hybrid			2022-12-25	WOS:000289282200039
J	Trainor, BC; Pride, MC; Landeros, RV; Knoblauch, NW; Takahashi, EY; Silva, AL; Crean, KK				Trainor, Brian C.; Pride, Michael C.; Landeros, Rosalina Villalon; Knoblauch, Nicholas W.; Takahashi, Elizabeth Y.; Silva, Andrea L.; Crean, Katie K.			Sex Differences in Social Interaction Behavior Following Social Defeat Stress in the Monogamous California Mouse (Peromyscus californicus)	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CONDITIONED DEFEAT; DOPAMINE RELEASE; LIFE EVENTS; DEPRESSION; MICE; AGGRESSION; RECEPTORS; FEMALE; PHOTOPERIOD	Stressful life experiences are known to be a precipitating factor for many mental disorders. The social defeat model induces behavioral responses in rodents (e.g. reduced social interaction) that are similar to behavioral patterns associated with mood disorders. The model has contributed to the discovery of novel mechanisms regulating behavioral responses to stress, but its utility has been largely limited to males. This is disadvantageous because most mood disorders have a higher incidence in women versus men. Male and female California mice (Peromyscus californicus) aggressively defend territories, which allowed us to observe the effects of social defeat in both sexes. In two experiments, mice were exposed to three social defeat or control episodes. Mice were then behaviorally phenotyped, and indirect markers of brain activity and corticosterone responses to a novel social stimulus were assessed. Sex differences in behavioral responses to social stress were long lasting (4 wks). Social defeat reduced social interaction responses in females but not males. In females, social defeat induced an increase in the number of phosphorylated CREB positive cells in the nucleus accumbens shell after exposure to a novel social stimulus. This effect of defeat was not observed in males. The effects of defeat in females were limited to social contexts, as there were no differences in exploratory behavior in the open field or light-dark box test. These data suggest that California mice could be a useful model for studying sex differences in behavioral responses to stress, particularly in neurobiological mechanisms that are involved with the regulation of social behavior.	[Trainor, Brian C.; Pride, Michael C.; Landeros, Rosalina Villalon; Knoblauch, Nicholas W.; Takahashi, Elizabeth Y.; Silva, Andrea L.; Crean, Katie K.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis	Trainor, BC (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	bctrainor@ucdavis.edu	Trainor, Brian C./L-3618-2016	Trainor, Brian C./0000-0002-4627-5478; Villalon Landeros, Rosalina/0000-0001-5022-5935; Knoblauch, Nicholas/0000-0002-2890-6520	National Institutes of Health [R21 MH090392]; UC Davis; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH090392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant R21 MH090392 and a UC Davis Academic Senate Grant to BCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Becker JB, 2007, J NEUROSCI, V27, P11851, DOI 10.1523/JNEUROSCI.3565-07.2007; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; Cooper MA, 2005, BEHAV NEUROSCI, V119, P1042, DOI 10.1037/0735-7044.119.4.1042; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Davis ES, 2004, NEUROSCIENCE, V127, P611, DOI 10.1016/j.neuroscience.2004.05.034; Davis ES, 2003, HORM BEHAV, V44, P185, DOI 10.1016/S0018-506X(03)00128-4; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Dudman JT, 2003, J NEUROCHEM, V87, P922, DOI 10.1046/j.1471-4159.2003.02067.x; Ferris MJ, 2007, INT J DEV NEUROSCI, V25, P445, DOI 10.1016/j.ijdevneu.2007.08.009; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fuxjager MJ, 2010, P NATL ACAD SCI USA, V107, P12393, DOI 10.1073/pnas.1001394107; Fuxjager MJ, 2009, HORM BEHAV, V56, P214, DOI 10.1016/j.yhbeh.2009.04.009; Glasper ER, 2005, BRAIN BEHAV IMMUN, V19, P61, DOI 10.1016/j.bbi.2004.03.002; Goel N, 2008, ENDOCRINOLOGY, V149, P6399, DOI 10.1210/en.2008-0433; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Huhman KL, 2003, HORM BEHAV, V44, P293, DOI 10.1016/j.yhbeh.2003.05.001; Huhman KL, 2005, BIOL AGGRESSION, P295; Jasnow AM, 2004, BEHAV NEUROSCI, V118, P1052, DOI 10.1037/0735-7044.118.5.1052; Jasnow AM, 2001, BRAIN RES, V920, P142, DOI 10.1016/S0006-8993(01)03054-2; KAHN MW, 1961, J GENET PSYCHOL, V98, P211, DOI 10.1080/00221325.1961.10534371; Keller J, 2006, BIOL PSYCHIAT, V60, P275, DOI 10.1016/j.biopsych.2005.10.014; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kercmar J, 2011, BEHAV BRAIN RES, V216, P647, DOI 10.1016/j.bbr.2010.09.007; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kudryavtseva NN, 2002, BEHAV BRAIN RES, V133, P83, DOI 10.1016/S0166-4328(01)00443-0; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Lim MM, 2005, J COMP NEUROL, V487, P75, DOI 10.1002/cne.20532; Markham CM, 2008, LEARN MEMORY, V15, P6, DOI 10.1101/lm.768208; Meerlo, 1996, Stress, V1, P21; Meerlo P, 1999, J NEUROENDOCRINOL, V11, P925; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nazarian A, 2009, PSYCHOPHARMACOLOGY, V203, P641, DOI 10.1007/s00213-008-1411-5; NELSON RJ, 1995, PHYSIOL BEHAV, V57, P1175, DOI 10.1016/0031-9384(94)00380-N; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Overli O, 2004, HORM BEHAV, V45, P324, DOI 10.1016/j.yhbeh.2004.01.001; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; POTEGAL M, 1993, BEHAV NEURAL BIOL, V60, P93, DOI 10.1016/0163-1047(93)90159-F; Prendergast BJ, 2001, Q REV BIOL, V76, P293, DOI 10.1086/393989; RIBBLE DO, 1990, BEHAV ECOL SOCIOBIOL, V26, P9; Ruis MAW, 1999, PSYCHONEUROENDOCRINO, V24, P285, DOI 10.1016/S0306-4530(98)00050-X; SACHAR EJ, 1973, ARCH GEN PSYCHIAT, V28, P19; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schneier FR, 2000, AM J PSYCHIAT, V157, P457, DOI 10.1176/appi.ajp.157.3.457; Schneier FR, 2009, DEPRESS ANXIETY, V26, P411, DOI 10.1002/da.20543; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Silva AL, 2010, BEHAV BRAIN RES, V208, P528, DOI 10.1016/j.bbr.2009.12.038; STEINMAN MQ, 2011, EUR J NEURO IN PRESS; Szego EM, 2006, J NEUROSCI, V26, P4104, DOI 10.1523/JNEUROSCI.0222-06.2006; Ter Horst GJ, 2009, PHYSIOL BEHAV, V97, P239, DOI 10.1016/j.physbeh.2009.02.036; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Tiihonen J, 1997, AM J PSYCHIAT, V154, P239; Trainor BC, 2010, NEUROSCIENCE, V165, P325, DOI 10.1016/j.neuroscience.2009.10.050; Trainor BC, 2004, HORM BEHAV, V45, P115, DOI 10.1016/j.yhbeh.2003.09.006; Trainor BC, 2008, HORM BEHAV, V53, P192, DOI 10.1016/j.yhbeh.2007.09.016; Trainor BC, 2006, GEN COMP ENDOCR, V148, P252, DOI 10.1016/j.ygcen.2006.03.006; Trainor BC, 2010, HORM BEHAV, V58, P506, DOI 10.1016/j.yhbeh.2010.04.008; van Kampen Marja, 2002, Stress, V5, P37; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.0.CO;2-0; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3	76	104	104	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17405	10.1371/journal.pone.0017405	http://dx.doi.org/10.1371/journal.pone.0017405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364768	Green Published, gold, Green Submitted			2022-12-25	WOS:000287764100055
J	Di Meglio, P; Di Cesare, A; Laggner, U; Chu, CC; Napolitano, L; Villanova, F; Tosi, I; Capon, F; Trembath, RC; Peris, K; Nestle, FO				Di Meglio, Paola; Di Cesare, Antonella; Laggner, Ute; Chu, Chung-Ching; Napolitano, Luca; Villanova, Federica; Tosi, Isabella; Capon, Francesca; Trembath, Richard C.; Peris, Ketty; Nestle, Frank O.			The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR-BETA; GENOME-WIDE ASSOCIATION; T-HELPER-CELLS; INTESTINAL INFLAMMATION; AUTOIMMUNE INFLAMMATION; CROHNS-DISEASE; PSORIASIS-VULGARIS; IL-23; INTERLEUKIN-23	IL-23 and Th17 cells are key players in tissue immunosurveillance and are implicated in human immune-mediated diseases. Genome-wide association studies have shown that the IL23R R381Q gene variant protects against psoriasis, Crohn's disease and ankylosing spondylitis. We investigated the immunological consequences of the protective IL23R R381Q gene variant in healthy donors. The IL23R R381Q gene variant had no major effect on Th17 cell differentiation as the frequency of circulating Th17 cells was similar in carriers of the IL23R protective (A) and common (G) allele. Accordingly, Th17 cells generated from (and G donors produced similar amounts of Th17 cytokines. However, IL-23-mediated Th17 cell effector function was impaired, as Th17 cells from (allele carriers had significantly reduced IL-23-induced IL-17(production and STAT3 phosphorylation compared to G allele carriers. Our functional analysis of (human disease-associated gene variant demonstrates that IL23R R381Q exerts its protective effects through selective attenuation of IL-23-induced Th17 cell effector function without interfering with Th17 differentiation, and highlights its importance in the protection against IL-23-induced tissue pathologies.	[Di Meglio, Paola; Di Cesare, Antonella; Laggner, Ute; Chu, Chung-Ching; Napolitano, Luca; Villanova, Federica; Tosi, Isabella; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Di Meglio, Paola; Di Cesare, Antonella; Laggner, Ute; Chu, Chung-Ching; Napolitano, Luca; Villanova, Federica; Tosi, Isabella; Capon, Francesca; Trembath, Richard C.; Nestle, Frank O.] NIHR Biomed Res Ctr, London, England; [Capon, Francesca; Trembath, Richard C.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Di Cesare, Antonella; Peris, Ketty] Univ Aquila, Dept Dermatol, I-67100 Laquila, Italy	University of London; King's College London; University of London; King's College London; University of L'Aquila	Di Meglio, P (corresponding author), Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England.	frank.nestle@kcl.ac.uk	Capon, Francesca/F-4763-2011	Capon, Francesca/0000-0003-2432-5793; Trembath, Richard/0000-0003-0550-3400; Peris, Ketty/0000-0002-5237-0463; Di Meglio, Paola/0000-0002-2066-7780	Wellcome Trust [GR078173MA]; National Institutes of Health [RO1AR040065]; NIHR Comprehensive Biomedical Research Centre Guy's; St. Thomas' Hospital and King's College London; Medical Research Council UK [G0601387]; Dunhill Medical Trust; SIDeMaST; Wyeth Advances in Psoriasis Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040065] Funding Source: NIH RePORTER; MRC [G0601387] Funding Source: UKRI; Medical Research Council [G0601387, G0600698B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Comprehensive Biomedical Research Centre Guy's; St. Thomas' Hospital and King's College London; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); SIDeMaST; Wyeth Advances in Psoriasis Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We acknowledge support by the following grant funding bodies: Wellcome Trust Programme GR078173MA, National Institutes of Health RO1AR040065, NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' Hospital and King's College London, Medical Research Council UK Programme G0601387 and fellowships,Dunhill Medical Trust. A.D.C. was supported by a SIDeMaST fellowship award. L.N. was supported by an unrestricted Wyeth Advances in Psoriasis Research Grant Programme Award. The funders had no role in study design, data collection and analysis, decision to publish, or p[reparation of the manuscript.	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; de Paus RA, 2008, MOL IMMUNOL, V45, P3889, DOI 10.1016/j.molimm.2008.06.029; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duffin KC, 2009, J INVEST DERMATOL, V129, P827, DOI 10.1038/jid.2008.308; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Rueda B, 2008, ANN RHEUM DIS, V67, P1451, DOI 10.1136/ard.2007.080283; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wang XW, 2009, RHEUMATOL INT, V29, P1343, DOI 10.1007/s00296-009-0883-x; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	41	196	200	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17160	10.1371/journal.pone.0017160	http://dx.doi.org/10.1371/journal.pone.0017160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364948	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600033
J	Pandit, B; Gartel, AL				Pandit, Bulbul; Gartel, Andrei L.			Thiazole Antibiotic Thiostrepton Synergize with Bortezomib to Induce Apoptosis in Cancer Cells	PLOS ONE			English	Article							ANTICANCER; COMBINATION; INHIBITORS; CURCUMIN	Thiazole antibiotic, thiostrepton was recently identified as proteasome inhibitor. We investigated the therapeutic potential of the combination of thiostrepton and proteasome inhibitor bortezomib (Velcade) on various human tumor cell lines. Combination of sub-lethal concentrations of thiostrepton and bortezomib induced potent apoptosis and inhibition of long-term colony formation in a wide variety of human cancer cell lines. The synergistic relationship between thiostrepton and bortezomib combination was also quantitatively demonstrated by calculating their combination index values that were much lower than 1 in all studied cell lines. The synergy between these drugs was based on their proteasome inhibitory activities, because thiostrepton modification, thiostrepton methyl ester, which did not have intact quinaldic acid ring and did not inhibit proteasome activity failed to demonstrate any synergy in combination with bortezomib.	[Pandit, Bulbul; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Gartel, Andrei L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Pandit, B (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	agartel@uic.edu			National Institutes of Health [1RO1CA1294414, 1R21CA134615]; NATIONAL CANCER INSTITUTE [R21CA134615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health grants 1RO1CA1294414 and 1R21CA134615 (A. L. Gartel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Pandit B, 2011, CANCER BIOL THER, V11, P43, DOI 10.4161/cbt.11.1.13854; Pandit B, 2010, PROSTATE, V70, P825, DOI 10.1002/pros.21116; Park J, 2008, MOL ONCOL, V2, P317, DOI 10.1016/j.molonc.2008.09.006; Schoof S, 2010, ANGEW CHEM INT EDIT, V49, P3317, DOI 10.1002/anie.200906988; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520	9	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17110	10.1371/journal.pone.0017110	http://dx.doi.org/10.1371/journal.pone.0017110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365012	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482800026
J	Cattaneo, M; Lotti, LV; Martino, S; Alessio, M; Conti, A; Bachi, A; Mariani-Costantini, R; Biunno, I				Cattaneo, Monica; Lotti, Lavinia Vittoria; Martino, Simone; Alessio, Massimo; Conti, Antonio; Bachi, Angela; Mariani-Costantini, Renato; Biunno, Ida			Secretion of Novel SEL1L Endogenous Variants Is Promoted by ER Stress/UPR via Endosomes and Shed Vesicles in Human Cancer Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; UBIQUITIN-PROTEASOME PATHWAY; DISULFIDE BOND FORMATION; QUALITY-CONTROL; IN-VITRO; HELICOBACTER-PYLORI; MISFOLDED PROTEINS; MASS-SPECTROMETRY; TUMOR PROGRESSION	We describe here two novel endogenous variants of the human endoplasmic reticulum (ER) cargo receptor SEL1LA, designated p38 and p28. Biochemical and RNA interference studies in tumorigenic and non-tumorigenic cells indicate that p38 and p28 are N-terminal, ER-anchorless and more stable relative to the canonical transmembrane SEL1LA. P38 is expressed and constitutively secreted, with increase after ER stress, in the KMS11 myeloma line and in the breast cancer lines MCF7 and SKBr3, but not in the non-tumorigenic breast epithelial MCF10A line. P28 is detected only in the poorly differentiated SKBr3 cell line, where it is secreted after ER stress. Consistently with the presence of p38 and p28 in culture media, morphological studies of SKBr3 and KMS11 cells detect N-terminal SEL1L immunolabeling in secretory/degradative compartments and extracellularly-released membrane vesicles. Our findings suggest that the two new SEL1L variants are engaged in endosomal trafficking and secretion via vesicles, which could contribute to relieve ER stress in tumorigenic cells. P38 and p28 could therefore be relevant as diagnostic markers and/or therapeutic targets in cancer.	[Cattaneo, Monica; Biunno, Ida] CNR, Inst Biomed Technol, Milan, Italy; [Lotti, Lavinia Vittoria; Martino, Simone] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy; [Alessio, Massimo; Conti, Antonio; Bachi, Angela] Ist Sci San Raffaele, I-20132 Milan, Italy; [Mariani-Costantini, Renato] Univ G DAnnunzio, Dept Oncol & Expt Med, Chieti, Italy; [Mariani-Costantini, Renato] Univ G dAnnunzio, Aging Res Ctr CeSI, Chieti, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Sapienza University Rome; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Cattaneo, M (corresponding author), CNR, Inst Biomed Technol, Milan, Italy.	ida.biunno@itb.cnr.it	Mariani-Costantini, Renato/B-6637-2012; Conti, Antonio/AAN-7161-2020; Alessio, Massimo/L-4518-2019; bachi, angela/B-3527-2015; Alessio, Massimo/K-7028-2014	Mariani-Costantini, Renato/0000-0002-4440-1848; Conti, Antonio/0000-0001-9150-5271; bachi, angela/0000-0003-4842-6556; /0000-0002-1866-5866; , IDA_2/0000-0002-1068-4763; Alessio, Massimo/0000-0002-4133-3472	Ministero Universita e Ricerca (MIUR) [MIUR-FIRB nRBIP064CRT]; MAPLOMBARDIA [7/193]; MIUR from the University La Sapienza; G. d'Annunzio University; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Ministero Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); MAPLOMBARDIA; MIUR from the University La Sapienza; G. d'Annunzio University; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from MIUR-FIRB nRBIP064CRT Ministero Universita e Ricerca (MIUR), and MAPLOMBARDIA, Grant 7/193 ar 3 to IB, MIUR 60% grants from the University La Sapienza to LVL, MIUR 60% grants 2008-2010 from G. d'Annunzio University to RMC, and by a 2009 grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to RMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Manilla G, 2010, J PROTEOME RES, V9, P2062, DOI 10.1021/pr8007489; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Bader N, 2007, EXP GERONTOL, V42, P864, DOI 10.1016/j.exger.2007.03.010; Balleine RL, 2000, GENE CHROMOSOME CANC, V29, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1005>3.0.CO;2-O; Barberis MCP, 2006, HISTOPATHOLOGY, V48, P614, DOI 10.1111/j.1365-2559.2005.02274.x; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Boutros R, 2003, J MOL BIOL, V332, P675, DOI 10.1016/S0022-2836(03)00944-6; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BYRNE JA, 1995, CANCER RES, V55, P2896; Byrne JA, 1996, GENOMICS, V35, P523, DOI 10.1006/geno.1996.0393; Cattaneo M, 2003, ONCOGENE, V22, P6359, DOI 10.1038/sj.onc.1206665; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cattaneo M, 2009, J BIOL CHEM, V284, P11405, DOI 10.1074/jbc.M805408200; Chan P, 2006, PROTEOMICS, V6, P3494, DOI 10.1002/pmic.200500534; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chignard N, 2006, GASTROENTEROLOGY, V130, P2010, DOI 10.1053/j.gastro.2006.02.058; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dees E Claire, 2006, Future Oncol, V2, P121, DOI 10.2217/14796694.2.1.121; Deml L, 2005, INFECT IMMUN, V73, P4732, DOI 10.1128/IAI.73.8.4732-4742.2005; Deng XT, 2007, CANCER INFORM, V3, P183; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Ferrero S, 2006, HUM PATHOL, V37, P505, DOI 10.1016/j.humpath.2005.12.012; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Granelli P, 2004, CLIN CANCER RES, V10, P5857, DOI 10.1158/1078-0432.CCR-04-0075; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; HYNES NE, 1989, J CELL BIOCHEM, V39, P167, DOI 10.1002/jcb.240390208; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lewis JD, 2007, MOL CANCER RES, V5, P133, DOI 10.1158/1541-7786.MCR-06-0245; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lotti LV, 2002, GENE CHROMOSOME CANC, V35, P193, DOI 10.1002/gcc.10105; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Mittl PRE, 2000, J BIOL CHEM, V275, P17693, DOI 10.1074/jbc.M001869200; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Orlandi R, 2002, CANCER RES, V62, P567; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Proux-Gillardeaux V, 2003, BIOCHEM J, V370, P213, DOI 10.1042/BJ20021309; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Reed Steven I., 2006, V42, P147, DOI 10.1007/b136681; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott Melissa D, 2003, Methods Mol Biol, V232, P67; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SOULE HD, 1990, CANCER RES, V50, P6075; Spiess C, 1997, J BIOL CHEM, V272, P22125, DOI 10.1074/jbc.272.35.22125; Thomas DDH, 2002, J BIOL CHEM, V277, P35496, DOI 10.1074/jbc.M110917200; Thomas DDH, 2010, AM J PHYSIOL-CELL PH, V298, pC725, DOI 10.1152/ajpcell.00455.2009; Tiacci E, 2005, BLOOD, V105, P2812, DOI 10.1182/blood-2004-07-2630; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wilson SHD, 2001, GENOMICS, V76, P81, DOI 10.1006/geno.2001.6610; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	83	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17206	10.1371/journal.pone.0017206	http://dx.doi.org/10.1371/journal.pone.0017206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359144	gold, Green Submitted, Green Published			2022-12-25	WOS:000287482300039
J	Hosoda, K; Suzuki, S; Yamauchi, Y; Shiroguchi, Y; Kashiwagi, A; Ono, N; Mori, K; Yomo, T				Hosoda, Kazufumi; Suzuki, Shingo; Yamauchi, Yoshinori; Shiroguchi, Yasunori; Kashiwagi, Akiko; Ono, Naoaki; Mori, Kotaro; Yomo, Tetsuya			Cooperative Adaptation to Establishment of a Synthetic Bacterial Mutualism	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; PHENOTYPIC PLASTICITY; INITIAL-STAGE; EVOLUTION; CONFLICT; COMPETITION; GENES	To understand how two organisms that have not previously been in contact can establish mutualism, it is first necessary to examine temporal changes in their phenotypes during the establishment of mutualism. Instead of tracing back the history of known, well-established, natural mutualisms, we experimentally simulated the development of mutualism using two genetically-engineered auxotrophic strains of Escherichia coli, which mimic two organisms that have never met before but later establish mutualism. In the development of this synthetic mutualism, one strain, approximately 10 hours after meeting the partner strain, started oversupplying a metabolite essential for the partner's growth, eventually leading to the successive growth of both strains. This cooperative phenotype adaptively appeared only after encountering the partner strain but before the growth of the strain itself. By transcriptome analysis, we found that the cooperative phenotype of the strain was not accompanied by the local activation of the biosynthesis and transport of the oversupplied metabolite but rather by the global activation of anabolic metabolism. This study demonstrates that an organism has the potential to adapt its phenotype after the first encounter with another organism to establish mutualism before its extinction. As diverse organisms inevitably encounter each other in nature, this potential would play an important role in the establishment of a nascent mutualism in nature.	[Hosoda, Kazufumi; Suzuki, Shingo; Shiroguchi, Yasunori; Ono, Naoaki; Yomo, Tetsuya] Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, Suita, Osaka, Japan; [Yamauchi, Yoshinori; Mori, Kotaro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka, Japan; [Kashiwagi, Akiko] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Suita, Osaka, Japan	Osaka University; Osaka University; Hirosaki University; Japan Science & Technology Agency (JST)	Hosoda, K (corresponding author), Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, Suita, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Suzuki, Shingo/O-3651-2014	Suzuki, Shingo/0000-0003-1332-3194; ONO, Naoaki/0000-0002-7722-055X	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by both the "Global Centers of Excellence Program" and the "Special Coordination Funds for Promoting Science and Technology: Yuragi Project" of the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1125, DOI 10.1098/rstb.2008.0285; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Bar-Yam Y, 2009, SCIENCE, V323, P1016, DOI 10.1126/science.1163225; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Begon M., 1996, ECOLOGY; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOUCHER DH, 1982, ANNU REV ECOL SYST, V13, P315, DOI 10.1146/annurev.es.13.110182.001531; BUCHSBAUM RALPH, 1934, SCIENCE, V80, P408, DOI 10.1126/science.80.2079.408; Cashel M., 1996, E COLI SALMONELLA CE, V2; Chuang JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.57; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong G, 2003, NATURE, V424, P16, DOI 10.1038/424016b; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Hooshangi S, 2008, CURR OPIN BIOTECH, V19, P550, DOI 10.1016/j.copbio.2008.10.007; Hosoda K, 2008, P BIONETICS 2008 ICS, P1; Hu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010619; Huang Sui, 2004, Briefings in Functional Genomics & Proteomics, V2, P279, DOI 10.1093/bfgp/2.4.279; Kashiwagi A, 2009, METAB ENG, V11, P56, DOI 10.1016/j.ymben.2008.08.002; Katsuyama C, 2009, J THEOR BIOL, V256, P644, DOI 10.1016/j.jtbi.2008.10.024; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; May R., 2007, THEORETICAL ECOLOGY, V3rd; McArthur J.V., 2006, MICROBIAL ECOLOGY EV; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ono N, 2008, BIOINFORMATICS, V24, P1278, DOI 10.1093/bioinformatics/btn109; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Reaka-Kudla M. L., 1997, BIODIVERSITY; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Ross-Gillespie A, 2009, EVOLUTION, V63, P2315, DOI 10.1111/j.1558-5646.2009.00723.x; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Shimada M, 2010, POPUL ECOL, V52, P5, DOI 10.1007/s10144-009-0187-8; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Song H, 2009, NAT CHEM BIOL, V5, P929, DOI 10.1038/nchembio.244; Suzuki Takao, 2006, Biophysics (Nagoya-shi), V2, P63, DOI 10.2142/biophysics.2.63; Todoriki M, 2002, BIOSYSTEMS, V65, P105, DOI 10.1016/S0303-2647(02)00006-0; TSUCHIYA HM, 1972, J BACTERIOL, V110, P1147, DOI 10.1128/JB.110.3.1147-1153.1972; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; WADDINGTON CH, 1952, NATURE, V169, P278, DOI 10.1038/169278a0; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West-Eberhard Mary Jane, 2003, pi; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Yamada A, 2008, BIOSYSTEMS, V92, P1, DOI 10.1016/j.biosystems.2007.10.004	61	54	55	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17105	10.1371/journal.pone.0017105	http://dx.doi.org/10.1371/journal.pone.0017105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359225	Green Submitted, Green Published, gold			2022-12-25	WOS:000287392700049
J	Mukherjee, S; Machado, FS; Huang, HA; Oz, HS; Jelicks, LA; Prado, CM; Koba, W; Fine, EJ; Zhao, DZ; Factor, SM; Collado, JE; Weiss, LM; Tanowitz, HB; Ashton, AW				Mukherjee, Shankar; Machado, Fabiana S.; Huang, Huang; Oz, Helieh S.; Jelicks, Linda A.; Prado, Cibele M.; Koba, Wade; Fine, Eugene J.; Zhao, Dazhi; Factor, Stephen M.; Collado, J. Elias; Weiss, Louis M.; Tanowitz, Herbert B.; Ashton, Anthony W.			Aspirin Treatment of Mice Infected with Trypanosoma cruzi and Implications for the Pathogenesis of Chagas Disease	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NITRIC-OXIDE SYNTHASE; HEART-DISEASE; INDUCIBLE CYCLOOXYGENASE; LYMPHOCYTE-PROLIFERATION; PGE(2) INVOLVEMENT; ACUTE-PHASE; BRUCEI; MICROCIRCULATION; ENDOTHELIN-1	Chagas disease, caused by infection with Trypanosoma cruzi, is an important cause of cardiovascular disease. It is increasingly clear that parasite-derived prostaglandins potently modulate host response and disease progression. Here, we report that treatment of experimental T. cruzi infection (Brazil strain) beginning 5 days post infection (dpi) with aspirin (ASA) increased mortality (2-fold) and parasitemia (12-fold). However, there were no differences regarding histopathology or cardiac structure or function. Delayed treatment with ASA (20 mg/kg) beginning 60 dpi did not increase parasitemia or mortality but improved ejection fraction. ASA treatment diminished the profile of parasite-and host-derived circulating prostaglandins in infected mice. To distinguish the effects of ASA on the parasite and host bio-synthetic pathways we infected cyclooxygenase-1 (COX-1) null mice with the Brazil-strain of T. cruzi. Infected COX-1 null mice displayed a reduction in circulating levels of thromboxane (TX)A(2) and prostaglandin (PG)F-2 alpha. Parasitemia was increased in COX-1 null mice compared with parasitemia and mortality in ASA-treated infected mice indicating the effects of ASA on mortality potentially had little to do with inhibition of prostaglandin metabolism. Expression of SOCS-2 was enhanced, and TRAF6 and TNF alpha reduced, in the spleens of infected ASA-treated mice. Ablation of the initial innate response to infection may cause the increased mortality in ASA-treated mice as the host likely succumbs more quickly without the initiation of the "cytokine storm'' during acute infection. We conclude that ASA, through both COX inhibition and other "off-target'' effects, modulates the progression of acute and chronic Chagas disease. Thus, eicosanoids present during acute infection may act as immunomodulators aiding the transition to and maintenance of the chronic phase of the disease. A deeper understanding of the mechanism of ASA action may provide clues to the differences between host response in the acute and chronic T. cruzi infection.	[Mukherjee, Shankar; Huang, Huang; Prado, Cibele M.; Zhao, Dazhi; Factor, Stephen M.; Collado, J. Elias; Weiss, Louis M.; Tanowitz, Herbert B.; Ashton, Anthony W.] Albert Einstein Coll Med, Dept Pathol, Div Parasitol, New York, NY USA; [Machado, Fabiana S.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Oz, Helieh S.] Univ Kentucky, Med Ctr, Ctr Oral Hlth Res, Lexington, KY USA; [Jelicks, Linda A.; Koba, Wade; Fine, Eugene J.] Albert Einstein Coll Med, Dept Nucl Med, New York, NY USA; [Jelicks, Linda A.; Koba, Wade; Fine, Eugene J.] Albert Einstein Coll Med, M Donald Blaufox Lab Mol Imaging Physiol & Biophy, New York, NY USA; [Prado, Cibele M.; Zhao, Dazhi; Collado, J. Elias; Weiss, Louis M.; Tanowitz, Herbert B.] Albert Einstein Coll Med, Dept Med, Div Infect Dis, New York, NY USA; [Prado, Cibele M.] Univ Sao Paulo, Dept Pathol, BR-14049 Ribeirao Preto, Brazil; [Ashton, Anthony W.] Univ Sydney, Kolling Inst Med Res, Div Perinatal Res, Sydney, NSW 2006, Australia	Yeshiva University; Universidade Federal de Minas Gerais; University of Kentucky; Yeshiva University; Yeshiva University; Yeshiva University; Universidade de Sao Paulo; University of Sydney; Kolling Institute of Medical Research	Mukherjee, S (corresponding author), Albert Einstein Coll Med, Dept Pathol, Div Parasitol, New York, NY USA.	herbert.tanowitz@einstein.yu.edu	Jelicks, Linda/L-9740-2019; Prado, Cibele M/P-5773-2016; Oliveira, Claudia DL/G-8618-2011	Jelicks, Linda/0000-0002-6438-1792; Prado, Cibele M/0000-0003-4321-0879; Simao Machado, Fabiana/0000-0001-9272-5209	United States National Institutes of Health [AI-76248]; National Health and Medical Research Council of Australia [512154, 402847]; American Heart Association [0735252N]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [576200/2008-5, 473670/2008-9]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [14916]; Fogarty International [D43TW007129]; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076248] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); American Heart Association(American Heart Association); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fogarty International(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the United States National Institutes of Health (HBT [AI-76248]) and the National Health and Medical Research Council of Australia (AWA [512154]). The work was also supported by a Career Development Award from the American Heart Association (SM [0735252N]), the National Health and Medical Research Council of Australia (AWA [402847]), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (FSM [576200/2008-5, 473670/2008-9]), and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (FSM [14916]). CMP was supported by a Fogarty International Training Grant (HBT [D43TW007129]). The funding bodies indicated had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla GK, 2008, EXP PARASITOL, V118, P514, DOI 10.1016/j.exppara.2007.11.003; Ashton AW, 2007, J EXP MED, V204, P929, DOI 10.1084/jem.20062432; Cardoni RL, 2004, MEDIAT INFLAMM, V13, P235, DOI 10.1080/09637480400003022; CELENTANO AM, 1995, PROSTAGLANDINS, V49, P141, DOI 10.1016/0090-6980(95)00002-R; Chandra M, 2002, INT J PARASITOL, V32, P207, DOI 10.1016/S0020-7519(01)00320-4; FACTOR SM, 1985, AM J TROP MED HYG, V34, P246, DOI 10.4269/ajtmh.1985.34.246; FIEDLER VB, 1988, PHARMACOTHERAPY, V8, P158; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Huang H, 1997, CARDIOVASC PATHOL, V6, P161, DOI 10.1016/S1054-8807(96)00094-4; Huang H, 1999, J MOL CELL CARDIOL, V31, P75, DOI 10.1006/jmcc.1998.0848; Hyland KV, 2006, TRENDS PARASITOL, V22, P101, DOI 10.1016/j.pt.2006.01.001; Jelicks LA, 1999, AM J TROP MED HYG, V61, P207, DOI 10.4269/ajtmh.1999.61.207; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kabututu Z, 2003, INT J PARASITOL, V33, P219, DOI 10.1016/S0020-7519(02)00253-9; Konkle ME, 2009, J MED CHEM, V52, P2846, DOI 10.1021/jm801643b; Kubata BK, 2000, J EXP MED, V192, P1327, DOI 10.1084/jem.192.9.1327; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Machado FS, 2009, ADV EXP MED BIOL, V666, P78; Machado FS, 2008, MICROBES INFECT, V10, P1558, DOI 10.1016/j.micinf.2008.09.009; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Michelin MA, 2005, EXP PARASITOL, V111, P71, DOI 10.1016/j.exppara.2005.05.001; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; OPPERDOES FR, 1982, MOL BIOCHEM PARASIT, V5, P309, DOI 10.1016/0166-6851(82)90038-X; Paiva CN, 2007, EUR J IMMUNOL, V37, P1355, DOI 10.1002/eji.200636705; Parente L, 2003, BIOCHEM PHARMACOL, V65, P153, DOI 10.1016/S0006-2952(02)01422-3; Petkova SB, 2001, INT J PARASITOL, V31, P499, DOI 10.1016/S0020-7519(01)00168-0; Petkova SB, 2000, CARDIOVASC PATHOL, V9, P257, DOI 10.1016/S1054-8807(00)00045-4; Pinge P, 1999, CELL IMMUNOL, V193, P90, DOI 10.1006/cimm.1999.1463; Prado CM, 2009, AM J TROP MED HYG, V81, P900, DOI 10.4269/ajtmh.2009.09-0338; Ramakrishnan R, 2001, INT IMMUNOPHARMACOL, V1, P2035, DOI 10.1016/S1567-5769(01)00132-1; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; SAGE L, 1981, TROPENMED PARASITOL, V32, P215; Santovito D, 2009, CURR OPIN LIPIDOL, V20, P402, DOI 10.1097/MOL.0b013e32832fa22c; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smith WL, 1997, THROMB HAEMOSTASIS, V78, P627; Smith WL, 1997, ADV EXP MED BIOL, V400, P189; SterinBorda L, 1996, CLIN IMMUNOL IMMUNOP, V81, P122, DOI 10.1006/clin.1996.0167; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; Tanowitz HB, 2005, INFECT IMMUN, V73, P2496, DOI 10.1128/IAI.73.4.2496-2503.2005; Tanowitz HB, 1996, J PARASITOL, V82, P124, DOI 10.2307/3284127; TANOWITZ HB, 1990, AM J TROP MED HYG, V43, P274, DOI 10.4269/ajtmh.1990.43.274; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Tatakihara VLH, 2008, FEMS IMMUNOL MED MIC, V52, P47, DOI 10.1111/j.1574-695X.2007.00340.x; Zordoky BNM, 2008, CURR DRUG METAB, V9, P122	46	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16959	10.1371/journal.pone.0016959	http://dx.doi.org/10.1371/journal.pone.0016959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347238	Green Published, gold			2022-12-25	WOS:000287369200012
J	Peden, MC; Min, J; Meyers, C; Lukowski, Z; Li, QH; Boye, SL; Levine, M; Hauswirth, WW; Ratnakaram, R; Dawson, W; Smith, WC; Sherwood, MB				Peden, Marc C.; Min, Jeff; Meyers, Craig; Lukowski, Zachary; Li, Qiuhong; Boye, Sanford L.; Levine, Monica; Hauswirth, William W.; Ratnakaram, Ramakrishna; Dawson, William; Smith, Wesley C.; Sherwood, Mark B.			Ab-Externo AAV-Mediated Gene Delivery to the Suprachoroidal Space Using a 250 Micron Flexible Microcatheter	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; THERAPY	Background: The current method of delivering gene replacement to the posterior segment of the eye involves a three-port pars plana vitrectomy followed by injection of the agent through a 37-gauge cannula, which is potentially wrought with retinal complications. In this paper we investigate the safety and efficacy of delivering adeno-associated viral (AAV) vector to the suprachoroidal space using an ab externo approach that utilizes an illuminated microcatheter. Methods: 6 New Zealand White rabbits and 2 Dutch Belted rabbits were used to evaluate the ab externo delivery method. sc-AAV5-smCBA-hGFP vector was delivered into the suprachoroidal space using an illuminated iTrackTM 250A microcatheter. Six weeks after surgery, the rabbits were sacrificed and their eyes evaluated for AAV transfection using immunofluorescent antibody staining of GFP. Results: Immunostaining of sectioned and whole-mounted eyes demonstrated robust transfection in all treated eyes, with no fluorescence in untreated control eyes. Transfection occurred diffusely and involved both the choroid and the retina. No apparent adverse effects caused by either the viral vector or the procedure itself could be seen either clinically or histologically. Conclusions: The ab externo method of delivery using a microcatheter was successful in safely and effectively delivering a gene therapy agent to the suprachoroidal space. This method presents a less invasive alternative to the current method of virally vectored gene delivery.	[Peden, Marc C.; Min, Jeff; Meyers, Craig; Lukowski, Zachary; Li, Qiuhong; Boye, Sanford L.; Levine, Monica; Hauswirth, William W.; Ratnakaram, Ramakrishna; Dawson, William; Smith, Wesley C.; Sherwood, Mark B.] Univ Florida, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Peden, MC (corresponding author), Univ Florida, Gainesville, FL 32610 USA.	sherwood@ufl.edu; sherwood@ufl.edu		hauswirth, william/0000-0002-3244-4947; Min, Jeff/0000-0003-4633-6792	Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY021721] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This study was funded in part by an unrestricted departmental grant from Research to Prevent Blindness. This financial supporter had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Lewis RA, 2007, J CATARACT REFR SURG, V33, P1217, DOI 10.1016/j.jcrs.2007.03.051; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1994; Olsen TW, 2006, AM J OPHTHALMOL, V142, P777, DOI 10.1016/j.ajo.2006.05.045; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	11	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17140	10.1371/journal.pone.0017140	http://dx.doi.org/10.1371/journal.pone.0017140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347253	Green Published, Green Submitted, gold			2022-12-25	WOS:000287364500034
J	Simpfendorfer, CA; Yeiser, BG; Wiley, TR; Poulakis, GR; Stevens, PW; Heupel, MR				Simpfendorfer, Colin A.; Yeiser, Beau G.; Wiley, Tonya R.; Poulakis, Gregg R.; Stevens, Philip W.; Heupel, Michelle R.			Environmental Influences on the Spatial Ecology of Juvenile Smalltooth Sawfish (Pristis pectinata): Results from Acoustic Monitoring	PLOS ONE			English	Article							SHARKS CARCHARHINUS-LEUCAS; RAYS RHINOPTERA-BONASUS; MOVEMENT PATTERNS; FLORIDA ESTUARY; BULL SHARKS; SUMMER NURSERY; BEHAVIORAL THERMOREGULATION; TRIAKIS-SEMIFASCIATA; WESTERN ATLANTIC; SALINITY CHANGE	To aid recovery efforts of smalltooth sawfish (Pristis pectinata) populations in U.S. waters a research project was developed to assess how changes in environmental conditions within estuarine areas affected the presence, movements, and activity space of this endangered species. Forty juvenile P. pectinata were fitted with acoustic tags and monitored within the lower 27 km of the Caloosahatchee River estuary, Florida, between 2005 and 2007. Sawfish were monitored within the study site from 1 to 473 days, and the number of consecutive days present ranged from 1 to 125. Residency index values for individuals varied considerably, with annual means highest in 2005 (0.95) and lowest in 2007 (0.73) when several P. pectinata moved upriver beyond detection range during drier conditions. Mean daily activity space was 1.42 km of river distance. The distance between 30-minute centers of activity was typically <0.1 km, suggesting limited movement over short time scales. Salinity electivity analysis demonstrated an affinity for salinities between 18 and at least 24 psu, suggesting movements are likely made in part, to remain within this range. Thus, freshwater flow from Lake Okeechobee (and its effect on salinity) affects the location of individuals within the estuary, although it remains unclear whether or not these movements are threatening recovery.	[Simpfendorfer, Colin A.; Yeiser, Beau G.; Wiley, Tonya R.; Heupel, Michelle R.] Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA; [Poulakis, Gregg R.; Stevens, Philip W.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Charlotte Harbor Field Lab, Port Charlotte, FL USA	Mote Marine Laboratory & Aquarium; Florida Fish & Wildlife Conservation Commission	Simpfendorfer, CA (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Fishing & Fisheries Res Ctr, Townsville, Qld 4811, Australia.	colin.simpfendorfer@jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011; Wiley, Tonya/AAO-7329-2020	Simpfendorfer, Colin A/0000-0002-0295-2238; Heupel, Michelle/0000-0002-8245-7332	NOAA Fisheries Office of Protected Resources, South Florida Water Management District, National Fish and Wildlife Foundation, National Geographic Committee for Research and Exploration; Disney Wildlife Conservation Fund; Florida Fish and Wildlife Conservation Commission	NOAA Fisheries Office of Protected Resources, South Florida Water Management District, National Fish and Wildlife Foundation, National Geographic Committee for Research and Exploration(National Geographic Society); Disney Wildlife Conservation Fund; Florida Fish and Wildlife Conservation Commission	Financial support was provided by NOAA Fisheries Office of Protected Resources, South Florida Water Management District, National Fish and Wildlife Foundation, National Geographic Committee for Research and Exploration, The Disney Wildlife Conservation Fund, and the Florida Fish and Wildlife Conservation Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Collins AB, 2007, J FISH BIOL, V71, P1159, DOI 10.1111/j.1095-8649.2007.01590.x; Collins AB, 2008, ESTUAR COAST, V31, P1174, DOI 10.1007/s12237-008-9100-5; Compagno Leonard J. V., 1995, Journal of Aquariculture and Aquatic Sciences, V7, P62; Doering PH, 1988, 9802 CHARL HARB NAT, P229; Dowd WW, 2010, J EXP BIOL, V213, P210, DOI 10.1242/jeb.031781; Grubbs R. Dean, 2007, V50, P63; Grubbs R. Dean, 2007, V50, P87; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heithaus MR, 2004, CRC MAR BIOL SER, P487; Heupel Michelle R., 2007, V50, P265; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2001, ELECT TAGGING TRACKI; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Hopkins TE, 2003, ENVIRON BIOL FISH, V66, P279, DOI 10.1023/A:1023907121605; Matern SA, 2000, ENVIRON BIOL FISH, V58, P173, DOI 10.1023/A:1007625212099; NMFS, 2009, REC PLAN SMALLT SAWF; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; Poulakis Gregg R., 2004, Florida Scientist, V67, P27; Seitz Jason C., 2002, Florida Scientist, V65, P256; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Simpfendorfer CA, 2000, ENVIRON BIOL FISH, V58, P371, DOI 10.1023/A:1007675111597; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Simpfendorfer CA, 2004, CRC MAR BIOL SER, P553; Simpfendorfer CA, 2010, BIOL CONSERV, V143, P1460, DOI 10.1016/j.biocon.2010.03.021; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Sklar FH, 1998, ENVIRON MANAGE, V22, P547, DOI 10.1007/s002679900127; Thorburn D. C., 2006, BIOL ECOLOGY TROPHIC, P135; Thorburn DC, 2007, ZOOTAXA, P27; THORSON TB, 1974, COPEIA, P560; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Whitty JM, 2009, MAR FRESHWATER RES, V60, P306, DOI 10.1071/MF08169; Wiley TR, ENDANGERED IN PRESS; Yeiser BG, 2008, MAR FRESHWATER RES, V59, P489, DOI 10.1071/MF07181	35	62	62	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16918	10.1371/journal.pone.0016918	http://dx.doi.org/10.1371/journal.pone.0016918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347294	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000287364500012
J	To, AWM; Ribe, EM; Chuang, TT; Schroeder, JE; Lovestone, S				To, Alvina W. M.; Ribe, Elena M.; Chuang, Tsu Tshen; Schroeder, Joern E.; Lovestone, Simon			The epsilon 3 and epsilon 4 Alleles of Human APOE Differentially Affect Tau Phosphorylation in Hyperinsulinemic and Pioglitazone Treated Mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; APOLIPOPROTEIN-E GENOTYPE; AMYLOID PRECURSOR PROTEIN; ALZHEIMER-LIKE CHANGES; TRANSGENIC MICE; DIABETES-MELLITUS; INTRANASAL INSULIN; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; BEHAVIORAL DEFICITS	Background: Impaired insulin signalling is increasingly thought to contribute to Alzheimer's disease (AD). The epsilon 4 isoform of the APOE gene is the greatest genetic risk factor for sporadic, late onset AD, and is also associated with risk for type 2 diabetes mellitus (T2DM). Neuropathological studies reported the highest number of AD lesions in brain tissue of epsilon 4 diabetic patients. However other studies assessing AD pathology amongst the diabetic population have produced conflicting reports and have failed to show an increase in AD-related pathology in diabetic brain. The thiazolidinediones (TZDs), peroxisome proliferator-activated receptor gamma agonists, are peripheral insulin sensitisers used to treat T2DM. The TZD, pioglitazone, improved memory and cognitive functions in mild to moderate AD patients. Since it is not yet clear how apoE isoforms influence the development of T2DM and its progression to AD, we investigated amyloid beta and tau pathology in APOE knockout mice, carrying human APOE epsilon 3 or epsilon 4 transgenes after diet-induced insulin resistance with and without pioglitazone treatment. Methods: Male APOE knockout, APOE epsilon 3-transgenic and APOE epsilon 4-transgenic mice, together with background strain C57BL6 mice were kept on a high fat diet (HFD) or low fat diet (LFD) for 32 weeks, or were all fed HFD for 32 weeks and during the final 3 weeks animals were treated with pioglitazone or vehicle. Results: All HFD animals developed hyperglycaemia with elevated plasma insulin. Tau phosphorylation was reduced at 3 epitopes (Ser396, Ser202/Thr205 and Thr231) in all HFD, compared to LFD, animals independent of APOE genotype. The introduction of pioglitazone to HFD animals led to a significant reduction in tau phosphorylation at the Ser202/Thr205 epitope in APOE epsilon 3 animals only. We found no changes in APP processing however the levels of soluble amyloid beta 40 was reduced in APOE knockout animals treated with pioglitazone.	[To, Alvina W. M.; Ribe, Elena M.; Lovestone, Simon] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Chuang, Tsu Tshen] GlaxoSmithKline, Stem Cell DPU, Cambridge, MA USA; [Schroeder, Joern E.] GlaxoSmithKline, Neurosci CEDD, Harlow, Essex, England	University of London; King's College London; GlaxoSmithKline; GlaxoSmithKline	To, AWM (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	Simon.lovestone@kcl.ac.uk		Lovestone, Simon/0000-0003-0473-4565; Ribe, Elena/0000-0003-2854-2576	Biotechnology and Biological Sciences Research Council (BBSRC) [PAAPALA]; GlaxoSmithKline [PAAPALA]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline)	All work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) CASE award scheme jointly with GlaxoSmithKline (website http://www.bbsrc.ac.uk/). Grant number: PAAPALA. The BBSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JE Schroeder and TT Chuang are employees of GlaxoSmithKline and were involved with the study design, data collection and analysis and decision to publish.	Alafuzoff I, 2009, NEUROPATH APPL NEURO, V35, P60, DOI 10.1111/j.1365-2990.2008.00948.x; ARBONESMAINAR JM, 2010, FASEB J; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Arvanitakis Z, 2006, J NUTR HEALTH AGING, V10, P287; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bodles AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1100, DOI 10.1152/ajpendo.00187.2006; Bolten CW, 2007, GENE REGUL SYST BIO, V1, P73; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Buttini M, 2010, AM J PATHOL, V177, P563, DOI 10.2353/ajpath.2010.090973; Camacho IE, 2004, J NEUROSCI, V24, P10908, DOI 10.1523/JNEUROSCI.3987-04.2004; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chung SH, 2009, BMB REP, V42, P467, DOI 10.5483/BMBRep.2009.42.8.467; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Cole AR, 2007, NEUROSCI BIOBEHAV R, V31, P1046, DOI 10.1016/j.neubiorev.2007.04.004; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; Craft S, 2003, PSYCHONEUROENDOCRINO, V28, P809, DOI 10.1016/S0306-4530(02)00087-2; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; d'Abramo C, 2005, BIOCHEM J, V391, P693, DOI 10.1042/BJ20050560; d'Abramo C, 2006, J NEUROCHEM, V98, P1068, DOI 10.1111/j.1471-4159.2006.03931.x; Francis G, 2009, DIABETES, V58, P934, DOI 10.2337/db08-1287; Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; GENIS I, 1995, NEUROSCI LETT, V199, P5, DOI 10.1016/0304-3940(95)12007-Q; Gibson GE, 2000, ANN NEUROL, V48, P297, DOI 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Heitner J, 1997, NEUROLOGY, V49, P1306, DOI 10.1212/WNL.49.5.1306; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hoe HS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-18; HOYER S, 1991, ANN NY ACAD SCI, V640, P53; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; JOLIVALT CG, 2009, EXP NEUROL; JULIEN C, 2008, NEUROBIOL AGING; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kobayashi M, 2003, NEUROREPORT, V14, P699, DOI 10.1097/00001756-200304150-00008; KOHJIMA M, 2010, ENDOCRINOLOGY; Kummer MP, 2008, PPAR RES, V2008, DOI 10.1155/2008/403896; Kypreos KE, 2009, FEBS J, V276, P5720, DOI 10.1111/j.1742-4658.2009.07301.x; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Ljungberg MC, 2002, NEUROREPORT, V13, P867, DOI 10.1097/00001756-200205070-00026; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Moroz N, 2008, J ALZHEIMERS DIS, V15, P29; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; SATO T, 2009, NEUROBIOL AGING; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; Wang YL, 2002, J BIOL CHEM, V277, P31781, DOI 10.1074/jbc.M204279200; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yan Q, 2003, J NEUROSCI, V23, P7504; Zhou Jie, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P272	80	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16991	10.1371/journal.pone.0016991	http://dx.doi.org/10.1371/journal.pone.0016991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347323	Green Submitted, Green Published, gold			2022-12-25	WOS:000287363000028
J	Zhao, XG; Cao, MD; Liu, JJ; Zhu, HZ; Nelson, DR; Liu, C				Zhao, Xiangxuan; Cao, Mengde; Liu, Joy J.; Zhu, Haizhen; Nelson, David R.; Liu, Chen			Reactive Oxygen Species Is Essential for Cycloheximide to Sensitize Lexatumumab-Induced Apoptosis in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; TUMOR-NECROSIS-FACTOR; PROSTATE EPITHELIAL-CELLS; ALPHA-MEDIATED APOPTOSIS; KAPPA-B ACTIVATION; COLON-CANCER CELLS; LIGAND TRAIL; AGONISTIC ANTIBODY; SURVIVIN LEVELS; UP-REGULATION	This study aims to investigate apoptosis induced by lexatumumab (Lexa) in hepatocellular carcinoma (HCC) cells. We assessed the sensitivity of HCC cell lines and normal human hepatocytes to Lexa and explored the sensitization of HCC cells to Lexa-induced apoptosis by cycloheximide (CHX). Our data indicated that CHX sensitized HCC cell lines to Lexa-induced apoptosis, whereas treatment using solely CHX or Lexa was ineffective. The sequential treatment of CHX followed by Lexa dramatically induced caspase-dependent apoptosis in HCC cells and had synergistically increased intracellular rates of reactive oxygen species (ROS). Additionally, when ROS production was blocked by N-acetyl-L-cysteine (NAC), HCC cells were protected against Lexa and CHX combination treatment-induced apoptosis. ROS generation induced by combination treatment of Lexa and CHX triggered pro-apoptotic protein Bax oligomerization, conformation change, and translocation to mitochondria, which resulted in the release of cytochrome c and subsequent cell death. Furthermore, HSP90 was involved in mediating Lexa and CHX combination treatment-induced ROS increase and apoptotic death. More importantly, we observed that combination treatment of Lexa and CHX did not cause apoptotic toxicity in normal human primary hepatocytes. These results suggest that Lexa and CHX combination treatment merits investigation for the development of therapies for patients with HCC.	[Zhao, Xiangxuan; Liu, Joy J.; Zhu, Haizhen; Liu, Chen] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; [Zhao, Xiangxuan; Liu, Joy J.; Zhu, Haizhen; Liu, Chen] Univ Florida, Coll Med, Dept Immunol, Gainesville, FL USA; [Zhao, Xiangxuan; Liu, Joy J.; Zhu, Haizhen; Liu, Chen] Univ Florida, Coll Med, Dept Lab Med, Gainesville, FL USA; [Cao, Mengde; Nelson, David R.] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhao, XG (corresponding author), Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA.	liu@pathology.ufl.edu			National Institutes of Health [R01CA133086]; University of Florida; NATIONAL CANCER INSTITUTE [R01CA133086, K24CA139570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the National Institutes of Health: R01CA133086 to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund.	Abdollahi T, 2005, APOPTOSIS, V10, P1383, DOI 10.1007/s10495-005-2139-x; Belyanskaya LL, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-66; Brooks AD, 2005, CANCER IMMUNOL IMMUN, V54, P499, DOI 10.1007/s00262-004-0595-8; Camidge DR, 2010, CLIN CANCER RES, V16, P1256, DOI 10.1158/1078-0432.CCR-09-1267; Chaudhari AA, 2007, ONCOL REP, V18, P71; Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Chopra DP, 2004, CANCER LETT, V203, P145, DOI 10.1016/j.canlet.2003.09.016; DEL MMS, 2001, BIOCHEMISTRY-US, V40, P9983; Deuffic S, 1998, LANCET, V351, P214, DOI 10.1016/S0140-6736(05)78179-4; Dieterle A, 2009, INT J CANCER, V125, P932, DOI 10.1002/ijc.24374; Forero-Torres A, 2010, CANCER BIOTHER RADIO, V25, P13, DOI 10.1089/cbr.2009.0673; Gao F, 2010, J ZHEJIANG UNIV-SC B, V11, P608, DOI 10.1631/jzus.B1001007; Gong J, 2006, MOL CANCER THER, V5, P2991, DOI 10.1158/1535-7163.MCT-06-0188; Grotzer MA, 2000, ONCOGENE, V19, P4604, DOI 10.1038/sj.onc.1203816; He Song-qing, 2003, Zhonghua Zhongliu Zazhi, V25, P116; He Songqing, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P51; Hernandez A, 2001, J GASTROINTEST SURG, V5, P56, DOI 10.1016/S1091-255X(01)80014-7; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huang F, 2009, FREE RADICAL BIO MED, V46, P1186, DOI 10.1016/j.freeradbiomed.2009.01.026; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim S, 2008, J CELL BIOCHEM, V104, P895, DOI 10.1002/jcb.21672; Koornstra JJ, 2003, J PATHOL, V200, P327, DOI 10.1002/path.1364; Lee SH, 2010, MOL IMMUNOL, V47, P816, DOI 10.1016/j.molimm.2009.09.041; Lin TT, 2011, CARCINOGENESIS, V32, P154, DOI 10.1093/carcin/bgq234; Lirdprapamongkol K, 2010, IN VIVO, V24, P501; Liu DH, 2007, ACTA PHARMACOL SIN, V28, P1907, DOI 10.1111/j.1745-7254.2007.00702.x; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Luster TA, 2009, MOL CANCER THER, V8, P292, DOI 10.1158/1535-7163.MCT-08-0918; Ma YL, 2006, MOL CANCER THER, V5, P170, DOI 10.1158/1535-7163.MCT-05-0129; Maddipatla S, 2007, CLIN CANCER RES, V13, P4556, DOI 10.1158/1078-0432.CCR-07-0680; Mahalingam D, 2009, BRIT J CANCER, V100, P1415, DOI 10.1038/sj.bjc.6605021; Menoret E, 2006, BLOOD, V108, P1346, DOI 10.1182/blood-2005-12-007971; Mora R, 2009, GLIA, V57, P561, DOI 10.1002/glia.20785; Mori E, 2004, CELL DEATH DIFFER, V11, P203, DOI 10.1038/sj.cdd.4401331; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nesterov A, 2002, ONCOGENE, V21, P1135, DOI 10.1038/sj.onc.1205151; Patsos HA, 2010, INT J ONCOL, V37, P187, DOI 10.3892/ijo_00000666; Perotti C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2193; Robles AI, 2006, CLIN CANCER RES, V12, P6547, DOI 10.1158/1078-0432.CCR-06-1178; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Seol DW, 2001, CANCER RES, V61, P1138; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Smith MR, 2007, CLIN CANCER RES, V13, p5528S, DOI 10.1158/1078-0432.CCR-07-0982; Su CC, 2006, ANTICANCER RES, V26, P4379; Sundararajan R, 2001, J VIROL, V75, P7506, DOI 10.1128/JVI.75.16.7506-7516.2001; Sung ES, 2009, MOL CANCER THER, V8, P2276, DOI 10.1158/1535-7163.MCT-09-0235; TAKENAGA K, 1984, INT J CANCER, V34, P83, DOI 10.1002/ijc.2910340115; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Yamaguchi H, 2002, CANCER RES, V62, P466; Yamanaka T, 2000, HEPATOLOGY, V32, P482, DOI 10.1053/jhep.2000.16266; Zhang L, 2007, CANCER LETT, V251, P146, DOI 10.1016/j.canlet.2006.11.013; Zhao C, 2004, CELL SIGNAL, V16, P313, DOI 10.1016/j.cellsig.2003.08.005	59	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16966	10.1371/journal.pone.0016966	http://dx.doi.org/10.1371/journal.pone.0016966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347335	Green Submitted, gold, Green Published			2022-12-25	WOS:000287363000026
J	Kasai, A; Bai, SL; Li, TZ; Harada, T				Kasai, Atsushi; Bai, Songling; Li, Tianzhong; Harada, Takeo			Graft-Transmitted siRNA Signal from the Root Induces Visual Manifestation of Endogenous Post-Transcriptional Gene Silencing in the Scion	PLOS ONE			English	Article							RNA; MOVEMENT; PHLOEM; PLANTS; EXPRESSION; SPREAD	In plants, post-transcriptional gene silencing (PTGS) spreads systemically, being transmitted from the silenced stock to the scion expressing the corresponding transgene. It has been reported that a graft-transmitted siRNA signal can also induce PTGS of an endogenous gene, but this was done by top-grafting using silenced stock. In the present study involving grafting of Nicotiana benthamiana, we found that PTGS of an endogenous gene, glutamate-1-semialdehyde aminotransferase (GSA), which acts as a visible marker of RNAi via inhibition of chlorophyll synthesis, was manifested along the veins of newly developed leaves in the wild-type scion by the siRNA signal synthesized only in companion cells of the rootstock.	[Kasai, Atsushi; Bai, Songling; Harada, Takeo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Li, Tianzhong] China Agr Univ, Lab Fruit Cell & Mol Breeding, Beijing 100094, Peoples R China	Hirosaki University; China Agricultural University	Kasai, A (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan.	tharada@cc.hirosaki-u.ac.jp	Bai, Songling/X-9850-2019	Bai, Songling/0000-0002-8103-3095	Program for Promotion of Basic Activities for Innovative Bioscience (PROBRAIN) in Japan;  [22380003]	Program for Promotion of Basic Activities for Innovative Bioscience (PROBRAIN) in Japan; 	This work was supported by the Program for Promotion of Basic Activities for Innovative Bioscience (PROBRAIN) in Japan, a Grant-in-Aid for Scientific Research in Japan (22380003) and a Grant for Hirosaki University Institutional Research. The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON R, 1990, P NATL ACAD SCI USA, V87, P1820, DOI 10.1073/pnas.87.5.1820; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Crete P, 2001, PLANT J, V28, P493, DOI 10.1046/j.1365-313X.2001.01171.x; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Harada T, 2010, SCI HORTIC-AMSTERDAM, V125, P545, DOI 10.1016/j.scienta.2010.05.013; Hedtke B, 2007, PLANT MOL BIOL, V64, P733, DOI 10.1007/s11103-007-9194-3; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; HOFGEN R, 1994, P NATL ACAD SCI USA, V91, P1726, DOI 10.1073/pnas.91.5.1726; Kanehira A, 2010, TREE GENET GENOMES, V6, P635, DOI 10.1007/s11295-010-0279-9; Kasai A., 2010, Open Plant Science Journal, V4, P1, DOI 10.2174/1874294701004010001; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; Kragler F, 2010, PLANT SCI, V178, P99, DOI 10.1016/j.plantsci.2009.12.006; Lin SI, 2008, PLANT PHYSIOL, V147, P732, DOI 10.1104/pp.108.116269; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Matsuda Y, 2002, PROTOPLASMA, V220, P51, DOI 10.1007/s00709-002-0027-6; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mudge K., 2009, Horticultural Reviews, V35, P437; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oparka KJ, 1999, PLANT CELL, V11, P739, DOI 10.1105/tpc.11.4.739; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; SJOLUND RD, 1997, PLANT CELL, V11, P739; Stadler R, 1996, BOT ACTA, V109, P299, DOI 10.1111/j.1438-8677.1996.tb00577.x; Suarez-Lopez P, 2005, INT J DEV BIOL, V49, P761, DOI 10.1387/ijdb.052002ps; Tournier B, 2006, PLANT J, V47, P383, DOI 10.1111/j.1365-313X.2006.02796.x; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Xu HY, 2010, TREE GENET GENOMES, V6, P1013, DOI 10.1007/s11295-010-0309-7	33	33	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16895	10.1371/journal.pone.0016895	http://dx.doi.org/10.1371/journal.pone.0016895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347381	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700052
J	Malcom, JW				Malcom, Jacob W.			Smaller, Scale-Free Gene Networks Increase Quantitative Trait Heritability and Result in Faster Population Recovery	PLOS ONE			English	Article							RAPID EVOLUTION; PREVENT EXTINCTION; NATURAL-SELECTION; DUPLICATIONS; CONVERGENCE; EPISTASIS; ARCHITECTURE; ADAPTATION; DYNAMICS	One of the goals of biology is to bridge levels of organization. Recent technological advances are enabling us to span from genetic sequence to traits, and then from traits to ecological dynamics. The quantitative genetics parameter heritability describes how quickly a trait can evolve, and in turn describes how quickly a population can recover from an environmental change. Here I propose that we can link the details of the genetic architecture of a quantitative trait-i.e., the number of underlying genes and their relationships in a network-to population recovery rates by way of heritability. I test this hypothesis using a set of agent-based models in which individuals possess one of two network topologies or a linear genotype-phenotype map, 16-256 genes underlying the trait, and a variety of mutation and recombination rates and degrees of environmental change. I find that the network architectures introduce extensive directional epistasis that systematically hides and reveals additive genetic variance and affects heritability: network size, topology, and recombination explain 81% of the variance in average heritability in a stable environment. Network size and topology, the width of the fitness function, pre-change additive variance, and certain interactions account for similar to 75% of the variance in population recovery times after a sudden environmental change. These results suggest that not only the amount of additive variance, but importantly the number of loci across which it is distributed, is important in regulating the rate at which a trait can evolve and populations can recover. Taken in conjunction with previous research focused on differences in degree of network connectivity, these results provide a set of theoretical expectations and testable hypotheses for biologists working to span levels of organization from the genotype to the phenotype, and from the phenotype to the environment.	Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Malcom, JW (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	jmalcom@mail.utexas.edu	/AAD-1873-2020	/0000-0002-4904-8369	University of Texas at Austin	University of Texas at Austin	This work was supported in part by a start-up grant from the University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amoutzias GD, 2004, EMBO REP, V5, P274, DOI 10.1038/sj.embor.7400096; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; B³rger R., 2000, MATH THEORY SELECTIO; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Barton N. H., 2007, EVOLUTION; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Cowperthwaite MC, 2007, ANNU REV ECOL EVOL S, V38, P203, DOI 10.1146/annurev.ecolsys.38.091206.095507; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Edwards Alexis C, 2009, BMC Biol, V7, P29, DOI 10.1186/1741-7007-7-29; Falconer D. S, 1996, INTRO QUANTITATIVE G; Frank SA, 1999, J THEOR BIOL, V197, P281, DOI 10.1006/jtbi.1998.0872; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hanski I., 1999, METAPOPULATION ECOLO; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Hermisson J, 2003, AM NAT, V161, P708, DOI 10.1086/374204; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; KIMBRELL T, 2010, EVOLUTIONARY ECOLOGY; Kimbrell T, 2007, AM NAT, V169, P370, DOI 10.1086/511314; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Naciri-Graven Y, 2003, EVOLUTION, V57, P706, DOI 10.1111/j.0014-3820.2003.tb00284.x; Ohno S., 1970, EVOLUTION GENE DUPLI; Platts Adrian E., 2009, P227, DOI 10.1007/978-1-59745-440-7_13; R Development Core Team, 2009, R FDN STAT COMP; Repsilber D, 2009, EURASIP J BIOINFO SY, V2009; Roff Derek A., 1992; Rokas A, 2008, MOL BIOL EVOL, V25, P1943, DOI 10.1093/molbev/msn143; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Stearns SC, 2003, AM NAT, V161, P171, DOI 10.1086/367983; Stumpf MPH, 2007, TRENDS ECOL EVOL, V22, P366, DOI 10.1016/j.tree.2007.04.004; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Wagner A, 1996, BIOL CYBERN, V74, P557, DOI 10.1007/BF00209427; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Weigensberg I, 1996, EVOLUTION, V50, P2149, DOI 10.1111/j.1558-5646.1996.tb03605.x; Wilenski U., 1999, NETLOGO; Wolf JB, 2003, P NATL ACAD SCI USA, V100, P4655, DOI 10.1073/pnas.0635741100; Yee TW, 2008, R NEWS, V8, P28; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Zhou Q, 2008, J GENET GENOMICS, V35, P639, DOI 10.1016/S1673-8527(08)60085-5	61	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14645	10.1371/journal.pone.0014645	http://dx.doi.org/10.1371/journal.pone.0014645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347400	Green Submitted, Green Published, gold			2022-12-25	WOS:000287361700001
J	Ninove, L; Nougairede, A; Gazin, C; Thirion, L; Delogu, I; Zandotti, C; Charrel, RN; De Lamballerie, X				Ninove, Laetitia; Nougairede, Antoine; Gazin, Celine; Thirion, Laurence; Delogu, Ilenia; Zandotti, Christine; Charrel, Remi N.; De Lamballerie, Xavier			RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests	PLOS ONE			English	Article							REAL-TIME PCR; QUANTITATIVE PCR; INFLUENZA-VIRUS; ASSAY; QUANTIFICATION; SPECIMENS; STEP	Real-time PCR techniques are now commonly used for the detection of viral genomes in various human specimens and require for validation both external and internal controls (ECs and ICs). In particular, ICs added to clinical samples are necessary to monitor the extraction, reverse transcription, and amplification steps in order to detect false-negative results resulting from PCR-inhibition or errors in the technical procedure. Here, we performed a large scale evaluation of the use of bacteriophages as ICs in routine molecular diagnosis. This allowed to propose simple standardized procedures (i) to design specific ECs for both DNA and RNA viruses and (ii) to use T4 (DNA) or MS2 (RNA) phages as ICs in routine diagnosis. Various technical formats for using phages as ICs were optimised and validated. Subsequently, T4 and MS2 ICs were evaluated in routine real-time PCR or RT-PCR virological diagnostic tests, using a series of 8,950 clinical samples (representing 36 distinct specimen types) sent to our laboratory for the detection of a variety of DNA and RNA viruses. The frequency of inefficient detection of ICs was analyzed according to the nature of the sample. Inhibitors of enzymatic reactions were detected at high frequency in specific sample types such as heparinized blood and bone marrow (>70%), broncho-alveolar liquid (41%) and stools (36%). The use of T4 and MS2 phages as ICs proved to be cost-effective, flexible and adaptable to various technical procedures of real-time PCR detection in virology. It represents a valuable strategy for enhancing the quality of routine molecular diagnosis in laboratories that use in-house designed diagnostic systems, which can conveniently be associated to the use of specific synthetic ECs. The high rate of inhibitors observed in a variety of specimen types should stimulate the elaboration of improved technical protocols for the extraction and amplification of nucleic acids.	[Ninove, Laetitia; Nougairede, Antoine; Thirion, Laurence; Delogu, Ilenia; Zandotti, Christine; Charrel, Remi N.; De Lamballerie, Xavier] Univ Aix Marseille 2, UMR190, Marseille, France; [Ninove, Laetitia; Nougairede, Antoine; Thirion, Laurence; Delogu, Ilenia; Zandotti, Christine; Charrel, Remi N.; De Lamballerie, Xavier] Inst Rech Dev, Marseille, France; [Ninove, Laetitia; Nougairede, Antoine; Gazin, Celine; Zandotti, Christine; Charrel, Remi N.; De Lamballerie, Xavier] Assistance Publ Hop Marseille, Marseille, France; [De Lamballerie, Xavier] EHESP Sch Publ Hlth, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ninove, L (corresponding author), Univ Aix Marseille 2, UMR190, Marseille, France.	xavier.de-lamballerie@univmed.fr		Charrel, Remi/0000-0002-7675-8251	AP-HM Public Hospital system; Universite de la Mediterranee	AP-HM Public Hospital system; Universite de la Mediterranee	This study has been funded by AP-HM Public Hospital system and by Universite de la Mediterranee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study is based on results obtained in the virological diagnosis of patients in the AP-HM Public Hospital.	Aberham C, 2001, J VIROL METHODS, V92, P183, DOI 10.1016/S0166-0934(00)00292-5; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Dreier J, 2006, J CLIN MICROBIOL, V44, P2714, DOI 10.1128/JCM.00443-06; Garbino J, 2004, AM J RESP CRIT CARE, V170, P1197, DOI 10.1164/rccm.200406-781OC; Gerriets JE, 2008, J MOL DIAGN, V10, P28, DOI 10.2353/jmoldx.2008.070028; Griscelli F, 2001, J CLIN MICROBIOL, V39, P4362, DOI 10.1128/JCM.39.12.4362-4369.2001; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Kessler HH, 2000, J CLIN MICROBIOL, V38, P2638, DOI 10.1128/JCM.38.7.2638-2642.2000; Lallemand F, 2000, J CLIN MICROBIOL, V38, P1404, DOI 10.1128/JCM.38.4.1404-1408.2000; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Locatelli G, 2000, J CLIN MICROBIOL, V38, P4042, DOI 10.1128/JCM.38.11.4042-4048.2000; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Ninove L, 2010, VECTOR-BORNE ZOONOT, V10, P237, DOI 10.1089/vbz.2009.0110; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Perez-Ruiz M, 2007, J CLIN VIROL, V39, P276, DOI 10.1016/j.jcv.2007.05.003; Rolfe KJ, 2007, J CLIN VIROL, V39, P318, DOI 10.1016/j.jcv.2007.05.005; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Watkins-Riedel T, 2002, DIAGN MICR INFEC DIS, V42, P99, DOI 10.1016/S0732-8893(01)00330-3; Whiley DM, 2001, J CLIN MICROBIOL, V39, P4357, DOI 10.1128/JCM.39.12.4357-4361.2001; Yu XF, 2008, J CLIN MICROBIOL, V46, P837, DOI 10.1128/JCM.01904-07	22	93	96	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16142	10.1371/journal.pone.0016142	http://dx.doi.org/10.1371/journal.pone.0016142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347398	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700012
J	Marois, L; Vaillancourt, M; Pare, G; Gagne, V; Fernandes, MJG; Rollet-Labelle, E; Naccache, PH				Marois, Louis; Vaillancourt, Myriam; Pare, Guillaume; Gagne, Valerie; Fernandes, Maria J. G.; Rollet-Labelle, Emmanuelle; Naccache, Paul H.			CIN85 Modulates the Down-regulation of Fc gamma RIIa Expression and Function by c-Cbl in a PKC-dependent Manner in Human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECEPTOR-MEDIATED PHAGOCYTOSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYROSINE PHOSPHORYLATION; LIPID RAFTS; RHEUMATOID-ARTHRITIS; IMMUNOGLOBULIN-G; ADAPTER PROTEIN; CROSS-LINKING; HIGH-DENSITY	We previously described a non-classical mechanism that arrests Fc gamma RIIa signaling in human neutrophils once engaged by immune complexes or opsonized pathogens. The engagement of Fc gamma RIIa leads to its ubiquitination by the ubiquitin ligase c-Cbl and degradation by the proteasome. Herein, we further examined some of the events regulating this novel pathway. The adaptor protein CIN85 was described in other systems to be involved in the regulation of the c-Cbl-dependent pathway. We found that CIN85 is expressed in human neutrophils and that it translocates like c-Cbl from the cytosol to the plasma membrane following receptor cross-linking. CIN85 was also recruited to the same subset of high density detergent-resistant membrane fractions in which stimulated Fc gamma RIIa partitioned with c-Cbl. The integrity of these microdomains is essential to the Fc gamma RIIa degradation process because the cholesterol-depleting agent methyl-beta-cyclodextrin inhibits this event. Silencing the expression of CIN85 by siRNA in dibutyryl cyclic AMP-differentiated PLB 985 cells prevented Fc gamma RIIa degradation and increased IgG-mediated phagocytosis. Confocal microscopy revealed that the presence of CIN85 is essential to the proper sorting of Fc gamma RIIa during endocytosis. We also provide direct evidence that CIN85 is a substrate of serine/threonine kinase PKCs. Classical PKCs positively regulate Fc gamma RIIa ubiquitination and degradation because these events were inhibited by Go6976, a classical PKC inhibitor. We conclude that the ubiquitination and degradation of stimulated Fc gamma RIIa mediated by c-Cbl are positively regulated by the adaptor protein CIN85 in a PKC-dependent manner and that these events contribute to the termination of Fc gamma RIIa signaling.	[Marois, Louis; Vaillancourt, Myriam; Pare, Guillaume; Gagne, Valerie; Fernandes, Maria J. G.; Rollet-Labelle, Emmanuelle; Naccache, Paul H.] Univ Laval, Ctr Rech Rhumatol & Immunol, Ctr Rech CHUQ, Dept Microbiol Infectiol & Immunol,Fac Med, Quebec City, PQ G1V 4G2, Canada	Laval University	Rollet-Labelle, E (corresponding author), Univ Laval, Ctr Rech Rhumatol & Immunol, Ctr Rech CHUQ, Dept Microbiol Infectiol & Immunol,Fac Med, 2705 Blvd Laurier,Room T1-49, Quebec City, PQ G1V 4G2, Canada.	emmanuelle.rollet@crchul.ulaval.ca		Marois, Louis/0000-0002-1567-5583	Canadian Institutes of Health Research (CIHR); Canadian Arthritis Network	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported in part by grants from the Canadian Institutes of Health Research (CIHR).; Recipient of a Canadian Arthritis Network Graduate Award and a CIHR Doctoral Research Award.	Artcanuthurry Valerie, 1996, Seminars in Thrombosis and Hemostasis, V22, P317, DOI 10.1055/s-2007-999026; Barabe F, 2002, J IMMUNOL, V168, P4042, DOI 10.4049/jimmunol.168.8.4042; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Belostocki K, 2005, CLIN IMMUNOL, V117, P78, DOI 10.1016/j.clim.2005.07.001; BRUMELL JH, 1994, AM J PHYSIOL-CELL PH, V267, pC1574, DOI 10.1152/ajpcell.1994.267.6.C1574; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Danielsen EM, 2006, MOL MEMBR BIOL, V23, P71, DOI 10.1080/09687860500445604; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; DUSI S, 1994, BIOCHEM BIOPH RES CO, V201, P30, DOI 10.1006/bbrc.1994.1665; Fernandes MJG, 2006, BIOCHEM J, V393, P351, DOI 10.1042/BJ20050129; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Havrylov S, 2010, TRAFFIC, V11, P721, DOI 10.1111/j.1600-0854.2010.01061.x; Hogarth PM, 2002, CURR OPIN IMMUNOL, V14, P798, DOI 10.1016/S0952-7915(02)00409-0; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2365; HUNDT M, 1992, EUR J IMMUNOL, V22, P811, DOI 10.1002/eji.1830220327; HUNTER S, 1994, P NATL ACAD SCI USA, V91, P10232, DOI 10.1073/pnas.91.21.10232; Ibarrola I, 1997, BBA-MOL CELL RES, V1357, P348, DOI 10.1016/S0167-4889(97)00034-7; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kabouridis PS, 2006, MOL MEMBR BIOL, V23, P49, DOI 10.1080/09687860500453673; KIMBERLY RP, 1995, ARTHRITIS RHEUM, V38, P306, DOI 10.1002/art.1780380303; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Kurakin AV, 2003, J BIOL CHEM, V278, P34102, DOI 10.1074/jbc.M305264200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LIANG L, 1995, BIOCHEM J, V306, P489, DOI 10.1042/bj3060489; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; MAROIS L, 2011, ADV MED BIOL, V15, P123; Marois L, 2011, J BIOL CHEM, V286, P3509, DOI 10.1074/jbc.M110.169516; Marois L, 2009, J IMMUNOL, V182, P2374, DOI 10.4049/jimmunol.0801420; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mayer AMS, 1997, LIFE SCI, V61, pPL199, DOI 10.1016/S0024-3205(97)00713-3; Melander F, 2004, BIOCHEM BIOPH RES CO, V317, P1000, DOI 10.1016/j.bbrc.2004.03.147; Molfetta R, 2005, J IMMUNOL, V175, P4208, DOI 10.4049/jimmunol.175.7.4208; Naccache PH, 1997, J LEUKOCYTE BIOL, V62, P901, DOI 10.1002/jlb.62.6.901; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Peruzzi G, 2007, J IMMUNOL, V179, P2089, DOI 10.4049/jimmunol.179.4.2089; Popa-Nita O, 2009, J IMMUNOL, V183, P2104, DOI 10.4049/jimmunol.0900906; Qiu WS, 1998, J LEUKOCYTE BIOL, V63, P631, DOI 10.1002/jlb.63.5.631; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RICHARD S, 1994, BIOCHEM BIOPH RES CO, V199, P653, DOI 10.1006/bbrc.1994.1278; ROLLET E, 1994, J IMMUNOL, V153, P353; Rollet-Labelle E, 2004, BIOCHEM J, V381, P919, DOI 10.1042/BJ20031808; Rollet-Labelle E, 2000, J IMMUNOL, V164, P1020, DOI 10.4049/jimmunol.164.2.1020; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; Sardjono CT, 2003, IMMUNOL CELL BIOL, V81, P374, DOI 10.1046/j.1440-1711.2003.01182.x; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slaughter N, 2003, CLIN IMMUNOL, V108, P138, DOI 10.1016/S1521-6616(03)00097-4; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583	63	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15073	15084		10.1074/jbc.M110.213660	http://dx.doi.org/10.1074/jbc.M110.213660			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372129	Green Published, hybrid			2022-12-25	WOS:000289788300038
J	Tang, HP; Rothery, RA; Voss, JE; Weiner, JH				Tang, Huipo; Rothery, Richard A.; Voss, James E.; Weiner, Joel H.			Correct Assembly of Iron-Sulfur Cluster FS0 into Escherichia coli Dimethyl Sulfoxide Reductase (DmsABC) Is a Prerequisite for Molybdenum Cofactor Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MOLYBDOPTERIN GUANINE DINUCLEOTIDE; INDUCIBLE FORMATE DEHYDROGENASE; MENAQUINOL BINDING-SITE; NITRATE REDUCTASE; DIMETHYLSULFOXIDE REDUCTASE; SPECTROSCOPIC CHARACTERIZATION; FUMARATE REDUCTASE; CATALYTIC SUBUNIT; ELECTRON-TRANSFER	The FS0 [4Fe-4S] cluster of the catalytic subunit (DmsA) of Escherichia coli dimethyl sulfoxide reductase (DmsABC) plays a key role in the electron transfer relay. We have now established an additional role for the cluster in directing molybdenum cofactor assembly during enzyme maturation. EPR spectroscopy indicates that FS0 has a high spin ground state (S = 3/2) in its reduced form, resulting in an EPR spectrum with a peak at g similar to 5.0. The cluster is predicted to be in close proximity to the molybdo-bis(pyranopterin guanine dinucleotide) (Mo-bisPGD) cofactor, which provides the site of dimethyl sulfoxide reduction. Comparison with nitrate reductase A (NarGHI) indicates that a sequence of residues ((CTVNC22)-C-18) plays a role in both FS0 and Mo-bisPGD coordination. A DmsA(Delta N21) mutant prevented Mo-bisPGD binding and resulted in a degenerate [3Fe-4S] cluster form of FS0 being assembled. DmsA belongs to the Type II subclass of Mo-bisPGD-containing catalytic subunits that is distinguished from the Type I subclass by having three rather than two residues between the first two Cys residues coordinating FS0 and a conserved Arg residue rather than a Lys residue following the fourth cluster coordinating Cys. We introduced a Type I Cys group into DmsA in two stages. We changed its sequence from (18)C(A)TVNC(B)GSRC(C)P(27) to 18C(A)TYC(B)GVGC(C)G(26) (similar to that of formate dehydrogenase (FdnG)) and demonstrated that this eliminated both Mo-bisPGD binding and EPR-detectable FS0. We then combined this change with a DmsA(R61K) mutation and demonstrated that this additional change partially rescued Mo-bisPGD insertion.	[Tang, Huipo; Rothery, Richard A.; Voss, James E.; Weiner, Joel H.] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada	University of Alberta	Weiner, JH (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, 474 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	jweiner@ualberta.ca		Rothery, Richard/0000-0003-3265-1783	Canadian Institutes of Health Research [MOP15292]; Natural Sciences and Engineering Research Council of Canada; Queen Elizabeth II graduate scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen Elizabeth II graduate scholarship	This work was supported in part by Canadian Institutes of Health Research Grant MOP15292.; Supported by a Natural Sciences and Engineering Research Council of Canada graduate studentship and a Queen Elizabeth II graduate scholarship.	BERG BL, 1991, J BIOL CHEM, V266, P22386; BERG BL, 1990, GENETICS, V125, P691; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; BILOUS PT, 1985, J BACTERIOL, V162, P1151, DOI 10.1128/JB.162.3.1151-1155.1985; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; BLASCO F, 1989, MOL GEN GENET, V218, P249, DOI 10.1007/BF00331275; BLASCO F, 1990, MOL GEN GENET, V222, P104, DOI 10.1007/BF00283030; Bogachev AV, 1996, J BACTERIOL, V178, P6233, DOI 10.1128/jb.178.21.6233-6237.1996; BRETON J, 1994, FEBS LETT, V345, P76, DOI 10.1016/0014-5793(94)00445-5; CAMMACK R, 1990, BIOCHEMISTRY-US, V29, P8410, DOI 10.1021/bi00488a030; Chan CS, 2010, FEBS LETT, V584, P4553, DOI 10.1016/j.febslet.2010.10.043; Cheng VWT, 2005, BIOCHEMISTRY-US, V44, P8068, DOI 10.1021/bi050362p; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Duderstadt RE, 1999, FEBS LETT, V454, P21, DOI 10.1016/S0014-5793(99)00766-8; FLINT DH, 1992, BIOCHEMISTRY-US, V31, P10331, DOI 10.1021/bi00157a022; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; Gladyshev VN, 1996, J BIOL CHEM, V271, P8095, DOI 10.1074/jbc.271.14.8095; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; Hettmann T, 2003, BIOCHEM BIOPH RES CO, V310, P40, DOI 10.1016/j.bbrc.2003.08.114; JOHNSON JL, 1991, J BIOL CHEM, V266, P12140; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kirillova O, 2007, ACTA CRYSTALLOGR D, V63, P348, DOI 10.1107/S0907444906055065; KOWAL AT, 1995, BIOCHEMISTRY-US, V34, P12284, DOI 10.1021/bi00038a024; KRAFFT T, 1992, EUR J BIOCHEM, V206, P503, DOI 10.1111/j.1432-1033.1992.tb16953.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; Li HM, 2009, CAN J MICROBIOL, V55, P179, DOI [10.1139/W08-111, 10.1139/w08-111]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magalon A, 1998, BIOCHEMISTRY-US, V37, P7363, DOI 10.1021/bi972858f; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MULLER A, 1992, FEBS LETT, V303, P36, DOI 10.1016/0014-5793(92)80472-S; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; PLUNKETT G, 1993, NUCLEIC ACIDS RES, V21, P3391, DOI 10.1093/nar/21.15.3391; Ray N, 2003, FEBS LETT, V534, P156, DOI 10.1016/S0014-5793(02)03839-5; ROTHERY RA, 1995, J BACTERIOL, V177, P2057, DOI 10.1128/jb.177.8.2057-2063.1995; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; Rothery RA, 2005, FEBS J, V272, P313, DOI 10.1111/j.1742-4658.2004.04469.x; ROTHERY RA, 1991, BIOCHEMISTRY-US, V30, P8296, DOI 10.1021/bi00098a003; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Rothery RA, 1999, J BIOL CHEM, V274, P13002, DOI 10.1074/jbc.274.19.13002; Rothery RA, 1999, BIOCHEMISTRY-US, V38, P12747, DOI 10.1021/bi990533o; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; Rothery RA, 1998, EUR J BIOCHEM, V254, P588, DOI 10.1046/j.1432-1327.1998.2540588.x; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rothery RA, 2010, J BIOL CHEM, V285, P8801, DOI 10.1074/jbc.M109.066027; SAMBASIVARAO D, 1991, J BACTERIOL, V173, P5935, DOI 10.1128/jb.173.19.5935-5943.1991; SAMBASIVARAO D, 1990, J BACTERIOL, V172, P5938, DOI 10.1128/jb.172.10.5938-5948.1990; Sambasivarao D, 2000, J BIOL CHEM, V275, P22526, DOI 10.1074/jbc.M909289199; Sambasivarao D, 2002, BIOCHEM CELL BIOL, V80, P435, DOI 10.1139/O02-131; Sambasivarao D, 2001, J BIOL CHEM, V276, P20167, DOI 10.1074/jbc.M010369200; Sambrook J, 2001, MOL CLONING LAB MANU; Stanley NR, 2002, MOL MICROBIOL, V43, P1005, DOI 10.1046/j.1365-2958.2002.02797.x; Stevens CM, 2009, J MOL BIOL, V389, P124, DOI 10.1016/j.jmb.2009.03.069; Trieber CA, 1996, J BIOL CHEM, V271, P4620; TRIEBER CA, 1994, J BIOL CHEM, V269, P7103; VANARK G, 1977, BIOCHIM BIOPHYS ACTA, V459, P119, DOI 10.1016/0005-2728(77)90014-7; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Zhao ZW, 1998, J BIOL CHEM, V273, P20758, DOI 10.1074/jbc.273.33.20758	64	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15147	15154		10.1074/jbc.M110.213306	http://dx.doi.org/10.1074/jbc.M110.213306			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357619	hybrid, Green Published			2022-12-25	WOS:000289788300046
J	Koksal, AC; Cingolani, G				Koksal, Adem C.; Cingolani, Gino			Dimerization of Vaccinia Virus VH1 Is Essential for Dephosphorylation of STAT1 at Tyrosine 701	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; PROTEIN PHOSPHATASES; CRYSTAL-STRUCTURE; H1 PHOSPHATASE; IN-VIVO; SPECIFICITY; PHOSPHORYLATION; ULTRACENTRIFUGATION; MACROMOLECULES	The gene product of Vaccinia virus gene H1, VH1, is the first identified dual specificity phosphatase (DSP). The human genome encodes 38 different VH1-like DSPs, which include major regulators of signaling pathways, highly dysregulated in disease states. VH1 down-regulates cellular antiviral response by dephosphorylating activated STAT1 in the IFN-gamma/STAT1 signaling pathway. In this report, we have investigated the molecular basis for VH1 catalytic activity. Using small-angle x-ray scattering (SAXS), we determined that VH1 exists in solution as a boomerang-shaped dimer. Targeted alanine mutations in the dimerization domain (aa 1-27) decrease phosphatase activity while leaving the dimer intact. Deletion of the N-terminal dimer swapped helix (aa 1-20) completely abolishes dimerization and severely reduces phosphatase activity. An engineered chimera of VH1 that contains only one active site retains wild-type levels of catalytic activity. Thus, a dimeric quaternary structure, as opposed to two cooperative active sites within the same dimer is essential for VH1 catalytic activity. Together with laforin, VH1 is the second DSP reported in literature for which dimerization via an N-terminal dimerization domain is necessary for optimal catalytic activity. We propose that dimerization may represent a common mechanism to regulate the activity and substrate recognition of DSPs, often assumed to function as monomers.	[Koksal, Adem C.; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Koksal, Adem C.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu		Koksal, Adem/0000-0002-3163-7421	National Institutes of Health [GM074846-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074846-01A1.	Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2004, J BIOL CHEM, V279, P35768, DOI 10.1074/jbc.M403412200; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Derrien M, 1999, J VIROL, V73, P7287, DOI 10.1128/JVI.73.9.7287-7296.1999; Deshpande T, 1999, J BIOL CHEM, V274, P16590, DOI 10.1074/jbc.274.23.16590; Ducruet AP, 2005, ANNU REV PHARMACOL, V45, P725, DOI 10.1146/annurev.pharmtox.45.120403.100040; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; Koksal AC, 2009, J BIOL CHEM, V284, P10129, DOI 10.1074/jbc.M808362200; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mann BA, 2008, J INTERF CYTOK RES, V28, P367, DOI 10.1089/jir.2007.0113; Mercer J, 2003, J VIROL, V77, P8857, DOI 10.1128/JVI.77.16.8857-8871.2003; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Phan J, 2007, ACTA CRYSTALLOGR D, V63, P698, DOI 10.1107/S0907444907014904; Portman JJ, 2010, CURR OPIN STRUC BIOL, V20, P11, DOI 10.1016/j.sbi.2009.12.013; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	37	24	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14373	14382		10.1074/jbc.M111.226357	http://dx.doi.org/10.1074/jbc.M111.226357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362620	Green Published, hybrid			2022-12-25	WOS:000289556200059
J	Yang, K; Proweller, A				Yang, Ke; Proweller, Aaron			Vascular Smooth Muscle Notch Signals Regulate Endothelial Cell Sensitivity to Angiogenic Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORPUS-LUTEUM; BLOOD-VESSELS; GROWTH-FACTOR; MURAL CELLS; EXPRESSION; JAGGED1; MICE; DLL4; ANGIOPOIETIN-1; PERICYTES	The evolutionarily conserved Notch signaling pathway is required for normal vascular development and function, and genetic associations link select Notch receptors and ligands to human clinical syndromes featuring blood vessel abnormalities and stroke susceptibility. A previously described mouse model engineered to suppress canonical Notch signaling in vascular smooth muscle cells (vSMCs) revealed surprising anatomical defects in arterial patterning and vessel maturation, suggesting that vSMCs have the functional capacity to influence blood vessel formation in a Notch signaling-dependent manner. In further analyses using this model system, we now show that explanted aortic ring tissue and Matrigel implants from the smooth muscle Notch signaling-deficient mice yield markedly diminished responses to angiogenic stimuli. Furthermore, cultured Notch signaling-deficient primary vSMCs have reduced proliferation and migration capacities and reveal diminished expression of PDGF receptor beta and JAGGED1 ligand. These observations prompted a series of endothelial cell (EC)-vSMC co-culture experiments that revealed a requirement for intact vSMC Notch signals via JAGGED1 for efficient EC Notch1 receptor activation and EC proliferation. Taken together, these studies suggest a heterotypic model wherein Notch signaling in vSMCs provides early instructive cues to neighboring ECs important for optimal postnatal angiogenesis.	Case Western Reserve Univ, Case Cardiovasc Res Inst, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Inst Heart & Vasc, Univ Hosp Harrington McLaughlin, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Proweller, A (corresponding author), Case Western Reserve Univ, Dept Med, 4530 Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44122 USA.	aaron.proweller@case.edu			National Institutes of Health [K08-HL079072, R01-HL096603-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096603, K08HL079072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08-HL079072 and R01-HL096603-01 (to A. P.).	Amselgruber WM, 1999, ANAT HISTOL EMBRYOL, V28, P157, DOI 10.1046/j.1439-0264.1999.00195.x; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kitamoto T, 2005, BIOCHEM BIOPH RES CO, V331, P1154, DOI 10.1016/j.bbrc.2005.03.241; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Redmer DA, 2001, BIOL REPROD, V65, P879, DOI 10.1095/biolreprod65.3.879; Reynolds LP, 2000, ENDOCRINE, V12, P1, DOI 10.1385/ENDO:12:1:1; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Sundberg C, 2002, LAB INVEST, V82, P387, DOI 10.1038/labinvest.3780433; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5	35	26	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13741	13753		10.1074/jbc.M110.181842	http://dx.doi.org/10.1074/jbc.M110.181842			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349836	Green Published, hybrid			2022-12-25	WOS:000289282200092
J	Gregory, R; Darby, AC; Irving, H; Coulibaly, MB; Hughes, M; Koekemoer, LL; Coetzee, M; Ranson, H; Hemingway, J; Hall, N; Wondji, CS				Gregory, Richard; Darby, Alistair C.; Irving, Helen; Coulibaly, Mamadou B.; Hughes, Margaret; Koekemoer, Lizette L.; Coetzee, Maureen; Ranson, Hilary; Hemingway, Janet; Hall, Neil; Wondji, Charles S.			A De Novo Expression Profiling of Anopheles funestus, Malaria Vector in Africa, Using 454 Pyrosequencing	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; MICROARRAY	Background: Anopheles funestus is one of the major malaria vectors in Africa and yet there are few genomic tools available for this species compared to An. gambiae. To start to close this knowledge gap, we sequenced the An. funestus transcriptome using cDNA libraries developed from a pyrethroid resistant laboratory strain and a pyrethroid susceptible field strain from Mali. Results: Using a pool of life stages (pupae, larvae, adults: females and males) for each strain, 454 sequencing generated 375,619 reads (average length of 182 bp). De novo assembly generated 18,103 contigs with average length of 253 bp. The average depth of coverage of these contigs was 8.3. In total 20.8% of all reads were novel when compared to reference databases. The sequencing of the field strain generated 204,758 reads compared to 170,861 from the insecticide resistant laboratory strain. The contigs most differentially represented in the resistant strain belong to the P450 gene family and cuticular genes which correlates with previous studies implicating both of these gene families in pyrethroid resistance. qPCR carried out on six contigs indicates that these ESTs could be suitable for gene expression studies such as microarray. 31,000 sites were estimated to contain Single Nucleotide Polymorphisms (SNPs) and analysis of SNPs from 20 contigs suggested that most of these SNPs are likely to be true SNPs. Gene conservation analysis confirmed the close phylogenetic relationship between An. funestus and An. gambiae. Conclusion: This study represents a significant advance for the genetics and genomics of An. funestus since it provides an extensive set of both Expressed Sequence Tags (ESTs) and SNPs which can be readily adopted for the design of new genomic tools such as microarray or SNP platforms.	[Gregory, Richard; Darby, Alistair C.; Hughes, Margaret; Hall, Neil] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Irving, Helen; Ranson, Hilary; Hemingway, Janet; Wondji, Charles S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Coulibaly, Mamadou B.] Malaria Res & Training Ctr, Bamako, Mali; [Koekemoer, Lizette L.; Coetzee, Maureen] Univ Witwatersrand, Div Virol & Communicable Dis Surveillance, Johannesburg, South Africa; [Koekemoer, Lizette L.; Coetzee, Maureen] NICD, Johannesburg, South Africa	University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Institute for Communicable Diseases (NICD)	Gregory, R (corresponding author), Univ Liverpool, Sch Biol Sci, Cornwall House, Liverpool L69 3BX, Merseyside, England.	c.s.wondji@liverpool.ac.uk	Hall, Neil/A-8717-2013; Coetzee, Maureen/AAI-1413-2020; Coulibaly, Mamadou/AAE-7006-2019; Darby, Alistair/I-6485-2012; Wondji, Charles/AAG-1510-2020; Coetzee, Maureen/AAW-4739-2020	Hall, Neil/0000-0002-7995-3810; Coetzee, Maureen/0000-0003-2019-866X; Darby, Alistair/0000-0002-3786-6209; Hemingway, Janet/0000-0002-3200-7173; Wondji, Charles S./0000-0003-0791-3673; Hall, Neil/0000-0003-2808-0009; Koekemoer, Lizette/0000-0003-4236-6345; Ranson, Hilary/0000-0003-2332-8247	National Institute of Health (NIH) [IU01 A1058271-01]; Wellcome Trust [083515/Z/07/Z]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Institute of Health (NIH) grant IU01 A1058271-01 and by a Wellcome Trust Research Career Development Fellowship (083515/Z/07/Z) to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; AWOLOLA TS, 2008, T R SOC TROP MED HYG; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morlais I, 2003, INSECT MOL BIOL, V12, P631, DOI 10.1046/j.1365-2583.2003.00449.x; Serazin AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007976; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-5; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574	16	46	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17418	10.1371/journal.pone.0017418	http://dx.doi.org/10.1371/journal.pone.0017418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364769	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000287764100060
J	Meng, LS; He, XJ; Zhu, WH; Yang, XD; Jiang, CS; Sun, QZ; Asim, RMB; Zhang, SM; Xue, QA; Xie, XF; Lu, SM				Meng, Liesu; He, Xiaojing; Zhu, Wenhua; Yang, Xudong; Jiang, Congshan; Sun, Qingzhu; Asim, Raza M. B.; Zhang, Simeng; Xue, Qian; Xie, Xinfang; Lu, Shemin			TLR3 and TLR7 Modulate IgE Production in Antigen Induced Pulmonary Inflammation via Influencing IL-4 Expression in Immune Organs	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; EXPERIMENTAL ASTHMA; RESPONSE MODIFIER; EPITHELIAL-CELLS; DENDRITIC CELLS; NITRIC-OXIDE; IMIQUIMOD; DISEASE	Background: Toll-like receptors (TLRs) as pattern recognition receptors, participate in both innate and adaptive immune responses, and seem to play an important role in the pathogenesis of asthma. This study aimed to identify key TLRs involved in antigen induced pulmonary inflammation (AIPI), a rat model for asthma, and to explore the role of TLRs in the disease development. Methods and Findings: E3 rats were sensitized with ovalbumin (OVA)/alum intraperitoneally and intranasally challenged with OVA to induce AIPI model. TLR1-9 and cytokine mRNA expression in spleen, lung and mediastinal lymph node (mLN) tissues were screened by quantitative real-time polymerase chain reaction. TLR7 expression was found to be significantly down-regulated in spleen while TLR3 and TLR8 expression was up-regulated in mLN of AIPI rats. Furthermore, imiquimod (a ligand of TLR7) and TLR3 specific short-hairpin RNA plasmid for RNA interference were administrated, respectively, in vivo to AIPI rats to observe their effects on the disease by assessing various asthmatic parameters. The numbers of total cells, eosinophils, macrophages and lymphocytes were counted according to differential morphology in bronchoalveolar lavage fluid. Serum IgE and OVA specific IgG(1) concentration was detected by enzyme-linked immunosorbent assay. The results showed that both TLR7 ligand treatment and TLR3 RNAi in vivo decreased serum IgE level and interleukin-4 mRNA expression. Conclusion/Significance: TLR3 in mLN and TLR7 in spleen both systemically modulate disease development in AIPI rats via altering serum IgE concentration relevant to Th2 responses. And these findings may provide an important clue for further research in the asthma pathogenesis and suggest a new remedy for asthma treatment.	[Meng, Liesu; He, Xiaojing; Zhu, Wenhua; Yang, Xudong; Jiang, Congshan; Sun, Qingzhu; Asim, Raza M. B.; Zhang, Simeng; Xue, Qian; Xie, Xinfang; Lu, Shemin] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China; [Meng, Liesu; He, Xiaojing; Zhu, Wenhua; Yang, Xudong; Jiang, Congshan; Sun, Qingzhu; Asim, Raza M. B.; Lu, Shemin] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Meng, LS (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China.	shemin.lu@gmail.com	Lu, Shemin/AAI-6479-2021; Lu, Shemin/M-3350-2018	Lu, Shemin/0000-0002-5535-8320; Zhu, Wenhua/0000-0002-2820-2427; Lu, Shemin/0000-0001-8250-850X; Jiang, Congshan/0000-0002-7457-6243	National Natural Science Foundation of China [30630058, 30801027, 81070030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30630058, 30801027 and 81070030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; Bian T, 2006, CHINESE MED J-PEKING, V119, P640, DOI 10.1097/00029330-200604020-00005; Camateros P, 2007, AM J RESP CRIT CARE, V175, P1241, DOI 10.1164/rccm.200701-054OC; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Curtis Jeffrey L, 2005, Proc Am Thorac Soc, V2, P412, DOI 10.1513/pats.200507-070JS; Du Q, 2009, CLIN EXP PHARMACOL P, V36, P43, DOI 10.1111/j.1440-1681.2008.05027.x; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Frotscher B, 2002, J INVEST DERMATOL, V119, P1059, DOI 10.1046/j.1523-1747.2002.19531.x; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Hoffjan S, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-34; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kumar RK, 2002, AM J RESP CELL MOL, V27, P267, DOI 10.1165/rcmb.F248; [龙静雯 LONG Jing-wen], 2009, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V30, P550; Long JW, 2009, ACTA PHARMACOL SIN, V30, P965, DOI 10.1038/aps.2009.61; Meng LS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3034; Moisan J, 2006, AM J PHYSIOL-LUNG C, V290, pL987, DOI 10.1152/ajplung.00440.2005; Nishitsuji M, 2004, EXP LUNG RES, V30, P723, DOI 10.1080/01902140490517827; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Quarcoo D, 2004, CLIN EXP ALLERGY, V34, P1314, DOI 10.1111/j.1365-2222.2004.02023.x; Raza Asim M.B., 2010, SWISS MED WEEKLY, V140, DOI DOI 10.4414/SMW.2010.13128; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Roponen M, 2010, EUR RESPIR J, V35, P64, DOI 10.1183/09031936.00172008; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Sel S, 2007, J IMMUNOL, V178, P7805, DOI 10.4049/jimmunol.178.12.7805; Shahzad M, 2009, PULM PHARMACOL THER, V22, P37, DOI 10.1016/j.pupt.2008.11.006; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Tantisira K, 2004, GENES IMMUN, V5, P343, DOI 10.1038/sj.gene.6364096; Tomai MA, 2000, CELL IMMUNOL, V203, P55, DOI 10.1006/cimm.2000.1673; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Torres R, 2005, ARCH BRONCONEUMOL, V41, P141, DOI 10.1016/S0300-2896(05)70605-0; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wang XF, 2008, INT J CHEM REACT ENG, V6; Werner M, 2003, J ALLERGY CLIN IMMUN, V112, P323, DOI 10.1067/mai.2003.1648; Xirakia C, 2010, AM J RESP CRIT CARE, V181, P1207, DOI 10.1164/rccm.200908-1255OC; Yang IA, 2004, GENES IMMUN, V5, P41, DOI 10.1038/sj.gene.6364037; Yang XD, 2010, J ASTHMA, V47, P135, DOI 10.3109/02770900903483808; Zhang XD, 2004, J ALLERGY CLIN IMMUN, V113, P320, DOI 10.1016/j.jaci.2003.11.047	46	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17252	10.1371/journal.pone.0017252	http://dx.doi.org/10.1371/journal.pone.0017252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364926	gold, Green Submitted, Green Published			2022-12-25	WOS:000287764100035
J	Urcuqui-Inchima, S; Patino, C; Zapata, X; Garcia, MP; Arteaga, J; Chamot, C; Kumar, A; Hernandez-Verdun, D				Urcuqui-Inchima, Silvio; Patino, Claudia; Zapata, Ximena; Patricia Garcia, Maria; Arteaga, Jose; Chamot, Christophe; Kumar, Ajit; Hernandez-Verdun, Daniele			Production of HIV Particles Is Regulated by Altering Sub-Cellular Localization and Dynamics of Rev Induced by Double-Strand RNA Binding Protein	PLOS ONE			English	Article							NUCLEAR EXPORT ELEMENTS; MESSENGER-RNA; GENE-EXPRESSION; VIRUS; NF90; PHOSPHORYLATION; REPLICATION; TRAFFICKING; TRANSLATION; LOCATION	Human immunodeficiency virus (HIV)-1 encoded Rev is essential for export from the nucleus to the cytoplasm, of unspliced and singly spliced transcripts coding for structural and nonstructural viral proteins. This process is spatially and temporally coordinated resulting from the interactions between cellular and viral proteins. Here we examined the effects of the subcellular localization and dynamics of Rev on the efficiency of nucleocytoplasmic transport of HIV-1 Gag transcripts and virus particle production. Using confocal microscopy and fluorescence recovery after bleaching (FRAP), we report that NF90ctv, a cellular protein involved in Rev function, alters both the sub-cellular localization and dynamics of Rev in vivo, which drastically affects the accumulation of the viral protein p24. The CRM1-dependent nuclear export of Gag mRNA linked to the Rev Response Element (RRE) is dependent on specific domains of the NF90ctv protein. Taken together, our results demonstrate that the appropriate intracellular localization and dynamics of Rev could regulate Gag assembly and HIV-1 replication.	[Urcuqui-Inchima, Silvio; Patino, Claudia; Zapata, Ximena; Patricia Garcia, Maria] Univ Antioquia, Sede Invest Univ, Grp Inmunoviol, Medellin, Colombia; [Arteaga, Jose] Univ Ind Santander, Bucaramanga, Colombia; [Chamot, Christophe; Hernandez-Verdun, Daniele] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, Paris, France; [Kumar, Ajit] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC USA	Universidad de Antioquia; Universidad Industrial de Santander; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; George Washington University	Urcuqui-Inchima, S (corresponding author), Univ Antioquia, Sede Invest Univ, Grp Inmunoviol, Medellin, Colombia.	silviourcuqui@gmail.com		Arteaga, H Jose/0000-0002-5270-9017; Urcuqui-Inchima, Silvio/0000-0002-2865-3041	Colciencias [111534319145]; Universidad de Antioquia; Fundacion para la Promocion de la Investigacion y la Tecnologia [2211]; CNRS [UMR 7592]; University Paris 7 (France)	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia; Fundacion para la Promocion de la Investigacion y la Tecnologia; CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris 7 (France)	This study was supported by Colciencias, grant 111534319145 and Universidad de Antioquia, and by Fundacion para la Promocion de la Investigacion y la Tecnologia, grant 2211; CNRS funding to "Nuclear and cell cycle" group and Imagery platform of Institut Jacques Monod UMR 7592, University Paris 7 (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbottah ET, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-41; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; Boris-Lawrie K, 2001, LIFE SCI, V69, P2697, DOI 10.1016/S0024-3205(01)01360-1; Chatel-Chaix L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-41; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; DUNDR M, 1995, J CELL SCI, V108, P2811; FISCHER U, 1994, EMBO J, V13, P4105, DOI 10.1002/j.1460-2075.1994.tb06728.x; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; HE JL, 1995, J VIROL, V69, P4587, DOI 10.1128/JVI.69.7.4587-4592.1995; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Jin J, 2007, J VIROL, V81, P11226, DOI 10.1128/JVI.00431-07; Jin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006551; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Lechertier T, 2009, EXP CELL RES, V315, P928, DOI 10.1016/j.yexcr.2009.01.016; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Merrill MK, 2006, J VIROL, V80, P6936, DOI 10.1128/JVI.00243-06; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; RUGGIERI A, 2007, GASTROENTEROLOGY, V12, P7; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Saunders LR, 2001, GENOMICS, V71, P256, DOI 10.1006/geno.2000.6423; Sherer NM, 2009, J VIROL, V83, P8525, DOI 10.1128/JVI.00699-09; Shin HJ, 2002, ARCH VIROL, V147, P471, DOI 10.1007/s007050200001; STAUBER R, 1995, VIROLOGY, V213, P439, DOI 10.1006/viro.1995.0016; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Urcuqui-Inchima S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-83; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000	42	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16686	10.1371/journal.pone.0016686	http://dx.doi.org/10.1371/journal.pone.0016686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364984	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600013
J	Mathew, SS; Hablitz, JJ				Mathew, Seena S.; Hablitz, John J.			Presynaptic NMDA Receptors Mediate IPSC Potentiation at GABAergic Synapses in Developing Rat Neocortex	PLOS ONE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; SYNAPTIC-TRANSMISSION; TONIC FACILITATION; GLUTAMATE RELEASE; GABA; ACTIVATION; INHIBITION; MATURATION; PLASTICITY	Background: NMDA receptors are traditionally viewed as being located postsynaptically, at both synaptic and extrasynaptic locations. However, both anatomical and physiological studies have indicated the presence of NMDA receptors located presynaptically. Physiological studies of presynaptic NMDA receptors on neocortical GABAergic terminals and their possible role in synaptic plasticity are lacking. Methodology/Principal Findings: We report here that presynaptic NMDA receptors are present on GABAergic terminals in developing (postnatal day (PND) 12-15) but not older (PND21-25) rat frontal cortex. Using MK-801 in the recording pipette to block postsynaptic NMDA receptors, evoked and miniature IPSCs were recorded in layer II/III pyramidal cells in the presence of AMPA/KA receptor antagonists. Bath application of NMDA or NMDA receptor antagonists produced increases and decreases in mIPSC frequency, respectively. Physiologically patterned stimulation (10 bursts of 10 stimuli at 25 Hz delivered at 1.25 Hz) induced potentiation at inhibitory synapses in PND12-15 animals. This consisted of an initial rapid, large increase in IPSC amplitude followed by a significant but smaller persistent increase. Similar changes were not observed in PND21-25 animals. When 20 mM BAPTA was included in the recording pipette, potentiation was still observed in the PND12-15 group indicating that postsynaptic increases in calcium were not required. Potentiation was not observed when patterned stimulation was given in the presence of D-APV or the NR2B subunit antagonist Ro25-6981. Conclusions/Significance: The present results indicate that presynaptic NMDA receptors modulate GABA release onto neocortical pyramidal cells. Presynaptic NR2B subunit containing NMDA receptors are also involved in potentiation at developing GABAergic synapses in rat frontal cortex. Modulation of inhibitory GABAergic synapses by presynaptic NMDA receptors may be important for proper functioning of local cortical networks during development.	[Mathew, Seena S.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Mathew, SS (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	jhablitz@uab.edu			National Institutes of Health [NS22373, NS63342, P30-NS47466, P30-HD38985, P30-NS57098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, P30NS057098, R01NS022373, R21NS063342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health research grants NS22373 and NS63342, and core facilities grants, P30-NS47466, P30-HD38985 and P30-NS57098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Axmacher N, 2004, NEUROIMAGE, V22, P1014, DOI 10.1016/j.neuroimage.2004.02.009; Bandrowski AE, 2003, J NEUROPHYSIOL, V89, P1308, DOI 10.1152/jn.00644.2002; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; BURGARD EC, 1994, DEV BRAIN RES, V80, P275, DOI 10.1016/0165-3806(94)90113-9; BUSTOS G, 1992, BRAIN RES, V585, P105, DOI 10.1016/0006-8993(92)91195-K; Campbell SL, 2004, NEUROSCIENCE, V127, P625, DOI 10.1016/j.neuroscience.2004.05.030; Campbell SL, 2007, NEUROPHARMACOLOGY, V53, P37, DOI 10.1016/j.neuropharm.2007.04.008; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Charton JP, 1999, BRAIN RES, V816, P609, DOI 10.1016/S0006-8993(98)01243-8; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Featherstone DE, 2008, NEUROSCIENTIST, V14, P171, DOI 10.1177/1073858407308518; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Glitsch M, 1999, J NEUROSCI, V19, P511; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Li YH, 2007, J NEUROPHYSIOL, V97, P817, DOI 10.1152/jn.00980.2006; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; MARTIN D, 1991, J NEUROCHEM, V56, P1647, DOI 10.1111/j.1471-4159.1991.tb02063.x; Mathew SS, 2008, NEUROPHARMACOLOGY, V55, P106, DOI 10.1016/j.neuropharm.2008.05.005; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; MORISHITA W, 1991, NEUROREPORT, V2, P533; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Paquet M, 2000, J COMP NEUROL, V423, P330, DOI 10.1002/1096-9861(20000724)423:2<330::AID-CNE10>3.0.CO;2-9; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; ROSE GM, 1986, NEUROSCI LETT, V69, P244, DOI 10.1016/0304-3940(86)90487-8; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Tovar KR, 1999, J NEUROSCI, V19, P4180; TROMMER BL, 1995, EXP NEUROL, V131, P83, DOI 10.1016/0014-4886(95)90010-1; Varela JA, 1999, J NEUROSCI, V19, P4293; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Woodhall G, 2001, J NEUROPHYSIOL, V86, P1644, DOI 10.1152/jn.2001.86.4.1644; XIE Z, 1991, NEUROREPORT, V2, P389, DOI 10.1097/00001756-199107000-00009; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006	56	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17311	10.1371/journal.pone.0017311	http://dx.doi.org/10.1371/journal.pone.0017311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365001	Green Published, gold, Green Submitted			2022-12-25	WOS:000287482800046
J	Longo, MS; O'Neill, MJ; O'Neill, RJ				Longo, Mark S.; O'Neill, Michael J.; O'Neill, Rachel J.			Abundant Human DNA Contamination Identified in Non-Primate Genome Databases	PLOS ONE			English	Article							ERRORS; BLAST	During routine screens of the NCBI databases using human repetitive elements we discovered an unlikely level of nucleotide identity across a broad range of phyla. To ascertain whether databases containing DNA sequences, genome assemblies and trace archive reads were contaminated with human sequences, we performed an in depth search for sequences of human origin in non-human species. Using a primate specific SINE, AluY, we screened 2,749 non-primate public databases from NCBI, Ensembl, JGI, and UCSC and have found 492 to be contaminated with human sequence. These represent species ranging from bacteria (B. cereus) to plants (Z. mays) to fish (D. rerio) with examples found from most phyla. The identification of such extensive contamination of human sequence across databases and sequence types warrants caution among the sequencing community in future sequencing efforts, such as human re-sequencing. We discuss issues this may raise as well as present data that gives insight as to how this may be occurring.	[Longo, Mark S.; O'Neill, Michael J.; O'Neill, Rachel J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Longo, MS (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	rachel.oneill@uconn.edu	Puigbò, Pere/A-2214-2008		NSF	NSF(National Science Foundation (NSF))	This work was funded by the NSF (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katz TJ, 2006, SCIENCE, V313, P1236; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kyrpides NC, 1998, SCIENCE, V281, P1457; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu GE, 2009, GENOME RES, V19, P876, DOI 10.1101/gr.083972.108; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Rutty GN, 2003, INT J LEGAL MED, V117, P170, DOI 10.1007/s00414-002-0348-14; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	13	68	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16410	10.1371/journal.pone.0016410	http://dx.doi.org/10.1371/journal.pone.0016410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358816	Green Submitted, Green Published, gold			2022-12-25	WOS:000287392700018
J	Ho, JQ; Asagiri, M; Hoffmann, A; Ghosh, G				Ho, Jessica Q.; Asagiri, Masataka; Hoffmann, Alexander; Ghosh, Gourisankar			NF-kappa B Potentiates Caspase Independent Hydrogen Peroxide Induced Cell Death	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; TNF-ALPHA; ACTIVATION; APOPTOSIS; TRANSCRIPTION; PATHWAY; SURVIVAL; KINASE	Background: The pro-survival activity of NF-kappa B in response to a variety of stimuli has been extensively characterized. Although there have been a few reports addressing the pro-cell death role of NF-kappa B, the precise mechanism of NF-kappa B's procell death function still remains elusive. Methodology/Principal Findings: In the present study, we investigated the role of NF-kappa B in cell death induced by chronic insult with hydrogen peroxide (H2O2). Here, we show that NF-kappa B promotes H2O2 induced caspase independent but PARP dependent fibroblast cell death. The pro-death activity of NF-kappa B is due to the DNA binding activity of RelA, which is induced through IKK-mediated I kappa B alpha degradation. NF-kappa B dependent pro-survival genes, Bcl-2 and XIAP, were significantly repressed, while NF-kappa B dependent pro-death genes, TNF alpha and Fas Ligand, were induced in response to H2O2. Conclusions/Significance: We discovered an unexpected function of NF-kappa B, in that it potentiates chronic H2O2 exposure induced cell death, and suggest that NF-kappa B mediates cell death through the repression of pro-survival genes and induction of pro-death genes. Since unremitting exposure of tissues to H2O2 and other reactive oxygen species can lead to several degenerative disorders and diseases, our results have important implications for the use of NF-kappa B inhibitors in therapeutic drug design.	[Ho, Jessica Q.; Asagiri, Masataka; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ho, JQ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	gghosh@ucsd.edu			National Institutes of Health [GM071862, GM085490]; Ruth L. Kirschstein National Research Service [NIH/NCI T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085490, P01GM071862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM071862 and GM085490. JQH is supported by the Ruth L. Kirschstein National Research Service Award NIH/NCI T32 CA009523. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Behl C, 2002, BIOL CHEM, V383, P521, DOI 10.1515/BC.2002.053; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gloire G, 2006, ONCOGENE, V25, P5485, DOI 10.1038/sj.onc.1209542; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lin KI, 1998, J CELL BIOL, V141, P1479, DOI 10.1083/jcb.141.7.1479; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; NAKAMURA Y, 1995, AM J RESP CRIT CARE, V151, P1497, DOI 10.1164/ajrccm.151.5.7735606; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Takahashi A, 2002, EXP LUNG RES, V28, P275, DOI 10.1080/01902140252964366; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Veuger SJ, 2009, ONCOGENE, V28, P832, DOI 10.1038/onc.2008.439; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wang YJ, 2004, J IMMUNOL, V173, P6820, DOI 10.4049/jimmunol.173.11.6820; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Xiao J, 2010, BIOL PHARM BULL, V33, P444, DOI 10.1248/bpb.33.444; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006	50	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16815	10.1371/journal.pone.0016815	http://dx.doi.org/10.1371/journal.pone.0016815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347231	gold, Green Submitted, Green Published			2022-12-25	WOS:000287369200007
J	Espinosa, N; Marino, J; de Labra, C; Cudeiro, J				Espinosa, Nelson; Marino, Jorge; de Labra, Carmen; Cudeiro, Javier			Cortical Modulation of the Transient Visual Response at Thalamic Level: A TMS Study	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; TRANSCRANIAL MAGNETIC STIMULATION; RECEPTIVE-FIELD ORGANIZATION; RETINAL GANGLION-CELLS; CATS STRIATE CORTEX; SPATIAL SUMMATION; X-CELLS; SPATIOTEMPORAL ORGANIZATION; RELAY CELLS; LGN BURSTS	The transient visual response of feline dorsal lateral geniculate nucleus (dLGN) cells was studied under control conditions and during the application of repetitive transcranial magnetic stimulation at 1 Hz (rTMS@1Hz) on the primary visual cortex (V1). The results show that rTMS@1Hz modulates the firing mode of Y cells, inducing an increase in burst spikes and a decrease in tonic firing. On the other hand, rTMS@1Hz modifies the spatiotemporal characteristics of receptive fields of X cells, inducing a delay and a decrease of the peak response, and a change of the surround/center amplitude ratio of RF profiles. These results indicate that V1 controls the activity of the visual thalamus in a different way in the X and Y pathways, and that this feedback control is consistent with functional roles associated with each cell type.	[Espinosa, Nelson] Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, La Coruna, Spain; Univ A Coruna, Biomed Inst Coruna INIBIC, La Coruna, Spain	Universidade da Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Espinosa, N (corresponding author), Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, La Coruna, Spain.	jcud@udc.es	de Labra, Carmen/C-9992-2017	de Labra, Carmen/0000-0002-5306-0475; Cudeiro, Javier/0000-0002-6597-6077; , Gerontology Research Group/0000-0001-7207-9481	MICINN, Spain [BFU2009-08169]; Xunta de Galicia (Conselleria de Educacion) [2007/000140-0]	MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia (Conselleria de Educacion)(Xunta de Galicia)	The work was supported by grants BFU2009-08169-MICINN, Spain and Xunta de Galicia (Conselleria de Educacion-2007/000140-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alitto HJ, 2005, J NEUROSCI, V25, P514, DOI 10.1523/JNEUROSCI.3369-04.2005; Aydin-Abidin S, 2006, J PHYSIOL-LONDON, V574, P443, DOI 10.1113/jphysiol.2006.108464; BERARDI N, 1984, J PHYSIOL-LONDON, V357, P525, DOI 10.1113/jphysiol.1984.sp015515; Briggs F, 2009, NEURON, V62, P135, DOI 10.1016/j.neuron.2009.02.024; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; CLELAND BG, 1985, J PHYSIOL-LONDON, V369, P249, DOI 10.1113/jphysiol.1985.sp015899; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; de Labra C, 2007, CEREB CORTEX, V17, P1376, DOI 10.1093/cercor/bhl048; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; FUKUDA Y, 1976, BRAIN RES, V113, P188, DOI 10.1016/0006-8993(76)90018-4; FUNKE K, 1995, J PHYSIOL-LONDON, V485, P715, DOI 10.1113/jphysiol.1995.sp020764; Funke K, 1996, NEUROREPORT, V7, P2130, DOI 10.1097/00001756-199609020-00013; Funke K, 1997, PROG NEUROBIOL, V53, P67, DOI 10.1016/S0301-0082(97)00032-4; GEISERT EE, 1981, BRAIN RES, V208, P409, DOI 10.1016/0006-8993(81)90568-0; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Grieve KL, 2009, BRAIN RES, V1273, P48, DOI 10.1016/j.brainres.2009.03.053; Grubb MS, 2005, J NEUROPHYSIOL, V93, P3224, DOI 10.1152/jn.00445.2004; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KALIL RE, 1970, J NEUROPHYSIOL, V33, P459, DOI 10.1152/jn.1970.33.3.459; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; LINDSTROM S, 1990, J PHYSIOL-LONDON, V429, P259, DOI 10.1113/jphysiol.1990.sp018255; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; MCCLURKIN JW, 1984, J PHYSIOL-LONDON, V348, P135, DOI 10.1113/jphysiol.1984.sp015103; Mix A, 2010, EUR J NEUROSCI, V32, P1575, DOI 10.1111/j.1460-9568.2010.07425.x; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; MONTERO VM, 1985, EXP BRAIN RES, V60, P603; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; Murphy PC, 1996, J NEUROSCI, V16, P1180; Murphy PC, 2000, J NEUROSCI, V20, P845, DOI 10.1523/JNEUROSCI.20-02-00845.2000; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; PALMER LA, 1991, NEURAL BASIS VISUAL, P246; Pasley BN, 2009, NEURON, V62, P291, DOI 10.1016/j.neuron.2009.03.012; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Rivadulla C, 2003, J PHYSIOL-LONDON, V553, P601, DOI 10.1113/jphysiol.2003.048561; Rivadulla C, 2002, J NEUROSCI, V22, P2956, DOI 10.1523/JNEUROSCI.22-07-02956.2002; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Sack AT, 2006, CURR OPIN NEUROBIOL, V16, P593, DOI 10.1016/j.conb.2006.06.016; SHAPLEY R, 1975, NATURE, V256, P411, DOI 10.1038/256411a0; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; SINGER W, 1977, PHYSIOL REV, V57, P386, DOI 10.1152/physrev.1977.57.3.386; Smith GD, 2002, J NEUROSCI, V22, P10242; VIDNYANSZKY Z, 1994, J COMP NEUROL, V349, P259, DOI 10.1002/cne.903490208; Waleszczyk WJ, 2005, EXP NEUROL, V196, P54, DOI 10.1016/j.expneurol.2005.07.006; Wang W, 2006, NAT NEUROSCI, V9, P1330, DOI 10.1038/nn1768; Wang X, 2007, NEURON, V55, P465, DOI 10.1016/j.neuron.2007.06.039; Wassermann EM, 1996, LANCET, V347, P825, DOI 10.1016/S0140-6736(96)90898-3; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Zhan XJ, 1999, J NEUROPHYSIOL, V81, P2360, DOI 10.1152/jn.1999.81.5.2360	63	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17041	10.1371/journal.pone.0017041	http://dx.doi.org/10.1371/journal.pone.0017041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347322	Green Published, gold, Green Submitted			2022-12-25	WOS:000287363000033
J	Rocca, MA; Valsasina, P; Pagani, E; Bianchi-Marzoli, S; Milesi, J; Falini, A; Comi, G; Filippi, M				Rocca, Maria A.; Valsasina, Paola; Pagani, Elisabetta; Bianchi-Marzoli, Stefania; Milesi, Jacopo; Falini, Andrea; Comi, Giancarlo; Filippi, Massimo			Extra-Visual Functional and Structural Connection Abnormalities in Leber's Hereditary Optic Neuropathy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; RESTING-STATE NETWORKS; BEHAVIORAL-DEVELOPMENT; ENERGY-METABOLISM; GREY-MATTER; BRAIN; CORTEX; MUTATION; BASES	We assessed abnormalities within the principal brain resting state networks (RSNs) in patients with Leber's hereditary optic neuropathy (LHON) to define whether functional abnormalities in this disease are limited to the visual system or, conversely, tend to be more diffuse. We also defined the structural substrates of fMRI changes using a connectivity-based analysis of diffusion tensor (DT) MRI data. Neuro-ophthalmologic assessment, DT MRI and RS fMRI data were acquired from 13 LHON patients and 13 healthy controls. RS fMRI data were analyzed using independent component analysis and SPM5. A DT MRI connectivity-based parcellation analysis was performed using the primary visual and auditory cortices, bilaterally, as seed regions. Compared to controls, LHON patients had a significant increase of RS fluctuations in the primary visual and auditory cortices, bilaterally. They also showed decreased RS fluctuations in the right lateral occipital cortex and right temporal occipital fusiform cortex. Abnormalities of RS fluctuations were correlated significantly with retinal damage and disease duration. The DT MRI connectivity-based parcellation identified a higher number of clusters in the right auditory cortex in LHON vs. controls. Differences of cluster-centroid profiles were found between the two groups for all the four seeds analyzed. For three of these areas, a correspondence was found between abnormalities of functional and structural connectivities. These results suggest that functional and structural abnormalities extend beyond the visual network in LHON patients. Such abnormalities also involve the auditory network, thus corroborating the notion of a cross-modal plasticity between these sensory modalities in patients with severe visual deficits.	[Rocca, Maria A.; Valsasina, Paola; Pagani, Elisabetta; Filippi, Massimo] Inst Sci, Neuroimaging Res Unit, Milan, Italy; [Rocca, Maria A.; Valsasina, Paola; Pagani, Elisabetta; Bianchi-Marzoli, Stefania; Milesi, Jacopo; Falini, Andrea; Comi, Giancarlo; Filippi, Massimo] Univ Osped San Raffaele, Milan, Italy; [Rocca, Maria A.; Valsasina, Paola; Pagani, Elisabetta; Comi, Giancarlo; Filippi, Massimo] Inst Sci, Dept Neurosci, Dept Neurol, Inst Expt Neurol, Milan, Italy; [Bianchi-Marzoli, Stefania; Milesi, Jacopo] Inst Sci, Dept Ophthalmol, Milan, Italy; [Falini, Andrea] Inst Sci, Dept Neuroradiol, Milan, Italy	Vita-Salute San Raffaele University	Rocca, MA (corresponding author), Inst Sci, Neuroimaging Res Unit, Milan, Italy.	m.filippi@hsr.it	Filippi, Massimo/K-1755-2018; Rocca, Maria Assunta/K-1619-2018; Valsasina, Paola/K-5820-2016	Filippi, Massimo/0000-0002-5485-0479; Rocca, Maria Assunta/0000-0003-2358-4320; Valsasina, Paola/0000-0001-5390-2655; falini, andrea/0000-0002-1461-8755; Pagani, Elisabetta/0000-0002-1850-1175				Abu-Amero KK, 2010, BRIT J OPHTHALMOL, V94, P256, DOI 10.1136/bjo.2009.165571; Audoin B, 2006, BRAIN, V129, P1031, DOI 10.1093/brain/awl039; BARBIROLI B, 1995, NEUROLOGY, V45, P1364, DOI 10.1212/WNL.45.7.1364; BARCELLA V, 2010, HUM BRAIN MAPP; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Ciccarelli O, 2005, HUM BRAIN MAPP, V25, P308, DOI 10.1002/hbm.20101; CORTELLI P, 1991, NEUROLOGY, V41, P1211, DOI 10.1212/WNL.41.8.1211; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DeVolder AG, 1997, BRAIN RES, V750, P235, DOI 10.1016/S0006-8993(96)01352-2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; Haselgrove JC, 1996, MAGNET RESON MED, V36, P960, DOI 10.1002/mrm.1910360620; Herschkowitz N, 2000, BRAIN DEV-JPN, V22, P411, DOI 10.1016/S0387-7604(00)00185-6; Herschkowitz N, 1997, NEUROPEDIATRICS, V28, P296, DOI 10.1055/s-2007-973720; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Inglese M, 2001, J NEUROL NEUROSUR PS, V70, P444, DOI 10.1136/jnnp.70.4.444; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; JOHNS DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1577, DOI 10.1001/archopht.1992.01080230077025; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kitajima M, 1997, AM J NEURORADIOL, V18, P1291; Leclerc C, 2000, NEUROREPORT, V11, P545, DOI 10.1097/00001756-200002280-00024; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Lodi R, 2002, J NEUROL NEUROSUR PS, V72, P805, DOI 10.1136/jnnp.72.6.805; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Mendola JD, 2005, HUM BRAIN MAPP, V25, P222, DOI 10.1002/hbm.20109; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160; Perrin M, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/368406; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Rocca MA, 2009, HUM BRAIN MAPP, V30, P276, DOI 10.1002/hbm.20504; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; von dem Hagen EAH, 2005, EUR J NEUROSCI, V22, P2475, DOI 10.1111/j.1460-9568.2005.04433.x; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17081	10.1371/journal.pone.0017081	http://dx.doi.org/10.1371/journal.pone.0017081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347331	Green Submitted, Green Published, gold			2022-12-25	WOS:000287363000036
J	Banerjee, A; Rao, DN				Banerjee, Arun; Rao, Desirazu N.			Functional Analysis of an Acid Adaptive DNA Adenine Methyltransferase from Helicobacter pylori 26695	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; RESTRICTION-MODIFICATION SYSTEM; CATALYTIC-PROPERTIES; METHYLATION; IDENTIFICATION; MECHANISM; BINDING; MOTIFS; GENES; PURIFICATION	HP0593 DNA-(N-6-adenine)-methyltransferase (HP0593 MTase) is a member of a Type III restriction-modification system in Helicobacter pylori strain 26695. HP0593 MTase has been cloned, overexpressed and purified heterologously in Escherichia coli. The recognition sequence of the purified MTase was determined as 5'-GCAG-3' and the site of methylation was found to be adenine. The activity of HP0593 MTase was found to be optimal at pH 5.5. This is a unique property in context of natural adaptation of H. pylori in its acidic niche. Dot-blot assay using antibodies that react specifically with DNA containing m6A modification confirmed that HP0593 MTase is an adenine-specific MTase. HP0593 MTase occurred as both monomer and dimer in solution as determined by gel-filtration chromatography and chemical-crosslinking studies. The nonlinear dependence of methylation activity on enzyme concentration indicated that more than one molecule of enzyme was required for its activity. Analysis of initial velocity with AdoMet as a substrate showed that two molecules of AdoMet bind to HP0593 MTase, which is the first example in case of Type III MTases. Interestingly, metal ion cofactors such as Co2+, Mn2+, and also Mg2+ stimulated the HP0593 MTase activity. Preincubation and isotope partitioning analyses clearly indicated that HP0593 MTase-DNA complex is catalytically competent, and suggested that DNA binds to the MTase first followed by AdoMet. HP0593 MTase shows a distributive mechanism of methylation on DNA having more than one recognition site. Considering the occurrence of GCAG sequence in the potential promoter regions of physiologically important genes in H. pylori, our results provide impetus for exploring the role of this DNA MTase in the cellular processes of H. pylori.	[Banerjee, Arun; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Banerjee, A (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	dnrao@biochem.iisc.ernet.in			Department of Biotechnology, New Delhi, India [BT/PR10407/BRB/10/604/2008]; CSIR; DST	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	The project was funded by Department of Biotechnology, New Delhi, India, grant number BT/PR10407/BRB/10/604/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Genomic DNA of H. pylori 26695 strain and antibodies against N<SUP>6</SUP>-methyladenine were kindly provided by New England Biolabs, USA. Arathi is thanked for technical assistance. Sreelatha is acknowledged for help with BIACORE experiments. Ruchika Sharma, Dr. Shivakumara B and Ritesh Kumar are acknowledged for critical reading of the manuscript and critical discussion. AB thanks CSIR for a Senior Research Fellowship. DNR acknowledges DST for the J.C.Bose Fellowship.	Adams GM, 1997, BIOCHEMISTRY-US, V36, P8284, DOI 10.1021/bi961885n; AHAMD I, 1994, J MOL BIOL, V242, P378, DOI 10.1006/jmbi.1994.1588; AHMAD I, 1995, GENE, V157, P143, DOI 10.1016/0378-1119(95)00671-R; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Ang S, 2001, INFECT IMMUN, V69, P1679, DOI 10.1128/IAI.69.3.1679-1686.2001; BALGANESH TS, 1987, EMBO J, V6, P3543, DOI 10.1002/j.1460-2075.1987.tb02681.x; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; BERGERAT A, 1991, P NATL ACAD SCI USA, V88, P6394, DOI 10.1073/pnas.88.15.6394; Bhattacharya SK, 1999, J BIOL CHEM, V274, P14743, DOI 10.1074/jbc.274.21.14743; Bheemanaik S, 2003, J BIOL CHEM, V278, P7863, DOI 10.1074/jbc.M211458200; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Bheemanaik S, 2006, BIOL CHEM, V387, P515, DOI 10.1515/BC.2006.067; Bist P, 2003, J BIOL CHEM, V278, P41837, DOI 10.1074/jbc.M307053200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter MA, 2008, NUCLEIC ACIDS RES, V36, P5417, DOI 10.1093/nar/gkn528; Chan SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009071; Chang KC, 2001, BIOCHEM BIOPH RES CO, V288, P961, DOI 10.1006/bbrc.2001.5877; DELACAMPA AG, 1987, J MOL BIOL, V196, P457, DOI 10.1016/0022-2836(87)90024-6; Didier W., 2006, NATURE REV, V4, P183; DIEKMANN S, 1987, EMBO J, V6, P4213, DOI 10.1002/j.1460-2075.1987.tb02769.x; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P1579, DOI 10.1093/nar/20.7.1579; ENGEL JD, 1978, J BIOL CHEM, V253, P927; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Jeltsch A, 1998, J MOL BIOL, V275, P747, DOI 10.1006/jmbi.1997.1492; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Joseph N, 2004, DNA REPAIR, V3, P1561, DOI 10.1016/j.dnarep.2004.06.014; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lindstrom WM, 2000, J BIOL CHEM, V275, P4912, DOI 10.1074/jbc.275.7.4912; MADHUSOODANAN UK, 2010, CRIT REV BIOCHEM MOL, V39, P1; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Mruk I, 2003, MICROBIOL-SGM, V149, P3331, DOI 10.1099/mic.0.26562-0; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Piekarowicz A, 1999, J MOL BIOL, V293, P1055, DOI 10.1006/jmbi.1999.3198; Polaczek P, 1998, MOL GEN GENET, V258, P488, DOI 10.1007/s004380050759; Pues H, 1999, BIOCHEMISTRY-US, V38, P1426, DOI 10.1021/bi9818016; REICH NO, 1991, BIOCHEMISTRY-US, V30, P2933, DOI 10.1021/bi00225a029; ROSE IA, 1980, ADV ENZYMOL RELAT AR, V64, P47; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; Saha S, 1998, BIOL CHEM, V379, P511, DOI 10.1515/bchm.1998.379.4-5.511; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHERZER E, 1987, J BIOL CHEM, V262, P15225; Segel IH., 1993, ENZYME KINETICS BEHA; Shier VK, 2001, J BIOL CHEM, V276, P14744, DOI 10.1074/jbc.M010688200; Thomas CB, 2006, NUCLEIC ACIDS RES, V34, P806, DOI 10.1093/nar/gkj486; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vitkute J, 2001, J BACTERIOL, V183, P443, DOI 10.1128/JB.183.2.443-450.2001; Watanabe M, 2006, APPL ENVIRON MICROB, V72, P5367, DOI 10.1128/AEM.00433-06; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; WILSON GG, 1991, NUCLEIC ACIDS RES, V19, P2539, DOI 10.1093/nar/19.10.2539; WU JC, 1987, J BIOL CHEM, V262, P4778; Zinoviev VV, 2004, MOL BIOL+, V38, P737, DOI 10.1023/B:MBIL.0000043943.07792.80	57	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16810	10.1371/journal.pone.0016810	http://dx.doi.org/10.1371/journal.pone.0016810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347417	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000287361700036
J	Chen, DS; Barry, AE; Leliwa-Sytek, A; Smith, TA; Peterson, I; Brown, SM; Migot-Nabias, F; Deloron, P; Kortok, MM; Marsh, K; Daily, JP; Ndiaye, D; Sarr, O; Mboup, S; Day, KP				Chen, Donald S.; Barry, Alyssa E.; Leliwa-Sytek, Aleksandra; Smith, Terry-Ann; Peterson, Ingrid; Brown, Stuart M.; Migot-Nabias, Florence; Deloron, Philippe; Kortok, Moses M.; Marsh, Kevin; Daily, Johanna P.; Ndiaye, Daouda; Sarr, Ousmane; Mboup, Souleymane; Day, Karen P.			A Molecular Epidemiological Study of var Gene Diversity to Characterize the Reservoir of Plasmodium falciparum in Humans in Africa	PLOS ONE			English	Article							SICKLE-CELL TRAIT; MALARIA TRANSMISSION; MICROSATELLITE MARKERS; HAPTOGLOBIN GENOTYPE; POPULATION; DENSITY; NUMBER; REPERTOIRE; PATTERNS; KILIFI	Background: The reservoir of Plasmodium infection in humans has traditionally been defined by blood slide positivity. This study was designed to characterize the local reservoir of infection in relation to the diverse var genes that encode the major surface antigen of Plasmodium falciparum blood stages and underlie the parasite's ability to establish chronic infection and transmit from human to mosquito. Methodology/Principal Findings: We investigated the molecular epidemiology of the var multigene family at local sites in Gabon, Senegal and Kenya which differ in parasite prevalence and transmission intensity. 1839 distinct var gene types were defined by sequencing DBL alpha domains in the three sites. Only 76 (4.1%) var types were found in more than one population indicating spatial heterogeneity in var types across the African continent. The majority of var types appeared only once in the population sample. Non-parametric statistical estimators predict in each population at minimum five to seven thousand distinct var types. Similar diversity of var types was seen in sites with different parasite prevalences. Conclusions/Significance: Var population genomics provides new insights into the epidemiology of P. falciparum in Africa where malaria has never been conquered. In particular, we have described the extensive reservoir of infection in local African sites and discovered a unique var population structure that can facilitate superinfection through minimal overlap in var repertoires among parasite genomes. Our findings show that var typing as a molecular surveillance system defines the extent of genetic complexity in the reservoir of infection to complement measures of malaria prevalence. The observed small scale spatial diversity of var genes suggests that var genetics could greatly inform current malaria mapping approaches and predict complex malaria population dynamics due to the import of var types to areas where no widespread pre-existing immunity in the population exists.	[Chen, Donald S.; Barry, Alyssa E.; Leliwa-Sytek, Aleksandra; Smith, Terry-Ann; Peterson, Ingrid; Day, Karen P.] NYU, Sch Med, Dept Med Parasitol, New York, NY 10012 USA; [Chen, Donald S.] NYU, Sch Med, Dept Med, New York, NY USA; [Barry, Alyssa E.; Day, Karen P.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Barry, Alyssa E.] Ctr Populat Hlth, Burnet Inst, Melbourne, Vic, Australia; [Barry, Alyssa E.] Monash Univ, Dept Med, Cent & Eastern Clin Sch, Clayton, Vic 3800, Australia; [Brown, Stuart M.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Migot-Nabias, Florence; Deloron, Philippe] Univ Paris 05, Inst Rech Dev, Fac Pharm, Paris, France; [Kortok, Moses M.; Marsh, Kevin] Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya; [Daily, Johanna P.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Daily, Johanna P.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Ndiaye, Daouda; Sarr, Ousmane; Mboup, Souleymane] Cheikh Anta Diop Univ, Fac Med & Pharm, Dakar, Senegal	New York University; New York University; University of Oxford; Burnet Institute; Monash University; New York University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Kenya Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University Cheikh Anta Diop Dakar	Chen, DS (corresponding author), NYU, Sch Med, Dept Med Parasitol, New York, NY 10012 USA.	Karen.day@nyumc.org	Deloron, Philippe/G-6305-2010; Day, Karen/F-3697-2015	Deloron, Philippe/0000-0003-4705-2484; Day, Karen/0000-0002-6115-6135; Migot-Nabias, Florence/0000-0001-9982-594X; Barry, Alyssa/0000-0002-1189-2310	NIH/Fogarty International [TW001503]; Bill and Melinda Gates Foundation/Broad Institute; European Union [IC18-CT98-0359]; Wellcome Trust [041354]; NIH/National Institute of General Medical Sciences [GM061351-07]; NIH/National Institute of Allergy and Infectious Disease [R01 AI084156]; NIH [F32AI071765]; Victorian Endowment for Science Knowledge and Innovation; National Health and Medical Research Council, Australia; FOGARTY INTERNATIONAL CENTER [D43TW001503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071765, R01AI084156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061351] Funding Source: NIH RePORTER	NIH/Fogarty International(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill and Melinda Gates Foundation/Broad Institute(Bill & Melinda Gates Foundation); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Endowment for Science Knowledge and Innovation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge NIH/Fogarty International TW001503: "Training in Malaria Pathogenesis and Diversity in Africa", Bill and Melinda Gates Foundation/Broad Institute: "P. falciparum Genetic Diversity" and ExxonMobil-HSPH Program on Malaria for support of the Senegal field sample collection. Isolates were collected in Gabon thanks to the European Union INCO Programme (contract no. IC18-CT98-0359). This work was supported by Wellcome Trust Programme grant No. 041354 awarded to KPD, NIH/National Institute of General Medical Sciences grant GM061351-07, and NIH/National Institute of Allergy and Infectious Disease grant R01 AI084156. DSC was supported by a NIH Ruth L. Kirschstein National Research Service Award (F32AI071765). AEB was supported by an Innovation Fellowship from the Victorian Endowment for Science Knowledge and Innovation and a Howard Florey Centenary Fellowship from the National Health and Medical Research Council, Australia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2006, MOL BIOCHEM PARASIT, V150, P157, DOI 10.1016/j.molbiopara.2006.07.007; Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Aubouy A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-12; Aubouy A, 2003, ANTIMICROB AGENTS CH, V47, P231, DOI 10.1128/AAC.47.1.231-237.2003; BABIKER HA, 1994, PARASITOLOGY, V109, P413, DOI 10.1017/S0031182000080665; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; BURKOT TR, 1988, AM J TROP MED HYG, V39, P135, DOI 10.4269/ajtmh.1988.39.135; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chao A, 2009, PROGRAM SPADE SPECIE; Colwell R. K., 2006, ESTIMATES VERSION 8; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Direction de la Prevision et de la Statistique/Ministere de l'Economie et des finances, 2004, PROJ POP SEN ISS REC; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; EARLE WC, 1962, WHOMAL333; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; EYLES DON E., 1951, JOUR NATL MALARIA SOC, V10, P327; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; FELGER I, 1993, EXP PARASITOL, V77, P372, DOI 10.1006/expr.1993.1094; Fowkes FJI, 2006, AM J TROP MED HYG, V74, P26, DOI 10.4269/ajtmh.2006.74.26; Fowler EV, 2002, MOL BIOCHEM PARASIT, V120, P117, DOI 10.1016/S0166-6851(01)00443-1; Gil LHS, 2003, J MED ENTOMOL, V40, P636, DOI 10.1603/0022-2585-40.5.636; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guerin PJ, 2009, CURR OPIN INFECT DIS, V22, P593, DOI 10.1097/QCO.0b013e328332c4a7; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; *I BRAS GEOGR EST, 2004, CENS MUN PORT VELH 2; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; MACDONALD G, 1964, B WORLD HEALTH ORGAN, V31, P365; *MARA, 2004, POP RISK MAL; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Mu J., 2005, PLOS BIOL, V3, pe335; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Ndiaye D, 2006, ACTA TROP, V99, P106, DOI 10.1016/j.actatropica.2006.07.002; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Ntoumi F, 2002, IMMUNOL LETT, V84, P9, DOI 10.1016/S0165-2478(02)00131-1; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; *PLASM WRIT GROUP, 2008, COMPR SEQ PROP PLASM; Sallenave-Sales S, 2000, PARASITOL RES, V86, P692, DOI 10.1007/PL00008554; Shen TJ, 2003, ECOLOGY, V84, P798, DOI 10.1890/0012-9658(2003)084[0798:PTNONS]2.0.CO;2; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Smith T, 1999, T ROY SOC TROP MED H, V93, pS53, DOI 10.1016/S0035-9203(99)90328-0; Staalsoe T, 2002, J INFECT DIS, V186, P719, DOI 10.1086/342390; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250	66	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							10.1371	10.1371/journal.pone.0016629	http://dx.doi.org/10.1371/journal.pone.0016629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347415	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700023
J	Hawlitschek, O; Porch, N; Hendrich, L; Balke, M				Hawlitschek, Oliver; Porch, Nick; Hendrich, Lars; Balke, Michael			Ecological Niche Modelling and nDNA Sequencing Support a New, Morphologically Cryptic Beetle Species Unveiled by DNA Barcoding	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; POTENTIAL DISTRIBUTION; DIVING BEETLES; ARID ZONE; CONSERVATISM; EVOLUTION; DISTRIBUTIONS; COLEOPTERA; SPECIATION; GENUS	Background: DNA sequencing techniques used to estimate biodiversity, such as DNA barcoding, may reveal cryptic species. However, disagreements between barcoding and morphological data have already led to controversy. Species delimitation should therefore not be based on mtDNA alone. Here, we explore the use of nDNA and bioclimatic modelling in a new species of aquatic beetle revealed by mtDNA sequence data. Methodology/Principal Findings: The aquatic beetle fauna of Australia is characterised by high degrees of endemism, including local radiations such as the genus Antiporus. Antiporus femoralis was previously considered to exist in two disjunct, but morphologically indistinguishable populations in south-western and south-eastern Australia. We constructed a phylogeny of Antiporus and detected a deep split between these populations. Diagnostic characters from the highly variable nuclear protein encoding arginine kinase gene confirmed the presence of two isolated populations. We then used ecological niche modelling to examine the climatic niche characteristics of the two populations. All results support the status of the two populations as distinct species. We describe the south-western species as Antiporus occidentalis sp.n. Conclusion/Significance: In addition to nDNA sequence data and extended use of mitochondrial sequences, ecological niche modelling has great potential for delineating morphologically cryptic species.	[Hawlitschek, Oliver; Hendrich, Lars; Balke, Michael] Zool State Collect, Dept Entomol, Munich, Germany; [Porch, Nick] Deakin Univ, Sch Life & Environm Sci, Melbourne, Vic, Australia; [Balke, Michael] Univ Munich, GeoBioCtr, Munich, Germany	Deakin University; University of Munich	Hawlitschek, O (corresponding author), Zool State Collect, Dept Entomol, Munich, Germany.	Coleoptera-ZSM@zsm.mwn.de		Hawlitschek, Oliver/0000-0001-8010-4157	German Research Foundation (DFG) [HE5729/1-1, BA2152/7-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work, as well as ongoing research on the Australian predaceous water beetle fauna was supported by grants from the German Research Foundation (DFG) to Lars Hendrich (HE5729/1-1) and Michael Balke (BA2152/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; ANDERSSON L, 1990, TAXON, V39, P375, DOI 10.2307/1223084; Ayala FJ, 1997, P NATL ACAD SCI USA, V94, P7776, DOI 10.1073/pnas.94.15.7776; Balke M, 2007, MOL PHYLOGENET EVOL, V42, P505, DOI 10.1016/j.ympev.2006.07.019; Balke M, 2009, P ROY SOC B-BIOL SCI, V276, P2359, DOI 10.1098/rspb.2009.0015; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; BRANCUCCI M, 1984, AQUAT INSECT, V6, P149, DOI 10.1080/01650428409361178; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; Buffington Matthew, 2008, American Entomologist, V54, P222; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Chefaoui RM, 2005, BIOL CONSERV, V122, P327, DOI 10.1016/j.biocon.2004.08.005; Cooper SJB, 2002, INVERTEBR SYST, V16, P589, DOI 10.1071/IT01039; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Frakes LA, 1987, FAUNA AUSTR A, P1; GOLOBOFF P, 2000, TNT TREE ANAL USING; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HABEL JC, 2010, GLOBAL CHAN IN PRESS; HABEL JC, 2010, BIOL J LINN IN PRESS; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HASEGAWA M, 1989, JPN J GENET, V64, P243, DOI 10.1266/jjg.64.243; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hendrich L., 2004, Koleopterologische Rundschau, V74, P75; Hendrich L., 2001, Linzer Biologische Beitraege, V33, P299; HENDRICH L, 2010, PLOS ONE UNPUB; Hendrich Lars, 2009, Zootaxa, V2288, P1; Hendrich Lars, 2010, Zootaxa, V2338, P35; Hendrich L, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2134.1.4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakob SS, 2010, MOL ECOL, V19, P1423, DOI 10.1111/j.1365-294X.2010.04582.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Johnson NK, 2002, MOL ECOL, V11, P2065, DOI 10.1046/j.1365-294X.2002.01588.x; KEMP EM, 1981, ECOLOGICAL BIOGEOGRA, V1, P31; Knapp S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010502; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Lobo JM, 2006, DIVERS DISTRIB, V12, P179, DOI 10.1111/j.1366-9516.2005.00214.x; LORD J, 1995, AM NAT, V146, P349, DOI 10.1086/285804; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mayr E., 1942, P1; Miller K.B., 2003, Latissimus, V17, P1; Miller M. A., 2010, CIPRES PORTALS; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murienne J, 2009, BIOL J LINN SOC, V97, P177, DOI 10.1111/j.1095-8312.2008.01184.x; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; PAGE RDM, 2010, NATURE P; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Porch N, 2010, QUATERNARY SCI REV, V29, P633, DOI 10.1016/j.quascirev.2009.10.014; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rice NH, 2003, BIOL J LINN SOC, V80, P369, DOI 10.1046/j.1095-8312.2003.00242.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; RODDER D, 2010, SYSTEMATICS CLIMATE; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Rodder D, 2010, PAC SCI, V64, P11, DOI 10.2984/64.1.011; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Watts C. H. S., 1997, Records of the South Australian Museum (Adelaide), V30, P35; Watts C. H. S., 2000, Records of the South Australian Museum (Adelaide), V33, P17; Watts C.H.S., 1978, AUSTR J ZOOLOGY S, V57, P1, DOI DOI 10.1071/AJZS057; WATTS CHS, 2004, T ROY SOC S AUS, V130, P123; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Williams W.D., 1987, P156; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	101	45	46	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16662	10.1371/journal.pone.0016662	http://dx.doi.org/10.1371/journal.pone.0016662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347370	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700027
J	Wang, M; Yuan, J; Li, TG; Liu, Y; Wu, JB; Di, BA; Chen, X; Xu, XH; Lu, EJ; Li, KB; Liu, YH; Wu, YJ; Chen, XF; He, P; Wang, YL; Liu, JH				Wang, Ming; Yuan, Jun; Li, Tiegang; Liu, Yang; Wu, Jibin; Di, Biao; Chen, Xi; Xu, Xinhong; Lu, Enjie; Li, Kuibiao; Liu, Yanhui; Wu, Yejian; Chen, Xiongfei; He, Peng; Wang, Yulin; Liu, Jianhua			Antibody Dynamics of 2009 Influenza A (H1N1) Virus in Infected Patients and Vaccinated People in China	PLOS ONE			English	Article							RESPONSES; CHILDREN; ADULTS	Background: To evaluate the risk of the recurrence and the efficiency of the vaccination, we followed-up antibody responses in patients with the 2009 pandemic H1N1 influenza and persons who received the pandemic H1N1 vaccine in Guangzhou China. Methods: We collected serum samples from 129 patients and 86 vaccinated persons at day 0, 15, 30, 180 after the disease onset or the vaccination, respectively. Antibody titers in these serum samples were determined by haemagglutination inhibition (HI) assay using a local isolated virus strain A/Guangdong Liwan/SWL1538/2009(H1N1). Results: HI antibody positive rate of the patients increased significantly from 0% to 60% at day 15 (chi(2)=78, P<0.001) and 100% at day 30 (chi(2)=23, P<0.001), but decreased significantly to 52% at day 180 (chi(2)=38, P<0.001), while that of vaccinated subjects increased from 0% to 78% at day 15 (chi(2)=110, P<0.001) and 81% at day 30 (chi(2)=0.32, P=0.57), but decreased significantly to 34% at day 180 (chi(2)=39, P<0.001). Geometric mean titers (GMT) of HI antibodies in positive samples from the patients did not change significantly between day 15 and day 30 (T=0.92, P=0.36), but it decreased significantly from 80 at day 30 to 52 at day 180 (T=4.5, P<0.001). GMT of vaccinated persons increased significantly from 100 at day 15 to 193 at day 30 (T=4.5, P<0.001), but deceased significantly to 74 at day 180 (T=5.1, P<0.001). Compared to the patients, the vaccinated subjects showed lower seroconversion rate (chi(2)=11, P<0.001; chi(2)=5.9, P=0.015), but higher GMT (T=6.0, P<0.001; T=3.6, P=0.001) at day 30 and day 180, respectively. Conclusion: Vaccination of 2009 influenza A (H1N1) was effective. However, about half or more recovered patients and vaccinated persons might have lost sufficient immunity against the recurrence of the viral infection after half a year. Vaccination or re-vaccination may be necessary for prevention of the recurrence.	[Wang, Ming; Yuan, Jun; Li, Tiegang; Liu, Yang; Wu, Jibin; Di, Biao; Chen, Xi; Xu, Xinhong; Lu, Enjie; Li, Kuibiao; Liu, Yanhui; Wu, Yejian; Chen, Xiongfei; He, Peng; Wang, Yulin; Liu, Jianhua] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China		Wang, M (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	wangming@gzcdc.org.cn			Ministry of Science and Technology of the People's Republic of China [2009ZX10004-306]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This study was funded by the Ministry of Science and Technology of the People's Republic of China (grant 2009ZX10004-306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; BERNSTEIN DI, 1982, PEDIATRICS, V69, P404; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; KILBOURNE ED, 1976, J INFECT DIS, V134, P384, DOI 10.1093/infdis/134.4.384; Perez CM, 2010, EMERG INFECT DIS, V16, P156, DOI 10.3201/eid1601.091420; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; *WHO, 2010, FOC H1N1 NOW POSTP P; *WHO, 2010, DIR GEN STAT FOLL 7; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	14	30	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16809	10.1371/journal.pone.0016809	http://dx.doi.org/10.1371/journal.pone.0016809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347418	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700035
J	Worringham, C; Rojek, A; Stewart, I				Worringham, Charles; Rojek, Amanda; Stewart, Ian			Development and Feasibility of a Smartphone, ECG and GPS Based System for Remotely Monitoring Exercise in Cardiac Rehabilitation	PLOS ONE			English	Article							ATTENDANCE; ADHERENCE; OUTCOMES; SURGERY; SPEED; COST	Background: Despite its efficacy and cost-effectiveness, exercise-based cardiac rehabilitation is undertaken by less than one-third of clinically eligible cardiac patients in every country for which data is available. Reasons for non-participation include the unavailability of hospital-based rehabilitation programs, or excessive travel time and distance. For this reason, there have been calls for the development of more flexible alternatives. Methodology and Principal Findings: We developed a system to enable walking-based cardiac rehabilitation in which the patient's single-lead ECG, heart rate, GPS-based speed and location are transmitted by a programmed smartphone to a secure server for real-time monitoring by a qualified exercise scientist. The feasibility of this approach was evaluated in 134 remotely-monitored exercise assessment and exercise sessions in cardiac patients unable to undertake hospital-based rehabilitation. Completion rates, rates of technical problems, detection of ECG changes, pre- and post-intervention six minute walk test (6 MWT), cardiac depression and Quality of Life (QOL) were key measures. The system was rated as easy and quick to use. It allowed participants to complete six weeks of exercise-based rehabilitation near their homes, worksites, or when travelling. The majority of sessions were completed without any technical problems, although periodic signal loss in areas of poor coverage was an occasional limitation. Several exercise and post-exercise ECG changes were detected. Participants showed improvements comparable to those reported for hospital-based programs, walking significantly further on the post-intervention 6 MWT, 637 m (95% CI: 565-726), than on the pre- test, 524 m (95% CI: 420-655), and reporting significantly reduced levels of cardiac depression and significantly improved physical health-related QOL. Conclusions and Significance: The system provided a feasible and very flexible alternative form of supervised cardiac rehabilitation for those unable to access hospital-based programs, with the potential to address a well-recognised deficiency in health care provision in many countries. Future research should assess its longer-term efficacy, cost-effectiveness and safety in larger samples representing the spectrum of cardiac morbidity and severity.	[Worringham, Charles; Rojek, Amanda; Stewart, Ian] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Worringham, C (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	c.worringham@qut.edu.au	Stewart, Ian B/I-9927-2012	Stewart, Ian/0000-0003-1741-718X; Rojek, Amanda/0000-0002-3948-0756	Australian Research Council [LP0562608]	Australian Research Council(Australian Research Council)	This work was supported by a Linkage Grant LP0562608 from the Australian Research Council awarded to Queensland University of Technology and Alive Technologies, Pty Ltd. Funding agency URL: http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Institute of Health and Welfare, 2008, AUSTR HLTH 2008; Bethell H, 2009, HEART, V95, P271, DOI 10.1136/hrt.2007.134338; Briffa TG, 2005, MED J AUSTRALIA, V183, P450, DOI 10.5694/j.1326-5377.2005.tb07121.x; Carlson J J, 2001, J Cardiopulm Rehabil, V21, P363, DOI 10.1097/00008483-200111000-00004; Carlson JJ, 2000, AM J CARDIOL, V86, P17, DOI 10.1016/S0002-9149(00)00822-5; Collins L, 2001, Aust Health Rev, V24, P51; Cooper AF, 2005, CLIN REHABIL, V19, P87, DOI 10.1191/0269215505cr818oa; Dalal HM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5631; Dollard Joanne, 2004, Eur J Cardiovasc Nurs, V3, P27, DOI 10.1016/j.ejcnurse.2003.10.002; Dunlay SM, 2009, AM HEART J, V158, P852, DOI 10.1016/j.ahj.2009.08.010; Fiorina C, 2007, EUR J CARDIO-THORAC, V32, P724, DOI 10.1016/j.ejcts.2007.08.013; FLETCHER GF, 1984, CHEST, V86, P198, DOI 10.1378/chest.86.2.198; GRALL SK, 2000, CLIN EXERC PHYSL, V2, P133; Hare DL, 1996, J PSYCHOSOM RES, V40, P379, DOI 10.1016/0022-3999(95)00612-5; Higgins RO, 2008, MED J AUSTRALIA, V188, P712, DOI 10.5694/j.1326-5377.2008.tb01852.x; Jackson L, 2005, HEART, V91, P10, DOI 10.1136/hrt.2004.045559; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Le Faucheur A, 2008, CIRCULATION, V117, P897, DOI 10.1161/CIRCULATIONAHA.107.725994; Papadakis S, 2005, EUR J CARDIOV PREV R, V12, P513; Pavy B, 2006, ARCH INTERN MED, V166, P2329, DOI 10.1001/archinte.166.21.2329; Scalvini S, 2009, J TELEMED TELECARE, V15, P297, DOI 10.1258/jtt.2009.090208; Scott IA, 2003, MED J AUSTRALIA, V179, P341, DOI 10.5694/j.1326-5377.2003.tb05588.x; SHAW DK, 1995, AM J CARDIOL, V76, P1069, DOI 10.1016/S0002-9149(99)80300-2; SQUIRES RW, 1991, AM J CARDIOL, V67, P962, DOI 10.1016/0002-9149(91)90168-K; Sundararajan V, 2004, MED J AUSTRALIA, V180, P268, DOI 10.5694/j.1326-5377.2004.tb05923.x; Thompson DR, 2009, HEART, V95, P1897, DOI 10.1136/hrt.2009.173732; Townshend AD, 2008, MED SCI SPORT EXER, V40, P124, DOI 10.1249/mss.0b013e3181590bc2; Wenger NK, 2008, J AM COLL CARDIOL, V51, P1619, DOI 10.1016/j.jacc.2008.01.030; 2005, MMWR MORB MORTAL WKL, V57, P89	29	124	130	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14669	10.1371/journal.pone.0014669	http://dx.doi.org/10.1371/journal.pone.0014669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347403	Green Published, gold			2022-12-25	WOS:000287361700003
J	Dalrymple, MB; Jaeger, WC; Eidne, KA; Pfleger, KDG				Dalrymple, Matthew B.; Jaeger, Werner C.; Eidne, Karin A.; Pfleger, Kevin D. G.			Temporal Profiling of Orexin Receptor-Arrestin-Ubiquitin Complexes Reveals Differences between Receptor Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; BETA-ARRESTIN; HORMONE RECEPTOR; INDEPENDENT INTERNALIZATION; 7-TRANSMEMBRANE RECEPTORS; DEPENDENT INTERNALIZATION; ENDOCYTIC TRAFFICKING; MEDIATED ENDOCYTOSIS; ERK1/2 ACTIVATION	Orexin G protein-coupled receptors (OxRs) and their cognate agonists have been implicated in a number of disorders since their recent discovery, ranging from narcolepsy to formation of addictive behavior. Bioluminescence resonance energy transfer assays of agonist-occupied OxRs provided evidence for a strong dose-dependent interaction with both trafficking proteins beta-arrestin 1 and 2 that required unusually high agonist concentrations compared with inositol phosphate signaling. This appears to be reflected in functional differences in potency with respect to orexin A (OxA) and OxR2-dependent ERK1/2 phosphorylation after 90 min compared with 2 min, potentially consistent with beta-arrestin-mediated versus G protein-mediated signaling, respectively. Furthermore, extended bioluminescence resonance energy transfer kinetic data monitoring OxA-dependent receptor-beta-arrestin and beta-arrestin-ubiquitin proximity suggested subtype-specific differences in receptor trafficking, with OxR2 activation resulting in more sustained receptor-beta-arrestin-ubiquitin complex formation than elicited by OxR1 activation. Enzyme-linked immunosorbent assay (ELISA) data also revealed that OxR1 underwent significantly more rapid recycling compared with OxR2. Finally, we have observed sustained OxA-dependent ERK1/2 phosphorylation in the presence of OxR2 compared with OxR1. Although both OxR subtypes could be classified as class B receptors for beta-arrestin usage based on the initial strength of interaction with both beta-arrestins, our temporal profiling revealed tangible differences between OxR subtypes. Consequently, OxR1 appears to fit uneasily into the commonly used beta-arrestin classification scheme. More importantly, it is hoped that this improved profiling capability, enabling the subtleties of protein complex formation, stability, and duration to be assessed in live cells, will help unlock the therapeutic potential of targeting these receptors.	[Pfleger, Kevin D. G.] Western Australian Inst Med Res, Lab Mol Endocrinol G Protein Coupled Receptors, QEII Med Ctr, Perth, WA 6009, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Pfleger, KDG (corresponding author), Western Australian Inst Med Res, Lab Mol Endocrinol G Protein Coupled Receptors, QEII Med Ctr, B Block, Perth, WA 6009, Australia.	kpfleger@waimr.uwa.edu.au	Pfleger, Kevin/H-5629-2014	Pfleger, Kevin/0000-0001-8261-9189	National Health and Medical Research Council of Australia [404087, 212064, 353709]; Australian postgraduate award; Australian Research Council [FT100100271]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government); Australian Research Council(Australian Research Council)	This work was supported in part by the National Health and Medical Research Council of Australia via Project Grant 404087 (to K. A. E. and K. D. G. P.) and Fellowships 212064 and 353709 (to K. A. E. and K. D. G. P., respectively).; Recipient of an Australian postgraduate award.; Australian Research Council Future Fellow supported by Grant FT100100271.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Berglund MM, 2003, J PHARMACOL EXP THER, V306, P147, DOI 10.1124/jpet.103.051227; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Charest PG, 2003, J BIOL CHEM, V278, P41541, DOI 10.1074/jbc.M306589200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dikic I, 2009, NAT STRUCT MOL BIOL, V16, P1208, DOI 10.1038/nsmb1209-1209; Dromey Jasmin R., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P51, DOI 10.2174/187153008783928352; Gehret AU, 2010, BIOCHEM J, V428, P235, DOI 10.1042/BJ20100139; Gray JA, 2003, MOL PHARMACOL, V63, P961, DOI 10.1124/mol.63.5.961; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; Heinonen MV, 2008, ACTA PHYSIOL, V192, P471, DOI 10.1111/j.1748-1716.2008.01836.x; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; Lee HJ, 2007, BIOCHEM J, V404, P141, DOI 10.1042/BJ20061826; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Pfleger KDG, 2007, BIOCHEM SOC T, V35, P764, DOI 10.1042/BST0350764; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ponimaskin E, 2005, MOL PHARMACOL, V67, P1434, DOI 10.1124/mol.104.008748; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Prossnitz ER, 2004, LIFE SCI, V75, P893, DOI 10.1016/j.lfs.2004.04.003; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen TN, 2004, EUR J BIOCHEM, V271, P4366, DOI 10.1111/j.1432-1033.2004.04371.x; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Tang JY, 2008, CELL SIGNAL, V20, P1651, DOI 10.1016/j.cellsig.2008.05.010; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Torrecilla I, 2006, CURR PHARM DESIGN, V12, P1797, DOI 10.2174/138161206776873716; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; Vrecl M, 1998, MOL ENDOCRINOL, V12, P1818, DOI 10.1210/me.12.12.1818; Werry TD, 2006, CURR PHARM DESIGN, V12, P1683, DOI 10.2174/138161206776873725	68	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16726	16733		10.1074/jbc.M111.223537	http://dx.doi.org/10.1074/jbc.M111.223537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21378163	Green Published, hybrid			2022-12-25	WOS:000290301900020
J	Franklin, NE; Taylor, GS; Vacratsis, PO				Franklin, Norah E.; Taylor, Gregory S.; Vacratsis, Panayiotis O.			Endosomal Targeting of the Phosphoinositide 3-Phosphatase MTMR2 Is Regulated by an N-terminal Phosphorylation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; MYOTUBULARIN-RELATED PROTEIN-2; TUMOR-SUPPRESSOR; MASS-SPECTROMETRY; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MEMBRANE TRAFFICKING; LIPID 2ND-MESSENGER; PDZ DOMAIN; PHOSPHATASE; PTEN	MTMR2 is a member of the myotubularin family of inositol lipid phosphatases, a large protein-tyrosine phosphatase subgroup that is conserved from yeast to humans. Furthermore, the peripheral neuromuscular disease Charcot-Marie Tooth disease type 4B has been attributed to mutations in the mtmr2 gene. Because the molecular mechanisms regulating MTMR2 have been poorly defined, we investigated whether reversible phosphorylation might regulate MTMR2 function. We used mass spectrometry-based methods to identify a high stoichiometry phosphorylation site on serine 58 of MTMR2. Phosphorylation at Ser(58), or a phosphomimetic S58E mutation, markedly decreased MTMR2 localization to endocytic vesicular structures. In contrast, a phosphorylation-deficient MTMR2 mutant (S58A) displayed constitutive localization to early endocytic structures. This localization pattern was accompanied by displacement of a PI(3) P-specific sensor protein and an increase in signal transduction pathways. Thus, MTMR2 phosphorylation is likely to be a critical mechanism by which MTMR2 access to its lipid substrate(s) is temporally and spatially regulated, thereby contributing to the control of downstream endosome maturation events.	[Franklin, Norah E.; Vacratsis, Panayiotis O.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Taylor, Gregory S.] Univ Nebraska, Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Windsor; University of Nebraska System; University of Nebraska Medical Center	Taylor, GS (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	gstaylor@unmc.edu; vacratsi@uwindsor.ca			National Institutes of Health National Center for Research Resources; Canadian Institutes of Health Research (CIHR) [89870]	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported, in whole or in part, by a National Institutes of Health National Center for Research Resources grant to the Nebraska Center for Cellular Signaling (to G. S. T.) and Operating Grant 89870 from Canadian Institutes of Health Research (CIHR) (to P. O. V.).	Alexiou GA, 2010, NEUROL NEUROCHIR POL, V44, P80; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Keough T, 2000, RAPID COMMUN MASS SP, V14, P2348, DOI 10.1002/1097-0231(20001230)14:24<2348::AID-RCM175>3.0.CO;2-8; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Klemm C, 2006, J MASS SPECTROM, V41, P1623, DOI 10.1002/jms.1129; Laporte J, 2002, J CELL SCI, V115, P3105; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; LIN A, 1990, P NATL ACAD SCI USA, V87, P8565, DOI 10.1073/pnas.87.21.8565; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Robinson FL, 2005, J BIOL CHEM, V280, P31699, DOI 10.1074/jbc.M505159200; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Suter U, 2007, CELL MOL LIFE SCI, V64, P3261, DOI 10.1007/s00018-007-7381-7; Taylor Gregory S, 2004, Methods Mol Biol, V284, P217; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; TILLY BC, 1993, J BIOL CHEM, V268, P19919; Vacratsis PO, 2002, BIOCHEMISTRY-US, V41, P5613, DOI 10.1021/bi016075c; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vartak N, 2010, EMBO J, V29, P2689, DOI 10.1038/emboj.2010.184; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	49	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.209122	http://dx.doi.org/10.1074/jbc.M110.209122			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21372139	Green Published, hybrid			2022-12-25	WOS:000290022800025
J	Meissner, M; Weissgerber, P; Londono, JEC; Prenen, J; Link, S; Ruppenthal, S; Molkentin, JD; Lipp, P; Nilius, B; Freichel, M; Flockerzi, V				Meissner, Marcel; Weissgerber, Petra; Londono, Juan E. Camacho; Prenen, Jean; Link, Sabine; Ruppenthal, Sandra; Molkentin, Jeffery D.; Lipp, Peter; Nilius, Bernd; Freichel, Marc; Flockerzi, Veit			Moderate Calcium Channel Dysfunction in Adult Mice with Inducible Cardiomyocyte-specific Excision of the cacnb2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; CARDIAC DEVELOPMENT; CA2+ CHANNELS; HEART; HETEROGENEITY; EXPRESSION; PROTEIN; MODELS; BRAIN	The major L-type voltage-gated calcium channels in heart consist of an alpha 1C (Ca(V)1.2) subunit usually associated with an auxiliary beta subunit (Ca-V beta 2). In embryonic cardiomyocytes, both the complete and the cardiac myocyte-specific null mutant of Ca-V beta 2 resulted in reduction of L-type calcium currents by up to 75%, compromising heart function and causing defective remodeling of intra-and extra-embryonic blood vessels followed by embryonic death. Here we conditionally excised the Ca-V beta 2 gene (cacnb2) specifically in cardiac myocytes of adult mice (KO). Upon gene deletion, Ca-V beta 2 protein expression declined by > 96% in isolated cardiac myocytes and by > 74% in protein fractions from heart. These latter protein fractions include Ca-V beta 2 proteins expressed in cardiac fibroblasts. Surprisingly, mice did not show any obvious impairment, although cacnb2 excision was not compensated by expression of other Ca-V beta proteins or changes of Ca(V)1.2 protein levels. Calcium currents were still dihydropyridine-sensitive, but current density at 0 mV was reduced by < 29%. The voltage for half-maximal activation was slightly shifted to more depolarized potentials in KO cardiomyocytes when compared with control cells, but the difference was not significant. In summary, Ca-V beta 2 appears to be a much stronger modulator of L-type calcium currents in embryonic than in adult cardiomyocytes. Although essential for embryonic survival, Ca-V beta 2 down-regulation in cardiomyocytes is well tolerated by the adult mice.	[Meissner, Marcel; Weissgerber, Petra; Londono, Juan E. Camacho; Link, Sabine; Ruppenthal, Sandra; Lipp, Peter; Freichel, Marc; Flockerzi, Veit] Univ Saarland, D-66421 Homburg, Germany; [Prenen, Jean; Nilius, Bernd] Katholieke Univ Leuven, Dept Mol Celbiol, Lab Ionenkanaalonderzoek, B-3000 Louvain, Belgium; [Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	Saarland University; KU Leuven; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Flockerzi, V (corresponding author), Univ Saarland, Gebaude 46, D-66421 Homburg, Germany.	veit.flockerzi@uks.eu		Camacho Londono, Juan E./0000-0003-0673-7583; Molkentin, Jeffery/0000-0002-3558-6529	Interuniversity Attraction Poles Programme Belgian State - Belgian Science Policy [P6/28]; Research Council of the KU Leuven [GOA 2004/07]; Flemish Government [EF/95/010]; Deutsche Forschungsgemeinschaft [SFB530, KFO196, GK 1326, SFB894]; Homburger Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitaet des Saarlandes	Interuniversity Attraction Poles Programme Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Research Council of the KU Leuven(KU Leuven); Flemish Government(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Homburger Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitaet des Saarlandes	This work was supported by Interuniversity Attraction Poles Programme Belgian State - Belgian Science Policy, P6/28, the Research Council of the KU Leuven (Grant GOA 2004/07), the Flemish Government (Excellentiefinanciering, Grant EF/95/010) (to B. N. and J. P.), the Deutsche Forschungsgemeinschaft (Grants SFB530, KFO196, and GK 1326 (to P. L., M. F., and V. F.), Grant SFB894 (to P. W., M. F., and V. F.), the Homburger Forschungsforderungsprogramm HOMFOR (P. L., M. M., P. W., M. F., and V. F.), and the Forschungskommission der Universitaet des Saarlandes (P. L., M. F., and V. F.).	Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Cingolani E, 2007, CIRC RES, V101, P166, DOI 10.1161/CIRCRESAHA.107.155721; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; DROOGMANS G, 1989, J PHYSIOL-LONDON, V419, P627, DOI 10.1113/jphysiol.1989.sp017890; Droogmans G., 1997, WINASCD; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Striessnig J, 2008, CHANNELS, V2, P233, DOI 10.4161/chan.2.4.5847; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Verrou C, 1999, BIOL CHEM, V380, P1435, DOI 10.1515/BC.1999.184; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1	24	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.227819	http://dx.doi.org/10.1074/jbc.M111.227819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21357697	Green Published, hybrid			2022-12-25	WOS:000290022800028
J	Sun, RL; Zhang, Y; Lv, QS; Liu, B; Jin, M; Zhang, WJ; He, Q; Deng, MJ; Liu, XT; Li, GC; Li, YH; Zhou, GH; Xie, PL; Xie, XM; Hu, JY; Duan, ZJ				Sun, Ruili; Zhang, Yu; Lv, Qingshan; Liu, Bei; Jin, Miao; Zhang, Weijia; He, Qing; Deng, Minjie; Liu, Xueting; Li, Guancheng; Li, Yuehui; Zhou, Guohua; Xie, Pingli; Xie, Xiumei; Hu, Jinyue; Duan, Zhaojun			Toll-like Receptor 3 (TLR3) Induces Apoptosis via Death Receptors and Mitochondria by Up-regulating the Transactivating p63 Isoform alpha (TAP63 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; NEGATIVE REGULATION; CANCER-CELLS; P53 HOMOLOG; RECOGNITION; VIRUS; ACTIVATION; INTERFERON; INFECTION	Toll-like receptor 3 (TLR3), a member of the pathogen recognition receptors, is widely expressed in various cells and has been shown to activate immune signaling pathways by recognizing viral double-stranded RNA. Recently, it was reported that the activation of TLR3 induced apoptosis in some cells, but the detailed molecular mechanism is not fully understood. In this study, we found that in endothelial cells polyinosinic-polycytidylic acid (poly(I-C)) induced dose-and time-dependent cell apoptosis, which was elicited by TLR3 activation, as TLR3 neutralization and down-regulation repressed the apoptosis. Poly(I-C) induced the activation of both caspases 8 and 9, indicating that TLR3 triggered the signaling of both the extrinsic and intrinsic apoptotic pathways. Poly(I-C) up-regulated tumor necrosis factor-related apoptosis-inducing ligand and its receptors, death receptors 4/5, resulting in initiating the extrinsic pathway. Furthermore, poly(I-C) down-regulated anti-apoptotic protein, B cell lymphoma 2 (Bcl-2), and up-regulated Noxa, a key Bcl-2 homology 3-only antagonist of Bcl-2, leading to the priming of the intrinsic pathway. A p53-related protein, the transactivating p63 isoform alpha (TAp63 alpha), was induced by TLR3 activation and contributed to the activation of both the intrinsic and extrinsic apoptotic pathways. Both the cells deficient in p63 gene expression by RNA interference and cells that overexpressed the N-terminally truncated p63 isoform alpha (Delta Np63 alpha), a dominant-negative variant of TAp63 alpha, by gene transfection, survived TLR3 activation. Taken together, TAp63 alpha is a crucial regulator downstream of TLR3 to induce cell death via death receptors and mitochondria.	[Sun, Ruili; He, Qing; Deng, Minjie; Liu, Xueting; Hu, Jinyue] Wuhan Univ, Cent Lab, Renmin Hosp, Wuhan 430060, Peoples R China; [Zhang, Yu; Zhang, Weijia; Li, Guancheng; Li, Yuehui; Zhou, Guohua; Xie, Pingli; Hu, Jinyue] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Sun, Ruili] XinXiang Med Univ, Dept Lab Med, Xinxiang 453003, Peoples R China; [Lv, Qingshan; Xie, Xiumei] Cent S Univ, Dept Geriatr Cardiol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Liu, Bei] Wuhan Univ Sci & Technol, Dept Pathol, Affiliated Tianyou Hosp, Wuhan 430064, Peoples R China; [Jin, Miao; Duan, Zhaojun] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 100052, Peoples R China	Wuhan University; Central South University; Xinxiang Medical University; Central South University; Wuhan University of Science & Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Hu, JY (corresponding author), Wuhan Univ, Cent Lab, Renmin Hosp, 99 Ziyang Rd, Wuhan 430060, Peoples R China.	jinyuehu@whu.edu.cn; zhaojund@126.com	Lyu, Qingshan/AAE-1924-2019		State Key Laboratory for Molecular Virology and Genetic Engineering, China [2008-K-0002]	State Key Laboratory for Molecular Virology and Genetic Engineering, China	The work was supported in part by the Opening Project of State Key Laboratory for Molecular Virology and Genetic Engineering Grant 2008-K-0002, China.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gifford SM, 2004, J ENDOCRINOL, V182, P485, DOI 10.1677/joe.0.1820485; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hutchens M, 2008, J IMMUNOL, V180, P483, DOI 10.4049/jimmunol.180.1.483; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaiser WJ, 2004, J IMMUNOL, V172, P1699, DOI 10.4049/jimmunol.172.3.1699; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kemp TJ, 2005, BLOOD, V106, P3474, DOI 10.1182/blood-2005-03-1327; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Ruckdeschel K, 2004, J IMMUNOL, V173, P3320, DOI 10.4049/jimmunol.173.5.3320; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435	42	89	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.178798	http://dx.doi.org/10.1074/jbc.M110.178798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21367858	hybrid, Green Published			2022-12-25	WOS:000290022800032
J	Chen, S; Barbieri, JT				Chen, Sheng; Barbieri, Joseph T.			Association of Botulinum Neurotoxin Serotype A Light Chain with Plasma Membrane-bound SNAP-25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE RECOGNITION; ENDOPLASMIC-RETICULUM; PSEUDOMONAS EXOTOXIN; TOXIN; LOCALIZATION; TRANSLOCATION; RESIDUES; COMPLEX; SYSTEM; TRAFFICKING	The Clostridium botulinum neurotoxins (BoNTs) cleave SNARE proteins, which inhibit binding and thus fusion of neurotransmitter vesicles to the plasma membrane of peripheral neurons. BoNTs comprise an N-terminal light chain (LC) and C-terminal heavy chain, which are linked by a disulfide bond. There are seven serotypes (A-G) of BoNTs based upon immunological neutralization. Although the binding and entry of BoNT/A into neurons has been subjected to considerable investigation, the intracellular events that allow BoNT/A to efficiently cleave SNAP-25 within neurons is less well understood. Earlier studies showed that intracellular LC/A bound to the plasma membrane of neurons. In this study, intracellular LC/A is shown to directly bind SNAP-25 on the plasma membrane. Solid phase binding showed that the N-terminal residues of LC/A bound residues 80-110 of SNAP-25, which was also observed in cultured neurons. Association of the N-terminal 8 amino acids of LC/A and residues 80-110 of SNAP-25 also enhanced substrate cleavage. These findings explain how LC/A associates with SNAP-25 on the plasma membrane and provide a basis for LC/A cleavage of SNAP-25 within the SNARE complex.	[Chen, Sheng] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hung Hom Kowloon, Hong Kong, Peoples R China; [Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Hong Kong Polytechnic University; Medical College of Wisconsin	Barbieri, JT (corresponding author), 8701 Watertown Plank Rd,Microbiol & Mol Genet BSB, Milwaukee, WI 53226 USA.	jtb01@mcw.edu		Chen, Sheng/0000-0003-3526-7808	National Institutes of Health through the Great Lakes Regional Center of Excellence [U54 AI057153]; Hong Kong PolyU Competitive Research Grant for Newly Recruited Junior Academic Staff [G-YH87]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health through the Great Lakes Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong PolyU Competitive Research Grant for Newly Recruited Junior Academic Staff; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057153 through the Great Lakes Regional Center of Excellence (to J.T.B.).; Supported by Hong Kong PolyU Competitive Research Grant for Newly Recruited Junior Academic Staff (Grant G-YH87).	Agarwal R, 2005, BIOCHEMISTRY-US, V44, P8291, DOI 10.1021/bi050253a; Bajohrs M, 2004, EMBO REP, V5, P1090, DOI 10.1038/sj.embor.7400278; Baldwin MR, 2007, BIOCHEMISTRY-US, V46, P3200, DOI 10.1021/bi602396x; Bhidayasiri Roongroj, 2006, Expert Rev Neurother, V6, P863, DOI 10.1586/14737175.6.6.863; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Bossi P, 2003, PRESSE MED, V32, P463; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Carruthers A, 2008, Skin Therapy Lett, V13, P1; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Dolly JO, 2006, EUR J NEUROL, V13, P1, DOI 10.1111/j.1468-1331.2006.01648.x; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Fernandez-Salas E, 2004, MOVEMENT DISORD, V19, pS23, DOI 10.1002/mds.20006; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; Jackson ME, 1999, J CELL SCI, V112, P467; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Josko Deborah, 2004, Clin Lab Sci, V17, P30; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Mahajan ST, 2007, AM J OBSTET GYNECOL, V196, P7, DOI 10.1016/j.ajog.2006.03.108; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Perez-Branguli F, 1999, FEBS LETT, V458, P60, DOI 10.1016/S0014-5793(99)01120-5; Rossetto O, 2002, CURR PROBL DERMATOL, V30, P117; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Smith DC, 2006, TRAFFIC, V7, P379, DOI 10.1111/j.1600-0854.2006.00391.x; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tsai YC, 2010, P NATL ACAD SCI USA, V107, P16554, DOI 10.1073/pnas.1008302107; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Wang JF, 2011, J BIOL CHEM, V286, P6375, DOI 10.1074/jbc.M110.181784; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Zhang Y, 2007, CELL MICROBIOL, V9, P2192, DOI 10.1111/j.1462-5822.2007.00949.x; Zhang Y, 2007, J BIOL CHEM, V282, P13022, DOI 10.1074/jbc.M606305200	42	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15067	15072		10.1074/jbc.M111.224493	http://dx.doi.org/10.1074/jbc.M111.224493			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21378164	Green Published, hybrid			2022-12-25	WOS:000289788300037
J	Kilaru, A; Herrfurth, C; Keereetaweep, J; Hornung, E; Venables, BJ; Feussner, I; Chapman, KD				Kilaru, Aruna; Herrfurth, Cornelia; Keereetaweep, Jantana; Hornung, Ellen; Venables, Barney J.; Feussner, Ivo; Chapman, Kent D.			Lipoxygenase-mediated Oxidation of Polyunsaturated N-Acylethanolamines in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID AMIDE HYDROLASE; 9-LIPOXYGENASE PATHWAY; CANNABINOID RECEPTOR; THALIANA SEEDLINGS; ROOT DEVELOPMENT; ANANDAMIDE; METABOLISM; ENDOCANNABINOIDS; OXYLIPINS; SUBSTRATE	N-Acylethanolamines (NAEs) are bioactive fatty acid derivatives that occur in all eukaryotes. In plants, NAEs have potent negative growth-regulating properties, and fatty acid amide hydrolase (FAAH)-mediated hydrolysis is a primary catabolic pathway that operates during seedling establishment to deplete these compounds. Alternatively, polyunsaturated (PU)-NAEs may serve as substrates for lipid oxidation. In Arabidopsis, PU-NAEs (NAE 18: 2 and NAE 18: 3) were the most abundant NAE species in seeds, and their levels were depleted during seedling growth even in FAAH tDNA knock-out plants. Therefore, we hypothesized that lipoxygenase (LOX) participated in the metabolism of PU-NAEs through the formation of NAE-oxylipins. Comprehensive chromatographic and mass spectrometric methods were developed to identify NAE hydroperoxides and -hydroxides. Recombinant Arabidopsis LOX enzymes expressed in Escherichia coli utilized NAE 18: 2 and NAE 18: 3 as substrates with AtLOX1 and AtLOX5 exhibiting 9-LOX activity and AtLOX2, AtLOX3, AtLOX4, and AtLOX6 showing predominantly 13-LOX activity. Feeding experiments with exogenous PU-NAEs showed they were converted to hydroxide metabolites indicating that indeed Arabidopsis seedlings had the capacity for LOX-mediated metabolism of PU-NAEs in planta. Detectable levels of endogenous NAE-oxylipin metabolites were identified in FAAH fatty acid amide hydrolase seedlings but not in wild-type or FAAH overexpressors, suggesting that NAE hydroxide pools normally do not accumulate unless flux through hydrolysis is substantially reduced. These data suggest that Arabidopsis LOXs indeed compete with FAAH to metabolize PU-NAEs during seedling establishment. Identification of endogenous amide-conjugated oxylipins suggests potential significance of these metabolites in vivo, and FAAH mutants may offer opportunities to address this in the future.	[Kilaru, Aruna; Keereetaweep, Jantana; Venables, Barney J.; Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA; [Herrfurth, Cornelia; Hornung, Ellen; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst Plant Sci, D-37077 Gottingen, Germany	University of North Texas System; University of North Texas Denton; University of Gottingen	Kilaru, A (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	akilaru@msu.edu	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Chapman, Kent/0000-0003-0489-3072; Keereetaweep, Jantana/0000-0001-8314-9289	United States Department of Energy, Office of Energy Biosciences [DE-FG02-05ER15647]	United States Department of Energy, Office of Energy Biosciences(United States Department of Energy (DOE))	This work was supported by United States Department of Energy, Office of Energy Biosciences, Grant DE-FG02-05ER15647.	Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Berger S, 2001, BBA-MOL CELL BIOL L, V1533, P266, DOI 10.1016/S1388-1981(01)00161-5; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Blee E, 1998, PROG LIPID RES, V37, P33, DOI 10.1016/S0163-7827(98)00004-6; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Chapman KD, 1999, PLANT PHYSIOL, V120, P1157, DOI 10.1104/pp.120.4.1157; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Gobel C, 2001, J BIOL CHEM, V276, P6267, DOI 10.1074/jbc.M008606200; Hanus LO, 2007, CHEM BIODIVERS, V4, P1828, DOI 10.1002/cbdv.200790154; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Keereetaweep J, 2010, FEBS LETT, V584, P3215, DOI 10.1016/j.febslet.2010.06.008; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Kim SC, 2010, PLANT SCI, V178, P411, DOI 10.1016/j.plantsci.2010.02.017; Kim SC, 2009, J BIOL CHEM, V284, P34065, DOI 10.1074/jbc.M109.059022; Kozak KR, 2002, PROSTAG LEUKOTR ESS, V66, P211, DOI 10.1054/plef.2001.0359; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Motes CM, 2005, PROTOPLASMA, V226, P109, DOI 10.1007/s00709-005-0124-4; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pappan K, 1998, ARCH BIOCHEM BIOPHYS, V353, P131, DOI 10.1006/abbi.1998.0640; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Schmid HHO, 2000, CHEM PHYS LIPIDS, V108, P71, DOI 10.1016/S0009-3084(00)00188-2; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Shrestha R, 2002, PLANT PHYSIOL, V130, P391, DOI 10.1104/pp.004689; Shrestha R, 2006, BBA-MOL CELL BIOL L, V1761, P324, DOI 10.1016/j.bbalip.2006.03.004; Snider NT, 2008, J PHARMACOL EXP THER, V327, P538, DOI 10.1124/jpet.108.141796; Snider NT, 2010, PHARMACOL REV, V62, P136, DOI 10.1124/pr.109.001081; Snider NT, 2009, MOL PHARMACOL, V75, P965, DOI 10.1124/mol.108.053439; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; van der Stelt M, 2000, EUR J BIOCHEM, V267, P2000, DOI 10.1046/j.1432-1327.2000.01203.x; van Zadelhoff G, 1998, BIOCHEM BIOPH RES CO, V248, P33, DOI 10.1006/bbrc.1998.8910; vanderStelt M, 1997, FEBS LETT, V411, P287, DOI 10.1016/S0014-5793(97)00718-7; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Venables BJ, 2005, PHYTOCHEMISTRY, V66, P1913, DOI 10.1016/j.phytochem.2005.06.014; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103; Weichert H, 1999, FEBS LETT, V464, P133, DOI 10.1016/S0014-5793(99)01697-X; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Woodward DF, 2008, BRIT J PHARMACOL, V153, P410, DOI 10.1038/sj.bjp.0707434	50	24	24	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15205	15214		10.1074/jbc.M110.217588	http://dx.doi.org/10.1074/jbc.M110.217588			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372125	hybrid, Green Published			2022-12-25	WOS:000289788300052
J	VanderWielen, BD; Yuan, ZY; Friedmann, DR; Kovall, RA				VanderWielen, Bradley D.; Yuan, Zhenyu; Friedmann, David R.; Kovall, Rhett A.			Transcriptional Repression in the Notch Pathway THERMODYNAMIC CHARACTERIZATION OF CSL-MINT (Msx2-INTERACTING NUCLEAR TARGET PROTEIN) COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; ACCESSIBLE SURFACE-AREAS; RBP-J; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; ANKYRIN REPEATS; HEAT-CAPACITY; CO-REPRESSOR; TARGET GENES; BINDING	The Notch pathway is a conserved cell-to-cell signaling mechanism that mediates cell fate decisions in metazoans. Canonical signaling results in changes in gene expression, which is regulated by the nuclear effector of the pathway CSL (CBF1/RBP-J, Su(H), Lag-1). CSL is a DNA binding protein that functions as either a repressor or an activator of transcription, depending upon whether it is complexed by transcriptional corepressor or coactivator proteins, respectively. In stark contrast to CSL-coactivator complexes, e. g. the transcriptionally active CSL-Notch-Mastermind ternary complex, the structure and function of CSL-corepressor complexes are poorly understood. The corepressor MINT (Msx2-interacting nuclear target protein) has been shown in vivo to antagonize Notch signaling and shown in vitro to biochemically interact with CSL; however, the molecular details of this interaction are only partially defined. Here, we provide a quantitative thermodynamic binding analysis of CSL-MINT complexes. Using isothermal titration calorimetry, we demonstrate that MINT forms a high affinity complex with CSL, and we also delineate the domains of MINT and CSL that are necessary and sufficient for complex formation. Moreover, we show in cultured cells that this region of MINT can inhibit Notch signaling in transcriptional reporter assays. Taken together, our results provide functional insights into how CSL is converted from a repressor to an activator of transcription.	[VanderWielen, Bradley D.; Yuan, Zhenyu; Kovall, Rhett A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Friedmann, David R.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University System of Ohio; University of Cincinnati; The Wistar Institute	Kovall, RA (corresponding author), 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	kovallra@ucmail.uc.edu			National Institutes of Health [CA120199]; Leukemia and Lymphoma Society; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA120199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120199. This work was also supported by a Leukemia and Lymphoma Society award (to R. A. K.) and a predoctoral fellowship from the American Heart Association (to D. R. F.).	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Bertagna A, 2008, BIOCHEM SOC T, V36, P157, DOI 10.1042/BST0360157; Bigas A, 2010, INT J DEV BIOL, V54, P1175, DOI 10.1387/ijdb.093049ab; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1997, DEVELOPMENT, V124, P4133; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; OKA C, 1995, DEVELOPMENT, V121, P3291; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Salat D, 2008, MOL CELL BIOL, V28, P3502, DOI 10.1128/MCB.01966-07; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Surendran K, 2010, DEV BIOL, V337, P386, DOI 10.1016/j.ydbio.2009.11.017; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wyman J, 1990, BINDING LINKAGE FUNC; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zweifel ME, 2001, BIOCHEMISTRY-US, V40, P14344, DOI 10.1021/bi011435h; Zweifel ME, 2001, BIOCHEMISTRY-US, V40, P14357, DOI 10.1021/bi011436+	56	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14892	14902		10.1074/jbc.M110.181156	http://dx.doi.org/10.1074/jbc.M110.181156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372128	Green Published, hybrid			2022-12-25	WOS:000289788300019
J	Zhou, WB; Bercury, K; Cummiskey, J; Luong, N; Lebin, J; Freed, CR				Zhou, Wenbo; Bercury, Kathryn; Cummiskey, Jessica; Luong, Nancy; Lebin, Jacob; Freed, Curt R.			Phenylbutyrate Up-regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-SYNUCLEIN; TRANSGENIC MOUSE MODEL; SODIUM PHENYLBUTYRATE; CHEMICAL CHAPERONES; LEWY BODIES; IN-VITRO; GENE; EXPRESSION; AGGREGATION; MUTATIONS	Parkinson disease is caused by the death of midbrain dopamine neurons from oxidative stress, abnormal protein aggregation, and genetic predisposition. In 2003, Bonifati et al. (23) found that a single amino acid mutation in the DJ-1 protein was associated with early-onset, autosomal recessive Parkinson disease (PARK7). The mutation L166P prevents dimerization that is essential for the antioxidant and gene regulatory activity of the DJ-1 protein. Because low levels of DJ-1 cause Parkinson, we reasoned that overexpression might stop the disease. We found that overexpression of DJ-1 improved tolerance to oxidative stress by selectively up-regulating the rate-limiting step in glutathione synthesis. When we imposed a different metabolic insult, A53T mutant alpha-synuclein, we found that DJ-1 turned on production of the chaperone protein Hsp-70 without affecting glutathione synthesis. After screening a number of small molecules, we have found that the histone deacetylase inhibitor phenylbutyrate increases DJ-1 expression by 300% in the N27 dopamine cell line and rescues cells from oxidative stress and mutant alpha-synuclein toxicity. In mice, phenylbutyrate treatment leads to a 260% increase in brain DJ-1 levels and protects dopamine neurons against 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP) toxicity. In a transgenic mouse model of diffuse Lewy body disease, long-term administration of phenylbutyrate reduces alpha-synuclein aggregation in brain and prevents age-related deterioration in motor and cognitive function. We conclude that drugs that up-regulate DJ-1 gene expression may slow the progression of Parkinson disease by moderating oxidative stress and protein aggregation.	[Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Med, Aurora, CO 80045 USA; [Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Pharmacol, Aurora, CO 80045 USA; [Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Neurol, Aurora, CO 80045 USA; [Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Neurosurg, Aurora, CO 80045 USA; [Zhou, Wenbo; Bercury, Kathryn; Freed, Curt R.] Univ Colorado Denver, Sch Med, Neurosci Program, Aurora, CO 80045 USA; [Cummiskey, Jessica; Freed, Curt R.] Univ Colorado Denver, Sch Med, Human Med Genet Program, Aurora, CO 80045 USA; [Luong, Nancy; Freed, Curt R.] Univ Colorado Denver, Sch Med, Program Biomed Sci, Aurora, CO 80045 USA; [Lebin, Jacob] Univ Colorado, Biochem Program, Boulder, CO 80309 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Freed, CR (corresponding author), Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Med, Mailstop C-237,12700 E 19th Ave, Aurora, CO 80045 USA.	curt.freed@ucdenver.edu			Parkinson Disease Foundation	Parkinson Disease Foundation	This work was supported by Charles and Joanne Ackerman, the Leopold Korn and Michael Korn Professorship in Parkinson Disease at the University of Colorado School of Medicine, and the Parkinson Disease Foundation.	Adams FS, 1996, NEUROCHEM RES, V21, P619, DOI 10.1007/BF02527762; Allam MF, 2005, NEUROL RES, V27, P206, DOI 10.1179/016164105X22057; Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Baba M, 1998, AM J PATHOL, V152, P879; Bonifati V, 2005, Minerva Med, V96, P175; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brahe C, 2005, EUR J HUM GENET, V13, P256, DOI 10.1038/sj.ejhg.5201320; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Clark LN, 2004, MOVEMENT DISORD, V19, P796, DOI 10.1002/mds.20131; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cudkowicz ME, 2009, AMYOTROPH LATERAL SC, V10, P99, DOI 10.1080/17482960802320487; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; Gardian G, 2004, NEUROMOL MED, V5, P235, DOI 10.1385/NMM:5:3:235; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hashimoto M, 2003, ANN NY ACAD SCI, V991, P171; Hogarth P, 2007, MOVEMENT DISORD, V22, P1962, DOI 10.1002/mds.21632; Huang Y, 2004, BRAIN RES REV, V46, P44, DOI 10.1016/j.brainresrev.2004.04.007; Ibanez P, 2003, NEUROLOGY, V61, P1429, DOI 10.1212/01.WNL.0000094121.48373.FD; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kaul S, 2005, MOL BRAIN RES, V139, P137, DOI 10.1016/j.molbrainres.2005.05.022; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Morris HR, 2005, ANN MED, V37, P86, DOI 10.1080/07853890510007269; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Ono K, 2009, PARKINSONISM RELAT D, V15, P649, DOI 10.1016/j.parkreldis.2009.03.002; Papp E, 2006, HANDB EXP PHARM, V172, P405; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Taira T, 2001, GENE, V263, P285, DOI 10.1016/S0378-1119(00)00590-4; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Tremolizzo L, 2005, AMYOTROPH LATERAL SC, V6, P185, DOI 10.1080/14660820510033614; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200; Zhou WB, 2002, BRAIN RES, V926, P42, DOI 10.1016/S0006-8993(01)03292-9; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200	58	113	118	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14941	14951		10.1074/jbc.M110.211029	http://dx.doi.org/10.1074/jbc.M110.211029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372141	Green Published, hybrid			2022-12-25	WOS:000289788300024
J	Gu, XB; Schroeder, SJ				Gu, Xiaobo; Schroeder, Susan J.			Different Sequences Show Similar Quaternary Interaction Stabilities in Prohead Viral RNA Self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PACKAGING MOTOR; PORTAL MOTOR; PRNA; MECHANISM; DELIVERY; BINDING; DIMERS; DOMAIN; CONSTRUCTION; REQUIREMENT	Prohead RNA (pRNA) is an essential component of the self-assembling phi 29 bacteriophage DNA packaging motor. Different related species of bacteriophage share only 12% similarity in pRNA sequences. The secondary structure for pRNA is conserved, however. In this study, we present evidence for self-assembly in different pRNA sequences and new measurements of the energetics for the quaternary interactions in pRNA dimers and trimers. The energetics for self-assembly in different pRNA sequences are similar despite very different sequences in the loop-loop interactions. The architecture surrounding the interlocking loops contributes to the stability of the pRNA quaternary interactions, and sequence variation outside the interlocking loops may counterbalance the changes in the loop sequences. Thus, the evolutionary divergence of pRNA sequences maintains not only conservation of function and secondary structure but also stabilities of quaternary interactions. The self-assembly of pRNA can be fine-tuned with variations in magnesium chloride, sodium chloride, temperature, and concentration. The ability to control pRNA self-assembly holds promise for the development of nanoparticle therapeutic applications for this biological molecule. The pRNA system is well suited for future studies to further understand the energetics of RNA tertiary and quaternary interactions, which can provide insight into larger biological assemblies such as viruses and biomolecular motors.	[Schroeder, Susan J.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Schroeder, SJ (corresponding author), Univ Oklahoma, Dept Chem & Biochem, 101 Stephenson Pkwy, Norman, OK 73019 USA.	susan.schroeder@ou.edu	gu, xiaobo/F-5817-2014	Schroeder, Susan/0000-0003-4755-2294	Oklahoma Center for the Advancement of Science and Technology [HR09-160]; American Chemical Society [090039]; National Science Foundation [0844913]	Oklahoma Center for the Advancement of Science and Technology; American Chemical Society(American Chemical Society); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Grant HR09-160 from the Oklahoma Center for the Advancement of Science and Technology and by Institutional Research Grant 090039 from the American Chemical Society (to the University of Oklahoma Cancer Center).; Supported by National Science Foundation CAREER Grant 0844913. To whom correspondence should be addressed: University of Oklahoma, 101 Stephenson Pkwy., Norman, OK 73019. Tel.: 405-325-3092; Fax: 405-325-6111; E-mail: susan.schroeder@ou.edu.	Afonin KA, 2008, J AM CHEM SOC, V130, P93, DOI 10.1021/ja071516m; Afonin KA, 2010, NAT NANOTECHNOL, V5, P676, DOI [10.1038/NNANO.2010.160, 10.1038/nnano.2010.160]; Atz R, 2007, J MOL BIOL, V369, P239, DOI 10.1016/j.jmb.2007.03.033; BAILEY S, 1990, J BIOL CHEM, V265, P22365; BORER PN, 1975, HDB BIOCH MOL BIOL N, V1, P589; Brookes E, 2006, PROG COLL POL SCI S, V131, P33, DOI 10.1007/2882_004; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chen CP, 1999, RNA, V5, P805, DOI 10.1017/S1355838299990350; Chen CP, 1997, J VIROL, V71, P495, DOI 10.1128/JVI.71.1.495-500.1997; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Fang Y, 2005, BIOCHEMISTRY-US, V44, P9348, DOI 10.1021/bi0475020; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; Garver K, 1997, RNA, V3, P1068; Grabow WW, 2011, NANO LETT, V11, P878, DOI 10.1021/nl104271s; GRIMES S, 1990, J MOL BIOL, V215, P559, DOI 10.1016/S0022-2836(05)80168-8; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Guo PX, 2005, J NANOSCI NANOTECHNO, V5, P1964, DOI 10.1166/jnn.2005.446; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Guo S, 2006, GENE THER, V13, P814, DOI 10.1038/sj.gt.3302716; Guo SC, 2005, HUM GENE THER, V16, P1097, DOI 10.1089/hum.2005.16.1097; Kitamura A, 2008, NUCLEIC ACIDS RES, V36, P839, DOI 10.1093/nar/gkm874; Ko SH, 2008, J AM CHEM SOC, V130, P17684, DOI 10.1021/ja806075d; Koyfman AY, 2005, J AM CHEM SOC, V127, P11886, DOI 10.1021/ja051144m; Lee TJ, 2009, ANN BIOMED ENG, V37, P2064, DOI 10.1007/s10439-009-9723-0; Liu HY, 2007, CANCER BIOL THER, V6, P697; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Nasalean L, 2006, NUCLEIC ACIDS RES, V34, P1381, DOI 10.1093/nar/gkl008; Nguyen MT, 2010, BIOCHEMISTRY-US, V49, P10574, DOI 10.1021/bi101521p; REID RJD, 1994, J BIOL CHEM, V269, P18656; REID RJD, 1994, J BIOL CHEM, V269, P9084; REID RJD, 1994, J BIOL CHEM, V269, P5157; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Robinson MA, 2006, NUCLEIC ACIDS RES, V34, P2698, DOI 10.1093/nar/gkl318; Severcan I, 2010, NAT CHEM, V2, P772, DOI [10.1038/nchem.733, 10.1038/NCHEM.733]; Severcan I, 2009, NANO LETT, V9, P1270, DOI 10.1021/nl900261h; Shu D, 2003, J NANOSCI NANOTECHNO, V3, P295, DOI 10.1166/jnn.2003.160; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Trottier M, 2000, RNA, V6, P1257, DOI 10.1017/S1355838200992501; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xiao F, 2008, NUCLEIC ACIDS RES, V36, P6620, DOI 10.1093/nar/gkn669; Yu J, 2010, J MOL BIOL, V400, P186, DOI 10.1016/j.jmb.2010.05.002; Zhang CL, 1997, RNA, V3, P315; Zhang F, 1998, MOL CELL, V2, P141, DOI 10.1016/S1097-2765(00)80123-9; Zhang HFM, 2009, ANTIVIR RES, V83, P307, DOI 10.1016/j.antiviral.2009.07.005; Zhao W, 2008, J MOL BIOL, V383, P520, DOI 10.1016/j.jmb.2008.08.056	50	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14419	14426		10.1074/jbc.M110.191064	http://dx.doi.org/10.1074/jbc.M110.191064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349846	Green Published, hybrid			2022-12-25	WOS:000289556200063
J	Kodama, T; Takehara, T; Hikita, H; Shimizu, S; Shigekawa, M; Li, W; Miyagi, T; Hosui, A; Tatsumi, T; Ishida, H; Kanto, T; Hiramatsu, N; Yin, XM; Hayashi, N				Kodama, Takahiro; Takehara, Tetsuo; Hikita, Hayato; Shimizu, Satoshi; Shigekawa, Minoru; Li, Wei; Miyagi, Takuya; Hosui, Atsushi; Tatsumi, Tomohide; Ishida, Hisashi; Kanto, Tatsuya; Hiramatsu, Naoki; Yin, Xiao-Ming; Hayashi, Norio			BH3-only Activator Proteins Bid and Bim Are Dispensable for Bak/Bax-dependent Thrombocyte Apoptosis Induced by Bcl-xL Deficiency MOLECULAR REQUISITES FOR THE MITOCHONDRIAL PATHWAY TO APOPTOSIS IN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; BH3 DOMAINS; CELL-DEATH; BAX; FAMILY; MICE; MCL-1; LIVER; LIFE; DISRUPTION	A pivotal step in the mitochondrial pathway of apoptosis is activation of Bak and Bax, although the molecular mechanism remains controversial. To examine whether mitochondrial apoptosis can be induced by just a lack of antiapoptotic Bcl-2-like proteins or requires direct activators of the BH3-only proteins including Bid and Bim, we studied the molecular requisites for platelet apoptosis induced by Bcl-xL deficiency. Severe thrombocytopenia induced by thrombocyte-specific Bcl-xL knock-out was fully rescued in a Bak and Bax double knock-out background but not with single knock-out of either one. In sharp contrast, deficiency of either Bid, Bim, or both did not alleviate thrombocytopenia in Bcl-xL knock-out mice. An in vitro study revealed that ABT-737, a Bad mimetic, induced platelet apoptosis in association with a conformational change of the amino terminus, translocation from the cytosol to mitochondria, and homo-oligomerization of Bax. ABT-737-induced Bax activation and apoptosis were also observed in Bid/Bim-deficient platelets. Human platelets, upon storage, underwent spontaneous apoptosis with a gradual decline of Bcl-xL expression despite a decrease in Bid and Bim expression. Apoptosis was attenuated in Bak/Bax-deficient or Bcl-xL-overexpressing platelets but not in Bid/Bim-deficient platelets upon storage. In conclusion, platelet lifespan is regulated by a fine balance between anti-and proapoptotic multidomain Bcl-2 family proteins. Despite residing in platelets, BH3-only activator proteins Bid and Bim are dispensable for Bax activation and mitochondrial apoptosis.	[Kodama, Takahiro; Takehara, Tetsuo; Hikita, Hayato; Shimizu, Satoshi; Shigekawa, Minoru; Li, Wei; Miyagi, Takuya; Hosui, Atsushi; Tatsumi, Tomohide; Ishida, Hisashi; Kanto, Tatsuya; Hiramatsu, Naoki] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yin, Xiao-Ming] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Hayashi, Norio] Kansai Rosai Hosp, Amagasaki, Hyogo 6608511, Japan	Osaka University; Indiana University System; Indiana University-Purdue University Indianapolis; Kansai Rosai Hospital	Takehara, T (corresponding author), Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp	Kodama, Takahiro/AAW-9605-2021; Hosui, Atsushi/AAC-1771-2020	Kodama, Takahiro/0000-0002-6250-1324; Hosui, Atsushi/0000-0003-0777-8045				Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; AULT KA, 1995, EXP HEMATOL, V23, P996; Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Chaiyarit S, 2009, ANAL BIOCHEM, V394, P249, DOI 10.1016/j.ab.2009.07.026; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; FEINSTEIN MB, 1975, J GEN PHYSIOL, V66, P561, DOI 10.1085/jgp.66.5.561; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Hikita H, 2009, HEPATOLOGY, V50, P1972, DOI 10.1002/hep.23207; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; HOLMSEN H, 1989, ANN MED, V21, P23, DOI 10.3109/07853898909149178; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kodama T, 2010, GASTROENTEROLOGY, V138, P2487, DOI 10.1053/j.gastro.2010.02.054; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li JZ, 2000, TRANSFUSION, V40, P1320, DOI 10.1046/j.1537-2995.2000.40111320.x; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Perrotta PL, 2003, TRANSFUSION, V43, P526, DOI 10.1046/j.1537-2995.2003.00349.x; Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424; Ross AJ, 1998, NAT GENET, V18, P251, DOI 10.1038/ng0398-251; Takehara T, 2003, CANCER RES, V63, P3054; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yamagata H, 2009, ONCOGENE, V28, P3563, DOI 10.1038/onc.2009.213; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081	44	68	71	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13905	13913		10.1074/jbc.M110.195370	http://dx.doi.org/10.1074/jbc.M110.195370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367852	hybrid, Green Published			2022-12-25	WOS:000289556200013
J	Kothandapani, A; Dangeti, VSMN; Brown, AR; Banze, LA; Wang, XH; Sobol, RW; Patrick, SM				Kothandapani, Anbarasi; Dangeti, Venkata Srinivas Mohan Nimai; Brown, Ashley R.; Banze, Lauren A.; Wang, Xiao-Hong; Sobol, Robert W.; Patrick, Steve M.			Novel Role of Base Excision Repair in Mediating Cisplatin Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINK; DNA-POLYMERASE-BETA; REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; CYTOSINE DEAMINATION; CARRIER LIGAND; ABASIC SITES; GPG ADDUCTS; DAMAGED DNA	Using isogenic mouse embryonic fibroblasts and human cancer cell lines, we show that cells defective in base excision repair (BER) display a cisplatin-specific resistant phenotype. This was accompanied by enhanced repair of cisplatin interstrand cross-links (ICLs) and ICL-induced DNA double strand breaks, but not intrastrand adducts. Cisplatin induces abasic sites with a reduced accumulation in uracil DNA glycosylase (UNG) null cells. We show that cytosines that flank the cisplatin ICLs undergo preferential oxidative deamination in vitro, and AP endonuclease 1 (APE1) can cleave the resulting ICL DNA substrate following removal of the flanking uracil. We also show that DNA polymerase beta has low fidelity at the cisplatin ICL site after APE1 incision. Down-regulating ERCC1-XPF in BER-deficient cells restored cisplatin sensitivity. Based on our results, we propose a novel model in which BER plays a positive role in maintaining cisplatin cytotoxicity by competing with the productive cisplatin ICL DNA repair pathways.	[Kothandapani, Anbarasi; Dangeti, Venkata Srinivas Mohan Nimai; Patrick, Steve M.] Univ Toledo, Dept Biochem & Canc Biol, Toledo, OH 43614 USA; [Sobol, Robert W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Brown, Ashley R.; Banze, Lauren A.; Wang, Xiao-Hong; Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Sobol, Robert W.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA	University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Patrick, SM (corresponding author), 3035 Arlington Ave, Toledo, OH 43614 USA.	Stephan.Patrick@utoledo.edu	Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563	National Institutes of Health [1R01-GM088249, CA132385, GM087798, CA148629]; American Cancer Society (ACS) [RSG-06-163-01-GMC]; NATIONAL CANCER INSTITUTE [R01CA148629, P20CA132385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088249, R43GM087798, R44GM087798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01-GM088249 (to S. M. P.) and CA132385, GM087798, and CA148629 (to R. W. S.). This study was also supported by grants from the American Cancer Society (ACS, RSG-06-163-01-GMC) (to S. M. P.).	Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Allan JM, 1998, CANCER RES, V58, P3965; Arora S, 2010, DNA REPAIR, V9, P745, DOI 10.1016/j.dnarep.2010.03.010; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; Boudsocq F, 2005, MOL PHARMACOL, V67, P1485, DOI 10.1124/mol.104.001776; BRABEC V, 1990, BIOPHYS CHEM, V35, P129, DOI 10.1016/0301-4622(90)80003-P; BRABEC V, 1993, BIOCHEMISTRY-US, V32, P11676, DOI 10.1021/bi00094a025; Carpenter M, 2006, NUCLEIC ACIDS RES, V34, P3762, DOI 10.1093/nar/gkl545; CHEN H, 1993, BIOCHEMISTRY-US, V32, P3535, DOI 10.1021/bi00065a003; Clingen PH, 2008, BIOCHEM PHARMACOL, V76, P19, DOI 10.1016/j.bcp.2008.03.025; Clingen PH, 2007, EXP CELL RES, V313, P753, DOI 10.1016/j.yexcr.2006.11.007; Coste F, 1999, NUCLEIC ACIDS RES, V27, P1837, DOI 10.1093/nar/27.8.1837; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; De Silva IU, 2002, NUCLEIC ACIDS RES, V30, P3848, DOI 10.1093/nar/gkf479; EASTMAN A, 1988, BIOCHEMISTRY-US, V27, P4730, DOI 10.1021/bi00413a022; Fagan PA, 1996, NUCLEIC ACIDS RES, V24, P1566, DOI 10.1093/nar/24.8.1566; FORTINI P, 1992, CARCINOGENESIS, V13, P87, DOI 10.1093/carcin/13.1.87; FREDERICO LA, 1993, BIOCHEMISTRY-US, V32, P6523, DOI 10.1021/bi00077a005; FROSINA G, 1994, BIOCHEM J, V304, P699, DOI 10.1042/bj3040699; Hlavin EM, 2010, BIOCHEMISTRY-US, V49, P3977, DOI 10.1021/bi902169q; KASPARKOVA J, 1995, BIOCHEMISTRY-US, V34, P12379, DOI 10.1021/bi00038a035; Kasparkova J, 2008, CHEM-EUR J, V14, P1330, DOI 10.1002/chem.200701352; KUMARESAN KR, 1992, BIOCHEMISTRY-US, V31, P6774, DOI 10.1021/bi00144a018; LIUZZI M, 1985, J BIOL CHEM, V260, P5252; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; Miyagawa K, 2008, CANCER SCI, V99, P187, DOI 10.1111/j.1349-7006.2007.00644.x; Mogi S, 2006, DNA REPAIR, V5, P731, DOI 10.1016/j.dnarep.2006.03.009; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Patrick SM, 2008, BIOCHEMISTRY-US, V47, P10188, DOI 10.1021/bi800460d; Prewett M, 2007, CLIN CANCER RES, V13, P7432, DOI 10.1158/1078-0432.CCR-07-1768; Raaphorst GP, 2002, INT J HYPERTHER, V18, P33, DOI 10.1080/02656730110072352; Raaphorst GP, 2001, ANTICANCER RES, V21, P2079; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Reardon JT, 1999, CANCER RES, V59, P3968; Satoh M, 2003, J PHARMACOL EXP THER, V305, P1183, DOI 10.1124/jpet.102.047522; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; TILBY MJ, 1991, CANCER RES, V51, P123; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Turchi JJ, 1997, BIOCHEMISTRY-US, V36, P7586, DOI 10.1021/bi963124q; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang D, 2009, LUNG CANCER, V66, P298, DOI 10.1016/j.lungcan.2009.02.019; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Wilson DM, 2010, TRENDS BIOCHEM SCI, V35, P247, DOI 10.1016/j.tibs.2010.01.003; Yan L, 2007, CLIN CANCER RES, V13, P1532, DOI 10.1158/1078-0432.CCR-06-1595	51	61	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14564	14574		10.1074/jbc.M111.225375	http://dx.doi.org/10.1074/jbc.M111.225375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357694	Green Published, hybrid			2022-12-25	WOS:000289556200076
J	Kulkarni, SD; Muralidharan, B; Panda, AC; Bakthavachalu, B; Vindu, A; Seshadri, V				Kulkarni, Shardul D.; Muralidharan, Bhavana; Panda, Amaresh C.; Bakthavachalu, Baskar; Vindu, Arya; Seshadri, Vasudevan			Glucose-stimulated Translation Regulation of Insulin by the 5 ' UTR-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST POLY(A)-BINDING PROTEIN; PROINSULIN MESSENGER-RNA; RAT PANCREATIC-ISLETS; DISULFIDE-ISOMERASE; 5'-UNTRANSLATED REGION; PROLYL 4-HYDROXYLASE; BETA-SUBUNIT; BIOSYNTHESIS; INITIATION; CELLS	Insulin is the key regulator of glucose homeostasis in mammals, and glucose-stimulated insulin biosynthesis is essential for maintaining glucose levels in a narrow range in mammals. Glucose specifically promotes the translation of insulin in pancreatic beta-islet, and the untranslated regions of insulin mRNA play a role in such regulation. Specific factors in the beta-islets bind to the insulin 5' UTR and regulate its translation. In the present study we identify protein-disulfide isomerase (PDI) as a key regulator of glucose-stimulated insulin biosynthesis. We show that both in vitro and in vivo PDI can specifically associate with the 5' UTR of insulin mRNA. Immunodepletion of PDI from the islet extract results in loss of glucose-stimulated translation indicating a critical role for PDI in insulin biosynthesis. Similarly, transient overexpression of PDI resulted in specific translation activation by glucose. We show that the RNA binding activity of PDI is mediated through PABP. PDI catalyzes the reduction of the PABP disulfide bond resulting in specific binding of PABP to the insulin 5' UTR. We also show that glucose stimulation of the islets results in activation of a specific kinase that can phosphorylate PDI. These findings identify PDI and PABP as important players in glucose homeostasis.	[Kulkarni, Shardul D.; Muralidharan, Bhavana; Panda, Amaresh C.; Bakthavachalu, Baskar; Vindu, Arya; Seshadri, Vasudevan] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Seshadri, V (corresponding author), Natl Ctr Cell Sci, Pune 411007, Maharashtra, India.	seshadriv@nccs.res.in	Kulkarni, Shardul/AAD-2205-2020; Vindu, Arya/GQP-2981-2022; Panda, Amaresh C./H-5459-2019; Kulkarni, S/AAO-8388-2020	Kulkarni, Shardul/0000-0003-3814-4432; Panda, Amaresh C./0000-0003-3189-8995; Vindu, Arya/0000-0001-8711-2037; Bakthavachalu, Baskar/0000-0002-5114-3429; Muralidharan, Bhavana/0000-0003-1184-0833	Department of Biotechnology, India [BT/PR5813/BRB/10/411/2005]; National Centre for Cell Science, India; Council of Scientific and Industrial Research, India; Indian Council of Medical Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Centre for Cell Science, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported in part by Department of Biotechnology, India, Grant BT/PR5813/BRB/10/411/2005 and a intramural grant from the National Centre for Cell Science, India (to V. S.).; Supported by fellowships from Council of Scientific and Industrial Research, India.; Supported by a fellowship from Indian Council of Medical Research, India.	Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; CAMPBELL IL, 1982, CLIN SCI, V62, P449, DOI 10.1042/cs0620449; CHEN K, 1992, BLOOD, V79, P2226; Coppari S, 2002, J CELL BIOCHEM, V85, P325, DOI 10.1002/jcb.10137; DANON A, 1994, EMBO J, V13, P2227, DOI 10.1002/j.1460-2075.1994.tb06500.x; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Fong CL, 2000, J BIOL CHEM, V275, P8275, DOI 10.1074/jbc.275.12.8275; Gerner C, 1999, J CELL BIOCHEM, V74, P145, DOI 10.1002/(SICI)1097-4644(19990801)74:2<145::AID-JCB1>3.0.CO;2-#; Greenman IC, 2005, BIOCHEM J, V391, P291, DOI 10.1042/BJ20050468; Hernandez-Sanchez C, 2003, EMBO J, V22, P5582, DOI 10.1093/emboj/cdg515; Hotchkiss KA, 1998, BBA-PROTEIN STRUCT M, V1388, P478, DOI 10.1016/S0167-4838(98)00211-8; ITOH N, 1978, FEBS LETT, V93, P343, DOI 10.1016/0014-5793(78)81136-3; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; JAHR H, 1980, EUR J BIOCHEM, V110, P499, DOI 10.1111/j.1432-1033.1980.tb04892.x; Kim J, 2002, PLANT CELL PHYSIOL, V43, P1238, DOI 10.1093/pcp/pcf129; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; KNAACK D, 1994, DIABETES, V43, P1413, DOI 10.2337/diabetes.43.12.1413; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Leibiger B, 2000, J BIOL CHEM, V275, P30153, DOI 10.1074/jbc.M005216200; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; Muralidharan B, 2007, FEBS LETT, V581, P4103, DOI 10.1016/j.febslet.2007.07.050; PERMUTT MA, 1975, FED PROC, V34, P1549; PERMUTT MA, 1974, J BIOL CHEM, V249, P2738; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Shalev A, 2002, ENDOCRINOLOGY, V143, P2541, DOI 10.1210/en.143.7.2541; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; VanderWaal RP, 2002, J CELL BIOCHEM, V85, P689, DOI 10.1002/jcb.10169; WELSH M, 1986, BIOCHEM J, V235, P459, DOI 10.1042/bj2350459; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Wicksteed B, 2007, CELL METAB, V5, P221, DOI 10.1016/j.cmet.2007.02.007; WROBLEWSKI VJ, 1992, DIABETES, V41, P539, DOI 10.2337/diabetes.41.4.539; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200	41	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14146	14156		10.1074/jbc.M110.190553	http://dx.doi.org/10.1074/jbc.M110.190553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357685	Green Published, hybrid			2022-12-25	WOS:000289556200038
J	Liu, H; Aldrich, RW				Liu, He; Aldrich, Richard W.			Tissue-specific N Terminus of the HCN4 Channel Affects Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; RABBIT SINOATRIAL NODE; PACEMAKER CHANNELS; CATION CHANNELS; INTERSUBUNIT INTERACTION; SOCIAL SIGNAL; HUMAN HEART; CURRENT IF; MODULATION; CAMP	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are expressed in the brain and heart and are essential for physiological functions in cardiac and nervous systems. We identified two Hcn4 mRNA variants with different transcription start sites and differential expression patterns in mouse brain and heart. Only one mRNA variant was detected in the brain, whereas both variants were found in the heart. Patch clamp recordings of these two variants in HEK293H cells revealed different electrophysiological properties in channel activation. Mutagenesis studies showed that three positively charged amino acids (Arg-9, Lys-10, and Lys-22) contribute to the functional difference. Our results demonstrate that HCN4 channels are expressed in different patterns in mouse brain and heart and that the N terminus is important for HCN4 channel activation.	[Liu, He; Aldrich, Richard W.] Univ Texas Austin, Neurobiol Sect, Ctr Learning & Memory, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Aldrich, RW (corresponding author), Univ Texas Austin, Neurobiol Sect, Ctr Learning & Memory, 1 Univ Stn,C0920, Austin, TX 78712 USA.	raldrich@mail.utexas.edu						Accili EA, 1997, J PHYSIOL-LONDON, V500, P643, DOI 10.1113/jphysiol.1997.sp022049; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; Ishii TM, 2007, BIOCHEM BIOPH RES CO, V359, P592, DOI 10.1016/j.bbrc.2007.05.127; Ishii TM, 2001, J PHYSIOL-LONDON, V537, P93, DOI 10.1111/j.1469-7793.2001.0093k.x; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Lin HX, 2009, CELL PHYSIOL BIOCHEM, V23, P317, DOI 10.1159/000218178; Liu H, 2008, J NEUROSCI, V28, P9173, DOI 10.1523/JNEUROSCI.2783-08.2008; Liu H, 2007, DEV NEUROBIOL, V67, P1289, DOI 10.1002/dneu.20404; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; Shi WM, 1999, CIRC RES, V85, pE1; Stillitano F, 2008, J MOL CELL CARDIOL, V45, P289, DOI 10.1016/j.yjmcc.2008.04.013; Todorovic J, 2010, P NATL ACAD SCI USA, V107, P7987, DOI 10.1073/pnas.1001845107; Tran N, 2002, J BIOL CHEM, V277, P43588, DOI 10.1074/jbc.M208477200; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Wicks NL, 2009, PFLUG ARCH EUR J PHY, V458, P877, DOI 10.1007/s00424-009-0687-6; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zakon HH, 2008, J EXP BIOL, V211, P1814, DOI 10.1242/jeb.015982; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zheng J, 2003, J NEUROSCI, V23, P8167	33	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14209	14214		10.1074/jbc.M110.215640	http://dx.doi.org/10.1074/jbc.M110.215640			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372143	hybrid, Green Published			2022-12-25	WOS:000289556200044
J	Shi, JH; Qian, W; Yin, XM; Iqbal, K; Grundke-Iqbal, I; Gu, XS; Ding, F; Gong, CX; Liu, F				Shi, Jianhua; Qian, Wei; Yin, Xiaomin; Iqbal, Khalid; Grundke-Iqbal, Inge; Gu, Xiaosong; Ding, Fei; Gong, Cheng-Xin; Liu, Fei			Cyclic AMP-dependent Protein Kinase Regulates the Alternative Splicing of Tau Exon 10 A MECHANISM INVOLVED IN TAU PATHOLOGY OF ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SR PROTEINS; NUCLEAR IMPORT; PICKS-DISEASE; FRONTOTEMPORAL DEMENTIA; SPORADIC TAUOPATHIES; CATALYTIC SUBUNIT; FACTOR ASF/SF2; MOUSE-BRAIN; PHOSPHORYLATION	Hyperphosphorylation and deposition of tau into neurofibrillary tangles is a hallmark of Alzheimer disease (AD). Alternative splicing of tau exon 10 generates tau isoforms containing three or four microtubule binding repeats (3R-tau and 4R-tau), which are equally expressed in adult human brain. Dysregulation of exon 10 causes neurofibrillary degeneration. Here, we report that cyclic AMP-dependent protein kinase, PKA, phosphorylates splicing factor SRSF1, modulates its binding to tau pre-mRNA, and promotes tau exon 10 inclusion in cultured cells and in vivo in rat brain. PKA-C alpha, but not PKA-C alpha, interacts with SRSF1 and elevates SRSF1-mediated tau exon 10 inclusion. In AD brain, the decreased level of PKA-C alpha correlates with the increased level of 3R-tau. These findings suggest that a down-regulation of PKA dysregulates the alternative splicing of tau exon 10 and contributes to neurofibrillary degeneration in AD by causing an imbalance in 3R-tau and 4R-tau expression.	[Liu, Fei] Nantong Univ, Sch Med, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Shi, Jianhua; Qian, Wei; Yin, Xiaomin] Nantong Univ, Sch Med, Dept Biochem, Nantong 226001, Jiangsu, Peoples R China; [Iqbal, Khalid; Grundke-Iqbal, Inge; Gong, Cheng-Xin; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA	Nantong University; Nantong University; Institute for Basic Research in Developmental Disabilities	Liu, F (corresponding author), Nantong Univ, Sch Med, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.	feiliu63@hotmail.com	Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X	National Institutes of Health [AG027429, AG019158]; National Natural Science Foundation of China [30973143, 81030059, 30801202]; Natural Science Foundation of Jiangsu Province, China [BK2009159]; U.S. Alzheimer's Association [NIRG-08-91126]; NIA, National Institutes of Health [P30 AG19610]; NATIONAL INSTITUTE ON AGING [P30AG019610, R01AG019158, R01AG027429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); U.S. Alzheimer's Association(Alzheimer's Association); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG027429 (to C.-X. G.) and AG019158 (to K. I.). This work was supported by National Natural Science Foundation of China Grants 30973143 and 81030059 (to F. L.) and 30801202 (to J. S.), Natural Science Foundation of Jiangsu Province, China, Grant BK2009159 (to F. L.), and U.S. Alzheimer's Association Grant NIRG-08-91126 (to F. L.).; We thank M. Marlow for editorial suggestions and J. Murphy for secretarial assistance. The Brain Donation Program is supported in part by NIA, National Institutes of Health Grant P30 AG19610 (to the Arizona Alzheimer's Disease Core Center).	Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Boutajangout A, 2004, FEBS LETT, V576, P183, DOI 10.1016/j.febslet.2004.09.011; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chambers CB, 1999, ANN NEUROL, V46, P325, DOI 10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Connell JW, 2005, MOL BRAIN RES, V137, P104, DOI 10.1016/j.molbrainres.2005.02.014; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; DEGARCINI EM, 1986, BIOCHEM BIOPH RES CO, V141, P790, DOI 10.1016/S0006-291X(86)80242-X; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; FOSS KB, 1992, CYTOGENET CELL GENET, V60, P22, DOI 10.1159/000133286; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Graveley BR, 2004, MOL CELL, V13, P302, DOI 10.1016/S1097-2765(04)00055-3; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lace G, 2009, BRAIN, V132, P1324, DOI 10.1093/brain/awp059; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; Li HZ, 2009, J BIOL CHEM, V284, P16191, DOI 10.1074/jbc.M900393200; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Neumann M, 2001, ANN NEUROL, V50, P503, DOI 10.1002/ana.1223; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Pickering-Brown S, 2000, ANN NEUROL, V48, P859, DOI 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang JN, 2004, J NEUROCHEM, V88, P1078, DOI 10.1046/j.1471-4159.2003.02232.x; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Yasojima K, 1999, BRAIN RES, V831, P301, DOI 10.1016/S0006-8993(99)01486-9; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x	61	67	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14639	14648		10.1074/jbc.M110.204453	http://dx.doi.org/10.1074/jbc.M110.204453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367856	Green Published, hybrid			2022-12-25	WOS:000289556200083
J	Zerrad, L; Merli, A; Schroder, GF; Varga, A; Graczer, E; Pernot, P; Round, A; Vas, M; Bowler, MW				Zerrad, Louiza; Merli, Angelo; Schroeder, Gunnar F.; Varga, Andrea; Graczer, Eva; Pernot, Petra; Round, Adam; Vas, Maria; Bowler, Matthew W.			A Spring-loaded Release Mechanism Regulates Domain Movement and Catalysis in Phosphoglycerate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION STRUCTURE; 3-PHOSPHOGLYCERATE KINASE; COMPLEX; NUCLEOTIDE; REFINEMENT; SCATTERING; MOTIONS; BINDING; CLOSURE; HINGE	Phosphoglycerate kinase (PGK) is the enzyme responsible for the first ATP-generating step of glycolysis and has been implicated extensively in oncogenesis and its development. Solution small angle x-ray scattering (SAXS) data, in combination with crystal structures of the enzyme in complex with substrate and product analogues, reveal a new conformation for the resting state of the enzyme and demonstrate the role of substrate binding in the preparation of the enzyme for domain closure. Comparison of the x-ray scattering curves of the enzyme in different states with crystal structures has allowed the complete reaction cycle to be resolved both structurally and temporally. The enzyme appears to spend most of its time in a fully open conformation with short periods of closure and catalysis, thereby allowing the rapid diffusion of substrates and products in and out of the binding sites. Analysis of the open apoenzyme structure, defined through deformable elastic network refinement against the SAXS data, suggests that interactions in a mostly buried hydrophobic region may favor the open conformation. This patch is exposed on domain closure, making the open conformation more thermodynamically stable. Ionic interactions act to maintain the closed conformation to allow catalysis. The short time PGK spends in the closed conformation and its strong tendency to rest in an open conformation imply a spring-loaded release mechanism to regulate domain movement, catalysis, and efficient product release.	[Zerrad, Louiza; Pernot, Petra; Bowler, Matthew W.] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Merli, Angelo] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Struct Biol & Biophys, D-52425 Julich, Germany; [Varga, Andrea; Graczer, Eva; Vas, Maria] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1518 Budapest, Hungary; [Round, Adam] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France	European Synchrotron Radiation Facility (ESRF); University of Parma; Helmholtz Association; Research Center Julich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; European Molecular Biology Laboratory (EMBL)	Bowler, MW (corresponding author), European Synchrotron Radiat Facil, Struct Biol Grp, 6 Rue Jules Horowitz, F-38043 Grenoble, France.	bowler@esrf.fr	Bowler, Matthew/B-5722-2011; Graczer, Eva/N-1053-2016; Bowler, Matthew/I-7461-2019; Schröder, Gunnar F/H-5261-2013	Bowler, Matthew/0000-0003-0465-3351; Bowler, Matthew/0000-0003-0465-3351; Schröder, Gunnar F/0000-0003-1803-5431; Round, Adam/0000-0002-0723-8228	Hungarian National Research Grant [77978]	Hungarian National Research Grant	This work was supported in part by Hungarian National Research Grant 77978.	Auerbach G, 1997, STRUCTURE, V5, P1475, DOI 10.1016/S0969-2126(97)00297-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balog E, 2007, BIOPHYS J, V92, P1709, DOI 10.1529/biophysj.106.093195; BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; Bernstein BE, 1997, NATURE, V385, P275, DOI 10.1038/385275a0; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2010, NEW J CHEM, V34, P784, DOI 10.1039/b9nj00718k; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; DAVIES GJ, 1994, ACTA CRYSTALLOGR D, V50, P202, DOI 10.1107/S0907444993011138; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flachner B, 2005, BIOCHEMISTRY-US, V44, P16853, DOI 10.1021/bi051726g; Flachner B, 2004, BIOCHEMISTRY-US, V43, P3436, DOI 10.1021/bi035022n; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gondeau C, 2008, NUCLEIC ACIDS RES, V36, P3620, DOI 10.1093/nar/gkn212; HARLOS K, 1992, PROTEINS, V12, P133, DOI 10.1002/prot.340120207; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kovari Z, 2002, BIOCHEMISTRY-US, V41, P8796, DOI 10.1021/bi020210j; Krishnan P, 2003, J BIOL CHEM, V278, P36726, DOI 10.1074/jbc.M307052200; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Lay AJ, 2002, J BIOL CHEM, V277, P9062, DOI 10.1074/jbc.M111531200; LESLIE AG, 1992, JOINT CCP4 EACMB NEW, V26; Mathe C, 2006, ANTIVIR RES, V71, P276, DOI 10.1016/j.antiviral.2006.04.017; May A, 1996, PROTEINS, V24, P292; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Palmai Z, 2009, PROTEINS, V77, P319, DOI 10.1002/prot.22437; Pernot P, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012009; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Sanchez-Weatherby J, 2009, ACTA CRYSTALLOGR D, V65, P1237, DOI 10.1107/S0907444909037822; Sawyer GM, 2008, PROTEINS, V71, P1134, DOI 10.1002/prot.21801; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Szabo J, 2008, BIOCHEMISTRY-US, V47, P6735, DOI 10.1021/bi800411w; Szilagyi AN, 2001, J MOL BIOL, V306, P499, DOI 10.1006/jmbi.2000.4294; Varga A, 2005, FEBS J, V272, P1867, DOI 10.1111/j.1742-4658.2005.04618.x; Varga A, 2006, FEBS LETT, V580, P2698, DOI 10.1016/j.febslet.2006.04.024; Varga A, 2009, FEBS LETT, V583, P3660, DOI 10.1016/j.febslet.2009.10.048	44	45	49	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14040	14048		10.1074/jbc.M110.206813	http://dx.doi.org/10.1074/jbc.M110.206813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349853	Green Published, hybrid			2022-12-25	WOS:000289556200026
J	Zhang, C; Chen, XH; Zhang, X; Gao, L; Kong, PY; Peng, XG; Liang, X; Gao, L; Gong, Y; Wang, QY				Zhang, Cheng; Chen, Xing-Hua; Zhang, Xi; Gao, Lei; Kong, Pei-Yan; Peng, Xian-gui; Liang, Xue; Gao, Li; Gong, Yi; Wang, Qing-Yu			Human Umbilical Cord Blood-derived Stromal Cells, a New Resource in the Suppression of Acute Graft-versus-host Disease in Haploidentical Stem Cell Transplantation in Sublethally Irradiated Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-TRANSPLANTATION; NATURAL-KILLER-CELLS; NK CELLS; HEMATOLOGIC MALIGNANCIES; ACUTE GVHD; IN-VITRO; PROLIFERATION; PROPHYLAXIS; RESISTANT; GLOBULIN	Human umbilical cord blood-derived stromal cells (hUCBDSCs), a novel population isolated from CD34(+) cells by our laboratory, exerted an immunosuppressive effect on xenogenic T cells. This study aimed to investigate whether hUCBDSCs play a critical role in the suppression of acute graft-versus-host disease (aGVHD). The hUCBDSCs were co-cultured with splenocytes (SPCs) of donor C57BL/6 mice. The aGVHD in the recipient (B6 x BALB/c) F1 mice was induced by the infusion of bone marrow cells and SPCs from donor mice following sublethal irradiation. The shift in vivo for hUCBDSCs was detected. The proliferation and cell cycle of SPCs were tested by cell counting kit-8 and flow cytometry, respectively. The expression of CD49b natural killer (NK) cells and CD3 T cells was detected by flow cytometry in co-culture and post-transplantation. IL-4, and IFN-gamma were detected by ELISA in the serum of co-culture and post-transplantation. The survival tune, body weight, clinical score, and histopathological score were recorded for mice post-transplantation. The hUCBDSCs promoted the proliferation of SPCs and significantly increased the ratio of the S and G(2)/M phase (p < 0.05). The hUCBDSCs significantly increased the expression of CD49b NK cells and IL-4 protein and decreased the expression of CD3 T cells and IFN-gamma protein both in vitro and in vivo. The survival time of mice with co-transplantation of hUCBDSCs was significantly prolonged, and decreased clinical and histopathological scores were also observed. The hUCBDSCs were continually detected in the target organs of GVHD. These results suggest that hUCBDSCs possess the capability of suppressing aGVHD, possibly via their influence on CD3 T cells, NK cells, and cytokines.	[Zhang, Cheng; Chen, Xing-Hua; Zhang, Xi; Gao, Lei; Kong, Pei-Yan; Peng, Xian-gui; Liang, Xue; Gao, Li; Gong, Yi; Wang, Qing-Yu] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing 400037, Peoples R China	Army Medical University	Zhang, C (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing 400037, Peoples R China.	chzhang2003@tom.com; xhchen888@yahoo.com.cn			National Natural Science Foundation [30971109]; Chong Qing Chongqing Science and Technology Commission [2009BA5011]; Innovation Foundation for Young Scientists of Third Military Medical University [2009D226]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chong Qing Chongqing Science and Technology Commission; Innovation Foundation for Young Scientists of Third Military Medical University	This work was supported by National Natural Science Foundation Grant 30971109, Natural Science Foundation Project of Chong Qing Chongqing Science and Technology Commission 2009BA5011, and the Innovation Foundation for Young Scientists of Third Military Medical University Grant 2009D226.	Alyea EP, 2008, BEST PRACT RES CL HA, V21, P239, DOI 10.1016/j.beha.2008.02.012; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Barrett AJ, 2008, BEST PRACT RES CL HA, V21, P165, DOI 10.1016/j.beha.2008.02.004; Boissel L, 2008, BIOL BLOOD MARROW TR, V14, P1031, DOI 10.1016/j.bbmt.2008.06.016; Cao DL, 2009, TRANSPL IMMUNOL, V20, P243, DOI 10.1016/j.trim.2008.10.011; Chen XH, 2009, BLOOD CELL MOL DIS, V43, P98, DOI 10.1016/j.bcmd.2009.02.005; Chen XH, 2009, BIOL BLOOD MARROW TR, V15, P266, DOI 10.1016/j.bbmt.2008.11.029; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Gao L, 2006, BLOOD CELL MOL DIS, V36, P322, DOI 10.1016/j.bcmd.2005.12.036; Grass JA, 1999, BLOOD, V93, P3140; Hao L, 2009, CROAT MED J, V50, P351, DOI 10.3325/cmj.2009.50.351; Ho VT, 2008, BEST PRACT RES CL HA, V21, P223, DOI 10.1016/j.beha.2008.02.009; Itakura S, 2007, AM J TRANSPLANT, V7, P336, DOI 10.1111/j.1600-6143.2006.01643.x; Koh LP, 2008, BLOOD CELL MOL DIS, V40, P20, DOI 10.1016/j.bcmd.2007.06.017; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Min CK, 2007, BONE MARROW TRANSPL, V39, P637, DOI 10.1038/sj.bmt.1705644; Nash RA, 2000, BLOOD, V96, P2062; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Ruggeri L, 2008, BLOOD CELL MOL DIS, V40, P84, DOI 10.1016/j.bcmd.2007.06.029; Ruggeri L, 2006, SEMIN CANCER BIOL, V16, P404, DOI 10.1016/j.semcancer.2006.07.007; Savani BN, 2007, LEUKEMIA, V21, P2145, DOI 10.1038/sj.leu.2404892; Schulze A, 2008, EXP HEMATOL, V36, P378, DOI 10.1016/j.exphem.2007.12.006; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Tanaka J, 2009, HUM IMMUNOL, V70, P701, DOI 10.1016/j.humimm.2009.06.002; Tisato V, 2007, LEUKEMIA, V21, P1992, DOI 10.1038/sj.leu.2404847; Toubai T, 2008, BEST PRACT RES CL HA, V21, P101, DOI 10.1016/j.beha.2008.02.005; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Zeiser R, 2004, ANN HEMATOL, V83, P551, DOI 10.1007/s00277-004-0890-7; Zhang C, 2010, TRANSFUSION MED, V20, P169, DOI 10.1111/j.1365-3148.2010.00990.x; Zhang Cheng, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P1437	33	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13723	13732		10.1074/jbc.M110.144691	http://dx.doi.org/10.1074/jbc.M110.144691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349838	Green Published, hybrid			2022-12-25	WOS:000289282200090
J	Brito, JC; Martinez-Freiria, F; Sierra, P; Sillero, N; Tarroso, P				Brito, Jose C.; Martinez-Freiria, Fernando; Sierra, Pablo; Sillero, Neftali; Tarroso, Pedro			Crocodiles in the Sahara Desert: An Update of Distribution, Habitats and Population Status for Conservation Planning in Mauritania	PLOS ONE			English	Article							CROCODYLUS-NILOTICUS; CLIMATE; QUATERNARY; MODELS; NORTH; FLORA	Background: Relict populations of Crocodylus niloticus persist in Chad, Egypt and Mauritania. Although crocodiles were widespread throughout the Sahara until the early 20(th) century, increased aridity combined with human persecution led to local extinction. Knowledge on distribution, occupied habitats, population size and prey availability is scarce in most populations. This study evaluates the status of Saharan crocodiles and provides new data for Mauritania to assist conservation planning. Methodology/Principal Findings: A series of surveys in Mauritania detected crocodile presence in 78 localities dispersed across 10 river basins and most tended to be isolated within river basins. Permanent gueltas and seasonal tamourts were the most common occupied habitats. Crocodile encounters ranged from one to more than 20 individuals, but in most localities less than five crocodiles were observed. Larger numbers were observed after the rainy season and during night sampling. Crocodiles were found dead in between water points along dry river-beds suggesting the occurrence of dispersal. Conclusion/Significance: Research priorities in Chad and Egypt should focus on quantifying population size and pressures exerted on habitats. The present study increased in by 35% the number of known crocodile localities in Mauritania. Gueltas are crucial for the persistence of mountain populations. Oscillations in water availability throughout the year and the small dimensions of gueltas affect biological traits, including activity and body size. Studies are needed to understand adaptation traits of desert populations. Molecular analyses are needed to quantify genetic variability, population sub-structuring and effective population size, and detect the occurrence of gene flow. Monitoring is needed to detect demographical and genetical trends in completely isolated populations. Crocodiles are apparently vulnerable during dispersal events. Awareness campaigns focusing on the vulnerability and relict value of crocodiles should be implemented. Classification of Mauritanian mountains as protected areas should be prioritised.	[Brito, Jose C.; Martinez-Freiria, Fernando; Tarroso, Pedro] Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Inst Ciencias Agr Vaira, Vairao, Portugal; [Sillero, Neftali] Univ Porto, CICGE, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Brito, JC (corresponding author), Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Inst Ciencias Agr Vaira, Vairao, Portugal.	jcbrito@mail.icav.up.pt	Brito, José C./A-7831-2010; Tarroso, Pedro/I-3023-2012; Sillero, Neftali/C-1803-2008; Martínez-Freiría, Fernando/L-7075-2013	Brito, José C./0000-0001-5444-8132; Tarroso, Pedro/0000-0002-2694-1170; Sillero, Neftali/0000-0002-3490-3780; Martínez-Freiría, Fernando/0000-0003-2311-8960	National Geographic Society [8412-08]; Fundacao para a Ciencia e Tecnologia [PTDC/BIA-BEC/099934/2008]	National Geographic Society(National Geographic Society); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported in part by the National Geographic Society (8412-08) and by the Fundacao para a Ciencia e Tecnologia (PTDC/BIA-BEC/099934/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL F, 1928, B COMITE ETUDES HIST, V21, P346; Anyamba A, 2005, J ARID ENVIRON, V63, P596, DOI 10.1016/j.jaridenv.2005.03.007; Baha El Din S., 2006, GUIDE REPTILES AMPHI; Behra O., 1994, CROCODILE SPECIALIST, V13, P4; BERNEZAT JL, 2002, IMMIDIR TASSILI OUBL; Bishop JM, 2009, BIOL CONSERV, V142, P2335, DOI 10.1016/j.biocon.2009.05.016; Bons J, 1996, ANFIBIOS REPTILES MA; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; BRITO JC, 2005, FROGLOG, V71, P3; Brito JC, 2010, MAMMALIA, V74, P449, DOI 10.1515/MAMM.2010.055; Brooks N, 2004, DROUGHT AFRICAN SAHE; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; CLARK JD, 1971, GEOGR J, V137, P455; Cooper A, 2006, J ARID ENVIRON, V67, P116, DOI 10.1016/j.jaridenv.2006.02.003; de Smet K, 1998, HYDROBIOLOGIA, V391, P81, DOI 10.1023/A:1003592123079; DEODATUS F, 2004, CROCODILE SPECIALIST, V23, P5; Drake NA, 2008, PALAEOGEOGR PALAEOCL, V263, P131, DOI 10.1016/j.palaeo.2008.02.005; Dumont H.J., 1982, Palaeoecology of Africa and the Surrounding Islands, V14, P1; ESRI, 2006, ARCMAP 9 2; Fabre J., 2005, TERVUREN AFRICAN GEO, V108; FUCHS G, 1989, AFR ARCHAEOL REV, V7, P127; Fuchs K. H., 1974, STUTTGARTER BEITRA A, V266, P1; Gautier EF, 1926, GEOGR REV, V16, P378, DOI 10.2307/208708; Geniez P, 2004, AMPHIBIANS REPTILES; *GLC, 2003, GLOB LAND COV YEAR 2; GOTELLI NJ, 1991, AM NAT, V138, P768, DOI 10.1086/285249; Hancock GR, 2006, EARTH SURF PROC LAND, V31, P1394, DOI 10.1002/esp.1335; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holl AFC, 2009, CR GEOSCI, V341, P703, DOI 10.1016/j.crte.2009.04.005; Holmes JA, 2008, SCIENCE, V320, P752, DOI 10.1126/science.1158105; HUBERT H, 1920, B COMITE ETUDES HIST, V26, P401; JOLEAUD L, 1933, B SOC ZOOLOGIQUE FRA, V58, P397; KIRSCHJUNG KP, 2007, CONSERVATION UTILISA, P109; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Lacaux JP, 2007, REMOTE SENS ENVIRON, V106, P66, DOI 10.1016/j.rse.2006.07.012; Lavauden L., 1926, VERTEBRES SAHARA; Le Houerou HN, 1997, J ARID ENVIRON, V37, P619, DOI 10.1006/jare.1997.0315; LEBERRE M, 1989, FAUNE SAHARA AMPHIBI; Leblanc MJ, 2006, PALAEOGEOGR PALAEOCL, V230, P230, DOI 10.1016/j.palaeo.2005.07.016; LLUCH P, 2006, CROCODILES, P104; Lluch Pascal, 2004, Bulletin de la Societe Herpetologique de France, V111-112, P5; MCINTOSH SK, 1986, J AFR HIST, V27, P413, DOI 10.1017/S0021853700023252; Monod T., 1964, Bull Inst fr Afr noire, V26A, P1393; Monod T., 1937, MEHAREES EXPLORATION; MONOD T, 1950, MEMOIRES I FONDAMENT, V8, P1; MONTEIL V, 1951, NOTES DOCUMENTS I HA, V8; Munch Z, 2007, HYDROGEOL J, V15, P19, DOI 10.1007/s10040-006-0125-1; MUNIER P, 1952, ETUDES MAURITANIENNE, V3, P1; *NAT RES COUNC, 1981, ENV DEGR MAUR BOARD; NICKEL H, 2003, OKOLOGISCHE UNTERSUC, P89; Padial J. M., 2006, Graellsia, V62, P159; PADIAL JM, 2011, AMPHIBIAN CONSERVATI; Paeth H, 2007, CLIMATIC CHANGE, V83, P401, DOI 10.1007/s10584-006-9235-y; Petit-Maire N, 1983, AFR ARCHAEOL REV, V1, P105; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; QUEZEL P, 1978, ANN MO BOT GARD, V65, P479, DOI 10.2307/2398860; ROBERTY G, 1958, B IFAN, V20, P869; ROGNON P, 1967, ANN ASSOC AM GEOGR, V57, P115, DOI 10.1111/j.1467-8306.1967.tb00594.x; *SAH CONS FUND, 2007, SANDSCRIPT, V2, P4; SANDFORD KS, 1960, GEOGR J, V126, P27; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002995; SEURAT LG, 1925, B SOC HIST NATURELLE, V16, P153; Shine T, 2001, ORYX, V35, P260, DOI 10.1046/j.1365-3008.2001.00187.x; Shirley M.H., 2008, CROCODILE SPECIALIST, V27, P17; STAUDINGER P, 1928, SITZ BER GES NATURF, V4, P141; TELLERI JL, 2008, LAC GABOU RESEAU HYD; Telleria JL, 2008, ORYX, V42, P292, DOI 10.1017/S0030605308007850; Thesiger W, 1939, GEOGR J, V94, P433, DOI 10.2307/1787293; Trape S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004400; Trutnau L., 2006, CROCODILIANS THEIR N; TUBIANA J, 1995, COURRIER NATURE, V153, P26; VILLIERS A, 1958, INITIATIONS AFRICAIN, V25, P1; Ward D, 2009, BIO HABIT, P1; WENDORF F, 1987, AFR ARCHAEOL REV, V5, P49; [No title captured]	77	41	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e14734	10.1371/journal.pone.0014734	http://dx.doi.org/10.1371/journal.pone.0014734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364897	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100005
J	Koo, MS; Manca, C; Yang, G; O'Brien, P; Sung, N; Tsenova, L; Subbian, S; Fallows, D; Muller, G; Ehrt, S; Kaplan, G				Koo, Mi-Sun; Manca, Claudia; Yang, Guibin; O'Brien, Paul; Sung, Nackmoon; Tsenova, Liana; Subbian, Selvakumar; Fallows, Dorothy; Muller, George; Ehrt, Sabine; Kaplan, Gilla			Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice	PLOS ONE			English	Article							MICROBIAL ENUMERATION TECHNIQUE; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; MOUSE TISSUES; IN-VITRO; PULMONARY TUBERCULOSIS; TUBERCLE BACILLI; CONTROLLED-TRIAL; CYCLIC-AMP; T-CELLS	Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is one of the leading infectious disease causes of morbidity and mortality worldwide. Though current antibiotic regimens can cure the disease, treatment requires at least six months of drug therapy. One reason for the long duration of therapy is that the currently available TB drugs were selected for their ability to kill replicating organisms and are less effective against subpopulations of non-replicating persistent bacilli. Evidence from in vitro models of Mtb growth and mouse infection studies suggests that host immunity may provide some of the environmental cues that drive Mtb towards non-replicating persistence. We hypothesized that selective modulation of the host immune response to modify the environmental pressure on the bacilli may result in better bacterial clearance during TB treatment. For this proof of principal study, we compared bacillary clearance from the lungs of Mtb-infected mice treated with the anti-TB drug isoniazid (INH) in the presence and absence of an immunomodulatory phosphodiesterase 4 inhibitor (PDE4i), CC-3052. The effects of CC-3052 on host global gene expression, induction of cytokines, and T cell activation in the lungs of infected mice were evaluated. We show that CC-3052 modulates the innate immune response without causing generalized immune suppression. Immune modulation combined with INH treatment improved bacillary clearance and resulted in smaller granulomas and less lung pathology, compared to treatment with INH alone. This novel strategy of combining anti-TB drugs with an immune modulating molecule, if applied appropriately to patients, may shorten the duration of TB treatment and improve clinical outcome.	[Koo, Mi-Sun; Manca, Claudia; Yang, Guibin; O'Brien, Paul; Sung, Nackmoon; Tsenova, Liana; Subbian, Selvakumar; Fallows, Dorothy; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Muller, George] Celgene Corp, San Diego, CA USA; [Sung, Nackmoon] Natl Masan Hosp, Clin Res Ctr, Masan, Gyeongsangnam, South Korea	Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University; Bristol-Myers Squibb; Celgene Corporation	Koo, MS (corresponding author), Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA.	kaplangi@umdnj.edu	Ehrt, Sabine/AAU-6449-2020	Subbian, Selvakumar/0000-0003-2021-8632	Bill and Melinda Gates Foundation; The Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054338] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); The Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the Bill and Melinda Gates Foundation. NS was funded by The Heiser Program for Research in Leprosy and Tuberculosis. The funders had no role in study design and data collection as well as decision to publish. However, GM is an employee of Celgene and GK is on the board of Celgene, and Celgene approved the decision to publish and reviewed the manuscript before publication.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Bartek IL, 2009, TUBERCULOSIS, V89, P310, DOI 10.1016/j.tube.2009.06.001; Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Bilaceroglu S, 1999, INT J TUBERC LUNG D, V3, P47; BLOOM BR, 1994, IMMUNOBIOLOGY, V191, P526, DOI 10.1016/S0171-2985(11)80459-6; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Caruso AM, 1999, J IMMUNOL, V162, P5407; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Corral LG, 1999, J IMMUNOL, V163, P380; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GONZALEZJUARRER.M, 2009, CELL, V40, P398; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Guckian M, 2000, CLIN EXP IMMUNOL, V121, P472, DOI 10.1046/j.1365-2249.2000.01332.x; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; HORNE NW, 1960, BRIT MED J, V2, P1751, DOI 10.1136/bmj.2.5215.1751; Jain S. K., 2008, MICROBE, V3, P285, DOI [DOI 10.1128/MICROBE.3.285.1, DOI 10.1128/MICR0BE.3.285.1]; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Manca C, 1999, J IMMUNOL, V162, P6740; Marino S, 2007, PLOS COMPUT BIOL, V3, P1909, DOI 10.1371/journal.pcbi.0030194; Marriott JB, 2002, CLIN EXP IMMUNOL, V130, P75, DOI 10.1046/j.1365-2249.2002.01954.x; Marriott JB, 1998, J IMMUNOL, V161, P4236; Mayanja-Kizza H, 2005, J INFECT DIS, V191, P856, DOI 10.1086/427995; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; MUTHUSWAMY P, 1995, CHEST, V107, P1621, DOI 10.1378/chest.107.6.1621; Nathan C., 2004, TUBERCULOSIS, V84, P215; NUSSLER AK, 1994, J BIOL CHEM, V269, P1257; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Scanga CA, 1999, INFECT IMMUN, V67, P4531, DOI 10.1128/IAI.67.9.4531-4538.1999; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Thorn CF, 2002, AMYLOID, V9, P229, DOI 10.3109/13506120209114098; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; TSENOVA L, 1997, J AM BIOL SAFETY ASS, V2, P20; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wallis RS, 2004, AIDS, V18, P257, DOI 10.1097/00002030-200401230-00015; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914; WHO, 2010, GLOB TUB CONTR SHORT	56	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17091	10.1371/journal.pone.0017091	http://dx.doi.org/10.1371/journal.pone.0017091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364878	Green Submitted, gold, Green Published			2022-12-25	WOS:000287764100027
J	Liu, MX; Wang, L; Shi, ZBA; Zhang, Z; Zhang, K; Shen, JH				Liu, Mingxin; Wang, Li; Shi, Zhanbiao; Zhang, Zhen; Zhang, Kan; Shen, Jianhua			Mental Health Problems among Children One-Year after Sichuan Earthquake in China: A Follow-up Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DEPRESSIVE REACTIONS; EXPOSURE; ADOLESCENTS; SURVIVORS; RISK; PREVALENCE; SYMPTOMS; VIOLENCE; AGE	Background: On May 12, 2008, a destructive earthquake registering 8.0 on the Richter scale struck Sichuan Province, southwest China. Beichuan County was the epicenter which was one of the areas nearly completely destroyed by the earthquake. In Beichuan, about 15000 people died and 3000 people were missing. Specially, the earthquake took 1587 students' and 214 teachers' lives from the elementary and middle schools there. The main purpose of the study was to provide a better understanding of mental health problems and associated risk factors among children after earthquake. Method: Three hundred and thirty grades 3-5 children completed the questionnaire of disaster - related experience and the Trauma Symptom Checklist for Children-Alternate Version (TSCC-A). The first survey was carried out six months after the earthquake, and the second one was carried out six months later. The measurements and methodology applied in the two sessions were identical. Results: The prevalence rates of the problems at two time-points were 23.3% and 22.7% for anxiety, 14.5% and 16.1% for depression, and 11.2% and 13.4% for PTSD, respectively. Among demographic variables, no significant age difference existed, while it was found that 6 months after the earthquake, symptoms of anxiety, depression and PTSD were significantly more common among students in grades 4 and 5 than those in grade 3, Initial exposure to death, bereavement and extreme fear were significant predictive factors for the occurrence of anxiety, depression and PTSD. Conclusions: Findings of this study suggest that posttraumatic mental health problems after natural disaster in children may have reached epidemic proportions and remain high for a long period. Psychologist and social workers should pay more attention to children who experienced more traumatic stresses and provide appropriate mental health interventions. Implications and limitations of these findings were discussed.	[Liu, Mingxin; Wang, Li; Shi, Zhanbiao; Zhang, Zhen] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Kan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Shen, Jianhua] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Toronto	Liu, MX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangli1@psych.ac.cn		wang, li/0000-0002-1459-3412	National Foundation of Natural Science [30900402, 31040001]; China Postdoctoral Science Foundation [200902143, 20100470595]; Institute of Psychology, Chinese Academy of Sciences [O9CX143014]; Chinese Academy of Sciences	National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Foundation of Natural Science (No. 30900402 and No. 31040001), http://www.nsfc.gov.cn, China Postdoctoral Science Foundation (No. 200902143 and No. 20100470595), http://www.chinapostdoctor.org.cn/, and a grant for science development from Institute of Psychology, Chinese Academy of Sciences (No. O9CX143014), www.psych.ac.cn, and the Knowledge Innovation Project of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briere J, 2000, J TRAUMA STRESS, V13, P661, DOI 10.1023/A:1007814301369; Briere J., 1996, TRAUMA SYMPTOM CHECK; Bulut S, 2005, SCHOOL PSYCHOL INT, V26, P55, DOI 10.1177/0143034305050893; CAHAN S, 1989, CHILD DEV, V60, P1239, DOI 10.2307/1130797; Chou FHC, 2007, PSYCHIAT CLIN NEUROS, V61, P370, DOI 10.1111/j.1440-1819.2007.01688.x; Cook A, 2008, J ENVIRON MONITOR, V10, P167, DOI 10.1039/b713256p; Crone DA, 1999, J EDUC PSYCHOL, V91, P604, DOI 10.1037/0022-0663.91.4.604; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Garbarino J, 1996, CHILD DEV, V67, P33, DOI 10.1111/j.1467-8624.1996.tb01717.x; Goenjian AK, 2001, AM J PSYCHIAT, V158, P788, DOI 10.1176/appi.ajp.158.5.788; Ho J, 2008, J INTERPERS VIOLENCE, V23, P136, DOI 10.1177/0886260507307653; Lai TJ, 2004, J PSYCHIATR RES, V38, P313, DOI 10.1016/j.jpsychires.2003.08.005; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Roussos A, 2005, AM J PSYCHIAT, V162, P530, DOI 10.1176/appi.ajp.162.3.530; Rustemli A, 1996, J SOC BEHAV PERS, V11, P767; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Udwin O, 2000, J CHILD PSYCHOL PSYC, V41, P969, DOI 10.1111/1469-7610.00685; UDWIN O, 1993, J CHILD PSYCHOL PSYC, V34, P115, DOI 10.1111/j.1469-7610.1993.tb00974.x; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Wickrama KAS, 2007, SOC SCI MED, V64, P713, DOI 10.1016/j.socscimed.2006.09.031	21	115	123	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14706	10.1371/journal.pone.0014706	http://dx.doi.org/10.1371/journal.pone.0014706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373188	Green Published, gold			2022-12-25	WOS:000287657500002
J	Nourein, AB; Abass, MA; Nugud, AHD; El Hassan, I; Snow, RW; Noor, AM				Nourein, Amal B.; Abass, Mohammed A.; Nugud, Abdel Hameed D.; El Hassan, Ibrahim; Snow, Robert W.; Noor, Abdisalan M.			Identifying Residual Foci of Plasmodium falciparum Infections for Malaria Elimination: The Urban Context of Khartoum, Sudan	PLOS ONE			English	Article							RISK; CLUSTERS; VIVAX; COAST	Background: Identifying the location and size of residual foci of infections is critical where malaria elimination is the primary goal. Here the spatial heterogeneity of Plasmodium falciparum infections within the urban extent of Khartoum state in Sudan is investigated using data from cross-sectional surveys undertaken from 1999 to 2008 to inform the Khartoum Malaria Free Initiative (KMFI). Methods: From 1999-2008 the KMFI undertook cross-sectional surveys of 256 clusters across 203 random samples of residential blocks in the urban Khartoum state in September of each year. Within sampled blocks, at least five persons, including at least one child under the age of five years, were selected from each household. Blood smears were collected from the sampled individuals to examine the presence of P. falciparum parasites. Residential blocks were mapped. Data were analysed for spatial clustering using the Bernoulli model and the significance of clusters were tested using the Kulldorff scan statistic. Results: A total of 128,510 malaria slide examinations were undertaken during the study period. In 1999, overall prevalence was 2.5%, rising to 3.2% in 2000 and consistently staying below 1% in subsequent years. From 2006, over 90% of all surveyed clusters reported no infections. Spatial clustering of infections was present in each year but not statistically significant in the years 2001, 2002, 2004 and 2008. Spatial clusters of high infection were often located at the junction of the Blue and White Niles. Conclusion: Persisting foci of malaria infection in Khartoum are likely to distort wide area assessments and disproportionately affect future transmission within the city limits. Improved investments in surveillance that combines both passive and active case detection linked to a geographic information system and a more detailed analysis of the location and stability of foci should be undertaken to facilitate and track malaria elimination in the state of Khartoum.	[Nourein, Amal B.; El Hassan, Ibrahim] Univ Khartoum, Dept Parasitol, Inst Endem Dis, Khartoum, Sudan; [Abass, Mohammed A.] Khartoum State Malaria Control Programme, Khartoum Malaria Free Initiat, Khartoum, Sudan; [Nugud, Abdel Hameed D.] Minist Hlth Sudan, Natl Hlth Lab, Khartoum, Sudan; [El Hassan, Ibrahim] Univ Jazan, Fac Med, Jazan, Saudi Arabia; [Snow, Robert W.; Noor, Abdisalan M.] Univ Oxford, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, KEMRI,Wellcome Trust Res Programme, Nairobi, Kenya; [Snow, Robert W.; Noor, Abdisalan M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	University of Khartoum; Jazan University; University of Oxford	Nourein, AB (corresponding author), Univ Khartoum, Dept Parasitol, Inst Endem Dis, Khartoum, Sudan.	anoor@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Khartoum State Malaria Control Programme; World Health Organization; Japanese government; Global Fund; Wellcome Trust [079080, 081829]; ABM; Wellcome Trust, UK; Kenya Medical Research Institute; Novartis in Africa; Pfizer	Khartoum State Malaria Control Programme; World Health Organization(World Health Organization); Japanese government; Global Fund; Wellcome Trust(Wellcome TrustEuropean Commission); ABM; Wellcome Trust, UK(Wellcome Trust); Kenya Medical Research Institute; Novartis in Africa; Pfizer(Pfizer)	The study received funding from the Khartoum State Malaria Control Programme with support from the World Health Organization, the Japanese government and the Global Fund to Fight AIDS, Tuberculosis and Malaria. RWS is supported by the Wellcome Trust through a Principal Research Fellowship (#079080) which also supported ABM during her internship to complete this work. VAA is supported by a grant to Professor Snow from the Wellcome Trust. AMN is supported by the Wellcome Trust as a Research Training Fellow (#081829). This work forms part of the output of the Malaria Atlas Project ( MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, UK. RWS and AMN also acknowledge the support from the Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RWS has received funding from Novartis for chairing meetings of national control programmes in Africa and has received a research grant from Pfizer. All other authors have no conflicts of interest.	Baird JK, 2009, ANN TROP PAEDIATR, V29, P251, DOI 10.1179/027249309X12547917868808; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; BALFOUR A, 2004, 1 WELL TROP RES LAB; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; *CBS, 2009, CBS YB; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; *FED MIN HLTH, 2010, NAT MAL IND SURV NO; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hernandez-Avila JE, 2006, SALUD PUBLICA MEXICO, V48, P405, DOI 10.1590/S0036-36342006000500007; IHOUSE ME, 1997, P NATL ACAD SCI USA, V94, P338; KHALIFA SM, 2008, E MEDTR MED J, V14, P206; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mirghani SE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-172; MOONEN B, 2010, LANCET, DOI DOI 10.1016/S0140-6736(10)61269X; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Osorio L, 2007, TROP MED INT HEALTH, V12, P331, DOI 10.1111/j.1365-3156.2006.01791.x; Petrarca V, 2000, MED VET ENTOMOL, V14, P149, DOI 10.1046/j.1365-2915.2000.00231.x; PULL JH, 1972, AM J TROP MED HYG, V21, P651, DOI 10.4269/ajtmh.1972.21.651; Schellenberg JA, 1998, INT J EPIDEMIOL, V27, P323, DOI 10.1093/ije/27.2.323; Shanks GD, 2005, T ROY SOC TROP MED H, V99, P71, DOI 10.1016/j.trstmh.2004.04.001; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; *STATSCAN, SOFTW SPAT TEMP SPAC; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005	34	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16948	10.1371/journal.pone.0016948	http://dx.doi.org/10.1371/journal.pone.0016948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373202	Green Published, gold, Green Submitted			2022-12-25	WOS:000287657500025
J	von Figura, G; Wagner, M; Nalapareddy, K; Hartmann, D; Kleger, A; Guachalla, LM; Rolyan, H; Adler, G; Rudolph, KL				von Figura, Guido; Wagner, Martin; Nalapareddy, Kodandaramireddy; Hartmann, Daniel; Kleger, Alexander; Guachalla, Luis Miguel; Rolyan, Harshvardhan; Adler, Guido; Rudolph, Karl Lenhard			Regeneration of the Exocrine Pancreas Is Delayed in Telomere-Dysfunctional Mice	PLOS ONE			English	Article							TUBULAR COMPLEXES; LIVER-CIRRHOSIS; SENESCENCE; CELLS; GENE; DISEASE; CANCER; RATS	Introduction: Telomere shortening is a cell-intrinsic mechanism that limits cell proliferation by induction of DNA damage responses resulting either in apoptosis or cellular senescence. Shortening of telomeres has been shown to occur during human aging and in chronic diseases that accelerate cell turnover, such as chronic hepatitis. Telomere shortening can limit organ homeostasis and regeneration in response to injury. Whether the same holds true for pancreas regeneration in response to injury is not known. Methods: In the present study, pancreatic regeneration after acute cerulein-induced pancreatitis was studied in late generation telomerase knockout mice with short telomeres compared to telomerase wild-type mice with long telomeres. Results: Late generation telomerase knockout mice exhibited impaired exocrine pancreatic regeneration after acute pancreatitis as seen by persistence of metaplastic acinar cells and markedly reduced proliferation. The expression levels of p53 and p21 were not significantly increased in regenerating pancreas of late generation telomerase knockout mice compared to wild-type mice. Conclusion: Our results indicate that pancreatic regeneration is limited in the context of telomere dysfunction without evidence for p53 checkpoint activation.	[von Figura, Guido; Nalapareddy, Kodandaramireddy; Hartmann, Daniel; Kleger, Alexander; Guachalla, Luis Miguel; Rolyan, Harshvardhan; Rudolph, Karl Lenhard] Univ Ulm, Inst Mol Med, Ulm, Germany; [von Figura, Guido; Nalapareddy, Kodandaramireddy; Hartmann, Daniel; Kleger, Alexander; Guachalla, Luis Miguel; Rolyan, Harshvardhan; Rudolph, Karl Lenhard] Univ Ulm, Max Planck Res Grp Stem Cell Aging, Ulm, Germany; [von Figura, Guido; Wagner, Martin; Kleger, Alexander; Adler, Guido] Univ Ulm, Dept Internal Med, D-7900 Ulm, Germany; [Hartmann, Daniel] Tech Univ Munich, Dept Surg, Munich, Germany	Ulm University; Max Planck Society; Ulm University; Ulm University; Technical University of Munich	von Figura, G (corresponding author), Univ Ulm, Inst Mol Med, Ulm, Germany.	lenhard.rudolph@uni-ulm.de	; Rolyan, Harshvardhan/G-2461-2017	Kleger, Alexander/0000-0003-0592-5232; Nalapareddy, Kodandaramireddy/0000-0003-3290-5114; Guachalla, Luis Miguel/0000-0003-1152-9930; Hartmann, Daniel/0000-0003-4366-8986; Rudolph, Karl Lenhard/0000-0002-4839-2862; Rolyan, Harshvardhan/0000-0001-8967-9627	Deutsche Forschungsgemeinschaft [SFB518]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by Deutsche Forschungsgemeinschaft (SFB518). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BOCKMAN DE, 1982, AM J SURG, V144, P243, DOI 10.1016/0002-9610(82)90518-9; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; DELISLE RC, 1990, PANCREAS, V5, P381, DOI 10.1097/00006676-199007000-00002; Elsasser H P, 1986, Pancreas, V1, P421, DOI 10.1097/00006676-198609000-00006; Gardner TB, 2008, PANCREATOLOGY, V8, P265, DOI 10.1159/000134274; Ishii A, 2006, EXP GERONTOL, V41, P882, DOI 10.1016/j.exger.2006.06.036; Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0; Lechel A, 2007, GASTROENTEROLOGY, V132, P1465, DOI 10.1053/j.gastro.2007.01.045; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Satyanarayana A, 2004, CELL CYCLE, V3, P1405, DOI 10.4161/cc.3.11.1212; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; WILLEMER S, 1992, EUR SURG RES, V24, P29, DOI 10.1159/000129237; WILLEMER S, 1987, PANCREAS, V2, P669, DOI 10.1097/00006676-198711000-00008; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17122	10.1371/journal.pone.0017122	http://dx.doi.org/10.1371/journal.pone.0017122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364961	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600031
J	Monson, NL; Cravens, P; Hussain, R; Harp, CT; Cummings, M; Martin, MD; Ben, LH; Do, J; Lyons, JA; Lovette-Racke, A; Cross, AH; Racke, MK; Stuve, O; Shlomchik, M; Eagar, TN				Monson, Nancy L.; Cravens, Petra; Hussain, Rehana; Harp, Christopher T.; Cummings, Matthew; Martin, Maria de Pilar; Ben, Li-Hong; Do, Julie; Lyons, Jeri-Anne; Lovette-Racke, Amy; Cross, Anne H.; Racke, Michael K.; Stueve, Olaf; Shlomchik, Mark; Eagar, Todd N.			Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; B-CELLS; INDUCTION; DEPLETION; PROTEIN; TOLERANCE; CTLA-4; IL-10; MICE; EAE	Recent clinical trials have established B cell depletion by the anti-CD20 chimeric antibody Rituximab as a beneficial therapy for patients with relapsing-remitting multiple sclerosis (MS). The impact of Rituximab on T cell responses remains largely unexplored. In the experimental autoimmune encephalomyelitis (EAE) model of MS in mice that express human CD20, Rituximab administration rapidly depleted peripheral B cells and strongly reduced EAE severity. B cell depletion was also associated with diminished Delayed Type Hypersensitivity (DTH) and a reduction in T cell proliferation and IL-17 production during recall immune response experiments. While Rituximab is not considered a broad immunosuppressant, our results indicate a role for B cells as a therapeutic cellular target in regulating encephalitogenic T cell responses in specific tissues.	[Monson, Nancy L.; Cravens, Petra; Hussain, Rehana; Harp, Christopher T.; Cummings, Matthew; Martin, Maria de Pilar; Ben, Li-Hong; Do, Julie; Stueve, Olaf; Eagar, Todd N.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Monson, Nancy L.; Eagar, Todd N.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Lyons, Jeri-Anne] Univ Wisconsin, Milwaukee, WI 53201 USA; [Lovette-Racke, Amy] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Cross, Anne H.] Washington Univ, Dept Neurol, St Louis, MO USA; [Racke, Michael K.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Stueve, Olaf] VA N Texas Hlth Care Syst, Neurol Sect, Med Serv, Dallas, TX USA; [Shlomchik, Mark] Yale Univ, Sch Med, Lab Med & Immunobiol, New Haven, CT USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Milwaukee; University System of Ohio; Ohio State University; Washington University (WUSTL); University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Yale University	Monson, NL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.	Todd.eagar@utsouthwestern.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Cross, Anne/0000-0003-0829-7569	University of Texas Southwestern Medical Center Department of Neurology; National Multiple Sclerosis Society [PP1122, RG3267]; Howson Funds	University of Texas Southwestern Medical Center Department of Neurology; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Howson Funds	This work was supported by funds provided by the University of Texas Southwestern Medical Center Department of Neurology. This work was supported by grants from the National Multiple Sclerosis Society to NLM (PP1122 and RG3267) and Howson Funds to NLM. The funders had no role in study desing, data collection, analysis, decision to publish or preparation of the manuscript.	Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Bauman TM, 2004, FRONT BIOSCI-LANDMRK, V9, P2302, DOI 10.2741/1398; Martin MD, 2007, FRONT BIOSCI-LANDMRK, V12, P2735, DOI 10.2741/2268; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Eagar TN, 2004, J IMMUNOL, V172, P7442, DOI 10.4049/jimmunol.172.12.7442; Eagar TN, 2002, EUR J IMMUNOL, V32, P972, DOI 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M; EINFELD DA, 1988, EMBO J, V7, P711, DOI 10.1002/j.1460-2075.1988.tb02867.x; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Grillo-Lopez AJ, 2002, SEMIN ONCOL, V29, P105, DOI 10.1053/sonc.2002.30145; Harp CT, 2010, EUR J IMMUNOL, V40, P2942, DOI 10.1002/eji.201040516; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; HERRMANN P, 1988, IMMUNOBIOLOGY, V177, P382, DOI 10.1016/S0171-2985(88)80006-8; LEDBETTER JA, 1986, HUM IMMUNOL, V15, P30, DOI 10.1016/0198-8859(86)90315-0; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Martin MD, 2008, ARCH NEUROL-CHICAGO, V65, P1596, DOI 10.1001/archneur.65.12.noc80051; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Menge T, 2008, DRUGS, V68, P2445, DOI 10.2165/0003495-200868170-00004; PRESS OW, 1987, BLOOD, V69, P584; Saville MW, 2003, BLOOD, V102, P408, DOI 10.1182/blood-2003-03-1005; STUVE O, 2005, ARCH NEUROL IN PRESS; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; 2008, FDA MEDWATCH INFORM	23	62	63	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17103	10.1371/journal.pone.0017103	http://dx.doi.org/10.1371/journal.pone.0017103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359213	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700048
J	Zhang, FY; Chen, LQ; Qin, JG; Zhao, WH; Wu, P; Yu, N; Ma, LB				Zhang, Fengying; Chen, Liqiao; Qin, Jianguang; Zhao, Weihong; Wu, Ping; Yu, Na; Ma, Lingbo			cDNA Cloning and Expression Analysis of Gustavus Gene in the Oriental River Prawn Macrobrachium nipponense	PLOS ONE			English	Article							SOCS-BOX MOTIF; SPRY-DOMAIN; STRUCTURAL BASIS; GERM PLASM; PROTEIN; RECOGNITION; INTERACTS; ELEGANS; FAMILY; SPSB2	The gustavus gene is required for localizing pole plasm and specifying germ cells. Research on gustavus gene expression will advance our understanding of the biological function of gustavus in animals. A cDNA encoding gustavus protein was identified and termed MnGus in the oriental river prawn Macrobrachium nipponense. Bioinformatic analyses showed that this gene encoded a protein of 262 amino acids and the protein belongs to the Spsb1 family. Real-time quantitative PCR analyses revealed that the expression level of MnGus in prawn embryos was slightly higher at the cleavage stage than at the blastula stage, and reached the maximum level during the zoea stage of embryos. The minimum level of MnGus expression occurred during the perinucleolus stage in the ovary, while the maximum was at the oil globule stage, and then the level of MnGus expression gradually decreased with the advancement of ovarian development. The expression level of MnGus in muscle was much higher than that in other tissues in mature prawn. The gustavus cDNA sequence was firstly cloned from the oriental river prawn and the pattern of gene expression was described during oocyte maturation, embryonic development, and in other tissues. The differential expression patterns of MnGus in the embryo, ovary and other somatic tissues suggest that the gustavus gene performs multiple physiological functions in the oriental river prawn.	[Zhang, Fengying; Chen, Liqiao; Zhao, Weihong; Wu, Ping; Yu, Na] E China Normal Univ, Coll Life Sci, Shanghai 200062, Peoples R China; [Zhang, Fengying; Ma, Lingbo] Chinese Acad Fishery Sci, E China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Qin, Jianguang] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	East China Normal University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Flinders University South Australia	Zhang, FY (corresponding author), E China Normal Univ, Coll Life Sci, Shanghai 200062, Peoples R China.	lqchen@bio.ecnu.edu.cn		Chen, Liqiao/0000-0003-0138-7828; Qin, Jianguang/0000-0003-2448-8058	Shanghai Committee of Science and Technology, China [08DZ1906401, 10JC1404100]; National Natural Science Foundation of China [30771670]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200802690012]; National Basic Research Program (973 Program) [2009CB118702]; Shanghai Agriculture Science and Technology Key Grant [2-1]; National Key Technology RD Program [2006BAD01A13]; E-Institute of Shanghai Municipal Education Commission [E03009]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Basic Research Program (973 Program)(National Basic Research Program of China); Shanghai Agriculture Science and Technology Key Grant; National Key Technology RD Program(National Key Technology R&D Program); E-Institute of Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	Funding: This study was supported by the Shanghai Committee of Science and Technology, China (08DZ1906401, 10JC1404100), the National Natural Science Foundation of China (No. 30771670), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 200802690012), the National Basic Research Program (973 Program, No. 2009CB118702), the Shanghai Agriculture Science and Technology Key Grant (No. 2-1, 2009), and the National Key Technology R&D Program (No. 2006BAD01A13) and partially by the E-Institute of Shanghai Municipal Education Commission (No. E03009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EDDY EM, 1975, INT REV CYTOL, V43, P229; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Gao X.G., 2006, BIOTECHNOL B S, P438, DOI DOI 10.3969/J.ISSN.1002-5464.2006.Z1.097; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kleiber ML, 2009, GENOMICS, V93, P358, DOI 10.1016/j.ygeno.2008.11.011; Kress TL, 2004, J CELL BIOL, V165, P203, DOI 10.1083/jcb.200309145; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kugler JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009048; Li JZ, 2009, BIOCHEM GENET, V47, P179, DOI 10.1007/s10528-008-9215-1; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; MAHOWALD AP, 1992, SCIENCE, V255, P1216, DOI 10.1126/science.1372132; Markussen FH, 1997, COLD SPRING HARB SYM, V62, P13; Meeratana P, 2007, AQUACULTURE, V270, P249, DOI 10.1016/j.aquaculture.2007.03.009; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pelegri F, 1999, CURR BIOL, V9, P1431, DOI 10.1016/S0960-9822(00)80112-8; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Qiu GF, 2005, COMP BIOCHEM PHYS B, V140, P171, DOI 10.1016/j.cbpc.2004.09.027; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Schisa JA, 2001, DEVELOPMENT, V128, P1287; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STROME S, 1992, NATURE, V358, P368; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Wang DK, 2005, J BIOL CHEM, V280, P16393, DOI 10.1074/jbc.M413897200; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Xing Y, 2006, REPRODUCTION, V131, P905, DOI 10.1530/rep.1.01046; Zhang FY, 2010, COMP BIOCHEM PHYS B, V155, P288, DOI 10.1016/j.cbpb.2009.11.013; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; [赵艳民 ZHAO Yanmin], 2006, [华东师范大学学报. 自然科学版, Journal of East China Normal University. Natural Science], P75	33	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17170	10.1371/journal.pone.0017170	http://dx.doi.org/10.1371/journal.pone.0017170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359189	Green Published, Green Submitted, gold			2022-12-25	WOS:000287392700057
J	Lewellyn, EB; Loeb, DD				Lewellyn, Eric B.; Loeb, Daniel D.			Serine Phosphoacceptor Sites within the Core Protein of Hepatitis B Virus Contribute to Genome Replication Pleiotropically	PLOS ONE			English	Article							STRAND DNA-SYNTHESIS; HEPADNAVIRUS REVERSE TRANSCRIPTION; ARGININE-RICH DOMAIN; CIS-ACTING SEQUENCES; RNA ENCAPSIDATION; VIRAL-DNA; PREGENOME ENCAPSIDATION; STEM-LOOP; PHOSPHORYLATION; SIGNAL	The core protein of hepatitis B virus can be phosphorylated at serines 155, 162, and 170. The contribution of these serine residues to DNA synthesis was investigated. Core protein mutants were generated in which each serine was replaced with either alanine or aspartate. Aspartates can mimic constitutively phosphorylated serines while alanines can mimic constitutively dephosphorylated serines. The ability of these mutants to carry out each step of DNA synthesis was determined. Alanine substitutions decreased the efficiency of minus-strand DNA elongation, primer translocation, circularization, and plus-strand DNA elongation. Aspartate substitutions also reduced the efficiency of these steps, but the magnitude of the reduction was less. Our findings suggest that phosphorylated serines are required for multiple steps during DNA synthesis. It has been proposed that generation of mature DNA requires serine dephosphorylation. Our results suggest that completion of rcDNA synthesis requires phosphorylated serines.	[Lewellyn, Eric B.; Loeb, Daniel D.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lewellyn, EB (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	loeb@oncology.wisc.edu			NIH [R01 AI060018, P01 CA022443, T32 CA009135]; NATIONAL CANCER INSTITUTE [P01CA022443, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 AI060018, P01 CA022443, and T32 CA009135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TM, 2008, VIROLOGY, V379, P30, DOI 10.1016/j.virol.2008.06.021; ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Basagoudanavar SH, 2007, J VIROL, V81, P1641, DOI 10.1128/JVI.01671-06; BEAMES B, 1993, VIROLOGY, V194, P597, DOI 10.1006/viro.1993.1299; CHIANG PW, 1992, VIROLOGY, V186, P701, DOI 10.1016/0042-6822(92)90037-P; Chua PK, 2010, J VIROL, V84, P2340, DOI 10.1128/JVI.01666-09; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; DELIUS H, 1983, J VIROL, V47, P337, DOI 10.1128/JVI.47.2.337-343.1983; Gazina EV, 2000, J VIROL, V74, P4721, DOI 10.1128/JVI.74.10.4721-4728.2000; GERLICH WH, 1980, CELL, V21, P801, DOI 10.1016/0092-8674(80)90443-2; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Jiang T, 2009, BIOPHYS J, V96, P3065, DOI 10.1016/j.bpj.2009.01.009; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Kock J, 1998, J VIROL, V72, P9116; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; LEHMANN EL, 1975, BLOCKED COMP 2 TREAT, P120; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Lewellyn EB, 2007, J VIROL, V81, P6207, DOI 10.1128/JVI.00210-07; Lewellyn EB, 2011, J VIROL, V85, P1298, DOI 10.1128/JVI.01957-10; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Liu N, 2004, J VIROL, V78, P642, DOI 10.1128/JVI.78.2.642-649.2004; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 1996, J VIROL, V70, P2764, DOI 10.1128/JVI.70.5.2764-2773.1996; Perlman DH, 2005, P NATL ACAD SCI USA, V102, P9020, DOI 10.1073/pnas.0502138102; POLLACK JR, 1993, J VIROL, V67, P3254, DOI 10.1128/JVI.67.6.3254-3263.1993; PUGH J, 1989, J VIROL, V63, P1371, DOI 10.1128/JVI.63.3.1371-1376.1989; Rieger A, 1996, J VIROL, V70, P585, DOI 10.1128/JVI.70.1.585-589.1996; SEEGER C, 1986, SCIENCE, V232, P477, DOI 10.1126/science.3961490; STAPRANS S, 1991, J VIROL, V65, P1255, DOI 10.1128/JVI.65.3.1255-1262.1991; SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/pnas.72.11.4597; TAVIS JE, 1994, J VIROL, V68, P3536, DOI 10.1128/JVI.68.6.3536-3543.1994; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; *WHO, 2008, 204 WHO; WILL H, 1987, J VIROL, V61, P904, DOI 10.1128/JVI.61.3.904-911.1987; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	41	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17202	10.1371/journal.pone.0017202	http://dx.doi.org/10.1371/journal.pone.0017202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21358805	Green Published, Green Submitted, gold			2022-12-25	WOS:000287369200028
J	Stawarczyk, D; Majerus, S; Maquet, P; D'Argembeau, A				Stawarczyk, David; Majerus, Steve; Maquet, Pierre; D'Argembeau, Arnaud			Neural Correlates of Ongoing Conscious Experience: Both Task-Unrelatedness and Stimulus-Independence Are Related to Default Network Activity	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; LEFT INTRAPARIETAL SULCUS; STREAM-OF-CONSCIOUSNESS; SHORT-TERM-MEMORY; WORKING-MEMORY; WANDERING MINDS; BRAIN ACTIVITY; RESTING STATE; AUTOBIOGRAPHICAL MEMORY; SUBJECTIVE EXPERIENCE	The default mode network (DMN) is a set of brain regions that consistently shows higher activity at rest compared to tasks requiring sustained focused attention toward externally presented stimuli. The cognitive processes that the DMN possibly underlies remain a matter of debate. It has alternately been proposed that DMN activity reflects unfocused attention toward external stimuli or the occurrence of internally generated thoughts. The present study aimed at clarifying this issue by investigating the neural correlates of the various kinds of conscious experiences that can occur during task performance. Four classes of conscious experiences (i.e., being fully focused on the task, distractions by irrelevant sensations/perceptions, interfering thoughts related to the appraisal of the task, and mind-wandering) that varied along two dimensions ("task-relatedness" and "stimulus-dependency") were sampled using thought-probes while the participants performed a go/no-go task. Analyses performed on the intervals preceding each probe according to the reported subjective experience revealed that both dimensions are relevant to explain activity in several regions of the DMN, namely the medial prefrontal cortex, posterior cingulate cortex/precuneus, and posterior inferior parietal lobe. Notably, an additive effect of the two dimensions was demonstrated for midline DMN regions. On the other hand, lateral temporal regions (also part of the DMN) were specifically related to stimulus-independent reports. These results suggest that midline DMN regions underlie cognitive processes that are active during both internal thoughts and external unfocused attention. They also strengthen the view that the DMN can be fractionated into different subcomponents and reveal the necessity to consider both the stimulus-dependent and the task-related dimensions of conscious experiences when studying the possible functional roles of the DMN.	[Stawarczyk, David; Majerus, Steve; D'Argembeau, Arnaud] Univ Liege, Dept Cognit Sci, Liege, Belgium; [Maquet, Pierre] Univ Liege, Cyclotron Res Ctr, Liege, Belgium	University of Liege; University of Liege	Stawarczyk, D (corresponding author), Univ Liege, Dept Cognit Sci, Liege, Belgium.	d.stawarczyk@ulg.ac.be	Majerus, Steve/D-4678-2009	Majerus, Steve/0000-0002-8206-8097; D'Argembeau, Arnaud/0000-0003-3618-9768; , Pierre/0000-0003-3106-3357	National Fund for Scientific Research (Belgium)	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The authors are supported by the National Fund for Scientific Research (Belgium; http://www2.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Benoit RG, 2010, NEUROIMAGE, V50, P1340, DOI 10.1016/j.neuroimage.2009.12.091; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Christoff K, NEUROSCIENC IN PRESS; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cunningham S., 2000, J MENTAL IMAG, V24, P61; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; D'Argembeau A, 2010, SOC NEUROSCI-UK, V5, P187, DOI 10.1080/17470910903233562; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dumontheil I, 2010, Q J EXP PSYCHOL, V63, P1740, DOI 10.1080/17470210903538114; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Forster S, 2008, J EXP PSYCHOL-APPL, V14, P73, DOI 10.1037/1076-898X.14.1.73; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; GIAMBRA LM, 1995, CONSCIOUS COGN, V4, P1, DOI 10.1006/ccog.1995.1001; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Gilbert SJ, 2006, J EXP PSYCHOL HUMAN, V32, P45, DOI 10.1037/0096-1523.32.1.45; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Gold S. R., 1985, IMAGIN COGN PERS, V5, P117; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Kim H, 2010, NEUROIMAGE, V49, P1045, DOI 10.1016/j.neuroimage.2009.07.058; KLINGER E, 1980, J PERS SOC PSYCHOL, V39, P1222, DOI 10.1037/h0077724; Klinger E., 2009, HDB IMAGINATION MENT, P225, DOI DOI 10.4324/9780203809846.CH15; Lustig C, 2001, EUR J COGN PSYCHOL, V13, P107, DOI 10.1080/09541440042000241; Lutz A, 2003, J CONSCIOUSNESS STUD, V10, P31; Majerus S, 2007, NEUROIMAGE, V35, P353, DOI 10.1016/j.neuroimage.2006.12.008; Majerus S, 2006, NEUROIMAGE, V32, P880, DOI 10.1016/j.neuroimage.2006.03.048; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mason MF, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1141078; Matthews G, 1999, HDB COPING THEORY RE, P333; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McGuire PK, 1996, NEUROREPORT, V7, P2095; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; SINGER JL, 1993, CIBA F SYMP, V174, P100; Singer JL, 1998, EMPIRICAL PERSPECTIV, P141; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2008, BRAIN COGNITION, V66, P50, DOI 10.1016/j.bandc.2007.05.004; Smallwood J, 2007, PSYCHON B REV, V14, P527, DOI 10.3758/BF03194102; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stawarczyk D, ACTA PSYCHO IN PRESS; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; TEASDALE JD, 1993, EUR J COGN PSYCHOL, V5, P417, DOI 10.1080/09541449308520128; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Unsworth N, 2010, INTELLIGENCE, V38, P111, DOI 10.1016/j.intell.2009.08.002; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Walther S, 2010, NEUROREPORT, V21, P191, DOI 10.1097/WNR.0b013e328335640f; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	95	200	203	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16997	10.1371/journal.pone.0016997	http://dx.doi.org/10.1371/journal.pone.0016997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721PR	21347270	Green Published, gold			2022-12-25	WOS:000287367600030
J	Gilbert, MR; Douris, N; Tongjai, S; Green, CB				Gilbert, Misty R.; Douris, Nicholas; Tongjai, Siripong; Green, Carla B.			Nocturnin Expression Is Induced by Fasting in the White Adipose Tissue of Restricted Fed Mice	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ARNT-LIKE PROTEIN-1; CIRCADIAN CLOCK; REGULATED GENE; ENERGY-BALANCE; LIPOLYSIS; LIVER; FAT; PHOSPHORYLATION; TRANSCRIPTION	The relationship between circadian clocks and metabolism is intimate and complex and a number of recent studies have begun to reveal previously unknown effects of food and its temporal availability on the clock and the rhythmic transcriptome of peripheral tissues. Nocturnin, a circadian deadenylase, is expressed rhythmically in a wide variety of tissues, but we report here that Nocturnin expression is arrhythmic in epididymal white adipose tissue (eWAT) of mice housed in 12: 12 LD with ad libitum access to food. However, Nocturnin expression becomes rhythmic in eWAT of mice placed on restricted feeding. We show here that Nocturnin's rhythmic expression pattern is not dependent upon feeding, nor is it acutely induced by feeding in the liver or eWAT of ad libitum fed mice. However, Nocturnin is acutely induced by the absence of the expected meal in eWAT of restricted fed mice. A rise in cAMP levels also induces Nocturnin expression, suggesting that Nocturnin's induction in eWAT by fasting is likely mediated through the same pathways that activate lipolysis. Therefore, this suggests that Nocturnin plays a role in linking nutrient sensing by the circadian clock to lipid mobilization in the adipocytes.	[Gilbert, Misty R.; Douris, Nicholas; Tongjai, Siripong; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of Virginia	Gilbert, MR (corresponding author), Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40536 USA.	Carla.Green@utsouthwestern.edu		Tongjai, Siripong/0000-0001-6451-675X	National Institutes of Health [R01 GM076626, R01 MH090247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH090247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institutes of Health R01 GM076626 and R01 MH090247 to CBG (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; BELFRAGE P, 1980, FEBS LETT, V111, P120, DOI 10.1016/0014-5793(80)80775-7; BOLINDER J, 1983, J CLIN ENDOCR METAB, V57, P455, DOI 10.1210/jcem-57-3-455; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; GALITZKY J, 1995, FUND CLIN PHARMACOL, V9, P324, DOI 10.1111/j.1472-8206.1995.tb00506.x; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Gimble JM, 2009, OBES REV, V10, P46, DOI 10.1111/j.1467-789X.2009.00661.x; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Gronke S, 2009, GENETICS, V183, P219, DOI 10.1534/genetics.109.105601; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107; KAWAMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P732, DOI 10.1073/pnas.78.2.732; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu XR, 2002, MOL CELL BIOL, V22, P7501, DOI 10.1128/MCB.22.21.7501-7511.2002; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; MAURIEGE P, 1987, EUR J CLIN INVEST, V17, P156, DOI 10.1111/j.1365-2362.1987.tb02395.x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; TRAYHURN P, 1995, FEBS LETT, V368, P488, DOI 10.1016/0014-5793(95)00719-P; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	40	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17051	10.1371/journal.pone.0017051	http://dx.doi.org/10.1371/journal.pone.0017051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347334	Green Submitted, Green Published, gold			2022-12-25	WOS:000287363000035
J	Nausch, N; Midzi, N; Mduluza, T; Maizels, RM; Mutapi, F				Nausch, Norman; Midzi, Nicholas; Mduluza, Takafira; Maizels, Rick M.; Mutapi, Francisca			Regulatory and Activated T Cells in Human Schistosoma haematobium Infections	PLOS ONE			English	Article							INTERLEUKIN-5 PRODUCTION; HELMINTH INFECTION; MANSONI INFECTION; IMMUNE REGULATION; RESPONSES; IMMUNOPATHOLOGY; FOXP3; DISEASE; CD4(+); TH2	Acquired immunity against helminths is characterised by a complex interplay between the effector Th1 and Th2 immune responses and it slowly manifests with age as a result of cumulative exposure to parasite antigens. Data from experimental models suggest that immunity is also influenced by regulatory T cells (Treg), but as yet studies on Treg in human schistosome infections are limited. This study investigated the relationship between schistosome infection intensity and the two cell populations regulatory T cells (Treg: CD4(+(dim))CD(25+(high))FOXP(3+)CD127(low)), and activated (Tact: CD4(+)CD25(+)FOXP3(-)) T cells in Zimbabweans exposed to Schistosoma haematobium parasites. Participants were partitioned into two age groups, young children (8-13 years) in whom schistosome infection levels were rising to peak and older people (14+ years) with declining infection levels. The relationship between Tact proportions and schistosome infection intensity remained unchanged with age. However Treg proportions rose significantly with increasing infection in the younger age group. In contrast Treg were negatively correlated to infection intensity in the older age group. The relative proportions of regulatory T cells differ significantly between young individuals in whom high infection is associated with an enhanced regulatory phenotype and older infected patients in whom the regulatory response is attenuated. This may influence or reflect different stages of the development of protective schistosome acquired immunity and immunopathogenesis.	[Nausch, Norman; Maizels, Rick M.; Mutapi, Francisca] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Midzi, Nicholas] Natl Inst Hlth Res, Harare, Zimbabwe; [Mduluza, Takafira] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe	University of Edinburgh; University of Zimbabwe	Nausch, N (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh, Midlothian, Scotland.	nnausch@staffmail.ed.ac.uk	Nausch, Norman/L-9276-2013; Nausch, Norman/M-4526-2019	Nausch, Norman/0000-0002-9704-2148; Nausch, Norman/0000-0002-9704-2148; Mutapi, Francisca/0000-0002-2537-3466	Wellcome Trust UK [WT082028MA]; Medical Research Council UK [G81/538]; Cunningham Trust; Carnegie Trust for the Universities of Scotland	Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cunningham Trust; Carnegie Trust for the Universities of Scotland	This work was supported by Wellcome Trust UK (Grant no WT082028MA), http://www.wellcome.ac.uk/; Medical Research Council UK (Grant no G81/538), www.mrc.ac.uk; Cunningham Trust; and Carnegie Trust for the Universities of Scotland, http://www.carnegie-trust.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sherbiny M, 2003, ACTA TROP, V88, P117, DOI 10.1016/S0001-706X(03)00195-5; Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Black CL, 2010, J INFECT DIS, V202, P399, DOI 10.1086/653828; Capron A, 1999, MICROBES INFECT, V1, P485, DOI 10.1016/S1286-4579(99)80086-0; Capron A, 2004, CLIN REV ALLERG IMMU, V26, P25, DOI 10.1385/CRIAI:26:1:25; Cavassani KA, 2006, J IMMUNOL, V177, P5811, DOI 10.4049/jimmunol.177.9.5811; Cheever AW, 2000, IMMUNOL TODAY, V21, P465, DOI 10.1016/S0167-5699(00)01626-1; Correa-Oliveira R, 1998, BRAZ J MED BIOL RES, V31, P171, DOI 10.1590/S0100-879X1998000100024; Everts B, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000667; Faal N, 2006, PLOS MED, V3, P1292, DOI 10.1371/journal.pmed.0030266; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hoffmann KF, 2002, ADV PARASIT, V52, P265, DOI 10.1016/S0065-308X(02)52014-5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; KING CH, 1989, J INFECT DIS, V160, P686, DOI 10.1093/infdis/160.4.686; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Layland LE, 2010, J IMMUNOL, V184, P713, DOI 10.4049/jimmunol.0901435; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; McKinley L, 2006, J IMMUNOL, V177, P6215, DOI 10.4049/jimmunol.177.9.6215; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; MDULUZA M, 2007, GATEWAY BIOMEDICAL R; Mduluza T, 2003, IMMUNOL LETT, V88, P249, DOI 10.1016/S0165-2478(03)00088-9; Medhat A, 1998, J INFECT DIS, V178, P512, DOI 10.1086/515630; MEVIN MD, 1982, LAB PROCEDURES DIAGN; Midzi N, 2008, T ROY SOC TROP MED H, V102, P1039, DOI 10.1016/j.trstmh.2008.05.024; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; MOTT KE, 1983, B SOC PATHOL EXOT, V76, P101; Mouk EMO, 2009, AM J TROP MED HYG, V80, P475, DOI 10.4269/ajtmh.2009.80.475; Mutapi F, 1998, J INFECT DIS, V178, P289, DOI 10.1086/517456; Mutapi F, 2002, LANCET INFECT DIS, V2, P219, DOI 10.1016/S1473-3099(02)00240-2; Mutapi F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-96; NDHLOVU P, 1992, 1992 NATL SCHISTOSOM; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Rausch S, 2008, INFECT IMMUN, V76, P1908, DOI 10.1128/IAI.01233-07; Reilly L, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-158; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Scott JT, 2000, PARASITE IMMUNOL, V22, P341, DOI 10.1046/j.1365-3024.2000.00311.x; Sokal R. R., 2012, BIOMETRY; Stothard JR, 2002, T ROY SOC TROP MED H, V96, P507, DOI 10.1016/S0035-9203(02)90421-9; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Taylor JJ, 2006, J IMMUNOL, V176, P5839, DOI 10.4049/jimmunol.176.10.5839; Taylor MD, 2005, J IMMUNOL, V174, P4924, DOI 10.4049/jimmunol.174.8.4924; Teixeira-Carvalho A, 2008, ACTA TROP, V108, P139, DOI 10.1016/j.actatropica.2008.04.010; Utzinger J, 2001, PARASITOLOGY, V122, P537, DOI 10.1017/S0031182001007752; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Watanabe K, 2009, PARASITE IMMUNOL, V31, P440, DOI 10.1111/j.1365-3024.2009.01127.x; Watanabe K, 2007, AM J TROP MED HYG, V77, P676, DOI 10.4269/ajtmh.2007.77.676; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; WOOLHOUSE MEJ, 1991, NATURE, V351, P757, DOI 10.1038/351757a0; World Health Organization, 2002, PREV CONTR SCHIST SO; Wynn TA, 2000, PARASITOL TODAY, V16, P497, DOI 10.1016/S0169-4758(00)01788-9; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	63	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16860	10.1371/journal.pone.0016860	http://dx.doi.org/10.1371/journal.pone.0016860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347311	Green Published, gold, Green Submitted			2022-12-25	WOS:000287363000020
J	Peh, KSH; Sonke, B; Lloyd, J; Quesada, CA; Lewis, SL				Peh, Kelvin S. -H.; Sonke, Bonaventure; Lloyd, Jon; Quesada, Carlos A.; Lewis, Simon L.			Soil Does Not Explain Monodominance in a Central African Tropical Forest	PLOS ONE			English	Article							RAIN-FOREST; RESERVE	Background: Soil characteristics have been hypothesised as one of the possible mechanisms leading to monodominance of Gilbertiodendron dewerei in some areas of Central Africa where higher-diversity forest would be expected. However, the differences in soil characteristics between the G. dewevrei-dominated forest and its adjacent mixed forest are still poorly understood. Here we present the soil characteristics of the G. dewevrei forest and quantify whether soil physical and chemical properties in this monodominant forest are significantly different from the adjacent mixed forest. Methodology/Principal Findings: We sampled top soil (0-5, 5-10, 10-20, 20-30 cm) and subsoil (150-200 cm) using an augur in 661 ha areas of intact central Africa forest in SE Cameroon, three independent patches of G. dewevrei-dominated forest and three adjacent areas (450-800 m apart), all chosen to be topographically homogeneous. Analysis - subjected to Bonferroni correction procedure - revealed no significant differences between the monodominant and mixed forests in terms of soil texture, median particle size, bulk density, pH, carbon (C) content, nitrogen (N) content, C: N ratio, C: total NaOH-extractable P ratio and concentrations of labile phosphorous (P), inorganic NaOH-extractable P, total NaOH-extractable P, aluminium, barium, calcium, copper, iron, magnesium, manganese, molybdenum, nickel, potassium, selenium, silicon, sodium and zinc. Prior to Bonferroni correction procedure, there was a significant lower level of silicon concentration found in the monodominant than mixed forest deep soil; and a significant lower level of nickel concentration in the monodominant than mixed forest top soil. Nevertheless, these were likely to be the results of multiple tests of significance. Conclusions/Significance: Our results do not provide clear evidence of soil mediation for the location of monodominant forests in relation to adjacent mixed forests. It is also likely that G. dewevrei does not influence soil chemistry in the monodominant forests.	[Peh, Kelvin S. -H.; Lloyd, Jon; Quesada, Carlos A.; Lewis, Simon L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Peh, Kelvin S. -H.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Sonke, Bonaventure] Univ Yaounde I, Plant Systemat & Ecol Lab, Higher Teachers Training Coll, Yaounde, Cameroon; [Lloyd, Jon] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia	University of Leeds; University of Cambridge; University of Yaounde I; University of Queensland	Peh, KSH (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	kelvin.peh@gmail.com	Lloyd, Jonathan J/F-8893-2010; Peh, Kelvin/C-3408-2013	Lloyd, Jonathan J/0000-0002-5458-9960; Peh, Kelvin/0000-0002-2921-1341; Lewis, Simon/0000-0002-8066-6851	Marie Curie EST Fellowship; Royal Society	Marie Curie EST Fellowship(European Commission); Royal Society(Royal Society of London)	The sources of funding are Marie Curie EST Fellowship and Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brady N.C., 1999, NATURE PROPERTIES SO; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Cherry S, 1998, WILDLIFE SOC B, V26, P947; CLARK DA, 1995, ECOLOGY, V76, P2581, DOI 10.2307/2265829; Conway D., 1992, COMP SOIL PARAMETERS; DECKERS JF, 2003, EVOLUTION TROPICAL S; Dupain J, 2004, ORYX, V38, P209, DOI 10.1017/S0030605304000365; HART TB, 1989, AM NAT, V133, P613, DOI 10.1086/284941; Hart TB, 1985, THESIS MICHIGAN STAT; Henkel TW, 2003, J TROP ECOL, V19, P417, DOI 10.1017/S0266467403003468; *IUSS, 2006, WORLD SOIL RES REP, V103; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P159; Martijena NE, 1998, J BIOGEOGR, V25, P707, DOI 10.1046/j.1365-2699.1998.2540707.x; MCGINLEY M, 2008, ENCY EARTH UN ENV PR; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nascimento MT, 1997, GLOBAL ECOL BIOGEOGR, V6, P387, DOI 10.2307/2997339; Newbery DM, 1997, ECOL MONOGR, V67, P367, DOI 10.1890/0012-9615(1997)067[0367:PDIALA]2.0.CO;2; Peh K.S-H., 2011, J VEGETATIO IN PRESS; PEH KSH, 2011, J ECOLOGY IN PRESS; PLEYSIER JL, 1980, SOIL SCI, V129, P205, DOI 10.1097/00010694-198004000-00002; Powers JS, 2004, J TROP ECOL, V20, P587, DOI 10.1017/S0266467404001877; QUESADA CA, 2009, THESIS U LEEDS LEEDS; Rhoades CC, 1997, AGROFOREST SYST, V39, P31, DOI 10.1023/A:1005995201216; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richards P.W., 1996, TROPICAL RAIN FOREST, VSecond edition; SONKE B, 2004, THESIS U LIBRE BRUXE; Tilman D., 1982, Monographs in Population Biology, pi; Torti SD, 2001, AM NAT, V157, P141, DOI 10.1086/318629; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; VANREEEUWIJK LP, 2002, PROCEDURES SOIL ANAL; Whitney KD, 1998, J TROP ECOL, V14, P351, DOI 10.1017/S0266467498000273; WILME L, 2002, RESERVE FAUNE DJA; ZINKE PJ, 1962, ECOLOGY, V43, P130, DOI 10.2307/1932049	34	38	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16996	10.1371/journal.pone.0016996	http://dx.doi.org/10.1371/journal.pone.0016996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347320	gold, Green Published, Green Accepted			2022-12-25	WOS:000287363000030
J	Wanke, D; Hohenstatt, ML; Dynowski, M; Bloss, U; Hecker, A; Elgass, K; Hummel, S; Hahn, A; Caesar, K; Schleifenbaum, F; Harter, K; Berendzen, KW				Wanke, Dierk; Hohenstatt, Mareike L.; Dynowski, Marek; Bloss, Ulrich; Hecker, Andreas; Elgass, Kirstin; Hummel, Sabine; Hahn, Achim; Caesar, Katharina; Schleifenbaum, Frank; Harter, Klaus; Berendzen, Kenneth W.			Alanine Zipper-Like Coiled-Coil Domains Are Necessary for Homotypic Dimerization of Plant GAGA-Factors in the Nucleus and Nucleolus	PLOS ONE			English	Article							PROTEIN INTERACTIONS; DNA-BINDING; TRANSCRIPTION; PROMOTER; TROPOMYOSIN; ACTIVATION; MECHANISMS; PREDICTION; SEQUENCES; TRANSPORT	GAGA-motif binding proteins control transcriptional activation or repression of homeotic genes. Interestingly, there are no sequence similarities between animal and plant proteins. Plant BBR/BPC-proteins can be classified into two distinct groups: Previous studies have elaborated on group I members only and so little is known about group II proteins. Here, we focused on the initial characterization of AtBPC6, a group II protein from Arabidopsis thaliana. Comparison of orthologous BBR/BPC sequences disclosed two conserved signatures besides the DNA binding domain. A first peptide signature is essential and sufficient to target AtBPC6-GFP to the nucleus and nucleolus. A second domain is predicted to form a zipper-like coiled-coil structure. This novel type of domain is similar to Leucine zippers, but contains invariant alanine residues with a heptad spacing of 7 amino acids. By yeast-2-hybrid and BiFC-assays we could show that this Alanine zipper domain is essential for homotypic dimerization of group II proteins in vivo. Interhelical salt bridges and charge-stabilized hydrogen bonds between acidic and basic residues of the two monomers are predicted to form an interaction domain, which does not follow the classical knobs-into-holes zipper model. FRET-FLIM analysis of GFP/RFP-hybrid fusion proteins validates the formation of parallel dimers in planta. Sequence comparison uncovered that this type of domain is not restricted to BBR/BPC proteins, but is found in all kingdoms.	[Wanke, Dierk; Hohenstatt, Mareike L.; Dynowski, Marek; Bloss, Ulrich; Hecker, Andreas; Elgass, Kirstin; Hummel, Sabine; Hahn, Achim; Caesar, Katharina; Schleifenbaum, Frank; Harter, Klaus; Berendzen, Kenneth W.] Univ Tubingen, Ctr Plant Mol Biol ZMBP Plant Physiol, Tubingen, Germany	Eberhard Karls University of Tubingen	Wanke, D (corresponding author), Univ Tubingen, Ctr Plant Mol Biol ZMBP Plant Physiol, Tubingen, Germany.	dierk.wanke@zmbp.uni-tuebingen.de	Wanke, Dierk/AAA-8529-2019	Berendzen, Kenneth/0000-0001-9870-6164	Deutsche Forschungsgemeinschaft (DFG) [(Ha2146/9-2]; Ministry for Education and Research; Ministry for Science, Research and Arts Baden-Wurttemberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry for Education and Research; Ministry for Science, Research and Arts Baden-Wurttemberg	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) to KH (Ha2146/9-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like thank all the group members at the ZMBP-Plant Physiology for their constant support, advice and critical discussion on the manuscript; special thanks to Friederike Ladwig, Sebastien Peter and Anne Mohrholz for contributing ideas to the present version of the manuscript. We would like to acknowledge bwGrid, member of the German D-Grid initiative, founded by the Ministry for Education and Research and the Ministry for Science, Research and Arts Baden-Wurttemberg, for providing the computational resources (http://www.bw-grid.de).	Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berendzen K, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-4; Berendzen KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-522; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Brown JH, 2010, PROTEIN SCI, V19, P1366, DOI 10.1002/pro.415; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dunin-Horkawicz S, 2010, J STRUCT BIOL, V170, P226, DOI 10.1016/j.jsb.2010.01.023; Elgass K, 2010, ANAL BIOANAL CHEM, V398, P1919, DOI 10.1007/s00216-010-4127-4; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fujioka M, 2008, DEVELOPMENT, V135, P4131, DOI 10.1242/dev.024554; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GERNERT KM, 1995, PROTEIN SCI, V4, P2252, DOI 10.1002/pro.5560041102; Golovnin A, 2008, EMBO REP, V9, P440, DOI 10.1038/embor.2008.32; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Horak J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-77; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Ishii K, 2003, MOL CELL, V11, P237, DOI 10.1016/S1097-2765(03)00010-8; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Kooiker M, 2005, PLANT CELL, V17, P722, DOI 10.1105/tpc.104.030130; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lehmann M, 2004, TRENDS GENET, V20, P15, DOI 10.1016/j.tig.2003.11.005; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Liu J, 2002, J BIOL CHEM, V277, P48708, DOI 10.1074/jbc.M208773200; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mahmoudi T, 2002, EMBO J, V21, P1775, DOI 10.1093/emboj/21.7.1775; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Meister RJ, 2004, PLANT J, V37, P426, DOI 10.1046/j.1365-313X.2003.01971.x; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nilsson I, 2003, J BIOL CHEM, V278, P29389, DOI 10.1074/jbc.M212310200; Noiges R, 2006, BBA-MOL CELL RES, V1763, P1011, DOI 10.1016/j.bbamcr.2006.08.029; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Petrascheck M, 2005, NUCLEIC ACIDS RES, V33, P3743, DOI 10.1093/nar/gki689; Reiser L, 2000, PLANT MOL BIOL, V42, P151, DOI 10.1023/A:1006384122567; Roig C, 2004, GENETICS, V167, P439, DOI 10.1534/genetics.167.1.439; Rusanov AL, 2010, J BIOPHOTONICS, V3, P774, DOI 10.1002/jbio.201000065; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sangwan I, 2002, PLANT PHYSIOL, V129, P1788, DOI 10.1104/pp.002618; Santi L, 2003, PLANT J, V34, P813, DOI 10.1046/j.1365-313X.2003.01767.x; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; Schweinsberg S, 2004, GENETICS, V168, P1371, DOI 10.1534/genetics.104.029561; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Shaw PJ, 2004, CURR OPIN PLANT BIOL, V7, P614, DOI 10.1016/j.pbi.2004.09.011; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; Solan A, 2002, J MOL BIOL, V317, P601, DOI 10.1006/jmbi.2002.5427; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Toukmaji A, 2000, J CHEM PHYS, V113, P10913, DOI 10.1063/1.1324708; Tsiantis M, 2003, NAT REV GENET, V4, P169, DOI 10.1038/nrg1002; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Vaquero A, 2008, BBA-GENE REGUL MECH, V1779, P312, DOI 10.1016/j.bbagrm.2008.02.005; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; Voss TC, 2005, BIOTECHNIQUES, V38, P413, DOI 10.2144/05383RV01; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wanke Dierk, 2009, V479, P291, DOI 10.1007/978-1-59745-289-2_19; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yaguchi S, 2003, J BIOL CHEM, V278, P29760, DOI 10.1074/jbc.M301441200; Yamamoto YY, 2009, PLANT J, V60, P350, DOI 10.1111/j.1365-313X.2009.03958.x	76	34	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16070	10.1371/journal.pone.0016070	http://dx.doi.org/10.1371/journal.pone.0016070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347358	gold, Green Published, Green Submitted			2022-12-25	WOS:000287363000005
J	Cavina-Pratesi, C; Kuhn, G; Ietswaart, M; Milner, AD				Cavina-Pratesi, Cristiana; Kuhn, Gustav; Ietswaart, Magdalena; Milner, A. David			The Magic Grasp: Motor Expertise in Deception	PLOS ONE			English	Article							VISUAL CONTROL; HANDEDNESS; BRAIN; BODY	Background: Most of us are poor at faking actions. Kinematic studies have shown that when pretending to pick up imagined objects (pantomimed actions), we move and shape our hands quite differently from when grasping real ones. These differences between real and pantomimed actions have been linked to separate brain pathways specialized for different kinds of visuomotor guidance. Yet professional magicians regularly use pantomimed actions to deceive audiences. Methodology and Principal Findings: In this study, we tested whether, despite their skill, magicians might still show kinematic differences between grasping actions made toward real versus imagined objects. We found that their pantomimed actions in fact closely resembled real grasps when the object was visible (but displaced) (Experiment 1), but failed to do so when the object was absent (Experiment 2). Conclusions and Significance: We suggest that although the occipito-parietal visuomotor system in the dorsal stream is designed to guide goal-directed actions, prolonged practice may enable it to calibrate actions based on visual inputs displaced from the action.	[Cavina-Pratesi, Cristiana; Milner, A. David] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Kuhn, Gustav] Brunel Univ, Dept Psychol, Uxbridge UB8 3PH, Middx, England; [Ietswaart, Magdalena] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Durham University; Brunel University; Northumbria University	Cavina-Pratesi, C (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, England.	cristiana.cavina-pratesi@durham.ac.uk	Kuhn, Gustav/A-9155-2013	Kuhn, Gustav/0000-0003-2888-914X; Ietswaart, Magdalena/0000-0003-4576-9393	Medical Research Council [G0401090]; MRC [G0401090] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Medical Research Council (G0401090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Gonzalez CLR, 2008, NEUROPSYCHOLOGIA, V46, P624, DOI 10.1016/j.neuropsychologia.2007.09.006; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Iriki A, 1996, NEUROREPORT, V7, P2325; JEANNEROD M, 1986, NEUROPSYCHOLOGIA, V24, P41, DOI 10.1016/0028-3932(86)90042-4; Jeannerod M., 1981, ATTENTION PERFORM, P153; Kroliczak G, 2007, J NEUROPHYSIOL, V97, P2410, DOI 10.1152/jn.00778.2006; Kuhn G, 2008, TRENDS COGN SCI, V12, P349, DOI 10.1016/j.tics.2008.05.008; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; RUNESON S, 1983, J EXP PSYCHOL GEN, V112, P585, DOI 10.1037/0096-3445.112.4.585; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170	17	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16568	10.1371/journal.pone.0016568	http://dx.doi.org/10.1371/journal.pone.0016568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347416	Green Accepted, Green Published, gold			2022-12-25	WOS:000287361700021
J	Cha, DH; Linn, CE; Teal, PEA; Zhang, AJ; Roelofs, WL; Loeb, GM				Cha, Dong H.; Linn, Charles E., Jr.; Teal, Peter E. A.; Zhang, Aijun; Roelofs, Wendell L.; Loeb, Gregory M.			Eavesdropping on Plant Volatiles by a Specialist Moth: Significance of Ratio and Concentration	PLOS ONE			English	Article							GREEN LEAF VOLATILES; HOST LOCATION; RESPONSES; IDENTIFICATION; HERBIVORY; INSECT; DISCRIMINATION; LEPIDOPTERA; EMISSIONS; ECOLOGY	We investigated the role that the ratio and concentration of ubiquitous plant volatiles play in providing host specificity for the diet specialist grape berry moth Paralobesia viteana (Clemens) in the process of locating its primary host plant Vitis sp. In the first flight tunnel experiment, using a previously identified attractive blend with seven common but essential components ("optimized blend''), we found that doubling the amount of six compounds singly [(E)- & (Z)-linalool oxides, nonanal, decanal, beta-caryophyllene, or germacrene-D], while keeping the concentration of other compounds constant, significantly reduced female attraction (average 76% full and 59% partial upwind flight reduction) to the synthetic blends. However, doubling (E)-4,8-dimethyl 1,3,7-nonatriene had no effect on female response. In the second experiment, we manipulated the volatile profile more naturally by exposing clonal grapevines to Japanese beetle feeding. In the flight tunnel, foliar damage significantly reduced female landing on grape shoots by 72% and full upwind flight by 24%. The reduction was associated with two changes: (1) more than a two-fold increase in total amount of the seven essential volatile compounds, and (2) changes in their relative ratios. Compared to the optimized blend, synthetic blends mimicking the volatile ratio emitted by damaged grapevines resulted in an average of 87% and 32% reduction in full and partial upwind orientation, respectively, and the level of reduction was similar at both high and low doses. Taken together, these results demonstrate that the specificity of a ubiquitous volatile blend is determined, in part, by the ratio of key volatile compounds for this diet specialist. However, P. viteana was also able to accommodate significant variation in the ratio of some compounds as well as the concentration of the overall mixture. Such plasticity may be critical for phytophagous insects to successfully eavesdrop on variable host plant volatile signals.	[Cha, Dong H.; Linn, Charles E., Jr.; Roelofs, Wendell L.; Loeb, Gregory M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Teal, Peter E. A.] ARS, Chem Res Unit, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, Inst Plant Sci, USDA, Beltsville, MD USA	Cornell University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cha, DH (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	gme1@cornell.edu	Cha, Dong H/A-3977-2013		USDA NRI [2005-35302-16154]	USDA NRI(United States Department of Agriculture (USDA))	This work was partially supported by USDA NRI grant #2005-35302-16154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Cha DH, 2008, J CHEM ECOL, V34, P622, DOI 10.1007/s10886-008-9474-7; Cha DH, 2010, FOREST ECOL MANAG, V259, P1930, DOI 10.1016/j.foreco.2010.02.004; Chamberlain K, 2006, J CHEM ECOL, V32, P565, DOI 10.1007/s10886-005-9016-5; D'Alessandro M, 2009, J CHEM ECOL, V35, P999, DOI 10.1007/s10886-009-9692-7; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Gouinguene SP, 2002, PLANT PHYSIOL, V129, P1296, DOI 10.1104/pp.001941; Hilker M., 2007, BEHAV ECOLOGY INSECT, P92, DOI DOI 10.1007/S00359-004-0576-6; Hillier NK, 2006, J COMP PHYSIOL A, V192, P199, DOI 10.1007/s00359-005-0061-x; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Kollner TG, 2004, PHYTOCHEMISTRY, V65, P1895, DOI 10.1016/j.phytochem.2004.05.021; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1457, DOI 10.1007/BF02035145; Loughrin JH, 1997, PHYTOCHEMISTRY, V45, P919, DOI 10.1016/S0031-9422(97)00076-9; Najar-Rodriguez AJ, 2010, J EXP BIOL, V213, P3388, DOI 10.1242/jeb.046284; Nojima S, 2003, J CHEM ECOL, V29, P321, DOI 10.1023/A:1022677827233; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Penuelas J, 2004, TRENDS ECOL EVOL, V19, P402, DOI 10.1016/j.tree.2004.06.002; Pichersky E, 2006, TRENDS PLANT SCI, V11, P421, DOI 10.1016/j.tplants.2006.07.007; PIEMENTEL D, 2004, ENCY PLANT CROP SCI, V1, P407; Pinero JC, 2007, ENTOMOL EXP APPL, V125, P185, DOI 10.1111/j.1570-7458.2007.00614.x; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Rose USR, 2005, PLANTA, V222, P327, DOI 10.1007/s00425-005-1528-2; *SAS I, 2009, SAS STAT 9 2 US GUID, DOI DOI 10.1007/S10886-008-9474-7; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; SCHOONHOVEN LM, 1998, INSECT PLANT BIOL; Tasin M, 2006, NATURWISSENSCHAFTEN, V93, P141, DOI 10.1007/s00114-005-0077-7; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010; van Dam NM, 2008, PLANT BIOLOGY, V10, P29, DOI 10.1055/s-2007-964961; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Webster B, 2010, PHYTOCHEMISTRY, V71, P81, DOI 10.1016/j.phytochem.2009.09.029; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6	45	61	61	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e17033	10.1371/journal.pone.0017033	http://dx.doi.org/10.1371/journal.pone.0017033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347337	Green Submitted, gold, Green Published			2022-12-25	WOS:000287361700065
J	Horner, JR; Goodwin, MB; Myhrvold, N				Horner, John R.; Goodwin, Mark B.; Myhrvold, Nathan			Dinosaur Census Reveals Abundant Tyrannosaurus and Rare Ontogenetic Stages in the Upper Cretaceous Hell Creek Formation (Maastrichtian), Montana, USA	PLOS ONE			English	Article							GROWTH DYNAMICS; PREDATOR	Background: A dinosaur census recorded during the Hell Creek Project (1999-2009) incorporates multiple lines of evidence from geography, taphohistory, stratigraphy, phylogeny and ontogeny to investigate the relative abundance of large dinosaurs preserved in the Upper Cretaceous Hell Creek Formation of northeastern Montana, USA. Overall, the dinosaur skeletal assemblages in the Hell Creek Formation (excluding lag-influenced records) consist primarily of subadult or small adult size individuals. Small juveniles and large adults are both extremely rare, whereas subadult individuals are relatively common. We propose that mature individuals of at least some dinosaur taxa either lived in a separate geographic locale analogous to younger individuals inhabiting an upland environment where sedimentation rates were relatively less, or these taxa experienced high mortality before reaching terminal size where late stage and often extreme cranial morphology is expressed. Methodology/Principal Findings: Tyrannosaurus skeletons are as abundant as Edmontosaurus, an herbivore, in the upper Hell Creek Formation and nearly twice as common in the lower third of the formation. Smaller, predatory dinosaurs (e. g., Troodon and dromaeosaurids) are primarily represented by teeth found in microvertebrate localities and their skeletons or identifiable lag specimens were conspicuously absent. This relative abundance suggests Tyrannosaurus was not a typical predator and likely benefited from much wider food choice opportunities than exclusively live prey and/or specific taxa. Tyrannosaurus adults may not have competed with Tyrannosaurus juveniles if the potential for selecting carrion increased with size during ontogeny. Conclusions/Significance: Triceratops is the most common dinosaur and isolated skulls contribute to a significant portion of this census. Associated specimens of Triceratops consisting of both cranial and postcranial elements remain relatively rare. This rarity may be explained by a historical collecting bias influenced by facies and taphonomic factors. The limited discovery of postcranial elements may also depend on how extensive a fossil quarry is expanded after a skull is collected.	[Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Goodwin, Mark B.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Myhrvold, Nathan] Intellectual Ventures, Bellevue, WA USA	Montana State University System; Montana State University Bozeman; University of California System; University of California Berkeley; Intellectual Ventures	Horner, JR (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	jhorner@montana.edu		Myhrvold, Nathan/0000-0003-3994-5143; Goodwin, Mark/0000-0001-7127-439X	Intellectual Ventures; Windway Foundation; Smithsonian Institution; University of California Museum of Paleontology	Intellectual Ventures; Windway Foundation; Smithsonian Institution(Smithsonian Institution); University of California Museum of Paleontology	This work was supported with funding by the following individuals: James Kinsey, Catherine B. Reynolds, and Homer Hickam. Intellectual Ventures, the Windway Foundation, and the Smithsonian Institution provided additional funding. The University of California Museum of Paleontology provided funding to MBG. NM is the founder and CEO of Intellectual Ventures and contributed to the study design. Homer Hickham participated as a Hell Creek Project volunteer in the field in Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Boyd CA, 2009, J VERTEBR PALEONTOL, V29, P758, DOI 10.1671/039.029.0328; Brown B, 1907, B AM MUS NAT HIST, V23, P823; CARPENTER K, 1982, Contributions to Geology University of Wyoming, V20, P123; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; CLOSS G, 1993, ECOLOGY, V74, P238, DOI 10.2307/1939518; Dodson P., 1983, Mosasaur, V1, P89; DODSON P, 1987, OCCASIONAL PAPER TYR, V3, P70; Farlow James O., 2002, Paleontological Society Papers, V8, P251; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; Farlow James O., 1994, Historical Biology, V7, P159; Farlow JO, 2002, HIST BIOL, V16, P21, DOI DOI 10.1080/0891296031000154687; FOWLER DW, 2009, CINCINNATI MUSEUM CT, V3; Goodwin Mark B., 2010, P551; Goodwin MB, 2006, J VERTEBR PALEONTOL, V26, P103, DOI 10.1671/0272-4634(2006)26[103:TSKTSN]2.0.CO;2; Holtz T.R., 2008, TYRANNOSAURUS REX TY, P371; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; MARSH OC, 1891, AM J SCI 3, V42, P265, DOI DOI 10.2475/AJS.S3-42.249.265; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; Mills M. G. L., 2003, KALAHARI HYENAS COMP; Paul G.S., 2008, TYRANNOSAURUS REX, P307; Pearson DA, 2002, GEOL S AM S, P145; Russell DA, 2002, GEOL S AM S, P169; RUSSELL DA, 1977, NATURAL HIST SERIES, V4; Ruxton GD, 2003, P ROY SOC B-BIOL SCI, V270, P731, DOI 10.1098/rspb.2002.2279; Scannella J.B., 2009, CINCINNATI MUSEUM CT, V3, P148; SCANNELLA JB, 2009, J VERTEBRATE PALEONT, V29, P128; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; SHEEHAN PM, 1991, SCIENCE, V254, P835, DOI 10.1126/science.11536489; SINCLAIR ARE, 1995, SERENGETI, V2; STERNBERG CM, 1955, ANN REPT NAT MUS CAN, V136, P120; White PD, 1998, PALAIOS, V13, P41, DOI 10.2307/3515280; Wilson JB, 1996, OECOLOGIA, V106, P272, DOI 10.1007/BF00328608	41	76	79	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16574	10.1371/journal.pone.0016574	http://dx.doi.org/10.1371/journal.pone.0016574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347420	gold, Green Submitted, Green Published			2022-12-25	WOS:000287361700022
J	Murthy, AK; Chaganty, BKR; Troutman, T; Guentzel, MN; Yu, JJ; Ali, SK; Lauriano, CM; Chambers, JP; Klose, KE; Arulanandam, BP				Murthy, Ashlesh K.; Chaganty, Bharat K. R.; Troutman, Ty; Guentzel, M. Neal; Yu, Jieh-Juen; Ali, Syed Khalid; Lauriano, Crystal M.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.			Mannose-Containing Oligosaccharides of Non-Specific Human Secretory Immunoglobulin A Mediate Inhibition of Vibrio cholerae Biofilm Formation	PLOS ONE			English	Article							HUMAN-IGA ANTIBODIES; O1 EL-TOR; ESCHERICHIA-COLI; MUCOSAL SURFACES; PROTECTION; COMPONENT; IMMUNITY; EXPRESSION; MICE; IMMUNIZATION	The role of antigen-specific secretory IgA (SIgA) has been studied extensively, whereas there is a limited body of evidence regarding the contribution of non-specific SIgA to innate immune defenses against invading pathogens. In this study, we evaluated the effects of non-specific SIgA against infection with Vibrio cholerae O139 strain MO10 and biofilm formation. Seven day old infant mice deficient in IgA (IgA(-/-) mice) displayed significantly greater intestinal MO10 burden at 24 hr post-challenge when compared to IgA(+/+) pups. Importantly, cross-fostering of IgA(-/-) pups with IgA(+/+) nursing dams reversed the greater susceptibility to MO10 infection, suggesting a role for non-specific SIgA in protection against the infection. Since biofilm formation is associated with virulence of MO10, we further examined the role of human non-specific SIgA on this virulence phenotype of the pathogen. Human non-specific SIgA, in a dose-dependent fashion, significantly reduced the biofilm formation by MO10 without affecting the viability of the bacterium. Such an inhibitory effect was not induced by human serum IgA, IgG, or IgM, suggesting a role for the oligosaccharide-rich secretory component (SC) of SIgA. This was supported by the demonstration that SIgA treated with endoglycosidase H, to cleave the high-mannose containing terminal chitobiose residues, did not induce a reduction in biofilm formation by MO10. Furthermore, the addition of free mannose per se, across a wide dose range, induced significant reduction in MO10 biofilm formation. Collectively, these results suggest that mannose containing oligosacchardies within human non-specific secretory IgA can alter important virulence phenotypes of Vibrio cholerae such as biofilm formation, without affecting viability of the microorganism. Such effects may contribute significantly to innate immune defenses against invading pathogens in vivo in the gastrointestinal tract.	[Murthy, Ashlesh K.; Chaganty, Bharat K. R.; Troutman, Ty; Guentzel, M. Neal; Yu, Jieh-Juen; Ali, Syed Khalid; Lauriano, Crystal M.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.] S Texas Ctr Emerging Infect Dis, Dept Biol, San Antonio, TX USA		Murthy, AK (corresponding author), S Texas Ctr Emerging Infect Dis, Dept Biol, San Antonio, TX USA.	Bernard.arulanandam@utsa.edu	Arulanandam, Bernard P/O-9501-2014	Troutman, Ty/0000-0001-8925-8080; Chaganty, Bharat Kumar Reddy/0000-0003-3281-6218	National Institutes of Health [AR048973, GM01894]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR048973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was funded National Institutes of Health Grants AR048973 and GM01894. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AL, 2010, INFECT IMMUN, V78, P4402, DOI 10.1128/IAI.00398-10; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; CAMARA LM, 1995, ADV EXP MED BIOL, V371, P673; CLARK JA, 1983, AM J CLIN PATHOL, V80, P210, DOI 10.1093/ajcp/80.2.210; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Cunningham-Rundles C, 2001, J CLIN IMMUNOL, V21, P303, DOI 10.1023/A:1012241117984; Dallas SD, 1998, J MED MICROBIOL, V47, P879, DOI 10.1099/00222615-47-10-879; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; EUBANKS ER, 1977, INFECT IMMUN, V15, P533, DOI 10.1128/IAI.15.2.533-538.1977; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Flajnik MF, 2010, NAT IMMUNOL, V11, P777, DOI 10.1038/ni0910-777; GIUGLIANO LG, 1995, J MED MICROBIOL, V42, P3, DOI 10.1099/00222615-42-1-3; GUENTZEL MN, 1977, INFECT IMMUN, V15, P539, DOI 10.1128/IAI.15.2.539-548.1977; GUENTZEL MN, 1974, INFECT IMMUN, V10, P167, DOI 10.1128/IAI.10.1.167-172.1974; GUENTZEL MN, 1975, INFECT IMMUN, V11, P890, DOI 10.1128/IAI.11.5.890-897.1975; GUENTZEL MN, 1981, SCAN ELECTRON MICROS, P115; Harriman GR, 1999, J IMMUNOL, V162, P2521; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hsiao A, 2006, P NATL ACAD SCI USA, V103, P14542, DOI 10.1073/pnas.0604650103; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; LAMM ME, 1992, ADV EXP MED BIOL, V327, P91; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Lauriano CM, 2004, J BACTERIOL, V186, P4864, DOI 10.1128/JB.186.15.4864-4874.2004; Mason KL, 2008, ADV EXP MED BIOL, V635, P1, DOI 10.1007/978-0-387-09550-9_1; MAZANEC MB, 1992, P NATL ACAD SCI USA, V89, P6901, DOI 10.1073/pnas.89.15.6901; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Murthy AK, 2006, J GASTROEN HEPATOL, V21, P1372, DOI 10.1111/j.1440-1746.2006.04312.x; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; NIKOLOVA EB, 1994, SCAND J IMMUNOL, V39, P275, DOI 10.1111/j.1365-3083.1994.tb03371.x; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; RUSSELL MW, 1989, EUR J IMMUNOL, V19, P2243, DOI 10.1002/eji.1830191210; TOMANA M, 1972, J IMMUNOL, V108, P1631; VANDERHEIJDEN PJ, 1987, IMMUNOLOGY, V62, P551; WALDOR MK, 1994, INFECT IMMUN, V62, P72, DOI 10.1128/IAI.62.1.72-78.1994; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	43	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16847	10.1371/journal.pone.0016847	http://dx.doi.org/10.1371/journal.pone.0016847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347387	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700044
J	Nada, RM; Maal, TJJ; Breuning, KH; Berge, SJ; Mostafa, YA; Kuijpers-Jagtman, AM				Nada, Rania M.; Maal, Thomas J. J.; Breuning, K. Hero; Berge, Stefaan J.; Mostafa, Yehya A.; Kuijpers-Jagtman, Anne Marie			Accuracy and Reproducibility of Voxel Based Superimposition of Cone Beam Computed Tomography Models on the Anterior Cranial Base and the Zygomatic Arches	PLOS ONE			English	Article							ORTHOGNATHIC SURGERY PATIENTS; 3-DIMENSIONAL ANALYSIS	Superimposition of serial Cone Beam Computed Tomography (CBCT) scans has become a valuable tool for three dimensional (3D) assessment of treatment effects and stability. Voxel based image registration is a newly developed semi-automated technique for superimposition and comparison of two CBCT scans. The accuracy and reproducibility of CBCT superimposition on the anterior cranial base or the zygomatic arches using voxel based image registration was tested in this study. 16 pairs of 3D CBCT models were constructed from pre and post treatment CBCT scans of 16 adult dysgnathic patients. Each pair was registered on the anterior cranial base three times and on the left zygomatic arch twice. Following each superimposition, the mean absolute distances between the 2 models were calculated at 4 regions: anterior cranial base, forehead, left and right zygomatic arches. The mean distances between the models ranged from 0.2 to 0.37 mm (SD 0.08-0.16) for the anterior cranial base registration and from 0.2 to 0.45 mm (SD 0.09-0.27) for the zygomatic arch registration. The mean differences between the two registration zones ranged between 0.12 to 0.19 mm at the 4 regions. Voxel based image registration on both zones could be considered as an accurate and a reproducible method for CBCT superimposition. The left zygomatic arch could be used as a stable structure for the superimposition of smaller field of view CBCT scans where the anterior cranial base is not visible.	[Nada, Rania M.; Breuning, K. Hero; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Oral Biol, NL-6525 ED Nijmegen, Netherlands; [Nada, Rania M.; Maal, Thomas J. J.; Breuning, K. Hero; Berge, Stefaan J.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, 3D Facial Imaging Res Grp Nijmegen Bruges, NL-6525 ED Nijmegen, Netherlands; [Maal, Thomas J. J.; Berge, Stefaan J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Nada, Rania M.; Mostafa, Yehya A.] Cairo Univ, Dept Orthodont, Fac Oral & Dent Med, Cairo, Egypt	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Egyptian Knowledge Bank (EKB); Cairo University	Nada, RM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Oral Biol, NL-6525 ED Nijmegen, Netherlands.	orthodontics@dent.umcn.nl	Kuijpers-Jagtman, Anne Marie/A-9413-2008; Berge, Stefaan/AAP-3708-2020; Maal, Thomas JJ/L-4497-2015; Bergé, S.J./H-8011-2014; Breuning, K.H./L-4228-2015	Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Maal, Thomas JJ/0000-0002-1702-4733; 	Dutch Technology Foundation [STW 10315]; Netherlands Ministry of Foreign Affairs; Netherlands Organization for International Cooperation in Higher Education (Nuffic) [NFP-PhD: CF 2916/2006]	Dutch Technology Foundation(Technologiestichting STW); Netherlands Ministry of Foreign Affairs; Netherlands Organization for International Cooperation in Higher Education (Nuffic)	This work was supported by a grant from the Dutch Technology Foundation (STW 10315). R. Nada was funded by the Netherlands Fellowship Program PhD studies, Netherlands Ministry of Foreign Affairs and Netherlands Organization for International Cooperation in Higher Education (Nuffic), grant number: NFP-PhD: CF 2916/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cevidanes LHS, 2005, DENTOMAXILLOFAC RAD, V34, P369, DOI 10.1259/dmfr/17102411; Cevidanes LHC, 2009, AM J ORTHOD DENTOFAC, V136, P94, DOI 10.1016/j.ajodo.2009.01.018; Cevidanes LHS, 2007, AM J ORTHOD DENTOFAC, V131, P44, DOI 10.1016/j.ajodo.2005.03.029; Cevidanes LHS, 2006, AM J ORTHOD DENTOFAC, V129, P611, DOI 10.1016/j.ajodo.2005.12.008; Grauer D, 2009, AM J ORTHOD DENTOFAC, V136, P460, DOI 10.1016/j.ajodo.2009.04.016; Hajeer Mohammad Y, 2002, Int J Adult Orthodon Orthognath Surg, V17, P318; Heymann GC, 2010, AM J ORTHOD DENTOFAC, V137, P274, DOI 10.1016/j.ajodo.2009.07.009; Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Okano T, 2009, DENTOMAXILLOFAC RAD, V38, P79, DOI 10.1259/dmfr/14769929; Palomo JM, 2008, ORAL SURG ORAL MED O, V105, P773, DOI 10.1016/j.tripleo.2007.12.019; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Swennen GRJ, 2009, J CRANIOFAC SURG, V20, P297, DOI 10.1097/SCS.0b013e3181996803; Terajima M, 2008, AM J ORTHOD DENTOFAC, V134, P100, DOI 10.1016/j.ajodo.2006.06.027	14	101	105	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16520	10.1371/journal.pone.0016520	http://dx.doi.org/10.1371/journal.pone.0016520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347419	gold, Green Published, Green Submitted			2022-12-25	WOS:000287361700018
J	Prots, I; Skapenko, A; Lipsky, PE; Schulze-Koops, H				Prots, Iryna; Skapenko, Alla; Lipsky, Peter E.; Schulze-Koops, Hendrik			Analysis of the Transcriptional Program of Developing Induced Regulatory T Cells	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TGF-BETA; RETINOIC-ACID; CUTTING EDGE; FOXP3 EXPRESSION; GENE-EXPRESSION; INDUCTION; DIFFERENTIATION; TREG; COMMITMENT	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). To gain insight into the mechanisms governing iTreg development, we performed longitudinal transcriptional profiling of CD25+ T cells during their differentiation from uncommitted naive CD4 T cells. Microarray analysis of mRNA from CD25+ iTregs early after stimulation revealed expression of genes involved in cell cycle progression and T cell activation, which largely overlapped with genes expressed in CD25+ effector T cells (Teffs) used as a control. Whereas expression of these genes remained elevated in Teffs, it declined gradually in developing iTregs, resulting in a more quiescent phenotype in mature iTregs. A similar pattern of kinetics was observed for biological processes and for intracellular pathways over-represented within the expressed genes. A maximum dichotomy of transcriptional activity between iTregs and Teffs was reached at late stages of their maturation. Of interest, members of the FoxO and FoxM1 transcription factor family pathways exhibited a reciprocal expression pattern in iTregs and Teffs, suggesting a role of these transcription factors in determining T cell fate.	[Prots, Iryna; Skapenko, Alla; Schulze-Koops, Hendrik] Univ Munich, Med Poliklin, Div Rheumatol, D-8000 Munich, Germany; [Lipsky, Peter E.] Natl Inst Arthrit & Musculoskeletal & Skin, NIH, Bethesda, MD USA	University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Prots, I (corresponding author), Univ Munich, Med Poliklin, Div Rheumatol, Pettenkoferstr 8A, D-8000 Munich, Germany.	alla.skapenko@med.uni-muenchen.de	Prots, Iryna/O-7982-2018	Prots, Iryna/0000-0001-9561-0909	Deutsche Forschungsgemeinschaft [Schu786/8-1, Schu786/2-5, SK59/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp; Grants Schu786/8-1, Schu786/2-5, and SK59/4-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2008, J CLIN IMMUNOL, V28, P619, DOI 10.1007/s10875-008-9254-8; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2006, EUR J IMMUNOL, V36, P1360, DOI 10.1002/eji.200636171; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Golshayan D, 2007, BLOOD, V109, P827, DOI 10.1182/blood-2006-05-025460; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jaeckel E, 2006, SEMIN IMMUNOL, V18, P89, DOI 10.1016/j.smim.2006.01.011; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pfoertner S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r54; Pillai V, 2007, IMMUNOL LETT, V114, P9, DOI 10.1016/j.imlet.2007.08.012; ROSENBERG SA, 1979, J IMMUNOL, V122, P926; Sakaguchi S, 2005, INT REV IMMUNOL, V24, P211, DOI 10.1080/08830180590934976; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Skapenko A, 2001, J IMMUNOL, V166, P4283, DOI 10.4049/jimmunol.166.7.4283; Stockis J, 2009, EUR J IMMUNOL, V39, P869, DOI 10.1002/eji.200838807; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	60	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16913	10.1371/journal.pone.0016913	http://dx.doi.org/10.1371/journal.pone.0016913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347372	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700053
J	Reneerkens, J; Grond, K; Schekkerman, H; Tulp, I; Piersma, T				Reneerkens, Jeroen; Grond, Kirsten; Schekkerman, Hans; Tulp, Ingrid; Piersma, Theunis			Do Uniparental Sanderlings Calidris alba Increase Egg Heat Input to Compensate for Low Nest Attentiveness?	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; INCUBATION SCHEDULES; WOOD DUCKS; DEMANDS; TEMPERATURE; GROWTH; BIRDS; SHOREBIRDS; INVESTMENT; ATTENDANCE	Birds breeding in cold environments regularly have to interrupt incubation to forage, causing a trade-off between two mutually exclusive behaviours. Earlier studies showed that uniparental Arctic sandpipers overall spend less time incubating their eggs than biparental species, but interspecific differences in size and ecology were potential confounding factors. This study reports on a within-species comparison of breeding schedules and metal egg temperatures in uni- and biparental sanderlings (Calidris alba) in Northeast Greenland in relation to ambient temperature. We recorded incubation schedules with nest temperature loggers in 34 sanderling clutches (13 uniparentals, 21 biparentals). The temperature of a metal egg placed within the clutch of 17 incubating birds (6 uniparentals, 9 biparentals) was measured as an indicator of the heat put into eggs. Recess frequency, recess duration and total recess time were higher in uniparentals than in biparentals and positively correlated with ambient temperatures in uniparentals only. Uniparental sanderlings maintained significantly higher metal egg temperatures during incubation than biparentals (1.4 degrees C difference on average). Our results suggest that uniparental sanderlings compensate for the lower nest attendance, which may prolong the duration of the incubation period and negatively affect the condition of the hatchlings, by maintaining a higher heat flux into the eggs.	[Reneerkens, Jeroen; Grond, Kirsten; Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Schekkerman, Hans] Dutch Ctr Field Ornithol, SOVON, Nijmegen, Netherlands; [Tulp, Ingrid] Inst Marine Resources & Ecosyst Studies, Ijmuiden, Netherlands; [Piersma, Theunis] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Texel, Netherlands	University of Groningen; Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Reneerkens, J (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands.	J.W.H.Reneerkens@rug.nl	Reneerkens, Jeroen/J-3880-2015; Grond, Kirsten/J-9862-2019; Piersma, Theunis/D-1871-2012	Reneerkens, Jeroen/0000-0003-0674-8143; Grond, Kirsten/0000-0001-6197-7139; Piersma, Theunis/0000-0001-9668-466X; Schekkerman, Hans/0000-0003-3127-4832	Netherlands Organization for Scientific Research (NWO) [851.40.072]; Schure-Beijerinck-Popping Fund	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Schure-Beijerinck-Popping Fund	This work was supported by an International Polar Year grant (851.40.072) by the Netherlands Organization for Scientific Research (NWO) to T. Piersma and J. Reneerkens, and by a research grant by the Schure-Beijerinck-Popping Fund (http://www.knaw.nl/cfdata/funding/funding_detail.cfm?orgid = 103) to I. Tulp and H. Schekkerman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlRashidi M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-1; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Ardia DR, 2009, J ANIM ECOL, V78, P4, DOI 10.1111/j.1365-2656.2008.01453.x; BOSQUE C, 1995, AM NAT, V145, P234, DOI 10.1086/285738; CAREY C, 2001, AVIAN INCUBATION BEH, P238; Cresswell W, 2003, BEHAV ECOL, V14, P97, DOI 10.1093/beheco/14.1.97; Cresswell W, 2004, BEHAV ECOL, V15, P498, DOI 10.1093/beheco/arh042; D'Alba L, 2009, J THERM BIOL, V34, P93, DOI 10.1016/j.jtherbio.2008.11.005; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; DEEMING DC, 2001, AVIAN INCUBATION BEH, P63; Groscolas R, 2000, AM J PHYSIOL-REG I, V279, pR2104, DOI 10.1152/ajpregu.2000.279.6.R2104; Hainsworth FR, 1998, J AVIAN BIOL, V29, P113, DOI 10.2307/3677188; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hepp GR, 2005, J AVIAN BIOL, V36, P523; Jongbloed Frank, 2006, Limosa, V79, P63; KALAS JA, 1986, ARDEA, V74, P185; Klaassen M, 2003, AVIAN MIGRATION, P237; KOMEDA S, 1983, AUK, V100, P48, DOI 10.1093/auk/100.1.48; Liebezeit JR, 2007, CONDOR, V109, P32, DOI 10.1650/0010-5422(2007)109[32:ATDOSE]2.0.CO;2; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; LOFALDLI L, 1985, HOLARCTIC ECOL, V8, P107; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; MEHLUM F, 1991, FAUNA NOR C, V1, P33; Meltofte H, 2008, ADV ECOL RES, V40, P101, DOI 10.1016/S0065-2504(07)00005-0; Meltofte Hans, 2007, Meddelelser om Gronland Bioscience, V59, P1; NORTON DW, 1972, CONDOR, V74, P164, DOI 10.2307/1366280; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; PARMELEE D F, 1970, Living Bird, V9, P97; PARMELEE DF, 1973, IBIS, V115, P218, DOI 10.1111/j.1474-919X.1973.tb02638.x; Perez JH, 2008, BIOL LETTERS, V4, P468, DOI 10.1098/rsbl.2008.0266; PIENKOWSKI M W, 1976, British Birds, V69, P165; Piersma T, 2003, FUNCT ECOL, V17, P356, DOI 10.1046/j.1365-2435.2003.00741.x; Piersma T, 1996, HDB BIRDS WORLD, V3, P444; Piersma Theunis, 2006, Wader Study Group Bulletin, V109, P83; Pulliainen E, 1997, ARDEA, V85, P67; Rasbash J, 2004, USERS GUIDE MLWIN; Reid JM, 2000, FUNCT ECOL, V14, P560, DOI 10.1046/j.1365-2435.2000.00446.x; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Reid JM, 2002, OX ORN SER, V13, P314; Reneerkens Jeroen, 2009, Wader Study Group Bulletin, V116, P2; Reneerkens Jeroen, 2005, Wader Study Group Bulletin, V106, P12; Romanoff A. L., 1949, AVIAN EGG; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; SCHMIDT NM, 2010, BIOBASIS CONCEPTUAL; Smith PA, 2010, OECOLOGIA, V163, P613, DOI 10.1007/s00442-010-1644-y; THIBAULT M, 1995, CAN J ZOOL, V73, P879, DOI 10.1139/z95-103; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Tinbergen JM, 2002, OX ORN SER, V13, P299; Tombre IM, 1996, J ANIM ECOL, V65, P325, DOI 10.2307/5878; Tomkovich P.S., 2001, Ornitologiya, V29, P125; Tulp I, 2006, J AVIAN BIOL, V37, P207, DOI 10.1111/j.2006.0908-8857.03519.x; TULP I, 2007, THESIS U GRONINGEN; Tulp I, 2008, ARCTIC, V61, P48; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; VLECK CM, 1980, AM ZOOL, V20, P405; WARD D, 1990, AUK, V107, P10; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Williams Joseph B., 1996, P375; Yasue M, 2008, J ETHOL, V26, P99, DOI 10.1007/s10164-007-0034-3; [No title captured]	61	34	35	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16834	10.1371/journal.pone.0016834	http://dx.doi.org/10.1371/journal.pone.0016834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347377	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700041
J	Hu, JZ; Nudelman, G; Shimoni, Y; Kumar, M; Ding, YM; Lopez, C; Hayot, F; Wetmur, JG; Sealfon, SC				Hu, Jianzhong; Nudelman, German; Shimoni, Yishai; Kumar, Madhu; Ding, Yaomei; Lopez, Carolina; Hayot, Fernand; Wetmur, James G.; Sealfon, Stuart C.			Role of Cell-to-Cell Variability in Activating a Positive Feedback Antiviral Response in Human Dendritic Cells	PLOS ONE			English	Article							GENE-EXPRESSION; IMMUNE-RESPONSE; VIRAL-INFECTION; MATURATION; RNA; BIFURCATION; DYNAMICS; PROMOTER; VIRUSES; NOISE	In the first few hours following Newcastle disease viral infection of human monocyte-derived dendritic cells, the induction of IFNB1 is extremely low and the secreted type I interferon response is below the limits of ELISA assay. However, many interferon-induced genes are activated at this time, for example DDX58 (RIGI), which in response to viral RNA induces IFNB1. We investigated whether the early induction of IFNBI in only a small percentage of infected cells leads to low level IFN secretion that then induces IFN-responsive genes in all cells. We developed an agent-based mathematical model to explore the IFNBI and DDX58 temporal dynamics. Simulations showed that a small number of early responder cells provide a mechanism for efficient and controlled activation of the DDX58-IFNBI positive feedback loop. The model predicted distributions of single cell responses that were confirmed by single cell mRNA measurements. The results suggest that large cell-to-cell variation plays an important role in the early innate immune response, and that the variability is essential for the efficient activation of the IFNB1 based feedback loop.	[Hu, Jianzhong; Kumar, Madhu; Ding, Yaomei; Lopez, Carolina; Wetmur, James G.; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Nudelman, German; Shimoni, Yishai; Hayot, Fernand; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Nudelman, German; Shimoni, Yishai; Hayot, Fernand; Wetmur, James G.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Hu, JZ (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	james.wetmur@mssm.edu	Lopez, Carolina/A-8887-2008; Hu, Jianzhong/ABE-4311-2020; Hu, Jianzhong/P-6305-2014	Lopez, Carolina/0000-0002-7669-6572; Hu, Jianzhong/0000-0001-8546-5111; Hu, Jianzhong/0000-0001-8546-5111; SEALFON, Stuart/0000-0001-5791-1217	National Institute of Allergy and Infectious Diseases [HHSN266200500021C, U19 AI06231]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract HHSN266200500021C and grant U19 AI06231 from the National Institute of Allergy and Infectious Diseases. The funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin A, 1998, GENETICS, V149, P1633; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Coppey M, 2007, BIOPHYS J, V93, P1917, DOI 10.1529/biophysj.107.109736; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hu J, 2009, BIOPHYS J, V97, P1984, DOI 10.1016/j.bpj.2009.05.067; Hu JZ, 2007, NUCLEIC ACIDS RES, V35, P5232, DOI 10.1093/nar/gkm557; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lopez CB, 2006, J VIROL, V80, P3128, DOI 10.1128/JVI.80.7.3128-3134.2006; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Nair VD, 2004, J BIOL CHEM, V279, P27494, DOI 10.1074/jbc.M312135200; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Pascal V, 2006, IMMUNOL REV, V214, P9, DOI 10.1111/j.1600-065X.2006.00452.x; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; Qiao L, 2010, BIOPHYS J, V98, P505, DOI 10.1016/j.bpj.2009.10.049; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Tournier JN, 2010, TRENDS MOL MED, V16, P303, DOI 10.1016/j.molmed.2010.04.006; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Zaslavsky E, 2010, J IMMUNOL, V184, P2908, DOI 10.4049/jimmunol.0903453	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16614	10.1371/journal.pone.0016614	http://dx.doi.org/10.1371/journal.pone.0016614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347441	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600010
J	Pfafferott, K; Gaudieri, S; Ulsenheimer, A; James, I; Heeg, M; Nolan, D; John, M; Rauch, A; Mallal, S; Lucas, A; Klenerman, P; Diepolder, HM; Lucas, M				Pfafferott, Katja; Gaudieri, Silvana; Ulsenheimer, Axel; James, Ian; Heeg, Malte; Nolan, David; John, Mina; Rauch, Andri; Mallal, Simon; Lucas, Andrew; Klenerman, Paul; Diepolder, Helmut M.; Lucas, Michaela			Constrained Pattern of Viral Evolution in Acute and Early HCV Infection Limits Viral Plasticity	PLOS ONE			English	Article							HEPATITIS-C VIRUS; T-CELL RESPONSE; IMMUNE-RESPONSES; IMMUNOLOGICAL DETERMINANTS; SEQUENCE DIVERSITY; SOURCE OUTBREAK; HIV-1 GAG; CLEARANCE; ESCAPE; PERSISTENCE	Cellular immune responses during acute Hepatitis C virus (HCV) and HIV infection are a known correlate of infection outcome. Viral adaptation to these responses via mutation(s) within CD8+ T-cell epitopes allows these viruses to subvert host immune control. This study examined HCV evolution in 21 HCV genotype 1-infected subjects to characterise the level of viral adaptation during acute and early HCV infection. Of the total mutations observed 25% were within described CD8+ T-cell epitopes or at viral adaptation sites. Most mutations were maintained into the chronic phase of HCV infection (75%). The lack of reversion of adaptations and high proportion of silent substitutions suggests that HCV has structural and functional limitations that constrain evolution. These results were compared to the pattern of viral evolution observed in 98 subjects during a similar phase in HIV infection from a previous study. In contrast to HCV, evolution during acute HIV infection is marked by high levels of amino acid change relative to silent substitutions, including a higher proportion of adaptations, likely reflecting strong and continued CD8+ T-cell pressure combined with greater plasticity of the virus. Understanding viral escape dynamics for these two viruses is important for effective T cell vaccine design.	[Pfafferott, Katja; Gaudieri, Silvana; James, Ian; Nolan, David; John, Mina; Rauch, Andri; Mallal, Simon; Lucas, Andrew; Lucas, Michaela] Murdoch Univ, Inst Immunol & Infect Dis, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia; [Pfafferott, Katja; Gaudieri, Silvana; James, Ian; Nolan, David; John, Mina; Rauch, Andri; Mallal, Simon; Lucas, Andrew; Lucas, Michaela] Royal Perth Hosp, Perth, WA, Australia; [Gaudieri, Silvana] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia; [Gaudieri, Silvana] Univ Western Australia, Ctr Forens Sci, Perth, WA 6009, Australia; [Ulsenheimer, Axel; Heeg, Malte; Diepolder, Helmut M.] Univ Munich, Dept Med 2, Munich, Germany; [Ulsenheimer, Axel; Heeg, Malte; Diepolder, Helmut M.] Univ Munich, Inst Immunol, D-8000 Munich, Germany; [Rauch, Andri] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Klenerman, Paul] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	Murdoch University; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Munich; University of Munich; University of Bern; University Hospital of Bern; University of Bern; University of Oxford	Pfafferott, K (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia.	michaela.lucas@health.wa.gov.au	Mallal, Simon Alexander/HDM-9561-2022; Rauch, Andri/E-9948-2017	Mallal, Simon Alexander/0000-0002-7036-1309; Rauch, Andri/0000-0001-5297-6062; , Silvana/0000-0001-6873-0198; klenerman, paul/0000-0003-4307-9161; Lucas, Michaela/0000-0001-8881-9990; Lucas, Andrew Douglas/0000-0003-2899-1806	National Health and Medical Research Council of Australia [334603, 384702]; Roche; Swiss National Science Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Roche(Roche Holding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The research described in this manuscript has been funded by the National Health and Medical Research Council of Australia (Grant numbers 334603 and 384702) and a Pillar Award from Roche. A. R. was supported by a Grant for Prospective Researchers from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Barnes E, 2004, EUR J IMMUNOL, V34, P1570, DOI 10.1002/eji.200424898; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Cox AL, 2005, HEPATOLOGY, V42, P104, DOI 10.1002/hep.20749; Dazert E, 2009, J CLIN INVEST, V119, P376, DOI 10.1172/JCI36587; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; *FRAHM NLCABC, 2008, HIV MOL IMMUNOLOGY, P3; Gaudieri S, 2006, J VIROL, V80, P11094, DOI 10.1128/JVI.00912-06; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; GRAUR D, 1985, J MOL EVOL, V21, P221, DOI 10.1007/BF02102356; Gruner NH, 2000, J INFECT DIS, V181, P1528, DOI 10.1086/315450; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kuntzen T, 2007, J VIROL, V81, P11658, DOI 10.1128/JVI.00995-07; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Rauch A, 2009, HEPATOLOGY, V50, P1017, DOI 10.1002/hep.23101; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Tester I, 2005, J EXP MED, V201, P1725, DOI 10.1084/jem.20042284; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Timm J, 2007, WORLD J GASTROENTERO, V13, P4808, DOI 10.3748/wjg.v13.i36.4808; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Yusim Karina, 2005, Appl Bioinformatics, V4, P217, DOI 10.2165/00822942-200504040-00002	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16797	10.1371/journal.pone.0016797	http://dx.doi.org/10.1371/journal.pone.0016797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347433	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600029
J	Uno, Y; Uehara, S; Kohara, S; Iwasaki, K; Nagata, R; Fukuzaki, K; Utoh, M; Murayama, N; Yamazaki, H				Uno, Yasuhiro; Uehara, Shotaro; Kohara, Sakae; Iwasaki, Kazuhide; Nagata, Ryoichi; Fukuzaki, Koichiro; Utoh, Masahiro; Murayama, Norie; Yamazaki, Hiroshi			Newly Identified CYP2C93 Is a Functional Enzyme in Rhesus Monkey, but Not in Cynomolgus Monkey	PLOS ONE			English	Article							MACACA-FASCICULARIS; ESCHERICHIA-COLI; CYTOCHROME-P450; CYP3A5; LIVER; EXPRESSION; VARIANTS; CLONING; HYDROXYLATION; TOLBUTAMIDE	Cynomolgus monkey and rhesus monkey are used in drug metabolism studies due to their evolutionary closeness and physiological resemblance to human. In cynomolgus monkey, we previously identified cytochrome P450 (P450 or CYP) 2C76 that does not have a human ortholog and is partly responsible for species differences in drug metabolism between cynomolgus monkey and human. In this study, we report characterization of CYP2C93 cDNA newly identified in cynomolgus monkey and rhesus monkey. The CYP2C93 cDNA contained an open reading frame of 490 amino acids approximately 84-86% identical to human CYP2Cs. CYP2C93 was located in the genomic region, which corresponded to the intergenic region in the human genome, indicating that CYP2C93 does not correspond to any human genes. CYP2C93 mRNA was expressed predominantly in the liver among 10 tissues analyzed. The CYP2C93 proteins heterologously expressed in Escherichia coli metabolized human CYP2C substrates, diclofenac, flurbiprofen, paclitaxel, S-mephenytoin, and tolbutamide. In addition to a normal transcript (SV1), an aberrantly spliced transcript (SV2) lacking exon 2 was identified, which did not give rise to a functional protein due to frameshift and a premature termination codon. Mini gene assay revealed that the genetic variant IVS2-1G>T at the splice site of intron 1, at least partly, accounted for the exon-2 skipping; therefore, this genotype would influence CYP2C93-mediated drug metabolism. SV1 was expressed in 6 of 11 rhesus monkeys and 1 of 8 cynomolgus monkeys, but the SV1 in the cynomolgus monkey was nonfunctional due to a rare null genotype (c.102T>del). These results suggest that CYP2C93 can play roles as a drug-metabolizing enzyme in rhesus monkeys (not in cynomolgus monkeys), although its relative contribution to drug metabolism has yet to be validated.	[Uno, Yasuhiro; Uehara, Shotaro; Kohara, Sakae; Nagata, Ryoichi; Fukuzaki, Koichiro; Utoh, Masahiro] Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Kainan, Japan; [Iwasaki, Kazuhide] Shin Nippon Biomed Labs Ltd, Business Dev Dept, Osaka, Japan; [Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan	Shin Nippon Biomedical Laboratories Ltd.; Shin Nippon Biomedical Laboratories Ltd.; Showa Pharmaceutical University	Uno, Y (corresponding author), Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Kainan, Japan.	uno-yasuhiro@snbl.co.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261; Uehara, Shotaro/0000-0002-1359-8828; Uno, Yasuhiro/0000-0001-9040-1681	Shin Nippon Biomedical Laboratories, Ltd.	Shin Nippon Biomedical Laboratories, Ltd.	The funder, Shin Nippon Biomedical Laboratories, Ltd., had no role in study design, data collection and analysis, or preparation of the manuscript, but approved the decision to publish.	Chen WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-82; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; GOTOH O, 1992, J BIOL CHEM, V267, P83; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Inoue K, 1997, PHARMACOGENETICS, V7, P103, DOI 10.1097/00008571-199704000-00003; Iwata H, 1998, BIOCHEM PHARMACOL, V55, P1315, DOI 10.1016/S0006-2952(97)00643-6; KOMORI M, 1992, BIOCHIM BIOPHYS ACTA, V1171, P141, DOI 10.1016/0167-4781(92)90113-E; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; Magness CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r60; Matsunaga Tamihide, 2002, Drug Metab Pharmacokinet, V17, P117, DOI 10.2133/dmpk.17.117; Mitsuda M, 2006, J BIOCHEM, V139, P865, DOI 10.1093/jb/mvj093; Narimatsu S, 2006, BIOCHEM PHARMACOL, V72, P1738, DOI 10.1016/j.bcp.2006.08.025; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; SHARER JE, 1995, DRUG METAB DISPOS, V23, P1231; Tang CY, 2007, BIOCHEM PHARMACOL, V73, P880, DOI 10.1016/j.bcp.2006.11.016; Uno Y, 2007, XENOBIOTICA, V37, P30, DOI 10.1080/00498250600968275; UNO Y, 2009, J VET MED S IN PRESS; Uno Y, 2008, FEBS LETT, V582, P351, DOI 10.1016/j.febslet.2007.12.031; Uno Y, 2006, MOL PHARMACOL, V70, P477, DOI 10.1124/mol.106.022673; Uno Y, 2010, CURR DRUG METAB, V11, P142, DOI 10.2174/138920010791110854; Uno Y, 2010, J VET MED SCI, V72, P225, DOI 10.1292/jvms.09-0341; Uno Y, 2010, DRUG METAB DISPOS, V38, P209, DOI 10.1124/dmd.109.029710; Uno Y, 2009, DRUG METAB DISPOS, V37, P14, DOI 10.1124/dmd.108.023622; Yamazaki H, 1998, BIOCHEM PHARMACOL, V56, P243, DOI 10.1016/S0006-2952(98)00133-6; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578	27	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16923	10.1371/journal.pone.0016923	http://dx.doi.org/10.1371/journal.pone.0016923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347438	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600034
J	Delluc, S; Ravot, G; Maillere, B				Delluc, Stephanie; Ravot, Gilles; Maillere, Bernard			Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors	FASEB JOURNAL			English	Article						humanization; immunogenicity; naive	SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLINICAL-RESPONSE; RITUXIMAB TREATMENT; TRANSGENIC MICE; HEMOPHILIA-A; FACTOR-VIII; IFN-BETA; IMMUNOGENICITY; TOLERANCE; ETANERCEPT	Therapeutic antibodies are generally partially to fully humanized, yet they can show unwanted immunogenicity and lead to antibody response and adverse effects when administered to humans. As immunogenicity relies on a T-cell-dependent mechanism, we have evaluated in vitro the size of the preexisting CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors. Specific CD4 T cells of individuals with different HLA-DR allotypes were amplified by in vitro stimulation and quantified. Well-known immunogenic proteins, KLH and a murine antibody, exhibited a strong in vitro T-cell response characterized by a mean of preexisting T cells >1 cell/10(6) cells. In contrast, the preexisting CD4 T-cell repertoires specific to 2 chimeric, 2 humanized, and 2 fully human antibodies remained generally inferior to this value, confirming the role of species-specific sequences in their shaping. Mean values ranged from 0.01 to 0.3 cell/10(6) cells and varied not necessarily in relationship with the humanization level of the therapeutic antibodies. Relationship with their known immunogenicity is discussed. These results contribute to a better understanding and prediction of immunogenicity of therapeutic antibodies in humans.-Delluc, S., Ravot, G., Maillere, B. Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors. FASEB J. 25, 2040-2048 (2011). www.fasebj.org	[Delluc, Stephanie; Ravot, Gilles] Proteus, F-30035 Nimes 1, France; [Maillere, Bernard] Commissariat Energie Atom & Energies Alternat, Inst Biol & Technol Saclay, Serv Ingn Mol Prot, Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Maillere, B (corresponding author), CEA, iBiTecS, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France.	sdelluc@proteus.fr; bernard.maillere@cea.fr			Proteus; Commissariat a l'Energie Atomique et aux Energies Alternatives	Proteus; Commissariat a l'Energie Atomique et aux Energies Alternatives	The authors thank Prof. J.-L. Prugnaud (St. Antoine Hospital, Paris, France) and Dr. Ingrid Marchal-Gerez (Proteus) for advice. The authors also thank Prof. J.-L. Prugnaud, Prof. A. Buzyn (Necker-Enfants Malades Hospital, Paris, France), Prof. M. Breban (Ambroise Pare Hospital, Boulogne-Billancourt, France) and Prof. S. Oudard (European Georges Pompidou Hospital, Paris, France) for the kind gift of therapeutic antibodies. This work was supported by Proteus and the Commissariat a l'Energie Atomique et aux Energies Alternatives.	Antonelli G, 1996, CLIN EXP IMMUNOL, V104, P384, DOI 10.1046/j.1365-2249.1996.43747.x; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Barbosa MDFS, 2006, CLIN IMMUNOL, V118, P42, DOI 10.1016/j.clim.2005.08.017; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Bender NK, 2007, RHEUMATOL INT, V27, P269, DOI 10.1007/s00296-006-0183-7; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; BOGEN B, 1993, EMBO J, V12, P357, DOI 10.1002/j.1460-2075.1993.tb05664.x; BOULAIN JC, 1982, SCIENCE, V217, P732, DOI 10.1126/science.7100919; BRAY GL, 1993, AM J HEMATOL, V42, P375, DOI 10.1002/ajh.2830420408; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CIBOTTI R, 1992, P NATL ACAD SCI USA, V89, P416, DOI 10.1073/pnas.89.1.416; De Groot AS, 2008, BLOOD, V112, P3303, DOI 10.1182/blood-2008-02-138073; de Vries MK, 2009, ANN RHEUM DIS, V68, P531, DOI 10.1136/ard.2008.089979; de Vries MK, 2007, ANN RHEUM DIS, V66, P1252, DOI 10.1136/ard.2007.072397; Delluc S, 2010, BLOOD, V116, P4542, DOI 10.1182/blood-2010-04-280875; Denton CP, 2009, ANN RHEUM DIS, V68, P1433, DOI 10.1136/ard.2008.096123; Dore RK, 2007, CLIN EXP RHEUMATOL, V25, P40; Duda PW, 2000, J IMMUNOL, V165, P7300, DOI 10.4049/jimmunol.165.12.7300; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Haribhai D, 2003, J IMMUNOL, V170, P3007, DOI 10.4049/jimmunol.170.6.3007; HLA Colombani J, 1993, HLA FONCTIONS IMMUNI; Jacquemin M, 2003, BLOOD, V101, P1351, DOI 10.1182/blood-2002-05-1369; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Lippolis JD, 2002, J IMMUNOL, V169, P5089, DOI 10.4049/jimmunol.169.9.5089; Loirat D, 2003, INT IMMUNOL, V15, P1125, DOI 10.1093/intimm/dxg117; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Peng A, 2009, J PHARM SCI-US, V98, P4480, DOI 10.1002/jps.21765; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Piro LD, 1999, ANN ONCOL, V10, P655, DOI 10.1023/A:1008389119525; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Sandborn WJ, 2007, GUT, V56, P1232, DOI 10.1136/gut.2006.106781; Schmidt E, 2009, CLIN IMMUNOL, V132, P334, DOI 10.1016/j.clim.2009.05.007; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Smith KGC, 2006, ARTHRITIS RHEUM-US, V54, P2970, DOI 10.1002/art.22046; Tanaka Yoshiya, 2007, Mod Rheumatol, V17, P191; Thurlings RM, 2010, ANN RHEUM DIS, V69, P409, DOI 10.1136/ard.2009.109041; Tyring S, 2007, ARCH DERMATOL, V143, P719, DOI 10.1001/archderm.143.6.719; Valmori D, 2005, CLIN IMMUNOL, V117, P161, DOI 10.1016/j.clim.2005.07.004; Van Walle I, 2007, EXPERT OPIN BIOL TH, V7, P405, DOI 10.1517/14712598.7.3.405; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671; Yeung VP, 2004, J IMMUNOL, V172, P6658, DOI 10.4049/jimmunol.172.11.6658; YULE TD, 1993, J IMMUNOL, V151, P3057; Zhang Y, 2005, EUR J IMMUNOL, V35, P1066, DOI 10.1002/eji.200425847	54	45	45	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					2040	2048		10.1096/fj.10-173872	http://dx.doi.org/10.1096/fj.10-173872			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21368101				2022-12-25	WOS:000291023800026
J	Srougi, MC; Burridge, K				Srougi, Melissa C.; Burridge, Keith			The Nuclear Guanine Nucleotide Exchange Factors Ect2 and Net1 Regulate RhoB-Mediated Cell Death after DNA Damage	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HUMAN-BREAST-CANCER; GTPASE RHOB; INDUCED APOPTOSIS; EXPRESSION; PROTEINS; ACTIVATION; ONCOGENE; AKT; BIM	Commonly used antitumor treatments, including radiation and chemotherapy, function by damaging the DNA of rapidly proliferating cells. However, resistance to these agents is a predominant clinical problem. A member of the Rho family of small GTPases, RhoB has been shown to be integral in mediating cell death after ionizing radiation (IR) or other DNA damaging agents in Ras-transformed cell lines. In addition, RhoB protein expression increases after genotoxic stress, and loss of RhoB expression causes radio-and chemotherapeutic resistance. However, the signaling pathways that govern RhoB-induced cell death after DNA damage remain enigmatic. Here, we show that RhoB activity increases in human breast and cervical cancer cell lines after treatment with DNA damaging agents. Furthermore, RhoB activity is necessary for DNA damage-induced cell death, as the stable loss of RhoB protein expression using shRNA partially protects cells and prevents the phosphorylation of c-Jun N-terminal kinases (JNKs) and the induction of the pro-apoptotic protein Bim after IR. The increase in RhoB activity after genotoxic stress is associated with increased activity of the nuclear guanine nucleotide exchange factors (GEFs), Ect2 and Net1, but not the cytoplasmic GEFs p115 RhoGEF or Vav2. Importantly, loss of Ect2 and Net1 via siRNA-mediated protein knock-down inhibited IR-induced increases in RhoB activity, reduced apoptotic signaling events, and protected cells from IR-induced cell death. Collectively, these data suggest a mechanism involving the nuclear GEFs Ect2 and Net1 for activating RhoB after genotoxic stress, thereby facilitating cell death after treatment with DNA damaging agents.	[Srougi, Melissa C.; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA; [Srougi, Melissa C.; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Srougi, MC (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	melissa_srougi@med.unc.edu		Srougi, Melissa/0000-0003-2183-0233	National Institutes of Health [GM029860]; American Cancer Society [PF-09-048-01-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant GM029860 (to K.B.). M.C.S. is supported by the American Cancer Society Postdoctoral Fellowship PF-09-048-01-GMC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Adnane J, 2002, CLIN CANCER RES, V8, P2225; Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Bentle MS, 2007, CANCER RES, V67, P6936, DOI 10.1158/0008-5472.CAN-07-0935; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; CARMICHAEL J, 1989, EUR J CANCER CLIN ON, V25, P527, DOI 10.1016/0277-5379(89)90266-6; Chan AML, 1996, ONCOGENE, V12, P1259; DECREMOUX P, 1994, INT J CANCER, V59, P408, DOI 10.1002/ijc.2910590320; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Forget MA, 2002, CLIN EXP METASTAS, V19, P9, DOI 10.1023/A:1013884426692; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fritz G, 2001, J BIOL CHEM, V276, P3115, DOI 10.1074/jbc.M005058200; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garcia-Mata R, 2007, MOL CELL BIOL, V27, P8683, DOI 10.1128/MCB.00157-07; Guerra L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002254; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kamasani U, 2004, CANCER RES, V64, P8389, DOI 10.1158/0008-5472.CAN-04-2437; Kim CH, 2010, BIOCHEM BIOPH RES CO, V391, P1182, DOI 10.1016/j.bbrc.2009.12.012; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kong JY, 2005, BIOCHEM CELL BIOL, V83, P608, DOI 10.1139/o05-066; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; ROCHLITZ CF, 1989, CANCER RES, V49, P357; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Scoumanne A, 2006, CANCER RES, V66, P6271, DOI 10.1158/0008-5472.CAN-06-0121; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Trapp T, 2001, MOL CELL NEUROSCI, V17, P883, DOI 10.1006/mcne.2001.0971; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Yang JY, 2006, INT J ONCOL, V29, P643	53	41	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17108	10.1371/journal.pone.0017108	http://dx.doi.org/10.1371/journal.pone.0017108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373644	Green Published, Green Submitted, gold			2022-12-25	WOS:000287657500033
J	Murdolo, G; Nowotny, B; Celi, F; Donati, M; Bini, V; Papi, F; Gornitzka, G; Castellani, S; Roden, M; Falorni, A; Herder, C; Falorni, A				Murdolo, Giuseppe; Nowotny, Bettina; Celi, Federica; Donati, Miranda; Bini, Vittorio; Papi, Francesco; Gornitzka, Gabi; Castellani, Serena; Roden, Michael; Falorni, Adriano; Herder, Christian; Falorni, Alberto			Inflammatory Adipokines, High Molecular Weight Adiponectin, and Insulin Resistance: A Population-Based Survey in Prepubertal Schoolchildren	PLOS ONE			English	Article							BODY-MASS INDEX; COOPERATIVE HEALTH RESEARCH; METABOLIC SYNDROME; OBESE CHILDREN; PLASMA LEPTIN; MONICA/KORA AUGSBURG; GENDER-DIFFERENCES; SCHOOL-CHILDREN; ADIPOSE-TISSUE; 3 PROVINCES	Background: The aim of this study was to investigate sex differences and associations of high molecular weight (HMW) adiponectin, leptin and proinflammatory adipokines, individually or in combinations, with adiposity and insulin resistance (IR) measures in prepubertal childhood. Methodology: We studied 305 prepubertal children (boys/girls: 144/161; Tanner stage 1; age: 5-13 yr), included in a cohort of 44,231 adolescents who participated in an extensive Italian school-based survey. According to Cole's criteria, 105 individuals were lean (L; boys/girls: 59/46), 60 overweight (OW; boys/girls: 32/28) and 140 obese (OB; boys/girls: 70/70). Measurements comprised total and HMW adiponectin, leptin, as well as a panel of proinflammatory adipokines/chemokines associated with diabetes risk. Principal Findings: Leptin-, and the leptin-to-HMW adiponectin ratio (L/HMW)-, increased progressively (p<0.0001) from L to OW to OB boys and girls. When compared with L peers, OW and OB girls exhibited lower (p<0.001) HMW adiponectin levels, while in boys the HMW multimers did not differ significantly across the BMI-stratified groups. OB girls displayed higher (p, 0.05) IL-8, IL-18, monocyte chemoattractant protein-1 (MCP-1) and soluble intercellular adhesion molecule-1 levels (sICAM-1) than L girls, whereas increased macrophage migration inhibitory factor (MIF) concentrations in OB vs OW boys were seen. HMW adiponectin (negatively), leptin or inflammatory markers (positively) correlated with adiposity and IR measures. In multivariate models, leptin represented a strong and independent determinant of HOMA-IR (R-2 0.378; p<0.01). Adjustment for age, BMIz-score, lipids and inflammatory mediators abolished the association between leptin and HOMA-IR in boys, while in girls leptin remained still a significant predictor of IR (R-2 0.513; p<0.01). Finally, in both sexes, the joint effect of the L/HMW did not improve the prediction of basal IR as compared with leptin levels alone, which were mainly explained by the BMIz-score. Conclusions: In prepubertal children, leptin emerges as a sex-independent discrimination marker of adiposity degree and as a useful, sex-associated predictor of the systemic insulin resistance.	[Murdolo, Giuseppe; Donati, Miranda; Bini, Vittorio; Falorni, Alberto] Univ Perugia, Dept Internal Med, Sect Internal Med Endocrine & Metab Sci, I-06100 Perugia, Italy; [Nowotny, Bettina; Gornitzka, Gabi; Roden, Michael; Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Celi, Federica; Papi, Francesco; Castellani, Serena; Falorni, Adriano] Univ Perugia, Dept Surg Sci & Publ Hlth, Sect Pediat, I-06100 Perugia, Italy; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, Univ Clin, Dusseldorf, Germany	University of Perugia; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Perugia; Heinrich Heine University Dusseldorf	Murdolo, G (corresponding author), Univ Perugia, Dept Internal Med, Sect Internal Med Endocrine & Metab Sci, I-06100 Perugia, Italy.	gmurdolo@tiscalinet.it	Roden, Michael/AAD-3843-2019; Bini, Vittorio/AAA-1104-2019; Murdolo, Giuseppe/I-1812-2012; FALORNI, Alberto/E-5747-2011; Bini, Vittorio/F-5134-2010	Bini, Vittorio/0000-0001-8404-2918; FALORNI, Alberto/0000-0003-4532-3519; Bini, Vittorio/0000-0001-8404-2918; Nowotny, Bettina/0000-0002-0671-9644; Murdolo, Giuseppe/0000-0001-5654-1760	Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany)	Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany)	This work was partly supported by the Federal Ministry of Health (Berlin, Germany) and the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Andersen KK, 2007, J CLIN ENDOCR METAB, V92, P1857, DOI 10.1210/jc.2006-2310; [Anonymous], 2004, PEDIATRICS, V114, P555; Araki S, 2006, J CLIN ENDOCR METAB, V91, P5113, DOI 10.1210/jc.2006-1051; Aygun AD, 2005, MEDIAT INFLAMM, P180, DOI 10.1155/MI.2005.180; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Celi F, 2003, EUR J CLIN NUTR, V57, P1045, DOI 10.1038/sj.ejcn.1601640; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Di Stefano G, 2000, INT J OBESITY, V24, P1586, DOI 10.1038/sj.ijo.0801448; Falorni A, 1998, INT J OBESITY, V22, P1197, DOI 10.1038/sj/ijo/0800746; Falorni A, 1997, INT J OBESITY, V21, P881, DOI 10.1038/sj.ijo.0800485; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hak AE, 2001, J CLIN ENDOCR METAB, V86, P4398, DOI 10.1210/jc.86.9.4398; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2006, EUR J ENDOCRINOL, V154, P311, DOI 10.1530/eje.1.02090; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Herder C, 2005, GESUNDHEITSWESEN, V67, pS115, DOI 10.1055/s-2005-858252; Herder C, 2007, J CLIN ENDOCR METAB, V92, P4569, DOI 10.1210/jc.2007-0955; Herder C, 2006, DIABETES CARE, V29, P1626, DOI 10.2337/dc05-1900; Hung YJ, 2006, INT J CLIN PRACT, V60, P1582, DOI 10.1111/j.1742-1241.2006.00909.x; Inoue M, 2005, METABOLISM, V54, P281, DOI 10.1016/j.metabol.2004.09.006; Karakas M, 2009, ATHEROSCLEROSIS; Lee MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE858, DOI 10.1152/ajpendo.00439.2006; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Mangge H, 2008, OBESITY, V16, P2578, DOI 10.1038/oby.2008.439; MARTOSMORENO G, 2010, OBESITY; McNeely MJ, 1999, DIABETES CARE, V22, P65, DOI 10.2337/diacare.22.1.65; MURDOLO G, 2009, J CLIN ENDOCRINOL ME; Ong KK, 2006, DIABETES, V55, P1337, DOI 10.2337/db05-1272; Punthakee Z, 2006, J CLIN ENDOCR METAB, V91, P2119, DOI 10.1210/jc.2005-2346; Sabin MA, 2006, J CLIN ENDOCR METAB, V91, P332, DOI 10.1210/jc.2005-1571; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Sbarbati A, 2006, PEDIATRICS, V117, P220, DOI 10.1542/peds.2004-2854; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Tsou PL, 2004, DIABETES CARE, V27, P308, DOI 10.2337/diacare.27.2.308; Valle M, 2005, DIABETES METAB, V31, P55, DOI 10.1016/S1262-3636(07)70167-2; Valle M, 2003, INT J OBESITY, V27, P13, DOI 10.1038/sj.ijo.0802154; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Xie LL, 2008, BBA-MOL BASIS DIS, V1782, P99, DOI 10.1016/j.bbadis.2007.12.003	43	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17264	10.1371/journal.pone.0017264	http://dx.doi.org/10.1371/journal.pone.0017264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365005	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482800041
J	Purcell, O; di Bernardo, M; Grierson, CS; Savery, NJ				Purcell, Oliver; di Bernardo, Mario; Grierson, Claire S.; Savery, Nigel J.			A Multi-Functional Synthetic Gene Network: A Frequency Multiplier, Oscillator and Switch	PLOS ONE			English	Article							ESCHERICHIA-COLI; MAMMALIAN OSCILLATOR; TOGGLE SWITCH; CELLS; EXPRESSION; PROTEINS; BEHAVIOR; BIOLOGY; PATTERN	We present the design and analysis of a synthetic gene network that performs frequency multiplication. It takes oscillatory transcription factor concentrations, such as those produced from the currently available genetic oscillators, as an input, and produces oscillations with half the input frequency as an output. Analysis of the bifurcation structure also reveals novel, programmable multi-functionality; in addition to functioning as a frequency multiplier, the network is able to function as a switch or an oscillator, depending on the temporal nature of the input. Multi-functionality is often observed in neuronal networks, where it is suggested to allow for the efficient coordination of different responses. This network represents a significant theoretical addition that extends the capabilities of synthetic gene networks.	[Purcell, Oliver; di Bernardo, Mario] Univ Bristol, Bristol Ctr Complex Sci, Dept Engn Math, Bristol, Avon, England; [di Bernardo, Mario] Univ Naples Federico 2, Dept Syst & Comp Engn, Naples, Italy; [Grierson, Claire S.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Savery, Nigel J.] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Bristol; University of Naples Federico II; University of Bristol; University of Bristol	Purcell, O (corresponding author), Univ Bristol, Bristol Ctr Complex Sci, Dept Engn Math, Bristol, Avon, England.	enoep@bristol.ac.uk	di Bernardo, Mario/I-2805-2012; di Bernardo, Mario/AAL-9311-2021	di Bernardo, Mario/0000-0002-2171-4745; Savery, Nigel/0000-0002-0803-4075	Engineering and Physical Sciences Research Council (EPSRC)	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was provided by the Engineering and Physical Sciences Research Council (EPSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Conrad E, 2008, J R SOC INTERFACE, V5, pS9, DOI 10.1098/rsif.2008.0046.focus; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Deiters A, 2009, CURR OPIN CHEM BIOL, V13, P678, DOI 10.1016/j.cbpa.2009.09.026; DOEDEL E, 2007, AUTO 07 SOFTWARE CON; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Getting P.A., 1985, P3; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; Giesecke AV, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100053; Gommans WM, 2005, J MOL BIOL, V354, P507, DOI 10.1016/j.jmb.2005.06.082; Guantes R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012314; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kinkhabwala A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002030; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Neupert J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn545; Park KS, 2005, J BACTERIOL, V187, P5496, DOI 10.1128/JB.187.15.5496-5499.2005; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Soffe SR, 1997, J COMP PHYSIOL A, V180, P711, DOI 10.1007/s003590050085; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tigges M, 2010, NUCLEIC ACIDS RES, V38, P2702, DOI 10.1093/nar/gkq121; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457	35	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16140	10.1371/journal.pone.0016140	http://dx.doi.org/10.1371/journal.pone.0016140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359152	gold, Green Submitted, Green Published			2022-12-25	WOS:000287482300015
J	Kristiansson, E; Fick, J; Janzon, A; Grabic, R; Rutgersson, C; Weijdegard, B; Soderstrom, H; Larsson, DGJ				Kristiansson, Erik; Fick, Jerker; Janzon, Anders; Grabic, Roman; Rutgersson, Carolin; Weijdegard, Birgitta; Soderstrom, Hanna; Larsson, D. G. Joakim			Pyrosequencing of Antibiotic-Contaminated River Sediments Reveals High Levels of Resistance and Gene Transfer Elements	PLOS ONE			English	Article							QUINOLONE RESISTANCE; AQUATIC ENVIRONMENT; BACTERIA; DATABASE; WATER; IDENTIFICATION; METAGENOMICS; MECHANISMS; EMERGENCE; INTEGRONS	The high and sometimes inappropriate use of antibiotics has accelerated the development of antibiotic resistance, creating a major challenge for the sustainable treatment of infections world-wide. Bacterial communities often respond to antibiotic selection pressure by acquiring resistance genes, i.e. mobile genetic elements that can be shared horizontally between species. Environmental microbial communities maintain diverse collections of resistance genes, which can be mobilized into pathogenic bacteria. Recently, exceptional environmental releases of antibiotics have been documented, but the effects on the promotion of resistance genes and the potential for horizontal gene transfer have yet received limited attention. In this study, we have used culture-independent shotgun metagenomics to investigate microbial communities in river sediments exposed to waste water from the production of antibiotics in India. Our analysis identified very high levels of several classes of resistance genes as well as elements for horizontal gene transfer, including integrons, transposons and plasmids. In addition, two abundant previously uncharacterized resistance plasmids were identified. The results suggest that antibiotic contamination plays a role in the promotion of resistance genes and their mobilization from environmental microbes to other species and eventually to human pathogens. The entire life-cycle of antibiotic substances, both before, under and after usage, should therefore be considered to fully evaluate their role in the promotion of resistance.	[Kristiansson, Erik; Janzon, Anders; Rutgersson, Carolin; Weijdegard, Birgitta; Larsson, D. G. Joakim] Univ Gothenburg, Dept Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Kristiansson, Erik] Chalmers Univ Technol, Dept Math Stat, S-41296 Gothenburg, Sweden; [Fick, Jerker; Grabic, Roman; Soderstrom, Hanna] Umea Univ, Dept Chem, Umea, Sweden	University of Gothenburg; Chalmers University of Technology; Umea University	Kristiansson, E (corresponding author), Univ Gothenburg, Dept Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	joakim.larsson@fysiologi.gu.se	Grabic, Roman/AAF-5412-2021; Larsson, D.G. Joakim/E-5243-2011; Berglund Fick, Jerker/HDO-5788-2022; Grabic, Roman/B-1289-2013	Grabic, Roman/0000-0002-0935-2075; Larsson, D.G. Joakim/0000-0002-5496-0328; Grabic, Roman/0000-0002-0935-2075; Soderstrom, Hanna/0000-0003-1341-7879; Fick, Jerker/0000-0002-3949-7371	Swedish Research Council (VR); Swedish International Development Cooperation Agency (SIDA); Swedish Society for Medical Research (SSMF); Swedish Research Council for Environment; Agricultural Sciences and Spatial Planning (FORMAS); Swedish Foundation for Strategic Environmental Research (MISTRA); Adlerbertska Research Foundation; Helge Ax:son Johnsons Research Foundation	Swedish Research Council (VR)(Swedish Research Council); Swedish International Development Cooperation Agency (SIDA); Swedish Society for Medical Research (SSMF); Swedish Research Council for Environment(Swedish Research Council Formas); Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Foundation for Strategic Environmental Research (MISTRA)(Swedish Foundation for Strategic Research); Adlerbertska Research Foundation; Helge Ax:son Johnsons Research Foundation	The research was funded by the Swedish Research Council (VR, www.vr.se), the Swedish International Development Cooperation Agency (SIDA, www.sida.se), the Swedish Society for Medical Research (SSMF, www.ssmf.se), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, www.formas.se), the Swedish Foundation for Strategic Environmental Research (MISTRA, www.mistra.org), Adlerbertska Research Foundation (http://www.gu.se/forskning/stipendier/gustipendier/adlerbertska_forskningsstiftelsen) and Helge Ax:son Johnsons Research Foundation (http://www.haxsonj.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Allen HK, 2010, NAT REV MICROBIOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carlsson G, 2009, ENVIRON TOXICOL CHEM, V28, P2656, DOI 10.1897/08-524.1; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; D'Costa VM, 2007, CURR OPIN MICROBIOL, V10, P481, DOI 10.1016/j.mib.2007.08.009; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; Dudoit S, 2008, SPRINGER SER STAT, P1; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hooper SD, 2010, BIOINFORMATICS, V26, P295, DOI 10.1093/bioinformatics/btp687; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Jacoby G, 2008, ANTIMICROB AGENTS CH, V52, P2297, DOI 10.1128/AAC.00147-08; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Li D, 2008, ENVIRON TOXICOL CHEM, V27, P80, DOI 10.1897/07-080.1; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Rodriguez-Martinez JM, 2008, J ANTIMICROB CHEMOTH, V61, P1240, DOI 10.1093/jac/dkn115; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7; Xia RR, 2010, ANTIMICROB AGENTS CH, V54, P3471, DOI 10.1128/AAC.01668-09; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y	55	358	377	3	230	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17038	10.1371/journal.pone.0017038	http://dx.doi.org/10.1371/journal.pone.0017038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359229	Green Published, gold			2022-12-25	WOS:000287392700038
J	Silver, AC; Williams, D; Faucher, J; Horneman, AJ; Gogarten, JP; Graf, J				Silver, Adam C.; Williams, David; Faucher, Joshua; Horneman, Amy J.; Gogarten, J. Peter; Graf, Joerg			Complex Evolutionary History of the Aeromonas veronii Group Revealed by Host Interaction and DNA Sequence Data	PLOS ONE			English	Article							III SECRETION SYSTEM; SALMONICIDA SUBSP SALMONICIDA; HORIZONTAL GENE-TRANSFER; ET-AL. 1990; GALLERIA-MELLONELLA; MEDICINAL LEECH; DETECTING RECOMBINATION; PHYLOGENETIC ANALYSIS; PHENOTYPIC DATA; MODEL SYSTEM	Aeromonas veronii biovar sobria, Aeromonas veronii biovar veronii, and Aeromonas allosaccharophila are a closely related group of organisms, the Aeromonas veronii Group, that inhabit a wide range of host animals as a symbiont or pathogen. In this study, the ability of various strains to colonize the medicinal leech as a model for beneficial symbiosis and to kill wax worm larvae as a model for virulence was determined. Isolates cultured from the leech out-competed other strains in the leech model, while most strains were virulent in the wax worms. Three housekeeping genes, recA, dnaJ and gyrB, the gene encoding chitinase, chiA, and four loci associated with the type three secretion system, ascV, ascFG, aexT, and aexU were sequenced. The phylogenetic reconstruction failed to produce one consensus tree that was compatible with most of the individual genes. The Approximately Unbiased test and the Genetic Algorithm for Recombination Detection both provided further support for differing evolutionary histories among this group of genes. Two contrasting tests detected recombination within aexU, ascFG, ascV, dnaJ, and gyrB but not in aexT or chiA. Quartet decomposition analysis indicated a complex recent evolutionary history for these strains with a high frequency of horizontal gene transfer between several but not among all strains. In this study we demonstrate that at least for some strains, horizontal gene transfer occurs at a sufficient frequency to blur the signal from vertically inherited genes, despite strains being adapted to distinct niches. Simply increasing the number of genes included in the analysis is unlikely to overcome this challenge in organisms that occupy multiple niches and can exchange DNA between strains specialized to different niches. Instead, the detection of genes critical in the adaptation to specific niches may help to reveal the physiological specialization of these strains.	[Silver, Adam C.; Williams, David; Faucher, Joshua; Gogarten, J. Peter; Graf, Joerg] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Horneman, Amy J.] VA Maryland Hlth Care Syst, Pathol Serv, Baltimore, MD USA; [Horneman, Amy J.] Univ Maryland, Sch Med, Dept Med & Res Technol, Baltimore, MD 21201 USA; [Horneman, Amy J.] VA Maryland Hlth Care Syst, Lab Med Serv, Baltimore, MD USA	University of Connecticut; University System of Maryland; University of Maryland Baltimore	Silver, AC (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	joerg.graf@uconn.edu	Graf, Joerg/ABI-2447-2020	Graf, Joerg/0000-0001-5320-2712; Gogarten, Johann Peter/0000-0001-6459-6518; Williams, David/0000-0002-6925-7408	NSF [MCB 0448052, DEB 0830024]; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was supported by the NSF CAREER grant MCB 0448052 to JG and NSF Grant DEB 0830024 to JPG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Alperi A, 2010, INT J SYST EVOL MICR, V60, P2048, DOI 10.1099/ijs.0.014621-0; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; Braun M, 2002, J BACTERIOL, V184, P1851, DOI 10.1128/JB.184.7.1851-1858.2002; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Burr SE, 2005, MICROBIOL-SGM, V151, P2111, DOI 10.1099/mic.0.27926-0; Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003; Carnahan AM, 2001, THESIS U MARYLAND CO, P1; Chan CX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-412; Darwin C., 1859, ORIGIN SPECIES MEANS; deChalain TMB, 1996, J RECONSTR MICROSURG, V12, P165, DOI 10.1055/s-2007-1006471; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESTEVE C, 1995, J APPL BACTERIOL, V78, P555, DOI 10.1111/j.1365-2672.1995.tb03099.x; Farfan M, 2010, SYST APPL MICROBIOL, V33, P427, DOI 10.1016/j.syapm.2010.09.005; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Graf J, 1999, INFECT IMMUN, V67, P1; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grunewald S, 2007, MOL BIOL EVOL, V24, P532, DOI 10.1093/molbev/msl180; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; HANNINEN ML, 1995, J MED MICROBIOL, V42, P26, DOI 10.1099/00222615-42-1-26; HASEGAWA M, 1989, EVOLUTION, V43, P672, DOI 10.1111/j.1558-5646.1989.tb04264.x; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Huys G, 2002, INT J SYST EVOL MICR, V52, P1969, DOI [10.1099/ijs.0.01996-0, 10.1099/00207713-52-6-1969]; Huys G, 2001, SYST APPL MICROBIOL, V24, P177, DOI 10.1078/0723-2020-00038; IHAKA R, 1996, J COMPUT GRAPH STAT, V5, P99; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 1991, FEMS MICROBIOL LETT, V90, P29; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Kupfer M, 2006, INT J SYST EVOL MICR, V56, P2743, DOI 10.1099/ijs.0.63650-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laufer AS, 2008, APPL ENVIRON MICROB, V74, P6151, DOI 10.1128/AEM.00795-08; MARTINEZMURCIA AJ, 1992, FEMS MICROBIOL LETT, V91, P199; Minana-Galbis D, 2009, INT J SYST EVOL MICR, V59, P1976, DOI 10.1099/ijs.0.005413-0; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nhung PH, 2007, INT J SYST EVOL MICR, V57, P1232, DOI 10.1099/ijs.0.64957-0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; REED LJ, 1938, AM J HYG, V27, P93; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Retchless AC, 2010, P NATL ACAD SCI USA, V107, P11453, DOI 10.1073/pnas.1001291107; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rio RVM, 2007, MICROBIOL-SGM, V153, P1897, DOI 10.1099/mic.0.2006/003020-0; Rio RVM, 2009, APPL ENVIRON MICROB, V75, P6890, DOI 10.1128/AEM.01129-09; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saavedra MJ, 2007, ANTON LEEUW INT J G, V91, P159, DOI 10.1007/s10482-006-9107-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sepe A, 2008, LETT APPL MICROBIOL, V46, P439, DOI 10.1111/j.1472-765X.2008.02339.x; Sha J, 2005, INFECT IMMUN, V73, P6446, DOI 10.1128/IAI.73.10.6446-6457.2005; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Shimodaira H, 2008, J STAT PLAN INFER, V138, P1227, DOI 10.1016/j.jspi.2007.04.001; Sierra JC, 2007, MICROB PATHOGENESIS, V43, P147, DOI 10.1016/j.micpath.2007.05.003; Silver AC, 2007, J BACTERIOL, V189, P6763, DOI 10.1128/JB.00685-07; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Silver AC, 2009, DNA CELL BIOL, V28, P383, DOI 10.1089/dna.2009.0867; SNEATH PHA, 1993, INT J SYST BACTERIOL, V43, P626, DOI 10.1099/00207713-43-3-626; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; SUGITA H, 1995, APPL ENVIRON MICROB, V61, P4128, DOI 10.1128/AEM.61.11.4128-4130.1995; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032; Zhaxybayeva Olga, 2009, V532, P195, DOI 10.1007/978-1-60327-853-9_11	74	52	55	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16751	10.1371/journal.pone.0016751	http://dx.doi.org/10.1371/journal.pone.0016751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359176	gold, Green Published, Green Submitted			2022-12-25	WOS:000287392700023
J	Tarimo, EAM; Thorson, A; Kohi, TW; Bakari, M; Mhalu, F; Kulane, A				Tarimo, Edith A. M.; Thorson, Anna; Kohi, Thecla W.; Bakari, Muhammad; Mhalu, Fred; Kulane, Asli			Reasons for Declining to Enoll in a Phase I and II HIV Vaccine Trial after Randomization among Eligible Volunteers in Dar es Salaam, Tanzania	PLOS ONE			English	Article							RECRUITMENT; BARRIERS; WOMEN; WILLINGNESS; PARTICIPATE; ACHIEVE; FUTURE; RISK	Background: Recruitment, enrollment and retention of volunteers in an HIV vaccine trial is important in the efforts to ultimately develop a vaccine that can prevent new HIV infections. Following recruitment, some randomized individuals decline to be enrolled in an HIV vaccine trial. The reasons for such a decision are not well known. This article describes why individuals who were randomized in a phase I and II HIV vaccine trial in Dar es Salaam, Tanzania declined to be enrolled. Methods: Face-to-face interviews were conducted with 14 individuals (7 men and 7 women). Repeated readings of the 14 interview transcripts to look for reasons for declining to enroll in the trial were performed. Data was analyzed using the content analysis approach. Results: Informants expressed fear of the outcome of an experimental HIV vaccine in their lives. Unlike women, some men were concerned over the effect of the vaccine on their reproduction intentions. Women were concerned about the unknown effects of the vaccine in their bodies. Also, to a large extent, informants faced resistance from significant others such as fiancees, parents, relatives, and friends. Women were influenced by their potential intimate sexual partners; men were forbidden by their parents, and mothers had the most influential opinion. Conclusions: Fear of the negative outcome of an experimental vaccine and resistance from significant others are the main reasons for declining to enroll in the HIV vaccine trial among eligible volunteers after randomization. The resistance from the significant others provides valuable guidance for designing future trials in Tanzania; for example, expanding the HIV vaccine trial education to the general population from the onset of the trial design.	[Tarimo, Edith A. M.; Thorson, Anna; Kulane, Asli] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden; [Tarimo, Edith A. M.; Kohi, Thecla W.] Muhimbili Univ Hlth & Allied Sci, Dept Nursing Management, Dar Es Salaam, Tanzania; [Bakari, Muhammad] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Mhalu, Fred] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania	Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Tarimo, EAM (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden.	etarimo54@yahoo.co.uk		Kulane, Asli/0000-0002-5823-7559; Thorson, Anna/0000-0002-8703-6561	Swedish International Agency for Development Cooperation (SIDA)	Swedish International Agency for Development Cooperation (SIDA)	The study was supported with funding from the Swedish International Agency for Development Cooperation (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airhihenbuwa CO., 2007, HEALING OUR DIFFEREN; [Anonymous], 2007, QUALITATIVE METHODOL; Brown-Peterside P, 2000, J URBAN HEALTH, V77, P425, DOI 10.1007/BF02386751; Brown-Peterside P, 2001, AM J PUBLIC HEALTH, V91, P1377, DOI 10.2105/AJPH.91.9.1377; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; de Bruyn G, 2005, JAIDS-J ACQ IMM DEF, V39, P499, DOI 10.1097/01.qai.0000148532.12329.df; Esparza J, 2002, VACCINE, V20, P1897, DOI 10.1016/S0264-410X(02)00062-2; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harro CD, 2004, JAIDS-J ACQ IMM DEF, V37, P1385, DOI 10.1097/01.qai.0000122983.87519.b5; *INT AIDS VACC IN, 2009, DAT AIDS VACC CAND C; McGrath JW, 2001, J ACQ IMMUN DEF SYND, V27, P381, DOI 10.1097/00126334-200108010-00009; Mills E, 2006, PLOS MED, V3, P308, DOI 10.1371/journal.pmed.0030094; Mills E, 2004, AIDS, V18, P2235, DOI 10.1097/00002030-200411190-00003; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; Newman PA, 2004, AIDS PATIENT CARE ST, V18, P691, DOI 10.1089/apc.2004.18.691; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rudy ET, 2005, AIDS EDUC PREV, V17, P253, DOI 10.1521/aeap.17.4.253.66529; Ruzagira E, 2009, TROP MED INT HEALTH, V14, P196, DOI 10.1111/j.1365-3156.2008.02200.x; *SAAVI, 2009, HIV VACC INF LIN 080; Tarimo EAM, 2009, GLOBAL HLTH ACTION, V2, DOI [10.3402/gha.v3402:3400.1953, DOI 10.3402/GHA.V3402:3400.1953]; Tarimo EAM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-292; Unaids, 2008, SUBS AFR AIDS EP UPD; *UNAIDS, 2009, AIDS EP UPD	25	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14619	10.1371/journal.pone.0014619	http://dx.doi.org/10.1371/journal.pone.0014619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721YC	21358826	Green Published, Green Submitted, gold			2022-12-25	WOS:000287392700002
J	Zavada, A; Buckley, CL; Martinez, D; Rospars, JP; Nowotny, T				Zavada, Andrei; Buckley, Christopher L.; Martinez, Dominique; Rospars, Jean-Pierre; Nowotny, Thomas			Competition-Based Model of Pheromone Component Ratio Detection in the Moth	PLOS ONE			English	Article							SPODOPTERA-LITTORALIS LEPIDOPTERA; LOCUST ANTENNAL LOBE; MANDUCA-SEXTA; SPHINX MOTH; CHEMICAL COMMUNICATION; HELIOTHIS-VIRESCENS; ODOR DISCRIMINATION; PROJECTION NEURONS; NEURAL ASSEMBLIES; AGROTIS-SEGETUM	For some moth species, especially those closely interrelated and sympatric, recognizing a specific pheromone component concentration ratio is essential for males to successfully locate conspecific females. We propose and determine the properties of a minimalist competition-based feed-forward neuronal model capable of detecting a certain ratio of pheromone components independently of overall concentration. This model represents an elementary recognition unit for the ratio of binary mixtures which we propose is entirely contained in the macroglomerular complex (MGC) of the male moth. A set of such units, along with projection neurons (PNs), can provide the input to higher brain centres. We found that (1) accuracy is mainly achieved by maintaining a certain ratio of connection strengths between olfactory receptor neurons (ORN) and local neurons (LN), much less by properties of the interconnections between the competing LNs proper. An exception to this rule is that it is beneficial if connections between generalist LNs (i.e. excited by either pheromone component) and specialist LNs (i.e. excited by one component only) have the same strength as the reciprocal specialist to generalist connections. (2) successful ratio recognition is achieved using latency-to-first-spike in the LN populations which, in contrast to expectations with a population rate code, leads to a broadening of responses for higher overall concentrations consistent with experimental observations. (3) when longer durations of the competition between LNs were observed it did not lead to higher recognition accuracy.	[Zavada, Andrei; Buckley, Christopher L.; Nowotny, Thomas] Univ Sussex, Brighton, E Sussex, England; [Martinez, Dominique] LORIA, CORTEX Team, Vandoeuvre Les Nancy, France; [Rospars, Jean-Pierre] INRA, Unite Phytopharm & Mediateurs Chim, F-78026 Versailles, France	University of Sussex; Universite de Lorraine; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Zavada, A (corresponding author), Univ Sussex, Brighton, E Sussex, England.	a.zavada@sussex.ac.uk	Nowotny, Thomas/C-3883-2012	Nowotny, Thomas/0000-0002-4451-915X; Buckley, Christopher L/0000-0002-8551-9121	Biotechnology and Biological Sciences Research Council [BB/F005113/1]; French-British ANR BBSRC SysBio 006 01 "Pherosys'' initiative; BBSRC [BB/F005113/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500315/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French-British ANR BBSRC SysBio 006 01 "Pherosys'' initiative(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (grant number BB/F005113/1) within the French-British ANR BBSRC SysBio 006 01 "Pherosys'' initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTON S, 1994, J COMP NEUROL, V350, P199, DOI 10.1002/cne.903500205; AVRON E, 1995, BIOSYSTEMS, V36, P101, DOI 10.1016/0303-2647(95)01531-O; AvRon E, 1996, BIOSYSTEMS, V39, P241, DOI 10.1016/0303-2647(96)01620-6; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; CHRISTENSEN TA, 1989, CHEM SENSES, V14, P463, DOI 10.1093/chemse/14.3.463; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Christensen Thomas A., 1994, Progress in Zoology, V39, P37; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Getz WM, 1999, CHEM SENSES, V24, P351, DOI 10.1093/chemse/24.4.351; HANSSON BS, 1995, J COMP PHYSIOL A, V177, P535, DOI 10.1007/BF00207183; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; Husch A, 2008, J NEUROPHYSIOL, V99, P320, DOI 10.1152/jn.00719.2007; Husch A, 2009, J NEUROPHYSIOL, V102, P2834, DOI 10.1152/jn.00627.2009; Husch A, 2009, J NEUROSCI, V29, P716, DOI 10.1523/JNEUROSCI.3677-08.2009; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kwok YC, 2007, THESIS U LEICESTER; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Linster C, 1994, J Comput Neurosci, V1, P231, DOI 10.1007/BF00961735; Linster C, 1996, CHEM SENSES, V21, P19, DOI 10.1093/chemse/21.1.19; LINSTER C, 1993, NEURAL COMPUT, V5, P228, DOI 10.1162/neco.1993.5.2.228; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; MATSUMOTO SG, 1981, PROC R SOC SER B-BIO, V213, P249, DOI 10.1098/rspb.1981.0066; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; PRESS WH, 1992, NUMERICAL RECIPES C, pCH15; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; SANES JR, 1976, DEV BIOL, V51, P282, DOI 10.1016/0012-1606(76)90144-5; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Schneider D, 1970, NEUROSCIENCES 2ND ST, P511; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Todd Julie L., 1999, P67; TOTH M, 1992, J CHEM ECOL, V18, P1337, DOI 10.1007/BF00994360; Traub R.D., 1991, NEURONAL NETWORKS HI; TUMLINSON JH, 1989, ARCH INSECT BIOCHEM, V10, P255, DOI 10.1002/arch.940100402; Vickers NJ, 1998, J COMP NEUROL, V400, P35; VICKERS NJ, 1991, J COMP PHYSIOL A, V169, P275; WALDROP B, 1987, J COMP PHYSIOL A, V161, P23, DOI 10.1007/BF00609452; Wu WQ, 1996, P NATL ACAD SCI USA, V93, P8022, DOI 10.1073/pnas.93.15.8022	47	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16308	10.1371/journal.pone.0016308	http://dx.doi.org/10.1371/journal.pone.0016308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21373177	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000287392700016
J	McCoy, M; Campbell, I; Stone, P; Fedorchuk, C; Wijayawardana, S; Easley, K				McCoy, Matthew; Campbell, Ismay; Stone, Pamela; Fedorchuk, Curtis; Wijayawardana, Sameera; Easley, Kirk			Intra-Examiner and Inter-Examiner Reproducibility of Paraspinal Thermography	PLOS ONE			English	Article							INTRAEXAMINER RELIABILITY; CORRELATION-COEFFICIENT; INTEREXAMINER	Objective: The objective of this study was to evaluate the intra-examiner and inter-examiner reproducibility of paraspinal thermography using an infrared scanner. Materials and Methods: The thermal functions of a commercially available infrared scanner (Insight Subluxation Station (R)) were evaluated for clinical reliability. Two practicing clinicians conducted the measures on 100 subjects. Intra class correlation coefficients (ICCs) and concordance correlation coefficients (CCCs) were calculated from the collected data. Results: Mean bilateral paraspinal skin temperature was 89.78 degrees F and ranged from 88.77 degrees F to 91.43 degrees F. Intra class correlation coefficients (ICCs) for agreement and consistency ranged from 0.959 to 0.976. Concordance correlation coefficients (CCCs) ranged from 0.783 to 0.859 with tight confidence intervals indicating robust estimates of these quantities. Conclusion: This study revealed excellent intra-examiner and inter-examiner reproducibility of paraspinal thermography using a commercially available unit.	[McCoy, Matthew] Life Univ Coll Chiropract, Div Clin Sci, Marietta, GA USA; [Wijayawardana, Sameera; Easley, Kirk] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University	McCoy, M (corresponding author), Life Univ Coll Chiropract, Div Clin Sci, Marietta, GA USA.	matthewmccoy@comcast.net	Easley, Kirk A/K-6910-2015	Easley, Kirk A/0000-0003-4419-2617				BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; BRAND NE, 1982, J MANIP PHYSIOL THER, V5, P113; DeBoer KF, 1985, RES FORUM, V2, P4; DUFF SA, 1976, CHIROPRACTIC CLIN RE, pR6; EBRALL PS, 1994, CHIROPR J AUSTR, V24, P139; Guyton AC, 1986, TXB MED PHYSL; Haber M, 2005, J DATA SCI, V3, P69; HART J, 2000, J VERTEBRAL SUBLUXAT, V3, P1; HART JF, 2001, J CHIROPRACTIC ED, V15, P30; Hart John, 2007, J Can Chiropr Assoc, V51, P175; KEATING JC, 1990, J MANIP PHYSIOL THER, V13, P463; Kyneur JS, 1991, CHIROPR J AUST, V21, P82; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MILLER JL, 1967, INT REV CHIROPRA APR, P39; OWENS E, 2000, J CHIROPRACTIC ED, V14, P44; Owens EF, 2004, J MANIP PHYSIOL THER, V27, P155, DOI 10.1016/j.jmpt.2003.12.019; OWENS EF, 2000, CHIROPR RES J, V7, P65; Palmer BJ, 1951, CHIROPRACTIC CLIN CO, VXXV; PERDEW W, 1976, DIG CHIRO EC     MAY, P60; PLAUGHER G, 1991, J MANIP PHYSIOL THER, V14, P361; PLAUGHER G, 1992, J MANIP PHYSIOL THER, V15, P368; RADEMACHER WJ, 1994, CHIROPR TECH, V6, P84; SCHRAM SB, 1982, J MANIP PHYSIOL THER, V5, P5; SENZON SA, 2000, J VERTEBRAL SUBLUXAT, V4, P17; SPECTOR B, 1981, J MANIP PHYSIOL THER, V4, P30; STEWART MS, 1989, J MANIP PHYSIOL THER, V12, P345; UEMATSU E, 1988, J NEUROSURG, V69, P552	27	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16535	10.1371/journal.pone.0016535	http://dx.doi.org/10.1371/journal.pone.0016535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347290	Green Published, gold, Green Submitted			2022-12-25	WOS:000287364500002
J	Ribeiro, D; Ellwanger, K; Glagow, D; Theofilopoulos, S; Corsini, NS; Martin-Villalba, A; Niehrs, C; Arenas, E				Ribeiro, Diogo; Ellwanger, Kristina; Glagow, Desiree; Theofilopoulos, Spyridon; Corsini, Nina S.; Martin-Villalba, Ana; Niehrs, Christof; Arenas, Ernest			Dkk1 Regulates Ventral Midbrain Dopaminergic Differentiation and Morphogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; WNT/BETA-CATENIN; HEAD INDUCTION; INHIBITOR DICKKOPF-1; INT-1 PROTOONCOGENE; BETA-CATENIN/TCF; PRECHORDAL PLATE; LIMB DEVELOPMENT; MOUSE; EXPRESSION	Dickkopf1 (Dkk1) is a Wnt/beta-catenin inhibitor that participates in many processes during embryonic development. One of its roles during embryogenesis is to induce head formation, since Dkk1-null mice lack head structures anterior to midbrain. The Wnt/beta-catenin pathway is also known to regulate different aspects of ventral midbrain (VM) dopaminergic (DA) neuron development and, in vitro, Dkk1-mediated inhibition of the Wnt/beta-catenin pathway improves the DA differentiation in mouse embryonic stem cells (mESC). However, the in vivo function of Dkk1 on the development of midbrain DA neurons remains to be elucidated. Here we examined Dkk1(+/-) embryos and found that Dkk1 is required for the differentiation of DA precursors/neuroblasts into DA neurons at E13.5. This deficit persisted until E17.5, when a defect in the number and distribution of VM DA neurons was detected. Furthermore, analysis of the few Dkk1(-/-) embryos that survived until E17.5 revealed a more severe loss of midbrain DA neurons and morphogenesis defects. Our results thus show that Dkk1 is required for midbrain DA differentiation and morphogenesis.	[Ribeiro, Diogo; Theofilopoulos, Spyridon; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Sect, Stockholm, Sweden; [Ellwanger, Kristina; Niehrs, Christof] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Embryol, D-6900 Heidelberg, Germany; [Glagow, Desiree; Corsini, Nina S.; Martin-Villalba, Ana] German Canc Res Ctr, Div Mol Neurobiol, D-6900 Heidelberg, Germany	Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Ribeiro, D (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Sect, Stockholm, Sweden.	ernest.arenas@ki.se	Arenas, Ernest/AAO-5231-2020; Theofilopoulos, Spyridon/B-2075-2015; Seib, Desiree/AAF-2801-2021; Theofilopoulos, Spyridon/E-1508-2011	Arenas, Ernest/0000-0003-0197-6577; Theofilopoulos, Spyridon/0000-0003-1986-0943; Seib, Desiree/0000-0001-9953-8270; Martin-Villalba, Ana/0000-0002-9405-8910; Corsini, Nina/0000-0001-6731-3544; Ribeiro, Diogo/0000-0003-4400-8752	Swedish Foundation for Strategic Research (INGVAR and CEDB); Swedish Research Council [VR2008:2811]; Norwegian Research Council; Karolinska Institutet; Portuguese Government [SFRH/BD/24585/2005]	Swedish Foundation for Strategic Research (INGVAR and CEDB)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); Karolinska Institutet(Karolinska Institutet); Portuguese Government(Portuguese Foundation for Science and Technology)	This work was supported by grants from the Swedish Foundation for Strategic Research (INGVAR and CEDB), Swedish Research Council (VR2008:2811 and DBRM), Norwegian Research Council, and Karolinska Institutet to EA, and DR was supported by the Foundation for Science and Technology from the Portuguese Government (SFRH/BD/24585/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barrantes ID, 2003, GENE DEV, V17, P2239, DOI 10.1101/gad.269103; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Castelo-Branco G, 2010, DEV DYNAM, V239, P211, DOI 10.1002/dvdy.22094; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; CONLON RA, 1993, GUIDE TECHNIQUES MOU, P373; Gaulden J, 2008, HUM MOL GENET, V17, pR60, DOI 10.1093/hmg/ddn119; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Grotewold L, 1999, MECH DEVELOP, V89, P151, DOI 10.1016/S0925-4773(99)00194-X; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kazanskaya O, 2000, DEVELOPMENT, V127, P4981; Kong XB, 2009, IN VITRO CELL DEV-AN, V45, P185, DOI 10.1007/s11626-008-9157-2; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; LIEVEN O, 2010, DEV BIOL; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402	47	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e15786	10.1371/journal.pone.0015786	http://dx.doi.org/10.1371/journal.pone.0015786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347250	Green Published, gold, Green Submitted			2022-12-25	WOS:000287364500001
J	Dale, JJ; Stankus, AM; Burns, MS; Meyer, CG				Dale, Jonathan J.; Stankus, Austin M.; Burns, Michael S.; Meyer, Carl G.			The Shark Assemblage at French Frigate Shoals Atoll, Hawai'i: Species Composition, Abundance and Habitat Use	PLOS ONE			English	Article							CAPTURE PROBABILITIES VARY; ESTIMATING POPULATION-SIZE; VISUAL-CENSUS; GALEOCERDO-CUVIER; REEF SHARKS; CARCHARHINUS GALAPAGENSIS; ANNOTATED CHECKLIST; MOVEMENT PATTERNS; CLOSED POPULATION; CLIPPERTON ATOLL	Empirical data on the abundance and habitat preferences of coral reef top predators are needed to evaluate their ecological impacts and guide management decisions. We used longline surveys to quantify the shark assemblage at French Frigate Shoals (FFS) atoll from May to August 2009. Fishing effort consisted of 189 longline sets totaling 6,862 hook hours of soak time. A total of 221 sharks from 7 species were captured, among which Galapagos (Carcharhinus galapagensis, 36.2%), gray reef (Carcharhinus amblyrhynchos, 25.8%) and tiger (Galeocerdo cuvier, 20.4%) sharks were numerically dominant. A lack of blacktip reef sharks (Carcharhinus melanopterus) distinguished the FFS shark assemblage from those at many other atolls in the Indo-Pacific. Compared to prior underwater visual survey estimates, longline methods more accurately represented species abundance and composition for the majority of shark species. Sharks were significantly less abundant in the shallow lagoon than adjacent habitats. Recaptures of Galapagos sharks provided the first empirical estimate of population size for any Galapagos shark population. The overall recapture rate was 5.4%. Multiple closed population models were evaluated, with Chao M-h ranking best in model performance and yielding a population estimate of 668 sharks with 95% confidence intervals ranging from 289-1720. Low shark abundance in the shallow lagoon habitats suggests removal of a small number of sharks from the immediate vicinity of lagoonal islets may reduce short-term predation on endangered monk seal (Monachus schauinslandi) pups, but considerable fishing effort would be required to catch even a small number of sharks. Additional data on long-term movements and habitat use of sharks at FFS are required to better assess the likely ecological impacts of shark culling.	[Dale, Jonathan J.; Stankus, Austin M.; Burns, Michael S.; Meyer, Carl G.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Dale, Jonathan J.; Stankus, Austin M.] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Dale, JJ (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA.	jjdale@hawaii.edu			National Marine Sanctuary Program [MOA 2005-008/6882]; Protected Species Division of the National Marine Fisheries Service	National Marine Sanctuary Program; Protected Species Division of the National Marine Fisheries Service	This study was funded by an award to Hawaii Institute of Marine Biology from the National Marine Sanctuary Program (MOA 2005-008/6882). Additional funding was provided by the Protected Species Division of the National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 1997, REV BIOL TROP, V45, P813; BROCK RE, 1979, MAR BIOL, V54, P281, DOI 10.1007/BF00395790; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; CHAO A, 1992, BIOMETRICS, V48, P201, DOI 10.2307/2532750; CHAO A, 1989, BIOMETRICS, V45, P427, DOI 10.2307/2531487; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Compagno L.J.V., 2005, SHARKS WORLD; Connell SD, 1998, AUST J ECOL, V23, P579, DOI 10.1111/j.1442-9993.1998.tb00768.x; DECROSTA MA, 1984, UNIHISEAGRANTMR8401, P75; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMartini EE, 2005, MAR ECOL PROG SER, V297, P259, DOI 10.3354/meps297259; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 1997, FISH RES, V32, P33, DOI 10.1016/S0165-7836(97)00038-6; GRIGG RW, 1994, MAR ECOL PROG SER, V103, P25, DOI 10.3354/meps103025; Guillemette M, 2001, J APPL ECOL, V38, P1, DOI 10.1046/j.1365-2664.2001.00564.x; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holzwarth Stephani R., 2006, Atoll Research Bulletin, P257; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Lobel Phillip S., 2004, Pacific Science, V58, P65, DOI 10.1353/psc.2004.0007; MacNeil MA, 2008, J FISH BIOL, V73, P1748, DOI 10.1111/j.1095-8649.2008.02067.x; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; Papastamatiou YP, 2009, J FISH BIOL, V75, P647, DOI 10.1111/j.1095-8649.2009.02329.x; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; RANDALL JE, 1985, PAC SCI, V39, P24; Randall John E., 1993, Pacific Science, V47, P356; Rexstad E., 1991, USERS GUIDE INTERACT; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Robertson DR, 1996, CORAL REEFS, V15, P121, DOI 10.1007/s003380050032; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sims DW, 2001, MAR BIOL, V139, P1165; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; STEVENS JD, 1984, PROC R SOC SER B-BIO, V222, P79, DOI 10.1098/rspb.1984.0050; TAYLOR LR, 1994, SHARKS HAWAII; Wetherbee BM, 1996, ENVIRON BIOL FISH, V45, P299, DOI 10.1007/BF00003099; WHITE G. C., 1978, USERS MANUAL PROGRAM; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; ZIPPIN CALVIN, 1958, JOUR WILDLIFE MANAGEMENT, V22, P82, DOI 10.2307/3797301	49	20	20	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16962	10.1371/journal.pone.0016962	http://dx.doi.org/10.1371/journal.pone.0016962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347321	Green Published, gold, Green Submitted			2022-12-25	WOS:000287363000025
J	Dunstan, A; Bradshaw, CJA; Marshall, J				Dunstan, Andrew; Bradshaw, Corey J. A.; Marshall, Justin			Nautilus at Risk - Estimating Population Size and Demography of Nautilus pompilius	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; LIVING NAUTILUS; CHAMBERED NAUTILUS; ADMIRALTY ISLANDS; GROWTH; CEPHALOPODA; FIJI; MACROMPHALUS; SHELL; PALAU	The low fecundity, late maturity, long gestation and long life span of Nautilus suggest that this species is vulnerable to over-exploitation. Demand from the ornamental shell trade has contributed to their rapid decline in localized populations. More data from wild populations are needed to design management plans which ensure Nautilus persistence. We used a variety of techniques including capture-mark-recapture, baited remote underwater video systems, ultrasonic telemetry and remotely operated vehicles to estimate population size, growth rates, distribution and demographic characteristics of an unexploited Nautilus pompilius population at Osprey Reef (Coral Sea, Australia). We estimated a small and dispersed population of between 844 and 4467 individuals (14.6-77.4 km(-2)) dominated by males (83: 17 male: female) and comprised of few juveniles (<10%). These results provide the first Nautilid population and density estimates which are essential elements for long-term management of populations via sustainable catch models. Results from baited remote underwater video systems provide confidence for their more widespread use to assess efficiently the size and density of exploited and unexploited Nautilus populations worldwide.	[Dunstan, Andrew] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] S Australian Res & Dev Inst, Henley Beach, SA, Australia; [Marshall, Justin] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Adelaide; University of Adelaide; University of Queensland	Dunstan, A (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	andy.dunstan@gmail.com	Bradshaw, Corey J.A./A-1311-2008	Bradshaw, Corey J.A./0000-0002-5328-7741; Marshall, Justin/0000-0001-9006-6713	Undersea Explorer; University of Queensland; University of Western Australia; Australian Research Council [ID LP0775179]	Undersea Explorer; University of Queensland(University of Queensland); University of Western Australia; Australian Research Council(Australian Research Council)	Funding for this work came from Undersea Explorer, University of Queensland, University of Western Australia and from an Australian Research Council Linkage Project: Project ID LP0775179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JM, 1990, J CEPHALOPOD BIOL, V2, P1; Beaman, 2010, 3DGBR HIGH RESOLUTIO; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CARLSON BA, 1979, PAC SCI, V33, P118; Collins D., 2010, NAUTILUS BIOL PALEOB, P421; DEANGELIS P, 2010, 8 INT S CEPH PRES DI; Del Norte-Campos A.G.C., 2005, PHUKET MAR BIO CEN R, V66, P299; DUNSTAN A, 2010, FISHERIES R IN PRESS; DUNSTAN A, 2010, PLOS ONE IN PRESS; Hanlon R. T., 1996, CEPHALOPOD BEHAV; HAVEN N, 1977, MAR BIOL, V42, P177, DOI 10.1007/BF00391570; HEWITT R, 2010, NAUTILUS BIOL PALEOB, P435; KANIE Y, 1979, Venus the Japanese Journal of Malacology, V38, P129; KANIE Y, 1980, PALEOBIOLOGY, V6, P44, DOI 10.1017/S0094837300012483; Landman N.H., 2010, NAUTILUS BIOL PALEOB, P401, DOI DOI 10.1007/978-90-481-3299-7_28; LANDMAN NH, 1988, EARTH PLANET SC LETT, V89, P28, DOI 10.1016/0012-821X(88)90030-1; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; ODOR RK, 1993, NATURE, V362, P626, DOI 10.1038/362626a0; OKUBO S, 1995, VELIGER, V38, P192; Saunders W. B., 2010, NAUTILUS BIOL PALEOB; SAUNDERS WB, 1987, NAUTILUS, V101, P93; SAUNDERS WB, 1990, NATL GEOGR RES, V6, P504; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; SAUNDERS WB, 1978, PALEOBIOLOGY, V4, P349, DOI 10.1017/S0094837300006047; Saunders WB, 2010, NAUTILUS BIOL PALEOB, V6, P137; SCHWARZ CJ, JOLLYSEBER MODEL MOD, P195; Sinclair B, 2007, REV FISH BIOL FISHER, V17, P223, DOI 10.1007/s11160-006-9030-x; Strugnell JM, 2007, REV FISH BIOL FISHER, V17, P337, DOI 10.1007/s11160-007-9043-0; Swan A.R.H., 2010, NAUTILUS BIOL PALEOB, P85, DOI [DOI 10.1007/978-90-481-3299-7_6, 10.1007/978-90-481-3299-7_6]; TANABE K, 1990, MALACOLOGIA, V31, P297; WARD P, 1980, LETHAIA, V13, P182, DOI 10.1111/j.1502-3931.1980.tb01050.x; WARD P, 1977, PALEOBIOLOGY, V3, P377, DOI 10.1017/S0094837300005534; WARD P, 1981, PALEOBIOLOGY, V7, P481, DOI 10.1017/S0094837300025537; WARD P, 1983, CEPHALOPOD LIFE CYCL, P137; Ward P. D., 1987, NATURAL HIST NAUTILU; WARD PD, 1980, VELIGER, V22, P259; Ward PD, 1997, J PALEONTOL, V71, P1054, DOI 10.1017/S0022336000036039; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Westermann B, 2004, J EXP ZOOL PART A, V301A, P930, DOI 10.1002/jez.a.116; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; ZANN LP, 1984, VELIGER, V27, P19	43	38	39	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16716	10.1371/journal.pone.0016716	http://dx.doi.org/10.1371/journal.pone.0016716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347360	Green Published, Green Submitted, gold			2022-12-25	WOS:000287363000013
J	Gaebel, R; Furlani, D; Sorg, H; Polchow, B; Frank, J; Bieback, K; Wang, WW; Klopsch, C; Ong, LL; Li, WZ; Ma, N; Steinhoff, G				Gaebel, Ralf; Furlani, Dario; Sorg, Heiko; Polchow, Bianca; Frank, Johannes; Bieback, Karen; Wang, Weiwei; Klopsch, Christian; Ong, Lee-Lee; Li, Wenzhong; Ma, Nan; Steinhoff, Gustav			Cell Origin of Human Mesenchymal Stem Cells Determines a Different Healing Performance in Cardiac Regeneration	PLOS ONE			English	Article							HUMAN BONE-MARROW; UMBILICAL-CORD BLOOD; SKELETAL MYOBLAST TRANSPLANTATION; MYOCARDIAL-INFARCTION; ADIPOSE-TISSUE; STROMAL CELLS; CARDIOMYOCYTE TRANSPLANTATION; PROGENITOR CELLS; GENE DELIVERY; SCAR TISSUE	The possible different therapeutic efficacy of human mesenchymal stem cells (hMSC) derived from umbilical cord blood (CB), adipose tissue (AT) or bone marrow (BM) for the treatment of myocardial infarction (MI) remains unexplored. This study was to assess the regenerative potential of hMSC from different origins and to evaluate the role of CD105 in cardiac regeneration. Male SCID mice underwent LAD-ligation and received the respective cell type (400,000/per animal) intramyocardially. Six weeks post infarction, cardiac catheterization showed significant preservation of left ventricular functions in BM and CD105(+)-CB treated groups compared to CB and nontreated MI group (MI-C). Cell survival analyzed by quantitative real time PCR for human GAPDH and capillary density measured by immunostaining showed consistent results. Furthermore, cardiac remodeling can be significantly attenuated by BM-hMSC compared to MI-C. Under hypoxic conditions in vitro, remarkably increased extracellular acidification and apoptosis has been detected from CB-hMSC compared to BM and CD105 purified CB-derived hMSC. Our findings suggests that hMSC originating from different sources showed a different healing performance in cardiac regeneration and CD105(+) hMSC exhibited a favorable survival pattern in infarcted hearts, which translates into a more robust preservation of cardiac function.	[Gaebel, Ralf; Furlani, Dario; Sorg, Heiko; Polchow, Bianca; Frank, Johannes; Wang, Weiwei; Klopsch, Christian; Ong, Lee-Lee; Li, Wenzhong; Ma, Nan; Steinhoff, Gustav] Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, Rostock, Germany; [Bieback, Karen] German Red Cross Blood Serv Baden Wurttemberg Hes, Inst Transfus Med & Immunol, Mannheim, Germany	University of Rostock	Gaebel, R (corresponding author), Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, Rostock, Germany.	wenzhong.li@med.uni-rostock.de; nan.ma@med.uni-rostock.de	ma, nan/AAF-6968-2020; Steinhoff, Gustav/AAB-1848-2020; Ma, Nan/L-1282-2013; Li, Wenzhong/I-2882-2014	ma, nan/0000-0003-4006-1003; Ma, Nan/0000-0003-4006-1003; Sorg, Heiko/0000-0001-6827-0857	Standardization for Regenerative Therapy - Mesenchymal Stem Cells (START-MSC); Sonderforschungsbereich/Transregio [37]; German Federal Ministry of Education and Research [0313191]; German Helmholtz Association; Mecklenburg-Vorpommern; German Federal Ministry of Education and Research; German Research Foundation [0402710]; Forderkennzeichen A (Ministry of Education (Germany, Berlin) [0312138]; Ministry of Economy (Mecklenburg-West Pommerania, Schwerin [V220-630-08-TFMV-F/S-035]; Marie Curie International Research Staff Exchange Scheme [IRSES, FP7-PEOPLE-2009-IRSES]; Reference and Translation Center for Cardiac Stem Cell Therapy (RTC)	Standardization for Regenerative Therapy - Mesenchymal Stem Cells (START-MSC); Sonderforschungsbereich/Transregio(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Helmholtz Association(Helmholtz Association); Mecklenburg-Vorpommern; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Forderkennzeichen A (Ministry of Education (Germany, Berlin); Ministry of Economy (Mecklenburg-West Pommerania, Schwerin; Marie Curie International Research Staff Exchange Scheme(European Commission); Reference and Translation Center for Cardiac Stem Cell Therapy (RTC)	This work was supported by Standardization for Regenerative Therapy - Mesenchymal Stem Cells (START-MSC); Sonderforschungsbereich/Transregio 37 (B5, B2 and A4); German Federal Ministry of Education and Research, BioChancePlus program (0313191); The German Helmholtz Association, Mecklenburg-Vorpommern, German Federal Ministry of Education and Research, German Research Foundation (Nachwuchsgruppe Regenerative Medizin Regulation der Stammzellmigration 0402710); Forderkennzeichen 0312138 A (Ministry of Education (Germany, Berlin)); V220-630-08-TFMV-F/S-035 (Ministry of Economy (Mecklenburg-West Pommerania, Schwerin)); Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-2009-IRSES); the Reference and Translation Center for Cardiac Stem Cell Therapy (RTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bieback K, 2008, BIO-MED MATER ENG, V18, pS71; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Furlani D, 2009, CELL TRANSPLANT, V18, P319, DOI 10.3727/096368909788534906; Goodwin HS, 2001, BIOL BLOOD MARROW TR, V7, P581, DOI 10.1053/bbmt.2001.v7.pm11760145; Hao JM, 1999, J MOL CELL CARDIOL, V31, P667, DOI 10.1006/jmcc.1998.0902; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jia ZQ, 1997, TRANSPLANT P, V29, P2093, DOI 10.1016/S0041-1345(97)00247-9; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882; Li RK, 1996, ANN THORAC SURG, V62, P654; Li RK, 2001, ANN THORAC SURG, V72, P1957, DOI 10.1016/S0003-4975(01)03216-7; Li WZ, 2008, J GENE MED, V10, P897, DOI 10.1002/jgm.1208; Li WZ, 2007, J MAGN MAGN MATER, V311, P336, DOI 10.1016/j.jmmm.2006.11.201; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Ma N, 2005, CARDIOVASC RES, V66, P45, DOI 10.1016/j.cardiores.2004.12.013; Ma N, 2006, CARDIOVASC RES, V71, P158, DOI 10.1016/j.cardiores.2006.03.020; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Nesselmann Catharina, 2010, Ther Adv Cardiovasc Dis, V4, P27, DOI 10.1177/1753944709353338; Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081; Ong LL, 2010, TISSUE ENG PART C-ME, V16, P1069, DOI [10.1089/ten.tec.2009.0641, 10.1089/ten.TEC.2009.0641]; OU L, 2010, J CELL MOL MED; Penn MS, 2008, CIRC RES, V102, P1471, DOI 10.1161/CIRCRESAHA.108.175174; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; SCHALLMOSER K, HAEMATOLOGICA, V95, P867; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Thedinga E, 2007, TOXICOL APPL PHARM, V220, P33, DOI 10.1016/j.taap.2006.12.027; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Van de Kerkhof PCM, 1998, ACTA DERM-VENEREOL, V78, P19; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; WAGNER W, TISSUE ENG B, V16, P445; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wang BQ, 2002, AM J PHYSIOL-HEART C, V282, pH1685, DOI 10.1152/ajpheart.00266.2001; WANG W, 2010, J CELL MOL MED; Wang WW, 2010, J CELL MOL MED, V14, P392, DOI 10.1111/j.1582-4934.2008.00624.x; Wang WW, 2009, INT J ARTIF ORGANS, V32, P141, DOI 10.1177/039139880903200304; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Wikstrom P, 2002, PROSTATE, V51, P268, DOI 10.1002/pros.10083; Yoo KJ, 2000, ANN THORAC SURG, V70, P859, DOI 10.1016/S0003-4975(00)01630-1; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	61	104	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e15652	10.1371/journal.pone.0015652	http://dx.doi.org/10.1371/journal.pone.0015652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347366	Green Published, Green Submitted, gold			2022-12-25	WOS:000287363000004
J	Allam, US; Krishna, MG; Lahiri, A; Joy, O; Chakravortty, D				Allam, Uday Shankar; Krishna, M. Gopala; Lahiri, Amit; Joy, Omana; Chakravortty, Dipshikha			Salmonella enterica Serovar Typhimurium Lacking hfq Gene Confers Protective Immunity against Murine Typhoid	PLOS ONE			English	Article							ADENINE METHYLASE MUTANTS; LIVE ATTENUATED BACTERIA; III SECRETION SYSTEM; RNA CHAPERONE HFQ; PATHOGENICITY ISLAND-2; ESCHERICHIA-COLI; DENDRITIC CELLS; ORAL CHALLENGE; IFN-GAMMA; T-CELLS	Salmonella enterica is an important enteric pathogen and its various serovars are involved in causing both systemic and intestinal diseases in humans and domestic animals. The emergence of multidrug-resistant strains of Salmonella leading to increased morbidity and mortality has further complicated its management. Live attenuated vaccines have been proven superior over killed or subunit vaccines due to their ability to induce protective immunity. Of the various strategies used for the generation of live attenuated vaccine strains, focus has gradually shifted towards manipulation of virulence regulator genes. Hfq is a RNA chaperon which mediates the binding of small RNAs to the mRNA and assists in post-transcriptional gene regulation in bacteria. In this study, we evaluated the efficacy of the Salmonella Typhimurium Dhfq strain as a candidate for live oral vaccine in murine model of typhoid fever. Salmonella hfq deletion mutant is highly attenuated in cell culture and animal model implying a significant role of Hfq in bacterial virulence. Oral immunization with the Salmonella hfq deletion mutant efficiently protects mice against subsequent oral challenge with virulent strain of Salmonella Typhimurium. Moreover, protection was induced upon both multiple as well as single dose of immunizations. The vaccine strain appears to be safe for use in pregnant mice and the protection is mediated by the increase in the number of CD4(+) T lymphocytes upon vaccination. The levels of serum IgG and secretory-IgA in intestinal washes specific to lipopolysaccharide and outer membrane protein were significantly increased upon vaccination. Furthermore, hfq deletion mutant showed enhanced antigen presentation by dendritic cells compared to the wild type strain. Taken together, the studies in murine immunization model suggest that the Salmonella hfq deletion mutant can be a novel live oral vaccine candidate.	[Allam, Uday Shankar] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; Indian Inst Sci, Biosafety Labs, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Allam, US (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Allam, Uday/HDN-4342-2022; Mannala, Gopala Krishna/ABF-2325-2020; Chakravortty, Dipshikha/AAI-4448-2020; chakravortty, dipshikha/A-9492-2009	Allam, Uday/0000-0003-4641-3903; LAHIRI, AMIT/0000-0003-0307-3478; Chakravortty, Dipshikha/0000-0002-7838-5145	Indian Institute of Science, Bangalore, India; Department of Biotechnology [DBT 197, DBT 172]; DST-FIST (Department of Science and Technology); U.G.C.	Indian Institute of Science, Bangalore, India; Department of Biotechnology; DST-FIST (Department of Science and Technology)(Department of Science & Technology (India)); U.G.C.(University Grants Commission, India)	This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and Department of Biotechnology (DBT 197 and DBT 172) to D. C. Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST-FIST (Department of Science and Technology-Infrastructure support grant) and UGC (University Grant Commission-special assistance) is acknowledged. U.S.A. acknowledges U.G.C. for fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Cagiola M, 2007, VET MICROBIOL, V121, P330, DOI 10.1016/j.vetmic.2006.12.018; Chan K, 2003, J BACTERIOL, V185, P553, DOI 10.1128/JB.185.2.553-563.2003; CHAO Y, 2010, CURR OPIN MICROBIOL; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Cheminay C, 2008, INT J MED MICROBIOL, V298, P87, DOI 10.1016/j.ijmm.2007.08.006; Coynault C, 1996, MOL MICROBIOL, V22, P149, DOI 10.1111/j.1365-2958.1996.tb02664.x; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeRoeck D, 2007, NEW ENGL J MED, V357, P1069, DOI 10.1056/NEJMp078144; Dueger EL, 2001, INFECT IMMUN, V69, P7950, DOI 10.1128/IAI.69.12.7950-7954.2001; Eckmann L, 1996, J IMMUNOL, V156, P2894; El Ghany MA, 2007, INFECT IMMUN, V75, P1835, DOI 10.1128/IAI.01655-06; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Hamid N, 2008, CLIN VACCINE IMMUNOL, V15, P1461, DOI 10.1128/CVI.00093-08; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; IVANOFF B, 1994, B WORLD HEALTH ORGAN, V72, P957; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Karem KL, 1996, VACCINE, V14, P1495, DOI 10.1016/S0264-410X(96)00118-1; KEITEL WA, 1994, VACCINE, V12, P195, DOI 10.1016/0264-410X(94)90194-5; Khan SA, 2003, VACCINE, V21, P538, DOI 10.1016/S0264-410X(02)00410-3; Kirkpatrick BD, 2006, VACCINE, V24, P116, DOI 10.1016/j.vaccine.2005.08.008; Kotton CN, 2006, VACCINE, V24, P6216, DOI 10.1016/j.vaccine.2006.05.094; Krishnan L, 1996, J IMMUNOL, V156, P644; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; MASTROENI P, 1992, MICROB PATHOGENESIS, V13, P477, DOI 10.1016/0882-4010(92)90014-F; Matsui H, 2003, INFECT IMMUN, V71, P30, DOI 10.1128/IAI.71.1.30-39.2003; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Mizuno Y, 2003, CLIN EXP IMMUNOL, V131, P111, DOI 10.1046/j.1365-2249.2003.02060.x; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Nagarajan AG, 2009, VACCINE, V27, P2804, DOI 10.1016/j.vaccine.2009.02.092; Nagy G, 2004, INFECT IMMUN, V72, P4297, DOI 10.1128/IAI.72.7.4297-4301.2004; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Negi VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009139; Northen H, 2010, VACCINE, V28, P940, DOI 10.1016/j.vaccine.2009.10.146; OBRIEN AD, 1981, J IMMUNOL, V126, P1368; Pejcic-Karapetrovic B, 2007, J IMMUNOL, V179, P6088, DOI 10.4049/jimmunol.179.9.6088; Peters SE, 2010, INFECT IMMUN, V78, P326, DOI 10.1128/IAI.00768-09; Pie S, 1997, INFECT IMMUN, V65, P4509, DOI 10.1128/IAI.65.11.4509-4514.1997; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Sagi SSK, 2006, VACCINE, V24, P7135, DOI 10.1016/j.vaccine.2006.06.056; Secundino I, 2006, IMMUNOLOGY, V117, P59, DOI 10.1111/j.1365-2567.2005.02263.x; Singh SP, 1996, MICROB PATHOGENESIS, V21, P249, DOI 10.1006/mpat.1996.0059; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Srinivasan A, 2009, J IMMUNOL, V182, P7838, DOI 10.4049/jimmunol.0900382; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Viret JF, 1999, INFECT IMMUN, V67, P3680, DOI 10.1128/IAI.67.7.3680-3685.1999; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104	64	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16667	10.1371/journal.pone.0016667	http://dx.doi.org/10.1371/journal.pone.0016667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347426	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000287361700028
J	Liu, BJ; Wang, P; Wang, ZJ; Zhang, W				Liu, Bianjiang; Wang, Peng; Wang, Zengjun; Zhang, Wei			The Use of Anti-VDAC2 Antibody for the Combined Assessment of Human Sperm Acrosome Integrity and Ionophore A23187-Induced Acrosome Reaction	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; MITOCHONDRIAL OUTER-MEMBRANE; HUMAN SPERMATOZOA; VDAC ISOFORMS; LOCALIZATION; EXPRESSION; BINDING; PORIN; FLUX; CAPACITATION	Voltage-dependent anion channel (VDAC) is mainly located in the mitochondrial outer membrane and participates in many biological processes. In mammals, three VDAC subtypes (VDAC1, 2 and 3) have been identified. Although VDAC has been extensively studied in various tissues and cells, there is little knowledge about the distribution and function of VDAC in male mammalian reproductive system. Several studies have demonstrated that VDAC exists in mammalian spermatozoa and is implicated in spermatogenesis, sperm maturation, motility and fertilization. However, there is no knowledge about the respective localization and function of three VDAC subtypes in human spermatozoa. In this study, we focused on the presence of VDAC2 in human spermatozoa and its possible role in the acrosomal integrity and acrosome reaction using specific anti-VDAC2 monoclonal antibody for the first time. The results exhibited that native VDAC2 existed in the membrane components of human spermatozoa. The co-incubation of spermatozoa with anti-VDAC2 antibody did not affect the acrosomal integrity and acrosome reaction, but inhibited ionophore A23187-induced intracellular Ca(2+) increase. Our study suggested that VDAC2 was located in the acrosomal membrane or plasma membrane of human spermatozoa, and played putative roles in sperm functions through mediating Ca(2+) transmembrane transport.	[Liu, Bianjiang; Wang, Peng; Wang, Zengjun; Zhang, Wei] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Lab Reprod Med, Nanjing, Peoples R China	Nanjing Medical University	Liu, BJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Lab Reprod Med, Nanjing, Peoples R China.	zengjunwang@njmu.edu.cn; zhangwei@njmu.edu.cn			National Natural Science Foundation of China [30872575]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from National Natural Science Foundation of China (No.: 30872575). URL: http://www.nsfc.gov.cn/Portal0/default124.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1993, J ANDROL, V14, P132; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; DEPINTO V, 1985, BIOCHIM BIOPHYS ACTA, V813, P230; DOHERTY CM, 1995, J ANDROL, V16, P36; DOMINGUEZ L, 1995, INT J ANDROL, V18, P203, DOI 10.1111/j.1365-2605.1995.tb00411.x; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Guarino F, 2006, BIOCHEM BIOPH RES CO, V346, P665, DOI 10.1016/j.bbrc.2006.05.172; Hinsch KD, 2004, J BIOL CHEM, V279, P15281, DOI 10.1074/jbc.M313433200; Hinsch KD, 2001, BBA-GENE STRUCT EXPR, V1518, P329, DOI 10.1016/S0167-4781(01)00199-3; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Israelson A, 2007, CELL CALCIUM, V41, P235, DOI 10.1016/j.ceca.2006.06.005; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Krasznai Z, 2006, CELL MOTIL CYTOSKEL, V63, P66, DOI 10.1002/cm.20108; LINDEN M, 1984, BIOCHIM BIOPHYS ACTA, V770, P93, DOI 10.1016/0005-2736(84)90077-4; Liu BJ, 2010, BIOCHEM BIOPH RES CO, V397, P633, DOI 10.1016/j.bbrc.2010.06.025; Liu BJ, 2009, BIOCHEM BIOPH RES CO, V378, P366, DOI 10.1016/j.bbrc.2008.10.177; Liu DY, 1996, HUM REPROD, V11, P551, DOI 10.1093/HUMREP/11.3.551; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; ShoshanBarmatz V, 1996, FEBS LETT, V386, P205, DOI 10.1016/0014-5793(96)00442-5; SORGATO MC, 1993, CRIT REV BIOCHEM MOL, V28, P127; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Trevino CL, 2004, FEBS LETT, V563, P87, DOI 10.1016/S0014-5793(04)00257-1; Triphan X, 2008, PFLUG ARCH EUR J PHY, V455, P677, DOI 10.1007/s00424-007-0316-1; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Wang ZJ, 2007, BIOL REPROD, V77, P476, DOI 10.1095/biolreprod.107.060194; World Health Organization, 1999, WHO LAB MAN EX HUM S; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yamamoto T, 2006, J PROTEOME RES, V5, P3336, DOI 10.1021/pr060291w; Yoshida M, 2003, P NATL ACAD SCI USA, V100, P149, DOI 10.1073/pnas.0135565100; Young C, 2009, FERTIL STERIL, V91, P2230, DOI 10.1016/j.fertnstert.2008.05.021; Yu WH, 1996, J BIOENERG BIOMEMBR, V28, P93, DOI 10.1007/BF02110638; Zhang J, 2010, HUM REPROD, V25, P29, DOI 10.1093/humrep/dep356	45	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16985	10.1371/journal.pone.0016985	http://dx.doi.org/10.1371/journal.pone.0016985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347391	Green Submitted, gold, Green Published			2022-12-25	WOS:000287361700062
J	Kavaler, S; Morinaga, H; Jih, A; Fan, WQ; Hedlund, M; Varki, A; Kim, JJ				Kavaler, Sarah; Morinaga, Hidetaka; Jih, Alice; Fan, WuQiang; Hedlund, Maria; Varki, Ajit; Kim, Jane J.			Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency	FASEB JOURNAL			English	Article						diabetes; sialic acid; pancreatic islet	N-GLYCOLYLNEURAMINIC ACID; SIALIC-ACID; INSULIN-RESISTANCE; HUMAN-EVOLUTION; RECEPTOR; GLUCOSE; DIETARY; SECRETION; BIOLOGY	Type 2 diabetes is highly prevalent in human populations, particularly in obese individuals, and is characterized by progressive pancreatic beta-cell dysfunction and insulin resistance. Most mammals, including Old World primates, express two major kinds of sialic acids, N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), typically found at the distal ends of glycoconjugate chains at the cell surface. Humans are uniquely unable to produce endogenous Neu5Gc due to an inactivating mutation in the CMP-Neu5Ac hydroxylase (CMAH) gene. The CMAH enzyme catalyzes the generation of CMP-Neu5Gc by the transfer of a single oxygen atom to the acyl group of CMP-Neu5Ac. Here, we show that mice bearing a human-like deletion of the Cmah gene exhibit fasting hyperglycemia and glucose intolerance following a high-fat diet. This phenotype is caused not by worsened insulin resistance but by compromised pancreatic beta-cell function associated with a 65% decrease in islet size and area and 50% decrease in islet number. Obese Cmah-null mice also show an similar to 40% reduction in response to insulin secretagogues in vivo. These findings show that human evolution-like changes in sialic acid composition impair pancreatic beta-cell function and exacerbate glucose intolerance in mice. This may lend insight into the pathogenesis of type 2 diabetes in obese humans.-Kavaler, S., Morinaga, H., Jih, A., Fan, W. Q., Hedlund, M., Varki, A., Kim, J. J. Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency. FASEB J. 25, 1887-1893 (2011). www.fasebj.org	[Kim, Jane J.] Univ Calif San Diego, Dept Pediat, Div Pediat Endocrinol & Diabet, La Jolla, CA 92093 USA; [Morinaga, Hidetaka; Fan, WuQiang; Hedlund, Maria; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hedlund, Maria; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hedlund, Maria; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Kim, Jane J.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Kim, JJ (corresponding author), Univ Calif San Diego, Dept Pediat, Div Pediat Endocrinol & Diabet, 9500 Gilman Dr,MC 0673, La Jolla, CA 92093 USA.	janekim@ucsd.edu		Kim, Jane/0000-0002-0228-0128	U.S. National Institutes of Health [DK075479, DK063491, GM32373]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK075479, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373, R37GM032373] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health grants DK075479 (J.K.), DK063491 DERC Pilot and Feasibility Award (J.K.), and GM32373 (A.V.). The authors thank Nissi Varki [University of California-San Diego (UCSD) Histology Core] for immunohistochemistry studies on pancreatic tissues. Thanks are due also to Jerrold Olefsky (UCSD) for helpful discussions and support.	Arabkhari M, 2010, GLYCOBIOLOGY, V20, P603, DOI 10.1093/glycob/cwq010; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; HANSEN BC, 1990, AM J PHYSIOL, V259, pR612, DOI 10.1152/ajpregu.1990.259.3.R612; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; JONES S M, 1974, Laboratory Animals (London), V8, P161, DOI 10.1258/002367774781005788; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Kim JJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1694, DOI 10.1152/ajpendo.00430.2006; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LEROITH D, 2004, DIABETES MELLITUS FU; Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M; Marcelli-Tourvieille S, 2006, DIABETES METAB, V32, P295, DOI 10.1016/S1262-3636(07)70283-5; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MORDES JP, 1981, AM J MED, V70, P353, DOI 10.1016/0002-9343(81)90772-5; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685; PIMENTA W, 1995, JAMA-J AM MED ASSOC, V273, P1855, DOI 10.1001/jama.273.23.1855; Tahara H, 2010, J IMMUNOL, V184, P3269, DOI 10.4049/jimmunol.0902857; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276	29	23	24	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2011	25	6					1887	1893		10.1096/fj.10-175281	http://dx.doi.org/10.1096/fj.10-175281			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21350118	Green Published			2022-12-25	WOS:000291023800012
J	Bannister, JP; Thomas-Gatewood, CM; Neeb, ZP; Adebiyi, A; Cheng, XY; Jaggar, JH				Bannister, John P.; Thomas-Gatewood, Candice M.; Neeb, Zachary P.; Adebiyi, Adebowale; Cheng, Xiaoyang; Jaggar, Jonathan H.			Ca(V)1.2 Channel N-terminal Splice Variants Modulate Functional Surface Expression in Resistance Size Artery Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNEL; HIGH BLOOD-PRESSURE; CA2+ CHANNEL; AUXILIARY SUBUNITS; ALPHA(1) SUBUNIT; BETA-SUBUNIT; GENE; CALMODULIN; MECHANISM; CURRENTS	Voltage-dependent Ca2+ (Ca(V)1.2) channels are the primary Ca2+ influx pathway in arterial smooth muscle cells and are essential for contractility regulation by a variety of stimuli, including intravascular pressure. Arterial smooth muscle cell Ca(V)1.2 mRNA is alternatively spliced at exon 1 (e1), generating e1b or e1c variants, with e1c exhibiting relatively smooth muscle-specific expression in the cardiovascular system. Here, we examined physiological functions of Ca(V)1.2e1 variants and tested the hypothesis that targeting Ca(V)1.2e1 modulates resistance size cerebral artery contractility. Custom antibodies that selectively recognize Ca(V)1.2 channel proteins containing sequences encoded by either e1b (Ca(V)1.2e1b) or e1c (Ca(V)1.2e1c) both detected Ca(V)1.2 in rat and human cerebral arteries. shRNA targeting e1b or e1c reduced expression of that Ca(V)1.2 variant, induced compensatory up-regulation of the other variant, decreased total Ca(V)1.2, and reduced intravascular pressure- and depolarization-induced vasoconstriction. Ca(V)1.2e1b and Ca(V)1.2e1c knockdown reduced whole cell Ca(V)1.2 currents, with Ca(V)1.2e1c knockdown most effectively reducing total Ca(V)1.2 and inducing the largest vasodilation. Knockdown of alpha(2)delta-1, a Ca(V)1.2 auxiliary subunit, reduced surface expression of both Ca(V)1.2e1 variants, inhibiting Ca(V)1.2e1c more than Ca(V)1.2e1b. e1b or e1c overexpression reduced Ca(V)1.2 surface expression and whole cell currents, leading to vasodilation, with e1c overexpression inducing the largest effect. In summary, data indicate that arterial smooth muscle cells express Ca(V)1.2 channels containing e1b or e1c-encoded N termini that contribute to Ca(V)1.2 surface expression, alpha(2)delta-1 preferentially traffics the Ca(V)1.2e1c variant to the plasma membrane, and targeting of Ca(V)1.2e1 message or the Ca(V)1.2 channel proximal N terminus induces vasodilation.	[Bannister, John P.; Thomas-Gatewood, Candice M.; Neeb, Zachary P.; Adebiyi, Adebowale; Cheng, Xiaoyang; Jaggar, Jonathan H.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Jaggar, JH (corresponding author), UT Memphis Hlth Sci Ctr, Dept Physiol, 894 Union Ave,Ste 426, Memphis, TN 38163 USA.	jjaggar@uthsc.edu	Cheng, Xiaoyang/N-9970-2019; Tuluc, Petronel/C-2527-2011; Cheng, Xiaoyang/M-1257-2017; Cheng, Xiaoyang/A-1729-2012	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Adebiyi, Adebowale/0000-0002-7033-1871	National Institutes of Health [HL67061, HL094378, KO1 HL096411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094378, K01HL096411, R01HL067061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67061 and HL094378 (to J.H.J.) and KO1 HL096411 (to A.A.).	Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Adebiyi A, 2008, MOL PHARMACOL, V74, P736, DOI 10.1124/mol.108.048165; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Babai N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008602; Bannister JP, 2009, CIRC RES, V105, P948, DOI 10.1161/CIRCRESAHA.109.203620; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cheng XY, 2007, J BIOL CHEM, V282, P29211, DOI 10.1074/jbc.M610623200; Cheng XY, 2009, AM J PHYSIOL-HEART C, V297, pH680, DOI 10.1152/ajpheart.00109.2009; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Gollasch M, 1997, KIDNEY BLOOD PRESS R, V20, P355, DOI 10.1159/000174250; HENKEL AW, 1994, ANAL BIOCHEM, V223, P329, DOI 10.1006/abio.1994.1595; Jaggar JH, 2001, AM J PHYSIOL-CELL PH, V281, pC439, DOI 10.1152/ajpcell.2001.281.2.C439; Jurkat-Rott K, 2004, J PHYSIOL-LONDON, V554, P609, DOI 10.1113/jphysiol.2003.052712; LESH RE, 1995, CIRC RES, V77, P220, DOI 10.1161/01.RES.77.2.220; Liao P, 2004, J BIOL CHEM, V279, P50329, DOI 10.1074/jbc.M409436200; Marsh James D, 2008, Trans Am Clin Climatol Assoc, V119, P171; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Navedo MF, 2007, AM J PHYSIOL-HEART C, V293, pH1359, DOI 10.1152/ajpheart.00450.2007; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Pesic A, 2004, CIRC RES, V94, pE97, DOI 10.1161/01.RES.0000131495.93500.3c; POWERS PA, 1991, GENOMICS, V10, P835, DOI 10.1016/0888-7543(91)90471-P; Pratt PF, 2002, HYPERTENSION, V40, P214, DOI 10.1161/01.HYP.0000025877.23309.36; Reimer D, 2000, FEBS LETT, V467, P65, DOI 10.1016/S0014-5793(00)01124-8; Selli C, 2009, VASC PHARMACOL, V51, P96, DOI 10.1016/j.vph.2009.04.001; Seth M, 2004, P NATL ACAD SCI USA, V101, P16683, DOI 10.1073/pnas.0407537101; Sonkusare S, 2006, VASC PHARMACOL, V44, P131, DOI 10.1016/j.vph.2005.10.005; Takahashi E, 2006, COMPARATIVE MED, V56, P168; Tang ZZ, 2007, CELL CALCIUM, V41, P417, DOI 10.1016/j.ceca.2006.08.002; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Triggle DJ, 2007, BIOCHEM PHARMACOL, V74, P1, DOI 10.1016/j.bcp.2007.01.016; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Zhao GL, 2008, AM J PHYSIOL-CELL PH, V295, pC1376, DOI 10.1152/ajpcell.00362.2008; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200	39	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15058	15066		10.1074/jbc.M110.182816	http://dx.doi.org/10.1074/jbc.M110.182816			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357696	Green Published, hybrid			2022-12-25	WOS:000289788300036
J	Guo, JL; Lee, VMY				Guo, Jing L.; Lee, Virginia M. -Y.			Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENTS; BLOOD-BRAIN-BARRIER; FTDP-17 MISSENSE MUTATIONS; FIBRILLIZATION IN-VITRO; FRONTOTEMPORAL DEMENTIA; NEUROFIBRILLARY TANGLES; P301L TAU; ADSORPTIVE ENDOCYTOSIS; ALPHA-SYNUCLEIN	Neurofibrillary tangles (NFTs) in Alzheimer disease and related tauopathies are composed of insoluble hyperphosphorylated Tau protein, but the mechanisms underlying the conversion of highly soluble Tau into insoluble NFTs remain elusive. Here, we demonstrate that introduction of minute quantities of misfolded preformed Tau fibrils (Tau pffs) into Tau-expressing cells rapidly recruit large amounts of soluble Tau into filamentous inclusions resembling NFTs with unprecedented efficiency, suggesting a "seeding"-recruitment process as a highly plausible mechanism underlying NFT formation in vivo. Consistent with the emerging concept of prion-like transmissibility of disease-causing amyloidogenic proteins, we found that spontaneous uptake of Tau pffs into cells is likely mediated by endocytosis, suggesting a potential mechanism for the propagation of Tau lesions in tauopathy brains. Furthermore, sequestration of soluble Tau by pff-induced Tau aggregates attenuates microtubule overstabilization in Tau-expressing cells, supporting the hypothesis of a Tau loss-of-function toxicity in cells harboring NFTs. In summary, our study establishes a cellular system that robustly develops authentic NFT-like Tau aggregates, which provides mechanistic insights into NFT pathogenesis and a potential tool for identifying Tau-based therapeutics.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), 3rd Floor,Maloney Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	vmylee@upenn.edu			National Institutes of Health [AG17586]; Cure Alzheimer Fund; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG17586. This work was also supported by Cure Alzheimer Fund.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Banks WA, 1998, J CELL SCI, V111, P533; Banks WA, 1997, LIFE SCI, V61, pPL119, DOI 10.1016/S0024-3205(97)00597-3; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Boutte AM, 2005, J ALZHEIMERS DIS, V8, P1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BROADWELL RD, 1988, P NATL ACAD SCI USA, V85, P632, DOI 10.1073/pnas.85.2.632; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GONATAS NK, 1973, J CELL BIOL, V59, P436, DOI 10.1083/jcb.59.2.436; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2005, BBA-MOL BASIS DIS, V1739, P251, DOI 10.1016/j.bbadis.2004.06.014; LEE VMY, 1994, NEUROBIOL AGING, V15, pS87; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Merrick SE, 1997, J NEUROSCI, V17, P5726; Mirra SS, 1999, J NEUROPATH EXP NEUR, V58, P335, DOI 10.1097/00005072-199904000-00004; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; PAULABARBOSA M, 1987, BRAIN RES, V417, P139, DOI 10.1016/0006-8993(87)90188-0; POLLOCK NJ, 1986, LANCET, V2, P1211; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; van Swieten JC, 1999, ANN NEUROL, V46, P617, DOI 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102	67	408	418	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15317	15331		10.1074/jbc.M110.209296	http://dx.doi.org/10.1074/jbc.M110.209296			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372138	Green Published, hybrid			2022-12-25	WOS:000289788300063
J	Yoshimura, K; Miyamoto, Y; Yasuhara, R; Maruyama, T; Akiyama, T; Yamada, A; Takami, M; Suzawa, T; Tsunawaki, S; Tachikawa, T; Baba, K; Kamijo, R				Yoshimura, Kentaro; Miyamoto, Yoichi; Yasuhara, Rika; Maruyama, Toshifumi; Akiyama, Tomohito; Yamada, Atsushi; Takami, Masamichi; Suzawa, Tetsuo; Tsunawaki, Shoko; Tachikawa, Tetsuhiko; Baba, Kazuyoshi; Kamijo, Ryutaro			Monocarboxylate Transporter-1 Is Required for Cell Death in Mouse Chondrocytic ATDC5 Cells Exposed to Interleukin-1 beta via Late Phase Activation of Nuclear Factor kappa B and Expression of Phagocyte-type NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR CHONDROCYTES; MITOCHONDRIAL DYSFUNCTION; PATHWAY; FAMILY; TRANSCRIPTION; LOCALIZATION; DEGRADATION; COMPLEX; ALPHA; DRUG	Interleukin-1 beta(IL-1 beta) induces cell death in chondrocytes in a nitric oxide (NO)- and reactive oxygen species (ROS)-dependent manner. In this study, increased production of lactate was observed in IL-1 beta-treated mouse chondrocytic ATDC5 cells prior to the onset of their death. IL-1 beta-induced cell death in ATDC5 cells was suppressed by introducing an siRNA for monocarboxylate transporter-1 (MCT-1), a lactate transporter distributed in plasma and mitochondrial inner membranes. Mct-1 knockdown also prevented IL-1 beta-induced expression of phagocyte-type NADPH oxidase (NOX-2), an enzyme specialized for production of ROS, whereas it did not have an effect on inducible NO synthase. Suppression of IL-1 beta-induced cell death by Nox-2 siRNA indicated that NOX-2 is involved in cell death. Phosphorylation and degradation of inhibitor of kappa B alpha (I kappa B alpha) from 5 to 20 min after the addition of IL-1 beta was not affected by Mct-1 siRNA. In addition, I kappa B alpha was slightly decreased after 12 h of incubation with IL-1 beta, and the decrease was prominent after 36 h, whereas activation of p65/RelA was observed from 12 to 48 h after exposure to IL-1 beta. These changes were not seen in Mct-1-silenced cells. Forced expression of I kappa B alpha super repressor as well as treatment with the I kappa B kinase inhibitor BAY 11-7082 suppressed NOX-2 expression. Furthermore, Mct-1 siRNA lowered the level of ROS generated after 15-h exposure to IL-1 beta, whereas a ROS scavenger, N-acetylcysteine, suppressed both late phase degradation of I kappa B alpha and Nox-2 expression. These results suggest that MCT-1 contributes to NOX-2 expression via late phase activation of NF-kappa B in a ROS-dependent manner in ATDC5 cells exposed to IL-1 beta.	[Yoshimura, Kentaro; Miyamoto, Yoichi; Maruyama, Toshifumi; Akiyama, Tomohito; Yamada, Atsushi; Takami, Masamichi; Suzawa, Tetsuo; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo 1428555, Japan; [Yasuhara, Rika; Tachikawa, Tetsuhiko] Showa Univ, Sch Dent, Dept Oral Pathol & Diag, Tokyo 1428555, Japan; [Maruyama, Toshifumi; Akiyama, Tomohito; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo 1428555, Japan; [Tsunawaki, Shoko] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo 1578535, Japan	Showa University; Showa University; Showa University; National Center for Child Health & Development - Japan	Miyamoto, Y (corresponding author), 1-5-8 Hatanodai,Shinagawa Ku, Tokyo 1428555, Japan.	yoichim@dent.showa-u.ac.jp	Baba, Kazuyoshi/AAY-2304-2021	Takami, Masamichi/0000-0002-4506-3975; Yasuhara, Rika/0000-0003-2282-6295; Baba, Kazuyoshi/0000-0001-8025-2168	Japan Society for the Promotion of Science [21592372]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [22890181] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research 21592372 from the Japan Society for the Promotion of Science and by the High-Tech Research Center Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, 2005-2009.	Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Clark RA, 2004, MECH AGEING DEV, V125, P799, DOI 10.1016/j.mad.2004.08.009; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cristofanon S, 2009, FASEB J, V23, P45, DOI 10.1096/fj.07-104109; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; DECLERCK LS, 1994, J IMMUNOL METHODS, V172, P115, DOI 10.1016/0022-1759(94)90384-0; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Del Carlo Marcello Jr, 2008, Curr Rheumatol Rep, V10, P37; Enesa K, 2008, J BIOL CHEM, V283, P18582, DOI 10.1074/jbc.M801312200; Frein D, 2005, BIOCHEM PHARMACOL, V70, P811, DOI 10.1016/j.bcp.2005.04.012; Ganster RW, 2000, NITRIC OXIDE BIOL PA, P129; Gauss KA, 2007, J LEUKOCYTE BIOL, V82, P729, DOI 10.1189/jlb.1206735; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; HELESTRAP AP, 2004, PFLUGERS ARCH, V447, P619; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Kamata H, 2002, FEBS LETT, V519, P231, DOI 10.1016/S0014-5793(02)02712-6; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Krebs Danielle L., 1999, Methods in Cell Science, V21, P57, DOI 10.1023/A:1009843325770; MAIER R, 1994, BBA-PROTEIN STRUCT M, V1208, P145, DOI 10.1016/0167-4838(94)90171-6; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rozen S, 2000, Methods Mol Biol, V132, P365; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Samuvel DJ, 2009, J IMMUNOL, V182, P2476, DOI 10.4049/jimmunol.0802059; Shikhman AR, 2004, AM J PHYSIOL-ENDOC M, V286, pE980, DOI 10.1152/ajpendo.00243.2003; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Whiteman M, 2004, FASEB J, V18, P1395, DOI 10.1096/fj.03-1096fje; Yasuhara R, 2005, BIOCHEM J, V389, P315, DOI 10.1042/BJ20041996	37	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14744	14752		10.1074/jbc.M111.221259	http://dx.doi.org/10.1074/jbc.M111.221259			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21372137	Green Published, hybrid			2022-12-25	WOS:000289788300003
J	Liebau, MC; Hopker, K; Muller, RU; Schmedding, I; Zank, S; Schairer, B; Fabretti, F; Hohne, M; Bartram, MP; Dafinger, C; Hackl, M; Burst, V; Habbig, S; Zentgraf, H; Blaukat, A; Walz, G; Benzing, T; Schermer, B				Liebau, Max C.; Hoepker, Katja; Mueller, Roman U.; Schmedding, Ingolf; Zank, Sibylle; Schairer, Benjamin; Fabretti, Francesca; Hoehne, Martin; Bartram, Malte P.; Dafinger, Claudia; Hackl, Matthias; Burst, Volker; Habbig, Sandra; Zentgraf, Hanswalter; Blaukat, Andree; Walz, Gerd; Benzing, Thomas; Schermer, Bernhard			Nephrocystin-4 Regulates Pyk2-induced Tyrosine Phosphorylation of Nephrocystin-1 to Control Targeting to Monocilia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE NEPHRONOPHTHISIS; CAENORHABDITIS-ELEGANS; PACS-1 BINDING; PRIMARY CILIUM; PROTEIN; GENE; PYK2; KINASE; ACTIVATION; MUTATIONS	Nephronophthisis is the most common genetic cause of end-stage renal failure during childhood and adolescence. Genetic studies have identified disease-causing mutations in at least 11 different genes (NPHP1-11), but the function of the corresponding nephrocystin proteins remains poorly understood. The two evolutionarily conserved proteins nephrocystin-1 (NPHP1) and nephrocystin-4 (NPHP4) interact and localize to cilia in kidney, retina, and brain characterizing nephronophthisis and associated pathologies as result of a ciliopathy. Here we show that NPHP4, but not truncating patient mutations, negatively regulates tyrosine phosphorylation of NPHP1. NPHP4 counteracts Pyk2-mediated phosphorylation of three defined tyrosine residues of NPHP1 thereby controlling binding of NPHP1 to the trans-Golgi sorting protein PACS-1. Knockdown of NPHP4 resulted in an accumulation of NPHP1 in trans-Golgi vesicles of ciliated retinal epithelial cells. These data strongly suggest that NPHP4 acts upstream of NPHP1 in a common pathway and support the concept of a role for nephrocystin proteins in intracellular vesicular transport.	[Liebau, Max C.; Hoepker, Katja; Mueller, Roman U.; Schmedding, Ingolf; Zank, Sibylle; Schairer, Benjamin; Fabretti, Francesca; Hoehne, Martin; Bartram, Malte P.; Dafinger, Claudia; Hackl, Matthias; Burst, Volker; Habbig, Sandra; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Div Renal, Dept Med, D-50937 Cologne, Germany; [Liebau, Max C.; Hoepker, Katja; Mueller, Roman U.; Schmedding, Ingolf; Zank, Sibylle; Schairer, Benjamin; Fabretti, Francesca; Hoehne, Martin; Bartram, Malte P.; Dafinger, Claudia; Hackl, Matthias; Burst, Volker; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany; [Liebau, Max C.; Habbig, Sandra] Univ Cologne, Dept Pediat, D-50937 Cologne, Germany; [Zentgraf, Hanswalter] German Canc Res Ctr, Dept Tumor Virol, D-69120 Heidelberg, Germany; [Blaukat, Andree] Merck KGaA, TA Oncol, Merck Serono Res, D-64293 Darmstadt, Germany; [Walz, Gerd] Univ Hosp Freiburg, Div Renal, D-79104 Freiburg, Germany	University of Cologne; University of Cologne; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); Merck KGaA; EMD Serono Inc.; University of Freiburg	Schermer, B (corresponding author), Univ Hosp Cologne, Div Renal, Dept Med, Kerpener Str 62, D-50937 Cologne, Germany.	bernhard.schermer@uk-koeln.de	Liebau, Max Christoph/K-3470-2019; Benzing, Thomas/X-5476-2019; Müller, Roman-Ulrich/AAK-3493-2021; Schermer, Bernhard/E-9972-2014; Habbig, Sandra/AHC-1168-2022	Liebau, Max Christoph/0000-0003-0494-9080; Müller, Roman-Ulrich/0000-0001-6910-0745; Schermer, Bernhard/0000-0002-5194-9000; Hohne, Martin/0000-0001-8698-5389; Hackl, Matthias/0000-0002-4199-3374	German Research Foundation [BE 2212, SCHE 1562, SFB 635, SFB 832]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grants BE 2212, SCHE 1562, SFB 635, and SFB 832.	Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Astier A, 1997, J BIOL CHEM, V272, P228; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Blaukat A, 2001, J BIOL CHEM, V276, P40431, DOI 10.1074/jbc.M107024200; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hinners I, 2003, EMBO REP, V4, P1182, DOI 10.1038/sj.embor.7400018; Hoefele Julia, 2005, Hum Mutat, V25, P411, DOI 10.1002/humu.9326; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Jauregui AR, 2005, EXP CELL RES, V305, P333, DOI 10.1016/j.yexcr.2005.01.008; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2009, J MED GENET, V46, P663, DOI 10.1136/jmg.2009.066613; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Scott GK, 2003, EMBO J, V22, P6234, DOI 10.1093/emboj/cdg596; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wang Q, 2003, J BIOL CHEM, V278, P32936, DOI 10.1074/jbc.M303261200; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Winkelbauer ME, 2005, J CELL SCI, V118, P5575, DOI 10.1242/jcs.02665; Wolf MTF, 2005, J AM SOC NEPHROL, V16, P676, DOI 10.1681/ASN.2003121025	43	17	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14237	14245		10.1074/jbc.M110.165464	http://dx.doi.org/10.1074/jbc.M110.165464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357692	Green Published, hybrid			2022-12-25	WOS:000289556200047
J	Mant, A; Elliott, D; Eyers, PA; O'Kelly, IM				Mant, Alexandra; Elliott, David; Eyers, Patrick A.; O'Kelly, Ita M.			Protein Kinase A Is Central for Forward Transport of Two-pore Domain Potassium Channels K(2P)3.1 and K(2P)9.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; K+ CHANNEL; BINDING; TASK-1; EXPRESSION; RSK; PHOSPHORYLATION; ANESTHETICS; SEQUENCE; SUBUNIT	Acid-sensitive two-pore domain potassium channels (K(2P)3.1 and K(2P)9.1) play key roles in both physiological and pathophysiological mechanisms, the most fundamental of which is control of resting membrane potential of cells in which they are expressed. These background "leak" channels are constitutively active once expressed at the plasma membrane, and hence tight control of their targeting and surface expression is fundamental to the regulation of K+ flux and cell excitability. The chaperone protein, 14-3-3, binds to a critical phosphorylated serine in the channel C termini of K(2P)3.1 and K(2P)9.1 (Ser(393) and Ser(373), respectively) and overcomes retention in the endoplasmic reticulum by beta COP. We sought to identify the kinase responsible for phosphorylation of the terminal serine in human and rat variants of K(2P)3.1 and K(2P)9.1. Adopting a bioinformatic approach, three candidate protein kinases were identified: cAMP-dependent protein kinase, ribosomal S6 kinase, and protein kinase C. In vitro phosphorylation assays were utilized to determine the ability of the candidate kinases to phosphorylate the channel C termini. Electrophysiological measurements of human K(2P)3.1 transiently expressed in HEK293 cells and cell surface assays of GFP-tagged K(2P)3.1 and K(2P)9.1 enabled the determination of the functional implications of phosphorylation by specific kinases. All of our findings support the conclusion that cAMP-dependent protein kinase is responsible for the phosphorylation of the terminal serine in both K(2P)3.1 and K(2P)9.1.	[Mant, Alexandra; O'Kelly, Ita M.] Univ Southampton, Southampton Gen Hosp, Div Human Genet, Ctr Human Dev Stem Cells & Regenerat, Southampton SO16 6YD, Hants, England; [Elliott, David] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Eyers, Patrick A.] Univ Sheffield, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England	University of Southampton; University of Leeds; University of Sheffield	O'Kelly, IM (corresponding author), Univ Southampton, Southampton Gen Hosp, Div Human Genet, Ctr Human Dev Stem Cells & Regenerat, Duthie Bldg,Mail Point 808,Tremona Rd, Southampton SO16 6YD, Hants, England.	I.M.O'Kelly@southampton.ac.uk		Mant, Alexandra/0000-0001-7169-209X	Biotechnology and Biological Sciences Research Council [BB/E014453/2]; Biotechnology and Biological Sciences Research Council [BB/E014453/1] Funding Source: researchfish; Medical Research Council [G120/1030] Funding Source: researchfish; BBSRC [BB/E014453/1, BB/E014453/2] Funding Source: UKRI; MRC [G120/1030] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Biotechnology and Biological Sciences Research Council Award BB/E014453/2 (to I.M.O.).	ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Czirjak G, 2000, MOL ENDOCRINOL, V14, P863, DOI 10.1210/me.14.6.863; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Duprat F, 2007, TRENDS NEUROSCI, V30, P573, DOI 10.1016/j.tins.2007.08.003; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gao XL, 2010, J BIOL CHEM, V285, P6970, DOI 10.1074/jbc.M109.083642; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Kindler CH, 1999, ANESTHESIOLOGY, V90, P1092, DOI 10.1097/00000542-199904000-00024; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Lu Z, 2008, CIRC RES, V103, P269, DOI 10.1161/CIRCRESAHA.107.166678; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; MOLLER DE, 1994, AM J PHYSIOL, V266, pC351, DOI 10.1152/ajpcell.1994.266.2.C351; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Roberts NA, 2005, BRIT J PHARMACOL, V145, P477, DOI 10.1038/sj.bjp.0706210; Smith JA, 2005, CANCER RES, V65, P1027; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	29	18	18	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14110	14119		10.1074/jbc.M110.190702	http://dx.doi.org/10.1074/jbc.M110.190702			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357689	Green Published, hybrid			2022-12-25	WOS:000289556200034
J	Langer, K; Dian, C; Rybin, V; Muller, CW; Petosa, C				Langer, Karla; Dian, Cyril; Rybin, Vladimir; Mueller, Christoph W.; Petosa, Carlo			Insights into the Function of the CRM1 Cofactor RanBP3 from the Structure of Its Ran-Binding Domain	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; GUANINE-NUCLEOTIDE EXCHANGE; PROTEIN; LOCALIZATION; TRANSPORT; RECEPTOR; COMPLEX; LINKS	Proteins bearing a leucine-rich nuclear export signal (NES) are exported from the nucleus by the transport factor CRM1, which forms a cooperative ternary complex with the NES-bearing cargo and with the small GTPase Ran. CRM1-mediated export is regulated by RanBP3, a Ran-interacting nuclear protein. Unlike the related proteins RanBP1 and RanBP2, which promote disassembly of the export complex in the cytosol, RanBP3 acts as a CRM1 cofactor, enhancing NES export by stabilizing the export complex in the nucleus. RanBP3 also alters the cargo selectivity of CRM1, promoting recognition of the NES of HIV-1 Rev and of other cargos while deterring recognition of the import adaptor protein Snurportin1. Here we report the crystal structure of the Ran-binding domain (RBD) from RanBP3 and compare it to RBD structures from RanBP1 and RanBP2 in complex with Ran and CRM1. Differences among these structures suggest why RanBP3 binds Ran with unusually low affinity, how RanBP3 modulates the cargo selectivity of CRM1, and why RanBP3 promotes assembly rather than disassembly of the export complex. The comparison of RBD structures thus provides an insight into the functional diversity of Ran-binding proteins.	[Langer, Karla; Rybin, Vladimir; Mueller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Dian, Cyril; Petosa, Carlo] Univ Grenoble 1, CNRS, Commissariat Energie Atom & Energies Alternat, Inst Biol Struct Jean Pierre Ebel,UMR 5075, Grenoble, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Langer, K (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	cmueller@embl.de; carlo.petosa@ibs.fr	Müller, Christoph W/I-7420-2012; Dian, Cyril/I-4285-2012	Müller, Christoph W/0000-0003-2176-8337; Dian, Cyril/0000-0002-6349-3901; Petosa, Carlo/0000-0002-9975-1167	Rhone-Alpes Region; ANRS/Fondation de France; CNRS; ANR	Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); ANRS/Fondation de France(ANRSFondation de FranceFrench National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	KL was supported by a CIBLE pre-doctoral fellowship from the Rhone-Alpes Region. CP acknowledges support from the ANRS/Fondation de France (AIJC program), CNRS (ATIP program), and ANR (program blanc, NucExp grant). URLs: http://www.rhonealpes.fr, http://www.anrs.fr, http://www.cnrs.fr, http://www.fondationdefrance.org, http://www.agence- nationale-recherche.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Engelsma D, 2008, MOL BIOL CELL, V19, P2544, DOI 10.1091/mbc.E08-01-0009; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Floer M, 1999, J BIOL CHEM, V274, P16279, DOI 10.1074/jbc.274.23.16279; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Geyer JP, 2005, J MOL BIOL, V348, P711, DOI 10.1016/j.jmb.2005.02.033; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Koyama M, 2010, EMBO J, V29, P2002, DOI 10.1038/emboj.2010.89; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Mueller L, 1998, FEBS LETT, V427, P330, DOI 10.1016/S0014-5793(98)00459-1; Nemergut ME, 2002, J BIOL CHEM, V277, P17385, DOI 10.1074/jbc.c100620200; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Welch K, 1999, MOL CELL BIOL, V19, P8400; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17011	10.1371/journal.pone.0017011	http://dx.doi.org/10.1371/journal.pone.0017011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364925	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100018
J	Trivigno, C; Haerry, TE				Trivigno, Catherine; Haerry, Theodor E.			The Drosophila Mitochondrial Translation Elongation Factor G1 Contains a Nuclear Localization Signal and Inhibits Growth and DPP Signaling	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; 2ND CHROMOSOME; MUTATIONS; MELANOGASTER; PROTEIN; EFG1	Mutations in the human mitochondrial elongation factor G1 (EF-G1) are recessive lethal and cause death shortly after birth. We have isolated mutations in iconoclast (ico), which encodes the highly conserved Drosophila orthologue of EF-G1. We find that EF-G1 is essential during fly development, but its function is not required in every tissue. In contrast to null mutations, missense mutations exhibit stronger, possibly neomorphic phenotypes that lead to premature death during embryogenesis. Our experiments show that EF-G1 contains a secondary C-terminal nuclear localization signal. Expression of missense mutant forms of EF-G1 can accumulate in the nucleus and cause growth and patterning defects and animal lethality. We find that transgenes that encode mutant human EF-G1 proteins can rescue ico mutants, indicating that the underlying problem of the human disease is not just the loss of enzymatic activity. Our results are consistent with a model where EF-G1 acts as a retrograde signal from mitochondria to the nucleus to slow down cell proliferation if mitochondrial energy output is low.	[Trivigno, Catherine; Haerry, Theodor E.] Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA; [Trivigno, Catherine] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Trivigno, C (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	thaerry@gmail.com			National Institutes of Health [1 R15 GM071394-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM071394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health 1 R15 GM071394-01 to TEH (from 2004-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Becker T, 2009, CURR OPIN CELL BIOL, V21, P484, DOI 10.1016/j.ceb.2009.04.002; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Newsome TP, 2000, DEVELOPMENT, V127, P851; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; RAFTERY LA, 1995, GENETICS, V139, P241; TIONG SYK, 1990, GENETICS, V124, P889; Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559	20	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16799	10.1371/journal.pone.0016799	http://dx.doi.org/10.1371/journal.pone.0016799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364917	Green Published, gold, Green Submitted			2022-12-25	WOS:000287764100010
J	Sabri, M; Ai, JL; Marsden, PA; Macdonald, RL				Sabri, Mohammed; Ai, Jinglu; Marsden, Philip A.; Macdonald, R. Loch			Simvastatin Re-Couples Dysfunctional Endothelial Nitric Oxide Synthase in Experimental Subarachnoid Hemorrhage	PLOS ONE			English	Article							COA-REDUCTASE INHIBITOR; ATTENUATES CEREBRAL VASOSPASM; STATIN USE; COLLAGEN CONTENT; IN-VITRO; METALLOPROTEINASES; STABILIZATION; PEROXYNITRITE; CHOLESTEROL; SUPEROXIDE	Reduced endothelial nitric oxide synthase (eNOS) function has been linked to secondary complications of subarachnoid hemorrhage (SAH). We previously found that there is increased eNOS function after SAH but that it is uncoupled, leading to secondary complications such as vasospasm, microthromboembolism and neuronal apoptosis. Here we test the hypothesis that recoupling eNOS with simvastatin can prevent these complications. SAH was created in mice that were treated with vehicle or simvastatin starting 2 weeks before or 30 minutes after SAH. SAH increased phosphorylated eNOS which was prevented by pre- or post-treatment with simvastatin. Simvastatin pre-treatment also prevented the increase in eNOS monomer formation that was associated with SAH, decreased superoxide anion radical production and increased NO. These changes were associated with decreased vasospasm, microthromboemboli and neuronal injury. The data suggest that simvastatin re-couples eNOS after SAH, leading to decreased secondary complications such as vasospasm, microthromboemboli and neuronal injury.	[Sabri, Mohammed; Ai, Jinglu; Macdonald, R. Loch] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Sabri, Mohammed; Ai, Jinglu; Macdonald, R. Loch] St Michaels Hosp, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Sabri, Mohammed; Ai, Jinglu; Macdonald, R. Loch] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Marsden, Philip A.] St Michaels Hosp, Div Renal, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Marsden, Philip A.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Sabri, M (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	Macdonaldlo@smh.ca	Marsden, Philip A/B-1441-2012	AI, JINGLU/0000-0001-7414-0207	Physician's Services Incorporated Foundation [07-039]; Brain Aneurysm Foundation	Physician's Services Incorporated Foundation; Brain Aneurysm Foundation	This work was supported by Physician's Services Incorporated Foundation (http://www.psifoundation.org, grant # 07-039) and the Brain Aneurysm Foundation (http://www.bafound.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2001, CIRCULATION, V103, P276; Aoki T, 2008, STROKE, V39, P1276, DOI 10.1161/STROKEAHA.107.503086; Berra L V, 2007, J Neurosurg Sci, V51, P1; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Clark JF, 2008, FRONT BIOSCI-LANDMRK, V13, P1806, DOI 10.2741/2801; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Espey MG, 2002, P NATL ACAD SCI USA, V99, P11127, DOI 10.1073/pnas.152157599; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fukumoto Y, 2001, CIRCULATION, V103, P993; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Huhle G, 1999, THROMB RES, V95, P229, DOI 10.1016/S0049-3848(99)00037-7; KERZ T, 2008, NEUROL RES; Kramer AH, 2008, NEUROSURGERY, V62, P422, DOI 10.1227/01.neu.0000316009.19012.e3; Leber A, 1999, J BIOL CHEM, V274, P37658, DOI 10.1074/jbc.274.53.37658; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; MACDONALD RL, 1994, FREE RADICAL BIO MED, V16, P633; McGirt MJ, 2006, J NEUROSURG, V105, P671, DOI 10.3171/jns.2006.105.5.671; McGirt MJ, 2006, NEUROSURGERY, V58, P945, DOI 10.1227/01.NEU.0000210262.67628.7E; McGirt MJ, 2002, STROKE, V33, P2317, DOI 10.1161/01.STR.0000027207.67639.1E; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Parra A, 2005, NEUROSURGERY, V56, P476, DOI 10.1227/01.NEU.0000153925.96889.8A; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Pluta RM, 2006, NEUROL RES, V28, P730, DOI 10.1179/016164106X152052; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Rikitake Y, 2001, ATHEROSCLEROSIS, V154, P87, DOI 10.1016/S0021-9150(00)00468-8; SABRI M, 2010, J CEREB BLOOD FLOW M; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Singhal AB, 2005, NEUROLOGY, V64, P1008, DOI 10.1212/01.WNL.0000154523.21633.0E; Stein SC, 2006, NEUROSURGERY, V59, P781, DOI 10.1227/01.NEU.0000227519.27569.45; Sugawara T, 2008, ACTA NEUROCHIR SUPPL, V102, P391, DOI 10.1007/978-3-211-85578-2_76; Sugawara T, 2008, J NEUROSCI RES, V86, P3635, DOI 10.1002/jnr.21807; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Takata K, 2009, J NEUROSURG ANESTH, V21, P326, DOI 10.1097/ANA.0b013e3181acfde7; Teichert AM, 2000, AM J PHYSIOL-HEART C, V278, pH1352, DOI 10.1152/ajpheart.2000.278.4.H1352; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Vergouwen MDI, 2010, STROKE, V41, pE47, DOI 10.1161/STROKEAHA.109.556332; Wang Q, 2005, BRIT J PHARMACOL, V144, P933, DOI 10.1038/sj.bjp.0706106; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wiesbauer F, 2002, BRIT J PHARMACOL, V135, P284, DOI 10.1038/sj.bjp.0704454; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	47	35	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17062	10.1371/journal.pone.0017062	http://dx.doi.org/10.1371/journal.pone.0017062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373645	Green Published, Green Submitted, gold			2022-12-25	WOS:000287657500030
J	Castoria, G; D'Amato, L; Ciociola, A; Giovannelli, P; Giraldi, T; Sepe, L; Paolella, G; Barone, MV; Migliaccio, A; Auricchio, F				Castoria, Gabriella; D'Amato, Loredana; Ciociola, Alessandra; Giovannelli, Pia; Giraldi, Tiziana; Sepe, Leandra; Paolella, Giovanni; Barone, Maria Vittoria; Migliaccio, Antimo; Auricchio, Ferdinando			Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A Association	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROGESTERONE-RECEPTOR; FILAMIN-A; INTEGRATING SIGNALS; ESTRADIOL-RECEPTOR; DNA-SYNTHESIS; CROSS-TALK; ESTROGEN; ACTIVATION; SRC	Background: Androgen receptor (AR) controls male morphogenesis, gametogenesis and prostate growth as well as development of prostate cancer. These findings support a role for AR in cell migration and invasiveness. However, the molecular mechanism involved in AR-mediated cell migration still remains elusive. Methodology/Principal Findings: Mouse embryo NIH3T3 fibroblasts and highly metastatic human fibrosarcoma HT1080 cells harbor low levels of transcriptionally incompetent AR. We now report that, through extra nuclear action, AR triggers migration of both cell types upon stimulation with physiological concentrations of the androgen R1881. We analyzed the initial events leading to androgen-induced cell migration and observed that challenging NIH3T3 cells with 10 nM R1881 rapidly induces interaction of AR with filamin A (FlnA) at cytoskeleton. AR/FlnA complex recruits integrin beta 1, thus activating its dependent cascade. Silencing of AR, FlnA and integrin beta 1 shows that this ternary complex controls focal adhesion kinase (FAK), paxillin and Rac, thereby driving cell migration. FAK-null fibroblasts migrate poorly and Rac inhibition by EHT impairs motility of androgen-treated NIH3T3 cells. Interestingly, FAK and Rac activation by androgens are independent of each other. Findings in human fibrosarcoma HT1080 cells strengthen the role of Rac in androgen signaling. The Rac inhibitor significantly impairs androgen-induced migration in these cells. A mutant AR, deleted of the sequence interacting with FlnA, fails to mediate FAK activation and paxillin tyrosine phosphorylation in androgen-stimulated cells, further reinforcing the role of AR/FlnA interaction in androgen-mediated motility. Conclusions/Significance: The present report, for the first time, indicates that the extra nuclear AR/FlnA/integrin beta 1 complex is the key by which androgen activates signaling leading to cell migration. Assembly of this ternary complex may control organ development and prostate cancer metastasis.	[Castoria, Gabriella; D'Amato, Loredana; Ciociola, Alessandra; Giovannelli, Pia; Giraldi, Tiziana; Migliaccio, Antimo; Auricchio, Ferdinando] Univ Naples Federico II, Dipartimento Patol Gen, Naples, Italy; [Barone, Maria Vittoria] Univ Naples Federico II, European Lab Invest Food Induced Dis, Dipartimento Pediat, Naples, Italy; [Sepe, Leandra; Paolella, Giovanni] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Castoria, G (corresponding author), Univ Naples Federico II, Dipartimento Patol Gen, Naples, Italy.	antimo.migliaccio@unina2.it	Giovannelli, Pia/J-7931-2019; Migliaccio, Antimo/AAB-3376-2019; Castoria, Gabriella/I-3349-2019	Castoria, Gabriella/0000-0002-0576-4494; Migliaccio, Antimo/0000-0002-4197-2055; BARONE, Maria Vittoria/0000-0001-6190-4917; Giovannelli, Pia/0000-0002-2488-917X	Italian Association for Cancer Research (A.I.R.C.) [IG 5389]	Italian Association for Cancer Research (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro)	Funding: This work was supported by the Italian Association for Cancer Research (A.I.R.C., Grant No. IG 5389). P. G. was supported by a fellowship from A.I.R.C. (ITALY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1999, DEVELOPMENT, V126, P1655; Ashcroft GS, 2002, J CLIN INVEST, V110, P615, DOI 10.1172/JCI200215704; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Boonyaratanakornkit V, MOL CELL, V8, P269; Bulens F, 1997, J BIOL CHEM, V272, P663; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cantarella C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S12; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Castoria G, 2004, MOL CELL BIOL, V24, P7643, DOI 10.1128/MCB.24.17.7643-7653.2004; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Castoria G, 2008, FRONT BIOSCI-LANDMRK, V13, P1318, DOI 10.2741/2764; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CHAUDHURI PK, 1980, CANCER RES, V40, P861; Chauhan S, 2004, J BIOL CHEM, V279, P937, DOI 10.1074/jbc.M311325200; Cheng HL, 2000, J BIOL CHEM, V275, P27197; Chuang KH, 2009, J EXP MED, V206, P1181, DOI 10.1084/jem.20082521; Cunha GR, 2008, DIFFERENTIATION, V76, P578, DOI 10.1111/j.1432-0436.2008.00290.x; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fu XD, 2010, ENDOCR-RELAT CANCER, V17, P431, DOI 10.1677/ERC-09-0258; Fu XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002790; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giretti MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002238; Hatzoglou A, 2005, J CLIN ENDOCR METAB, V90, P893, DOI 10.1210/jc.2004-0801; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Papakonstanti EA, 2003, MOL ENDOCRINOL, V17, P870, DOI 10.1210/me.2002-0253; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vallejo G, 2005, MOL ENDOCRINOL, V19, P3023, DOI 10.1210/me.2005-0016; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhao Z, 2009, P NATL ACAD SCI USA, V106, P7221, DOI 10.1073/pnas.0812597106; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	57	76	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17218	10.1371/journal.pone.0017218	http://dx.doi.org/10.1371/journal.pone.0017218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359179	Green Submitted, gold, Green Published			2022-12-25	WOS:000287392700062
J	Morello, E; Saussereau, E; Maura, D; Huerre, M; Touqui, L; Debarbieux, L				Morello, Eric; Saussereau, Emilie; Maura, Damien; Huerre, Michel; Touqui, Lhousseine; Debarbieux, Laurent			Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention	PLOS ONE			English	Article							RESISTANCE; VIRUSES; ISOLATE; HOST	Multidrug-resistant bacteria are the cause of an increasing number of deadly pulmonary infections. Because there is currently a paucity of novel antibiotics, phage therapy-the use of specific viruses that infect bacteria-is now more frequently being considered as a potential treatment for bacterial infections. Using a mouse lung-infection model caused by a multidrug resistant Pseudomonas aeruginosa mucoid strain isolated from a cystic fibrosis patient, we evaluated bacteriophage treatments. New bacteriophages were isolated from environmental samples and characterized. Bacteria and bacteriophages were applied intranasally to the immunocompetent mice. Survival was monitored and bronchoalveolar fluids were analysed. Quantification of bacteria, bacteriophages, pro-inflammatory and cytotoxicity markers, as well as histology and immunohistochemistry analyses were performed. A curative treatment (one single dose) administrated 2 h after the onset of the infection allowed over 95% survival. A four-day preventive treatment (one single dose) resulted in a 100% survival. All of the parameters measured correlated with the efficacy of both curative and preventive bacteriophage treatments. We also showed that in vitro optimization of a bacteriophage towards a clinical strain improved both its efficacy on in vivo treatments and its host range on a panel of 20 P. aeruginosa cystic fibrosis strains. This work provides an incentive to develop clinical studies on pulmonary bacteriophage therapy to combat multidrug-resistant lung infections.	[Morello, Eric; Saussereau, Emilie; Maura, Damien; Debarbieux, Laurent] Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France; [Huerre, Michel] Inst Pasteur, Dept Infect & Epidemiol, Histotechnol & Pathol Unit, Paris, France; [Touqui, Lhousseine] Inst Pasteur, Dept Infect & Epidemiol, Innate Host Def & Inflammat Unit, Paris, France; [Touqui, Lhousseine] INSERM, U874, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Morello, E (corresponding author), Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France.	laurent.debarbieux@pasteur.fr	MORELLO, Eric/P-8087-2016	MORELLO, Eric/0000-0002-2009-4919; Debarbieux, Laurent/0000-0001-6875-5758	Institut Pasteur PTR [255]; Vaincre la Mucoviscidose [IC0704]	Institut Pasteur PTR; Vaincre la Mucoviscidose	Funding was provided by Institut Pasteur PTR N<SUP>o</SUP>255, Vaincre la Mucoviscidose grant IC0704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Boulanger Pascale, 2009, V502, P227, DOI 10.1007/978-1-60327-565-1_13; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Clark Jason R, 2004, Expert Rev Vaccines, V3, P463, DOI 10.1586/14760584.3.4.463; Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; DelicAttree I, 1996, MICROBIOL-UK, V142, P2785, DOI 10.1099/13500872-142-10-2785; DIF F, 2010, EUR ESP J; Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Gorski A, 2009, CURR OPIN INVEST DR, V10, P766; Gould IM, 2008, INT J ANTIMICROB AG, V32, pS2, DOI 10.1016/j.ijantimicag.2008.06.016; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Knezevic P, 2008, J MICROBIOL METH, V74, P114, DOI 10.1016/j.mimet.2008.03.005; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Kurzepa A, 2009, CLIN EXP MED, V9, P93, DOI 10.1007/s10238-008-0027-8; Kutateladze M, 2008, MED MALADIES INFECT, V38, P426, DOI 10.1016/j.medmal.2008.06.023; KUTATELADZE M, 2010, TRENDS BIOTECHNOL; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Miedzybrodzki R, 2005, VIRUS RES, V110, P1, DOI 10.1016/j.virusres.2005.01.009; Nordmann P, 2007, CURR OPIN MICROBIOL, V10, P436, DOI 10.1016/j.mib.2007.07.004; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Ventura GMD, 2009, J IMMUNOL, V183, P670, DOI 10.4049/jimmunol.0801497; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x	34	175	187	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16963	10.1371/journal.pone.0016963	http://dx.doi.org/10.1371/journal.pone.0016963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347240	Green Published, gold			2022-12-25	WOS:000287369200013
J	Biot, FV; Valade, E; Garnotel, E; Chevalier, J; Villard, C; Thibault, FM; Vidal, DR; Pages, JM				Biot, Fabrice V.; Valade, Eric; Garnotel, Eric; Chevalier, Jacqueline; Villard, Claude; Thibault, Francois M.; Vidal, Dominique R.; Pages, Jean-Marie			Involvement of the Efflux Pumps in Chloramphenicol Selected Strains of Burkholderia thailandensis: Proteomic and Mechanistic Evidence	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ENTEROBACTER-AEROGENES; ANTIBIOTIC SUSCEPTIBILITY; PSEUDOMONAS-PSEUDOMALLEI; MEMBRANE-PERMEABILITY; OUTER-MEMBRANE; ACTIVE EFFLUX; MAR MUTANTS; DRUG EFFLUX; BPEAB-OPRB	Burkholderia is a bacterial genus comprising several pathogenic species, including two species highly pathogenic for humans, B. pseudomallei and B. mallei. B. thailandensis is a weakly pathogenic species closely related to both B. pseudomallei and B. mallei. It is used as a study model. These bacteria are able to exhibit multiple resistance mechanisms towards various families of antibiotics. By sequentially plating B. thailandensis wild type strains on chloramphenicol we obtained several resistant variants. This chloramphenicol-induced resistance was associated with resistance against structurally unrelated antibiotics including quinolones and tetracyclines. We functionally and proteomically demonstrate that this multidrug resistance phenotype, identified in chloramphenicol-resistant variants, is associated with the overexpression of two different efflux pumps. These efflux pumps are able to expel antibiotics from several families, including chloramphenicol, quinolones, tetracyclines, trimethoprim and some beta-lactams, and present a partial susceptibility to efflux pump inhibitors. It is thus possible that Burkholderia species can develop such adaptive resistance mechanisms in response to antibiotic pressure resulting in emergence of multidrug resistant strains. Antibiotics known to easily induce overexpression of these efflux pumps should be used with discernment in the treatment of Burkholderia infections.	[Biot, Fabrice V.; Valade, Eric; Garnotel, Eric; Chevalier, Jacqueline; Thibault, Francois M.; Vidal, Dominique R.; Pages, Jean-Marie] Univ Mediterrane, IFR88, Fac Med & Pharm, UMR MD 1, Marseille, France; [Biot, Fabrice V.; Valade, Eric; Thibault, Francois M.; Vidal, Dominique R.] Inst Rech Biomed Armees, CRSSA, Unite Bacteriol, UMR MD 1, La Tronche, France; [Garnotel, Eric] Hop Instruct Armees Laveran, Marseille, France; [Villard, Claude] Univ Mediterrane, Fac Pharm, INSERM UMR 911 CRO2, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Biot, FV (corresponding author), Univ Mediterrane, IFR88, Fac Med & Pharm, UMR MD 1, Marseille, France.	evalade@crssa.net	PAGES, jean-marie/F-2555-2013	PAGES, jean-marie/0000-0001-7092-7977; BIOT, Fabrice/0000-0002-3632-2146; Villard, claude/0000-0002-6600-0762	Ministry of Defense [23e]; Universite de la Mediterranee	Ministry of Defense; Universite de la Mediterranee	This study was supported by the Ministry of Defense (Grant 23e) and by the Universite de la Mediterranee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Chan YY, 2004, ANTIMICROB AGENTS CH, V48, P1128, DOI 10.1128/AAC.48.4.1128-1135.2004; Chaowagul W, 2005, ANTIMICROB AGENTS CH, V49, P4020, DOI 10.1128/AAC.49.10.4020-4025.2005; Chevalier J, 2004, ANTIMICROB AGENTS CH, V48, P1043, DOI 10.1128/AAC.48.3.1043-1046.2004; Chevalier J, 2010, INT J ANTIMICROB AG, V36, P164, DOI 10.1016/j.ijantimicag.2010.03.027; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Ghisalberti D, 2005, BIOCHEM BIOPH RES CO, V328, P1113, DOI 10.1016/j.bbrc.2005.01.069; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; GODFREY AJ, 1991, ANTIMICROB AGENTS CH, V35, P1635, DOI 10.1128/AAC.35.8.1635; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Kumar A, 2006, ANTIMICROB AGENTS CH, V50, P3460, DOI 10.1128/AAC.00440-06; Kumar Ayush, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS145, DOI 10.1016/S0035-9203(08)70032-4; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Mamelli L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006443; MCMURRY LM, 1994, ANTIMICROB AGENTS CH, V38, P542, DOI 10.1128/AAC.38.3.542; MIMA T, 2010, J ANTIMICROB CH 1021; Mima T, 2010, ANTIMICROB AGENTS CH, V54, P3113, DOI 10.1128/AAC.01803-09; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Ong C, 2004, GENOME RES, V14, P2295, DOI 10.1101/gr.1608904; Pages JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004817; Pages JM, 2009, BBA-PROTEINS PROTEOM, V1794, P826, DOI 10.1016/j.bbapap.2008.12.011; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Trunck LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000519; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Yoshihara E, 2009, FEMS MICROBIOL LETT, V299, P200, DOI 10.1111/j.1574-6968.2009.01752.x; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46	39	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16892	10.1371/journal.pone.0016892	http://dx.doi.org/10.1371/journal.pone.0016892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347382	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700051
J	Graveland, H; Wagenaar, JA; Bergs, K; Heesterbeek, H; Heederik, D				Graveland, Haitske; Wagenaar, Jaap A.; Bergs, Kelly; Heesterbeek, Hans; Heederik, Dick			Persistence of Livestock Associated MRSA CC398 in Humans Is Dependent on Intensity of Animal Contact	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NASAL CARRIAGE; RISK-FACTORS; COLONIZATION; DURATION; EPIDEMIOLOGY; INFECTION; ORIGIN; ST398	Introduction: The presence of Livestock Associated MRSA (LA-MRSA) in humans is associated with intensity of animal contact. It is unknown whether the presence of LA-MRSA is a result of carriage or retention of MRSA-contaminated dust. We conducted a longitudinal study among 155 veal farmers in which repeated nasal and throat swabs were taken for MRSA detection. Periods with and without animal exposure were covered. Methods: Randomly, 51 veal calf farms were visited from June - December 2008. Participants were asked to fill in questionnaires (n = 155) to identify potential risk factors for MRSA colonisation. Nasal and throat swabs were repeatedly taken from each participant for approximately 2 months. Swabs were analysed for MRSA and MSSA by selective bacteriological culturing. Spa-types of the isolates were identified and a ST398 specific PCR was performed. Data were analyzed using generalized estimation equations (GEE) to allow for correlated observations within individuals. Results: Mean MRSA prevalence was 38% in farmers and 16% in family members. Presence of MRSA in farmers was strongly related to duration of animal contact and was strongly reduced in periods with absence of animal contact (258%). Family members, especially children, were more often carriers when the farmer was a carrier (OR = 2, P<0.05). Only 7% (n = 11) of the participants appeared to be persistent carriers. A large heterogeneity in spa-types was detected, however 92.7% belonged to LA-MRSA CC398. A surprisingly high fraction of the spa-types (7.3%) did not belong to CC398. Conclusion: The presence of LA-MRSA in farmers is strongly animal-exposure related. The rapidly decreasing MRSA prevalence during absence of animal contact suggests that LA-MRSA is a poor persistent colonizer in most humans. These results are of relevance for MRSA control strategies.	[Graveland, Haitske; Bergs, Kelly; Heederik, Dick] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Graveland, Haitske; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Graveland, Haitske; Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Wagenaar, Jaap A.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Heederik, Dick] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Graveland, H (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	h.graveland@uu.nl		Heederik, Dick/0000-0002-4550-1437; Heesterbeek, Hans/0000-0001-8537-6418	Dutch Product Boards for Livestock, Meat and Eggs; Dutch Ministry of Agriculture, Nature and Food Quality	Dutch Product Boards for Livestock, Meat and Eggs; Dutch Ministry of Agriculture, Nature and Food Quality	The study was supported by the Dutch Product Boards for Livestock, Meat and Eggs and the Dutch Ministry of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dall'Antonia M, 2005, J HOSP INFECT, V61, P62, DOI 10.1016/j.jhin.2005.01.008; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; EHRENKRANTZ NJ, 1964, NEW ENGL J MED, V271, P225, DOI 10.1056/NEJM196407302710503; Fluit AC, 2001, J CLIN MICROBIOL, V39, P3727, DOI 10.1128/JCM.39.10.3727-3732.2001; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Graveland H, 2009, VET MICROBIOL, V139, P121, DOI 10.1016/j.vetmic.2009.05.019; Hamscher G, 2003, ENVIRON HEALTH PERSP, V111, P1590, DOI 10.1289/ehp.6288; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; LIPPMANN M, 1980, BRIT J IND MED, V37, P337; MacKinnon MM, 2000, J HOSP INFECT, V46, P216, DOI [10.1053/jhin.2000.0807, 10.1016/S0195-6701(00)90807-7]; Marschall J, 2006, INFECT CONT HOSP EP, V27, P1206, DOI 10.1086/507917; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; NOBLE WC, 1964, J CLIN PATHOL, V17, P79, DOI 10.1136/jcp.17.1.79; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Portengen L, 2005, J ALLERGY CLIN IMMUN, V115, P797, DOI 10.1016/j.jaci.2004.11.046; Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296; SANFORD MD, 1994, CLIN INFECT DIS, V19, P1123, DOI 10.1093/clinids/19.6.1123; Scanvic A, 2001, CLIN INFECT DIS, V32, P1393, DOI 10.1086/320151; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; van den Broek IVF, 2008, EPIDEMIOL INFECT, V24, P1; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; van Rijen MML, 2009, J HOSP INFECT, V72, P299, DOI 10.1016/j.jhin.2009.05.006; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; van Trijp MJCA, 2007, INFECT CONT HOSP EP, V28, P970, DOI 10.1086/519210; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; Wassenberg M W M, 2008, Ned Tijdschr Geneeskd, V152, P2681; Wertheim HFL, 2005, CRIT CARE, V9, P257, DOI 10.1186/cc3720; Wilson RD, 2004, ANAESTH INTENS CARE, V32, P202, DOI 10.1177/0310057X0403200207	35	143	144	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16830	10.1371/journal.pone.0016830	http://dx.doi.org/10.1371/journal.pone.0016830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347386	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700039
J	Kiialainen, A; Karlberg, O; Ahlford, A; Sigurdsson, S; Lindblad-Toh, K; Syvanen, AC				Kiialainen, Anna; Karlberg, Olof; Ahlford, Annika; Sigurdsson, Snaevar; Lindblad-Toh, Kerstin; Syvanen, Ann-Christine			Performance of Microarray and Liquid Based Capture Methods for Target Enrichment for Massively Parallel Sequencing and SNP Discovery	PLOS ONE			English	Article							GENOMIC SELECTION; MUTATIONS; GENE; AMPLIFICATION; HYBRIDIZATION	Targeted sequencing is a cost-efficient way to obtain answers to biological questions in many projects, but the choice of the enrichment method to use can be difficult. In this study we compared two hybridization methods for target enrichment for massively parallel sequencing and single nucleotide polymorphism (SNP) discovery, namely Nimblegen sequence capture arrays and the SureSelect liquid-based hybrid capture system. We prepared sequencing libraries from three HapMap samples using both methods, sequenced the libraries on the Illumina Genome Analyzer, mapped the sequencing reads back to the genome, and called variants in the sequences. 74-75% of the sequence reads originated from the targeted region in the SureSelect libraries and 41-67% in the Nimblegen libraries. We could sequence up to 99.9% and 99.5% of the regions targeted by capture probes from the SureSelect libraries and from the Nimblegen libraries, respectively. The Nimblegen probes covered 0.6 Mb more of the original 3.1 Mb target region than the SureSelect probes. In each sample, we called more SNPs and detected more novel SNPs from the libraries that were prepared using the Nimblegen method. Thus the Nimblegen method gave better results when judged by the number of SNPs called, but this came at the cost of more over-sampling.	[Kiialainen, Anna; Karlberg, Olof; Ahlford, Annika; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sigurdsson, Snaevar; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Sigurdsson, Snaevar; Lindblad-Toh, Kerstin] Harvard & Massachusetts Inst Technol MIT, Broad Inst, Cambridge, MA USA	Uppsala University; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kiialainen, A (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	anna.kiialainen@medsci.uu.se		Sigurdsson, Snaevar/0000-0003-4860-6311	European Community [FP7/2007-2013, HEALTH-F4-2007-201413]; Nordic Centre of Excellence in Disease Genetics; Nordic Sequencing Infrastructure; Swedish Research Council for Science and Technology [2009-5594]; Knut and Alice Wallenberg Foundation; Swedish Cancer Foundation	European Community(European Commission); Nordic Centre of Excellence in Disease Genetics; Nordic Sequencing Infrastructure; Swedish Research Council for Science and Technology(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Foundation	This research was supported through funds from The European Community's Seventh Framework Programme [FP7/2007-2013, ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413] (AK, A-CS); the Nordic Centre of Excellence in Disease Genetics (AK); The Nordic Sequencing Infrastructure (KL-T, A-CS); The Swedish Research Council for Science and Technology [2009-5594] (A-CS); the Knut and Alice Wallenberg Foundation (A-CS); and the Swedish Cancer Foundation (A-CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bolze A, 2010, AM J HUM GENET; Dahl F, 2007, P NATL ACAD SCI USA, V104, P9387, DOI 10.1073/pnas.0702165104; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fredriksson S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm078; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; JOHANSSON H, 2010, NUCL ACIDS RES; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; LOVETT M, 2001, CURR PROTOC HUM GENE, pCH6; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; SUMMERER D, 2010, GENOMICS; TEER JK, 2010, GENOME RES; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	41	17	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16486	10.1371/journal.pone.0016486	http://dx.doi.org/10.1371/journal.pone.0016486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347407	gold, Green Published			2022-12-25	WOS:000287361700017
J	Liew, SH; Sarraj, MA; Drummond, AE; Findlay, JK				Liew, Seng H.; Sarraj, Mai A.; Drummond, Ann E.; Findlay, Jock K.			Estrogen-Dependent Gene Expression in the Mouse Ovary	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; DEFICIENT ARKO MICE; GRANULOSA-CELLS; TARGETED DISRUPTION; RECEPTOR-BETA; RODENT OVARY; PHENOTYPE; OOCYTE; TESTIS; DIFFERENTIATION	Estrogen (E) plays a pivotal role in regulating the female reproductive system, particularly the ovary. However, the number and type of ovarian genes influenced by estrogen remain to be fully elucidated. In this study, we have utilized wild-type (WT) and aromatase knockout (ArKO; estrogen free) mouse ovaries as an in vivo model to profile estrogen dependent genes. RNA from each individual ovary (n = 3) was analyzed by a microarray-based screen using Illumina Sentrix Mouse WG-6 BeadChip (45,281 transcripts). Comparative analysis (GeneSpring) showed differential expression profiles of 450 genes influenced by E, with 291 genes up-regulated and 159 down-regulated by 2-fold or greater in the ArKO ovary compared to WT. Genes previously reported to be E regulated in ArKO ovaries were confirmed, in addition to novel genes not previously reported to be expressed or regulated by E in the ovary. Of genes involved in 5 diverse functional processes (hormonal processes, reproduction, sex differentiation and determination, apoptosis and cellular processes) 78 had estrogen-responsive elements (ERE). These analyses define the transcriptome regulated by E in the mouse ovary. Further analysis and investigation will increase our knowledge pertaining to how E influences follicular development and other ovarian functions.	[Liew, Seng H.; Sarraj, Mai A.; Drummond, Ann E.; Findlay, Jock K.] Prince Henrys Inst Med Res, Melbourne, Vic, Australia; [Liew, Seng H.; Findlay, Jock K.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia	Prince Henry's Institute of Medical Research; Monash University	Liew, SH (corresponding author), Prince Henrys Inst Med Res, Melbourne, Vic, Australia.	Jason.liew@princehenrys.org	Liew, Seng/G-8432-2011	Liew, Seng Hii/0000-0001-5514-9871; Sarraj, Mai/0000-0001-9891-8159; Drummond, Ann/0000-0002-2183-6013	National Health and Medical Research Council of Australia [Regkeys 494802, 441101]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The financial support of the National Health and Medical Research Council of Australia (Regkeys 494802 and 441101) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3605, DOI 10.1093/nar/gkg517; BRANNSTROM M, 1993, BIOL REPROD, V48, P277, DOI 10.1095/biolreprod48.2.277; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Britt KL, 2002, FASEB J, V16, P1389, DOI 10.1096/fj.01-0992com; Britt KL, 2004, BIOL REPROD, V71, P1712, DOI 10.1095/biolreprod.104.028175; Britt KL, 2004, ENDOCRINOLOGY, V145, P3950, DOI 10.1210/en.2003-1628; Britt KL, 2001, J STEROID BIOCHEM, V79, P181, DOI 10.1016/S0960-0760(01)00158-3; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Charpentier AH, 2000, CANCER RES, V60, P5977; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Chen Y, 2009, J ENDOCRINOL, V202, P407, DOI 10.1677/JOE-09-0109; Constam DB, 2000, GENE DEV, V14, P1146; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Diaz FJ, 2008, BIOL REPROD, V78, P176, DOI 10.1095/biolreprod.107.063537; Drake JM, 2003, APOPTOSIS, V8, P389, DOI 10.1023/A:1024181203729; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hellani A, 2000, ENDOCRINOLOGY, V141, P3012, DOI 10.1210/en.141.8.3012; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2003, ENDOCRINOLOGY, V144, P4597, DOI 10.1210/en.2003-0048; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Jones MEE, 2001, J STEROID BIOCHEM, V79, P3, DOI 10.1016/S0960-0760(01)00136-4; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; LIEW SH, 2010, MOL CELL ENDOCRINOL; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Praz V, 2002, NUCLEIC ACIDS RES, V30, P322, DOI 10.1093/nar/30.1.322; Ren Y, 2009, MOL ENDOCRINOL, V23, P711, DOI 10.1210/me.2008-0391; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Russell MC, 2007, BIOL REPROD, V77, P226, DOI 10.1095/biolreprod.106.053629; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wang C, 2009, J LIPID RES, V50, P2164, DOI 10.1194/jlr.M800533-JLR200; Wijgerde M, 2005, ENDOCRINOLOGY, V146, P3558, DOI 10.1210/en.2005-0311; WU TCJ, 1992, MOL REPROD DEV, V33, P407, DOI 10.1002/mrd.1080330406; Zachos NC, 2002, BIOL REPROD, V67, P1148, DOI 10.1095/biolreprod67.4.1148; Zhang H, 2009, MOL REPROD DEV, V76, P514, DOI 10.1002/mrd.20973	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14672	10.1371/journal.pone.0014672	http://dx.doi.org/10.1371/journal.pone.0014672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347412	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700006
J	Salmela, E; Lappalainen, T; Liu, JJ; Sistonen, P; Andersen, PM; Schreiber, S; Savontaus, ML; Czene, K; Lahermo, P; Hall, P; Kere, J				Salmela, Elina; Lappalainen, Tuuli; Liu, Jianjun; Sistonen, Pertti; Andersen, Peter M.; Schreiber, Stefan; Savontaus, Marja-Liisa; Czene, Kamila; Lahermo, Paivi; Hall, Per; Kere, Juha			Swedish Population Substructure Revealed by Genome-Wide Single Nucleotide Polymorphism Data	PLOS ONE			English	Article							PATTERNS; ASSOCIATION; SWEDEN; LIBRARY; PACKAGE; COMMON; LOCI	The use of genome-wide single nucleotide polymorphism (SNP) data has recently proven useful in the study of human population structure. We have studied the internal genetic structure of the Swedish population using more than 350,000 SNPs from 1525 Swedes from all over the country genotyped on the Illumina HumanHap550 array. We have also compared them to 3212 worldwide reference samples, including Finns, northern Germans, British and Russians, based on the more than 29,000 SNPs that overlap between the Illumina and Affymetrix 250K Sty arrays. The Swedes - especially southern Swedes - were genetically close to the Germans and British, while their genetic distance to Finns was substantially longer. The overall structure within Sweden appeared clinal, and the substructure in the southern and middle parts was subtle. In contrast, the northern part of Sweden, Norrland, exhibited pronounced genetic differences both within the area and relative to the rest of the country. These distinctive genetic features of Norrland probably result mainly from isolation by distance and genetic drift caused by low population density. The internal structure within Sweden (F-ST = 0.0005 between provinces) was stronger than that in many Central European populations, although smaller than what has been observed for instance in Finland; importantly, it is of the magnitude that may hamper association studies with a moderate number of markers if cases and controls are not properly matched geographically. Overall, our results underline the potential of genome-wide data in analyzing substructure in populations that might otherwise appear relatively homogeneous, such as the Swedes.	[Salmela, Elina; Lappalainen, Tuuli; Lahermo, Paivi] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Salmela, Elina; Lappalainen, Tuuli; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Salmela, Elina; Lappalainen, Tuuli; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Lappalainen, Tuuli] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Sistonen, Pertti] Finnish Red Cross Blood Transfus Serv, Helsinki, Finland; [Andersen, Peter M.] Umea Univ, Dept Neurol, Umea Univ Hosp, S-90187 Umea, Sweden; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Dept Gen Internal Med, Kiel, Germany; [Savontaus, Marja-Liisa] Univ Turku, Dept Med Genet, Turku, Finland; [Czene, Kamila] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Kere, Juha] Karolinska Univ Hosp, Clin Res Ctr, Huddinge, Sweden	University of Helsinki; University of Helsinki; University of Geneva; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Umea University; University of Kiel; University of Turku; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Salmela, E (corresponding author), Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.	juha.kere@ki.se	Liu, Jianjun/AAK-4989-2020; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Lappalainen, Tuuli/AAE-6532-2020	Liu, Jianjun/0000-0002-3255-3019; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Lappalainen, Tuuli/0000-0002-7746-8109; Czene, Kamila/0000-0002-3233-5695; Salmela, Elina/0000-0003-1326-4462	Sigrid Juselius Foundation; Emil Aaltonen foundation; Academy of Finland; Research Foundation of the University of Helsinki; Swedish Research Council; National Genome Research Network through the German Ministry of Education and Science; popgen biobank through the German Ministry of Education and Science; DFG; National Institutes of Health [R01 CA104021-05]; Agency for Science, Technology and Research (A*STAR); Wellcome Trust [076113]; NATIONAL CANCER INSTITUTE [R01CA104021] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen foundation; Academy of Finland(Academy of Finland); Research Foundation of the University of Helsinki; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Genome Research Network through the German Ministry of Education and Science; popgen biobank through the German Ministry of Education and Science; DFG(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sigrid Juselius Foundation (http://www.sigridjuselius.fi) (ES, TL, JK), Emil Aaltonen foundation (http://www.emilaaltonen.fi) (TL, PL), Academy of Finland (http://www.aka.fi/fi/A/) (TL, JK), Research Foundation of the University of Helsinki (http://www.helsinki.fi/tiedesaatio/index.htm) (TL), Swedish Research Council (http://www.vr.se) (JK), National Genome Research Network (NGFN; http://www.ngfn.de) and the popgen biobank (http://www.popgen.de), both through the German Ministry of Education and Science (SS), DFG excellence cluster "inflammation at interfaces" (SS), National Institutes of Health (http://www.nih.gov) grant number R01 CA104021-05 (KC, PH), Agency for Science, Technology and Research (A*STAR) (JL, KC, PH). Funding for the WTCCC project was provided by the Wellcome Trust (http://www.wellcome.ac.uk/) under award 076113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Einarsdottir E, 2007, HEREDITAS, V144, P171, DOI 10.1111/j.2007.0018-0661.02007.x; Einarsdottir K, 2006, PLOS MED, V3, P895, DOI 10.1371/journal.pmed.0030168; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Hannelius U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-54; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LINDKVIST T, 2003, CAMBRIDGE HIST SCAND; LINDQVIST H, 2006, HIST SWEDEN; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Myhre Bjorn, 2003, CAMBRIDGE HIST SCAND, P60; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P274, DOI 10.1038/nature07566; Nychka D., 2007, FIELDS TOOLS SPATIAL; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; Pitkanen K., 2007, SUOMEN VAESTO, P41; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2022, R LANG ENV STAT COMP; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; SIIRIAINEN A, 2003, CAMBRIDGE HIST SCAND; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; VIRTARANTAKNOWLES K, 1991, HUM HERED, V41, P248, DOI 10.1159/000154009	41	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16747	10.1371/journal.pone.0016747	http://dx.doi.org/10.1371/journal.pone.0016747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347369	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700031
J	Wong, CM; Wong, CCL; Ng, YL; Au, SLK; Ko, FCF; Ng, IOL				Wong, Chun-Ming; Wong, Carmen Chak-Lui; Ng, Yeung-Lam; Au, Sandy Leung-Kuen; Ko, Frankie Chi-Fat; Ng, Irene Oi-Lin			Transcriptional Repressive H3K9 and H3K27 Methylations Contribute to DNMT1-Mediated DNA Methylation Recovery	PLOS ONE			English	Article							HUMAN CANCER-CELLS; TUMOR-SUPPRESSOR GENES; DE-NOVO METHYLATION; IN-VIVO ACTIVITY; HISTONE H3; HEPATOCELLULAR-CARCINOMA; EPIGENETIC THERAPY; NEUROSPORA-CRASSA; HUMAN-DISEASE; CPG ISLANDS	DNA methylation and histone modifications are two major epigenetic events regulating gene expression and chromatin structure, and their alterations are linked to human carcinogenesis. DNA methylation plays an important role in tumor suppressor gene inactivation, and can be revised by DNA methylation inhibitors. The reversible nature of DNA methylation forms the basis of epigenetic cancer therapy. However, it has been reported that DNA re-methylation and gene re-silencing could occur after removal of demethylation treatment and this may significantly hamper the therapeutic value of DNA methylation inhibitors. In this study we have provided detailed evidence demonstrating that mammalian cells possess a bona fide DNA methylation recovery system. We have also shown that DNA methylation recovery was mediated by the major human DNA methyltransferase, DNMT1. In addition, we found that H3K9-tri-methylation and H3K27-tri-methylation were closely associated with this DNA methylation recovery. These persistent transcriptional repressive histone modifications may have a crucial role in regulating DNMT1-mediated DNA methylation recovery. Our findings may have important implications towards a better understanding of epigenetic regulation and future development of epigenetic therapeutic intervention.	[Wong, Chun-Ming] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Pathol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CM (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	iolng@hku.hk	WONG, Chun-Ming/A-6739-2009; Ko, Frankie Chi Fat/C-4759-2009; Wong, Carmen Chak Lui/C-4660-2009	WONG, Chun-Ming/0000-0002-2497-7858; Ko, Frankie Chi Fat/0000-0002-0393-9668; Wong, Carmen Chak Lui/0000-0001-5866-4705; Ng, Irene Oi-lin/0000-0001-7532-2029	Hong Kong Research Grants Council [HKU 1/06C, HKU 7/CRG/09]; Michael and Betty Kadoorie Cancer Genetics Research Program	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Michael and Betty Kadoorie Cancer Genetics Research Program	The study was supported by Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09) and Michael and Betty Kadoorie Cancer Genetics Research Program 2004. I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CM, 1999, MOL CELL BIOL, V19, P6690; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Fahrner JA, 2002, CANCER RES, V62, P7213; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; ISSA JP, 2005, NAT REV DRUG DISCO S, pS6, DOI DOI 10.1038/NRD1726; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kagey JD, 2010, MOL CANCER RES, V8, P1048, DOI 10.1158/1541-7786.MCR-10-0189; Liu ZF, 2006, RAPID COMMUN MASS SP, V20, P1117, DOI 10.1002/rcm.2423; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rudek MA, 2005, J CLIN ONCOL, V23, P3906, DOI 10.1200/JCO.2005.07.450; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Si J, 2010, CANCER RES, V70, P6968, DOI 10.1158/0008-5472.CAN-09-4474; SPADA F, 2002, CANCER RES, V62, P7213; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Velicescu M, 2002, CANCER RES, V62, P2378; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong CCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002779; Wong CM, 2007, HEPATOLOGY, V45, P1129, DOI 10.1002/hep.21578; Wong CM, 2003, CANCER RES, V63, P7646; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	46	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16702	10.1371/journal.pone.0016702	http://dx.doi.org/10.1371/journal.pone.0016702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347439	Green Submitted, Green Published, gold			2022-12-25	WOS:000287077600020
J	Miki, Y; Calvino, FR; Pogni, R; Giansanti, S; Ruiz-Duenas, FJ; Martinez, MJ; Basosi, R; Romero, A; Martinez, AT				Miki, Yuta; Calvino, Fabiola R.; Pogni, Rebecca; Giansanti, Stefania; Ruiz-Duenas, Francisco J.; Jesus Martinez, Mara; Basosi, Riccardo; Romero, Antonio; Martinez, Angel T.			Crystallographic, Kinetic, and Spectroscopic Study of the First Ligninolytic Peroxidase Presenting a Catalytic Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; VERSATILE PEROXIDASE; HORSERADISH-PEROXIDASE; MICROBIAL-DEGRADATION; PLEUROTUS-ERYNGII; SUBSTRATE-BINDING; ELECTRON-TRANSFER; PROTEIN RADICALS; VERATRYL ALCOHOL; OXIDATION SITES	Trametes cervina lignin peroxidase (LiP) is a unique enzyme lacking the catalytic tryptophan strictly conserved in all other LiPs and versatile peroxidases (more than 30 sequences available). Recombinant T. cervina LiP and site-directed variants were investigated by crystallographic, kinetic, and spectroscopic techniques. The crystal structure shows three substrate oxidation site candidates involving His-170, Asp-146, and Tyr-181. Steady-state kinetics for oxidation of veratryl alcohol (the typical LiP substrate) by variants at the above three residues reveals a crucial role of Tyr-181 in LiP activity. Moreover, assays with ferrocytochrome c show that its ability to oxidize large molecules (a requisite property for oxidation of the lignin polymer) originates in Tyr-181. This residue is also involved in the oxidation of 1,4-dimethoxybenzene, a reaction initiated by the one-electron abstraction with formation of substrate cation radical, as described for the well known Phanerochaete chrysosporium LiP. Detailed spectroscopic and kinetic investigations, including low temperature EPR, show that the porphyrin radical in the two-electron activated T. cervina LiP is unstable and rapidly receives one electron from Tyr-181, forming a catalytic protein radical, which is identified as an H-bonded neutral tyrosyl radical. The crystal structure reveals a partially exposed location of Tyr-181, compatible with its catalytic role, and several neighbor residues probably contributing to catalysis: (i) by enabling substrate recognition by aromatic interactions; (ii) by acting as proton acceptor/donor from Tyr-181 or H-bonding the radical form; and (iii) by providing the acidic environment that would facilitate oxidation. This is the first structure-function study of the only ligninolytic peroxidase described to date that has a catalytic tyrosine.	[Miki, Yuta; Calvino, Fabiola R.; Ruiz-Duenas, Francisco J.; Jesus Martinez, Mara; Romero, Antonio; Martinez, Angel T.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Pogni, Rebecca; Giansanti, Stefania; Basosi, Riccardo] Univ Siena, Dept Chem, I-53100 Siena, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Siena	Martinez, AT (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, E-28040 Madrid, Spain.	ATMartinez@cib.csic.es	Romero, Antonio/K-5754-2014; Ruiz-Dueñas, Francisco J/L-9837-2015; Martínez, Angel T/G-7284-2017; Martinez, Maria Jesus/F-9147-2015; Basosi, Riccardo/E-7497-2011	Romero, Antonio/0000-0002-6990-6973; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Martínez, Angel T/0000-0002-1584-2863; Martinez, Maria Jesus/0000-0003-2166-1097; Basosi, Riccardo/0000-0003-1026-7668	Spanish projects (RAPERO) [BIO2008-01533, BFU2008-02595]; European project BIORENEW [NMP2-CT-2006-026456]; European project PEROXICATS [KBBE-2010-4-265397]; Italian Ministry of University and Research (MIUR) [20072R7WWA]	Spanish projects (RAPERO); European project BIORENEW; European project PEROXICATS; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Spanish projects BIO2008-01533 (RAPERO) and BFU2008-02595, the European projects BIORENEW (NMP2-CT-2006-026456) and PEROXICATS (KBBE-2010-4-265397), and the Italian Ministry of University and Research (MIUR) project 20072R7WWA.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRY BA, 1988, CHEM SCRIPTA, V28A, P117; BENECKY MJ, 1993, BIOCHEMISTRY-US, V32, P11929, DOI 10.1021/bi00095a024; Bernini C, 2010, APPL MAGN RESON, V37, P279, DOI 10.1007/s00723-009-0068-5; Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365; Brunow G., 2010, LIGNIN LIGNANS ADV C, V1st, P267; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davydov R, 2010, J AM CHEM SOC, V132, P14995, DOI 10.1021/ja1059747; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Dunford H. B., 1999, HEME PEROXIDASES, P281; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelpke MDS, 2002, BIOCHEMISTRY-US, V41, P3498, DOI 10.1021/bi011930d; Gold MH, 2000, MET IONS BIOL SYST, V37, P559; Guallar V, 2008, J PHYS CHEM B, V112, P13460, DOI 10.1021/jp806435d; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kapich AN, 2010, ENZYME MICROB TECH, V46, P136, DOI 10.1016/j.enzmictec.2009.09.014; KERSTEN PJ, 1990, BIOCHEM J, V268, P475, DOI 10.1042/bj2680475; KERSTEN PJ, 1985, J BIOL CHEM, V260, P2609; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P13107, DOI 10.1021/bi961297+; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P6418, DOI 10.1021/bi9601666; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; MCCONNELL HM, 1957, J PHYS CHEM-US, V61, P1018, DOI 10.1021/j150553a048; Mester T, 2001, J BIOL CHEM, V276, P22985, DOI 10.1074/jbc.M010739200; Miki Y, 2006, J FAC AGR KYUSHU U, V51, P99; Miki Y, 2011, BIOTECHNOL LETT, V33, P1423, DOI 10.1007/s10529-011-0571-2; Miki Y, 2010, FEMS MICROBIOL LETT, V304, P39, DOI 10.1111/j.1574-6968.2009.01880.x; Miki Y, 2009, PROTEIN EXPRES PURIF, V68, P208, DOI 10.1016/j.pep.2009.06.003; Mino H, 2008, PHOTOSYNTH RES, V98, P151, DOI 10.1007/s11120-008-9380-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PALMER G, 1983, IRON PORPHYRINS 2, P43; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Piontek K, 2001, BIOCHEM SOC T, V29, P111, DOI 10.1042/BST0290111; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P37, DOI 10.1007/978-3-642-12627-7_3; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Ruiz-Duenas FJ, 2009, J BIOL CHEM, V284, P7986, DOI 10.1074/jbc.M808069200; Sasaki S, 2008, PHYTOCHEMISTRY, V69, P348, DOI 10.1016/j.phytochem.2007.08.020; SCHULZ CE, 1979, FEBS LETT, V103, P102, DOI 10.1016/0014-5793(79)81259-4; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Smith AT, 2009, P NATL ACAD SCI USA, V106, P16084, DOI 10.1073/pnas.0904535106; Smith AT, 1998, CURR OPIN CHEM BIOL, V2, P269, DOI 10.1016/S1367-5931(98)80069-0; SMITH WL, 1992, BIOCHEMISTRY-US, V31, P3, DOI 10.1021/bi00116a001; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sundaramoorthy M, 1997, J BIOL CHEM, V272, P17574, DOI 10.1074/jbc.272.28.17574; Svistunenko DA, 2002, BIOPHYS J, V83, P2845, DOI 10.1016/S0006-3495(02)75293-4; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WARIISHI H, 1994, BIOCHEMISTRY-US, V33, P5545, DOI 10.1021/bi00184a025	58	42	42	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15525	15534		10.1074/jbc.M111.220996	http://dx.doi.org/10.1074/jbc.M111.220996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367853	Green Published, hybrid			2022-12-25	WOS:000289788300080
J	Pan, PW; Feldman, JL; Devries, MK; Dong, AP; Edwards, AM; Denu, JM				Pan, Patricia W.; Feldman, Jessica L.; Devries, Mark K.; Dong, Aiping; Edwards, Aled M.; Denu, John M.			Structure and Biochemical Functions of SIRT6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE/PROTEIN DEACETYLASES; ADP-RIBOSE; DEPENDENT DEACETYLATION; PROTEIN DEACETYLASE; CALORIE RESTRICTION; GLUCOSE-HOMEOSTASIS; MAXIMUM-LIKELIHOOD; SIR2-LIKE PROTEINS; LIFE-SPAN; MECHANISM	SIRT6 is a member of the evolutionarily conserved sirtuin family of NAD(+)-dependent protein deacetylases and functions in genomic stability and transcriptional control of glucose metabolism. Early reports suggested that SIRT6 performs ADP-ribosylation, whereas more recent studies have suggested that SIRT6 functions mainly as a histone deacetylase. Thus, the molecular functions of SIRT6 remain uncertain. Here, we perform biochemical, kinetic, and structural studies to provide new mechanistic insight into the functions of SIRT6. Utilizing three different assays, we provide biochemical and kinetic evidence that SIRT6-dependent histone deacetylation produces O-acetyl-ADP-ribose but at a rate similar to 1,000 times slower than other highly active sirtuins. To understand the molecular basis for such low deacetylase activity, we solved the first crystal structures of this class IV sirtuin in complex with ADP-ribose and the non-hydrolyzable analog of O-acetyl-ADP-ribose, 2'-N-acetyl-ADP-ribose. The structures revealed unique features of human SIRT6, including a splayed zinc-binding domain and the absence of a helix bundle that in other sirtuin structures connects the zinc-binding motif and Rossmann fold domain. SIRT6 also lacks the conserved, highly flexible, NAD(+)-binding loop and instead contains a stable single helix. These differences led us to hypothesize that SIRT6, unlike all other studied sirtuins, would be able to bind NAD(+) in the absence of an acetylated substrate. Indeed, we found that SIRT6 binds NAD(+) with relatively high affinity (K-d = 27 +/- 1 mu M) in the absence of an acetylated substrate. Isothermal titration calorimetry and tryptophan fluorescence binding assays suggested that ADP-ribose and NAD(+) induce different structural perturbations and that NADH does not bind to SIRT6. Collectively, these new insights imply a unique activating mechanism and/or the possibility that SIRT6 could act as an NAD(+) metabolite sensor.	[Feldman, Jessica L.; Devries, Mark K.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Pan, Patricia W.; Edwards, Aled M.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Edwards, Aled M.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L7, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, 1300 Univ Ave,MSC 551, Madison, WI 53706 USA.	jmdenu@wisc.edu		Edwards, Aled/0000-0002-4782-6016	National Institutes of Health [GM065386]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, R01GM065386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065386 (to J. M. D.). This research was also supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Anamika K, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/365637; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pils B, 2004, MOL BIOL EVOL, V21, P625, DOI 10.1093/molbev/msh055; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	61	194	203	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14575	14587		10.1074/jbc.M111.218990	http://dx.doi.org/10.1074/jbc.M111.218990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362626	Green Published, hybrid			2022-12-25	WOS:000289556200077
J	Shen, Q; Bai, YC; Chang, KCN; Wang, YJ; Burris, TP; Freedman, LP; Thompson, CC; Nagpal, S				Shen, Qi; Bai, Yuchen; Chang, Ken C. N.; Wang, Yongjun; Burris, Thomas P.; Freedman, Leonard P.; Thompson, Catherine C.; Nagpal, Sunil			Liver X Receptor-Retinoid X Receptor (LXR-RXR) Heterodimer Cistrome Reveals Coordination of LXR and AP1 Signaling in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYLARGININE DEIMINASE; ATOPIC-DERMATITIS; EPIDERMAL DIFFERENTIATION; TRANSCRIPTION FACTORS; PERMEABILITY BARRIER; MURINE EPIDERMIS; GENE-EXPRESSION; BINDING; ACTIVATORS; PROMOTER	Liver X receptors (LXRs) play a critical role in regulating lipid synthesis and transport in numerous tissues. In the skin, activation of LXR induces keratinocyte differentiation and improves epidermal permeability barrier homeostasis. To elucidate the mechanism of LXR action in skin, we mapped its cistrome by identifying LXR beta-RXR alpha binding sites using ChIP-on-chip in normal human epidermal keratinocytes (NHEKs). The cistrome was integrated with transcription data to obtain a global view of LXR action in keratinocyte biology. Here, we identify 2035 LXR beta-RXR alpha binding sites containing 4794 LXR response elements in NHEKs and show the presence of consensus heterodimer active regions in genes involved in keratinocyte lipid transport/synthesis and terminal differentiation. Bioinformatics analysis of the cistrome revealed an enrichment of AP1 cis-regulatory motifs in the vicinity of the LXR beta-RXR alpha binding sites. Importantly, we have demonstrated a direct interaction between LXR and Jun/Fos, indicating that the cooperation between LXR and AP1 may orchestrate keratinocyte differentiation. Finally, we corroborated these results by genome-wide mapping of the c-Fos and c-Jun cistromes in NHEKs, demonstrating that 77% of all the LXR beta-RXR alpha binding regions show the presence of AP1 motifs at adjacent locations. Our findings provide new insight into the mechanism of LXR action in keratinocyte differentiation, lipid production and barrier formation, further strengthening the validation of LXR as a potential therapeutic target for skin disorders including skin aging, psoriasis, and atopic dermatitis.	[Shen, Qi; Bai, Yuchen; Chang, Ken C. N.; Freedman, Leonard P.; Thompson, Catherine C.; Nagpal, Sunil] Wyeth Res, Dept Womens Hlth & Musculoskeletal Biol, Nucl Receptors & Dermatol, Collegeville, PA 19426 USA; [Wang, Yongjun; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA	Pfizer; Scripps Research Institute	Nagpal, S (corresponding author), Merck Res Labs, 770 Sumneytown Pike, West Point, PA 19486 USA.	sunil.nagpal@merck.com	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449				Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chang KCN, 2008, MOL ENDOCRINOL, V22, P2407, DOI 10.1210/me.2008-0232; Chavanas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003408; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Costet P, 2000, J BIOL CHEM, V275, P28240; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; DiSepio D, 1999, DRUG DISCOV TODAY, V4, P222, DOI 10.1016/S1359-6446(99)01335-5; Elias Peter M, 2009, Clin Med Dermatol, V2, P1; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Hanley K, 2000, J INVEST DERMATOL, V114, P545, DOI 10.1046/j.1523-1747.2000.00895.x; Ishida-Yamamoto A, 2000, J INVEST DERMATOL, V114, P701, DOI 10.1046/j.1523-1747.2000.00936.x; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jiang YJ, 2008, J INVEST DERMATOL, V128, P104, DOI 10.1038/sj.jid.5700944; Jiang YJ, 2006, J LIPID RES, V47, P2248, DOI 10.1194/jlr.M600163-JLR200; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Komuves LG, 2002, J INVEST DERMATOL, V118, P25, DOI 10.1046/j.0022-202x.2001.01628.x; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Nemoto-Hasebe I, 2009, J INVEST DERMATOL, V129, P682, DOI 10.1038/jid.2008.280; Ohsawa T, 1999, J DERMATOL SCI, V19, P68, DOI 10.1016/S0923-1811(98)00051-6; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmuth M, 2004, J INVEST DERMATOL, V123, P41, DOI 10.1111/j.0022-202X.2004.22707.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Singh M, 2006, DERMATOL THER, V19, P297, DOI 10.1111/j.1529-8019.2006.00087.x; Strong CD, 2010, HUM MOL GENET, V19, P1453, DOI 10.1093/hmg/ddq019; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	44	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14554	14563		10.1074/jbc.M110.165704	http://dx.doi.org/10.1074/jbc.M110.165704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349840	Green Published, hybrid			2022-12-25	WOS:000289556200075
J	Lingaraju, GM; Davis, CA; Setser, JW; Samson, LD; Drennan, CL				Lingaraju, Gondichatnahalli M.; Davis, C. Ainsley; Setser, Jeremy W.; Samson, Leona D.; Drennan, Catherine L.			Structural Basis for the Inhibition of Human Alkyladenine DNA Glycosylase (AAG) by 3,N-4-Ethenocytosine-containing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCISION-REPAIR ENZYMES; MICROSATELLITE INSTABILITY; DAMAGE; MUTAGENESIS; ADDUCT	Reactive oxygen and nitrogen species, generated by neutrophils and macrophages in chronically inflamed tissues, readily damage DNA, producing a variety of potentially genotoxic etheno base lesions; such inflammation-related DNA damage is now known to contribute to carcinogenesis. Although the human alkyladenine DNA glycosylase (AAG) can specifically bind DNA containing either 1,N-6-ethenoadenine (epsilon A) lesions or 3,N-4-ethenocytosine (epsilon C) lesions, it can only excise epsilon A lesions. AAG binds very tightly to DNA containing epsilon C lesions, forming an abortive protein-DNA complex; such binding not only shields epsilon C from repair by other enzymes but also inhibits AAG from acting on other DNA lesions. To understand the structural basis for inhibition, we have characterized the binding of AAG to DNA containing epsilon C lesions and have solved a crystal structure of AAG bound to a DNA duplex containing the epsilon C lesion. This study provides the first structure of a DNA glycosylase in complex with an inhibitory base lesion that is induced endogenously and that is also induced upon exposure to environmental agents such as vinyl chloride. We identify the primary cause of inhibition as a failure to activate the nucleotide base as an efficient leaving group and demonstrate that the higher binding affinity of AAG for epsilon C versus epsilon A is achieved through formation of an additional hydrogen bond between Asn-169 in the active site pocket and the O-2 of epsilon C. This structure provides the basis for the design of AAG inhibitors currently being sought as an adjuvant for cancer chemotherapy.	[Lingaraju, Gondichatnahalli M.; Samson, Leona D.; Drennan, Catherine L.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; [Lingaraju, Gondichatnahalli M.; Samson, Leona D.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Davis, C. Ainsley; Setser, Jeremy W.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Samson, Leona D.; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Samson, Leona D.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), 77 Massachusetts Ave, Cambridge, MA 02193 USA.	Isamson@mit.edu; cdrennan@mit.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [P30-ES002109, GM65337, GM65337-03S2, CA055042, CA092584]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; Repligen Koch Institute for Integrated Cancer Research; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); Repligen Koch Institute for Integrated Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-ES002109 (to C. L D. and L D. S.), GM65337 (to C. L D.), GM65337-03S2 (to C. A. D.), and CA055042 and CA092584 (to L D. S.).; The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract Number DE-AC02-05CH11231.; Supported by a Repligen Koch Institute for Integrated Cancer Research Graduate Fellowship.	Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartsch H, 2002, CANCER DETECT PREV, V26, P308, DOI 10.1016/S0361-090X(02)00093-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Connor EE, 2002, CHEM BIOL, V9, P1033, DOI 10.1016/S1074-5521(02)00215-6; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Gros L, 2003, MUTAT RES-FUND MOL M, V531, P219, DOI 10.1016/j.mrfmmm.2003.07.008; Gros L, 2004, J BIOL CHEM, V279, P17723, DOI 10.1074/jbc.M314010200; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Klapacz J, 2010, MOL CELL, V37, P843, DOI 10.1016/j.molcel.2010.01.038; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lee CYI, 2009, BIOCHEMISTRY-US, V48, P1850, DOI 10.1021/bi8018898; Levine RL, 2000, CANCER RES, V60, P4098; Margison GP, 2007, DNA REPAIR, V6, P1222, DOI 10.1016/j.dnarep.2007.03.014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miao F, 2000, J BIOL CHEM, V275, P28433, DOI 10.1074/jbc.M001064200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; SAMSON L, 1991, P NATL ACAD SCI USA, V88, P9127, DOI 10.1073/pnas.88.20.9127; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Wang P, 2006, TOXICOL LETT, V166, P237, DOI 10.1016/j.toxlet.2006.06.647; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	27	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13205	13213		10.1074/jbc.M110.192435	http://dx.doi.org/10.1074/jbc.M110.192435			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349833	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000289282200041
J	Matsumoto, A; Onoyama, I; Sunabori, T; Kageyama, R; Okano, H; Nakayama, KI				Matsumoto, Akinobu; Onoyama, Ichiro; Sunabori, Takehiko; Kageyama, Ryoichiro; Okano, Hideyuki; Nakayama, Keiichi I.			Fbxw7-dependent Degradation of Notch Is Required for Control of "Stemness" and Neuronal-Glial Differentiation in Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX GENES; UBIQUITIN LIGASE; CYCLIN-E; TUMOR-SUPPRESSOR; MIND BOMB; C-MYC; PROTEOLYSIS; ACTIVATION; PATHWAY; GLIOGENESIS	Control of the growth and differentiation of neural stem cells is fundamental to brain development and is largely dependent on the Notch signaling pathway. The mechanism by which the activity of Notch is regulated during brain development has remained unclear, however. Fbxw7 (also known as Fbw7, SEL-10, hCdc4, or hAgo) is the F-box protein subunit of an Skp1-Cul1-F-box protein (SCF)-type ubiquitin ligase complex that plays a central role in the degradation of Notch family members. We now show that mice with brain-specific deletion of Fbxw7 (Nestin-Cre/Fbxw7(F/F) mice) die shortly after birth with morphological abnormalities of the brain and the absence of suckling behavior. The maintenance of neural stern cells was sustained in association with the accumulation of Notch! and Notch3, as well as up-regulation of Notch target genes in the mutant mice. Astrogenesis was also enhanced in the mutant mice in vivo, and the differentiation of neural progenitor cells was skewed toward astrocytes rather than neurons in vitro, with the latter effect being reversed by treatment of the cells with a pharmacological inhibitor of the Notch signaling pathway. Our results thus implicate Fbxw7 as a key regulator of the maintenance and differentiation of neural stein cells in the brain.	[Matsumoto, Akinobu; Onoyama, Ichiro; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Matsumoto, Akinobu; Onoyama, Ichiro; Kageyama, Ryoichiro; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Sunabori, Takehiko; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Kyushu University; Japan Science & Technology Agency (JST); Keio University; Kyoto University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Matsumoto, Akinobu/GPF-4945-2022; Okano, Hideyuki/I-7584-2019	Matsumoto, Akinobu/0000-0002-4077-3935	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Cau E, 2000, DEVELOPMENT, V127, P2323; Chan YM, 1998, CELL, V94, P423, DOI 10.1016/S0092-8674(00)81583-4; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Handler M, 2000, DEVELOPMENT, V127, P2593; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lutolf S, 2002, DEVELOPMENT, V129, P373; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Masuda K, 2010, ONCOGENE, V29, P1798, DOI 10.1038/onc.2009.469; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Robey E, 1997, CURR OPIN GENET DEV, V7, P551, DOI 10.1016/S0959-437X(97)80085-8; Sakamoto M, 2003, J BIOL CHEM, V278, P44808, DOI 10.1074/jbc.M300448200; Satow T, 2001, J NEUROSCI, V21, P1265; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Selkoe DJ, 2000, CURR OPIN NEUROBIOL, V10, P50, DOI 10.1016/S0959-4388(99)00054-9; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018	49	83	89	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13754	13764		10.1074/jbc.M110.194936	http://dx.doi.org/10.1074/jbc.M110.194936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349854	Green Published, hybrid			2022-12-25	WOS:000289282200093
J	Baguelin, M; Hoschler, K; Stanford, E; Waight, P; Hardelid, P; Andrews, N; Miller, E				Baguelin, Marc; Hoschler, Katja; Stanford, Elaine; Waight, Pauline; Hardelid, Pia; Andrews, Nick; Miller, Elizabeth			Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation	PLOS ONE			English	Article								Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversion intervals and allows integration of information on the temporal distribution of cases from clinical surveillance. Among a family of candidate incidences, a likelihood function is derived by reconstructing the change in seroprevalence from seroconversion following infection and comparing it with the observed sequence of positivity among the samples. This method is applied to derive the cumulative and weekly incidence of A/H1N1 pandemic influenza in England during the second wave using sera taken between September 2009 and February 2010 in four age groups (1-4, 5-14, 15-24, 25-44 years). The highest cumulative incidence was in 5-14 year olds (59%, 95% credible interval (CI): 52%, 68%) followed by 1-4 year olds (49%, 95% CI: 38%, 61%), rates 20 and 40 times higher respectively than estimated from clinical surveillance. The method provides a more accurate and continuous measure of incidence than achieved by comparing prevalence in samples grouped by time period.	[Baguelin, Marc; Waight, Pauline; Miller, Elizabeth] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England; [Baguelin, Marc] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Hoschler, Katja] Hlth Protect Agcy, Resp Virus Unit, Virus Reference Dept, London, England; [Stanford, Elaine] Hlth Protect Agcy, Vaccine Evaluat Seroepidemiol Unit, Manchester, Lancs, England; [Hardelid, Pia; Andrews, Nick] Hlth Protect Agcy, Stat Unit, London, England	Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; Health Protection Agency; Health Protection Agency	Baguelin, M (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England.	marc.baguelin@hpa.org.uk	Hardelid, Pia/K-3353-2013	Hardelid, Pia/0000-0002-0154-1306	National Institute for Health Research; Novartis; Sanofi Pasteur; Baxter; CSL Australia	National Institute for Health Research(National Institute for Health Research (NIHR)); Novartis(Novartis); Sanofi Pasteur; Baxter; CSL Australia	The testing of the serological samples was supported by the National Institute for Health Research Health Technology Assessment Programme (http://www.hta.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KH: In 2006 Sanofi Pasteur paid conference fees and accommodations for an international meeting at which he presented data for a Sanofi vaccine study. ES has received support to attend a scientific meeting from Wyeth Vaccines in 2006. The RVU lab (KH) has received funding for influenza vaccine work from Novartis, Sanofi Pasteur, Baxter and CSL Australia. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors (MB, PW, PH, NA, EM) have declared that no competing interests exist.	Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Donaldson LJ, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c612; Ellis J, 2009, EUROSURVEILLANCE, V14; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Gilks WR, 2005, MARKOV CHAIN MONTE C; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; VANHOEK AJ, RESPONSE GUEST EDITO; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; [No title captured]	15	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17074	10.1371/journal.pone.0017074	http://dx.doi.org/10.1371/journal.pone.0017074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373639	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000287657500031
J	Suzuki, H; Osaki, K; Sano, K; Alam, AHMK; Nakamura, Y; Ishigaki, Y; Kawahara, K; Tsukahara, T				Suzuki, Hitoshi; Osaki, Ken; Sano, Kaori; Alam, A. H. M. Khurshid; Nakamura, Yuichiro; Ishigaki, Yasuhito; Kawahara, Kozo; Tsukahara, Toshifumi			Comprehensive Analysis of Alternative Splicing and Functionality in Neuronal Differentiation of P19 Cells	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; GENOME; TRANSCRIPTION; INSIGHTS; MEMORY; FOX-2; MEF2C	Background: Alternative splicing, which produces multiple mRNAs from a single gene, occurs in most human genes and contributes to protein diversity. Many alternative isoforms are expressed in a spatio-temporal manner, and function in diverse processes, including in the neural system. Methodology/Principal Findings: The purpose of the present study was to comprehensively investigate neural-splicing using P19 cells. GeneChip Exon Array analysis was performed using total RNAs purified from cells during neuronal cell differentiation. To efficiently and readily extract the alternative exon candidates, 9 filtering conditions were prepared, yielding 262 candidate exons (236 genes). Semiquantitative RT-PCR results in 30 randomly selected candidates suggested that 87% of the candidates were differentially alternatively spliced in neuronal cells compared to undifferentiated cells. Gene ontology and pathway analyses suggested that many of the candidate genes were associated with neural events. Together with 66 genes whose functions in neural cells or organs were reported previously, 47 candidate genes were found to be linked to 189 events in the gene-level profile of neural differentiation. By text-mining for the alternative isoform, distinct functions of the isoforms of 9 candidate genes indicated by the result of Exon Array were confirmed. Conclusions/Significance: Alternative exons were successfully extracted. Results from the informatics analyses suggested that neural events were primarily governed by genes whose expression was increased and whose transcripts were differentially alternatively spliced in the neuronal cells. In addition to known functions in neural cells or organs, the uninvestigated alternative splicing events of 11 genes among 47 candidate genes suggested that cell cycle events are also potentially important. These genes may help researchers to differentiate the roles of alternative splicing in cell differentiation and cell proliferation.	[Suzuki, Hitoshi; Tsukahara, Toshifumi] Japan Adv Inst Sci & Technol, Ctr Nano Mat & Technol, Nomi, Ishikawa, Japan; [Osaki, Ken; Nakamura, Yuichiro; Kawahara, Kozo] World Fus Co Ltd, Chuo Ku, Tokyo, Japan; [Sano, Kaori; Alam, A. H. M. Khurshid] Japan Adv Inst Sci & Technol, Grad Sch Mat Sci, Nomi, Ishikawa, Japan; [Ishigaki, Yasuhito] Kanazawa Med Univ, Med Res Inst, Kanazawa, Ishikawa, Japan	Japan Advanced Institute of Science & Technology (JAIST); Japan Advanced Institute of Science & Technology (JAIST); Kanazawa Medical University	Suzuki, H (corresponding author), Japan Adv Inst Sci & Technol, Ctr Nano Mat & Technol, Nomi, Ishikawa, Japan.	suzuki-h@jaist.ac.jp		Alam, AHM Khurshid/0000-0003-2690-6559	JAIST Foundation; JSPS; HLW; World Fusion Co. Ltd.	JAIST Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); HLW; World Fusion Co. Ltd.	Funding: This work was supported by Grants-in-Aid from the JAIST Foundation and in part by JSPS, HLW, and World Fusion Co. Ltd. KO and YN are World Fusion Co. Ltd. employees and KK is an executive. They performed data analyses in this study. The other funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ab Hakim NH, 2010, GENES CELLS, V15, P255, DOI 10.1111/j.1365-2443.2009.01378.x; *AFF INC, 2006, ID VAL ALT SPL EV, P1; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Ha KCH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-519; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Moller-Levet CS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000571; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Novichkova S, 2003, BIOINFORMATICS, V19, P1699, DOI 10.1093/bioinformatics/btg207; Roberts GC, 2002, CURR OPIN CHEM BIOL, V6, P375, DOI 10.1016/S1367-5931(02)00320-4; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Xing Y, 2008, RNA, V14, P1470, DOI 10.1261/rna.1070208; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	36	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16880	10.1371/journal.pone.0016880	http://dx.doi.org/10.1371/journal.pone.0016880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365003	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482800019
J	Gad, GF; Mohamed, HA; Ashour, HM				Gad, Gamal F.; Mohamed, Heba A.; Ashour, Hossam M.			Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram-Negative Bacteria from Infected Patients in Upper Egypt	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIBIOTICS; COMBINATION; PREVALENCE; THERAPY; MEXXY; MONOTHERAPY; ENZYMES	With the re-emergence of older antibiotics as valuable choices for treatment of serious infections, we studied the aminoglycoside resistance of Gram-negative bacteria isolated from patients with ear, urinary tract, skin, and gastrointestinal tract infections at Minia university hospital in Egypt. Escherichia coli (mainly from urinary tract and gastrointestinal tract infections) was the most prevalent isolate (28.57%), followed by Pseudomonas aeruginosa (25.7%) (mainly from ear discharge and skin infections). Isolates exhibited maximal resistance against streptomycin (83.4%), and minimal resistance against amikacin (17.7%) and intermediate degrees of resistance against neomycin, kanamycin, gentamicin, and tobramycin. Resistance to older aminoglycosides was higher than newer aminoglycoides. The most common aminoglycoside resistance phenotype was that of streptomycin resistance, present as a single phenotype or in combination, followed by kanamycin-neomycin as determined by interpretative reading. The resistant Pseudomonas aeruginosa strains were capable of producing aminoglycoside-modifying enzymes and using efflux as mechanisms of resistance. Using checkerboard titration method, the most frequently-observed outcome in combinations of aminoglycosides with beta-lactams or quinolones was synergism. The most effective combination was amikacin with ciprofloxacin (100% Synergism), whereas the least effective combination was gentamicin with amoxicillin (53.3% Synergistic, 26.7% additive, and 20% indifferent FIC indices). Whereas the studied combinations were additive and indifferent against few of the tested strains, antagonism was never observed. The high resistance rates to aminoglycosides exhibited by Gram-negative bacteria in this study could be attributed to the selective pressure of aminoglycoside usage which could be controlled by successful implementation of infection control measures.	[Gad, Gamal F.; Mohamed, Heba A.] Menia Univ, Dept Microbiol & Immunol, Fac Pharm, Al Minya, Egypt; [Ashour, Hossam M.] Cairo Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt; [Ashour, Hossam M.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA	Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Cairo University; Wayne State University	Gad, GF (corresponding author), Menia Univ, Dept Microbiol & Immunol, Fac Pharm, Al Minya, Egypt.	hossam@wayne.edu		Ashour, Hossam/0000-0002-1256-7368				Abd-El-Haleem D, 2003, J ENVIRON MONITOR, V5, P865, DOI 10.1039/b307476e; Beauchamp D, 2007, ADV DRUG DELIVER REV, V59, P896, DOI 10.1016/j.addr.2006.07.028; BENVENISTE R, 1971, FEBS LETT, V14, P293, DOI 10.1016/0014-5793(71)80282-X; Cirioni O, 2007, PEPTIDES, V28, P747, DOI 10.1016/j.peptides.2007.01.001; Clinical and Laboratory Standards Institute (CLSI), 2007, M100S15 CLSI; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Drusano GL, 2007, CLIN INFECT DIS, V45, P753, DOI 10.1086/520991; Falagas ME, 2008, EXPERT REV ANTI-INFE, V6, P593, DOI 10.1586/14787210.6.5.593; Falagas ME, 2007, CURR OPIN CRIT CARE, V13, P592, DOI 10.1097/MCC.0b013e32827851d7; FOSSE T, 1983, PATHOL BIOL, V31, P483; Freundlich M, 2007, J ANTIMICROB CHEMOTH, V60, P1115, DOI 10.1093/jac/dkm354; Gad GF, 2008, J UROLOGY, V180, P176, DOI 10.1016/j.juro.2008.03.081; Gad GF, 2007, J ANTIMICROB CHEMOTH, V60, P1010, DOI 10.1093/jac/dkm348; GIAMARELLOU H, 1986, AM J MED, V80, P126, DOI 10.1016/0002-9343(86)90490-0; Goldin AB, 2007, PEDIATRICS, V119, P905, DOI 10.1542/peds.2006-2040; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1371, DOI 10.1128/AAC.47.4.1371-1375.2003; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Leibovici L, 2007, J ANTIMICROB CHEMOTH, V60, P911, DOI 10.1093/jac/dkm377; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V48, P87, DOI 10.1093/jac/48.suppl_1.87; Llano-Sotelo B, 2002, CHEM BIOL, V9, P455, DOI 10.1016/S1074-5521(02)00125-4; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Lorian V., 2005, ANTIBIOTICS LAB MED; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Neonakis I, 2003, INT J ANTIMICROB AG, V22, P526, DOI 10.1016/S0924-8579(03)00152-3; Over U, 2001, CLIN MICROBIOL INFEC, V7, P470, DOI 10.1046/j.1198-743x.2001.00284.x; Paul M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003344.pub2; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Schmitz FJ, 1999, EUR J CLIN MICROBIOL, V18, P414, DOI 10.1007/s100960050310; Shahid M, 2005, INDIAN J MED RES, V122, P324; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Tsai Tung-Yuan, 2007, Journal of Microbiology Immunology and Infection, V40, P481; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Vogne C, 2004, ANTIMICROB AGENTS CH, V48, P1676, DOI 10.1128/AAC.48.5.1676-1680.2004	36	37	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17224	10.1371/journal.pone.0017224	http://dx.doi.org/10.1371/journal.pone.0017224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359143	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300041
J	Caetano, C; Klier, S; de Bruin, RAM				Caetano, Catia; Klier, Steffi; de Bruin, Robertus A. M.			Phosphorylation of the MBF Repressor Yox1p by the DNA Replication Checkpoint Keeps the G1/S Cell-Cycle Transcriptional Program Active	PLOS ONE			English	Article							FISSION YEAST	Background: In fission yeast Schizosaccharomyces pombe G1/S cell-cycle regulated transcription depends upon MBF. A negative feedback loop involving Nrm1p and Yox1p bound to MBF leads to transcriptional repression as cells exit G1 phase. However, activation of the DNA replication checkpoint response during S phase results in persistent expression of MBF-dependent genes. Methodology/Principal Findings: This report shows that Yox1p binding to MBF is Nrm1-dependent and that Yox1p and Nrm1p require each other to bind and repress MBF targets. In response to DNA replication stress both Yox1p and Nrm1p dissociate from MBF at promoters leading to de-repression of MBF targets. Inactivation of Yox1p is an essential part of the checkpoint response. Cds1p (human Chk2p) checkpoint protein kinase-dependent phosphorylation of Yox1p promotes its dissociation from the MBF transcription factor. We establish that phosphorylation of Yox1p at Ser114, Thr115 is required for maximal checkpoint-dependent activation of the G1/S cell-cycle transcriptional program. Conclusions/Significance: This study shows that checkpoint-dependent phosphorylation of Yox1p at Ser114, Thr115 results in de-repression of the MBF transcriptional program. The remodeling of the cell cycle transcriptional program by the DNA replication checkpoint is likely to comprise an important mechanism for the avoidance of genomic instability.	[Caetano, Catia; Klier, Steffi; de Bruin, Robertus A. M.] UCL, MRC Lab Mol Cell Biol, London, England	MRC Laboratory Molecular Biology; University of London; University College London	Caetano, C (corresponding author), UCL, MRC Lab Mol Cell Biol, London, England.	r.debruin@ucl.ac.uk			MRC	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This work was funded by the MRC (http://www.mrc.ac.uk/index.htm). R.A.M. de Bruin is a recipient of an MRC Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aligianni S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000626; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; Ayte J, 2001, NAT CELL BIOL, V3, P1043, DOI 10.1038/ncb1201-1043; AYTE J, 1995, MOL CELL BIOL, V15, P2589; Baum B, 1997, EMBO J, V16, P4676, DOI 10.1093/emboj/16.15.4676; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; CALIGIURI M, 1993, CELL, V72, P607, DOI 10.1016/0092-8674(93)90079-6; Chu Z, 2009, MOL CELLULAR BIOL; Chu ZQ, 2007, MOL BIOL CELL, V18, P1756, DOI 10.1091/mbc.E06-10-0928; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; de Bruin RAM, 2009, CELL CYCLE, V8, P214, DOI 10.4161/cc.8.2.7412; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; Dutta C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006944; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; MIYAMOTO M, 1994, EMBO J, V13, P1873, DOI 10.1002/j.1460-2075.1994.tb06456.x; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; NAKASHIMA N, 1995, EMBO J, V14, P4794, DOI 10.1002/j.1460-2075.1995.tb00161.x; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Rhind N, 2000, J CELL SCI, V113, P3889; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Seo GJ, 2003, BIOCHEM BIOPH RES CO, V304, P339, DOI 10.1016/S0006-291X(03)00589-8; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Tahara S, 1998, MOL BIOL CELL, V9, P1577, DOI 10.1091/mbc.9.6.1577; TANAKA K, 1992, EMBO J, V11, P4923, DOI 10.1002/j.1460-2075.1992.tb05599.x; Whitehall S, 1999, MOL BIOL CELL, V10, P3705, DOI 10.1091/mbc.10.11.3705; Zhu Y, 1997, EMBO J, V16, P1023, DOI 10.1093/emboj/16.5.1023	34	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17211	10.1371/journal.pone.0017211	http://dx.doi.org/10.1371/journal.pone.0017211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359180	Green Published, Green Submitted, gold			2022-12-25	WOS:000287392700060
J	Makani, J; Cox, SE; Soka, D; Komba, AN; Oruo, J; Mwamtemi, H; Magesa, P; Rwezaula, S; Meda, E; Mgaya, J; Lowe, B; Muturi, D; Roberts, DJ; Williams, TN; Pallangyo, K; Kitundu, J; Fegan, G; Kirkham, FJ; Marsh, K; Newton, CR				Makani, Julie; Cox, Sharon E.; Soka, Deogratius; Komba, Albert N.; Oruo, Julie; Mwamtemi, Hadija; Magesa, Pius; Rwezaula, Stella; Meda, Elineema; Mgaya, Josephine; Lowe, Brett; Muturi, David; Roberts, David J.; Williams, Thomas N.; Pallangyo, Kisali; Kitundu, Jesse; Fegan, Gregory; Kirkham, Fenella J.; Marsh, Kevin; Newton, Charles R.			Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania	PLOS ONE			English	Article							PNEUMOCOCCAL PROPHYLAXIS; BLOOD-TRANSFUSION; NATURAL-HISTORY; DISEASE; CHILDREN; SURVIVAL; DEATH; DISORDERS; MORBIDITY; JAMAICA	Background: The World Health Organization has declared Sickle Cell Anemia (SCA) a public health priority. There are 300,000 births/year, over 75% in Africa, with estimates suggesting that 6 million Africans will be living with SCA if average survival reaches half the African norm. Countries such as United States of America and United Kingdom have reduced SCA mortality from 3 to 0.13 per 100 person years of observation (PYO), with interventions such as newborn screening, prevention of infections and comprehensive care, but implementation of interventions in African countries has been hindered by lack of locally appropriate information. The objective of this study was to determine the incidence and factors associated with death from SCA in Dar-es-Salaam. Methods and Findings: A hospital-based cohort study was conducted, with prospective surveillance of 1,725 SCA patients recruited from 2004 to 2009, with 209 (12%) lost to follow up, while 86 died. The mortality rate was 1.9 (95% CI 1.5, 2.9) per 100 PYO, highest under 5-years old [7.3 (4.8-11.0)], adjusting for dates of birth and study enrollment. Independent risk factors, at enrollment to the cohort, predicting death were low hemoglobin (<5 g/dL) [3.8 (1.8-8.2); p = 0.001] and high total bilirubin (>= 102 mu mol/L) [1.7 (1.0-2.9); p = 0.044] as determined by logistic regression. Conclusions: Mortality in SCA in Africa is high, with the most vulnerable period being under 5-years old. This is most likely an underestimate, as this was a hospital cohort and may not have captured SCA individuals with severe disease who died in early childhood, those with mild disease who are undiagnosed or do not utilize services at health facilities. Prompt and effective treatment for anemia in SCA is recommended as it is likely to improve survival. Further research is required to determine the etiology, pathophysiology and the most appropriate strategies for management of anemia in SCA.	[Makani, Julie; Cox, Sharon E.; Soka, Deogratius; Komba, Albert N.; Oruo, Julie; Mwamtemi, Hadija; Magesa, Pius; Rwezaula, Stella; Meda, Elineema; Mgaya, Josephine; Pallangyo, Kisali; Kitundu, Jesse; Newton, Charles R.] Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Dar Es Salaam, Tanzania; [Makani, Julie; Lowe, Brett; Roberts, David J.; Williams, Thomas N.; Marsh, Kevin] Univ Oxford, Nuffield Dept Med, Oxford, England; [Cox, Sharon E.; Fegan, Gregory; Newton, Charles R.] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England; [Lowe, Brett; Muturi, David; Williams, Thomas N.; Fegan, Gregory; Marsh, Kevin; Newton, Charles R.] KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya; [Roberts, David J.] John Radcliffe Hosp, Natl Hlth Serv Blood & Transplant, Oxford OX3 9DU, England; [Williams, Thomas N.] INDEPTH Network Demog Surveillance Sites, Accra, Ghana; [Kirkham, Fenella J.; Newton, Charles R.] UCL, Inst Child Hlth, Neurosci Unit, London, England	Muhimbili University of Health & Allied Sciences; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; NHS Blood & Transplant (NHSBT); University of Oxford; INDEPTH Network; University of London; University College London	Makani, J (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Dar Es Salaam, Tanzania.	jmakani@muhas.ac.tz	Kirkham, Fenella/C-2442-2009; Newton, Charles RJC/B-7578-2014; Makani, Julie/N-9370-2013; Makani, Julie/E-8525-2017; Fegan, Greg W/O-8079-2018; Newton, Charles/V-7872-2019; Cox, Sharon E/ABA-7986-2020	Kirkham, Fenella/0000-0002-2443-7958; Newton, Charles RJC/0000-0002-6999-5507; Makani, Julie/0000-0002-4801-6250; Makani, Julie/0000-0002-4801-6250; Fegan, Greg W/0000-0002-2663-2765; Newton, Charles/0000-0002-6999-5507; Cox, Sharon E/0000-0002-9908-2936	Wellcome Trust, UK [JKM 072064, 080025, 084538]; Kenya Medical Research Institute (KEMRI) - Centre for Geographic Medicine Research (Coast)	Wellcome Trust, UK(Wellcome Trust); Kenya Medical Research Institute (KEMRI) - Centre for Geographic Medicine Research (Coast)	This work was supported by the Wellcome Trust, UK (JKM 072064; Project grant 080025; Strategic award 084538) and Kenya Medical Research Institute (KEMRI) - Centre for Geographic Medicine Research (Coast). CRN is funded by the Wellcome Trust. DJR is supported by a programme grant from the National Institutes of Health Research to NHS Blood and Transplant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christianson A., 2006, GLOBAL REPORT BIRTH; CNAAN A, 1989, STAT MED, V8, P1255, DOI 10.1002/sim.4780081009; de Montalembert M, 2008, ARCH DIS CHILD, V93, P715; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Ikefuna A N, 2007, Niger J Clin Pract, V10, P24; Juwah AI, 2004, ARCH DIS CHILD, V89, P572, DOI 10.1136/adc.2003.037374; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kizito ME, 2007, ARCH DIS CHILD, V92, P21, DOI 10.1136/adc.2005.088807; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; LEIKIN SL, 1989, PEDIATRICS, V84, P500; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; National Malaria Control Programme, 2006, NAT GUID MAL DIAGN T; OBARO S, 2009, ARCH DIS CHILD; Odunvbun ME, 2008, PUBLIC HEALTH, V122, P1111, DOI 10.1016/j.puhe.2008.01.008; Olabode J O, 2006, West Afr J Med, V25, P284; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1990, SEMIN HEMATOL, V27, P360; POWARS DR, 1975, SEMIN HEMATOL, V12, P267; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; Rahimy MC, 2009, J CLIN PATHOL, V62, P46, DOI 10.1136/jcp.2008.059113; RWEZAULA S, 2010, NEONATAL SCREENING H; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Telfer P, 2007, HAEMATOLOGICA, V92, P905, DOI 10.3324/haematol.10937; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; Tshilolo L, 2008, PUBLIC HEALTH, V122, P933, DOI 10.1016/j.puhe.2007.12.005; Tshilolo LM, 2007, INDIAN J PEDIATR, V74, P735, DOI 10.1007/s12098-007-0129-4; VICHINSKY EP, 1991, SEMIN HEMATOL, V28, P220; Wahl S, 2009, CURR OPIN PEDIATR, V21, P15, DOI 10.1097/MOP.0b013e328321882e; Weatherall D, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P663; *WHO, 2006, WHO MARCH DIM M GEN; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5; WILLIAMS TN, 2009, LANCET; Yanni E, 2009, J PEDIATR-US, V154, P541, DOI 10.1016/j.jpeds.2008.09.052; 2008, ANAL INFORM MANAGEME	36	171	175	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14699	10.1371/journal.pone.0014699	http://dx.doi.org/10.1371/journal.pone.0014699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358818	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000287392700012
J	Ahmad, N; Boutron, I; Dechartres, A; Durieux, P; Ravaud, P				Ahmad, Nizar; Boutron, Isabelle; Dechartres, Agnes; Durieux, Pierre; Ravaud, Philippe			Geographical Representativeness of Published and Ongoing Randomized Controlled Trials. The Example of: Tobacco Consumption and HIV Infection	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SYSTEMATIC REVIEWS; COCHRANE REVIEWS; MEDICAL JOURNALS; GLOBAL BURDEN; HEALTH; DISEASE; METAANALYSES; ACHIEVE; QUALITY	Background: The challenge for evidence-based healthcare is to reduce mortality and the burden of diseases. This study aimed to compare where research is conducted to where research is needed for 2 public health priorities: tobacco consumption and HIV infection. Methods: We identified randomized controlled trials (RCTs) included in Cochrane systematic reviews published between 1997 and 2007 and registered ongoing RCTs identified in January 2009 through the World Health Organization's International Clinical Trials Registry Platform (WHO-ICTRP) evaluating interventions aimed at reducing or stopping tobacco use and treating or preventing HIV infection. We used the WHO and World Bank reports to classify the countries by income level, as well as map the global burden of disease and mortality attributable to tobacco use and HIV infection to the countries where the trials performed. Results: We evaluated 740 RCTs included in systematic reviews and 346 ongoing RCTs. For tobacco use, 4% of RCTs included in systematic reviews and 2% of ongoing trials were performed in low-and middle-income countries, even though these countries represented 70% of the mortality related to tobacco use. For HIV infection, 31% of RCTs included in systematic reviews and 33% of ongoing trials were performed in low-and middle-income countries, even though these countries represented 99% of the mortality related to HIV infection. Conclusions: Our results highlight an important underrepresentation of low-and middle-income countries in currently available evidence (RCTs included in systematic reviews) and awaiting evidence (registered ongoing RCTs) for reducing or stopping tobacco use and treating or preventing HIV infection.	[Ahmad, Nizar; Boutron, Isabelle; Dechartres, Agnes; Ravaud, Philippe] INSERM, U738, Paris, France; [Ahmad, Nizar; Boutron, Isabelle; Dechartres, Agnes; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Ahmad, Nizar; Boutron, Isabelle; Dechartres, Agnes; Ravaud, Philippe] Univ Paris 05, Fac Med, Paris, France; [Durieux, Pierre; Ravaud, Philippe] APHP, INSERM, HAS, Ctr Med Fondee Preuves,EHESP, Paris, France; [Durieux, Pierre] Univ Paris 05, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ahmad, N (corresponding author), INSERM, U738, Paris, France.	nizar.ahmad@htd.aphp.fr	ravaud, philippe/C-1694-2009	Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206	Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France; Institut National du Cancer (INCA), France	Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France; Institut National du Cancer (INCA), France(Institut National du Cancer (INCA) France)	This work was supported by a grant "Recherche sur la Recherche" from the "Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France" and a grant from the Institut National du Cancer (INCA), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto ML, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4846; Buekens P, 2004, JAMA-J AM MED ASSOC, V291, P2639, DOI 10.1001/jama.291.21.2639; CALDWELL JC, 1993, SOC SCI MED, V36, P125, DOI 10.1016/0277-9536(93)90204-H; Chinnock P, 2005, PLOS MED, V2, P367, DOI 10.1371/journal.pmed.0020107; Daar AS, 2009, SCIENCE, V324, P1642, DOI 10.1126/science.324_1642; Eisinger F, 1999, LANCET, V353, P919, DOI 10.1016/S0140-6736(98)07516-3; Fryatt R, 2010, LANCET, V375, P419, DOI 10.1016/S0140-6736(09)61833-X; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Harris E, 2000, BRIT MED J, V321, P817, DOI 10.1136/bmj.321.7264.817; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; Jadad AR, 2000, BRIT MED J, V320, P537, DOI 10.1136/bmj.320.7234.537; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, REP GLOB HIV AIDS EP; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; LOUIS J, 10 90 REP HLTH RES 2; MCDEVITT TM, WP98 US CENS BUR; McMichael C, 2005, J PUBLIC HEALTH-UK, V27, P215, DOI 10.1093/pubmed/fdi024; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; *ONU, 2005, POP DIV WORLD POP PR; Oxman AD, 2010, LANCET, V375, P427, DOI 10.1016/S0140-6736(09)61251-4; Perel P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001696; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Rochon PA, 2004, CAN MED ASSOC J, V170, P1673, DOI 10.1503/cmaj.1031006; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Sheriff RJS, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-69; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; Swingler GH, 2003, BRIT MED J, V327, P1083, DOI 10.1136/bmj.327.7423.1083; [UNAIDS WHO], AIDS EP UPD DEC 2007; VOLMINK J, 2007, COCHRANE DB SYST REV, V24; WHO, WORLD HLTH STAT REP; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yusuf S, 2002, STAT MED, V21, P2859, DOI 10.1002/sim.1290	37	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16878	10.1371/journal.pone.0016878	http://dx.doi.org/10.1371/journal.pone.0016878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347383	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700048
J	Chan, J; Ko, FCF; Yeung, YS; Ng, IOL; Yam, JWP				Chan, Jenny; Ko, Frankie Chi Fat; Yeung, Yin-Shan; Ng, Irene Oi-Lin; Yam, Judy Wai Ping			Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma	PLOS ONE			English	Article							ACTIN STRESS FIBERS; PROTEIN-KINASE; EXPRESSION INCREASES; DEPENDENT REGULATION; BETA-CATENIN; CANCER; ILK; AKT; ACTIVATION; TUMOR	Background: Integrin-linked kinase (ILK) was first discovered as an integrin beta 1-subunit binding protein. It localizes at the focal adhesions and is involved in cytoskeleton remodeling. ILK overexpression and its dysregulated signaling cascades have been reported in many human cancers. Aberrant expression of ILK influenced a wide range of signaling pathways and cellular functions. Although ILK has been well characterized in many malignancies, its role in hepatocellular carcinoma (HCC) is still largely unknown. Methodology/Principal Findings: Quantitative PCR analysis was used to examine ILK mRNA expression in HCC clinical samples. It was shown that ILK was overexpressed in 36.9% (21/57) of HCC tissues when compared to the corresponding non-tumorous livers. The overall ILK expression level was significantly higher in tumorous tissues (P = 0.004), with a significant stepwise increase in expression level along tumor progression from tumor stage I to IV (P = 0.045). ILK knockdown stable clones were established in two HCC cell lines, BEL7402 and HLE, and were subjected to different functional assays. Knockdown of ILK significantly suppressed HCC cell growth, motility and invasion in vitro and inhibited tumorigenicity in vivo. Western blot analysis revealed a reduced phosphorylated-Akt (pAkt) at Serine-473 expression in ILK knockdown stable clones when compared to control clones. Conclusion/Significance: This study provides evidence about the clinical relevance of ILK in hepatocarcinogenesis. ILK was found to be progressively elevated along HCC progression. Here our findings also provide the first validation about the oncogenic capacity of ILK in vivo by suppressing its expression in HCC cells. The oncogenic role of ILK is implicated to be mediated by Akt pathway.	[Chan, Jenny; Ko, Frankie Chi Fat; Yeung, Yin-Shan; Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Ko, Frankie Chi Fat; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin] Univ Hong Kong, Li Ka Shing Fac Med, Liver Canc & Hepatitis Res Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, J (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	judyyam@pathology.hku.hk	Ko, Frankie Chi Fat/C-4759-2009; Yam, Judy Wai Ping/C-4454-2009	Ko, Frankie Chi Fat/0000-0002-0393-9668; Yam, Judy Wai Ping/0000-0002-5637-121X; Ng, Irene Oi-lin/0000-0001-7532-2029	University of Hong Kong; Hong Kong Research Grants Council [HKU7798/07M]; Outstanding Young Researcher Award	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Outstanding Young Researcher Award	This work was supported by The University of Hong Kong Seed Funding Programme for Basic Research, Hong Kong Research Grants Council (HKU7798/07M), and Outstanding Young Researcher Award (to J.W.P. Yam). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bravou V, 2006, J PATHOL, V208, P91, DOI 10.1002/path.1860; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Chung DH, 1998, VIRCHOWS ARCH, V433, P113, DOI 10.1007/s004280050225; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fukui K, 2006, J CANCER RES CLIN, V132, P627, DOI 10.1007/s00432-006-0107-7; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Haase M, 2008, J HISTOCHEM CYTOCHEM, V56, P819, DOI 10.1369/jhc.2008.951095; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1997, GENOMICS, V42, P177, DOI 10.1006/geno.1997.4719; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Intaraprasong P, 2007, ANTICANCER RES, V27, P4371; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Ko FCF, 2010, LIVER INT, V30, P139, DOI 10.1111/j.1478-3231.2009.02133.x; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peroukides S, 2008, ONCOL REP, V20, P1337, DOI 10.3892/or_00000149; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Roxburgh P, 2008, ADV THER, V25, P1089, DOI 10.1007/s12325-008-0113-z; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Wang DS, 2007, J GASTROEN HEPATOL, V22, P1916, DOI 10.1111/j.1440-1746.2006.04534.x; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Yam JWP, 2006, HEPATOLOGY, V44, P881, DOI 10.1002/hep.21339; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561	35	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16984	10.1371/journal.pone.0016984	http://dx.doi.org/10.1371/journal.pone.0016984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347395	Green Submitted, gold, Green Published			2022-12-25	WOS:000287361700061
J	Torrent, M; Andreu, D; Nogues, VM; Boix, E				Torrent, Marc; Andreu, David; Nogues, Victoria M.; Boix, Ester			Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model	PLOS ONE			English	Article							COMPUTER-AIDED-DESIGN; SELECTIVE CYTOTOXICITY; QSAR DESCRIPTORS; HOST-DEFENSE; MEMBRANES; AGGREGATION; TEMPORINS; MELITTIN; POTENT; PORES	The increasing rate in antibiotic-resistant bacterial strains has become an imperative health issue. Thus, pharmaceutical industries have focussed their efforts to find new potent, non-toxic compounds to treat bacterial infections. Antimicrobial peptides (AMPs) are promising candidates in the fight against antibiotic-resistant pathogens due to their low toxicity, broad range of activity and unspecific mechanism of action. In this context, bioinformatics' strategies can inspire the design of new peptide leads with enhanced activity. Here, we describe an artificial neural network approach, based on the AMP's physicochemical characteristics, that is able not only to identify active peptides but also to assess its antimicrobial potency. The physicochemical properties considered are directly derived from the peptide sequence and comprise a complete set of parameters that accurately describe AMPs. Most interesting, the results obtained dovetail with a model for the AMP's mechanism of action that takes into account new concepts such as peptide aggregation. Moreover, this classification system displays high accuracy and is well correlated with the experimentally reported data. All together, these results suggest that the physicochemical properties of AMPs determine its action. In addition, we conclude that sequence derived parameters are enough to characterize antimicrobial peptides.	[Torrent, Marc; Nogues, Victoria M.; Boix, Ester] Univ Autonoma Barcelona, Biosci Fac, Dept Biochem & Mol Biol, Cerdanyola Del Valles, Spain; [Torrent, Marc; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain	Autonomous University of Barcelona; Pompeu Fabra University	Torrent, M (corresponding author), Univ Autonoma Barcelona, Biosci Fac, Dept Biochem & Mol Biol, Cerdanyola Del Valles, Spain.	marc.torrent@uab.cat	Boix, Ester/B-9038-2012; Nogues, M. Victoria/H-6100-2015; Andreu, David/I-4359-2014; Burgas, Marc Torrent/A-5171-2010	Boix, Ester/0000-0003-1790-2142; Nogues, M. Victoria/0000-0002-7104-0961; Andreu, David/0000-0002-6317-6666; Burgas, Marc Torrent/0000-0001-6567-3474	Alianza Cuatro Universidades (Spain); European Union [HEALTH-F3-2008-223414]; Spanish Ministry of Science and Innovation [BIO2008-04487-CO3-02, BFU2009-09371]; Generalitat de Catalunya [SGR2009-494, SGR2009-795]	Alianza Cuatro Universidades (Spain); European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	M.T. is the recipient of a postdoctoral grant from Alianza Cuatro Universidades (Spain). Work supported by the European Union (HEALTH-F3-2008-223414), the Spanish Ministry of Science and Innovation (BIO2008-04487-CO3-02, BFU2009-09371) and the Generalitat de Catalunya (SGR2009-494, SGR2009-795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Andres E, 2004, J INTERN MED, V255, P519, DOI 10.1046/j.1365-2796.2003.01278.x; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; BROWN LR, 1980, BIOCHIM BIOPHYS ACTA, V622, P231, DOI 10.1016/0005-2795(80)90034-3; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cherkasov A, 2004, MOLECULES, V9, P1034, DOI 10.3390/91201034; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; de Groot NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009383; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Feder R, 2000, J BIOL CHEM, V275, P4230, DOI 10.1074/jbc.275.6.4230; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Frecer V, 2004, ANTIMICROB AGENTS CH, V48, P3349, DOI 10.1128/AAC.48.9.3349-3357.2004; Frecer V, 2006, BIOORGAN MED CHEM, V14, P6065, DOI 10.1016/j.bmc.2006.05.005; Giuliani A, 2008, CELL MOL LIFE SCI, V65, P2450, DOI 10.1007/s00018-008-8188-x; Gorr SU, 2008, PEPTIDES, V29, P2118, DOI 10.1016/j.peptides.2008.09.019; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; He K, 1996, BIOPHYS J, V70, P2659, DOI 10.1016/S0006-3495(96)79835-1; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kustanovich I, 2002, J BIOL CHEM, V277, P16941, DOI 10.1074/jbc.M111071200; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Mangoni ML, 2007, J PEPT SCI, V13, P603, DOI 10.1002/psc.853; NGUYEN LT, 2010, PLOS ONE, V2; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Oyston PCF, 2009, J MED MICROBIOL, V58, P977, DOI 10.1099/jmm.0.011122-0; Poole Keith, 2003, Curr Opin Investig Drugs, V4, P128; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Taboureau O, 2006, CHEM BIOL DRUG DES, V68, P48, DOI 10.1111/j.1747-0285.2006.00405.x; Taboureau O, 2010, METHODS MOL BIOL, V618, P77, DOI 10.1007/978-1-60761-594-1_6; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Torrent M, 2010, FEBS J, V277, P1713, DOI 10.1111/j.1742-4658.2010.07595.x; Torrent M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-373	38	129	134	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16968	10.1371/journal.pone.0016968	http://dx.doi.org/10.1371/journal.pone.0016968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347392	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700059
J	Yang, XL; Wang, Y; Guo, W; Xie, Y; Xie, Q; Fan, LJ; Zhou, XP				Yang, Xiuling; Wang, Yu; Guo, Wei; Xie, Yan; Xie, Qi; Fan, Longjiang; Zhou, Xueping			Characterization of Small Interfering RNAs Derived from the Geminivirus/Betasatellite Complex Using Deep Sequencing	PLOS ONE			English	Article							DICER-LIKE PROTEINS; SIRNA BIOGENESIS; VIRUS; DNA; ARABIDOPSIS; PLANT; PATHWAY; GEMINIVIRUSES; FUNCTIONALITY; ACCUMULATION	Background: Small RNA (sRNA)-guided RNA silencing is a critical antiviral defense mechanism employed by a variety of eukaryotic organisms. Although the induction of RNA silencing by bipartite and monopartite begomoviruses has been described in plants, the nature of begomovirus/betasatellite complexes remains undefined. Methodology/Principal Findings: Solanum lycopersicum plant leaves systemically infected with Tomato yellow leaf curl China virus (TYLCCNV) alone or together with its associated betasatellite (TYLCCNB), and Nicotiana benthamiana plant leaves systemically infected with TYLCCNV alone, or together with TYLCCNB or with mutant TYLCCNB were harvested for RNA extraction; sRNA cDNA libraries were then constructed and submitted to Solexa-based deep sequencing. Both sense and anti-sense TYLCCNV and TYLCCNB-derived sRNAs (V-sRNAs and S-sRNAs) accumulated preferentially as 22 nucleotide species in infected S. lycopersicum and N. benthamiana plants. High resolution mapping of V-sRNAs and S-sRNAs revealed heterogeneous distribution of V-sRNA and S-sRNA sequences across the TYLCCNV and TYLCCNB genomes. In TYLCCNV-infected S. lycopersicum or N. benthamiana and TYLCCNV and beta C1-mutant TYLCCNB co-infected N. benthamiana plants, the primary TYLCCNV targets were AV2 and the 5' terminus of AV1. In TYLCCNV and betasatellite-infected plants, the number of V-sRNAs targeting this region decreased and the production of V-sRNAs increased corresponding to the overlapping regions of AC2 and AC3, as well as the 3' terminal of AC1. beta C1 is the primary determinant mediating symptom induction and also the primary silencing target of the TYLCCNB genome even in its mutated form. Conclusions/Significance: We report the first high-resolution sRNA map for a monopartite begomovirus and its associated betasatellite using Solexa-based deep sequencing. Our results suggest that viral transcript might act as RDR substrates resulting in dsRNA and secondary siRNA production. In addition, the betasatellite affected the amount of V-sRNAs detected in S. lycopersicum and N. benthamiana plants.	[Yang, Xiuling; Guo, Wei; Xie, Yan; Zhou, Xueping] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yu; Fan, Longjiang] Zhejiang Univ, Inst Crop Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Qi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Yang, XL (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zzhou@zju.edu.cn	Guo, Wei/J-9488-2015; Xie, Qi/P-1464-2016	Guo, Wei/0000-0002-6411-6227; Xie, Qi/0000-0002-8262-9093; Yang, Xiuling/0000-0002-7355-5643; Fan, Longjiang/0000-0003-4846-0500; Wang, Yu/0000-0002-2819-4551	National Natural Science Foundation of China [30530520]; National Key Basic Research and Development Program of China [2006CB101903]; National High Technology Research and Development Program of China (863 Program) [2007AA10Z413]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This research was financially supported by the National Natural Science Foundation of China (Grant No. 30530520), the National Key Basic Research and Development Program of China (2006CB101903) and the National High Technology Research and Development Program of China (863 Program) (Grant No. 2007AA10Z413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Aragao FJL, 2009, NAT BIOTECHNOL, V27, P1086, DOI 10.1038/nbt1209-1086; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bisaro DM, 2006, VIROLOGY, V344, P158, DOI 10.1016/j.virol.2005.09.041; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Chellappan P, 2004, J VIROL, V78, P7465, DOI 10.1128/JVI.78.14.7465-7477.2004; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cui XF, 2005, J VIROL, V79, P10764, DOI 10.1128/JVI.79.16.10764-10775.2005; Cui XF, 2004, J VIROL, V78, P13966, DOI 10.1128/JVI.78.24.13966-13974.2004; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; GERMAN M, 2010, MOL PLANT PATHOL, V11, P347; Guo W, 2008, APPL ENVIRON MICROB, V74, P1909, DOI 10.1128/AEM.02461-07; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Hagen C, 2008, PHYTOPATHOLOGY, V98, P1029, DOI 10.1094/PHYTO-98-9-1029; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Jeske H, 2001, EMBO J, V20, P6158, DOI 10.1093/emboj/20.21.6158; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mansoor S, 2006, TRENDS PLANT SCI, V11, P209, DOI 10.1016/j.tplants.2006.03.003; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Muangsan N, 2004, PLANT J, V38, P1004, DOI 10.1111/j.1365-313X.2004.02103.x; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Pilartz M, 2003, J VIROL, V77, P10808, DOI 10.1128/JVI.77.20.10808-10818.2003; PILARTZ M, 1992, VIROLOGY, V189, P800, DOI 10.1016/0042-6822(92)90610-2; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Raja P, 2010, BBA-GENE REGUL MECH, V1799, P337, DOI 10.1016/j.bbagrm.2010.01.004; Ribeiro SG, 2007, J VIROL, V81, P1563, DOI 10.1128/JVI.01238-06; Rodriguez-Negrete EA, 2009, J VIROL, V83, P1332, DOI 10.1128/JVI.01474-08; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Saunders K, 2000, P NATL ACAD SCI USA, V97, P6890, DOI 10.1073/pnas.97.12.6890; Sharma P, 2008, J GEN PLANT PATHOL, V74, P189, DOI 10.1007/s10327-008-0085-5; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vanitharani R, 2005, TRENDS PLANT SCI, V10, P144, DOI 10.1016/j.tplants.2005.01.005; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xie Y, 2002, CHINESE SCI BULL, V47, P197, DOI 10.1360/02tb9047; Xie ZX, 2008, BBA-GENE REGUL MECH, V1779, P720, DOI 10.1016/j.bbagrm.2008.02.009; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	54	61	62	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16928	10.1371/journal.pone.0016928	http://dx.doi.org/10.1371/journal.pone.0016928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347388	Green Published, gold			2022-12-25	WOS:000287361700054
J	Kasaikina, MV; Lobanov, AV; Malinouski, MY; Lee, BC; Seravalli, J; Fomenko, DE; Turanov, AA; Finney, L; Vogt, S; Park, TJ; Miller, RA; Hatfield, DL; Gladyshev, VN				Kasaikina, Marina V.; Lobanov, Alexei V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Seravalli, Javier; Fomenko, Dmitri E.; Turanov, Anton A.; Finney, Lydia; Vogt, Stefan; Park, Thomas J.; Miller, Richard A.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Reduced Utilization of Selenium by Naked Mole Rats Due to a Specific Defect in GPx1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEST-LIVING RODENT; GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; MICE; RESISTANCE; SELENOCYSTEINE; CELLS; SELENOPROTEINS; DETERMINANTS; REQUIREMENT	Naked mole rat (MR) Heterocephalus glaber is a rodent model of delayed aging because of its unusually long life span (> 28 years). It is also not known to develop cancer. In the current work, tissue imaging by x-ray fluorescence microscopy and direct analyses of trace elements revealed low levels of selenium in the MR liver and kidney, whereas MR and mouse brains had similar selenium levels. This effect was not explained by uniform selenium deficiency because methionine sulfoxide reductase activities were similar in mice and MR. However, glutathione peroxidase activity was an order of magnitude lower in MR liver and kidney than in mouse tissues. In addition, metabolic labeling of MR cells with Se-75 revealed a loss of the abundant glutathione peroxidase 1 (GPx1) band, whereas other selenoproteins were preserved. To characterize the MR selenoproteome, we sequenced its liver transcriptome. Gene reconstruction revealed standard selenoprotein sequences except for GPx1, which had an early stop codon, and SelP, which had low selenocysteine content. When expressed in HEK 293 cells, MR GPx1 was present in low levels, and its expression could be rescued neither by removing the early stop codon nor by replacing its SECIS element. In addition, GPx1 mRNA was present in lower levels in MR liver than in mouse liver. To determine if GPx1 deficiency could account for the reduced selenium content, we analyzed GPx1 knock-out mice and found reduced selenium levels in their livers and kidneys. Thus, MR is characterized by the reduced utilization of selenium due to a specific defect in GPx1 expression.	[Kasaikina, Marina V.; Lobanov, Alexei V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Turanov, Anton A.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Kasaikina, Marina V.; Lobanov, Alexei V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Turanov, Anton A.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kasaikina, Marina V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Seravalli, Javier; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Kasaikina, Marina V.; Malinouski, Mikalai Y.; Lee, Byung Cheon; Seravalli, Javier; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Finney, Lydia] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Vogt, Stefan] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Miller, Richard A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, New Res Bldg,Rm 435,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Vogt, Stefan/B-9547-2009; Gladyshev, Vadim N/A-9894-2013; Vogt, Stefan/J-7937-2013; Gladyshev, Vadim N/J-6187-2013	Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513; Lee, Byung Cheon/0000-0003-1467-1940; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [GM061603, CA080946, AG021518]; Center for Cancer Research, NCI, National Institutes of Health; Department of Energy Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA080946, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518, U19AG023122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061603, CA080946, and AG021518 (to V. N. G.) and the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to D. L. H.). This work was also supported by the Department of Energy Office of Science under Contract DE-AC02-06CH11357.	Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Beck MA, 1998, FASEB J, V12, P1143, DOI 10.1096/fasebj.12.12.1143; BEHNE D, 1983, J NUTR, V113, P456, DOI 10.1093/jn/113.2.456; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; Donovan J, 2010, ANTIOXID REDOX SIGN, V12, P881, DOI 10.1089/ars.2009.2878; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; ESWORTHY RS, 1995, CANCER RES, V55, P957; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Fu YX, 1999, FREE RADICAL BIO MED, V27, P605, DOI 10.1016/S0891-5849(99)00104-5; Gladyshev VN, 1998, BIOCHEM BIOPH RES CO, V251, P488, DOI 10.1006/bbrc.1998.9495; Gorbunova V, 2008, AGE, V30, P111, DOI 10.1007/s11357-008-9053-4; Ichimura Y, 2004, J UROLOGY, V172, P728, DOI 10.1097/01.ju.0000130942.40597.9d; Jensen C, 2008, J ANIM PHYSIOL AN N, V92, P481, DOI 10.1111/j.1439-0396.2007.00738.x; Kehr S, 2009, J MOL BIOL, V389, P808, DOI 10.1016/j.jmb.2009.04.024; Kramer B, 2004, GEN COMP ENDOCR, V139, P206, DOI 10.1016/j.ygcen.2004.09.006; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lei XG, 2002, METHOD ENZYMOL, V347, P213; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Lei XG, 2005, J NUTR, V135, P2295, DOI 10.1093/jn/135.10.2295; Lei XG, 2011, ANTIOXID REDOX SIGN, V14, P489, DOI 10.1089/ars.2010.3416; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Lubos E., 2010, ANTIOXID RE IN PRESS; McMullen CA, 2010, ANAT REC, V293, P918, DOI 10.1002/ar.21107; MILLS GC, 1957, J BIOL CHEM, V229, P189; MOSCOW JA, 1994, CARCINOGENESIS, V15, P2769, DOI 10.1093/carcin/15.12.2769; Mueller AS, 2009, J ANIM PHYSIOL AN N, V93, P313, DOI 10.1111/j.1439-0396.2008.00849.x; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Sunde RA, 1997, BIOMED ENVIRON SCI, V10, P346; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Twining BS, 2003, ANAL CHEM, V75, P3806, DOI 10.1021/ac034227z; Wang XD, 2011, ANTIOXID REDOX SIGN, V14, P391, DOI 10.1089/ars.2010.3302; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533; Woodley R, 2002, COMP BIOCHEM PHYS A, V133, P827, DOI 10.1016/S1095-6433(02)00199-X	47	24	24	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17005	17014		10.1074/jbc.M110.216267	http://dx.doi.org/10.1074/jbc.M110.216267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21372135	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000290301900051
J	Nishi, K; Ono, T; Nakamura, T; Fukunaga, N; Izumi, M; Watanabe, H; Suenaga, A; Maruyama, T; Yamagata, Y; Curry, S; Otagiri, M				Nishi, Koji; Ono, Tomomi; Nakamura, Teruya; Fukunaga, Naoko; Izumi, Miyoko; Watanabe, Hiroshi; Suenaga, Ayaka; Maruyama, Toru; Yamagata, Yuriko; Curry, Stephen; Otagiri, Masaki			Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human alpha(1)-Acid Glycoprotein Genetic Variants, the A and F1*S Forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-ACID GLYCOPROTEIN; HIGH-AFFINITY BINDING; MOLECULAR-GRAPHICS; CARBOHYDRATE UNITS; SITE; PROTEIN; SYSTEM; UCN-01; MOIETIES; ACID	Human alpha(1)-acid glycoprotein (hAGP) in serum functions as a carrier of basic drugs. In most individuals, hAGP exists as a mixture of two genetic variants, the F1*S and A variants, which bind drugs with different selectivities. We prepared a mutant of the A variant, C149R, and showed that its drug-binding properties were indistinguishable from those of the wild type. In this study, we determined the crystal structures of this mutant hAGP alone and complexed with disopyramide (DSP), amitriptyline (AMT), and the nonspecific drug chlorpromazine (CPZ). The crystal structures revealed that the drug-binding pocket on the A variant is located within an eight-stranded beta-barrel, similar to that found in the F1*S variant and other lipocalin family proteins. However, the binding region of the A variant is narrower than that of the F1*S variant. In the crystal structures of complexes with DSP and AMT, the two aromatic rings of each drug interact with Phe-49 and Phe-112 at the bottom of the binding pocket. Although the structure of CPZ is similar to those of DSP and AMT, its fused aromatic ring system, which is extended in length by the addition of a chlorine atom, appears to dictate an alternative mode of binding, which explains its nonselective binding to the F1*S and A variant hAGPs. Modeling experiments based on the co-crystal structures suggest that, in complexes of DSP, AMT, or CPZ with the F1*S variant, Phe-114 sterically hinders interactions with DSP and AMT, but not CPZ.	[Nishi, Koji; Ono, Tomomi; Fukunaga, Naoko; Izumi, Miyoko; Watanabe, Hiroshi; Suenaga, Ayaka; Maruyama, Toru; Otagiri, Masaki] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Nakamura, Teruya; Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kumamoto 8620973, Japan; [Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Nishi, Koji] Keio Univ, Sch Med, Dept Clin Pharmacokinet & Pharmacodynam, Tokyo 1608582, Japan; [Curry, Stephen] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Shinjuku Ku, London SW7 2AZ, England; [Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600822, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Keio University; Imperial College London; Sojo University	Otagiri, M (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	otagirim@ph.sojo-u.ac.jp		Curry, Stephen/0000-0002-0552-8870; Nakamura, Teruya/0000-0003-2013-3057	Japan Society for the Promotion of Science [21390161]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research KAKENHI 21390161 from the Japan Society for the Promotion of Science.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budai L, 2009, ANAL BIOANAL CHEM, V393, P991, DOI 10.1007/s00216-008-2518-6; Chuang VTG, 2005, BBA-GEN SUBJECTS, V1725, P385, DOI 10.1016/j.bbagen.2005.05.021; Delano WL., 2002, PYMOL MOL GRAPHICS S; Eap C B, 1989, Prog Clin Biol Res, V300, P111; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1997, JOINT CCP4 ESF EACMB; FRIEDMAN ML, 1986, BIOCHEM J, V236, P149, DOI 10.1042/bj2360149; Fuse E, 1998, CANCER RES, V58, P3248; Gambacorti-Passerini C, 2003, CLIN CANCER RES, V9, P625; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Holladay JW, 2001, DRUG METAB DISPOS, V29, P299; IMAMURA H, 1993, BIOL PHARM BULL, V16, P926; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Katsuki M, 2005, J BIOL CHEM, V280, P1384, DOI 10.1074/jbc.M411076200; Katsuki M, 2004, PHARM RES-DORDR, V21, P1648, DOI 10.1023/B:PHAM.0000041461.93787.6b; Kishino S, 2001, EUR J CLIN PHARMACOL, V57, P583, DOI 10.1007/s002280100354; Kopecky V, 2003, BIOCHEM BIOPH RES CO, V300, P41, DOI 10.1016/S0006-291X(02)02765-1; KREMER JMH, 1988, PHARMACOL REV, V40, P1; KUTE T, 1976, BIOCHIM BIOPHYS ACTA, V420, P195, DOI 10.1016/0005-2795(76)90358-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; MARUYAMA T, 1990, CHEM PHARM BULL, V38, P1688; Nishi K, 2010, DRUG METAB PHARMACOK, V25, P200, DOI 10.2133/dmpk.25.200; Nishi K, 2009, J PHARM SCI-US, V98, P4316, DOI 10.1002/jps.21697; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; SCHMID K, 1978, FED PROC, V37, P1298; SCHMID K, 1977, BIOCHIM BIOPHYS ACTA, V492, P291, DOI 10.1016/0005-2795(77)90080-0; Schonfeld DL, 2008, J MOL BIOL, V384, P393, DOI 10.1016/j.jmb.2008.09.020; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; YOSHIMA H, 1981, J BIOL CHEM, V256, P8476; YUASA I, 1993, VOX SANG, V64, P47, DOI 10.1111/j.1423-0410.1993.tb02514.x	34	64	65	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14427	14434		10.1074/jbc.M110.208926	http://dx.doi.org/10.1074/jbc.M110.208926			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349832	hybrid, Green Published			2022-12-25	WOS:000289556200064
J	Hedlund, M; Nagaeva, O; Kargl, D; Baranov, V; Mincheva-Nilsson, L				Hedlund, Malin; Nagaeva, Olga; Kargl, Dominic; Baranov, Vladimir; Mincheva-Nilsson, Lucia			Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; MHC CLASS-I; PROSTATE-CANCER; DOWN-REGULATION; NK CELLS; EXPRESSION; LEUKEMIA; RECEPTOR; IMMUNORECEPTOR; CYTOTOXICITY	Immune evasion from NK surveillance related to inadequate NK-cell function has been suggested as an explanation of the high incidence of relapse and fatal outcome of many blood malignancies. In this report we have used Jurkat and Raji cell lines as a model for studies of the NKG2D receptor-ligand system in T-and B cell leukemia/lymphoma. Using real-time quantitative RT-PCR and immunoflow cytometry we show that Jurkat and Raji cells constitutively express mRNA and protein for the stress-inducible NKG2D ligands MICA/B and ULBP1 and 2, and up-regulate the expression in a cell-line specific and stress-specific manner. Furthermore, we revealed by electron microscopy, immunoflow cytometry and western blot that these ligands were expressed and secreted on exosomes, nanometer-sized microvesicles of endosomal origin. Acting as a decoy, the NKG2D ligand-bearing exosomes downregulate the in vitro NKG2D receptor-mediated cytotoxicity and thus impair NK-cell function. Interestingly, thermal and oxidative stress enhanced the exosome secretion generating more soluble NKG2D ligands that aggravated the impairment of the cytotoxic response. Taken together, our results might partly explain the clinically observed NK-cell dysfunction in patients suffering from leukemia/lymphoma. The adverse effect of thermal and oxidative stress, enhancing the release of immunosuppressive exosomes, should be considered when cytostatic and hyperthermal anti-cancer therapies are designed.	[Hedlund, Malin; Nagaeva, Olga; Kargl, Dominic; Baranov, Vladimir; Mincheva-Nilsson, Lucia] Umea Univ, Dept Clin Microbiol, Div Clin Immunol, Umea, Sweden	Umea University	Hedlund, M (corresponding author), Umea Univ, Dept Clin Microbiol, Div Clin Immunol, Umea, Sweden.	lucia.mincheva-nilsson@climi.umu.se		Kargl, Dominic/0000-0001-7206-1708	Swedish National Cancer Research Foundation Cancerfonden [CAN 2010/495]; research foundations Cancerforskningsfonden I Norrland [AMP 08-587]; Centrala ALF medel and Spjutspetsanslag, Vasterbottens Lans Landsting and Insamlingsstiftelsen at the Medical Faculty, Umea University	Swedish National Cancer Research Foundation Cancerfonden; research foundations Cancerforskningsfonden I Norrland; Centrala ALF medel and Spjutspetsanslag, Vasterbottens Lans Landsting and Insamlingsstiftelsen at the Medical Faculty, Umea University	This work was supported by the Swedish National Cancer Research Foundation Cancerfonden (CAN 2010/495), and the research foundations Cancerforskningsfonden I Norrland (AMP 08-587), Centrala ALF medel and Spjutspetsanslag, Vasterbottens Lans Landsting and Insamlingsstiftelsen at the Medical Faculty, Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Clayton A, 2009, CURR ONCOL, V16, P187; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Coudert JD, 2006, SEMIN CANCER BIOL, V16, P333, DOI 10.1016/j.semcancer.2006.07.008; Fernandez-Messina L, 2010, J BIOL CHEM, V285, P8543, DOI 10.1074/jbc.M109.045906; GONZALES C, 2006, CURR TOP MICROBIOL I, V298, P121; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayashi T, 2006, CANCER RES, V66, P563, DOI 10.1158/0008-5472.CAN-05-2776; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Koga T, 2005, BIOCHEM BIOPH RES CO, V337, P1319, DOI 10.1016/j.bbrc.2005.09.184; Lanca T, 2010, BLOOD, V115, P2407, DOI 10.1182/blood-2009-08-237123; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Wodnar-Filipowicz A, 2006, SWISS MED WKLY, V136, P359; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438	36	237	244	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16899	10.1371/journal.pone.0016899	http://dx.doi.org/10.1371/journal.pone.0016899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364924	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100014
J	Cao, Y; Staropoli, JF; Biswas, S; Espinola, JA; MacDonald, ME; Lee, JM; Cotman, SL				Cao, Yi; Staropoli, John F.; Biswas, Sunita; Espinola, Janice A.; MacDonald, Marcy E.; Lee, Jong-Min; Cotman, Susan L.			Distinct Early Molecular Responses to Mutations Causing vLINCL and JNCL Presage ATP Synthase Subunit C Accumulation in Cerebellar Cells	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; LINK BATTEN-DISEASE; LYSOSOMAL STORAGE; CLN3 PROTEIN; EXPRESSION; PATHWAYS; DEATH; MICE; NCLF	Variant late-infantile neuronal ceroid lipofuscinosis (vLINCL), caused by CLN6 mutation, and juvenile neuronal ceroid lipofuscinosis (JNCL), caused by CLN3 mutation, share clinical and pathological features, including lysosomal accumulation of mitochondrial ATP synthase subunit c, but the unrelated CLN6 and CLN3 genes may initiate disease via similar or distinct cellular processes. To gain insight into the NCL pathways, we established murine wild-type and CbCln6(nclf/nclf) cerebellar cells and compared them to wild-type and CbCln3(Delta ex7/8/Delta ex7/8) cerebellar cells. CbCln6(nclf/nclf) cells and CbCln3(Delta ex7/8/Delta ex7/8) cells both displayed abnormally elongated mitochondria and reduced cellular ATP levels and, as cells aged to confluence, exhibited accumulation of subunit c protein in Lamp 1-positive organelles. However, at sub-confluence, endoplasmic reticulum PDI immunostain was decreased only in CbCln6(nclf/nclf) cells, while fluid-phase endocytosis and LysoTracker (R) labeled vesicles were decreased in both CbCln6(nclf/nclf) and CbCln3(Delta ex7/8/Delta ex7/8) cells, though only the latter cells exhibited abnormal vesicle subcellular distribution. Furthermore, unbiased gene expression analyses revealed only partial overlap in the cerebellar cell genes and pathways that were altered by the Cln3(Delta ex7/8) and Cln6(nclf) mutations. Thus, these data support the hypothesis that CLN6 and CLN3 mutations trigger distinct processes that converge on a shared pathway, which is responsible for proper subunit c protein turnover and neuronal cell survival.	[Cao, Yi; Staropoli, John F.; Biswas, Sunita; Espinola, Janice A.; MacDonald, Marcy E.; Lee, Jong-Min; Cotman, Susan L.] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Cao, Y (corresponding author), Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA.	cotman@helix.mgh.harvard.edu			Batten Disease Support and Research Association; National Institute of Neurological Disorders and Stroke, National Institutes of Health [NS33648]; National Tay-Sachs and Allied Diseases Association; Massachusetts Alzheimer's Disease Research Center; Harvard NeuroDiscovery Center; Dubai-Harvard Foundation for Medical Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033648] Funding Source: NIH RePORTER	Batten Disease Support and Research Association; National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Tay-Sachs and Allied Diseases Association; Massachusetts Alzheimer's Disease Research Center; Harvard NeuroDiscovery Center; Dubai-Harvard Foundation for Medical Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Batten Disease Support and Research Association (www.bdsra.org; Postdoctoral Fellowships to Y.C. and S.B., Grant to S.L.C.), by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (www.ninds.nih.gov; NS33648, to M.E.M.), the National Tay-Sachs and Allied Diseases Association (www.ntsad.org; to S.L.C.), the Massachusetts Alzheimer's Disease Research Center and Harvard NeuroDiscovery Center Pilot Study Grants Program (madrc.mgh.harvard.edu; to S.L.C.) and the Dubai-Harvard Foundation for Medical Research (www.dhfmr.hms.harvard.edu; to S.L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Blaveri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012596; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; Crabtree JS, 2009, CANCER RES, V69, P6171, DOI 10.1158/0008-5472.CAN-08-4471; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Getty AL, 2011, EXP CELL RES, V317, P51, DOI 10.1016/j.yexcr.2010.09.007; HALL NA, 1987, CLIN CHIM ACTA, V170, P323, DOI 10.1016/0009-8981(87)90143-4; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; KOMINAMI E, 1992, J BIOCHEM, V111, P278, DOI 10.1093/oxfordjournals.jbchem.a123749; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Kurze AK, 2010, HUM MUTAT, V31, pE1163, DOI 10.1002/humu.21184; Kyttala A, 2006, BBA-MOL BASIS DIS, V1762, P920, DOI 10.1016/j.bbadis.2006.05.007; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Lyly A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-83; MARTIN JJ, 1991, DEV NEUROSCI-BASEL, V13, P331, DOI 10.1159/000112182; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narayan SB, 2006, ANN NEUROL, V60, P570, DOI 10.1002/ana.20975; Nijssen PCG, 2003, BRAIN PATHOL, V13, P574; PALMER DN, 1989, ADV EXP MED BIOL, V266, P211; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Pearce DA, 1999, NAT GENET, V22, P55, DOI 10.1038/8861; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Persaud-Sawin DA, 2005, APOPTOSIS, V10, P973, DOI 10.1007/s10495-005-0733-6; Persaud-Sawin DANW, 2002, HUM MOL GENET, V11, P2129, DOI 10.1093/hmg/11.18.2129; Persaud-Sawin DA, 2007, PEDIATR RES, V61, P146, DOI 10.1203/pdr.0b013e31802d8a4a; Puranam KL, 1999, MOL GENET METAB, V66, P294, DOI 10.1006/mgme.1999.2834; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; Siintola E, 2006, BBA-MOL BASIS DIS, V1762, P857, DOI 10.1016/j.bbadis.2006.05.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Vella F, 2002, IUBMB LIFE, V54, P89, DOI 10.1080/15216540214307; Vesa J, 2002, MOL BIOL CELL, V13, P2410, DOI 10.1091/mbc.E02-01-0031; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Williams RE, 2006, BBA-MOL BASIS DIS, V1762, P865, DOI 10.1016/j.bbadis.2006.07.001; Wisniewski K E, 1988, Am J Med Genet Suppl, V5, P27	57	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17118	10.1371/journal.pone.0017118	http://dx.doi.org/10.1371/journal.pone.0017118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359198	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300030
J	Dumanis, SB; Cha, HJ; Song, JM; Trotter, JH; Spitzer, M; Lee, JY; Weeber, EJ; Turner, RS; Pak, DTS; Rebeck, GW; Hoe, HS				Dumanis, Sonya B.; Cha, Hyun-Jung; Song, Jung Min; Trotter, Justin H.; Spitzer, Matthew; Lee, Ji-Yun; Weeber, Edwin J.; Turner, R. Scott; Pak, Daniel T. S.; Rebeck, G. William; Hoe, Hyang-Sook			ApoE Receptor 2 Regulates Synapse and Dendritic Spine Formation	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; AMPA RECEPTORS; LIPOPROTEIN RECEPTORS; NEURONAL MIGRATION; NEURITE OUTGROWTH; PYRAMIDAL NEURONS; F-SPONDIN; PLASTICITY; REELIN; EXPRESSION	Background: Apolipoprotein E receptor 2 (ApoEr2) is a postsynaptic protein involved in long-term potentiation (LTP), learning, and memory through unknown mechanisms. We examined the biological effects of ApoEr2 on synapse and dendritic spine formation-processes critical for learning and memory. Methodology/Principal Findings: In a heterologous co-culture synapse assay, overexpression of ApoEr2 in COS7 cells significantly increased colocalization with synaptophysin in primary hippocampal neurons, suggesting that ApoEr2 promotes interaction with presynaptic structures. In primary neuronal cultures, overexpression of ApoEr2 increased dendritic spine density. Consistent with our in vitro findings, ApoEr2 knockout mice had decreased dendritic spine density in cortical layers II/III at 1 month of age. We also tested whether the interaction between ApoEr2 and its cytoplasmic adaptor proteins, specifically X11 alpha and PSD-95, affected synapse and dendritic spine formation. X11 alpha decreased cell surface levels of ApoEr2 along with synapse and dendritic spine density. In contrast, PSD-95 increased cell surface levels of ApoEr2 as well as synapse and dendritic spine density. Conclusions/Significance: These results suggest that ApoEr2 plays important roles in structure and function of CNS synapses and dendritic spines, and that these roles are modulated by cytoplasmic adaptor proteins X11 alpha and PSD-95.	[Dumanis, Sonya B.; Cha, Hyun-Jung; Song, Jung Min; Spitzer, Matthew; Rebeck, G. William; Hoe, Hyang-Sook] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Lee, Ji-Yun; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA; [Cha, Hyun-Jung; Song, Jung Min; Spitzer, Matthew; Turner, R. Scott; Hoe, Hyang-Sook] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Trotter, Justin H.; Weeber, Edwin J.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL USA	Georgetown University; Georgetown University; Georgetown University; State University System of Florida; University of South Florida	Dumanis, SB (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	hh69@georgetown.edu	Rebeck, George William/J-2192-2012; Lee, Ji-Yun/F-8127-2013; Trotter, Justin H/I-6458-2012; Weeber, Edwin J/A-5396-2012; Turner, Raymond Scott/G-2263-2011	Rebeck, George William/0000-0001-6276-248X; Turner, Raymond Scott/0000-0001-7534-2935; Lee, Ji-Yun/0000-0002-4053-6577; Spitzer, Matthew/0000-0002-5291-3819; Dumanis, Sonya/0000-0002-3345-9497	National Institutes of Health (NIH) [AG032330 (HSH), AG032330-02S1(HSH), AG034253(HSH), P01 AG030128 (GWR), NS048085 (DTSP), AG026478 (RST)]; National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG034253, R03AG032330, P01AG030128, R01AG026478] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by grants from the National Institutes of Health (NIH) AG032330 (HSH), AG032330-02S1(HSH), AG034253(HSH), P01 AG030128 (GWR), NS048085 (DTSP), and AG026478 (RST), and from the National Science Foundation Graduate Research Fellowship (SBD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2006, INT J DEV NEUROSCI, V24, P133, DOI 10.1016/j.ijdevneu.2005.11.008; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Clatworthy AE, 1999, NEUROSCIENCE, V90, P903, DOI 10.1016/S0306-4522(98)00489-8; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; HOE HS, 2009, J BIOL CHEM; HOE HS, 2008, MOL NEUROBIOL; Hoe HS, 2007, J NEUROSCI, V27, P10895, DOI 10.1523/JNEUROSCI.3135-07.2007; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Minami SS, 2010, FASEB J, V24, P58, DOI 10.1096/fj.09-138123; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Okamoto M, 2000, EUR J NEUROSCI, V12, P3067, DOI 10.1046/j.1460-9568.2000.00200.x; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	45	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17203	10.1371/journal.pone.0017203	http://dx.doi.org/10.1371/journal.pone.0017203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347244	Green Submitted, Green Published, gold			2022-12-25	WOS:000287369200029
J	Krissak, R; Mistretta, CA; Henzler, T; Chatzikonstantinou, A; Scharf, J; Schoenberg, SO; Fink, C				Krissak, Radko; Mistretta, Charles A.; Henzler, Thomas; Chatzikonstantinou, Anastasios; Scharf, Johann; Schoenberg, Stefan O.; Fink, Christian			Noise Reduction and Image Quality Improvement of Low Dose and Ultra Low Dose Brain Perfusion CT by HYPR-LR Processing	PLOS ONE			English	Article							DUAL-SOURCE CT; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; ACUTE STROKE; RECONSTRUCTION; ANGIOGRAPHY; PERFORMANCE	Purpose: To evaluate image quality and signal characteristics of brain perfusion CT (BPCT) obtained by low-dose (LD) and ultra-low-dose (ULD) protocols with and without post-processing by highly constrained back-projection (HYPR)-local reconstruction (LR) technique. Methods and Materials: Simultaneous BPCTs were acquired in 8 patients on a dual-source-CT by applying LD (80 kV, 200 mAs, 14 x 1.2 mm) on tube A and ULD (80 kV, 30 mAs, 14 x 1.2 mm) on tube B. Image data from both tubes was reconstructed with identical parameters and post-processed using the HYPR-LR. Correlation coefficients between mean and maximum (MAX) attenuation values within corresponding ROIs, area under attenuation curve (AUC), and signal to noise ratio (SNR) of brain parenchyma were assessed. Subjective image quality was assessed on a 5-point scale by two blinded observers (1:excellent, 5: non-diagnostic). Results: Radiation dose of ULD was more than six times lower compared to LD. SNR was improved by HYPR: ULD vs. ULD+HYPR: 1.9 +/- 0.3 vs. 8.4 +/- 1.7, LD vs. LD+HYPR: 5.0 +/- 0.7 vs. 13.4 +/- 2.4 (both p<0.0001). There was a good correlation between the original datasets and the HYPR-LR post-processed datasets: r = 0.848 for ULD and ULD+HYPR and r = 0.933 for LD and LD+HYPR (p < 0.0001 for both). The mean values of the HYPR-LR post-processed ULD dataset correlated better with the standard LD dataset (r = 0.672) than unprocessed ULD (r = 0.542), but both correlations were significant (p < 0.0001). There was no significant difference in AUC or MAX. Image quality was rated excellent (1.3) in LD+HYPR and non-diagnostic (5.0) in ULD. LD and ULD+HYPR images had moderate image quality (3.3 and 2.7). Conclusion: SNR and image quality of ULD-BPCT can be improved to a level similar to LD-BPCT when using HYPR-LR without distorting attenuation measurements. This can be used to substantially reduce radiation dose. Alternatively, LD images can be improved by HYPR-LR to higher diagnostic quality.	[Krissak, Radko; Henzler, Thomas; Schoenberg, Stefan O.; Fink, Christian] Univ Heidelberg, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Heidelberg, Germany; [Mistretta, Charles A.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Chatzikonstantinou, Anastasios] Univ Heidelberg, Med Fac Mannheim, Univ Med Ctr Mannheim, Dept Neurol, Heidelberg, Germany; [Scharf, Johann] Univ Heidelberg, Dept Neuroradiol, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Wisconsin System; University of Wisconsin Madison; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Krissak, R (corresponding author), Univ Heidelberg, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Heidelberg, Germany.	radko.krissak@umm.de			Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz) [StSch 4543]	Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz)	Funding: This work was supported in part (R.K., S.O.S., C.F.) by a research grant from the Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz; StSch 4543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barfett JJ, 2010, INVEST RADIOL, V45, P370, DOI 10.1097/RLI.0b013e3181e1939d; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cohnen M, 2006, AM J NEURORADIOL, V27, P1741; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Imanishi Y, 2005, EUR RADIOL, V15, P41, DOI 10.1007/s00330-004-2459-1; Johnson KM, 2008, MAGN RESON MED, V59, P456, DOI 10.1002/mrm.21505; Koenig M, 1998, RADIOLOGY, V209, P85, DOI 10.1148/radiology.209.1.9769817; Konig M, 2003, EUR J RADIOL, V45, pS11, DOI 10.1016/S0720-048X(02)00359-5; Liu X, 2009, RADIOLOGY, V253, P98, DOI [10.1148/radiol.2531081677, 10.1148/radiol.2531081677/-/DC1]; McCollough CH, 2008, MED PHYS, V35, P764, DOI 10.1118/1.2826559; McCollough CH, 2007, RADIOLOGY, V243, P775, DOI 10.1148/radiol.2433061165; Mistretta CA, 2006, MAGN RESON MED, V55, P30, DOI 10.1002/mrm.20772; Morhard D, 2010, INVEST RADIOL, V45, P363, DOI 10.1097/RLI.0b013e3181e1956f; Nabavi DG, 1999, RADIOLOGY, V213, P141, DOI 10.1148/radiology.213.1.r99oc03141; Supanich M, 2009, PHYS MED BIOL, V54, P4575, DOI 10.1088/0031-9155/54/14/013; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Youn SW, 2008, AM J ROENTGENOL, V191, pW120, DOI 10.2214/AJR.07.2519	20	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17098	10.1371/journal.pone.0017098	http://dx.doi.org/10.1371/journal.pone.0017098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347259	Green Published, gold, Green Submitted			2022-12-25	WOS:000287364500027
J	Baine, MJ; Chakraborty, S; Smith, LM; Mallya, K; Sasson, AR; Brand, RE; Batra, SK				Baine, Michael J.; Chakraborty, Subhankar; Smith, Lynette M.; Mallya, Kavita; Sasson, Aaron R.; Brand, Randall E.; Batra, Surinder K.			Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic Utility	PLOS ONE			English	Article							EXPRESSION PROFILES; MOLECULAR MARKERS; SUPPRESSOR-CELLS; BREAST-CANCER; CARCINOMA; BIOMARKERS; CA19-9; MOUSE	Background: It is well known that many malignancies, including pancreatic cancer (PC), possess the ability to evade the immune system by indirectly downregulating the mononuclear cell machinery necessary to launch an effective immune response. This knowledge, in conjunction with the fact that the trancriptome of peripheral blood mononuclear cells has been shown to be altered in the context of many diseases, including renal cell carcinoma, lead us to study if any such alteration in gene expression exists in PC as it may have diagnostic utility. Methods and Findings: PBMC samples from 26 PC patients and 33 matched healthy controls were analyzed by whole genome cDNA microarray. Three hundred eighty-three genes were found to be significantly different between PC and healthy controls, with 65 having at least a 1.5 fold change in expression. Pathway analysis revealed that many of these genes fell into pathways responsible for hematopoietic differentiation, cytokine signaling, and natural killer (NK) cell and CD8+ T-cell cytotoxic response. Unsupervised hierarchical clustering analysis identified an eight-gene predictor set, consisting of SSBP2, Ube2b-rs1, CA5B, F5, TBC1D8, ANXA3, ARG1, and ADAMTS20, that could distinguish PC patients from healthy controls with an accuracy of 79% in a blinded subset of samples from treatment naive patients, giving a sensitivity of 83% and a specificity of 75%. Conclusions: In summary, we report the first in-depth comparison of global gene expression profiles of PBMCs between PC patients and healthy controls. We have also identified a gene predictor set that can potentially be developed further for use in diagnostic algorithms in PC. Future directions of this research should include analysis of PBMC expression profiles in patients with chronic pancreatitis as well as increasing the number of early-stage patients to assess the utility of PBMCs in the early diagnosis of PC.	[Baine, Michael J.; Batra, Surinder K.] Univ Nebraska Med Ctr Omaha, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Chakraborty, Subhankar; Mallya, Kavita; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Smith, Lynette M.] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Sasson, Aaron R.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA; [Brand, Randall E.] Univ Pittsburgh, Sch Med, Div Gastroenterol, Pittsburgh, PA USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Baine, MJ (corresponding author), Univ Nebraska Med Ctr Omaha, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	sbatra@unmc.edu			National Institutes of Health [RO1 CA131944, RO1 CA78590, RO1 CA 133774, EDRN UO1 CA 111294, SPORE P50 CA127297]; National Center for Research Resources, NIH [P20 RR016469]; NATIONAL CANCER INSTITUTE [U01CA111294, R01CA131944, P50CA127297, R01CA133774, R01CA078590] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (RO1 CA131944, RO1 CA78590, RO1 CA 133774, EDRN UO1 CA 111294, and SPORE P50 CA127297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The UNMC Microarray Core Facility receives partial support from the INBRE Program of the National Center for Research Resources, NIH grant number P20 RR016469.	American Cancer Society, 2022, CANC FACTS FIGURES 2; [Anonymous], 1999, ANTICANCER RES, V19, P2811; Bluth M, 2008, ARCH SURG-CHICAGO, V143, P227, DOI 10.1001/archsurg.2007.73; Brandt R, 2004, PANCREATOLOGY, V4, P587, DOI 10.1159/000082241; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; CHAKRABORTY S, 2010, BIOCHIM BIOPHYS ACTA, V1815, P44; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; DiMagno EP, 1999, GASTROENTEROLOGY, V117, P1464, DOI 10.1016/S0016-5085(99)70298-2; Edwards CJ, 2007, MOL MED, V13, P40, DOI 10.2119/2006-000056.Edwards; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Goggins M, 2005, J CLIN ONCOL, V23, P4524, DOI 10.1200/JCO.2005.19.711; Hansen CN, 2009, APMIS, V117, P53, DOI 10.1111/j.1600-0463.2008.00015.x; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Huang H, 2010, AM J GASTROENTEROL, V105, P1661, DOI 10.1038/ajg.2010.32; Liang JJ, 2009, INT J CLIN EXP PATHO, V2, P1; Mikuriya K, 2007, INT J ONCOL, V30, P849; *NAT CANC I, 1975, SURV EP END RES CANC; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; PLESKOW DK, 1989, ANN INTERN MED, V110, P704, DOI 10.7326/0003-4819-110-9-704; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Simon R, 2007, CANCER INFORM, V3, P11; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; Sun CJ, 2009, J PERINAT MED, V37, P609, DOI 10.1515/JPM.2009.103; Talmadge JE, 2007, CLIN CANCER RES, V13, P5243, DOI 10.1158/1078-0432.CCR-07-0182; Torres MP, 2010, MOL CANCER THER, V9, P1419, DOI 10.1158/1535-7163.MCT-10-0075; Twine NC, 2003, CANCER RES, V63, P6069; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zhao F, 2009, IMMUNOLOGY, V128, P141, DOI 10.1111/j.1365-2567.2009.03105.x	32	85	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17014	10.1371/journal.pone.0017014	http://dx.doi.org/10.1371/journal.pone.0017014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347333	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000287363000031
J	Haapkyla, J; Unsworth, RKF; Flavell, M; Bourne, DG; Schaffelke, B; Willis, BL				Haapkylae, Jessica; Unsworth, Richard K. F.; Flavell, Mike; Bourne, David G.; Schaffelke, Britta; Willis, Bette L.			Seasonal Rainfall and Runoff Promote Coral Disease on an Inshore Reef	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BLACK BAND DISEASE; SPATIAL VARIABILITY; NUTRIENT ENRICHMENT; ORGANIC-CARBON; TERRESTRIAL; ECOLOGY; SEDIMENTS; RATES; TEMPERATURE	Background: Declining water quality coupled with the effects of climate change are rapidly increasing coral diseases on reefs worldwide, although links between coral diseases and environmental parameters remain poorly understood. This is the first study to document a correlation between coral disease and water quality on an inshore reef. Methodology/Principal Findings: The temporal dynamics of the coral disease atramentous necrosis (AN) was investigated over two years within inshore populations of Montipora aequituberculata in the central Great Barrier Reef, in relation to rainfall, salinity, temperature, water column chlorophyll a, suspended solids, sedimentation, dissolved organic carbon, and particulate nitrogen, phosphorus and organic carbon. Overall, mean AN prevalence was 10-fold greater during summer wet seasons than winter dry seasons. A 2.5-fold greater mean disease abundance was detected during the summer of 2009 (44 +/- SE 6.7 diseased colonies per 25 m(2)), when rainfall was 1.6-fold greater than in the summer of 2008. Two water quality parameters explained 67% of the variance in monthly disease prevalence in a Partial Least Squares regression analysis; disease abundance was negatively correlated with salinity (R2 = -0.6) but positively correlated with water column particulate organic carbon concentration (R2 = 0.32). Seasonal temperature patterns were also positively correlated with disease abundance, but explained only a small portion of the variance. Conclusions/Significance: The results suggest that rainfall and associated runoff may facilitate seasonal disease outbreaks, potentially by reducing host fitness or by increasing pathogen virulence due to higher availability of nutrients and organic matter. In the future, rainfall and seawater temperatures are likely to increase due to climate change which may lead to decreased health of inshore reefs.	[Haapkylae, Jessica; Flavell, Mike; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Haapkylae, Jessica; Bourne, David G.; Schaffelke, Britta] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Unsworth, Richard K. F.] Univ Glamorgan, Biol Sci Res Unit, Pontypridd CF37 1DL, M Glam, Wales	James Cook University; Australian Institute of Marine Science; University of South Wales	Haapkyla, J (corresponding author), James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	Jessica.Haapkyla@jcu.edu.au	Bourne, David G/B-5073-2008; Unsworth, Richard K.F./C-1266-2009	Bourne, David G/0000-0002-1492-8710; Unsworth, Richard K.F./0000-0003-0036-9724	Australian Research Council; Australian Institute of Marine Science at James Cook University (AIMS@JCU)	Australian Research Council(Australian Research Council); Australian Institute of Marine Science at James Cook University (AIMS@JCU)	This work was supported by an Australian Research Council Grant and Australian Institute of Marine Science at James Cook University (AIMS@JCU) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2005, MAR POLLUT BULL, V51, P239, DOI 10.1016/j.marpolbul.2004.10.033; Anthony SL, 2008, DIS AQUAT ORGAN, V81, P255, DOI 10.3354/dao01962; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Brodie JE, 2005, MAR FRESHWATER RES, V56, P279, DOI 10.1071/MF04081; BRUCKNER AW, 2002, PRIORITIES EFFECTIVE; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Chartrand KM, 2009, MAR BIOL, V156, P1691, DOI 10.1007/s00227-009-1204-3; Clarke K. R., 1994, CHANGE MARINE COMMUN, P172; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; DEATH G, 2008, RES PUBLICATION GREA, V89; DeVantier LM, 1997, WORKSHOP SERIES GREA, V22, P65; DEVLIN M, 2001, RES PUBLICATION GREA, V68; Devlin M, 2009, MAR FRESHWATER RES, V60, P1109, DOI 10.1071/MF08343; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Farnsworth EJ, 1998, GLOBAL ECOL BIOGEOGR, V7, P15, DOI 10.2307/2997694; Furnas M, 2005, MAR POLLUT BULL, V51, P253, DOI 10.1016/j.marpolbul.2004.11.010; Furnas M., 2003, CATCHMENT CORALS TER; Furnas M.J., 1995, RES PUBLICATION GREA; HAAPKYLA J, 2010, CORAL REEFS; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, AM NAT, V164, pS1, DOI 10.1086/424611; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson PTJ, 2010, ECOL APPL, V20, P16, DOI 10.1890/08-0633.1; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kaczmarsky LT, 2006, DIS AQUAT ORGAN, V69, P9, DOI 10.3354/dao069009; Kaczmarsky LT, 2005, CARIBB J SCI, V41, P124; Kim Kiho, 2002, P813; King B, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P145; KING B, 2002, 44 CRC REEF RES CTR; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; LARCOMBE P, 1995, CORAL REEFS, V14, P163, DOI 10.1007/BF00367235; LONERGAN C, 2006, THESIS J COOK U TOWN; Maughan M., 2008, P WAT 2008 INC 31 HY, P1912; McCallum H, 2003, ECOL LETT, V6, P1062, DOI 10.1046/j.1461-0248.2003.00545.x; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; *REEF RAINF RES CT, 2010, REEF RESC MAR MON PR; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; ROY KJ, 1971, PAC SCI, V25, P234; SATO Y, 2009, P ROY SOC LOND B BIO, V27, P2795, DOI DOI 10.1098/RSPB.2009.0481; Schaffelke B, 2005, MAR POLLUT BULL, V51, P279, DOI 10.1016/j.marpolbul.2004.10.025; SCHAFFELKE B, 2007, WATER QUALITY ECOSYS; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Trenberth KE, 1998, CLIMATIC CHANGE, V39, P667, DOI 10.1023/A:1005319109110; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Veron JEN, 2008, CORAL REEFS, V27, P459, DOI 10.1007/s00338-008-0381-8; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Walsh KJE, 2000, J CLIMATE, V13, P3029, DOI 10.1175/1520-0442(2000)013<3029:TCIINA>2.0.CO;2; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; WOLANSKI E, 1983, AUST J MAR FRESH RES, V34, P49	77	116	116	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16893	10.1371/journal.pone.0016893	http://dx.doi.org/10.1371/journal.pone.0016893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347317	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000287363000022
J	Ong, EBB; Watanabe, N; Saito, A; Futamura, Y; Abd El Galil, KH; Koito, A; Najimudin, N; Osada, H				Ong, Eugene Boon Beng; Watanabe, Nobumoto; Saito, Akiko; Futamura, Yushi; Abd El Galil, Khaled Hussein; Koito, Atsushi; Najimudin, Nazalan; Osada, Hiroyuki			Vipirinin, a Coumarin-based HIV-1 Vpr Inhibitor, Interacts with a Hydrophobic Region of VPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REGULATORY PROTEIN VPR; PROTEASOMAL DEGRADATION; GENOTOXIC AGENTS; UBIQUITIN LIGASE; HIGH-THROUGHPUT; CELL-GROWTH; TRANSCRIPTION; REPLICATION; MACROPHAGES	The human immunodeficiency virus 1 (HIV-1) viral protein R (Vpr) is an accessory protein that has been shown to have multiple roles in HIV-1 pathogenesis. By screening chemical libraries in the RIKEN Natural Products Depository, we identified a 3-phenyl coumarin-based compound that inhibited the cell cycle arrest activity of Vpr in yeast and Vpr-dependent viral infection of human macrophages. We determined its minimal pharmacophore through a structure-activity relationship study and produced more potent derivatives. We detected direct binding, and by assaying a panel of Vpr mutants, we found the hydrophobic region about residues Glu-25 and Gln-65 to be potentially involved in the binding of the inhibitor. Our findings exposed a targeting site on Vpr and delineated a convenient approach to explore other targeting sites on the protein using small molecule inhibitors as bioprobes.	[Ong, Eugene Boon Beng; Watanabe, Nobumoto; Saito, Akiko; Futamura, Yushi; Osada, Hiroyuki] RIKEN Adv Sci Inst, Chem Biol Core Facil, Dept Biol Chem, Wako, Saitama 3510198, Japan; [Ong, Eugene Boon Beng; Watanabe, Nobumoto; Najimudin, Nazalan; Osada, Hiroyuki] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia; [Abd El Galil, Khaled Hussein; Koito, Atsushi] Kumamoto Univ, Dept Retrovirol & Self Def, Fac Life Sci, Kumamoto 8608556, Japan	RIKEN; Universiti Sains Malaysia; Kumamoto University	Watanabe, N (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nwatanab@riken.jp; hisyo@riken.jp	Osada, Hiroyuki/N-4305-2014; Najimudin, Nazalan/A-8368-2011; Beng, Eugene Ong Boon/A-2774-2015; Saito, Akiko/AAF-9531-2019; Watanabe, Nobumoto/N-6959-2015; Osada, Hiroyuki/AAY-6254-2020; Najimudin, Nazalan/B-2952-2011; Futamura, Yushi/C-7615-2017	Beng, Eugene Ong Boon/0000-0001-6259-9029; Watanabe, Nobumoto/0000-0002-2130-1334; Futamura, Yushi/0000-0002-4224-6944	RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan	RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Chemical Biology Project of RIKEN and grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. E. B. O. is pursuing this work as a RIKEN Asia Program Associate.	Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Barberis Alcide, 2005, Drug Discov Today Technol, V2, P187, DOI 10.1016/j.ddtec.2005.05.022; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bourbigot S, 2005, BIOCHEM J, V387, P333, DOI 10.1042/BJ20041759; Budavari S., 2001, MERCK INDEX ENCY CHE, V13th; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; FELMEIST.A, 1972, J PHARM SCI-US, V61, P151, DOI 10.1002/jps.2600610202; Fritz JV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-87; Fujino Y, 2000, CHEM PHARM BULL, V48, P298; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Hoshino S, 2010, J LEUKOCYTE BIOL, V87, P1133, DOI 10.1189/jlb.0809547; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Kamata M, 2006, BIOCHEM BIOPH RES CO, V348, P1101, DOI 10.1016/j.bbrc.2006.07.158; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Kostova I, 2006, BIOINORG CHEM APPL, V2006, DOI [10.1155/BCA/2006/68274, 10.1155/BCA/2006/25651]; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Leroux FR, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.13; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; MACREADIE IG, 1995, P NATL ACAD SCI USA, V92, P2770, DOI 10.1073/pnas.92.7.2770; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Morellet N, 2009, CURR HIV RES, V7, P184, DOI 10.2174/157016209787581490; Pandey RC, 2009, CURR HIV RES, V7, P114, DOI 10.2174/157016209787581508; PAROLIN C, 1990, FEMS MICROBIOL LETT, V68, P341, DOI 10.1016/S0378-1097(05)80065-5; Richter SN, 2009, CURR MED CHEM, V16, P267, DOI 10.2174/092986709787002646; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Thotala D, 2004, VIROLOGY, V328, P89, DOI 10.1016/j.virol.2004.07.013; Tomiki T, 2006, J COMPUT AIDED CHEM, V7, P157; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; Tristem M, 1998, VIROLOGY, V240, P232, DOI 10.1006/viro.1997.8929; Vanitharani R, 2001, VIROLOGY, V289, P334, DOI 10.1006/viro.2001.1153; WANG LL, 1995, J BIOL CHEM, V270, P25564, DOI 10.1074/jbc.270.43.25564; Watanabe N, 2006, FEBS LETT, V580, P2598, DOI 10.1016/j.febslet.2006.04.007; Xiao Y, 2008, VIROLOGY, V372, P384, DOI 10.1016/j.virol.2007.10.036; Zhang SG, 1998, GENE, V212, P157, DOI 10.1016/S0378-1119(98)00178-4; Zhao H, 1997, J MED CHEM, V40, P242, DOI 10.1021/jm960450v; Zhao RY, 2011, J NEUROIMMUNE PHARM; Zhao YQ, 2000, FRONT BIOSCI-LANDMRK, V5, pD905, DOI 10.2741/zhao	49	80	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14049	14056		10.1074/jbc.M110.185397	http://dx.doi.org/10.1074/jbc.M110.185397			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357691	Green Published, hybrid			2022-12-25	WOS:000289556200027
J	Huang, CJ; Ferfoglia, F; Raleff, F; Kramer, A				Huang, Ching-Jung; Ferfoglia, Fabio; Raleff, Flore; Kraemer, Angela			Interaction Domains and Nuclear Targeting Signals in Subunits of the U2 Small Nuclear Ribonucleoprotein Particle-associated Splicing Factor SF3a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-NUCLEUS; BRANCH SITE; YEAST PRP9; IN-VIVO; SNRNP; PROTEINS; RNA; SPLICEOSOME; COMPLEX	Human splicing factor SF3a is a component of the mature U2 small nuclear ribonucleoprotein particle (snRNP) and its three subunits of 60, 66, and 120 kDa are essential for splicing in vitro and in vivo. The SF3a heterotrimer forms in the cytoplasm and enters the nucleus independently of the U2 snRNP. Here, we have analyzed domains required for in vitro interactions between the SF3a subunits. Our results indicate that the SF3a66-SF3a120 interaction is mediated by a 27-amino acid region in SF3a120 C-terminal to the second suppressor-of-white-apricot and prp21/spp91 domain and amino acids 108 210 of SF3a66. Neither of these sequences contains known structural motifs, suggesting that the interaction domains are novel. Moreover, an similar to 100-amino acid region, including the SURP2 domain of SF3a120 but extending into neighboring regions, is sufficient for binding to SF3a60. Analysis of determinants for nuclear import of SF3a demonstrates that SF3a120 provides the major nuclear localization signal and SF3a60 contributes to nuclear import.	[Huang, Ching-Jung; Ferfoglia, Fabio; Raleff, Flore; Kraemer, Angela] Univ Geneva, Fac Sci, Dept Cell Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Kramer, A (corresponding author), Univ Geneva, Dept Cell Biol Sci 3, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	angela.kraemer@unige.ch			Swiss National Science Foundation [3100-068239]; European Science Foundation [ERAS-CT-2003-980409]; European Commission [EURASNET-LSHG-CT-2005-518238]; Fondation MEDIC; Canton of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation MEDIC; Canton of Geneva	This work was supported by grants from the Swiss National Science Foundation (3100-068239), the European Science Foundation EUROCORES Programme EuroDYNA (ERAS-CT-2003-980409), the European Commission (EURASNET-LSHG-CT-2005-518238), the Fondation MEDIC, and the Canton of Geneva (to A. K.).	BEHRENS SE, 1993, P NATL ACAD SCI USA, V90, P8229, DOI 10.1073/pnas.90.17.8229; BENNETT M, 1993, SCIENCE, V262, P105, DOI 10.1126/science.8211113; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; BROSI R, 1993, SCIENCE, V262, P102, DOI 10.1126/science.8211112; BROSI R, 1993, J BIOL CHEM, V268, P17640; CHIARA MD, 1994, P NATL ACAD SCI USA, V91, P6403, DOI 10.1073/pnas.91.14.6403; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KRAMER A, 1994, NUCLEIC ACIDS RES, V22, P5223, DOI 10.1093/nar/22.24.5223; KRAMER A, 1995, RNA, V1, P260; Kramer A, 2005, BIOCHEM SOC T, V33, P439; Kuwasako K, 2006, STRUCTURE, V14, P1677, DOI 10.1016/j.str.2006.09.009; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Nesic D, 2001, MOL CELL BIOL, V21, P6406, DOI 10.1128/MCB.21.19.6406-6417.2001; Rain JC, 1996, RNA, V2, P535; SCHAPPERT K, 1991, MOL GEN GENET, V226, P277, DOI 10.1007/BF00273613; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; WILL CL, 2006, RNA WORLD, V3, P369; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008	31	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13106	13114		10.1074/jbc.M110.201491	http://dx.doi.org/10.1074/jbc.M110.201491			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349847	Green Published, hybrid			2022-12-25	WOS:000289282200031
J	Castells-Roca, L; Garcia-Martinez, J; Moreno, J; Herrero, E; Belli, G; Perez-Ortin, JE				Castells-Roca, Laia; Garcia-Martinez, Jose; Moreno, Joaquin; Herrero, Enrique; Belli, Gemma; Perez-Ortin, Jose E.			Heat Shock Response in Yeast Involves Changes in Both Transcription Rates and mRNA Stabilities	PLOS ONE			English	Article							GENE-EXPRESSION; STRESS RESPONSES; ACTIVATION; REVEALS; SYSTEM; CELLS	We have analyzed the heat stress response in the yeast Saccharomyces cerevisiae by determining mRNA levels and transcription rates for the whole transcriptome after a shift from 25 degrees C to 37 degrees C. Using an established mathematical algorithm, theoretical mRNA decay rates have also been calculated from the experimental data. We have verified the mathematical predictions for selected genes by determining their mRNA decay rates at different times during heat stress response using the regulatable tetO promoter. This study indicates that the yeast response to heat shock is not only due to changes in transcription rates, but also to changes in the mRNA stabilities. mRNA stability is affected in 62% of the yeast genes and it is particularly important in shaping the mRNA profile of the genes belonging to the environmental stress response. In most cases, changes in transcription rates and mRNA stabilities are homodirectional for both parameters, although some interesting cases of antagonist behavior are found. The statistical analysis of gene targets and sequence motifs within the clusters of genes with similar behaviors shows that both transcriptional and post-transcriptional regulons apparently contribute to the general heat stress response by means of transcriptional factors and RNA binding proteins.	[Castells-Roca, Laia; Herrero, Enrique; Belli, Gemma] Univ Lleida, Dept Ciencies Med Basiques, Lleida, Catalunya, Spain; [Castells-Roca, Laia; Herrero, Enrique; Belli, Gemma] Univ Lleida, IRBLleida, Lleida, Catalunya, Spain; [Moreno, Joaquin; Perez-Ortin, Jose E.] Univ Valencia, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Valencia, Spain; [Garcia-Martinez, Jose] Univ Valencia, Secc Chips DNA Serv Cent Suport Invest Expt, Valencia, Spain	Universitat de Lleida; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University of Valencia; University of Valencia	Castells-Roca, L (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Lleida, Catalunya, Spain.	gemma.belli@cmb.udl.cat; jose.e.perez@uv.es	Herrero, Enrique/B-5592-2009; Pérez-Ortín, José E./K-8582-2014; Garcia-Martinez, Jose/X-4995-2019; belli, gemma/A-7424-2011; Castells Roca, Laia/C-4444-2011; Garcia-Martinez, Jose/F-6790-2016; Bellí, Gemma/AAD-5325-2019; Castells-Roca, Laia/I-1227-2015	Herrero, Enrique/0000-0002-6763-111X; Pérez-Ortín, José E./0000-0002-1992-513X; Garcia-Martinez, Jose/0000-0001-5866-5994; belli, gemma/0000-0002-4161-3204; Garcia-Martinez, Jose/0000-0001-5866-5994; Bellí, Gemma/0000-0002-4161-3204; Castells-Roca, Laia/0000-0002-4604-9999	MICINN [BFU2007-62703, CSD 2007-0020, BFU2007-67575-CO3-01/BMC]; Generalitat de Catalunya [SGR2 009-196]; Generalitat Valenciana [ACOMP/2009/368]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by grants BFU2007-62703 and CSD 2007-0020 (MICINN) and SGR2 009-196 (Generalitat de Catalunya) to E.H., and BFU2007-67575-CO3-01/BMC (MICINN) ACOMP/2009/368 (Generalitat Valenciana) to J.E.P.-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, BIOPHYS J, V89, pL61, DOI 10.1529/biophysj.105.074195; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Etchells SA, 2005, J BIOL CHEM, V280, P28118, DOI 10.1074/jbc.M504110200; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r222; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hayles B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009908; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kim TS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r75; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Mejia YX, 2008, J MOL BIOL, V382, P628, DOI 10.1016/j.jmb.2008.06.079; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Perez-Ortin Jose E., 2007, Briefings in Functional Genomics & Proteomics, V6, P282, DOI 10.1093/bfgp/elm029; Riezman H, 2004, CELL CYCLE, V3, P61; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; ROWLEY A, 1993, MOL CELL BIOL, V13, P1034, DOI 10.1128/MCB.13.2.1034; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trott A, 2003, TOP CURR GENET, V1, P71; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Yamamoto A, 2007, EUKARYOT CELL, V6, P1373, DOI 10.1128/EC.00098-07; Yamamoto N, 2008, EUKARYOT CELL, V7, P783, DOI 10.1128/EC.00029-08	41	70	72	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17272	10.1371/journal.pone.0017272	http://dx.doi.org/10.1371/journal.pone.0017272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364882	Green Published, gold, Green Submitted			2022-12-25	WOS:000287764100040
J	Guo, YC; Bao, YH; Wang, H; Hu, XX; Zhao, ZH; Li, N; Zhao, YF				Guo, Yongchen; Bao, Yonghua; Wang, Hui; Hu, Xiaoxiang; Zhao, Zhihui; Li, Ning; Zhao, Yaofeng			A Preliminary Analysis of the Immunoglobulin Genes in the African Elephant (Loxodonta africana)	PLOS ONE			English	Article							HEAVY-CHAIN LOCUS; ORNITHORHYNCHUS-ANATINUS PLATYPUS; TOXOPLASMA-GONDII ANTIBODIES; CONSTANT-REGION GENES; HORSE SICKNESS VIRUS; AMINO-ACID-SEQUENCES; HUMAN GERMLINE GENES; HUMAN-IGG SUBCLASSES; LIGHT-CHAIN; ASIAN ELEPHANTS	The genomic organization of the IgH (Immunoglobulin heavy chain), Ig kappa (Immunoglobulin kappa chain), and Ig lambda (Immunoglobulin lambda chain) loci in the African elephant (Loxodonta africana) was annotated using available genome data. The elephant IgH locus on scaffold 57 spans over 2,974 kb, and consists of at least 112 V-H gene segments, 87 D-H gene segments (the largest number in mammals examined so far), six J(H) gene segments, a single mu, a delta remnant, and eight gamma genes (alpha and epsilon genes are missing, most likely due to sequence gaps). The Ig kappa locus, found on three scaffolds (202, 50 and 86), contains a total of 153 V-kappa gene segments, three J(kappa) segments, and a single C-kappa gene. Two different transcriptional orientations were determined for these V-kappa gene segments. In contrast, the Ig lambda locus on scaffold 68 includes 15 V-lambda gene segments, all with the same transcriptional polarity as the downstream J(lambda)-C-lambda cluster. These data suggest that the elephant immunoglobulin gene repertoire is highly diverse and complex. Our results provide insights into the immunoglobulin genes in a placental mammal that is evolutionarily distant from humans, mice, and domestic animals.	[Guo, Yongchen; Hu, Xiaoxiang; Li, Ning; Zhao, Yaofeng] China Agr Univ, Coll Biol Sci, State Key Lab AgroBiotechnol, Beijing 100094, Peoples R China; [Bao, Yonghua; Wang, Hui] Xinxiang Med Univ, Dept Basic Immunol, Xinxiang, Peoples R China; [Zhao, Zhihui] Jilin Univ, Coll Anim Sci & Vet Med, Div Agr, Changchun 130023, Peoples R China; [Zhao, Yaofeng] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China	China Agricultural University; Xinxiang Medical University; Jilin University; Qingdao Agricultural University	Guo, YC (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab AgroBiotechnol, Beijing 100094, Peoples R China.	baoyonghua2005@yahoo.com.cn; yaofengzhao@cau.edu.cn		Wang, Hui/0000-0002-2454-3814	National Science Fund for Distinguished Young Scholars [30725029]; Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program) [2010CB945300]; University of China	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China); University of China	This research was supported by the National Science Fund for Distinguished Young Scholars (30725029), the Taishan Scholar Foundation of Shandong Province, the National Basic Research Program of China (973 Program-2010CB945300) and Program for New Century Excellent Talents in University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 1998, IMMUNOGENETICS, V47, P355, DOI 10.1007/s002510050370; Almagro JC, 2006, MOL IMMUNOL, V43, P1836, DOI 10.1016/j.molimm.2005.10.017; Almagro JC, 1996, IMMUNOGENETICS, V43, P92; Bao YH, 2010, VET IMMUNOL IMMUNOP, V137, P64, DOI 10.1016/j.vetimm.2010.04.011; BECK OE, 1981, CLIN EXP IMMUNOL, V43, P626; BELL RG, 1974, IMMUNOLOGY, V27, P1103; BELL RG, 1977, IMMUNOLOGY, V33, P917; Belov K, 2003, COMP BIOCHEM PHYS A, V136, P811, DOI 10.1016/S1095-6433(03)00165-X; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; Bhat MN, 1997, J WILDLIFE DIS, V33, P919, DOI 10.7589/0090-3558-33.4.919; BINEPAL VS, 1992, VET MICROBIOL, V31, P19, DOI 10.1016/0378-1135(92)90137-I; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; BRUGGEMANN M, 1986, P NATL ACAD SCI USA, V83, P6075, DOI 10.1073/pnas.83.16.6075; BUTLER JE, 1994, VET IMMUNOL IMMUNOP, V43, P5, DOI 10.1016/0165-2427(94)90114-7; Charlton KA, 2000, J IMMUNOL, V164, P6221, DOI 10.4049/jimmunol.164.12.6221; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141; Dangolla A, 2006, VET PARASITOL, V137, P172, DOI 10.1016/j.vetpar.2005.11.028; DAVIES FG, 1977, VET REC, V100, P291, DOI 10.1136/vr.100.14.291; EDELMAN GM, 1969, ANNU REV BIOCHEM, V38, P415, DOI 10.1146/annurev.bi.38.070169.002215; Evans A, 2008, EPIDEMIOL INFECT, V136, P1261, DOI 10.1017/S0950268807009806; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; FORMENTY P, 1994, REV SCI TECH OIE, V13, P737, DOI 10.20506/rst.13.3.798; FRIPPIAT JP, 1995, HUM MOL GENET, V4, P983; Gambon-Deza F, 2009, MOL IMMUNOL, V46, P2515, DOI 10.1016/j.molimm.2009.05.025; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HAINO M, 1994, J BIOL CHEM, V269, P2619; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hendricks J, 2010, IMMUNOGENETICS, V62, P479, DOI 10.1007/s00251-010-0448-x; Honjo T., 2003, MOL BIOL B CELLS; Hove T, 1999, J PARASITOL, V85, P372, DOI 10.2307/3285650; HOWELL P G, 1973, Onderstepoort Journal of Veterinary Research, V40, P41; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; Kawasaki K, 2001, EUR J IMMUNOL, V31, P1017, DOI 10.1002/1521-4141(200104)31:4<1017::AID-IMMU1017>3.3.CO;2-V; KELLY PJ, 1993, COMP IMMUNOL MICROB, V16, P299, DOI 10.1016/0147-9571(93)90159-3; Kelly PJ, 1998, COMP IMMUNOL MICROB, V21, P65, DOI 10.1016/S0147-9571(97)80053-7; King DP, 1998, COMP BIOCHEM PHYS B, V121, P363, DOI 10.1016/S0305-0491(98)10118-9; Kirschbaum T, 1996, EUR J IMMUNOL, V26, P1613, DOI 10.1002/eji.1830260731; Kirschbaum T, 1998, EUR J IMMUNOL, V28, P1458, DOI 10.1002/(SICI)1521-4141(199805)28:05&lt;1458::AID-IMMU1458&gt;3.0.CO;2-5; KNIGHT KL, 1985, J IMMUNOL, V134, P1245; KNIGHT KL, 1994, ADV IMMUNOL, V56, P179, DOI 10.1016/S0065-2776(08)60452-6; KNIGHT KL, 1988, J IMMUNOL, V140, P3654; KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P100, DOI 10.1159/000049189; LESK AM, 1982, J MOL BIOL, V160, P325, DOI 10.1016/0022-2836(82)90179-6; Lucier MR, 1998, J IMMUNOL, V161, P5438; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; Lyashchenko KP, 2006, CLIN VACCINE IMMUNOL, V13, P722, DOI 10.1128/CVI.00133-06; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; MARQUEZ MEI, 1995, COMP BIOCHEM PHYS B, V112, P569, DOI 10.1016/0305-0491(95)00101-8; METZLER AE, 1990, J WILDLIFE DIS, V26, P41, DOI 10.7589/0090-3558-26.1.41; Mikota SK, 2001, J ZOO WILDLIFE MED, V32, P1, DOI 10.1638/1042-7260(2001)032[0001:EADOMT]2.0.CO;2; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Oni O, 2006, VET REC, V159, P420, DOI 10.1136/vr.159.13.420; OTA T, 1994, MOL BIOL EVOL, V11, P469; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; PECH M, 1985, J MOL BIOL, V183, P291, DOI 10.1016/0022-2836(85)90001-4; PORTER RR, 1967, BIOCHEM J, V105, P417, DOI 10.1042/bj1050417; Qin T, 2008, DEV COMP IMMUNOL, V32, P156, DOI 10.1016/j.dci.2007.05.007; REYNAUD CA, 1991, EUR J IMMUNOL, V21, P2661, DOI 10.1002/eji.1830211104; RIEMANN H P, 1975, Journal of Wildlife Diseases, V11, P529; Roux KH, 1997, J IMMUNOL, V159, P3372; ROUX KH, 1998, P NATL ACAD SCI, V95; Schrenzel MD, 1997, IMMUNOGENETICS, V45, P386, DOI 10.1007/s002510050220; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0; Sinclair MC, 1997, J IMMUNOL, V159, P3883; SUN J, 1994, J IMMUNOL, V153, P5618; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Tang L, 2001, VET IMMUNOL IMMUNOP, V80, P259, DOI 10.1016/S0165-2427(01)00318-X; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; Thomas RK, 2004, LANCET ONCOL, V5, P11, DOI 10.1016/S1470-2045(03)01319-6; Tuntasuvan D, 2001, J PARASITOL, V87, P229, DOI 10.1645/0022-3395(2001)087[0229:SOTGIE]2.0.CO;2; TURNBULL PCB, 1991, VET REC, V128, P399, DOI 10.1136/vr.128.17.399; VANDIJK KW, 1993, EUR J IMMUNOL, V23, P832, DOI 10.1002/eji.1830230410; VARGASMADRAZO E, 1995, J MOL BIOL, V246, P74, DOI 10.1006/jmbi.1994.0067; Wagner B, 2004, J IMMUNOL, V173, P3230, DOI 10.4049/jimmunol.173.5.3230; Wagner B, 2002, IMMUNOGENETICS, V54, P353, DOI 10.1007/s00251-002-0458-4; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; Ye J, 2004, IMMUNOGENETICS, V56, P399, DOI 10.1007/s00251-004-0712-z; Zhang YA, 2003, VET IMMUNOL IMMUNOP, V95, P81, DOI 10.1016/S0165-2427(03)00105-3; Zhao YF, 2009, J IMMUNOL, V183, P3285, DOI 10.4049/jimmunol.0900469; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200; Zhao ZH, 2007, DEV COMP IMMUNOL, V31, P1034, DOI 10.1016/j.dci.2007.01.002	88	35	46	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16889	10.1371/journal.pone.0016889	http://dx.doi.org/10.1371/journal.pone.0016889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364892	gold, Green Submitted, Green Published			2022-12-25	WOS:000287764100013
J	Ou, WB; Yi, TF; Kim, JM; Khorana, HG				Ou, Wen-bin; Yi, Tingfang; Kim, Jong-Myoung; Khorana, H. Gobind			The Roles of Transmembrane Domain Helix-III during Rhodopsin Photoactivation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CYSTEINE SUBSTITUTION MUTANTS; METARHODOPSIN-II; TRANSDUCIN ACTIVATION; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; RETINITIS-PIGMENTOSA; TERTIARY STRUCTURE; LIGHT-ACTIVATION; GLYCINE 121	Background: Rhodopsin, the prototypic member of G protein-coupled receptors (GPCRs), undergoes isomerization of 11-cis-retinal to all-trans-retinal upon photoactivation. Although the basic mechanism by which rhodopsin is activated is well understood, the roles of whole transmembrane (TM) helix-III during rhodopsin photoactivation in detail are not completely clear. Principal Findings: We herein use single-cysteine mutagenesis technique to investigate conformational changes in TM helices of rhodopsin upon photoactivation. Specifically, we study changes in accessibility and reactivity of cysteine residues introduced into the TM helix-III of rhodopsin. Twenty-eight single-cysteine mutants of rhodopsin (P107C-R135C) were prepared after substitution of all natural cysteine residues (C140/C167/C185/C222/C264/C316) by alanine. The cysteine mutants were expressed in COS-1 cells and rhodopsin was purified after regeneration with 11-cis-retinal. Cysteine accessibility in these mutants was monitored by reaction with 4,4'-dithiodipyridine (4-PDS) in the dark and after illumination. Most of the mutants except for T108C, G109C, E113C, I133C, and R135C showed no reaction in the dark. Wide variation in reactivity was observed among cysteines at different positions in the sequence 108-135 after photoactivation. In particular, cysteines at position 115, 119, 121, 129, 131, 132, and 135, facing 11-cis-retinal, reacted with 4-PDS faster than neighboring amino acids. The different reaction rates of mutants with 4-PDS after photoactivation suggest that the amino acids in different positions in helix-III are exposed to aqueous environment to varying degrees. Significance: Accessibility data indicate that an aqueous/hydrophobic boundary in helix-III is near G109 and I133. The lack of reactivity in the dark and the accessibility of cysteine after photoactivation indicate an increase of water/4-PDS accessibility for certain cysteine-mutants at Helix-III during formation of Meta II. We conclude that photoactivation resulted in water-accessible at the chromophore-facing residues of Helix-III.	[Ou, Wen-bin; Kim, Jong-Myoung; Khorana, H. Gobind] MIT, Dept Biol, Cambridge, MA USA; [Yi, Tingfang] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Ou, WB (corresponding author), Tsinghua Univ Jiaxing, Yangtze Delta Reg Inst, Jiaxing, Zhejiang, Peoples R China.	ouwb75@gmail.com; Khorana@mit.edu	Ou, Wen-Bin/J-1142-2019	, Wenbin/0000-0002-6311-9442	National Institutes of Health [GM28289]; National Eye Institute [EY11716]; National Science Foundation [EIA-0225609]; NATIONAL EYE INSTITUTE [R01EY011716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028289, R37GM028289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM28289, National Eye Institute Grant EY11716, and National Science Foundation Grant EIA-0225609. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Andres A, 2003, BIOCHEM BIOPH RES CO, V303, P294, DOI 10.1016/S0006-291X(03)00328-0; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; Cai KW, 1997, P NATL ACAD SCI USA, V94, P14267, DOI 10.1073/pnas.94.26.14267; Choi G, 2002, BIOCHEMISTRY-US, V41, P7318, DOI 10.1021/bi025507w; Ernst OP, 2002, CHEMBIOCHEM, V3, P968, DOI 10.1002/1439-7633(20021004)3:10<968::AID-CBIC968>3.0.CO;2-Q; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; *GPCRDB, INF SYST G PROT COUP; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hornak V, 2010, J MOL BIOL, V396, P510, DOI 10.1016/j.jmb.2009.12.003; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Klein-Seetharaman J, 1999, BIOCHEMISTRY-US, V38, P7938, DOI 10.1021/bi990013t; Klein-Seetharaman J, 1999, P NATL ACAD SCI USA, V96, P13744, DOI 10.1073/pnas.96.24.13744; Klein-Seetharaman J, 2002, CHEMBIOCHEM, V3, P981, DOI 10.1002/1439-7633(20021004)3:10<981::AID-CBIC981>3.0.CO;2-9; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Madathil S, 2009, J BIOL CHEM, V284, P28801, DOI 10.1074/jbc.M109.002030; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; MIN KC, 1993, J BIOL CHEM, V268, P9400; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; RIDGE KD, 1995, BIOCHEMISTRY-US, V34, P8804, DOI 10.1021/bi00027a032; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Yang K, 1996, BIOCHEMISTRY-US, V35, P12464, DOI 10.1021/bi960848t; Yeagle PL, 2001, BIOCHEMISTRY-US, V40, P11932, DOI 10.1021/bi015543f	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17398	10.1371/journal.pone.0017398	http://dx.doi.org/10.1371/journal.pone.0017398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364764	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100053
J	Xue, B; Sukumaran, S; Nie, J; Jusko, WJ; DuBois, DC; Almon, RR				Xue, Bai; Sukumaran, Siddharth; Nie, Jing; Jusko, William J.; DuBois, Debra C.; Almon, Richard R.			Adipose Tissue Deficiency and Chronic Inflammation in Diabetic Goto-Kakizaki Rats	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; GENE-EXPRESSION; CIRCADIAN VARIATIONS; DISEASE; OBESITY; LEPTIN; LIVER; GLUCOCORTICOIDS; ADIPONECTIN; DISRUPTION	Type 2 diabetes (T2DM) is a heterogeneous group of diseases that is progressive and involves multiple tissues. Goto-Kakizaki (GK) rats are a polygenic model with elevated blood glucose, peripheral insulin resistance, a non-obese phenotype, and exhibit many degenerative changes observed in human T2DM. As part of a systems analysis of disease progression in this animal model, this study characterized the contribution of adipose tissue to pathophysiology of the disease. We sacrificed subgroups of GK rats and appropriate controls at 4, 8, 12, 16 and 20 weeks of age and carried out a gene array analysis of white adipose tissue. We expanded our physiological analysis of the animals that accompanied our initial gene array study on the livers from these animals. The expanded analysis included adipose tissue weights, HbA1c, additional hormonal profiles, lipid profiles, differential blood cell counts, and food consumption. HbA1c progressively increased in the GK animals. Altered corticosterone, leptin, and adiponectin profiles were also documented in GK animals. Gene array analysis identified 412 genes that were differentially expressed in adipose tissue of GKs relative to controls. The GK animals exhibited an age-specific failure to accumulate body fat despite their relatively higher calorie consumption which was well supported by the altered expression of genes involved in adipogenesis and lipogenesis in the white adipose tissue of these animals, including Fasn, Acly, Kklf9, and Stat3. Systemic inflammation was reflected by chronically elevated white blood cell counts. Furthermore, chronic inflammation in adipose tissue was evident from the differential expression of genes involved in inflammatory responses and activation of natural immunity, including two interferon regulated genes, Ifit and Iipg, as well as MHC class II genes. This study demonstrates an age specific failure to accumulate adipose tissue in the GK rat and the presence of chronic inflammation in adipose tissue from these animals.	[Xue, Bai; Sukumaran, Siddharth; Nie, Jing; DuBois, Debra C.; Almon, Richard R.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Jusko, William J.; DuBois, Debra C.; Almon, Richard R.] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Jusko, William J.; Almon, Richard R.] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Xue, B (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	almon@buffalo.edu	Jusko, William J/G-4885-2015; Sukumaran, Siddharth/I-6911-2012		National Institute of General Medical Sciences, NIH [GM 24211]; UB-Pfizer Strategic Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024211, R37GM024211] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UB-Pfizer Strategic Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institute of General Medical Sciences, NIH (GM 24211) and the UB-Pfizer Strategic Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2008, J PHARMACOL EXP THER, V326, P700, DOI 10.1124/jpet.108.140186; Almon RR, 2007, ENDOCRINOLOGY, V148, P2209, DOI 10.1210/en.2006-0790; Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Almon RR, 2005, J ENDOCRINOL, V184, P219, DOI 10.1677/joe.1.05953; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Bach AG, 2010, ENDOCRINOLOGY, V151, P2483, DOI 10.1210/en.2009-1299; Bahtiyar Gul, 2004, Curr Diab Rep, V4, P194, DOI 10.1007/s11892-004-0023-7; Barbu A, 2009, MOL CELL ENDOCRINOL, V299, P163, DOI 10.1016/j.mce.2008.11.019; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; BOMALASKI JS, 1989, J IMMUNOL, V142, P3957; Brunetti P, 2007, INT J CLIN PRACT, V61, P3, DOI 10.1111/j.1742-1241.2007.01359.x; Buren J, 2008, ARCH BIOCHEM BIOPHYS, V474, P91, DOI 10.1016/j.abb.2008.02.034; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Ettinger RA, 2006, J IMMUNOL, V176, P1988, DOI 10.4049/jimmunol.176.3.1988; Ettinger RA, 2004, IMMUNOGENETICS, V56, P585, DOI 10.1007/s00251-004-0725-7; Fife KL, 2008, J PHARMACOL EXP THER, V327, P707, DOI 10.1124/jpet.108.142398; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; Gale SM, 2004, J NUTR, V134, P295, DOI 10.1093/jn/134.2.295; Goto Y, 1988, Adv Exp Med Biol, V246, P29; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hackl H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r108; Halleux CM, 2001, BIOCHEM BIOPH RES CO, V288, P1102, DOI 10.1006/bbrc.2001.5904; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hazra A, 2008, PHARM RES-DORDR, V25, P769, DOI 10.1007/s11095-007-9371-8; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Knobler H, 2003, AM J GASTROENTEROL, V98, P2751, DOI 10.1016/j.amjgastroenterol.2003.06.002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Maekawa F, 2006, J NEUROENDOCRINOL, V18, P748, DOI 10.1111/j.1365-2826.2006.01470.x; MCNEELY M, 2004, CLIN DIABETES, V22, P42; Mealey BL, 2008, COMPEND CONTIN ED DE, V29, P410; Mealey BL, 2008, COMPEND CONTIN ED DE, V29, P412; Mealey Brian L, 2008, Compend Contin Educ Dent, V29, P402; Mofredj A, 2002, DIGEST DIS SCI, V47, P1649, DOI 10.1023/A:1015852110353; MOXLEY RT, 1978, J CLIN INVEST, V62, P857, DOI 10.1172/JCI109198; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; Plachot C, 2001, HISTOCHEM CELL BIOL, V116, P131; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006; Rana JS, 2004, DIABETES CARE, V27, P2478, DOI 10.2337/diacare.27.10.2478; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Tiengo A, 2008, DIABETES METAB, V34, P447, DOI 10.1016/j.diabet.2008.08.001; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; YUAN JH, 1993, TOXICOL APPL PHARM, V119, P131, DOI 10.1006/taap.1993.1052; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	59	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17386	10.1371/journal.pone.0017386	http://dx.doi.org/10.1371/journal.pone.0017386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364767	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100050
J	Francis, SM; Chakrabarti, S; Dick, FA				Francis, Sarah M.; Chakrabarti, Subrata; Dick, Frederick A.			A Context-Specific Role for Retinoblastoma Protein-Dependent Negative Growth Control in Suppressing Mammary Tumorigenesis	PLOS ONE			English	Article							MEDIATED G(1) ARREST; CELL-CYCLE CONTROL; BREAST-CANCER; GLAND DEVELOPMENT; MICE LACKING; NEU PROTOONCOGENE; EPITHELIAL-CELLS; TRANSGENIC MICE; FACTOR-BETA; TGF-BETA	Background: The ability to respond to anti-growth signals is critical to maintain tissue homeostasis and loss of this negative growth control safeguard is considered a hallmark of cancer. Negative growth regulation generally occurs during the G0/G1 phase of the cell cycle, yet the redundancy and complexity among components of this regulatory network has made it difficult to discern how negative growth cues protect cells from aberrant proliferation. Methodology/Principal Findings: The retinoblastoma protein (pRB) acts as the final barrier to prevent cells from entering into the cell cycle. By introducing subtle changes in the endogenous mouse Rb1 gene (Rb1(Delta L)), we have previously shown that interactions at the LXCXE binding cleft are necessary for the proper response to anti-growth signals such as DNA damage and TGF-beta, with minimal effects on overall development. This disrupts the balance of pro-and anti-growth signals in mammary epithelium of Rb1(Delta L/Delta L) mice. Here we show that Rb1(Delta L/Delta L) mice are more prone to mammary tumors in the Wapp53(R172H) transgenic background indicating that negative growth regulation is important for tumor suppression in these mice. In contrast, the same defect in anti-growth control has no impact on Neu-induced mammary tumorigenesis. Conclusions/Significance: Our work demonstrates that negative growth control by pRB acts as a crucial barrier against oncogenic transformation. Strikingly, our data also reveals that this tumor suppressive effect is context-dependent.	[Francis, Sarah M.; Dick, Frederick A.] London Reg Canc Program, London, ON, Canada; [Francis, Sarah M.; Dick, Frederick A.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Dick, Frederick A.] Childrens Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Francis, SM (corresponding author), London Reg Canc Program, London, ON, Canada.	fdick@uwo.ca		Chakrabarti, Subrata/0000-0002-0208-1401	Cancer Research Society; Canadian Institutes of Health Research [MOP-64253]	Cancer Research Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants from the Cancer Research Society and the Canadian Institutes of Health Research (MOP-64253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORG A, 1992, CANCER RES, V52, P2991; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Ewan KBR, 2005, AM J PATHOL, V167, P409, DOI 10.1016/S0002-9440(10)62985-9; Fernandez PL, 1998, J CLIN PATHOL-MOL PA, V51, P305, DOI 10.1136/mp.51.6.305; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Florenes VA, 1996, ONCOGENE, V13, P2447; Francis SM, 2009, MOL CELL BIOL, V29, P4455, DOI 10.1128/MCB.00473-09; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hojilla CV, 2007, J CELL SCI, V120, P1050, DOI 10.1242/jcs.003335; Iavarone A, 1997, NATURE, V387, P417; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nielsen NH, 1997, ONCOGENE, V14, P295, DOI 10.1038/sj.onc.1200833; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PIETILAINEN T, 1995, EUR J CANCER, V31A, P329, DOI 10.1016/0959-8049(94)00463-F; Robinson GW, 2001, ONCOGENE, V20, P7115, DOI 10.1038/sj.onc.1204888; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Talluri S, 2010, MOL CELL BIOL, V30, P948, DOI 10.1128/MCB.01168-09; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16434	10.1371/journal.pone.0016434	http://dx.doi.org/10.1371/journal.pone.0016434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364977	Green Submitted, gold, Green Published			2022-12-25	WOS:000287656600007
J	Quintana, AM; Zhou, YE; Pena, JJ; O'Rourke, JP; Ness, SA				Quintana, Anita M.; Zhou, Ye E.; Pena, Janeth J.; O'Rourke, John P.; Ness, Scott A.			Dramatic Repositioning of c-Myb to Different Promoters during the Cell Cycle Observed by Combining Cell Sorting with Chromatin Immunoprecipitation	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC-CELLS; FORMALDEHYDE CROSS-LINKING; V-MYB; SANT DOMAIN; NF-Y; CANCER-CELLS; TRANSCRIPTION; EXPRESSION; GENE; LEUKEMIA	The c-Myb transcription factor is a critical regulator of proliferation and stem cell differentiation, and mutated alleles of c-Myb are oncogenic, but little is known about changes in c-Myb activity during the cell cycle. To map the association of c-Myb with specific target genes during the cell cycle, we developed a novel Fix-Sort-ChIP approach, in which asynchronously growing cells were fixed with formaldehyde, stained with Hoechst 33342 and separated into different cell cycle fractions by flow sorting, then processed for chromatin immunoprecipitation (ChIP) assays. We found that c-Myb actively repositions, binding to some genes only in specific cell cycle phases. In addition, the specificity of c-Myb is dramatically different in small subpopulations of cells, for example cells in the G2/M phase of the cell cycle, than in the bulk population. The repositioning of c-Myb during the cell cycle is not due to changes in its expression and also occurs with ectopically expressed, epitope-tagged versions of c-Myb. The repositioning occurs in established cell lines, in primary human CD34+ hematopoietic progenitors and in primary human acute myeloid leukemia cells. The combination of fixation, sorting and ChIP analysis sheds new light on the dynamic nature of gene regulation during the cell cycle and provides a new type of tool for the analysis of gene regulation in small subsets of cells, such as cells in a specific phase of the cell cycle.	[Quintana, Anita M.; Zhou, Ye E.; Pena, Janeth J.; O'Rourke, John P.; Ness, Scott A.] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Quintana, AM (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	ness@unm.edu	Ness, Scott/AAV-4009-2020	Ness, Scott/0000-0001-6965-8909; Quintana, Anita/0000-0002-3596-1587	NIH [5R01CA058443, 5R01CA105257]; NIDDK Core Center of Excellence in Hematology [DK56465];  [5F31HL090024-03]; NATIONAL CANCER INSTITUTE [P30CA118100, R01CA058443, R01CA105257] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL090024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Core Center of Excellence in Hematology; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants 5R01CA058443 and 5R01CA105257 (to SAN). AMQ was partially supported by grant 5F31HL090024-03. Purified CD34+ cells were provided by the Fred Hutchinson Cancer Research Center Large-Scale Cell Processing Core, supported by NIDDK Core Center of Excellence in Hematology grant DK56465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Bies J, 2000, ONCOGENE, V19, P2846, DOI 10.1038/sj.onc.1203613; Bies J, 2001, BLOOD CELL MOL DIS, V27, P422, DOI 10.1006/bcmd.2001.0400; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Donati G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002066; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Frampton J, 1996, GENE DEV, V10, P2720, DOI 10.1101/gad.10.21.2720; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; Gatta R, 2008, NUCLEIC ACIDS RES, V36, P6592, DOI 10.1093/nar/gkn699; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Juan G, 2002, CYTOMETRY, V49, P170, DOI 10.1002/cyto.10173; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Lei WL, 2005, BLOOD, V105, P3855, DOI 10.1182/blood-2004-08-3342; Lei WL, 2004, J BIOL CHEM, V279, P29519, DOI 10.1074/jbc.M403133200; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Ness SA, 1996, BBA-REV CANCER, V1288, pF123, DOI 10.1016/S0304-419X(96)00027-3; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; O'Rourke JP, 2008, MOL CELL BIOL, V28, P2091, DOI 10.1128/MCB.01870-07; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Panzenbock B, 1998, BLOOD, V92, P3658, DOI 10.1182/blood.V92.10.3658.422k18_3658_3668; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ratajczak MZ, 1998, BLOOD, V91, P1934, DOI 10.1182/blood.V91.6.1934.1934_1934_1946; Rombouts EJC, 2004, BLOOD, V104, P550, DOI 10.1182/blood-2004-02-0566; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Spoo AC, 2007, BLOOD, V109, P786, DOI 10.1182/blood-2006-05-024844; Vandenbark GR, 1996, CELL GROWTH DIFFER, V7, P1383; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	49	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17362	10.1371/journal.pone.0017362	http://dx.doi.org/10.1371/journal.pone.0017362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364958	Green Published, gold, Green Submitted			2022-12-25	WOS:000287656600045
J	Kalia, LV; Kalia, SK; Chau, H; Lozano, AM; Hyman, BT; McLean, PJ				Kalia, Lorraine V.; Kalia, Suneil K.; Chau, Hien; Lozano, Andres M.; Hyman, Bradley T.; McLean, Pamela J.			Ubiquitinylation of alpha-Synuclein by Carboxyl Terminus Hsp70-Interacting Protein (CHIP) Is Regulated by Bcl-2-Associated Athanogene 5 (BAG5)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DEPENDENT E3 LIGASE; PARKINSONS-DISEASE; LEWY BODIES; MOLECULAR CHAPERONES; NUCLEOTIDE EXCHANGE; COCHAPERONE BAG2; QUALITY-CONTROL; CELL-DEATH; DEGRADATION	Parkinson's disease (PD) is a common neurodegenerative condition in which abnormalities in protein homeostasis, or proteostasis, may lead to accumulation of the protein alpha-synuclein (alpha-syn). Mutations within or multiplications of the gene encoding alpha-syn are known to cause genetic forms of PD and polymorphisms in the gene are recently established risk factors for idiopathic PD. alpha-syn is a major component of Lewy bodies, the intracellular proteinaceous inclusions which are pathological hallmarks of most forms of PD. Recent evidence demonstrates that alpha-syn can self associate into soluble oligomeric species and implicates these alpha-syn oligomers in cell death. We have previously shown that carboxyl terminus of Hsp70-interacting protein (CHIP), a co-chaperone molecule with E3 ubiquitin ligase activity, may reduce the levels of toxic alpha-syn oligomers. Here we demonstrate that alpha-syn is ubiquitinylated by CHIP both in vitro and in cells. We find that the products from ubiquitinylation by CHIP include both monoubiquitinylated and polyubiquitinylated forms of alpha-syn. We also demonstrate that CHIP and alpha-syn exist within a protein complex with the co-chaperone bcl-2-associated athanogene 5 (BAG5) in brain. The interaction of CHIP with BAG5 is mediated by Hsp70 which binds to the tetratricopeptide repeat domain of CHIP and the BAG domains of BAG5. The Hsp70-mediated association of BAG5 with CHIP results in inhibition of CHIP E3 ubiquitin ligase activity and subsequently reduces alpha-syn ubiquitinylation. Furthermore, we use a luciferase-based protein-fragment complementation assay of alpha-syn oligomerization to investigate regulation of alpha-syn oligomers by CHIP in living cells. We demonstrate that BAG5 mitigates the ability of CHIP to reduce alpha-syn oligomerization and that non-ubiquitinylated alpha-syn has an increased propensity for oligomerization. Thus, our results identify CHIP as an E3 ubiquitin ligase of alpha-syn and suggest a novel function for BAG5 as a modulator of CHIP E3 ubiquitin ligase activity with implications for CHIP-mediated regulation of alpha-syn oligomerization.	[Kalia, Lorraine V.; Kalia, Suneil K.; Hyman, Bradley T.; McLean, Pamela J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Kalia, Lorraine V.] Univ Toronto, Div Neurol, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Kalia, Suneil K.; Lozano, Andres M.] Univ Toronto, Div Neurosurg, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Kalia, Lorraine V.; Kalia, Suneil K.; Chau, Hien; Lozano, Andres M.] Univ Toronto, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON, Canada	Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kalia, LV (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA.	lorraine.kalia@utoronto.ca	Lozano, Andres M/A-5058-2012	Kalia, Lorraine/0000-0002-9384-1305; Lozano, Andres M./0000-0001-8257-3694; Kalia, Suneil/0000-0003-2054-1915; McLean, Pamela/0000-0003-4870-5715	NIH/NINDS [NS 063963]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063963] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS grant NS 063963 and research grants from the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arakawa A, 2010, STRUCTURE, V18, P309, DOI 10.1016/j.str.2010.01.004; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Briknarova K, 2002, J BIOL CHEM, V277, P31172, DOI 10.1074/jbc.M202792200; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Franssens V, 2010, CELL DEATH DIFFER, V17, P746, DOI 10.1038/cdd.2009.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	62	103	108	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14695	10.1371/journal.pone.0014695	http://dx.doi.org/10.1371/journal.pone.0014695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358815	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700008
J	Wang, LX; Million, M; Rivier, J; Rivier, C; Craft, N; Stenzel-Poore, MP; Tache, Y				Wang, Lixin; Million, Mulugeta; Rivier, Jean; Rivier, Catherine; Craft, Noah; Stenzel-Poore, Mary P.; Tache, Yvette			CRF Receptor Antagonist Astressin-B Reverses and Prevents Alopecia in CRF Over-Expressing Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; HAIR-GROWTH; TRANSGENIC MICE; DIFFERENTIAL EXPRESSION; CUTANEOUS EXPRESSION; STRESS-RESPONSE; MOUSE MODELS; HPA AXIS; SKIN; UROCORTIN	Corticotropin-releasing factor (CRF) signaling pathways are involved in the stress response, and there is growing evidence supporting hair growth inhibition of murine hair follicle in vivo upon stress exposure. We investigated whether the blockade of CRF receptors influences the development of hair loss in CRF over-expressing (OE)-mice that display phenotypes of Cushing's syndrome and chronic stress, including alopecia. The non-selective CRF receptors antagonist, astressin-B (5 mu g/mouse) injected peripherally once a day for 5 days in 4-9 months old CRF-OE alopecic mice induced pigmentation and hair re-growth that was largely retained for over 4 months. In young CRF-OE mice, astressin-B prevented the development of alopecia that occurred in saline-treated mice. Histological examination indicated that alopecic CRF-OE mice had hair follicle atrophy and that astressin-B revived the hair follicle from the telogen to anagen phase. However, astressin-B did not show any effect on the elevated plasma corticosterone levels and the increased weights of adrenal glands and visceral fat in CRF-OE mice. The selective CRF2 receptor antagonist, astressin(2)-B had moderate effect on pigmentation, but not on hair regrowth. The commercial drug for alopecia, minoxidil only showed partial effect on hair re-growth. These data support the existence of a key molecular switching mechanism triggered by blocking peripheral CRF receptors with an antagonist to reset hair growth in a mouse model of alopecia associated with chronic stress.	[Wang, Lixin; Million, Mulugeta; Tache, Yvette] Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Div Digest Dis,Dept Med,CURE, Los Angeles, CA 90095 USA; [Wang, Lixin; Million, Mulugeta; Tache, Yvette] Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Ctr Neurobiol Stress, Los Angeles, CA 90095 USA; [Rivier, Jean; Rivier, Catherine] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, San Diego, CA 92138 USA; [Craft, Noah] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Div Dermatol,Dept Med,Los Angeles Biomed Res Inst, Torrance, CA USA; [Craft, Noah] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Div Infect Dis,Dept Med,Los Angeles Biomed Res In, Torrance, CA USA; [Stenzel-Poore, Mary P.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Salk Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon Health & Science University	Wang, LX (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Div Digest Dis,Dept Med,CURE, Los Angeles, CA 90095 USA.	milllionmulugeta@mednet.ucla.edu			Department of Veterans Affairs; NIH [R01 DK-57238, R21 DK-068155, RO1 DK-078676, R01 DK-33061, P50 DK-64539, DK PO1-26741]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033061, R21DK068155, R01DK078676, R01DK057238, P01DK026741, P50DK064539] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Research Career Scientist Award, Department of Veterans Affairs (Y. Tache); and the following NIH grants: R01 DK-57238 (Y. Tache); R21 DK-068155 and RO1 DK-078676 (M. Million); R01 DK-33061 (Y. Tache, M. Million); P50 DK-64539 (Y. Tache, M. Million); DK PO1-26741 (J. Rivier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Botchkarev VA, 2003, AM J PATHOL, V162, P709, DOI 10.1016/S0002-9440(10)63866-7; Chen C, 2006, CURR MED CHEM, V13, P1261, DOI 10.2174/092986706776873014; Coste SC, 2001, PEPTIDES, V22, P733, DOI 10.1016/S0196-9781(01)00386-2; Dirks A, 2002, EUR J NEUROSCI, V16, P1751, DOI 10.1046/j.1460-9568.2002.02245.x; Goebel M, 2010, NEUROSCI LETT; Harrison S, 2009, CLEV CLIN J MED, V76, P361, DOI 10.3949/ccjm.76a.08080; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Kauser S, 2006, FASEB J, V20, P882, DOI 10.1096/fj.05-5257com; Martinez V, 2002, J PHARMACOL EXP THER, V301, P611, DOI 10.1124/jpet.301.2.611; Messenger AG, 2004, BRIT J DERMATOL, V150, P186, DOI 10.1111/j.1365-2133.2004.05785.x; Million M, 2007, AM J PHYSIOL-REG I, V292, pR1429, DOI 10.1152/ajpregu.00626.2006; Paus R, 2010, PIGMENT CELL MELANOM; Peters EMJ, 2006, EXP DERMATOL, V15, P1, DOI 10.1111/j.0906-6705.2005.00372.x; Porter RM, 2003, J ANAT, V202, P125, DOI 10.1046/j.1469-7580.2003.00140.x; Rivier J, 2002, J MED CHEM, V45, P4737, DOI 10.1021/jm0202122; Rivier JE, 1999, J MED CHEM, V42, P3175, DOI 10.1021/jm9902133; Roloff B, 1998, FASEB J, V12, P287, DOI 10.1096/fasebj.12.3.287; Selye H, 1950, PHYSL PATHOLOGY EXPO; Shirai A, 2001, J DERMATOL SCI, V25, P213, DOI 10.1016/S0923-1811(00)00147-X; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Slominski A, 1996, FEBS LETT, V399, P175, DOI 10.1016/S0014-5793(96)01315-4; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Slominski AT, 1999, ANN NY ACAD SCI, V885, P287; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Stengel A, 2009, ENDOCRINOLOGY, V150, P153, DOI 10.1210/en.2008-0723; StenzelPoore MP, 1996, ANN NY ACAD SCI, V780, P36, DOI 10.1111/j.1749-6632.1996.tb15110.x; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; Tobin DJ, 2005, MOL CELL ENDOCRINOL, V243, P1, DOI 10.1016/j.mce.2005.09.001; Turnbull AV, 1999, ENDOCRINOLOGY, V140, P1013, DOI 10.1210/en.140.2.1013; Vegesna V, 2002, ENDOCRINOLOGY, V143, P4389, DOI 10.1210/en.2002-220118; Wang LX, 2001, AM J PHYSIOL-REG I, V281, pR1401, DOI 10.1152/ajpregu.2001.281.5.R1401; Wood GA, 2005, EXP DERMATOL, V14, P373; Zhang XQ, 2009, J INVEST DERMATOL, V129, P1527, DOI 10.1038/jid.2008.371	38	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16377	10.1371/journal.pone.0016377	http://dx.doi.org/10.1371/journal.pone.0016377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359208	gold, Green Published, Green Submitted			2022-12-25	WOS:000287392700017
J	Homolka, D; Ivanek, R; Forejt, J; Jansa, P				Homolka, David; Ivanek, Robert; Forejt, Jiri; Jansa, Petr			Differential Expression of Non-Coding RNAs and Continuous Evolution of the X Chromosome in Testicular Transcriptome of Two Mouse Species	PLOS ONE			English	Article							HYBRID STERILITY; HUMAN GENOME; GENE; INACTIVATION; TESTIS; MICE; SPERMATOGENESIS; DROSOPHILA; CELLS; IDENTIFICATION	Background: Tight regulation of testicular gene expression is a prerequisite for male reproductive success, while differentiation of gene activity in spermatogenesis is important during speciation. Thus, comparison of testicular transcriptomes between closely related species can reveal unique regulatory patterns and shed light on evolutionary constraints separating the species. Methodology/Principal Findings: Here, we compared testicular transcriptomes of two closely related mouse species, Mus musculus and Mus spretus, which diverged more than one million years ago. We analyzed testicular expression using tiling arrays overlapping Chromosomes 2, X, Y and mitochondrial genome. An excess of differentially regulated non-coding RNAs was found on Chromosome 2 including the intronic antisense RNAs, intergenic RNAs and premature forms of Piwi-interacting RNAs (piRNAs). Moreover, striking difference was found in the expression of X-linked G6pdx gene, the parental gene of the autosomal retrogene G6pd2. Conclusions/Significance: The prevalence of non-coding RNAs among differentially expressed transcripts indicates their role in species-specific regulation of spermatogenesis. The postmeiotic expression of G6pdx in Mus spretus points towards the continuous evolution of X-chromosome silencing and provides an example of expression change accompanying the out-of-the X-chromosomal retroposition.	[Homolka, David; Ivanek, Robert; Forejt, Jiri; Jansa, Petr] Acad Sci Czech Republ, Inst Mol Genet, Dept Mouse Mol Genet, Ctr Appl Genom, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Homolka, D (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Mouse Mol Genet, Ctr Appl Genom, Prague, Czech Republic.	pjansa@img.cas.cz	Jansa, Petr/B-8153-2019; Jansa, Petr/G-6360-2014; Forejt, Jiri/AAF-5276-2019; Forejt, Jiri/G-7719-2012; Ivanek, Robert/A-8852-2008	Jansa, Petr/0000-0002-1406-1707; Forejt, Jiri/0000-0002-2793-3623; Forejt, Jiri/0000-0002-2793-3623; Ivanek, Robert/0000-0002-8403-056X	Czech Science Foundation (GACR) [301/07/1383]; Ministry of Education, Youth and Sports of the Czech Republic [IM6837805002, AV0Z5052514]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Czech Science Foundation (GACR), Grant 301/07/1383 and nos. IM6837805002 and AV0Z5052514 from the Ministry of Education, Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; Chan WY, 2006, GENOMICS, V87, P681, DOI 10.1016/j.ygeno.2005.12.006; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Hendriksen PJM, 1997, GENOMICS, V41, P350, DOI 10.1006/geno.1997.4673; Homolka D, 2007, GENOME RES, V17, P1431, DOI 10.1101/gr.6520107; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Mahler KL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-626; Marcon E, 2008, CHROMOSOME RES, V16, P243, DOI 10.1007/s10577-007-1190-6; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Shiao MS, 2007, MOL BIOL EVOL, V24, P2242, DOI 10.1093/molbev/msm153; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Voolstra C, 2007, GENOME RES, V17, P42, DOI 10.1101/gr.5683806; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Yan W, 2009, EPIGENETICS, P4; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17198	10.1371/journal.pone.0017198	http://dx.doi.org/10.1371/journal.pone.0017198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347268	Green Published, gold, Green Submitted			2022-12-25	WOS:000287367600041
J	Flanagan, KA; Webb, W; Stowers, L				Flanagan, Kelly A.; Webb, William; Stowers, Lisa			Analysis of Male Pheromones That Accelerate Female Reproductive Organ Development	PLOS ONE			English	Article							MALE-MOUSE URINE; VOMERONASAL ORGAN; HOUSE MOUSE; SEXUAL-MATURATION; SYNTHETIC CHEMOSIGNALS; PUBERTY ACCELERATION; INDUCED OVULATION; PREPUTIAL GLAND; MALE AGGRESSION; MUS-MUSCULUS	Male odors can influence a female's reproductive physiology. In the mouse, the odor of male urine results in an early onset of female puberty. Several volatile and protein pheromones have previously been reported to each account for this bioactivity. Here we bioassay inbred BALB/cJ females to study pheromone-accelerated uterine growth, a developmental hallmark of puberty. We evaluate the response of wild-type and mutant mice lacking a specialized sensory transduction channel, TrpC2, and find TrpC2 function to be necessary for pheromone-mediated uterine growth. We analyze the relative effectiveness of pheromones previously identified to accelerate puberty through direct bioassay and find none to significantly accelerate uterine growth in BALB/cJ females. Complementary to this analysis, we have devised a strategy of partial purification of the uterine growth bioactivity from male urine and applied it to purify bioactivity from three different laboratory strains. The biochemical characteristics of the active fraction of all three strains are inconsistent with that of previously known pheromones. When directly analyzed, we are unable to detect previously known pheromones in urine fractions that generate uterine growth. Our analysis indicates that pheromones emitted by males to advance female puberty remain to be identified.	[Flanagan, Kelly A.; Webb, William; Stowers, Lisa] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Flanagan, KA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	stowers@scripps.edu	Stowers, Lisa/K-6137-2015	Stowers, Lisa/0000-0002-4403-1269	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [2R01DC006885, 1R01CD009413]; Skaggs Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009413, R01DC006885] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Skaggs Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The submitted work was funded by the National Institutes of Health/National Institute on Deafness and Other Communication Disorders 2R01DC006885 and 1R01CD009413 and the Skaggs Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Bimova B, 2009, BEHAV PROCESS, V80, P20, DOI 10.1016/j.beproc.2008.08.004; BRONSON FH, 1973, BIOL REPROD, V9, P449, DOI 10.1093/biolreprod/9.5.449; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; CLARK AJ, 1985, EMBO J, V4, P3159, DOI 10.1002/j.1460-2075.1985.tb04059.x; CLISSOLD PM, 1984, BIOCHEM GENET, V22, P379, DOI 10.1007/BF00484236; CLISSOLD PM, 1982, GENE, V18, P211, DOI 10.1016/0378-1119(82)90158-5; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; DRICKAMER LC, 1981, DEV PSYCHOBIOL, V14, P487, DOI 10.1002/dev.420140511; DRICKAMER LC, 1976, J REPROD FERTIL, V46, P369, DOI 10.1530/jrf.0.0460369; DRICKAMER LC, 1986, PHYSIOL BEHAV, V37, P741, DOI 10.1016/0031-9384(86)90179-4; GAGNAIRE F, 1989, J APPL TOXICOL, V9, P301, DOI 10.1002/jat.2550090504; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; JEMIOLO B, 1992, PHYSIOL BEHAV, V52, P521, DOI 10.1016/0031-9384(92)90341-X; JEMIOLO B, 1991, PHYSIOL BEHAV, V50, P1119, DOI 10.1016/0031-9384(91)90570-E; KANEKO N, 1980, BIOL REPROD, V22, P873, DOI 10.1095/biolreprod22.4.873; Kelliher KR, 2006, EUR J NEUROSCI, V23, P3385, DOI 10.1111/j.1460-9568.2006.04866.x; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Koyama S, 2004, HORM BEHAV, V46, P303, DOI 10.1016/j.yhbeh.2004.03.002; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; LOMAS DE, 1982, J REPROD FERTIL, V66, P101, DOI 10.1530/jrf.0.0660101; Ma WD, 1999, CHEM SENSES, V24, P289, DOI 10.1093/chemse/24.3.289; Matsumoto S, 2010, BIOSCI BIOTECH BIOCH, V74, P223, DOI 10.1271/bbb.90756; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; NISHIMURA K, 1989, J EXP ZOOL, V251, P300, DOI 10.1002/jez.1402510306; NISHIMURA K, 1979, OKAYAMA DAIGAKU  FEB, P23; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; NOVOTNY M, 1984, EXPERIENTIA, V40, P217, DOI 10.1007/BF01963608; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Oliva AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011359; PANDEY SD, 1988, ACTA PHYSIOL HUNG, V72, P165; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; PRICE MA, 1992, J EXP ZOOL, V264, P42, DOI 10.1002/jez.1402640107; Ramm SA, 2008, P ROY SOC B-BIOL SCI, V275, P1727, DOI 10.1098/rspb.2008.0302; Rekwot PI, 2001, ANIM REPROD SCI, V65, P157, DOI 10.1016/S0378-4320(00)00223-2; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Rock F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000429; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Sharrow SD, 2002, PROTEIN SCI, V11, P2247, DOI 10.1110/ps.0204202; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; VANDENBERGH JG, 1969, ENDOCRINOLOGY, V84, P658, DOI 10.1210/endo-84-3-658; VANDENBERGH JG, 1972, J REPROD FERTIL, V28, P397, DOI 10.1530/jrf.0.0280397; VANDENBERGH JG, 1976, BIOL REPROD, V15, P260, DOI 10.1095/biolreprod15.2.260; VANDENBERGH JG, 1975, J REPROD FERTIL, V43, P515, DOI 10.1530/jrf.0.0430515; WHITTEN WK, 1958, J ENDOCRINOL, V17, P307, DOI 10.1677/joe.0.0170307; ZARROW MX, 1971, BIOL REPROD, V4, P52, DOI 10.1093/biolreprod/4.1.52; ZARROW MX, 1973, J REPROD FERTIL, V35, P81, DOI 10.1530/jrf.0.0350081; Zhang JX, 2007, CHEM SENSES, V32, P293, DOI 10.1093/chemse/bjl058	61	39	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16660	10.1371/journal.pone.0016660	http://dx.doi.org/10.1371/journal.pone.0016660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347429	gold, Green Published			2022-12-25	WOS:000287077600013
J	Ochala, J; Lehtokari, VL; Iwamoto, H; Li, MS; Feng, HZ; Jin, JP; Yagi, N; Wallgren-Pettersson, C; Penisson-Besnier, I; Larsson, L				Ochala, Julien; Lehtokari, Vilma-Lotta; Iwamoto, Hiroyuki; Li, Meishan; Feng, Han-Zhong; Jin, Jian-Ping; Yagi, Naoto; Wallgren-Pettersson, Carina; Penisson-Besnier, Isabelle; Larsson, Lars			Disrupted myosin cross-bridge cycling kinetics triggers muscle weakness in nebulin-related myopathy	FASEB JOURNAL			English	Article						congenital myopathy; tropomyosin activation	X-RAY-DIFFRACTION; FILAMENT REGULATORY PROTEINS; VITRO MOTILITY ASSAY; SKELETAL-MUSCLE; NEMALINE MYOPATHY; SHORTENING VELOCITY; CALCIUM ACTIVATION; STRUCTURAL-CHANGES; SARCOMERE LENGTH; FORCE GENERATION	Nebulin is a giant protein expressed at high levels in skeletal muscle. Mutations in the nebulin gene (NEB) lead to muscle weakness and various congenital myopathies. Despite increasing clinical and scientific interest, the pathogenesis of weakness remains unknown. The present study, therefore, aims at unraveling the underlying molecular mechanisms. Hence, we recorded and analyzed the mechanics as well as the X-ray diffraction patterns of human membrane-permeabilized single muscle fibers expressing nebulin mutations. Results demonstrated that, during contraction, the cycling rate of myosin heads attaching to actin is dramatically perturbed, causing a reduction in the fraction of myosin-actin interactions in the strong binding state. This phenomenon prevents complete thin-filament activation, more especially proper and full tropomyosin movement, further limiting additional binding of myosin cross-bridges. At the cell level, this reduces the force-generating capacity and, overall, provokes muscle weakness. To reverse such a negative cascade of events, future potential therapeutic interventions should, therefore, focus on the triggering component, the altered myosin cross-bridge cycling kinetics.-Ochala, J., Lehtokari, V.-L., Iwamoto, H., Li, M., Feng, H.-Z., Jin, J. P., Yagi, N., Wallgren-Pettersson, C. Penisson-Besnier, I., Larsson, L. Disrupted myosin cross-bridge cycling kinetics triggers muscle weakness in nebulin-related myopathy. FASEB J. 25, 1903-1913 (2011). www.fasebj.org	[Ochala, Julien; Li, Meishan; Larsson, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lehtokari, Vilma-Lotta; Wallgren-Pettersson, Carina] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Lehtokari, Vilma-Lotta; Wallgren-Pettersson, Carina] Univ Helsinki, Folkhalsan Inst Genet, Haartman Inst, Helsinki, Finland; [Iwamoto, Hiroyuki; Yagi, Naoto] Japan Synchrotron Radiat Res Inst, Hyogo, Japan; [Feng, Han-Zhong; Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Penisson-Besnier, Isabelle] Ctr Hosp Univ Angers, Ctr Reference Malad Neuromusculaires, Dept Neurol, Angers, France; [Larsson, Lars] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Uppsala University; University of Helsinki; University of Helsinki; Japan Synchrotron Radiation Research Institute; Wayne State University; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ochala, J (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Entrance 85,3rd Floor, SE-75185 Uppsala, Sweden.	julien.ochala@neuro.uu.se	Ochala, Julien/K-4120-2017; Jin, Jian-Ping/AAD-1149-2020; Larsson, Lars/AAY-1347-2021	Ochala, Julien/0000-0002-6358-2920; Lehtokari, Vilma-Lotta/0000-0002-8276-0972; Jin, JP/0000-0001-9932-1063; Larsson, Lars/0000-0003-3722-035X	Swedish Research Council [8651]; Association Francaise contre les Myopathies; Tore Nilson Stiftelse; Stiftelsen Apotekare Hedbergs Fond for Medicinsk Forskning; Rektors Resebidrag fran Wallenbergstiftelsen; U.S. National Institutes of Health [AR-048816]; Academy of Finland; Sigrid Juselius Foundation; Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa; Swedish Cancer Foundation; European Commission [CT-223756]; King Gustaf V and Queen Victoria's Foundation; Thureus Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Tore Nilson Stiftelse; Stiftelsen Apotekare Hedbergs Fond for Medicinsk Forskning; Rektors Resebidrag fran Wallenbergstiftelsen; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa; Swedish Cancer Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); King Gustaf V and Queen Victoria's Foundation; Thureus Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. P. Marcorelles for the electron microscopy study and Y. Hedstrom, C. Dumez, and I. Viau for excellent technical assistance. The authors also thank Dr. K. Pelin for helpful comments on the manuscript. X-ray experiments were performed under the approval of the SPring-8 Proposal Review Committee (2009B1918). This study was supported by grants from the Swedish Research Council, Association Francaise contre les Myopathies, Tore Nilson Stiftelse, Stiftelsen Apotekare Hedbergs Fond for Medicinsk Forskning, and Rektors Resebidrag fran Wallenbergstiftelsen to J.O.; the U.S. National Institutes of Health (AR-048816) to J.-P.J.; the Academy of Finland, Association Francaise contre les Myopathies, Sigrid Juselius Foundation, Finska Lakaresallskapet, and Medicinska Understodsforeningen Liv och Halsa to C.W.-P.; and the Swedish Research Council (8651), Association Francaise contre les Myopathies, Swedish Cancer Foundation, European Commission (MyoAge, Fp7 CT-223756), King Gustaf V and Queen Victoria's Foundation, and Thureus Foundation to L.L.	Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Chandra M, 2009, J BIOL CHEM, V284, P30889, DOI 10.1074/jbc.M109.049718; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; Gokhin DS, 2009, AM J PHYSIOL-CELL PH, V296, pC1123, DOI 10.1152/ajpcell.00503.2008; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hook P, 1999, J PHYSIOL-LONDON, V520, P463, DOI 10.1111/j.1469-7793.1999.00463.x; Hook P, 2000, J MUSCLE RES CELL M, V21, P357, DOI 10.1023/A:1005614212575; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Iwamoto H, 2003, BIOPHYS J, V85, P2492, DOI 10.1016/S0006-3495(03)74672-4; Iwamoto H, 2002, J MOL BIOL, V317, P707, DOI 10.1006/jmbi.2002.5449; Iwamoto H, 2001, J MOL BIOL, V305, P863, DOI 10.1006/jmbi.2000.4334; Iwamoto H, 2009, J MOL BIOL, V390, P99, DOI 10.1016/j.jmb.2009.05.002; JIN JP, 1995, J BIOL CHEM, V270, P6908; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370; Martyn DA, 2007, BIOPHYS J, V92, P4379, DOI 10.1529/biophysj.106.096768; MCDONALD KS, 1995, J APPL PHYSIOL, V79, P1796, DOI 10.1152/jappl.1995.79.5.1796; MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177, DOI 10.1113/jphysiol.1979.sp012845; OCHALA J, P NATL ACAD SCI US, V107, P9807; Ochala J, 2008, J MOL MED-JMM, V86, P1197, DOI 10.1007/s00109-008-0380-9; Ogut O, 2003, J BIOL CHEM, V278, P3089, DOI 10.1074/jbc.M205853200; Ottenheijm CAC, 2010, J STRUCT BIOL, V170, P334, DOI 10.1016/j.jsb.2009.11.013; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; Pappas C. T., J CELL BIOL, V189, P859; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Penisson-Besnier I, 2007, NEUROMUSCULAR DISORD, V17, P330, DOI 10.1016/j.nmd.2007.01.017; Regnier M, 1998, BIOPHYS J, V74, P2005, DOI 10.1016/S0006-3495(98)77907-X; Reiser PJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P112, DOI 10.1016/j.abb.2006.06.013; Romero NB, 2009, NEUROLOGY, V73, P1159, DOI 10.1212/WNL.0b013e3181bacf45; Root DD, 2001, BIOCHEMISTRY-US, V40, P1171, DOI 10.1021/bi0015010; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; Solaro RJ, 2009, IDRUGS, V12, P243; Thedinga E, 1999, J MUSCLE RES CELL M, V20, P785, DOI 10.1023/A:1005658825375; TONINO P, J CELL SCI, V123, P384; Wakayama J, 2004, BIOPHYS J, V87, P430, DOI 10.1529/biophysj.103.035063; Wallgren-Pettersson C, 2007, BRAIN, V130, P1465, DOI 10.1093/brain/awm094; Wang K, 1996, J BIOL CHEM, V271, P4304; WANG K, 1988, J CELL BIOL, V107, P2199, DOI 10.1083/jcb.107.6.2199; Wang K, 1996, ADV BIOPHYS, V33, P123; Yagi N, 2003, BIOPHYS J, V84, P1093, DOI 10.1016/S0006-3495(03)74925-X	45	39	39	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2011	25	6					1903	1913		10.1096/fj.10-176727	http://dx.doi.org/10.1096/fj.10-176727			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21350120	Green Published			2022-12-25	WOS:000291023800014
J	Dong, XY; Guo, P; Sun, XD; Li, QN; Dong, JT				Dong, Xue-Yuan; Guo, Peng; Sun, Xiaodong; Li, Qunna; Dong, Jin-Tang			Estrogen Up-regulates ATBF1 Transcription but Causes Its Protein Degradation in Estrogen Receptor-alpha-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; EPITHELIAL-CELLS; PROSTATE-CANCER; MENSTRUAL-CYCLE; PROGESTERONE-RECEPTOR; GASTRIC-CANCER; HEALTHY WOMEN; MAMMARY-GLAND; C-MYC; ACTIVATION	The proper level of estrogen-estrogen receptor (ER) signaling is important for the maintenance of epithelial homeostasis in the breast. In a previous study we demonstrated that ATBF1, which has been suggested as a tumor suppressor in breast cancer, inhibited estrogen-mediated cell proliferation by selectively competing with AIB1 for binding to the ER. However, the expression of ATBF1 mRNA was shown to positively correlate with ER in breast cancer specimens. We, therefore, examined whether estrogen regulates ATBF1. We demonstrated that estrogen up-regulated the transcription of ATBF1, which was mediated by the direct binding of the ER onto the ATBF1 promoter, and that a half-estrogen-responsive element in the ATBF1 promoter was essential for ER direct binding. Furthermore, we found that estrogen at lower levels increased, but at higher levels decreased the expression of ATBF1 protein, which involved the degradation of ATBF1 protein by the estrogen-responsive proteasome system. ATBF1 protein levels fluctuate with estrogen levels. Although lower levels of estrogen increased ATBF1 protein expression, ATBF1 still inhibited cell proliferation caused by lower levels of estrogen. These findings not only reveal an autoregulatory feedback loop between ATBF1 and estrogen-ER signaling but also suggest that ATBF1 plays a role in both the maintenance of breast epithelial homeostasis and breast tumorigenesis caused by elevated estrogen levels.	Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Dong, JT (corresponding author), 1365-C Clifton Rd, Atlanta, GA 30322 USA.	j.dong@emory.edu	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022	Dong, Jin-Tang/0000-0003-2349-5782; Guo, Peng/0000-0002-4575-8443	National Institutes of Health [CA85560]; Department of Defense [W81XWH-08-1-0328]; Georgia Cancer Coalition Award [GCC130042]; NATIONAL CANCER INSTITUTE [R01CA085560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Georgia Cancer Coalition Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA85560 (to J.-T.D.). This work was also supported by Department of Defense Grant W81XWH-08-1-0328 and Georgia Cancer Coalition Award GCC130042 (both to X.-Y.D.).	Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16; Anderson E, 1998, J MAMMARY GLAND BIOL, V3, P23, DOI 10.1023/A:1018718117113; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Berns A, 2010, NATURE, V468, P519, DOI 10.1038/468519a; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; BRUNNER N, 1993, CANCER RES, V53, P3229; Burger A, 2006, NEOPLASIA, V8, P689, DOI 10.1593/neo.06469; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cho YG, 2007, CLIN CANCER RES, V13, P4355, DOI 10.1158/1078-0432.CCR-07-0619; Clarke RB, 2006, MATURITAS, V54, P327, DOI 10.1016/j.maturitas.2006.06.002; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cleton-Jansen AM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-105; Cottone E, 2001, INT J BIOL MARKER, V16, P151, DOI 10.1177/172460080101600301; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; DUBIK D, 1992, ONCOGENE, V7, P1587; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Farage MA, 2009, OBSTET GYNECOL SURV, V64, P58, DOI 10.1097/OGX.0b013e3181932a37; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Ferguson AT, 1997, CRIT REV ONCOGENESIS, V8, P29, DOI 10.1615/CritRevOncog.v8.i1.20; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Guo P, 2009, J BIOL CHEM, V284, P28243, DOI 10.1074/jbc.M109.036160; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Hartel A, 2003, J STEROID BIOCHEM, V84, P231, DOI 10.1016/S0960-0760(03)00033-5; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Jamerson MH, 2000, ONCOGENE, V19, P1065, DOI 10.1038/sj.onc.1203268; Kai K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-262; Kaspar P, 1999, J BIOL CHEM, V274, P14422, DOI 10.1074/jbc.274.20.14422; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Kim CJ, 2008, HISTOPATHOLOGY, V52, P552, DOI 10.1111/j.1365-2559.2008.02980.x; Kimura N, 2008, J MOL ENDOCRINOL, V40, P75, DOI 10.1677/JME-07-0108; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lemieux P, 1996, J STEROID BIOCHEM, V56, P87, DOI 10.1016/0960-0760(95)00269-3; Li H, 2002, GYNECOL ONCOL, V84, P216, DOI 10.1006/gyno.2001.6498; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Mori Y, 2007, INT J CANCER, V121, P241, DOI 10.1002/ijc.22654; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Soderqvist G, 1997, AM J OBSTET GYNECOL, V176, P123, DOI 10.1016/S0002-9378(97)80024-5; SODERQVIST G, 1993, AM J OBSTET GYNECOL, V168, P874; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2007, J CANCER RES CLIN, V133, P103, DOI 10.1007/s00432-006-0148-y; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Xu JY, 2006, PROSTATE, V66, P1082, DOI 10.1002/pros.20430; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; ZAJCHOWSKI DA, 1993, CANCER RES, V53, P5004; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang ZH, 2005, CLIN CANCER RES, V11, P193	60	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13879	13890		10.1074/jbc.M110.187849	http://dx.doi.org/10.1074/jbc.M110.187849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367855	hybrid, Green Published			2022-12-25	WOS:000289556200011
J	Kansanen, E; Bonacci, G; Schopfer, FJ; Kuosmanen, SM; Tong, KI; Leinonen, H; Woodcock, SR; Yamamoto, M; Carlberg, C; Yla-Herttuala, S; Freeman, BA; Levonen, AL				Kansanen, Emilia; Bonacci, Gustavo; Schopfer, Francisco J.; Kuosmanen, Suvi M.; Tong, Kit I.; Leinonen, Hanna; Woodcock, Steven R.; Yamamoto, Masayuki; Carlberg, Carsten; Yla-Herttuala, Seppo; Freeman, Bruce A.; Levonen, Anna-Liisa			Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; PHASE-2 RESPONSE; GENE-EXPRESSION; DEFENSE SYSTEM; SENSOR KEAP1; DLG MOTIFS; OLEIC ACID; PROTEIN	Nitro-fatty acids (NO2-FAs) are electrophilic signaling mediators formed in vivo via nitric oxide (NO)- and nitrite (NO2-)-dependent reactions. Nitro-fatty acids modulate signaling cascades via reversible covalent post-translational modification of nucleophilic amino acids in regulatory proteins and enzymes, thus altering downstream signaling events, such as Keap1-Nrf2-antioxidant response element (ARE)-regulated gene expression. In this study, we investigate the molecular mechanisms by which 9- and 10-nitro-octadec-9-enoic acid (OA-NO2) activate the transcription factor Nrf2, focusing on the post-translational modifications of cysteines in the Nrf2 inhibitor Keap1 by nitroalkylation and its downstream responses. Of the two regioisomers, 9-nitrooctadec-9-enoic acid was a more potent ARE inducer than 10-nitro-octadec-9-enoic acid. The most OA-NO2-reactive Cys residues in Keap1 were Cys(38), Cys(226), Cys(257), Cys(273), Cys(288), and Cys(489). Of these, Cys(273) and Cys(288) accounted for similar to 50% of OA-NO2 reactions in a cellular milieu. Notably, Cys(151) was among the least OA-NO2-reactive of the Keap1 Cys residues, with mutation of Cys(151) having no effect on net OA-NO2 reaction with Keap1 or on ARE activation. Unlike many other Nrf2-activating electrophiles, OA-NO2 enhanced rather than diminished the binding between Keap1 and the Cul3 subunit of the E3 ligase for Nrf2. OA-NO2 canthereforebe categorized as a Cys(151)-independent Nrf2 activator, which in turn can influence the pattern of gene expression and therapeutic actions of nitroalkenes.	[Bonacci, Gustavo; Schopfer, Francisco J.; Woodcock, Steven R.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Kansanen, Emilia; Leinonen, Hanna; Yla-Herttuala, Seppo; Levonen, Anna-Liisa] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, FIN-70211 Kuopio, Finland; [Kuosmanen, Suvi M.; Carlberg, Carsten] Univ Eastern Finland, Dept Biosci, FIN-70211 Kuopio, Finland; [Tong, Kit I.; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Eastern Finland; University of Eastern Finland; Tohoku University; University of Luxembourg	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	freerad@pitt.edu; anna-liisa.levonen@uef.fi	Linna-Kuosmanen, Suvi/P-4574-2018; Schopfer, Francisco Jose/AAE-8125-2020; Woodcock, Steven/AAE-9199-2020; Freeman, Bruce A/H-9342-2012; Carlberg, Carsten/C-9075-2011; Schopfer, Francisco/AAW-6505-2021; Yamamoto, Masayuki/A-4873-2010	Linna-Kuosmanen, Suvi/0000-0002-3278-2727; Schopfer, Francisco Jose/0000-0001-9526-695X; Carlberg, Carsten/0000-0003-2633-0684; Yamamoto, Masayuki/0000-0002-9073-9436; Yla-Herttuala, Seppo/0000-0001-7593-2708; Levonen, Anna-Liisa/0000-0002-6575-2137; Kansanen, Emilia/0000-0001-6029-8097	National Institutes of Health [HL58115, HL64937]; Finnish Cultural Foundation; Academy of Finland; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Finnish Cancer Organizations; American Diabetes Association; Complexa, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058115, R01HL058115, R01HL064937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; American Diabetes Association(American Diabetes Association); Complexa, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58115 and HL64937 (to B.A.F., G.B., and F.J.S.). This work was also supported by grants from the Finnish Cultural Foundation (to E.K. and A.-L.L.), the Academy of Finland (to C.C. and A.-L.L.), the Finnish Foundation for Cardiovascular Research, the Sigrid Juselius Foundation, the Finnish Cancer Organizations (to A.-L.L.), and the American Diabetes Association (to F.J.S.). B.A.F. acknowledges a financial interest in Complexa, Inc.	Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Copple IM, 2008, HEPATOLOGY, V48, P1292, DOI 10.1002/hep.22472; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Gorczynski MJ, 2009, J MED CHEM, V52, P4631, DOI 10.1021/jm900326c; Hurttila H, 2008, GENE THER, V15, P1271, DOI 10.1038/gt.2008.75; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Kansanen E, 2009, FREE RADICAL BIO MED, V47, P1310, DOI 10.1016/j.freeradbiomed.2009.06.030; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levonen AL, 2001, ARTERIOSCL THROM VAS, V21, P1846, DOI 10.1161/hq1101.098488; Li L, 2008, J BIOL CHEM, V283, P3248, DOI 10.1074/jbc.M708702200; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang XJ, 2008, TOXICOL APPL PHARM, V230, P383, DOI 10.1016/j.taap.2008.03.003; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang JF, 2010, CIRC RES, V107, P540, DOI 10.1161/CIRCRESAHA.110.218404; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	43	151	155	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14019	14027		10.1074/jbc.M110.190710	http://dx.doi.org/10.1074/jbc.M110.190710			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357422	Green Published, hybrid			2022-12-25	WOS:000289556200024
J	Kovacic, PB; Chowdhury, HH; Velebit, J; Kreft, M; Jensen, J; Zorec, R				Kovacic, Petra Brina; Chowdhury, Helena H.; Velebit, Jelena; Kreft, Marko; Jensen, Jorgen; Zorec, Robert			New Insights into Cytosolic Glucose Levels during Differentiation of 3T3-L1 Fibroblasts into Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; INSULIN-RESISTANCE; PHOSPHORYLATION STATE; PHORBOL ESTER; HEXOSE UPTAKE; TRANSPORT; MODULATION; RESPONSIVENESS; ISOPROTERENOL; STIMULATION	Cytosolic glucose concentration reflects the balance between glucose entry across the plasma membrane and cytosolic glucose utilization. In adipocytes, glucose utilization is considered very rapid, meaning that every glucose molecule entering the cytoplasm is quickly phosphorylated. Thus, the cytosolic free glucose concentration is considered to be negligible; however, it was never measured directly. In the present study, we monitored cytosolic glucose dynamics in 3T3-L1 fibroblasts and adipocytes by expressing a fluorescence resonance energy transfer (FRET)-based glucose nanosensor: fluorescent indicator protein FLIPglu-600 mu.. Specifically, we monitored cytosolic glucose responses by varying transmembrane glucose concentration gradient. The changes in cytosolic glucose concentration were detected in only 56% of 3T3-L1 fibroblasts and in 14% of 3T3-L1 adipocytes. In adipocytes, the resting cytosolic glucose concentration was reduced in comparison with the one recorded in fibroblasts. Membrane permeabilization increased cytosolic glucose concentration in adipocytes, and glycolytic inhibitor iodoacetate failed to increase cytosolic glucose concentration, indicating low adipocyte permeability for glucose at rest. We also examined the effects of insulin and adrenaline. Insulin significantly increased cytosolic glucose concentration in adipocytes by a factor of 3.6; however, we recorded no effect on delta ratio (Delta R) in fibroblasts. Adrenaline increased cytosolic glucose concentration in fibroblasts but not in adipocytes. However, in adipocytes in insulin-stimulated conditions, glucose clearance was significantly faster following adrenaline addition in comparison with controls (p < 0.001). Together, these results demonstrate that during differentiation, adipocytes develop more efficient mechanisms for maintaining low cytosolic glucose concentration, predominantly with reduced membrane permeability for glucose.	[Chowdhury, Helena H.; Kreft, Marko; Zorec, Robert] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Ljubljana 1000, Slovenia; [Kovacic, Petra Brina; Chowdhury, Helena H.; Velebit, Jelena; Kreft, Marko; Zorec, Robert] Biomed Ctr, Ljubljana 1000, Slovenia; [Jensen, Jorgen] Norwegian Sch Sport Sci, Dept Phys Performance, N-0864 Oslo, Norway	University of Ljubljana; Norwegian School of Sport Sciences	Zorec, R (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Zaloska 4, Ljubljana 1000, Slovenia.	robert.zorec@mf.uni-lj.si	Jensen, Jørgen/O-2245-2013; Chowdhury, Helena/ADV-0582-2022; Zorec, Robert/AAD-7180-2021	Chowdhury, Helena/0000-0001-8252-573X; Zorec, Robert/0000-0002-7478-3875	Ministry of Higher Education, Sciences and Technology of the Republic of Slovenia [P3 310 381]; European Commission [QLG1-CT2001/02233]	Ministry of Higher Education, Sciences and Technology of the Republic of Slovenia; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Grant P3 310 381 from the Ministry of Higher Education, Sciences and Technology of the Republic of Slovenia, by a grant from the Ministry of Higher Education, Sciences and Technology of the Republic of Slovenia (to P. B. K.), and by European Commission GrowBeta Grant QLG1-CT2001/02233.	Aslesen R, 1998, AM J PHYSIOL-ENDOC M, V275, pE448, DOI 10.1152/ajpendo.1998.275.3.E448; Chen XL, 2005, J PROTEOME RES, V4, P570, DOI 10.1021/pr049772a; CUSHMAN SW, 1983, ADIPOCYTE OBESITY CE, P105; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; Elmendorf JS, 1999, EXP CELL RES, V253, P55, DOI 10.1006/excr.1999.4675; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; FLIER JS, 1983, ANNU REV MED, V34, P145, DOI 10.1146/annurev.me.34.020183.001045; FURLER SM, 1991, AM J PHYSIOL, V261, pE337, DOI 10.1152/ajpendo.1991.261.3.E337; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GRUBER K, 1971, N-S ARCH PHARMAKOL, V271, P361, DOI 10.1007/BF00997125; HARRISON SA, 1991, P NATL ACAD SCI USA, V88, P7839, DOI 10.1073/pnas.88.17.7839; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JENSEN J, 1995, BIOCHEM MOL BIOL INT, V35, P145; John SA, 2008, PFLUG ARCH EUR J PHY, V456, P307, DOI 10.1007/s00424-007-0395-z; JOOST HG, 1986, J BIOL CHEM, V261, P33; JOOST HG, 1987, J BIOL CHEM, V262, P11261; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KAHN CR, 1978, METABOLISM, V27, P1893; KIRSCH DM, 1983, BIOCHEM J, V216, P737, DOI 10.1042/bj2160737; KLETZIEN RF, 1973, J BIOL CHEM, V248, P711; KURODA M, 1987, J BIOL CHEM, V262, P245; Lafontan M, 1995, OBES RES, V3, pS507, DOI 10.1002/j.1550-8528.1995.tb00220.x; Lefrere I, 2002, J BIOL CHEM, V277, P39169, DOI 10.1074/jbc.M205084200; Monjo M, 2005, AM J PHYSIOL-ENDOC M, V289, pE145, DOI 10.1152/ajpendo.00563.2004; Mulder AH, 2005, AM J PHYSIOL-ENDOC M, V289, pE627, DOI 10.1152/ajpendo.00079.2004; NISHIMURA H, 1991, P NATL ACAD SCI USA, V88, P11500, DOI 10.1073/pnas.88.24.11500; OLEFSKY JM, 1989, ENDOCRINOLOGY, P1369; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; PURICH DL, 1971, J BIOL CHEM, V246, P3456; RESH MD, 1982, J BIOL CHEM, V257, P6978; ROSEN OM, 1978, J BIOL CHEM, V253, P7579; SMITH U, 1984, J BIOL CHEM, V259, P8758; TRAYHURN P, 2007, OBES BEW S, V1, P41; Webb J.L., 1966, ENZYMES METABOL INH, VIII, P1; WHITESELL RR, 1985, J BIOL CHEM, V260, P2894	37	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13370	13381		10.1074/jbc.M110.200980	http://dx.doi.org/10.1074/jbc.M110.200980			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349852	Green Published, hybrid			2022-12-25	WOS:000289282200057
J	Sacchi, O; Rossi, ML; Canella, R; Fesce, R				Sacchi, Oscar; Rossi, Maria Lisa; Canella, Rita; Fesce, Riccardo			Changes in Cationic Selectivity of the Nicotinic Channel at the Rat Ganglionic Synapse: A Role for Chloride Ions?	PLOS ONE			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; SYMPATHETIC NEURON; ACETYLCHOLINE-RECEPTORS; VOLTAGE-CLAMP; INTRACELLULAR SODIUM; AUTONOMIC GANGLIA; CELLS; SUBUNIT; PHOSPHORYLATION; ALPHA-7	The permeability of the nicotinic channel (nAChR) at the ganglionic synapse has been examined, in the intact rat superior cervical ganglion in vitro, by fitting the Goldman current equation to the synaptic current (EPSC) I-V relationship. Subsynaptic nAChRs, activated by neurally-released acetylcholine (ACh), were thus analyzed in an intact environment as natively expressed by the mature sympathetic neuron. Postsynaptic neuron hyperpolarization (from -40 to -90 mV) resulted in a change of the synaptic potassium/sodium permeability ratio (P-K/P-Na) from 1.40 to 0.92, corresponding to a reversible shift of the apparent acetylcholine equilibrium potential, E-ACh, by about +10 mV. The effect was accompanied by a decrease of the peak synaptic conductance (g(syn)) and of the EPSC decay time constant. Reduction of [Cl-](o) to 18 mM resulted in a change of P-K/P-Na from 1.57 (control) to 2.26, associated with a reversible shift of EACh by about -10 mV. Application of 200 nM alpha BgTx evoked P-K/P-Na and g(syn) modifications similar to those observed in reduced [Cl-](o). The two treatments were overlapping and complementary, as if the same site/mechanism were involved. The difference current before and after chloride reduction or toxin application exhibited a strongly positive equilibrium potential, which could not be explained by the block of a calcium component of the EPSC. Observations under current-clamp conditions suggest that the driving force modification of the EPSC due to P-K/P-Na changes represent an additional powerful integrative mechanism of neuron behavior. A possible role for chloride ions is suggested: the nAChR selectivity was actually reduced by increased chloride gradient (membrane hyperpolarization), while it was increased, moving towards a channel preferentially permeable for potassium, when the chloride gradient was reduced.	[Sacchi, Oscar; Rossi, Maria Lisa; Canella, Rita] Univ Ferrara, Sect Physiol & Biophys, Dept Biol & Evolut, I-44100 Ferrara, Italy; [Fesce, Riccardo] Insubria Univ, DBSF, Varese, Italy; [Fesce, Riccardo] Insubria Univ, Ctr Neurosci, Varese, Italy	University of Ferrara; University of Insubria; University of Insubria	Sacchi, O (corresponding author), Univ Ferrara, Sect Physiol & Biophys, Dept Biol & Evolut, I-44100 Ferrara, Italy.	sho@unife.it	Rossi, Maria Lisa/D-4251-2011	Rossi, Maria Lisa/0000-0002-9057-7422; fesce, riccardo/0000-0001-9473-896X	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [2006050200-002, 2006050200-003]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This paper was supported by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca within the national research project PRIN 2006 (2006050200-002 O.S. and 2006050200-003 R.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAVAREZLEEFMAN.FJ, 1988, J PHYSL, V406, P225; BALLANYI K, 1985, J PHYSIOL-LONDON, V365, P41, DOI 10.1113/jphysiol.1985.sp015758; BELLUZZI O, 1991, PROG BIOPHYS MOL BIO, V55, P1, DOI 10.1016/0079-6107(91)90009-H; BELLUZZI O, 1985, J PHYSIOL-LONDON, V358, P91, DOI 10.1113/jphysiol.1985.sp015542; BELLUZZI O, 1985, J PHYSIOL-LONDON, V358, P109, DOI 10.1113/jphysiol.1985.sp015543; CHRISTOFFERSEN GRJ, 1975, COMP BIOCHEM PHYS A, V52, P317, DOI 10.1016/S0300-9629(75)80094-6; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Cuevas J, 2000, J PHYSIOL-LONDON, V525, P735, DOI 10.1111/j.1469-7793.2000.t01-1-00735.x; DeKoninck P, 1995, J NEUROSCI, V15, P7966; DERKACH VA, 1983, J PHYSIOL-LONDON, V336, P511, DOI 10.1113/jphysiol.1983.sp014595; DUN N, 1976, NEUROPHARMACOLOGY, V15, P211, DOI 10.1016/0028-3908(76)90066-6; FORSTER I, 1995, P ROY SOC B-BIOL SCI, V260, P139, DOI 10.1098/rspb.1995.0071; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gotti C, 2000, BEHAV BRAIN RES, V113, P183, DOI 10.1016/S0166-4328(00)00212-6; Gotti C, 1998, BRIT J PHARMACOL, V124, P1197, DOI 10.1038/sj.bjp.0701957; Henderson P, 1907, Z PHYS CHEM-STOCH VE, V59, P118; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Knopfel T, 1998, EUR J NEUROSCI, V10, P1926, DOI 10.1046/j.1460-9568.1998.00195.x; KOKETSU K, 1969, FED PROC, V28, P101; KUBA K, 1979, PFLUG ARCH EUR J PHY, V378, P205, DOI 10.1007/BF00592737; MACDERMOTT AB, 1980, J GEN PHYSIOL, V75, P39, DOI 10.1085/jgp.75.1.39; MANDELZYS A, 1995, J NEUROPHYSIOL, V74, P1212, DOI 10.1152/jn.1995.74.3.1212; MIDDLETON P, 1986, P NATL ACAD SCI USA, V83, P4967, DOI 10.1073/pnas.83.13.4967; OBATA K, 1974, BRAIN RES, V73, P71, DOI 10.1016/0006-8993(74)91008-7; Paradiso K, 1998, J NEUROSCI, V18, P9227; Pitt SJ, 2008, J NEUROSCI, V28, P11454, DOI 10.1523/JNEUROSCI.3890-08.2008; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; RANG HP, 1981, J PHYSIOL-LONDON, V311, P23, DOI 10.1113/jphysiol.1981.sp013571; Rose CR, 1997, J PHYSIOL-LONDON, V499, P573, DOI 10.1113/jphysiol.1997.sp021951; Sacchi O, 2008, NEUROSCIENCE, V154, P1360, DOI 10.1016/j.neuroscience.2008.04.058; Sacchi O, 1999, J NEUROPHYSIOL, V82, P1662, DOI 10.1152/jn.1999.82.4.1662; Sacchi O, 1998, J NEUROPHYSIOL, V79, P727, DOI 10.1152/jn.1998.79.2.727; Sacchi O, 2000, J NEUROPHYSIOL, V83, P3254, DOI 10.1152/jn.2000.83.6.3254; Sacchi O, 1998, J NEUROSCI METH, V80, P171, DOI 10.1016/S0165-0270(97)00199-4; SELYANKO AA, 1979, J AUTONOM NERV SYST, V1, P127, DOI 10.1016/0165-1838(79)90011-0; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Skok MV, 1999, NEUROSCIENCE, V93, P1427, DOI 10.1016/S0306-4522(99)00160-8; Skok VI, 2002, AUTON NEUROSCI-BASIC, V97, P1, DOI 10.1016/S1566-0702(01)00386-1; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tsubokawa H, 1999, J PHYSIOL-LONDON, V517, P135, DOI 10.1111/j.1469-7793.1999.0135z.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Voitenko S V, 2000, Neurosci Behav Physiol, V30, P19, DOI 10.1007/BF02461388; Yu CR, 1998, J PHYSIOL-LONDON, V509, P651, DOI 10.1111/j.1469-7793.1998.651bm.x	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17318	10.1371/journal.pone.0017318	http://dx.doi.org/10.1371/journal.pone.0017318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364885	Green Published, gold, Green Submitted			2022-12-25	WOS:000287764100045
J	Horn, T; Robertson, BC; Will, M; Eason, DK; Elliott, GP; Gemmell, NJ				Horn, Thorsten; Robertson, Bruce C.; Will, Margaret; Eason, Daryl K.; Elliott, Graeme P.; Gemmell, Neil J.			Inheritance of Telomere Length in a Bird	PLOS ONE			English	Article							KAKAPO STRIGOPS-HABROPTILUS; SEQUENCE; CHICKEN; AGE	Telomere dynamics are intensively studied in human ageing research and epidemiology, with many correlations reported between telomere length and age-related diseases, cancer and death. While telomere length is influenced by environmental factors there is also good evidence for a strong heritable component. In human, the mode of telomere length inheritance appears to be paternal and telomere length differs between sexes, with females having longer telomeres than males. Genetic factors, e.g. sex chromosomal inactivation, and non-genetic factors, e. g. antioxidant properties of oestrogen, have been suggested as possible explanations for these sex-specific telomere inheritance and telomere length differences. To test the influence of sex chromosomes on telomere length, we investigated inheritance and sex-specificity of telomere length in a bird species, the kakapo (Strigops habroptilus), in which females are the heterogametic sex (ZW) and males are the homogametic (ZZ) sex. We found that, contrary to findings in humans, telomere length was maternally inherited and also longer in males. These results argue against an effect of sex hormones on telomere length and suggest that factors associated with heterogamy may play a role in telomere inheritance and sex-specific differences in telomere length.	[Horn, Thorsten; Robertson, Bruce C.; Will, Margaret; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Robertson, Bruce C.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Eason, Daryl K.; Elliott, Graeme P.] Dept Conservat, Natl Kakapo Team, Nelson, New Zealand; [Gemmell, Neil J.] Univ Otago, Dept Anat & Struct Biol, Ctr Reprod & Genom, Dunedin, New Zealand	University of Canterbury; University of Otago; University of Otago	Horn, T (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	thorstenhorn@gmx.net	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637	Rio Tinto Alcan NZ, NZ Department of Conservation, Landcare Research's FRST OBI 'Sustaining and Restoring Biodiversity' [CO9X0503]; University of Canterbury College of Science; University of Canterbury	Rio Tinto Alcan NZ, NZ Department of Conservation, Landcare Research's FRST OBI 'Sustaining and Restoring Biodiversity'; University of Canterbury College of Science; University of Canterbury	Rio Tinto Alcan NZ, NZ Department of Conservation, Landcare Research's FRST OBI 'Sustaining and Restoring Biodiversity' contract CO9X0503 and a University of Canterbury College of Science research grant provided financial support. TH was supported by a University of Canterbury PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arnold AP, 2008, ANNU REV GENOM HUM G, V9, P109, DOI 10.1146/annurev.genom.9.081307.164220; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Aviv A, 2006, J GERONTOL A-BIOL, V61, P871, DOI 10.1093/gerona/61.8.871; Baird DM, 2008, EXP GERONTOL, V43, P15, DOI 10.1016/j.exger.2007.10.002; Baird DM, 2006, EXP GERONTOL, V41, P1223, DOI 10.1016/j.exger.2006.09.009; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Bolzan AD, 2006, MUTAT RES-REV MUTAT, V612, P189, DOI 10.1016/j.mrrev.2005.12.003; Clout Mick N., 2006, Notornis, V53, P1; Cockrem JF, 1995, AUK, V112, P253, DOI 10.2307/4088787; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Delany ME, 2003, POULTRY SCI, V82, P917, DOI 10.1093/ps/82.6.917; Eason Daryl K., 2006, Notornis, V53, P27; Elliott Graeme P., 2006, Notornis, V53, P164; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; Horn T, 2008, AUST J ZOOL, V56, P207, DOI 10.1071/ZO08046; McQueen HA, 2009, CHROMOSOME RES, V17, P687, DOI 10.1007/s10577-009-9056-8; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Miller HC, 2003, CONSERV GENET, V4, P265, DOI 10.1023/A:1024037601708; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Robertson Bruce C., 2006, Notornis, V53, P173; Robertson BC, 2009, MOL ECOL RESOUR, V9, P664, DOI 10.1111/j.1755-0998.2008.02506.x; Saldanha CJ, 1997, GEN COMP ENDOCR, V105, P390, DOI 10.1006/gcen.1996.6841; Swanberg SE, 2010, EXP GERONTOL, V45, P647, DOI 10.1016/j.exger.2010.04.002	31	51	51	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17199	10.1371/journal.pone.0017199	http://dx.doi.org/10.1371/journal.pone.0017199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364951	Green Published, gold, Green Submitted			2022-12-25	WOS:000287656600035
J	Gilroy, KL; Austin, CA				Gilroy, Kathryn L.; Austin, Caroline A.			The Impact of the C-Terminal Domain on the Interaction of Human DNA Topoisomerase II alpha and beta with DNA	PLOS ONE			English	Article							POSITIVELY SUPERCOILED DNA; BIMODAL RECOGNITION; STRUCTURAL BASIS; CLEAVAGE; BINDING; MECHANISM; RESISTANCE; INHIBITION; EXPRESSION; MUTATIONS	Background: Type II DNA topoisomerases are essential, ubiquitous enzymes that act to relieve topological problems arising in DNA from normal cellular activity. Their mechanism of action involves the ATP-dependent transport of one DNA duplex through a transient break in a second DNA duplex; metal ions are essential for strand passage. Humans have two isoforms, topoisomerase II alpha and topoisomerase II beta, that have distinct roles in the cell. The C-terminal domain has been linked to isoform specific differences in activity and DNA interaction. Methodology/Principal Findings: We have investigated the role of the C-terminal domain in the binding of human topoisomerase II alpha and topoisomerase II beta to DNA in fluorescence anisotropy assays using full length and C-terminally truncated enzymes. We find that the C-terminal domain of topoisomerase II beta but not topoisomerase II alpha affects the binding of the enzyme to the DNA. The presence of metal ions has no effect on DNA binding. Additionally, we have examined strand passage of the full length and truncated enzymes in the presence of a number of supporting metal ions and find that there is no difference in relative decatenation between isoforms. We find that calcium and manganese, in addition to magnesium, can support strand passage by the human topoisomerase II enzymes. Conclusions/Significance: The C-terminal domain of topoisomerase II beta, but not that of topoisomerase II alpha, alters the enzyme's K-D for DNA binding. This is consistent with previous data and may be related to the differential modes of action of the two isoforms in vivo. We also show strand passage with different supporting metal ions for human topoisomerase II alpha or topoisomerase II beta, either full length or C-terminally truncated. They all show the same preferences, whereby Mg > Ca > Mn.	[Gilroy, Kathryn L.; Austin, Caroline A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Gilroy, KL (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland.	caroline.austin@ncl.ac.uk		Austin, Caroline/0000-0002-1921-5947; Gilroy, Kathryn/0000-0003-4607-194X	Newcastle University	Newcastle University	Funded by a studentship to Kathryn Gilroy from Newcastle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Baldwin EL, 2004, BIOCHEMISTRY-US, V43, P728, DOI 10.1021/bi035472f; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Bist P, 2003, J BIOL CHEM, V278, P41837, DOI 10.1074/jbc.M307053200; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Deweese JE, 2009, BIOCHEMISTRY-US, V48, P1862, DOI 10.1021/bi8023256; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; Gilroy KL, 2006, NUCLEIC ACIDS RES, V34, P1597, DOI 10.1093/nar/gkl057; Grishin NV, 2000, NUCLEIC ACIDS RES, V28, P2229, DOI 10.1093/nar/28.11.2229; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Leontiou C, 2006, MOL PHARMACOL, V69, P130, DOI 10.1124/mol.105.015933; Leontiou C, 2004, MOL PHARMACOL, V66, P430; Leontiou C, 2003, FEBS LETT, V554, P206, DOI 10.1016/S0014-5793(03)01172-4; Leontiou C, 2007, MOL PHARMACOL, V71, P1006, DOI 10.1124/mol.106.032953; Li W, 1997, J BIOL CHEM, V272, P31190, DOI 10.1074/jbc.272.49.31190; McClendon AK, 2006, BIOCHEMISTRY-US, V45, P11674, DOI 10.1021/bi0520838; McClendon AK, 2008, BIOCHEMISTRY-US, V47, P13169, DOI 10.1021/bi800453h; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; McNamara S, 2008, MOL CELL BIOL, V28, P2066, DOI 10.1128/MCB.01576-07; Meczes EL, 1997, CANCER CHEMOTH PHARM, V39, P367, DOI 10.1007/s002800050585; Meczes EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001754; Morant-Lhomel A, 2006, BIOCHIMIE, V88, P253, DOI 10.1016/j.biochi.2005.08.003; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P6402, DOI 10.1021/bi00394a015; ROCA J, 1993, J BIOL CHEM, V268, P14250; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Timsit Y, 1998, J MOL BIOL, V284, P1289, DOI 10.1006/jmbi.1998.2281; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WASSERMAN RA, 1993, CANCER RES, V53, P3591; West KL, 2000, BIOCHEMISTRY-US, V39, P1223, DOI 10.1021/bi991328b; West KL, 1999, NUCLEIC ACIDS RES, V27, P984, DOI 10.1093/nar/27.4.984; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	42	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14693	10.1371/journal.pone.0014693	http://dx.doi.org/10.1371/journal.pone.0014693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358820	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000287392700007
J	Samuel, MS; Lourenco, FC; Olson, MF				Samuel, Michael S.; Lourenco, Filipe C.; Olson, Michael F.			K-Ras Mediated Murine Epidermal Tumorigenesis Is Dependent upon and Associated with Elevated Rac1 Activity	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; SMALL-MOLECULE INHIBITORS; RHO-GTPASES; CANCER; PROGRESSION; KINASES; COMPLEX	A common goal for potential cancer therapies is the identification of differences in protein expression or activity that would allow for the selective targeting of tumor vs. normal cells. The Ras proto-oncogene family (K-Ras, H-Ras and N-Ras) are amongst the most frequently mutated genes in human cancers. As a result, there has been substantial effort dedicated to determining which pathways are activated by Ras signaling and, more importantly, which of these contribute to cancer. Although the most widely studied Ras-regulated signaling pathway is the Raf/mitogen-activated protein kinase cascade, previous research in model systems has revealed that the Rac1 GTP-binding protein is also required for Ras-induced biological responses. However, what have been lacking are rigorous in vivo Rac1 target validation data and a clear demonstration that in Ras-driven hyperplastic lesions, Rac1 activity is increased. Using a combination of genetically-modified mouse models that allow for the tissue-selective activation or deletion of signaling molecules and an activation-state sensitive Rac1 antibody that detects GTP-bound Rac1, we found that Rac1 contributes to K-Ras induced epidermal papilloma initiation and growth and that Rac1 activity is elevated by oncogenic K-Ras in vivo. Previously, it was not practical to assess Rac1 activation status in the most commonly used format for clinical tumor specimens, formalin-fixed paraffin embedded (FFPE) tissues samples. However, this study clearly demonstrates that Rac1 is essential for K-Ras driven epithelial cell hyperproliferation and that Rac1 activity is elevated in tissues expressing mutant oncogenic K-Ras, while also characterizing the activation-state specific Rac1-GTP antibody as a probe to examine Rac1 activation status in FFPE samples. Our findings will facilitate further research on the status of Rac1 activity in human tumors and will help to define the tumor types of the patient population that could potentially benefit from therapies targeting Rac activation or downstream effector signaling pathways.	[Samuel, Michael S.; Lourenco, Filipe C.; Olson, Michael F.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Samuel, MS (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	M.Samuel@beatson.gla.ac.uk; m.olson@beatson.gla.ac.uk	Olson, Michael F/A-3240-2011; Olson, Michael/ABA-4240-2021; Lourenco, Filipe/G-9254-2011; Samuel, Michael/D-2706-2011	Olson, Michael/0000-0003-3428-3507; Lourenco, Filipe/0000-0002-9655-2488; Samuel, Michael/0000-0001-7880-6379	Cancer Research UK; Think Pink breast cancer group	Cancer Research UK(Cancer Research UK); Think Pink breast cancer group	This study was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All work was carried out under a project license, and in accord with guidelines, from the Home Office. We acknowledge the support of the Think Pink breast cancer group who funded purchase of the NDP slide scanner and the assistance of Clare Orange in image analysis. Thanks to David Tuveson (Cambridge Research Institute) for LSL-K-Ras<SUP>G12D</SUP> mice. Thanks also to Laura Machesky and Owen Sansom (Beatson Institute for Cancer Research) for access to mouse strains in their collections.	BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Vaught D, 2009, MOL BIOL CELL, V20, P2572, DOI 10.1091/mbc.E08-04-0378; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; Yi CL, 2010, BIOCHEM PHARMACOL, V80, P683, DOI 10.1016/j.bcp.2010.03.012	27	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17143	10.1371/journal.pone.0017143	http://dx.doi.org/10.1371/journal.pone.0017143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21358804	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000287369200025
J	Weiss, M; Sykorova, Z; Garnica, S; Riess, K; Martos, F; Krause, C; Oberwinkler, F; Bauer, R; Redecker, D				Weiss, Michael; Sykorova, Zuzana; Garnica, Sigisfredo; Riess, Kai; Martos, Florent; Krause, Cornelia; Oberwinkler, Franz; Bauer, Robert; Redecker, Dirk			Sebacinales Everywhere: Previously Overlooked Ubiquitous Fungal Endophytes	PLOS ONE			English	Article							NEOTTIA-NIDUS-AVIS; PIRIFORMOSPORA-INDICA; MYCORRHIZAL ASSOCIATIONS; DNA-SEQUENCES; CELL-DEATH; RESISTANCE; ERICACEAE; COMMON; PLANT; MYCOBIONTS	Inconspicuous basidiomycetes from the order Sebacinales are known to be involved in a puzzling variety of mutualistic plant-fungal symbioses (mycorrhizae), which presumably involve transport of mineral nutrients. Recently a few members of this fungal order not fitting this definition and commonly referred to as 'endophytes' have raised considerable interest by their ability to enhance plant growth and to increase resistance of their host plants against abiotic stress factors and fungal pathogens. Using DNA-based detection and electron microscopy, we show that Sebacinales are not only extremely versatile in their mycorrhizal associations, but are also almost universally present as symptomless endophytes. They occurred in field specimens of bryophytes, pteridophytes and all families of herbaceous angiosperms we investigated, including liverworts, wheat, maize, and the non-mycorrhizal model plant Arabidopsis thaliana. They were present in all habitats we studied on four continents. We even detected these fungi in herbarium specimens originating from pioneering field trips to North Africa in the 1830s/40s. No geographical or host patterns were detected. Our data suggest that the multitude of mycorrhizal interactions in Sebacinales may have arisen from an ancestral endophytic habit by specialization. Considering their proven beneficial influence on plant growth and their ubiquity, endophytic Sebacinales may be a previously unrecognized universal hidden force in plant ecosystems.	[Weiss, Michael; Garnica, Sigisfredo; Riess, Kai; Krause, Cornelia; Oberwinkler, Franz; Bauer, Robert] Univ Tubingen, Inst Evolut & Okol, Tubingen, Germany; [Sykorova, Zuzana; Redecker, Dirk] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Martos, Florent] Univ La Reunion, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Denis, France	Eberhard Karls University of Tubingen; University of Basel; University of La Reunion	Weiss, M (corresponding author), Univ Tubingen, Inst Evolut & Okol, Tubingen, Germany.	michael.weiss@uni-tuebingen.de	Krause, Cornelia/P-6049-2014; Weiß, Michael/F-6206-2012; Kolaříková, Zuzana/C-3558-2009; Sigisfredo, Garnica/P-6506-2014; Florent, Martos/B-5151-2014; Riess, Kai/B-5491-2015	Krause, Cornelia/0000-0002-7886-3629; Weiß, Michael/0000-0002-4869-9186; Florent, Martos/0000-0003-1213-5466; Riess, Kai/0000-0002-8804-0175; Kolarikova, Zuzana/0000-0002-3693-2657				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barazani O, 2005, OECOLOGIA, V146, P234, DOI 10.1007/s00442-005-0193-2; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; CULLINGS K, 1994, J EVOLUTION BIOL, V7, P501, DOI 10.1046/j.1420-9101.1994.7040501.x; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Druege U, 2007, SCI HORTIC-AMSTERDAM, V112, P422, DOI 10.1016/j.scienta.2007.01.018; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Glen M, 2002, MYCORRHIZA, V12, P243, DOI 10.1007/s00572-002-0180-y; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kottke I, 2003, MYCOL RES, V107, P957, DOI 10.1017/S0953756203008141; McKendrick SL, 2002, NEW PHYTOL, V154, P233, DOI 10.1046/j.1469-8137.2002.00372.x; Neubert K, 2006, APPL ENVIRON MICROB, V72, P1118, DOI 10.1128/AEM.72.2.1118-1128.2006; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P465, DOI 10.1111/j.1399-3054.2004.00424.x; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Schafer P, 2007, FEMS MICROBIOL LETT, V275, P1, DOI 10.1111/j.1574-6968.2007.00848.x; Selosse MA, 2002, MOL ECOL, V11, P1831, DOI 10.1046/j.1365-294X.2002.01553.x; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Selosse MA, 2009, MYCOL RES, V113, P1062, DOI 10.1016/j.mycres.2009.07.004; Setaro S, 2006, NEW PHYTOL, V169, P355, DOI 10.1111/j.1469-8137.2005.01583.x; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; Urban A, 2003, MYCOL RES, V107, P3, DOI 10.1017/S0953756202007116; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Varma A., 2001, MYCOTA, VIX, P125; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; WARCUP JH, 1988, NEW PHYTOL, V110, P227, DOI 10.1111/j.1469-8137.1988.tb00256.x; Weiss M, 1998, CAN J BOT, V76, P1170, DOI 10.1139/cjb-76-7-1170; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	43	139	145	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16793	10.1371/journal.pone.0016793	http://dx.doi.org/10.1371/journal.pone.0016793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347229	Green Submitted, Green Published, gold			2022-12-25	WOS:000287369200006
J	Yang, JL; Wang, LL; Zhang, HA; Qiu, LM; Wang, H; Song, LS				Yang, Jialong; Wang, Lingling; Zhang, Huan; Qiu, Limei; Wang, Hao; Song, Linsheng			C-Type Lectin in Chlamys farreri (CfLec-1) Mediating Immune Recognition and Opsonization	PLOS ONE			English	Article							SHRIMP FENNEROPENAEUS-CHINENSIS; HORNWORM MANDUCA-SEXTA; BOMBYX-MORI; CELLULAR ENCAPSULATION; COMPLEMENT ACTIVATION; MONOCLONAL-ANTIBODY; INNATE IMMUNITY; HEMOCYTES; RECEPTORS; PROTEIN	Background: C-type lectins are a superfamily of Ca(2+) dependent carbohydrate-recognition proteins that play significant diverse roles in nonself-recognition and clearance of invaders. Though they are well characterized in vertebrates, the study of the potential function and mechanism of C-type lectins in invertebrate immunity is still in its infancy. Methodology: A C-type lectin (CfLec-1) from scallop Chlamys farreri, a dominant cultured mollusk species in China, was selected to investigate its mRNA expression, localization and the possible functions in innate immunity in the present study. After scallop was stimulated by three typical PAMPs, the mRNA expression of CfLec-1 in hemocytes was poles apart. It was significantly up-regulated (p < 0.01) after scallops were stimulated by LPS or beta-glucan, but significantly down-regulated (p < 0.01) after PGN stimulation. The binding ability of recombinant CfLec-1 (designated as rCfLec-1) towards eight PAMPs was investigated subsequently by PAMPs microarray, which revealed rCfLec-1 could bind LPS, PGN and mannan in vitro, indicating CfLec-1 served as a PRR involved in the pathogen recognition. Immunofluorescence assay with polyclonal antibody specific for CfLec-1 revealed that CfLec-1 was mainly located in the mantle and gill of the scallop. CfLec-1 could bind to the surface of scallop hemocytes and recruited hemocytes to enhance their encapsulation in vitro, and this process could be specifically blocked by anti-rCfLec-1 antibody. Meanwhile, rCfLec-1 could also enhance the phagocytic activity of scallop hemocytes against Escherichia coli. Conclusions: The results clearly suggested that CfLec-1 in C. farreri not only served as a PRR involved in the PAMPs recognition, but also functioned as an opsonin participating in the clearance of invaders. It is therefore suspected that CfLec-1 could be an attachment-molecule to nonself-agents acting as an alternative to immunoglobulin in vertebrates.	[Yang, Jialong; Wang, Lingling; Zhang, Huan; Qiu, Limei; Wang, Hao; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Yang, Jialong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, JL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China [2010CB126404]; NSFC [41006096, 40806064, 30730070, 30925028]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (No. 2010CB126404), http://www.973.gov.cn/; and grants (Nos. 41006096, 40806064 and 30730070,30925028) from NSFC, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bulgakov AA, 2004, FISH SHELLFISH IMMUN, V16, P487, DOI 10.1016/j.fsi.2003.08.006; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Cheng SF, 2006, J VIROL METHODS, V135, P173, DOI 10.1016/j.jviromet.2006.03.016; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; FRENETTE PS, 1995, P NATL ACAD SCI USA, V92, P7450, DOI 10.1073/pnas.92.16.7450; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; Lin YB, 2007, DEV COMP IMMUNOL, V31, P1073, DOI 10.1016/j.dci.2007.02.001; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P301, DOI 10.1016/j.dci.2005.05.006; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P289, DOI 10.1016/j.dci.2005.05.005; Liu YC, 2007, MOL IMMUNOL, V44, P598, DOI 10.1016/j.molimm.2006.01.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Loukas A, 1999, CURR BIOL, V9, P825, DOI 10.1016/S0960-9822(99)80366-2; Luo T, 2003, FEBS LETT, V551, P53, DOI 10.1016/S0014-5793(03)00891-3; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Ohta M, 2006, DEV COMP IMMUNOL, V30, P867, DOI 10.1016/j.dci.2005.12.005; Petersen SV, 2000, MOL IMMUNOL, V37, P803, DOI 10.1016/S0161-5890(01)00004-9; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Tunkijjanukij S, 1998, DEV COMP IMMUNOL, V22, P139, DOI 10.1016/S0145-305X(98)00017-2; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Wang H, 2007, MOL IMMUNOL, V44, P722, DOI 10.1016/j.molimm.2006.04.015; Wang N, 2008, DEV COMP IMMUNOL, V32, P1034, DOI 10.1016/j.dci.2008.02.001; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Yan PS, 2002, METHODS, V27, P162, DOI 10.1016/S1046-2023(02)00070-1; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 2001, ADV EXP MED BIOL, V484, P191; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zennadi R, 2006, BLOOD, V108, p361A; Zhang H, 2009, FISH SHELLFISH IMMUN, V26, P707, DOI 10.1016/j.fsi.2009.02.017; Zhang H, 2009, DEV COMP IMMUNOL, V33, P780, DOI 10.1016/j.dci.2009.01.003; Zheng PL, 2008, FISH SHELLFISH IMMUN, V24, P286, DOI 10.1016/j.fsi.2007.11.014; Zucchetti I, 2008, DIFFERENTIATION, V76, P267, DOI 10.1111/j.1432-0436.2007.00214.x	59	89	98	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17089	10.1371/journal.pone.0017089	http://dx.doi.org/10.1371/journal.pone.0017089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347232	Green Published, Green Submitted, gold			2022-12-25	WOS:000287369200021
J	Mathis, JM; Bhatia, S; Khandelwal, A; Kovesdi, I; Lokitz, SJ; Odaka, Y; Takalkar, AM; Terry, T; Curiel, DT				Mathis, J. Michael; Bhatia, Shilpa; Khandelwal, Alok; Kovesdi, Imre; Lokitz, Stephen J.; Odaka, Yoshi; Takalkar, Amol M.; Terry, Tracee; Curiel, David T.			Genetic Incorporation of Human Metallothionein into the Adenovirus Protein IX for Non-Invasive SPECT Imaging	PLOS ONE			English	Article							TYPE-1 THYMIDINE KINASE; BICISTRONIC ADENOVIRUS; REPORTER GENE; TUMOR-CELLS; IN-VIVO; BINDING; VIRUS; EXPRESSION; DOMAINS; CANCER	As the limits of existing treatments for cancer are recognized, clearly novel therapies must be considered for successful treatment; cancer therapy using adenovirus vectors is a promising strategy. However tracking the biodistribution of adenovirus vectors in vivo is limited to invasive procedures such as biopsies, which are error prone, non-quantitative, and do not give a full representation of the pharmacokinetics involved. Current non-invasive imaging strategies using reporter gene expression have been applied to analyze adenoviral vectors. The major drawback to approaches that tag viruses with reporter genes is that these systems require initial viral infection and subsequent cellular expression of a reporter gene to allow non-invasive imaging. As an alternative to conventional vector detection techniques, we developed a specific genetic labeling system whereby an adenoviral vector incorporates a fusion between capsid protein IX and human metallothionein. Our study herein clearly demonstrates our ability to rescue viable adenoviral particles that display functional metallothionein (MT) as a component of their capsid surface. We demonstrate the feasibility of (99m)Tc binding in vitro to the pIX-MT fusion on the capsid of adenovirus virions using a simple transchelation reaction. SPECT imaging of a mouse after administration of a (99m)Tc-radiolabeled virus showed clear localization of radioactivity to the liver. This result strongly supports imaging using pIX-MT, visualizing the normal biodistribution of Ad primarily to the liver upon injection into mice. The ability we have developed to view real-time biodistribution in their physiological milieu represents a significant tool to study adenovirus biology in vivo.	[Mathis, J. Michael; Bhatia, Shilpa; Odaka, Yoshi; Terry, Tracee] LSU Hlth Sci Ctr, Dept Cellular Biol, Gene Therapy Program, Shreveport, LA USA; [Mathis, J. Michael; Bhatia, Shilpa; Odaka, Yoshi; Terry, Tracee] LSU Hlth Sci Ctr, Dept Anat, Gene Therapy Program, Shreveport, LA USA; [Khandelwal, Alok; Lokitz, Stephen J.; Takalkar, Amol M.] Biomed Res Fdn NW Louisiana, Shreveport, LA USA; [Kovesdi, Imre] VectorLogics Inc, Birmingham, AL USA; [Curiel, David T.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Washington University (WUSTL)	Mathis, JM (corresponding author), LSU Hlth Sci Ctr, Dept Cellular Biol, Gene Therapy Program, Shreveport, LA USA.	jmathi@lsuhsc.edu	Odaka, Yoshinobu/AAY-6918-2021; Mathis, J. Michael/J-1379-2018	Odaka, Yoshinobu/0000-0003-3966-5475; Kovesdi, Imre/0000-0002-0322-3969; Mathis, J. Michael/0000-0001-5528-5195	NIH [2R42CA114921, 5R01CA121187-03, 5R01-CA111569]; Louisiana Gene Therapy Research Consortium; Feist-Weiller Cancer Center; NATIONAL CANCER INSTITUTE [R01CA154697, R42CA114921, R01CA111569, R01CA121187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Gene Therapy Research Consortium; Feist-Weiller Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by NIH grants 2R42CA114921, 5R01CA121187-03 and 5R01-CA111569, and funding from the Louisiana Gene Therapy Research Consortium and the Feist-Weiller Cancer Center. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Imre Kovesdi is Chief Executive Officer of VectorLogics, Inc; he contributed to the preparation of the manuscript and interpretation of the data. No other funding was provided by VectorLogics.	Akalu A, 1999, J VIROL, V73, P6182, DOI 10.1128/JVI.73.7.6182-6187.1999; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; BOULANGER P, 1979, J GEN VIROL, V44, P783, DOI 10.1099/0022-1317-44-3-783; Bult W, 2009, Q J NUCL MED MOL IM, V53, P325; DAS C, 1992, P NATL ACAD SCI USA, V89, P9749, DOI 10.1073/pnas.89.20.9749; de Vrij J, 2008, GENE THER, V15, P978, DOI 10.1038/gt.2008.26; Dmitriev IP, 2002, J VIROL, V76, P6893, DOI 10.1128/JVI.76.14.6893-6899.2002; Fabry CMS, 2009, J VIROL, V83, P1135, DOI 10.1128/JVI.01808-08; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Gkialas I, 2008, J BUON, V13, P177; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Haviv YS, 2002, MOL CANCER THER, V1, P321; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hedley SJ, 2006, CANCER IMMUNOL IMMUN, V55, P1412, DOI 10.1007/s00262-006-0158-2; Ibrahim SM, 2008, WORLD J GASTROENTERO, V14, P1664, DOI 10.3748/wjg.14.1664; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kuruppu D, 2007, CURR CANCER DRUG TAR, V7, P175, DOI 10.2174/156800907780058871; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Liang Q, 2002, GENE THER, V9, P1659, DOI 10.1038/sj.gt.3301899; Luo D, 1996, J BIOCHEM-TOKYO, V120, P229; Maheshwari G, 2004, J VIROL METHODS, V118, P141, DOI 10.1016/j.jviromet.2004.02.003; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mathis JM, 2005, ONCOGENE, V24, P7775, DOI 10.1038/sj.onc.1209044; Matthews K, 2009, CLIN CANCER RES, V15, P4131, DOI 10.1158/1078-0432.CCR-08-3354; Matthews QL, 2006, MOL IMAGING, V5, P510, DOI 10.2310/7290.2006.00029; MERRON A, 2007, GENE THER; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; MONTASER A, 1992, P SOC EXP BIOL MED, V200, P321, DOI 10.3181/00379727-200-43437; Morelock M M, 1987, Experientia Suppl, V52, P247; NIELSON KB, 1985, J BIOL CHEM, V260, P5342; Noureddini SC, 2005, MOL PHARMACEUT, V2, P341, DOI 10.1021/mp050045c; PAIK CH, 1985, INT J NUCL MED BIOL, V12, P3, DOI 10.1016/0047-0740(85)90004-X; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Peng KW, 2002, NAT MED, V8, P527, DOI 10.1038/nm0502-527; Rosa-Calatrava M, 2001, J VIROL, V75, P7131, DOI 10.1128/JVI.75.15.7131-7141.2001; SANO T, 1992, P NATL ACAD SCI USA, V89, P1534, DOI 10.1073/pnas.89.5.1534; SAWYER JR, 1992, P NATL ACAD SCI USA, V89, P9754, DOI 10.1073/pnas.89.20.9754; Tolcher AW, 2006, J CLIN ONCOL, V24, P2052, DOI 10.1200/JCO.2005.03.6756; Vellinga J, 2007, GENE THER, V14, P664, DOI 10.1038/sj.gt.3302908; Vellinga J, 2005, J VIROL, V79, P3206, DOI 10.1128/JVI.79.5.3206-3210.2005; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; VIRZI F, 1995, BIOCONJUGATE CHEM, V6, P139, DOI 10.1021/bc00031a018; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Whitfield RJ, 2009, J CHROMATOGR A, V1216, P2725, DOI 10.1016/j.chroma.2008.11.010; Yang M, 2000, P NATL ACAD SCI USA, V97, P12278, DOI 10.1073/pnas.97.22.12278; Zinn KR, 2002, RADIOLOGY, V223, P417, DOI 10.1148/radiol.2232010501; J GENE MED CLIN TRIA	48	7	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16792	10.1371/journal.pone.0016792	http://dx.doi.org/10.1371/journal.pone.0016792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347423	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700034
J	Lurie, G; Gaudet, MM; Spurdle, AB; Carney, ME; Wilkens, LR; Yang, HP; Weiss, NS; Webb, PM; Thompson, PJ; Terada, K; Setiawan, VW; Rebbeck, TR; Prescott, J; Orlow, I; O'Mara, T; Olson, SH; Narod, SA; Matsuno, RK; Lissowska, J; Liang, XL; Levine, DA; Le Marchand, L; Kolonel, LN; Henderson, BE; Garcia-Closas, M; Doherty, JA; De Vivo, I; Chen, C; Brinton, LA; Akbari, MR; Goodman, MT				Lurie, Galina; Gaudet, Mia M.; Spurdle, Amanda B.; Carney, Michael E.; Wilkens, Lynne R.; Yang, Hannah P.; Weiss, Noel S.; Webb, Penelope M.; Thompson, Pamela J.; Terada, Keith; Setiawan, Veronica Wendy; Rebbeck, Timothy R.; Prescott, Jennifer; Orlow, Irene; O'Mara, Tracy; Olson, Sara H.; Narod, Steven A.; Matsuno, Rayna K.; Lissowska, Jolanta; Liang, Xiaolin; Levine, Douglas A.; Le Marchand, Loic; Kolonel, Laurence N.; Henderson, Brian E.; Garcia-Closas, Montserrat; Doherty, Jennifer Anne; De Vivo, Immaculata; Chen, Chu; Brinton, Louise A.; Akbari, Mohammad R.; Goodman, Marc T.		Epidemiology Endometrial Canc	The Obesity-Associated Polymorphisms FTO rs9939609 and MC4R rs17782313 and Endometrial Cancer Risk in Non-Hispanic White Women	PLOS ONE			English	Article							GENE-EXPRESSION; FAT MASS; ENDOGENOUS HORMONES; ENERGY-INTAKE; FOOD-INTAKE; VARIANT; CHILDHOOD; INSULIN	Overweight and obesity are strongly associated with endometrial cancer. Several independent genome-wide association studies recently identified two common polymorphisms, FTO rs9939609 and MC4R rs17782313, that are linked to increased body weight and obesity. We examined the association of FTO rs9939609 and MC4R rs17782313 with endometrial cancer risk in a pooled analysis of nine case-control studies within the Epidemiology of Endometrial Cancer Consortium (E2C2). This analysis included 3601 non-Hispanic white women with histologically-confirmed endometrial carcinoma and 5275 frequency-matched controls. Unconditional logistic regression models were used to assess the relation of FTO rs9939609 and MC4R rs17782313 genotypes to the risk of endometrial cancer. Among control women, both the FTO rs9939609 A and MC4R rs17782313 C alleles were associated with a 16% increased risk of being overweight (p = 0.001 and p = 0.004, respectively). In case-control analyses, carriers of the FTO rs9939609 AA genotype were at increased risk of endometrial carcinoma compared to women with the TT genotype [ odds ratio (OR) = 1.17; 95% confidence interval (CI): 1.03-1.32, p = 0.01]. However, this association was no longer apparent after adjusting for body mass index (BMI), suggesting mediation of the gene-disease effect through body weight. The MC4R rs17782313 polymorphism was not related to endometrial cancer risk (per allele OR = 0.98; 95% CI: 0.91-1.06; p = 0.68). FTO rs9939609 is a susceptibility marker for white non-Hispanic women at higher risk of endometrial cancer. Although FTO rs9939609 alone might have limited clinical or public health significance for identifying women at high risk for endometrial cancer beyond that of excess body weight, further investigation of obesity-related genetic markers might help to identify the pathways that influence endometrial carcinogenesis.	[Lurie, Galina; Wilkens, Lynne R.; Thompson, Pamela J.; Matsuno, Rayna K.; Le Marchand, Loic; Kolonel, Laurence N.; Goodman, Marc T.] Univ Hawaii, Canc Res Ctr Hawaii, Canc Epidemiol Program, Honolulu, HI 96813 USA; [Gaudet, Mia M.] Amer Canc Soc Inc, Epidemiol Res Program, Atlanta, GA USA; [Spurdle, Amanda B.; Webb, Penelope M.; O'Mara, Tracy] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Spurdle, Amanda B.; Webb, Penelope M.; O'Mara, Tracy] PO Royal Brisbane Hosp, Brisbane, Qld, Australia; [Carney, Michael E.; Terada, Keith] Univ Hawaii, Dept Obstet & Gynecol, John A Burns Sch Med, Honolulu, HI 96813 USA; [Yang, Hannah P.; Garcia-Closas, Montserrat; Brinton, Louise A.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Weiss, Noel S.; Chen, Chu] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Weiss, Noel S.; Doherty, Jennifer Anne; Chen, Chu] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Setiawan, Veronica Wendy; Henderson, Brian E.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Abramson Canc Ctr, Philadelphia, PA USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Orlow, Irene; Olson, Sara H.; Liang, Xiaolin] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [O'Mara, Tracy] Queensland Univ Technol, Hormone Dependent Canc Grp, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Narod, Steven A.; Akbari, Mohammad R.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Matsuno, Rayna K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Chen, Chu] Univ Washington, Dept Otolaryngol Head & Neck Surg, Sch Med, Seattle, WA 98195 USA	Cancer Research Center of Hawaii; University of Hawaii System; American Cancer Society; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Southern California; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Queensland University of Technology (QUT); University of Toronto; University Toronto Affiliates; Womens College Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle	Lurie, G (corresponding author), Univ Hawaii, Canc Res Ctr Hawaii, Canc Epidemiol Program, Honolulu, HI 96813 USA.	glurie@crch.hawaii.edu	Ursin, Giske/U-6637-2017; Berrino, Franco/AAC-2364-2020; Weiderpass, Elisabete/AAP-2747-2021; Krogh, Vittorio/K-2628-2016; Brinton, Louise A/G-7486-2015; Webb, Penelope/D-5736-2013; Garcia-Closas, Montserrat/AAZ-6930-2021; Rebbeck, Timothy/GLU-8348-2022; Spurdle, Amanda B/A-4978-2011; Weiderpass, Elisabete/M-4029-2016; Garcia-Closas, Montserrat/F-3871-2015; O'Mara, Tracy/M-7508-2016; Bandera, Elisa V/M-4169-2014; Narod, Steven A/AAA-6112-2022; Lissowska, Jolanta/AAH-3252-2020	Ursin, Giske/0000-0002-0835-9507; Berrino, Franco/0000-0002-4858-1866; Weiderpass, Elisabete/0000-0003-2237-0128; Krogh, Vittorio/0000-0003-0122-8624; Brinton, Louise A/0000-0003-3853-8562; Webb, Penelope/0000-0003-0733-5930; Garcia-Closas, Montserrat/0000-0003-1033-2650; Rebbeck, Timothy/0000-0002-4799-1900; Spurdle, Amanda B/0000-0003-1337-7897; Weiderpass, Elisabete/0000-0003-2237-0128; Garcia-Closas, Montserrat/0000-0003-1033-2650; O'Mara, Tracy/0000-0002-5436-3232; Bandera, Elisa V/0000-0002-8789-2755; Lissowska, Jolanta/0000-0003-2695-5799; Sacerdote, Carlotta/0000-0002-8008-5096; Orlow, Irene/0000-0001-6234-6961; McCullough, Marjorie/0000-0003-3025-6341; La Vecchia, Carlo/0000-0003-1441-897X; De Vivo, Immaculata/0000-0002-7185-7402; Friberg, Emilie/0000-0001-7874-4243; Setiawan, Veronica/0000-0001-9239-5692; Olson, Sara/0000-0003-0182-2754; Levine, Douglas/0000-0003-1038-8232; van den Brandt, Piet/0000-0001-8781-8099; Goodman, Marc/0000-0002-4839-3021	Australian National Endometrial Cancer Study [339435, 4196615, 403031, 457636]; Estrogen; Diet; Genetics; Endometrial Cancer study, NJ, USA [NIH R01CA38918]; Fred Hutchinson Cancer Research Center Case-Control Study, WA, USA [NIH R35 CA 39779, R01 CA 75977, R03 CA 80636, N01 HD 23166, K05 CA 92002, R01 CA 105212, R01 CA87538]; Fred Hutchinson Cancer Research Center; Hawaii Endometrial Cancer Study, Hawaii, USA [NIH P01CA33619, R01CA58598, N01CN67001, N01 PC35137]; Nurses' Health Study [NIH CAO82838, CA134958]; Polish Endometrial Cancer Study of the NCI; Toronto Case-Control Endometrial Cancer Study (Canadian Institute of Health Research, CIHR), Multiethnic Cohort Study [NIH CA63464, CA54281]; Women's Insights and Shared Experiences, PA, USA [NIH P01-CA77596]; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010126] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	Australian National Endometrial Cancer Study; Estrogen; Diet; Genetics; Endometrial Cancer study, NJ, USA; Fred Hutchinson Cancer Research Center Case-Control Study, WA, USA; Fred Hutchinson Cancer Research Center; Hawaii Endometrial Cancer Study, Hawaii, USA; Nurses' Health Study; Polish Endometrial Cancer Study of the NCI; Toronto Case-Control Endometrial Cancer Study (Canadian Institute of Health Research, CIHR), Multiethnic Cohort Study(Canadian Institutes of Health Research (CIHR)); Women's Insights and Shared Experiences, PA, USA; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Australian National Endometrial Cancer Study (NHMRC ID #339435, TCCQ ID #4196615, TCCT IDs #403031 and #457636), Estrogen, Diet, Genetics, and Endometrial Cancer study, NJ, USA (NIH R01CA38918), Fred Hutchinson Cancer Research Center Case-Control Study, WA, USA (NIH R35 CA 39779, R01 CA 75977, R03 CA 80636, N01 HD 23166, K05 CA 92002, R01 CA 105212, R01 CA87538 and funds from the Fred Hutchinson Cancer Research Center), Hawaii Endometrial Cancer Study, Hawaii, USA (NIH P01CA33619, R01CA58598, N01CN67001, N01 PC35137), Nurses' Health Study (NIH CAO82838, CA134958), Polish Endometrial Cancer Study (Intramural Program of the NCI), Toronto Case-Control Endometrial Cancer Study (Canadian Institute of Health Research, CIHR), Multiethnic Cohort Study (NIH CA63464, CA54281), Women's Insights and Shared Experiences, PA, USA (NIH P01-CA77596, Dr. Mia Gaudet (American Cancer Society, Atlanta, GA, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors, Dr. Mia Gaudet is employed by the American Cancer Society (since October 4th 2010). Dr Gaudet contributed the data for the Polish Endometrial Cancer Study that was funded by the National Cancer Institute. Her current employment by the American Cancer Society does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akhmedkhanov A, 2001, ANN NY ACAD SCI, V943, P296, DOI 10.1111/j.1749-6632.2001.tb03811.x; Altekruse SF, 2010, SEER CANC STAT REV 1; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; BULUN SE, 1994, J STEROID BIOCHEM, V49, P319, DOI 10.1016/0960-0760(94)90274-7; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Dina C, 2008, CURR OPIN CLIN NUTR, V11, P378, DOI 10.1097/MCO.0b013e328303e5e6; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Olson SH, 2009, CANCER CAUSE CONTROL, V20, P491, DOI 10.1007/s10552-008-9290-y; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SIITERI PK, 1978, CANCER RES, V38, P4360; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0	33	47	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16756	10.1371/journal.pone.0016756	http://dx.doi.org/10.1371/journal.pone.0016756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347432	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600021
J	Bell, EL; Emerling, BM; Ricoult, SJH; Guarente, L				Bell, E. L.; Emerling, B. M.; Ricoult, S. J. H.; Guarente, L.			SirT3 suppresses hypoxia inducible factor 1 alpha and tumor growth by inhibiting mitochondrial ROS production	ONCOGENE			English	Article						SirT3; ROS; HIF; mitochondria; hypoxia	REPLICATIVE LIFE-SPAN; CALORIE RESTRICTION; HIF-ALPHA; PROLYL HYDROXYLATION; OXIDATIVE STRESS; COMPLEX-III; CANCER; TUMORIGENESIS; METABOLISM; PROTEIN	It has become increasing clear that alterations in cellular metabolism have a key role in the generation and maintenance of cancer. Some of the metabolic changes can be attributed to the activation of oncogenes or loss of tumor suppressors. Here, we show that the mitochondrial sirtuin, SirT3, acts as a tumor suppressor via its ability to suppress reactive oxygen species (ROS) and regulate hypoxia inducible factor 1 alpha (HIF-1 alpha). Primary mouse embryo fibroblasts (MEFs) or tumor cell lines expressing SirT3 short-hairpin RNA exhibit a greater potential to proliferate, and augmented HIF-1a protein stabilization and transcriptional activity in hypoxic conditions. SirT3 knockdown increases tumorigenesis in xenograft models, and this is abolished by giving mice the anti-oxidant N-acetyl cysteine. Moreover, overexpression of SirT3 inhibits stabilization of HIF-1 alpha protein in hypoxia and attenuates increases in HIF-1 alpha transcriptional activity. Critically, overexpression of SirT3 decreases tumorigenesis in xenografts, even when induction of the sirtuin occurs after tumor initiation. These data suggest that SirT3 acts to suppress the growth of tumors, at least in part through its ability to suppress ROS and HIF-1 alpha. Oncogene (2011) 30, 2986-2996; doi:10.1038/onc.2011.37;published online 28 February 2011	[Guarente, L.] MIT, Paul F Glenn Lab, Dept Biol, Cambridge, MA 02139 USA; [Emerling, B. M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Syst Biol,Div Signal Transduct, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Guarente, L (corresponding author), MIT, Paul F Glenn Lab, Dept Biol, 77 Massachusetts Ave,Bldg 68 Room 280, Cambridge, MA 02139 USA.	leng@mit.edu			NRSA; American Cancer Society; NIH; Paul F Glenn Foundation; NATIONAL INSTITUTE ON AGING [R01AG015339, R01AG011119] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F Glenn Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Allyson Evans, Eric Williams, and Matt Vander Heiden for helpful comments on the manuscript and data, as well as Marcia Haigis and Lydia Finley for sharing unpublished information. This work is supported by NRSA postdoctoral fellowship to ELB, an American Cancer Society postdoctoral fellowship to BME and grants from the NIH and a gift from the Paul F Glenn Foundation to LG.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Breyton C, 2000, BBA-BIOENERGETICS, V1459, P467, DOI 10.1016/S0005-2728(00)00185-7; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	43	341	359	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	26					2986	2996		10.1038/onc.2011.37	http://dx.doi.org/10.1038/onc.2011.37			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	785QZ	21358671	Green Published, hybrid			2022-12-25	WOS:000292245100009
J	Westhofen, P; Watzka, M; Marinova, M; Hass, M; Kirfel, G; Muller, J; Bevans, CG; Muller, CR; Oldenburg, J				Westhofen, Philipp; Watzka, Matthias; Marinova, Milka; Hass, Moritz; Kirfel, Gregor; Mueller, Jens; Bevans, Carville G.; Mueller, Clemens R.; Oldenburg, Johannes			Human Vitamin K 2,3-Epoxide Reductase Complex Subunit 1-like 1 (VKORC1L1) Mediates Vitamin K-dependent Intracellular Antioxidant Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROQUINONES REDUCED FORMS; XENOBIOTIC RECEPTOR SXR; EPOXIDE-REDUCTASE; ENDOPLASMIC-RETICULUM; OSTEOBLASTIC CELLS; ACTIVE-SITE; DEFICIENCY; PROTEIN; WARFARIN; QUINONE	Human vitamin K 2,3-epoxide reductase complex subunit 1-like 1 (VKORC1L1), expressed in HEK 293T cells and localized exclusively to membranes of the endoplasmic reticulum, was found to support both vitamin K 2,3-epoxide reductase (VKOR) and vitamin K reductase enzymatic activities. Michaelis-Menten kinetic parameters for dithiothreitol-driven VKOR activity were: K-m (mu M) = 4.15 (vitamin K-1 epoxide) and 11.24 (vitamin K-2 epoxide); V-max (nmol.mg(-1).hr(-1)) = 2.57 (vitamin K-1 epoxide) and 13.46 (vitamin K-2 epoxide). Oxidative stress induced by H2O2 applied to cultured cells up-regulated VKORC1L1 expression and VKOR activity. Cell viability under conditions of no induced oxidative stress was increased by the presence of vitamins K-1 and K-2 but not ubinquinone-10 and was specifically dependent on VKORC1L1 expression. Intracellular reactive oxygen species levels in cells treated with 2,3-dimethoxy-1,4-naphthoquinone were mitigated in a VKORC1L1 expression-dependent manner. Intracellular oxidative damage to membrane intrinsic proteins was inversely dependent on VKORC1L1 expression and the presence of vitamin K-1. Taken together, our results suggest that VKORC1L1 is responsible for driving vitamin K-mediated intracellular antioxidation pathways critical to cell survival.	[Westhofen, Philipp; Watzka, Matthias; Marinova, Milka; Hass, Moritz; Mueller, Jens; Bevans, Carville G.; Oldenburg, Johannes] Univ Clin Bonn, Inst Expt Hematol & Transfus Med, D-53127 Bonn, Germany; [Kirfel, Gregor] Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany; [Mueller, Clemens R.] Univ Wurzburg, Biozentrum Hubland, Inst Human Genet, D-97074 Wurzburg, Germany	University of Bonn; University of Bonn; University of Wurzburg	Oldenburg, J (corresponding author), Univ Clin Bonn, Inst Expt Hematol & Transfus Med, Sigmund Freud Str 25, D-53127 Bonn, Germany.	johannes.oldenburg@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020; Bevans, Carville/C-6651-2009; Müller, Jens/A-8264-2012	Bevans, Carville/0000-0001-7389-2124; Müller, Jens/0000-0001-7713-9631; Oldenburg, Johannes/0000-0002-1585-4100	National Genome Research Net Cardiovascular Diseases, Germany [BMBF/DLR-01GS0424/NHK-S12T21]	National Genome Research Net Cardiovascular Diseases, Germany	This work was supported by Grant BMBF/DLR-01GS0424/NHK-S12T21 from the National Genome Research Net Cardiovascular Diseases, Germany.	Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Fregin A, 2002, BLOOD, V100, P3229, DOI 10.1182/blood-2002-03-0698; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; HILDEBRANDT EF, 1984, ARCH BIOCHEM BIOPHYS, V228, P480, DOI 10.1016/0003-9861(84)90014-6; Horie-Inoue K, 2008, J BONE MINER METAB, V26, P9, DOI 10.1007/s00774-007-0792-6; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; KISHI T, 1993, CLIN INVESTIGATOR, V71, pS71; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Li JR, 2003, J NEUROSCI, V23, P5816; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Q, 2010, PHARMACOL THERAPEUT, V125, P376, DOI 10.1016/j.pharmthera.2009.11.004; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; MUKAI K, 1993, BIOCHIM BIOPHYS ACTA, V1157, P313, DOI 10.1016/0304-4165(93)90115-O; MUKAI K, 1992, J BIOL CHEM, V267, P22277; Oldenburg J, 2000, THROMB HAEMOSTASIS, V84, P937; Oldenburg J, 2006, ANTIOXID REDOX SIGN, V8, P347, DOI 10.1089/ars.2006.8.347; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Schaafhausen A, 2011, THROMB HAEMOSTASIS, V105, P285, DOI 10.1160/TH10-07-0483; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Sly LM, 2008, J IMMUNOL, V181, P3850, DOI 10.4049/jimmunol.181.6.3850; Spohn G, 2009, THROMB HAEMOSTASIS, V101, P1044, DOI 10.1160/TH09-03-0204; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki Y, 2009, MOL IMMUNOL, V46, P2200, DOI 10.1016/j.molimm.2009.04.013; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Tanaka T, 2006, CELL CYCLE, V5, P2671, DOI 10.4161/cc.5.22.3472; Tishler M, 1940, J AM CHEM SOC, V62, P2866, DOI 10.1021/ja01867a066; Vervoort LMT, 1997, BIOCHEM PHARMACOL, V54, P871, DOI 10.1016/S0006-2952(97)00254-2; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watzka M, 2011, J THROMB HAEMOST, V9, P109, DOI 10.1111/j.1538-7836.2010.04095.x	47	65	73	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15085	15094		10.1074/jbc.M110.210971	http://dx.doi.org/10.1074/jbc.M110.210971			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367861	hybrid, Green Published			2022-12-25	WOS:000289788300039
J	El Moustaine, D; Perrier, V; Van Ba, IAT; Meersman, F; Ostapchenko, VG; Baskakov, IV; Lange, R; Torrent, J				El Moustaine, Driss; Perrier, Veronique; Van Ba, Isabelle Acquatella-Tran; Meersman, Filip; Ostapchenko, Valeriy G.; Baskakov, Ilia V.; Lange, Reinhard; Torrent, Joan			Amyloid Features and Neuronal Toxicity of Mature Prion Fibrils Are Highly Sensitive to High Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; P COMPONENT SCINTIGRAPHY; PROTEINASE-K RESISTANCE; ALZHEIMERS-DISEASE; IN-VITRO; CRYOELECTRON MICROSCOPY; STRUCTURAL POLYMORPHISM; INDUCED DISSOCIATION; TRANSITION-STATE; ALPHA-SYNUCLEIN	Prion proteins (PrP) can aggregate into toxic and possibly infectious amyloid fibrils. This particular macrostructure confers on them an extreme and still unexplained stability. To provide mechanistic insights into this self-assembly process, we used high pressure as a thermodynamic tool for perturbing the structure of mature amyloid fibrils that were prepared from recombinant full-length mouse PrP. Application of high pressure led to irreversible loss of several specific amyloid features, such as thioflavin T and 8-anilino-1-naphthalene sulfonate binding, alteration of the characteristic proteinase K digestion pattern, and a significant decrease in the beta-sheet structure and cytotoxicity of amyloid fibrils. Partial disaggregation of the mature fibrils into monomeric soluble PrP was observed. The remaining amyloid fibrils underwent a change in secondary structure that led to morphologically different fibrils composed of a reduced number of proto-filaments. The kinetics of these reactions was studied by recording the pressure-induced dissociation of thioflavin T from the amyloid fibrils. Analysis of the pressure and temperature dependence of the relaxation rates revealed partly unstructured and hydrated kinetic transition states and highlighted the importance of collapsing and hydrating inter- and intramolecular cavities to overcome the high free energy barrier that stabilizes amyloid fibrils.	[Torrent, Joan] Univ Montpellier 2, INSERM U710, CC 105, F-34095 Montpellier 5, France; [El Moustaine, Driss; Perrier, Veronique; Van Ba, Isabelle Acquatella-Tran; Lange, Reinhard; Torrent, Joan] Ecole Prat Hautes Etud, F-75007 Paris, France; [Meersman, Filip] Katholieke Univ Leuven, Dept Chem, B-3001 Louvain, Belgium; [Ostapchenko, Valeriy G.; Baskakov, Ilia V.] Univ Maryland, Dept Anat & Neurobiol, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); KU Leuven; University System of Maryland; University of Maryland Baltimore	Torrent, J (corresponding author), Univ Montpellier 2, INSERM U710, CC 105, Pl Eugene Bataillon, F-34095 Montpellier 5, France.	joan.torrent@inserm.fr	Perrier, Veronique/AAK-3594-2020	TORRENT, Joan/0000-0002-6908-4084; Ostapchenko, Valeriy/0000-0002-3629-7702; perrier, veronique/0000-0002-6570-7504	National Institutes of Health [NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS045585 (to I. V. B.).	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Akasaka K, 2007, BIOCHEMISTRY-US, V46, P10444, DOI 10.1021/bi700648b; Alvarez-Martinez MT, 2003, BBA-PROTEINS PROTEOM, V1645, P228, DOI 10.1016/S1570-9639(02)00536-8; BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Breydo Leonid, 2008, V459, P105, DOI 10.1007/978-1-59745-234-2_8; Brown P, 2003, P NATL ACAD SCI USA, V100, P6093, DOI 10.1073/pnas.1031826100; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calamai M, 2005, J MOL BIOL, V346, P603, DOI 10.1016/j.jmb.2004.11.067; Callahan NA, 2001, J BIOL CHEM, V276, P28022, DOI 10.1074/jbc.M103629200; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; Dirix C, 2005, J MOL BIOL, V347, P903, DOI 10.1016/j.jmb.2005.01.073; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; El Moustaine D, 2008, FEBS J, V275, P2021, DOI 10.1111/j.1742-4658.2008.06356.x; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2009, PRION, V3, P89; Fernandez-Busquets X, 2008, CURR MED CHEM, V15, P1336, DOI 10.2174/092986708784534938; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Font J, 2006, BIOPHYS J, V91, P2264, DOI 10.1529/biophysj.106.082552; Forst P, 2000, RHEOL ACTA, V39, P566, DOI 10.1007/s003970000114; Garcia AF, 2004, J GEN VIROL, V85, P261, DOI 10.1099/vir.0.19410-0; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Gobbi M, 2006, J BIOL CHEM, V281, P843, DOI 10.1074/jbc.M506164200; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; Grudzielanek S, 2006, J MOL BIOL, V356, P497, DOI 10.1016/j.jmb.2005.11.075; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; HAWKINS PN, 1993, ARTHRITIS RHEUM, V36, P842, DOI 10.1002/art.1780360616; HAWKINS PN, 1993, Q J MED, V86, P365; Heindl P, 2005, BRAZ J MED BIOL RES, V38, P1223, DOI 10.1590/S0100-879X2005000800010; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863; Kamatari YO, 2005, J MOL BIOL, V349, P916, DOI 10.1016/j.jmb.2005.04.010; Langkilde AE, 2009, FEBS LETT, V583, P2600, DOI 10.1016/j.febslet.2009.05.040; Latif ARA, 2007, BIOPHYS J, V92, P323, DOI 10.1529/biophysj.106.088120; Laurine E, 2003, J BIOL CHEM, V278, P51770, DOI 10.1074/jbc.M306767200; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Loksztejn A, 2009, BIOCHEMISTRY-US, V48, P4846, DOI 10.1021/bi900394b; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Madine J, 2008, J AM CHEM SOC, V130, P14990, DOI 10.1021/ja802483d; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Meersman F, 2003, BIOPHYS CHEM, V104, P297, DOI 10.1016/S0301-4622(02)00385-X; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Merzel F, 2002, P NATL ACAD SCI USA, V99, P5378, DOI 10.1073/pnas.082335099; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Milhiet PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013240; Mishra R, 2008, ANGEW CHEM INT EDIT, V47, P6518, DOI 10.1002/anie.200802027; Morel B, 2010, J PHYS CHEM B, V114, P4010, DOI 10.1021/jp9102993; Niraula TN, 2004, P NATL ACAD SCI USA, V101, P4089, DOI 10.1073/pnas.0305798101; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Rydh A, 1998, EUR J NUCL MED, V25, P709; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Takeda T, 2008, BIOPHYS J, V95, P1758, DOI 10.1529/biophysj.108.131698; Tan SY, 1996, KIDNEY INT, V50, P282, DOI 10.1038/ki.1996.313; Torrent J, 2006, BBA-PROTEINS PROTEOM, V1764, P489, DOI 10.1016/j.bbapap.2006.01.002; Torrent J, 2005, PROTEIN SCI, V14, P956, DOI 10.1110/ps.04989405; Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d; Torrent J, 2003, BIOCHEMISTRY-US, V42, P1318, DOI 10.1021/bi0269916; VANELDIK R, 1989, CHEM REV, V89, P549, DOI 10.1021/cr00093a005; VIDUGIRIS GJA, 1995, BIOCHEMISTRY-US, V34, P4909, DOI 10.1021/bi00015a001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Woenckhaus J, 2001, BIOPHYS J, V80, P1518, DOI 10.1016/S0006-3495(01)76124-3	84	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13448	13459		10.1074/jbc.M110.192872	http://dx.doi.org/10.1074/jbc.M110.192872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21357423	Green Published, hybrid			2022-12-25	WOS:000289282200065
J	Chakraborty, C; Agoramoorthy, G; Hsu, MJ				Chakraborty, Chiranjib; Agoramoorthy, Govindasamy; Hsu, Minna J.			Exploring the Evolutionary Relationship of Insulin Receptor Substrate Family Using Computational Biology	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; O-GLYCOSYLATION; PROTEIN GLYCOSYLATION; IRS PROTEINS; INFORMATION; DOMAIN; CONSERVATION; CONSURF; SYSTEM	Insulin receptor substrate (IRS) harbors proteins such as IRS1, IRS2, IRS3, IRS4, IRS5 and IRS6. These key proteins act as vital downstream regulators in the insulin signaling pathway. However, little is known about the evolutionary relationship among the IRS family members. This study explores the potential to depict the evolutionary relationship among the IRS family using bioinformatics, algorithm analysis and mathematical models.	[Chakraborty, Chiranjib] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India; [Agoramoorthy, Govindasamy] Tajen Univ, Coll Environm & Hlth Sci, Yanpu, Taiwan; [Hsu, Minna J.] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Vellore Institute of Technology; National Sun Yat Sen University	Hsu, MJ (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.	hsumin@mail.nsysu.edu.tw	Chakraborty, Chiranjib/J-4847-2013	Chakraborty, Chiranjib/0000-0002-3958-239X; Hsu, Minna J/0000-0001-7681-3532; Agoramoorthy, Govindasamy/0000-0002-8936-6978				ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Anand S, 2010, FEBS LETT, V584, P3170, DOI 10.1016/j.febslet.2010.06.004; ANGELA MV, 1998, MOL ENDOCRINOL, V12, P688; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Balakrishnan S, 2010, INDIAN J BIOTECHNOL, V9, P24; Branden C., 1999, INTRO PROTEIN STRUCT; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Chakraborty C, 2006, CURR PROTEIN PEPT SC, V7, P113, DOI 10.2174/138920306776359759; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Deo N., 1974, GRAPH THEORY APPL EN; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Hounsell EF, 1996, GLYCOCONJUGATE J, V13, P19, DOI 10.1007/BF01049675; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kirnarsky L, 1998, BIOCHEMISTRY-US, V37, P12811, DOI 10.1021/bi981034a; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; MITTAL R, 1994, MICROELECTRON RELIAB, V34, P1301, DOI 10.1016/0026-2714(94)90143-0; Park SY, 2008, NAT STRUCT MOL BIOL, V15, P224, DOI 10.1038/nsmb0308-224; Renteria ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003667; Robert F, 2009, EXPERT OPIN THER TAR, V13, P1279, DOI 10.1517/14728220903241625; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Vainshtein I, 2001, J BIOL CHEM, V276, P8073, DOI 10.1074/jbc.M008436200; Van Obberghen E, 2001, EUR J CLIN INVEST, V31, P966, DOI 10.1046/j.1365-2362.2001.00896.x; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	41	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16580	10.1371/journal.pone.0016580	http://dx.doi.org/10.1371/journal.pone.0016580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364910	Green Published, gold, Green Submitted			2022-12-25	WOS:000287764100006
J	Chipperfield, JD; Dytham, C; Hovestadt, T				Chipperfield, Joseph D.; Dytham, Calvin; Hovestadt, Thomas			An Updated Algorithm for the Generation of Neutral Landscapes by Spectral Synthesis	PLOS ONE			English	Article							FRACTAL LANDSCAPES; STRUCTURED LANDSCAPES; MODELS; CONNECTIVITY; ENVIRONMENTS; HETEROGENEITY; RESPONSES; EVOLUTION; DYNAMICS; PATTERNS	Background: Patterns that arise from an ecological process can be driven as much from the landscape over which the process is run as it is by some intrinsic properties of the process itself. The disentanglement of these effects is aided if it possible to run models of the process over artificial landscapes with controllable spatial properties. A number of different methods for the generation of so-called 'neutral landscapes' have been developed to provide just such a tool. Of these methods, a particular class that simulate fractional Brownian motion have shown particular promise. The existing methods of simulating fractional Brownian motion suffer from a number of problems however: they are often not easily generalisable to an arbitrary number of dimensions and produce outputs that can exhibit some undesirable artefacts. Methodology: We describe here an updated algorithm for the generation of neutral landscapes by fractional Brownian motion that do not display such undesirable properties. Using Monte Carlo simulation we assess the anisotropic properties of landscapes generated using the new algorithm described in this paper and compare it against a popular benchmark algorithm. Conclusion/Significance: The results show that the existing algorithm creates landscapes with values strongly correlated in the diagonal direction and that the new algorithm presented here corrects this artefact. A number of extensions of the algorithm described here are also highlighted: we describe how the algorithm can be employed to generate landscapes that display different properties in different dimensions and how they can be combined with an environmental gradient to produce landscapes that combine environmental variation at the local and macro scales.	[Chipperfield, Joseph D.; Hovestadt, Thomas] Univ Wurzburg, Field Stn Fabrikschleichach, Rauhenebrach, Germany; [Chipperfield, Joseph D.; Dytham, Calvin] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Hovestadt, Thomas] Museum Natl Hist Nat, Brunoy, France	University of Wurzburg; University of York - UK; Museum National d'Histoire Naturelle (MNHN)	Chipperfield, JD (corresponding author), Univ Wurzburg, Field Stn Fabrikschleichach, Rauhenebrach, Germany.	j.chipperfield@biozentrum.uni-wuerzburg.de	; Chipperfield, Joseph/A-8280-2018	Dytham, Calvin/0000-0002-4111-9484; Chipperfield, Joseph/0000-0003-3314-0846; Hovestadt, Thomas/0000-0001-7368-6013	NERC/UKPopNet [NER/S/R/2005/13941]; DFG [1374, HO 2051/2-1]	NERC/UKPopNet(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); DFG(German Research Foundation (DFG))	This research was supported by a NERC/UKPopNet studentship (NER/S/R/2005/13941 - http://bioltfws1.york.ac.uk/UKPopNet/studentships/jchipperfield) and by the DFG Priority Program 1374 'Infrastructure-Biodiversity-Exploratories' (HO 2051/2-1 http://www.biodiversity-exploratories.de/Projects/contributing-projects/modeling-remote-sensing/beam). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bascompte J, 2002, AM NAT, V159, P128, DOI 10.1086/324793; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Dey S, 2006, J THEOR BIOL, V238, P78, DOI 10.1016/j.jtbi.2005.05.013; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; FORNEY KA, 1989, CONSERV BIOL, V3, P45, DOI 10.1111/j.1523-1739.1989.tb00223.x; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Gardner RH, 1999, LANDSCAPE ECOLOGICAL ANALYSIS: ISSUES AND APPLICATIONS, P280; GARDNER RH, 1991, QUANTITATIVE METHODS, P289; Gardner RH, 2007, LANDSCAPE ECOL, V22, P15, DOI 10.1007/s10980-006-9011-4; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I., 2002, METAPOPULATION ECOLO; Hovestadt T, 2001, P ROY SOC B-BIOL SCI, V268, P385, DOI 10.1098/rspb.2000.1379; Keitt TH, 2000, LANDSCAPE ECOL, V15, P479, DOI 10.1023/A:1008193015770; LAVOREL S, 1993, OIKOS, V67, P521, DOI 10.2307/3545364; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; MANDELBROT BB, 1982, COMMUN ACM, V25, P581; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; MILNE BT, 1992, AM NAT, V139, P32, DOI 10.1086/285312; Moloney KA, 1996, ECOLOGY, V77, P375, DOI 10.2307/2265616; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; NOSS RF, 1991, LANDSCAPE LINKAGES AND BIODIVERSITY, P27; ODEN NL, 1986, SYST ZOOL, V35, P608, DOI 10.2307/2413120; ONEILL RV, 1992, LANDSCAPE ECOL, V7, P55, DOI 10.1007/BF02573957; PALMER MW, 1992, AM NAT, V139, P375, DOI 10.1086/285332; Peitgen H.-O., 1988, SCI FRACTAL IMAGES; PRESS WH, 2007, NUMERICAL RECIPIES; Shima JS, 2010, ECOLOGY, V91, P1215, DOI 10.1890/08-2058.1; Travis JMJ, 2004, OIKOS, V104, P410; With KA, 1997, CONSERV BIOL, V11, P1069, DOI 10.1046/j.1523-1739.1997.96210.x; With KA, 1997, OIKOS, V79, P219, DOI 10.2307/3546007; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; With KA, 1999, ECOLOGY, V80, P1340, DOI 10.1890/0012-9658(1999)080[1340:MRTPSI]2.0.CO;2	35	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17040	10.1371/journal.pone.0017040	http://dx.doi.org/10.1371/journal.pone.0017040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347228	gold, Green Submitted, Green Published			2022-12-25	WOS:000287369200015
J	Graham, AC; Carr, KD; Sieve, AN; Indramohan, M; Break, TJ; Berg, RE				Graham, Amy C.; Carr, Karen D.; Sieve, Amy N.; Indramohan, Mohanalaxmi; Break, Timothy J.; Berg, Rance E.			IL-22 Production Is Regulated by IL-23 During Listeria monocytogenes Infection but Is Not Required for Bacterial Clearance or Tissue Protection	PLOS ONE			English	Article							INNATE IMMUNE PROTECTION; MUCOSAL HOST-DEFENSE; T-CELLS; ADAPTIVE IMMUNITY; TH17 CELLS; MICE; INTERLEUKIN-22; IL-12; ROLES; INFLAMMATION	Listeria monocytogenes (LM) is a gram-positive bacterium that is a common contaminant of processed meats and dairy products. In humans, ingestion of LM can result in intracellular infection of the spleen and liver, which can ultimately lead to septicemia, meningitis, and spontaneous abortion. Interleukin (IL)-23 is a cytokine that regulates innate and adaptive immune responses by inducing the production of IL-17A, IL-17F, and IL-22. We have recently demonstrated that the IL-23/IL-17 axis is required for optimal recruitment of neutrophils to the liver, but not the spleen, during LM infection. Furthermore, these cytokines are required for the clearance of LM during systemic infection. In other infectious models, IL-22 induces the secretion of anti-microbial peptides and protects tissues from damage by preventing apoptosis. However, the role of IL-22 has not been thoroughly investigated during LM infection. In the present study, we show that LM induces the production of IL-22 in vivo. Interestingly, IL-23 is required for the production of IL-22 during primary, but not secondary, LM infection. Our findings suggest that IL-22 is not required for clearance of LM during primary or secondary infection, using both systemic and mucosal models of infection. IL-22 is also not required for the protection of LM infected spleens and livers from organ damage. Collectively, these data indicate that IL-22 produced during LM infection must play a role other than clearance of LM or protection of tissues from pathogen- or immune-mediated damage.	[Graham, Amy C.; Carr, Karen D.; Sieve, Amy N.; Indramohan, Mohanalaxmi; Break, Timothy J.; Berg, Rance E.] Univ N Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Graham, AC (corresponding author), Univ N Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA.	Rance.Berg@unthsc.edu		Break, Timothy/0000-0001-5987-7817	National Institutes of Health (NIH) [AI064592, AI072946]; Texas Norman Hackerman Advanced Research Program Grant [000130-002502007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI064592, F32AI072946] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Norman Hackerman Advanced Research Program Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) AI064592 and a Texas Norman Hackerman Advanced Research Program Grant #000130-002502007 (to R.E.B.). A.N.S. was supported by NIH AI072946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Ghilardi N, 2007, SEMIN IMMUNOL, V19, P383, DOI 10.1016/j.smim.2007.10.016; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Henry CJ, 2008, J IMMUNOL, V181, P8576, DOI 10.4049/jimmunol.181.12.8576; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manohar M, 2001, INFECT IMMUN, V69, P3542, DOI 10.1128/IAI.69.6.3542-3549.2001; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Merrick JC, 1997, AM J PATHOL, V151, P785; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Miura T, 2000, FEMS IMMUNOL MED MIC, V28, P335, DOI 10.1111/j.1574-695X.2000.tb01495.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang W, 2008, MUCOSAL IMMUNOL, V1, P335, DOI 10.1038/mi.2008.26; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PINE L, 1990, INFECT IMMUN, V58, P2940, DOI 10.1128/IAI.58.9.2940-2945.1990; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	43	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17171	10.1371/journal.pone.0017171	http://dx.doi.org/10.1371/journal.pone.0017171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347242	Green Published, Green Submitted, gold			2022-12-25	WOS:000287369200026
J	Wang, DV; Tsien, JZ				Wang, Dong V.; Tsien, Joe Z.			Convergent Processing of Both Positive and Negative Motivational Signals by the VTA Dopamine Neuronal Populations	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS DOPAMINE; LATERAL HABENULA; PREFRONTAL CORTEX; REWARD; ENCODE; DIFFERENTIATE; ADDICTION; BEHAVIOR; PATTERN	Dopamine neurons in the ventral tegmental area (VTA) have been traditionally studied for their roles in reward-related motivation or drug addiction. Here we study how the VTA dopamine neuron population may process fearful and negative experiences as well as reward information in freely behaving mice. Using multi-tetrode recording, we find that up to 89% of the putative dopamine neurons in the VTA exhibit significant activation in response to the conditioned tone that predict food reward, while the same dopamine neuron population also respond to the fearful experiences such as free fall and shake events. The majority of these VTA putative dopamine neurons exhibit suppression and offset-rebound excitation, whereas similar to 25% of the recorded putative dopamine neurons show excitation by the fearful events. Importantly, VTA putative dopamine neurons exhibit parametric encoding properties: their firing change durations are proportional to the fearful event durations. In addition, we demonstrate that the contextual information is crucial for these neurons to respectively elicit positive or negative motivational responses by the same conditioned tone. Taken together, our findings suggest that VTA dopamine neurons may employ the convergent encoding strategy for processing both positive and negative experiences, intimately integrating with cues and environmental context.	[Wang, Dong V.] E China Normal Univ, Key Lab MOE & STCSM, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China; [Wang, Dong V.; Tsien, Joe Z.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Wang, Dong V.; Tsien, Joe Z.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA	East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wang, DV (corresponding author), E China Normal Univ, Key Lab MOE & STCSM, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China.	jtsien@mcg.edu			NIMH [MH060236]; NIA [AG024022, AG034663, AG025918]; Georgia Research Alliance;  [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024022, R01AG025918, R01AG034663] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from NIMH (MH060236), NIA (AG024022, AG034663 & AG025918), USAMRA00002, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; DEPAULIS A, 1992, EXP BRAIN RES, V90, P307; DIANA M, 1993, P NATL ACAD SCI USA, V90, P7966, DOI 10.1073/pnas.90.17.7966; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Frank MJ, 2009, J MOL CELL BIOL, V1, P15, DOI 10.1093/jmcb/mjp010; GRACE AA, 1984, J NEUROSCI, V4, P2877; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Joshua M, 2009, NEURON, V62, P695, DOI 10.1016/j.neuron.2009.04.026; Karreman M, 1996, J NEUROCHEM, V66, P589; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Komendantov AO, 2002, J NEUROPHYSIOL, V87, P1526, DOI 10.1152/jn.00255.2001; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lee RS, 2001, J NEUROSCI, V21, P1757; Levita L, 2002, BEHAV BRAIN RES, V137, P115, DOI 10.1016/S0166-4328(02)00287-5; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; MILLR JD, 1983, BRAIN RES, V273, P133, DOI 10.1016/0006-8993(83)91101-0; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Narayanan Nandakumar S., 2009, V489, P135, DOI 10.1007/978-1-59745-543-5_7; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	52	78	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17047	10.1371/journal.pone.0017047	http://dx.doi.org/10.1371/journal.pone.0017047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347237	Green Submitted, Green Published, gold			2022-12-25	WOS:000287369200016
J	Rosa, DS; Ribeiro, SP; Almeida, RR; Mairena, EC; Postol, E; Kalil, J; Cunha-Neto, E				Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Almeida, Rafael Ribeiro; Mairena, Eliane Conti; Postol, Edilberto; Kalil, Jorge; Cunha-Neto, Edecio			A DNA Vaccine Encoding Multiple HIV CD4 Epitopes Elicits Vigorous Polyfunctional, Long-Lived CD4(+) and CD8(+) T Cell Responses	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PROTECTIVE IMMUNITY; ELITE CONTROLLERS; RHESUS-MONKEYS; CENTRAL MEMORY; INFECTION; CHALLENGE; STEP; PREDICTION; CORRELATE	T-cell based vaccines against HIV have the goal of limiting both transmission and disease progression by inducing broad and functionally relevant T cell responses. Moreover, polyfunctional and long-lived specific memory T cells have been associated to vaccine-induced protection. CD4(+) T cells are important for the generation and maintenance of functional CD8(+) cytotoxic T cells. We have recently developed a DNA vaccine encoding 18 conserved multiple HLA-DR-binding HIV-1 CD4 epitopes (HIVBr18), capable of eliciting broad CD4(+) T cell responses in multiple HLA class II transgenic mice. Here, we evaluated the breadth and functional profile of HIVBr18-induced immune responses in BALB/c mice. Immunized mice displayed high-magnitude, broad CD4(+)/CD8(+) T cell responses, and 8/18 vaccine-encoded peptides were recognized. In addition, HIVBr18 immunization was able to induce polyfunctional CD4(+) and CD8(+) T cells that proliferate and produce any two cytokines (IFN gamma/TNF alpha, IFN gamma/IL-2 or TNF alpha/IL-2) simultaneously in response to HIV-1 peptides. For CD4(+) T cells exclusively, we also detected cells that proliferate and produce all three tested cytokines simultaneously (IFN gamma/TNF alpha/IL-2). The vaccine also generated long-lived central and effector memory CD4(+) T cells, a desirable feature for T-cell based vaccines. By virtue of inducing broad, polyfunctional and long-lived T cell responses against conserved CD4(+) T cell epitopes, combined administration of this vaccine concept may provide sustained help for CD8(+) T cells and antibody responses-elicited by other HIV immunogens.	[Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Almeida, Rafael Ribeiro; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Dept Med,Lab Clin Immunol & Allergy LIM60, Sao Paulo, Brazil; [Mairena, Eliane Conti; Postol, Edilberto; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Mairena, Eliane Conti; Postol, Edilberto; Kalil, Jorge; Cunha-Neto, Edecio] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Rosa, Daniela Santoro] Fed Univ Sao Paulo UNIFESP, Div Immunol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Rosa, DS (corresponding author), Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Dept Med,Lab Clin Immunol & Allergy LIM60, Sao Paulo, Brazil.	edecunha@gmail.com	KALIL, JORGE/C-8029-2012; Almeida, Rafael Ribeiro/F-8014-2014; Rosa, Daniela S/D-2190-2012; Cunha-Neto, Edecio/B-4157-2009	KALIL, JORGE/0000-0001-8415-4274; Almeida, Rafael Ribeiro/0000-0003-3984-7527; Rosa, Daniela S/0000-0003-4536-891X; Cunha-Neto, Edecio/0000-0002-3699-3345	Brazilian National Research Council (CNPq); Sao Paulo State Research Funding Agency (FAPESP); International Centre of Genetic Engineering and Biotechnology (ICGEB); Brazilian Ministry of Health (Brazil)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Centre of Genetic Engineering and Biotechnology (ICGEB); Brazilian Ministry of Health (Brazil)	This research was supported by the Brazilian National Research Council (CNPq), Sao Paulo State Research Funding Agency (FAPESP), International Centre of Genetic Engineering and Biotechnology (ICGEB) and by the Brazilian Ministry of Health (Brazil). D. S. Rosa, S. P. Ribeiro and R. R. Almeida are recipients of a Sao Paulo State Research Funding Agency (FAPESP) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; ATHERTON ND, 1989, CLIN CHEM, V35, P975; BenMohamed L, 2003, J VIROL, V77, P9463, DOI 10.1128/JVI.77.17.9463-9473.2003; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; FERRE AL, 2010, J VIROL; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Iwai LK, 2003, MOL MED, V9, P209, DOI 10.1007/BF03402131; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; Martinez V, 2005, J INFECT DIS, V191, P2053, DOI 10.1086/430320; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Pancre V, 2007, VACCINE, V25, P5927, DOI 10.1016/j.vaccine.2007.05.038; Pike R, 2009, J VIROL, V83, P11211, DOI 10.1128/JVI.01225-09; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Rosa DS, 2006, MICROBES INFECT, V8, P2130, DOI 10.1016/j.micinf.2006.03.012; Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; von Gegerfelt A, 2010, J IMMUNOL, V185, P3348, DOI 10.4049/jimmunol.1000572; Wang M, 2009, CLIN EXP IMMUNOL, V155, P441, DOI 10.1111/j.1365-2249.2008.03856.x; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Yamamoto T, 2009, J VIROL, V83, P5514, DOI 10.1128/JVI.00145-09; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW180, DOI 10.1093/nar/gki479	56	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16921	10.1371/journal.pone.0016921	http://dx.doi.org/10.1371/journal.pone.0016921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347287	Green Published, gold, Green Submitted			2022-12-25	WOS:000287364500013
J	Perdikis, D; Huys, R; Jirsa, V				Perdikis, Dionysios; Huys, Raoul; Jirsa, Viktor			Complex Processes from Dynamical Architectures with Time-Scale Hierarchy	PLOS ONE			English	Article							MOTOR PROGRAMS; RHYTHMICAL MOVEMENTS; ARM MOVEMENTS; DISCRETE; PERCEPTION; SUPERPOSITION; COORDINATION; RECOGNITION; PRIMITIVES; EXCITATOR	The idea that complex motor, perceptual, and cognitive behaviors are composed of smaller units, which are somehow brought into a meaningful relation, permeates the biological and life sciences. However, no principled framework defining the constituent elementary processes has been developed to this date. Consequently, functional configurations (or architectures) relating elementary processes and external influences are mostly piecemeal formulations suitable to particular instances only. Here, we develop a general dynamical framework for distinct functional architectures characterized by the time-scale separation of their constituents and evaluate their efficiency. Thereto, we build on the (phase) flow of a system, which prescribes the temporal evolution of its state variables. The phase flow topology allows for the unambiguous classification of qualitatively distinct processes, which we consider to represent the functional units or modes within the dynamical architecture. Using the example of a composite movement we illustrate how different architectures can be characterized by their degree of time scale separation between the internal elements of the architecture (i.e. the functional modes) and external interventions. We reveal a tradeoff of the interactions between internal and external influences, which offers a theoretical justification for the efficient composition of complex processes out of non-trivial elementary processes or functional modes.	[Perdikis, Dionysios; Huys, Raoul; Jirsa, Viktor] Univ Mediterranean, Inst Sci Mouvement UMR6233, Theoret Neurosci Grp, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Perdikis, D (corresponding author), Univ Mediterranean, Inst Sci Mouvement UMR6233, Theoret Neurosci Grp, Marseille, France.	dionysios.perdikis@etumel.univmed.fr	Jirsa, Viktor/M-4630-2016	Jirsa, Viktor/0000-0002-8251-8860; Perdikis, Dionysios/0000-0003-0103-7094	Codebox research; James S. McDonnell Foundation	Codebox research; James S. McDonnell Foundation	Codebox research and the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLER WL, 1989, J SOC BIOL STRUCT, V12, P1, DOI 10.1016/0140-1750(89)90015-8; Beek PJ, 1996, J EXP PSYCHOL HUMAN, V22, P1077; BEEK PJ, 1988, TOOLS CONSTRUCTING D, V7, P301; Bernstein N.A., 1967, COORDINATION REGULAT; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; BROCKETT RW, 1988, COMPUTER CONTROL MOV, P534; Buchanan JJ, 2003, EXP BRAIN RES, V150, P473, DOI 10.1007/s00221-003-1471-z; BULLOCK D, 1993, BIOL CYBERN, V70, P15, DOI 10.1007/BF00202562; Casati R, 2009, PHILOS PSYCHOL, V22, P77, DOI 10.1080/09515080802703711; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; DAFFERTSHOFER A, 1994, PATTERN RECOGN, V27, P1697, DOI 10.1016/0031-3203(94)90087-6; DEGALLIER S, 2006, MOVEMENT GENERATION; DITZINGER T, 2011, NONLINEAR DYNAMICS H, V328; Egerstedt M, 2003, SPRINGER TRAC ADV RO, V4, P75; FELDMAN AG, 1980, NEUROSCIENCE, V5, P81, DOI 10.1016/0306-4522(80)90073-1; FELDMAN AG, 1980, NEUROSCIENCE, V5, P91, DOI 10.1016/0306-4522(80)90074-3; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; Fink PW, 2009, J MOTOR BEHAV, V41, P147, DOI 10.3200/JMBR.41.2.147-157; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000081; GISZTER SF, 1993, J NEUROSCI, V13, P467; Haken H, 2004, SYNERGETIC COMPUTERS, V2nd ed.; Hock HS, 2010, STUD COMPUT INTELL, V328, P151; Horridge A., 2009, WHAT DOES HON SEE; Huerta R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238104; Huys R, 2010, NEUROSCI LETT, V472, P24, DOI 10.1016/j.neulet.2010.01.047; Huys R, 2010, P ROY SOC B-BIOL SCI, V277, P1179, DOI 10.1098/rspb.2009.1954; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; KAY BA, 1991, J EXP PSYCHOL HUMAN, V17, P183, DOI 10.1037/0096-1523.17.1.183; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Klippel A, 2009, SPAT COGN COMPUT, V9, P233, DOI 10.1080/13875860903039172; KUGLER PN, 1980, CONCEPT COORDINATIVE, V1, P3; Latash M., 1993, CONTROL HUMAN MOVEME; Marr D., 2010, VISION; McLeod P, 2001, SYNTHESE, V129, P173, DOI 10.1023/A:1013003423323; Mehta TR, 2008, AUTOMATICA, V44, P1912, DOI 10.1016/j.automatica.2007.11.024; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mitra S, 1998, HUM MOVEMENT SCI, V17, P17, DOI 10.1016/S0167-9457(97)00023-7; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Nakanishi J, 2004, ROBOT AUTON SYST, V47, P79, DOI 10.1016/j.robot.2004.03.003; Palmer F. R, 1976, SEMANTICS NEW OUTLIN; PILLAI AS, 2008, STRUCTURED FLOWS MAN; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; POLIT A, 1978, SCIENCE, V201, P1235, DOI 10.1126/science.99813; POLIT A, 1979, J NEUROPHYSIOL, V42, P183, DOI 10.1152/jn.1979.42.1.183; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Schaal S, 2003, PHILOS T R SOC B, V358, P537, DOI 10.1098/rstb.2002.1258; SCHAAL S, 2000, NONLINEAR DYNAMICAL; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schmidt RA, 2005, MOTOR CONTROL LEARNI; SCHONER G, 1990, BIOL CYBERN, V63, P257, DOI 10.1007/BF00203449; Seneff S, 2005, SPEECH COMMUN, V46, P204, DOI 10.1016/j.specom.2005.03.005; Shannon C.E., 1963, MATH THEORY COMMUNIC; SHEVCHENKO M, 2009, IMAGE VISION COMPUTI; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Tuller B, 2008, NEW IDEAS PSYCHOL, V26, P208, DOI 10.1016/j.newideapsych.2007.07.002; van Mourik AM, 2006, BIOL CYBERN, V94, P233, DOI 10.1007/s00422-005-0041-9; Verwey WB, 2003, J MOTOR BEHAV, V35, P171, DOI 10.1080/00222890309602131; Wang B, 2007, P NATL ACAD SCI USA, V104, P21014, DOI 10.1073/pnas.0709664104; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	75	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16589	10.1371/journal.pone.0016589	http://dx.doi.org/10.1371/journal.pone.0016589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347363	Green Published, gold, Green Submitted			2022-12-25	WOS:000287363000010
J	Scharf, SH; Liebl, C; Binder, EB; Schmidt, MV; Muller, MB				Scharf, Sebastian H.; Liebl, Claudia; Binder, Elisabeth B.; Schmidt, Mathias V.; Mueller, Marianne B.			Expression and Regulation of the Fkbp5 Gene in the Adult Mouse Brain	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; GLUCOCORTICOID-RECEPTOR; TREATMENT RESPONSE; POSTNATAL ONTOGENY; CHILDHOOD TRAUMA; STRESS; POLYMORPHISMS; DEPRESSION; RISK; ASSOCIATION	Background: Chronic stress has been found to be a major risk factor for various human pathologies. Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, which is tightly regulated via, among others, the glucocorticoid receptor (GR). The activity of the GR is modulated by a variety of proteins, including the co-chaperone FK506 binding protein 51 (FKBP5). Although FKBP5 has been associated with risk for affective disorders and has been implicated in GR sensitivity, previous studies focused mainly on peripheral blood, while information about basal distribution and induction in the central nervous system are sparse. Methodology/Principal Findings: In the present study, we describe the basal expression pattern of Fkbp5 mRNA in the brain of adult male mice and show the induction of Fkbp5 mRNA via dexamethasone treatment or different stress paradigms. We could show that Fkbp5 is often, but not exclusively, expressed in regions also known for GR expression, for example the hippocampus. Furthermore, we were able to induce Fkbp5 expression via dexamethasone in the CA1 and DG subregions of the hippocampus, the paraventricular nucleus (PVN) and the central amygdala (CeA). Increase of Fkbp5 mRNA was also found after restrained stress and 24 hours of food deprivation in the PVN and the CeA, while in the hippocampus only food deprivation caused an increase in Fkbp5 mRNA. Conclusions/Significance: Interestingly, regions with a low basal expression showed higher increase in Fkbp5 mRNA following induction than regions with high basal expression, supporting the hypothesis that GR sensitivity is, at least partly, mediated via Fkbp5. In addition, this also supports the use of Fkbp5 gene expression as a marker for GR sensitivity. In summary, we were able to give an overview of the basal expression of fkbp5 mRNA as well as to extend the findings of induction of Fkbp5 and its regulatory influence on GR sensitivity from peripheral blood to the brain.	[Scharf, Sebastian H.; Liebl, Claudia; Mueller, Marianne B.] Max Planck Inst Psychiat, Res Grp Mol Stress Physiol, Munich, Germany; [Binder, Elisabeth B.] Max Planck Inst Psychiat, Res Grp Mol Genet Affect Disorders, Munich, Germany; [Schmidt, Mathias V.] Max Planck Inst Psychiat, Res Grp Neurobiol Stress, D-80804 Munich, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Scharf, SH (corresponding author), Max Planck Inst Psychiat, Res Grp Mol Stress Physiol, Munich, Germany.	sscharf@mpipsykl.mpg.de	Binder, Elisabeth B/K-8905-2014; Müller, Marianne B./AAL-8911-2021	Müller, Marianne B./0000-0002-0269-6131; Scharf, Sebastian/0000-0002-9129-4723; Schmidt, Mathias/0000-0002-3788-2268	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The present study was funded by the Max Planck Society. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Brent D, 2010, AM J PSYCHIAT, V167, P190, DOI 10.1176/appi.ajp.2009.09040576; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Checkley S, 1996, BRIT MED BULL, V52, P597; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Elenkov IJ, 2000, ANN NY ACAD SCI, V917, P94; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; JUSTER RP, 2009, NEUROSCIENC IN PRESS; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; LAVEBRATT C, 2010, J AFFECTIVE IN PRESS; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lekman M, 2008, BIOL PSYCHIAT, V63, P1103, DOI 10.1016/j.biopsych.2007.10.026; Lightman SL, 2008, J NEUROENDOCRINOL, V20, P880, DOI 10.1111/j.1365-2826.2008.01711.x; Navailles S, 2010, DEV NEUROSCI-BASEL, V32, P139, DOI 10.1159/000293989; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Pahwa P, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-84; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pryce CR, 2008, BRAIN RES REV, V57, P596, DOI 10.1016/j.brainresrev.2007.08.005; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; SOUSA RJ, 1989, MOL ENDOCRINOL, V3, P481, DOI 10.1210/mend-3-3-481; Szymanska M, 2009, PSYCHONEUROENDOCRINO, V34, P822, DOI 10.1016/j.psyneuen.2008.12.012; Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6; Tyrka AR, 2009, BIOL PSYCHIAT, V66, P681, DOI 10.1016/j.biopsych.2009.05.012; VANEEKELEN JAM, 1991, DEV BRAIN RES, V61, P33, DOI 10.1016/0165-3806(91)90111-U; Vermeer H, 2004, EUR J ENDOCRINOL, V150, P41, DOI 10.1530/eje.0.1500041; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Wang JL, 2005, PSYCHOL MED, V35, P865, DOI 10.1017/S0033291704003241; Willour VL, 2009, MOL PSYCHIATR, V14, P261, DOI 10.1038/sj.mp.4002141; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Yao M, 2008, J COMP NEUROL, V508, P967, DOI 10.1002/cne.21716; Zobel A, 2010, INT J NEUROPSYCHOPH, V13, P649, DOI 10.1017/S1461145709991155; Zobel AW, 1999, AM J PSYCHIAT, V156, P949, DOI 10.1176/ajp.156.6.949	46	147	148	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16883	10.1371/journal.pone.0016883	http://dx.doi.org/10.1371/journal.pone.0016883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347384	gold, Green Published, Green Submitted			2022-12-25	WOS:000287361700050
J	Staples, GO; Shi, XF; Zaia, J				Staples, Gregory O.; Shi, Xiaofeng; Zaia, Joseph			Glycomics Analysis of Mammalian Heparan Sulfates Modified by the Human Extracellular Sulfatase HSulf2	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; IN-VIVO; PROTEOGLYCANS; BINDING; QSULF1; SULF2; 6-O-ENDOSULFATASES; OLIGOSACCHARIDES; ENDOSULFATASE; 6-O-SULFATION	Background: The Sulfs are a family of endosulfatases that selectively modify the 6O-sulfation state of cell-surface heparan sulfate (HS) molecules. Sulfs serve as modulators of cell-signaling events because the changes they induce alter the cell surface co-receptor functions of HS chains. A variety of studies have been aimed at understanding how Sulfs modify HS structure, and many of these studies utilize Sulf knockout cell lines as the source for the HS used in the experiments. However, genetic manipulation of Sulfs has been shown to alter the expression levels of HS biosynthetic enzymes, and in these cases an assessment of the fine structural changes induced solely by Sulf enzymatic activity is not possible. Therefore, the present work aims to extend the understanding of substrate specificities of HSulf2 using in vitro experiments to compare HSulf2 activities on HS from different organ tissues. Methodology/Principal Findings: To further the understanding of Sulf enzymatic activity, we conducted in vitro experiments where a variety of mammalian HS substrates were modified by recombinant human Sulf2 (HSulf2). Subsequent to treatment with HSulf2, the HS samples were exhaustively depolymerized and analyzed using size-exclusion liquid chromatography-mass spectrometry (SEC-LC/MS). We found that HSulf2 activity was highly dependent on the structural features of the HS substrate. Additionally, we characterized, for the first time, the activity of HSulf2 on the non-reducing end (NRE) of HS chains. The results indicate that the action pattern of HSulf2 at the NRE is different compared to internally within the HS chain. Conclusions/Significance: The results of the present study indicate that the activity of Sulfs is dependent on the unique structural features of the HS populations that they edit. The activity of HSulf2 at HS NREs implicates the Sulfs as key regulators of this region of the chains, and concomitantly, the protein-binding events that occur there.	[Staples, Gregory O.; Shi, Xiaofeng; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA	Boston University	Staples, GO (corresponding author), Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA.	jzaia@bu.edu	Shi, Xiaofeng/B-8700-2011; Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Staples, Gregory/0000-0003-2616-4380	NIH [P41RR10888, R01HL098950]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH grants P41RR10888 and R01HL098950 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2006, ANN REV CELL DEV BIO; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chau BN, 2009, CANCER RES, V69, P1368, DOI 10.1158/0008-5472.CAN-08-2742; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Hitchcock AM, 2006, BIOCHEMISTRY-US, V45, P2350, DOI 10.1021/bi052100t; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Mochizuki H, 2008, J BIOL CHEM, V283, P31237, DOI 10.1074/jbc.M801586200; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Naimy H, 2008, BIOCHEMISTRY-US, V47, P3155, DOI 10.1021/bi702043e; Naimy H, 2010, BIOCHEMISTRY-US, V49, P3743, DOI 10.1021/bi100135d; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Sundaram M, 2003, P NATL ACAD SCI USA, V100, P651, DOI 10.1073/pnas.252643299; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200	47	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16689	10.1371/journal.pone.0016689	http://dx.doi.org/10.1371/journal.pone.0016689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347431	gold, Green Published, Green Submitted			2022-12-25	WOS:000287077600018
J	Buache, E; Etique, N; Alpy, F; Stoll, I; Muckensturm, M; Reina-San-Martin, B; Chenard, MP; Tomasetto, C; Rio, MC				Buache, E.; Etique, N.; Alpy, F.; Stoll, I.; Muckensturm, M.; Reina-San-Martin, B.; Chenard, M. P.; Tomasetto, C.; Rio, M. C.			Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice	ONCOGENE			English	Article						TFF1/pS2; breast cancer; gain- and loss-of-function; human mammary cell lines; tumorigenicity; TFF1-KO mice	ESTROGEN-RECEPTOR; TRANSGENIC MICE; CATHEPSIN-D; IN-VIVO; EXPRESSION; PS2; INDUCTION; PEPTIDES; PROTEIN; DIFFERENTIATION	Although trefoil factor 1 (TFF1; previously named pS2) is abnormally expressed in about 50% of human breast tumors, its physiopathological role in this disease has been poorly studied. Moreover, controversial data have been reported. TFF1 function in the mammary gland therefore needs to be clarified. In this study, using retroviral vectors, we performed TFF1 gain-or loss-of-function experiments in four human mammary epithelial cell lines: normal immortalized TFF1-negative MCF10A, malignant TFF1-negative MDA-MB-231 and malignant TFF1-positive MCF7 and ZR75.1. The expression of TFF1 stimulated the migration and invasion in the four cell lines. Forced TFF1 expression in MCF10A, MDA-MB-231 and MCF7 cells did not modify anchorage-dependent or -independent cell proliferation. By contrast, TFF1 knockdown in MCF7 enhanced soft-agar colony formation. This increased oncogenic potential of MCF7 cells in the absence of TFF1 was confirmed in vivo in nude mice. Moreover, chemically induced tumorigenesis in TFF1-deficient (TFF1-KO) mice led to higher tumor incidence in the mammary gland and larger tumor size compared with wild-type mice. Similarly, tumor development was increased in the TFF1-KO ovary and lung. Collectively, our results clearly show that TFF1 does not exhibit oncogenic properties, but rather reduces tumor development. This beneficial function of TFF1 is in agreement with many clinical studies reporting a better outcome for patients with TFF1-positive breast primary tumors. Oncogene (2011) 30, 3261-3273; doi:10.1038/onc.2011.41; published online 28 February 2011	[Buache, E.; Etique, N.; Alpy, F.; Stoll, I.; Reina-San-Martin, B.; Tomasetto, C.; Rio, M. C.] Univ Strasbourg, INSERM, U964, IGBMC,CNRS,UMR 7104, Illkirch Graffenstaden, France; [Muckensturm, M.; Chenard, M. P.] CHU Hautepierre, Serv Anat Pathol Gen, F-67098 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg	Rio, MC (corresponding author), Univ Strasbourg, INSERM, U964, IGBMC,CNRS,UMR 7104, Illkirch Graffenstaden, France.	rio@igbmc.fr	Alpy, Fabien/ABD-5893-2020; Tomasetto, Catherine Laure/J-2783-2014; Reina-San-Martin, Bernardo/I-9484-2016; Chenard, Marie-Pierre/O-2373-2016; Alpy, Fabien/H-8941-2016; etique, nicolas/J-4159-2017	Alpy, Fabien/0000-0002-0526-0720; Tomasetto, Catherine Laure/0000-0002-1811-5848; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Alpy, Fabien/0000-0002-0526-0720; etique, nicolas/0000-0001-6613-9257	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer; Ligue Nationale Francaise contre le Cancer (LNCC; Comites du Haut-Rhin et du Bas-Rhin; Fondation pour la Recherche Medicale; LNCC	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Francaise contre le Cancer (LNCC; Comites du Haut-Rhin et du Bas-Rhin; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); LNCC	We would like to thank Corinne Wendling for technical help, and Emmanuelle Liaudet and Susan Chan for helpful discussion. This work was supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the Hopital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, and the Ligue Nationale Francaise contre le Cancer (LNCC; Equipe labellisee 2010) and the Comites du Haut-Rhin et du Bas-Rhin. Etique N and Buache E were recipient of Fondation pour la Recherche Medicale and LNCC fellowship, respectively.	Amiry N, 2009, ENDOCRINOLOGY, V150, P4473, DOI 10.1210/en.2009-0066; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bossenmeyer-Pourie C, 2002, J CELL BIOL, V157, P761, DOI 10.1083/jcb200108056; Buron N, 2008, INVEST OPHTH VIS SCI, V49, P3790, DOI 10.1167/iovs.07-1270; CAPONY F, 1989, CANCER RES, V49, P3904; Chenard MP, 2004, PEPTIDES, V25, P737, DOI 10.1016/j.peptides.2003.11.018; Choi EJ, 2009, DIFFERENTIATION, V77, P412, DOI 10.1016/j.diff.2008.12.004; Corte MD, 2006, BREAST CANCER RES TR, V96, P63, DOI 10.1007/s10549-005-9041-7; Crosier M, 2001, AM J PATHOL, V159, P215, DOI 10.1016/S0002-9440(10)61687-2; deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Emami S, 2001, FASEB J, V15, P351, DOI 10.1096/fj.00-0355com; FOEKENS JA, 1990, CANCER RES, V50, P3832; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Hoffmann W, 2007, CURR MED CHEM, V14, P2716, DOI 10.2174/092986707782023226; Karam SM, 2008, CELL PROLIFERAT, V41, P923, DOI 10.1111/j.1365-2184.2008.00562.x; Katoh M, 2003, INT J MOL MED, V12, P3; Khan ZE, 2003, GASTROENTEROLOGY, V125, P510, DOI 10.1016/S0016-5085(03)00908-9; KIDA N, 1993, EUR J BIOCHEM, V215, P671, DOI 10.1111/j.1432-1033.1993.tb18078.x; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Mackay A, 2009, BREAST CANCER RES TR, V118, P481, DOI 10.1007/s10549-008-0296-7; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Markicevic M, 2008, ADV EXP MED BIOL, V617, P341; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; Mikhitarian K, 2005, CLIN CANCER RES, V11, P3697, DOI 10.1158/1078-0432.CCR-04-2164; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; Playford RJ, 1996, P NATL ACAD SCI USA, V93, P2137, DOI 10.1073/pnas.93.5.2137; Poulsom R, 1997, J PATHOL, V183, P30, DOI 10.1002/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K; Press DJ, 2010, EPIDEMIOLOGY, V21, P566, DOI 10.1097/EDE.0b013e3181e08eb3; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Regalo G, 2005, CELL MOL LIFE SCI, V62, P2910, DOI 10.1007/s00018-005-5478-4; Ribieras S, 1998, BBA-REV CANCER, V1378, pF61, DOI 10.1016/S0304-419X(98)00016-X; RIO MC, 1991, GASTROENTEROLOGY, V100, P375, DOI 10.1016/0016-5085(91)90205-Y; RIO MC, 1987, P NATL ACAD SCI USA, V84, P9243, DOI 10.1073/pnas.84.24.9243; RIO MC, 1988, SCIENCE, V241, P705, DOI 10.1126/science.3041593; Rodrigues S, 2006, ONCOGENE, V25, P6628, DOI 10.1038/sj.onc.1209665; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Scott DJ, 2007, INT J ONCOL, V31, P557; Shi SQ, 2006, WORLD J GASTROENTERO, V12, P3119, DOI 10.3748/wjg.v12.i19.3119; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Stotter A, 2010, CRIT REV ONCOL HEMAT, V75, P249, DOI 10.1016/j.critrevonc.2009.10.008; Surowiak P, 2006, BRIT J CANCER, V95, P339, DOI 10.1038/sj.bjc.6603254; Thim L, 1997, CELL MOL LIFE SCI, V53, P888, DOI 10.1007/s000180050108; Thullberg M, 2008, CELL CYCLE, V7, P984, DOI 10.4161/cc.7.8.5674; Thuwajit P, 2007, HEPATOL RES, V37, P295, DOI 10.1111/j.1872-034X.2007.00045.x; Tjensvoll K, 2009, BREAST CANCER RES TR, V116, P329, DOI 10.1007/s10549-008-0204-1; TOMASETTO C, 1989, MOL ENDOCRINOL, V3, P1579, DOI 10.1210/mend-3-10-1579; Tomasetto C, 2005, CELL MOL LIFE SCI, V62, P2916, DOI 10.1007/s00018-005-5479-3; Tomasetto C, 2000, GASTROENTEROLOGY, V118, P70, DOI 10.1016/S0016-5085(00)70415-X; Tosco A, 2010, CELL MOL LIFE SCI, V67, P1943, DOI 10.1007/s00018-010-0309-7; Vestergaard EM, 2008, EARLY HUM DEV, V84, P631, DOI 10.1016/j.earlhumdev.2008.04.001; Wilson CL, 2006, ENDOCR-RELAT CANCER, V13, P617, DOI 10.1677/erc.1.01165	58	74	76	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	29					3261	3273		10.1038/onc.2011.41	http://dx.doi.org/10.1038/onc.2011.41			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	795VW	21358676	hybrid, Green Published			2022-12-25	WOS:000293006800005
J	Cozzi, R; Malito, E; Nuccitelli, A; D'Onofrio, M; Martinelli, M; Ferlenghi, I; Grandi, G; Telford, JL; Maione, D; Rinaudo, CD				Cozzi, Roberta; Malito, Enrico; Nuccitelli, Annalisa; D'Onofrio, Mariapina; Martinelli, Manuele; Ferlenghi, Ilaria; Grandi, Guido; Telford, John L.; Maione, Domenico; Rinaudo, C. Daniela			Structure analysis and site-directed mutagenesis of defined key residues and motives for pilus-related sortase C1 in group B Streptococcus	FASEB JOURNAL			English	Article						pilus islands; pilus polymerization; backbone protein; ancillary proteins; in vivo complementation mutagenesis	STAPHYLOCOCCUS-AUREUS; CELL-WALL; CRYSTAL-STRUCTURES; PROTEIN; TRANSPEPTIDASE; VACCINE; IDENTIFICATION; COLONIZATION	In group B Streptococcus (GBS), 3 structurally distinct types of pili have been discovered as potential virulence factors and vaccine candidates. The pilus-forming proteins are assembled into high-molecular-weight polymers via a transpeptidation mechanism mediated by specific class C sortases. Using a multidisciplinary approach including bioinformatics, structural and biochemical studies, and in vivo mutagenesis, we performed a broad characterization of GBS sortase C1 of pilus island 2a. The high-resolution X-ray structure of the enzyme revealed that the active site, into the beta-barrel core of the enzyme, is made of the catalytic triad His157-Cys219-Arg228 and covered by a loop, known as the "lid." We show that the catalytic triad and the predicted N- and C-terminal transmembrane regions are required for the enzyme activity. Interestingly, by in vivo complementation mutagenesis studies, we found that the deletion of the entire lid loop or mutations in specific lid key residues had no effect on catalytic activity of the enzyme. In addition, kinetic characterizations of recombinant enzymes indicate that the lid mutants can still recognize and cleave the substrate-mimicking peptide at least as well as the wild-type protein.-Cozzi, R., Malito, E., Nuccitelli, A., D'Onofrio, M., Martinelli, M., Ferlenghi, I., Grandi, G., Telford, J. L., Maione, D., Rinaudo, C. D. Structure analysis and site-directed mutagenesis of defined key residues and motives for pilus-related sortase C1 in group B Streptococcus. FASEB J. 25, 1874-1886 (2011). www.fasebj.org	[Cozzi, Roberta; Malito, Enrico; Nuccitelli, Annalisa; Martinelli, Manuele; Ferlenghi, Ilaria; Grandi, Guido; Telford, John L.; Maione, Domenico; Rinaudo, C. Daniela] Novartis Vaccines & Diagnost, Siena, Italy; [Malito, Enrico] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [D'Onofrio, Mariapina] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy	Novartis; Novartis; University of Verona	Maione, D (corresponding author), Novartis Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020	Grandi, Guido/0000-0001-9724-2185; martinelli, manuele/0000-0002-9371-076X; D'ONOFRIO, Mariapina/0000-0002-8699-0847	University of Bologna (Bologna, Italy)	University of Bologna (Bologna, Italy)	The authors are grateful to Glen Spraggon (Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA) and to Matthew Bottomley (Novartis Vaccines, Siena, Italy) for valuable discussions and critical review of the manuscript. The authors thank Prof. Tom Alber (University of California, Berkeley, CA, USA) for fruitful discussion of the sortase enzyme structures. The authors thank Roberto Rosini (Novartis Vaccines) for providing the GBS KO strain 515 Delta(SrtC1 + SrtC2). R.C. is the recipient of a Novartis fellowship from the Ph.D. program in Cellular, Molecular and Industrial Biology of the University of Bologna (Bologna, Italy).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guttilla IK, 2009, J BACTERIOL, V191, P5603, DOI 10.1128/JB.00627-09; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Kling DE, 1999, BIOTECHNIQUES, V27, P24, DOI 10.2144/99271bm03; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; VIGUERA AR, 1995, BIOCHEMISTRY-US, V34, P8771, DOI 10.1021/bi00027a028; WEINER EM, J BIOL CHEM; WIRTH R, 1986, J BACTERIOL, V165, P831, DOI 10.1128/jb.165.3.831-836.1986; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	43	25	25	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1874	1886		10.1096/fj.10-174797	http://dx.doi.org/10.1096/fj.10-174797			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21357525				2022-12-25	WOS:000291023800011
J	Mackey, AL; Brandstetter, S; Schjerling, P; Bojsen-Moller, J; Qvortrup, K; Pedersen, MM; Doessing, S; Kjaer, M; Magnusson, SP; Langberg, H				Mackey, Abigail L.; Brandstetter, Simon; Schjerling, Peter; Bojsen-Moller, Jens; Qvortrup, Klaus; Pedersen, Mette M.; Doessing, Simon; Kjaer, Michael; Magnusson, S. Peter; Langberg, Henning			Sequenced response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle	FASEB JOURNAL			English	Article						insulin-like growth factor-1; satellite cells; collagen; tenascin C; repeated bout effect	ECCENTRIC EXERCISE; IGF-I; CONNECTIVE-TISSUE; GENE-EXPRESSION; SATELLITE CELL; LENGTHENING CONTRACTIONS; MATRICELLULAR PROTEINS; RESISTANCE EXERCISE; SINGLE BOUT; TENASCIN-C	The purpose of this study was to test the hypothesis that remodeling of skeletal muscle extracellular matrix (ECM) is involved in protecting human muscle against injury. Biopsies were obtained from medial gastrocnemius muscles after a single bout of electrical stimulation (B) or a repeated bout (RB) 30 d later, or 30 d after a single stimulation bout (RBc). A muscle biopsy was collected from the control leg for comparison with the stimulated leg. Satellite cell content, tenascin C, and muscle regeneration were assessed by immunohistochemistry; real-time PCR was used to measure mRNA levels of collagens, laminins, heat-shock proteins (HSPs), inflammation, and related growth factors. The large responses of HSPs, CCL2, and tenascin C detected 48 h after a single bout were attenuated in the RB trial, indicative of protection against injury. Satellite cell content and 12 target genes, including IGF-1, were elevated 30 d after a single bout. Among those displaying the greatest difference vs. control muscle, ECM laminin-beta 1 and collagen types I and III were elevated similar to 6- to 9-fold (P<0.001). The findings indicate that the sequenced events of load-induced early deadhesion and later strengthening of skeletal muscle ECM play a role in protecting human muscle against future injury.-Mackey, A. L., Brandstetter, S., Schjerling, P., Bojsen-Moller, J., Qvortrup, K., Pedersen, M. M., Doessing, S. Kjaer, M., Magnusson, S. P., Langberg, H. Sequenced response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle. FASEB J. 25, 1943-1959 (2011). www.fasebj.org	[Mackey, Abigail L.; Brandstetter, Simon; Schjerling, Peter; Bojsen-Moller, Jens; Pedersen, Mette M.; Doessing, Simon; Kjaer, Michael; Magnusson, S. Peter; Langberg, Henning] Bispebjerg Hosp, Inst Sports Med, Dept Orthopaed Surg M, DK-2400 Copenhagen NV, Denmark; [Mackey, Abigail L.; Brandstetter, Simon; Schjerling, Peter; Bojsen-Moller, Jens; Pedersen, Mette M.; Doessing, Simon; Kjaer, Michael; Magnusson, S. Peter; Langberg, Henning] Univ Copenhagen, Ctr Healthy Aging, Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Qvortrup, Klaus] Univ Copenhagen, Dept Biomed Sci, Panum Inst, DK-1168 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen	Mackey, AL (corresponding author), Bispebjerg Hosp, Inst Sports Med, Dept Orthopaed Surg M, Bldg 8,1st Floor,Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	abigail.mackey@gmail.com	Magnusson, S. Peter/AAD-5903-2022; Schjerling, Peter/F-6194-2011; Magnusson, Peter/AAN-1631-2020; Mackey, Abigail/D-1060-2009; Kjaer, Michael/W-6842-2019; Pedersen, Mette Merete/H-2947-2019	Magnusson, S. Peter/0000-0002-4308-5484; Schjerling, Peter/0000-0001-7138-3211; Mackey, Abigail/0000-0002-2017-4580; Kjaer, Michael/0000-0002-4582-8755; Brandstetter, Susanne/0000-0002-7021-8895; Langberg, Henning/0000-0001-8454-6534; Qvortrup, Klaus/0000-0001-8811-0260; bojsen-moller, jens/0000-0001-6737-446X	Nordea Foundation; Danish Agency for Science Technology and Innovation (Medical Research Council); Danish Rheumatism Association [R74-A1088]; Lundbeck Foundation	Nordea Foundation; Danish Agency for Science Technology and Innovation (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Rheumatism Association; Lundbeck Foundation(Lundbeckfonden)	Casper Mortensen and Christine Bodilsen are gratefully acknowledged for help with recruiting subjects and collecting data. The excellent technical assistance involved in taking the blood samples and preparing the muscle biopsies (Camilla Hansen) and the preparation of samples for electron microscopy (Mary-Ann Gleie) is warmly acknowledged. The F1.652, A4.951, and A4.74 antibodies developed by Helen M. Blau were obtained from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA, USA), developed under the auspices of the U.S. National Institute of Child Health and Human Development and maintained by the Department of Biological Sciences, University of Iowa. Funding is gratefully acknowledged from the Nordea Foundation (Healthy Aging grant), the Danish Agency for Science Technology and Innovation (Medical Research Council), the Danish Rheumatism Association (R74-A1088), and the Lundbeck Foundation.	Aldayel A, 2010, EUR J APPL PHYSIOL, V108, P709, DOI 10.1007/s00421-009-1278-0; Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Bamman MM, 2007, J APPL PHYSIOL, V102, P2232, DOI 10.1152/japplphysiol.00024.2007; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; BISCHOFF R, 1990, DEVELOPMENT, V109, P943; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; CLARKSON PM, 1987, CLIN SCI, V73, P383, DOI 10.1042/cs0730383; Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827; Crameri RM, 2004, MATRIX BIOL, V23, P259, DOI 10.1016/j.matbio.2004.05.009; Eriksson A, 2006, HISTOCHEM CELL BIOL, V126, P409, DOI 10.1007/s00418-006-0176-3; Fluck M, 2000, J CELL SCI, V113, P3583; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; FUKUNAGA T, 1992, J ORTHOPAED RES, V10, P926, DOI 10.1002/jor.1100100623; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442, DOI 10.1007/PL00000616; Haddad F, 2002, J APPL PHYSIOL, V93, P394, DOI 10.1152/japplphysiol.01153.2001; Hameed M, 2003, J PHYSIOL-LONDON, V547, P247, DOI 10.1113/jphysiol.2002.032136; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; HIKIDA RS, 1983, J NEUROL SCI, V59, P185, DOI 10.1016/0022-510X(83)90037-0; Hill M, 2003, J ANAT, V203, P89, DOI 10.1046/j.1469-7580.2003.00195.x; Hubal MJ, 2008, AM J PHYSIOL-REG I, V294, pR1628, DOI 10.1152/ajpregu.00853.2007; JONES DA, 1986, J PHYSIOL-LONDON, V375, P435, DOI 10.1113/jphysiol.1986.sp016126; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kalliokoski KK, 2007, CLIN PHYSIOL FUNCT I, V27, P239, DOI 10.1111/j.1475-097X.2007.00744.x; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; LAPIER TK, 1995, J APPL PHYSIOL, V78, P1065, DOI 10.1152/jappl.1995.78.3.1065; Lapointe BM, 2002, AM J PHYSIOL-REG I, V282, pR323, DOI 10.1152/ajpregu.00339.2001; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mackey AL, 2008, J APPL PHYSIOL, V105, P1620, DOI 10.1152/japplphysiol.90952.2008; Mackey AL, 2010, J APPL PHYSIOL, V109, P1920, DOI 10.1152/japplphysiol.00789.2010; Mackey AL, 2009, MUSCLE NERVE, V40, P455, DOI 10.1002/mus.21369; Mackey AL, 2005, SCAND J MED SCI SPOR, V15, P402, DOI 10.1111/j.1600-0838.2005.00449.x; Mackey AL, 2004, J APPL PHYSIOL, V97, P197, DOI 10.1152/japplphysiol.01174.2003; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; MIKKELSEN UR, 2010, SCAND J MED SCI SPOR, DOI DOI 10.1111/J.1600-0838.2010.01170.X; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nosaka K, 2001, MED SCI SPORT EXER, V33, P1490, DOI 10.1097/00005768-200109000-00011; Paulsen G, 2009, J APPL PHYSIOL, V107, P570, DOI 10.1152/japplphysiol.00209.2009; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299; ROUND JM, 1987, J NEUROL SCI, V82, P1, DOI 10.1016/0022-510X(87)90002-5; Sarasa-Renedo A, 2005, SCAND J MED SCI SPOR, V15, P223, DOI 10.1111/j.1600-0838.2005.00461.x; SUOMINEN H, 1975, EUR J APPL PHYSIOL O, V34, P249, DOI 10.1007/BF00999938; Thompson HS, 2002, ACTA PHYSIOL SCAND, V174, P47, DOI 10.1046/j.1365-201x.2002.00922.x; Vissing K, 2004, FASEB J, V18, P94, DOI 10.1096/fj.04-2084fje; Vissing K, 2009, ACTA PHYSIOL, V196, P283, DOI 10.1111/j.1748-1716.2008.01940.x; Yang SY, 1996, J MUSCLE RES CELL M, V17, P487, DOI 10.1007/BF00123364; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6	52	126	130	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1943	1959		10.1096/fj.10-176487	http://dx.doi.org/10.1096/fj.10-176487			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21368102	Green Published			2022-12-25	WOS:000291023800018
J	Street, VA; Li, J; Robbins, CA; Kallman, JC				Street, Valerie A.; Li, Jin; Robbins, Carol A.; Kallman, Jeremy C.			A DNA Variant within the MYO7A Promoter Regulates YY1 Transcription Factor Binding and Gene Expression Serving as a Potential Dominant DFNA11 Auditory Genetic Modifier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; MOUSE INNER-EAR; MYOSIN-VIIA; HEARING IMPAIRMENT; LOW-FREQUENCY; IDENTIFICATION; MUTATION; COCHLEA; CELL; SHAKER-1	Mutations within MYO7A can lead to recessive and dominant forms of inherited hearing loss. We previously identified a large pedigree (referred to as the HL2 family) with hearing loss that first impacts the low and mid frequencies segregating a dominant MYO7A mutation in exon 17 at DNA residue G2164C. The MYO7A(G2164C) mutation predicts a nonconservative glycine-to-arginine (G722R) amino acid substitution at a highly conserved glycine residue. The degree of low and mid frequency hearing loss varies markedly in the family, suggesting the presence of a genetic modifier that either rescues or exacerbates the primary MYO7A(G2164C) mutation. Here we describe a single nucleotide polymorphism (SNP) T/C at position -4128 in the wild-type MYO7A promoter allele that sorts with the degree of hearing loss severity in the pedigree. Electrophoretic mobility shift assay analysis indicates that the SNP differentially regulates the binding of the YY1 transcription factor with the T-4128 allele creating an YY1 binding site. Immunocytochemistry demonstrates that Yy1 is expressed in hair cell nuclei within the cochlea. Given that Myo7a is also expressed in cochlear hair cells, Yy1 shows the appropriate localization to regulate Myo7a transcription within the inner ear. YY1 appears to be acting as a transcriptional repressor as the MYO7A promoter allele containing the T-4128 SNP drives 41 and 46% less reporter gene expression compared with the C-4128 SNP in the ARPE-19 and HeLa cell lines, respectively. The T-4128 SNP may be contributing to the severe hearing loss phenotype in the HL2 pedigree by reducing expression of the wild-type MYO7A allele.	[Street, Valerie A.; Li, Jin; Robbins, Carol A.; Kallman, Jeremy C.] Univ Washington, Dept Otolaryngol Head & Neck Surg, VM Bloedel Hearing Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Street, VA (corresponding author), Univ Washington, HNS Dept, VM Bloedel Hearing Res Ctr, Seattle, WA 98195 USA.	vastreet@u.washington.edu			National Institutes of Health [DC04945, P30 DC04661]; V. M. Bloedel Hearing Research Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661, R03DC004945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. M. Bloedel Hearing Research Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC04945 (to V. A. S.) and P30 DC04661 (to the V. M. Bloedel Core). This work was also supported by a grant from the V. M. Bloedel Hearing Research Center (to V. A. S.).	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boeda B, 2001, HUM MOL GENET, V10, P1581, DOI 10.1093/hmg/10.15.1581; Bolz Hanno, 2004, Hum Mutat, V24, P274, DOI 10.1002/humu.9272; Daudet N, 2009, DEV BIOL, V326, P86, DOI 10.1016/j.ydbio.2008.10.033; Di Leva F, 2006, AUDIOL NEURO-OTOL, V11, P157, DOI 10.1159/000091199; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Jin ZH, 2003, TOHOKU J EXP MED, V200, P137, DOI 10.1620/tjem.200.137; Kallman JC, 2008, OTOL NEUROTOL, V29, P860, DOI 10.1097/MAO.0b013e3181825651; Knipper M, 1998, DEVELOPMENT, V125, P3709; Lu ZJ, 2008, DEV NEUROBIOL, V68, P1059, DOI 10.1002/dneu.20635; Luijendijk MWJ, 2004, HUM GENET, V115, P149, DOI 10.1007/s00439-004-1137-3; MARTINEZMONEDER.R, 2006, ASS RES OT MIDW M BA, P285; Masotti C, 2005, GENE, V359, P44, DOI 10.1016/j.gene.2005.06.004; Miyazaki H, 2006, DEV GROWTH DIFFER, V48, P429, DOI 10.1111/j.1440-169x.2006.00879.x; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; Roberson DW, 2002, HEARING RES, V172, P62, DOI 10.1016/S0378-5955(02)00512-9; Rylski M, 2008, NEUROCHEM RES, V33, P2556, DOI 10.1007/s11064-008-9757-y; Sage C, 2000, HEARING RES, V150, P70, DOI 10.1016/S0378-5955(00)00183-0; Street VA, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013557; STREET VA, 1995, GENOMICS, V29, P123, DOI 10.1006/geno.1995.1222; Tamagawa Y, 2000, ADV OTO-RHINO-LARYNG, V56, P103	27	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15278	15286		10.1074/jbc.M111.228304	http://dx.doi.org/10.1074/jbc.M111.228304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21378158	hybrid, Green Published			2022-12-25	WOS:000289788300059
J	Zhang, F; Liu, S; Yang, F; Zheng, J; Wang, KW				Zhang, Feng; Liu, Shuang; Yang, Fan; Zheng, Jie; Wang, KeWei			Identification of a Tetrameric Assembly Domain in the C Terminus of Heat-activated TRPV1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT DOMAIN; CAPSAICIN RECEPTOR; ION-CHANNEL; VANILLOID RECEPTOR-1; PHOSPHORYLATION; DETERMINANT; SENSITIVITY; SUBUNITS	Transient receptor potential (TRP) channels as cellular sensors are thought to function as tetramers. Yet, the molecular determinants governing channel multimerization remain largely elusive. Here we report the identification of a segment comprising 21 amino acids (residues 752-772 of mouse TRPV1) after the known TRP-like domain in the channel C terminus that functions as a tetrameric assembly domain (TAD). Purified recombinant C-terminal proteins of TRPV1-4, but not the N terminus, mediated the protein-protein interaction in an in vitro pulldown assay. Western blot analysis combined with electrophysiology and calcium imaging demonstrated that TAD exerted a robust dominant-negative effect on wild-type TRPV1. When fused with the membrane-tethered peptide Gap43, the TAD blocked the formation of stable homomultimers. Calcium imaging and current recordings showed that deletion of the TAD in a poreless TRPV1 mutant subunit suppressed its dominant-negative phenotype, confirming the involvement of the TAD in assembly of functional channels. Our findings suggest that the C-terminal TAD in TRPV1 channels functions as a domain that is conserved among TRPV1-4 and mediates a direct subunit-subunit interaction for tetrameric assembly.	[Zhang, Feng; Liu, Shuang; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100191, Peoples R China; [Wang, KeWei] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100191, Peoples R China; [Yang, Fan; Zheng, Jie] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	Peking University; Peking University; University of California System; University of California Davis	Zheng, J (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	jzheng@ucdavis.edu; wangkw@bjmu.edu.cn	Yang, Fan/GYU-4249-2022; Yang, Fan/AAA-6904-2022; Zhang, Feng/R-3368-2016; Zhu, Ren-Yuan/V-8966-2019; Zhang, Feng/R-3019-2019; Yang, Fan/C-6586-2012; Yang, Fan/J-4562-2015	Yang, Fan/0000-0002-0520-5254; Zhu, Ren-Yuan/0000-0003-3091-7461; Yang, Fan/0000-0002-9406-7710; Yang, Fan/0000-0002-9406-7710	National Science Foundation of China [30630017, 30970919]; Ministry of Science Technology of China [2007CB512100]; Ministry of Education of China [B07001]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation of China Research Grants 30630017 and 30970919 (to K. W. W.), Ministry of Science Technology of China "973 Program" 2007CB512100, and Ministry of Education of China 111 Project China B07001.	Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807	31	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15308	15316		10.1074/jbc.M111.223941	http://dx.doi.org/10.1074/jbc.M111.223941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357419	hybrid, Green Published			2022-12-25	WOS:000289788300062
J	Kayser, MS; Lee, AC; Hruska, M; Dalva, MB				Kayser, Matthew S.; Lee, Anderson C.; Hruska, Martin; Dalva, Matthew B.			Preferential Control of Basal Dendritic Protrusions by EphB2	PLOS ONE			English	Article							EXCITATORY SYNAPSE FORMATION; RECEPTOR TYROSINE KINASES; PYRAMIDAL NEURONS; SPINE MORPHOGENESIS; MODULATION; EXPRESSION; MORPHOLOGY; EPHRINS; BRAIN; GENE	The flow of information between neurons in many neural circuits is controlled by a highly specialized site of cell-cell contact known as a synapse. A number of molecules have been identified that are involved in central nervous system synapse development, but knowledge is limited regarding whether these cues direct organization of specific synapse types or on particular regions of individual neurons. Glutamate is the primary excitatory neurotransmitter in the brain, and the majority of glutamatergic synapses occur on mushroom-shaped protrusions called dendritic spines. Changes in the morphology of these structures are associated with long-lasting modulation of synaptic strength thought to underlie learning and memory, and can be abnormal in neuropsychiatric disease. Here, we use rat cortical slice cultures to examine how a previously-described synaptogenic molecule, the EphB2 receptor tyrosine kinase, regulates dendritic protrusion morphology in specific regions of the dendritic arbor in cortical pyramidal neurons. We find that alterations in EphB2 signaling can bidirectionally control protrusion length, and knockdown of EphB2 expression levels reduces the number of dendritic spines and filopodia. Expression of wild-type or dominant negative EphB2 reveals that EphB2 preferentially regulates dendritic protrusion structure in basal dendrites. Our findings suggest that EphB2 may act to specify synapse formation in a particular subcellular region of cortical pyramidal neurons.	[Kayser, Matthew S.; Lee, Anderson C.; Hruska, Martin; Dalva, Matthew B.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Kayser, MS (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	dalva@mail.med.upenn.edu		Kayser, Matthew/0000-0003-2359-4967; Dalva, Matthew/0000-0002-7737-8787	Dana Foundation;  [RO1-DA022727];  [RO1-MH086425]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022727] Funding Source: NIH RePORTER	Dana Foundation; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RO1-DA022727, RO1-MH086425 and the Dana Foundation to Dr. Dalva supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic SD, 2010, J NEUROSCI RES, V88, P2991, DOI 10.1002/jnr.22444; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; LARKMAN AU, 1991, J COMP NEUROL, V306, P307, DOI 10.1002/cne.903060207; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; McAllister A. Kimberley, 2004, V245, P197; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104	30	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17417	10.1371/journal.pone.0017417	http://dx.doi.org/10.1371/journal.pone.0017417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364901	Green Published, gold, Green Submitted			2022-12-25	WOS:000287764100059
J	Garcia-Dominguez, CA; Martinez, N; Gragera, T; Perez-Rodriguez, A; Retana, D; Leon, G; Sanchez, A; Oliva, JL; Perez-Sala, D; Rojas, JM				Garcia-Dominguez, Carlota A.; Martinez, Natalia; Gragera, Teresa; Perez-Rodriguez, Andrea; Retana, Diana; Leon, Gonzalo; Sanchez, Agustin; Luis Oliva, Jose; Perez-Sala, Dolores; Rojas, Jose M.			Sprouty2 and Spred1-2 Proteins Inhibit the Activation of the ERK Pathway Elicited by Cyclopentenone Prostanoids	PLOS ONE			English	Article							15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); DROSOPHILA-SPROUTY; RECEPTOR; GROWTH; PROSTAGLANDINS; FGF; D-2; DELTA-12-PROSTAGLANDIN-J2; DIFFERENTIATION; IDENTIFICATION	Sprouty and Spred proteins have been widely implicated in the negative regulation of the fibroblast growth factor receptor-extracellular regulated kinase (ERK) pathway. In considering the functional role of these proteins, we explored their effects on ERK activation induced by cyclopentenone prostanoids, which bind to and activate Ras proteins. We therefore found that ectopic overexpression in HeLa cells of human Sprouty2, or human Spred1 or 2, inhibits ERK1/2 and Elk-1 activation triggered by the cyclopentenone prostanoids PGA(1) and 15d-PGJ(2). Furthermore, we found that in HT cells that do not express Sprouty2 due to hypermethylation of its gene-promoter, PGA1-provoked ERK activation was more intense and sustained compared to other hematopoietic cell lines with unaltered Sprouty2 expression. Cyclopentenone prostanoids did not induce Sprouty2 tyrosine phosphorylation, in agreement with its incapability to activate tyrosine-kinase receptors. However, Sprouty2 Y55F, which acts as a defective mutant upon tyrosine-kinase receptor stimulation, did not inhibit cyclopentenone prostanoids-elicited ERK pathway activation. In addition, Sprouty2 did not affect the Ras-GTP levels promoted by cyclopentenone prostanoids. These results unveil both common and differential features in the activation of Ras-dependent pathways by cyclopentenone prostanoids and growth factors. Moreover, they provide the first evidence that Sprouty and Spred proteins are negative regulators of the ERK/Elk-1 pathway activation induced not only by growth-factors, but also by reactive lipidic mediators.	[Garcia-Dominguez, Carlota A.; Martinez, Natalia; Gragera, Teresa; Perez-Rodriguez, Andrea; Retana, Diana; Leon, Gonzalo; Sanchez, Agustin; Luis Oliva, Jose; Rojas, Jose M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Area Biol Celular & Desarrollo, Unidad Biol Celular, Madrid, Spain; [Perez-Sala, Dolores] CSIC, Ctr Invest Biol, Dept Biol Fis Quim, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Garcia-Dominguez, CA (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Area Biol Celular & Desarrollo, Unidad Biol Celular, Madrid, Spain.	jmrojas@isciii.es	Perez-Sala, Dolores/L-5969-2014; LEON ESPINOSA, GONZALO/I-4135-2015; Rojas, José M/D-3718-2018; Rojas, José M./AAA-3354-2021	Perez-Sala, Dolores/0000-0003-0600-665X; LEON ESPINOSA, GONZALO/0000-0002-9921-2614; Rojas, José M/0000-0002-5383-3482; Rojas, José M./0000-0002-7547-2825; Retana, Diana/0000-0002-8442-2053	Fondo de Investigaciones Sanitarias (FIS)-Beca de Formacion en Investigacion (BEFI); Comunidad de Madrid; Instituto de Salud Carlos III; Ministerio de Educacion y Ciencia; Fondo de Investigaciones Sanitarias -FIS-, Instituto de Salud Carlos III -ISCII; Ministerio de Educacion y Ciencia, Spain [SAF2006-04247]; FIS-Intrasalud [PS09/00562]; ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer) [RD06/0020/0003]; Spanish Association Against Cancer (AECC); RETIC (Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos) from ISCIII [RD07/0064/0007]; European Union Cooperation [CM1001];  [SAF2009-11642]	Fondo de Investigaciones Sanitarias (FIS)-Beca de Formacion en Investigacion (BEFI)(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias -FIS-, Instituto de Salud Carlos III -ISCII(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia, Spain(Spanish Government); FIS-Intrasalud; ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer)(Instituto de Salud Carlos III); Spanish Association Against Cancer (AECC); RETIC (Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos) from ISCIII; European Union Cooperation; 	CAGD, APR, AS, TG, and GL were recipients of fellowships from the Fondo de Investigaciones Sanitarias (FIS)-Beca de Formacion en Investigacion (BEFI) (to CAGD), Comunidad de Madrid (to APR), Instituto de Salud Carlos III (AS), and the Ministerio de Educacion y Ciencia (to TG and GL). JLO is member of the Miguel Servet Program (Fondo de Investigaciones Sanitarias -FIS-, Instituto de Salud Carlos III -ISCIII-). This work was supported by grants SAF2006-04247 from the Ministerio de Educacion y Ciencia, Spain, FIS-Intrasalud (PS09/00562) and ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer; RD06/0020/0003) from the Instituto de Salud Carlos III, and the Spanish Association Against Cancer (AECC) to JMR, and by SAF2009-11642 and RETIC (Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos; RD07/0064/0007) from ISCIII, to DPS. Work was also supported by a grant from European Union Cooperation in the field of Scientific and Technical research (COST) Action CM1001 to DPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Diez-Dacal B, 2010, THESCIENTIFICWORLDJO, V10, P655, DOI 10.1100/tsw.2010.69; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Garzon B, 2010, CHEM-BIOL INTERACT, V183, P212, DOI 10.1016/j.cbi.2009.09.019; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hatanaka M, 2010, J PHARMACOL SCI, V113, P89, DOI 10.1254/jphs.10001SC; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; KATO T, 1986, CANCER RES, V46, P3538; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; KIM IK, 1993, FEBS LETT, V321, P209, DOI 10.1016/0014-5793(93)80110-G; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Martinez N, 2007, CELL SIGNAL, V19, P2277, DOI 10.1016/j.cellsig.2007.07.008; Millan O, 2006, CARCINOGENESIS, V27, P328, DOI 10.1093/carcin/bgi213; Monneret G, 2003, J PHARMACOL EXP THER, V304, P349, DOI 10.1124/jpet.102.042937; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Parker J, 1995, PROSTAGLANDINS, V50, P359, DOI 10.1016/0090-6980(95)00136-0; Pena-Dos-Santos DR, 2009, NEUROSCIENCE, V163, P1211, DOI 10.1016/j.neuroscience.2009.07.052; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Reich A, 1999, DEVELOPMENT, V126, P4139; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rovin BH, 2002, KIDNEY INT, V61, P1293, DOI 10.1046/j.1523-1755.2002.00282.x; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sanchez A, 2008, ONCOGENE, V27, P4969, DOI 10.1038/onc.2008.129; Santoro MG, 1997, TRENDS MICROBIOL, V5, P276, DOI 10.1016/S0966-842X(97)01066-4; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Schuligoi R, 2007, BIOCHEM PHARMACOL, V74, P107, DOI 10.1016/j.bcp.2007.03.023; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wilmer WA, 2001, BIOCHEM BIOPH RES CO, V281, P57, DOI 10.1006/bbrc.2001.4301; Yoon HJ, 2008, J IMMUNOL, V180, P8400, DOI 10.4049/jimmunol.180.12.8400; Zarich N, 2000, ONCOGENE, V19, P5872, DOI 10.1038/sj.onc.1203955; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16787	10.1371/journal.pone.0016787	http://dx.doi.org/10.1371/journal.pone.0016787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364986	Green Published, gold			2022-12-25	WOS:000287656600020
J	Reichel, CA; Lerchenberger, M; Uhl, B; Rehberg, M; Berberich, N; Zahler, S; Wymann, MP; Krombach, F				Reichel, Christoph A.; Lerchenberger, Max; Uhl, Bernd; Rehberg, Markus; Berberich, Nina; Zahler, Stefan; Wymann, Matthias P.; Krombach, Fritz			Plasmin Inhibitors Prevent Leukocyte Accumulation and Remodeling Events in the Postischemic Microvasculature	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; IN-VIVO; APROTININ; ADHESION; REPERFUSION; NEUTROPHILS; EXPRESSION; MIGRATION; ISCHEMIA; RECEPTOR	Clinical trials revealed beneficial effects of the broad-spectrum serine protease inhibitor aprotinin on the prevention of ischemia-reperfusion (I/R) injury. The underlying mechanisms remained largely unclear. Using in vivo microscopy on the cremaster muscle of male C57BL/6 mice, aprotinin as well as inhibitors of the serine protease plasmin including tranexamic acid and epsilon-aminocaproic acid were found to significantly diminish I/R-elicited intravascular firm adherence and (subsequent) transmigration of neutrophils. Remodeling of collagen IV within the postischemic perivenular basement membrane was almost completely abrogated in animals treated with plasmin inhibitors or aprotinin. In separate experiments, incubation with plasmin did not directly activate neutrophils. Extravascular, but not intravascular administration of plasmin caused a dose-dependent increase in numbers of firmly adherent and transmigrated neutrophils. Blockade of mast cell activation as well as inhibition of leukotriene synthesis or antagonism of the platelet-activating-factor receptor significantly reduced plasmin-dependent neutrophil responses. In conclusion, our data suggest that extravasated plasmin(ogen) mediates neutrophil recruitment in vivo via activation of perivascular mast cells and secondary generation of lipid mediators. Aprotinin as well as the plasmin inhibitors tranexamic acid and e-aminocaproic acid interfere with this inflammatory cascade and effectively prevent postischemic neutrophil responses as well as remodeling events within the vessel wall.	[Reichel, Christoph A.; Lerchenberger, Max; Uhl, Bernd; Rehberg, Markus; Krombach, Fritz] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Berberich, Nina; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany; [Wymann, Matthias P.] Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland	University of Munich; University of Munich; University of Basel	Reichel, CA (corresponding author), Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany.	christoph.reichel@med.uni-muenchen.de	Wymann, Matthias P/C-3227-2008	Wymann, Matthias P/0000-0003-3349-4281; Zahler, Stefan/0000-0002-5140-7287; Rehberg, Markus/0000-0001-7314-6332	Deutsche Forschungsgemeinschaft (DFG) [RE 2885/1-1]; Friedrich-Baur-Stiftung; European Commission [LHSG-CT-2003-502935]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Baur-Stiftung; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by Deutsche Forschungsgemeinschaft (DFG; RE 2885/1-1 to C.A.R.; www.dfg.de), Friedrich-Baur-Stiftung (to C.A.R.; www.baur-stiftung.de), and European Commission grant LHSG-CT-2003-502935 (Network of Excellence 'MAIN' to F.K. and M.P.W.; www.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulos G, 2000, J THORAC CARDIOV SUR, V120, P361, DOI 10.1067/mtc.2000.106323; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Buerke M, 2007, CIRCULATION, V116, pI121, DOI 10.1161/CIRCULATIONAHA.106.680249; Bull DA, 2003, ANN THORAC SURG, V75, pS735, DOI 10.1016/S0003-4975(02)04702-1; Carter JM, 2008, BRIT J PHARMACOL, V155, P93, DOI 10.1038/bjp.2008.223; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Del Rosso M, 2008, FRONT BIOSCI-LANDMRK, V13, P4667, DOI 10.2741/3032; Edagawa M, 1999, TRANSPLANTATION, V67, P944, DOI 10.1097/00007890-199904150-00003; Frangogiannis NG, 2007, THROMB HAEMOSTASIS, V97, P738, DOI 10.1160/TH07-01-0022; GABOURY JP, 1995, J IMMUNOL, V154, P804; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Henry D, 2009, CAN MED ASSOC J, V180, P183, DOI 10.1503/cmaj.081109; Hruby Z, 2000, RES EXP MED, V199, P295, DOI 10.1007/s004330050127; Johnston B, 1999, MICROCIRCULATION, V6, P153; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lister KJ, 2007, MICROCIRCULATION, V14, P709, DOI 10.1080/10739680701404879; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Majumdar M, 2004, J BIOL CHEM, V279, P37528, DOI 10.1074/jbc.M401372200; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mempel TR, 2003, J VASC RES, V40, P435, DOI 10.1159/000073902; Montrucchio G, 1996, CIRCULATION, V93, P2152, DOI 10.1161/01.CIR.93.12.2152; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Reichel CA, 2008, J LEUKOCYTE BIOL, V83, P864, DOI 10.1189/jlb.1007666; Reichel CA, 2009, ARTERIOSCL THROM VAS, V29, P1787, DOI 10.1161/ATVBAHA.109.193268; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shaw AD, 2008, NEW ENGL J MED, V358, P784, DOI 10.1056/NEJMoa0707768; Silva AR, 2002, J IMMUNOL, V168, P4112, DOI 10.4049/jimmunol.168.8.4112; Sodha Neel R, 2006, Expert Rev Cardiovasc Ther, V4, P151, DOI 10.1586/14779072.4.2.151; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Triggiani M, 2008, CLIN EXP IMMUNOL, V153, P7, DOI 10.1111/j.1365-2249.2008.03714.x; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Weide I, 1996, THROMB HAEMOSTASIS, V76, P561; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; YAMURA TAKUSO, 1961, ACTA MED NAGASAKIENSIA, V5, P142; Young RE, 2007, BRIT J PHARMACOL, V151, P628, DOI 10.1038/sj.bjp.0707267	42	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17229	10.1371/journal.pone.0017229	http://dx.doi.org/10.1371/journal.pone.0017229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364954	Green Submitted, Green Published, gold			2022-12-25	WOS:000287656600036
J	Moore, TV; Clay, BS; Ferreira, CM; Williams, JW; Rogozinska, M; Cannon, JL; Shilling, RA; Marzo, AL; Sperling, AI				Moore, Tamson V.; Clay, Bryan S.; Ferreira, Caroline M.; Williams, Jesse W.; Rogozinska, Magdalena; Cannon, Judy L.; Shilling, Rebecca A.; Marzo, Amanda L.; Sperling, Anne I.			Protective Effector Memory CD4 T Cells Depend on ICOS for Survival	PLOS ONE			English	Article							SCHISTOSOMA-MANSONI EGGS; INFLUENZA-VIRUS INFECTION; EARLY IL-4 PRODUCTION; ATOPIC ASTHMA; AIRWAY-HYPERRESPONSIVENESS; ANTIGEN; RESPONSES; NAIVE; LYMPHOCYTES; GENERATION	Memory CD4 T cells play a vital role in protection against re-infection by pathogens as diverse as helminthes or influenza viruses. Inducible costimulator (ICOS) is highly expressed on memory CD4 T cells and has been shown to augment proliferation and survival of activated CD4 T cells. However, the role of ICOS costimulation on the development and maintenance of memory CD4 T cells remains controversial. Herein, we describe a significant defect in the number of effector memory (EM) phenotype cells in ICOS-/- and ICOSL-/- mice that becomes progressively more dramatic as the mice age. This decrease was not due to a defect in the homeostatic proliferation of EM phenotype CD4 T cells in ICOS-/- or ICOSL-/- mice. To determine whether ICOS regulated the development or survival of EM CD4 T cells, we utilized an adoptive transfer model. We found no defect in development of EM CD4 T cells, but long-term survival of ICOS-/- EM CD4 T cells was significantly compromised compared to wild-type cells. The defect in survival was specific to EM cells as the central memory (CM) ICOS-/- CD4 T cells persisted as well as wild type cells. To determine the physiological consequences of a specific defect in EM CD4 T cells, wild-type and ICOS-/- mice were infected with influenza virus. ICOS-/- mice developed significantly fewer influenza-specific EM CD4 T cells and were more susceptible to re-infection than wild-type mice. Collectively, our findings demonstrate a role for ICOS costimulation in the maintenance of EM but not CM CD4 T cells.	[Moore, Tamson V.; Clay, Bryan S.; Ferreira, Caroline M.; Williams, Jesse W.; Cannon, Judy L.; Shilling, Rebecca A.; Sperling, Anne I.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Moore, Tamson V.; Clay, Bryan S.; Ferreira, Caroline M.; Williams, Jesse W.; Cannon, Judy L.; Shilling, Rebecca A.; Sperling, Anne I.] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; [Rogozinska, Magdalena; Marzo, Amanda L.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA	University of Chicago; University of Chicago; Rush University	Moore, TV (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	asperlin@uchicago.edu	Ferreira, Caroline M/D-3949-2012; Sperling, Anne/ACZ-2351-2022	Cannon, Judy/0000-0003-0069-8106; Williams, Jesse/0000-0003-3815-0891; Marzo, amanda/0000-0002-5839-0430; Sperling, Anne I./0000-0002-4265-9212	NIH [R01 AI67697]; Blowitz-Ridgeway Foundation;  [5T32AI07090];  [P01-AI56352]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI059105, U19AI095230, T32AI007090, R01AI067697, P01AI056352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blowitz-Ridgeway Foundation; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by NIH Grant R01 AI67697 and a grant from the Blowitz-Ridgeway Foundation. Support for BSC and TVM was provided by 5T32AI07090 and a supplement to P01-AI56352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2001, J IMMUNOL, V166, P926, DOI 10.4049/jimmunol.166.2.926; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; Barefoot BE, 2009, CLIN VACCINE IMMUNOL, V16, P488, DOI 10.1128/CVI.00451-08; Bjorkdahl O, 2003, IMMUNOLOGY, V110, P170, DOI 10.1046/j.1365-2567.2003.01727.x; BOUWER HGA, 1994, J NEUROIMMUNOL, V54, P87; Bradley LM, 2000, IMMUNOL RES, V21, P149, DOI 10.1385/IR:21:2-3:149; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; BUSSE WW, 1995, AM J RESP CRIT CARE, V152, P388, DOI 10.1164/ajrccm.152.1.7599853; CELLS IN, SFDS; Claesson MH, 1999, J IMMUNOL, V162, P3702; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Cossarizza A, 1996, MECH AGEING DEV, V86, P173, DOI 10.1016/0047-6374(95)01691-0; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dooms H, 2006, IMMUNOL REV, V211, P23, DOI 10.1111/j.0105-2896.2006.00387.x; Elliott David E., 1996, Methods (Orlando), V9, P255, DOI 10.1006/meth.1996.0032; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hengel RL, 2003, J IMMUNOL, V170, P28, DOI 10.4049/jimmunol.170.1.28; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Humphreys IR, 2006, EUR J IMMUNOL, V36, P2928, DOI 10.1002/eji.200636155; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Kroczek R, 2005, J ALLERGY CLIN IMMUN, V116, P906, DOI 10.1016/j.jaci.2005.07.005; Lara-Marquez ML, 2001, CLIN EXP ALLERGY, V31, P1232, DOI 10.1046/j.1365-2222.2001.01146.x; Linton PJ, 1997, IMMUNOL REV, V160, P9, DOI 10.1111/j.1600-065X.1997.tb01023.x; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mahajan S, 2007, EUR J IMMUNOL, V37, P1796, DOI 10.1002/eji.200636661; Mendez A, 2002, VACCINE, V20, P3702, DOI 10.1016/S0264-410X(02)00376-6; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Metwali Ahmed, 1996, Methods (Orlando), V9, P305, DOI 10.1006/meth.1996.0035; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; MOUNTFORD AP, 1992, IMMUNOLOGY, V75, P250; Nakagome K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-46; Palmer DR, 2002, EUR J IMMUNOL, V32, P652, DOI 10.1002/1521-4141(200203)32:3<652::AID-IMMU652>3.0.CO;2-9; PAULOS CM, SCI TRANSL MED, V2; Rhee EG, 2002, J EXP MED, V195, P1565, DOI 10.1084/jem.20020147; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; ROBINSON DS, 1993, THORAX, V48, P26, DOI 10.1136/thx.48.1.26; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SABIN EA, 1995, J IMMUNOL, V155, P4844; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; Salek-Ardakani S, 2006, VACCINE, V24, P872, DOI 10.1016/j.vaccine.2005.07.108; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Soroosh P, 2007, J IMMUNOL, V179, P5014, DOI 10.4049/jimmunol.179.8.5014; Sporici RA, 2001, CLIN IMMUNOL, V100, P277, DOI 10.1006/clim.2001.5074; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Swain SL, 2004, VIRAL IMMUNOL, V17, P197, DOI 10.1089/0882824041310577; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Takahashi N, 2009, J IMMUNOL, V182, P5515, DOI 10.4049/jimmunol.0803256; Tang AL, 2006, AM J TRANSPLANT, V6, P1275, DOI 10.1111/j.1600-6143.2006.01317.x; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; VELLA AT, 1992, J IMMUNOL, V148, P2283; VELLA AT, 1992, J IMMUNOL, V149, P1714; WATANABE M, 2005, INT IMMUNOL; Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhong WM, 2001, J IMMUNOL, V167, P1379, DOI 10.4049/jimmunol.167.3.1379	65	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16529	10.1371/journal.pone.0016529	http://dx.doi.org/10.1371/journal.pone.0016529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364749	Green Published, gold, Green Submitted			2022-12-25	WOS:000287482800009
J	Owen, K; Charlton-Robb, K; Thompson, R				Owen, Kylie; Charlton-Robb, Kate; Thompson, Ross			Resolving the Trophic Relations of Cryptic Species: An Example Using Stable Isotope Analysis of Dolphin Teeth	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; WHALES ORCINUS-ORCA; TURSIOPS-TRUNCATUS; MARINE MAMMALS; COMMON DOLPHIN; DIET; NITROGEN; CARBON; POPULATIONS; DELTA-N-15	Understanding the foraging ecology and diet of animals can play a crucial role in conservation of a species. This is particularly true where species are cryptic and coexist in environments where observing feeding behaviour directly is difficult. Here we present the first information on the foraging ecology of a recently identified species of dolphin (Southern Australian bottlenose dolphin (SABD)) and comparisons to the common bottlenose dolphin (CBD) in Victoria, Australia, using stable isotope analysis of teeth. Stable isotope signatures differed significantly between SABD and CBD for both delta C-13 (-14.4 parts per thousand vs. -15.5 parts per thousand respectively) and delta N-15 (15.9 parts per thousand vs. 15.0 parts per thousand respectively), suggesting that the two species forage in different areas and consume different prey. This finding supports genetic and morphological data indicating that SABD are distinct from CBD. In Victoria, the SABD is divided into two distinct populations, one in the large drowned river system of Port Phillip Bay and the other in a series of coastal lakes and lagoons called the Gippsland Lakes. Within the SABD species, population differences were apparent. The Port Phillip Bay population displayed a significantly higher delta N-15 than the Gippsland Lakes population (17.0 parts per thousand vs. 15.5 parts per thousand), suggesting that the Port Phillip Bay population may feed at a higher trophic level a result which is supported by analysis of local food chains. Important future work is required to further understand the foraging ecology and diet of this newly described, endemic, and potentially endangered species of dolphin.	[Owen, Kylie; Charlton-Robb, Kate; Thompson, Ross] Monash Univ, Australian Ctr Biodivers, Clayton, Vic 3800, Australia; [Owen, Kylie; Charlton-Robb, Kate; Thompson, Ross] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Charlton-Robb, Kate] Monash Univ, CESAR, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	Owen, K (corresponding author), Monash Univ, Australian Ctr Biodivers, Clayton, Vic 3800, Australia.	kylie.owen3@optusnet.com	Thompson, Ross/D-7996-2013; Owen, Kylie/K-9400-2015	Thompson, Ross/0000-0002-5287-2455; Owen, Kylie/0000-0002-8986-482X; Robb, Kate/0000-0002-7038-3612	Holsworth Wildlife Research Endowment [MU-3900655]	Holsworth Wildlife Research Endowment	Funding: This research was supported by the Holsworth Wildlife Research Endowment (www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/) (MU-3900655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT I, 1977, ECOL MONOGR, V47, P151, DOI 10.2307/1942615; Nino-Torres CA, 2006, MAR MAMMAL SCI, V22, P831, DOI 10.1111/j.1748-7692.2006.00065.x; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Blanco C, 2001, J MAR BIOL ASSOC UK, V81, P1053, DOI 10.1017/S0025315401005057; Carabel S, 2006, J EXP MAR BIOL ECOL, V336, P254, DOI 10.1016/j.jembe.2006.06.001; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Charlton Kate, 2006, Journal of Cetacean Research and Management, V8, P173; Chiaradia A, 2010, ICES J MAR SCI, V67, P1710, DOI 10.1093/icesjms/fsq067; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DICKMAN CR, 1988, J MAMMAL, V69, P108, DOI 10.2307/1381753; EVANS K, 2007, S A M MAR MAMM AG FA, P10; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Gannon DP, 2004, MAR MAMMAL SCI, V20, P527, DOI 10.1111/j.1748-7692.2004.tb01177.x; Grellier K, 2006, CAN J FISH AQUAT SCI, V63, P1982, DOI 10.1139/F06-092; HALE P, 2002, INTERACTIONS DOLPHIN; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson KA, 2004, MAR MAMMAL SCI, V20, P621, DOI 10.1111/j.1748-7692.2004.tb01183.x; Hobson KA, 1997, MAR MAMMAL SCI, V13, P114, DOI 10.1111/j.1748-7692.1997.tb00615.x; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; HOELZEL AR, 1991, HEREDITY, V66, P191, DOI 10.1038/hdy.1991.24; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Jennings S, 2003, MAR BIOL, V142, P1131, DOI 10.1007/s00227-003-1020-0; Jensen KR, 1997, EVOL ECOL, V11, P301, DOI 10.1023/A:1018468420368; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kingston SE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-245; Knoff A, 2008, MAR MAMMAL SCI, V24, P128, DOI 10.1111/j.1748-7692.2007.00174.x; Kurle CM, 2007, MAR ECOL PROG SER, V342, P303, DOI 10.3354/meps342303; Lesage V, 2001, MAR ECOL PROG SER, V210, P203, DOI 10.3354/meps210203; Lusseau SM, 2006, MAR ECOL PROG SER, V321, P283, DOI 10.3354/meps321283; Mcilwee AP, 1998, FUNCT ECOL, V12, P223, DOI 10.1046/j.1365-2435.1998.00181.x; Menard F, 2006, MAR ECOL PROG SER, V323, P223, DOI 10.3354/meps323223; Meynier L, 2008, MAR ECOL PROG SER, V354, P277, DOI 10.3354/meps07246; Moeller LM, 2008, MOL PHYLOGENET EVOL, V49, P674, DOI 10.1016/j.ympev.2008.08.011; Moller LM, 2001, MAR MAMMAL SCI, V17, P249, DOI 10.1111/j.1748-7692.2001.tb01269.x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; POORE G, 1982, MAR FRESHWATER RES, V33, P901; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R Core Team, 2022, R LANG ENV STAT COMP; Real J, 1996, J WILDLIFE MANAGE, V60, P632, DOI 10.2307/3802082; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Tollit DJ, 1997, CAN J FISH AQUAT SCI, V54, P105, DOI 10.1139/cjfas-54-1-105; Walker JL, 1999, MAR MAMMAL SCI, V15, P335, DOI 10.1111/j.1748-7692.1999.tb00805.x; Walker JL, 1999, MAR MAMMAL SCI, V15, P314, DOI 10.1111/j.1748-7692.1999.tb00804.x; WEBB PW, 1990, T AM FISH SOC, V119, P629, DOI 10.1577/1548-8659(1990)119<0629:LITBOL>2.3.CO;2; WILLIAMS MJ, 1981, J EXP MAR BIOL ECOL, V52, P103, DOI 10.1016/0022-0981(81)90174-X; Yonezaki Shiroh, 2003, Mammal Study, V28, P97, DOI 10.3106/mammalstudy.28.97	56	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16457	10.1371/journal.pone.0016457	http://dx.doi.org/10.1371/journal.pone.0016457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364748	gold, Green Published, Green Submitted			2022-12-25	WOS:000287482800007
J	Brischoux, F; Gartner, GEA; Garland, T; Bonnet, X				Brischoux, Francois; Gartner, Gabriel E. A.; Garland, Theodore, Jr.; Bonnet, Xavier			Is Aquatic Life Correlated with an Increased Hematocrit in Snakes?	PLOS ONE			English	Article							SEA-SNAKE; PELAMIS-PLATURUS; REPTILES; METABOLISM; LIZARDS; ECTOTHERMY; ESTUARINE; TOLERANCE; EVOLUTION; ENDURANCE	Background: Physiological adaptations that allow air-breathing vertebrates to remain underwater for long periods mainly involve modifications of the respiratory system, essentially through increased oxygen reserves. Physiological constraints on dive duration tend to be less critical for ectotherms than for endotherms because the former have lower mass-specific metabolic rates. Moreover, comparative studies between marine and terrestrial ectotherms have yet to show overall distinct physiological differences specifically associated with oxygen reserves. Methodology/Principal Findings: We used phylogenetically informed statistical models to test if habitat affects hematocrit (an indicator of blood oxygen stores) in snakes, a lineage that varies widely in habitat use. Our results indicate that both phylogenetic position (clade) and especially habitat are significant predictors of hematocrit. Our analysis also confirms the peculiar respiratory physiology of the marine Acrochordus granulatus. Conclusion/Significance: Contrary to previous findings, marine snakes have significantly-albeit slightly-elevated hematocrit, which should facilitate increased aerobic dive times. Longer dives could have consequences for foraging, mate searching, and predation risks. Alternatively, but not exclusively, increased Hct in marine species might also help to fuel other oxygen-demanding physiological adaptations, such as those involved in osmoregulation.	[Brischoux, Francois; Bonnet, Xavier] Ctr Etud Biol Chize CNRS, F-79360 Villiers En Bois, France; [Gartner, Gabriel E. A.; Garland, Theodore, Jr.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Riverside	Brischoux, F (corresponding author), Ctr Etud Biol Chize CNRS, F-79360 Villiers En Bois, France.	francois.brischoux@gmail.com		Bonnet, Xavier/0000-0001-6150-8199; Garland, Theodore/0000-0002-7916-3552	CNRS; US NSF [DEB-0416085]	CNRS(Centre National de la Recherche Scientifique (CNRS)); US NSF(National Science Foundation (NSF))	Funding was provided by the CNRS and US NSF grant DEB-0416085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avolio C, 2006, AM NAT, V167, P728, DOI 10.1086/503386; BELKIN DA, 1963, SCIENCE, V139, P492, DOI 10.1126/science.139.3554.492; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bonnet X, 2002, AUSTRAL ECOL, V27, P442, DOI 10.1046/j.1442-9993.2002.01198.x; Boyd IL, 1997, TRENDS ECOL EVOL, V12, P213, DOI 10.1016/S0169-5347(97)01054-9; Brischoux F, 2008, J EVOLUTION BIOL, V21, P324, DOI 10.1111/j.1420-9101.2007.01438.x; Brischoux F, 2011, J MORPHOL IN PRESS; Brischoux F, 2007, P 11 ANN M HLTH SCI; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; DAWSON WR, 1977, EVOLUTION, V31, P891, DOI 10.1111/j.1558-5646.1977.tb01083.x; de Queiroz A, 2006, AM NAT, V167, P684, DOI 10.1086/503118; DUNSON WA, 1980, COPEIA, P268; DUNSON WA, 1989, B MAR SCI, V44, P229; Garland T, 1999, ANIM BEHAV, V58, P77, DOI 10.1006/anbe.1999.1132; GARLAND T, 1987, AM J PHYSIOL, V252, pR439, DOI 10.1152/ajpregu.1987.252.3.R439; GARLAND T, 1987, EVOLUTION, V41, P1404, DOI 10.1111/j.1558-5646.1987.tb02478.x; Gartner GEA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P43, DOI 10.1086/648509; GRAHAM JB, 1974, RESP PHYSIOL, V21, P1, DOI 10.1016/0034-5687(74)90002-4; Heatwole H, 1975, BIOL SEA SNAKES, P289; Heatwole H, 1993, FAMILY HYDROPHIIDAE, V2, P310; HEATWOLE H, 1999, AUSTR NATURAL HIST S; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; LILLYWHITE HB, 1989, SCIENCE, V245, P293, DOI 10.1126/science.2749262; LILLYWHITE HB, 1988, J HERPETOL, V22, P434, DOI 10.2307/1564338; LUTCAVAGE ME, 1992, CAN J ZOOL, V70, P348, DOI 10.1139/z92-051; MILLIGAN LP, 1985, J NUTR, V115, P1374, DOI 10.1093/jn/115.10.1374; Murphy J. C., 2007, HOMALOPSID SNAKES EV; POUGH FH, 1977, J COMP PHYSIOL, V116, P337, DOI 10.1007/BF00689041; POUGH FH, 1980, AM NAT, V115, P92, DOI 10.1086/283547; RUBINOFF I, 1986, MAR BIOL, V91, P181, DOI 10.1007/BF00569434; SCHMIDTNIELSEN K, 1958, NATURE, V182, P783, DOI 10.1038/182783a0; SEYMOUR RS, 1976, AUST J ZOOL, V24, P313, DOI 10.1071/ZO9760313; Seymour RS, 1982, BIOL REPTILIA, P1; SHELTON G, 1982, J EXP BIOL, V100, P245; Shine R, 1993, FAUNA FLORA AUSTR, V2, P322; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; WOJTASZEK JS, 1991, COMP BIOCHEM PHYS A, V100, P805, DOI 10.1016/0300-9629(91)90296-O	41	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17077	10.1371/journal.pone.0017077	http://dx.doi.org/10.1371/journal.pone.0017077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359216	gold, Green Published, Green Submitted			2022-12-25	WOS:000287392700046
J	Lanini, S; D'Arezzo, S; Puro, V; Martini, L; Imperi, F; Piselli, P; Montanaro, M; Paoletti, S; Visca, P; Ippolito, G				Lanini, Simone; D'Arezzo, Silvia; Puro, Vincenzo; Martini, Lorena; Imperi, Francesco; Piselli, Pierluca; Montanaro, Marco; Paoletti, Simonetta; Visca, Paolo; Ippolito, Giuseppe			Molecular Epidemiology of a Pseudomonas aeruginosa Hospital Outbreak Driven by a Contaminated Disinfectant-Soap Dispenser	PLOS ONE			English	Article							INFECTIONS; RISK; UNIT	Background and Objective: Pseudomonas aeruginosa infection represents a main cause of morbidity and mortality among immunocompromised patients. This study describes a fatal epidemic of P. aeruginosa that occurred in a hematology unit in Italy. Methods: Retrospective cohort study, prospective surveillance, auditing, extensive testing on healthcare workers and environmental investigation were performed to define the dynamics and potential causes of transmission. RAPD, macrorestriction analyses and sequence typing were used to define relationships between P. aeruginosa isolates. Results: Eighteen cases of infection were identified in the different phases of the investigation. Of these, five constitute a significant molecular cluster of infection. A P. aeruginosa strain with the same genetic fingerprint and sequence type (ST175) as clinical isolates strain was also isolated from a heavily contaminated triclosan soap dispenser. Discussion and Conclusions: Our results are consistent with the hypothesis that patients became indirectly infected, e. g., during central venous catheter handling through contaminated items, and that the triclosan soap dispenser acted as a common continuous source of P. aeruginosa infection. Since P. aeruginosa is intrinsically unsusceptible to triclosan, the use of triclosan-based disinfectant formulations should be avoided in those healthcare settings hosting patients at high risk of P. aeruginosa infection.	[Lanini, Simone; D'Arezzo, Silvia; Puro, Vincenzo; Martini, Lorena; Piselli, Pierluca; Ippolito, Giuseppe] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Imperi, Francesco; Visca, Paolo] Univ Roma Tre, Dept Biol, Rome, Italy; [Montanaro, Marco; Paoletti, Simonetta] UOC Ematol Azienda Unita Sanit Locale Viterbo, Viterbo, Italy	IRCCS Lazzaro Spallanzani; Roma Tre University	Lanini, S (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.	simone.lanini@inmi.it	Piselli, Pierluca/K-5337-2016; Ippolito, Giuseppe/J-7207-2017; D'Arezzo, Silvia/B-5324-2017; Visca, Paolo/G-8977-2014; Imperi, Francesco/AAA-3671-2021; Lanini, Simone/C-7523-2012	Piselli, Pierluca/0000-0002-7342-0263; D'Arezzo, Silvia/0000-0002-7783-6194; Lanini, Simone/0000-0002-6743-4001; puro, vincenzo/0000-0003-0291-4490; Visca, Paolo/0000-0002-6128-7039; Ippolito, Giuseppe/0000-0002-1076-2979	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by grants from the Italian Ministry of Health ('Ricerca Corrente 2006 IRCCS Lazzaro Spallanzani'). The Italian Ministry of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-43; Aktas E, 2010, INFECT CONT HOSP EP, V31, P1199, DOI 10.1086/657077; [Anonymous], WORLDWIDE DATABASE N; Aumeran C, 2007, J HOSP INFECT, V65, P47, DOI 10.1016/j.jhin.2006.08.009; Buffet-Bataillon S, 2009, J HOSP INFECT, V72, P17, DOI 10.1016/j.jhin.2009.01.010; Clinical and Laboratory Standards Institute, 2007, METH DIL ANT SUSC TE, P1; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; DiazGranados CA, 2009, INFECT CONT HOSP EP, V30, P550, DOI 10.1086/597235; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Engelhart S, 2002, J HOSP INFECT, V52, P93, DOI 10.1053/jhin.2002.1279; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Fanci R, 2009, BONE MARROW TRANSPL, V43, P335, DOI 10.1038/bmt.2008.319; Hakki M, 2007, BONE MARROW TRANSPL, V39, P687, DOI 10.1038/sj.bmt.1705653; Iversen BG, 2007, CLIN INFECT DIS, V44, P794, DOI 10.1086/511644; Koburger T, 2010, J ANTIMICROB CHEMOTH, V65, P1712, DOI 10.1093/jac/dkq212; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P1129, DOI 10.1128/JCM.34.5.1129-1135.1996; McCann S, 2004, BONE MARROW TRANSPL, V33, P519, DOI 10.1038/sj.bmt.1704380; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Orsi GB, 2006, SCAND J INFECT DIS, V38, P1085, DOI 10.1080/00365540600794402; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Shimono Nobuyuki, 2008, Journal of Infection and Chemotherapy, V14, P418, DOI 10.1007/s10156-008-0645-9; Speert DP, 2002, AM J RESP CRIT CARE, V166, P988, DOI 10.1164/rccm.2203011; Stone SP, 2007, J ANTIMICROB CHEMOTH, V59, P833, DOI 10.1093/jac/dkm055; Sturmer T, 2000, J CLIN EPIDEMIOL, V53, P57, DOI 10.1016/S0895-4356(99)00137-7; Sung LL, 2000, J CLIN MICROBIOL, V38, P1127, DOI 10.1128/JCM.38.3.1127-1130.2000; Takahashi H, 2004, INFECT CONT HOSP EP, V25, P156, DOI 10.1086/502367; Trautmann M, 2005, AM J INFECT CONTROL, V33, pS41, DOI 10.1016/j.ajic.2005.03.006; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Vianelli N, 2006, HAEMATOL-HEMATOL J, V91, P983; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07; World Health Organization, 2009, WHO GHID HAND HYG HL	31	68	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17064	10.1371/journal.pone.0017064	http://dx.doi.org/10.1371/journal.pone.0017064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359222	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700042
J	Quakkelaar, ED; Redeker, A; Haddad, EK; Harari, A; McCaughey, SM; Duhen, T; Filali-Mouhim, A; Goulet, JP; Loof, NM; Ossendorp, F; Perdiguero, B; Heinen, P; Gomez, CE; Kibler, KV; Koelle, DM; Sekaly, RP; Sallusto, F; Lanzavecchia, A; Pantaleo, G; Esteban, M; Tartaglia, J; Jacobs, BL; Melief, CJM				Quakkelaar, Esther D.; Redeker, Anke; Haddad, Elias K.; Harari, Alexandre; McCaughey, Stella Mayo; Duhen, Thomas; Filali-Mouhim, Abdelali; Goulet, Jean-Philippe; Loof, Nikki M.; Ossendorp, Ferry; Perdiguero, Beatriz; Heinen, Paul; Gomez, Carmen E.; Kibler, Karen V.; Koelle, David M.; Sekaly, Rafick P.; Sallusto, Federica; Lanzavecchia, Antonio; Pantaleo, Giuseppe; Esteban, Mariano; Tartaglia, Jim; Jacobs, Bertram L.; Melief, Cornelis J. M.			Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; CELLULAR IMMUNE-RESPONSES; PHASE-I TRIAL; VACCINIA VIRUS; DENDRITIC CELLS; IMMUNOGENICITY; CANDIDATES; GENE; VACCINATION; MVA	Attenuated poxviruses are safe and capable of expressing foreign antigens. Poxviruses are applied in veterinary vaccination and explored as candidate vaccines for humans. However, poxviruses express multiple genes encoding proteins that interfere with components of the innate and adaptive immune response. This manuscript describes two strategies aimed to improve the immunogenicity of the highly attenuated, host-range restricted poxvirus NYVAC: deletion of the viral gene encoding type-I interferon-binding protein and development of attenuated replication-competent NYVAC. We evaluated these newly generated NYVAC mutants, encoding HIV-1 env, gag, pol and nef, for their ability to stimulate HIV-specific CD8 T-cell responses in vitro from blood mononuclear cells of HIV-infected subjects. The new vectors were evaluated and compared to the parental NYVAC vector in dendritic cells (DCs), RNA expression arrays, HIV gag expression and cross-presentation assays in vitro. Deletion of type-I interferon-binding protein enhanced expression of interferon and interferon-induced genes in DCs, and increased maturation of infected DCs. Restoration of replication competence induced activation of pathways involving antigen processing and presentation. Also, replication-competent NYVAC showed increased Gag expression in infected cells, permitting enhanced cross-presentation to HIV-specific CD8 T cells and proliferation of HIV-specific memory CD8 T-cells in vitro. The recombinant NYVAC combining both modifications induced interferon-induced genes and genes involved in antigen processing and presentation, as well as increased Gag expression. This combined replication-competent NYVAC is a promising candidate for the next generation of HIV vaccines.	[Quakkelaar, Esther D.; Redeker, Anke; Loof, Nikki M.; Ossendorp, Ferry; Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Haddad, Elias K.; Filali-Mouhim, Abdelali; Goulet, Jean-Philippe; Sekaly, Rafick P.] CR CHUM, Immunol Lab, Montreal, PQ, Canada; [Harari, Alexandre; Pantaleo, Giuseppe] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Harari, Alexandre; Pantaleo, Giuseppe] Swiss Vaccine Res Inst, Lausanne, Switzerland; [McCaughey, Stella Mayo; Koelle, David M.] Univ Washington, Dept Med, Seattle, WA USA; [Duhen, Thomas; Sallusto, Federica; Lanzavecchia, Antonio] Biomed Res Inst, Bellinzona, Switzerland; [Perdiguero, Beatriz; Heinen, Paul; Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Kibler, Karen V.; Jacobs, Bertram L.] Arizona State Univ, Tempe, AZ USA; [Tartaglia, Jim] Sanofi Pasteur, Swiftwater, PA USA; [Melief, Cornelis J. M.] ISA Pharmaceut B V, Bilthoven, Netherlands; [Koelle, David M.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite de Montreal; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Washington; University of Washington Seattle; Universita della Svizzera Italiana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Arizona State University; Arizona State University-Tempe; Sanofi-Aventis; Fred Hutchinson Cancer Center	Quakkelaar, ED (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	c.melief@lumc.nl	Koelle, David/Q-6529-2016; Gomez, Carmen Elena/K-1940-2014; Esteban, Mariano/ABG-5375-2020; Redeker, Anke/A-1953-2019; Pantaleo, Giuseppe/K-6163-2016; Perdiguero, Beatriz/K-6587-2017	Koelle, David/0000-0003-1255-9023; Gomez, Carmen Elena/0000-0002-5414-7935; Esteban, Mariano/0000-0003-0846-2827; Redeker, Anke/0000-0002-5832-6332; Perdiguero, Beatriz/0000-0001-6276-7766; Harari, Alexandre/0000-0002-1055-2090	Bill and Melinda Gates Foundation; Sanofi Pasteur; ISA Pharmaceuticals	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Sanofi Pasteur; ISA Pharmaceuticals	This study was conducted as part of the Poxvirus T cell Vaccine Discovery Consortium (PTVDC) as part of the Collaboration for AIDS Vaccine Discovery (CAVD) with support from the Bill and Melinda Gates Foundation. JT and CJMM are employees of Sanofi Pasteur and ISA Pharmaceuticals, respectively, and as such, Sanofi Pasteur and ISA Pharmaceuticals are considered by PLoS ONE to have funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI A, 1995, J VIROL, V69, P4633; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bins AD, 2007, J IMMUNOL, V179, P2126, DOI 10.4049/jimmunol.179.4.2126; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; ESPMARK JA, 1978, TISSUE ANTIGENS, V11, P279, DOI 10.1111/j.1399-0039.1978.tb01259.x; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778; Hel Z, 2002, VIROLOGY, V304, P125, DOI 10.1006/viro.2002.1722; Jackson SS, 2005, J VIROL, V79, P6554, DOI 10.1128/JVI.79.10.6554-6559.2005; Jing LC, 2005, J IMMUNOL, V175, P7550, DOI 10.4049/jimmunol.175.11.7550; Jing LC, 2009, J IMMUNOL METHODS, V347, P36, DOI 10.1016/j.jim.2009.05.011; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McNeil AJ, 1996, QJM-INT J MED, V89, P177; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; OGUIURA N, 1993, J GEN VIROL, V74, P1409, DOI 10.1099/0022-1317-74-7-1409; Paoletti E, 1996, P NATL ACAD SCI USA, V93, P11349, DOI 10.1073/pnas.93.21.11349; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; PERKUS ME, 1995, J LEUKOCYTE BIOL, V58, P1; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shen XF, 2002, J IMMUNOL, V169, P4222, DOI 10.4049/jimmunol.169.8.4222; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUTTER G, 1994, J VIROL, V68, P4109, DOI 10.1128/JVI.68.7.4109-4116.1994; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; TARTAGLIA J, 1994, DEV BIOL STAND, V82, P125; Terajima M, 2008, HUM IMMUNOL, V69, P815, DOI 10.1016/j.humimm.2008.09.009; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	61	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16819	10.1371/journal.pone.0016819	http://dx.doi.org/10.1371/journal.pone.0016819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347234	Green Published, gold			2022-12-25	WOS:000287369200009
J	Wiley, AS				Wiley, Andrea S.			Milk Intake and Total Dairy Consumption: Associations with Early Menarche in NHANES 1999-2004	PLOS ONE			English	Article							BODY-MASS INDEX; GROWTH-FACTOR-I; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; ADOLESCENT GIRLS; SECULAR TRENDS; IGF-I; PUBERTAL MATURATION; INTERVENTION TRIAL; PRESCHOOL-CHILDREN	Background: Several components of dairy products have been linked to earlier menarche. Methods/Findings: This study assessed whether positive associations exist between childhood milk consumption and age at menarche or the likelihood of early menarche (< 12 yrs) in a U.S. sample. Data derive from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Two samples were utilized: 2657 women age 20-49 yrs and 1008 girls age 9-12 yrs. In regression analysis, a weak negative relationship was found between frequency of milk consumption at 512 yrs and age at menarche (daily milk intake beta = -0.32, P < 0.10; "sometimes/variable milk intake'' beta = -0.38, P < 0.06, each compared to intake rarely/never). Cox regression yielded no greater risk of early menarche among those who drank milk "sometimes/varied'' or daily vs. never/rarely (HR: 1.20, P < 0.42, HR: 1.25, P < 0.23, respectively). Among the 9-12 yr olds, Cox regression indicated that neither total dairy kcal, calcium and protein, nor daily milk intake in the past 30 days contributed to early menarche. Girls in the middle tertile of milk intake had a marginally lower risk of early menarche than those in the highest tertile (HR: 0.6, P < 0.06). Those in the lowest tertiles of dairy fat intake had a greater risk of early menarche than those in the highest (HR: 1.5, P < 0.05, HR: 1.6, P < 0.07, lowest and middle tertile, respectively), while those with the lowest calcium intake had a lower risk of early menarche (HR: 0.6, P < 0.05) than those in the highest tertile. These relationships remained after adjusting for overweight or overweight and height percentile; both increased the risk of earlier menarche. Blacks were more likely than Whites to reach menarche early (HR: 1.7, P < 0.03), but not after controlling for overweight. Conclusions: There is some evidence that greater milk intake is associated with an increased risk of early menarche, or a lower age at menarche.	Indiana Univ, Dept Anthropol, Program Human Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Wiley, AS (corresponding author), Indiana Univ, Dept Anthropol, Program Human Biol, Bloomington, IN 47405 USA.	wileya@Indiana.edu						Adair LS, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e59; Allsworth JE, 2005, ANN EPIDEMIOL, V15, P438, DOI 10.1016/j.annepidem.2004.12.010; Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Berkey CS, 2009, CANCER EPIDEM BIOMAR, V18, P1881, DOI 10.1158/1055-9965.EPI-08-1163; Berkey CS, 2000, AM J EPIDEMIOL, V152, P446, DOI 10.1093/aje/152.5.446; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; BILEZIKIAN JP, 1994, JAMA-J AM MED ASSOC, V272, P1942, DOI 10.1001/jama.1994.03520240070044; Bini V, 2000, EUR J CLIN NUTR, V54, P214, DOI 10.1038/sj.ejcn.1600922; Biro FM, 2006, J PEDIATR-US, V148, P234, DOI 10.1016/j.jpeds.2005.10.020; Bratberg GH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-54; Cadogan J, 1997, BMJ-BRIT MED J, V315, P1255, DOI 10.1136/bmj.315.7118.1255; CAMPANA WM, 1995, HDB MILK COMPOSITION, P476; [Center for Disease Control National Center for Health Statistics], 2007, NAT HLTH NURT EX SUR; Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), 2006, NATL HLTH NUTR EXAMI; Chang SH, 2000, ARCH PEDIAT ADOL MED, V154, P880, DOI 10.1001/archpedi.154.9.880; Chevalley T, 2005, J CLIN ENDOCR METAB, V90, P44, DOI 10.1210/jc.2004-1043; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P861, DOI 10.1093/oxfordjournals.aje.a114723; CRAMER DW, 1995, MATURITAS, V22, P79, DOI 10.1016/0378-5122(95)00928-E; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Demerath EW, 2004, AM J CLIN NUTR, V80, P441, DOI 10.1093/ajcn/80.2.441; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; Dunger DB, 2006, MOL CELL ENDOCRINOL, V254, P140, DOI 10.1016/j.mce.2006.04.003; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; ELLISON PT, 1994, ANNU REV ANTHROPOL, V23, P255, DOI 10.1146/annurev.an.23.100194.001351; Eveleth PB, 1990, WORLDWIDE VARIATION; Fall CHD, 2000, CLIN ENDOCRINOL, V53, P69, DOI 10.1046/j.1365-2265.2000.01047.x; Fiorito LM, 2006, J AM DIET ASSOC, V106, P1851, DOI 10.1016/j.jada.2006.08.003; FREDERICK L, 1992, J AM DIET ASSOC, V92, P299; FRIEDENREICH CM, 1992, EPIDEMIOL REV, V14, P177, DOI 10.1093/oxfordjournals.epirev.a036086; FRISCH RE, 1970, SCIENCE, V169, P397, DOI 10.1126/science.169.3943.397; Geronimus AT, 1999, SOC SCI MED, V49, P1623, DOI 10.1016/S0277-9536(99)00246-4; Gunther ALB, 2010, J NUTR, V140, P565, DOI 10.3945/jn.109.114934; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P852; Hoppe C, 2004, EUR J CLIN NUTR, V58, P1211, DOI 10.1038/sj.ejcn.1601948; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Jensen RG, 1995, HDB MILK COMPOSITION, P428; JUSKEVICH JC, 1990, SCIENCE, V249, P875, DOI 10.1126/science.2203142; Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P2534, DOI 10.1210/jc.80.8.2534; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Kalkwarf HJ, 2003, AM J CLIN NUTR, V77, P257, DOI 10.1093/ajcn/77.1.257; Kaplowitz P, 2006, CURR OPIN OBSTET GYN, V18, P487, DOI 10.1097/01.gco.0000242949.02373.09; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; KAPRIO J, 1995, HUM BIOL, V67, P739; Kerver JM, 2010, AM J CLIN NUTR, V91, P643, DOI 10.3945/ajcn.2009.28205; KHAN AD, 1995, J NUTR, V125, pS1090; Koo MM, 2002, PUBLIC HEALTH NUTR, V5, P353, DOI 10.1079/PHN2002261; KULIN HE, 1982, AM J CLIN NUTR, V36, P527, DOI 10.1093/ajcn/36.3.527; Legro RS, 2000, J CLIN ENDOCR METAB, V85, P1021, DOI 10.1210/jc.85.3.1021; LUOTO R, 1994, AM J EPIDEMIOL, V139, P64, DOI 10.1093/oxfordjournals.aje.a116936; Maclure M, 1991, AM J CLIN NUTR, P54; MARLOWE TJ, 1958, J ANIM SCI, V17, P706, DOI 10.2527/jas1958.173706x; MOISAN J, 1990, CANCER CAUSE CONTROL, V1, P149, DOI 10.1007/BF00053166; Novotny R, 2004, J NUTR, V134, P1905, DOI 10.1093/jn/134.8.1905; Ong KK, 2006, MOL CELL ENDOCRINOL, V254, P8, DOI 10.1016/j.mce.2006.04.018; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Patton, 2004, MILK ITS REMARKABLE, DOI 10.4324/9781315124513; PERRON M, 1985, J AM DIET ASSOC, V85, P573; Petridou E, 1996, INT J CANCER, V68, P193, DOI 10.1002/(SICI)1097-0215(19961009)68:2<193::AID-IJC9>3.0.CO;2-T; Phillips SM, 2003, INT J OBESITY, V27, P1106, DOI 10.1038/sj.ijo.0802370; REYNOLDS WL, 1978, J ANIM SCI, V47, P584, DOI 10.2527/jas1978.473584x; Rich-Edwards JW, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-28; Rockett HRH, 2003, CURR OPIN CLIN NUTR, V6, P557, DOI 10.1097/00075197-200309000-00009; Rogers I, 2006, PUBLIC HEALTH NUTR, V9, P359, DOI 10.1079/PHN2006853; Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146; Salsberry PJ, 2009, NURS RES, V58, P382, DOI 10.1097/NNR.0b013e3181b4b921; SANCHEZ A, 1981, MED HYPOTHESES, V7, P1339, DOI 10.1016/0306-9877(81)90124-9; Serdula MK, 2001, ANNU REV NUTR, V21, P475, DOI 10.1146/annurev.nutr.21.1.475; Silva ID, 2002, INT J EPIDEMIOL, V31, P405, DOI 10.1093/intjepid/31.2.405; STATACorp Inc, 2008, STATA 10; Tam CS, 2006, J CLIN ENDOCR METAB, V91, P4369, DOI 10.1210/jc.2006-0953; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; Vicini J, 2008, J AM DIET ASSOC, V108, P1198, DOI 10.1016/j.jada.2008.04.021; Vink EE, 2010, OBESITY, V18, P1247, DOI 10.1038/oby.2009.366; Wattigney Wendy A., 1999, Ethnicity and Disease, V9, P181; Wehkalampi K, 2008, AM J HUM BIOL, V20, P417, DOI 10.1002/ajhb.20748; Wiley AS, 2010, AM J HUM BIOL, V22, P517, DOI 10.1002/ajhb.21042; Wiley AS, 2009, ANN HUM BIOL, V36, P125, DOI 10.1080/03014460802680466; Wiley AS, 2005, AM J HUM BIOL, V17, P425, DOI 10.1002/ajhb.20411; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; WYSHAK G, 1982, NEW ENGL J MED, V306, P1033, DOI 10.1056/NEJM198204293061707; Zarow R, 2008, AM J HUM BIOL, V20, P146, DOI 10.1002/ajhb.20701; Zhu K, 2006, AM J CLIN NUTR, V83, P714, DOI 10.1093/ajcn.83.3.714	88	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14685	10.1371/journal.pone.0014685	http://dx.doi.org/10.1371/journal.pone.0014685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347271	Green Published, gold, Green Submitted			2022-12-25	WOS:000287367600009
J	Duzdevich, D; Li, JL; Whang, J; Takahashi, H; Takeyasu, K; Dryden, DTF; Morton, AJ; Edwardson, JM				Duzdevich, Daniel; Li, Jinliang; Whang, Jhoon; Takahashi, Hirohide; Takeyasu, Kunio; Dryden, David T. F.; Morton, A. Jennifer; Edwardson, J. Michael			Unusual Structures Are Present in DNA Fragments Containing Super-Long Huntingtin CAG Repeats	PLOS ONE			English	Article							III RESTRICTION ENZYMES; ATOMIC-FORCE MICROSCOPY; HUMAN GENETIC-DISEASE; AGE-OF-ONSET; TRIPLET REPEAT; MUTANT HUNTINGTIN; MYOTONIC-DYSTROPHY; DYNAMIC MUTATIONS; TRANSGENIC MICE; INSTABILITY	Background: In the R6/2 mouse model of Huntington's disease (HD), expansion of the CAG trinucleotide repeat length beyond about 300 repeats induces a novel phenotype associated with a reduction in transcription of the transgene. Methodology/Principal Findings: We analysed the structure of polymerase chain reaction (PCR)-generated DNA containing up to 585 CAG repeats using atomic force microscopy (AFM). As the number of CAG repeats increased, an increasing proportion of the DNA molecules exhibited unusual structural features, including convolutions and multiple protrusions. At least some of these features are hairpin loops, as judged by cross-sectional analysis and sensitivity to cleavage by mung bean nuclease. Single-molecule force measurements showed that the convoluted DNA was very resistant to untangling. In vitro replication by PCR was markedly reduced, and TseI restriction enzyme digestion was also hindered by the abnormal DNA structures. However, significantly, the DNA gained sensitivity to cleavage by the Type III restriction-modification enzyme, EcoP15I. Conclusions/Significance: "Super-long'' CAG repeats are found in a number of neurological diseases and may also appear through CAG repeat instability. We suggest that unusual DNA structures associated with super-long CAG repeats decrease transcriptional efficiency in vitro. We also raise the possibility that if these structures occur in vivo, they may play a role in the aetiology of CAG repeat diseases such as HD.	[Duzdevich, Daniel; Morton, A. Jennifer; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Li, Jinliang; Whang, Jhoon] Laragen Inc, Culver City, CA USA; [Takahashi, Hirohide; Takeyasu, Kunio] Kyoto Univ, Lab Plasma Membrane & Nucl Signaling, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan; [Dryden, David T. F.] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh, Midlothian, Scotland	University of Cambridge; Kyoto University; University of Edinburgh	Duzdevich, D (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	ajm41@cam.ac.uk; jme1000@cam.ac.uk	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346; Duzdevich, Daniel/0000-0002-8225-6071; Takahashi, Hirohide/0000-0002-2553-8806	CHDI Foundation, Inc.; BBSRC Japan; JSPS; Cambridge European Trust; Emmanuel College, Cambridge	CHDI Foundation, Inc.; BBSRC Japan(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cambridge European Trust; Emmanuel College, Cambridge	Funding: This work was supported by CHDI Foundation, Inc. (AJM), a BBSRC Japan Partnering Award (JME), a JSPS Japan-UK Bilateral Joint Project Award (KT), and a JSPS Grant-in-Aid for Basic Research (KT). DD received funding from the Cambridge European Trust. HT holds a Grant-in-Aid Fellowship from the JSPS. DTFD gratefully acknowledges the award of a Derek Brewer Visiting Fellowship at Emmanuel College, Cambridge, during the tenure of which this paper was written. JL and JW are employees of Laragen, Inc., and contributed reagents for the study. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 1996, FEBS LETT, V390, P161, DOI 10.1016/0014-5793(96)00651-5; Andresen JM, 2007, ANN HUM GENET, V71, P295, DOI 10.1111/j.1469-1809.2006.00335.x; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Baldi P, 1999, BIOINFORMATICS, V15, P918, DOI 10.1093/bioinformatics/15.11.918; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bochtler M, 2006, EMBO J, V25, P2219, DOI 10.1038/sj.emboj.7601096; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chastain PD, 1998, J MOL BIOL, V275, P405, DOI 10.1006/jmbi.1997.1502; Crampton N, 2007, EMBO J, V26, P3815, DOI 10.1038/sj.emboj.7601807; Dixon KT, 2003, GENE EXPRESSION, V11, P221, DOI 10.3727/000000003783992234; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Janscak P, 1999, EMBO J, V18, P2638, DOI 10.1093/emboj/18.9.2638; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; Kienberger F, 2005, J MOL BIOL, V347, P597, DOI 10.1016/j.jmb.2005.01.042; Kono Y, 1999, INTERNAL MED, V38, P407, DOI 10.2169/internalmedicine.38.407; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Li JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-71; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0; Milunsky JM, 2003, CLIN GENET, V64, P70, DOI 10.1034/j.1399-0004.2003.00108.x; Moncke-Buchner E, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf082; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Morton AJ, 2000, J NEUROCYTOL, V29, P679, DOI 10.1023/A:1010887421592; MUTTER GL, 1995, NUCLEIC ACIDS RES, V23, P1411; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P6269, DOI 10.1093/nar/gkp679; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Norremolle A, 2004, AM J MED GENET A, V130A, P154, DOI 10.1002/ajmg.a.30128; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Poirier J, 1999, HUM MUTAT, V13, P328, DOI 10.1002/(SICI)1098-1004(1999)13:4<328::AID-HUMU10>3.0.CO;2-J; Potaman VN, 2004, NUCLEIC ACIDS RES, V32, P1224, DOI 10.1093/nar/gkh274; Reddy YVR, 2000, J MOL BIOL, V298, P597, DOI 10.1006/jmbi.2000.3673; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Sinden RR, 2002, J BIOSCIENCES, V27, P53, DOI 10.1007/BF02703683; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; Wang YH, 2007, FRONT BIOSCI-LANDMRK, V12, P4731, DOI 10.2741/2422; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056	52	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17119	10.1371/journal.pone.0017119	http://dx.doi.org/10.1371/journal.pone.0017119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347256	gold, Green Submitted, Green Published			2022-12-25	WOS:000287364500030
J	Ragert, P; Nierhaus, T; Cohen, LG; Villringer, A				Ragert, Patrick; Nierhaus, Till; Cohen, Leonardo G.; Villringer, Arno			Interhemispheric Interactions between the Human Primary Somatosensory Cortices	PLOS ONE			English	Article							POSTERIOR CORPUS-CALLOSUM; MOTOR CORTEX; MEDIAN NERVE; CONNECTIONS; STIMULATION; INFORMATION; MODULATION; PLASTICITY; FIELDS; INPUT	In the somatosensory domain it is still unclear at which processing stage information reaches the opposite hemispheres. Due to dense transcallosal connections, the secondary somatosensory cortex (S2) has been proposed to be the key candidate for interhemispheric information transfer. However, recent animal studies showed that the primary somatosensory cortex (S1) might as well account for interhemispheric information transfer. Using paired median nerve somatosensory evoked potential recordings in humans we tested the hypothesis that interhemispheric inhibitory interactions in the somatosensory system occur already in an early cortical processing stage such as S1. Conditioning right S1 by electrical median nerve (MN) stimulation of the left MN (CS) resulted in a significant reduction of the N20 response in the target (left) S1 relative to a test stimulus (TS) to the right MN alone when the interstimulus interval between CS and TS was between 20 and 25 ms. No such changes were observed for later cortical components such as the N20/P25, N30, P40 and N60 amplitude. Additionally, the subcortically generated P14 response in left S1 was also not affected. These results document the existence of interhemispheric inhibitory interactions between S1 in human subjects in the critical time interval of 20-25 ms after median nerve stimulation.	[Ragert, Patrick; Nierhaus, Till; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Cohen, Leonardo G.] NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA; [Nierhaus, Till; Villringer, Arno] Charite, Dept Neurol, Berlin, Germany; [Villringer, Arno] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany	Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Ragert, P (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	ragert@cbs.mpg.de	Nierhaus, Till/ABG-8386-2020	Nierhaus, Till/0000-0003-0906-592X; Villringer, Arno/0000-0003-2604-2404	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002978, ZIANS003030] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; Blankenburg F, 2008, J NEUROSCI, V28, P13202, DOI 10.1523/JNEUROSCI.3043-08.2008; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003; Fabri M, 2001, J COGNITIVE NEUROSCI, V13, P1071, DOI 10.1162/089892901753294365; Frot M, 1999, CEREB CORTEX, V9, P854, DOI 10.1093/cercor/9.8.854; GOLDRING S, 1970, ELECTROEN CLIN NEURO, V29, P537, DOI 10.1016/0013-4694(70)90096-9; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Hoechstetter K, 2001, NEUROIMAGE, V14, P759, DOI 10.1006/nimg.2001.0855; Iwamura Y, 2001, NEUROSCIENTIST, V7, P419, DOI 10.1177/107385840100700511; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; JONES EG, 1980, NEUROSCI LETT, V19, P167, DOI 10.1016/0304-3940(80)90189-5; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; Lee EK, 1998, J CLIN NEUROPHYSIOL, V15, P227, DOI 10.1097/00004691-199805000-00006; Lewis GN, 2007, CLIN NEUROPHYSIOL, V118, P2656, DOI 10.1016/j.clinph.2007.08.027; MANZONI T, 1989, EXP BRAIN RES, V76, P251; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PICARD N, 1990, BRAIN RES, V536, P97, DOI 10.1016/0006-8993(90)90013-2; PIDOUX B, 1979, ELECTROEN CLIN NEURO, V46, P715, DOI 10.1016/0013-4694(79)90111-1; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Sonoo M, 1996, EVOKED POTENTIAL, V100, P319, DOI 10.1016/0168-5597(96)95035-2; Staines WR, 2002, NEUROIMAGE, V15, P190, DOI 10.1006/nimg.2001.0953; Stancak A, 2002, BRAIN RES, V936, P47, DOI 10.1016/S0006-8993(02)02502-7; Voller B, 2006, ANN NEUROL, V59, P385, DOI 10.1002/ana.20689; Werhahn KJ, 2002, NAT NEUROSCI, V5, P936, DOI 10.1038/nn917; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954	29	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16150	10.1371/journal.pone.0016150	http://dx.doi.org/10.1371/journal.pone.0016150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347308	Green Published, gold			2022-12-25	WOS:000287363000006
J	Arun, P; Aleti, V; Parikh, K; Manne, V; Chilukuri, N				Arun, Peethambaran; Aleti, Vineela; Parikh, Kalpana; Manne, Veeraswamy; Chilukuri, Nageswararao			Senescence Marker Protein 30 (SMP30) Expression in Eukaryotic Cells: Existence of Multiple Species and Membrane Localization	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; DIISOPROPYL PHOSPHOROFLUORIDATE; ENDOGENOUS REGUCALCIN; SOLUBLE FRACTION; RAT; LIVER; KINASE; MICE; PURIFICATION; DEFICIENCY	Senescence marker protein (SMP30), also known as regucalcin, is a 34 kDa cytosolic marker protein of aging which plays an important role in intracellular Ca2+ homeostasis, ascorbic acid biosynthesis, oxidative stress, and detoxification of chemical warfare nerve agents. In our goal to investigate the activity of SMP30 for the detoxification of nerve agents, we have produced a recombinant adenovirus expressing human SMP30 as a fusion protein with a hemaglutinin tag (Ad-SMP30-HA). Ad-SMP30-HA transduced the expression of SMP30-HA and two additional forms of SMP30 with molecular sizes similar to 28 kDa and 24 kDa in HEK-293A and C3A liver cells in a dose and time-dependent manner. Intravenous administration of Ad-SMP30-HA in mice results in the expression of all the three forms of SMP30 in the liver and diaphragm. LC-MS/MS results confirmed that the lower molecular weight 28 kDa and 24 kDa proteins are related to the 34 kDa SMP30. The 28 kDa and 24 kDa SMP30 forms were also detected in normal rat liver and mice injected with Ad-SMP30-HA suggesting that SMP30 does exist in multiple forms under physiological conditions. Time course experiments in both cell lines suggest that the 28 kDa and 24 kDa SMP30 forms are likely generated from the 34 kDa SMP30. Interestingly, the 28 kDa and 24 kDa SMP30 forms appeared initially in the cytosol and shifted to the particulate fraction. Studies using small molecule inhibitors of proteolytic pathways revealed the potential involvement of beta and gamma-secretases but not calpains, lysosomal proteases, proteasome and caspases. This is the first report describing the existence of multiple forms of SMP30, their preferential distribution to membranes and their generation through proteolysis possibly mediated by secretase enzymes.	[Arun, Peethambaran; Aleti, Vineela; Parikh, Kalpana; Manne, Veeraswamy; Chilukuri, Nageswararao] Walter Reed Army Inst Res, Dept Mol Pharmacol, Div Biochem, Silver Spring, MD 20910 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Arun, P (corresponding author), Walter Reed Army Inst Res, Dept Mol Pharmacol, Div Biochem, Silver Spring, MD 20910 USA.	nageswararao.chilukuri@us.army.mil	manne, veeraswamy/B-1954-2010	manne, veeraswamy/0000-0002-1179-5529	Defense Threat Reduction Agency (DTRA) [D0024_07_WR_C]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	The work is supported by funds from Defense Threat Reduction Agency (DTRA, Project # D0024_07_WR_C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter T, 2006, INT J MOL MED, V18, P171; Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4; Boyiri T, 2009, INT J ONCOL, V35, P559, DOI 10.3892/ijo_00000367; Feng DY, 2004, ANN NY ACAD SCI, V1019, P360, DOI 10.1196/annals.1297.062; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U; Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841; Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3; Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5; Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Ishigami A, 2005, CELL TISSUE RES, V320, P243, DOI 10.1007/s00441-004-1073-5; Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091; Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158; Katsumata T, 1998, J CELL BIOCHEM, V71, P569, DOI 10.1002/(SICI)1097-4644(19981215)71:4<569::AID-JCB11>3.0.CO;2-Z; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028; Leparc GG, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm989; LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5; Meyer EL, 2003, J BIOL CHEM, V278, P23786, DOI 10.1074/jbc.M301360200; Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274; Misawa H, 2000, INT J MOL MED, V5, P283; Nakagawa T, 2008, INT J MOL MED, V21, P605; Nakagawa T, 2006, J CELL BIOCHEM, V99, P1064, DOI 10.1002/jcb.20863; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Omura M, 1999, J CELL BIOCHEM, V75, P437, DOI 10.1002/(SICI)1097-4644(19991201)75:3<437::AID-JCB9>3.3.CO;2-N; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A; Somiari RI, 2003, PROTEOMICS, V3, P1863, DOI 10.1002/pmic.200300560; Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3; Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005; Szokalska A, 2009, CANCER RES, V69, P4235, DOI 10.1158/0008-5472.CAN-08-3439; Tsurusaki Y, 2001, BIOL PHARM BULL, V24, P958, DOI 10.1248/bpb.24.958; Tsurusaki Y, 2000, INT J MOL MED, V6, P655; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Wu Y, 2007, J BIOL CHEM, V282, P4841, DOI 10.1074/jbc.M607156200; Yamaguchi M, 2002, INT J MOL MED, V10, P377; Yamaguchi M, 2005, INT J MOL MED, V15, P371; YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915; Yamaguchi M, 2004, INT J MOL MED, V14, P647; Yamaguchi M, 2000, BIOCHEM BIOPH RES CO, V276, P1, DOI 10.1006/bbrc.2000.3359; YAMAGUCHI M, 1981, CHEM PHARM BULL, V29, P567; Yamaguchi M, 2000, LIFE SCI, V66, P1769, DOI 10.1016/S0024-3205(99)00602-5; Yates Jr, 2000, METH MOL B, V146, P17, DOI 10.1385/1-59259-045-4:17	45	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16545	10.1371/journal.pone.0016545	http://dx.doi.org/10.1371/journal.pone.0016545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347421	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700020
J	Hausberger, M; Muller, C; Lunel, C				Hausberger, Martine; Muller, Christine; Lunel, Christophe			Does Work Affect Personality? A Study in Horses	PLOS ONE			English	Article							HEART-RATE; TEMPERAMENT; RESPONSES; TRAITS; STRESS; TESTS	It has been repeatedly hypothesized that job characteristics are related to changes in personality in humans, but often personality models still omit effects of life experience. Demonstrating reciprocal relationships between personality and work remains a challenge though, as in humans, many other influential factors may interfere. This study investigates this relationship by comparing the emotional reactivity of horses that differed only by their type of work. Horses are remarkable animal models to investigate this question as they share with humans working activities and their potential difficulties, such as "interpersonal" conflicts or "suppressed emotions". An earlier study showed that different types of work could be associated with different chronic behavioural disorders. Here, we hypothesised that type of work would affect horses' personality. Therefore over one hundred adult horses, differing only by their work characteristics were presented standardised behavioural tests. Subjects lived under the same conditions (same housing, same food), were of the same sex (geldings), and mostly one of two breeds, and had not been genetically selected for their current type of work. This is to our knowledge the first time that a direct relationship between type of work and personality traits has been investigated. Our results show that horses from different types of work differ not as much in their overall emotional levels as in the ways they express emotions (i.e. behavioural profile). Extremes were dressage horses, which presented the highest excitation components, and voltige horses, which were the quietest. The horses' type of work was decided by the stall managers, mostly on their jumping abilities, but unconscious choice based on individual behavioural characteristics cannot be totally excluded. Further research would require manipulating type of work. Our results nevertheless agree with reports on humans and suggest that more attention should be given to work characteristics when evaluating personalities.	[Hausberger, Martine; Muller, Christine; Lunel, Christophe] Univ Rennes 1, Unite Mixte Rech CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Hausberger, M (corresponding author), Univ Rennes 1, Unite Mixte Rech CNRS, UMR Ethol Anim & Humaine 6552, Campus Beaulieu, Rennes, France.	martine.hausberger@univ-rennes1.fr			French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by the French Ministry of Research (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson MK, 1999, APPL ANIM BEHAV SCI, V63, P11, DOI 10.1016/S0168-1591(98)00237-8; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; CLEMENT F, 1995, CR ACAD SCI III-VIE, V318, P859; Cook WR, 2002, J EQUINE VET SCI, V22, P7, DOI 10.1016/S0737-0806(02)70207-4; Costa PT., 1999, HDB PERSONALITY THEO, V2, P51, DOI DOI 10.1007/978-1-4615-0763-5_; FISKE JC, 1979, J ANIM SCI, V49, P583, DOI 10.2527/jas1979.492583x; Hausberger M, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P33; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; JONES RB, 1989, PSYCHOL REC, V39, P397, DOI 10.1007/BF03395891; KILEYWORTHINGTON M, 1976, BEHAVIOUR, V56, P69, DOI 10.1163/156853976X00307; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; LeScolan N, 1997, BEHAV PROCESS, V41, P257, DOI 10.1016/S0376-6357(97)00052-1; LESIMPLE C, 2010, APPL ANIMAL IN PRESS; Lloyd AS, 2008, APPL ANIM BEHAV SCI, V112, P369, DOI 10.1016/j.applanim.2007.08.010; Lloyd AS, 2007, APPL ANIM BEHAV SCI, V105, P205, DOI 10.1016/j.applanim.2006.05.017; Mann S, 2004, BRIT J GUID COUNS, V32, P205, DOI 10.1080/0369880410001692247; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; Momozawa Y, 2005, APPL ANIM BEHAV SCI, V92, P77, DOI 10.1016/j.applanim.2004.11.006; Morris PH, 2002, PERS INDIV DIFFER, V33, P67, DOI 10.1016/S0191-8869(01)00136-2; O'Brien A, 2008, ANXIETY STRESS COPIN, V21, P55, DOI 10.1080/10615800701529504; Roberts BW, 2000, J RES PERS, V34, P26, DOI 10.1006/jrpe.1999.2259; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; Seaman SC, 2002, APPL ANIM BEHAV SCI, V78, P175, DOI 10.1016/S0168-1591(02)00095-3; Visser EK, 2003, EQUINE VET J, V35, P176, DOI 10.2746/042516403776114108; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; WARING GH, 1983, NOYES PUBL; Wolff A, 1997, BEHAV PROCESS, V40, P209, DOI 10.1016/S0376-6357(97)00784-5	32	29	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14659	10.1371/journal.pone.0014659	http://dx.doi.org/10.1371/journal.pone.0014659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347405	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700002
J	Chen, YL; Li, X; Ye, QQ; Tian, J; Jing, RM; Xie, ZJ				Chen, Yiliang; Li, Xin; Ye, Qiqi; Tian, Jiang; Jing, Runming; Xie, Zijian			Regulation of alpha 1 Na/K-ATPase Expression by Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK TYPE-C; NA+/K+-ATPASE; SIGNAL-TRANSDUCTION; MEMBRANE TRAFFICKING; CARDIAC MYOCYTES; PROTEIN-KINASES; PLASMA-MEMBRANE; CELL-GROWTH; ANNEXIN-II; NA,K-ATPASE	We have reported that alpha 1 Na/K-ATPase regulates the trafficking of caveolin-1 and consequently alters cholesterol distribution in the plasma membrane. Here, we report the reciprocal regulation of alpha 1 Na/K-ATPase by cholesterol. Acute exposure of LLC-PK1 cells to methyl beta-cyclodextrin led to parallel decreases in cellular cholesterol and the expression of alpha 1 Na/K-ATPase. Cholesterol repletion fully reversed the effect of methyl beta-cyclodextrin. Moreover, inhibition of intracellular cholesterol trafficking to the plasma membrane by compound U18666A had the same effect on alpha 1 Na/K-ATPase. Similarly, the expression of alpha 1, but not alpha 2 and alpha 3, Na/K-ATPase was significantly reduced in the target organs of Niemann-Pick type C mice where the intracellular cholesterol trafficking is blocked. Mechanistically, decreases in the plasma membrane cholesterol activated Src kinase and stimulated the endocytosis and degradation of alpha 1 Na/K-ATPase through Src- and ubiquitination-dependent pathways. Thus, the new findings, taken together with what we have already reported, revealed a previously unrecognized feed-forward mechanism by which cells can utilize the Src-dependent interplay among Na/K-ATPase, caveolin-1, and cholesterol to effectively alter the structure and function of the plasma membrane.	[Xie, Zijian] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43614 USA; [Li, Xin; Jing, Runming] Huazhong Univ Sci & Technol, Dept Pediat, Union Hosp, Wuhan 430074, Hubei, Peoples R China	University System of Ohio; University of Toledo; Huazhong University of Science & Technology	Xie, ZJ (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Coll Med, 3000 Arlington Ave, Toledo, OH 43614 USA.	zi-jian.xie@utoledo.edu		Chen, Yiliang/0000-0001-9786-8305	National Institutes of Health [HL-36573, GM 78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 and GM 78565.	Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; CHEN M, 1995, BBA-MOL BASIS DIS, V1272, P101, DOI 10.1016/0925-4439(95)00073-D; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Dada LA, 2007, CELL SIGNAL, V19, P1893, DOI 10.1016/j.cellsig.2007.04.013; DELUISE M, 1980, NEW ENGL J MED, V303, P1017, DOI 10.1056/NEJM198010303031801; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Garver WS, 2007, J CELL BIOCHEM, V101, P498, DOI 10.1002/jcb.21200; Garver WS, 1999, BBA-MOL BASIS DIS, V1453, P193, DOI 10.1016/S0925-4439(98)00101-X; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hailstones D, 1998, J LIPID RES, V39, P369; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Lange Y, 2002, J LIPID RES, V43, P198; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lange Y, 1999, J LIPID RES, V40, P2264; Lecuona E, 2009, AM J RESP CELL MOL, V41, P671, DOI 10.1165/rcmb.2008-0365OC; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Xie ZJ, 1999, J BIOL CHEM, V274, P19323, DOI 10.1074/jbc.274.27.19323; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Zhang M, 2009, BIOSCIENCE REP, V29, P193, DOI 10.1042/BSR20090032	43	34	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15517	15524		10.1074/jbc.M110.204396	http://dx.doi.org/10.1074/jbc.M110.204396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21362623	hybrid, Green Published			2022-12-25	WOS:000289788300079
J	Koehler, C; Carlier, L; Veggi, D; Balducci, E; Di Marcello, F; Ferrer-Navarro, M; Pizza, M; Daura, X; Soriani, M; Boelens, R; Bonvin, AMJJ				Koehler, Christian; Carlier, Ludovic; Veggi, Daniele; Balducci, Enrico; Di Marcello, Federica; Ferrer-Navarro, Mario; Pizza, Mariagrazia; Daura, Xavier; Soriani, Marco; Boelens, Rolf; Bonvin, Alexandre M. J. J.			Structural and Biochemical Characterization of NarE, an Iron-containing ADP-ribosyltransferase from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS TOXIN; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; BINDING SITE; RIBOSYLATION; SEQUENCE; HADDOCK; C-13	NarE is a 16 kDa protein identified from Neisseria meningitidis, one of the bacterial pathogens responsible for meningitis. NarE belongs to the family of ADP-ribosyltransferases (ADPRT) and catalyzes the transfer of ADP-ribose moieties to arginine residues in target protein acceptors. Many pathogenic bacteria utilize ADP-ribosylating toxins to modify and alter essential functions of eukaryotic cells. NarE is further the first ADPRT which could be shown to bind iron through a Fe-S center, which is crucial for the catalytic activity. Here we present the NMR solution structure of NarE, which shows structural homology to other ADPRTs. Using NMR titration experiments we could identify from Chemical Shift Perturbation data both the NAD binding site, which is in perfect agreement with a consensus sequence analysis between different ADPRTs, as well as the iron coordination site, which consists of 2 cysteines and 2 histidines. This atypical iron coordination is also capable to bind zinc. These results could be fortified by site-directed mutagenesis of the catalytic region, which identified two functionally crucial residues. We could further identify a main interaction region of NarE with antibodies using two complementary methods based on antibody immobilization, proteolytic digestion, and mass spectrometry. This study combines structural and functional features of NarE providing for the first time a characterization of an iron-dependent ADPRT.	[Koehler, Christian; Carlier, Ludovic; Boelens, Rolf; Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Ferrer-Navarro, Mario; Daura, Xavier] Univ Autonoma Barcelona, Inst Biotechnol & Biomed, Bellaterra 08193, Barcelona, Spain; [Veggi, Daniele; Di Marcello, Federica; Pizza, Mariagrazia; Soriani, Marco] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Daura, Xavier] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Balducci, Enrico] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy	Utrecht University; Autonomous University of Barcelona; Novartis; ICREA; University of Camerino	Bonvin, AMJJ (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.m.j.j.bonvin@uu.nl	Daura, Xavier/C-9275-2009; Bonvin, Alexandre M.J.J./A-5420-2009; Boelens, Rolf/B-4702-2009	Daura, Xavier/0000-0001-9235-6730; Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Boelens, Rolf/0000-0002-6939-8913; SORIANI, Marco/0000-0002-9752-5844; Carlier, Ludovic/0000-0002-9036-6561; Balducci, Enrico/0000-0001-6147-9033; Ferrer-Navarro, Mario/0000-0001-9990-914X	European Union [LSHB-CT-2006-037325]; eNMR Project [213010]; National GRID Initiatives of Italy, Germany; The Netherlands; ICREA Funding Source: Custom	European Union(European Commission); eNMR Project; National GRID Initiatives of Italy, Germany; The Netherlands(Netherlands Government); ICREA(ICREA)	This project was supported by funding under the Sixth Research Framework Programme of the European Union (Ref. LSHB-CT-2006-037325, BacAbs). The eNMR Project (European FP7 e-Infrastructure Grant, Contract no. 213010), supported by the National GRID Initiatives of Italy, Germany, and The Netherlands.	Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bonvin Alexandre M. J. J., 2010, Journal of Structural and Functional Genomics, V11, P1, DOI 10.1007/s10969-010-9084-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlier L, 2011, BIOMOL NMR ASSIGN, V5, P35, DOI 10.1007/s12104-010-9261-6; CLORE GM, 1991, PROG NUCL MAG RES SP, V23, P43, DOI 10.1016/0079-6565(91)80002-J; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Del Vecchio M, 2009, J BIOL CHEM, V284, P33040, DOI 10.1074/jbc.M109.057547; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Genco CA, 2010, NEISSERIA: MOLECULAR MECHANISMS OF PATHOGENESIS, P1; Goddard T.D., SPARKY 3; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; GUENTERT P, 2004, AUTOMATED NMR PROTEI, P353; Hazes B, 1996, J MOL BIOL, V258, P661, DOI 10.1006/jmbi.1996.0277; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jobling MG, 2001, J BACTERIOL, V183, P4024, DOI 10.1128/JB.183.13.4024-4032.2001; Kato-Murayama M, 2005, J MOL BIOL, V348, P295, DOI 10.1016/j.jmb.2005.02.049; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; Masignani V, 2003, MOL MICROBIOL, V50, P1055, DOI 10.1046/j.1365-2958.2003.03770.x; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Peter JF, 2001, ANAL CHEM, V73, P4012, DOI 10.1021/ac010258n; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Soriani M, 2010, J BIOL CHEM, V285, P30126, DOI 10.1074/jbc.M110.118513; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; XU YR, 1994, J BIOL CHEM, V269, P9993	39	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14842	14851		10.1074/jbc.M110.193623	http://dx.doi.org/10.1074/jbc.M110.193623			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367854	Green Published, hybrid			2022-12-25	WOS:000289788300014
J	McNulty, DE; Li, ZG; White, CD; Sacks, DB; Annan, RS				McNulty, Dean E.; Li, Zhigang; White, Colin D.; Sacks, David B.; Annan, Roland S.			MAPK Scaffold IQGAP1 Binds the EGF Receptor and Modulates Its Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE-C; PHOSPHORYLATION-DEPENDENT MANNER; ACTIN-BINDING; INTEGRATES CA2+/CALMODULIN; CELL-PROLIFERATION; SMALL GTPASES; B-RAF; CALMODULIN; CDC42	Cellular responses produced by EGF are mediated through the receptor (EGFR) and by various enzymes and scaffolds. Recent studies document IQGAP1 as a scaffold for the MAPK cascade, binding directly to B-Raf, MEK, and ERK and regulating their activation in response to EGF. We previously showed that EGF is unable to activate B-Raf in cells lacking IQGAP1. However, the mechanism by which IQGAP1 links B-Raf to EGFR was unknown. Here we report that endogenous EGFR and IQGAP1 co-localize and co-immunoprecipitate in cells. EGF has no effect on the association, but Ca2+ attenuates binding. In vitro analysis demonstrated a direct association mediated through the IQ and kinase domains of IQGAP1 and EGFR, respectively. Calmodulin disrupts this interaction. Using a mass spectrometry-based assay, we show that EGF induces phosphorylation of IQGAP1 Ser(1443), a residue known to be phosphorylated by PKC. This phosphorylation is eliminated by pharmacological inhibition of either EGFR or PKC and transfection with small interfering RNA directed against the PKC alpha isoform. In IQGAP1-null cells, EGF-stimulated tyrosine phosphorylation of EGFR is severely attenuated. Normal levels of autophosphorylation are restored by reconstituting wild type IQGAP1 and enhanced by an IQGAP1 S1443D mutant. Collectively, these data demonstrate a functional interaction between IQGAP1 and EGFR and suggest that IQGAP1 modulates EGFR activation.	[McNulty, Dean E.; Annan, Roland S.] GlaxoSmithKline Inc, Prote & Biol Mass Spectrometry Lab, Collegeville, PA 19426 USA; [McNulty, Dean E.] UMDNJ Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Li, Zhigang; White, Colin D.; Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Li, Zhigang; White, Colin D.; Sacks, David B.] Harvard Univ, Sch Med, Boston, MA 02115 USA	GlaxoSmithKline; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), NIH, DLM, 10 Ctr Dr,Bldg 10,Rm 2C427, Bethesda, MD 20892 USA.	sacksdb@mail.nih.gov; roland.s.annan@gsk.com		Sacks, David/0000-0003-3100-0735	National Institutes of Health [RO1-CA93645]; Department of Defense [BC087504 (FY08)]; NATIONAL CANCER INSTITUTE [R01CA093645] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported, in whole or in part, by a grant from the National Institutes of Health Grant RO1-CA93645 (to D.B.S.). This work was also supported by the Department of Defense Breast Cancer Research Program Grant BC087504 (FY08) (to C.D.W.).	Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brown MD, 2008, J BIOL CHEM, V283, P35212, DOI 10.1074/jbc.M803477200; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chen P, 1996, MOL BIOL CELL, V7, P871, DOI 10.1091/mbc.7.6.871; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hubbard SR, 2009, CELL, V137, P1181, DOI 10.1016/j.cell.2009.06.008; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; Lombardo CR, 1995, BIOCHEMISTRY-US, V34, P16456, DOI 10.1021/bi00050a029; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; LUND KA, 1990, J BIOL CHEM, V265, P20517; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison P, 1996, J BIOL CHEM, V271, P12891, DOI 10.1074/jbc.271.22.12891; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; SATO KI, 1995, BIOCHEM BIOPH RES CO, V215, P1078, DOI 10.1006/bbrc.1995.2574; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Utz I, 1996, ANTICANCER RES, V16, P289; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Wang YP, 2008, INT J MOL MED, V22, P79; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278	61	62	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15010	15021		10.1074/jbc.M111.227694	http://dx.doi.org/10.1074/jbc.M111.227694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21349850	Green Published, hybrid			2022-12-25	WOS:000289788300031
J	Cabrera, JR; Bouzas-Rodriguez, J; Tauszig-Delamasure, S; Mehlen, P				Cabrera, Jorge R.; Bouzas-Rodriguez, Jimena; Tauszig-Delamasure, Servane; Mehlen, Patrick			RET Modulates Cell Adhesion via Its Cleavage by Caspase in Sympathetic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; NEUROTROPHIC FACTOR; CADHERIN SUPERFAMILY; SURVIVAL FACTOR; GDNF FAMILY; APOPTOSIS; GANGLIA; REVEALS; GROWTH	RET is a tyrosine kinase receptor involved in numerous cellular mechanisms including proliferation, neuronal navigation, migration, and differentiation upon binding with glial cell derived neurotrophic factor family ligands. RET is an atypical tyrosine kinase receptor containing four cadherin domains in its extracellular part. Furthermore, it has been shown to act as a dependence receptor. Such a receptor is active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. However, different data suggest that RET is not always associated with the cell death/survival balance but rather provides positional information. We demonstrate here that caspase cleavage of RET is involved in the regulation of adhesion in sympathetic neurons. The cleavage of RET generates an N-terminal truncated fragment that functions as a cadherin accessory protein, modifying cadherin environment and potentiating cadherin-mediated cell aggregation. Thus, the caspase cleavage of RET generates two RET fragments: one intracellular domain that can trigger cell death in apoptotic permissive settings, and one membrane-anchored ectodomain with cadherin accessory activity. We propose that this latter function may notably be important for the adequate development of the superior cervical ganglion.	[Cabrera, Jorge R.; Bouzas-Rodriguez, Jimena; Tauszig-Delamasure, Servane; Mehlen, Patrick] Univ Lyon, Apoptosis Canc & Dev Lab, Equipe Labellisee La Ligue, Ctr Cancerol Lyon,INSERM U1052,CNRS UMR586,Ctr Le, F-69008 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Mehlen, P (corresponding author), Univ Lyon, Apoptosis Canc & Dev Lab, Equipe Labellisee La Ligue, Ctr Cancerol Lyon,INSERM U1052,CNRS UMR586,Ctr Le, F-69008 Lyon, France.	mehlen@lyon.fnclcc.fr	Tauszig-Delamasure, Servane/G-7192-2017; Tauszig-Delamasure, Servane/AAJ-6493-2020; Cabrera, Jorge Rubén/H-6310-2015	Tauszig-Delamasure, Servane/0000-0003-4926-0199; Tauszig-Delamasure, Servane/0000-0003-4926-0199; Cabrera, Jorge Rubén/0000-0003-4481-0198	CNRS; Centre Leon Berard; Universite de Lyon; Ligue Contre le Cancer; Institut National du Cancer; Agence Nationale de la Recherche blanche; Specific Targeted Research Projects Hermione; Apoptosis Mechanisms in Cancer and AIDS; Fondation pour la Recherche Medicale; Consejo Nacional de Ciencia y Tecnologia	CNRS(Centre National de la Recherche Scientifique (CNRS)); Centre Leon Berard; Universite de Lyon; Ligue Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche blanche(French National Research Agency (ANR)); Specific Targeted Research Projects Hermione; Apoptosis Mechanisms in Cancer and AIDS; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by an institutional grant from CNRS (to P. M.), the Centre Leon Berard (to P. M.), the Universite de Lyon (to P. M.) and from the Ligue Contre le Cancer (to P. M.), Institut National du Cancer (to P. M.), Agence Nationale de la Recherche blanche (to P. M.), Specific Targeted Research Projects Hermione (to P. M.), and Apoptosis Mechanisms in Cancer and AIDS (to P. M.).; Supported by the Fondation pour la Recherche Medicale.; Supported by Consejo Nacional de Ciencia y Tecnologia.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anders J, 2001, J BIOL CHEM, V276, P35808, DOI 10.1074/jbc.M104968200; Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Canibano C, 2007, EMBO J, V26, P2015, DOI 10.1038/sj.emboj.7601636; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Encinas M, 2008, CELL DEATH DIFFER, V15, P1510, DOI 10.1038/cdd.2008.76; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Gould TW, 2008, J NEUROSCI, V28, P2131, DOI 10.1523/JNEUROSCI.5185-07.2008; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Kasemeier-Kulesa JC, 2006, DEVELOPMENT, V133, P4839, DOI 10.1242/dev.02662; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; MCCARTHY KD, 1976, BRAIN RES, V114, P391, DOI 10.1016/0006-8993(76)90962-8; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mille F, 2009, NAT CELL BIOL, V11, P739, DOI 10.1038/ncb1880; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Schalm SS, 2010, P NATL ACAD SCI USA, V107, P13894, DOI 10.1073/pnas.1007182107; TAKAHASHI M, 1993, ONCOGENE, V8, P2925; Takeichi M., 2001, CURR PROTOC CELL BIO, V9; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Tsui CC, 2010, J NEUROSCI, V30, P5149, DOI 10.1523/JNEUROSCI.5246-09.2010; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	33	13	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14628	14638		10.1074/jbc.M110.195461	http://dx.doi.org/10.1074/jbc.M110.195461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357690	Green Published, hybrid			2022-12-25	WOS:000289556200082
J	Liu, YT; Lee, SY; Neely, E; Nandar, W; Moyo, M; Simmons, Z; Connor, JR				Liu, Yiting; Lee, Sang Y.; Neely, Elizabeth; Nandar, Wint; Moyo, Mthabisi; Simmons, Zachary; Connor, James R.			Mutant HFE H63D Protein Is Associated with Prolonged Endoplasmic Reticulum Stress and Increased Neuronal Vulnerability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEMOCHROMATOSIS GENE HFE; PARKINSONS-DISEASE; ER STRESS; TRANSFERRIN RECEPTOR; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; CASPASE-3 ACTIVATION; IRON-METABOLISM; SPORADIC ALS	A specific polymorphism in the hemochromatosis (HFE) gene, H63D, is over-represented in neurodegenerative disorders such as amyotrophic lateral sclerosis and Alzheimer disease. Mutations of HFE are best known as being associated with cellular iron overload, but the mechanism by which HFE H63D might increase the risk of neuron degeneration is unclear. Here, using an inducible expression cell model developed from a human neuronal cell line SH-SY5Y, we reported that the presence of the HFE H63D protein activated the unfolded protein response (UPR). This response was followed by a persistent endoplasmic reticulum (ER) stress, as the signals of UPR sensors attenuated and followed by up-regulation of caspase-3 cleavage and activity. Our in vitro findings were recapitulated in a transgenic mouse model carrying Hfe H67D, the mouse equivalent of the human H63D mutation. In this model, UP R activation was detected in the lumbar spinal cord at 6 months then declined at 12 months in association with increased caspase-3 cleavage. Moreover, upon the prolonged ER stress, the number of cells expressing HFE H63D in early apoptosis was increased moderately. Cell proliferation was decreased without increased cell death. Additionally, despite increased iron level in cells carrying HFE H63D, it appeared that ER stress was not responsive to the change of cellular iron status. Overall, our studies indicate that the HFE H63D mutant protein is associated with prolonged ER stress and chronically increased neuronal vulnerability.	[Liu, Yiting; Lee, Sang Y.; Neely, Elizabeth; Nandar, Wint; Connor, James R.] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Simmons, Zachary] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Moyo, Mthabisi] Ave Maria Univ, Dept Biol, Ave Maria, FL 34142 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Liu, YT (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, H110,500 Univ Dr, Hershey, PA 17033 USA.	yliu2@hmc.psu.edu		Lee, Sang/0000-0003-3911-8316; Moyo, Mthabisi/0000-0002-7321-9834	Paul and Harriett Campbell Fund; Zimmerman Family Love Fund; Judith & Jean Pape Adams Charitable Foundation	Paul and Harriett Campbell Fund; Zimmerman Family Love Fund; Judith & Jean Pape Adams Charitable Foundation	This work was supported by the Paul and Harriett Campbell Fund for ALS Research, the Zimmerman Family Love Fund, and the Judith & Jean Pape Adams Charitable Foundation.	Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Bahram S, 1999, P NATL ACAD SCI USA, V96, P13312, DOI 10.1073/pnas.96.23.13312; Berlin D, 2004, NEUROBIOL AGING, V25, P465, DOI 10.1016/j.neurobiolaging.2003.06.008; Connor JR, 2006, J ALZHEIMERS DIS, V10, P267; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Dekker MCJ, 2003, NEUROSCI LETT, V348, P117, DOI 10.1016/S0304-3940(03)00713-4; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Golub MS, 2005, NUTR NEUROSCI, V8, P239, DOI 10.1080/10284150500277685; Goodall EF, 2005, NEUROLOGY, V65, P934, DOI 10.1212/01.wnl.0000176032.94434.d4; Guerreiro RJ, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-24; HALL EC, 2009, NEUROBIOL AGING; Holmstrom P, 2003, J HEPATOL, V39, P308, DOI 10.1016/S0168-8278(03)00293-9; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; Lee SY, 2007, FASEB J, V21, P564, DOI 10.1096/fj.06-6397com; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; MITCHELL RM, 2009, NEUROBIOL IN PRESS; NANDAR W, 2010, AMYOTROPH LATERAL SC, V11, P54; Oates PS, 1997, AM J PHYSIOL-GASTR L, V273, pG636, DOI 10.1152/ajpgi.1997.273.3.G636; Oliveira SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006618; POWELL L, 2000, IRON METABOLISM HLTH; Price DL, 1999, NATURE, V399, pA3, DOI 10.1038/399a003; Restagno G, 2007, J NEUROL NEUROSUR PS, V78, P327, DOI 10.1136/jnnp.2006.092338; Ristic S, 2005, NEUROSCI LETT, V383, P301, DOI 10.1016/j.neulet.2005.04.045; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Sutedja NA, 2007, ARCH NEUROL-CHICAGO, V64, P63, DOI 10.1001/archneur.64.1.63; Tomatsu S, 2003, P NATL ACAD SCI USA, V100, P15788, DOI 10.1073/pnas.2237037100; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; WANG XM, 2004, J NEUROL SCI, V227, pU1511; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yen AA, 2004, NEUROLOGY, V62, P1611, DOI 10.1212/01.WNL.0000123114.04644.CC; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445	46	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13161	13170		10.1074/jbc.M110.170944	http://dx.doi.org/10.1074/jbc.M110.170944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349849	Green Published, hybrid			2022-12-25	WOS:000289282200037
J	Campa, D; Husing, A; Stein, A; Dostal, L; Boeing, H; Pischon, T; Tjonneland, A; Roswall, N; Overvad, K; Ostergaard, JN; Rodriguez, L; Sala, N; Sanchez, MJ; Larranaga, N; Huerta, JM; Barricarte, A; Khaw, KT; Wareham, N; Travis, RC; Allen, NE; Lagiou, P; Trichopoulou, A; Trichopoulos, D; Palli, D; Sieri, S; Tumino, R; Sacerdote, C; van Kranen, H; Bueno-de-Mesquita, HB; Hallmans, G; Johansson, M; Romieu, I; Jenab, M; Cox, DG; Siddiq, A; Riboli, E; Canzian, F; Kaaks, R				Campa, Daniele; Huesing, Anika; Stein, Angelika; Dostal, Lucie; Boeing, Heiner; Pischon, Tobias; Tjonneland, Anne; Roswall, Nina; Overvad, Kim; Ostergaard, Jane Nautrup; Rodriguez, Laudina; Sala, Nuria; Sanchez, Maria-Jose; Larranaga, Nerea; Maria Huerta, Jose; Barricarte, Aurelio; Khaw, Kay-Tee; Wareham, Nicholas; Travis, Ruth C.; Allen, Naomi E.; Lagiou, Pagona; Trichopoulou, Antonia; Trichopoulos, Dimitrios; Palli, Domenico; Sieri, Sabina; Tumino, Rosario; Sacerdote, Carlotta; van Kranen, Henk; Bueno-de-Mesquita, H. Bas; Hallmans, Goran; Johansson, Mattias; Romieu, Isabelle; Jenab, Mazda; Cox, David G.; Siddiq, Afshan; Riboli, Elio; Canzian, Federico; Kaaks, Rudolf			Genetic Variability of the mTOR Pathway and Prostate Cancer Risk in the European Prospective Investigation on Cancer (EPIC)	PLOS ONE			English	Article							KINASE-C-IOTA; TUBEROUS SCLEROSIS; CELL-GROWTH; PKC-IOTA; MAMMALIAN TARGET; PROTEIN; RAPAMYCIN; COMPLEX; LAMBDA/IOTA; EXPRESSION	The mTOR (mammalian target of rapamycin) signal transduction pathway integrates various signals, regulating ribosome biogenesis and protein synthesis as a function of available energy and amino acids, and assuring an appropriate coupling of cellular proliferation with increases in cell size. In addition, recent evidence has pointed to an interplay between the mTOR and p53 pathways. We investigated the genetic variability of 67 key genes in the mTOR pathway and in genes of the p53 pathway which interact with mTOR. We tested the association of 1,084 tagging SNPs with prostate cancer risk in a study of 815 prostate cancer cases and 1,266 controls nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). We chose the SNPs (n = 11) with the strongest association with risk (p<0.01) and sought to replicate their association in an additional series of 838 prostate cancer cases and 943 controls from EPIC. In the joint analysis of first and second phase two SNPs of the PRKCI gene showed an association with risk of prostate cancer (ORallele = 0.85, 95% CI 0.78-0.94, p = 1.3 x 10(-3) for rs546950 and ORallele = 0.84, 95% CI 0.76-0.93, p = 5.6 x 10(-4) for rs4955720). We confirmed this in a meta-analysis using as replication set the data from the second phase of our study jointly with the first phase of the Cancer Genetic Markers of Susceptibility (CGEMS) project. In conclusion, we found an association with prostate cancer risk for two SNPs belonging to PRKCI, a gene which is frequently overexpressed in various neoplasms, including prostate cancer.	[Campa, Daniele; Huesing, Anika; Stein, Angelika; Dostal, Lucie; Canzian, Federico; Kaaks, Rudolf] German Canc Res Ctr, Heidelberg, Germany; [Boeing, Heiner; Pischon, Tobias] Deutsch Inst Ernahrungsforsch, Dept Epidemiol, Potsdam, Germany; [Tjonneland, Anne; Roswall, Nina] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Overvad, Kim; Ostergaard, Jane Nautrup] Aarhus Univ Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg Hosp, Aalborg, Denmark; [Overvad, Kim; Ostergaard, Jane Nautrup] Aarhus Univ, Dept Epidemiol, Sch Publ Hlth, DK-8000 Aarhus C, Denmark; [Rodriguez, Laudina] Hlth & Hlth Care Serv Council, Publ Hlth & Participat Directorate, Asturias, Spain; [Sala, Nuria] ICO IDIBELL, Barcelona, Spain; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez, Maria-Jose; Larranaga, Nerea; Maria Huerta, Jose; Barricarte, Aurelio] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Larranaga, Nerea] Basque Govt, Publ Hlth Dept Gipuzkoa, Gipuzkoa, Spain; [Maria Huerta, Jose] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Cambridge, England; [Wareham, Nicholas] MRC Epidemiol Unit, Cambridge, England; [Travis, Ruth C.; Allen, Naomi E.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Lagiou, Pagona; Trichopoulou, Antonia] Univ Athens, Sch Med, WHO Collaborating Ctr Food & Nutr Policies, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Lagiou, Pagona; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Sieri, Sabina] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Histopathol Unit, Ragusa, Italy; [Sacerdote, Carlotta] Ctr Canc Prevent CPO Piemonte, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn HuGeF, Turin, Italy; [van Kranen, Henk; Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, Ctr Nutr & Hlth CVG, Bilthoven, Netherlands; [Hallmans, Goran; Johansson, Mattias] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Johansson, Mattias; Romieu, Isabelle; Jenab, Mazda] Int Agcy Res Canc, F-69372 Lyon, France; [Cox, David G.; Siddiq, Afshan; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, London, England; [Cox, David G.] Ctr Leon Berard, INSERM, F-69373 Lyon, France	Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Danish Cancer Society; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Basque Government; Murcia Regional Health Council; Public Health Institute of Navarra; University of Cambridge; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Netherlands National Institute for Public Health & the Environment; Umea University; World Health Organization; International Agency for Research on Cancer (IARC); Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Campa, D (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	r.kaaks@dkfz.de	Sánchez, Maria-José/D-1087-2011; Roswall, Nina/AAJ-6700-2020; Hüsing, Anika/U-1296-2019; Huerta, José María/N-8654-2015; Johansson, Mattias/ABF-3365-2020; Khaw, Kay-Tee/AAZ-3209-2021; Pischon, Tobias/HGE-8577-2022; Cox, David G/A-2023-2009; Sieri, Sabina/K-4667-2016; Cox, David/ABA-7454-2020; Canzian, Federico/I-2804-2014; Campa, Daniele/K-1617-2016; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Sala, Nuria/G-8471-2015	Sánchez, Maria-José/0000-0003-4817-0757; Roswall, Nina/0000-0003-3071-1658; Huerta, José María/0000-0002-9637-3869; Pischon, Tobias/0000-0003-1568-767X; Cox, David G/0000-0002-2152-9259; Sieri, Sabina/0000-0001-5201-172X; Campa, Daniele/0000-0003-3220-9944; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Riboli, Elio/0000-0001-6795-6080; Johansson, Mattias/0000-0002-3116-5081; Siddiq, Afshan/0000-0002-9110-1434; Canzian, Federico/0000-0002-4261-4583; Sacerdote, Carlotta/0000-0002-8008-5096; Tjonneland, Anne/0000-0003-4385-2097; Sala, Nuria/0000-0003-3585-7613; PALLI, Domenico/0000-0002-5558-2437; Cox, David/0000-0003-2047-4687; Jenab, Mazda/0000-0002-0573-1852; Ostergaard, Jane Nautrup/0000-0002-0627-1237; tumino, rosario/0000-0003-2666-414X; Husing, Anika/0000-0002-2685-9732; Overvad, Kim/0000-0001-6429-7921; Larranaga, Nerea/0000-0002-9993-9880	US Army Medical Research and Material Command [W81XWH-05-1-0156]; European Commission (SANCO); Ligue contre le Cancer (France); Societe 3M (France); Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM); German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Spanish Ministry of Health; Cancer Research UK; Medical Research Council, UK; Hellenic Ministry of Health and Social Solidarity; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer; Italian National Research Council; Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF) (The Netherlands); Statistics Netherlands; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society; Medical Research Council [G1000143, MC_U106179471, G0401527] Funding Source: researchfish	US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Ligue contre le Cancer (France); Societe 3M (France)(3M); Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); German Cancer Aid(Deutsche Krebshilfe); German Cancer Research Center; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Cancer Research UK(Cancer Research UK); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hellenic Ministry of Health and Social Solidarity; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF) (The Netherlands)(Netherlands GovernmentWorld Cancer Research Fund International (WCRF)); Statistics Netherlands; Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society(Norwegian Cancer Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Specific results of this study were obtained with financial support from the US Army Medical Research and Material Command (W81XWH-05-1-0156). http://cdmrp.army.mil/pcrp/default.shtml. The EPIC study was funded by "Europe Against Cancer" Programme of the European Commission (SANCO); Ligue contre le Cancer (France); Societe 3M (France); Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM); German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health; the participating regional governments and institutions of Spain; Cancer Research UK; Medical Research Council, UK; Hellenic Ministry of Health and Social Solidarity; the Stavros Niarchos Foundation and the Hellenic Health Foundation; Italian Association for Research on Cancer; Italian National Research Council; Dutch Ministry of Public Health, Welfare and Sports (VWS), Dutch Ministry of Health, Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) (The Netherlands); Statistics Netherlands; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto K, 1998, BIOCHEM J, V335, P417, DOI 10.1042/bj3350417; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DIAZMECO MT, 1993, MOL CELL BIOL, V13, P4770, DOI 10.1128/MCB.13.8.4770; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gomez-Martin C, 2005, CLIN LUNG CANCER, V7, pS13, DOI 10.3816/CLC.2005.s.003; Gustafson WC, 2004, J BIOL CHEM, V279, P9400, DOI 10.1074/jbc.M312840200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hudes Gary R, 2007, Clin Adv Hematol Oncol, V5, P772; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Jaeschke A, 2003, CURR TOP MICROBIOL, V279, P283; Jin X, 2007, BIOCHEM BIOPH RES CO, V364, P476, DOI 10.1016/j.bbrc.2007.10.042; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kojima Y, 2008, HUM PATHOL, V39, P824, DOI 10.1016/j.humpath.2007.11.001; Koren R, 2004, ONCOL REP, V11, P321; KOUTROS S, 2003, CANCER RES, V70, P2389; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Q, 2008, HEPATOB PANCREAT DIS, V7, P70; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; LODA M, CANC CELL, V17, P311; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; MEHTA MS, BREAST CANC RES TREA; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Nupponen NN, 1998, CANCER GENET CYTOGEN, V101, P53, DOI 10.1016/S0165-4608(97)00060-5; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rubio-Viqueira B, 2006, CURR OPIN INVEST DR, V7, P501; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Saleem M, 2005, CANCER RES, V65, P11203, DOI 10.1158/0008-5472.CAN-05-1965; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16914	10.1371/journal.pone.0016914	http://dx.doi.org/10.1371/journal.pone.0016914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373201	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000287657500023
J	Mody, RK; Greene, SA; Gaul, L; Sever, A; Pichette, S; Zambrana, I; Dang, T; Gass, A; Wood, R; Herman, K; Cantwell, LB; Falkenhorst, G; Wannemuehler, K; Hoekstra, RM; McCullum, I; Cone, A; Franklin, L; Austin, J; Delea, K; Behravesh, CB; Sodha, SV; Yee, JC; Emanuel, B; Al-Khaldi, SF; Jefferson, V; Williams, IT; Griffin, PM; Swerdlow, DL				Mody, Rajal K.; Greene, Sharon A.; Gaul, Linda; Sever, Adrianne; Pichette, Sarah; Zambrana, Ingrid; Dang, Thi; Gass, Angie; Wood, Rene; Herman, Karen; Cantwell, Laura B.; Falkenhorst, Gerhard; Wannemuehler, Kathleen; Hoekstra, Robert M.; McCullum, Isaac; Cone, Amy; Franklin, Lou; Austin, Jana; Delea, Kristin; Behravesh, Casey Barton; Sodha, Samir V.; Yee, J. Christopher; Emanuel, Brian; Al-Khaldi, Sufian F.; Jefferson, Val; Williams, Ian T.; Griffin, Patricia M.; Swerdlow, David L.			National Outbreak of Salmonella Serotype Saintpaul Infections: Importance of Texas Restaurant Investigations in Implicating Jalapeno Peppers	PLOS ONE			English	Article							INTERNATIONAL OUTBREAK; FRESH PRODUCE; MULTISTATE OUTBREAK; UNITED-STATES; CONSUMPTION; TOMATOES; GROWTH	Background: In May 2008, PulseNet detected a multistate outbreak of Salmonella enterica serotype Saintpaul infections. Initial investigations identified an epidemiologic association between illness and consumption of raw tomatoes, yet cases continued. In mid-June, we investigated two clusters of outbreak strain infections in Texas among patrons of Restaurant A and two establishments of Restaurant Chain B to determine the outbreak's source. Methodology/Principal Findings: We conducted independent case-control studies of Restaurant A and B patrons. Patients were matched to well controls by meal date. We conducted restaurant environmental investigations and traced the origin of implicated products. Forty-seven case-patients and 40 controls were enrolled in the Restaurant A study. Thirty case-patients and 31 controls were enrolled in the Restaurant Chain B study. In both studies, illness was independently associated with only one menu item, fresh salsa (Restaurant A: matched odds ratio [mOR], 37; 95% confidence interval [CI], 7.2-386; Restaurant B: mOR, 13; 95% CI 1.3-infinity). The only ingredient in common between the two salsas was raw jalapeno peppers. Cultures of jalapeno peppers collected from an importer that supplied Restaurant Chain B and serrano peppers and irrigation water from a Mexican farm that supplied that importer with jalapeno and serrano peppers grew the outbreak strain. Conclusions/Significance: Jalapeno peppers, contaminated before arrival at the restaurants and served in uncooked fresh salsas, were the source of these infections. Our investigations, critical in understanding the broader multistate outbreak, exemplify an effective approach to investigating large foodborne outbreaks. Additional measures are needed to reduce produce contamination.	[Mody, Rajal K.; Sever, Adrianne] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Mody, Rajal K.; Greene, Sharon A.; Herman, Karen; Cantwell, Laura B.; Falkenhorst, Gerhard; Wannemuehler, Kathleen; Hoekstra, Robert M.; McCullum, Isaac; Austin, Jana; Behravesh, Casey Barton; Sodha, Samir V.; Williams, Ian T.; Griffin, Patricia M.; Swerdlow, David L.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Gaul, Linda; Dang, Thi] Texas Dept State Hlth Serv, Austin, TX USA; [Pichette, Sarah; Zambrana, Ingrid; Yee, J. Christopher; Emanuel, Brian; Al-Khaldi, Sufian F.; Jefferson, Val] US FDA, Silver Spring, MD USA; [Gass, Angie; Wood, Rene; Cone, Amy; Franklin, Lou] Wichita Falls Wichita Cty Publ Hlth Dist, Wichita Falls, TX USA; [Delea, Kristin] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Texas Department of State Health Services; US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Mody, RK (corresponding author), Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	rmody@cdc.gov	BARTON BEHRAVESH, Casey/HDL-8040-2022	BARTON BEHRAVESH, Casey/0000-0003-2270-5573; Hoekstra, Robert Michael/0000-0002-0340-8015; Wannemuehler, Kathleen/0000-0001-9535-6277; Greene, Sharon/0000-0002-4037-7908	core government	core government	This work was supported by core government funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews W.A., 2007, BACTERIOLOGICAL ANAL; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P325; Beuchat LR, 1997, EMERG INFECT DIS, V3, P459, DOI 10.3201/eid0304.970407; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1045; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P929; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; Isaacs S, 2005, J FOOD PROTECT, V68, P191, DOI 10.4315/0362-028X-68.1.191; Long S M, 2002, Commun Dis Public Health, V5, P101; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Ma L, 2010, J FOOD PROTECT, V73, P434, DOI 10.4315/0362-028X-73.3.434; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Nutt JD, 2003, BIORESOURCE TECHNOL, V89, P313, DOI 10.1016/S0960-8524(03)00084-1; Pezzoli L, 2008, FOODBORNE PATHOG DIS, V5, P661, DOI 10.1089/fpd.2008.0103; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Sivapalasingam S, 2003, CLIN INFECT DIS, V37, P1585, DOI 10.1086/379710; Tauxe R, 1997, J FOOD PROTECT, V60, P1400, DOI 10.4315/0362-028X-60.11.1400; U.S. Food and Drug Administration, 2009, FOOD COD 2009; U.S. Food and Drug Administration (FDA), 2009, PROGR INF MAN RET FO; US Food and Drug Administration (US FDA), 2008, SALM SAINTP OUTBR	24	52	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16579	10.1371/journal.pone.0016579	http://dx.doi.org/10.1371/journal.pone.0016579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373185	gold, Green Submitted, Green Published			2022-12-25	WOS:000287657500012
J	Micciche, F; Da Riva, L; Fabbi, M; Pilotti, S; Mondellini, P; Ferrini, S; Canevari, S; Pierotti, MA; Bongarzone, I				Micciche, Francesca; Da Riva, Luca; Fabbi, Marina; Pilotti, Silvana; Mondellini, Piera; Ferrini, Silvano; Canevari, Silvana; Pierotti, Marco A.; Bongarzone, Italia			Activated Leukocyte Cell Adhesion Molecule Expression and Shedding in Thyroid Tumors	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; GENE-EXPRESSION; DOWN-REGULATION; CARCINOMA; CANCER; ALCAM; MARKER; ALCAM/CD166; SURVIVAL; PROGRESSION	Activated leukocyte cell adhesion molecule (ALCAM, CD166) is expressed in various tissues, cancers, and cancer-initiating cells. Alterations in expression of ALCAM have been reported in several human tumors, and cell adhesion functions have been proposed to explain its association with cancer. Here we documented high levels of ALCAM expression in human thyroid tumors and cell lines. Through proteomic characterization of ALCAM expression in the human papillary thyroid carcinoma cell line TPC-1, we identified the presence of a full-length membrane-associated isoform in cell lysate and of soluble ALCAM isoforms in conditioned medium. This finding is consistent with proteolytically shed ALCAM ectodomains. Nonspecific agents, such as phorbol myristate acetate (PMA) or ionomycin, provoked increased ectodomain shedding. Epidermal growth factor receptor stimulation also enhanced ALCAM secretion through an ADAM17/TACE-dependent pathway. ADAM17/TACE was expressed in the TPC-1 cell line, and ADAM17/TACE silencing by specific small interfering RNAs reduced ALCAM shedding. In addition, the CGS27023A inhibitor of ADAM17/TACE function reduced ALCAM release in a dose-dependent manner and inhibited cell migration in a wound-healing assay. We also provide evidence for the existence of novel O-glycosylated forms and of a novel 60-kDa soluble form of ALCAM, which is particularly abundant following cell stimulation by PMA. ALCAM expression in papillary and medullary thyroid cancer specimens and in the surrounding non-tumoral component was studied by western blot and immunohistochemistry, with results demonstrating that tumor cells overexpress ALCAM. These findings strongly suggest the possibility that ALCAM may have an important role in thyroid tumor biology.	[Micciche, Francesca; Da Riva, Luca; Mondellini, Piera; Bongarzone, Italia] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Prote Lab, Milan, Italy; [Fabbi, Marina; Ferrini, Silvano] Ist Nazl Ric Canc, Lab Immunol Therapy, I-16132 Genoa, Italy; [Pilotti, Silvana] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Lab Expt Mol Pathol, Milan, Italy; [Canevari, Silvana] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Unit Mol Therapies, Milan, Italy; [Pierotti, Marco A.] Fdn IRCCS Ist Nazl Tumori, Sci Directorate, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS AOU San Martino IST; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Micciche, F (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Prote Lab, Milan, Italy.	italia.bongarzone@istitutotumori.mi.it	Pierotti, Marco Alessandro/AAC-4728-2022; Bongarzone, Italia/B-9544-2017; Fabbi, Marina/I-1290-2012	Pierotti, Marco Alessandro/0000-0002-7431-8332; Bongarzone, Italia/0000-0003-2530-9170; Ferrini, Silvano/0000-0001-7254-2616; Fabbi, Marina/0000-0002-4203-2022	Fondazione Cariplo (Milan, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC) (Milan, Italy); Alleanza Contro il Cancro (ACC)	Fondazione Cariplo (Milan, Italy)(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro (AIRC) (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro (ACC)	This work was supported by grants from Fondazione Cariplo (Milan, Italy), the Associazione Italiana per la Ricerca sul Cancro (AIRC) (Milan, Italy), and Alleanza Contro il Cancro (ACC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi V, 1998, THYROID, V8, P23, DOI 10.1089/thy.1998.8.23; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Corrias MV, 2010, CELL ONCOL, V32, P77, DOI 10.3233/CLO-2009-0494; Davies SR, 2008, ONCOL REP, V19, P555; DeLellis R, 2004, WHO CLASSIFICATION T; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; El Demellawy D, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-5; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Fenton CL, 2001, ANN CLIN LAB SCI, V31, P245; Garcia-Rostan G, 2001, AM J PATHOL, V158, P987, DOI 10.1016/S0002-9440(10)64045-X; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gorla L, 2009, MOL CARCINOGEN, V48, P220, DOI 10.1002/mc.20474; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Jain SJ, 2004, CANCER RES, V64, P3907, DOI 10.1158/0008-5472.CAN-03-3801; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Jezierska A, 2006, MED SCI MONITOR, V12, pBR245; JIN Z, 2010, ONCOGENE; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kim EY, 2009, CLIN ENDOCRINOL, V71, P581, DOI 10.1111/j.1365-2265.2009.03537.x; King JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-266; Kulasingam V, 2009, INT J CANCER, V125, P9, DOI 10.1002/ijc.24292; Landriscina M, 2010, ANTICANCER RES, V30, P473; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Piazza T, 2005, J CELL SCI, V118, P1515, DOI 10.1242/jcs.02280; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Rodriguez-Antona C, 2010, ENDOCR-RELAT CANCER, V17, P7, DOI 10.1677/ERC-08-0304; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Scarpino S, 2007, J PATHOL, V212, P411, DOI 10.1002/path.2183; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; Verma A, 2005, ONCOLOGY-BASEL, V68, P462, DOI 10.1159/000086989; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Wells SA, 2000, WORLD J SURG, V24, P952, DOI 10.1007/s002680010166; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139	42	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17141	10.1371/journal.pone.0017141	http://dx.doi.org/10.1371/journal.pone.0017141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364949	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600032
J	Hao, CY; Wang, LF; Ge, HM; Dong, YC; Zhang, XY				Hao, Chenyang; Wang, Lanfen; Ge, Hongmei; Dong, Yuchen; Zhang, Xueyong			Genetic Diversity and Linkage Disequilibrium in Chinese Bread Wheat (Triticum aestivum L.) Revealed by SSR Markers	PLOS ONE			English	Article							SOYBEAN GLYCINE-MAX; ORYZA-SATIVA L.; POPULATION-STRUCTURE; CORE COLLECTION; MICROSATELLITE MARKERS; MOLECULAR DIVERSITY; MINIMUM NUMBER; DURUM-WHEAT; GERMPLASM; GENOME	Two hundred and fifty bread wheat lines, mainly Chinese mini core accessions, were assayed for polymorphism and linkage disequilibrium (LD) based on 512 whole-genome microsatellite loci representing a mean marker density of 5.1 cM. A total of 6,724 alleles ranging from 1 to 49 per locus were identified in all collections. The mean PIC value was 0.650, ranging from 0 to 0.965. Population structure and principal coordinate analysis revealed that landraces and modern varieties were two relatively independent genetic sub-groups. Landraces had a higher allelic diversity than modern varieties with respect to both genomes and chromosomes in terms of total number of alleles and allelic richness. 3,833 (57.0%) and 2,788 (41.5%) rare alleles with frequencies of <5% were found in the landrace and modern variety gene pools, respectively, indicating greater numbers of rare variants, or likely new alleles, in landraces. Analysis of molecular variance (AMOVA) showed that A genome had the largest genetic differentiation and D genome the lowest. In contrast to genetic diversity, modern varieties displayed a wider average LD decay across the whole genome for locus pairs with r(2)>0.05 (P<0.001) than the landraces. Mean LD decay distance for the landraces at the whole genome level was <5 cM, while a higher LD decay distance of 5-10 cM in modern varieties. LD decay distances were also somewhat different for each of the 21 chromosomes, being higher for most of the chromosomes in modern varieties (<5 similar to 25 cM) compared to landraces (<5 similar to 15 cM), presumably indicating the influences of domestication and breeding. This study facilitates predicting the marker density required to effectively associate genotypes with traits in Chinese wheat genetic resources.	[Hao, Chenyang; Wang, Lanfen; Ge, Hongmei; Dong, Yuchen; Zhang, Xueyong] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Utilizat, Minist Agr,Natl Key Facil Crop Gene Resources & G, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Hao, CY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Utilizat, Minist Agr,Natl Key Facil Crop Gene Resources & G, Beijing, Peoples R China.	xueyongz@caas.net.cn			Chinese Ministry of Science and Technology [2010CB125900, 2004CB117202]; Modern Agricultural Technical System; National Natural Science Foundation of China [30900898]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Modern Agricultural Technical System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Ministry of Science and Technology (2010CB125900, 2004CB117202), Modern Agricultural Technical System, and National Natural Science Foundation of China (30900898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dong Y.C., 2003, J PLANT GENET RESOUR, V4, P1, DOI DOI 10.13430/J.CNKI.JPGR.2003.01.001; Dreisigacker S, 2004, CROP SCI, V44, P381, DOI 10.2135/cropsci2004.0381; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Garris AJ, 2003, GENETICS, V165, P759; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Gupta PK, 2002, THEOR APPL GENET, V105, P413, DOI 10.1007/s00122-002-0865-9; Hamblin MT, 2004, GENETICS, V167, P471, DOI 10.1534/genetics.167.1.471; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hao CY, 2006, MOL BREEDING, V17, P69, DOI 10.1007/s11032-005-2453-6; He Z., 2001, HIST WHEAT BREEDING; HEDRICK PW, 1987, GENETICS, V117, P331; Horvath A, 2009, THEOR APPL GENET, V119, P1523, DOI 10.1007/s00122-009-1153-8; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Payseur BA, 2009, MOL BIOL EVOL, V26, P1369, DOI 10.1093/molbev/msp052; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Roder MS, 1998, GENETICS, V149, P2007; Roder MS, 2002, THEOR APPL GENET, V106, P67, DOI 10.1007/s00122-002-1061-7; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Wang J, 2008, J CEREAL SCI, V48, P836, DOI 10.1016/j.jcs.2008.06.005; Wang RH, 2008, THEOR APPL GENET, V117, P1141, DOI 10.1007/s00122-008-0852-x; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; You GX, 2004, MOL BREEDING, V14, P397, DOI 10.1007/s11032-004-0285-4; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1; Zhang XY, 2002, THEOR APPL GENET, V106, P112, DOI 10.1007/s00122-002-1016-z; ZHANG ZW, PLANT AN GEN 14 C SA; Zhu YL, 2003, GENETICS, V163, P1123; Zhuang QS., 2003, CHINESE WHEAT IMPROV	58	122	131	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17279	10.1371/journal.pone.0017279	http://dx.doi.org/10.1371/journal.pone.0017279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365016	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482800043
J	Wang, G; Chen, G; Zheng, DH; Cheng, GH; Tang, H				Wang, Gang; Chen, Gang; Zheng, Dahai; Cheng, Genhong; Tang, Hong			PLP2 of Mouse Hepatitis Virus A59 (MHV-A59) Targets TBK1 to Negatively Regulate Cellular Type I Interferon Signaling Pathway	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; PAPAIN-LIKE PROTEASE; NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; E3 UBIQUITIN LIGASE; DOUBLE-STRANDED-RNA; IFN-BETA PROMOTER; ANTIVIRAL RESPONSES; INNATE IMMUNITY; SYNDROME CORONAVIRUS	Background: Coronaviruses such as severe acute respiratory syndrome (SARS) coronavirus (SCoV) and mouse hepatitis virus A59 (MHV-A59) have evolved strategies to disable the innate immune system for productive replication and spread of infection. We have previously shown that papain-like protease domain 2 (PLP2), a catalytic domain of the nonstructural protein 3 (nsp3) of MHV-A59, encodes a deubiquitinase (DUB) and inactivates IFN regulatory factor 3 (IRF3) thereby the type I interferon (IFN) response. Principal Findings: Here we provide further evidence that PLP2 may also target TANK-binding kinase-1 (TBK1), the upstream kinase of IRF3 in the IFN signaling pathway. Overexpression experiments showed that PLP2 deubiquitinated TBK1 and reduced its kinase activity, hence inhibited IFN-beta reporter activity. Albeit promiscuous in deubiquitinating cellular proteins, PLP2 inactivated TBK1 and IFN-beta response in TNF receptor associated factor 3 (TRAF3) deficient cells, suggesting that targeting TBK1 would be sufficient for PLP2 to inhibit IRF3 activation. This notion was further supported by in vitro kinase assays, in which prior treatment of TBK1 with PLP2 inhibited its kinase activity to phosphorylate IRF3. Intriguing enough, results of PLP2 overexpression system and MHV-A59 infection system proved that PLP2 formed an inactive complex with TBK1 and IRF3 in the cytoplasm and the presence of PLP2 stabilized the hypo-phosphorylated IRF3-TBK1 complex in a dose-dependent manner. Conclusions: These results suggest that PLP2 not only inactivates TBK1, but also prevents IRF3 nuclear translocation hence inhibits IFN transcription activation. Identification of the conserved DUB activity of PLP2 in suppression of IFN signaling would provide a useful clue to the development of therapeutics against coronaviruses infection.	[Wang, Gang; Chen, Gang; Zheng, Dahai; Tang, Hong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Wang, Gang; Tang, Hong] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100080, Peoples R China; [Wang, Gang] Grad Univ, Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, G (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	tanghong@moon.ibp.ac.cn	Wang, Gang/AEO-7822-2022		Ministry of Science and Technology of China [2007DFC30190, 2009CB522506, 2011CB946104]; Chinese Academy of Sciences [KSCX1-YW-10, 2010-Biols-CAS-0201]; National Natural Science Foundation of China [31030031, 30728006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069120] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by grants from the National Basic Research Program of Ministry of Science and Technology of China (2007DFC30190, 2009CB522506, 2011CB946104) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-10, 2010-Biols-CAS-0201) to H. T. and a grant from National Natural Science Foundation of China (31030031) to H. T. and (30728006) to G. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Bibeau-Poirier A, 2008, CYTOKINE, V43, P359, DOI 10.1016/j.cyto.2008.07.012; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kuo LL, 2003, J VIROL, V77, P4597, DOI 10.1128/JVI.77.8.4597-4608.2003; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lu LL, 2008, J BIOL CHEM, V283, P14269, DOI 10.1074/jbc.M710089200; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Reily MM, 2006, EMBO J, V25, P108, DOI 10.1038/sj.emboj.7600919; Rose KM, 2010, J VIROL, V84, P5656, DOI 10.1128/JVI.00211-10; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tsuchida T, 2009, CELL RES, V19, P3, DOI 10.1038/cr.2009.1; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zheng DH, 2008, CELL RES, V18, P1105, DOI 10.1038/cr.2008.294; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	47	41	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17192	10.1371/journal.pone.0017192	http://dx.doi.org/10.1371/journal.pone.0017192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364999	Green Submitted, gold, Green Published			2022-12-25	WOS:000287482800032
J	O'Reilly, LP; Watkins, SC; Smithgall, TE				O'Reilly, Linda P.; Watkins, Simon C.; Smithgall, Thomas E.			An Unexpected Role for the Clock Protein Timeless in Developmental Apoptosis	PLOS ONE			English	Article							SRC FAMILY KINASE; TYROSINE KINASE; MAMMALIAN TIMELESS; CRYSTAL-STRUCTURE; CIRCADIAN CLOCK; HNRNP K; DIFFERENTIATION; ACTIVATION; CELLS; HCK	Background: Programmed cell death is critical not only in adult tissue homeostasis but for embryogenesis as well. One of the earliest steps in development, formation of the proamniotic cavity, involves coordinated apoptosis of embryonic cells. Recent work from our group demonstrated that c-Src protein-tyrosine kinase activity triggers differentiation of mouse embryonic stem (mES) cells to primitive ectoderm-like cells. In this report, we identified Timeless (Tim), the mammalian ortholog of a Drosophila circadian rhythm protein, as a binding partner and substrate for c-Src and probed its role in the differentiation of mES cells. Methodology/Principal Findings: To determine whether Tim is involved in ES cell differentiation, Tim protein levels were stably suppressed using shRNA. Tim-defective ES cell lines were then tested for embryoid body (EB) formation, which models early mammalian development. Remarkably, confocal microscopy revealed that EBs formed from the Tim-knockdown ES cells failed to cavitate. Cells retained within the centers of the failed cavities strongly expressed the pluripotency marker Oct4, suggesting that further development is arrested without Tim. Immunoblots revealed reduced basal Caspase activity in the Tim-defective EBs compared to wild-type controls. Furthermore, EBs formed from Tim-knockdown cells demonstrated resistance to staurosporine-induced apoptosis, consistent with a link between Tim and programmed cell death during cavitation. Conclusions/Significance: Our data demonstrate a novel function for the clock protein Tim during a key stage of early development. Specifically, EBs formed from ES cells lacking Tim showed reduced caspase activity and failed to cavitate. As a consequence, further development was halted, and the cells present in the failed cavity remained pluripotent. These findings reveal a new function for Tim in the coordination of ES cell differentiation, and raise the intriguing possibility that circadian rhythms and early development may be intimately linked.	[O'Reilly, Linda P.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O'Reilly, LP (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsmithga@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [GM077629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health grant GM077629 (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Anneren C, 2008, CLIN SCI, V115, P43, DOI 10.1042/CS20070388; Araki T, 2003, NEPHRON EXP NEPHROL, V93, P117, DOI 10.1159/000069552; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Denham M, 2006, STEM CELLS, V24, P918, DOI 10.1634/stemcells.2005-0151; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eckert JJ, 2004, REPRODUCTION, V127, P653, DOI 10.1530/rep.1.00150; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Li ZX, 2000, P NATL ACAD SCI USA, V97, P10038, DOI 10.1073/pnas.97.18.10038; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Meyn MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000311; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Pene-Dumitrescu T, 2010, J BIOL CHEM, V285, P21446, DOI 10.1074/jbc.M109.090043; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Rappoport JZ, 2008, BIOCHEM J, V412, P415, DOI 10.1042/BJ20080474; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Scott MP, 2002, J BIOL CHEM, V277, P28238, DOI 10.1074/jbc.M202783200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	41	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17157	10.1371/journal.pone.0017157	http://dx.doi.org/10.1371/journal.pone.0017157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359199	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000287482300032
J	Llandres, AL; Rodriguez-Girones, MA				Llandres, Ana L.; Rodriguez-Girones, Miguel A.			Spider Movement, UV Reflectance and Size, but Not Spider Crypsis, Affect the Response of Honeybees to Australian Crab Spiders	PLOS ONE			English	Article							WAIT PREDATOR; PREY; CHOICE; INFLORESCENCES; VISITATION; COLORATION	According to the crypsis hypothesis, the ability of female crab spiders to change body colour and match the colour of flowers has been selected because flower visitors are less likely to detect spiders that match the colour of the flowers used as hunting platform. However, recent findings suggest that spider crypsis plays a minor role in predator detection and some studies even showed that pollinators can become attracted to flowers harbouring Australian crab spider when the UV contrast between spider and flower increases. Here we studied the response of Apis mellifera honeybees to the presence of white or yellow Thomisus spectabilis Australian crab spiders sitting on Bidens alba inflorescences and also the response of honeybees to crab spiders that we made easily detectable painting blue their forelimbs or abdomen. To account for the visual systems of crab spider's prey, we measured the reflectance properties of the spiders and inflorescences used for the experiments. We found that honeybees did not respond to the degree of matching between spiders and inflorescences (either chromatic or achromatic contrast): they responded similarly to white and yellow spiders, to control and painted spiders. However spider UV reflection, spider size and spider movement determined honeybee behaviour: the probability that honeybees landed on spider-harbouring inflorescences was greatest when the spiders were large and had high UV reflectance or when spiders were small and reflected little UV, and honeybees were more likely to reject inflorescences if spiders moved as the bee approached the inflorescence. Our study suggests that only the large, but not the small Australian crab spiders deceive their preys by reflecting UV light, and highlights the importance of other cues that elicited an anti-predator response in honeybees.	[Llandres, Ana L.; Rodriguez-Girones, Miguel A.] Estn Expt Zonas Aridas CSIC, Dept Funct & Evolutionary Ecol, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Llandres, AL (corresponding author), Estn Expt Zonas Aridas CSIC, Dept Funct & Evolutionary Ecol, Almeria, Spain.	allandres@eeza.csic.es	Rodriguez-Girones, Miguel A/H-1859-2015	Rodriguez-Girones, Miguel A/0000-0002-5619-9819	Spanish Ministry of Science and Technology [CGL2007-63223]; CSIC [PIE 2006 3 OI 073, I3P-BPD2005]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC	Funding: This work was supported by the Spanish Ministry of Science and Technology (project CGL2007-63223 to MARG) and CSIC (project PIE 2006 3 OI 073 to MARG and studentship I3P-BPD2005 to ALL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, INFORM THEORY EXTENS; Brechbuhl R, 2010, BASIC APPL ECOL, V11, P76, DOI 10.1016/j.baae.2009.07.001; Brechbuhl R, 2010, P ROY SOC B-BIOL SCI, V277, P739, DOI 10.1098/rspb.2009.1632; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P545; Chittka L., 2005, PRACTICAL POLLINATIO, P157; Clark RW, 2004, ETHOLOGY, V110, P471, DOI 10.1111/j.1439-0310.2004.00982.x; Cott H. B, 1957, ADAPTIVE COLORATION; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; EBERHARD WG, 1977, SCIENCE, V198, P1173, DOI 10.1126/science.198.4322.1173; ERSON RA, 1981, OECOLOGIA, V49, P67; Gabritscbevsky E, 1927, J EXP ZOOL, V47, P251, DOI 10.1002/jez.1400470207; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Hatle JD, 2001, ENVIRON ENTOMOL, V30, P51, DOI 10.1603/0046-225X-30.1.51; Heiling AM, 2005, J EXP BIOL, V208, P3925, DOI 10.1242/jeb.01861; Heiling AM, 2005, J EXP BIOL, V208, P1785, DOI 10.1242/jeb.01585; Heiling AM, 2004, P ROY SOC B-BIOL SCI, V271, pS196, DOI 10.1098/rsbl.2003.0138; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Herberstein ME, 2009, EVOL ECOL, V23, P621, DOI 10.1007/s10682-008-9260-6; Higginson AD, 2007, ENTOMOL GEN, V29, P165; Hopkins, 1886, ILLUSTRATED AUSTRALA; Ings TC, 2008, CURR BIOL, V18, P1520, DOI 10.1016/j.cub.2008.07.074; Llandres AL, 2011, ECOL ENTOMOL, V36, P72, DOI 10.1111/j.1365-2311.2010.01246.x; Metcalfe NB, 1997, J ANIM ECOL, V66, P866, DOI 10.2307/6002; Morse D. H., 2007, PREDATOR FLOWER LIFE; MORSE DH, 1986, AM MIDL NAT, V116, P341, DOI 10.2307/2425742; Nelson XJ, 2010, ANIM BEHAV, V79, P555, DOI 10.1016/j.anbehav.2009.12.011; OLIVE CW, 1982, ECOLOGY, V63, P912, DOI 10.2307/1937231; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Reader T, 2006, BEHAV ECOL, V17, P933, DOI 10.1093/beheco/arl027; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; Shafir S, 1998, BEHAV ECOL, V9, P74, DOI 10.1093/beheco/9.1.74; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; Weigel Gertrud, 1941, ZEITSCHR VERGLEICH PHYSIOL, V29, P195; Yong TH, 2003, ANN ENTOMOL SOC AM, V96, P643, DOI 10.1603/0013-8746(2003)096[0643:NBAPAB]2.0.CO;2	39	27	28	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17136	10.1371/journal.pone.0017136	http://dx.doi.org/10.1371/journal.pone.0017136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359183	Green Submitted, Green Published, gold			2022-12-25	WOS:000287392700053
J	Pereira, CF; Ellenberg, PC; Jones, KL; Fernandez, TL; Smyth, RP; Hawkes, DJ; Hijnen, M; Vivet-Boudou, V; Marquet, R; Johnson, I; Mak, J				Pereira, Candida F.; Ellenberg, Paula C.; Jones, Kate L.; Fernandez, Tara L.; Smyth, Redmond P.; Hawkes, David J.; Hijnen, Marcel; Vivet-Boudou, Valerie; Marquet, Roland; Johnson, Iain; Mak, Johnson			Labeling of Multiple HIV-1 Proteins with the Biarsenical-Tetracysteine System	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LIVING CELLS; REVERSE-TRANSCRIPTASE; ELECTRON-MICROSCOPY; LIVE CELLS; IN-VIVO; VISUALIZATION; INFECTION; BINDING; FLUORESCENCE	Due to its small size and versatility, the biarsenical-tetracysteine system is an attractive way to label viral proteins for live cell imaging. This study describes the genetic labeling of the human immunodeficiency virus type 1 (HIV-1) structural proteins (matrix, capsid and nucleocapsid), enzymes (protease, reverse transcriptase, RNAse H and integrase) and envelope glycoprotein 120 with a tetracysteine tag in the context of a full-length virus. We measure the impact of these modifications on the natural virus infection and, most importantly, present the first infectious HIV-1 construct containing a fluorescently-labeled nucleocapsid protein. Furthermore, due to the high background levels normally associated with the labeling of tetracysteine-tagged proteins we have also optimized a metabolic labeling system that produces infectious virus containing the natural envelope glycoproteins and specifically labeled tetracysteine-tagged proteins that can easily be detected after virus infection of T-lymphocytes. This approach can be adapted to other viral systems for the visualization of the interplay between virus and host cell during infection.	[Pereira, Candida F.; Ellenberg, Paula C.; Jones, Kate L.; Fernandez, Tara L.; Smyth, Redmond P.; Hawkes, David J.; Hijnen, Marcel; Mak, Johnson] Ctr Virol, Burnet Inst, Melbourne, Vic, Australia; [Pereira, Candida F.; Ellenberg, Paula C.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Hijnen, Marcel; Mak, Johnson] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Mak, Johnson] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Smyth, Redmond P.; Vivet-Boudou, Valerie; Marquet, Roland] Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, Strasbourg, France; [Johnson, Iain] Life Technologies Corp, Eugene, OR USA	Burnet Institute; Monash University; Monash University; Monash University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Thermo Fisher Scientific	Pereira, CF (corresponding author), Ctr Virol, Burnet Inst, Melbourne, Vic, Australia.	mak@burnet.edu.au	Smyth, Redmond/AAP-1637-2020; mak, johnson/H-4605-2014; mak, johnson/S-2457-2019; Ellenberg, paula/AAW-5460-2021	mak, johnson/0000-0002-5229-5707; mak, johnson/0000-0002-5229-5707; Ellenberg, Paula/0000-0002-7622-9106; Smyth, Redmond/0000-0002-1580-0671; Hawkes, David/0000-0002-3882-801X; Marquet, Roland/0000-0002-4209-3976	National Health and Medical Research Council of Australia; Pfizer; European Commission; Portuguese Foundation for Science and Technology	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pfizer(Pfizer); European Commission(European CommissionEuropean Commission Joint Research Centre); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by grants from the National Health and Medical Research Council of Australia (C.F.P. and J.M.), Pfizer Fellowship (J.M.), the European Social Fund of the European Commission (C.F.P.) and the Portuguese Foundation for Science and Technology (C.F.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Campbell EM, 2008, TRENDS MICROBIOL, V16, P580, DOI 10.1016/j.tim.2008.09.006; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Das SC, 2009, J VIROL, V83, P2611, DOI 10.1128/JVI.01668-08; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hearps AC, 2007, J FLUORESC, V17, P593, DOI 10.1007/s10895-007-0225-x; Hill MK, 2002, J VIROL, V76, P11245, DOI 10.1128/JVI.76.22.11245-11253.2002; Hill MK, 2001, J VIROL, V75, P6835, DOI 10.1128/JVI.75.15.6835-6840.2001; Lanman J, 2008, J STRUCT BIOL, V161, P439, DOI 10.1016/j.jsb.2007.09.009; Li Y, 2010, J VIROL, V84, P7204, DOI 10.1128/JVI.00203-10; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mire CE, 2009, J VIROL, V83, P12139, DOI 10.1128/JVI.00955-09; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137	31	74	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17016	10.1371/journal.pone.0017016	http://dx.doi.org/10.1371/journal.pone.0017016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347302	Green Published, gold			2022-12-25	WOS:000287364500022
J	Thorslund, SE; Edgren, T; Pettersson, J; Nordfelth, R; Sellin, ME; Ivanova, E; Francis, MS; Isaksson, EL; Wolf-Watz, H; Fallman, M				Thorslund, Sara E.; Edgren, Tomas; Pettersson, Jonas; Nordfelth, Roland; Sellin, Mikael E.; Ivanova, Ekaterina; Francis, Matthew S.; Isaksson, Elin L.; Wolf-Watz, Hans; Fallman, Maria			The RACK1 Signaling Scaffold Protein Selectively Interacts with Yersinia pseudotuberculosis Virulence Function	PLOS ONE			English	Article							III SECRETION SYSTEM; MOUSE PERITONEAL-MACROPHAGES; HOST-CELL MEMBRANES; PSEUDOMONAS-AERUGINOSA; PORE FORMATION; GAP ACTIVITY; KINASE-C; DEPENDENT TRANSLOCATION; SHIGELLA-FLEXNERI; OUTER PROTEINS	Many Gram-negative bacteria use type III secretion systems to translocate effector proteins into host cells. These effectors interfere with cellular functions in a highly regulated manner resulting in effects that are beneficial for the bacteria. The pathogen Yersinia can resist phagocytosis by eukaryotic cells by translocating Yop effectors into the target cell cytoplasm. This is called antiphagocytosis, and constitutes an important virulence feature of this pathogen since it allows survival in immune cell rich lymphoid organs. We show here that the virulence protein YopK has a role in orchestrating effector translocation necessary for productive antiphagocytosis. We present data showing that YopK influences Yop effector translocation by modulating the ratio of the pore-forming proteins YopB and YopD in the target cell membrane. Further, we show that YopK that can interact with the translocators, is exposed inside target cells and binds to the eukaryotic signaling protein RACK1. This protein is engaged upon Y. pseudotuberculosis-mediated beta 1-integrin activation and localizes to phagocytic cups. Cells with downregulated RACK1 levels are protected from antiphagocytosis. This resistance is not due to altered levels of translocated antiphagocytic effectors, and cells with reduced levels of RACK1 are still sensitive to the later occurring cytotoxic effect caused by the Yop effectors. Further, a yopK mutant unable to bind RACK1 shows an avirulent phenotype during mouse infection, suggesting that RACK1 targeting by YopK is a requirement for virulence. Together, our data imply that the local event of Yersinia-mediated antiphagocytosis involves a step where YopK, by binding RACK1, ensures an immediate specific spatial delivery of antiphagocytic effectors leading to productive inhibition of phagocytosis.	[Thorslund, Sara E.; Edgren, Tomas; Pettersson, Jonas; Nordfelth, Roland; Sellin, Mikael E.; Ivanova, Ekaterina; Francis, Matthew S.; Isaksson, Elin L.; Wolf-Watz, Hans; Fallman, Maria] Umea Univ, Dept Mol Biol, Umea, Sweden; [Thorslund, Sara E.; Edgren, Tomas; Nordfelth, Roland; Francis, Matthew S.; Isaksson, Elin L.; Wolf-Watz, Hans; Fallman, Maria] Umea Univ, UCMR, Umea, Sweden	Umea University; Umea University	Thorslund, SE (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	maria.fallman@molbiol.umu.se		Sellin, Mikael/0000-0002-8355-0803; Francis, Matthew/0000-0001-6817-9535	Swedish Research Council VR-M [521-2008-2603, K2008-58X-11222-14-3]; J. C. Kempes Memorial Fund	Swedish Research Council VR-M(Swedish Research Council); J. C. Kempes Memorial Fund	This work was supported by grants from the Swedish Research Council VR-M (521-2008-2603, H.W-W; K2008-58X-11222-14-3, M. F; http://www.vr.se), and S. E. T. acknowledges financial support from the J. C. Kempes Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aili M, 2006, CELL MICROBIOL, V8, P1020, DOI 10.1111/j.1462-5822.2005.00684.x; Aili M, 2003, MICROB PATHOGENESIS, V34, P297, DOI 10.1016/S0882-4010(03)00063-9; AILI M, 2008, INT J MED MICROBIOL, P183; Andersson K, 1999, INFECT IMMUN, V67, P2567, DOI 10.1128/IAI.67.5.2567-2574.1999; Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; BERGMAN T, 1994, J BACTERIOL, V176, P2619, DOI 10.1128/JB.176.9.2619-2626.1994; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; BOLIN I, 1982, INFECT IMMUN, V37, P506; BOLIN I, 1984, INFECT IMMUN, V43, P72; BOLIN I, 1988, MOL MICROBIOL, V2, P237, DOI 10.1111/j.1365-2958.1988.tb00025.x; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Buensuceso CS, 2001, J CELL SCI, V114, P1691; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Deleuil F, 2003, CELL MICROBIOL, V5, P53, DOI 10.1046/j.1462-5822.2003.00236.x; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Fallman M, 2002, INT J MED MICROBIOL, V291, P501; FALLMAN M, 1995, INFECT IMMUN, V63, P3117; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Garcia JT, 2006, INFECT IMMUN, V74, P5645, DOI 10.1128/IAI.00690-06; Goosney DL, 1999, INFECT IMMUN, V67, P490, DOI 10.1128/IAI.67.2.490-495.1999; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Guinet F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001688; Gustavsson A, 2004, J BIOL CHEM, V279, P22893, DOI 10.1074/jbc.M309693200; Gustavsson A, 2002, J CELL SCI, V115, P2669; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; HANSKI C, 1989, INFECT IMMUN, V57, P673, DOI 10.1128/IAI.57.3.673-678.1989; HEESEMANN J, 1985, J CLIN MICROBIOL, V22, P168, DOI 10.1128/JCM.22.2.168-175.1985; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; HOLMSTROM A, 1995, INFECT IMMUN, V63, P2269; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Isaksson EL, 2009, INFECT IMMUN, V77, P4740, DOI 10.1128/IAI.00333-09; Isberg RR, 2001, J CELL SCI, V114, P21; James P, 1996, GENETICS, V144, P1425; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Marra A, 1997, INFECT IMMUN, V65, P3412, DOI 10.1128/IAI.65.8.3412-3421.1997; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MULDER B, 1989, INFECT IMMUN, V57, P2534, DOI 10.1128/IAI.57.8.2534-2541.1989; Nordfelth R, 2001, INFECT IMMUN, V69, P3516, DOI 10.1128/IAI.69.5.3516-3518.2001; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Quitard S, 2006, CELL MICROBIOL, V8, P972, DOI 10.1111/j.1462-5822.2005.00680.x; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991; ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219; Spinner JL, 2008, INFECT IMMUN, V76, P3754, DOI 10.1128/IAI.00385-08; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Sundin C, 2001, CELL MICROBIOL, V3, P237, DOI 10.1046/j.1462-5822.2001.00108.x; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Tsang TM, 2010, INFECT IMMUN, V78, P3358, DOI 10.1128/IAI.00238-10; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Viboud GI, 2002, METHOD ENZYMOL, V358, P345; Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Zhang XA, 1999, J BIOL CHEM, V274, P11, DOI 10.1074/jbc.274.1.11	77	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16784	10.1371/journal.pone.0016784	http://dx.doi.org/10.1371/journal.pone.0016784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347310	Green Published, Green Submitted, gold			2022-12-25	WOS:000287363000018
J	Liang, LM; Liu, SQ; Yang, JK; Meng, ZH; Lei, LP; Zhang, KQ				Liang, Lianming; Liu, Shuqun; Yang, Jinkui; Meng, Zhaohui; Lei, Liping; Zhang, Keqin			Comparison of homology models and crystal structures of cuticle-degrading proteases from nematophagous fungi: structural basis of nematicidal activity	FASEB JOURNAL			English	Article						disulfide bridge; structural flexibility; electrostatic surface potential	NEMATODE-TRAPPING FUNGUS; EXTRACELLULAR SERINE-PROTEASE; MOLECULAR-DYNAMICS; CAENORHABDITIS-ELEGANS; PURIFICATION; SIMULATION; SUBTILISIN; STABILITY; INFECTION; ENZYMES	Cuticle-degrading proteases secreted by nematophagous fungi can degrade nematode cuticle during infection. Alkaline proteases from nematode-parasitic fungi show stronger nematicidal activity in vitro than neutral proteases from nematode-trapping fungi. Sequence alignment of these proteases revealed that the active-site residues were much conserved. Disulfide bridges in alkaline proteases not only contribute to the thermal stability of enzyme structure but also increase the flexibility of S1 and S4 pockets located at the substrate-binding site. Molecular electrostatic potential surfaces of these proteases change gradually from negative to positive while arranging in the order from neutral to alkaline proteases, possibly contributing to the distinct extent of substrate (nematode cuticle) attraction by proteases. The differences in flexibility of substrate-binding site and in electrostatic surface potential distribution between neutral and alkaline cuticle-degrading proteases are associated with the changes of their catalytic activities and nematicidal activities with fungal species. Our results indicate that nematode-parasitic and nematode-trapping fungi have evolved for distinct adaptation under selective pressure.-Liang, L., Liu, S., Yang, J., Meng, Z., Lei, L., Zhang, K. Comparison of homology models and crystal structures of cuticle-degrading proteases from nematophagous fungi: structural basis of nematicidal activity. FASEB J. 25, 1894-1902 (2011). www.fasebj.org	[Liang, Lianming; Liu, Shuqun; Yang, Jinkui; Meng, Zhaohui; Zhang, Keqin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Liang, Lianming; Liu, Shuqun; Yang, Jinkui; Meng, Zhaohui; Zhang, Keqin] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Peoples R China; [Meng, Zhaohui] Kunming Med Univ, Mol Cardiol Lab, Dept Cardiol, Affiliated Hosp 1, Kunming, Peoples R China; [Lei, Liping] Tobacco Agr Sci Inst Yunnan Prov, Yuxi, Peoples R China	Yunnan University; Yunnan University; Kunming Medical University; China National Tobacco Corporation	Zhang, KQ (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China.	kqzhang111@yahoo.com.cn	Liang, Lian-Ming/AAL-3861-2021; zhang, ke/AAH-8217-2019	Yang, Jinkui/0000-0002-3106-2189	National Basic Research Program of China [2007CB411600]; National Natural Science Foundation of China [30630003, 30860011, 30960229, 30660107]; Department of Science and Technology of Yunnan Province [2007PY-22, 2007C007Z, 2009CI052]; Yunnan Branch of China Tobacco Industrial Corporation [2010YN17]; Yunnan University [2010C02Z]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province; Yunnan Branch of China Tobacco Industrial Corporation; Yunnan University	The authors thank Dr. Jianping Xu (McMaster University, Hamilton, ON, Canada) for help and advice in this experiment and the High Performance Computer Center of Yunnan University for computational support. This work was jointly funded by the National Basic Research Program of China (approval 2007CB411600); projects from the National Natural Science Foundation of China (approvals 30630003, 30860011, 30960229, and 30660107); the Department of Science and Technology of Yunnan Province (approvals 2007PY-22, 2007C007Z, and 2009CI052); the Yunnan Branch of China Tobacco Industrial Corporation (grant 2010YN17); and Yunnan University (grant 2010C02Z).	Ahman J, 2002, APPL ENVIRON MICROB, V68, P3408, DOI 10.1128/AEM.68.7.3408-3415.2002; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Dong LQ, 2007, NEMATOLOGY, V9, P743, DOI 10.1163/156854107782024802; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIMMELHOCH S, 1978, EXP PARASITOL, V45, P208, DOI 10.1016/0014-4894(78)90061-9; Huang XW, 2004, RES MICROBIOL, V155, P811, DOI 10.1016/j.resmic.2004.07.003; JOSHI L, 1995, FEMS MICROBIOL LETT, V125, P211, DOI 10.1111/j.1574-6968.1995.tb07360.x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2006, PROCESS BIOCHEM, V41, P925, DOI 10.1016/j.procbio.2005.10.006; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Liang LM, 2010, FASEB J, V24, P1391, DOI 10.1096/fj.09-136408; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu SQ, 2010, J MOL MODEL, V16, P17, DOI 10.1007/s00894-009-0518-x; Liu SQ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-33; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; Morton CO, 2003, MYCOL RES, V107, P38, DOI 10.1017/S0953756202007050; MURRELL KD, 1983, EXP PARASITOL, V55, P331, DOI 10.1016/0014-4894(83)90030-9; Sakaguchi M, 2008, J BIOCHEM, V143, P625, DOI 10.1093/jb/mvn007; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SEGERS R, 1994, MICROBIOL-SGM, V140, P2715, DOI 10.1099/00221287-140-10-2715; STLEGER RJ, 1987, ARCH BIOCHEM BIOPHYS, V253, P221, DOI 10.1016/0003-9861(87)90655-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao Y, 2010, J BIOMOL STRUCT DYN, V28, P143, DOI 10.1080/073911010010524953; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; TUNLID A, 1994, MICROBIOL-UK, V140, P1687, DOI 10.1099/13500872-140-7-1687; Yang JK, 2007, APPL MICROBIOL BIOT, V75, P21, DOI 10.1007/s00253-007-0881-4; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Zhao ML, 2004, MYCOLOGIA, V96, P16, DOI 10.2307/3761982	36	20	25	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1894	1902		10.1096/fj.10-175653	http://dx.doi.org/10.1096/fj.10-175653			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21350115				2022-12-25	WOS:000291023800013
J	Wei, ZK; Peterson, JM; Wong, GW				Wei, Zhikui; Peterson, Jonathan M.; Wong, G. William			Metabolic Regulation by C1q/TNF-related Protein-13 (CTRP13) ACTIVATION OF AMP-ACTIVATED PROTEIN KINASE AND SUPPRESSION OF FATTY ACID-INDUCED JNK SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; CRYSTAL-STRUCTURE; COLLAGENOUS DOMAIN; ADIPOSE-TISSUE; ADIPONECTIN; EXPRESSION; GLUCOSE; FAMILY; GENE; MICE	Members of the C1q/TNF family play important and diverse roles in the immune, endocrine, skeletal, vascular, and sensory systems. Here, we identify and characterize CTRP13, a new and extremely conserved member of the C1q/TNF family. CTRP13 is preferentially expressed by adipose tissue and the brain in mice and predominantly by adipose tissue in humans. Within mouse adipose tissue, CTRP13 is largely expressed by cells of the stromal vascular compartment. Due to sexually dimorphic expression patterns, female mice have higher transcript and circulating CTRP13 levels than males. CTRP13 transcript and circulating levels are elevated in obese male mice, suggesting a potential role in energy metabolism. The insulin-sensitizing drug rosiglitazone also increases the expression of CTRP13 in adipocytes, which correlates with the insulin-sensitizing action of CTRP13. In a heterologous expression system, CTRP13 is secreted as a disulfide-linked oligomeric protein. When co-expressed, CTRP13 forms heteromeric complexes with a closely related family member, CTRP10. This heteromeric association does not involve conserved N-terminal Cys residues. Functional studies using purified recombinant protein demonstrated that CTRP13 is an adipokine that promotes glucose uptake in adipocytes, myotubes, and hepatocytes via activation of the AMPK signaling pathway. CTRP13 also ameliorates lipid-induced insulin resistance in hepatocytes through suppression of the SAPK/JNK stress signaling that impairs the insulin signaling pathway. Further, CTRP13 reduces glucose output in hepatocytes by inhibiting the mRNA expression of gluconeogenic enzymes, glucose-6-phosphatase and the cytosolic form of phosphoenolpyruvate carboxykinase. These results provide the first functional characterization of CTRP13 and establish its importance in glucose homeostasis.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institutes of Health [DK084171, F32DK084607]; American Heart Association [SDG2260721, PRE3790034]; Baltimore Diabetes Research and Training Center [P60DK079637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, F32DK084607, P30DK079637, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported in part by American Heart Association Grant SDG2260721 and Baltimore Diabetes Research and Training Center Grant P60DK079637.; Supported by American Heart Association Fellowship PRE3790034.; Supported by National Institutes of Health National Research Service Award F32DK084607.	Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs DB, 2009, BIOCHEMISTRY-US, V48, P12345, DOI 10.1021/bi9015555; Cheng A, 2006, BIOESSAYS, V28, P231, DOI 10.1002/bies.20375; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; GERSHONI JM, 1985, ANAL BIOCHEM, V146, P59, DOI 10.1016/0003-2697(85)90395-1; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; HAYWARD CPM, 1991, BLOOD, V77, P2556; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Iijima T, 2007, EUR J NEUROSCI, V25, P1049, DOI 10.1111/j.1460-9568.2007.05361.x; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; Illidge C, 2001, INT J BIOCHEM CELL B, V33, P521, DOI 10.1016/S1357-2725(01)00013-9; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Koide T, 2000, J BIOL CHEM, V275, P27957; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Lee W, 2010, FEBS LETT, V584, P968, DOI 10.1016/j.febslet.2010.01.040; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SHETTY M, 1993, J BIOL CHEM, V268, P17225; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Suzuki S, 2007, FEBS LETT, V581, P809, DOI 10.1016/j.febslet.2007.01.046; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; WEINSTEIN IB, 1975, CANCER RES, V35, P253; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yano W, 2008, ENDOCR J, V55, P515, DOI 10.1507/endocrj.K08E-093; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	72	102	113	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201087	http://dx.doi.org/10.1074/jbc.M110.201087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21378161	hybrid, Green Published			2022-12-25	WOS:000290022800005
J	Stoll, KE; Brzovic, PS; Davis, TN; Klevit, RE				Stoll, Kate E.; Brzovic, Peter S.; Davis, Trisha N.; Klevit, Rachel E.			The Essential Ubc4/Ubc5 Function in Yeast Is HECT E3-dependent, and RING E3-dependent Pathways Require Only Monoubiquitin Transfer by Ubc4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; PROTEIN LIGASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; E2 ENZYMES; IN-VITRO; COMPLEX; MECHANISMS; DETERMINANTS; DEGRADATION	The ubiquitin (Ub)-conjugating enzymes Ubc4 and Ubc5 are involved in a variety of ubiquitination pathways in yeast, including Rsp5- and anaphase-promoting complex (APC)-mediated pathways. We have found the double deletion of UBC4 and UBC5 genes in yeast to be lethal. To investigate the essential pathway disrupted by the ubc4/ubc5 deletion, several point mutations were inserted in Ubc4. The Ubc4 active site mutation C86A and the E3-binding mutations A97D and F63A were both unable to rescue the lethal phenotype, indicating that an active E3/E2 similar to Ub complex is required for the essential function of Ubc4/Ubc5. A mutation that specifically eliminates RING E3-catalyzed isopeptide formation but not HECT E3 transthiolation (N78S-Ubc4) rescued the lethal phenotype. Thus, the essential redundant function performed by Ubc4 and Ubc5 in yeast is with a HECT-type E3, likely the only essential HECT in yeast, Rsp5. Our results also suggest that Ubc1 can weakly replace Ubc4 to transfer mono-Ub with APC, but Ubc4 cannot replace Ubc1 for poly-Ub chain extension on APC substrates. Finally, the backside Ub-binding mutant S23R-Ubc4 has no observable effect in yeast. Together, our results are consistent with a model in which Ubc4 and Ubc5 are 1) the primary E2s for Rsp5 in yeast and 2) act as monoubiquitinating E2s in RING E3-catalyzed pathways, in contrast to the processive human ortholog UbcH5.	[Stoll, Kate E.; Brzovic, Peter S.; Davis, Trisha N.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Stoll, Kate E.; Klevit, Rachel E.] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, POB 357350, Seattle, WA 98195 USA.	klevit@uw.edu	Davis, Trisha/F-8584-2010; Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; Davis, Trisha/0000-0003-4797-3152	National Institutes of Health [R01 GM088055]; NIGMS [T32 GM008268]; National Science Foundation [MCB0615632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268, R01GM088055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM088055 (to R.E.K.) and Molecular Biophysics Training Grant T32 GM008268 from NIGMS (to K.E.S.). This work was also supported by National Science Foundation Grant MCB0615632 (to R.E.K.).	Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hwang GW, 2008, LIFE SCI, V82, P1182, DOI 10.1016/j.lfs.2008.04.002; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Panasenko OO, 2009, GENETICS, V181, P447, DOI 10.1534/genetics.108.095422; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	27	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15165	15170		10.1074/jbc.M110.203968	http://dx.doi.org/10.1074/jbc.M110.203968			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357418	hybrid, Green Published			2022-12-25	WOS:000289788300048
J	Gehret, JJ; Gu, LC; Gerwick, WH; Wipf, P; Sherman, DH; Smith, JL				Gehret, Jennifer J.; Gu, Liangcai; Gerwick, William H.; Wipf, Peter; Sherman, David H.; Smith, Janet L.			Terminal Alkene Formation by the Thioesterase of Curacin A Biosynthesis STRUCTURE OF A DECARBOXYLATING THIOESTERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; NATURAL-PRODUCT; POLYKETIDE; DOMAIN; MACROLACTONIZATION; SURFACTIN; INSIGHTS; CLUSTER; PHENIX	Curacin A is a polyketide synthase (PKS)-non-ribosomal peptide synthetase-derived natural product with potent anticancer properties generated by the marine cyanobacterium Lyngbya majuscula. Type I modular PKS assembly lines typically employ a thioesterase (TE) domain to off-load carboxylic acid or macrolactone products from an adjacent acyl carrier protein (ACP) domain. In a striking departure from this scheme the curacin A PKS employs tandem sulfotransferase and TE domains to form a terminal alkene moiety. Sulfotransferase sulfonation of beta-hydroxy-acyl-ACP is followed by TE hydrolysis, decarboxylation, and sulfate elimination (Gu, L., Wang, B., Kulkarni, A., Gehret, J. J., Lloyd, K. R., Gerwick, L., Gerwick, W. H., Wipf, P., Hakansson, K., Smith, J. L., and Sherman, D. H. (2009) J. Am. Chem. Soc. 131, 16033-16035). With low sequence identity to other PKS TEs (< 15%), the curacin TE represents a new thioesterase subfamily. The 1.7-angstrom curacin TE crystal structure reveals how the familiar alpha/beta-hydrolase architecture is adapted to specificity for beta-sulfated substrates. A Ser-His-Glu catalytic triad is centered in an open active site cleft between the core domain and a lid subdomain. Unlike TEs from other PKSs, the lid is fixed in an open conformation on one side by dimer contacts of a protruding helix and on the other side by an arginine anchor from the lid into the core. Adjacent to the catalytic triad, another arginine residue is positioned to recognize the substrate beta-sulfate group. The essential features of the curacin TE are conserved in sequences of five other putative bacterial ACP-ST-TE tridomains. Formation of a sulfate leaving group as a biosynthetic strategy to facilitate acyl chain decarboxylation is of potential value as a route to hydrocarbon biofuels.	[Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Gu, Liangcai; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Gehret, Jennifer J.; Gu, Liangcai; Sherman, David H.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Scripps Institution of Oceanography; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smith, JL (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu	Gu, Liangcai/E-4600-2010; Wipf, Peter/AAG-1771-2021; Gu, Liangcai/U-6908-2019	Wipf, Peter/0000-0001-7693-5863; 	National Institutes of Health [R01 DK42303, R01 CA108874, U01 TW007404]; National Institutes of Health, National Institute of General Medical Sciences [Y1-GM-1104]; National Cancer Institute through United States Department of Energy [Y1-CO-1020]; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute through United States Department of Energy; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK42303 (to J.L.S.), R01 CA108874 (to D.H.S., W.H.G., and P. W.), and U01 TW007404, and a Hans W. Vahlteich Professorship (to D.H.S.).; We thank Drs. Amol Kulkarni and Sarang Kulkarni for the synthesis of substrate analogs. Beamline 23ID-D is supported by the National Institutes of Health, National Institute of General Medical Sciences Grant Y1-GM-1104 and National Cancer Institute Grant Y1-CO-1020 through the GM/CA Collaborative Access Team at the APS, which is supported by the United States Department of Energy.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akey DL, 2006, NAT CHEM BIOL, V2, P537, DOI 10.1038/nchembio824; Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DelProposto J, 2009, PROTEIN EXPRES PURIF, V63, P40, DOI 10.1016/j.pep.2008.08.011; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Geders TW, 2007, J BIOL CHEM, V282, P35954, DOI 10.1074/jbc.M703921200; GERWICK WH, 1994, J ORG CHEM, V59, P1243, DOI 10.1021/jo00085a006; Giraldes JW, 2006, NAT CHEM BIOL, V2, P531, DOI 10.1038/nchembio822; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu LC, 2007, SCIENCE, V318, P970, DOI 10.1126/science.1148790; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Roongsawang N, 2007, CHEMBIOCHEM, V8, P501, DOI 10.1002/cbic.200600465; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Scaglione JB, 2010, ANGEW CHEM INT EDIT, V49, P5726, DOI 10.1002/anie.201000032; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Verdier-Pinard P, 1998, MOL PHARMACOL, V53, P62, DOI 10.1124/mol.53.1.62; YOUNG TC, 1986, NEW J CHEM, V10, P701; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	52	61	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14445	14454		10.1074/jbc.M110.214635	http://dx.doi.org/10.1074/jbc.M110.214635			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357626	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000289556200066
J	Sakamoto, T; Niiya, D; Seiki, M				Sakamoto, Takeharu; Niiya, Daigo; Seiki, Motoharu			Targeting the Warburg Effect That Arises in Tumor Cells Expressing Membrane Type-1 Matrix Metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; CANCER-CELLS; PERICELLULAR PROTEOLYSIS; TRANSCRIPTIONAL ACTIVITY; GLUCOSE-METABOLISM; BASEMENT-MEMBRANE; PRECURSOR PROTEIN; PYRUVATE-KINASE; GROWTH-FACTOR; MT1-MMP	Hypoxia inducible factor-1 (HIF-1) is a key transcription factor required for cellular adaptation to hypoxia, although its physiological roles and activation mechanisms during normoxia have not been studied sufficiently. The Warburg effect, which is a hallmark of malignant tumors that is characterized by increased activity of aerobic glycolysis, accompanies activation of HIF-1 during normoxia. Besides tumor cells that have multiple genetic and epigenetic alterations, normal macrophages also use glycolysis for ATP production by depending upon elevated HIF-1 activity even during normoxia. We recently found that activity of factor inhibiting HIF-1 (FIH-1) is specifically suppressed in macrophages by a nonproteolytic activity of membrane type-1 matrix metalloproteinase (MT1-MMP/MMP-14). Thus, MT1-MMP expressed in macrophages plays a significant role in regulating HIF-1 activity during normoxia. In the light of this finding, we examined here whether MT1-MMP contributes to the Warburg effect of tumor cells. All the tumor cell lines that express MT1-MMP exhibit increased glycolytic activity, and forced expression of MT1-MMP in MT1-MMP-negative tumor cells is sufficient to induce the Warburg effect. The cytoplasmic tail of MT1-MMP mediates the stimulation of aerobic glycolysis by increasing the expression of HIF-1 target genes. Specific intervention of the MT1-MMP-mediated activation of HIF-1 in tumor cells retarded tumor growth in mice. Systemic administration of a membrane-penetrating form of the cytoplasmic tail peptide in mice to inhibit HIF-1 activation competitively also exhibited a therapeutic effect on tumors.	[Sakamoto, Takeharu; Niiya, Daigo; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan	University of Tokyo	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Sakamoto, Takeharu/0000-0002-1225-1902; 	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Specific Coordination Fund for Promoting Science (to T. S.) and by a grant-in-aid for scientific research (S) on priority areas, the "Integrative Research toward the Conquest of Cancer," from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. S.).	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dang CV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe75; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guess CM, 2009, MATRIX BIOL, V28, P445, DOI 10.1016/j.matbio.2009.07.008; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koshikawa N, 2010, CANCER RES, V70, P6093, DOI 10.1158/0008-5472.CAN-10-0346; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; MICHL J, 1976, J EXP MED, V144, P1465, DOI 10.1084/jem.144.6.1465; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WARBURG O, 1930, METABOLISM TUMORS, P327; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679	58	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14691	14704		10.1074/jbc.M110.188714	http://dx.doi.org/10.1074/jbc.M110.188714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372132	Green Published, hybrid			2022-12-25	WOS:000289556200088
J	Chun, CZ; Remadevi, I; Schupp, MO; Samant, GV; Pramanik, K; Wilkinson, GA; Ramchandran, R				Chun, Chang Zoon; Remadevi, Indu; Schupp, Marcus-Oliver; Samant, Ganesh Vinayak; Pramanik, Kallal; Wilkinson, George Albert; Ramchandran, Ramani			Fli(+) etsrp(+) Hemato-Vascular Progenitor Cells Proliferate at the Lateral Plate Mesoderm during Vasculogenesis in Zebrafish	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; FACTOR VEGF; AORTIC ENDOTHELIUM; SIGNALING PATHWAY; SONIC-HEDGEHOG; DORSAL AORTA; DANIO-RERIO; CYCLIN D1; NOTCH	Background: Vasculogenesis, the de novo formation of blood vessels from precursor cells is critical for a developing embryo. However, the signals and events that dictate the formation of primary axial vessels remain poorly understood. Methodology/Principal Findings: In this study, we use ets-related protein-1 (etsrp), which is essential for vascular development, to analyze the early stages of vasculogenesis in zebrafish. We found etsrp(+) cells of the head, trunk and tail follow distinct developmental sequences. Using a combination of genetic, molecular and chemical approaches, we demonstrate that fli(+) etsrp(+) hemato-vascular progenitors (FEVPs) are proliferating at the lateral plate mesoderm (LPM). The Shh-VEGF-Notch-Hey2 signaling pathway controls the proliferation process, and experimental modulation of single components of this pathway alters etsrp(+) cell numbers at the LPM. Conclusions/Significance: This study for the first time defines factors controlling proliferation, and cell numbers of premigratory FEVPs in zebrafish.	[Chun, Chang Zoon; Remadevi, Indu; Schupp, Marcus-Oliver; Samant, Ganesh Vinayak; Pramanik, Kallal; Wilkinson, George Albert; Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Translat & Biomed Res Ctr, CRI Dev Vasc Biol Program, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Chun, CZ (corresponding author), Med Coll Wisconsin, Dept Pediat, Translat & Biomed Res Ctr, CRI Dev Vasc Biol Program, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	cchun@mcw.edu; rramchan@mcw.edu			Advancing Healthier Wisconsin grant; American Heart Association; Children's Research Institute; Children's Hospital of Wisconsin; National Institutes of Health [HL090712]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090712] Funding Source: NIH RePORTER	Advancing Healthier Wisconsin grant; American Heart Association(American Heart Association); Children's Research Institute; Children's Hospital of Wisconsin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	C.Z.C is partly supported by funds from an Advancing Healthier Wisconsin grant awarded to R. R. G. V. S was supported by a post-doctoral award from the American Heart Association. This work was also supported with start-up funds from Children's Research Institute, Children's Hospital of Wisconsin, and a National Institutes of Health grant HL090712 to R. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 1999, CURR BIOL, V9, P247, DOI 10.1016/S0960-9822(99)80113-4; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; BRODY TB, 2008, STUDY AIDS DEV PATHW; BRODY TB, 2009, STUDY AIDS DEV PATHW; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Campbell WA, 2002, BIOCHEMISTRY-US, V41, P3372, DOI 10.1021/bi015810h; Chun CZ, 2009, BLOOD, V113, P1192, DOI 10.1182/blood-2008-06-162156; Cleaver O, 1998, DEVELOPMENT, V125, P3905; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; Eriksson J, 2000, J MORPHOL, V244, P167, DOI 10.1002/(SICI)1097-4687(200006)244:3<167::AID-JMOR2>3.0.CO;2-J; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Go MJ, 1998, DEVELOPMENT, V125, P2031; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jia H, 2007, P NATL ACAD SCI USA, V104, P14008, DOI 10.1073/pnas.0702240104; Jonsson JI, 2001, EUR J IMMUNOL, V31, P3240, DOI 10.1002/1521-4141(200111)31:11<3240::AID-IMMU3240>3.0.CO;2-E; Lamont RE, 2006, SCI STKE, DOI [10.1126/stke.3552006pe39, DOI 10.1126/STKE.3552006PE39]; Latimer AJ, 2006, DEV BIOL, V298, P392, DOI 10.1016/j.ydbio.2006.05.039; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lee CY, 2009, CURR BIOL, V19, P1616, DOI 10.1016/j.cub.2009.07.073; Liang D, 1998, BBA-GENE STRUCT EXPR, V1397, P14, DOI 10.1016/S0167-4781(97)00233-9; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; MURRAY PDF, 1932, P R SOC LOND, V11, P497; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Salanga MC, 2010, DEV DYNAM, V239, P1178, DOI 10.1002/dvdy.22277; Scheer N, 2001, DEVELOPMENT, V128, P1099; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Traver D, 2002, CELL, V108, P731, DOI 10.1016/S0092-8674(02)00686-4; Weinstein BM, 2002, COLD SPRING HARB SYM, V67, P155, DOI 10.1101/sqb.2002.67.155; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Yarden A, 1995, BBA-GENE STRUCT EXPR, V1264, P257, DOI 10.1016/0167-4781(95)00175-1; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599; Zovein AC, 2006, P NATL ACAD SCI USA, V103, P12959, DOI 10.1073/pnas.0606018103	56	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e14732	10.1371/journal.pone.0014732	http://dx.doi.org/10.1371/journal.pone.0014732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364913	Green Published, gold, Green Submitted			2022-12-25	WOS:000287764100003
J	Vieira, AC; Reid, B; Cao, L; Mannis, MJ; Schwab, IR; Zhao, M				Vieira, Ana Carolina; Reid, Brian; Cao, Lin; Mannis, Mark J.; Schwab, Ivan R.; Zhao, Min			Ionic Components of Electric Current at Rat Corneal Wounds	PLOS ONE			English	Article							EPITHELIAL-CELLS; ASCORBIC-ACID; CHLORIDE TRANSPORT; IN-VITRO; FIELDS; MIGRATION; STIMULATION; SODIUM; RABBIT; CHANNELS	Background: Endogenous electric fields and currents occur naturally at wounds and are a strong signal guiding cell migration into the wound to promote healing. Many cells involved in wound healing respond to small physiological electric fields in vitro. It has long been assumed that wound electric fields are produced by passive ion leakage from damaged tissue. Could these fields be actively maintained and regulated as an active wound response? What are the molecular, ionic and cellular mechanisms underlying the wound electric currents? Methodology/Principal Findings: Using rat cornea wounds as a model, we measured the dynamic timecourses of individual ion fluxes with ion-selective probes. We also examined chloride channel expression before and after wounding. After wounding, Ca2+ efflux increased steadily whereas K+ showed an initial large efflux which rapidly decreased. Surprisingly, Na+ flux at wounds was inward. A most significant observation was a persistent large influx of Cl-, which had a time course similar to the net wound electric currents we have measured previously. Fixation of the tissues abolished ion fluxes. Pharmacological agents which stimulate ion transport significantly increased flux of Cl-, Na+ and K+. Injury to the cornea caused significant changes in distribution and expression of Cl- channel CLC2. Conclusions/Significance: These data suggest that the outward electric currents occurring naturally at corneal wounds are carried mainly by a large influx of chloride ions, and in part by effluxes of calcium and potassium ions. Ca2+ and Cl- fluxes appear to be mainly actively regulated, while K+ flux appears to be largely due to leakage. The dynamic changes of electric currents and specific ion fluxes after wounding suggest that electrical signaling is an active response to injury and offers potential novel approaches to modulate wound healing, for example eye-drops targeting ion transport to aid in the challenging management of non-healing corneal ulcers.	[Vieira, Ana Carolina; Mannis, Mark J.; Schwab, Ivan R.; Zhao, Min] Univ Calif Davis, Dept Ophthalmol, Davis, CA 95616 USA; [Vieira, Ana Carolina] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Reid, Brian; Cao, Lin; Zhao, Min] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA	University of California System; University of California Davis; Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California Davis	Vieira, AC (corresponding author), Univ Calif Davis, Dept Ophthalmol, Davis, CA 95616 USA.	brireid@ucdavis.edu	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	National Institutes of Health National Eye Institute [1R01EY019101]; Wellcome Trust [068012]; Research to Prevent Blindness, Inc.; NSFC [30628026]; UC Davis Dermatology Department; California Institute of Regenerative Medicine [RB1-01417]; NSF [MCB-0951199]; NATIONAL EYE INSTITUTE [R01EY019101] Funding Source: NIH RePORTER	National Institutes of Health National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NSFC(National Natural Science Foundation of China (NSFC)); UC Davis Dermatology Department; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health National Eye Institute grant 1R01EY019101 (to MZ and BR). The authors thank the Wellcome Trust for continuous support (068012). This work was also supported in part by Research to Prevent Blindness, Inc., an NSFC grant (30628026), and UC Davis Dermatology Department developmental fund. MZ is also supported by grants from the California Institute of Regenerative Medicine RB1-01417, NSF MCB-0951199. The funders had no role in study design, data collection/analysis, decision to publish, or preparation of the manuscript.	BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; BONANNO JA, 1991, OPTOMETRY VISION SCI, V68, P682, DOI 10.1097/00006324-199109000-00002; Brubaker RF, 2000, INVEST OPHTH VIS SCI, V41, P1681; BUCK MG, 1975, BIOCHIM BIOPHYS ACTA, V389, P251, DOI 10.1016/0005-2736(75)90319-3; Candia OA, 2004, EXP EYE RES, V78, P527, DOI 10.1016/j.exer.2003.08.015; CANDIA OA, 1973, EXP EYE RES, V15, P375, DOI 10.1016/0014-4835(73)90153-X; Cao L, 2010, EXP EYE RES, V90, P771, DOI 10.1016/j.exer.2010.03.013; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; Connon CJ, 2006, CELL TISSUE RES, V323, P177, DOI 10.1007/s00441-005-0059-2; Connon CJ, 2004, J HISTOCHEM CYTOCHEM, V52, P415, DOI 10.1177/002215540405200313; DONN A, 1959, ARCH OPHTHALMOL-CHIC, V62, P741, DOI 10.1001/archopht.1959.04220050003001; DONN A, 1959, ARCH OPHTHALMOL-CHIC, V62, P748, DOI 10.1001/archopht.1959.04220050010002; Du Bois-Reymond E., 1860, UNTERSUCHUNGEN THIER; Du Bois-Reymond EH, 1843, FISCHE; EPSTEIN FH, 1985, ANN NY ACAD SCI, V456, P187, DOI 10.1111/j.1749-6632.1985.tb14864.x; Farboud B, 2000, EXP EYE RES, V70, P667, DOI 10.1006/exer.2000.0830; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; HANNA C, 1966, AM J OPHTHALMOL, V61, P55, DOI 10.1016/0002-9394(66)90747-1; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; Huttenlocher A, 2007, NEW ENGL J MED, V356, P303, DOI 10.1056/NEJMcibr066496; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; KLYCE SD, 1985, CURR EYE RES, V4, P323, DOI 10.3109/02713688509025145; KLYCE SD, 1975, AM J PHYSIOL, V228, P1446, DOI 10.1152/ajplegacy.1975.228.5.1446; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; KUWABARA T, 1976, INVEST OPHTH VISUAL, V15, P4; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; MCGAHAN MC, 1982, BIOCHIM BIOPHYS ACTA, V689, P385, DOI 10.1016/0005-2736(82)90273-5; Mukerjee E V, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4326; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; Nuccitelli R, 2008, WOUND REPAIR REGEN, V16, P432, DOI 10.1111/j.1524-475X.2008.00389.x; Ojingwa JC, 2003, J INVEST DERMATOL, V121, P1, DOI 10.1046/j.1523-1747.2003.12454.x; PATEL N, 1982, J NEUROSCI, V2, P483; PETROUTSOS G, 1984, OPHTHALMIC RES, V16, P185, DOI 10.1159/000265322; Piccolino M, 1998, BRAIN RES BULL, V46, P381, DOI 10.1016/S0361-9230(98)00026-4; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; Reid B, 2010, CORNEA IN PRESS; Reid B, 2007, NAT PROTOC, V2, P661, DOI 10.1038/nprot.2007.91; Reid B, 2011, JOVE-J VIS EXP, DOI 10.3791/2358; REISS GR, 1986, ARCH OPHTHALMOL-CHIC, V104, P753; REUSS L, 1989, PHYSIOL REV, V69, P503, DOI 10.1152/physrev.1989.69.2.503; Robinson KR, 2003, BIOESSAYS, V25, P759, DOI 10.1002/bies.10307; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Smith PJS, 1999, MICROSC RES TECHNIQ, V46, P398, DOI 10.1002/(SICI)1097-0029(19990915)46:6<398::AID-JEMT8>3.0.CO;2-H; SMITH PJS, 1995, NATURE, V378, P645, DOI 10.1038/378645a0; SOONG HK, 1990, INVEST OPHTH VIS SCI, V31, P2278; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; STUMP RF, 1983, J CELL BIOL, V97, P1226, DOI 10.1083/jcb.97.4.1226; TANELIAN DL, 1992, INVEST OPHTH VIS SCI, V33, P3024; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; TURNHEIM K, 1991, PHYSIOL REV, V71, P429, DOI 10.1152/physrev.1991.71.2.429; VANDERHEYDEN C, 1975, EXP EYE RES, V20, P89, DOI 10.1016/0014-4835(75)90111-6; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; VANHAERINGEN NJ, 1981, SURV OPHTHALMOL, V26, P84, DOI 10.1016/0039-6257(81)90145-4; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143; ZADUNAISKY JA, 1973, EXP EYE RES, V15, P577, DOI 10.1016/0014-4835(73)90069-9; ZADUNAISKY JA, 1966, AM J PHYSIOL, V211, P506, DOI 10.1152/ajplegacy.1966.211.2.506; ZADUNAISKY JA, 1971, AM J PHYSIOL, V221, P1837, DOI 10.1152/ajplegacy.1971.221.6.1837; Zhao M, 1997, CURR EYE RES, V16, P973, DOI 10.1076/ceyr.16.10.973.9014; Zhao M, 1996, INVEST OPHTH VIS SCI, V37, P2548; Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	66	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17411	10.1371/journal.pone.0017411	http://dx.doi.org/10.1371/journal.pone.0017411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364900	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100057
J	Lan, TH; Kuravi, S; Lambert, NA				Lan, Tien-Hung; Kuravi, Sudhakiranmayi; Lambert, Nevin A.			Internalization Dissociates beta(2)-Adrenergic Receptors	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; BETA-2-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; HETERODIMERIZATION; OLIGOMERIZATION; TRAFFICKING; ACTIVATION; DYNAMIN	G protein-coupled receptors (GPCRs) self-associate as dimers or higher-order oligomers in living cells. The stability of associated GPCRs has not been extensively studied, but it is generally thought that these receptors move between the plasma membrane and intracellular compartments as intact dimers or oligomers. Here we show that beta(2)-adrenergic receptors (beta(2)ARs) that self-associate at the plasma membrane can dissociate during agonist-induced internalization. We use bioluminescence-resonance energy transfer (BRET) to monitor movement of beta(2)ARs between subcellular compartments. BRET between beta(2)ARs and plasma membrane markers decreases in response to agonist activation, while at the same time BRET between beta(2)ARs and endosome markers increases. Energy transfer between beta(2)ARs is decreased in a similar manner if either the donor-or acceptor-labeled receptor is mutated to impair agonist binding and internalization. These changes take place over the course of 30 minutes, persist after agonist is removed, and are sensitive to several inhibitors of arrestin-and clathrin-mediated endocytosis. The magnitude of the decrease in BRET between donor-and acceptor-labeled beta(2)ARs suggests that at least half of the receptors that contribute to the BRET signal are physically segregated by internalization. These results are consistent with the possibility that beta(2)ARs associate transiently with each other in the plasma membrane, or that beta(2)AR dimers or oligomers are actively disrupted during internalization.	[Lan, Tien-Hung; Kuravi, Sudhakiranmayi; Lambert, Nevin A.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	University System of Georgia; Augusta University	Lan, TH (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA.	nlambert@georgiahealth.edu			National Institutes of Health [GM078319, GM096762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319, R01GM096762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM078319 and GM096762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cao TT, 2005, MOL PHARMACOL, V67, P288, DOI 10.1124/mol.104.003608; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gregan B, 2004, J BIOL CHEM, V279, P27679, DOI 10.1074/jbc.M403601200; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Nankoe SR, 2006, TRENDS CELL BIOL, V16, P607, DOI 10.1016/j.tcb.2006.10.004; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Rabiet MJ, 2008, J BIOL CHEM, V283, P31038, DOI 10.1074/jbc.M805260200; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yesilaltay A, 2000, MOL BIOL CELL, V11, P2873, DOI 10.1091/mbc.11.9.2873; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	35	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17361	10.1371/journal.pone.0017361	http://dx.doi.org/10.1371/journal.pone.0017361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364942	gold, Green Submitted, Green Published			2022-12-25	WOS:000287656600044
J	Castillo, KD; Ries, JB; Weiss, JM				Castillo, Karl D.; Ries, Justin B.; Weiss, Jack M.			Declining Coral Skeletal Extension for Forereef Colonies of Siderastrea siderea on the Mesoamerican Barrier Reef System, Southern Belize	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; MARINE ECOLOGY; CLIMATE-CHANGE; GROWTH-RATES; ENVIRONMENTAL CONTROLS; PORITES-LUTEA; BACK REEF; PATTERNS; SUSCEPTIBILITY; CALCIFICATION	Background: Natural and anthropogenic stressors are predicted to have increasingly negative impacts on coral reefs. Understanding how these environmental stressors have impacted coral skeletal growth should improve our ability to predict how they may affect coral reefs in the future. We investigated century-scale variations in skeletal extension for the slow-growing massive scleractinian coral Siderastrea siderea inhabiting the forereef, backreef, and nearshore reefs of the Mesoamerican Barrier Reef System (MBRS) in the western Caribbean Sea. Methodology/Principal Findings: Thirteen S. siderea cores were extracted, slabbed, and X-rayed. Annual skeletal extension was estimated from adjacent low-and high-density growth bands. Since the early 1900s, forereef S. siderea colonies have shifted from exhibiting the fastest to the slowest average annual skeletal extension, while values for backreef and nearshore colonies have remained relatively constant. The rates of change in annual skeletal extension were -0.020+/-0.005, 0.011+/-0.006, and -0.008+/-0.006 mm yr(-1) per year [mean+/-SE] for forereef, backreef, and nearshore colonies respectively. These values for forereef and nearshore S. siderea were significantly lower by 0.031+/-0.008 and by 0.019+/-0.009 mm yr(-1) per year, respectively, than for backreef colonies. However, only forereef S. siderea exhibited a statistically significant decline in annual skeletal extension over the last century. Conclusions/Significance: Our results suggest that forereef S. siderea colonies are more susceptible to environmental stress than backreef and nearshore counterparts, which may have historically been exposed to higher natural baseline stressors. Alternatively, sediment plumes, nutrients, and pollution originating from watersheds of Guatemala and Honduras may disproportionately impact the forereef environment of the MBRS. We are presently reconstructing the history of environmental stressors that have impacted the MBRS to constrain the cause(s) of the observed reductions in coral skeletal growth. This should improve our ability to predict and potentially mitigate the effects of future environmental stressors on coral reef ecosystems.	[Castillo, Karl D.; Ries, Justin B.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Weiss, Jack M.] Univ N Carolina, Curriculum Environm & Ecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Castillo, KD (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	karl_castillo@unc.edu	Ries, Justin B/B-8391-2017	Ries, Justin B/0000-0001-8427-206X	Carolina Postdoctoral Program for Faculty Diversity; National Science Foundation (NSF) [1031995]; University of North Carolina (UNC)	Carolina Postdoctoral Program for Faculty Diversity; National Science Foundation (NSF)(National Science Foundation (NSF)); University of North Carolina (UNC)	This work was supported by funding from the Carolina Postdoctoral Program for Faculty Diversity (to Castillo), National Science Foundation (NSF) award #1031995 (to JBR), and a University of North Carolina (UNC) Faculty Development Grant (to JBR). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrefouet S, 2002, CORAL REEFS, V21, P43, DOI 10.1007/s00338-001-0199-0; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Atkinson MJ, 1995, CORAL REEFS, V14, P215, DOI 10.1007/BF00334344; Balding DJ, 2004, APPL LONGITUDINAL AN; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 2000, NATURE, V404, P142, DOI 10.1038/35004657; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2006, HYDROLOGIC MODELING; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carilli JE, 2008, NATURE P; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, MAR POLLUT BULL, V58, P1835, DOI 10.1016/j.marpolbul.2009.07.024; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; Cherubin LM, 2008, CORAL REEFS, V27, P503, DOI 10.1007/s00338-007-0348-1; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DODGE RE, 1977, J MAR RES, V35, P715; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Fritts H. C., 1976, TREE RINGS CLIMATE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Guzman HM, 2008, AMBIO, V37, P342, DOI 10.1579/07-A-372.1; GUZMAN HM, 1994, MAR ECOL PROG SER, V105, P231, DOI 10.3354/meps105231; Guzman HM, 1998, MAR ECOL PROG SER, V166, P109, DOI 10.3354/meps166109; HALLOCK P, 1986, Palaios, V1, P389, DOI 10.2307/3514476; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Helmle K. P., 2002, EUR M INT SOC REEF S; Heyman WD, 1999, ENVIRON MANAGE, V24, P229, DOI 10.1007/s002679900229; HIGHSMITH RC, 1979, J EXP MAR BIOL ECOL, V37, P105, DOI 10.1016/0022-0981(79)90089-3; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUSTON M, 1985, CORAL REEFS, V4, P19, DOI 10.1007/BF00302200; IPCC W, 2007, CLIM CHANG 2007 PHYS; Kerr RA, 2010, SCIENCE, V328, P1500, DOI 10.1126/science.328.5985.1500; Koltes Karen H., 2009, Smithsonian Contributions to the Marine Sciences, P379; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lugo-Fernandez A, 1998, CONT SHELF RES, V18, P1099, DOI 10.1016/S0278-4343(97)00020-4; McCook LJ, 1996, MAR ECOL PROG SER, V139, P179, DOI 10.3354/meps139179; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Nie BF, 1997, SCI CHINA SER D, V40, P173, DOI 10.1007/BF02878376; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; R Development Core Team, 2009, R FDN STAT COMP; SAS Institute Inc, 2004, SAS 9 1 3 HELP DOC; SCOFFIN TP, 1992, CORAL REEFS, V11, P1, DOI 10.1007/BF00291929; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smith LW, 2007, J EXP MAR BIOL ECOL, V341, P282, DOI 10.1016/j.jembe.2006.10.053; Steven Andrew D.L., 1997, P867; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; TOMASCIK T, 1991, MAR ECOL PROG SER, V77, P261, DOI 10.3354/meps077261; Torres JL, 2002, CARIBB J SCI, V38, P222; Veron J.E.N., 2000, CORALS WORLD, V1-3; Weis VM, 2010, MOL ECOL, V19, P1515, DOI 10.1111/j.1365-294X.2010.04575.x; Wolanski E, 2005, ESTUAR COAST SHELF S, V65, P153, DOI 10.1016/j.ecss.2005.06.003; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Zuur Alain F., 2009, P1	67	33	34	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14615	10.1371/journal.pone.0014615	http://dx.doi.org/10.1371/journal.pone.0014615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359203	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700001
J	Gan, LH; Chen, SJ; Zhong, J; Wang, X; Lam, EKY; Liu, X; Zhang, JB; Zhou, TH; Yu, J; Si, JM; Wang, LJ; Jin, HC				Gan, Lihong; Chen, Shujie; Zhong, Jing; Wang, Xian; Lam, Emily K. Y.; Liu, Xin; Zhang, Jianbin; Zhou, Tianhua; Yu, Jun; Si, Jianmin; Wang, Liangjing; Jin, Hongchuan			ZIC1 Is Downregulated through Promoter Hypermethylation, and Functions as a Tumor Suppressor Gene in Colorectal Cancer	PLOS ONE			English	Article							SIGNALING PATHWAY; IDENTIFICATION; EXPRESSION; PROTEIN; FAMILY; JNK; ANGIOPOIETIN-2; METHYLATION; CARCINOMA; HEDGEHOG	The transcription factor, Zinc finger of the cerebellum (ZIC1), plays a crucial role in vertebrate development. Recently, ZIC1 has also been found to participate in the progression of human cancers, including medulloblastomas, endometrial cancers, and mesenchymal neoplasms. However, the function of ZIC1 in colon cancer progression has not been defined. In this study, we demonstrate ZIC1 to be silenced or significantly downregulated in colon cancer cell lines. These effects were reversed by demethylation treatment with 5-aza-2'-deoxycytidine (Aza). ZIC1 expression is also significantly downregulated in primary colorectal cancer tissues relative to adjacent non-tumor tissues (p = 0.0001). Furthermore, methylation of ZIC1 gene promoter is frequently detected in primary tumor tissues (85%, 34/40), but not in adjacent non-tumor tissues. Ectopic expression of ZIC1 suppresses cell proliferation and induces apoptosis, which is associated with MAPK and PI3K/Akt pathways, as well as the Bcl-xl/Bad/Caspase3 cascade. To identify target candidates of ZIC1, we employed cDNA microarray and found that 337 genes are downregulated and 95 genes upregulated by ectopic expression of ZIC1, which were verified by 10 selected gene expressions by qRT-PCR. Taken together, our results suggest that ZIC1 may potentially function as a tumor suppressor gene, which is downregulated through promoter hypermethylation in colorectal cancers.	[Gan, Lihong; Zhong, Jing; Wang, Liangjing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Shujie; Si, Jianmin] Zhejiang Univ, Sir Run Run Shaw Hosp, Inst Clin, Lab Digest Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xian; Jin, Hongchuan] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Key Lab Biotherapy Zheijang Prov,Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Lam, Emily K. Y.; Liu, Xin; Zhang, Jianbin; Yu, Jun] Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Zhou, Tianhua] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Tianhua] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Chinese University of Hong Kong; Prince of Wales Hospital; Zhejiang University; Zhejiang University	Wang, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	Wanglj76@hotmail.com	Yu, Jun/D-8569-2015; zhou, tianhua/K-4908-2013; Jin, Hongchuan/C-3686-2009	Yu, Jun/0000-0001-5008-2153; zhou, tianhua/0000-0002-1791-2124; Wang, Xian/0000-0003-0041-7589; Jin, Hongchuan/0000-0002-6697-3097	National Natural Scientific Foundation of China [30900676]; Natural Scientific Foundation of Zhejiang Province of China [Y206280]; Department of Science and Technology of Zhejiang Province of China [2009C03012-3]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Zhejiang Province of China; Department of Science and Technology of Zhejiang Province of China	The study was supported by the National Natural Scientific Foundation of China (30900676), the Natural Scientific Foundation of Zhejiang Province of China (Y206280), and the Department of Science and Technology of Zhejiang Province of China (2009C03012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Etoh T, 2001, CANCER RES, V61, P2145; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grinberg I, 2005, CLIN GENET, V67, P290, DOI 10.1111/j.1399-0004.2005.00418.x; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; HERMAN JG, 1995, CANCER RES, V55, P4525; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Khor TO, 2004, CANCER LETT, V210, P139, DOI 10.1016/j.canlet.2004.01.017; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Lee BB, 2009, CLIN CANCER RES, V15, P6185, DOI 10.1158/1078-0432.CCR-09-0111; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Maurus D, 2009, GENE DEV, V23, P1461, DOI 10.1101/gad.517009; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Muhlmann G, 2009, J CLIN PATHOL, V62, P152, DOI 10.1136/jcp.2008.060590; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pourebrahim R, 2007, FEBS LETT, V581, P5122, DOI 10.1016/j.febslet.2007.09.061; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Vasaturo F, 2000, BREAST CANCER RES TR, V61, P69, DOI 10.1023/A:1006462323260; Wang JB, 2008, MOL CANCER THER, V7, P280, DOI 10.1158/1535-7163.MCT-07-2003; Wang LJ, 2009, BIOCHEM BIOPH RES CO, V379, P959, DOI 10.1016/j.bbrc.2008.12.180; Wang X, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-95; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Xie KP, 2003, CANCER CELL, V4, P245, DOI 10.1016/S1535-6108(03)00246-0; YU J, 2010, ONCOGENE        0830; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343	39	47	50	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16916	10.1371/journal.pone.0016916	http://dx.doi.org/10.1371/journal.pone.0016916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347233	gold, Green Submitted, Green Published			2022-12-25	WOS:000287369200011
J	Pandey, RK; Bhatt, KH; Dahiya, Y; Sodhi, A				Pandey, Rajeev Kumar; Bhatt, Kunal H.; Dahiya, Yogesh; Sodhi, Ajit			Mycobacterium indicus pranii Supernatant Induces Apoptotic Cell Death in Mouse Peritoneal Macrophages In Vitro	PLOS ONE			English	Article							KINASE-C-DELTA; PROTEIN-KINASE; MURINE MACROPHAGES; VACCINE; TUBERCULOSIS; RELEASE; GROWTH; PKC	Mycobacterium indicus pranii (MIP), also known as Mw, is a saprophytic, non-pathogenic strain of Mycobacterium and is commercially available as a heat-killed vaccine for leprosy and recently tuberculosis (TB) as part of MDT. In this study we provide evidence that cell-free supernatant collected from original MIP suspension induces rapid and enhanced apoptosis in mouse peritoneal macrophages in vitro. It is demonstrated that the MIP cell-free supernatant induced apoptosis is mitochondria-mediated and caspase independent and involves mitochondrial translocation of Bax and subsequent release of AIF and cytochrome c from the mitochondria. Experiments with pharmacological inhibitors suggest a possible role of PKC in mitochondria-mediated apoptosis of macrophages.	[Pandey, Rajeev Kumar; Bhatt, Kunal H.; Dahiya, Yogesh; Sodhi, Ajit] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Pandey, RK (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	ajit.sodhi@lycos.com	Bhatt, Kunal/ABA-3012-2020	Bhatt, Kunal/0000-0003-3401-5035; Pandey, Rajeev/0000-0002-7883-1854	Department of Biotechnology, Government of India, New Delhi [BT/PR7877/Med/14/1158/2006]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	Funding: Funded by Department of Biotechnology, Government of India, New Delhi, Project No. BT/PR7877/Med/14/1158/2006. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Aliprantis AO, 2001, INFECT IMMUN, V69, P6248, DOI 10.1128/IAI.69.10.6248-6255.2001; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Ciaramella A, 2000, CELL DEATH DIFFER, V7, P1270, DOI 10.1038/sj.cdd.4400761; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gronberg A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013839; Gupta S, 2008, J EUR ACAD DERMATOL, V22, P1089, DOI 10.1111/j.1468-3083.2008.02719.x; Hegde R, 2003, J BIOL CHEM, V278, P38699, DOI 10.1074/jbc.M303179200; HINGLEYWILSON SM, 2000, MOD ASP IMMUNOBIOL, V1, P96; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Kharkar Rajendra, 2002, J Indian Med Assoc, V100, P578; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patel Naresh, 2002, J Indian Med Assoc, V100, P191; REDDI PP, 1994, INT J LEPROSY, V62, P229; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Reyland ME, 2000, CELL DEATH DIFFER, V7, P1200, DOI 10.1038/sj.cdd.4400744; Roberts DL, 2001, J CELL BIOL, V153, P221, DOI 10.1083/jcb.153.1.221; Rojas M, 1997, J IMMUNOL, V159, P1352; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; Sharma P, 2005, LEPROSY REV, V76, P127; SINGH IG, 1992, INFECT IMMUN, V60, P257, DOI 10.1128/IAI.60.1.257-263.1992; SINGH IG, 1991, VACCINE, V9, P10, DOI 10.1016/0264-410X(91)90309-T; SODHI A, 1986, INT J IMMUNOPHARMACO, V8, P701, DOI 10.1016/0192-0561(86)90005-6; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Talwar G P, 1999, Int Rev Immunol, V18, P229, DOI 10.3109/08830189909043027; TALWAR GP, 1990, VACCINE, V8, P121, DOI 10.1016/0264-410X(90)90134-8; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YADAVA A, 1991, SCAND J IMMUNOL, V34, P23, DOI 10.1111/j.1365-3083.1991.tb01517.x; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	38	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17093	10.1371/journal.pone.0017093	http://dx.doi.org/10.1371/journal.pone.0017093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347304	Green Submitted, Green Published, gold			2022-12-25	WOS:000287364500026
J	Bhavaraju, K; Lakhani, PR; Dorsam, RT; Jin, JG; Hitchcock, IS; Sanjay, A; Kunapuli, SP				Bhavaraju, Kamala; Lakhani, Parth R.; Dorsam, Robert T.; Jin, Jianguo; Hitchcock, Ian S.; Sanjay, Archana; Kunapuli, Satya P.			G(12/13) Signaling Pathways Substitute for Integrin alpha IIb beta 3-Signaling for Thromboxane Generation in Platelets	PLOS ONE			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; MOLECULAR-MECHANISM; PROTEIN-KINASE; SHAPE CHANGE; RECEPTOR; ACTIVATION; INHIBITOR; ROLES; ALPHA(IIB)BETA(3)	Background: We have previously shown that ADP-induced TXA(2) generation requires signaling from alpha IIb beta 3 integrin in platelets. Here we observed that, unlike ADP, protease-activated receptor (PAR)-mediated TXA(2) generation occurs independently of alpha IIb beta 3. PAR agonists, but not ADP, activate G(12/13) signaling pathways. Hence, we evaluated the role of these pathways in TXA(2) generation. Principal Findings: Inhibition of ADP-induced thromboxane generation by fibrinogen receptor antagonist SC57101 was rescued by co-stimulation of G(12/13) pathways with YFLLRNP. This observation suggested an existence of a common signaling effector downstream of integrins and G(12/13) pathways. Hence, we evaluated role of three potential tyrosine kinases; c-Src, Syk and FAK (Focal Adhesion Kinase) that are known to be activated by integrins. c-Src and Syk kinase did not play a role in ADP-induced functional responses in platelets. Selective activation of G(12/13) pathways resulted in the activation of FAK, in the absence of integrin signaling. Interestingly, alpha IIb beta 3-mediated FAK activation occurred in a Src family kinase (SFK)-independent manner whereas G(12/13) pathway caused FAK activation in a SFK and RhoA-dependent manner. A FAK selective inhibitor TAE-226, blocked TXA(2) generation. However, in comparison to WT mice, Pf4-Cre/Fak-Floxed mice did not show any difference in platelet TXA(2) generation. Conclusions: Therefore, we conclude that differential activation of FAK occurs downstream of Integrins and G(12/13) pathways. However, the common effector molecule, possibly a tyrosine kinase downstream of integrins and G(12/13) pathways contributing to TXA(2) generation in platelets remains elusive.	[Bhavaraju, Kamala; Lakhani, Parth R.; Jin, Jianguo; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19122 USA; [Dorsam, Robert T.; Kunapuli, Satya P.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA; [Bhavaraju, Kamala; Dorsam, Robert T.; Jin, Jianguo; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Hitchcock, Ian S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sanjay, Archana] Temple Univ, Dept Anat & Cell Biol, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Bhavaraju, K (corresponding author), Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19122 USA.	spk@temple.edu		Hitchcock, Ian/0000-0001-7170-6703	National Institutes of Health [HL81322, HL80444, HL60683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080444, R01HL060683, R01HL081322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by HL81322, HL80444 and HL60683 from National Institutes of Health to SPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Bhavaraju K, 2008, EUR J PHARMACOL, V580, P285, DOI 10.1016/j.ejphar.2007.11.009; BRASS LP, 1993, ADV EXP MED BIOL, V344, P17; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Freedman JE, 2005, CIRCULATION, V112, P2725, DOI 10.1161/CIRCULATIONAHA.104.494468; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; GONG H, 2003, SCIENCE, V327, P340; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 2009, BIOCHEM PHARMACOL, V77, P835, DOI 10.1016/j.bcp.2008.11.017; Jones ML, 2009, BIOCHEM BIOPH RES CO, V389, P198, DOI 10.1016/j.bbrc.2009.08.132; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; LAGES B, 1988, BRIT J HAEMATOL, V68, P53, DOI 10.1111/j.1365-2141.1988.tb04179.x; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; MALMSTEN C, 1977, BRIT J HAEMATOL, V35, P511, DOI 10.1111/j.1365-2141.1977.tb00617.x; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Murugappan S, 2005, BLOOD, V106, P550, DOI 10.1182/blood-2004-12-4866; Murugappan S, 2004, SEMIN THROMB HEMOST, V30, P411, DOI 10.1055/s-2004-833476; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nieswandt B, 2002, J BIOL CHEM, V277, P39493, DOI 10.1074/jbc.M207256200; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Wonerow P, 2003, J BIOL CHEM, V278, P37520, DOI 10.1074/jbc.M305077200	47	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16586	10.1371/journal.pone.0016586	http://dx.doi.org/10.1371/journal.pone.0016586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347357	Green Published, gold, Green Submitted			2022-12-25	WOS:000287363000009
J	Lamers, SL; Poon, AFY; McGrath, MS				Lamers, Susanna L.; Poon, Art F. Y.; McGrath, Michael S.			HIV-1 Nef Protein Structures Associated with Brain Infection and Dementia Pathogenesis	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; I DOWN-REGULATION; ACTIVATION; EXPRESSION; ASTROCYTES; MOTIF; SRC; SUPPRESSION; TRAFFICKING; MECHANISMS	The difference between regional rates of HIV-associated dementia (HAD) in patients infected with different subtypes of HIV suggests that genetic determinants exist within HIV that influence the ability of the virus to replicate in the central nervous system (in Uganda, Africa, subtype D HAD rate is 89%, while subtype A HAD rate is 24%). HIV-1 nef is a multifunctional protein with known toxic effects in the brain compartment. The goal of the current study was to identify if specific three-dimensional nef structures may be linked to patients who developed HAD. HIV-1 nef structures were computationally derived for consensus brain and non-brain sequences from a panel of patients infected with subtype B who died due to varied disease pathologies and consensus subtype A and subtype D sequences from Uganda. Site directed mutation analysis identified signatures in brain structures that appear to change binding potentials and could affect folding conformations of brain-associated structures. Despite the large sequence variation between HIV subtypes, structural alignments confirmed that viral structures derived from patients with HAD were more similar to subtype D structures than to structures derived from patient sequences without HAD. Furthermore, structures derived from brain sequences of patients with HAD were more similar to subtype D structures than they were to their own non-brain structures. The potential finding of a brain-specific nef structure indicates that HAD may result from genetic alterations that alter the folding or binding potential of the protein.	[Lamers, Susanna L.] NYU, Polytech Inst, New York, NY 10012 USA; [Lamers, Susanna L.] BioInfoExperts, Thibodaux, LA USA; [McGrath, Michael S.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [McGrath, Michael S.] AIDS & Canc Specimen Resource W Coast ACSR, San Francisco, CA USA	New York University; New York University Tandon School of Engineering; University of California System; University of California San Francisco	Lamers, SL (corresponding author), NYU, Polytech Inst, New York, NY 10012 USA.	MMcGrath@php.ucsf.edu	Poon, Art/W-9811-2019	Poon, Art/0000-0003-3779-154X	National Institutes of Health (NIH) [U01-CA066529-16, U19-MH081835-04]; Canadian Institutes of Health Research (CIHR) [200802HFE]; NATIONAL CANCER INSTITUTE [U01CA066529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH081835] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project was funded by grants National Institutes of Health (NIH) U01-CA066529-16 and NIH U19-MH081835-04. The Canadian Institutes of Health Research (CIHR) Fellowships Award in HIV/AIDS Research (200802HFE) provided additional funding for Art F. Y. Poon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian K, 2007, VIROLOGY, V358, P119, DOI 10.1016/j.virol.2006.07.053; Banisadr Ghazal, 2005, Current Drug Targets - Inflammation and Allergy, V4, P387, DOI 10.2174/1568010054022097; BERGONZINI V, 2009, J NEUROVIROL, P1; Burke DF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-301; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Dai L, 2010, J VIROL, V84, P8327, DOI 10.1128/JVI.00741-10; Dunfee RL, 2007, VIROLOGY, V367, P222, DOI 10.1016/j.virol.2007.05.029; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Fischer-Smith Tracy, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010239; Foster JL, 2006, CELL, V125, P1034, DOI 10.1016/j.cell.2006.06.005; GARRY RF, 1991, AIDS, V5, P1381, DOI 10.1097/00002030-199111000-00017; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Irish BP, 2009, AM J INFECT DIS, V5, P231, DOI 10.3844/ajidsp.2009.231.258; Johannes L, 2003, TRAFFIC, V4, P323, DOI 10.1034/j.1600-0854.2003.00089.x; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Kramer-Hammerle S, 2005, GENE, V358, P31, DOI 10.1016/j.gene.2005.05.011; Lamers SL, 2010, J NEUROVIROL, V16, P230, DOI 10.3109/13550281003735709; Lamers SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005065; Lehmann MH, 2006, EXP CELL RES, V312, P3659, DOI 10.1016/j.yexcr.2006.08.008; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lim WA, 1996, STRUCTURE, V4, P657; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Liner KJ, 2007, J NEUROVIROL, V13, P291, DOI 10.1080/13550280701422383; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Marusic C, 2009, TRANSGENIC RES, V18, P499, DOI 10.1007/s11248-009-9244-5; Masliah E, 1996, CRIT REV NEUROBIOL, V10, P57, DOI 10.1615/CritRevNeurobiol.v10.i1.30; Olivieri KC, 2010, AIDS RES HUM RETROV, V26, P495, DOI 10.1089/aid.2009.0257; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Sacktor N, 2009, NEUROLOGY, V72, P165, DOI 10.1212/01.wnl.0000339042.96109.86; Sacktor NC, 2005, AIDS, V19, P1367; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Thomas ER, 2007, AIDS RES HUM RETROV, V23, P575, DOI 10.1089/aid.2006.0246; Thompson KA, 2003, J NEUROVIROL, V9, P442, DOI 10.1080/13550280390218715; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Trillo-Pazos G, 2000, BRAIN RES, V864, P315, DOI 10.1016/S0006-8993(00)02213-7; van de Bovenkamp M, 2002, EUR J CLIN INVEST, V32, P619, DOI 10.1046/j.1365-2362.2002.01029.x; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; WERNER T, 1991, AIDS, V5, P1301, DOI 10.1097/00002030-199111000-00003; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zhao L, 2009, SCI CHINA SER C, V52, P651, DOI 10.1007/s11427-009-0085-5; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1	54	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16659	10.1371/journal.pone.0016659	http://dx.doi.org/10.1371/journal.pone.0016659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347424	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700026
J	McGinnis, EM; Keil, A				McGinnis, E. Menton; Keil, Andreas			Selective Processing of Multiple Features in the Human Brain: Effects of Feature Type and Salience	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FEATURE-BASED ATTENTION; HEMISPHERIC-DIFFERENCES; VISUAL-ATTENTION; COLOR; CORTEX; CONJUNCTIONS; MECHANISMS; LOCATION; STIMULI	Identifying targets in a stream of items at a given constant spatial location relies on selection of aspects such as color, shape, or texture. Such attended (target) features of a stimulus elicit a negative-going event-related brain potential (ERP), termed Selection Negativity (SN), which has been used as an index of selective feature processing. In two experiments, participants viewed a series of Gabor patches in which targets were defined as a specific combination of color, orientation, and shape. Distracters were composed of different combinations of color, orientation, and shape of the target stimulus. This design allows comparisons of items with and without specific target features. Consistent with previous ERP research, SN deflections extended between 160-300 ms. Data from the subsequent P3 component (300-450 ms post-stimulus) were also examined, and were regarded as an index of target processing. In Experiment A, predominant effects of target color on SN and P3 amplitudes were found, along with smaller ERP differences in response to variations of orientation and shape. Manipulating color to be less salient while enhancing the saliency of the orientation of the Gabor patch (Experiment B) led to delayed color selection and enhanced orientation selection. Topographical analyses suggested that the location of SN on the scalp reliably varies with the nature of the to-be-attended feature. No interference of non-target features on the SN was observed. These results suggest that target feature selection operates by means of electrocortical facilitation of feature-specific sensory processes, and that selective electrocortical facilitation is more effective when stimulus saliency is heightened.	[McGinnis, E. Menton; Keil, Andreas] Univ Florida, NIMH, Ctr Study Emot & Attent, Gainesville, FL 32610 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); State University System of Florida; University of Florida	McGinnis, EM (corresponding author), Univ Florida, NIMH, Ctr Study Emot & Attent, Gainesville, FL 32610 USA.	mmcginnis@ufl.edu	Keil, Andreas/F-9427-2011	Keil, Andreas/0000-0002-4064-1924; Deweese, Menton/0000-0001-7361-3826	National Institute of Mental Health [P50-MH072850, R21 MH082702, R01 MH084392]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084932, R21MH082702, P50MH072850] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by National Institute of Mental Health grants P50-MH072850 and R21 MH082702 to P.J. Lang, by National Institute of Mental Health grant R01 MH084392 to A. Keil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINE CJ, 1984, ANN NY ACAD SCI, V425, P154, DOI 10.1111/j.1749-6632.1984.tb23525.x; Anllo-Vento L, 1998, HUM BRAIN MAPP, V6, P216, DOI 10.1002/(SICI)1097-0193(1998)6:4<216::AID-HBM3>3.0.CO;2-6; AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Clark VP, 1997, HUM BRAIN MAPP, V5, P293, DOI 10.1002/(SICI)1097-0193(1997)5:4<293::AID-HBM15>3.0.CO;2-F; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1992, ROCKY MT J MATH, V22, P837, DOI 10.1216/rmjm/1181072699; Eimer M, 1997, BIOL PSYCHOL, V44, P143, DOI 10.1016/S0301-0511(96)05217-9; GARNER WR, 1987, PERCEPT PSYCHOPHYS, V41, P202, DOI 10.3758/BF03208219; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Harter M. R., 1984, VARIETIES ATTENTION, P293; HARTER MR, 1978, ELECTROEN CLIN NEURO, V45, P628, DOI 10.1016/0013-4694(78)90163-3; HARTER MR, 1980, ELECTROEN CLIN NEURO, V49, P461, DOI 10.1016/0013-4694(80)90389-2; HARTER MR, 1982, NEUROPSYCHOLOGIA, V20, P421, DOI 10.1016/0028-3932(82)90041-0; HILLYARD SA, 1993, CURR OPIN NEUROBIOL, V3, P217, DOI 10.1016/0959-4388(93)90213-I; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Junghofer M, 1997, BRAIN TOPOGR, V9, P203, DOI 10.1007/BF01190389; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Keil A, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-23; Keil A, 2010, BRAIN RES, V1313, P172, DOI 10.1016/j.brainres.2009.12.006; KENEMANS JL, 1993, ELECTROEN CLIN NEURO, V88, P51, DOI 10.1016/0168-5597(93)90028-N; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Maris E, 2004, PSYCHOPHYSIOLOGY, V41, P142, DOI 10.1111/j.1469-8986.2003.00139.x; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martinovic J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003781; McMains SA, 2007, J NEUROPHYSIOL, V98, P2110, DOI 10.1152/jn.00538.2007; Muller MM, 2004, J COGNITIVE NEUROSCI, V16, P503, DOI 10.1162/089892904322926827; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; Smid HGOM, 1999, PSYCHOPHYSIOLOGY, V36, P264, DOI 10.1017/S0048577299971135; Stoppel CM, 2007, BRAIN RES, V1181, P51, DOI 10.1016/j.brainres.2007.07.019; Theeuwes J., 1995, CONVERGING OPERATION, P297; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Treisman A., 1993, ATTENTION SELECTION; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P89, DOI 10.1111/j.1469-8986.1989.tb03137.x; WIJERS AA, 1989, BIOL PSYCHOL, V29, P213, DOI 10.1016/0301-0511(89)90021-5; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P529, DOI 10.1111/j.1469-8986.1989.tb00706.x; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8	44	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16824	10.1371/journal.pone.0016824	http://dx.doi.org/10.1371/journal.pone.0016824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347379	gold, Green Submitted, Green Published			2022-12-25	WOS:000287361700037
J	Price, MHH; Proboszcz, SL; Routledge, RD; Gottesfeld, AS; Orr, C; Reynolds, JD				Price, Michael H. H.; Proboszcz, Stan L.; Routledge, Rick D.; Gottesfeld, Allen S.; Orr, Craig; Reynolds, John D.			Sea Louse Infection of Juvenile Sockeye Salmon in Relation to Marine Salmon Farms on Canada's West Coast	PLOS ONE			English	Article							LICE LEPEOPHTHEIRUS-SALMONIS; BRITISH-COLUMBIA; BROUGHTON ARCHIPELAGO; ONCORHYNCHUS-GORBUSCHA; DEVELOPMENTAL-STAGES; ATLANTIC SALMON; FRASER-RIVER; INFESTATION; SURVIVAL; DISEASE	Background: Pathogens are growing threats to wildlife. The rapid growth of marine salmon farms over the past two decades has increased host abundance for pathogenic sea lice in coastal waters, and wild juvenile salmon swimming past farms are frequently infected with lice. Here we report the first investigation of the potential role of salmon farms in transmitting sea lice to juvenile sockeye salmon (Oncorhynchus nerka). Methodology/Principal Findings: We used genetic analyses to determine the origin of sockeye from Canada's two most important salmon rivers, the Fraser and Skeena; Fraser sockeye migrate through a region with salmon farms, and Skeena sockeye do not. We compared lice levels between Fraser and Skeena juvenile sockeye, and within the salmon farm region we compared lice levels on wild fish either before or after migration past farms. We matched the latter data on wild juveniles with sea lice data concurrently gathered on farms. Fraser River sockeye migrating through a region with salmon farms hosted an order of magnitude more sea lice than Skeena River populations, where there are no farms. Lice abundances on juvenile sockeye in the salmon farm region were substantially higher downstream of farms than upstream of farms for the two common species of lice: Caligus clemensi and Lepeophtheirus salmonis, and changes in their proportions between two years matched changes on the fish farms. Mixed-effects models show that position relative to salmon farms best explained C. clemensi abundance on sockeye, while migration year combined with position relative to salmon farms and temperature was one of two top models to explain L. salmonis abundance. Conclusions/Significance: This is the first study to demonstrate a potential role of salmon farms in sea lice transmission to juvenile sockeye salmon during their critical early marine migration. Moreover, it demonstrates a major migration corridor past farms for sockeye that originated in the Fraser River, a complex of populations that are the subject of conservation concern.	[Price, Michael H. H.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Price, Michael H. H.] Raincoast Conservat Fdn, Sidney, BC, Canada; [Proboszcz, Stan L.; Orr, Craig] Watershed Watch Salmon Soc, Coquitlam, BC, Canada; [Routledge, Rick D.] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada; [Gottesfeld, Allen S.] Skeena Fisheries Commiss, Hazelton, BC, Canada; [Reynolds, John D.] Simon Fraser Univ, Dept Biol, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	University of Victoria; Simon Fraser University; Simon Fraser University	Price, MHH (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	pricem@uvic.ca	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	Coastal Alliance for Aquaculture Reform; David and Lucile Packard Foundation; Gordon and Betty Moore Foundation; Patrick Hodgson Family Foundation; Ritchie Foundation; Sandler Family Foundation; SOS Marine Conservation Foundation; Tom Buell Endowment Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)	Coastal Alliance for Aquaculture Reform; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Patrick Hodgson Family Foundation; Ritchie Foundation; Sandler Family Foundation; SOS Marine Conservation Foundation; Tom Buell Endowment Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was funded by: The Coastal Alliance for Aquaculture Reform (www.farmedanddangerous.org), David and Lucile Packard Foundation (www.packard.org), Gordon and Betty Moore Foundation (www.moore.org), Patrick Hodgson Family Foundation, Ritchie Foundation, Sandler Family Foundation, SOS Marine Conservation Foundation (www.saveoursalmon.ca), Tom Buell Endowment Fund, a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants to RD Routledge and JD Reynolds (www.nserc-crsng.gc.ca), and an NSERC Industrial Postgraduate Scholarship to MHH Price. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beacham TD, 2005, N AM J FISH MANAGE, V25, P763, DOI 10.1577/M04-080.1; Beacham TD, 2004, T AM FISH SOC, V133, P1117, DOI 10.1577/T04-001.1; Beamish R, 2009, AQUACULTURE, V297, P31, DOI 10.1016/j.aquaculture.2009.09.001; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Bjorn P. A., 1997, Nordic Journal of Freshwater Research, P60; *BRIT COL MIN AGR, 2008, FISH HLTH PROGR ANN; *BRIT COL MIN AGR, 2007, FISH HLTH PROGR ANN; Brooks KM, 2005, REV FISH SCI, V13, P177, DOI 10.1080/10641260500207109; *COH COMM, 2010, COMM INQ DECL SOCK S; Connors BM, 2010, J APPL ECOL, V47, P1372, DOI 10.1111/j.1365-2664.2010.01889.x; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Finstad B, 2007, AQUACULTURE, V273, P374, DOI 10.1016/j.aquaculture.2007.10.019; Ford JS, 2008, PLOS BIOL, V6, P411, DOI 10.1371/journal.pbio.0060033; FRASER NL, 2009, CONS BIOL, V23, P599; Gottesfeld AS, 2009, J FISH DIS, V32, P45, DOI 10.1111/j.1365-2761.2008.01003.x; Groot C., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P53; Heuch PA, 2005, AQUACULTURE, V246, P79, DOI 10.1016/j.aquaculture.2004.12.027; Holst JC, 2000, FISH RES, V48, P87, DOI 10.1016/S0165-7836(00)00116-8; *INT UN CONS NAT, 2008, PAC SOCK SALM ONC NE; JESSUP DA, 1991, WILDLIFE PRODUCTION, P438; JOHNSON SC, 1991, CAN J ZOOL, V69, P929, DOI 10.1139/z91-138; KABATA Z, 1972, J FISH RES BOARD CAN, V29, P1571, DOI 10.1139/f72-245; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; KRKOSEK M, 2010, ECOL APPL IN PRESS; Krkosek M, 2007, P R SOC B, V274, P3141, DOI 10.1098/rspb.2007.1122; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Krkosek M, 2006, P NATL ACAD SCI USA, V103, P15506, DOI 10.1073/pnas.0603525103; Krkosek M, 2011, CAN J FISH AQUAT SCI, V68, P17, DOI 10.1139/F10-137; Krkosek M, 2010, FRONT ECOL ENVIRON, V8, P201, DOI 10.1890/080097; Krkosek M, 2009, P ROY SOC B-BIOL SCI, V276, P2819, DOI 10.1098/rspb.2009.0317; *LEG ASS BRIT COL, 2007, SPEC COMM SUST AQ FI; Macdonald DW, 2006, BIOL CONSERV, V131, P143, DOI 10.1016/j.biocon.2006.05.007; *MAR HARV CORP, 2008, SUST REP; Marty GD, 2010, P NATL ACAD SCI USA, V107, P22599, DOI 10.1073/pnas.1009573108; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Morton A, 2004, CAN J FISH AQUAT SCI, V61, P147, DOI 10.1139/F04-016; Morton A, 2008, N AM J FISH MANAGE, V28, P523, DOI 10.1577/M07-042.1; Morton Alexandra, 2005, Alaska Fishery Research Bulletin, V11, P146; Murray AG, 2005, PREV VET MED, V67, P223, DOI 10.1016/j.prevetmed.2004.10.012; Murray AG, 2009, PREV VET MED, V88, P167, DOI 10.1016/j.prevetmed.2008.09.006; NESE L, 1993, DIS AQUAT ORGAN, V16, P79, DOI 10.3354/dao016079; NYLUND A, 1994, DIS AQUAT ORGAN, V19, P95, DOI 10.3354/dao019095; Orr C, 2007, N AM J FISH MANAGE, V27, P187, DOI 10.1577/M06-043.1; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; PARKER RR, 1964, J FISH RES BOARD CAN, V21, P873, DOI 10.1139/f64-085; Pella J, 2001, FISH B-NOAA, V99, P151; Penston MJ, 2008, DIS AQUAT ORGAN, V81, P109, DOI 10.3354/dao01946; Peterman R.M., 2010, SYNTH EV WORKSH DECL; Pike AW, 2000, ADV PARASIT, V44, P233; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Price MHH, 2010, CAN J FISH AQUAT SCI, V67, P1925, DOI 10.1139/F10-105; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Thirgood S, 2009, J APPL ECOL, V46, P454, DOI 10.1111/j.1365-2664.2009.01629.x; THOMSON RE, 1981, CAN SPEC PUB FISH AQ, V56; Tully O, 1999, PARASITOLOGY, V119, P41, DOI 10.1017/S003118209900445X; Webster SJ, 2007, CAN J FISH AQUAT SCI, V64, P672, DOI 10.1139/F07-043; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Withler RE, 2000, CAN J FISH AQUAT SCI, V57, P1985, DOI 10.1139/cjfas-57-10-1985; [No title captured]; 2009, ADAPTING CHANGE MANA	65	34	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16851	10.1371/journal.pone.0016851	http://dx.doi.org/10.1371/journal.pone.0016851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347456	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700045
J	Tiang, JM; Butcher, NJ; Cullinane, C; Humbert, PO; Minchin, RF				Tiang, Jacky M.; Butcher, Neville J.; Cullinane, Carleen; Humbert, Patrick O.; Minchin, Rodney F.			RNAi-Mediated Knock-Down of Arylamine N-acetyltransferase-1 Expression Induces E-cadherin Up-Regulation and Cell-Cell Contact Growth Inhibition	PLOS ONE			English	Article							ACETYLTRANSFERASE TYPE-I; N-ACETYLTRANSFERASE; CANCER CELLS; PROGNOSTIC-SIGNIFICANCE; TUMOR PROGRESSION; PROSTATE-CANCER; BREAST-CANCER; GENE; METABOLISM; CARCINOMA	Arylamine N-acetyltransferase-1 (NAT1) is an enzyme that catalyzes the biotransformation of arylamine and hydrazine substrates. It also has a role in the catabolism of the folate metabolite p-aminobenzoyl glutamate. Recent bioinformatics studies have correlated NAT1 expression with various cancer subtypes. However, a direct role for NAT1 in cell biology has not been established. In this study, we have knocked down NAT1 in the colon adenocarcinoma cell-line HT-29 and found a marked change in cell morphology that was accompanied by an increase in cell-cell contact growth inhibition and a loss of cell viability at confluence. NAT1 knock-down also led to attenuation in anchorage independent growth in soft agar. Loss of NAT1 led to the up-regulation of E-cadherin mRNA and protein levels. This change in E-cadherin was not attributed to RNAi off-target effects and was also observed in the prostate cancer cell-line 22Rv1. In vivo, NAT1 knock-down cells grew with a longer doubling time compared to cells stably transfected with a scrambled RNAi or to parental HT-29 cells. This study has shown that NAT1 affects cell growth and morphology. In addition, it suggests that NAT1 may be a novel drug target for cancer therapeutics.	[Tiang, Jacky M.; Butcher, Neville J.; Minchin, Rodney F.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Cullinane, Carleen; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	University of Queensland; Peter Maccallum Cancer Center	Tiang, JM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	n.butcher@uq.edu.au	Humbert, Patrick O/L-4264-2016	Humbert, Patrick O/0000-0002-1366-6691; Cullinane, Carleen/0000-0001-5833-6605; Minchin, Rodney/0000-0002-3178-4835; Butcher, Neville/0000-0002-0709-5589	National Health and Medical Research Foundation, Australia [NHMRC 569695]	National Health and Medical Research Foundation, Australia	This work was supported by National Health and Medical Research Foundation, Australia (NHMRC 569695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2003, MOL CANCER RES, V1, P826; Bieche I, 2004, BREAST CANCER RES, V6, pR252, DOI 10.1186/bcr784; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butcher N. J., 2002, Pharmacogenomics Journal, V2, P30, DOI 10.1038/sj.tpj.6500053; Butcher NJ, 2007, CANCER RES, V67, P85, DOI 10.1158/0008-5472.CAN-06-2635; Butcher NJ, 2004, J BIOL CHEM, V279, P22131, DOI 10.1074/jbc.M312858200; Butcher NJ, 2003, BIOCHEM J, V376, P441, DOI 10.1042/BJ20030650; Butcher NJ, 2000, MOL PHARMACOL, V57, P468, DOI 10.1124/mol.57.3.468; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cao W, 2005, PHARMACOGENOMICS J, V5, P255, DOI 10.1038/sj.tpj.6500319; Castillon N, 2002, LAB INVEST, V82, P989, DOI 10.1097/01.LAB.0000022221.88025.43; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gout S, 2004, EXP CELL RES, V299, P498, DOI 10.1016/j.yexcr.2004.06.008; Gustafson CE, 1996, CANCER RES, V56, P5238; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hawcroft G, 2007, ONCOGENE, V26, P3006, DOI 10.1038/sj.onc.1210113; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Howard EW, 2008, MINI-REV MED CHEM, V8, P496, DOI 10.2174/138955708784223521; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Mell LK, 2004, CLIN CANCER RES, V10, P5546, DOI 10.1158/1078-0432.CCR-0943-03; MINCHIN RF, 1995, BIOCHEM J, V307, P1; Motti ML, 2005, CARCINOGENESIS, V26, P1021, DOI 10.1093/carcin/bgi050; NAGASAWA H, 1995, CANCER RES, V55, P1842; NAVARRO P, 1991, J CELL BIOL, V115, P517, DOI 10.1083/jcb.115.2.517; Nelson Peter J, 2002, Kidney Int, V61, pS99; OKA H, 1993, CANCER RES, V53, P1696; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Siitonen SM, 1996, AM J CLIN PATHOL, V105, P394; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sugamori KS, 2003, MOL PHARMACOL, V64, P170, DOI 10.1124/mol.64.1.170; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Voutilainen KA, 2006, J CLIN PATHOL, V59, P460, DOI 10.1136/jcp.2005.029876; Wakefield L, 2007, BIOCHEM BIOPH RES CO, V364, P556, DOI 10.1016/j.bbrc.2007.10.026; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200	39	48	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e17031	10.1371/journal.pone.0017031	http://dx.doi.org/10.1371/journal.pone.0017031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347396	Green Published, gold			2022-12-25	WOS:000287361700064
J	Xu, X; Wang, X; Xiao, ZT; Li, Y; Wang, YH				Xu, Xue; Wang, Xia; Xiao, Zhengtao; Li, Yan; Wang, Yonghua			Two TPX2-Dependent Switches Control the Activity of Aurora A	PLOS ONE			English	Article							AMBER FORCE-FIELD; DYNAMICS SIMULATION; MOLECULAR-DYNAMICS; A ACTIVATION; KINASE; PROTEIN; CANCER; TPX2; CRYSTALLOGRAPHY; CENTROSOME	Aurora A is an important oncogenic kinase for mitotic spindle assembly and a potentially attractive target for human cancers. Its activation could be regulated by ATP cycle and its activator TPX2. To understand the activation mechanism of Aurora A, a series of 20 ns molecular dynamics (MD) simulations were performed on both the wild-type kinase and its mutants. Analyzing the three dynamic trajectories (Aurora A-ATP, Aurora A-ADP, and Aurora A-ADP-TPX2) at the residue level, for the first time we find two TPX2-dependent switches, i.e., switch-1 (Lys-143) and switch-2 (Arg-180), which are tightly associated with Aurora A activation. In the absence of TPX2, Lys-143 exhibits a "closed'' state, and becomes hydrogen-bonded to ADP. Once TPX2 binding occurs, switch-1 is forced to "open'' the binding site, thus pulling ADP away from Aurora A. Without facilitation of TPX2, switch-2 exits in an "open'' conformation which accompanies the outward-flipping movement of P.Thr288 (in an inactive conformation), leading to the crucial phosphothreonine exposed and accessible for deactivation. However, with the binding of TPX2, switch-2 is forced to undergo a "closed'' movement, thus capturing P.Thr288 into a buried position and locking its active conformation. Analysis of two Aurora A (K143A and R180A) mutants for the two switches further verifies their functionality and reliability in controlling Aurora activity. Our systems therefore suggest two switches determining Aurora A activation, which are important for the development of aurora kinase inhibitors.	[Xu, Xue; Wang, Xia; Xiao, Zhengtao; Wang, Yonghua] NW A&F Univ, Ctr Bioinformat, Yangling, Peoples R China; [Li, Yan] Dalian Univ Technol, Sch Chem Engn, Dalian, Peoples R China; [Li, Yan] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian, Peoples R China	Northwest A&F University - China; Dalian University of Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Wang, YH (corresponding author), NW A&F Univ, Ctr Bioinformat, Yangling, Peoples R China.	dcpwyh@163.com	Xiao, Zhengtao/AAD-3052-2019; , Paulin/U-9063-2019; WANG, XIA/S-3431-2018	Xiao, Zhengtao/0000-0002-5535-5381; , Paulin/0000-0001-6045-3712; WANG, XIA/0000-0003-1960-4157	National Natural Science Foundation of China [10801025]; Northwest A F University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest A F University	This work is financially supported by the National Natural Science Foundation of China (Grant No. 10801025) and also the Fund of Northwest A & F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bibby RA, 2009, J BIOL CHEM, V284, P33177, DOI 10.1074/jbc.M109.032722; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Goodsell D. S., 1996, OUR MOL NATURE BODYS; Groen AC, 2008, J CELL SCI, V121, P2293, DOI 10.1242/jcs.024018; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lu BZ, 2005, PROTEIN SCI, V14, P159, DOI 10.1110/ps.04894605; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Satinover DL, 2004, P NATL ACAD SCI USA, V101, P8625, DOI 10.1073/pnas.0402966101; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	28	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16757	10.1371/journal.pone.0016757	http://dx.doi.org/10.1371/journal.pone.0016757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347367	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700032
J	Ma, GZM; Stankovich, J; Kilpatrick, TJ; Binder, MD; Field, J				Ma, Gerry Z. M.; Stankovich, Jim; Kilpatrick, Trevor J.; Binder, Michele D.; Field, Judith		Australia New Zealand Multiple Scl	Polymorphisms in the Receptor Tyrosine Kinase MERTK Gene Are Associated with Multiple Sclerosis Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CUPRIZONE-INDUCED DEMYELINATION; APOPTOTIC CELLS; PROTEIN-S; TAM RECEPTORS; T-CELLS; GAS6; REPLICATION; LOCI; MICE	Multiple sclerosis (MS) is a debilitating, chronic demyelinating disease of the central nervous system affecting over 2 million people worldwide. The TAM family of receptor tyrosine kinases (TYRO3, AXL and MERTK) have been implicated as important players during demyelination in both animal models of MS and in the human disease. We therefore conducted an association study to identify single nucleotide polymorphisms (SNPs) within genes encoding the TAM receptors and their ligands associated with MS. Analysis of genotype data from a genome-wide association study which consisted of 1618 MS cases and 3413 healthy controls conducted by the Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) revealed several SNPs within the MERTK gene (Chromosome 2q14.1, Accession Number NG_011607.1) that showed suggestive association with MS. We therefore interrogated 28 SNPs in MERTK in an independent replication cohort of 1140 MS cases and 1140 healthy controls. We found 12 SNPs that replicated, with 7 SNPs showing p-values of less than 10 25 when the discovery and replication cohorts were combined. All 12 replicated SNPs were in strong linkage disequilibrium with each other. In combination, these data suggest the MERTK gene is a novel risk gene for MS susceptibility.	[Ma, Gerry Z. M.; Kilpatrick, Trevor J.; Binder, Michele D.; Field, Judith] Univ Melbourne, Florey Neurosci Inst, Multiple Sclerosis Div, Melbourne, Vic, Australia; [Ma, Gerry Z. M.; Kilpatrick, Trevor J.; Binder, Michele D.; Field, Judith] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Stankovich, Jim] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Tasmania; Menzies Institute for Medical Research	Ma, GZM (corresponding author), Univ Melbourne, Florey Neurosci Inst, Multiple Sclerosis Div, Melbourne, Vic, Australia.	judith.field@florey.edu.au	Kermode, Allan/G-3568-2019; MOSCATO, PABLO ALBERTO/G-7668-2013; Browning, Brian L/A-1178-2010; Brown, Matthew A/E-5749-2010; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	Kermode, Allan/0000-0002-4476-4016; Browning, Brian L/0000-0001-6454-6633; Brown, Matthew A/0000-0003-0538-8211; Moscato, Pablo/0000-0003-2570-5966; Binder, Michele/0000-0002-4494-6717; Scott, Rodney/0000-0001-7724-3404; Stankovich, Jim/0000-0001-9344-7749; Foote, Simon/0000-0002-9142-2107; Lechner-Scott, Jeannette/0000-0002-3850-447X; Field, Judith/0000-0002-7089-0999; Butzkueven, Helmut/0000-0003-3940-8727; Griffiths, Lyn/0000-0002-6774-5475; Slee, Mark/0000-0003-4323-2453; Kilpatrick, Trevor/0000-0003-3999-085X	Perpetual Trustees Australia Ltd [387]; Australian Research Council [LP0776744]; Australian Postgraduate Award; Multiple Sclerosis Research Australia Fellowship; Department of Innovation, Industry and Regional Development, Victoria, Australia; Perpetual Trustees Australia Ltd	Perpetual Trustees Australia Ltd; Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); Multiple Sclerosis Research Australia Fellowship; Department of Innovation, Industry and Regional Development, Victoria, Australia; Perpetual Trustees Australia Ltd	This work was supported by a grant from Perpetual Trustees Australia Ltd (Grant number 387) and the Australian Research Council (Linkage Project Grant Number LP0776744). G.Z.M.M is supported by an Australian Postgraduate Award. J.F. is supported by a Multiple Sclerosis Research Australia Fellowship. The Florey Neuroscience Institutes is supported by funding provided from the Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts: This work was funded by Perpetual Trustees Australia Ltd. This does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.	Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; Binder MD, 2009, NEUROSIGNALS, V17, P277, DOI 10.1159/000231894; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hiremath MM, 2008, J NEUROIMMUNOL, V203, P23, DOI 10.1016/j.jneuroim.2008.06.034; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li RH, 1996, J NEUROSCI, V16, P2012; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shankar SL, 2003, J NEUROSCI, V23, P4208; Shao WH, 2008, J IMMUNOL, V180, P7728, DOI 10.4049/jimmunol.180.11.7728; SHAO WH, 2010, J AUTOIMMUN; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Wallet MA, 2009, P NATL ACAD SCI USA, V106, P4810, DOI 10.1073/pnas.0900683106; Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807; Yagami T, 2002, NEUROPHARMACOLOGY, V43, P1289, DOI 10.1016/S0028-3908(02)00333-7	38	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16964	10.1371/journal.pone.0016964	http://dx.doi.org/10.1371/journal.pone.0016964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347448	Green Published, gold			2022-12-25	WOS:000287077600037
J	Duvernay, MT; Wang, H; Dong, CM; Guidry, JJ; Sackett, DL; Wu, GY				Duvernay, Matthew T.; Wang, Hong; Dong, Chunmin; Guidry, Jesse J.; Sackett, Dan L.; Wu, Guangyu			alpha(2B)-Adrenergic Receptor Interaction with Tubulin Controls Its Transport from the Endoplasmic Reticulum to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; 3RD INTRACELLULAR LOOP; ANGIOTENSIN-II RECEPTORS; TO-GOLGI TRANSPORT; C-TERMINAL TAIL; G-BETA-GAMMA; ALPHA(2)-ADRENERGIC RECEPTORS; ANTEROGRADE TRANSPORT; MUSCARINIC RECEPTORS; MEMBRANE TRAFFICKING	It is well recognized that the C terminus (CT) plays a crucial role in modulating G protein-coupled receptor (GPCR) transport from the endoplasmic reticulum (ER) to the cell surface. However the molecular mechanisms that govern CT-dependent ER export remain elusive. To address this issue, we used alpha(2B)-adrenergic receptor (alpha(2B)-AR) as a model GPCR to search for proteins interacting with the CT. By using peptide-conjugated affinity matrix combined with proteomics and glutathione S-transferase fusion protein pull-down assays, we identified tubulin directly interacting with the alpha(2B)-AR CT. The interaction domains weremappedto the acidic CT of tubulin and the basic Arg residues in the alpha(2B)-AR CT, particularly Arg-437, Arg-441, and Arg-446. More importantly, mutation of these Arg residues to disrupt tubulin interaction markedly inhibited alpha(2B)-AR transport to the cell surface and strongly arrested the receptor in the ER. These data provide the first evidence indicating that the alpha(2B)-AR C-terminal Arg cluster mediates its association with tubulin to coordinate its ER-to-cell surface traffic and suggest a novel mechanism of GPCR export through physical contact with microtubules.	[Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Duvernay, Matthew T.; Wang, Hong; Dong, Chunmin; Guidry, Jesse J.; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Wang, Hong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Sackett, Dan L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Integrat & Med Biophys, Program Phys Biol, NIH, Bethesda, MD 20892 USA	University System of Georgia; Augusta University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@georgiahealth.edu		Guidry, Jessie/0000-0002-5601-0430	National Institutes of Health [R01GM076167, P20RR018766]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM076167 (to G. W.) and P20RR018766 Principal Investigator: Daniel R. Kapusta, and by Intramural Research Funds of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (to D. L. S.).	Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen Y, 2009, J BIOL CHEM, V284, P1673, DOI 10.1074/jbc.M808303200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ciruela F, 2001, J NEUROCHEM, V76, P750, DOI 10.1046/j.1471-4159.2001.00099.x; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MIZUNO M, 1994, J CELL SCI, V107, P1321; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Narishige T, 1999, J BIOL CHEM, V274, P9692, DOI 10.1074/jbc.274.14.9692; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; POPOVA JS, 1994, J BIOL CHEM, V269, P21748; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SARASTE J, 1991, J CELL SCI, V100, P415; Sarma T, 2003, FASEB J, V17, P848, DOI 10.1096/fj.02-0730com; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Saugstad JA, 2002, J NEUROCHEM, V80, P980, DOI 10.1046/j.0022-3042.2002.00778.x; Saunders C, 2000, MOL PHARMACOL, V57, P44; Saunders C, 1997, J BIOL CHEM, V272, P19035, DOI 10.1074/jbc.272.30.19035; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Simon V, 2006, J BIOL CHEM, V281, P40310, DOI 10.1074/jbc.M603858200; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Themmen APN, 1996, EUR J ENDOCRINOL, V134, P533, DOI 10.1530/eje.0.1340533; Uemura K, 2004, CURR ALZHEIMER RES, V1, P1, DOI 10.2174/1567205043480528; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	62	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14080	14089		10.1074/jbc.M111.222323	http://dx.doi.org/10.1074/jbc.M111.222323			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357695	hybrid, Green Published			2022-12-25	WOS:000289556200031
J	Chicha, L; Feki, A; Boni, A; Irion, O; Hovatta, O; Jaconi, M				Chicha, Laurie; Feki, Anis; Boni, Alessandro; Irion, Olivier; Hovatta, Outi; Jaconi, Marisa			Human Pluripotent Stem Cells Differentiated in Fully Defined Medium Generate Hematopoietic CD34(+) and CD34(-) Progenitors with Distinct Characteristics	PLOS ONE			English	Article							HUMAN FIBROBLASTS; GROWTH-FACTOR; FLT3 LIGAND; IMMUNOGENICITY; EXPANSION; ANEMIA; LINES	Background: Differentiation of pluripotent stem cells in vitro provides a powerful means to investigate early developmental fates, including hematopoiesis. In particular, the use of a fully defined medium (FDM) would avoid biases induced by unidentified factors contained in serum, and would also allow key molecular mediators involved in such a process to be identified. Our goal was to induce in vitro, the differentiation of human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) into morphologically and phenotypically mature leukocytes and erythrocytes, in the complete absence of serum and feeder cells. Methodology/Principal Findings: ESC and iPSC were sequentially induced in liquid cultures for 4 days with bone morphogenic protein-4, and for 4 days with FLT3-ligand, stem cell factor, thrombopoietin and vascular endothelium growth factor. Cell differentiation status was investigated by both mRNA expression and FACS expression profiles. Cells were further sorted and assayed for their hematopoietic properties in colony-forming unit (CFU) assays. In liquid cultures, cells progressively down-modulated Oct-4 expression while a sizeable cell fraction expressed CD34 de novo. SCL/Tal1 and Runx1 transcripts were exclusively detected in CD34(+) cells. In clonal assays, both ESC and iPSC-derived cells generated CFU, albeit with a 150-fold lower efficacy than cord blood (CB) CD34(+) cells. ESC-derived CD34(+) cells generated myeloid and fully hemoglobinized erythroid cells whereas CD34(-) cells almost exclusively generated small erythroid colonies. Both ESC and iPSC-derived erythroid cells expressed embryonic and fetal globins but were unable to synthesize adult beta-globin in contrast with CB cells, suggesting that they had differentiated from primitive rather than from definitive hematopoietic progenitors. Conclusions/Significance: Short-term, animal protein-free culture conditions are sufficient to sustain the differentiation of human ESC and iPSC into primitive hematopoietic progenitors, which, in turn, produce more mature blood cell types. However, additional factors have yet to be identified to allow their differentiation into definitive erythroid cultures.	[Chicha, Laurie; Boni, Alessandro; Jaconi, Marisa] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Feki, Anis; Irion, Olivier; Hovatta, Outi] Univ Hosp Geneva, Dept Gynecol & Obstet, Stem Cell Res Lab, Geneva, Switzerland; [Hovatta, Outi] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	University of Geneva; University of Geneva; Karolinska Institutet	Chicha, L (corresponding author), Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland.	marisa.jaconi@unige.ch	Jaconi, Marisa EE/J-4392-2013	Jaconi, Marisa/0000-0002-2004-8226; Feki, Anis/0000-0002-9817-9445	European Molecular Biology Organization [ALTF-363-2006]; Roche Research Foundation; Dinu Lipatti-Dr. Henri Dubois-Ferriere Leukemia Foundation; Swiss National Science Foundation [310031-110002]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Roche Research Foundation; Dinu Lipatti-Dr. Henri Dubois-Ferriere Leukemia Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by European Molecular Biology Organization (LC, grant #ALTF-363-2006), the Roche Research Foundation (LC, MJ), the Dinu Lipatti-Dr. Henri Dubois-Ferriere Leukemia Foundation (LC) and the Swiss National Science Foundation (MJ, grant #310031-110002). Reagents such as Flt3-ligand and SCF have been kindly donated by Amgen, while VEGF and bFGF have been kindly provided by NCI Biological Resources branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Drukker M, 2006, METHOD ENZYMOL, V420, P391, DOI 10.1016/S0076-6879(06)20019-3; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Galic Z, 2006, P NATL ACAD SCI USA, V103, P11742, DOI 10.1073/pnas.0604244103; Grinnemo KH, 2008, CELL TISSUE RES, V331, P67, DOI 10.1007/s00441-007-0486-3; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Imreh MP, 2004, STEM CELLS DEV, V13, P337, DOI 10.1089/1547328041797534; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lu M, 2009, EXP HEMATOL, V37, P924, DOI 10.1016/j.exphem.2009.05.007; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; LYMAN SD, 1995, BLOOD, V86, P4091, DOI 10.1182/blood.V86.11.4091.bloodjournal86114091; McKinney-Freeman SL, 2007, CURR OPIN HEMATOL, V14, P343, DOI 10.1097/MOH.0b013e3281900edd; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Piacibello W, 1998, LEUKEMIA, V12, P718, DOI 10.1038/sj.leu.2401003; Piacibello W, 1998, Stem Cells, V16 Suppl 2, P243; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Senju S, 2007, STEM CELLS, V25, P2720, DOI 10.1634/stemcells.2007-0321; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; UNGER C, 2009, HUM REPROD; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; WodnarFilipowicz A, 1996, BLOOD, V88, P4493, DOI 10.1182/blood.V88.12.4493.bloodjournal88124493; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4	30	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e14733	10.1371/journal.pone.0014733	http://dx.doi.org/10.1371/journal.pone.0014733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364915	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100004
J	Putila, J; Remick, SC; Guo, NL				Putila, Joseph; Remick, Scot C.; Guo, Nancy Lan			Combining Clinical, Pathological, and Demographic Factors Refines Prognosis of Lung Cancer: A Population-Based Study	PLOS ONE			English	Article							K-RAS ONCOGENE; GENE-EXPRESSION; TUMOR VOLUME; RADIATION-THERAPY; PREDICT SURVIVAL; CELL; ADENOCARCINOMA; STAGE; VALIDATION; MODEL	Background: In the treatment of lung cancer, an accurate estimation of patient clinical outcome is essential for choosing an appropriate course of therapy. It is important to develop a prognostic stratification model which combines clinical, pathological and demographic factors for individualized clinical decision making. Methodology/Principal Findings: A total of 234,412 patients diagnosed with adenocarcinomas or squamous cell carcinomas of the lung or bronchus between 1988 and 2006 were retrieved from the SEER database to construct a prognostic model. A model was developed by estimating a Cox proportional hazards model on 500 bootstrapped samples. Two models, one using stage alone and another comprehensive model using additional covariates, were constructed. The comprehensive model consistently outperformed the model using stage alone in prognostic stratification and on Harrell's C, Nagelkerke's R(2), and Brier Scores in the whole patient population as well as in specific treatment modalities. Specifically, the comprehensive model generated different prognostic groups with distinct post-operative survival (log-rank P < 0.001) within surgical stage IA and IB patients in Kaplan-Meier analyses. Two additional patient cohorts (n = 1,991) were used as an external validation, with the comprehensive model again outperforming the model using stage alone with regards to prognostic stratification and the three evaluated metrics. Conclusion/Significance: These results demonstrate the feasibility of constructing a precise prognostic model combining multiple clinical, pathologic, and demographic factors. The comprehensive model significantly improves individualized prognosis upon AJCC tumor staging and is robust across a range of treatment modalities, the spectrum of patient risk, and in novel patient cohorts.	[Putila, Joseph; Remick, Scot C.; Guo, Nancy Lan] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Putila, Joseph; Guo, Nancy Lan] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA; [Remick, Scot C.] W Virginia Univ, Dept Med, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Putila, J (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	lguo@hsc.wvu.edu			NIH NLM [R01LM009500]; NCRR [P20RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R56LM009500, R01LM009500] Funding Source: NIH RePORTER	NIH NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by NIH NLM R01LM009500 (PI: Guo) and NCRR P20RR16440 and Supplement (PD: Guo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America Joint Committee on Cancer, 2010, AJCC CANC STAG MAN; Ball D, 2002, INT J RADIAT ONCOL, V54, P1007, DOI 10.1016/S0360-3016(02)03046-8; Basaki K, 2006, INT J RADIAT ONCOL, V64, P449, DOI 10.1016/j.ijrobp.2005.07.967; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Birim O, 2006, J THORAC CARDIOV SUR, V132, P491, DOI 10.1016/j.jtcvs.2006.04.010; Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; Bradley JD, 2002, INT J RADIAT ONCOL, V52, P49, DOI 10.1016/S0360-3016(01)01772-2; Brown JS, 1996, THORAX, V51, P564, DOI 10.1136/thx.51.6.564; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Dehing-Oberije C, 2010, INT J RAD ONCOL BIOL; Dehing-Oberije C, 2008, INT J RADIAT ONCOL, V70, P1039, DOI 10.1016/j.ijrobp.2007.07.2323; Dehing-Oberije C, 2009, INT J RADIAT ONCOL, V74, P355, DOI 10.1016/j.ijrobp.2008.08.052; Firat S, 2002, INT J RADIAT ONCOL, V54, P357, DOI 10.1016/S0360-3016(02)02939-5; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; HORIO Y, 1993, CANCER RES, V53, P1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; OROURKE MA, 1987, JAMA-J AM MED ASSOC, V258, P921, DOI 10.1001/jama.258.7.921; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Solan Merrill J, 2003, Semin Surg Oncol, V21, P64, DOI 10.1002/ssu.10023; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Surveillance Epidemiology and End Results (SEER) Program, 1969, SEER STAT DAT INC SE; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Visbal AL, 2004, ANN THORAC SURG, V78, P209, DOI 10.1016/j.athoracsur.2003.11.021; Werner-Wasik M, 2008, INT J RADIAT ONCOL, V70, P385, DOI 10.1016/j.ijrobp.2007.06.034	38	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17493	10.1371/journal.pone.0017493	http://dx.doi.org/10.1371/journal.pone.0017493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364765	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100067
J	Yang, SJ; Choi, JM; Chae, SW; Kim, WJ; Park, SE; Rhee, EJ; Lee, WY; Oh, KW; Park, SW; Kim, SW; Park, CY				Yang, Soo Jin; Choi, Jung Mook; Chae, Seoung Wan; Kim, Won Jun; Park, Se Eun; Rhee, Eun Jung; Lee, Won Young; Oh, Ki Won; Park, Sung Woo; Kim, Sun Woo; Park, Cheol-Young			Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats	PLOS ONE			English	Article							FATTY LIVER; PROTEIN-KINASE; NONALCOHOLIC STEATOHEPATITIS; MAMMALIAN SIRTUINS; LIPID-METABOLISM; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; THIAZOLIDINEDIONES; DISRUPTION; DISEASE	Background: Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. Methods: To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg.kg(-1).day(-1)) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes. Results: RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-alpha (Ppargc1a/PGC1-alpha) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-alpha and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects. Conclusion: Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis.	[Yang, Soo Jin; Choi, Jung Mook] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Diabet Res Inst, Seoul, South Korea; [Chae, Seoung Wan] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Pathol, Seoul, South Korea; [Kim, Won Jun; Park, Se Eun; Rhee, Eun Jung; Lee, Won Young; Oh, Ki Won; Park, Sung Woo; Kim, Sun Woo; Park, Cheol-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Yang, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Diabet Res Inst, Seoul, South Korea.	cydoctor@chol.com	LEE, WON-YOUNG/C-7249-2018; Rhee, Eun-Jung/M-9294-2015; Park, Cheol-Young/C-6690-2018	LEE, WON-YOUNG/0000-0002-1082-7592; Rhee, Eun-Jung/0000-0002-6108-7758; Park, Cheol-Young/0000-0002-9415-9965; Yang, Soo Jin/0000-0001-7892-7648	Korea Institute of Medicine	Korea Institute of Medicine	This work was supported by a grant from the Korea Institute of Medicine (http://www.kiom.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Z, 2010, BASIC CLIN PHARMACOL, V107, P663, DOI 10.1111/j.1742-7843.2010.00553.x; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kang JG, 2010, METABOLISM, V59, P46, DOI 10.1016/j.metabol.2009.07.004; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Promrat K, 2004, HEPATOLOGY, V39, P188, DOI 10.1002/hep.20012; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ratziu V, 2008, GASTROENTEROLOGY, V135, P100, DOI 10.1053/j.gastro.2008.03.078; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Samaha FF, 2006, ARTERIOSCL THROM VAS, V26, P624, DOI 10.1161/01.ATV.0000200136.56716.30; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yki-Jarvinen H, 2005, CURR MOL MED, V5, P287, DOI 10.2174/1566524053766031	41	55	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17057	10.1371/journal.pone.0017057	http://dx.doi.org/10.1371/journal.pone.0017057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373642	Green Published, Green Submitted, gold			2022-12-25	WOS:000287657500029
J	Ziu, MT; Fletcher, L; Rana, S; Jimenez, DF; Digicaylioglu, M				Ziu, Mateo; Fletcher, Lauren; Rana, Shushan; Jimenez, David F.; Digicaylioglu, Murat			Temporal Differences in MicroRNA Expression Patterns in Astrocytes and Neurons after Ischemic Injury	PLOS ONE			English	Article							GROWTH-FACTOR-I; TRANSIENT FOCAL ISCHEMIA; GENE-EXPRESSION; REAL-TIME; MICROARRAY ANALYSIS; MIRNA EXPRESSION; BRAIN-INJURY; HYPOXIA; PROLIFERATION; MECHANISMS	MicroRNAs (miRNAs) are small, non-protein-coding RNA molecules that modulate gene translation. Their expression is altered in many central nervous system (CNS) injuries suggesting a role in the cellular response to stress. Current studies in brain tissue have not yet described the cell-specific temporal miRNA expression patterns following ischemic injury. In this study, we analyzed the expression alterations of a set of miRNAs in neurons and astrocytes subjected to 60 minutes of ischemia and collected at different time-points following this injury. To mimic ischemic conditions and reperfusion in vitro, cortical primary neuronal and astrocytic cultures prepared from fetal rats were first placed in oxygen and glucose deprived (OGD) medium for 60 minutes, followed by their transfer into normoxic pre-conditioned medium. Total RNA was extracted at different time-points after the termination of the ischemic insult and the expression levels of miRNAs were measured. In neurons exposed to OGD, expression of miR-29b was upregulated 2-fold within 6 h and up to 4-fold at 24 h post-OGD, whereas induction of miR-21 was upregulated 2-fold after 24 h when compared to expression in neurons under normoxic conditions. In contrast, in astrocytes, miR-29b and miR-21 were upregulated only after 12 h. MiR-30b, 107, and 137 showed expression alteration in astrocytes, but not in neurons. Furthermore, we show that expression of miR-29b was significantly decreased in neurons exposed to Insulin-Like Growth Factor I (IGF-I), a well documented neuroprotectant in ischemic models. Our study indicates that miRNAs expression is altered in neurons and astrocytes after ischemic injury. Furthermore, we found that following OGD, specific miRNAs have unique cell-specific temporal expression patterns in CNS. Therefore the specific role of each miRNA in different intracellular processes in ischemic brain and the relevance of their temporal and spatial expression patterns warrant further investigation that may lead to novel strategies for therapeutic interventions.	[Ziu, Mateo; Fletcher, Lauren; Rana, Shushan; Jimenez, David F.; Digicaylioglu, Murat] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Ziu, MT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA.	muratd@uthscsa.edu	Ziu, Mateo/AAR-4991-2020; Digicaylioglu, Murat H/D-3302-2009	Ziu, Mateo/0000-0002-3671-2638; Rana, Shushan/0000-0002-9298-1605	University of Texas Health Science Center San Antonio [130267]; Department of Neurosurgery at the University of Texas Health Science Center at San Antonio, San Antonio, Texas	University of Texas Health Science Center San Antonio; Department of Neurosurgery at the University of Texas Health Science Center at San Antonio, San Antonio, Texas	This work was supported in part by the University Research Council Grants Program at the University of Texas Health Science Center San Antonio (Grant 130267) and by the Department of Neurosurgery at the University of Texas Health Science Center at San Antonio, San Antonio, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-52; Alajajian BB, 2009, NEUROREPORT, V20, P579, DOI 10.1097/WNR.0b013e328329a41a; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Aumiller V, 2008, BBA-GENE REGUL MECH, V1779, P692, DOI 10.1016/j.bbagrm.2008.04.008; Babar IA, 2008, FUTURE ONCOL, V4, P289, DOI 10.2217/14796694.4.2.289; Barbato C, 2007, BRAIN RES, V1175, P17, DOI 10.1016/j.brainres.2007.07.088; Barbato C, 2008, MAMM GENOME, V19, P541, DOI 10.1007/s00335-008-9129-6; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; CHRISTENSEN M, 2009, NEUROSCI LETT; Correa-Cerro LS, 2007, J NEUROPATH EXP NEUR, V66, P169, DOI 10.1097/01.jnen.0000248555.53079.d5; COTTRELL JE, 1995, J NEUROSURG ANESTH, V7, P31, DOI 10.1097/00008506-199501000-00007; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; DICHTER MA, 1978, BRAIN RES, V149, P279, DOI 10.1016/0006-8993(78)90476-6; Digicaylioglu M, 2004, P NATL ACAD SCI USA, V101, P9855, DOI 10.1073/pnas.0403172101; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guimbellot JS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-15; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kawahigashi Yutaka, 2009, Journal of Nippon Medical School, V76, P188; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krichevsky Anna M, 2007, ScientificWorldJournal, V7, P155; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; LIU DZ, 2009, J CEREB BLOOD FLOW M; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; LIU NK, 2009, EXP NEUROL; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Malagelada C, 2004, STROKE, V35, P2396, DOI 10.1161/01.STR.0000141160.66818.24; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; NELSON PT, 2009, NEUROSCIENCE LETT; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sonkoly E, 2009, J CELL MOL MED, V13, P24, DOI 10.1111/j.1582-4934.2008.00534.x; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Trivedi S, 2009, INT J NEUROSCI, V119, P1995, DOI 10.1080/00207450903139788; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang WX, 2008, BBA-GENE REGUL MECH, V1779, P749, DOI 10.1016/j.bbagrm.2008.01.005; Wang W, 2008, J CLIN NEUROSCI, V15, P278, DOI 10.1016/j.jocn.2007.02.004; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	83	93	101	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14724	10.1371/journal.pone.0014724	http://dx.doi.org/10.1371/journal.pone.0014724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373187	Green Submitted, gold, Green Published			2022-12-25	WOS:000287657500008
J	Cui, H; Kohsaka, A; Waki, H; Bhuiyan, MER; Gouraud, SS; Maeda, M				Cui, He; Kohsaka, Akira; Waki, Hidefumi; Bhuiyan, Mohammad E. R.; Gouraud, Sabine S.; Maeda, Masanobu			Metabolic Cycles Are Linked to the Cardiovascular Diurnal Rhythm in Rats with Essential Hypertension	PLOS ONE			English	Article							PERIPHERAL CIRCADIAN CLOCKS; BLOOD-PRESSURE; GENE-EXPRESSION; MICE; ALPHA; MOUSE; LIVER; HEART; TRANSACTIVATION; RESPONSIVENESS	Background: The loss of diurnal rhythm in blood pressure (BP) is an important predictor of end-organ damage in hypertensive and diabetic patients. Recent evidence has suggested that two major physiological circadian rhythms, the metabolic and cardiovascular rhythms, are subject to regulation by overlapping molecular pathways, indicating that dysregulation of metabolic cycles could desynchronize the normal diurnal rhythm of BP with the daily light/dark cycle. However, little is known about the impact of changes in metabolic cycles on BP diurnal rhythm. Methodology/Principal Findings: To test the hypothesis that feeding-fasting cycles could affect the diurnal pattern of BP, we used spontaneously hypertensive rats (SHR) which develop essential hypertension with disrupted diurnal BP rhythms and examined whether abnormal BP rhythms in SHR were caused by alteration in the daily feeding rhythm. We found that SHR exhibit attenuated feeding rhythm which accompanies disrupted rhythms in metabolic gene expression not only in metabolic tissues but also in cardiovascular tissues. More importantly, the correction of abnormal feeding rhythms in SHR restored the daily BP rhythm and was accompanied by changes in the timing of expression of key circadian and metabolic genes in cardiovascular tissues. Conclusions/Significance: These results indicate that the metabolic cycle is an important determinant of the cardiovascular diurnal rhythm and that disrupted BP rhythms in hypertensive patients can be normalized by manipulating feeding cycles.	[Cui, He; Kohsaka, Akira; Waki, Hidefumi; Bhuiyan, Mohammad E. R.; Gouraud, Sabine S.; Maeda, Masanobu] Wakayama Med Univ, Sch Med, Dept Physiol, Wakayama, Japan	Wakayama Medical University	Cui, H (corresponding author), Wakayama Med Univ, Sch Med, Dept Physiol, Wakayama, Japan.	kohsaka@wakayama-med.ac.jp	Gouraud, Sabine S. S/N-3395-2018	Gouraud, Sabine S. S/0000-0002-4917-0647; Waki, Hidefumi/0000-0002-4278-2077	Japan Society for the Promotion of Science [22590226, 20890198]; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Mishima Kaiun Memorial Foundation; Suzuken Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Suzuken Memorial Foundation	This work was supported by Grants-in-Aid for Scientific Research (22590226) and for Young Scientists (20890198) from the Japan Society for the Promotion of Science. Additional support came from the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Mishima Kaiun Memorial Foundation, and the Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan F, 2007, EUR J CLIN INVEST, V37, P709, DOI 10.1111/j.1365-2362.2007.01854.x; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Buijs RM, 2006, PROG BRAIN RES, V153, P341, DOI 10.1016/S0079-6123(06)53020-1; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Elmquist JK, 2001, PHYSIOL BEHAV, V74, P703, DOI 10.1016/S0031-9384(01)00613-8; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Goh BC, 2007, BIOCHEM BIOPH RES CO, V360, P828, DOI 10.1016/j.bbrc.2007.06.136; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Inoue I, 2005, J ATHEROSCLER THROMB, V12, P169, DOI 10.5551/jat.12.169; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; MILLARCRAIG MW, 1978, LANCET, V1, P795; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; OBRIEN E, 1988, LANCET, V2, P397; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PICKERING TG, 1982, JAMA-J AM MED ASSOC, V247, P992, DOI 10.1001/jama.247.7.992; Reilly DF, 2008, ARTERIOSCL THROM VAS, V28, P121, DOI 10.1161/ATVBAHA.107.152538; Reilly DF, 2007, ARTERIOSCL THROM VAS, V27, P1694, DOI 10.1161/ATVBAHA.107.144923; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rudic RD, 2005, CIRCULATION, V112, P2716, DOI 10.1161/CIRCULATIONAHA.105.568626; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Swoap SJ, 2004, AM J PHYSIOL-REG I, V286, pR108, DOI 10.1152/ajpregu.00405.2003; VERDECCHIA P, 1990, CIRCULATION, V81, P528, DOI 10.1161/01.CIR.81.2.528; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Wu T, 2008, GENE, V419, P27, DOI 10.1016/j.gene.2008.04.010; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	47	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17339	10.1371/journal.pone.0017339	http://dx.doi.org/10.1371/journal.pone.0017339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364960	Green Submitted, gold, Green Published			2022-12-25	WOS:000287656600041
J	Garcia, AP; Palou, M; Sanchez, J; Priego, T; Palou, A; Pico, C				Paula Garcia, Ana; Palou, Mariona; Sanchez, Juana; Priego, Teresa; Palou, Andreu; Pico, Catalina			Moderate Caloric Restriction during Gestation in Rats Alters Adipose Tissue Sympathetic Innervation and Later Adiposity in Offspring	PLOS ONE			English	Article							NEUROPEPTIDE-Y; PREADIPOCYTE PROLIFERATION; PRENATAL UNDERNUTRITION; FOOD-INTAKE; WHITE; LEPTIN; NEURONS; OBESITY; DIET; GENE	Maternal prenatal undernutrition predisposes offspring to higher adiposity in adulthood. Mechanisms involved in these programming effects, apart from those described in central nervous system development, have not been established. Here we aimed to evaluate whether moderate caloric restriction during early pregnancy in rats affects white adipose tissue (WAT) sympathetic innervation in the offspring, and its relationship with adiposity development. For this purpose, inguinal and retroperitoneal WAT (iWAT and rpWAT, respectively) were analyzed in male and female offspring of control and 20% caloric-restricted (from 1-12 d of pregnancy) (CR) dams. Body weight (BW), the weight, DNA-content, morphological features and the immunoreactive tyrosine hydroxylase and Neuropeptide Y area (TH+ and NPY+ respectively, performed by immunohistochemistry) of both fat depots, were studied at 25 d and 6 m of age, the latter after 2 m exposure to high fat diet. At 6 m of life, CR males but not females, exhibited greater BW, and greater weight and total DNA-content in iWAT, without changes in adipocytes size, suggesting the development of hyperplasia in this depot. However, in rpWAT, CR males but not females, showed larger adipocyte diameter, with no changes in DNA-content, suggesting the development of hypertrophy. These parameters were not different between control and CR animals at the age of 25 d. In iWAT, both at 25 d and 6 m, CR males but not females, showed lower TH+ and NPY+, suggesting lower sympathetic innervation in CR males compared to control males. In rpWAT, at 6 m but not at 25 d, CR males but not females, showed lower TH+ and NPY+. Thus, the effects of caloric restriction during gestation on later adiposity and on the differences in the adult phenotype between internal and subcutaneous fat depots in the male offspring may be associated in part with specific alterations in sympathetic innervation, which may impact on WAT architecture.	[Paula Garcia, Ana] Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigenom, Palma de Mallorca, Spain; CIBER Fisiopatol Obesidad Nutr CIBEROBN, Palma de Mallorca, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Garcia, AP (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigenom, Palma de Mallorca, Spain.	andreu.palou@uib.es	Palou, Mariona/S-2098-2018; Sanchez, Juana/K-9675-2014; Pico, Catalina/H-7115-2015; Palou, Andreu/K-9881-2014; Priego, Teresa/H-9880-2015; Palou, Mariona/H-9208-2015	Palou, Mariona/0000-0001-9918-3764; Sanchez, Juana/0000-0002-9176-8060; Pico, Catalina/0000-0001-6759-5844; Palou, Andreu/0000-0002-0295-4452; Priego, Teresa/0000-0001-5397-0877; Palou, Mariona/0000-0001-9918-3764	Spanish Government [AGL2009-11277]; European Union [244995, FP6-506360]	Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission)	The research leading to these results was supported by the Spanish Government (grant AGL2009-11277) and the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement n<SUP>o</SUP> 244995 (BIOCLAIMS Project). The authors' Laboratory is a member of the European Research Network of Excellence NuGO (The European Nutrigenomics Organization, EU Contract: n<SUP>o</SUP> FP6-506360). The CIBER de Fisiopatologia de la obesidad y nutricion is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BOULOUMIE A, 1994, J BIOL CHEM, V269, P30254; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; CONBOY VB, 1987, J ANAT, V154, P47; COUSIN B, 1993, ENDOCRINOLOGY, V133, P2255, DOI 10.1210/en.133.5.2255; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; DUMONT Y, 1992, PROG NEUROBIOL, V38, P125, DOI 10.1016/0301-0082(92)90038-G; FAUST IM, 1984, AM J PHYSIOL, V247, P1038; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Gerhardt CC, 1999, MOL PHARMACOL, V55, P255, DOI 10.1124/mol.55.2.255; Gettys TW, 1996, ENDOCRINOLOGY, V137, P4054, DOI 10.1210/en.137.9.4054; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano A, 2005, J HISTOCHEM CYTOCHEM, V53, P679, DOI 10.1369/jhc.4A6566.2005; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey K M, 2001, Public Health Nutr, V4, P611; Gomes SP, 2009, J NEUROSCI RES, V87, P3568, DOI 10.1002/jnr.22167; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; JONES DD, 1992, INT J OBESITY, V16, P349; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDBERG JM, 1983, NEUROSCI LETT, V42, P167, DOI 10.1016/0304-3940(83)90401-9; LUNDBERG JM, 1985, BIOCHEM BIOPH RES CO, V133, P30, DOI 10.1016/0006-291X(85)91837-6; MURPHY GJ, 1993, BIOCHEM PHARMACOL, V46, P575, DOI 10.1016/0006-2952(93)90540-D; Oliver P, 2001, PFLUG ARCH EUR J PHY, V442, P383, DOI 10.1007/s004240100540; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; PRIEGO T, 2008, OBESITY SILVER SPRIN, P780; Roca P, 1999, PFLUG ARCH EUR J PHY, V438, P628, DOI 10.1007/s004240051086; SANTER RM, 1990, J ANAT, V168, P57; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Yang KP, 2008, FASEB J, V22, P2452, DOI 10.1096/fj.07-100735; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488	43	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17313	10.1371/journal.pone.0017313	http://dx.doi.org/10.1371/journal.pone.0017313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364997	Green Submitted, Green Published, gold			2022-12-25	WOS:000287482800047
J	Zaidman-Remy, A; Poidevin, M; Herve, M; Welchman, DP; Paredes, JC; Fahlander, C; Steiner, H; Mengin-Lecreulx, D; Lemaitre, B				Zaidman-Remy, Anna; Poidevin, Mickael; Herve, Mireille; Welchman, David P.; Paredes, Juan C.; Fahlander, Carina; Steiner, Hakan; Mengin-Lecreulx, Dominique; Lemaitre, Bruno			Drosophila Immunity: Analysis of PGRP-SB1 Expression, Enzymatic Activity and Function	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; HOST-DEFENSE; BACTERIA; TOLL; LB; PHAGOCYTOSIS; ACTIVATION; RECEPTOR; AMIDASE; RELISH	Peptidoglycan is an essential and specific component of the bacterial cell wall and therefore is an ideal recognition signature for the immune system. Peptidoglycan recognition proteins (PGRPs) are conserved from insects to mammals and able to bind PGN (non-catalytic PGRPs) and, in some cases, to efficiently degrade it (catalytic PGRPs). In Drosophila, several non-catalytic PGRPs function as selective peptidoglycan receptors upstream of the Toll and Imd pathways, the two major signalling cascades regulating the systemic production of antimicrobial peptides. Recognition PGRPs specifically activate the Toll pathway in response to Lys-type peptidoglycan found in most Gram-positive bacteria and the Imd pathway in response to DAP-type peptidoglycan encountered in Gram-positive bacilli-type bacteria and in Gram-negative bacteria. Catalytic PGRPs on the other hand can potentially reduce the level of immune activation by scavenging peptidoglycan. In accordance with this, PGRP-LB and PGRP-SC1A/B/2 have been shown to act as negative regulators of the Imd pathway. In this study, we report a biochemical and genetic analysis of PGRP-SB1, a catalytic PGRP. Our data show that PGRP-SB1 is abundantly secreted into the hemolymph following Imd pathway activation in the fat body, and exhibits an enzymatic activity towards DAP-type polymeric peptidoglycan. We have generated a PGRP-SB1/2 null mutant by homologous recombination, but its thorough phenotypic analysis did not reveal any immune function, suggesting a subtle role or redundancy of PGRP-SB1/2 with other molecules. Possible immune functions of PGRP-SB1 are discussed.	[Zaidman-Remy, Anna; Poidevin, Mickael; Lemaitre, Bruno] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Herve, Mireille; Mengin-Lecreulx, Dominique] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol Cellulaire, UMR 8619, F-91405 Orsay, France; [Welchman, David P.; Paredes, Juan C.; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Fahlander, Carina; Steiner, Hakan] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stockholm University	Zaidman-Remy, A (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1200 Lisbon, Portugal.	bruno.lemaitre@epfl.ch	Lemaitre, Bruno/T-8146-2019; Zaidman-Rémy, Anna/C-2481-2016	Lemaitre, Bruno/0000-0001-7970-1667; Zaidman-Remy, Anna/0000-0003-2550-1752; Paredes, Juan C./0000-0002-0974-8109; MENGIN-LECREULX, Dominique/0000-0003-3205-0275	Bettencourt Foundation; ERC; Swiss National Science Foundation [3100A0-12079/1]; CNRS; Association pour la Recherche contre le Cancer	Bettencourt Foundation; ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	The laboratory of B. L. was funded by the Bettencourt Foundation (www.fondationbs.org), an ERC Advanced Investigators Grant (erc.europa.eu) and the Swiss National Science Foundation (3100A0-12079/1; www.snf.ch/E). A.Z.-R. was supported by fellowships from CNRS (www.dgdr.cnrs.fr) and the Association pour la Recherche contre le Cancer (www.arc-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggrawal K, 2007, BIOCHEM SOC T, V35, P1496, DOI 10.1042/BST0351496; Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chaput C, 2007, MICROBES INFECT, V9, P637, DOI 10.1016/j.micinf.2007.01.022; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Dziarski R, 2006, CELL MICROBIOL, V8, P1059, DOI 10.1111/j.1462-5822.2006.00726.x; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Li X, 2007, IMMUNITY, V27, P518, DOI 10.1016/j.immuni.2007.07.020; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Romeo Yves, 2008, V415, P379, DOI 10.1007/978-1-59745-570-1_22; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Troll JV, 2009, CELL MICROBIOL, V11, P1114, DOI 10.1111/j.1462-5822.2009.01315.x; TROLL JV, 2009, ENV MICROBIOL; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	42	72	78	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17231	10.1371/journal.pone.0017231	http://dx.doi.org/10.1371/journal.pone.0017231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364998	Green Published, gold			2022-12-25	WOS:000287482800036
J	Conover, MS; Mishra, M; Deora, R				Conover, Matt S.; Mishra, Meenu; Deora, Rajendar			Extracellular DNA Is Essential for Maintaining Bordetella Biofilm Integrity on Abiotic Surfaces and in the Upper Respiratory Tract of Mice	PLOS ONE			English	Article							PERTUSSIS INFECTION; STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL BIOFILMS; BPS POLYSACCHARIDE; YOUNG INFANTS; IN-VITRO; BRONCHISEPTICA; EPIDEMIOLOGY; PATHOGENESIS; RELEASE	Bacteria form complex and highly elaborate surface adherent communities known as biofilms which are held together by a self-produced extracellular matrix. We have previously shown that by adopting a biofilm mode of existence in vivo, the Gram negative bacterial pathogens Bordetella bronchiseptica and Bordetella pertussis are able to efficiently colonize and persist in the mammalian respiratory tract. In general, the bacterial biofilm matrix includes polysaccharides, proteins and extracellular DNA (eDNA). In this report, we investigated the function of DNA in Bordetella biofilm development. We show that DNA is a significant component of Bordetella biofilm matrix. Addition of DNase I at the initiation of biofilm growth inhibited biofilm formation. Treatment of pre-established mature biofilms formed under both static and flow conditions with DNase I led to a disruption of the biofilm biomass. We next investigated whether eDNA played a role in biofilms formed in the mouse respiratory tract. DNase I treatment of nasal biofilms caused considerable dissolution of the biofilm biomass. In conclusion, these results suggest that eDNA is a crucial structural matrix component of both in vitro and in vivo formed Bordetella biofilms. This is the first evidence for the ability of DNase I to disrupt bacterial biofilms formed on host organs.	[Conover, Matt S.; Deora, Rajendar] Wake Forest Univ Hlth Sci, Program Mol Genet, Winston Salem, NC 27106 USA; [Mishra, Meenu; Deora, Rajendar] Wake Forest Univ Hlth Sci, Dept Microbiol & Immunol, Winston Salem, NC USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Conover, MS (corresponding author), Wake Forest Univ Hlth Sci, Program Mol Genet, Winston Salem, NC 27106 USA.	rdeora@wfubmc.edu			National Institutes of Health [1R01AI075081, T32 AI07401]; United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2006-35604-16874]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075081, T32AI007401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in the laboratory of R.D. is supported by funds from the National Institutes of Health grant no. 1R01AI075081 and the National Research Initiative grant no. 2006-35604-16874 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture, Microbial Functional Genomics Program. M.S.C. is supported by a National Institutes of Health predoctoral training grant, T32 AI07401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; BEMIS DA, 1992, VET CLIN N AM-SMALL, V22, P1173, DOI 10.1016/S0195-5616(92)50308-4; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLEMMING HC, 2007, J BACTERIOL; Fry NK, 2004, J MED MICROBIOL, V53, P519, DOI 10.1099/jmm.0.45624-0; Bass JIF, 2010, J IMMUNOL, V184, P6386, DOI 10.4049/jimmunol.0901640; Gilberg S, 2002, J INFECT DIS, V186, P415, DOI 10.1086/341511; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Gregory DS, 2006, AM FAM PHYSICIAN, V74, P420; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lasa I, 2006, INT MICROBIOL, V9, P21; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; MOOI FR, INFECT GENET EVOL, V10, P36; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Raymond J, 2007, CLIN MICROBIOL INFEC, V13, P172, DOI 10.1111/j.1469-0691.2006.01616.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sakurai K, 2005, CHEM COMMUN, P4383, DOI 10.1039/b506673p; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Soane MC, 2000, RESP MED, V94, P791, DOI 10.1053/rmed.2000.0823; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Suri R, 2005, BIODRUGS, V19, P135, DOI 10.2165/00063030-200519030-00001; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; TUOMANEN E, 1989, J BIOL CHEM, V264, P11093; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WILSON R, 1991, INFECT IMMUN, V59, P337, DOI 10.1128/IAI.59.1.337-345.1991; Yeh SH, 2006, DRUGS, V66, P731, DOI 10.2165/00003495-200666060-00001	57	75	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16861	10.1371/journal.pone.0016861	http://dx.doi.org/10.1371/journal.pone.0016861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347299	Green Submitted, Green Published, gold			2022-12-25	WOS:000287364500011
J	Subramaniam, D; Ramalingam, S; Linehan, DC; Dieckgraefe, BK; Postier, RG; Houchen, CW; Jensen, RA; Anant, S				Subramaniam, Dharmalingam; Ramalingam, Satish; Linehan, David C.; Dieckgraefe, Brian K.; Postier, Russell G.; Houchen, Courtney W.; Jensen, Roy A.; Anant, Shrikant			RNA Binding Protein CUGBP2/CELF2 Mediates Curcumin-Induced Mitotic Catastrophe of Pancreatic Cancer Cells	PLOS ONE			English	Article							I CLINICAL-TRIAL; MESSENGER-RNA; CYCLOOXYGENASE-2 EXPRESSION; MYOTONIC-DYSTROPHY; CARCINOMA-CELLS; INHIBITION; APOPTOSIS; GROWTH; GEMCITABINE; THERAPY	Background: Curcumin inhibits the growth of pancreatic cancer tumor xenografts in nude mice; however, the mechanism of action is not well understood. It is becoming increasingly clear that RNA binding proteins regulate posttranscriptional gene expression and play a critical role in RNA stability and translation. Here, we have determined that curcumin modulates the expression of RNA binding protein CUGBP2 to inhibit pancreatic cancer growth. Methodology/Principal Findings: In this study, we show that curcumin treated tumor xenografts have a significant reduction in tumor volume and angiogenesis. Curcumin inhibited the proliferation, while inducing G2-M arrest and apoptosis resulting in mitotic catastrophe of various pancreatic cancer cells. This was further confirmed by increased phosphorylation of checkpoint kinase 2 (Chk2) protein coupled with higher levels of nuclear cyclin B1 and Cdc-2. Curcumin increased the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) mRNA, but protein levels were lower. Furthermore, curcumin increased the expression of RNA binding proteins CUGBP2/CELF2 and TIA-1. CUGBP2 binding to COX-2 and VEGF mRNA was also enhanced, thereby increasing mRNA stability, the half-life changing from 30 min to 8 h. On the other hand, silencer-mediated knockdown of CUGBP2 partially restored the expression of COX-2 and VEGF even with curcumin treatment. COX-2 and VEGF mRNA levels were reduced to control levels, while proteins levels were higher. Conclusion/Significance: Curcumin inhibits pancreatic tumor growth through mitotic catastrophe by increasing the expression of RNA binding protein CUGBP2, thereby inhibiting the translation of COX-2 and VEGF mRNA. These data suggest that translation inhibition is a novel mechanism of action for curcumin during the therapeutic intervention of pancreatic cancers.	[Subramaniam, Dharmalingam; Ramalingam, Satish; Anant, Shrikant] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Linehan, David C.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Dieckgraefe, Brian K.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Postier, Russell G.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK USA; [Houchen, Courtney W.; Anant, Shrikant] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Jensen, Roy A.] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA; [Jensen, Roy A.; Anant, Shrikant] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; Washington University (WUSTL); Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Subramaniam, D (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	dsubramaniam@kumc.edu; sanant@kumc.edu	Anant, Shrikant/AAF-8020-2020; Ramalingam, Satish/H-1577-2018; Jensen, Roy A/B-9739-2011	Ramalingam, Satish/0000-0002-3076-279X; Jensen, Roy A/0000-0003-4430-2281	NIH [DK062265, CA109269, CA135559]; NATIONAL CANCER INSTITUTE [R01CA135559, R01CA109269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants DK062265, CA109269 and CA135559. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, BIOCHEM SOC SYMP, V70, P233, DOI 10.1042/bss0700233; Burris H, 1997, EUR J CANCER, V33, pS18, DOI 10.1016/S0959-8049(96)00324-3; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Duffy JP, 2003, CURR OPIN GASTROEN, V19, P458, DOI 10.1097/00001574-200309000-00004; Esclatine A, 2004, J VIROL, V78, P8582, DOI 10.1128/JVI.78.16.8582-8592.2004; Gerecht PSD, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-69; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Grau R, 2004, CANCER RES, V64, P5162, DOI 10.1158/0008-5472.CAN-04-0849; Jee SH, 1998, J INVEST DERMATOL, V111, P656, DOI 10.1046/j.1523-1747.1998.00352.x; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Kanai M, 2010, CANC CHEMOTHER PHARM; Kawamori T, 1999, CANCER RES, V59, P597; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Krecicki T, 2004, J LARYNGOL OTOL, V118, P676; Kuo ML, 1996, BBA-MOL BASIS DIS, V1317, P95, DOI 10.1016/S0925-4439(96)00032-4; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lev-Ari S, 2005, CLIN CANCER RES, V11, P6738, DOI 10.1158/1078-0432.CCR-05-0171; Lev-Ari S, 2007, CANCER INVEST, V25, P411, DOI 10.1080/07357900701359577; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; Mehta K, 1997, ANTI-CANCER DRUG, V8, P470, DOI 10.1097/00001813-199706000-00010; Molina MA, 1999, CANCER RES, V59, P4356; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Mukhopadhyay D, 2003, ANN NY ACAD SCI, V1010, P504, DOI 10.1196/annals.1299.093; Nieto J, 2008, ONCOLOGIST, V13, P562, DOI 10.1634/theoncologist.2007-0181; Ramalingam S, 2008, AM J PHYSIOL-GASTR L, V294, pG971, DOI 10.1152/ajpgi.00540.2007; Real FX, 2003, GASTROENTEROLOGY, V124, P1958, DOI 10.1016/S0016-5085(03)00389-5; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Singletary K, 1998, CARCINOGENESIS, V19, P1039, DOI 10.1093/carcin/19.6.1039; Stan SD, 2010, NAT REV GASTRO HEPAT, V7, P347, DOI 10.1038/nrgastro.2010.61; Subramaniam D, 2008, AM J PHYSIOL-GASTR L, V294, pG1025, DOI 10.1152/ajpgi.00602.2007; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Swamy MV, 2008, NUTR CANCER, V60, P81, DOI 10.1080/01635580802416703; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308	48	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16958	10.1371/journal.pone.0016958	http://dx.doi.org/10.1371/journal.pone.0016958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347286	gold, Green Published			2022-12-25	WOS:000287364500015
J	Kauwe, JSK; Cruchaga, C; Karch, CM; Sadler, B; Lee, M; Mayo, K; Latu, W; Su'a, M; Fagan, AM; Holtzman, DM; Morris, JC; Goate, AM				Kauwe, John S. K.; Cruchaga, Carlos; Karch, Celeste M.; Sadler, Brooke; Lee, Mo; Mayo, Kevin; Latu, Wayne; Su'a, Manti; Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.		Alzheimer's Dis Neuroimaging Initi	Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AMYLOID-BETA; IDENTIFIES VARIANTS; IN-VIVO; SUSCEPTIBILITY; APOE; DEPOSITION; REVEALS; LOCI	Recent genome-wide association studies of Alzheimer's disease (AD) have identified variants in BIN1, CLU, CR1 and PICALM that show replicable association with risk for disease. We have thoroughly sampled common variation in these genes, genotyping 355 variants in over 600 individuals for whom measurements of two AD biomarkers, cerebrospinal fluid (CSF) 42 amino acid amyloid beta fragments (A beta(42)) and tau phosphorylated at threonine 181 (ptau(181)), have been obtained. Association analyses were performed to determine whether variants in BIN1, CLU, CR1 or PICALM are associated with changes in the CSF levels of these biomarkers. Despite adequate power to detect effects as small as a 1.05 fold difference, we have failed to detect evidence for association between SNPs in these genes and CSF A beta(42) or ptau(181) levels in our sample. Our results suggest that these variants do not affect risk via a mechanism that results in a strong additive effect on CSF levels of A beta(42) or ptau(181).	[Kauwe, John S. K.; Lee, Mo; Latu, Wayne; Su'a, Manti] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Cruchaga, Carlos; Karch, Celeste M.; Sadler, Brooke; Mayo, Kevin; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cruchaga, Carlos; Karch, Celeste M.; Mayo, Kevin; Fagan, Anne M.; Holtzman, David M.; Goate, Alison M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Cruchaga, Carlos; Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA	Brigham Young University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kauwe, JSK (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	kauwe@byu.edu	Juengling, Freimut D/L-8071-2016; MOSCATO, PABLO ALBERTO/G-7668-2013; Scharre, Douglas W/E-4030-2011; Obisesan, Thomas O/D-4184-2011; Payoux, Pierre/AGU-9727-2022; Kauwe, John/AAC-6646-2021; Morris, John C/A-1686-2012; Cruchaga, Carlos/ABF-4065-2020; Kauwe, John/B-2034-2009; Strittmatter, Stephen/F-5739-2011; Yushkevich, Paul A/O-6115-2014; Myers, Amanda J/B-1796-2010; Gaser, Christian/F-5103-2010	Juengling, Freimut D/0000-0002-2538-3074; Payoux, Pierre/0000-0002-1374-1620; Kauwe, John/0000-0001-8641-2468; Cruchaga, Carlos/0000-0002-0276-2899; Kauwe, John/0000-0001-8641-2468; Strittmatter, Stephen/0000-0001-8188-3092; Yushkevich, Paul A/0000-0001-8543-4016; Myers, Amanda J/0000-0002-3100-9396; Whitcher, Brandon/0000-0002-6452-2399; Mueller, Notger/0000-0002-5483-6423; Browndyke, Jeffrey/0000-0002-8573-7073; Lemaitre, Herve/0000-0002-5952-076X; Goate, Alison/0000-0002-0576-2472; Hampel, Harald/0000-0003-0894-8982; Gaser, Christian/0000-0002-9940-099X; Karch, Celeste/0000-0002-6854-5547; Looi, Jeffrey/0000-0003-3351-6911	AstraZeneca; National Institutes of Health [AG16208, P01AG03991, P50AG05681, P01AG026276, AG23185, AG05136]; Barnes-Jewish Hospital Foundation; Ford Foundation; Department of Veterans Affairs; Fundacion Alfonso Martin Escudero; National Institute on Aging [U01 AG024904]; National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005136, P01AG026276, R01AG016208, U01AG024904, U19AG010483, R01AG023185, P50AG005681] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Ford Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); Fundacion Alfonso Martin Escudero; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from AstraZeneca, National Institutes of Health (AG16208, P01AG03991, P50AG05681, P01AG026276, AG23185, AG05136), the Barnes-Jewish Hospital Foundation, Ford Foundation, the Department of Veterans Affairs, and an anonymous foundation. CC has a fellowship from Fundacion Alfonso Martin Escudero. Data collection and sharing for Alzheimer's Disease Neuroimaging Initiative (ADNI) (Principal Investigator Michael Weiner; National Institutes of Health grant U01 AG024904) is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Pfizer, Wyeth Research, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck & Co., AstraZeneca AB, Novartis, Alzheimer's Association, Eisai Global Clinical Development, Elan Corporation, Forest Laboratories, and the Institute for the Study of Aging, with participation from the United States Food and Drug Administration. Industry partnerships are coordinated through the Foundation for the National Institutes of Health. The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of California Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Jones L, 2010, BBA-MOL CELL BIOL L, V1801, P754, DOI 10.1016/j.bbalip.2010.04.005; Jozsi M, 2002, J IMMUNOL, V168, P2782, DOI 10.4049/jimmunol.168.6.2782; JUN G, 2010, METAANALYSIS CONFIRM; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kauwe JSK, 2009, NEUROGENETICS, V10, P13, DOI 10.1007/s10048-008-0150-4; KAUWE JS, 2010, J ALZHEIMERS DIS; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199	27	47	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e15918	10.1371/journal.pone.0015918	http://dx.doi.org/10.1371/journal.pone.0015918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347408	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700011
J	Marazziti, D; Di Pietro, C; Mandillo, S; Golini, E; Matteoni, R; Tocchini-Valentini, GP				Marazziti, Daniela; Di Pietro, Chiara; Mandillo, Silvia; Golini, Elisabetta; Matteoni, Rafaele; Tocchini-Valentini, Glauco P.			Absence of the GPR37/PAEL receptor impairs striatal Akt and ERK2 phosphorylation, Delta FosB expression, and conditioned place preference to amphetamine and cocaine	FASEB JOURNAL			English	Article						DA; DAT; D1 receptor; D2 receptor; cellular signaling pathways	SIGNAL-REGULATED KINASE; COUPLED PEPTIDE RECEPTOR; DOPAMINE TRANSPORTER; GENE-EXPRESSION; INCREASES PHOSPHORYLATION; MONOAMINE TRANSPORTERS; MOLECULAR-MECHANISMS; RAT STRIATUM; MICE LACKING; C-FOS	The orphan G-protein-coupled receptor 37 (GPR37) colocalizes with the dopamine (DA) transporter (DAT) in mouse nigrostriatal presynaptic membranes, and its genetic ablation in homozygous null-mutant (GPR37-KO) mice provokes the marked increase of plasma membrane expression of DAT, alteration of psychostimulant-induced locomotor activity, and reduction of catalepsy induced by DA-receptor antagonists. We report that extracts from GPR37-KO mice displayed biochemical alterations of the nigrostriatal signaling pathways mediated by D1 and D2 dopaminergic receptors. Null-mutant mice showed an increase of the basal phosphorylation level of the D2-regulated Akt kinase. The basal phosphorylation of the D1-activated ERK2 kinase was not altered, but acute treatments with amphetamine or cocaine failed to produce its specific increase, as detected in samples from wild-type littermates. Furthermore, the chronic administration of cocaine to GPR37-KO mice did not increase the expression of the Delta FosB transcription factor isoforms. Consistently, behavioral analysis showed that null-mutant animals did not respond to the incentive properties of amphetamine or cocaine, in conditioned place preference tests. Thus, the lack of GPR37 affects both ERK2- and Akt-mediated striatal signaling pathways, impairing the biochemical and behavioral responses typically induced by acute and chronic administration of psychostimulant drugs.-Marazziti, D., Di Pietro, C., Mandillo, S., Golini, E., Matteoni, R., and Tocchini-Valentini, G. P. Absence of the GPR37/PAEL receptor impairs striatal Akt and ERK2 phosphorylation, Delta FosB expression, and conditioned place preference to amphetamine and cocaine. FASEB J. 25, 2071-2081 (2011). www.fasebj.org	[Marazziti, Daniela; Di Pietro, Chiara; Mandillo, Silvia; Golini, Elisabetta; Matteoni, Rafaele; Tocchini-Valentini, Glauco P.] CNR, Ist Biol Cellulare, I-00015 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR)	Tocchini-Valentini, GP (corresponding author), CNR, Ist Biol Cellulare, Campus A Buzzati Traverso,Via E Ramarini 32, I-00015 Rome, Italy.	gtocchini@ibc.cnr.it	Mandillo, Silvia/E-6503-2019; Golini, Elisabetta/AAX-2849-2020; Daniela, Marazziti/AAC-1062-2022; Di Pietro, Chiara/AAA-7161-2021; Mandillo, Silvia/AAW-1363-2020	Mandillo, Silvia/0000-0002-4869-0974; Daniela, Marazziti/0000-0002-1582-9271; MATTEONI, RAFAELE/0000-0002-0314-5948; DI PIETRO, CHIARA/0000-0002-2680-1821	Italian Ministry of Research	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	The authors are grateful to C. Gross and G. Di Segni for critical reading of the manuscript. The authors greatly thank G. Di Franco, G. D'Erasmo, and A. Ventrera for excellent technical assistance; A. Ferrara and T. Cuccurullo for secretarial work. This study was supported by Italian Ministry of Research grants (FIRB-Internazionale G. Armenise Harvard Foundation 2005, FIRB-Idee Progettuali 2005, PRIN-Cofin. 2007), and EU-Framework Programmes 6 and 7 (EURASNET, EUMODIC, and PHENOSCALE contracts).	Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2006, J BIOL CHEM, V281, P32072, DOI 10.1074/jbc.M606062200; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Berhow MT, 1996, J NEUROSCI, V16, P4707; Borgkvist A, 2007, NEUROPSYCHOPHARMACOL, V32, P1995, DOI 10.1038/sj.npp.1301321; Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Budygin EA, 2004, P NATL ACAD SCI USA, V101, P7781, DOI 10.1073/pnas.0401418101; Cabib S, 1996, PSYCHOPHARMACOLOGY, V125, P92, DOI 10.1007/BF02247398; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; Choe ES, 2002, NEUROPSYCHOPHARMACOL, V27, P565; Dunham JH, 2009, BIOCHEMISTRY-US, V48, P10286, DOI 10.1021/bi9013775; Gainetdinov RR, 2002, TRENDS PHARMACOL SCI, V23, P367, DOI 10.1016/S0165-6147(02)02044-8; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Ghisi V, 2009, CELL SIGNAL, V21, P87, DOI 10.1016/j.cellsig.2008.09.011; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2007, NEUROSCI RES, V59, P413, DOI 10.1016/j.neures.2007.08.005; Jenab S, 2005, MOL BRAIN RES, V142, P134, DOI 10.1016/j.molbrainres.2005.08.015; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Marazziti D, 2004, P NATL ACAD SCI USA, V101, P10189, DOI 10.1073/pnas.0403661101; Marazziti D, 1998, GENOMICS, V53, P315, DOI 10.1006/geno.1998.5433; Marazziti D, 1997, GENOMICS, V45, P68, DOI 10.1006/geno.1997.4900; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Masson J, 1999, PHARMACOL REV, V51, P439; Mateo Y, 2004, P NATL ACAD SCI USA, V101, P372, DOI 10.1073/pnas.0207805101; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McGinty JF, 2008, J NEUROCHEM, V104, P1440, DOI 10.1111/j.1471-4159.2008.05240.x; Medvedev IO, 2005, PSYCHOPHARMACOLOGY, V180, P408, DOI 10.1007/s00213-005-2173-y; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1997, CURR OPIN NEUROBIOL, V7, P713, DOI 10.1016/S0959-4388(97)80094-3; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; NGUYEN TV, 1992, P NATL ACAD SCI USA, V89, P4270, DOI 10.1073/pnas.89.10.4270; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; Pavon N, 2006, BIOL PSYCHIAT, V59, P64, DOI 10.1016/j.biopsych.2005.05.044; Pich EM, 1997, SCIENCE, V275, P83; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; SCHECHTER MD, 1993, NEUROSCI BIOBEHAV R, V17, P21, DOI 10.1016/S0149-7634(05)80228-3; Shi XD, 2007, J NEUROCHEM, V103, P706, DOI 10.1111/j.1471-4159.2007.04760.x; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Sotnikova TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013452; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Uhl GR, 1996, CURR BIOL, V6, P935, DOI 10.1016/S0960-9822(02)00630-9; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Wang CH, 2005, J NEUROCHEM, V93, P899, DOI 10.1111/j.1471-4159.2005.03055.x; Xie ZH, 2009, BIOCHEM PHARMACOL, V78, P1095, DOI 10.1016/j.bcp.2009.05.031; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004	63	18	23	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					2071	2081		10.1096/fj.10-175737	http://dx.doi.org/10.1096/fj.10-175737			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21372109				2022-12-25	WOS:000291023800029
J	Salomonsson, E; Thijssen, VL; Griffioen, AW; Nilsson, UJ; Leffler, H				Salomonsson, Emma; Thijssen, Victor L.; Griffioen, Arjan W.; Nilsson, Ulf J.; Leffler, Hakon			The Anti-angiogenic Peptide Anginex Greatly Enhances Galectin-1 Binding Affinity for Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOSACCHARIDE SPECIFICITY; FLUORESCENCE POLARIZATION; LIGAND INTERACTIONS; CELL-SURFACE; TOLERANCE; LATTICES; THERAPY	Angiogenesis is a key event in cancer progression and therefore a promising target in cancer treatment. Galectin-1, a beta-galactoside binding lectin, is up-regulated in the endothelium of tumors of different origin and has been shown to be the target for anginex, a powerful anti-angiogenic peptide with anti-tumor activity. Here we show that when bound to anginex, galectin-1 binds various glycoproteins with hundred-to thousand-fold higher affinity. Anginex also interacts with galectin-2, -7, -8N, and -9N but not with galectin-3, -4, or -9C.	[Salomonsson, Emma; Leffler, Hakon] Lund Univ, Microbiol Sect, Inst Lab Med, SE-22362 Lund, Sweden; [Thijssen, Victor L.; Griffioen, Arjan W.] Vrije Univ Amsterdam Med Ctr, Angiogenesis Lab, Canc Ctr Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Nilsson, Ulf J.] Lund Univ, Div Organ Chem, SE-22100 Lund, Sweden	Lund University; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Lund University	Leffler, H (corresponding author), Lund Univ, Microbiol Sect, Inst Lab Med, Solvegatan 23, SE-22362 Lund, Sweden.	Hakon.Leffler@med.lu.se	Nilsson, Ulf J./L-3219-2014; Thijssen, Victor LJL/B-2792-2009; Leffler, Hakon/A-2416-2019	Nilsson, Ulf J./0000-0001-5815-9522; Thijssen, Victor LJL/0000-0002-6146-1842; Leffler, Hakon/0000-0003-4482-8945	Lund University Research School in Pharmaceutical Sciences; Swedish Research Council [2009-5656, 2009-5326]; Dutch Cancer Society [UM2008-4101, VU2009-4358]	Lund University Research School in Pharmaceutical Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by grants from the Lund University Research School in Pharmaceutical Sciences, the Swedish Research Council Grants 2009-5656 (to H. L.) and 2009-5326 (to U.J.N.), and Dutch Cancer Society Grants UM2008-4101 and VU2009-4358 (to V.L.T. and A.W.G.).	Arroyo MM, 2007, BBA-PROTEINS PROTEOM, V1774, P645, DOI 10.1016/j.bbapap.2007.03.007; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Cumpstey I, 2008, CHEM-EUR J, V14, P4233, DOI 10.1002/chem.200701932; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Le Mercier M, 2010, BRAIN PATHOL, V20, P17, DOI 10.1111/j.1750-3639.2009.00270.x; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Oberg CT, 2003, BIOCONJUGATE CHEM, V14, P1289, DOI 10.1021/bc034130j; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sorme P, 2004, ANAL BIOCHEM, V334, P36, DOI 10.1016/j.ab.2004.06.042; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; van der Schaft DWJ, 2002, FASEB J, V16, P1991, DOI 10.1096/fj.02-0509fje	23	32	33	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13801	13804		10.1074/jbc.C111.229096	http://dx.doi.org/10.1074/jbc.C111.229096			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372130	Green Published, hybrid			2022-12-25	WOS:000289556200002
J	Ghanta, KS; Li, DQ; Eswaran, J; Kumar, R				Ghanta, Krishna Sumanth; Li, Da-Qiang; Eswaran, Jeyanthy; Kumar, Rakesh			Gene Profiling of Mta1 Identifies Novel Gene Targets and Functions	PLOS ONE			English	Article							METASTASIS-ASSOCIATED PROTEIN-1; BREAST-CANCER; DNA-DAMAGE; ESTROGEN-RECEPTOR; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL REPRESSION; MAMMARY ADENOCARCINOMA; NUCLEAR RECEPTORS; CELL-LINES; COREGULATORS	Background: Metastasis-associated protein 1 (MTA1), a master dual co-regulatory protein is found to be an integral part of NuRD (Nucleosome Remodeling and Histone Deacetylation) complex, which has indispensable transcriptional regulatory functions via histone deacetylation and chromatin remodeling. Emerging literature establishes MTA1 to be a valid DNA-damage responsive protein with a significant role in maintaining the optimum DNA-repair activity in mammalian cells exposed to genotoxic stress. This DNA-damage responsive function of MTA1 was reported to be a P53-dependent and independent function. Here, we investigate the influence of P53 on gene regulation function of Mta1 to identify novel gene targets and functions of Mta1. Methods: Gene expression analysis was performed on five different mouse embryonic fibroblasts (MEFs) samples (i) the Mta1 wild type, (ii) Mta1 knock out (iii) Mta1 knock out in which Mta1 was reintroduced (iv) P53 knock out (v) P53 knock out in which Mta1 was over expressed using Affymetrix Mouse Exon 1.0 ST arrays. Further Hierarchical Clustering, Gene Ontology analysis with GO terms satisfying corrected p-value, 0.1, and the Ingenuity Pathway Analysis were performed. Finally, RT-qPCR was carried out on selective candidate genes. Significance/Conclusion: This study represents a complete genome wide screen for possible target genes of a coregulator, Mta1. The comparative gene profiling of Mta1 wild type, Mta1 knockout and Mta1 re-expression in the Mta1 knockout conditions define "bona fide'' Mta1 target genes. Further extensive analyses of the data highlights the influence of P53 on Mta1 gene regulation. In the presence of P53 majority of the genes regulated by Mta1 are related to inflammatory and antimicrobial responses whereas in the absence of P53 the predominant target genes are involved in cancer signaling. Thus, the presented data emphasizes the known functions of Mta1 and serves as a rich resource which could help us identify novel Mta1 functions.	[Ghanta, Krishna Sumanth; Eswaran, Jeyanthy; Kumar, Rakesh] George Washington Univ, Med Ctr, McCormick Genom & Prote Ctr, Washington, DC 20037 USA; [Li, Da-Qiang; Eswaran, Jeyanthy; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University; George Washington University	Ghanta, KS (corresponding author), George Washington Univ, Med Ctr, McCormick Genom & Prote Ctr, Washington, DC 20037 USA.	bcmjxe@gwumc.edu	Ghanta, Krishna S./M-1307-2019; Kumar, Rakesh/ABD-1065-2020	Ghanta, Krishna S./0000-0001-7502-3141; Kumar, Rakesh/0000-0001-7664-0803; Eswaran, Jeyanthy/0000-0003-0260-9517	National Institutes of Health [CA90970]; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grant CA90970 to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2006, J VIROL METHODS, V133, P41, DOI 10.1016/j.jviromet.2005.10.016; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Benest AV, 2009, NATURE, V458, P41, DOI 10.1038/458041a; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dobrzycka KM, 2003, ENDOCR-RELAT CANCER, V10, P517, DOI 10.1677/erc.0.0100517; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gentile M, 2001, ONCOGENE, V20, P7753, DOI 10.1038/sj.onc.1204993; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; HARPER JW, 1993, CELL, V75, P805; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DQ, 2010, CELL CYCLE, V9, P2071, DOI 10.4161/cc.9.11.11735; Li DQ, 2010, J BIOL CHEM, V285, P19802, DOI 10.1074/jbc.M109.085258; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Martini PGV, 2003, J STEROID BIOCHEM, V85, P117, DOI 10.1016/S0960-0760(03)00207-3; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; McMasters KM, 1996, ONCOGENE, V13, P1731; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Monaco C, 1997, GENOMICS, V46, P217, DOI 10.1006/geno.1997.5036; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Novac Natalia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P335; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; TOH Y, 1995, GENE, V159, P97, DOI 10.1016/0378-1119(94)00410-T; TOH Y, 1994, J BIOL CHEM, V269, P22958; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102	51	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17135	10.1371/journal.pone.0017135	http://dx.doi.org/10.1371/journal.pone.0017135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364872	Green Submitted, Green Published, gold			2022-12-25	WOS:000287764100031
J	Campana, SE; Dorey, A; Fowler, M; Joyce, W; Wang, ZL; Wright, D; Yashayaev, I				Campana, Steven E.; Dorey, Anna; Fowler, Mark; Joyce, Warren; Wang, Zeliang; Wright, Dan; Yashayaev, Igor			Migration Pathways, Behavioural Thermoregulation and Overwintering Grounds of Blue Sharks in the Northwest Atlantic	PLOS ONE			English	Article							PRIONACE-GLAUCA; DIVING BEHAVIOR; XIPHIAS-GLADIUS; THERMAL BIOLOGY; PELAGIC SHARKS; MOVEMENTS; OCEAN; TEMPERATURE; CEPHALOPODS; SWORDFISH	The blue shark Prionace glauca is the most abundant large pelagic shark in the Atlantic Ocean. Although recaptures of tagged sharks have shown that the species is highly migratory, migration pathways towards the overwintering grounds remain poorly understood. We used archival satellite pop-up tags to track 23 blue sharks over a mean period of 88 days as they departed the coastal waters of North America in the autumn. Within 1-2 days of entering the Gulf Stream (median date of 21 Oct), all sharks initiated a striking diel vertical migration, taking them from a mean nighttime depth of 74 m to a mean depth of 412 m during the day as they appeared to pursue vertically migrating squid and fish prey. Although functionally blind at depth, calculations suggest that there would be a similar to 2.5-fold thermoregulatory advantage to swimming and feeding in the markedly cooler deep waters, even if there was any reduced foraging success associated with the extreme depth. Noting that the Gulf Stream current speeds are reduced at depth, we used a detailed circulation model of the North Atlantic to examine the influence of the diving behaviour on the advection experienced by the sharks. However, there was no indication that the shark diving resulted in a significant modification of their net migratory pathway. The relative abundance of deep-diving sharks, swordfish, and sperm whales in the Gulf Stream and adjacent waters suggests that it may serve as a key winter feeding ground for large pelagic predators in the North Atlantic.	[Campana, Steven E.; Dorey, Anna; Fowler, Mark; Joyce, Warren; Wang, Zeliang; Wright, Dan; Yashayaev, Igor] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada	Campana, SE (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	steven.campana@dfo-mpo.gc.ca	Campana, Steven/L-7918-2019; Campana, Steven/C-3420-2013	Campana, Steven/0000-0002-7453-3761; Campana, Steven/0000-0001-8802-3976; Yashayaev, Igor/0000-0002-6976-7803	Fisheries and Oceans Canada	Fisheries and Oceans Canada	Funding was provided by Fisheries and Oceans Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-da-Silva AM, 2008, FISH RES, V92, P41, DOI 10.1016/j.fishres.2007.12.019; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Buencuerpo V, 1998, FISH B-NOAA, V96, P667; Campana SE, 2006, CAN J FISH AQUAT SCI, V63, P670, DOI 10.1139/f05-251; Campana SE, 2010, CAN J FISH AQUAT SCI, V67, P769, DOI 10.1139/F10-020; Campana SE, 2009, MAR ECOL PROG SER, V387, P241, DOI 10.3354/meps08109; CAREY FG, 1981, FISH B-NOAA, V79, P277; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Casey J.G., 1991, Underwater Naturalist, V19-20, P87; Casey JG, 1985, WORLD ANGLING RESOUR, P253; Childress JJ, 1998, J EXP BIOL, V201, P1223; CLARKE MR, 1974, J MAR BIOL ASSOC UK, V54, P949, DOI 10.1017/S0025315400057672; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; DAWE E G, 1985, Vie et Milieu, V35, P139; DAWE EG, 1988, MALACOLOGIA, V29, P235; Dowd WW, 2006, FISH B-NOAA, V104, P323; FEDULOV TP, 1986, OCEANOLOGY, V26, P229; Fristrup KM, 2002, MAR MAMMAL SCI, V18, P42, DOI 10.1111/j.1748-7692.2002.tb01017.x; GRUBER SH, 1967, SHARKS SKATES RAYS, P479; Henderson AC, 2001, J FISH BIOL, V58, P1347, DOI 10.1111/j.1095-8649.2001.tb02291.x; Hendrickson L. C., 2004, NMFSNE191 NOAA; *INT COMM CONS ATL, 2009, REP STAND COMM RES S, P270; *INT COMM CONV ATL, 2008, SCRS2008017 ICCAT; Kawahara S., 1985, NAFO SCI COUN STUDIE, V9, P59; KINZER J, 1985, MAR BIOL, V85, P313, DOI 10.1007/BF00393252; KITIGAWA T, 2006, FISHERIES SCI, V72, P149; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Kohler Nancy E., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P1231; KOHLER NE, 2008, SHARKS OPEN OCEAN BI, P00339; MADEC G, 1998, NOTES LPSL U P M CUR; Mandelman JW, 2008, REV FISH BIOL FISHER, V18, P427, DOI 10.1007/s11160-008-9084-z; McNeil JD, 1999, J GEOPHYS RES-OCEANS, V104, P15537, DOI 10.1029/1999JC900137; Mejuto J., 2008, 2008045 ICCAT SCRS; MEJUTO J, 2005, AQUAT LIVING RESOUR, V23, P25; Nakamura Yoshikazu, 1993, P331; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; NAKANO H, 2008, J MAR BIOL ASSOC UK, V56, P929; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, V3rd; Queiroz N, 2010, MAR ECOL PROG SER, V406, P265, DOI 10.3354/meps08500; Rodhouse PG, 1996, MAR ECOL PROG SER, V136, P37, DOI 10.3354/meps136037; Roper C.F.E., 1975, Smithsonian Contributions to Zoology, VNo. 209, P1; STEVENS JD, 1990, J MAR BIOL ASSOC UK, V70, P707, DOI 10.1017/S0025315400058999; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; Tanaka H, 2000, J EXP BIOL, V203, P1825; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Thompson KR, 2006, OCEAN MODEL, V13, P109, DOI 10.1016/j.ocemod.2005.11.003; VOVK A N, 1978, Malacological Review, V11, P130; Walker TI, 1998, MAR FRESHWATER RES, V49, pIII; Waring Gordon T., 1993, Fisheries Oceanography, V2, P101, DOI 10.1111/j.1365-2419.1993.tb00126.x; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; Wood AM, 1998, MAR ECOL PROG SER, V162, P25, DOI 10.3354/meps162025; Wright DG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003200; WROBLEWSKI JS, 1989, LIMNOL OCEANOGR, V34, P1563, DOI 10.4319/lo.1989.34.8.1563; [No title captured]	61	89	92	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16854	10.1371/journal.pone.0016854	http://dx.doi.org/10.1371/journal.pone.0016854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373198	Green Published, gold, Green Submitted			2022-12-25	WOS:000287657500019
J	Khan, JM; Ranganathan, S				Khan, Javed Mohammed; Ranganathan, Shoba			Understanding TR Binding to pMHC Complexes: How Does a TR Scan Many pMHC Complexes yet Preferentially Bind to One	PLOS ONE			English	Article							CELL-RECEPTOR RECOGNITION; CLASS-II MOLECULE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; SELF-PEPTIDE; HIGH-AFFINITY; MEAN FORCE; MHC; TCR	Understanding the basis of the binding of a T cell receptor (TR) to the peptide-MHC (pMHC) complex is essential due to the vital role it plays in adaptive immune response. We describe the use of computed binding (free) energy (BE), TR paratope, pMHC epitope, molecular surface electrostatic potential (MSEP) and calculated TR docking angle (h) to analyse 61 TR/pMHC crystallographic structures to comprehend TR/pMHC interaction. In doing so, we have successfully demonstrated a novel/rational approach for h calculation, obtained a linear correlation between BE and h without any "codon'' or amino acid preference, provided an explanation for TR ability to scan many pMHC ligands yet specifically bind one, proposed a mechanism for pMHC recognition by TR leading to T cell activation and illustrated the importance of the peptide in determining TR specificity, challenging the "germline bias'' theory.	[Khan, Javed Mohammed; Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Khan, Javed Mohammed; Ranganathan, Shoba] Macquarie Univ, ARC Ctr Excellence Bioinformat, Sydney, NSW 2109, Australia; [Ranganathan, Shoba] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Macquarie University; Macquarie University; National University of Singapore	Khan, JM (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	shoba.ranganathan@mq.edu.au		Ranganathan, Shoba/0000-0002-8290-813X	Macquarie University	Macquarie University	JMK gratefully acknowledges the award of a Macquarie University Research Excellence Scholarship. We also thank Mr. H.R. Cheruku, Macquarie University, Sydney for assistance. Open access publication charges were borne by Macquarie University.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chlewicki LK, 2005, J MOL BIOL, V346, P223, DOI 10.1016/j.jmb.2004.11.057; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Jerne NK, 2004, EUR J IMMUNOL, V34, P1234, DOI 10.1002/eji.200425132; Kaas Q, 2004, NUCLEIC ACIDS RES, V32, pD208, DOI 10.1093/nar/gkh042; Kaas Q, 2008, IMMUNOMICS REV, P19, DOI 10.1007/978-0-387-72968-8_2; Kaas Quentin, 2005, In Silico Biology, V5, P505; Khan Javed Mohammed, 2010, Immunome Res, V6 Suppl 1, pS2, DOI 10.1186/1745-7580-6-S1-S2; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P917, DOI 10.1016/j.dci.2005.03.003; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lefranc MP, 2001, T CELL RECEPTOR FACT; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Miller PJ, 2007, J MOL BIOL, V373, P315, DOI 10.1016/j.jmb.2007.07.028; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Wang LM, 2007, NAT STRUCT MOL BIOL, V14, P169, DOI 10.1038/nsmb1193; WEINER PK, 1982, P NATL ACAD SCI-BIOL, V79, P3754, DOI 10.1073/pnas.79.12.3754; Wilson IA, 1999, SCIENCE, V286, P1867, DOI 10.1126/science.286.5446.1867; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yoshida K, 2010, J CLIN INVEST, V120, P1578, DOI 10.1172/JCI41502; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	60	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17194	10.1371/journal.pone.0017194	http://dx.doi.org/10.1371/journal.pone.0017194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364947	Green Published, gold, Green Submitted			2022-12-25	WOS:000287656600034
J	Aeby, GS; Williams, GJ; Franklin, EC; Haapkyla, J; Harvell, CD; Neale, S; Page, CA; Raymundo, L; Vargas-Angel, B; Willis, BL; Work, TM; Davy, SK				Aeby, Greta S.; Williams, Gareth J.; Franklin, Erik C.; Haapkyla, Jessica; Harvell, C. Drew; Neale, Stephen; Page, Cathie A.; Raymundo, Laurie; Vargas-Angel, Bernardo; Willis, Bette L.; Work, Thierry M.; Davy, Simon K.			Growth Anomalies on the Coral Genera Acropora and Porites Are Strongly Associated with Host Density and Human Population Size across the Indo-Pacific	PLOS ONE			English	Article							BLACK BAND DISEASE; EMERGING INFECTIOUS-DISEASES; CLIMATE-CHANGE; TRANSMISSION DYNAMICS; METAGENOMIC ANALYSIS; NUTRIENT ENRICHMENT; HAWAIIAN-ISLANDS; GREEN TURTLES; WATER-QUALITY; FLORIDA-KEYS	Growth anomalies (GAs) are common, tumor-like diseases that can cause significant morbidity and decreased fecundity in the major Indo-Pacific reef-building coral genera, Acropora and Porites. GAs are unusually tractable for testing hypotheses about drivers of coral disease because of their pan-Pacific distributions, relatively high occurrence, and unambiguous ease of identification. We modeled multiple disease-environment associations that may underlie the prevalence of Acropora growth anomalies (AGA) (n = 304 surveys) and Porites growth anomalies (PGA) (n = 602 surveys) from across the Indo-Pacific. Nine predictor variables were modeled, including coral host abundance, human population size, and sea surface temperature and ultra-violet radiation anomalies. Prevalence of both AGAs and PGAs were strongly host density-dependent. PGAs additionally showed strong positive associations with human population size. Although this association has been widely posited, this is one of the first broad-scale studies unambiguously linking a coral disease with human population size. These results emphasize that individual coral diseases can show relatively distinct patterns of association with environmental predictors, even in similar diseases (growth anomalies) found on different host genera (Acropora vs. Porites). As human densities and environmental degradation increase globally, the prevalence of coral diseases like PGAs could increase accordingly, halted only perhaps by declines in host density below thresholds required for disease establishment.	[Aeby, Greta S.; Franklin, Erik C.] Hawaii Inst Marine Biol, Kaneohe, HI USA; [Williams, Gareth J.; Davy, Simon K.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Williams, Gareth J.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Haapkyla, Jessica; Neale, Stephen; Page, Cathie A.; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Haapkyla, Jessica; Neale, Stephen; Page, Cathie A.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Harvell, C. Drew] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Raymundo, Laurie] Univ Guam, Marine Lab, Univ Guam UOG Stn, Mangilao, GU 96923 USA; [Vargas-Angel, Bernardo] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Work, Thierry M.] US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA	Victoria University Wellington; University of California System; University of California San Diego; Scripps Institution of Oceanography; James Cook University; James Cook University; Cornell University; Australian Institute of Marine Science; University of Guam; University of Hawaii System; United States Department of the Interior; United States Geological Survey	Aeby, GS (corresponding author), Hawaii Inst Marine Biol, Kaneohe, HI USA.	greta@hawaii.edu; gareth@ucsd.edu	Raymundo, Laurie/AAE-5230-2020; Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090; Davy, Simon/0000-0003-3584-5356; Franklin, Erik/0000-0002-8660-3085; Williams, Dr Gareth J./0000-0001-7837-1619	Center for International Earth Science Information Network (CIESIN), Columbia University; United Nations Food and Agriculture Programme (FAO); National Aeronautics and Space Administration [NAS5-03117]; Office of National Marine Sanctuaries (NWHICRER) [MOA-2005-008/6882]; Australian Research Council; Global Environment Fund (GEF)/World Bank CRTR Program Coral Disease Working Group; NOAA; Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division; Victoria University of Wellington (VUW); New Zealand International Doctoral Research Scholarship; National Geographic Society	Center for International Earth Science Information Network (CIESIN), Columbia University; United Nations Food and Agriculture Programme (FAO); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Office of National Marine Sanctuaries (NWHICRER); Australian Research Council(Australian Research Council); Global Environment Fund (GEF)/World Bank CRTR Program Coral Disease Working Group; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division; Victoria University of Wellington (VUW); New Zealand International Doctoral Research Scholarship; National Geographic Society(National Geographic Society)	Funding: Human population data was provided by the Center for International Earth Science Information Network (CIESIN), Columbia University; United Nations Food and Agriculture Programme (FAO); and Centro Internacional de Agricultura Tropical (CIAT) with funding from the National Aeronautics and Space Administration under Contract NAS5-03117 for the Continued Operation of the Socioeconomic Data and Applications Center (SEDAC). GA gratefully acknowledges funding from the Office of National Marine Sanctuaries (NWHICRER MOA-2005-008/6882). BW acknowledges funding from the Australian Research Council and the Global Environment Fund (GEF)/World Bank CRTR Program Coral Disease Working Group. BVA's work was supported by the NOAA Coral Reef Conservation Program and the Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division. GW was supported by a Victoria University of Wellington (VUW) Vice-Chancellor's Strategic Research Scholarship and a New Zealand International Doctoral Research Scholarship. GW was additionally funded by grants from the National Geographic Society and the VUW Research Fund awarded to SD. LR was supported by the GEF/CRTR and the NOAA Coral Reef Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; Aeby GS, 2007, B MAR SCI, V80, P209; Aeby Greta Smith, 2006, Atoll Research Bulletin, P471; Aeby GS, 1998, J PARASITOL, V84, P1259, DOI 10.2307/3284684; Aguirre AA, 2008, ANN NY ACAD SCI, V1149, P1, DOI 10.1196/annals.1428.052; Altizer SM, 1997, P ROY SOC B-BIOL SCI, V264, P807, DOI 10.1098/rspb.1997.0113; ANDERS K, 1994, DIS AQUAT ORGAN, V19, P215, DOI 10.3354/dao019215; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Baker DM, 2007, MAR ECOL PROG SER, V343, P123, DOI 10.3354/meps06937; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Begon M, 1998, ECOL LETT, V1, P82; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; BRUCKNER AW, 1997, P 8 INT COR REEF S, V1, P601; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cheney D P, 1975, Adv Exp Med Biol, V64, P77; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Coles SL, 1998, CORAL REEFS, V17, P195, DOI 10.1007/s003380050118; Coyner DF, 2002, J WILDLIFE DIS, V38, P483, DOI 10.7589/0090-3558-38.3.483; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Davy SK, 2006, DIS AQUAT ORGAN, V69, P101, DOI 10.3354/dao069101; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Gateno D, 2003, MAR ECOL PROG SER, V258, P97, DOI 10.3354/meps258097; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jordan-Dahlgren E, 2004, CORAL HEALTH AND DISEASE, P105; Kaczmarsky L, 2007, J INVERTEBR PATHOL, V94, P218, DOI 10.1016/j.jip.2006.11.007; Kim Kiho, 2002, P813; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Peters EC, 1997, ENVIRON TOXICOL CHEM, V16, P12, DOI [10.1002/etc.5620160103, 10.1897/1551-5028(1997)016&lt;0012:EOTME&gt;2.3.CO;2]; PETERS EC, 1986, JNCI-J NATL CANCER I, V76, P895; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Ramsey D, 2002, J APPL ECOL, V39, P806, DOI 10.1046/j.1365-2664.2002.00760.x; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Richardson LL, 2009, DIS AQUAT ORGAN, V87, P79, DOI 10.3354/dao02083; Richardson LL, 2005, MAR ECOL PROG SER, V297, P147, DOI 10.3354/meps297147; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Rosenberg E, 1999, MICROBIAL ECOLOGY AND INFECTIOUS DISEASE, P242; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Santavy DL, 2001, HYDROBIOLOGIA, V460, P39, DOI 10.1023/A:1013194422440; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Veron J. E., 2000, CORALS WORLD, V1-3; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Wetz JJ, 2004, MAR POLLUT BULL, V48, P698, DOI 10.1016/j.marpolbul.2003.09.008; Williams GJ, 2008, CORAL REEFS, V27, P207, DOI 10.1007/s00338-007-0314-y; Williams GJ, 2011, J INVERTEBR PATHOL, V106, P165, DOI 10.1016/j.jip.2010.08.002; Williams GJ, 2010, MAR POLLUT BULL, V60, P1467, DOI 10.1016/j.marpolbul.2010.05.009; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Winkler R, 2004, MAR ECOL-P S Z N I, V25, P129, DOI 10.1111/j.1439-0485.2004.00020.x; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Work TM, 2001, J WILDLIFE DIS, V37, P574, DOI 10.7589/0090-3558-37.3.574; Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211; [No title captured]; [No title captured]; [No title captured]	108	60	60	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16887	10.1371/journal.pone.0016887	http://dx.doi.org/10.1371/journal.pone.0016887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365011	Green Published, Green Accepted, gold			2022-12-25	WOS:000287482800020
J	Celino, FT; Yamaguchi, S; Miura, C; Ohta, T; Tozawa, Y; Iwai, T; Miura, T				Celino, Fritzie T.; Yamaguchi, Sonoko; Miura, Chiemi; Ohta, Takashi; Tozawa, Yuzuru; Iwai, Toshiharu; Miura, Takeshi			Tolerance of Spermatogonia to Oxidative Stress Is Due to High Levels of Zn and Cu/Zn Superoxide Dismutase	PLOS ONE			English	Article							PROTEIN-SYNTHESIS SYSTEM; MALE JAPANESE EEL; REACTIVE OXYGEN; ANGUILLA-JAPONICA; ZINC-DEFICIENCY; FREE-RADICALS; HEAT-STRESS; FISH SPERMATOGENESIS; MALE-INFERTILITY; GENE-EXPRESSION	Background: Spermatogonia are highly tolerant to reactive oxygen species (ROS) attack while advanced-stage germ cells such as spermatozoa are much more susceptible, but the precise reason for this variation in ROS tolerance remains unknown. Methodology/Principal Findings: Using the Japanese eel testicular culture system that enables a complete spermatogenesis in vitro, we report that advanced-stage germ cells undergo intense apoptosis and exhibit strong signal for 8-hydroxy-29-deoxyguanosine, an oxidative DNA damage marker, upon exposure to hypoxanthine-generated ROS while spermatogonia remain unaltered. Activity assay of antioxidant enzyme, superoxide dismutase (SOD) and Western blot analysis using an anti-Copper/Zinc (Cu/Zn) SOD antibody showed a high SOD activity and Cu/Zn SOD protein concentration during early spermatogenesis. Immunohistochemistry showed a strong expression for Cu/Zn SOD in spermatogonia but weak expression in advanced-stage germ cells. Zn deficiency reduced activity of the recombinant eel Cu/Zn SOD protein. Cu/Zn SOD siRNA decreased Cu/Zn SOD expression in spermatogonia and led to increased oxidative damage. Conclusions/Significance: These data indicate that the presence of high levels of Cu/Zn SOD and Zn render spermatogonia resistant to ROS, and consequently protected from oxidative stress. These findings provide the biochemical basis for the high tolerance of spermatogonia to oxidative stress.	[Celino, Fritzie T.; Yamaguchi, Sonoko; Miura, Chiemi; Iwai, Toshiharu; Miura, Takeshi] Ehime Univ, Res Grp Reprod Physiol, S Ehime Fisheries Res Ctr, Ainan, Ehime, Japan; [Ohta, Takashi; Tozawa, Yuzuru] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan	Ehime University; Ehime University	Celino, FT (corresponding author), Ehime Univ, Res Grp Reprod Physiol, S Ehime Fisheries Res Ctr, Ainan, Ehime, Japan.	miutake@agr.ehime-u.ac.jp	Tozawa, Yuzuru/G-2657-2013; Tozawa, Yuzuru/AAM-9620-2020	Tozawa, Yuzuru/0000-0002-3885-1105; 	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This study was supported in part by Grant-in-Aid for Scientific Research (B) to TM and Grant-in-Aid for Young Scientists 2008 by Global COE Program from the Japan Society for the Promotion of Science (JSPS) to FTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Aitken RJ, 1999, J REPROD FERTIL, V115, P1; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Aruldhas MM, 2005, HUM REPROD, V20, P2801, DOI 10.1093/humrep/dei148; BAUCHE F, 1994, FEBS LETT, V349, P392, DOI 10.1016/0014-5793(94)00709-8; Bedwal R. S., 1994, CELL MOL LIFE SCI, V50, P624; BEEM KM, 1974, J BIOL CHEM, V249, P7298; BORDERS CL, 1985, BIOCHEM J, V230, P771, DOI 10.1042/bj2300771; BRAY TM, 1990, FREE RADICAL BIO MED, V8, P281, DOI 10.1016/0891-5849(90)90076-U; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CLIFTON DK, 1983, J ANDROL, V4, P387; de Lamirande E, 1997, Rev Reprod, V2, P48, DOI 10.1530/revreprod/2.1.48; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; El-Tawil AM, 2003, ANDROLOGIA, V35, P337, DOI 10.1046/j.0303-4569.2003.00588.x; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Halliwell B, 1996, BIOCHEM SOC T, V24, P1023, DOI 10.1042/bst0241023; HIDIROGLOU M, 1984, J DAIRY SCI, V67, P1147, DOI 10.3168/jds.S0022-0302(84)81416-2; Ishii T, 2005, FREE RADICAL RES, V39, P697, DOI 10.1080/10715760500130517; JOW WW, 1993, J ANDROL, V14, P439; Kaur P, 2003, INDIAN J BIOCHEM BIO, V40, P246; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; MARKLUND SL, 1986, FREE RADICALS AGING, P509; Merker HJ, 1997, J TRACE ELEM MED BIO, V11, P19, DOI 10.1016/S0946-672X(97)80004-1; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Miura T, 2003, FISH PHYSIOL BIOCHEM, V28, P181, DOI 10.1023/B:FISH.0000030522.71779.47; MIURA T, 1991, ZOOL SCI, V8, P63; Miura T, 2006, P NATL ACAD SCI USA, V103, P7333, DOI 10.1073/pnas.0508419103; NONOGAKI T, 1992, HUM REPROD, V7, P81, DOI 10.1093/oxfordjournals.humrep.a137565; Oteiza PL, 1996, P SOC EXP BIOL MED, V213, P85, DOI 10.3181/00379727-213-44040; Ozaki Y, 2006, COMP BIOCHEM PHYS B, V143, P309, DOI 10.1016/j.cbpb.2005.12.008; Ozaki Y, 2006, ENDOCRINOLOGY, V147, P5139, DOI 10.1210/en.2006-0391; Papagiannis I, 2004, ENVIRON INT, V30, P357, DOI 10.1016/j.envint.2003.08.002; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Paul C, 2009, BIOL REPROD, V80, P913, DOI 10.1095/biolreprod.108.071779; PELTOLA V, 1992, J ANDROL, V13, P450; Sanocka Dorota, 2004, Reprod Biol Endocrinol, V2, P12, DOI 10.1186/1477-7827-2-12; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; SOHAL R S, 1986, Journal of Free Radicals in Biology and Medicine, V2, P175, DOI 10.1016/S0748-5514(86)80067-8; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Winn RN, 2000, P NATL ACAD SCI USA, V97, P12655, DOI 10.1073/pnas.220428097; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106; Yousef MI, 2002, TOXICOLOGY, V175, P223, DOI 10.1016/S0300-483X(02)00049-5; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	53	81	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16938	10.1371/journal.pone.0016938	http://dx.doi.org/10.1371/journal.pone.0016938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364994	Green Submitted, Green Published, gold			2022-12-25	WOS:000287482800022
J	Vyas, AK; Yang, KC; Woo, D; Tzekov, A; Kovacs, A; Jay, PY; Hruz, PW				Vyas, Arpita Kalla; Yang, Kai-Chien; Woo, Dennis; Tzekov, Anatoly; Kovacs, Attila; Jay, Patrick Y.; Hruz, Paul W.			Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Murine Model of Dilated Cardiomyopathy	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; MYOCARDIAL SUBSTRATE METABOLISM; ACTIVATED PROTEIN-KINASE; HEART-FAILURE; UP-REGULATION; INSULIN; RAT; DOGS; REPERFUSION; EXPRESSION	Background: There is growing awareness of secondary insulin resistance and alterations in myocardial glucose utilization in congestive heart failure. Whether therapies that directly target these changes would be beneficial is unclear. We previously demonstrated that acute blockade of the insulin responsive facilitative glucose transporter GLUT4 precipitates acute decompensated heart failure in mice with advanced dilated cardiomyopathy. Our current objective was to determine whether pharmacologic enhancement of insulin sensitivity and myocardial glucose uptake preserves cardiac function and survival in the setting of primary heart failure. Methodology/Principal Findings: The GLP-1 agonist exenatide was administered twice daily to a murine model of dilated cardiomyopathy (TG9) starting at 56 days of life. TG9 mice develop congestive heart failure and secondary insulin resistance in a highly predictable manner with death by 12 weeks of age. Glucose homeostasis was assessed by measuring glucose tolerance at 8 and 10 weeks and tissue 2-deoxyglucose uptake at 75 days. Exenatide treatment improved glucose tolerance, myocardial GLUT4 expression and 2-deoxyglucose uptake, cardiac contractility, and survival over control vehicle-treated TG9 mice. Phosphorylation of AMP kinase and AKT was also increased in exenatide-treated animals. Total myocardial GLUT1 levels were not different between groups. Exenatide also abrogated the detrimental effect of the GLUT4 antagonist ritonavir on survival in TG9 mice. Conclusion/Significance: In heart failure secondary insulin resistance is maladaptive and myocardial glucose uptake is suboptimal. An incretin-based therapy, which addresses these changes, appears beneficial.	[Vyas, Arpita Kalla; Yang, Kai-Chien; Woo, Dennis; Tzekov, Anatoly; Jay, Patrick Y.; Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Kovacs, Attila] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Jay, Patrick Y.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Vyas, AK (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	hruz_p@kids.wustl.edu	Yang, Kai-Chien/AAO-6991-2021	Hruz, Paul/0000-0002-1478-3355; Yang, Kai-Chien/0000-0002-9128-9166	National Institutes of Health [P30DK056341 (NORC), DK064572, HL092798, DK 020579]; Children's Discovery Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK064572, P60DK020579, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by research grants P30DK056341 (NORC), DK064572 and HL092798 from the National Institutes of Health and the Children's Discovery Institute. Insulin assays were performed in the Diabetes Research and Training Center core laboratory funded by NIH grant DK 020579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Asmar M, 2010, CURR OPIN ENDOCRINOL, V17, P57, DOI 10.1097/MED.0b013e3283339051; Bose AK, 2005, CARDIOVASC DRUG THER, V19, P9, DOI 10.1007/s10557-005-6892-4; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Denissen JF, 1997, DRUG METAB DISPOS, V25, P489; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Grieve DJ, 2009, BRIT J PHARMACOL, V157, P1340, DOI 10.1111/j.1476-5381.2009.00376.x; Gros R, 2003, ENDOCRINOLOGY, V144, P2242, DOI 10.1210/en.2003-0007; Hausenloy DJ, 2008, CIRC-HEART FAIL, V1, P147, DOI 10.1161/CIRCHEARTFAILURE.108.810887; HOM FG, 1984, DIABETES, V33, P141, DOI 10.2337/diabetes.33.2.141; Hruz PW, 2008, FASEB J, V22, P2161, DOI 10.1096/fj.07-102269; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Liang GY, 2008, EXP BIOL MED, V233, P1142, DOI 10.3181/0801-RM-33; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; Morissette MR, 2003, J MOL CELL CARDIOL, V35, P1217, DOI 10.1016/S0022-2828(03)00212-8; Mulder P, 2006, ADV CARDIOL, V43, P97, DOI 10.1159/000095431; Peterson LR, 2008, DIABETES, V57, P32, DOI 10.2337/db07-1199; Poornima I, 2008, CIRC-HEART FAIL, V1, P153, DOI 10.1161/CIRCHEARTFAILURE.108.766402; RODRIGUES B, 1995, J MOL CELL CARDIOL, V27, P169, DOI 10.1016/S0022-2828(08)80016-8; Rosenblatt-Velin N, 2001, CARDIOVASC RES, V52, P407, DOI 10.1016/S0008-6363(01)00393-5; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Schwenk RW, 2008, CARDIOVASC RES, V79, P249, DOI 10.1093/cvr/cvn116; Sen P, 2003, MOL CELL BIOCHEM, V253, P241, DOI 10.1023/A:1026020101379; Shah Ankur, 2003, Rev Cardiovasc Med, V4 Suppl 6, pS50; SMITH SA, 1986, BIOCHEM J, V237, P789, DOI 10.1042/bj2370789; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Witteles RM, 2008, J AM COLL CARDIOL, V51, P93, DOI 10.1016/j.jacc.2007.10.021	27	50	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17178	10.1371/journal.pone.0017178	http://dx.doi.org/10.1371/journal.pone.0017178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359201	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300033
J	Nichols, FC; Yao, XD; Bajrami, B; Downes, J; Finegold, SM; Knee, E; Gallagher, JJ; Housley, WJ; Clark, RB				Nichols, Frank C.; Yao, Xudong; Bajrami, Bekim; Downes, Julia; Finegold, Sydney M.; Knee, Erica; Gallagher, James J.; Housley, William J.; Clark, Robert B.			Phosphorylated Dihydroceramides from Common Human Bacteria Are Recovered in Human Tissues	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS LIPIDS; SYSTEMIC INNATE IMMUNITY; RHEUMATOID-ARTHRITIS; MICROBIOTA; PERIODONTITIS; ASSOCIATION; DISEASE	Novel phosphorylated dihydroceramide (PDHC) lipids produced by the periodontal pathogen Porphyromonas gingivalis include phosphoethanolamine (PE DHC) and phosphoglycerol dihydroceramides (PG DHC) lipids. These PDHC lipids mediate cellular effects through Toll-like receptor 2 (TLR2) including promotion of IL-6 secretion from dendritic cells and inhibition of osteoblast differentiation and function in vitro and in vivo. The PE DHC lipids also enhance (TLR2)-dependent murine experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis. The unique non-mammalian structures of these lipids allows for their specific quantification in bacteria and human tissues using multiple reaction monitoring (MRM)-mass spectrometry (MS). Synthesis of these lipids by other common human bacteria and the presence of these lipids in human tissues have not yet been determined. We now report that synthesis of these lipids can be attributed to a small number of intestinal and oral organisms within the Bacteroides, Parabacteroides, Prevotella, Tannerella and Porphyromonas genera. Additionally, the PDHCs are not only present in gingival tissues, but are also present in human blood, vasculature tissues and brain. Finally, the distribution of these TLR2-activating lipids in human tissues varies with both the tissue site and disease status of the tissue suggesting a role for PDHCs in human disease.	[Nichols, Frank C.; Knee, Erica] Univ Connecticut, Sch Dent Med, Dept Oral Hlth & Diagnost Sci, Farmington, CT 06032 USA; [Yao, Xudong; Bajrami, Bekim] Univ Connecticut, Dept Chem, Storrs, CT USA; [Downes, Julia; Finegold, Sydney M.] VA Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA; [Gallagher, James J.] Univ Connecticut, Sch Med, Dept Surg, Farmington, CT 06032 USA; [Gallagher, James J.] Connecticut Vasc Inst, Hartford, CT USA; [Housley, William J.; Clark, Robert B.] Univ Connecticut, Sch Med, Dept Immunol, Farmington, CT 06032 USA; [Housley, William J.; Clark, Robert B.] Univ Connecticut, Sch Med, Dept Med, Farmington, CT 06032 USA	University of Connecticut; University of Connecticut; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Connecticut; University of Connecticut; University of Connecticut	Nichols, FC (corresponding author), Univ Connecticut, Sch Dent Med, Dept Oral Hlth & Diagnost Sci, Farmington, CT 06032 USA.	nichols@nso.uchc			National Multiple Sclerosis Society [RG4070-A-6]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by a grant from the National Multiple Sclerosis Society (RG4070-A-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKEMA EV, 2010, J RHEUMATOL; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; de Pablo P, 2008, J RHEUMATOL, V35, P70; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; FUKAMI H, 2010, J LIPID RES; GARBUS J, 1963, J BIOL CHEM, V238, P59; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MIKULS TR, 2008, INT IMMUNOPHARMACOL; Nichols FC, 2006, ORAL MICROBIOL IMMUN, V21, P84, DOI 10.1111/j.1399-302X.2006.00264.x; Nichols FC, 2004, J LIPID RES, V45, P2317, DOI 10.1194/jlr.M400278-JLR200; Nichols FC, 2009, AM J PATHOL, V175, P2430, DOI 10.2353/ajpath.2009.090544; Philpott DJ, 2010, NAT MED, V16, P160, DOI 10.1038/nm0210-160; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Wang YH, 2010, INFECT IMMUN, V78, P3726, DOI 10.1128/IAI.00225-10; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zahlten J, 2007, J DENT RES, V86, P635, DOI 10.1177/154405910708600710	21	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16771	10.1371/journal.pone.0016771	http://dx.doi.org/10.1371/journal.pone.0016771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347306	Green Published, gold, Green Submitted			2022-12-25	WOS:000287364500005
J	Putters, J; Almeida, ACD; van Kerkhof, P; van Rossum, AGSH; Gracanin, A; Strous, GJ				Putters, Joyce; Almeida, Ana C. da Silva; van Kerkhof, Peter; van Rossum, Agnes G. S. H.; Gracanin, Ana; Strous, Ger J.			Jak2 Is a Negative Regulator of Ubiquitin-Dependent Endocytosis of the Growth Hormone Receptor	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; ERYTHROPOIETIN RECEPTOR; FERM DOMAIN; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; DOWN-REGULATION; JANUS KINASE; DEGRADATION; SYSTEM	Background: Length and intensity of signal transduction via cytokine receptors is precisely regulated. Degradation of certain cytokine receptors is mediated by the ubiquitin ligase SCF(beta TrCP). In several instances, Janus kinase (Jak) family members can stabilise their cognate cytokine receptors at the cell surface. Principal Findings: In this study we show in Hek293 cells that Jak2 binding to the growth hormone receptor prevents endocytosis in a non-catalytic manner. Following receptor activation, the detachment of phosphorylated Jak2 induces down-regulation of the growth hormone receptor by SCF(beta TrCP). Using gamma 2A human fibroblast cells we show that both growth hormone-induced and constitutive growth hormone receptor endocytosis depend on the same factors, strongly suggesting that the modes of endocytosis are identical. Different Jak2 RNA levels in HepG2, IM9 and Hek293 cells indicate the importance of cellular concentration on growth hormone receptor function. Both Jak2 and bTrCP bind to neighbouring linear motifs in the growth hormone receptor tail without the requirement of modifications, indicating that growth hormone sensitivity is regulated by the cellular level of non-committed Jak2. Conclusions/Significance: As signal transduction of many cytokine receptors depends on Jak2, the study suggests an integrative role of Jak2 in cytokine responses based on its enzyme activity as well as its stabilising properties towards the receptors.	[Putters, Joyce; Almeida, Ana C. da Silva; van Kerkhof, Peter; van Rossum, Agnes G. S. H.; Strous, Ger J.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Putters, Joyce; Almeida, Ana C. da Silva; van Kerkhof, Peter; van Rossum, Agnes G. S. H.; Strous, Ger J.] Univ Med Ctr Utrecht, Inst Biomembranes, Utrecht, Netherlands; [Almeida, Ana C. da Silva; van Rossum, Agnes G. S. H.] Drug Discovery Factory BV, Bussum, Netherlands; [Gracanin, Ana] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	Putters, J (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	gstrous@umcutrecht.nl		van Kerkhof, Peter/0000-0002-8954-2230	The Netherlands Organisation for Scientific Research [NWO-ALW 814-02-011]; The European Network of Excellence, Rubicon [LSHG-CT-2005-018683]; The Marie Curie network, UbiRegulators [MRTN-CT-2006-034555]	The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); The European Network of Excellence, Rubicon; The Marie Curie network, UbiRegulators	This research was supported by The Netherlands Organisation for Scientific Research Grant NWO-ALW 814-02-011, to JP. The European Network of Excellence, Rubicon funded Agnes G.S.H. v R. (Grant LSHG-CT-2005-018683, Role of ubiquitin and ubiquitin-like modifiers in cellular regulation). The Marie Curie network, UbiRegulators, funded da Silva Almeida AC (Grant MRTN-CT-2006-034555). The funders, including the commercial company Drug Discovery Factory BV (DDF), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit T, 2000, J CLIN ENDOCR METAB, V85, P927, DOI 10.1210/jc.85.3.927; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; dos Santos CMA, 2001, J BIOL CHEM, V276, P10839, DOI 10.1074/jbc.M003635200; dos Santos GMA, 2001, J BIOL CHEM, V276, P32635, DOI 10.1074/jbc.M103583200; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P2228, DOI 10.1210/en.135.5.2228; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Goldsmith JF, 1997, AM J PHYSIOL-ENDOC M, V273, pE932, DOI 10.1152/ajpendo.1997.273.5.E932; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; He K, 2005, ENDOCRINOLOGY, V146, P4755, DOI 10.1210/en.2005-0514; He K, 2003, MOL ENDOCRINOL, V17, P2211, DOI 10.1210/me.2003-0256; Hilkens CMU, 2001, FEBS LETT, V505, P87, DOI 10.1016/S0014-5793(01)02783-1; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kumar KGS, 2003, EMBO J, V22, P5480; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Loesch K, 2007, ENDOCRINOLOGY, V148, P5955, DOI 10.1210/en.2007-0455; Meenhuis A, 2009, BIOCHEM J, V417, P737, DOI 10.1042/BJ20081153; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfaffl MW, 2002, DOMEST ANIM ENDOCRIN, V22, P91, DOI 10.1016/S0739-7240(01)00128-X; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Strous GJ, 1997, J BIOL CHEM, V272, P40; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933	51	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14676	10.1371/journal.pone.0014676	http://dx.doi.org/10.1371/journal.pone.0014676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347402	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700008
J	Zou, G; Chen, YL; Dong, HP; Lim, CC; Yap, LJ; Yau, YH; Shochat, SG; Lescar, J; Shi, PY				Zou, Gang; Chen, Yen-Liang; Dong, Hongping; Lim, Chin Chin; Yap, Li Jian; Yau, Yin Hoe; Shochat, Susana Geifman; Lescar, Julien; Shi, Pei-Yong			Functional Analysis of Two Cavities in Flavivirus NS5 Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; WEST-NILE-VIRUS; DENGUE VIRUS; CRYSTAL-STRUCTURE; NONSTRUCTURAL PROTEIN; ADENOSINE NUCLEOSIDE; HELICASE; DOMAIN; METHYLTRANSFERASE; IDENTIFICATION	Flavivirus NS5 protein encodes methyltransferase and RNA-dependent RNA polymerase (RdRp) activities. Structural analysis of flavivirus RdRp domains uncovered two conserved cavities (A and B). Both cavities are located in the thumb subdomains and represent potential targets for development of allosteric inhibitors. In this study, we used dengue virus as a model to analyze the function of the two RdRp cavities. Amino acids from both cavities were subjected to mutagenesis analysis in the context of genome-length RNA and recombinant NS5 protein; residues critical for viral replication were subjected to revertant analysis. For cavity A, we found that only one (Lys-756) of the seven selected amino acids is critical for viral replication. Alanine substitution of Lys-756 did not affect the RdRp activity, suggesting that this residue functions through a nonenzymatic mechanism. For cavity B, all four selected amino acids (Leu-328, Lys-330, Trp-859, and Ile-863) are critical for viral replication. Biochemical and revertant analyses showed that three of the four mutated residues (Leu-328, Trp-859, and Ile-863) function at the step of initiation of RNA synthesis, whereas the fourth residue (Lys-330) functions by interacting with the viral NS3 helicase domain. Collectively, our results have provided direct evidence for the hypothesis that cavity B, but not cavity A, from dengue virus NS5 polymerase could be a target for rational drug design.	[Zou, Gang; Chen, Yen-Liang; Dong, Hongping; Lim, Chin Chin; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Yap, Li Jian; Yau, Yin Hoe; Shochat, Susana Geifman; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Novartis; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Shi, PY (corresponding author), 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore.	pei_yong.shi@novartis.com	Hoe, YAU Yin/A-2817-2011; Zou, Gang/J-1833-2014	Hoe, YAU Yin/0000-0001-8136-2393; Zou, Gang/0000-0001-9607-7827				Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P3255, DOI 10.1128/AAC.00397-10; Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Deore RR, 2010, CURR MED CHEM, V17, P3806; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Hsieh SC, 2011, VIROLOGY, V410, P170, DOI 10.1016/j.virol.2010.11.006; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Lescar J, 2009, CURR OPIN STRUC BIOL, V19, P759, DOI 10.1016/j.sbi.2009.10.011; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323; Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011; Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	35	93	96	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14362	14372		10.1074/jbc.M110.214189	http://dx.doi.org/10.1074/jbc.M110.214189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349834	Green Published, hybrid			2022-12-25	WOS:000289556200058
J	Igura, M; Kohda, D				Igura, Mayumi; Kohda, Daisuke			Selective Control of Oligosaccharide Transfer Efficiency for the N-Glycosylation Sequon by a Point Mutation in Oligosaccharyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN GLYCOSYLATION; IMPORTANT DETERMINANT; CAMPYLOBACTER-JEJUNI; CONSENSUS SEQUENCE; ESCHERICHIA-COLI; AMINO-ACID; COMPLEX; OCCUPANCY; TOPOLOGY; POSITION	Asn-linked glycosylation is the most ubiquitous posttranslational protein modification in eukaryotes and archaea, and in some eubacteria. Oligosaccharyltransferase (OST) catalyzes the transfer of preassembled oligosaccharides on lipid carriers onto asparagine residues in polypeptide chains. Inefficient oligosaccharide transfer results in glycoprotein heterogeneity, which is particularly bothersome in pharmaceutical glycoprotein production. Amino acid variation at the X position of the Asn-X-Ser/Thr sequon is known to modulate the glycosylation efficiency. The best amino acid at X is valine, for an archaeal Pyrococcus furiosus OST. We performed a systematic alanine mutagenesis study of the archaeal OST to identify the essential and dispensable amino acid residues in the three catalytic motifs. We then investigated the effects of the dispensable mutations on the amino acid preference in the N-glycosylation sequon. One residue position was found to selectively affect the amino acid preference at the X position. This residue is located within the recently identified DXXKXXX(M/I) motif, suggesting the involvement of this motif in N-glycosylation sequon recognition. In applications, mutations at this position may facilitate the design of OST variants adapted to particular N-glycosylation sites to reduce the heterogeneity of glycan occupancy. In fact, a mutation at this position led to 9-fold higher activity relative to the wild-type enzyme, toward a peptide containing arginine at X in place of valine. This mutational approach is potentially applicable to eukaryotic and eubacterial OSTs for the production of homogenous glycoproteins in engineered mammalian and Escherichia coli cells.	[Igura, Mayumi; Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Kohda, D (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	kohda@bioreg.kyushu-u.ac.jp	Kohda, Daisuke/I-4990-2019	Kohda, Daisuke/0000-0001-8234-3776	Scientific Research on Innovative Areas [21121003]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Mizutani Foundation [090036]	Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 21121003, the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and Research Grant 090036 from the Mizutani Foundation for Glyco science.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Chavan M, 2003, J BIOL CHEM, V278, P51441, DOI 10.1074/jbc.M310456200; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; IGURA M, 2011, GLYCOBIOLOG IN PRESS; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Li L, 2010, BIOCHEM BIOPH RES CO, V394, P1069, DOI 10.1016/j.bbrc.2010.03.126; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Nita-Lazar M, 2005, GLYCOBIOLOGY, V15, P361, DOI 10.1093/glycob/cwi019; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PICARD V, 1995, BIOCHEMISTRY-US, V34, P8433, DOI 10.1021/bi00026a026; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WITTWER AJ, 1989, BIOCHEMISTRY-US, V28, P7662, DOI 10.1021/bi00445a022; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	32	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13255	13260		10.1074/jbc.M110.213900	http://dx.doi.org/10.1074/jbc.M110.213900			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21357684	Green Published, hybrid			2022-12-25	WOS:000289282200046
J	Wojcicki, JM; Holbrook, K; Lustig, RH; Epel, E; Caughey, AB; Munoz, RF; Shiboski, SC; Heyman, MB				Wojcicki, Janet M.; Holbrook, Katherine; Lustig, Robert H.; Epel, Elissa; Caughey, Aaron B.; Munoz, Ricardo F.; Shiboski, Stephen C.; Heyman, Melvin B.			Chronic Maternal Depression Is Associated with Reduced Weight Gain in Latino Infants from Birth to 2 Years of Age	PLOS ONE			English	Article							MEXICAN-AMERICAN CHILDREN; POSTNATAL DEPRESSION; RISK-FACTORS; PREGNANCY; GROWTH; IMPACT; PREVALENCE; SYMPTOMS; CORTISOL; STRESS	Background: Latino children are at increased risk for mirconutrient deficiencies and problems of overweight and obesity. Exposures in pregnancy and early postpartum may impact future growth trajectories. Objectives: To evaluate the relationship between prenatal and postnatal maternal depressive symptoms experienced in pregnancy and infant growth from birth to 2 years of age in a cohort of Latino infants. Methods: We recruited pregnant Latina mothers at two San Francisco hospitals and followed their healthy infants to 24 months of age. At 6, 12 and 24 months of age, infants were weighed and measured. Maternal depressive symptoms were assessed prenatally and at 4-6 weeks postpartum. Women who had high depressive symptoms at both time periods were defined as having chronic depression. Logistic mixed models were applied to compare growth curves and risk for overweight and underweight based on exposure to maternal depression. Results: We followed 181 infants to 24 months. At 12 and 24 months, respectively, 27.4% and 40.5% were overweight, and 5.6% and 2.2% were underweight. Exposure to chronic maternal depression was associated with underweight (OR = 12.12, 95% CI 1.86-78.78) and with reduced weight gain in the first 2 years of life (Coef = -0.48, 95% CI -0.94-0.01) compared with unexposed infants or infants exposed to episodic depression (depression at one time point). Exposure to chronic depression was also associated with reduced risk for overweight in the first 2 years of life (OR 0.28, 95% CI 0.03-0.92). Conclusions: Exposure to chronic maternal depression in the pre- and postnatal period was associated with reduced weight gain in the first two years of life and greater risk for failure to thrive, in comparison with unexposed infants or those exposed episodically. The infants of mothers with chronic depression may need additional nutritional monitoring and intervention.	[Wojcicki, Janet M.; Holbrook, Katherine; Heyman, Melvin B.] Univ Calif San Francisco, Dept Pediat, Div Pediat Gastroenterol & Nutr, San Francisco, CA 94143 USA; [Lustig, Robert H.] Univ Calif San Francisco, Dept Pediat, Div Pediat Endocrinol, San Francisco, CA 94143 USA; [Caughey, Aaron B.] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; [Shiboski, Stephen C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wojcicki, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Pediat Gastroenterol & Nutr, San Francisco, CA 94143 USA.	wojcicki@gmail.com	Lustig, Robert/O-9380-2019	Lustig, Robert/0000-0001-6983-2639	Hellman Family Foundation; Children's Digestive Health and Nutrition Foundation (CDHF); NIH [DK060617, DK080825]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080825, K24DK060617, T32DK007762] Funding Source: NIH RePORTER	Hellman Family Foundation; Children's Digestive Health and Nutrition Foundation (CDHF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the Hellman Family Foundation, the Children's Digestive Health and Nutrition Foundation (CDHF), NIH grant DK060617, DK080825 and by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Adewuya AO, 2008, J AFFECT DISORDERS, V108, P191, DOI 10.1016/j.jad.2007.09.013; Ajslev TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011136; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dennis CL, 2009, PEDIATRICS, V123, pE736, DOI 10.1542/peds.2008-1629; Ertel KA, 2010, PAEDIATR PERINAT EP, V24, P179, DOI 10.1111/j.1365-3016.2010.01098.x; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Field T, 2006, INFANT BEHAV DEV, V29, P268, DOI 10.1016/j.infbeh.2005.12.010; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Grote V, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-14; Hurley KM, 2008, J NUTR, V138, P799, DOI 10.1093/jn/138.4.799; Kim YN, 2006, J AM DIET ASSOC, V106, P385, DOI 10.1016/j.jada.2005.12.010; Melville JL, 2010, OBSTET GYNECOL, V116, P1064, DOI 10.1097/AOG.0b013e3181f60b0a; National Center for Health Statistics, 2000, CDC GROWTH CHARTS; O'Brien LM, 2004, PEDIATRICS, V113, P1242, DOI 10.1542/peds.113.5.1242; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Sandstead HH, 2008, AM J CLIN NUTR, V88, P1067, DOI 10.1093/ajcn/88.4.1067; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Taveras EM, 2010, PEDIATRICS, V125, P686, DOI 10.1542/peds.2009-2100; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; WOJCICKI JM, 2011, J HUMAN LAC IN PRESS; World Health Organization, 1995, PHYS STAT US INT ANT; Wright CM, 2006, ARCH DIS CHILD, V91, P312, DOI 10.1136/adc.2005.077750	29	40	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16737	10.1371/journal.pone.0016737	http://dx.doi.org/10.1371/journal.pone.0016737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373638	Green Submitted, Green Published, gold			2022-12-25	WOS:000287657500016
J	Friedman, N; Barzily-Rokni, M; Isaac, S; Eden, A				Friedman, Nathalie; Barzily-Rokni, Michal; Isaac, Sara; Eden, Amir			The Histone H2A Variant MacroH2A1 Does Not Localize to the Centrosome	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; NONHISTONE REGION; EXPRESSION; MICE; ISOFORMS; DELETION; GENES	MacroH2A1 is a histone H2A variant which contains a large non-histone C-terminal region of largely unknown function. Within this region is a macro domain which can bind ADP-ribose and related molecules. Most studies of macroH2A1 focus on the involvement of this variant in transcriptional repression. Studies in mouse embryos and in embryonic stem cells suggested that during early development macroH2A can be found at the centrosome. Centrosomal localization of macroH2A was later reported in somatic cells. Here we provide data showing that macroH2A1 does not localize to the centrosome and that the centrosomal signal observed with antibodies directed against the macroH2A1 non-histone region may be the result of antibody cross-reactivity.	[Friedman, Nathalie; Barzily-Rokni, Michal; Isaac, Sara; Eden, Amir] Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Inst Life Sci, Jerusalem, Israel	Hebrew University of Jerusalem	Friedman, N (corresponding author), Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Inst Life Sci, Jerusalem, Israel.	eden@vms.huji.ac.il			Israeli Science Foundation [1174/05, 1149/09]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by the Israeli Science Foundation (www.isf.org.il) grant numbers 1174/05 and 1149/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; BARZILYROKNI M, 2010, NUCLEIC ACIDS RES; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Boulard M, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-8; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; GARDNER RL, 1971, NATURE, V231, P385, DOI 10.1038/231385a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ma YH, 2005, J CELL SCI, V118, P1607, DOI 10.1242/jcs.02291; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Mermoud JE, 2001, EXP CELL RES, V268, P245, DOI 10.1006/excr.2001.5277; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Nesterova TB, 2002, DIFFERENTIATION, V69, P216, DOI 10.1046/j.1432-0436.2002.690415.x; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; PEHRSON JR, 1992, SCIENCE, V257, P1398; Rasmussen TP, 1999, NUCLEIC ACIDS RES, V27, P3685, DOI 10.1093/nar/27.18.3685; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; Rasmussen TP, 2001, CHROMOSOMA, V110, P411, DOI 10.1007/s004120100158; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; VIJAYKUMAR S, 1995, PROTEINS, V22, P290	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17262	10.1371/journal.pone.0017262	http://dx.doi.org/10.1371/journal.pone.0017262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364955	gold, Green Submitted, Green Published			2022-12-25	WOS:000287656600038
J	Hensley, SE; Das, SR; Gibbs, JS; Bailey, AL; Schmidt, LM; Bennink, JR; Yewdell, JW				Hensley, Scott E.; Das, Suman R.; Gibbs, James S.; Bailey, Adam L.; Schmidt, Loren M.; Bennink, Jack R.; Yewdell, Jonathan W.			Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance	PLOS ONE			English	Article							IN-VITRO; 4-GUANIDINO-NEU5AC2EN; MUTATIONS; VARIANTS; SENSITIVITY; GENERATION; ZANAMIVIR	Drugs inhibiting the influenza A virus (IAV) neuraminidase (NA) are the cornerstone of anti-IAV chemotherapy and prophylaxis in man. Drug-resistant mutations in NA arise frequently in human isolates, limiting the therapeutic application of NA inhibitors. Here, we show that antibody-driven antigenic variation in one domain of the H1 hemagglutinin Sa site leads to compensatory mutations in NA, resulting in NA antigenic variation and acquisition of drug resistance. These findings indicate that influenza A virus resistance to NA inhibitors can potentially arise from antibody driven HA escape, confounding analysis of influenza NA evolution in nature.	[Hensley, Scott E.; Das, Suman R.; Gibbs, James S.; Bailey, Adam L.; Schmidt, Loren M.; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hensley, SE (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	jyewdell@niaid.nih.gov	Das, Suman R/C-8760-2009; Das, Suman/ABB-7273-2020; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Das, Suman/0000-0003-2496-9724; 	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001055] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett JM, 1999, VIROLOGY, V265, P286, DOI 10.1006/viro.1999.0058; Blick TJ, 1998, VIROLOGY, V246, P95, DOI 10.1006/viro.1998.9194; Blick TJ, 1995, VIROLOGY, V214, P475, DOI 10.1006/viro.1995.0058; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; LACKENBY A, 2008, EURO SURVEILL; LARISA AVG, 2001, J INFECT DIS, V183, P523; LENTZ MR, 1984, VIROLOGY, V135, P257, DOI 10.1016/0042-6822(84)90135-1; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; MEMOLI MJ, J INFECT DIS, V201, P1397; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Staschke KA, 1995, VIROLOGY, V214, P642, DOI 10.1006/viro.1995.0078; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Yang P, 1997, VIROLOGY, V229, P155, DOI 10.1006/viro.1996.8421	21	56	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e15190	10.1371/journal.pone.0015190	http://dx.doi.org/10.1371/journal.pone.0015190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364978	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600003
J	Lee, CS; Dykema, KJ; Hawkins, DM; Cherba, DM; Webb, CP; Furge, KA; Duesbery, NS				Lee, Chih-Shia; Dykema, Karl J.; Hawkins, Danielle M.; Cherba, David M.; Webb, Craig P.; Furge, Kyle A.; Duesbery, Nicholas S.			MEK2 Is Sufficient but Not Necessary for Proliferation and Anchorage-Independent Growth of SK-MEL-28 Melanoma Cells	PLOS ONE			English	Article							ANTHRAX LETHAL FACTOR; MAP-KINASE-KINASE; PROTEOLYTIC INHIBITOR; FACTOR CLEAVES; GENE; ERK; BRAF; P38; INACTIVATION; ACTIVATION	Mitogen-activated protein kinase kinases (MKK or MEK) 1 and 2 are usually treated as redundant kinases. However, in assessing their relative contribution towards ERK-mediated biologic response investigators have relied on tests of necessity, not sufficiency. In response we developed a novel experimental model using lethal toxin (LeTx), an anthrax toxin-derived pan-MKK protease, and genetically engineered protease resistant MKK mutants (MKKcr) to test the sufficiency of MEK signaling in melanoma SK-MEL-28 cells. Surprisingly, ERK activity persisted in LeTx-treated cells expressing MEK2cr but not MEK1cr. Microarray analysis revealed non-overlapping downstream transcriptional targets of MEK1 and MEK2, and indicated a substantial rescue effect of MEK2cr on proliferation pathways. Furthermore, LeTx efficiently inhibited the cell proliferation and anchorage-independent growth of SK-MEL-28 cells expressing MKK1cr but not MEK2cr. These results indicate in SK-MEL-28 cells MEK1 and MEK2 signaling pathways are not redundant and interchangeable for cell proliferation. We conclude that in the absence of other MKK, MEK2 is sufficient for SK-MEL-28 cell proliferation. MEK1 conditionally compensates for loss of MEK2 only in the presence of other MKK.	[Lee, Chih-Shia; Hawkins, Danielle M.; Duesbery, Nicholas S.] Van Andel Res Inst, Lab Canc & Dev Cell Biol, Grand Rapids, MI USA; [Lee, Chih-Shia] Michigan State Univ, Grad Program Biochem & Mol Biol, E Lansing, MI 48824 USA; [Dykema, Karl J.; Furge, Kyle A.] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA; [Cherba, David M.; Webb, Craig P.] Van Andel Res Inst, Program Translat Med, Grand Rapids, MI USA	Van Andel Institute; Michigan State University; Van Andel Institute; Van Andel Institute	Lee, CS (corresponding author), Van Andel Res Inst, Lab Canc & Dev Cell Biol, Grand Rapids, MI USA.	duesbery@vai.org	Webb, Craig/I-8123-2012	DUESBERY, NICK/0000-0002-4258-5655; Duesbery, Nicholas/0000-0002-5708-4984				Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bromberg-White JL, 2008, METHOD ENZYMOL, V438, P355, DOI 10.1016/S0076-6879(07)38025-7; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Collisson EA, 2003, CANCER RES, V63, P5669; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ding Y, 2008, MOL CANCER THER, V7, P648, DOI 10.1158/1535-7163.MCT-07-2229; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Furge KA, 2007, ONCOGENE, V26, P1346, DOI 10.1038/sj.onc.1210256; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Govindarajan B, 2003, J BIOL CHEM, V278, P9790, DOI 10.1074/jbc.M212929200; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; LEE CS, 2010, CURRENT ENZ IN PRESS; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Scholl FA, 2009, ONCOGENE, V28, P1485, DOI 10.1038/onc.2008.459; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Scholl FA, 2009, CANCER RES, V69, P3772, DOI 10.1158/0008-5472.CAN-08-1963; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Singh Yogendra, 2005, P285; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tanami H, 2004, ONCOGENE, V23, P8796, DOI 10.1038/sj.onc.1208152; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Tsao H, 2000, CANCER RES, V60, P1800; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	52	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17165	10.1371/journal.pone.0017165	http://dx.doi.org/10.1371/journal.pone.0017165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365009	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482800029
J	Bello, SM; Parfitt, SA; Stringer, CB				Bello, Silvia M.; Parfitt, Simon A.; Stringer, Chris B.			Earliest Directly-Dated Human Skull-Cups	PLOS ONE			English	Article							GOUGHS CAVE; ANTERIOR TEETH; TROPHY-TAKING; LBK ENCLOSURE; HUMAN REMAINS; CUT-MARKS; CANNIBALISM; CUTMARKS; HOMINID; ATAPUERCA	Background: The use of human braincases as drinking cups and containers has extensive historic and ethnographic documentation, but archaeological examples are extremely rare. In the Upper Palaeolithic of western Europe, cut-marked and broken human bones are widespread in the Magdalenian (similar to 15 to 12,000 years BP) and skull-cup preparation is an element of this tradition. Principal Findings: Here we describe the post-mortem processing of human heads at the Upper Palaeolithic site of Gough's Cave (Somerset, England) and identify a range of modifications associated with the production of skull-cups. New analyses of human remains from Gough's Cave demonstrate the skilled post-mortem manipulation of human bodies. Results of the research suggest the processing of cadavers for the consumption of body tissues (bone marrow), accompanied by meticulous shaping of cranial vaults. The distribution of cut-marks and percussion features indicates that the skulls were scrupulously 'cleaned' of any soft tissues, and subsequently modified by controlled removal of the facial region and breakage of the cranial base along a sub-horizontal plane. The vaults were also 'retouched', possibly to make the broken edges more regular. This manipulation suggests the shaping of skulls to produce skull-cups. Conclusions: Three skull-cups have been identified amongst the human bones from Gough's Cave. New ultrafiltered radiocarbon determinations provide direct dates of about 14,700 cal BP, making these the oldest directly dated skull-cups and the only examples known from the British Isles.	[Bello, Silvia M.; Parfitt, Simon A.; Stringer, Chris B.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Parfitt, Simon A.] UCL, Inst Archaeol, London, England	Natural History Museum London; University of London; University College London	Bello, SM (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	s.bello@nhm.ac.uk	Bello, Silvia/ABW-5535-2022; Bello, Silvia/GZK-9069-2022		Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	The research is part of the "Ancient Human Occupation of Britain" project funded by the Leverhulme Trust. The trustees had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P., 2003, B NATURAL HIST MUSEU, V58, P59, DOI DOI 10.1017/5096804620300010X; Andrushko VA, 2005, AM J PHYS ANTHROPOL, V127, P375, DOI 10.1002/ajpa.20044; Andrushko VA, 2010, AM J PHYS ANTHROPOL, V141, P83, DOI 10.1002/ajpa.21117; [Anonymous], 1994, HUMAN EVOLUTION, DOI DOI 10.1007/BF02437262; Balch H. E., 1947, MENDIP CHEDDAR ITS G; Balfour H, 1897, J ROYAL ANTHROP I GR, V26, P340; Barton RNE, 2003, J QUATERNARY SCI, V18, P631, DOI 10.1002/jqs.772; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Belcastro MG, 2010, J HUM EVOL, V58, P522, DOI 10.1016/j.jhevol.2010.03.011; Bello S.M., 2011, ANCIENT HUMAN OCCUPA, P227; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Bello SM, 2010, AM J PHYS ANTHROPOL, P65; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; Binford L.R., 1981, BONES ANCIENT MEN MO; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Boulestin B., 1999, BRIT ARCHAEOLOGICAL, V776; Boulestin B, 2009, ANTIQUITY, V83, P968, DOI 10.1017/S0003598X00099282; Breuil H., 1909, ANTHROPOLOGIE, VXX, P523; Bueschgen WD, 1996, INT J OSTEOARCHAEOL, V6, P230; Buisson D., 1991, B SOC PREHIST FR, V88, P174; Caceres I, 2007, AM J PHYS ANTHROPOL, V133, P899, DOI 10.1002/ajpa.20610; Carbonell E, 2010, CURR ANTHROPOL, V51, P539, DOI 10.1086/653807; Cauwe N, 1996, B SOC PREHIST FR, V93, P342; Chaco RJ, 2007, TAKING DISPLAYING HU; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; Cook J., 1986, P U BRISTOL SPELAEOL, V17, P275; Cook J., 1991, LATE GLACIAL N W EUR, P160; CURRANT AP, 1989, ANTIQUITY, V63, P131, DOI 10.1017/S0003598X00075645; De Castro JMB, 2004, EVOL ANTHROPOL, V13, P25, DOI 10.1002/evan.10130; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; Dewbury AG, 2007, J ARCHAEOL SCI, V34, P354, DOI 10.1016/j.jas.2006.05.009; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; Finucane BC, 2008, AM J PHYS ANTHROPOL, V135, P75, DOI 10.1002/ajpa.20710; FRAYER DW, 1987, AM J PHYS ANTHROPOL, V74, P393, DOI 10.1002/ajpa.1330740311; Glory A., 1947, B MEM SOC ANTHRO PAR, V8, P114; Haglund WD, 1991, THESIS WASHINGTON U; Haverkort CM, 1999, INT J OSTEOARCHAEOL, V9, P147, DOI 10.1002/(SICI)1099-1212(199905/06)9:3<147::AID-OA466>3.0.CO;2-W; Hawkey D. E., 2003, B NATURAL HIST MUS S, V58, P23; Hillson SW, 2010, J HUM EVOL, V59, P493, DOI 10.1016/j.jhevol.2010.06.004; HOCART CH, 1993, RAPID COMMUN MASS SP, V7, P219, DOI 10.1002/rcm.1290070311; Humphrey L. T., 2002, B NAT HIST MUS LOND, V58, P135; Jacobi R., 2004, P PREHIST SOC, V70, P1, DOI [10.1017/S0079497X00001110, DOI 10.1017/S0079497X00001110]; Jacobi RM, 2009, QUATERNARY SCI REV, V28, P1895, DOI 10.1016/j.quascirev.2009.03.006; Keith A., 1929, P SOMERSET ARCHAEOLO, V74, P118; Laufer B, 1923, USE HUMAN SKULLS BON; Le Mort F, 1981, DEGRADATION ARTIFICI; Le Mort F., 1991, ANTHROPOLOGIE, V29, P189; Le Mort F., 1992, PEUPLEMENT MAGDALENI, P29; Le Mort F., 2003, REV ARCHEOL PICARDIE, V21, P117; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; MACPHAIL RI, 2003, B NATURAL HIST MUS S, V58, P51; Massola A., 1961, MANKIND, V5, P415; Meehan B, 1971, FORM DISTRIBUTION AN; Micozzi Marc S., 1997, P171; Orschiedt J, 2003, INT J OSTEOARCHAEOL, V13, P375, DOI 10.1002/oa.704; ORSCHIEDT J, 2002, PALEO, V14, P239; Orschiedt J, 2006, J CONFL ARCHAEOL, V2, P153, DOI 10.1163/157407706778942330; Pettit P., 2011, PALAEOLITHIC ORIGINS; Pickering TR, 2000, AM J PHYS ANTHROPOL, V111, P579, DOI 10.1002/(SICI)1096-8644(200004)111:4<579::AID-AJPA12>3.0.CO;2-Y; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Scott JE, 2009, J HUM EVOL, V57, P248, DOI 10.1016/j.jhevol.2009.05.012; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Street M, 2006, J HUM EVOL, V51, P551, DOI 10.1016/j.jhevol.2006.04.014; Stringer C. B., 2007, HOMO BRITANNICUS INC; Tubbs RS, 2008, CHILD NERV SYST, V24, P417, DOI 10.1007/s00381-007-0509-0; Turner C.G., 1999, MAN CORN CANNIBALISM; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; VILLA P, 1986, SCIENCE, V233, P431, DOI 10.1126/science.233.4762.431; Villa P., 1992, EVOLUTIONARY ANTHR, V1, P93, DOI DOI 10.1002/EVAN.1360010307; White T.D., 1992, PREHISTORIC CANNIBAL; WHITE TD, 1986, AM J PHYS ANTHROPOL, V69, P503, DOI 10.1002/ajpa.1330690410	72	52	54	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17026	10.1371/journal.pone.0017026	http://dx.doi.org/10.1371/journal.pone.0017026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359211	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700036
J	Danjo, R; Kawasaki, F; Ordway, RW				Danjo, Rie; Kawasaki, Fumiko; Ordway, Richard W.			A Tripartite Synapse Model in Drosophila	PLOS ONE			English	Article							SYNAPTICALLY RELEASED GLUTAMATE; CLIMBING FIBER; GLIA INTERACTIONS; PERIPHERAL GLIA; CALCIUM WAVES; TRANSPORTERS; ROLES; TRANSMISSION; DEPRESSION; NSF	Tripartite (three-part) synapses are defined by physical and functional interactions of glia with pre- and post-synaptic elements. Although tripartite synapses are thought to be of widespread importance in neurological health and disease, we are only beginning to develop an understanding of glial contributions to synaptic function. In contrast to studies of neuronal mechanisms, a significant limitation has been the lack of an invertebrate genetic model system in which conserved mechanisms of tripartite synapse function may be examined through large-scale application of forward genetics and genome-wide genetic tools. Here we report a Drosophila tripartite synapse model which exhibits morphological and functional properties similar to those of mammalian synapses, including glial regulation of extracellular glutamate, synaptically-induced glial calcium transients and glial coupling of synapses with tracheal structures mediating gas exchange. In combination with classical and cell-type specific genetic approaches in Drosophila, this model is expected to provide new insights into the molecular and cellular mechanisms of tripartite synapse function.	[Danjo, Rie] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, Ctr Mol & Cellular Neurosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Danjo, R (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	rwo4@psu.edu			National Institutes of Health (NIH) [R01 NS065983-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065983] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by National Institutes of Health (NIH) R01 NS065983-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2010, J NEUROSCI, V30, P5776, DOI 10.1523/JNEUROSCI.3957-09.2010; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beierlein M, 2006, J NEUROSCI, V26, P6958, DOI 10.1523/JNEUROSCI.0613-06.2006; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Besson MT, 2000, CURR BIOL, V10, P207, DOI 10.1016/S0960-9822(00)00339-0; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; BRAND AH, 1993, DEVELOPMENT, V118, P401; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Deitmer JW, 2010, BRAIN RES REV, V63, P113, DOI 10.1016/j.brainresrev.2009.10.006; Diamond JS, 2000, J NEUROPHYSIOL, V83, P2835, DOI 10.1152/jn.2000.83.5.2835; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dittman JS, 1998, J NEUROSCI, V18, P6147; Feng ZH, 2007, CURR OPIN PHARMACOL, V7, P316, DOI 10.1016/j.coph.2006.12.003; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Grosjean Y, 2008, NAT NEUROSCI, V11, P54, DOI 10.1038/nn2019; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Haydon PG, 2009, NEUROPHARMACOLOGY, V56, P83, DOI 10.1016/j.neuropharm.2008.06.050; Hoogland TM, 2009, P NATL ACAD SCI USA, V106, P3496, DOI 10.1073/pnas.0809269106; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jackson FR, 2008, NEURON GLIA BIOL, V4, P11, DOI 10.1017/S1740925X09000027; Kawasaki F, 1998, J NEUROSCI, V18, P10241; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kawasaki F, 1999, J NEUROPHYSIOL, V82, P123, DOI 10.1152/jn.1999.82.1.123; Kawasaki F, 2009, P NATL ACAD SCI USA, V106, P14658, DOI 10.1073/pnas.0907144106; Kurth-Nelson ZL, 2009, J NEUROSCI, V29, P11339, DOI 10.1523/JNEUROSCI.2493-09.2009; Metea MR, 2007, EXP PHYSIOL, V92, P635, DOI 10.1113/expphysiol.2006.036376; Metea MR, 2006, GLIA, V54, P650, DOI 10.1002/glia.20352; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Nedergaard M, 2010, CELL CALCIUM, V47, P140, DOI 10.1016/j.ceca.2009.11.010; Newman EA, 2004, GLIA, V47, P268, DOI 10.1002/glia.20030; Ohtsuki G, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.004.2009; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Piet R, 2007, J NEUROSCI, V27, P4027, DOI 10.1523/JNEUROSCI.0462-07.2007; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Rival T, 2006, J NEUROBIOL, V66, P1061, DOI 10.1002/neu.20270; Rochon D, 2001, J NEUROSCI, V21, P3819, DOI 10.1523/JNEUROSCI.21-11-03819.2001; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Seal RP, 1998, RECEPTOR CHANNEL, V6, P51; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Silies M, 2010, CURRENT OPINION NEUR, V21, P1; Soustelle L, 2002, DEV BIOL, V248, P294, DOI 10.1006/dbio.2002.0742; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Takatsuru Y, 2006, NEUROSCI RES, V54, P140, DOI 10.1016/j.neures.2005.11.002; Takatsuru Y, 2007, NEUROSCI LETT, V420, P85, DOI 10.1016/j.neulet.2007.04.062; Takayasu Y, 2004, EUR J NEUROSCI, V19, P1285, DOI 10.1111/j.1460-9568.2004.03224.x; Takayasu Y, 2009, ACTA PHYSIOL, V197, P1, DOI 10.1111/j.1748-1716.2009.02019.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Todd KJ, 2010, J NEUROSCI, V30, P11870, DOI 10.1523/JNEUROSCI.3165-10.2010; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	61	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17131	10.1371/journal.pone.0017131	http://dx.doi.org/10.1371/journal.pone.0017131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359186	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700052
J	Guimaraes, AJ; Nakayasu, ES; Sobreira, TJP; Cordero, RJB; Nimrichter, L; Almeida, IC; Nosanchuk, JD				Guimaraes, Allan Jefferson; Nakayasu, Ernesto S.; Sobreira, Tiago J. P.; Cordero, Radames J. B.; Nimrichter, Leonardo; Almeida, Igor C.; Nosanchuk, Joshua Daniel			Histoplasma capsulatum Heat-Shock 60 Orchestrates the Adaptation of the Fungus to Temperature Stress	PLOS ONE			English	Article							CELL-WALL; PULMONARY HISTOPLASMOSIS; SACCHAROMYCES-CEREVISIAE; PATHOGENIC FUNGUS; INTRACELLULAR-DISTRIBUTION; MITOCHONDRIAL ACTIVITY; IMMUNE-RESPONSES; PROTEIN; HEAT-SHOCK-PROTEIN-60; MORPHOGENESIS	Heat shock proteins (Hsps) are among the most widely distributed and evolutionary conserved proteins. Hsps are essential regulators of diverse constitutive metabolic processes and are markedly upregulated during stress. A 62 kDa Hsp (Hsp60) of Histoplasma capsulatum (Hc) is an immunodominant antigen and the major surface ligand to CR3 receptors on macrophages. However little is known about the function of this protein within the fungus. We characterized Hc Hsp60-protein interactions under different temperature to gain insights of its additional functions oncell wall dynamism, heat stress and pathogenesis. We conducted co-immunoprecipitations with antibodies to Hc Hsp60 using cytoplasmic and cell wall extracts. Interacting proteins were identified by shotgun proteomics. For the cell wall, 84 common interactions were identified among the 3 growth conditions, including proteins involved in heat-shock response, sugar and amino acid/protein metabolism and cell signaling. Unique interactions were found at each temperature [30 degrees C (81 proteins), 37 degrees C (14) and 37/40 degrees C (47)]. There were fewer unique interactions in cytoplasm [30 degrees C (6), 37 degrees C (25) and 37/40 degrees C (39)] and four common interactions, including additional Hsps and other known virulence factors. These results show the complexity of Hsp60 function and provide insights into Hc biology, which may lead to new avenues for the management of histoplasmosis.	[Guimaraes, Allan Jefferson; Nosanchuk, Joshua Daniel] Yeshiva Univ, Dept Med, Albert Einstein Coll Med, Div Infect Dis, Bronx, NY USA; [Guimaraes, Allan Jefferson; Cordero, Radames J. B.; Nosanchuk, Joshua Daniel] Yeshiva Univ, Dept Microbiol & Immunol, Albert Einstein Coll Med, Bronx, NY USA; [Nakayasu, Ernesto S.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Sobreira, Tiago J. P.] Heart Inst InCor, Lab Genet & Mol Cardiol, Grp Computat Biol, Sao Paulo, Brazil; [Nimrichter, Leonardo] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, Rio De Janeiro, Brazil; [Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; University of Texas System; University of Texas El Paso	Guimaraes, AJ (corresponding author), Yeshiva Univ, Dept Med, Albert Einstein Coll Med, Div Infect Dis, Bronx, NY USA.	josh.nosanchuk@einstein.yu.edu	Almeida, Igor C./AAF-9409-2019; Nimrichter, Leonardo/L-3545-2014; Nosanchuk, Joshua/AAS-7801-2021; Guimaraes, Allan J/E-2160-2014; Nakayasu, Ernesto S./AAJ-8374-2020; Guimaraes, Allan/AAQ-2343-2020; Cordero, Radamés JB/F-6912-2011; Sobreira, Tiago/C-1276-2008	Almeida, Igor C./0000-0002-2443-8213; Nimrichter, Leonardo/0000-0001-9281-6856; Guimaraes, Allan J/0000-0002-2856-9667; Nakayasu, Ernesto S./0000-0002-4056-2695; Guimaraes, Allan/0000-0002-2856-9667; Cordero, Radamés JB/0000-0002-3026-7094; Sobreira, Tiago/0000-0002-0217-0084	Fogarty International Center (NIH ) [D43-TW007129]; NIH [AI52733, 5G12RR008124-16A1]; Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center [NIH AI-51519]; Conselho Nacional de Desenvolvimento Tecnologico (CNPq, Brazil); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil); Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El Paso (NIH) [5G12RR008124-16A1, 5G12RR008124-16A1S1]; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, R01AI052733] Funding Source: NIH RePORTER	Fogarty International Center (NIH )(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center; Conselho Nacional de Desenvolvimento Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El Paso (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.J.G. and L.N. were supported in part by an Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH D43-TW007129). A.J.G and J.D.N. are supported in part by NIH AI52733 and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (NIH AI-51519). L.N. is supported by grants from Conselho Nacional de Desenvolvimento Tecnologico (CNPq, Brazil) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil). ICA is funded by NIH grant # 5G12RR008124-16A1. The authors thank the Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El Paso (NIH grants # 5G12RR008124-16A1 and 5G12RR008124-16A1S1), for the access to the LC-MS/MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Allendoerfer R, 1997, J INFECT DIS, V175, P905, DOI 10.1086/513989; Barreto A, 2003, CELL IMMUNOL, V222, P97, DOI 10.1016/S0008-8749(03)00115-1; BORGIA G, 1990, MYCOSES, V33, P405, DOI 10.1111/myc.1990.33.7-8.405; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200; CARUSO M, 1987, MOL MICROBIOL, V1, P151, DOI 10.1111/j.1365-2958.1987.tb00507.x; Davies EL, 2006, CLIN EXP IMMUNOL, V145, P183, DOI 10.1111/j.1365-2249.2006.03109.x; EISSENBERG LG, 1987, INFECT IMMUN, V55, P29, DOI 10.1128/IAI.55.1.29-34.1987; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Gomez BL, 1997, J CLIN MICROBIOL, V35, P2618, DOI 10.1128/JCM.35.10.2618-2622.1997; GOMEZ FJ, 1995, INFECT IMMUN, V63, P2587, DOI 10.1128/IAI.63.7.2587-2595.1995; GOMEZ FJ, 1991, INFECT IMMUN, V59, P4459, DOI 10.1128/IAI.59.12.4459-4464.1991; GOMEZ FJ, 1992, INFECT IMMUN, V60, P2565, DOI 10.1128/IAI.60.7.2565-2571.1992; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gophna U, 2003, INT J MED MICROBIOL, V292, P453, DOI 10.1078/1438-4221-00230; GUIMARAES AJ, 2010, MICROBIOLOGY RES, V2; GUIMARAES AJ, 2010, INFECT IMMUN; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Guimaraes AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003449; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Habich C, 2006, FEBS LETT, V580, P115, DOI 10.1016/j.febslet.2005.11.060; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jethmalani SM, 1997, J CELL BIOCHEM, V66, P98; Jethmalani SM, 1997, BIOCHEM BIOPH RES CO, V237, P382, DOI 10.1006/bbrc.1997.7127; Jurado JD, 2007, TOXICON, V49, P339, DOI 10.1016/j.toxicon.2006.10.004; KAMEI K, 1992, J MED VET MYCOL, V30, P385; KAUFMANN SHE, 1990, MED MICROBIOL IMMUN, V179, P61; KEATH EJ, 1989, INFECT IMMUN, V57, P1384, DOI 10.1128/IAI.57.5.1384-1390.1989; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LAMBOWITZ AM, 1983, NATURE, V303, P806, DOI 10.1038/303806a0; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Long KH, 2003, J IMMUNOL, V170, P487, DOI 10.4049/jimmunol.170.1.487; Lopes LCL, 2010, CLIN VACCINE IMMUNOL, V17, P1155, DOI 10.1128/CVI.00033-10; Lundgren DH, 2005, CURR PROTOC BIOINFOR, VChapter 13, pUnit 13 3; MARESCA B, 1989, MICROBIOL REV, V53, P186, DOI 10.1128/MMBR.53.2.186-209.1989; MARESCA B, 1981, P NATL ACAD SCI-BIOL, V78, P4596, DOI 10.1073/pnas.78.7.4596; Maresca B, 1993, Arch Med Res, V24, P247; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; MINCHIOTTI G, 1992, BIOCHIM BIOPHYS ACTA, V1131, P103, DOI 10.1016/0167-4781(92)90106-A; Mrsa V, 1997, YEAST, V13, P1145; Nosanchuk JD, 2003, J CLIN INVEST, V112, P1164, DOI [10.1172/JCI200319361, 10.1172/JCI19361]; PATRIARCA EJ, 1992, BIOCHEM CELL BIOL, V70, P207, DOI 10.1139/o92-031; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Pizzini CV, 1999, CLIN DIAGN LAB IMMUN, V6, P20, DOI 10.1128/CDLI.6.1.20-23.1999; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Shaner L, 2008, CURR GENET, V54, P1, DOI 10.1007/s00294-008-0193-y; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; SHAPIRO RS, 1990, VIRULENCE, V1, P45; SHEARER G, 1987, J GEN MICROBIOL, V133, P3375; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Srivastava P., 2004, CURR PROTOC IMMUNOL; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stone K., 1996, ENZYMATIC DIGESTION; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; TAPLEY TL, P NATL ACAD SCI US, V107, P1071; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Voos W, 2003, MOL CELL, V11, P1, DOI 10.1016/S1097-2765(03)00002-9; Voos W, 2009, RES MICROBIOL, V160, P718, DOI 10.1016/j.resmic.2009.08.003; Wolf A M, 1987, J Vet Intern Med, V1, P158, DOI 10.1111/j.1939-1676.1987.tb02008.x; WOLF JE, 1987, J IMMUNOL, V138, P582; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441	67	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e14660	10.1371/journal.pone.0014660	http://dx.doi.org/10.1371/journal.pone.0014660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347364	Green Submitted, gold, Green Published			2022-12-25	WOS:000287363000003
J	Hu, YH; Li, ZF; Wu, XH; Lu, QL				Hu, Yihong; Li, Zhi-fang; Wu, Xiaohua; Lu, Qilong			Large Induces Functional Glycans in an O-Mannosylation Dependent Manner and Targets GlcNAc Terminals on Alpha-Dystroglycan	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; RABBIT SKELETAL-MUSCLE; HAMSTER OVARY CELLS; HUMAN LARGE GENE; LAMININ-BINDING; ABNORMAL GLYCOSYLATION; MUTATIONS; PROTEIN; GLYCOPROTEIN	Alpha-dystroglycan (alpha-DG) is a ubiquitously expressed receptor for extracellular matrix proteins and some viruses, and plays a pivotal role in a number of pathological events, including cancer progression, muscular dystrophies, and viral infection. The O-glycans on alpha-DG are essential for its ligand binding, but the biosynthesis of the functional O-glycans remains obscure. The fact that transient overexpression of LARGE, a putative glycosyltransferase, up-regulates the functional glycans on alpha-DG to mediate its ligand binding implied that overexpression of LARGE may be a novel strategy to treat disorders with hypoglycosylation of alpha-DG. In this study, we focus on the effects of stable overexpression of Large on alpha-DG glycosylation in Chinese hamster ovary (CHO) cell and its glycosylation deficient mutants. Surprisingly, stable overexpression of Large in an O-mannosylation null deficient Lec15.2 CHO cells failed to induce the functional glycans on alpha-DG. Introducing the wild-type DPM2 cDNA, the deficient gene in the Lec15.2 cells, fully restored the Large-induced functional glycosylation, suggesting that Large induces the functional glycans in a DPM2/O-mannosylation dependent manner. Furthermore, stable overexpression of Large can effectively induce functional glycans on N-linked glycans in the Lec8 cells and ldlD cells growing in Gal deficient media, in both of which circumstances galactosylation are deficient. In addition, supplement of Gal to the ldlD cell culture media significantly reduces the amount of functional glycans induced by Large, suggested that galactosylation suppresses Large to induce the functional glycans. Thus our results revealed a mechanism by which Large competes with galactosyltransferase to target GlcNAc terminals to induce the functional glycans on alpha-DG.	[Hu, Yihong; Li, Zhi-fang; Wu, Xiaohua; Lu, Qilong] Carolinas Med Ctr, Cannon Res Ctr, Dept Neurol, McColl Lockwood Lab Muscular Dystrophy Res, Charlotte, NC 28203 USA	Carolinas Medical Center	Hu, YH (corresponding author), Carolinas Med Ctr, Cannon Res Ctr, Dept Neurol, McColl Lockwood Lab Muscular Dystrophy Res, Charlotte, NC 28203 USA.	xiaohua.wu@carolinashealthcare.org	lu, qi/HHS-2115-2022		Carolinas Muscular Dystrophy foundation	Carolinas Muscular Dystrophy foundation	This work is supported by Carolinas Muscular Dystrophy foundation (http://www.givechf.org/index.php?option = com_content&task = view&id = 28&Itemid = 44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAN JT, 2009, GLYCOBIOLOGY; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chiba A, 1997, J BIOL CHEM, V272, P2156; DEBERNABE DBV, 2009, J BIOL CHEM; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GORECKI DC, 1994, HUM MOL GENET, V3, P1589; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; McDearmon EL, 2003, J BIOL CHEM, V278, P44868, DOI 10.1074/jbc.M307026200; McDearmon EL, 2006, FEBS LETT, V580, P3381, DOI 10.1016/j.febslet.2006.05.010; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Rojek JA, 2007, J VIROL, V81, P5685, DOI 10.1128/JVI.02574-06; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Sgambato A, 2004, CANCER BIOL THER, V3, P967, DOI 10.4161/cbt.3.10.1132; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; STOLL J, 1982, P NATL ACAD SCI-BIOL, V79, P2296, DOI 10.1073/pnas.79.7.2296; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Ware FE, 1996, J BIOL CHEM, V271, P13935, DOI 10.1074/jbc.271.24.13935; Yamamoto T, 2008, INT J EXP PATHOL, V89, P332, DOI 10.1111/j.1365-2613.2008.00599.x; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; YOSHIDAMORIGUCH.T, SCIENCE, V327, P88	35	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16866	10.1371/journal.pone.0016866	http://dx.doi.org/10.1371/journal.pone.0016866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347376	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700046
J	Leo, C; Sala, V; Morello, M; Chiribiri, A; Riess, I; Mancardi, D; Schiaffino, S; Ponzetto, C; Crepaldi, T				Leo, Christian; Sala, Valentina; Morello, Mara; Chiribiri, Amedeo; Riess, Ilan; Mancardi, Daniele; Schiaffino, Stefano; Ponzetto, Carola; Crepaldi, Tiziana			Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MYOSIN GENE-EXPRESSION; GAP-JUNCTIONS; INTERCALATED DISC; INVASIVE GROWTH; STEM-CELLS; MYOCARDIUM; RECEPTOR; MICE; PHOSPHORYLATION	Background: The Hepatocyte Growth Factor (HGF) is a pleiotropic cytokine involved in many physiological processes, including skeletal muscle, placenta and liver development. Little is known about its role and that of Met tyrosine kinase receptor in cardiac development. Methodology/Principal Findings: In this study, we generated two transgenic mice with cardiac-specific, tetracycline-suppressible expression of either Hepatocyte Growth Factor (HGF) or the constitutively activated Tpr-Met kinase to explore: i) the effect of stimulation of the endogenous Met receptor by autocrine production of HGF and ii) the consequence of sustained activation of Met signalling in the heart. We first showed that Met is present in the neonatal cardiomyocytes and is responsive to exogenous HGF. Exogenous HGF starting from prenatal stage enhanced cardiac proliferation and reduced sarcomeric proteins and Connexin43 (Cx43) in newborn mice. As adults, these transgenics developed systolic contractile dysfunction. Conversely, prenatal Tpr-Met expression was lethal after birth. Inducing Tpr-Met expression during postnatal life caused early-onset heart failure, characterized by decreased Cx43, upregulation of fetal genes and hypertrophy. Conclusions/Significance: Taken together, our data show that excessive activation of the HGF/Met system in development may result in cardiac damage and suggest that Met signalling may be implicated in the pathogenesis of cardiac disease.	[Leo, Christian; Sala, Valentina; Riess, Ilan; Ponzetto, Carola; Crepaldi, Tiziana] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Morello, Mara; Chiribiri, Amedeo] Univ Turin, Dept Internal Med, Turin, Italy; [Mancardi, Daniele] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Schiaffino, Stefano] VIMM, Padua, Italy	University of Turin; University of Turin; University of Turin; Veneto Institute Molecular Medicine	Leo, C (corresponding author), Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy.	tiziana.crepaldi@unito.it	Sala, Valentina/K-4042-2012; crepaldi, tiziana/AAY-7207-2020; Chiribiri, Amedeo/T-2771-2019	Sala, Valentina/0000-0002-2283-2807; crepaldi, tiziana/0000-0003-3410-947X; Schiaffino, Stefano/0000-0002-5607-6421; MANCARDI, Daniele/0000-0003-3809-6047; Chiribiri, Amedeo/0000-0003-3394-4289	Compagnia di San Paolo; Fondazione CRT; Ministero dell'Istruzione dell'Universita e della Ricerca; Association Francaise contre les Myopathies (AFM); Regione Piemonte	Compagnia di San Paolo(Compagnia di San Paolo); Fondazione CRT(Fondazione CRT); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Regione Piemonte(Regione Piemonte)	This work was supported by funds from the Compagnia di San Paolo, Fondazione CRT, Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN), Association Francaise contre les Myopathies (AFM). V.S. is a Fellow of Universita Italo Francese. D.M. was supported by Regione Piemonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1989, LANCET, V2, P577; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Crepaldi T, 2007, J BIOL CHEM, V282, P6812, DOI 10.1074/jbc.M610916200; Doble BW, 2004, J CELL SCI, V117, P507, DOI 10.1242/jcs.00889; Feigenbaum H, 2005, ECHOCARDIOGRAPHY, V6th; Ferreira-Cornwell MC, 2002, J CELL SCI, V115, P1623; Giacobini P, 2007, J NEUROSCI, V27, P431, DOI 10.1523/JNEUROSCI.4979-06.2007; Gutstein DE, 2003, J CELL SCI, V116, P875, DOI 10.1242/jcs.00258; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; IKEJIMA K, 1995, BIOCHEM BIOPH RES CO, V214, P440, DOI 10.1006/bbrc.1995.2306; Kaprielian RR, 1998, CIRCULATION, V97, P651, DOI 10.1161/01.CIR.97.7.651; Kardami E, 1998, TRENDS CARDIOVAS MED, V8, P180, DOI 10.1016/S1050-1738(98)00007-3; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; MOORBY CD, 1995, EXP CELL RES, V219, P657, DOI 10.1006/excr.1995.1276; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Naitoh K, 2006, CARDIOVASC RES, V70, P374, DOI 10.1016/j.cardiores.2006.01.023; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Rappolee DA, 1996, CIRC RES, V78, P1028, DOI 10.1161/01.RES.78.6.1028; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; SCHIAFFINO S, 1993, TRENDS CARDIOVAS MED, V3, P12, DOI 10.1016/1050-1738(93)90022-X; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Song WM, 1999, DEV DYNAM, V214, P92, DOI 10.1002/(SICI)1097-0177(199901)214:1<92::AID-DVDY9>3.3.CO;2-O; Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF; Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691; Zammit PS, 2000, DEV DYNAM, V217, P75, DOI 10.1002/(SICI)1097-0177(200001)217:1<75::AID-DVDY7>3.0.CO;2-L	37	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14675	10.1371/journal.pone.0014675	http://dx.doi.org/10.1371/journal.pone.0014675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347410	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700007
J	Rodda, GH; Jarnevich, CS; Reed, RN				Rodda, Gordon H.; Jarnevich, Catherine S.; Reed, Robert N.			Challenges in Identifying Sites Climatically Matched to the Native Ranges of Animal Invaders	PLOS ONE			English	Article							SAMPLE SELECTION BIAS; SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; SPATIAL AUTOCORRELATION; POTENTIAL DISTRIBUTION; NICHE SHIFT; CONSERVATISM; HABITAT; TRANSFERABILITY; INVASIONS	Background: Species distribution models are often used to characterize a species' native range climate, so as to identify sites elsewhere in the world that may be climatically similar and therefore at risk of invasion by the species. This endeavor provoked intense public controversy over recent attempts to model areas at risk of invasion by the Indian Python (Python molurus). We evaluated a number of MaxEnt models on this species to assess MaxEnt's utility for vertebrate climate matching. Methodology/Principal Findings: Overall, we found MaxEnt models to be very sensitive to modeling choices and selection of input localities and background regions. As used, MaxEnt invoked minimal protections against data dredging, multi-collinearity of explanatory axes, and overfitting. As used, MaxEnt endeavored to identify a single ideal climate, whereas different climatic considerations may determine range boundaries in different parts of the native range. MaxEnt was extremely sensitive to both the choice of background locations for the python, and to selection of presence points: inclusion of just four erroneous localities was responsible for Pyron et al.'s conclusion that no additional portions of the U. S. mainland were at risk of python invasion. When used with default settings, MaxEnt overfit the realized climate space, identifying models with about 60 parameters, about five times the number of parameters justifiable when optimized on the basis of Akaike's Information Criterion. Conclusions/Significance: When used with default settings, MaxEnt may not be an appropriate vehicle for identifying all sites at risk of colonization. Model instability and dearth of protections against overfitting, multi-collinearity, and data dredging may combine with a failure to distinguish fundamental from realized climate envelopes to produce models of limited utility. A priori identification of biologically realistic model structure, combined with computational protections against these statistical problems, may produce more robust models of invasion risk.	[Rodda, Gordon H.; Jarnevich, Catherine S.; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA	United States Department of the Interior; United States Geological Survey	Rodda, GH (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA.	catherine_jarnevich@usgs.gov			U.S. government	U.S. government	This work was funded the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, though the USGS did review the manuscript to ensure conformance with USGS scientific standards.	Anderson DR, 2001, WILDLIFE SOC B, V29, P311; [Anonymous], P 21 INT C MACH LEAR; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Darwin C., 1877, DIFFERENT FORMS FLOW; DEYANG L, 1986, ACTA HERPETOL SIN, V5, P198; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; ELITH J, 2010, METHODS ECOLOGY EVOL, DOI DOI 10.1111/J.2041-210X.2010.00036.X; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; FREEDMAN DA, 1983, AM STAT, V37, P152, DOI 10.2307/2685877; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Khan MS., 2006, AMPHIBIANS REPTILES; Khan MS, 2002, GUIDE SNAKES PAKISTA; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Martin WK, 1996, EMU, V96, P166, DOI 10.1071/MU9960166; Mertens R., 1969, STUTTGARTER BEITR GE, V197, P1; Minton S. A., 1966, B AM MUS NAT HIST, V134, P29; NABHITABHATA J, 2005, STATUS MAMMALS REPTI; Peterson A. T., 2006, BIODIVERSITY INFORM, V3, P59, DOI DOI 10.17161/BI.V3I0.29; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips BL, 2008, WILDLIFE RES, V35, P222, DOI 10.1071/WR07101; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pyron RA, 2009, MOL ECOL, V18, P3443, DOI 10.1111/j.1365-294X.2009.04292.x; Pyron RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002931; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; REED RN, 2009, 20091202 US GEOL SUR, P1; REXSTAD EA, 1988, J WILDLIFE MANAGE, V52, P794, DOI 10.2307/3800948; Rodda Gordon H., 2007, P138; Rodda GH, 2009, BIOL INVASIONS, V11, P241, DOI 10.1007/s10530-008-9228-z; Rodder D, 2010, PAC SCI, V64, P11, DOI 10.2984/64.1.011; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Rodder D, 2008, NORTH-WEST J ZOOL, V4, P236; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; WARREN DL, 2010, ECOL APPL IN PRESS; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zambrano L, 2006, CAN J FISH AQUAT SCI, V63, P1903, DOI 10.1139/F06-088; 2008, FED REG, V73, P5784	68	101	103	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14670	10.1371/journal.pone.0014670	http://dx.doi.org/10.1371/journal.pone.0014670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347411	gold, Green Published, Green Submitted			2022-12-25	WOS:000287361700004
J	Kawahara, H; Okada, Y; Imai, T; Iwanami, A; Mischel, PS; Okano, H				Kawahara, Hironori; Okada, Yohei; Imai, Takao; Iwanami, Akio; Mischel, Paul S.; Okano, Hideyuki			Musashi1 Cooperates in Abnormal Cell Lineage Protein 28 (Lin28)-mediated Let-7 Family MicroRNA Biogenesis in Early Neural Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; POSTTRANSCRIPTIONAL REGULATION; REGULATED EXPRESSION; IN-VITRO; LIN28; LIN-28; MATURATION; LOCALIZATION; MARKER	Musashi1 (Msi1) is an RNA-binding protein that is highly expressed in neural stem/progenitor cells (NS/PCs) as well as in other tissue stem cells. Msi1 binds to the 3'-UTR of its target mRNAs in NS/PCs, prevents their translation, and interferes with NS/PC differentiation. We previously showed that Msi1 competes with eIF4G to bind poly(A)-binding protein and inhibits assembly of the 80 S ribosome. Here we show that Msi1 works in concert with Lin28 to regulate post-transcriptional microRNA (miRNA) biogenesis in the cropping step, which occurs in the nucleus. Lin28 and its binding partner terminal uridylyltransferase 4 (TUT4) are known to maintain embryonic stem cell pluripotency by blocking let-7 miRNA biogenesis at the dicing step. Interestingly, we found that during early neural differentiation of embryonic stem cells, Msi1 enhanced the localization of Lin28 to the nucleus and also inhibited the nuclear cropping step of another let-7 family miRNA, miR98. These results suggest that Msi1 can influence stem cell maintenance and differentiation by controlling the subcellular localization of proteins involved in miRNA biogenesis, as well as by regulating the translation of its target mRNA.	[Kawahara, Hironori; Okada, Yohei; Imai, Takao; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Shinjuku Ku, Tokyo 1608582, Japan; [Iwanami, Akio; Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Iwanami, Akio; Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Keio University; Keio University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan.	hidokano@a2.keio.jp	Okano, Hideyuki/I-7584-2019; Imai, Takao/L-1232-2013; Okada, Yohei/L-1662-2013		Japan Society for the Promotion of Science; Japanese Ministry of Education, Sports and Culture of Japan (MEXT); Keio University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Sports and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University	This work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology from Japan Society for the Promotion of Science and by grants from the Japanese Ministry of Education, Sports and Culture of Japan (MEXT) (to H. O.) (the Leading Project for Realization of Regenerative Medicine) and (to H. K.) (Grant-in-aid for Young Scientists (B)) and a Keio University grant-in-aid for the encouragement of young medical scientists.	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V139, P28, DOI 10.1016/j.cell.2009.09.013; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	43	64	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.199166	http://dx.doi.org/10.1074/jbc.M110.199166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21378162	hybrid, Green Published			2022-12-25	WOS:000290022800052
J	Peng, HJ; Henkels, KM; Mahankali, M; Dinauer, MC; Gomez-Cambronero, J				Peng, Hong-Juan; Henkels, Karen M.; Mahankali, Madhu; Dinauer, Mary C.; Gomez-Cambronero, Julian			Evidence for Two CRIB Domains in Phospholipase D2 (PLD2) That the Enzyme Uses to Specifically Bind to the Small GTPase Rac2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; ADP-RIBOSYLATION FACTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; CELL-MIGRATION; RHO-GTPASES; KINASE-C; CDC42; D1; ACTIVATION	Phospholipase D (PLD) and small GTPases are vital to cell signaling. We report that the Rac2 and the PLD2 isoforms exist in the cell as a lipase-GTPase complex that enables the two proteins to elicit their respective functionalities. A strong association between the two molecules was demonstrated by co-immunoprecipitation and was confirmed in living cells by FRET with CFP-Rac2 and YFP-PLD2 fluorescent chimeras. We have identified the amino acids in PLD2 that define a specific binding site to Rac2. This site is composed of two CRIB (Cdc42-and Rac-interactive binding) motifs that we have named "CRIB-1" and "CRIB-2" in and around the PH domain in PLD2. Deletion mutants PLD2-Delta CRIB-1/2 negate co-immunoprecipitation with Rac2 and diminish the FRET signal in living cells. The PLD2-Rac2 association was further confirmed in vitro using affinity-purified recombinant proteins. Binding was saturable with an apparent K-d of 3 nM and was diminished with PLD2-Delta CRIB mutants. Furthermore, PLD2 bound more efficiently to Rac2-GTP than to Rac2-GDP or to a GDP-constitutive Rac2-N17 mutant. Increasing concentrations of recombinant Rac2 in vitro and in vivo during cell adhesion inhibit PLD2. Conversely, Rac2 activity is increased in the presence of PLD2-WT but not in PLD2-Delta CRIB. We propose that in activated cells PLD2 affects Rac2 in an initial positive feedback, but as Rac2-GTP accumulates in the cell, this constitutes a "termination signal" leading to PLD2 inactivation.	[Peng, Hong-Juan; Henkels, Karen M.; Mahankali, Madhu; Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Dinauer, Mary C.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat Hematol Oncol, Indianapolis, IN 46202 USA	University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University Bloomington	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu	Peng, Hongjuan/GYV-5462-2022	Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056653, R01HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 (to J. G.-C.).	Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bi EF, 1999, CURR BIOL, V9, pR160, DOI 10.1016/S0960-9822(99)80102-X; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bompard G, 2003, J CELL SCI, V116, P2519, DOI 10.1242/jcs.00448; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; BROWN HA, 1995, J BIOL CHEM, V270, P14935, DOI 10.1074/jbc.270.25.14935; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Dinauer MC, 2003, CURR OPIN HEMATOL, V10, P8, DOI 10.1097/00062752-200301000-00003; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Du GW, 2000, MOL BIOL CELL, V11, P4359, DOI 10.1091/mbc.11.12.4359; Faugaret D, 2011, BIOCHEM PHARMACOL, V81, P144, DOI 10.1016/j.bcp.2010.09.014; Freiss G, 2004, B CANCER, V91, P325; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hiroyama M, 2005, J CELL PHYSIOL, V202, P608, DOI 10.1002/jcp.20156; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Kurz T, 2004, J MOL CELL CARDIOL, V36, P225, DOI 10.1016/j.yjmcc.2003.11.008; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P4385, DOI 10.1002/j.1460-2075.1995.tb00113.x; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Mohseni M, 2009, CELL ADHES MIGR, V3, P191, DOI 10.4161/cam.3.2.7375; Olivo C, 2000, ONCOGENE, V19, P1428, DOI 10.1038/sj.onc.1203440; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Powner DJ, 2002, FEBS LETT, V531, P62, DOI 10.1016/S0014-5793(02)03410-5; Powner DJ, 2002, MOL BIOL CELL, V13, P1252, DOI 10.1091/mbc.01-05-0235; Rivero F, 2002, J MUSCLE RES CELL M, V23, P737, DOI 10.1023/A:1024423611223; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schmidt M, 1996, J BIOL CHEM, V271, P2422, DOI 10.1074/jbc.271.5.2422; Schmidt M, 1999, J BIOL CHEM, V274, P14648, DOI 10.1074/jbc.274.21.14648; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; SINGER WD, 1995, J BIOL CHEM, V270, P14944, DOI 10.1074/jbc.270.25.14944; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Yamazaki M, 1999, J BIOL CHEM, V274, P6035, DOI 10.1074/jbc.274.10.6035	46	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.206672	http://dx.doi.org/10.1074/jbc.M110.206672			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21378159	Green Published, hybrid			2022-12-25	WOS:000290022800069
J	Garalde, DR; Simon, CA; Dahl, JM; Wang, H; Akeson, M; Lieberman, KR				Garalde, Daniel R.; Simon, Christopher A.; Dahl, Joseph M.; Wang, Hongyun; Akeson, Mark; Lieberman, Kate R.			Distinct Complexes of DNA Polymerase I (Klenow Fragment) for Base and Sugar Discrimination during Nucleotide Substrate Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; ANGSTROM RESOLUTION; ELECTRONIC CONTROL; CRYSTAL-STRUCTURES; KINETIC MECHANISM; STRUCTURAL BASIS; ACTIVE-SITE; NANOPORE; MOLECULES; REPLICATION	During each catalytic cycle, DNA polymerases select deoxyribonucleoside triphosphate (dNTP) substrates complementary to a templating base with high fidelity from a pool that includes noncomplementary dNTPs and both complementary and noncomplementary ribonucleoside triphosphates (rNTPs). The Klenow fragment of Escherichia coli DNA polymerase I (KF) achieves this through a series of conformational transitions that precede the chemical step of phosphodiester bond formation. Kinetic evidence from fluorescence and FRET experiments indicates that discrimination of the base and sugar moieties of the incoming nucleotide occurs in distinct, sequential steps during the selection pathway. Here we show that KF-DNA complexes formed with complementary rNTPs or with noncomplementary nucleotides can be distinguished on the basis of their properties when captured in an electric field atop the alpha-hemolysin nanopore. The average nanopore dwell time of KF-DNA complexes increased as a function of complementary rNTP concentration. The increase was less than that promoted by complementary dNTP, indicating that the rNTP complexes are more stable than KF-DNA binary complexes but less stable than KF-DNA-dNTP ternary complexes. KF-DNA-rNTP complexes could also be distinguished from KF-DNA-dNTP complexes on the basis of ionic current amplitude. In contrast to complementary rNTPs, noncomplementary dNTPs and rNTPs diminished the average nanopore dwell time of KF-DNA complexes in a concentration-dependent manner, suggesting that binding of a noncomplementary nucleotide keeps the KF-DNA complex in a less stable state. These results imply that nucleotide selection proceeds through a series of complexes of increasing stability in which substrates with the correct moiety promote the forward transitions.	[Dahl, Joseph M.; Akeson, Mark; Lieberman, Kate R.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Garalde, Daniel R.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Comp Engn, Santa Cruz, CA 95064 USA; [Simon, Christopher A.; Wang, Hongyun] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Lieberman, KR (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, 1156 High St,MS SOE2, Santa Cruz, CA 95064 USA.	lieberman@biology.ucsc.edu	Akeson, Mark/HCH-3046-2022		National Institutes of Health from the NHGRI [1RC2HG005553]; National Institutes of Health from the NIGMS [1R01GM087484-01A2]; National Science Foundation [DMS-0719361]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Institutes of Health from the NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RC2HG005553 from the NHGRI (to M. A.) and 1R01GM087484-01A2 from the NIGMS (to K. R. L. and M. A.).; Supported in part by National Science Foundation Grant DMS-0719361.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Datta K, 2010, P NATL ACAD SCI USA, V107, P17980, DOI 10.1073/pnas.1012277107; DeLucia AM, 2006, J BIOL CHEM, V281, P27286, DOI 10.1074/jbc.M604393200; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dzantiev L, 1999, J BIOL CHEM, V274, P3279, DOI 10.1074/jbc.274.6.3279; Dzantiev L, 2001, BIOCHEMISTRY-US, V40, P3215, DOI 10.1021/bi002569i; Gyarfas B, 2009, ACS NANO, V3, P1457, DOI 10.1021/nn900303g; Hurt N, 2009, J AM CHEM SOC, V131, P3772, DOI 10.1021/ja809663f; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Minnick DT, 2002, P NATL ACAD SCI USA, V99, P1194, DOI 10.1073/pnas.032457899; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; SAVAGE LJ, 1976, ANN STAT, V4, P441, DOI 10.1214/aos/1176343456; Stengel G, 2007, BIOCHEMISTRY-US, V46, P12289, DOI 10.1021/bi700755m; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696; Wilson NA, 2009, ACS NANO, V3, P995, DOI 10.1021/nn9000897	31	20	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14480	14492		10.1074/jbc.M111.218750	http://dx.doi.org/10.1074/jbc.M111.218750			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362617	hybrid, Green Published			2022-12-25	WOS:000289556200069
J	Gentile, MA; Melchiorre, S; Emolo, C; Moschioni, M; Gianfaldoni, C; Pancotto, L; Ferlenghi, I; Scarselli, M; Pansegrau, W; Veggi, D; Merola, M; Cantini, F; Ruggiero, P; Banci, L; Masignani, V				Gentile, Maria Antonietta; Melchiorre, Sara; Emolo, Carla; Moschioni, Monica; Gianfaldoni, Claudia; Pancotto, Laura; Ferlenghi, Ilaria; Scarselli, Maria; Pansegrau, Werner; Veggi, Daniele; Merola, Marcello; Cantini, Francesca; Ruggiero, Paolo; Banci, Lucia; Masignani, Vega			Structural and Functional Characterization of the Streptococcus pneumoniae RrgB Pilus Backbone D1 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; MAGNETIC-RESONANCE RELAXATION; GRAM-POSITIVE BACTERIA; MODEL-FREE APPROACH; ISOPEPTIDE BONDS; CORYNEBACTERIUM-DIPHTHERIAE; STABILIZING ISOPEPTIDE; OTITIS-MEDIA; UCSF CHIMERA; PROTEIN NMR	Streptococcus pneumoniae expresses on its surface adhesive pili, involved in bacterial attachment to epithelial cells and virulence. The pneumococcal pilus is composed of three proteins, RrgA, RrgB, and RrgC, each stabilized by intramolecular isopeptide bonds and covalently polymerized by means of intermolecular isopeptide bonds to form an extended fiber. RrgB is the pilus scaffold subunit and is protective in vivo in mouse models of sepsis and pneumonia, thus representing a potential vaccine candidate. The crystal structure of a major RrgB C-terminal portion featured an organization into three independently folded protein domains (D2-D4), whereas the N-terminal D1 domain (D1) remained unsolved. We have tested the four single recombinant RrgB domains in active and passive immunization studies and show that D1 is the most effective, providing a level of protection comparable with that of the full-length protein. To elucidate the structural features of D1, we solved the solution structure of the recombinant domain by NMR spectroscopy. The spectra analysis revealed that D1 has many flexible regions, does not contain any intramolecular isopeptide bond, and shares with the other domains an Ig-like fold. In addition, we demonstrated, by site-directed mutagenesis and complementation in S. pneumoniae, that the D1 domain contains the Lys residue (Lys-183) involved in the formation of the intermolecular isopeptide bonds and pilus polymerization. Finally, we present a model of the RrgB protein architecture along with the mapping of two surface-exposed linear epitopes recognized by protective antisera.	[Cantini, Francesca; Banci, Lucia] Univ Florence, Magnet Resonance Ctr, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Gentile, Maria Antonietta; Melchiorre, Sara; Emolo, Carla; Moschioni, Monica; Gianfaldoni, Claudia; Pancotto, Laura; Ferlenghi, Ilaria; Scarselli, Maria; Pansegrau, Werner; Veggi, Daniele; Merola, Marcello; Ruggiero, Paolo; Masignani, Vega] Novartis Vaccines & Diagnost Res Ctr, I-53100 Siena, Italy; [Merola, Marcello] Univ Naples Federico II, I-80126 Naples, Italy	University of Florence; Novartis; University of Naples Federico II	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr, Dept Chem, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	banci@cerm.unifi.it; vega.masignani@novartis.com	Cantini, Francesca/O-1220-2015	Cantini, Francesca/0000-0003-0526-6732; BANCI, LUCIA/0000-0003-0562-5774	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondi per gli Investimenti della Ricerca di Base-Proteomica) [RBRN07BMCT]; Integrated Structural Biology Infrastructure for Europ [211252]	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondi per gli Investimenti della Ricerca di Base-Proteomica)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Integrated Structural Biology Infrastructure for Europ	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondi per gli Investimenti della Ricerca di Base-Proteomica RBRN07BMCT) and Integrated Structural Biology Infrastructure for Europe Contract 211252. Because some of the authors are employees of Novartis Vaccines, there are competing financial interests.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fletcher MA, 2007, VACCINE, V25, P2507, DOI 10.1016/j.vaccine.2006.09.027; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guttilla IK, 2009, J BACTERIOL, V191, P5603, DOI 10.1128/JB.00627-09; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 1996, METHOD ENZYMOL, V266, P653; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Millar EV, 2009, PEDIATR INFECT DIS J, V28, P711, DOI 10.1097/INF.0b013e3181a06303; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; PEARLMAN AD, 1995, COMP PHYS COMMUN, V91, P1; Pelton SI, 2009, PEDIATR INFECT DIS J, V28, pS133, DOI 10.1097/INF.0b013e3181b6d81a; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Ryan MW, 2000, LARYNGOSCOPE, V110, P961, DOI 10.1097/00005537-200006000-00014; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4	55	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14588	14597		10.1074/jbc.M110.202739	http://dx.doi.org/10.1074/jbc.M110.202739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367860	Green Published, hybrid			2022-12-25	WOS:000289556200078
J	Mandal, P; Pratt, BT; Barnes, M; McMullen, MR; Nagy, LE				Mandal, Palash; Pratt, Brian T.; Barnes, Mark; McMullen, Megan R.; Nagy, Laura E.			Molecular Mechanism for Adiponectin-dependent M2 Macrophage Polarization LINK BETWEEN THE METABOLIC AND INNATE IMMUNE ACTIVITY OF FULL-LENGTH ADIPONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; RAT KUPFFER CELLS; FATTY LIVER; ALTERNATIVE ACTIVATION; OXIDATIVE STRESS; TERM TREATMENT; TNF-ALPHA; ETHANOL; INJURY; PROGRESSION	The anti-inflammatory effects of globular adiponectin (gAcrp) are mediated by IL-10/heme oxygenase 1 (HO-1)-dependent pathways. Although full-length (flAcrp) adiponectin also suppresses LPS-induced pro-inflammatory signaling, its signaling mechanisms are not yet understood. The aim of this study was to examine the differential mechanisms by which gAcrp and flAcrp suppress pro-inflammatory signaling in macrophages. Chronic ethanol feeding increased LPS-stimulated TNF-alpha expression by Kupffer cells, associated with a shift to an M1 macrophage polarization. Both gAcrp and flAcrp suppressed TNF-alpha expression in Kupffer cells; however, only the effect of gAcrp was dependent on IL-10. Similarly, inhibition of HO-1 activity or siRNA knockdown of HO-1 in RAW264.7 macrophages only partially attenuated the suppressive effects of flAcrp on MyD88-dependent and -independent cytokine signatures. Instead, flAcrp, acting via the adiponectin R2 receptor, potently shifted the polarization of Kupffer cells and RAW264.7 macrophages to an M2 phenotype. gAcrp, acting via the adiponectin R1 receptor, was much less effective at eliciting an M2 pattern of gene expression. M2 polarization was also partially dependent on AMP-activated kinase. flAcrp polarized RAW264.7 macrophages to an M2 phenotype in an IL-4/STAT6-dependent mechanism. flAcrp also increased the expression of genes involved in oxidative phosphorylation in RAW264.7 macrophages, similar to the effect of flAcrp on hepatocytes. In summary, these data demonstrate that gAcrp and flAcrp utilize differential signaling strategies to decrease the sensitivity of macrophages to activation by TLR4 ligands, with flAcrp utilizing an IL-4/STAT6-dependent mechanism to shift macrophage polarization to the M2/anti-inflammatory phenotype.	[Mandal, Palash; Pratt, Brian T.; McMullen, Megan R.; Nagy, Laura E.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA; [Barnes, Mark; Nagy, Laura E.] Case Western Reserve Univ, Dept Mol Med, Cleveland, OH 44120 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Mandal, P (corresponding author), Cleveland Clin Fdn, Lerner Res Inst NE 40, 9500 Euclid Ave, Cleveland, OH 44195 USA.	len2@case.edu	MANDAL, PALASH/I-5238-2019	MANDAL, PALASH/0000-0001-6612-3773	National Institutes of Health [RO1AA011975, R37AA011876]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011975, R37AA011876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AA011975 and R37AA011876 (to L. E. N.).	Balmer ML, 2010, CLIN SCI, V119, P431, DOI 10.1042/CS20100008; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Fukushima J, 2009, HEPATOL RES, V39, P724, DOI 10.1111/j.1872-034X.2009.00509.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mandal P, 2010, J IMMUNOL, V185, P4928, DOI 10.4049/jimmunol.1002060; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McVicker BL, 2007, WORLD J GASTROENTERO, V13, P4960, DOI 10.3748/wjg.v13.i37.4960; Nagy LE, 2003, EXP BIOL MED, V228, P882, DOI 10.1177/153537020322800803; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Pang MY, 2009, J HEPATOL, V50, P1192, DOI 10.1016/j.jhep.2009.01.021; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Rogers CQ, 2008, IUBMB LIFE, V60, P790, DOI 10.1002/iub.124; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Steinberg GR, 2009, FRONT BIOSCI-LANDMRK, V14, P1902, DOI 10.2741/3350; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Vidali M, 2008, TRENDS MOL MED, V14, P63, DOI 10.1016/j.molmed.2007.12.005; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049	44	182	194	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13460	13469		10.1074/jbc.M110.204644	http://dx.doi.org/10.1074/jbc.M110.204644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21357416	Green Published, hybrid			2022-12-25	WOS:000289282200066
J	Carre, A; Rachdi, L; Tron, E; Richard, B; Castanet, M; Schlumberger, M; Bidart, JM; Szinnai, G; Polak, M				Carre, Aurore; Rachdi, Latif; Tron, Elodie; Richard, Benedicte; Castanet, Mireille; Schlumberger, Martin; Bidart, Jean-Michel; Szinnai, Gabor; Polak, Michel			Hes1 Is Required for Appropriate Morphogenesis and Differentiation during Mouse Thyroid Gland Development	PLOS ONE			English	Article							CELL-PROLIFERATION; PROGENITOR CELLS; C-CELLS; EXPRESSION; THYMUS; GROWTH; NOTCH1; ONSET	Notch signalling plays an important role in endocrine development, through its target gene Hes1. Hes1, a bHLH transcriptional repressor, influences progenitor cell proliferation and differentiation. Recently, Hes1 was shown to be expressed in the thyroid and regulate expression of the sodium iodide symporter (Nis). To investigate the role of Hes1 for thyroid development, we studied thyroid morphology and function in mice lacking Hes1. During normal mouse thyroid development, Hes1 was detected from E9.5 onwards in the median anlage, and at E11.5 in the ultimobranchial bodies. Hes1(-/-) mouse embryos had a significantly lower number of Nkx2-1-positive progenitor cells (p < 0.05) at E9.5 and at E11.5. Moreover, Hes1(-/-) mouse embryos showed a significantly smaller total thyroid surface area (-40 to -60%) compared to wild type mice at all study time points (E9.5-E16.5). In both Hes1(-/-) and wild type mouse embryos, most Nkx2-1-positive thyroid cells expressed the cell cycle inhibitor p57 at E9.5 in correlation with low proliferation index. In Hes1(-/-) mouse embryos, fusion of the median anlage with the ultimobranchial bodies was delayed by 3 days (E16.5 vs. E13.5 in wild type mice). After fusion of thyroid anlages, hypoplastic Hes1(-/-) thyroids revealed a significantly decreased labelling area for T4 (-78%) and calcitonin (-65%) normalized to Nkx2-1 positive cells. Decreased T4-synthesis might be due to reduced Nis labelling area (-69%). These findings suggest a dual role of Hes1 during thyroid development: first, control of the number of both thyrocyte and C-cell progenitors, via a p57-independent mechanism; second, adequate differentiation and endocrine function of thyrocytes and C-cells.	[Carre, Aurore; Rachdi, Latif; Tron, Elodie; Richard, Benedicte; Castanet, Mireille; Polak, Michel] Univ Paris 05, INSERM, U845, Paris, France; [Schlumberger, Martin] Inst Gustave Roussy, Dept Nucl Med, Villejuif, France; [Bidart, Jean-Michel] Inst Gustave Roussy, Dept Biol Clin, F-94805 Villejuif, France; [Szinnai, Gabor] Univ Childrens Hosp Basel, Basel, Switzerland; [Szinnai, Gabor] Univ Basel, Dept Biomed, Basel, Switzerland; [Polak, Michel] Necker Enfants Malades Hosp, Paediat Endocrine Unit, Paris, France; [Polak, Michel] AP HP, Ctr Malad Endocriniennes Rares Croissance, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; University of Basel; University of Basel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Carre, A (corresponding author), Univ Paris 05, INSERM, U845, Paris, France.	michel.polak@nck.aphp.fr	Carre, Aurore/L-1021-2013; Rachdi, Latif/I-1988-2017	Carre, Aurore/0000-0002-6795-3629; Rachdi, Latif/0000-0002-1089-2837; Szinnai, Gabor/0000-0003-0559-2597	CIFRE; Ministere de l'Education Nationale et de la Recherche; European Society for Paediatric Endocrinology (ESPE); University Children's Hospital Basel, Basel, Switzerland; Electricite de France [RB 200605]; Sandoz France; Fondation Princesse Grace de la Principaute de Monaco	CIFRE; Ministere de l'Education Nationale et de la Recherche; European Society for Paediatric Endocrinology (ESPE); University Children's Hospital Basel, Basel, Switzerland; Electricite de France; Sandoz France(Novartis); Fondation Princesse Grace de la Principaute de Monaco	AC was supported by CIFRE in collaboration with HRA Pharma and by the Ministere de l'Education Nationale et de la Recherche. GS and MP received the Collaborative Research Unit Grant from the European Society for Paediatric Endocrinology (ESPE). GS received a Research Grant from the University Children's Hospital Basel, Basel, Switzerland. This study was supported in part by a grant from Electricite de France (RB 200605), by Sandoz France and by the Fondation Princesse Grace de la Principaute de Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Brown RS, 2000, ENDOCRINOLOGY, V141, P340, DOI 10.1210/en.141.1.340; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; Fagman H, 2006, DEV DYNAM, V235, P444, DOI 10.1002/dvdy.20653; Ferretti E, 2008, J CLIN ENDOCR METAB, V93, P4080, DOI 10.1210/jc.2008-0528; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ito T, 2000, DEVELOPMENT, V127, P3913; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kameda Y, 2007, J HISTOCHEM CYTOCHEM, V55, P1075, DOI 10.1369/jhc.7A7179.2007; Kameda Y, 2007, DEV DYNAM, V236, P262, DOI 10.1002/dvdy.21018; Kunnimalaiyaan M, 2006, J BIOL CHEM, V281, P39819, DOI 10.1074/jbc.M603578200; Lania G, 2009, DEV BIOL, V328, P109, DOI 10.1016/j.ydbio.2009.01.014; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Milenkovic M, 2007, J ENDOCRINOL, V192, P615, DOI 10.1677/JOE-06-0003; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Raetzman LT, 2007, DEV BIOL, V304, P455, DOI 10.1016/j.ydbio.2006.11.010; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Szinnai G, 2007, J CLIN ENDOCR METAB, V92, P70, DOI 10.1210/jc.2006-1450; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Xu PX, 2002, DEVELOPMENT, V129, P3033	26	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16752	10.1371/journal.pone.0016752	http://dx.doi.org/10.1371/journal.pone.0016752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364918	gold, Green Published, Green Submitted			2022-12-25	WOS:000287764100009
J	Gnocchi, VF; Scharner, J; Huang, Z; Brady, K; Lee, JS; White, RB; Morgan, JE; Sun, YB; Ellis, JA; Zammit, PS				Gnocchi, Viola F.; Scharner, Juergen; Huang, Zhe; Brady, Ken; Lee, Jaclyn S.; White, Robert B.; Morgan, Jennifer E.; Sun, Yin-Biao; Ellis, Juliet A.; Zammit, Peter S.			Uncoordinated Transcription and Compromised Muscle Function in the Lmna-Null Mouse Model of Emery-Dreifuss Muscular Dystrophy	PLOS ONE			English	Article							CHROMATIN BINDING-SITE; LAMIN-A/C DEFICIENCY; A-TYPE LAMINS; NUCLEAR-ENVELOPE; DILATED CARDIOMYOPATHY; SKELETAL-MUSCLE; SATELLITE CELLS; C-FOS; MUTATION; EXPRESSION	LMNA encodes both lamin A and C: major components of the nuclear lamina. Mutations in LMNA underlie a range of tissue-specific degenerative diseases, including those that affect skeletal muscle, such as autosomal-Emery-Dreifuss muscular dystrophy (A-EDMD) and limb girdle muscular dystrophy 1B. Here, we examine the morphology and transcriptional activity of myonuclei, the structure of the myotendinous junction and the muscle contraction dynamics in the lmna-null mouse model of A-EDMD. We found that there were fewer myonuclei in lmna-null mice, of which similar to 50% had morphological abnormalities. Assaying transcriptional activity by examining acetylated histone H3 and PABPN1 levels indicated that there was a lack of coordinated transcription between myonuclei lacking lamin A/C. Myonuclei with abnormal morphology and transcriptional activity were distributed along the length of the myofibre, but accumulated at the myotendinous junction. Indeed, in addition to the presence of abnormal myonuclei, the structure of the myotendinous junction was perturbed, with disorganised sarcomeres and reduced interdigitation with the tendon, together with lipid and collagen deposition. Functionally, muscle contraction became severely affected within weeks of birth, with specific force generation dropping as low as similar to 65% and similar to 27% of control values in the extensor digitorum longus and soleus muscles respectively. These observations illustrate the importance of lamin A/C for correct myonuclear function, which likely acts synergistically with myotendinous junction disorganisation in the development of A-EDMD, and the consequential reduction in force generation and muscle wasting.	[Gnocchi, Viola F.; Scharner, Juergen; Huang, Zhe; Lee, Jaclyn S.; White, Robert B.; Sun, Yin-Biao; Ellis, Juliet A.; Zammit, Peter S.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Brady, Ken] Kings Coll London, Ctr Ultrastruct Imaging, London WC2R 2LS, England; [Morgan, Jennifer E.] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England	University of London; King's College London; University of London; King's College London; University of London; University College London	Gnocchi, VF (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London WC2R 2LS, England.	peter.zammit@kcl.ac.uk	Sun, Yin-Biao/F-9988-2018; Scharner, Juergen/N-9534-2014; Zammit, peter/GXV-7746-2022; White, Robert/H-6080-2014	Sun, Yin-Biao/0000-0002-4992-8198; Scharner, Juergen/0000-0002-1110-8688; zammit, peter/0000-0001-9562-3072; Huang, Zhe/0000-0003-4943-3723; White, Robert/0000-0002-2854-0936	Medical Research Council [G0700307, G0601065]; Biomedical School, King's College London; EC [511978]; Wellcome Trust [085137/Z/08/Z]; Wellcome Trust University [084241/Z/07/Z]; British Heart Foundation [FS/09/001/26329]; laboratory of PSZ [223098]; European Commission; Muscular Dystrophy Campaign; MRC [G0601065, G0601943, G0700307] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical School, King's College London; EC(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Wellcome Trust University(Wellcome Trust); British Heart Foundation(British Heart Foundation); laboratory of PSZ; European Commission(European CommissionEuropean Commission Joint Research Centre); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	VFG was supported by The Medical Research Council project grant G0700307 (http://www.mrc.ac.uk/) awarded to PSZ, JEM and JAE. JS received funding from the Biomedical School, King's College London and the EC Network of Excellence MYORES (contract 511978). RBW and JSL were supported by The Wellcome Trust project grant 085137/Z/08/Z (http://www.wellcome.ac.uk/), JEM is financed by a Wellcome Trust University Award (084241/Z/07/Z), Y-BS has a British Heart Foundation Senior Research Fellowship (FS/09/001/26329) and ZH is funded by Medical Research Council grant G0601065, awarded to Professor Malcolm Irving. The laboratory of PSZ is also supported by OPTISTEM Grant Agreement number: 223098, from the European Commission 7th Framework Programme and The Muscular Dystrophy Campaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cohen TV, 2008, CURR TOP DEV BIOL, V84, P351, DOI 10.1016/S0070-2153(08)00607-8; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Emery AEH, 2000, NEUROMUSCULAR DISORD, V10, P228, DOI 10.1016/S0960-8966(00)00105-X; Fidzianska A, 2003, J NEUROL SCI, V210, P47, DOI 10.1016/S0022-510X(03)00012-1; Galiova G, 2008, EUR J CELL BIOL, V87, P291, DOI 10.1016/j.ejcb.2008.01.013; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; Grattan M. J., 2005, V264, P118, DOI 10.1002/0470093765.ch9; GRATTAN MJ, 2005, NOVART FDN SYMP, V264, P133; GRATTAN MJ, 2005, NOVART FDN SYMP, V264, P227; Hakelien AM, 2008, EXP CELL RES, V314, P1869, DOI 10.1016/j.yexcr.2008.02.018; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Kandert S, 2009, EUR J CELL BIOL, V88, P593, DOI 10.1016/j.ejcb.2009.06.002; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Marmiroli S, 2009, J CELL PHYSIOL, V220, P553, DOI 10.1002/jcp.21807; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; MENDEZ J, 1960, METABOLISM, V9, P184; Mittelbronn M, 2008, BRAIN PATHOL, V18, P338, DOI 10.1111/j.1750-3639.2008.00123.x; Monti RJ, 1999, J BIOMECH, V32, P371, DOI 10.1016/S0021-9290(98)00189-4; Morgan JE, 2010, EXP CELL RES, V316, P3100, DOI 10.1016/j.yexcr.2010.05.014; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Munshi A, 2009, J GENET GENOMICS, V36, P75, DOI 10.1016/S1673-8527(08)60094-6; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Park YE, 2009, NEUROMUSCULAR DISORD, V19, P29, DOI 10.1016/j.nmd.2008.09.018; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Reichart B, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-12; RIDGE JC, 1994, EXP MOL PATHOL, V61, P58, DOI 10.1006/exmp.1994.1025; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; Sabatelli P, 2001, MUSCLE NERVE, V24, P826, DOI 10.1002/mus.1076; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Scharner J, 2011, HUM MUTAT, V32, P152, DOI 10.1002/humu.21361; Scharner J, 2010, BIOCHEM SOC T, V38, P257, DOI 10.1042/BST0380257; Schirmer EC, 2008, MUTAT RES-FUND MOL M, V647, P112, DOI 10.1016/j.mrfmmm.2008.07.012; Sewry CA, 2001, NEUROPATH APPL NEURO, V27, P281, DOI 10.1046/j.0305-1846.2001.00323.x; Sewry CA, 2010, ACTA NEUROPATHOL, V120, P343, DOI 10.1007/s00401-010-0727-5; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; TIDBALL JG, 1992, ACTA NEUROPATHOL, V84, P135, DOI 10.1007/BF00311385; TIDBALL JG, 1991, J BIOMECH, V24, P43, DOI 10.1016/0021-9290(91)90376-X; TIDBALL JG, 1992, J APPL PHYSIOL, V73, P59, DOI 10.1152/jappl.1992.73.1.59; van Engelen BGM, 2005, NEUROLOGY, V64, P374, DOI 10.1212/01.WNL.0000149763.15180.00; Vaughan OA, 2001, J CELL SCI, V114, P2577; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Worman HJ, 2006, BBA-MOL CELL BIOL L, V1761, P626, DOI 10.1016/j.bbalip.2006.02.010; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661	64	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16651	10.1371/journal.pone.0016651	http://dx.doi.org/10.1371/journal.pone.0016651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364987	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600011
J	Yang, J; Yang, X; Chu, YW; Li, M				Yang, Ji; Yang, Xue; Chu, Yiwei; Li, Ming			Identification of Baicalin as an Immunoregulatory Compound by Controlling T(H)17 Cell Differentiation	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-HELPER-CELLS; ROR-GAMMA-T; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ARYL-HYDROCARBON RECEPTOR; TH17 CELLS; TGF-BETA; ANTIINFLAMMATORY ACTIVITY; TISSUE INFLAMMATION; IL-23 RECEPTOR	T(H)17 cells have been implicated in a growing list of inflammatory disorders. Antagonism of T(H)17 cells can be used for the treatment of inflammatory injury. Currently, very little is known about the natural compound controlling the differentiation of T(H)17 cells. Here, we showed that Baicalin, a compound isolated from a Chinese herb, inhibited T(H)17 cell differentiation both in vitro and in vivo. Baicalin might inhibit newly generated T(H)17 cells via reducing ROR gamma t expression, and together with up-regulating Foxp3 expression to suppress ROR gamma t-mediated IL-17 expression in established T(H)17 cells. In vivo treatment with Baicalin could inhibit T(H)17 cell differentiation, restrain T(H)17 cells infiltration into kidney, and protect MRL/lpr mice against nephritis. Our findings not only demonstrate that Baicalin could control T(H)17 cell differentiation but also suggest that Baicalin might be a promising therapeutic agent for the treatment of T(H)17 cells-mediated inflammatory diseases.	[Yang, Ji; Li, Ming] Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Yang, Xue] Fudan Univ, Div Rheumatol, Huashan Hosp, Shanghai 200433, Peoples R China; [Chu, Yiwei] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Yang, J (corresponding author), Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	li.ming@zs-hospital.sh.cn			National Natural Science Foundation of China [81000693]; Institutes of Biomedical Sciences of Fudan University [2009068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institutes of Biomedical Sciences of Fudan University	Funding: This work was supported by the National Natural Science Foundation of China (81000693), Institutes of Biomedical Sciences of Fudan University (2009068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Kang HK, 2007, J IMMUNOL, V178, P7849, DOI 10.4049/jimmunol.178.12.7849; Kang HK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2682; Kasai A, 2008, BIOL PHARM BULL, V31, P838, DOI 10.1248/bpb.31.838; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li BQ, 2000, IMMUNOPHARMACOLOGY, V49, P295, DOI 10.1016/S0162-3109(00)00244-7; Lin CC, 1996, AM J CHINESE MED, V24, P31, DOI 10.1142/S0192415X96000050; Liu LL, 2008, BIOCHEM PHARMACOL, V75, P914, DOI 10.1016/j.bcp.2007.10.009; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McHale JF, 1999, J IMMUNOL, V163, P3993; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang WJ, 2009, EUR J IMMUNOL, V39, P670, DOI 10.1002/eji.200839105; Pan HF, 2008, NAT CLIN PRACT RHEUM, V4, P352, DOI 10.1038/ncprheum0815; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wan JY, 2008, EUR J PHARMACOL, V587, P302, DOI 10.1016/j.ejphar.2008.02.081; Wang YG, 2008, MOD RHEUMATOL, V18, P385, DOI 10.1007/s10165-008-0074-8; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zeng Y, 2007, BRAZ J MED BIOL RES, V40, P1003, DOI 10.1590/S0100-879X2006005000115; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	52	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17164	10.1371/journal.pone.0017164	http://dx.doi.org/10.1371/journal.pone.0017164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359178	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700056
J	Katz, E; Dubois-Marshall, S; Sims, AH; Gautier, P; Caldwell, H; Meehan, RR; Harrison, DJ				Katz, Elad; Dubois-Marshall, Sylvie; Sims, Andrew H.; Gautier, Philippe; Caldwell, Helen; Meehan, Richard R.; Harrison, David J.			An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer	PLOS ONE			English	Article							TUMOR PROGRESSION; CLAUDIN-LOW; N-CADHERIN; CELLS; INVASION; METASTASIS; EXPRESSION; GENE; MOTILITY; SUBTYPES	The epithelial to mesenchymal transition (EMT) is a developmental program in which epithelial cells down-regulate their cell-cell junctions, acquire spindle cell morphology and exhibit cellular motility. In human breast cancer, invasion into surrounding tissue is the first step in metastatic progression. Here, we devised an in vitro model using selected cell lines, which recapitulates many features of EMT as observed in human breast cancer. By comparing the gene expression profiles of claudin-low breast cancers with the experimental model, we identified a 9-gene signature characteristic of EMT. This signature was found to distinguish a series of breast cancer cell lines that have demonstrable, classical EMT hallmarks, including loss of E-cadherin protein and acquisition of N-cadherin and vimentin expression. We subsequently developed a three-dimensional model to recapitulate the process of EMT with these cell lines. The cells maintain epithelial morphology when encapsulated in a reconstituted basement membrane, but undergo spontaneous EMT and invade into surrounding collagen in the absence of exogenous cues. Collectively, this model of EMT in vitro reveals the behaviour of breast cancer cells beyond the basement membrane breach and recapitulates the in vivo context for further investigation into EMT and drugs that may interfere with it.	[Katz, Elad; Dubois-Marshall, Sylvie; Sims, Andrew H.; Caldwell, Helen; Meehan, Richard R.; Harrison, David J.] Univ Edinburgh, Inst Genet & Mol Med, Breakthrough Breast Canc Res Unit, Edinburgh, Midlothian, Scotland; [Katz, Elad; Dubois-Marshall, Sylvie; Caldwell, Helen; Harrison, David J.] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh, Midlothian, Scotland; [Gautier, Philippe; Meehan, Richard R.] Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Katz, E (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Breakthrough Breast Canc Res Unit, Edinburgh, Midlothian, Scotland.	elad.katz@ed.ac.uk	Sims, Andrew/E-4819-2012; Gautier, Philippe/D-4067-2011	Sims, Andrew/0000-0001-9082-3665; harrison, david/0000-0001-9041-9988; Meehan, Richard/0000-0001-6471-6882	Edinburgh Experimental Cancer Medicine Centre; Breakthrough Breast Cancer; Scottish Funding Council; MRC [MC_U127574433] Funding Source: UKRI; Medical Research Council [MC_U127574433] Funding Source: researchfish	Edinburgh Experimental Cancer Medicine Centre; Breakthrough Breast Cancer; Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Clinical materials were obtained through the auspices of the Edinburgh Experimental Cancer Medicine Centre. This work was supported by Breakthrough Breast Cancer and the Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt LM, 2010, SEMIN CELL DEV BIOL, V21, P11, DOI 10.1016/j.semcdb.2009.10.003; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fanayan S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-7; Fernandez Y, 2010, CANCER TREAT REV, V36, P33, DOI 10.1016/j.ctrv.2009.10.001; Flanagan L, 1999, BREAST CANCER RES TR, V58, P193, DOI 10.1023/A:1006331716981; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wiercinska E, 2010, BREAST CANC RES TREA; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou CH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2210	42	45	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17083	10.1371/journal.pone.0017083	http://dx.doi.org/10.1371/journal.pone.0017083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347235	Green Published, Green Submitted, gold			2022-12-25	WOS:000287369200020
J	Wu, CC; Bossaerts, P; Knutson, B				Wu, Charlene C.; Bossaerts, Peter; Knutson, Brian			The Affective Impact of Financial Skewness on Neural Activity and Choice	PLOS ONE			English	Article							DECISION-MAKING; PROSPECT-THEORY; PREFRONTAL CORTEX; RISK-TAKING; REWARD; ACTIVATION; PREFERENCE; VARIANCE; REPRESENTATION; UNCERTAINTY	Few finance theories consider the influence of "skewness'' (or large and asymmetric but unlikely outcomes) on financial choice. We investigated the impact of skewed gambles on subjects' neural activity, self-reported affective responses, and subsequent preferences using functional magnetic resonance imaging (FMRI). Neurally, skewed gambles elicited more anterior insula activation than symmetric gambles equated for expected value and variance, and positively skewed gambles also specifically elicited more nucleus accumbens (NAcc) activation than negatively skewed gambles. Affectively, positively skewed gambles elicited more positive arousal and negatively skewed gambles elicited more negative arousal than symmetric gambles equated for expected value and variance. Subjects also preferred positively skewed gambles more, but negatively skewed gambles less than symmetric gambles of equal expected value. Individual differences in both NAcc activity and positive arousal predicted preferences for positively skewed gambles. These findings support an anticipatory affect account in which statistical properties of gambles-including skewness-can influence neural activity, affective responses, and ultimately, choice.	[Wu, Charlene C.; Knutson, Brian] Stanford Univ, Stanford, CA 94305 USA; [Bossaerts, Peter] CALTECH, Pasadena, CA 91125 USA	Stanford University; California Institute of Technology	Wu, CC (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	charlene.wu@stanford.edu	Bossaerts, Peter/AAZ-9851-2020; Bossaerts, Peter/O-9964-2015	Bossaerts, Peter/0000-0003-2308-2603; Knutson, Brian/0000-0002-7669-426X	National Science Foundation [0748915]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020006] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research was supported by National Science Foundation Grant 0748915 to BK and National Science Foundation Graduate Research Fellowship to CCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERFER CP, 1970, J BUS, V43, P341, DOI 10.1086/295286; Ang A, 2006, REV FINANC STUD, V19, P1191, DOI 10.1093/rfs/hhj035; ARDITTI FD, 1975, J FINANC, V30, P797, DOI 10.2307/2326859; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Chiu WH, 2005, MANAGE SCI, V51, P1816, DOI 10.1287/mnsc.1050.0431; COOMBS CH, 1981, J EXP PSYCHOL HUMAN, V7, P1110, DOI 10.1037/0096-1523.7.5.1110; COOMBS CH, 1960, J EXP PSYCHOL, V60, P265, DOI 10.1037/h0041444; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; EDWARDS W, 1954, AM J PSYCHOL, V67, P441, DOI 10.2307/1417935; EDWARDS W, 1953, AM J PSYCHOL, V66, P349, DOI 10.2307/1418231; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Gneezy U, 2003, J FINANC, V58, P821, DOI 10.1111/1540-6261.00547; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; KRAUS A, 1976, J FINANC, V31, P1085, DOI 10.2307/2326275; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Levy H, 2004, REV FINANC STUD, V17, P1015, DOI 10.1093/rfs/hhg062; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lovallo D, 2000, J BEHAV DECIS MAKING, V13, P179, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<179::AID-BDM332>3.0.CO;2-J; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; MENEZES C, 1980, AM ECON REV, V70, P921; Mitton T, 2007, REV FINANC STUD, V20, P1255, DOI 10.1093/revfin/hhm011; Miyamoto JM, 1996, OPER RES, V44, P313, DOI 10.1287/opre.44.2.313; Nielsen L, 2008, EMOTION, V8, P318, DOI 10.1037/1528-3542.8.3.318; Patton A. J., 2004, J FINANCIAL ECONOMET, V2, P130, DOI DOI 10.1093/JJFINEC/NBH006; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; QUIGGIN J, 1982, J ECON BEHAV ORGAN, V3, P323, DOI 10.1016/0167-2681(82)90008-7; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Symmonds M, 2010, J NEUROSCI, V30, P14380, DOI 10.1523/JNEUROSCI.1459-10.2010; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006	42	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16838	10.1371/journal.pone.0016838	http://dx.doi.org/10.1371/journal.pone.0016838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721QH	21347239	Green Accepted, gold, Green Published			2022-12-25	WOS:000287369200010
J	Choy, HA; Kelley, MM; Croda, J; Matsunaga, J; Babbitt, JT; Ko, AI; Picardeau, M; Haake, DA				Choy, Henry A.; Kelley, Melissa M.; Croda, Julio; Matsunaga, James; Babbitt, Jane T.; Ko, Albert I.; Picardeau, Mathieu; Haake, David A.			The Multifunctional LigB Adhesin Binds Homeostatic Proteins with Potential Roles in Cutaneous Infection by Pathogenic Leptospira interrogans	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEINS; STAPHYLOCOCCUS-AUREUS; MUCOSAL IMMUNOLOGY; CRYSTAL-STRUCTURE; HUMAN-FIBRINOGEN; GENE-EXPRESSION; TISSUE-REPAIR; MSCRAMM; REGION; MODEL	Leptospirosis is a potentially fatal zoonotic disease in humans and animals caused by pathogenic spirochetes, such as Leptospira interrogans. The mode of transmission is commonly limited to the exposure of mucous membrane or damaged skin to water contaminated by leptospires shed in the urine of carriers, such as rats. Infection occurs during seasonal flooding of impoverished tropical urban habitats with large rat populations, but also during recreational activity in open water, suggesting it is very efficient. LigA and LigB are surface localized proteins in pathogenic Leptospira strains with properties that could facilitate the infection of damaged skin. Their expression is rapidly induced by the increase in osmolarity encountered by leptospires upon transition from water to host. In addition, the immunoglobulin-like repeats of the Lig proteins bind proteins that mediate attachment to host tissue, such as fibronectin, fibrinogen, collagens, laminin, and elastin, some of which are important in cutaneous wound healing and repair. Hemostasis is critical in a fresh injury, where fibrinogen from damaged vasculature mediates coagulation. We show that fibrinogen binding by recombinant LigB inhibits fibrin formation, which could aid leptospiral entry into the circulation, dissemination, and further infection by impairing healing. LigB also binds fibroblast fibronectin and type III collagen, two proteins prevalent in wound repair, thus potentially enhancing leptospiral adhesion to skin openings. LigA or LigB expression by transformation of a nonpathogenic saprophyte, L. biflexa, enhances bacterial adhesion to fibrinogen. Our results suggest that by binding homeostatic proteins found in cutaneous wounds, LigB could facilitate leptospirosis transmission. Both fibronectin and fibrinogen binding have been mapped to an overlapping domain in LigB comprising repeats 9-11, with repeat 11 possibly enhancing binding by a conformational effect. Leptospirosis patient antibodies react with the LigB domain, suggesting applications in diagnosis and vaccines that are currently limited by the strain-specific leptospiral lipopolysaccharide coats.	[Choy, Henry A.; Matsunaga, James; Babbitt, Jane T.; Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Choy, Henry A.; Kelley, Melissa M.; Matsunaga, James; Babbitt, Jane T.] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Croda, Julio; Ko, Albert I.] Brasilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil; [Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil; [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France; [Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA; [Haake, David A.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA; [Haake, David A.] Univ Calif Los Angeles, Dept Mol Genet Microbiol & Immunol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Fundacao Oswaldo Cruz; Universidade Federal da Grande Dourados; Yale University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Choy, HA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	hachoy@ucla.edu	Ko, Albert/P-2343-2015; Croda, Julio/I-5172-2013	Ko, Albert/0000-0001-9023-2339; Croda, Julio/0000-0002-6665-6825	National Institutes of Health [R01 AI34431, U01 AI088752, D43 TW00919, R01 AI052473]; VA Medical Research Funds; Institut Pasteur, Paris, France; French Ministry of Research [ANR-08-MIE-018]; Oswaldo Cruz Foundation [PDTIS RVR05]; FOGARTY INTERNATIONAL CENTER [D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034431, R01AI052473, U01AI088752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Medical Research Funds(US Department of Veterans Affairs); Institut Pasteur, Paris, France; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Oswaldo Cruz Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (R01 AI34431, U01 AI088752, D43 TW00919, and R01 AI052473), VA Medical Research Funds (to D. A. H.), the Institut Pasteur, Paris, France, the French Ministry of Research (ANR-08-MIE-018), and the Fiocruz-Pasteur Scientific Cooperation Agreement, Oswaldo Cruz Foundation (PDTIS RVR05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum CL, 2005, DERMATOL SURG, V31, P674; BERNSTEIN JM, 1992, RESPIRATION, V59, P3; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Ham SA, 2010, J CELL MOL MED, V14, P1747, DOI 10.1111/j.1582-4934.2009.00816.x; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HAWIGER J, 1982, BIOCHEMISTRY-US, V21, P1407, DOI 10.1021/bi00535a047; Ito T, 1987, Nihon Juigaku Zasshi, V49, P875; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Liu CZ, 2005, THROMB HAEMOSTASIS, V94, P286, DOI 10.1160/TH05-03-0205; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Narita M, 2005, AM J TROP MED HYG, V73, P652, DOI 10.4269/ajtmh.2005.73.652; Nestle FO, 2007, J CLIN INVEST, V117, P2382, DOI 10.1172/JCI33349; Perkins S, 2001, J BIOL CHEM, V276, P44721, DOI 10.1074/jbc.M106741200; QUAGLINO D, 1991, J INVEST DERMATOL, V97, P34; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Thibeault SL, 2009, MUCOSAL IMMUNOL, V2, P122, DOI 10.1038/mi.2008.82; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	51	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16879	10.1371/journal.pone.0016879	http://dx.doi.org/10.1371/journal.pone.0016879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347378	Green Submitted, Green Published, gold			2022-12-25	WOS:000287361700049
J	Lundgren, O; Jodal, M; Jansson, M; Ryberg, AT; Svensson, L				Lundgren, Ove; Jodal, Mats; Jansson, Madeleine; Ryberg, Anders T.; Svensson, Lennart			Intestinal Epithelial Stem/Progenitor Cells Are Controlled by Mucosal Afferent Nerves	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CLOSTRIDIUM-DIFFICILE TOXIN; STEM-CELLS; SUBSTANCE-P; ELECTROLYTE SECRETION; INDUCED PROLIFERATION; MOLECULAR-MECHANISMS; SMOOTH-MUSCLE; COLON	Background: The maintenance of the intestinal epithelium is of great importance for the survival of the organism. A possible nervous control of epithelial cell renewal was studied in rats and mice. Methods: Mucosal afferent nerves were stimulated by exposing the intestinal mucosa to capsaicin (1.6 mM), which stimulates intestinal external axons. Epithelial cell renewal was investigated in the jejunum by measuring intestinal thymidine kinase (TK) activity, intestinal H-3-thymidine incorporation into DNA, and the number of crypt cells labeled with BrdU. The influence of the external gut innervation was minimized by severing the periarterial nerves. Principal Findings: Luminal capsaicin increased all the studied variables, an effect nervously mediated to judge from inhibitory effects on TK activity or H-3-thymidine incorporation into DNA by exposing the mucosa to lidocaine (a local anesthetic) or by giving four different neurotransmitter receptor antagonists i.v. (muscarinic, nicotinic, neurokinin1 (NK1) or calcitonin gene related peptide (CGRP) receptors). After degeneration of the intestinal external nerves capsaicin did not increase TK activity, suggesting the involvement of an axon reflex. Intra-arterial infusion of Substance P (SP) or CGRP increased intestinal TK activity, a response abolished by muscarinic receptor blockade. Immunohistochemistry suggested presence of M3 and M5 muscarinic receptors on the intestinal stem/progenitor cells. We propose that the stem/progenitor cells are controlled by cholinergic nerves, which, in turn, are influenced by mucosal afferent neuron(s) releasing acetylcholine and/or SP and/or CGRP. In mice lacking the capsaicin receptor, thymidine incorporation into DNA and number of crypt cells labeled with BrdU was lower than in wild type animals suggesting that nerves are important also in the absence of luminal capsaicin, a conclusion also supported by the observation that atropine lowered thymidine incorporation into DNA by 60% in control rat segments. Conclusion: Enteric nerves are of importance in maintaining the intestinal epithelial barrier.	[Lundgren, Ove; Jodal, Mats; Jansson, Madeleine] Univ Gothenburg, Physiol Sect, Sahlgrenska Acad, Gothenburg, Sweden; [Ryberg, Anders T.] Univ Gothenburg, Pharmacol Sect, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Svensson, Lennart] Linkoping Univ, Dept Mol Virol, Linkoping, Sweden	University of Gothenburg; University of Gothenburg; Linkoping University	Lundgren, O (corresponding author), Univ Gothenburg, Physiol Sect, Sahlgrenska Acad, Gothenburg, Sweden.	ove.lundgren@fysiologi.gu.se	svensson, lennart/K-6163-2019		Swedish Scientific Council [2855, 5951, 8266]; Royal Society of Arts and Sciences in Gothenburg; Magnus Bergvall's and Adlerberth Research foundations	Swedish Scientific Council; Royal Society of Arts and Sciences in Gothenburg; Magnus Bergvall's and Adlerberth Research foundations	This research was supported by the Swedish Scientific Council (2855, 5951, 8266), the Royal Society of Arts and Sciences in Gothenburg and the Magnus Bergvall's and Adlerberth Research foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Banks MR, 2005, BRIT J PHARMACOL, V144, P994, DOI 10.1038/sj.bjp.0706128; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; BREIMER ME, 1981, EXP CELL RES, V135, P1, DOI 10.1016/0014-4827(81)90293-7; Bueno L, 2002, GUT, V51, pI19, DOI 10.1136/gut.51.suppl_1.i19; CASSUTO J, 1981, GUT, V22, P958, DOI 10.1136/gut.22.11.958; CASSUTO J, 1981, SCAND J GASTROENTERO, V16, P377, DOI 10.3109/00365528109181984; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheng KR, 2003, CANCER RES, V63, P6744; Cheng KR, 2007, BIOCHEM PHARMACOL, V73, P1001, DOI 10.1016/j.bcp.2006.11.028; Ciura S, 2006, J NEUROSCI, V26, P9069, DOI 10.1523/JNEUROSCI.0877-06.2006; Costa LG, 2001, GROWTH FACTORS, V18, P227, DOI 10.3109/08977190109029112; Day DW, 2003, MORSON DAWSONS GASTR; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; Frucht H, 1999, CLIN CANCER RES, V5, P2532; Fujisawa H, 2005, BIOCHEM BIOPH RES CO, V338, P271, DOI 10.1016/j.bbrc.2005.07.183; Furness J.B., 2006, ENTERIC NERVOUS SYST; HOLLE GE, 1991, GASTROENTEROLOGY, V101, P1264, DOI 10.1016/0016-5085(91)90076-W; Holzer P, 2004, EUR J PHARMACOL, V500, P231, DOI 10.1016/j.ejphar.2004.07.028; Houghton SG, 2006, J SURG RES, V131, P53, DOI 10.1016/j.jss.2005.07.029; HUGHES CA, 1980, CLIN SCI, V59, P317, DOI 10.1042/cs0590317; IMONDI AR, 1969, EXP CELL RES, V58, P323, DOI 10.1016/0014-4827(69)90512-6; JODAL M, 1986, GASTROENTEROLOGY, V91, P225, DOI 10.1016/0016-5085(86)90463-4; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kagnoff MF, 2006, ANN NY ACAD SCI, V1072, P313, DOI 10.1196/annals.1326.038; Kaunitz JD, 2001, LIFE SCI, V69, P3073, DOI 10.1016/S0024-3205(01)01413-8; Keates AC, 1998, AM J PHYSIOL-GASTR L, V274, pG196, DOI 10.1152/ajpgi.1998.274.1.G196; KENNEDY MFG, 1983, CLIN EXP PHARMACOL P, V10, P577, DOI 10.1111/j.1440-1681.1983.tb00226.x; KLEMPERER HG, 1968, BIOCHEM J, V108, P541, DOI 10.1042/bj1080541; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Kordasti S, 2004, GUT, V53, P952, DOI 10.1136/gut.2003.033563; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LIPKIN M, 1974, CANCER, V34, P878, DOI 10.1002/1097-0142(197409)34:3+<878::AID-CNCR2820340715>3.0.CO;2-R; LUCK MS, 1993, CELL TISSUE RES, V271, P363, DOI 10.1007/BF00318623; Lundgren O, 2004, GASTROENTEROLOGY, V126, pA425; Lundgren O, 2000, SCIENCE, V287, P491, DOI 10.1126/science.287.5452.491; Lundgren O, 2002, PHARMACOL TOXICOL, V90, P109, DOI 10.1034/j.1600-0773.2002.900301.x; MacNaughton WK, 2005, MEM I OSWALDO CRUZ, V100, P211, DOI 10.1590/S0074-02762005000900036; Magami Y, 2002, J GASTROEN HEPATOL, V17, P262, DOI 10.1046/j.1440-1746.2002.02683.x; MANN R, 1989, HISTOCHEMISTRY, V92, P219, DOI 10.1007/BF00500921; Mantyh CR, 1996, GASTROENTEROLOGY, V111, P1272, DOI 10.1053/gast.1996.v111.pm8898641; MATHIAS JR, 1989, HDB PHYSL GASTROINTE, V1, P1153; McVey DC, 2001, PEPTIDES, V22, P1439, DOI 10.1016/S0196-9781(01)00463-6; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mourad FH, 2000, GUT, V47, P382, DOI 10.1136/gut.47.3.382; Nguyen C, 2003, CAN J PHYSIOL PHARM, V81, P920, DOI 10.1139/Y03-080; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pfaar O, 2009, SWISS MED WKLY, V139, P35, DOI smw-12468; Roza C, 2001, PAIN, V93, P213, DOI 10.1016/S0304-3959(01)00318-9; RUCHTI C, 1983, CELL TISSUE RES, V232, P625, DOI 10.1007/BF00216434; SALSER JS, 1973, CANCER RES, V33, P1889; Sambrook J, 2001, MOL CLONING LAB MANU; SANN H, 1995, NEUROSCI LETT, V198, P17, DOI 10.1016/0304-3940(95)11951-R; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHEVING LA, 1989, J BIOL CHEM, V264, P1735; SEE NA, 1990, J AUTONOM NERV SYST, V31, P219, DOI 10.1016/0165-1838(90)90188-O; Shah N, 2009, AM J PHYSIOL-CELL PH, V296, pC221, DOI 10.1152/ajpcell.00514.2008; SJOQVIST A, 1991, ACTA PHYSIOL SCAND, V142, P127, DOI 10.1111/j.1748-1716.1991.tb09137.x; Slack BE, 2000, BIOCHEM J, V348, P381, DOI 10.1042/0264-6021:3480381; Tamura CS, 1997, BRAIN RES, V770, P248, DOI 10.1016/S0006-8993(97)00855-X; Tobin G, 2006, J APPL PHYSIOL, V100, P1215, DOI 10.1152/japplphysiol.00779.2005; Turvill JL, 2000, GASTROENTEROLOGY, V119, P1037, DOI 10.1053/gast.2000.18147; TUTTON PJM, 1980, CANCER, V45, P1172, DOI 10.1002/1097-0142(19800315)45:5+<1172::AID-CNCR2820451322>3.0.CO;2-B; TUTTON PJM, 1975, CLIN EXP PHARMACOL P, V2, P269, DOI 10.1111/j.1440-1681.1975.tb03032.x; Ukegawa JI, 2003, J CANCER RES CLIN, V129, P272, DOI 10.1007/s00432-003-0433-y; VANNER S, 1994, AM J PHYSIOL-GASTR L, V267, pG650, DOI 10.1152/ajpgi.1994.267.4.G650; Vidrich A, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P307; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zucoloto S, 1997, RES EXP MED, V197, P117, DOI 10.1007/s004330050061; ZUCOLOTO S, 1988, CELL TISSUE KINET, V21, P213, DOI 10.1111/j.1365-2184.1988.tb00780.x	81	53	53	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16295	10.1371/journal.pone.0016295	http://dx.doi.org/10.1371/journal.pone.0016295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347406	gold, Green Published, Green Submitted			2022-12-25	WOS:000287361700013
J	Markiv, A; Peiris, D; Curley, GP; Odell, M; Dwek, MV				Markiv, Anatoliy; Peiris, Diluka; Curley, G. Paul; Odell, Mark; Dwek, Miriam V.			Identification, Cloning, and Characterization of Two N-Acetylgalactosamine-binding Lectins from the Albumen Gland of Helix pomatia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-REACTIVE HEMAGGLUTININ; BREAST-CANCER; HPA-BINDING; GEL-ELECTROPHORESIS; AGGLUTININ; SEPARATION; TUMOR; GLYCOSYLATION; PURIFICATION; INVOLVEMENT	Helix pomatia agglutinin (HPA), the lectin from the albumen gland of the Roman snail, has been used in histochemical studies relating glycosylation changes to the metastatic potential of solid tumors. To facilitate the use of HPA in a clinical (diagnostic) setting, detailed analysis of the lectin, including cloning and recombinant production of HPA, is required. A combination of isoelectric focusing, amino acid sequence analysis, and cloning revealed two polypeptides in native HPA preparations (HPAI and HPAII), both consistent with GalNAc-binding lectins of the H-type family. Pairwise sequence alignment showed that HPAI and HPAII share 54% sequence identity whereas molecular modeling using SWISS-MODEL suggests they are likely to adopt similar tertiary structure. The inherent heterogeneity of native HPA highlighted the need for production of functional recombinant protein; this was addressed by preparing His-thioredoxin-tagged fusion products in Escherichia coli Rosettagami B (DE3) cells. The recombinant lectins agglutinated human blood group A erythrocytes whereas their oligosaccharide specificity, evaluated using glycan microarrays, showed that they predominantly bind glycans with terminal alpha-GalNAc residues. Surface plasmon resonance with immobilized GalNAc-BSA confirmed that recombinant HPAI and HPAII bind strongly with this ligand (K-d = 0.60 nM and 2.00 nM, respectively) with a somewhat higher affinity to native HPA (K-d = 7.67 nM). Recombinant HPAII also bound the breast cancer cells of breast cancer tissue specimens in a manner similar to native lectin. The recombinant HPA described here shows important potential for future studies of cancer cell glycosylation and as a reagent for cancer prognostication.	[Markiv, Anatoliy; Peiris, Diluka; Curley, G. Paul; Odell, Mark; Dwek, Miriam V.] Univ Westminster, Sch Life Sci, Dept Mol & Appl Biosci, London W1W 6UW, England	Roehampton University; University of Westminster	Dwek, MV (corresponding author), Univ Westminster, Sch Life Sci, Dept Mol & Appl Biosci, 115 New Cavendish St, London W1W 6UW, England.	m.v.dwek@westminster.ac.uk		Dwek, Miriam/0000-0001-7184-2932; Markiv, Anatoliy/0000-0002-5307-0104	University of Westminster	University of Westminster	Supported by a University of Westminster Cavendish scholarship.	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brooks SA, 2003, ACTA HISTOCHEM, V105, P205, DOI 10.1078/0065-1281-00705; BROOKS SA, 1991, LANCET, V338, P71, DOI 10.1016/0140-6736(91)90071-V; Brooks SA, 2000, HISTOL HISTOPATHOL, V15, P143, DOI 10.14670/HH-15.143; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; Dwek MV, 2004, CURR CANCER DRUG TAR, V4, P425, DOI 10.2174/1568009043332899; Gorg A, 1999, ELECTROPHORESIS, V20, P712; HAMMARST.S, 1969, BIOCHEMISTRY-US, V8, P2696, DOI 10.1021/bi00835a002; HAMMARSTROM S, 1972, EUR J BIOCHEM, V25, P274, DOI 10.1111/j.1432-1033.1972.tb01694.x; HAMMARSTROM S, 1974, ANN NY ACAD SCI, V234, P183, DOI 10.1111/j.1749-6632.1974.tb53031.x; HAMMARSTROM S, 1972, Scandinavian Journal of Immunology, V1, P295, DOI 10.1111/j.1365-3083.1972.tb03295.x; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Kudo T, 2002, J BIOL CHEM, V277, P47724, DOI 10.1074/jbc.M205839200; LEATHEM AJ, 1987, LANCET, V1, P1054; Lisgarten JN, 2000, ACTA CRYSTALLOGR D, V56, P109, DOI 10.1107/S0907444999007957; MARKIV A, 2008, THESIS U WESTMINSTER; Okuyama T, 1998, CANCER-AM CANCER SOC, V82, P1468, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1468::AID-CNCR6>3.0.CO;2-5; Oyelaran O, 2009, J PROTEOME RES, V8, P3529, DOI 10.1021/pr9002245; Renwrantz L, 2009, J MOLLUS STUD, V75, P41, DOI 10.1093/mollus/eyn037; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHUMACHER U, 1994, CANCER-AM CANCER SOC, V74, P3104, DOI 10.1002/1097-0142(19941215)74:12<3104::AID-CNCR2820741207>3.0.CO;2-0; Schumacher U, 1997, HISTOCHEM J, V29, P677, DOI 10.1023/A:1026404832394; TAKATSU A, 1971, JPN J EXP MED, V41, P411; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Terasawa K, 1996, CANCER RES, V56, P2229; UHLENBRU.G, 1967, NATURE, V213, P76, DOI 10.1038/213076a0; VRETBLAD P, 1979, BIOCHIM BIOPHYS ACTA, V579, P52, DOI 10.1016/0005-2795(79)90086-2	29	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20260	20266		10.1074/jbc.M110.184515	http://dx.doi.org/10.1074/jbc.M110.184515			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21372134	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000291267600013
J	Luo, HM; Yang, J; Jin, HL; Huang, C; Fu, JW; Yang, F; Gong, H; Zeng, SQ; Luo, QM; Zhang, ZH				Luo, Haiming; Yang, Jie; Jin, Honglin; Huang, Chuan; Fu, Jianwei; Yang, Fei; Gong, Hui; Zeng, Shaoqun; Luo, Qingming; Zhang, Zhihong			Tetrameric far-red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo	FASEB JOURNAL			English	Article						optical imaging; multivalent probe; genetic engineering	CANCER; VISUALIZATION; SYSTEM; ORANGE; DRUGS	Relatively weak tumor affinities and short retention time in vivo hinder the application of targeting peptides in tumor molecular imaging. Multivalent strategies based on various scaffolds have been utilized to improve the ability of peptide-receptor binding or extend the clearance time of peptide-based probes. Here, we use a tetrameric far-red fluorescent protein (tfRFP) as a scaffold to create a self-assembled octavalent peptide fluorescent nanoprobe (Octa-FNP) using a genetic engineering approach. The multiligand connecting, fluorophore labeling and nanostructure formation of Octa-FNP were performed in one step. In vitro studies showed Octa-FNP is a 10-nm fluorescent probe with excellent serum stability. Cellular uptake of Octa-FNP by human nasopharyngeal cancer 5-8F cells is 15-fold of tetravalent probe, similar to 80-fold of monovalent probe and similar to 600-fold of nulvalent tfRFP. In vivo enhanced tumor targeting and intracellular uptake of Octa-FNP were confirmed using optical imaging and Western blot analysis. It achieved extremely high contrast of Octa-FNP signal between tumor tissue and normal organs, especially seldom Octa-FNP detected in liver and spleen. Owing to easy preparation, precise structural and functional control, and multivalent effect, Octa-FNP provides a powerful tool for tumor optical molecular imaging and evaluating the targeting ability of numerous peptides in vivo.-Luo, H., Yang, J., Jin, H., Huang, C., Fu, J., Yang, F., Gong, H., Zeng, S., Luo, Q., Zhang, Z. Tetrameric far-red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo. FASEB J. 25, 1865-1873 (2011). www.fasebj.org	[Luo, Haiming; Yang, Jie; Jin, Honglin; Huang, Chuan; Fu, Jianwei; Yang, Fei; Gong, Hui; Zeng, Shaoqun; Luo, Qingming; Zhang, Zhihong] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Zhang, ZH (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	czyzzh@mail.hust.edu.cn		Luo, Qingming/0000-0002-6725-9311; Jin, Honglin/0000-0002-4398-9539; Luo, Haiming/0000-0002-6226-5800	National Natural Science Foundation of China [30770525]; Program for New Century Excellent Talents in University of China [NCET-08-0220]; China-Canada Joint Health Research Initiative [NSFC30911120489]; CIHR [CCI-102936]; National High-Tech Research and Development Program of China [2006AA020801]; 111 Project of China [B07038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); China-Canada Joint Health Research Initiative; CIHR(Canadian Institutes of Health Research (CIHR)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); 111 Project of China(Ministry of Education, China - 111 Project)	The authors thank Dr. Gang Zheng (University of Toronto, Toronto, ON, Canada) for discussion. The authors thank Prof. Yi-Xin Zeng and Prof. Mu-Sheng Zeng (Sun Yat-sen University Cancer Center, Guangzhou, China) for providing the 5-8F cell line, and Jiabin Huang for the schematic diagram of Octa-FNP. The authors also thank the Analytical and Testing Center (Huazhong University of Science and Technology) for spectral measurements. This work was supported by the National Natural Science Foundation of China (grant 30770525), the Program for New Century Excellent Talents in University of China (NCET-08-0220 to Z.H.Z.), the China-Canada Joint Health Research Initiative (NSFC30911120489; CIHR CCI-102936), the National High-Tech Research and Development Program of China (2006AA020801), and the 111 Project of China (B07038).	Chu J, 2009, BIOSENS BIOELECTRON, V25, P234, DOI 10.1016/j.bios.2009.06.008; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Cuesta AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005381; Dacosta RS, 2009, J INNOV OPT HEAL SCI, V2, P407, DOI 10.1142/S1793545809000759; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Fan CY, 2008, FASEB J, V22, P3795, DOI 10.1096/fj.08-111484; Gao JH, 2010, BIOCONJUGATE CHEM, V21, P604, DOI 10.1021/bc900323v; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Huang YF, 2009, J AM CHEM SOC, V131, P17328, DOI 10.1021/ja907125t; Kredel S, 2008, CHEM BIOL, V15, P224, DOI 10.1016/j.chembiol.2008.02.008; Lee S, 2010, CHEM REV, V110, P3087, DOI 10.1021/cr900361p; Liu W, 2009, ANGEW CHEM INT EDIT, V48, P7346, DOI 10.1002/anie.200903556; Montet X, 2006, J MED CHEM, V49, P6087, DOI 10.1021/jm060515m; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Shadidi M, 2002, FASEB J, V16, P256, DOI 10.1096/fj.02-0280fje; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Ueno Y, 2007, J ELECTRON MICROSC, V56, P103, DOI 10.1093/jmicro/dfm011; Voskuhl J, 2009, CHEM SOC REV, V38, P495, DOI 10.1039/b803782p; Wang LJ, 2009, MOL PHARMACEUT, V6, P231, DOI 10.1021/mp800150r; Wang XF, 2007, CANCER RES, V67, P3337, DOI 10.1158/0008-5472.CAN-06-2480; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Xiong T, 2005, ORAL ONCOL, V41, P709, DOI 10.1016/j.oraloncology.2005.03.012; Yan YJ, 2011, AMINO ACIDS, V41, P1081, DOI 10.1007/s00726-010-0546-y	30	26	28	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1865	1873		10.1096/fj.10-174318	http://dx.doi.org/10.1096/fj.10-174318			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21350116				2022-12-25	WOS:000291023800010
J	Tian, Y; Bustos, V; Flajolet, M; Greengard, P				Tian, Yuan; Bustos, Victor; Flajolet, Marc; Greengard, Paul			A small-molecule enhancer of autophagy decreases levels of A beta and APP-CTF via Atg5-dependent autophagy pathway	FASEB JOURNAL			English	Article						Alzheimer's disease; SMER28; Beclin1; Ulk1	LIFE-SPAN; AMYLOID PROTEIN; DISEASE; TOR; ENDOPROTEOLYSIS; LOCALIZATION; ACCUMULATION; PRESENILIN-1; TRAFFICKING; INDUCTION	The hallmarks of Alzheimer's disease are the aggregates of amyloid-beta (A beta) peptide and tau protein. Autophagy is one major cellular pathway leading to the removal of aggregated proteins. We examined the possibility of inducing autophagy to reduce A beta peptide and the amyloid precursor protein (APP)-derived fragment APP-CTF levels in cell lines and primary neuronal cultures. We found that induction of autophagy either by small-molecule enhancers of rapamycin (SMER)28, a small-molecule enhancer of autophagy, or following starvation greatly decreased the levels of A beta peptide (apparent EC50 of similar to 10 mu M) and APP-CTF (apparent EC50 of similar to 20 mu M) in a gamma-secretase-independent manner. Pharmacological inhibition of autophagy led to a significant accumulation of A beta peptide and APP-CTF and diminished the effect of SMER28. Three essential components of the autophagic pathway, autophagy-related protein (Atg)5, Beclin1, and Ulk1, were shown to be involved in the degradation of A beta and APP-CTF, and Atg5 was necessary for the effect of SMER28. In addition, the autophagic marker light chain 3-II cocompartmentalized with APP-CTF. These results support the involvement of autophagy in the clearance of A beta and APP-CTF. We therefore propose that small molecule enhancers of autophagy, such as SMER28, may have therapeutic potential for the treatment of Alzheimer's disease and other proteinopathies.-Tian, Y., Bustos, V., Flajolet, M., Greengard, P. A small-molecule enhancer of autophagy decreases levels of A beta and APP-CTF via Atg5-dependent autophagy pathway. FASEB J. 25, 1934-1942 (2011). www.fasebj.org	[Tian, Yuan; Bustos, Victor; Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA	Rockefeller University	Flajolet, M (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10065 USA.	flajolm@rockefeller.edu; greengard@rockefeller.edu	Bustos, Victor/F-7080-2011	Greengard, Paul/0000-0002-4437-0893	U.S. National Institutes of Health [AG-09464]; Fisher Center for Alzheimer's Research Foundation; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fisher Center for Alzheimer's Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. Wenjie Luo and William Netzer for sharing reagents and for helpful discussion, Dr. Zhenyu Yue (Mount Sinai Medical College, New York, NY, USA) for providing reagents, and Dr. Noboru Mizushima (Department of Physiology and Cell Biology, Tokyo Medical and Dental University, Tokyo, Japan) for the use of Atg5<SUP>+/+</SUP> and Atg5<SUP>-/-</SUP> MEF cells. This work was supported by U.S. National Institutes of Health grant AG-09464 and the Fisher Center for Alzheimer's Research Foundation.	Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Netzer WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010943; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	49	165	172	2	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1934	1942		10.1096/fj.10-175158	http://dx.doi.org/10.1096/fj.10-175158			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21368103	Green Published			2022-12-25	WOS:000291023800017
J	Jinwal, UK; Trotter, JH; Abisambra, JF; Koren, J; Lawson, LY; Vestal, GD; O'Leary, JC; Johnson, AG; Jin, Y; Jones, JR; Li, QY; Weeber, EJ; Dickey, CA				Jinwal, Umesh K.; Trotter, Justin H.; Abisambra, Jose F.; Koren, John, III; Lawson, Lisa Y.; Vestal, Grant D.; O'Leary, John C., III; Johnson, Amelia G.; Jin, Ying; Jones, Jeffrey R.; Li, Qingyou; Weeber, Edwin J.; Dickey, Chad A.			The Hsp90 Kinase Co-chaperone Cdc37 Regulates Tau Stability and Phosphorylation Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PROTEIN; COCHAPERONE; CHIP; BETA; AGGREGATION; COMPLEX; MODEL; HEAT-SHOCK-PROTEIN-90; NEURODEGENERATION	The microtubule-associated protein tau, which becomes hyperphosphorylated and pathologically aggregates in a number of these diseases, is extremely sensitive to manipulations of chaperone signaling. For example, Hsp90 inhibitors can reduce the levels of tau in transgenic mouse models of tauopathy. Because of this, we hypothesized that a number of Hsp90 accessory proteins, termed co-chaperones, could also affect tau stability. Perhaps by identifying these co-chaperones, new therapeutics could be designed to specifically target these proteins and facilitate tau clearance. Here, we report that the co-chaperone Cdc37 can regulate aspects of tau pathogenesis. We found that suppression of Cdc37 destabilized tau, leading to its clearance, whereas Cdc37 overexpression preserved tau. Cdc37 was found to co-localize with tau in neuronal cells and to physically interact with tau from human brain. Moreover, Cdc37 levels significantly increased with age. Cdc37 knockdown altered the phosphorylation profile of tau, an effect that was due in part to reduced tau kinase stability, specifically Cdk5 and Akt. Conversely, GSK3 beta and Mark2 were unaffected by Cdc37 modulation. Cdc37 overexpression prevented whereas Cdc37 suppression potentiated tau clearance following Hsp90 inhibition. Thus, Cdc37 can regulate tau in two ways: by directly stabilizing it via Hsp90 and by regulating the stability of distinct tau kinases. We propose that changes in the neuronal levels or activity of Cdc37 could dramatically alter the kinome, leading to profound changes in the tau phosphorylation signature, altering its proteotoxicity and stability.	[Jinwal, Umesh K.; Abisambra, Jose F.; Koren, John, III; Lawson, Lisa Y.; Vestal, Grant D.; O'Leary, John C., III; Johnson, Amelia G.; Jin, Ying; Jones, Jeffrey R.; Li, Qingyou; Dickey, Chad A.] Univ S Florida, Dept Mol Med, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33613 USA; [Trotter, Justin H.; Li, Qingyou; Weeber, Edwin J.] Univ S Florida, Dept Mol Pharmacol & Physiol, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33613 USA; [Jinwal, Umesh K.] Univ S Florida, Coll Pharm, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33613 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, Alzheimers Inst, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Abisambra, Jose/V-6860-2019; Weeber, Edwin J/A-5396-2012; Dickey, Chad A/H-4441-2011; Abisambra, Joe/AAP-3269-2020; Trotter, Justin H/I-6458-2012	Abisambra, Jose/0000-0001-6341-679X; Jones, Jeffrey/0000-0002-7570-2571; Koren, John/0000-0002-6017-1763; Lawson, Lisa/0000-0002-4436-5357	National Institutes of Health, NIA [AG031291]; Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research; CurePSP; Alzheimer's Association [IIRG-09-130689, NIRG-10-174517]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, R00AG031291, K99AG031291] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research; CurePSP; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG031291 from NIA. This work was also supported by the Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research, CurePSP, and Alzheimer's Association Grants IIRG-09-130689 and NIRG-10-174517.	Abisambra JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008556; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Hardy J, 2006, J NEUROCHEM, V97, P1690, DOI 10.1111/j.1471-4159.2006.03979.x; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2004, DALTON T, P1189, DOI 10.1039/b400269e; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Mukaetova-Ladinska EB, 2000, AM J PATHOL, V157, P623, DOI 10.1016/S0002-9440(10)64573-7; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298	50	48	51	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16976	16983		10.1074/jbc.M110.182493	http://dx.doi.org/10.1074/jbc.M110.182493			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21367866	hybrid, Green Published			2022-12-25	WOS:000290301900047
J	Kretner, B; Fukumori, A; Gutsmiedl, A; Page, RM; Luebbers, T; Galley, G; Baumann, K; Haass, C; Steiner, H				Kretner, Benedikt; Fukumori, Akio; Gutsmiedl, Amelie; Page, Richard M.; Luebbers, Thomas; Galley, Guido; Baumann, Karlheinz; Haass, Christian; Steiner, Harald			Attenuated A beta(42) Responses to Low Potency gamma-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; AMYLOID DEPOSITION; TRANSGENIC MICE; MOUSE MODEL; GXGD-MOTIF; A-BETA-42; GENERATION; MUTATIONS; INHIBITORS	Sequential processing of the beta-amyloid precursor protein by beta- and gamma-secretase generates the amyloid beta-peptide (A beta), which is widely believed to play a causative role in Alzheimer disease. Selective lowering of the pathogenic 42-amino acid variant of A beta by gamma-secretase modulators (GSMs) is a promising therapeutic strategy. Here we report that mutations in presenilin (PS), the catalytic subunit of gamma-secretase, display differential responses to non-steroidal anti-inflammatory drug (NSAID)-type GSMs and more potent second-generation compounds. Although many pathogenic PS mutations resisted lowering of A beta(42) generation by the NSAID sulindac sulfide, the potent NSAID-like second-generation compound GSM-1 was capable of lowering A beta(42) for many but not all mutants. We further found that mutations at homologous positions in PS1 and PS2 can elicit differential A beta(42) responses to GSM-1, suggesting that a positive GSM-1 response depends on the spatial environment in gamma-secretase. The aggressive pathogenic PS1 L166P mutation was one of the few pathogenic mutations that resisted GSM-1, and Leu166 was identified as a critical residue with respect to the A beta(42)-lowering response of GSM-1. Finally, we found that GSM-1-responsive and -resistant PS mutants behave very similarly toward other potent second-generation compounds of different structural classes than GSM-1. Taken together, our data show that a positive A beta(42) response for PS mutants depends both on the particular mutation and the GSM used and that attenuated A beta(42) responses to low potency GSMs can be overcome for many PS mutants by second generation GSMs.	[Kretner, Benedikt; Fukumori, Akio; Gutsmiedl, Amelie; Page, Richard M.; Haass, Christian; Steiner, Harald] Univ Munich, DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Kretner, Benedikt; Fukumori, Akio; Gutsmiedl, Amelie; Page, Richard M.; Haass, Christian; Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Luebbers, Thomas; Galley, Guido; Baumann, Karlheinz] F Hoffmann La Roche Ltd, Preclin CNS Res, Div Pharmaceut, CH-4070 Basel, Switzerland	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Roche Holding	Steiner, H (corresponding author), Univ Munich, DZNE German Ctr Neurodegenerat Dis, Schillerstr 44, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (Collaborative Research Center) [SFB596]; Bundesministerium fur Bildung und Forschung; Ludwig-Maximilians-University Munich; Center for Integrated Protein Science Munich; Elitenetzwerk Bayern; LMUexcellent	Deutsche Forschungsgemeinschaft (Collaborative Research Center)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Ludwig-Maximilians-University Munich; Center for Integrated Protein Science Munich; Elitenetzwerk Bayern; LMUexcellent	This work was supported by the Deutsche Forschungsgemeinschaft (Collaborative Research Center (SFB596) "Molecular Mechanisms of Neurodegeneration" (to H. S. and C. H.), the Bundesministerium fur Bildung und Forschung ("Degenerative Dementias: Target Identification, Validation, and Translation into Treatment Strategies"; to C. H. and H. S.), the FoFoLe program of the Ludwig-Maximilians-University Munich (to B. K. and H. S.), and the Center for Integrated Protein Science Munich.; Supported by the Elitenetzwerk Bayern.; Supported by a LMUexcellent program research professorship.	Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Moliaka YK, 2004, FEBS LETT, V557, P185, DOI 10.1016/S0014-5793(03)01489-3; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Perez-Revuelta BI, 2010, J NEUROCHEM, V112, P940, DOI 10.1111/j.1471-4159.2009.06510.x; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Richards JG, 2003, J NEUROSCI, V23, P8989; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006	35	35	35	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15240	15251		10.1074/jbc.M110.213587	http://dx.doi.org/10.1074/jbc.M110.213587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357415	hybrid, Green Published			2022-12-25	WOS:000289788300055
J	Pashkov, V; Huang, J; Parameswara, VK; Kedzierski, W; Kurrasch, DM; Tall, GG; Esser, V; Gerard, RD; Uyeda, K; Towle, HC; Wilkie, TM				Pashkov, Victor; Huang, Jie; Parameswara, Vinay K.; Kedzierski, Wojciech; Kurrasch, Deborah M.; Tall, Gregory G.; Esser, Victoria; Gerard, Robert D.; Uyeda, Kosaku; Towle, Howard C.; Wilkie, Thomas M.			Regulator of G Protein Signaling (RGS16) Inhibits Hepatic Fatty Acid Oxidation in a Carbohydrate Response Element-binding Protein (ChREBP)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; N-TERMINAL DOMAIN; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ALPHA SUBUNITS; RECEPTOR GENE; PPAR-ALPHA; GLUCOSE; RAT; MOUSE	Gprotein-coupled receptor (GPCR) pathways control glucose and fatty acid metabolism and the onset of obesity and diabetes. Regulators of G protein signaling (RGS) are GTPase-activating proteins (GAPs) for G(i) and G(q) alpha-subunits that control the intensity and duration of GPCR signaling. Herein we determined the role of Rgs16 in GPCR regulation of liver metabolism. Rgs16 is expressed during the last few hours of the daily fast in periportal hepatocytes, the oxygen-rich zone of the liver where lipolysis and gluconeogenesis predominate. Rgs16 knock-out mice had elevated expression of fatty acid oxidation genes in liver, higher rates of fatty acid oxidation in liver extracts, and higher plasma beta-ketone levels compared with wild type mice. By contrast, transgenic mice that overexpressed RGS16 protein specifically in liver exhibited reciprocal phenotypes as well as low blood glucose levels compared with wild type littermates and fatty liver after overnight fasting. The transcription factor carbohydrate response element-binding protein (ChREBP), which induces fatty acid synthesis genes in response to high carbohydrate feeding, was unexpectedly required during fasting for maximal Rgs16 transcription in liver and in cultured primary hepatocytes during gluconeogenesis. Thus, RGS16 provides a signaling mechanism for glucose production to inhibit GPCR-stimulated fatty acid oxidation in hepatocytes.	[Pashkov, Victor; Huang, Jie; Kedzierski, Wojciech; Kurrasch, Deborah M.; Tall, Gregory G.; Wilkie, Thomas M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Parameswara, Vinay K.; Esser, Victoria] Univ Texas SW Med Ctr Dallas, Dept Internal Med Digest & Liver Dis, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol & Mol Biol, Dallas, TX 75390 USA; [Uyeda, Kosaku] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Towle, Howard C.] Univ Minnesota, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Minnesota System; University of Minnesota Twin Cities	Wilkie, TM (corresponding author), 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Thomas.Wilkie@UTSouthwestern.edu	Kurrasch, Deborah M/E-4506-2019	Kurrasch, Deborah M/0000-0002-9945-287X; Wilkie, Thomas/0000-0002-9357-637X	National Institutes of Health [GM61395, PAR-98-057, HL072551]; Welch Foundation [I-1382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL072551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242, R01GM061395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61395 and PAR-98-057 (to T.M.W.) and HL072551 (to D.K.O.). This work was also supported by Welch Foundation Grant I-1382 (to T.M.W.).	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Brown MS, 1998, NUTR REV, V56, pS1; DIETZEL C, 1987, MOL CELL BIOL, V7, P4169, DOI 10.1128/MCB.7.12.4169; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; Huang Jie, 2006, Comp Hepatol, V5, P8, DOI 10.1186/1476-5926-5-8; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Kuwata H, 2007, KOBE J MED SCI, V53, P275; Lamartina S, 2002, HUM GENE THER, V13, P199, DOI 10.1089/10430340252769734; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; LONG CS, 1982, NEUROLOGY, V32, P663, DOI 10.1212/WNL.32.6.663; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Luo X, 2001, MOL CELL, V7, P651, DOI 10.1016/S1097-2765(01)00211-8; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; MCGARRY JD, 1978, BIOCHIM BIOPHYS ACTA, V530, P305, DOI 10.1016/0005-2760(78)90150-9; Muallem S, 1999, CELL CALCIUM, V26, P173, DOI 10.1054/ceca.1999.0077; Ou-Yang YS, 2003, BIOSCIENCE REP, V23, P213, DOI 10.1023/B:BIRE.0000007694.71158.02; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 2002, P NATL ACAD SCI USA, V99, P10138, DOI 10.1073/pnas.152085999; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Srivastava RAK, 2000, NUCLEIC ACID PROTOCOLS HANDBOOK, P207; TONNAER JADM, 1986, BRAIN RES, V370, P200, DOI 10.1016/0006-8993(86)91125-X; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Towle HC, 2001, P NATL ACAD SCI USA, V98, P13476, DOI 10.1073/pnas.251530798; Veech RL, 2003, P NATL ACAD SCI USA, V100, P5578, DOI 10.1073/pnas.1132039100; Verrill C, 2002, J PHARMACOL TOX MET, V48, P103, DOI 10.1016/S1056-8719(03)00042-X; Villasenor A, 2010, DIS MODEL MECH, V3, P567, DOI 10.1242/dmm.003210; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Xu X, 1998, J BIOL CHEM, V273, P27275, DOI 10.1074/jbc.273.42.27275; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687	50	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15116	15125		10.1074/jbc.M110.216234	http://dx.doi.org/10.1074/jbc.M110.216234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357625	hybrid, Green Published			2022-12-25	WOS:000289788300042
J	Jovanovic, M; Burrows, PC; Bose, D; Camara, B; Wiesler, S; Zhang, XD; Wigneshweraraj, S; Weinzierl, ROJ; Buck, M				Jovanovic, Milija; Burrows, Patricia C.; Bose, Daniel; Camara, Beatriz; Wiesler, Simone; Zhang, Xiaodong; Wigneshweraraj, Sivaramesh; Weinzierl, Robert O. J.; Buck, Martin			Activity Map of the Escherichia coli RNA Polymerase Bridge Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II ELONGATION COMPLEX; STRUCTURAL BASIS; TRANSCRIPTION INHIBITION; ALLOSTERIC CONTROL; TRIGGER LOOP; CRYSTAL-STRUCTURE; BETA-SUBUNIT; CATALYSIS; SITE; ACTIVATION	Transcription, the synthesis of RNA from a DNA template, is performed by multisubunit RNA polymerases (RNAPs) in all cellular organisms. The bridge helix (BH) is a distinct feature of all multisubunit RNAPs and makes direct interactions with several active site-associated mobile features implicated in the nucleotide addition cycle and RNA and DNA binding. Because the BH has been captured in both kinked and straight conformations in different crystals structures of RNAP, recently supported by molecular dynamics studies, it has been proposed that cycling between these conformations is an integral part of the nucleotide addition cycle. To further evaluate the role of the BH, we conducted systematic alanine scanning mutagenesis of the Escherichia coli RNAP BH to determine its contributions to activities required for transcription. Combining our data with an atomic model of E. coli RNAP, we suggest that alterations in the interactions between the BH and (i) the trigger loop, (ii) fork loop 2, and (iii) switch 2 can help explain the observed changes in RNAP functionality associated with some of the BH variants. Additionally, we show that extensive defects in E. coli RNAP functionality depend upon a single previously not studied lysine residue (Lys-781) that is strictly conserved in all bacteria. It appears that direct interactions made by the BH with other conserved features of RNAP are lost in some of the E. coli alanine substitution variants, which we infer results in conformational changes in RNAP that modify RNAP functionality.	[Jovanovic, Milija; Burrows, Patricia C.; Wiesler, Simone; Weinzierl, Robert O. J.; Buck, Martin] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England; [Bose, Daniel; Zhang, Xiaodong] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Camara, Beatriz; Wigneshweraraj, Sivaramesh] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Microbiol, London SW7 2AZ, England; [Camara, Beatriz; Wigneshweraraj, Sivaramesh] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Burrows, PC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England.	pcb1@imperial.ac.uk; m.buck@imperial.ac.uk	Bose, Daniel/AAI-2775-2020	Bose, Daniel/0000-0002-0276-6486; Wigneshweraraj, Sivaramesh/0000-0002-1418-4029; Zhang, Xiaodong/0000-0001-9786-7038; Camara, Beatriz/0000-0001-5227-7499	Wellcome Trust [084599/Z/07/Z]; Biotechnology and Biological Sciences Research Council [BB/E00975/1, BB/E023703/1]; Biotechnology and Biological Sciences Research Council [BB/J002828/1, BB/D00862X/1] Funding Source: researchfish; Medical Research Council [G0501703] Funding Source: researchfish; BBSRC [BB/J002828/1, BB/E023703/1, BB/D00862X/1] Funding Source: UKRI; MRC [G0501703] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 084599/Z/07/Z and Biotechnology and Biological Sciences Research Council Grant BB/E00975/1 (to M. B.) and by Biotechnology and Biological Sciences Research Council David Phillips Fellowship BB/E023703/1 (to S. W.).	Artsimovitch I, 2003, SCIENCE, V302, P650, DOI 10.1126/science.1087526; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Burrows PC, 2010, P NATL ACAD SCI USA, V107, P9376, DOI 10.1073/pnas.1001188107; Burrows PC, 2009, J MOL BIOL, V387, P306, DOI 10.1016/j.jmb.2009.01.052; Camara B, 2010, P NATL ACAD SCI USA, V107, P2247, DOI 10.1073/pnas.0907908107; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2009, CURR OPIN STRUC BIOL, V19, P680, DOI 10.1016/j.sbi.2009.10.013; de Sousa MM, 2011, J THEOR BIOL, V271, P136, DOI 10.1016/j.jtbi.2010.11.028; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hein PP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-141; Joly N, 2008, J BIOL CHEM, V283, P13725, DOI 10.1074/jbc.M800801200; Joly N, 2007, MOL MICROBIOL, V66, P583, DOI 10.1111/j.1365-2958.2007.05901.x; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; Majovski RC, 2005, J BIOL CHEM, V280, P34917, DOI 10.1074/jbc.M502932200; Miropolskaya N, 2009, P NATL ACAD SCI USA, V106, P18942, DOI 10.1073/pnas.0905402106; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Nickels BE, 2004, CELL, V118, P281, DOI 10.1016/j.cell.2004.07.021; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Seibold SA, 2010, BBA-GENE REGUL MECH, V1799, P575, DOI 10.1016/j.bbagrm.2010.05.002; Svetlov V, 2007, NUCLEIC ACIDS RES, V35, P5694, DOI 10.1093/nar/gkm600; Svetlov V, 2009, CURR OPIN STRUC BIOL, V19, P701, DOI 10.1016/j.sbi.2009.10.002; Tan Lin, 2008, J Biol, V7, P40, DOI 10.1186/jbiol98; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Tupin A, 2010, EMBO J, V29, P2527, DOI 10.1038/emboj.2010.135; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WEDEL A, 1990, SCIENCE, V248, P486, DOI 10.1126/science.1970441; Weinzierl ROJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-134; Weinzierl ROJ, 2010, BIOCHEM SOC T, V38, P428, DOI 10.1042/BST0380428; Werner F, 2008, TRENDS MICROBIOL, V16, P247, DOI 10.1016/j.tim.2008.03.008; Wigneshweraraj SR, 2003, METHOD ENZYMOL, V370, P646; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732	49	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14469	14479		10.1074/jbc.M110.212902	http://dx.doi.org/10.1074/jbc.M110.212902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357417	hybrid, Green Published			2022-12-25	WOS:000289556200068
J	Ikonomov, OC; Sbrissa, D; Delvecchio, K; Xie, YF; Jin, JP; Rappolee, D; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Delvecchio, Khortnal; Xie, Yufen; Jin, Jian-Ping; Rappolee, Daniel; Shisheva, Assia			The Phosphoinositide Kinase PIKfyve Is Vital in Early Embryonic Development PREIMPLANTATION LETHALITY OF PIKfyve(-/-) EMBRYOS BUT NORMALITY OF PIKfyve(+/-) MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MAMMALIAN ORTHOLOG; VACUOLE FUNCTION; LIPID KINASE; 5-PHOSPHATE; EXPRESSION; FAB1P; 3-PHOSPHATASE; TRAFFICKING; METABOLISM	Gene mutations in the phosphoinositide-metabolizing enzymes are linked to various human diseases. In mammals, PIKfyve synthesizes PtdIns(3,5)P-2 and PtdIns5P lipids that regulate endosomal trafficking and responses to extracellular stimuli. The consequence of pikfyve gene ablation in mammals is unknown. To clarify the importance of PIKfyve and PIKfyve lipid products, in this study, we have characterized the first mouse model with global deletion of the pikfyve gene using the Cre-loxP approach. We report that nearly all PIKfyve(KO/KO) mutant embryos died before the 32-64-cell stage. Cultured fibroblasts derived from PIKfyve(flox/flox) embryos and rendered pikfyve-null by Cre recombinase expression displayed severely reduced DNA synthesis, consistent with impaired cell division causing early embryo lethality. The heterozygous PIKfyve(WT/KO) mice were born at the expected Mendelian ratio and developed into adulthood. PIKfyve(WT/KO) mice were ostensibly normal by several other in vivo, ex vivo, and in vitro criteria despite the fact that their levels of the PIKfyve protein and in vitro enzymatic activity in cells and tissues were 50-55% lower than those of wild-type mice. Consistently, steady-state levels of the PIKfyve products PtdIns(3,5)P-2 and PtdIns5P selectively decreased, but this reduction (35-40%) was 10-15% less than that expected based on PIKfyve protein reduction. The nonlinear decrease of the PIKfyve protein versus PIKfyve lipid products, the potential mechanism(s) discussed herein, may explain how one functional allele in PIKfyve(WT/KO) mice is able to support the demands for PtdIns(3,5)P-2/PtdIns5P synthesis during life. Our data also shed light on the known human disorder linked to PIKFYVE mutations.	[Ikonomov, Ognian C.; Sbrissa, Diego; Delvecchio, Khortnal; Jin, Jian-Ping; Rappolee, Daniel; Shisheva, Assia] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA; [Xie, Yufen; Rappolee, Daniel] Wayne State Univ, Dept Obstet & Gynecol, Sch Med, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Dept Physiol, Sch Med, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu	Jin, Jian-Ping/AAD-1149-2020	Delvecchio, Khortnal/0000-0002-5441-5709; Jin, JP/0000-0001-9932-1063	National Institutes of Health [DK58058]; Wayne State University (WSU); WSU School of Medicine Research Offices; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University (WSU); WSU School of Medicine Research Offices; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58058 (to A. S.). This work was also supported by Wayne State University (WSU) and the WSU School of Medicine Research Offices and the American Diabetes Association (to A. S.).	Balla T, 2006, J ENDOCRINOL, V188, P135, DOI 10.1677/joe.1.06595; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Best MD, 2010, NAT PROD REP, V27, P1403, DOI 10.1039/b923844c; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2010, J BIOL CHEM, V285, P26760, DOI 10.1074/jbc.C110.154658; Ikonomov OC, 2009, J BIOL CHEM, V284, P35794, DOI 10.1074/jbc.M109.037515; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Ko MSH, 2000, DEVELOPMENT, V127, P1737; Li SL, 2005, AM J HUM GENET, V77, P54, DOI 10.1086/431346; Majerus PW, 2009, J LIPID RES, V50, pS249, DOI 10.1194/jlr.R800072-JLR200; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; RAPPOLEE DA, 2011, INT REV CEL MOL BIO, V287, P43; Roberts HF, 2005, FEBS LETT, V579, P2868, DOI 10.1016/j.febslet.2005.04.027; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sbrissa D, 2002, J BIOL CHEM, V277, P47276, DOI 10.1074/jbc.M207576200; Sbrissa D, 2002, J BIOL CHEM, V277, P6073, DOI 10.1074/jbc.M110194200; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wang YC, 2005, FERTIL STERIL, V83, P1144, DOI 10.1016/j.fertnstert.2004.08.038; Whiteford CC, 1996, BIOCHEM J, V319, P851, DOI 10.1042/bj3190851; Whitley P, 2009, PLANT PHYSIOL, V151, P1812, DOI 10.1104/pp.109.146159; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	45	94	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13404	13413		10.1074/jbc.M111.222364	http://dx.doi.org/10.1074/jbc.M111.222364			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349843	hybrid, Green Published			2022-12-25	WOS:000289282200060
J	Mazzone, A; Bernard, CE; Strege, PR; Beyder, A; Galietta, LJV; Pasricha, PJ; Rae, JL; Parkman, HP; Linden, DR; Szurszewski, JH; Ordog, T; Gibbons, SJ; Farrugia, G				Mazzone, Amelia; Bernard, Cheryl E.; Strege, Peter R.; Beyder, Arthur; Galietta, Luis J. V.; Pasricha, Pankaj J.; Rae, James L.; Parkman, Henry P.; Linden, David R.; Szurszewski, Joseph H.; Oerdoeg, Tamas; Gibbons, Simon J.; Farrugia, Gianrico			Altered Expression of Ano1 Variants in Human Diabetic Gastroparesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED CL-CONDUCTANCE; NEURONAL NITRIC-OXIDE; INTERSTITIAL-CELLS; GASTROINTESTINAL-TRACT; CARBON-MONOXIDE; SMOOTH-MUSCLE; CAJAL; CHANNEL; RECEPTOR; DISEASE	Diabetes affects many organs including the stomach. Altered number and function of interstitial cells of Cajal (ICC), the gastrointestinal pacemaker cells, underlie a number of gastrointestinal motility disorders, including diabetic gastroparesis. In the muscle layers, ICC selectively express Ano1, thought to underlie classical Ca2+-activated Cl- currents. Mice homozygous for Ano1 knock-out exhibit abnormal ICC function and motility. Several transcripts for Ano1 are generated by alternative splicing of four exons. Here, we report expression levels of transcripts encoded by alternative splicing of Ano1 gene in gastric muscles of patients with diabetic gastroparesis and nondiabetic control tissues. Expression of mRNA from two alternatively transcribed exons are significantly different between patients and controls. Furthermore, patients with diabetic gastroparesis express mRNA for a previously unknown variant of Ano1. The 5' end of this novel variant lacks exons 1 and 2 and part of exon 3. Expression of this variant in HEK cells produces a decreased density of Ca2+-activated Cl- currents that exhibit slower kinetics compared with the full-length Ano1. These results identify important changes in expression and splicing of Ano1 in patients with diabetic gastroparesis that alter the electrophysiological properties of the channel. Changes in Ano1 expression in ICC may directly contribute to diabetic gastroparesis.	[Mazzone, Amelia; Bernard, Cheryl E.; Strege, Peter R.; Beyder, Arthur; Rae, James L.; Linden, David R.; Szurszewski, Joseph H.; Oerdoeg, Tamas; Gibbons, Simon J.; Farrugia, Gianrico] Mayo Clin, Div Gastroenterol & Hepatol, Dept Physiol & Biomed Engn, Enter Neurosci Program,Coll Med, Rochester, MN 55905 USA; [Galietta, Luis J. V.] Ist Giannina Gaslini, Mol Genet Lab, I-16147 Genoa, Italy; [Pasricha, Pankaj J.] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol, Stanford, CA 94305 USA; [Parkman, Henry P.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA	Mayo Clinic; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Farrugia, G (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Dept Physiol & Biomed Engn, Enter Neurosci Program,Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	farrugia.gianrico@mayo.edu	Galietta, Luis JV/HCG-8692-2022; yang, xiao-jun/B-1927-2009	Harrington, Jon/0000-0003-1293-5201; MAZZONE, Amelia/0000-0001-6236-6962; Gibbons, Simon/0000-0001-5311-5993; Galietta, Luis/0000-0001-8686-3461; Strege, Peter/0000-0003-4571-2207	National Institutes of Health [DK57061, DK52766, DK84567, DK73983, DK74008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK074008, U01DK074035, R01DK052766, U24DK074008, R01DK057061, U01DK073983, P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57061, DK52766, DK84567, DK73983, and DK74008.	Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Cheng TH, 2007, MOL CELL BIOL, V27, P111, DOI 10.1128/MCB.00235-06; Choi KM, 2007, NEUROGASTROENT MOTIL, V19, P585, DOI 10.1111/j.1365-2982.2007.00936.x; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Farrugia G, 2008, NEUROGASTROENT MOTIL, V20, P54, DOI 10.1111/j.1365-2982.2008.01109.x; Farrugia G, 1999, MICROSC RES TECHNIQ, V47, P321, DOI 10.1002/(SICI)1097-0029(19991201)47:5<321::AID-JEMT3>3.0.CO;2-J; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gibbons SJ, 2004, J PHYSIOL-LONDON, V556, P325, DOI 10.1113/jphysiol.2003.056556; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; He CL, 2001, GASTROENTEROLOGY, V121, P427, DOI 10.1053/gast.2001.26264; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Iwasaki H, 2006, J GASTROENTEROL, V41, P1076, DOI 10.1007/s00535-006-1909-8; Kraichely RE, 2007, NEUROGASTROENT MOTIL, V19, P245, DOI 10.1111/j.1365-2982.2006.00880.x; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Liu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009482; Miller SM, 2008, NEUROGASTROENT MOTIL, V20, P349, DOI 10.1111/j.1365-2982.2007.01040.x; Ordog T, 2000, DIABETES, V49, P1731, DOI 10.2337/diabetes.49.10.1731; Pasricha PJ, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-21; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Ward SM, 2006, J PHYSIOL-LONDON, V576, P675, DOI 10.1113/jphysiol.2006.117390; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yudt MR, 2002, MOL ENDOCRINOL, V16, P1719, DOI 10.1210/me.2002-0106; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	34	83	85	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13393	13403		10.1074/jbc.M110.196089	http://dx.doi.org/10.1074/jbc.M110.196089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349842	Green Published, hybrid			2022-12-25	WOS:000289282200059
J	Barone, MV; Zanzi, D; Maglio, M; Nanayakkara, M; Santagata, S; Lania, G; Miele, E; Ribecco, MTS; Maurano, F; Auricchio, R; Gianfrani, C; Ferrini, S; Troncone, R; Auricchio, S				Barone, M. Vittoria; Zanzi, Delia; Maglio, Mariantonia; Nanayakkara, Merlin; Santagata, Sara; Lania, Giuliana; Miele, Erasmo; Ribecco, Maria Teresa Silvia; Maurano, Francesco; Auricchio, Renata; Gianfrani, Carmen; Ferrini, Silvano; Troncone, Riccardo; Auricchio, Salvatore			Gliadin-Mediated Proliferation and Innate Immune Activation in Celiac Disease Are Due to Alterations in Vesicular Trafficking	PLOS ONE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; CELL-DEATH; IL-15; INTERLEUKIN-15; RECEPTOR; CYTOKINE; JUXTACRINE; EXPRESSION; SECRETION; RESPONSES	Background and Objectives: Damage to intestinal mucosa in celiac disease (CD) is mediated both by inflammation due to adaptive and innate immune responses, with IL-15 as a major mediator of the innate immune response, and by proliferation of crypt enterocytes as an early alteration of CD mucosa causing crypts hyperplasia. We have previously shown that gliadin peptide P31-43 induces proliferation of cell lines and celiac enterocytes by delaying degradation of the active epidermal growth factor receptor (EGFR) due to delayed maturation of endocytic vesicles. IL-15 is increased in the intestine of patients affected by CD and has pleiotropic activity that ultimately results in immunoregulatory cross-talk between cells belonging to the innate and adaptive branches of the immune response. Aims of this study were to investigate the role of P31-43 in the induction of cellular proliferation and innate immune activation. Methods/Principal Findings: Cell proliferation was evaluated by bromodeoxyuridine (BrdU) incorporation both in CaCo-2 cells and in biopsies from active CD cases and controls. We used real-time PCR to evaluate IL-15 mRNA levels and FACS as well as ELISA and Western Blot (WB) analysis to measure protein levels and distribution in CaCo-2 cells. Gliadin and P31-43 induce a proliferation of both CaCo-2 cells and CD crypt enterocytes that is dependent on both EGFR and IL-15 activity. In CaCo-2 cells, P31-43 increased IL-15 levels on the cell surface by altering intracellular trafficking. The increased IL-15 protein was bound to IL15 receptor (IL-15R) alpha, did not require new protein synthesis and functioned as a growth factor. Conclusion: In this study, we have shown that P31-43 induces both increase of the trans-presented IL-15/IL5R alpha complex on cell surfaces by altering the trafficking of the vesicular compartments as well as proliferation of crypt enterocytes with consequent remodelling of CD mucosa due to a cooperation of IL-15 and EGFR.	[Barone, M. Vittoria; Zanzi, Delia; Maglio, Mariantonia; Nanayakkara, Merlin; Santagata, Sara; Lania, Giuliana; Miele, Erasmo; Ribecco, Maria Teresa Silvia; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Barone, M. Vittoria; Zanzi, Delia; Maglio, Mariantonia; Nanayakkara, Merlin; Santagata, Sara; Lania, Giuliana; Miele, Erasmo; Ribecco, Maria Teresa Silvia; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Maurano, Francesco; Gianfrani, Carmen] CNR Avellino, Ist Sci Alimentaz, Avellino, Italy; [Ferrini, Silvano] Ist Nazl Ric Canc, Lab Immunol Therapy, I-16132 Genoa, Italy	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Genoa; IRCCS AOU San Martino IST	Barone, MV (corresponding author), Univ Naples Federico II, Dept Pediat, Naples, Italy.	mv.barone@unina.it	santagata, sara/AAA-5225-2020; Maurano, Francesco/H-6487-2013; AURICCHIO, RENATA/AAC-7718-2022	santagata, sara/0000-0001-8680-084X; Maurano, Francesco/0000-0002-6780-8325; Ferrini, Silvano/0000-0001-7254-2616; Ribecco, Maria Teresa Silvia/0000-0003-3278-9221; NANAYAKKARA, MERLIN/0000-0002-2569-4606; BARONE, Maria Vittoria/0000-0001-6190-4917	Regione Campania	Regione Campania(Regione Campania)	This work was supported by funds from Regione Campania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElela S, 1997, NUCLEIC ACIDS RES, V25, P1788, DOI 10.1093/nar/25.9.1788; Bamford RN, 1996, J LEUKOCYTE BIOL, V59, P476, DOI 10.1002/jlb.59.4.476; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; Barzegar C, 1998, ONCOGENE, V16, P2503, DOI 10.1038/sj.onc.1201775; Bernardo D, 2008, CLIN EXP IMMUNOL, V154, P64, DOI 10.1111/j.1365-2249.2008.03743.x; Budagian V, 2005, EMBO J, V24, P4260, DOI 10.1038/sj.emboj.7600874; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Ebert EC, 2005, IMMUNOLOGY, V115, P118, DOI 10.1111/j.1365-2567.2005.02132.x; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Gaggero A, 1999, EUR J IMMUNOL, V29, P1265, DOI 10.1002/(SICI)1521-4141(199904)29:04<1265::AID-IMMU1265>3.0.CO;2-V; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; Kinoshita N, 2002, J IMMUNOL, V169, P6187, DOI 10.4049/jimmunol.169.11.6187; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2001, AM J GASTROENTEROL, V96, P150; MARSH MN, 1992, EUR J GASTROEN HEPAT, V4, P667; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meazza R, 1997, EUR J IMMUNOL, V27, P1049, DOI 10.1002/eji.1830270502; Meazza R, 1996, ONCOGENE, V12, P2187; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; MULDER CJJ, 1993, GUT, V34, P1740, DOI 10.1136/gut.34.12.1740; PAXTON RJ, 2001, CURR PROTOC IMMUNOL, pCH6; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; SCITA G, NATURE, V28, P464; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Yano S, 2003, BIOCHEM BIOPH RES CO, V301, P841, DOI 10.1016/S0006-291X(03)00060-3; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656	41	48	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17039	10.1371/journal.pone.0017039	http://dx.doi.org/10.1371/journal.pone.0017039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364874	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100021
J	Kim, ML; Sorg, I; Arrieumerlou, C				Kim, Man Lyang; Sorg, Isabel; Arrieumerlou, Cecile			Endocytosis-Independent Function of Clathrin Heavy Chain in the Control of Basal NF-kappa B Activation	PLOS ONE			English	Article							RECEPTOR TRAFFICKING; PROTEINS; CELLS; TRANSCRIPTION; INHIBITOR; PATHWAYS; MICE	Background: Nuclear factor-kappa B (NF-kappa B) is a transcription factor that regulates the transcription of genes involved in a variety of biological processes, including innate and adaptive immunity, stress responses and cell proliferation. Constitutive or excessive NF-kappa B activity has been associated with inflammatory disorders and higher risk of cancer. In contrast to the mechanisms controlling inducible activation, the regulation of basal NF-kappa B activation is not well understood. Here we test whether clathrin heavy chain (CHC) contributes to the regulation of basal NF-kappa B activity in epithelial cells. Methodology: Using RNA interference to reduce endogenous CHC expression, we found that CHC is required to prevent constitutive activation of NF-kappa B and gene expression. Immunofluorescence staining showed constitutive nuclear localization of the NF-kappa B subunit p65 in absence of stimulation after CHC knockdown. Elevated basal p65 nuclear localization is caused by constitutive phosphorylation and degradation of inhibitor of NF-kappa B alpha (I kappa B alpha) through an I kappa B kinase alpha (IKK alpha)-dependent mechanism. The role of CHC in NF-kappa B signaling is functionally relevant as constitutive expression of the proinflammatory chemokine interleukin-8 (IL-8), whose expression is regulated by NF-kappa B, was found after CHC knockdown. Disruption of clathrin-mediated endocytosis by chemical inhibition or depletion of the mu 2-subunit of the endocytosis adaptor protein AP-2, and knockdown of clathrin light chain a (CHLa), failed to induce constitutive NF-kappa B activation and IL-8 expression, showing that CHC acts on NF-kappa B independently of endocytosis and CLCa. Conclusions: We conclude that CHC functions as a built-in molecular brake that ensures a tight control of basal NF-kappa B activation and gene expression in unstimulated cells. Furthermore, our data suggest a potential link between a defect in CHC expression and chronic inflammation disorder and cancer.	[Kim, Man Lyang; Sorg, Isabel; Arrieumerlou, Cecile] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Kim, ML (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	cecile.arrieumerlou@unibas.ch		ARRIEUMERLOU, Cecile/0000-0002-6463-2897	Swiss National Science Foundation [3100A0-113561]; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was funded by the Swiss National Science Foundation (grant 3100A0-113561 to CA; www.snf.ch) and the University of Basel (www.unibas.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; GIBSON AE, 1989, AM J PHYSIOL, V257, pC182, DOI 10.1152/ajpcell.1989.257.2.C182; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hayden Matthew S, 2006, Cell, V127, P1286; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Kim ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015371; Liberatore RA, 2009, P NATL ACAD SCI USA, V106, P17823, DOI 10.1073/pnas.0905935106; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004; Poupon V, 2008, P NATL ACAD SCI USA, V105, P168, DOI 10.1073/pnas.0707269105; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Prescott JL, 1998, ENDOCRINOLOGY, V139, P2111, DOI 10.1210/en.139.4.2111; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Weil R, 2003, IMMUNITY, V18, P13, DOI 10.1016/S1074-7613(02)00506-X; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17158	10.1371/journal.pone.0017158	http://dx.doi.org/10.1371/journal.pone.0017158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364927	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100032
J	Pezzementi, L; Nachon, F; Chatonnet, A				Pezzementi, Leo; Nachon, Florian; Chatonnet, Arnaud			Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes	PLOS ONE			English	Article							PERIPHERAL ANIONIC SITE; COLLAGEN-TAILED FORMS; ACTIVE-SITE; TORPEDO ACETYLCHOLINESTERASE; SUBSTRATE-INHIBITION; MAMMALIAN-CELLS; SKELETAL-MUSCLE; AMINO-ACIDS; IN-VIVO; CHOLINESTERASES	Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are thought to be the result of a gene duplication event early in vertebrate evolution. To learn more about the evolution of these enzymes, we expressed in vitro, characterized, and modeled a recombinant cholinesterase (ChE) from a teleost, the medaka Oryzias latipes. In addition to AChE, O. latipes has a ChE that is different from either vertebrate AChE or BChE, which we are classifying as an atypical BChE, and which may resemble a transitional form between the two. Of the fourteen aromatic amino acids in the catalytic gorge of vertebrate AChE, ten are conserved in the atypical BChE of O. latipes; by contrast, only eight are conserved in vertebrate BChE. Notably, the atypical BChE has one phenylalanine in its acyl pocket, while AChE has two and BChE none. These substitutions could account for the intermediate nature of this atypical BChE. Molecular modeling supports this proposal. The atypical BChE hydrolyzes acetylthiocholine (ATCh) and propionylthiocholine (PTCh) preferentially but butyrylthiocholine (BTCh) to a considerable extent, which is different from the substrate specificity of AChE or BChE. The enzyme shows substrate inhibition with the two smaller substrates but not with the larger substrate BTCh. In comparison, AChE exhibits substrate inhibition, while BChE does not, but may instead show substrate activation. The atypical BChE from O. latipes also shows a mixed pattern of inhibition. It is effectively inhibited by physostigmine, typical of all ChEs. However, although the atypical BChE is efficiently inhibited by the BChE-specific inhibitor ethopropazine, it is not by another BChE inhibitor, iso-OMPA, nor by the AChE-specific inhibitor BW284c51. The atypical BChE is found as a glycophosphatidylinositol-anchored (GPI-anchored) amphiphilic dimer (G(2)(a)), which is unusual for any BChE. We classify the enzyme as an atypical BChE and discuss its implications for the evolution of AChE and BChE and for ecotoxicology.	[Pezzementi, Leo] Birmingham So Coll, Dept Biol, Birmingham, AL 35254 USA; [Nachon, Florian] Inst Rech Biomed Armees, Dept Toxicol, La Tronche, France; [Chatonnet, Arnaud] INRA, Unite Mixte Rech 866, F-34060 Montpellier, France; [Chatonnet, Arnaud] Univ Montpellier I, Montpellier, France; [Chatonnet, Arnaud] Univ Montpellier 2, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier	Pezzementi, L (corresponding author), Birmingham So Coll, Dept Biol, Birmingham, AL 35254 USA.	lpezzeme@bsc.edu; chatonne@ensam.inra.fr	Chatonnet, Arnaud/E-2190-2017; Chatonnet, Arnaud/AAM-5569-2021	Chatonnet, Arnaud/0000-0002-4057-3896; 	National Institutes of Heath [R15 GM072510-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM072510] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institutes of Heath (http://www.nih.gov/) Academic Research Enhancement Award R15 GM072510-01 to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the funders.	Altamirano CV, 1999, CHEM-BIOL INTERACT, V119, P53, DOI 10.1016/S0009-2797(99)00013-7; Ariel N, 1998, BIOCHEM J, V335, P95, DOI 10.1042/bj3350095; AUSTIN L, 1953, BIOCHEM J, V54, P695, DOI 10.1042/bj0540695; Barak D, 2002, BIOCHEMISTRY-US, V41, P8245, DOI 10.1021/bi020143t; BARAK D, 1994, J BIOL CHEM, V269, P6296; Blong RM, 1997, BIOCHEM J, V327, P747, DOI 10.1042/bj3270747; Bosco K. H., 2008, BMC STRUCT BIOL, V8, P49; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; Chuiko GM, 2005, CHEM-BIOL INTERACT, V157, P365, DOI 10.1016/j.cbi.2005.10.053; Chuiko GM, 2003, COMP BIOCHEM PHYS B, V135, P55, DOI 10.1016/S1096-4959(03)00048-4; Chuiko GM, 2000, COMP BIOCHEM PHYS C, V127, P233, DOI 10.1016/S0742-8413(00)00150-X; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Combes D, 2000, J MOL BIOL, V300, P727, DOI 10.1006/jmbi.2000.3917; DAVIES RO, 1960, CAN J BIOCHEM PHYS, V38, P545; Delano W.L, 2002, PYMOL USERS MANUAL; DOCTOR BP, 1987, ANAL BIOCHEM, V166, P399, DOI 10.1016/0003-2697(87)90590-2; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; DUVAL N, 1992, J CELL BIOL, V118, P641, DOI 10.1083/jcb.118.3.641; El-Alfy A, 1998, TOXICOL APPL PHARM, V152, P175, DOI 10.1006/taap.1998.8479; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FLUCK RA, 1982, COMP BIOCHEM PHYS C, V72, P59, DOI 10.1016/0306-4492(82)90205-2; Fulton MH, 2001, ENVIRON TOXICOL CHEM, V20, P37, DOI [10.1897/1551-5028(2001)020&lt;0037:AIIEFA&gt;2.0.CO;2, 10.1002/etc.5620200104]; FUTERMAN AH, 1985, J NEUROCHEM, V45, P1487, DOI 10.1111/j.1471-4159.1985.tb07217.x; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIBNEY G, 1990, J BIOL CHEM, V265, P12576; GINDI T, 1979, J EMBRYOL EXP MORPH, V51, P209; GNATT A, 1994, J NEUROCHEM, V62, P749; HAREL M, 1992, P NATL ACAD SCI USA, V89, P10827, DOI 10.1073/pnas.89.22.10827; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOLLAND PWH, 1994, DEVELOPMENT, P125; INESTROSA NC, 1988, NEUROSCI LETT, V90, P186, DOI 10.1016/0304-3940(88)90809-9; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;487::AID-BIES11&gt;3.0.CO;2-8; JBILO O, 1994, TOXICON, V32, P1445, DOI 10.1016/0041-0101(94)90416-2; Kaplan D, 2001, BIOCHEMISTRY-US, V40, P7433, DOI 10.1021/bi010181x; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KASHIWAGI K, EXP ANIM, V59, P395; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; LAPPIN RI, 1985, DEV BIOL, V110, P269, DOI 10.1016/0012-1606(85)90086-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEGAY C, 1993, FEBS LETT, V315, P163, DOI 10.1016/0014-5793(93)81155-S; LEIBEL WS, 1988, J EXP ZOOL, V247, P209, DOI 10.1002/jez.1402470304; LEIBEL WS, 1988, J EXP ZOOL, V247, P198, DOI 10.1002/jez.1402470303; LEVY D, 1986, BIOCHEM PHARMACOL, V35, P1079, DOI 10.1016/0006-2952(86)90142-5; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; LI Y, 1993, J BIOL CHEM, V268, P5790; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; LOEWENSTEINLICHTENSTEIN Y, 1995, NAT MED, V1, P1082, DOI 10.1038/nm1095-1082; LoewensteinLichtenstein Y, 1996, MOL PHARMACOL, V50, P1423; LUNDIN SJ, 1968, ACTA CHEM SCAND, V22, P2183, DOI 10.3891/acta.chem.scand.22-2183; Mallender WD, 2000, BIOCHEMISTRY-US, V39, P7753, DOI 10.1021/bi000210o; Massiah MA, 2001, BIOCHEMISTRY-US, V40, P5682, DOI 10.1021/bi010243j; Masson P, 1996, EUR J BIOCHEM, V235, P36, DOI 10.1111/j.1432-1033.1996.00036.x; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; MIKALSEN A, 1986, COMP BIOCHEM PHYS C, V83, P447, DOI 10.1016/0742-8413(86)90152-0; MORALEV SN, 2007, COMP ENZYMOLOGY CHOL, P484; MOYA MA, 1991, COMP BIOCHEM PHYS C, V98, P299, DOI 10.1016/0742-8413(91)90209-C; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Nillos MG, 2007, ENVIRON TOXICOL CHEM, V26, P1949, DOI 10.1897/07-001R.1; Ordentlich A, 1998, J BIOL CHEM, V273, P19509, DOI 10.1074/jbc.273.31.19509; Ordentlich A, 1996, J BIOL CHEM, V271, P11953, DOI 10.1074/jbc.271.20.11953; ORDENTLICH A, 1995, J BIOL CHEM, V270, P2082, DOI 10.1074/jbc.270.5.2082; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Pezzementi L, 2003, COMP BIOCHEM PHYS B, V136, P813, DOI 10.1016/S1096-4959(03)00259-8; PEZZEMENTI L, 1987, J NEUROCHEM, V48, P1753, DOI 10.1111/j.1471-4159.1987.tb05733.x; Pezzementi L, 2010, CHEM-BIOL INTERACT, V187, P27, DOI 10.1016/j.cbi.2010.03.043; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Renault L, 2005, CHEM-BIOL INTERACT, V157, P339, DOI 10.1016/j.cbi.2005.10.100; ROBERTS WL, 1987, P NATL ACAD SCI USA, V84, P7817, DOI 10.1073/pnas.84.22.7817; Rosenberry TL, 1999, CHEM-BIOL INTERACT, V119, P85, DOI 10.1016/S0009-2797(99)00017-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders M, 1996, COMP BIOCHEM PHYS B, V115, P97, DOI 10.1016/0305-0491(96)00088-0; Saxena A, 1997, BIOCHEMISTRY-US, V36, P14642, DOI 10.1021/bi971425+; Schmidt EE, 2007, BIOESSAYS, V29, P262, DOI 10.1002/bies.20546; Scholz NL, 2006, ENVIRON TOXICOL CHEM, V25, P1185, DOI 10.1897/05-699.1; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; Shapira M, 1998, TOXICOL LETT, V103, P205, DOI 10.1016/S0378-4274(98)00308-7; SIKORAV JL, 1988, EMBO J, V7, P2983, DOI 10.1002/j.1460-2075.1988.tb03161.x; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Silver A., 1974, BIOL CHOLINESTERASES; Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; STIEGER S, 1989, EUR J BIOCHEM, V181, P633, DOI 10.1111/j.1432-1033.1989.tb14770.x; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Sutherland D, 1997, J EXP ZOOL, V277, P213, DOI 10.1002/(SICI)1097-010X(19970215)277:3<213::AID-JEZ3>3.0.CO;2-R; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; TOUTANT JP, 1985, J NEUROCHEM, V44, P580, DOI 10.1111/j.1471-4159.1985.tb05452.x; Ucar G, 2005, NEUROSCI LETT, V382, P327, DOI 10.1016/j.neulet.2005.03.028; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Walker C.H., 1991, Chemicals in Agriculture, V2, P1; Wheelock CE, 2005, AQUAT TOXICOL, V74, P172, DOI 10.1016/j.aquatox.2005.05.009; Whittaker VP, 2010, CHEM-BIOL INTERACT, V187, P23, DOI 10.1016/j.cbi.2010.02.041; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	104	47	47	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17396	10.1371/journal.pone.0017396	http://dx.doi.org/10.1371/journal.pone.0017396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364766	Green Published, gold			2022-12-25	WOS:000287764100052
J	Song, M; Du, HJ; Wu, N; Hou, B; Wu, GC; Wang, JA; Feng, H; Jiang, TZ				Song, Ming; Du, Hanjian; Wu, Nan; Hou, Bing; Wu, Guocai; Wang, Jian; Feng, Hua; Jiang, Tianzi			Impaired Resting-State Functional Integrations within Default Mode Network of Generalized Tonic-Clonic Seizures Epilepsy	PLOS ONE			English	Article							BRAIN; CONNECTIVITY; ARCHITECTURE; DISCHARGES; FMRI	Generalized tonic-clonic seizures (GTCS) are characterized by unresponsiveness and convulsions, which cause complete loss of consciousness. Many recent studies have found that the ictal alterations in brain activity of the GTCS epilepsy patients are focally involved in some brain regions, including thalamus, upper brainstem, medial prefrontal cortex, posterior midbrain regions, and lateral parietal cortex. Notably, many of these affected brain regions are the same and overlap considerably with the components of the so-called default mode network (DMN). Here, we hypothesize that the brain activity of the DMN of the GTCS epilepsy patients are different from normal controls, even in the resting state. To test this hypothesis, we compared the DMN of the GTCS epilepsy patients and the controls using the resting state functional magnetic resonance imaging. Thirteen brain areas in the DMN were extracted, and a complete undirected weighted graph was used to model the DMN for each participant. When directly comparing the edges of the graph, we found significant decreased functional connectivities within the DMN of the GTCS epilepsy patients comparing to the controls. As for the nodes of the graph, we found that the degree of some brain areas within the DMN was significantly reduced in the GTCS epilepsy patients, including the anterior medial prefrontal cortex, the bilateral superior frontal cortex, and the posterior cingulate cortex. Then we investigated into possible mechanisms of how GTCS epilepsy could cause the reduction of the functional integrations of DMN. We suggested the damaged functional integrations of the DMN in the GTCS epilepsy patients even during the resting state, which could help to understand the neural correlations of the impaired consciousness of GTCS epilepsy patients.	[Song, Ming; Hou, Bing; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Du, Hanjian; Wu, Nan; Wu, Guocai; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; University of Electronic Science & Technology of China; Army Medical University; Army Medical University	Song, M (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	fenghua8888@yahoo.com.cn; jiangtz@nlpr.ia.ac.cn	wang, jian/GVS-0711-2022; Hou, Bing/B-6241-2011; Feng, Hua/AAX-4121-2021; Jiang, Tianzi/I-4256-2012	Hou, Bing/0000-0002-4268-8144; Feng, Hua/0000-0003-4489-9217; Jiang, Tianzi/0000-0001-9531-291X; Du, Hanjian/0000-0002-2353-8802	National Key Basic Research and Development Program (973) [2011CB707800]; Natural Science Foundation of China [30730035, 30872660]; NSFC [60723005]; China Postdoctoral Science Foundation [20100470614]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was partially supported by the National Key Basic Research and Development Program (973) (Grant No. 2011CB707800 to TJ); the Natural Science Foundation of China (Grant No. 30730035 to TJ and Grant No. 30872660 to HF, HD, NW, GW, JW); the Excellent State Key Laboratory Project of NSFC (Grant No. 60723005 to MS); China Postdoctoral Science Foundation (Grant No. 20100470614 to BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y., 1995, J R STAT SOC, V57, P289, DOI [10.1111/j.2517-6161.1995.tb02031.x, DOI 10.1111/J.2517-6161.1995.TB02031.X]; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cavanna AE, 2009, NAT REV NEUROL, V5, P267, DOI 10.1038/nrneurol.2009.38; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Elger CE, 1998, NEUROPSYCHOBIOLOGY, V38, P145, DOI 10.1159/000026530; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Li QF, 2009, EPILEPSY RES, V87, P160, DOI 10.1016/j.eplepsyres.2009.08.018; Liu B, 2010, J NEUROSCI, V30, P64, DOI 10.1523/JNEUROSCI.3941-09.2010; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Song M, 2009, IEEE T AUTON MENT DE, V1, P101, DOI 10.1109/TAMD.2009.2029312; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042	37	53	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17294	10.1371/journal.pone.0017294	http://dx.doi.org/10.1371/journal.pone.0017294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364890	Green Submitted, Green Published, gold			2022-12-25	WOS:000287764100041
J	Lintas, C; Guidi, F; Manzi, B; Mancini, A; Curatolo, P; Persico, AM				Lintas, Carla; Guidi, Francesco; Manzi, Barbara; Mancini, Antonio; Curatolo, Paolo; Persico, Antonio M.			Lack of Infection with XMRV or Other MLV-Related Viruses in Blood, Post-Mortem Brains and Paternal Gametes of Autistic Individuals	PLOS ONE			English	Article							CYTOMEGALOVIRUS; ASSOCIATION; CHILDREN	Background: Autistic spectrum disorder (ASD) is characterized by impaired language, communication and social skills, as well as by repetitive and stereotypic patterns of behavior. Many autistic subjects display a dysregulation of the immune system which is compatible with an unresolved viral infection with prenatal onset, potentially due to vertical viral transmission. Recently, the xenotropic murine leukemia virus-related virus (XMRV) has been implicated in chronic fatigue syndrome (CFS) and in prostate cancer by several, though not all studies. Methodology/Principal Findings: We assessed whether XMRV or other murine leukemia virus (MLV)-related viruses are involved in autistic disorder. Using nested PCR targeted to gag genomic sequences, we screened DNA samples from: (i) peripheral blood of 102 ASD patients and 97 controls, (ii) post-mortem brain samples of 20 ASD patients and 17 sex- and age-matched controls, (iii) semen samples of 11 fathers of ASD children, 25 infertile individuals and 7 fertile controls. No XMRV gag DNA sequences were detected, whereas peripheral blood samples of 3/97 (3.1%) controls were positive for MLV. Conclusions/Significance: No MLV-related virus was detected in blood, brain, and semen samples of ASD patients or fathers. Hence infection with XMRV or other MLV-related viruses is unlikely to contribute to autism pathogenesis.	[Lintas, Carla; Persico, Antonio M.] Univ Campus Biomed, Lab Mol Psychiat & Neurogenet, Rome, Italy; [Lintas, Carla; Persico, Antonio M.] IRCCS Fdn Santa Lucia, Lab Mol Psychiat & Psychiat Genet, Dept Expt Neurosci, Rome, Italy; [Guidi, Francesco] Univ Cattolica Sacro Cuore, Inst Hematol, I-00168 Rome, Italy; [Manzi, Barbara; Curatolo, Paolo] Univ Tor Vergata, Dept Child Neuropsychiat, Rome, Italy; [Mancini, Antonio] Univ Cattolica Sacro Cuore, Dept Internal Med, I-00168 Rome, Italy	University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Lintas, C (corresponding author), Univ Campus Biomed, Lab Mol Psychiat & Neurogenet, Univ Campus Biomed, Rome, Italy.	A.Persico@unicampus.it	LINTAS, CARLA/AAB-6248-2022; Persico, Antonio/AAB-9504-2022; Guidi, Francesco/AAS-9209-2021	Lintas, Carla/0000-0003-1209-8554; Persico, Antonio/0000-0001-8910-4479	Italian Ministry for University, Scientific Research and Technology [2006058195, 2008BACT54]; Italian Ministry of Health [RFPS-2007-5-640174]; Fondazione Gaetano e Mafalda Luce (Milan, Italy); Autism Speaks (Princeton, N.J.); Autism Research Institute (San Diego, CA)	Italian Ministry for University, Scientific Research and Technology(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Gaetano e Mafalda Luce (Milan, Italy); Autism Speaks (Princeton, N.J.); Autism Research Institute (San Diego, CA)	This work was supported by the Italian Ministry for University, Scientific Research and Technology (P.R.I.N. n.2006058195 and 2008BACT54), the Italian Ministry of Health (RFPS-2007-5-640174), the Fondazione Gaetano e Mafalda Luce (Milan, Italy), a Trailblazer Award by Autism Speaks (Princeton, N.J.), and the Autism Research Institute (San Diego, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIA AL, 2010, CANC RES        1021; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; BARNES E, 2010, J INFECT DIS    1011; CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4; CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741; CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116; Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; DANIELSON BX, 2010, J INFECT DIS    0903; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischer N, 2010, EMERG INFECT DIS, V16, P1000, DOI 10.3201/eid1606.100066; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; HENRICH TX, 2010, J INFECT DIS    1011; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; IVARSSON SA, 1990, NEUROPEDIATRICS, V21, P102, DOI 10.1055/s-2008-1071471; Jeziorski E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-63; Kawatani M, 2010, PEDIATR INT, V52, P304, DOI 10.1111/j.1442-200X.2010.03027.x; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Lintas C, 2009, MOL PSYCHIATR, V14, P705, DOI 10.1038/mp.2008.21; Lintas C, 2009, J MED GENET, V46, P1, DOI 10.1136/jmg.2008.060871; Lintas C, 2010, J NEUROVIROL, V16, P141, DOI 10.3109/13550281003685839; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lopez-Pison J, 2005, REV NEUROLOGIA, V40, P733, DOI 10.33588/rn.4012.2004511; MARKOWITZ PI, 1983, J AUTISM DEV DISORD, V13, P249, DOI 10.1007/BF01531564; PERSICO AM, 2010, J NEUROVIROL; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Satterfield BC, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-14; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; STUBBS EG, 1978, J AUTISM CHILD SCHIZ, V8, P37, DOI 10.1007/BF01550276; STUBBS EG, 1984, J AUTISM DEV DISORD, V14, P183, DOI 10.1007/BF02409660; Sweeten TL, 2004, J AUTISM DEV DISORD, V34, P583, DOI 10.1007/s10803-004-2552-y; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van den Pol AN, 2006, TRENDS NEUROSCI, V29, P398, DOI 10.1016/j.tins.2006.06.002; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; VERHAEGH GW, 2010, PROSTATE        0928; Yamashita Y, 2003, J AUTISM DEV DISORD, V33, P455, DOI 10.1023/A:1025023131029; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	44	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16609	10.1371/journal.pone.0016609	http://dx.doi.org/10.1371/journal.pone.0016609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373179	Green Published, gold, Green Submitted			2022-12-25	WOS:000287657500013
J	Enerly, E; Steinfeld, I; Kleivi, K; Leivonen, SK; Aure, MR; Russnes, HG; Ronneberg, JA; Johnsen, H; Navon, R; Rodland, E; Makela, R; Naume, B; Perala, M; Kallioniemi, O; Kristensen, VN; Yakhini, Z; Borresen-Dale, AL				Enerly, Espen; Steinfeld, Israel; Kleivi, Kristine; Leivonen, Suvi-Katri; Aure, Miriam R.; Russnes, Hege G.; Ronneberg, Jo Anders; Johnsen, Hilde; Navon, Roy; Rodland, Einar; Makela, Rami; Naume, Bjorn; Perala, Merja; Kallioniemi, Olli; Kristensen, Vessela N.; Yakhini, Zohar; Borresen-Dale, Anne-Lise			miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors	PLOS ONE			English	Article							GENE-EXPRESSION DATA; BONE-MARROW; CANCER; MICRORNAS; SUBTYPES; MIR-150; DIFFERENTIATION; CLASSIFICATION; PROLIFERATION; PROFILES	Introduction: Few studies have performed expression profiling of both miRNA and mRNA from the same primary breast carcinomas. In this study we present and analyze data derived from expression profiling of 799 miRNAs in 101 primary human breast tumors, along with genome-wide mRNA profiles and extensive clinical information. Methods: We investigate the relationship between these molecular components, in terms of their correlation with each other and with clinical characteristics. We use a systems biology approach to examine the correlative relationship between miRNA and mRNAs using statistical enrichment methods. Results: We identify statistical significant differential expression of miRNAs between molecular intrinsic subtypes, and between samples with different levels of proliferation. Specifically, we point to miRNAs significantly associated with TP53 and ER status. We also show that several cellular processes, such as proliferation, cell adhesion and immune response, are strongly associated with certain miRNAs. We validate the role of miRNAs in regulating proliferation using high-throughput lysate-microarrays on cell lines and point to potential drivers of this process. Conclusion: This study provides a comprehensive dataset as well as methods and system-level results that jointly form a basis for further work on understanding the role of miRNA in primary breast cancer.	[Enerly, Espen; Kleivi, Kristine; Aure, Miriam R.; Russnes, Hege G.; Ronneberg, Jo Anders; Johnsen, Hilde; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Div Surg & Canc,Dept Genet, Oslo, Norway; [Steinfeld, Israel; Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Kleivi, Kristine; Leivonen, Suvi-Katri; Makela, Rami; Perala, Merja; Kallioniemi, Olli] VTT Tech Res Ctr Finland, Turku, Finland; [Enerly, Espen; Ronneberg, Jo Anders; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Navon, Roy; Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel; [Rodland, Einar] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Naume, Bjorn] Oslo Univ Hosp, Dept Oncol, Div Surg & Canc, Oslo, Norway; [Kallioniemi, Olli] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Kristensen, Vessela N.] Inst Clin Epidemiol & Mol Biol EPIGEN, Nordbyhagen, Norway; [Russnes, Hege G.] Oslo Univ Hosp, Div Pathol, Oslo, Norway	University of Oslo; Technion Israel Institute of Technology; VTT Technical Research Center Finland; University of Oslo; Agilent Technologies; University of Oslo; University of Oslo; University of Helsinki; University of Oslo	Enerly, E (corresponding author), Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Div Surg & Canc,Dept Genet, Oslo, Norway.	zohar_yakhini@agilent.com; a.l.borresen-dale@medisin.uio.no	Kallioniemi, Olli P/H-5111-2011; Leivonen, Suvi-Katri/AAK-3096-2021; Russnes, Hege Elisabeth Giercksky/N-6170-2015; Enerly, Espen/P-4666-2019	Kallioniemi, Olli P/0000-0002-3231-0332; Russnes, Hege Elisabeth Giercksky/0000-0001-8724-1891; Enerly, Espen/0000-0002-2974-2273; Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Yakhini, Zohar/0000-0002-0420-5412; Leivonen, Suvi-Katri/0000-0003-3224-0757	Norwegian Research Council [183621/S10, 175240/S10]; Norwegian Cancer Society [PK80108002, PK60287003]; EMBIO, University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); EMBIO, University of Oslo	This study has been supported with grants from Norwegian Research Council (# 183621/S10 and # 175240/S10) and Norwegian Cancer Society (PK80108002, PK60287003). EE has a Post Doctoral Research Fellowship from EMBIO, University of Oslo. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r90; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; CORNEY DC, 2007, MICRORNA 34B MICRORN; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; LEIVONEN SK, 2009, ONCOGENE; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Naume B, 2001, CLIN CANCER RES, V7, P4122; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; SORLIE T, 2001, GENE EXPR PATTERNS, P10869; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUN Y, 2008, BREAST CANC RES TREA; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	62	239	241	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16915	10.1371/journal.pone.0016915	http://dx.doi.org/10.1371/journal.pone.0016915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364938	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600024
J	Sala, E; Kizilkaya, Z; Yildirim, D; Ballesteros, E				Sala, Enric; Kizilkaya, Zafer; Yildirim, Derya; Ballesteros, Enric			Alien Marine Fishes Deplete Algal Biomass in the Eastern Mediterranean	PLOS ONE			English	Article							SPATIAL VARIATION; ISOTOPE; COMMUNITY; SHIFTS; REEFS	One of the most degraded states of the Mediterranean rocky infralittoral ecosystem is a barren composed solely of bare rock and patches of crustose coralline algae. Barrens are typically created by the grazing action of large sea urchin populations. In 2008 we observed extensive areas almost devoid of erect algae, where sea urchins were rare, on the Mediterranean coast of Turkey. To determine the origin of those urchin-less 'barrens', we conducted a fish exclusion experiment. We found that, in the absence of fish grazing, a well-developed algal assemblage grew within three months. Underwater fish censuses and observations suggest that two alien herbivorous fish from the Red Sea (Siganus luridus and S. rivulatus) are responsible for the creation and maintenance of these benthic communities with extremely low biomass. The shift from well-developed native algal assemblages to 'barrens' implies a dramatic decline in biogenic habitat complexity, biodiversity and biomass. A targeted Siganus fishery could help restore the macroalgal beds of the rocky infralittoral on the Turkish coast.	[Sala, Enric; Ballesteros, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Sala, Enric] Natl Geog Soc, Washington, DC USA; [Kizilkaya, Zafer; Yildirim, Derya] SAD EKOG, Ankara, Turkey	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); National Geographic Society	Sala, E (corresponding author), CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain.	esala@ngs.org	Ballesteros, Enric/K-6497-2012		Pew Charitable Trusts; Oak Foundation; Spanish Ministry of Science and Innovation [C5D2007-00067]	Pew Charitable Trusts; Oak Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research was funded by Pew Charitable Trusts, Oak Foundation, and the GRACCIE project C5D2007-00067 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLESTEROS E, 1990, Scientia Marina, V54, P155; BALLESTEROS E, 1992, VEGETALS ZONACIO LIT; Bariche M, 2006, CYBIUM, V30, P41; BARICHE M, 2002, THESIS U MEDITERRANE; Ben-Tuvia A., 1964, Bulletin of the State of Israel Sea Fishing Research Station, V37, P3; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Daniel B, 2009, CYBIUM, V33, P163; Deudero S, 2004, MAR BIOL, V145, P971, DOI 10.1007/s00227-004-1374-y; GOLANI D, 2010, CIESM ATLAS EXOTIC S, V1; Guidetti P, 2007, MAR ENVIRON RES, V63, P168, DOI 10.1016/j.marenvres.2006.08.002; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; Jennings S, 1997, MAR ECOL PROG SER, V146, P109, DOI 10.3354/meps146109; Lundberg B, 1999, ISR J ZOOL, V45, P127; Pinnegar JK, 2000, OECOLOGIA, V122, P399, DOI 10.1007/s004420050046; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; RUITTON S, 2001, ESTUARINE COASTAL SH, V50, P217; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1997, J EXP MAR BIOL ECOL, V212, P25, DOI 10.1016/S0022-0981(96)02745-1; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Soltan D, 2001, MAR POLLUT BULL, V42, P59, DOI 10.1016/S0025-326X(00)00116-8; Tortonese E., 1970, Doriana, V4, P1; VERLAQUE M, 1987, C INT PARACENTROTUS	23	154	163	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17356	10.1371/journal.pone.0017356	http://dx.doi.org/10.1371/journal.pone.0017356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364943	Green Published, gold, Green Submitted			2022-12-25	WOS:000287656600042
J	Davis, JS; Darcy, CJ; Yeo, TW; Jones, C; McNeil, YR; Stephens, DP; Celermajer, DS; Anstey, NM				Davis, Joshua S.; Darcy, Christabelle J.; Yeo, Tsin W.; Jones, Catherine; McNeil, Yvette R.; Stephens, Dianne P.; Celermajer, David S.; Anstey, Nicholas M.			Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis	PLOS ONE			English	Article							ORGAN BLOOD-FLOW; ENDOGENOUS INHIBITOR; CARDIOVASCULAR RISK; UNITED-STATES; DYSFUNCTION; ADMA; ANGIOPOIETIN-2; EPIDEMIOLOGY; THERAPIES; AMPLITUDE	Background: Plasma concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, are raised in patients with chronic vascular disease, causing increased cardiovascular risk and endothelial dysfunction, but the role of ADMA in acute inflammatory states is less well defined. Methods and Results: In a prospective longitudinal study in 67 patients with acute sepsis and 31 controls, digital microvascular reactivity was measured by peripheral arterial tonometry and blood was collected at baseline and 2-4 days later. Plasma ADMA and L-arginine concentrations were determined by high performance liquid chromatography. Baseline plasma L-arginine: ADMA ratio was significantly lower in sepsis patients (median [IQR] 63 [45-103]) than in hospital controls (143 [123-166], p<0.0001) and correlated with microvascular reactivity (r = 0.34, R-2 = 0.12, p = 0.02). Baseline plasma ADMA was independently associated with 28-day mortality (Odds ratio [95% CI] for death in those in the highest quartile (>= 0.66 mu mol/L) = 20.8 [2.2-195.0], p = 0.008), and was independently correlated with severity of organ failure. Increase in ADMA over time correlated with increase in organ failure and decrease in microvascular reactivity. Conclusions: Impaired endothelial and microvascular function due to decreased endothelial NO bioavailability is a potential mechanism linking increased plasma ADMA with organ failure and death in sepsis.	[Davis, Joshua S.; Darcy, Christabelle J.; Yeo, Tsin W.; Jones, Catherine; McNeil, Yvette R.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Int Hlth Div, Darwin, NT, Australia; [Davis, Joshua S.; Darcy, Christabelle J.; Yeo, Tsin W.; Jones, Catherine; McNeil, Yvette R.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Davis, Joshua S.; Yeo, Tsin W.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Celermajer, David S.] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Celermajer, David S.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Stephens, Dianne P.] Royal Darwin Hosp, Intens Care Unit, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Sydney; University of Sydney	Davis, JS (corresponding author), Menzies Sch Hlth Res, Int Hlth Div, Darwin, NT, Australia.	Joshua.Davis@menzies.edu.au	Yeo, Tsin Wen/F-9505-2015; Davis, Joshua/N-2288-2013	Celermajer, David/0000-0001-7640-0439; Jones, Catherine/0000-0002-1779-6231; Davis, Joshua/0000-0001-9864-5699; Stephens, Dianne/0000-0002-3785-6828	National Health and Medical Research Council of Australia (NHMRC) [290208, 496600]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the National Health and Medical Research Council of Australia (NHMRC Program Grants 290208, 496600; Fellowships to NMA and TWY, scholarship to JSD). The funding source played no role in the design or conduct of the study, nor in the drafting of the manuscript or the decision to submit it for publication.	Abbasi F, 2001, AM J CARDIOL, V88, P1201, DOI 10.1016/S0002-9149(01)02063-X; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Colonna VDG, 2007, EUR J PHARMACOL, V557, P178, DOI 10.1016/j.ejphar.2006.11.034; Colonna VDG, 2009, MED SCI MONITOR, V15, pRA91; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Davis JS, 2009, CRIT CARE, V13, DOI 10.1186/cc8055; Di Giantomasso D, 2003, CHEST, V124, P1053, DOI 10.1378/chest.124.3.1053; ENGELBERGER RP, 2010, SHOCK; Hamburg NM, 2009, TRENDS CARDIOVAS MED, V19, P6, DOI 10.1016/j.tcm.2009.03.001; Iapichino G, 2010, MINERVA ANESTESIOL, V76, P325; Jones CE, 2010, J CHROMATOGR B, V878, P8, DOI 10.1016/j.jchromb.2009.10.035; Juonala M, 2007, CIRCULATION, V116, P1367, DOI 10.1161/CIRCULATIONAHA.107.690016; KAO CC, 2008, CLIN SCI LOND; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Kuvin JT, 2007, VASC MED, V12, P13, DOI 10.1177/1358863x06076227; LANG CH, 1984, AM J PHYSIOL, V246, pR331, DOI 10.1152/ajpregu.1984.246.3.R331; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; NAKAMURA T, 2009, PHARM RES; Nijveldt RJ, 2003, NEPHROL DIAL TRANSPL, V18, P2542, DOI 10.1093/ndt/gfg452; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; O'Dwyer MJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5053; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Surdacki A, 1999, J CARDIOVASC PHARM, V33, P652, DOI 10.1097/00005344-199904000-00020; Trzeciak S, 2008, ACAD EMERG MED, V15, P399, DOI 10.1111/j.1553-2712.2008.00109.x; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; Vallet B, 2003, CRIT CARE, V7, P130, DOI 10.1186/cc1864; vanWandelen C, 1997, J CHROMATOGR A, V763, P11, DOI 10.1016/S0021-9673(96)00891-6; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zoccali C, 2007, NEPHROL DIAL TRANSPL, V22, P801, DOI 10.1093/ndt/gfl719	41	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17260	10.1371/journal.pone.0017260	http://dx.doi.org/10.1371/journal.pone.0017260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364995	gold, Green Published, Green Submitted			2022-12-25	WOS:000287482800040
J	Mair, N; Benetti, C; Andratsch, M; Leitner, MG; Constantin, CE; Camprubi-Robles, M; Quarta, S; Biasio, W; Kuner, R; Gibbins, IL; Kress, M; Haberberger, RV				Mair, Norbert; Benetti, Camilla; Andratsch, Manfred; Leitner, Michael G.; Constantin, Cristina E.; Camprubi-Robles, Maria; Quarta, Serena; Biasio, Wolfgang; Kuner, Rohini; Gibbins, Ian L.; Kress, Michaela; Haberberger, Rainer V.			Genetic Evidence for Involvement of Neuronally Expressed S1P(1) Receptor in Nociceptor Sensitization and Inflammatory Pain	PLOS ONE			English	Article							RAT SENSORY NEURONS; PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; RHEUMATOID-ARTHRITIS; VASCULAR MATURATION; NEUROTROPHIC FACTOR; SPHINGOSINE-1-PHOSPHATE; CELLS; KINASE; ROLES	Sphingosine-1-phosphate (S1P) is a key regulator of immune response. Immune cells, epithelia and blood cells generate high levels of S1P in inflamed tissue. However, it is not known if S1P acts on the endings of nociceptive neurons, thereby contributing to the generation of inflammatory pain. We found that the S1P(1) receptor for S1P is expressed in subpopulations of sensory neurons including nociceptors. Both S1P and agonists at the S1P(1) receptor induced hypersensitivity to noxious thermal stimulation in vitro and in vivo. S1P-induced hypersensitivity was strongly attenuated in mice lacking TRPV1 channels. S1P and inflammation-induced hypersensitivity was significantly reduced in mice with a conditional nociceptor-specific deletion of the S1P(1) receptor. Our data show that neuronally expressed S1P(1) receptors play a significant role in regulating nociceptor function and that S1P/S1P(1) signaling may be a key player in the onset of thermal hypersensitivity and hyperalgesia associated with inflammation.	[Mair, Norbert; Benetti, Camilla; Andratsch, Manfred; Leitner, Michael G.; Constantin, Cristina E.; Camprubi-Robles, Maria; Quarta, Serena; Biasio, Wolfgang; Kress, Michaela] Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Innsbruck, Austria; [Kuner, Rohini] Univ Heidelberg, Dept Pharmacol, D-6900 Heidelberg, Germany; [Gibbins, Ian L.; Haberberger, Rainer V.] Flinders Univ S Australia, Flinders Med Sci & Technol, Ctr Neurosci, Adelaide, SA 5001, Australia	Medical University of Innsbruck; Ruprecht Karls University Heidelberg; Flinders University South Australia	Mair, N (corresponding author), Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Innsbruck, Austria.	norbert.mair@i-med.ac.at	Leitner, Michael/N-8793-2019; Kuner, Rohini/AGU-0204-2022; Leitner, Michael G./D-7887-2014; Quarta, Serena/H-1037-2011	Leitner, Michael/0000-0002-3259-6481; Leitner, Michael G./0000-0002-3259-6481; Kress, Michaela/0000-0002-8921-7470; Haberberger, Rainer Viktor/0000-0001-8043-3786	Austrian Research Funding Agency FWF [P205620]; Australian National Health and Medical Research Council [535055]; International Association for the Study of Pain (IASP)	Austrian Research Funding Agency FWF(Austrian Science Fund (FWF)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); International Association for the Study of Pain (IASP)	This work was supported by the Austrian Research Funding Agency FWF (grant P205620 to M.K.), the Australian National Health and Medical Research Council (project grant 535055), and the International Association for the Study of Pain (IASP)(collaborative research grant to MK and RVH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Andratsch M, 2009, J NEUROSCI, V29, P13473, DOI 10.1523/JNEUROSCI.1822-09.2009; Bandhuvula P, 2007, TRENDS MOL MED, V13, P210, DOI 10.1016/j.molmed.2007.03.005; Bourgoin SG, 2010, CURR OPIN INVEST DR, V11, P515; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Coste O, 2008, J BIOL CHEM, V283, P32442, DOI 10.1074/jbc.M806410200; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Deng QL, 2007, MOL PHARMACOL, V71, P724, DOI 10.1124/mol.106.029223; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; Dittert I, 1998, J NEUROSCI METH, V82, P195, DOI 10.1016/S0165-0270(98)00051-X; FORSTER C, 1990, J NEUROSCI METH, V31, P109, DOI 10.1016/0165-0270(90)90155-9; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Hagen KB, 1997, J RHEUMATOL, V24, P1703; Hammad SM, 2008, PROSTAG OTH LIPID M, V85, P107, DOI 10.1016/j.prostaglandins.2007.11.002; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; LE SH, 2004, J CELL BIOCHEM, V92, P882; Lindfors PH, 2006, J NEUROSCI, V26, P1953, DOI 10.1523/JNEUROSCI.4065-05.2006; Linhart O, 2003, NEUROSCIENCE, V118, P69, DOI 10.1016/S0306-4522(02)00960-0; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Meng H, 2009, DEV DYNAM, V238, P487, DOI 10.1002/dvdy.21852; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Obreja O, 2005, BRAIN, V128, P1634, DOI 10.1093/brain/awh490; Obreja O, 2002, FASEB J, V16, P1497, DOI 10.1096/fj.02-0101com; Ohkawa R, 2008, ANN CLIN BIOCHEM, V45, P356, DOI 10.1258/acb.2007.007189; Park KA, 2005, TRENDS PHARMACOL SCI, V26, P571, DOI 10.1016/j.tips.2005.09.010; Pernia-Andrade AJ, 2009, SCIENCE, V325, P760, DOI 10.1126/science.1171870; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Saravanan Vadivelu, 2002, Expert Opin Pharmacother, V3, P845; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Siehler S, 2002, BBA-MOL CELL BIOL L, V1582, P94, DOI 10.1016/S1388-1981(02)00142-7; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tsunemi S, 2010, CLIN IMMUNOL, V136, P197, DOI 10.1016/j.clim.2010.03.428; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2006, J NEUROPHYSIOL, V96, P1042, DOI 10.1152/jn.00120.2006; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	63	56	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17268	10.1371/journal.pone.0017268	http://dx.doi.org/10.1371/journal.pone.0017268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359147	Green Published, gold, Green Submitted			2022-12-25	WOS:000287482300043
J	Tan, T; Tang, XH; Zhang, J; Niu, YY; Chen, HW; Li, B; Wei, QA; Ji, WZ				Tan, Tao; Tang, Xianghui; Zhang, Jing; Niu, Yuyu; Chen, Hongwei; Li, Bin; Wei, Qiang; Ji, Weizhi			Generation of Trophoblast Stem Cells from Rabbit Embryonic Stem Cells with BMP4	PLOS ONE			English	Article							PLACENTAL DEVELOPMENT; UTERINE EPITHELIUM; MOUSE EMBRYOS; IN-VITRO; TROPHECTODERM DIFFERENTIATION; CYTOTROPHOBLAST CELLS; GIANT-CELLS; IMPLANTATION; PROLIFERATION; EXPRESSION	Trophoblast stem (TS) cells are ideal models to investigate trophectoderm differentiation and placental development. Herein, we describe the derivation of rabbit trophoblast stem cells from embryonic stem (ES) cells. Rabbit ES cells generated in our laboratory were induced to differentiate in the presence of BMP4 and TS-like cell colonies were isolated and expanded. These cells expressed the molecular markers of mouse TS cells, were able to invade, give rise to derivatives of TS cells, and chimerize placental tissues when injected into blastocysts. The rabbit TS-like cells maintained self-renewal in culture medium with serum but without growth factors or feeder cells, whilst their proliferation and identity were compromised by inhibitors of FGFs and TGF-beta receptors. Taken together, our study demonstrated the derivation of rabbit TS cells and suggested the essential roles of FGF and TGF-beta signalings in maintenance of rabbit TS cell self-renewal.	[Tan, Tao; Tang, Xianghui; Zhang, Jing; Niu, Yuyu; Chen, Hongwei; Li, Bin; Wei, Qiang; Ji, Weizhi] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Tan, Tao; Zhang, Jing; Chen, Hongwei; Li, Bin; Wei, Qiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Tan, Tao; Tang, Xianghui; Zhang, Jing; Niu, Yuyu; Chen, Hongwei; Li, Bin; Wei, Qiang; Ji, Weizhi] Yunnan Key Lab Anim Reprod Biol, Kunming, Yunnan, Peoples R China; [Ji, Weizhi] Kunming Biomed Int, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tan, T (corresponding author), Chinese Acad Sci, Kunming Primate Res Ctr, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	wji@mail.kiz.ac.cn		Chen, Hongwei/0000-0002-9400-6053; tan, tao/0000-0002-7589-602X; Ji, Weizhi/0000-0003-2550-4224	Major State Research Development Program [2006CB701505, 2007CB947701]; National Basic Research Program [2006AA02A116]; Chinese Academy of Sciences [KSCX2-YW-R-47]; Chinese National Science Foundation [30570906, 30700159]	Major State Research Development Program; National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Major State Research Development Program 2006CB701505, 2007CB947701; National Basic Research Program 2006AA02A116; Chinese Academy of Sciences KSCX2-YW-R-47; and Chinese National Science Foundation 30570906 and 30700159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2009, MOL CELL BIOL, V29, P2748, DOI 10.1128/MCB.01391-08; Chuykin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009794; Denker H W, 1977, Adv Anat Embryol Cell Biol, V53, P3; Douglas GC, 2009, ENDOCR REV, V30, P228, DOI 10.1210/er.2009-0001; ENDERS AC, 1971, AM J ANAT, V132, P219, DOI 10.1002/aja.1001320208; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FARIA TN, 1991, BIOL REPROD, V44, P327, DOI 10.1095/biolreprod44.2.327; Grigor'eva EV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007161; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Hemberger M, 2004, DEV BIOL, V271, P362, DOI 10.1016/j.ydbio.2004.03.040; Hoffman LH, 1998, ENDOCRINOLOGY, V139, P266, DOI 10.1210/en.139.1.266; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; King A, 2000, PLACENTA, V21, pS113, DOI 10.1053/plac.1999.0526; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; LEE VH, 1995, BIOL REPROD, V52, P868, DOI 10.1095/biolreprod52.4.868; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Reyes A, 2000, MOL BIOL EVOL, V17, P979, DOI 10.1093/oxfordjournals.molbev.a026379; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; Wang Y, 2006, MOL HUM REPROD, V12, P451, DOI 10.1093/molehr/gal054; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; WINTERHAGER E, 1994, ANAT EMBRYOL, V189, P71; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761	38	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17124	10.1371/journal.pone.0017124	http://dx.doi.org/10.1371/journal.pone.0017124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359200	Green Published, gold, Green Submitted			2022-12-25	WOS:000287482300031
J	Jennes, W; Verheyden, S; Demanet, C; Menten, J; Vuylsteke, B; Nkengasong, JN; Kestens, L				Jennes, Wim; Verheyden, Sonja; Demanet, Christian; Menten, Joris; Vuylsteke, Bea; Nkengasong, John N.; Kestens, Luc			Low CD4+T Cell Counts among African HIV-1 Infected Subjects with Group B KIR Haplotypes in the Absence of Specific Inhibitory KIR Ligands	PLOS ONE			English	Article							MHC CLASS-I; NATURAL-KILLER-CELLS; VIRUS TYPE-1 INFECTION; HLA CLASS-I; EXPOSED UNINFECTED INDIVIDUALS; IMMUNOGLOBULIN-LIKE RECEPTORS; HIV-1 INFECTION; NK CELLS; CUTTING EDGE; DISEASE PROGRESSION	Natural killer (NK) cells are regulated by interactions between polymorphic killer immunoglobulin-like receptors (KIR) and human leukocyte antigens (HLA). Genotypic combinations of KIR3DS1/L1 and HLA Bw4-80I were previously shown to influence HIV-1 disease progression, however other KIR genes have not been well studied. In this study, we analyzed the influence of all activating and inhibitory KIR, in association with the known HLA inhibitory KIR ligands, on markers of disease progression in a West African population of therapy-naive HIV-1 infected subjects. We observed a significant association between carriage of a group B KIR haplotype and lower CD4+ T cell counts, with an additional effect for KIR3DS1 within the frame of this haplotype. In contrast, we found that individuals carrying genes for the inhibitory KIR ligands HLA-Bw4 as well as HLA-C1 showed significantly higher CD4+ T cell counts. These associations were independent from the viral load and from individual HIV-1 protective HLA alleles. Our data suggest that group B KIR haplotypes and lack of specific inhibitory KIR ligand genes, genotypes considered to favor NK cell activation, are predictive of HIV-1 disease progression.	[Jennes, Wim; Vuylsteke, Bea; Kestens, Luc] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium; [Verheyden, Sonja; Demanet, Christian] Univ Ziekenhuis Brussel, HLA, Brussels, Belgium; [Verheyden, Sonja; Demanet, Christian] Univ Ziekenhuis Brussel, Mol Hematol Lab, Brussels, Belgium; [Menten, Joris] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Vuylsteke, Bea; Nkengasong, John N.] Projet RETRO CI, Abidjan, Cote Ivoire; [Nkengasong, John N.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA	Institute of Tropical Medicine (ITM); University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Jennes, W (corresponding author), Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium.	wjennes@itg.be	Jennes, Wim/M-2523-2013	Jennes, Wim/0000-0002-3125-6389	Belgian Fund for Scientific Research (FWO-Vlaanderen) [G.0660.06]	Belgian Fund for Scientific Research (FWO-Vlaanderen)(FWO)	This work was supported by the Belgian Fund for Scientific Research (FWO-Vlaanderen), grant number G.0660.06. Website: www.fwo.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Flores-Villanueva PO, 2003, J IMMUNOL, V170, P1925, DOI 10.4049/jimmunol.170.4.1925; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Korbel DS, 2009, J IMMUNOL, V182, P6426, DOI 10.4049/jimmunol.0804224; Korenromp EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005950; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Lopez-Vazquez A, 2005, HUM IMMUNOL, V66, P285, DOI 10.1016/j.humimm.2005.01.001; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Marsh SGE, 2003, HUM IMMUNOL, V64, P648, DOI 10.1016/S0198-8859(03)00067-3; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Moesta AK, 2010, J IMMUNOL, V185, P4233, DOI 10.4049/jimmunol.1001951; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; Morvan M, 2009, J IMMUNOL, V182, P6727, DOI 10.4049/jimmunol.0900212; Nelson GW, 2004, J IMMUNOL, V173, P4273, DOI 10.4049/jimmunol.173.7.4273; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Qing ML, 2006, JAIDS-J ACQ IMM DEF, V41, P137, DOI 10.1097/01.qai.0000195607.25262.92; R Core Team, 2022, R LANG ENV STAT COMP; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Verheyden S, 2004, LEUKEMIA, V18, P2002, DOI 10.1038/sj.leu.2403525; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Ward Jeffrey, 2008, Curr HIV/AIDS Rep, V5, P44, DOI 10.1007/s11904-008-0008-2	55	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17043	10.1371/journal.pone.0017043	http://dx.doi.org/10.1371/journal.pone.0017043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347267	Green Published, Green Submitted, gold			2022-12-25	WOS:000287367600033
J	Ummanni, R; Mundt, F; Pospisil, H; Venz, S; Scharf, C; Barett, C; Falth, M; Kollermann, J; Walther, R; Schlomm, T; Sauter, G; Bokemeyer, C; Sultmann, H; Schuppert, A; Brummendorf, TH; Balabanov, S				Ummanni, Ramesh; Mundt, Frederike; Pospisil, Heike; Venz, Simone; Scharf, Christian; Barett, Christine; Faelth, Maria; Koellermann, Jens; Walther, Reinhard; Schlomm, Thorsten; Sauter, Guido; Bokemeyer, Carsten; Sueltmann, Holger; Schuppert, A.; Bruemmendorf, Tim H.; Balabanov, Stefan			Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ANDROGEN RECEPTOR; ARGINASE-II; EXPRESSION; PEROXIREDOXINS; PROGRESSION; BIOMARKERS; PROGNOSIS; STATISTICS; PRINCIPLE	Prostate cancer (PCa) is the most common type of cancer found in men and among the leading causes of cancer death in the western world. In the present study, we compared the individual protein expression patterns from histologically characterized PCa and the surrounding benign tissue obtained by manual micro dissection using highly sensitive two-dimensional differential gel electrophoresis (2D-DIGE) coupled with mass spectrometry. Proteomic data revealed 118 protein spots to be differentially expressed in cancer (n = 24) compared to benign (n = 21) prostate tissue. These spots were analysed by MALDI-TOF-MS/MS and 79 different proteins were identified. Using principal component analysis we could clearly separate tumor and normal tissue and two distinct tumor groups based on the protein expression pattern. By using a systems biology approach, we could map many of these proteins both into major pathways involved in PCa progression as well as into a group of potential diagnostic and/or prognostic markers. Due to complexity of the highly interconnected shortest pathway network, the functional sub networks revealed some of the potential candidate biomarker proteins for further validation. By using a systems biology approach, our study revealed novel proteins and molecular networks with altered expression in PCa. Further functional validation of individual proteins is ongoing and might provide new insights in PCa progression potentially leading to the design of novel diagnostic and therapeutic strategies.	[Ummanni, Ramesh; Mundt, Frederike; Barett, Christine; Bokemeyer, Carsten; Bruemmendorf, Tim H.; Balabanov, Stefan] Univ Hosp Eppendorf, Hubertus Wald Tumor Zentrum, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany; [Pospisil, Heike] Univ Appl Sci Wildau, Wildau, Germany; [Venz, Simone; Walther, Reinhard] Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany; [Venz, Simone; Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Interfacultary Inst Genet & Funct Genom, Greifswald, Germany; [Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol Head & Neck Surg, Greifswald, Germany; [Faelth, Maria; Sueltmann, Holger] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Koellermann, Jens; Sauter, Guido] Univ Hosp Eppendorf, Dept Pathol, Hamburg, Germany; [Schlomm, Thorsten] Univ Hosp Eppendorf, Prostate Canc Ctr, Hamburg, Germany; Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, Aachen, Germany; [Bruemmendorf, Tim H.] Rhein Westfal TH Aachen, Med Klin Hamatol & Onkol 4, Aachen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Applied Sciences Wildau; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; RWTH Aachen University; RWTH Aachen University	Ummanni, R (corresponding author), Univ Hosp Eppendorf, Hubertus Wald Tumor Zentrum, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany.	s.balabanov@uke.uni-hamburg.de	Sültmann, Holger/E-4534-2013; Pospisil, Heike/G-7377-2016; Balabanov, Stefan/E-9765-2014; Scharf, Christian/A-7931-2011	Sültmann, Holger/0000-0002-5257-8600; Scharf, Christian/0000-0001-6806-6450; Schuppert, Andreas/0000-0003-3783-6605	German Federal Ministry for Education and Research [01GS0890, 01GS0892, 01GS0189]	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry for Education and Research in the framework of the Program for Medical Genome Research (Grants: 01GS0890, 01GS0892, 01GS0189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandro Riccardo, 2005, Clin Colorectal Cancer, V4, P396, DOI 10.3816/CCC.2005.n.012; AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; CERUTTI PA, 1994, LANCET, V344, P862, DOI 10.1016/S0140-6736(94)92832-0; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Gao X, 1997, ADV EXP MED BIOL, V407, P41; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hessels D, 2004, EXPERT REV MOL DIAGN, V4, P513, DOI 10.1586/14737159.4.4.513; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; KILLIAN CS, 1986, J NATL CANCER I, V76, P179; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kumar-Sinha C, 2003, EXPERT REV MOL DIAGN, V3, P459, DOI 10.1586/14737159.3.4.459; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee S, 2002, CANCER LETT, V184, P197, DOI 10.1016/S0304-3835(02)00197-0; Lexander H, 2005, ANAL QUANT CYTOL, V27, P263; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Meehan KL, 2002, PROSTATE, V50, P54, DOI 10.1002/pros.10032; MELLINGER GT, 1967, J UROLOGY, V97, P331, DOI 10.1016/S0022-5347(17)63039-8; Mumenthaler SM, 2008, PROSTATE, V68, P1561, DOI 10.1002/pros.20816; Mumenthaler SM, 2008, INT J ONCOL, V32, P357; Nagy B, 2009, PATHOL ONCOL RES, V15, P279, DOI 10.1007/s12253-008-9077-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ornstein DK, 2000, ELECTROPHORESIS, V21, P2235, DOI 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.3.CO;2-1; Pang J, 2010, J PROTEOME RES, V9, P216, DOI 10.1021/pr900953s; Rotondo R, 2008, INT J CANCER, V123, P1108, DOI 10.1002/ijc.23437; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Russell D H, 1981, Prog Clin Biol Res, V75A, P207; SCARDINO PT, 1989, UROL CLIN N AM, V16, P635; Sciavolino PJ, 1998, ANN MED, V30, P357, DOI 10.3109/07853899809029935; Solassol K, 2005, ANAL BIOCHEM, V338, P26, DOI 10.1016/j.ab.2004.11.031; Tabib A, 1999, INT J BIOCHEM CELL B, V31, P1289, DOI 10.1016/S1357-2725(99)00098-9; Ummanni R, 2008, CANCER LETT, V266, P171, DOI 10.1016/j.canlet.2008.02.047	46	55	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16833	10.1371/journal.pone.0016833	http://dx.doi.org/10.1371/journal.pone.0016833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347291	Green Published, gold, Green Submitted			2022-12-25	WOS:000287364500008
J	Zhang, HQ; Cao, HJ; Kimelberg, HK; Zhou, M				Zhang, Huaqiu; Cao, H. James; Kimelberg, Harold K.; Zhou, Min			Volume Regulated Anion Channel Currents of Rat Hippocampal Neurons and Their Contribution to Oxygen-and-Glucose Deprivation Induced Neuronal Death	PLOS ONE			English	Article							SENSITIVE CHLORIDE CHANNELS; EXCITATORY AMINO-ACIDS; SIMULATED ISCHEMIA; CEREBRAL-ISCHEMIA; AREA CA1; RELEASE; TAMOXIFEN; GLUTAMATE; GABA; NEUROPROTECTION	Volume-regulated anion channels (VRAC) are widely expressed chloride channels that are critical for the cell volume regulation. In the mammalian central nervous system, the physiological expression of neuronal VRAC and its role in cerebral ischemia are issues largely unknown. We show that hypoosmotic medium induce an outwardly rectifying chloride conductance in CA1 pyramidal neurons in rat hippocampal slices. The induced chloride conductance was sensitive to some of the VRAC inhibitors, namely, IAA-94 (300 mu M) and NPPB (100 mu M), but not to tamoxifen (10 mu M). Using oxygen-andglucose deprivation (OGD) to simulate ischemic conditions in slices, VRAC activation appeared after OGD induced anoxic depolarization (AD) that showed a progressive increase in current amplitude over the period of post-OGD reperfusion. The OGD induced VRAC currents were significantly inhibited by inhibitors for glutamate AMPA (30 mu M NBQX) and NMDA (40 mu M AP-5) receptors in the OGD solution, supporting the view that induction of AD requires an excessive Na+-loading via these receptors that in turn to activate neuronal VRAC. In the presence of NPPB and DCPIB in the post-OGD reperfusion solution, the OGD induced CA1 pyramidal neuron death, as measured by TO-PRO-3-I staining, was significantly reduced, although DCPIB did not appear to be an effective neuronal VRAC blocker. Altogether, we show that rat hippocampal pyramidal neurons express functional VRAC, and ischemic conditions can initial neuronal VRAC activation that may contribute to ischemic neuronal damage.	[Zhang, Huaqiu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430074, Peoples R China; [Cao, H. James; Kimelberg, Harold K.; Zhou, Min] Ordway Res Inst, Albany, NY USA	Huazhong University of Science & Technology; Ordway Research Institute	Zhang, HQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430074, Peoples R China.	zhanghq_04@yahoo.com; mzhou@ordwayresearch.org		Zhou, Min/0000-0001-6249-2977	Charitable Leadership Foundation, Latham; National Science Foundation [ISO-0641828]; National Institutes of Health [RO1NS35205]; National Natural Science Foundation of China for Young Scholars [3090049]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035205] Funding Source: NIH RePORTER	Charitable Leadership Foundation, Latham; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an endowment created at Ordway Research Institute by M. Frank and Margaret Domiter Rudy, grants from Charitable Leadership Foundation, Latham (to HKK and MZ), National Science Foundation (ISO-0641828 to MZ), National Institutes of Health RO1NS35205 (to HKK) and National Natural Science Foundation of China for Young Scholars (3090049 to HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Allen NJ, 2004, J PHYSIOL-LONDON, V561, P485, DOI 10.1113/jphysiol.2004.070490; Allen NJ, 2004, J NEUROSCI, V24, P3837, DOI 10.1523/JNEUROSCI.5539-03.2004; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Barros LF, 2001, COMP BIOCHEM PHYS A, V130, P401, DOI 10.1016/S1095-6433(01)00438-X; Britton FC, 2000, AM J PHYSIOL-HEART C, V279, pH2225, DOI 10.1152/ajpheart.2000.279.5.H2225; Churchwell KB, 1996, J NEUROSCI, V16, P7447; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Eggermont J, 2001, CELL BIOCHEM BIOPHYS, V35, P263, DOI 10.1385/CBB:35:3:263; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; Haskew-Layton RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003543; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; Inoue H, 2007, J NEUROSCI RES, V85, P1427, DOI 10.1002/jnr.21279; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Leaney JL, 1997, J PHYSIOL-LONDON, V501, P555, DOI 10.1111/j.1469-7793.1997.555bm.x; Li GZ, 2004, NEUROCHEM RES, V29, P239, DOI 10.1023/B:NERE.0000010452.26022.a7; MCGILL JM, 1992, AM J PHYSIOL, V262, pG703, DOI 10.1152/ajpgi.1992.262.4.G703; Nilius B, 1998, PFLUG ARCH EUR J PHY, V436, P742, DOI 10.1007/s004240050697; Nilius B, 2000, CELL PHYSIOL BIOCHEM, V10, P313, DOI 10.1159/000016364; Nilius B, 1996, GEN PHARMACOL-VASC S, V27, P1131, DOI 10.1016/S0306-3623(96)00061-4; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 2004, CELL BIOCHEM BIOPHYS, V41, P233, DOI 10.1385/CBB:41:2:233; Okada Y, 2004, PFLUG ARCH EUR J PHY, V448, P287, DOI 10.1007/s00424-004-1276-3; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Patel AJ, 1998, J NEUROSCI, V18, P3117; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Phillis JW, 1998, BRAIN RES, V780, P352, DOI 10.1016/S0006-8993(97)01352-8; Phillis JW, 1997, BRAIN RES, V758, P9, DOI 10.1016/S0006-8993(97)00155-8; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Rasband W, IMAGEJ; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; VANHOOIJDONK CAEM, 1994, CYTOMETRY, V17, P185, DOI 10.1002/cyto.990170212; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Xie MJ, 2008, J CEREBR BLOOD F MET, V28, P456, DOI 10.1038/sj.jcbfm.9600545; Zhang HQ, 2008, EXP NEUROL, V212, P44, DOI 10.1016/j.expneurol.2008.03.006; Zhang HQ, 2009, BRAIN RES, V1247, P196, DOI 10.1016/j.brainres.2008.10.015; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	52	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16803	10.1371/journal.pone.0016803	http://dx.doi.org/10.1371/journal.pone.0016803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347298	gold, Green Submitted, Green Published			2022-12-25	WOS:000287364500007
J	Powell, ML; Leigh, KE; Poyry, TAA; Jackson, RJ; Brown, TDK; Brierley, I				Powell, Michael L.; Leigh, Kendra E.; Poeyry, Tuija A. A.; Jackson, Richard J.; Brown, T. David K.; Brierley, Ian			Further Characterisation of the Translational Termination-Reinitiation Signal of the Influenza B Virus Segment 7 RNA	PLOS ONE			English	Article							OPEN READING FRAME; 18S RIBOSOMAL-RNA; MESSENGER-RNA; INITIATION; SEQUENCE; EXPRESSION; MECHANISM; PROTEIN; CALICIVIRUS; EFFICIENCY	Termination-dependent reinitiation is used to co-ordinately regulate expression of the M1 and BM2 open-reading frames (ORFs) of the dicistronic influenza B segment 7 RNA. The start codon of the BM2 ORF overlaps the stop codon of the M1 ORF in the pentanucleotide UAAUG and similar to 10% of ribosomes terminating at the M1 stop codon reinitiate translation at the overlapping AUG. BM2 synthesis requires the presence of, and translation through, 45 nt of RNA immediately upstream of the UAAUG, known as the 'termination upstream ribosome binding site' (TURBS). This region may tether ribosomal 40S subunits to the mRNA following termination and a short region of the TURBS, motif 1, with complementarity to helix 26 of 18S rRNA has been implicated in this process. Here, we provide further evidence for a direct interaction between mRNA and rRNA using antisense oligonucleotide targeting and functional analysis in yeast cells. The TURBS also binds initiation factor eIF3 and we show here that this protein stimulates reinitiation from both wild-type and defective TURBS when added exogenously, perhaps by stabilising ribosome-mRNA interactions. Further, we show that the position of the TURBS with respect to the UAAUG overlap is crucial, and that termination too far downstream of the 18S complementary sequence inhibits the process, probably due to reduced 40S tethering. However, in reporter mRNAs where the restart codon alone is moved downstream, termination-reinitiation is inhibited but not abolished, thus the site of reinitiation is somewhat flexible. Reinitiation on distant AUGs is not inhibited in eIF4G-depleted RRL, suggesting that the tethered 40S subunit can move some distance without a requirement for linear scanning.	[Powell, Michael L.; Leigh, Kendra E.; Brown, T. David K.; Brierley, Ian] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Poeyry, Tuija A. A.; Jackson, Richard J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QP, England	University of Cambridge; University of Cambridge	Powell, ML (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	mlp34@cam.ac.uk		Leigh, Kendra/0000-0002-6467-3330	Biotechnology and Biological Sciences Research Council [BB/C007034/1]; Biotechnology and Biological Sciences Research Council [BB/D008190/1] Funding Source: researchfish; BBSRC [BB/C007034/1, BB/D008190/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) grant BB/C007034/1 awarded to RJJ, TDKB, and IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Ahmadian G, 2000, EMBO J, V19, P2681, DOI 10.1093/emboj/19.11.2681; Ali IK, 2001, EMBO J, V20, P4233, DOI 10.1093/emboj/20.15.4233; Baranov PV, 2006, TRENDS GENET, V22, P174, DOI 10.1016/j.tig.2006.01.005; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; BRIEDIS DJ, 1982, VIROLOGY, V116, P581, DOI 10.1016/0042-6822(82)90150-7; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2004, P NATL ACAD SCI USA, V101, P9590, DOI 10.1073/pnas.0308759101; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Girnary R, 2007, J GEN VIROL, V88, P226, DOI 10.1099/vir.0.82064-0; Grentzmann G, 1998, RNA, V4, P479; HIEBERT SW, 1986, VIROLOGY, V155, P747, DOI 10.1016/0042-6822(86)90237-0; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Hu MCY, 1999, P NATL ACAD SCI USA, V96, P1339, DOI 10.1073/pnas.96.4.1339; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; McCormick CJ, 2008, J VIROL, V82, P8917, DOI 10.1128/JVI.02362-07; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; Meyers G, 2007, J VIROL, V81, P9623, DOI 10.1128/JVI.00771-07; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Napthine S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008390; NYGARD O, 1982, NUCLEIC ACIDS RES, V10, P1327, DOI 10.1093/nar/10.4.1327; Panopoulos P, 2008, J BIOL CHEM, V283, P33087, DOI 10.1074/jbc.M804904200; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAVLAKIS G N, 1990, New Biologist, V2, P20; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Powell ML, 2008, RNA, V14, P2394, DOI 10.1261/rna.1231008; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000	41	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16822	10.1371/journal.pone.0016822	http://dx.doi.org/10.1371/journal.pone.0016822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347434	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600031
J	Weigelt, B; Warne, PH; Downward, J				Weigelt, B.; Warne, P. H.; Downward, J.			PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs	ONCOGENE			English	Article						PIK3CA; PTEN; mTOR; everolimus; PP242; breast cancer	DUAL PI3K/MTOR INHIBITOR; MAMMALIAN PROTEIN; HIGH-FREQUENCY; PHASE-II; PATHWAY; PI3K; GENE; KINASE; GROWTH; TEMSIROLIMUS	The phosphatidylinositol 3-kinase (PI3K) pathway is commonly activated in breast cancers due to frequent mutations in PIK3CA, loss of expression of PTEN or over-expression of receptor tyrosine kinases. PI3K pathway activation leads to stimulation of the key growth and proliferation regulatory kinase mammalian target of rapamycin (mTOR), which can be inhibited by rapamycin analogues and by kinase inhibitors; the effectiveness of these drugs in breast cancer treatment is currently being tested in clinical trials. To identify the molecular determinants of response to inhibitors that target mTOR via different mechanisms in breast cancer cells, we investigated the effects of pharmacological inhibition of mTOR using the allosteric mTORC1 inhibitor everolimus and the active-site mTORC1/mTORC2 kinase inhibitor PP242 on a panel of 31 breast cancer cell lines. We demonstrate here that breast cancer cells harbouring PIK3CA mutations are selectively sensitive to mTOR allosteric and kinase inhibitors. However, cells with PTEN loss of function are not sensitive to these drugs, suggesting that the functional consequences of these two mechanisms of activation of the mTOR pathway are quite distinct. In addition, a subset of HER2-amplified cell lines showed increased sensitivity to PP242, but not to everolimus, irrespective of the PIK3CA/PTEN status. These selective sensitivities were confirmed in more physiologically relevant three-dimensional cell culture models. Our findings provide a rationale to guide selection of breast cancer patients who may benefit from mTOR inhibitor therapy and highlight the importance of accurately assessing the expression of PTEN protein and not just its mutational status. Oncogene (2011) 30, 3222-3233; doi:10.1038/onc.2011.42; published online 28 February 2011	[Weigelt, B.; Warne, P. H.; Downward, J.] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3PX, England	Cancer Research UK	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julian.downward@cancer.org.uk	Downward, Julian/A-3251-2012	Downward, Julian/0000-0002-2331-4729	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank Miriam Molina Arcas, Ralph Fritsch, Elza de Bruin, Charles Swanton (CRUK London Research Institute) and Maryou Lambros and Jorge Reis-Filho (Breakthrough Breast Cancer Centre, London, UK) for helpful discussions, technical advice or critical reading of the manuscript, members of the LRI Equipment Park for sequencing and of the LRI FACS facility for cell-cycle analysis. We thank Morri Feldman and Kevan Shokat (UCSF) for providing PP242. This work was funded by Cancer Research UK.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Atkins MB, 2009, NAT REV DRUG DISCOV, V8, P535, DOI 10.1038/nrd2924; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Cobleigh MA, 2003, SEMIN ONCOL, V30, P117, DOI 10.1053/j.seminoncol.2003.08.013; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Ellard SL, 2009, J CLIN ONCOL, V27, P4536, DOI 10.1200/JCO.2008.21.3033; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; FORBES SA, 2008, CURR PROTOC HUM GE S, V57; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Kwitkowski VE, 2010, ONCOLOGIST, V15, P428, DOI 10.1634/theoncologist.2009-0178; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Pallares J, 2005, MODERN PATHOL, V18, P719, DOI 10.1038/modpathol.3800347; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Roidl A, 2010, ONCOGENE, V29, P1543, DOI 10.1038/onc.2009.432; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tomlinson GE, 1998, CANCER RES, V58, P3237; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	63	148	154	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	29					3222	3233		10.1038/onc.2011.42	http://dx.doi.org/10.1038/onc.2011.42			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	795VW	21358673				2022-12-25	WOS:000293006800002
J	Broser, M; Glockner, C; Gabdulkhakov, A; Guskov, A; Buchta, J; Kern, J; Muh, F; Dau, H; Saenger, W; Zouni, A				Broser, Matthias; Gloeckner, Carina; Gabdulkhakov, Azat; Guskov, Albert; Buchta, Joachim; Kern, Jan; Mueh, Frank; Dau, Holger; Saenger, Wolfram; Zouni, Athina			Structural Basis of Cyanobacterial Photosystem II Inhibition by the Herbicide Terbutryn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION-CENTER; OXYGEN-EVOLVING COMPLEX; RHODOPSEUDOMONAS-VIRIDIS; ELECTRON-TRANSFER; BINDING NICHE; MODEL; CHLORIDE; RESISTANCE; ENERGETICS; RESOLUTION	Herbicides that target photosystem II (PSII) compete with the native electron acceptor plastoquinone for binding at the Q(B) site in the D1 subunit and thus block the electron transfer from Q(A) to Q(B). Here, we present the first crystal structure of PSII with a bound herbicide at a resolution of 3.2 angstrom. The crystallized PSII core complexes were isolated from the thermophilic cyanobacterium Thermosynechococcus elongatus. The used herbicide terbutryn is found to bind via at least two hydrogen bonds to the Q(B) site similar to photosynthetic reaction centers in anoxygenic purple bacteria. Herbicide binding to PSII is also discussed regarding the influence on the redox potential of Q(A), which is known to affect photoinhibition. We further identified a second and novel chloride position close to the water-oxidizing complex and in the vicinity of the chloride ion reported earlier (Guskov, A., Kern, J., Gabdulkhakov, A., Broser, M., Zouni, A., and Saenger, W. (2009) Nat. Struct. Mol. Biol. 16, 334-342). This discovery is discussed in the context of proton transfer to the lumen.	[Gabdulkhakov, Azat; Guskov, Albert; Saenger, Wolfram] Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; [Broser, Matthias; Gloeckner, Carina; Kern, Jan; Mueh, Frank; Zouni, Athina] Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; [Buchta, Joachim; Dau, Holger] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany	Free University of Berlin; Technical University of Berlin; Free University of Berlin	Saenger, W (corresponding author), Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany.	saenger@chemie.fu-berlin.de; athina.zouni@tu-berlin.de	Guskov, Albert/G-1286-2016; Gabdulkhakov, Azat/H-4343-2013; Kern, Jan/G-2586-2013	Guskov, Albert/0000-0003-2340-2216; Gabdulkhakov, Azat/0000-0003-1016-5936; Dau, Holger/0000-0001-6482-7494; Kern, Jan/0000-0002-7272-1603	Deutsche Forschungsgemeinschaft [Sfb 498, A4, C6, C7]; center of excellence on Unifying Concepts in Catalysis [B1]; Russian Academy of Science on Molecular and Cellular Biology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); center of excellence on Unifying Concepts in Catalysis; Russian Academy of Science on Molecular and Cellular Biology	This work was supported by the Deutsche Forschungsgemeinschaft within the framework of Sfb 498 (projects A4, C6, and C7) and the center of excellence on Unifying Concepts in Catalysis (UniCat, project B1), coordinated by the Technische Universitat Berlin. The crystallographic part of this work was supported in part by the Program of the Russian Academy of Science on Molecular and Cellular Biology.	AJLANI G, 1989, PLANT MOL BIOL, V13, P469, DOI 10.1007/BF00027307; Barber J, 2004, PHYS CHEM CHEM PHYS, V6, P4737, DOI 10.1039/b407981g; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchta J, 2007, BBA-BIOENERGETICS, V1767, P565, DOI 10.1016/j.bbabio.2007.04.003; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; EGNER U, 1993, BIOCHIM BIOPHYS ACTA, V1142, P106, DOI 10.1016/0005-2728(93)90091-S; EGNER U, 1992, EUR J BIOCHEM, V206, P685, DOI 10.1111/j.1432-1033.1992.tb16974.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabdulkhakov A, 2009, STRUCTURE, V17, P1223, DOI 10.1016/j.str.2009.07.010; GLEITER HM, 1993, PHOTOSYNTH RES, V35, P41, DOI 10.1007/BF02185410; Grabolle M, 2005, BBA-BIOENERGETICS, V1708, P209, DOI 10.1016/j.bbabio.2005.03.007; Guskov A, 2010, CHEMPHYSCHEM, V11, P1160, DOI 10.1002/cphc.200900901; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HIRSCHBERG J, 1983, SCIENCE, V222, P1346, DOI 10.1126/science.222.4630.1346; Ishikita H, 2006, BIOCHEMISTRY-US, V45, P2063, DOI 10.1021/bi051615h; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Katona G, 2005, NAT STRUCT MOL BIOL, V12, P630, DOI 10.1038/nsmb948; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; Krieger-Liszkay A, 1998, BIOCHEMISTRY-US, V37, P17339, DOI 10.1021/bi9822628; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Krivanek R, 2007, BBA-BIOENERGETICS, V1767, P520, DOI 10.1016/j.bbabio.2007.02.013; Lancaster CRD, 1999, J MOL BIOL, V286, P883, DOI 10.1006/jmbi.1998.2532; Lancaster CRD, 2000, J BIOL CHEM, V275, P39364, DOI 10.1074/jbc.M008225200; Lancaster CRD, 2008, PRIMARY PROCESSES 2, P5, DOI 10.1039/9781847558169-00005; Lindberg K, 1996, BIOCHEMISTRY-US, V35, P14259, DOI 10.1021/bi961244s; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; Oettmeier W, 1999, CELL MOL LIFE SCI, V55, P1255, DOI 10.1007/s000180050370; OETTMEIER W, 1992, TOPICS PHOTOSYNTHESI, V11, P349; Olesen K, 2003, BIOCHEMISTRY-US, V42, P2025, DOI 10.1021/bi026175y; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Reifler MJ, 2001, J MOL RECOGNIT, V14, P157, DOI 10.1002/jmr.529; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Renger G., 2008, PRIMARY PROCESSES 2, P57, DOI [10.1039/9781847558169-00057, DOI 10.1039/9781847558169-00057]; Renger G, 2008, PRIMARY PROCESSES 2, P237; Renger G, 2007, PHOTOSYNTH RES, V92, P407, DOI 10.1007/s11120-007-9185-x; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; SOBOLEV V, 1995, PROTEINS, V21, P214, DOI 10.1002/prot.340210304; Sproviero EM, 2007, CURR OPIN STRUC BIOL, V17, P173, DOI 10.1016/j.sbi.2007.03.015; Takahashi R, 2010, BIOCHEMISTRY-US, V49, P5445, DOI 10.1021/bi100639q; Takahashi R, 2009, BIOCHEMISTRY-US, V48, P8994, DOI 10.1021/bi901195e; Takano A, 2008, PHOTOSYNTH RES, V98, P159, DOI 10.1007/s11120-008-9302-5; TIETJEN KG, 1991, PESTIC SCI, V31, P65, DOI 10.1002/ps.2780310108; TREBST A, 1987, Z NATURFORSCH C, V42, P742; Trebst A, 2007, PHOTOSYNTH RES, V92, P217, DOI 10.1007/s11120-007-9213-x; vanVliet P, 1996, BIOCHEMISTRY-US, V35, P1829, DOI 10.1021/bi9514471; Wydrzynski T. J., 2005, PHOTOSYSTEM; Zimmermann K, 2006, BBA-BIOENERGETICS, V1757, P106, DOI 10.1016/j.bbabio.2005.12.002; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	59	64	86	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.215970	http://dx.doi.org/10.1074/jbc.M110.215970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21367867	Green Published, hybrid			2022-12-25	WOS:000290022800036
J	Fuhs, SR; Insel, PA				Fuhs, Stephen R.; Insel, Paul A.			Caveolin-3 Undergoes SUMOylation by the SUMO E3 Ligase PIASy SUMOYLATION AFFECTS G-PROTEIN-COUPLED RECEPTOR DESENSITIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN BETA(1)-ADRENERGIC RECEPTOR; TYROSINE-PHOSPHATASE 1B; SKELETAL-MUSCLE CELLS; ESCHERICHIA-COLI; ADENYLYL-CYCLASE; LIPID RAFTS; BETA(2)-ADRENERGIC RECEPTOR; CARDIAC MYOCYTES; NUCLEAR EXPORT	Caveolin (Cav) proteins in the plasma membrane have numerous binding partners, but the determinants of these interactions are poorly understood. We show here that Cav-3 has a small ubiquitin-like modifier (SUMO) consensus motif (psi KX(D/E, where psi is a hydrophobic residue)) near the scaffolding domain and that Cav-3 is SUMOylated in a manner that is enhanced by the SUMO E3 ligase PIASy (protein inhibitor of activated STAT-y). Site-directed mutagenesis revealed that the consensus site lysine is the preferred SUMOylation site but that mutation of all lysines is required to abolish SUMOylation. Co-expression of a SUMOylation-deficient mutant of Cav-3 with beta-adrenergic receptors (beta ARs) alters the expression level of beta(2)ARs but not beta(1)ARs following agonist stimulation, thus implicating Cav-3 SUMOylation in the mechanisms for beta(2)AR but not beta(1)AR desensitization. Expression of endothelial nitric-oxide synthase (NOS3) was not altered by the SUMOylation-deficient mutant. Thus, SUMOylation is a covalent modification of caveolins that influence the regulation of certain signaling partners.	[Insel, Paul A.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	pinsel@ucsd.edu			National Institutes of Health [HL091071, GM066232, HL066941]; University of California at San Diego; Molecular Pharmacology through NIGMS, National Institutes of Health [T32 GM007752]; PhRMA Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, P01HL066941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at San Diego; Molecular Pharmacology through NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PhRMA Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091071, GM066232, and HL066941 (to P.A.I.).; Supported in part by the University of California at San Diego Graduate Training Program in Cellular and Molecular Pharmacology through NIGMS, National Institutes of Health, Grant T32 GM007752 as well as a PhRMA Foundation predoctoral fellowship in pharmacology/toxicology.	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Conrotto P, 2007, J PROTEOME RES, V6, P287, DOI 10.1021/pr060427q; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; De Arcangelis V, 2009, J BIOL CHEM, V284, P33824, DOI 10.1074/jbc.M109.020388; DIBNER MD, 1981, J BIOL CHEM, V256, P7343; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; Imoto S, 2008, BIOCHEM BIOPH RES CO, V370, P359, DOI 10.1016/j.bbrc.2008.03.116; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Lamb ME, 2002, BIOCHEMISTRY-US, V41, P14340, DOI 10.1021/bi020231d; Lee H, 2006, BIOCHEMISTRY-US, V45, P234, DOI 10.1021/bi051560j; Li X, 2010, BIOCHEM J, V428, P55, DOI 10.1042/BJ20091672; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Meek DW, 2003, MOL CANCER RES, V1, P1017; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Ostrom RS, 2004, J BIOL CHEM, V279, P19846, DOI 10.1074/jbc.M313440200; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Rodriguez-Munoz M, 2007, NEUROPSYCHOPHARMACOL, V32, P842, DOI 10.1038/sj.npp.1301184; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; Saitoh Hisato, 2009, V497, P211, DOI 10.1007/978-1-59745-566-4_14; Santibanez JF, 2008, CARDIOVASC RES, V77, P791, DOI 10.1093/cvr/cvm097; Scheschonka A, 2007, TRENDS NEUROSCI, V30, P85, DOI 10.1016/j.tins.2007.01.003; Schwartz EA, 2005, BIOCHEM J, V390, P199, DOI 10.1042/BJ20041182; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Smythe GM, 2003, J CELL SCI, V116, P4739, DOI 10.1242/jcs.00806; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383	61	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14830	14841		10.1074/jbc.M110.214270	http://dx.doi.org/10.1074/jbc.M110.214270			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21362625	hybrid, Green Published			2022-12-25	WOS:000289788300013
J	Qu, XX; Carbe, C; Tao, CQ; Powers, A; Lawrence, R; van Kuppevelt, TH; Cardoso, WV; Grobe, K; Esko, JD; Zhang, X				Qu, Xiuxia; Carbe, Christian; Tao, Chenqi; Powers, Andrea; Lawrence, Roger; van Kuppevelt, Toin H.; Cardoso, Wellington V.; Grobe, Kay; Esko, Jeffrey D.; Zhang, Xin			Lacrimal Gland Development and Fgf10-Fgfr2b Signaling Are Controlled by 2-O- and 6-O-sulfated Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITES; FGF; MICE; OLIGOSACCHARIDES; PROTEOGLYCANS; ANTIBODIES; PROTEINS; COMPLEX; ROLES; MOUSE	Heparan sulfate, an extensively sulfated glycosaminoglycan abundant on cell surface proteoglycans, regulates intercellular signaling through its binding to various growth factors and receptors. In the lacrimal gland, branching morphogenesis depends on the interaction of heparan sulfate with Fgf10-Fgfr2b. To address if lacrimal gland development and FGF signaling depends on 2-O-sulfation of uronic acids and 6-O-sulfation of glucosamine residues, we genetically ablated heparan sulfate 2-O and 6-O sulfotransferases (Hs2st, Hs6st1, and Hs6st2) in developing lacrimal gland. Using a panel of phage display antibodies, we confirmed that these mutations disrupted 2-O and/or 6-O but not N-sulfation of heparan sulfate. The Hs6st mutants exhibited significant lacrimal gland hypoplasia and a strong genetic interaction with Fgf10, demonstrating the importance of heparan sulfate 6-O sulfation in lacrimal gland FGF signaling. Altering Hs2st caused a much less severe phenotype, but the Hs2st;Hs6st double mutants completely abolished lacrimal gland development, suggesting that both 2-O and 6-O sulfation of heparan sulfate contribute to FGF signaling. Combined Hs2st; Hs6st deficiency synergistically disrupted the formation of Fgf10-Fgfr2b-heparan sulfate complex on the cell surface and prevented lacrimal gland induction by Fgf10 in explant cultures. Importantly, the Hs2st;Hs6st double mutants abrogated FGF downstream ERK signaling. Therefore, Fgf10-Fgfr2b signaling during lacrimal gland development is sensitive to the content or arrangement of O-sulfate groups in heparan sulfate. To our knowledge, this is the first study to show that simultaneous deletion of Hs2st and Hs6st exhibits profound FGF signaling defects in mammalian development.	[Qu, Xiuxia; Carbe, Christian; Tao, Chenqi; Powers, Andrea; Zhang, Xin] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Cardoso, Wellington V.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Grobe, Kay] Univ Munster, D-48149 Munster, Germany; [Lawrence, Roger; Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Indiana University System; Indiana University Bloomington; Radboud University Nijmegen; Boston University; University of Munster; University of California System; University of California San Diego	Zhang, X (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	xz4@iupui.edu	van Kuppevelt, A.H.M.S.M./L-4463-2015; Grobe, Kay/F-2399-2011	Cardoso, Wellington/0000-0002-2550-3697	National Institutes of Health [EY018868, GM33063, GM93131]; Ralph W. and Grace M. Showalter Research Trust; NATIONAL EYE INSTITUTE [R01EY018868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093131, R37GM033063, R01GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018868 (to X.Z.) and GM33063 and GM93131 (to J.D.E.). This work was also supported by the Ralph W. and Grace M. Showalter Research Trust Fund (to X.Z.).	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Cai ZG, 2010, J NEUROSCI, V30, P4110, DOI 10.1523/JNEUROSCI.4364-09.2010; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Govindarajan V, 2000, DEV BIOL, V225, P188, DOI 10.1006/dbio.2000.9812; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Izvolsky KI, 2008, GENESIS, V46, P8, DOI 10.1002/dvg.20355; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Nagai N, 2007, J BIOL CHEM, V282, P14942, DOI 10.1074/jbc.M610691200; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pan Y, 2010, DEVELOPMENT, V137, P1085, DOI 10.1242/dev.042820; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Sedita J, 2004, DEV DYNAM, V231, P782, DOI 10.1002/dvdy.20173; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200	47	60	60	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14435	14444		10.1074/jbc.M111.225003	http://dx.doi.org/10.1074/jbc.M111.225003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357686	hybrid, Green Published			2022-12-25	WOS:000289556200065
J	Sagane, K; Umemura, M; Ogawa-Mitsuhashi, K; Tsukahara, K; Yoko-o, T; Jigami, Y				Sagane, Koji; Umemura, Mariko; Ogawa-Mitsuhashi, Kaoru; Tsukahara, Kappei; Yoko-o, Takehiko; Jigami, Yoshifumi			Analysis of Membrane Topology and Identification of Essential Residues for the Yeast Endoplasmic Reticulum Inositol Acyltransferase Gwt1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR BIOSYNTHESIS; ACYL-COENZYME-A; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; PROTEINS; ACYLATION; ER; PALMITOYLTRANSFERASE; MUTAGENESIS; EXPRESSION	Glycosylphosphatidylinositol (GPI) is a post-translational modification that anchors cell surface proteins to the plasma membrane, and GPI modifications occur in all eukaryotes. Biosynthesis of GPI starts on the cytoplasmic face of the endoplasmic reticulum (ER) membrane, and GPI precursors flip from the cytoplasmic side to the luminal side of the ER, where biosynthesis of GPI precursors is completed. Gwt1p and PIG-W are inositol acyltransferases that transfer fatty acyl chains to the inositol moiety of GPI precursors in yeast and mammalian cells, respectively. To ascertain whether flipping across the ER membrane occurs before or after inositol acylation of GPI precursors, we identified essential residues of PIG-W and Gwt1p and determined the membrane topology of Gwt1p. Guided by algorithm-based predictions of membrane topology, we experimentally identified 13 transmembrane domains in Gwt1p. We found that Gwt1p, PIG-W, and their orthologs shared four conserved regions and that these four regions in Gwt1p faced the luminal side of the ER membrane. Moreover, essential residues of Gwt1p and PIG-W faced the ER lumen or were near the luminal edge of transmembrane domains. The membrane topology of Gwt1p suggested that inositol acylation occurred on the luminal side of the ER membrane. Rather than stimulate flipping of the GPI precursor across the ER membrane, inositol acylation of GPI precursors may anchor the precursors to the luminal side of the ER membrane, preventing flip-flops.	[Tsukahara, Kappei] Eisai & Co Ltd, Next Generat Syst Core Funct Unit, Eisai Prod Creat Syst, Tsukuba, Ibaraki 3002635, Japan; [Umemura, Mariko; Yoko-o, Takehiko; Jigami, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Higashi Ku, Tsukuba, Ibaraki 3058566, Japan; [Umemura, Mariko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan	Eisai Co Ltd; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Pharmacy & Life Sciences	Tsukahara, K (corresponding author), Eisai & Co Ltd, Next Generat Syst Core Funct Unit, Eisai Prod Creat Syst, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	k-tsukahara@hhc.eisai.co.jp; t.yoko-o@aist.go.jp	Yoko-o, Takehiko/L-7093-2018	Yoko-o, Takehiko/0000-0003-0291-8299; Sagane, Koji/0000-0001-5814-3037				Abe H, 2003, GLYCOBIOLOGY, V13, P87, DOI 10.1093/glycob/cwg014; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Caro LHP, 1997, YEAST, V13, P1477, DOI 10.1002/(SICI)1097-0061(199712)13:15<1477::AID-YEA184>3.0.CO;2-L; Chen R, 1998, P NATL ACAD SCI USA, V95, P9512, DOI 10.1073/pnas.95.16.9512; COSTELLO LC, 1992, J BIOL CHEM, V267, P8599; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; Guo ZM, 2001, J LIPID RES, V42, P1282; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; HIROSE S, 1992, J BIOL CHEM, V267, P5272; HYMAN R, 1988, TRENDS GENET, V4, P5, DOI 10.1016/0168-9525(88)90120-5; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; KINOSHITA T, 2000, BIOCHIM BIOPHYS ACTA, V4, P405; LEIDICH SD, 1994, J BIOL CHEM, V269, P10193; Lu XH, 2002, J BIOL CHEM, V277, P711, DOI 10.1074/jbc.M109427200; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Murakami Y, 2003, MOL BIOL CELL, V14, P4285, DOI 10.1091/mbc.E03-03-0193; Nakamoto K, 2010, BIOORG MED CHEM LETT, V20, P4624, DOI 10.1016/j.bmcl.2010.06.005; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Ogawa-Mitsuhashi K, 2009, YEAST, V26, P587, DOI 10.1002/yea.1708; Okamoto M, 2006, J BIOL CHEM, V281, P4013, DOI 10.1074/jbc.M504684200; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; SIKORSKI RS, 1989, GENETICS, V122, P19; SIPOS G, 1994, EMBO J, V13, P2789, DOI 10.1002/j.1460-2075.1994.tb06572.x; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Treber M, 2003, J BIOL CHEM, V278, P11145, DOI 10.1074/jbc.M210566200; Tsukahara K, 2003, MOL MICROBIOL, V48, P1029, DOI 10.1046/j.1365-2958.2003.03481.x; Umemura M, 2003, J BIOL CHEM, V278, P23639, DOI 10.1074/jbc.M301044200; URAKAZE M, 1992, J BIOL CHEM, V267, P6459; VIDUGIRIENE J, 1993, J CELL BIOL, V121, P987, DOI 10.1083/jcb.121.5.987; Vishwakarma RA, 2005, CHEM COMMUN, P453, DOI 10.1039/b413196g; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Watanabe R, 1996, J BIOL CHEM, V271, P26868, DOI 10.1074/jbc.271.43.26868	38	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14649	14658		10.1074/jbc.M110.193490	http://dx.doi.org/10.1074/jbc.M110.193490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367863	hybrid, Green Published			2022-12-25	WOS:000289556200084
J	Trusca, VG; Fuior, EV; Florea, IC; Kardassis, D; Simionescu, M; Gafencu, AV				Trusca, Violeta Georgeta; Fuior, Elena Valeria; Florea, Irina Cristina; Kardassis, Dimitris; Simionescu, Maya; Gafencu, Anca Violeta			Macrophage-specific Up-regulation of Apolipoprotein E Gene Expression by STAT1 Is Achieved via Long Range Genomic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; BONE-MARROW-TRANSPLANTATION; HIGH-DENSITY LIPOPROTEIN; TRANSGENIC MICE; APOE GENE; IN-VIVO; C-I; III HYPERLIPOPROTEINEMIA; CONTROL REGION; LDL RECEPTOR	In atherogenesis, macrophage-derived apolipoprotein E (apoE) has an athero-protective role by a mechanism that is not fully understood. We investigated the regulatory mechanisms involved in the modulation of apoE expression in macrophages. The experiments showed that the promoters of all genes of the apoE/apoCI/apoCIV/apoCII gene cluster are enhanced by multienhancer 2 (ME. 2), a regulatory region that is located 15.9 kb downstream of the apoE gene. ME. 2 interacts with the apoE promoter in a macrophage-specific manner. Transient transfections in RAW 264.7 macrophages showed that the activity of ME. 2 was strongly decreased by deletion of either 87 bp from the 5' end or 131 bp from the 3' end. We determined that the minimal fragment of this promoter that can be activated by ME. 2 is the proximal -100/+73 region. The analysis of the deletion mutants of ME. 2 revealed the importance of the 5' end of ME.2 in apoE promoter transactivation. Chromatin conformational capture assays demonstrated that both ME. 2 and ME. 1 physically interacted with the apoE promoter in macrophages. Our data showed that phorbol 12-myristate 13-acetate-induced differentiation of macrophages is accompanied by a robust induction of apoE and STAT1 expression. In macrophages (but not in hepatocytes), STAT1 up-regulated apoE gene expression via ME.2. The STAT1 binding site was located in the 174-182 region of ME.2. In conclusion, the specificity of the interactions between the two multienhancers (ME.1 and ME.2) and the apoE promoter indicates that these distal regulatory elements play an important role in the modulation of apoE gene expression in a cell-specific manner.	[Gafencu, Anca Violeta] Acad Romana, Inst Cellular Biol & Pathol, Sector 5, Bucharest 050568, Romania; [Kardassis, Dimitris] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71003, Crete, Greece; [Kardassis, Dimitris] Univ Crete, Sch Med, Iraklion 71003, Crete, Greece	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; Foundation for Research & Technology - Hellas (FORTH); University of Crete	Gafencu, AV (corresponding author), Acad Romana, Inst Cellular Biol & Pathol, Sector 5, Nicolae Simionescu 8,BP Hasdeu St, Bucharest 050568, Romania.	anca.gafencu@icbp.ro	Trusca, Violeta/AAS-9472-2021; Gafencu, Anca/AAP-8707-2020; Simionescu, Maya/C-4794-2011; Trusca, Violeta Georgeta I/H-5562-2013; Gafencu, Anca/C-3323-2011; Fuior, Elena/AAP-2673-2020	Gafencu, Anca/0000-0002-1290-1346; Fuior, Elena/0000-0001-9166-8417; Simionescu, Maya/0000-0003-2077-0400; Bivol (Trusca), Violeta Georgeta/0000-0003-2980-3811	CNCSIS-UEFISCSU [1307]; Romanian Academy;  [989/2009]	CNCSIS-UEFISCSU(Consiliul National al Cercetarii Stiintifice (CNCS)); Romanian Academy(Romanian Academy of Sciences); 	This work was financed by CNCSIS-UEFISCSU project 1307 (PNII-IDEI), contract 989/2009, and by the Romanian Academy.	Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; ALLAN CM, 1995, J BIOL CHEM, V270, P26278, DOI 10.1074/jbc.270.44.26278; ALLAN CM, 1995, GENOMICS, V28, P291, DOI 10.1006/geno.1995.1144; Allan CM, 1997, J BIOL CHEM, V272, P29113, DOI 10.1074/jbc.272.46.29113; AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; BASHEERUDDIN K, 1994, BBA-GENE STRUCT EXPR, V1218, P235, DOI 10.1016/0167-4781(94)90021-3; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; BRAND K, 1993, J CLIN INVEST, V91, P2031, DOI 10.1172/JCI116425; CLADARAS C, 1987, J BIOL CHEM, V262, P2310; DANIELSSON B, 1978, FEBS LETT, V86, P299, DOI 10.1016/0014-5793(78)80584-5; DAS HK, 1985, J BIOL CHEM, V260, P6240; Davignon J, 2005, ARTERIOSCL THROM VAS, V25, P267, DOI 10.1161/01.ATV.0000154570.50696.2c; Eagleton MJ, 2010, J VASC SURG, V51, P951, DOI 10.1016/j.jvs.2009.11.075; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Gafencu AV, 2007, J BIOL CHEM, V282, P21776, DOI 10.1074/jbc.M611422200; Garcia MA, 1996, J NEUROSCI, V16, P7550; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; GREEN PHR, 1979, J CLIN INVEST, V64, P233, DOI 10.1172/JCI109444; Grehan S, 2001, J INVEST DERMATOL, V116, P77, DOI 10.1046/j.1523-1747.2001.00213.x; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; LAUER SJ, 1988, J BIOL CHEM, V263, P7277; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; Mak PA, 2002, J BIOL CHEM, V277, P31900, DOI 10.1074/jbc.M202993200; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; MYKLEBOST O, 1988, HUM GENET, V78, P244, DOI 10.1007/BF00291670; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; OLAISEN B, 1982, HUM GENET, V62, P233, DOI 10.1007/BF00333526; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raffai RL, 2005, ARTERIOSCL THROM VAS, V25, P436, DOI 10.1161/01.ATV.0000152613.83243.12; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Salero E, 2003, BIOCHEM J, V370, P979, DOI 10.1042/BJ20021142; Salero E, 2001, J BIOL CHEM, V276, P1881, DOI 10.1074/jbc.M007008200; Sasaki H, 2009, J MED INVESTIG, V56, P33, DOI 10.2152/jmi.56.33; SCHAEFER EJ, 1979, LIPIDS, V14, P511, DOI 10.1007/BF02533471; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; Shih SJ, 2000, J BIOL CHEM, V275, P31567, DOI 10.1074/jbc.M005468200; SHORE VG, 1973, BIOCHEMISTRY-US, V12, P502, DOI 10.1021/bi00727a022; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; SIMONET WS, 1991, J BIOL CHEM, V266, P8651; SMIT M, 1988, HUM GENET, V78, P90, DOI 10.1007/BF00291243; SMITH JD, 1988, J BIOL CHEM, V263, P8300; VanEck M, 1997, ARTERIOSCL THROM VAS, V17, P3117, DOI 10.1161/01.ATV.17.11.3117; vonEckardstein A, 1996, CURR OPIN LIPIDOL, V7, P308, DOI 10.1097/00041433-199610000-00009; WU AL, 1980, AM J CLIN NUTR, V33, P582, DOI 10.1093/ajcn/33.3.582; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	57	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13891	13904		10.1074/jbc.M110.179572	http://dx.doi.org/10.1074/jbc.M110.179572			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372127	hybrid, Green Published			2022-12-25	WOS:000289556200012
J	Scholz, C; Parcej, D; Ejsing, CS; Robenek, H; Urbatsch, IL; Tampe, R				Schoelz, Christian; Parcej, David; Ejsing, Christer S.; Robenek, Horst; Urbatsch, Ina L.; Tampe, Robert			Specific Lipids Modulate the Transporter Associated with Antigen Processing (TAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; PICHIA-PASTORIS; ATP HYDROLYSIS; PEPTIDE-BINDING; P-GLYCOPROTEIN; MOLECULAR-MECHANISM; NUCLEOTIDE-BINDING; PROTEIN; PURIFICATION; INHIBITION	The transporter associated with antigen processing (TAP) plays a key role in adaptive immunity by translocating proteasomal degradation products from the cytosol into the endoplasmic reticulum lumen for subsequent loading onto major histocompatibility (MHC) class I molecules. For functional and structural analysis of this ATP-binding cassette complex, we established the overexpression of TAP in the methylotrophic yeast Pichia pastoris. Screening of optimal solubilization and purification conditions allowed the isolation of the heterodimeric transport complex, yielding 30 mg of TAP/liter of culture. Detailed analysis of TAP function in the membrane, solubilized, purified, and reconstituted states revealed a direct influence of the native lipid environment on activity. TAP-associated phospholipids, essential for function, were profiled by liquid chromatography Fourier transform mass spectrometry. The antigen translocation activity is stimulated by phosphatidylinositol and -ethanolamine, whereas cholesterol has a negative effect on TAP activity.	[Schoelz, Christian; Parcej, David; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Ejsing, Christer S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Robenek, Horst] Leibniz Inst Arterioskleroseforsch, D-48149 Munster, Germany; [Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA	Goethe University Frankfurt; University of Southern Denmark; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Schölz, Christian/K-2855-2014; Ejsing, Christer S/R-5922-2016; Parcej, David/AAW-7306-2020; Tampé, Robert/H-2953-2015	Schölz, Christian/0000-0002-1633-2072; Tampé, Robert/0000-0002-0403-2160; Ejsing, Christer S./0000-0003-4963-0276	German Research Foundation [SFB 807, TA157/7, AB149/1]; United States Department of Defense [W81XWH-05-1-0316]; Danish Council for independent Resarch [DOK1155860]; Lundbeckfonden [R45-A4342]; European Commission	German Research Foundation(German Research Foundation (DFG)); United States Department of Defense(United States Department of Defense); Danish Council for independent Resarch; Lundbeckfonden(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the German Research Foundation (SFB 807 Transport and Communication across Biological Membranes, Grants TA157/7 and AB149/1 to R. T.), the United States Department of Defense (Grant W81XWH-05-1-0316 to I. L U.), the Danish Council for independent Resarch (Grant DOK1155860 to C. S. E.), the Lundbeckfonden (Grant R45-A4342 to C. S. E.), and the European Drug Initiative on Channels and Transporters (EDICT to R. T.) funded by the European Commission Seventh Framework Program.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Brierley RA, 1997, US Patent, Patent No. [5, 612,198, 5612198]; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Ghanem E, 2010, J CELL SCI, V123, P4271, DOI 10.1242/jcs.060632; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; Keusekotten K, 2006, J BIOL CHEM, V281, P17545, DOI 10.1074/jbc.M602360200; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOOR H, 1963, J CELL BIOL, V17, P609, DOI 10.1083/jcb.17.3.609; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Oswald C, 2008, J STRUCT BIOL, V162, P85, DOI 10.1016/j.jsb.2007.11.006; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Reich-Slotky R, 2000, J BACTERIOL, V182, P993, DOI 10.1128/JB.182.4.993-1000.2000; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; SCORER CA, 1994, BIO-TECHNOL, V12, P181, DOI 10.1038/nbt0294-181; Shaikh SR, 2006, CHEM PHYS LIPIDS, V144, P1, DOI 10.1016/j.chemphyslip.2006.06.017; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; UEBEL S, 1995, J BIOL CHEM, V270, P18512, DOI 10.1074/jbc.270.31.18512; Urlinger S, 1997, EUR J BIOCHEM, V245, P266, DOI 10.1111/j.1432-1033.1997.00266.x; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van den Brink-van der Laan E, 2004, BIOCHEMISTRY-US, V43, P4240, DOI 10.1021/bi036129d; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055; Watanabe J, 1996, J ELECTRON MICROSC, V45, P171, DOI 10.1093/oxfordjournals.jmicro.a023429; Zhang W., 2000, BIOTECHNOL BIOPROC E, V5, P275, DOI DOI 10.1007/BF02942184; Zhang WH, 2000, BIOTECHNOL BIOENG, V70, P1, DOI 10.1002/1097-0290(20001005)70:1<1::AID-BIT1>3.0.CO;2-Y	54	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13346	13356		10.1074/jbc.M110.216416	http://dx.doi.org/10.1074/jbc.M110.216416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21357424	Green Published, hybrid			2022-12-25	WOS:000289282200055
J	Tang, XY; Sun, ZZ; Runne, C; Madsen, J; Domann, F; Henry, M; Lin, F; Chen, S				Tang, Xiaoyun; Sun, Zhizeng; Runne, Caitlin; Madsen, Joshua; Domann, Frederick; Henry, Michael; Lin, Fang; Chen, Songhai			A Critical Role of G beta gamma in Tumorigenesis and Metastasis of Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; PROTEIN-COUPLED RECEPTORS; CELL-MIGRATION; TUMOR-GROWTH; LYSOPHOSPHATIDIC ACID; SIGNAL-TRANSDUCTION; THROMBIN; TARGETS; DISSEMINATION; ANGIOGENESIS	A growing body of evidence indicates that G protein-coupled receptors (GPCRs) are involved in breast tumor progression and that targeting GPCRs may be a novel adjuvant strategy in cancer treatment. However, due to the redundant role of multiple GPCRs in tumor development, it may be necessary to target a common signaling component downstream of these receptors to achieve maximum efficacy. GPCRs transmit signals through heterotrimeric G proteins composed of G alpha and G beta gamma subunits. Here we evaluated the role of G beta gamma in breast tumor growth and metastasis both in vitro and in vivo. Our data show that blocking G beta gamma signaling with G alpha(t) or small molecule inhibitors blocked serum-induced breast tumor cell proliferation as well as tumor cell migration induced by various GPCRs in vitro. Moreover, induced expression of G alpha(t) in MDA-MB-231 cells inhibited primary tumor formation and retarded growth of existing breast tumors in nude mice. Blocking G beta gamma signaling also dramatically reduced the incidence of spontaneous lung metastasis from primary tumors and decreased tumor formation in the experimental lung metastasis model. Additional studies indicate that G beta gamma signaling may also play a role in the generation of a tumor microenvironment permissive for tumor progression, because the inhibition of G beta gamma signaling attenuated leukocyte infiltration and angiogenesis in primary breast tumors. Taken together, our data demonstrate a critical role of G beta gamma signaling in promoting breast tumor growth and metastasis and suggest that targeting G beta gamma may represent a novel therapeutic approach for breast cancer.	[Tang, Xiaoyun; Sun, Zhizeng; Runne, Caitlin; Chen, Songhai] Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Madsen, Joshua; Domann, Frederick] Univ Iowa, Dept Radiat Oncol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Henry, Michael] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Henry, Michael] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Lin, Fang] Univ Iowa, Dept Anat & Cell Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Chen, Songhai] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Chen, S (corresponding author), Bowen Sci Bldg,Rm 2-452,51 Newton Rd, Iowa City, IA 52242 USA.	songhai-chen@uiowa.edu		Lin, Fang/0000-0003-2179-7031; Domann, Frederick/0000-0002-0489-2179; Sun, Zhizeng/0000-0002-0033-5885; Henry, Michael/0000-0002-7871-245X; chen, songhai/0000-0001-7316-7125	National Institutes of Health, NCI [R01CA115438]; American Cancer Society [IRG-77-004-31]; NATIONAL CANCER INSTITUTE [R01CA115438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01CA115438. The work was also supported by American Cancer Society Grant IRG-77-004-31 (to S. C.).	Ali S, 2007, CANCER METAST REV, V26, P401, DOI 10.1007/s10555-007-9073-z; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; COUGHLIN SS, 2009, CANCER, V33, P318; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Lee BC, 2004, MOL CANCER RES, V2, P327; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liebmann C, 2004, CURR PHARM DESIGN, V10, P1937, DOI 10.2174/1381612043384367; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Prevost GP, 2006, CANCER RES, V66, P9227, DOI 10.1158/0008-5472.CAN-05-4205; Price JT, 1999, CANCER RES, V59, P5475; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Ruffell B, 2010, CYTOKINE GROWTH F R, V21, P3, DOI 10.1016/j.cytogfr.2009.11.002; Schmid BC, 2004, BREAST CANCER RES TR, V84, P247, DOI 10.1023/B:BREA.0000019962.18922.87; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Taborga M, 2007, MINI-REV MED CHEM, V7, P245, DOI 10.2174/138955707780059826; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; UI M, 1990, ADV SEC MESS PHOSPH, V24, P63; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; WEST RE, 1985, J BIOL CHEM, V260, P4428; Weydert CJ, 2009, CANCER BIOL THER, V8, P720, DOI 10.4161/cbt.8.8.7922; Wu XS, 2009, CURR PHARM DESIGN, V15, P742, DOI 10.2174/138161209787582165; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019	55	35	35	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13244	13254		10.1074/jbc.M110.206615	http://dx.doi.org/10.1074/jbc.M110.206615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349837	hybrid, Green Published			2022-12-25	WOS:000289282200045
J	Bol, SM; Moerland, PD; Limou, S; van Remmerden, Y; Coulonges, C; van Manen, D; Herbeck, JT; Fellay, J; Sieberer, M; Sietzema, JG; van't Slot, R; Martinson, J; Zagury, JF; Schuitemaker, H; van't Wout, AB				Bol, Sebastiaan M.; Moerland, Perry D.; Limou, Sophie; van Remmerden, Yvonne; Coulonges, Cedric; van Manen, Danielle; Herbeck, Joshua T.; Fellay, Jacques; Sieberer, Margit; Sietzema, Jantine G.; van't Slot, Ruben; Martinson, Jeremy; Zagury, Jean-Francois; Schuitemaker, Hanneke; van't Wout, Angelique B.			Genome-Wide Association Study Identifies Single Nucleotide Polymorphism in DYRK1A Associated with Replication of HIV-1 in Monocyte-Derived Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; MNB/DYRK1A PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; INFECTED MACROPHAGES; DOWN-SYNDROME; IN-VITRO; GENETIC ASSOCIATION; DUAL-SPECIFICITY	Background: HIV-1 infected macrophages play an important role in rendering resting T cells permissive for infection, in spreading HIV-1 to T cells, and in the pathogenesis of AIDS dementia. During highly active anti-retroviral treatment (HAART), macrophages keep producing virus because tissue penetration of antiretrovirals is suboptimal and the efficacy of some is reduced. Thus, to cure HIV-1 infection with antiretrovirals we will also need to efficiently inhibit viral replication in macrophages. The majority of the current drugs block the action of viral enzymes, whereas there is an abundance of yet unidentified host factors that could be targeted. We here present results from a genome-wide association study identifying novel genetic polymorphisms that affect in vitro HIV-1 replication in macrophages. Methodology/Principal Findings: Monocyte-derived macrophages from 393 blood donors were infected with HIV-1 and viral replication was determined using Gag p24 antigen levels. Genomic DNA from individuals with macrophages that had relatively low (n = 96) or high (n = 96) p24 production was used for SNP genotyping with the Illumina 610 Quad beadchip. A total of 494,656 SNPs that passed quality control were tested for association with HIV-1 replication in macrophages, using linear regression. We found a strong association between in vitro HIV-1 replication in monocyte-derived macrophages and SNP rs12483205 in DYRK1A (p = 2.16 x 10(-5)). While the association was not genome-wide significant (p < 1 x 10(-7)), we could replicate this association using monocyte-derived macrophages from an independent group of 31 individuals (p = 0.0034). Combined analysis of the initial and replication cohort increased the strength of the association (p = 4.84 x 10(-6)). In addition, we found this SNP to be associated with HIV-1 disease progression in vivo in two independent cohort studies (p = 0.035 and p = 0.0048). Conclusions/Significance: These findings suggest that the kinase DYRK1A is involved in the replication of HIV-1, in vitro in macrophages as well as in vivo.	[Bol, Sebastiaan M.; van Remmerden, Yvonne; van Manen, Danielle; Sieberer, Margit; Sietzema, Jantine G.; Schuitemaker, Hanneke; van't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab,Sanquin Res, NL-1105 AZ Amsterdam, Netherlands; [Bol, Sebastiaan M.; van Remmerden, Yvonne; van Manen, Danielle; Sieberer, Margit; Sietzema, Jantine G.; Schuitemaker, Hanneke; van't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Limou, Sophie; Coulonges, Cedric; Zagury, Jean-Francois] Conservatoire Natl Arts & Metiers, Chaire Bioinformat, Paris, France; [Limou, Sophie; Coulonges, Cedric; Zagury, Jean-Francois] Univ Paris 12, INSERM, U955, Paris, France; [Herbeck, Joshua T.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Fellay, Jacques] Duke Univ, Ctr Human Genome Variat, Durham, NC USA; [van't Slot, Ruben] Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, Utrecht, Netherlands; [Martinson, Jeremy] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Washington; University of Washington Seattle; Duke University; Utrecht University; Utrecht University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bol, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab,Sanquin Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.b.vantwout@amc.uva.nl	Fellay, Jacques/A-6681-2009; Moerland, Perry/AAG-1425-2020; Limou, Sophie/AHD-3272-2022	Fellay, Jacques/0000-0002-8240-939X; Moerland, Perry/0000-0002-2357-3659; Limou, Sophie/0000-0002-7702-8234; Bol, Sebastiaan/0000-0002-3843-6657; Martinson, Jeremy/0000-0003-4673-7238; van 't Wout, Angelique/0000-0003-3705-2392	Landsteiner Foundation Blood Research [0526]; European Union [029167]; National Institute of Allergy and Infectious Diseases; National Cancer Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, U01AI035039, U01AI035041, U01AI035042, U01AI035043, P30AI027757, R37AI047734, T32AI007140] Funding Source: NIH RePORTER	Landsteiner Foundation Blood Research; European Union(European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge funding from the Landsteiner Foundation Blood Research (registration number 0526) and the European Union (Marie Curie International Reintegration Grant 029167). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute. UO1-AI-35042, UL1-RR025005 (GCRC), UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1994, AIDS, V8, P1237, DOI 10.1097/00002030-199409000-00004; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Aquaro S, 2002, ANTIVIR RES, V55, P209, DOI 10.1016/S0166-3542(02)00052-9; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Badley AD, 1997, J EXP MED, V185, P55, DOI 10.1084/jem.185.1.55; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Bergamaschi A, 2009, J VIROL, V83, P12253, DOI 10.1128/JVI.01395-09; Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Chang J, 1996, J VIROL, V70, P7792, DOI 10.1128/JVI.70.11.7792-7803.1996; Chong YH, 1998, J MOL NEUROSCI, V10, P129, DOI 10.1007/BF02737124; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Ciuffi A, 2004, J VIROL, V78, P10747, DOI 10.1128/JVI.78.19.10747-10754.2004; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Crowe SM, 2006, CURR OPIN HIV AIDS, V1, P129, DOI 10.1097/01.COH.0000209583.89952.9d; DeGruttola V, 2000, ANTIVIR THER, V5, P41; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Eisert V, 2001, VIROLOGY, V286, P31, DOI 10.1006/viro.2001.0940; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fischer M, 2000, AIDS RES HUM RETROV, V16, P1135, DOI 10.1089/088922200414974; FOUCHIER RAM, 1994, J CLIN INVEST, V94, P1806, DOI 10.1172/JCI117529; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Gardiner K, 2006, BEHAV GENET, V36, P439, DOI 10.1007/s10519-006-9051-1; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hawkins T, 2010, ANTIVIR RES, V85, P201, DOI 10.1016/j.antiviral.2009.10.016; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; Herbeck JT, 2010, J INFECT DIS, V201, P618, DOI 10.1086/649842; Herbein G, 1998, J VIROL, V72, P660, DOI 10.1128/JVI.72.1.660-670.1998; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Huang YL, 2006, J IMMUNOL, V177, P2304, DOI 10.4049/jimmunol.177.4.2304; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Huysentruyt LC, 2010, J LEUKOCYTE BIOL, V87, P627, DOI 10.1189/jlb.0809564; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lambotte O, 2005, AIDS, V19, P217, DOI 10.1097/00002030-200501280-00018; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Lee ES, 2002, VIROLOGY, V299, P20, DOI 10.1006/viro.2002.1500; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lopez-Herrera A, 2005, BBA-MOL BASIS DIS, V1741, P55, DOI 10.1016/j.bbadis.2004.12.001; Luciano-Montalvo C, 2009, PLACENTA, V30, P464, DOI 10.1016/j.placenta.2009.03.003; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; MANN DL, 1990, J IMMUNOL, V144, P2152; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Naif HM, 1999, J VIROL, V73, P4866, DOI 10.1128/JVI.73.6.4866-4881.1999; Nakada M, 2001, CANCER RES, V61, P8896; NETTERWALD J, 2007, DRUG DISCOVERY DEV, V10, P18; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; PERNO CF, 1994, J LEUKOCYTE BIOL, V56, P381, DOI 10.1002/jlb.56.3.381; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Schacker T, 2000, J INFECT DIS, V181, P354, DOI 10.1086/315178; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tan KO, 2001, J BIOL CHEM, V276, P2802, DOI 10.1074/jbc.M008955200; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tatusova T, 2010, METHODS MOL BIOL, V609, P17, DOI 10.1007/978-1-60327-241-4_2; Toschi E, 2001, MOL BIOL CELL, V12, P2934, DOI 10.1091/mbc.12.10.2934; Van Gestel S, 2000, BEHAV GENET, V30, P141, DOI 10.1023/A:1001907321955; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Wu W, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-41; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; YANG ZY, 1993, NUCLEIC ACIDS RES, V21, P2831, DOI 10.1093/nar/21.12.2831; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zauli G, 2001, FASEB J, V15, P483, DOI 10.1096/fj.00-0354com; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	97	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17190	10.1371/journal.pone.0017190	http://dx.doi.org/10.1371/journal.pone.0017190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364930	gold, Green Published, Green Accepted			2022-12-25	WOS:000287764100034
J	Lupton, MK; Proitsi, P; Danillidou, M; Tsolaki, M; Hamilton, G; Wroe, R; Pritchard, M; Lord, K; Martin, BM; Kloszewska, I; Soininen, H; Mecocci, P; Vellas, B; Harold, D; Hollingworth, P; Lovestone, S; Powell, JF				Lupton, Michelle K.; Proitsi, Petroula; Danillidou, Makrina; Tsolaki, Magda; Hamilton, Gillian; Wroe, Richard; Pritchard, Megan; Lord, Kathryn; Martin, Belinda M.; Kloszewska, Iwona; Soininen, Hilkka; Mecocci, Patrizia; Vellas, Bruno; Harold, Denise; Hollingworth, Paul; Lovestone, Simon; Powell, John F.			Deep Sequencing of the Nicastrin Gene in Pooled DNA, the Identification of Genetic Variants That Affect Risk of Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; POLYMORPHISMS; POPULATION; MUTATIONS; CLU	Nicastrin is an obligatory component of the c-secretase; the enzyme complex that leads to the production of Ab fragments critically central to the pathogenesis of Alzheimer's disease (AD). Analyses of the effects of common variation in this gene on risk for late onset AD have been inconclusive. We investigated the effect of rare variation in the coding regions of the Nicastrin gene in a cohort of AD patients and matched controls using an innovative pooling approach and next generation sequencing. Five SNPs were identified and validated by individual genotyping from 311 cases and 360 controls. Association analysis identified a non-synonymous rare SNP (N417Y) with a statistically higher frequency in cases compared to controls in the Greek population (OR 3.994, CI 1.105-14.439, p = 0.035). This finding warrants further investigation in a larger cohort and adds weight to the hypothesis that rare variation explains some of genetic heritability still to be identified in Alzheimer's disease.	[Lupton, Michelle K.; Proitsi, Petroula; Wroe, Richard; Pritchard, Megan; Lord, Kathryn; Martin, Belinda M.; Lovestone, Simon; Powell, John F.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, London WC2R 2LS, England; [Harold, Denise; Hollingworth, Paul] Cardiff Univ, Sch Med, Dept Psychol Med & Neurol, MRC Ctr Neuropsychiatr Genet & Genom, Cardiff, S Glam, Wales; [Hamilton, Gillian] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Edinburgh, Midlothian, Scotland; [Danillidou, Makrina; Tsolaki, Magda] Aristotle Univ Thessaloniki, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Kloszewska, Iwona] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, Lodz, Poland; [Soininen, Hilkka] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Mecocci, Patrizia] Univ Perugia, Dept Clin & Expt Med, Sect Gerontol & Geriatr, I-06100 Perugia, Italy; [Vellas, Bruno] Hop Toulouse, Dept Internal & Geriatr Med, Toulouse, France	University of London; King's College London; Cardiff University; University of Edinburgh; Aristotle University of Thessaloniki; Medical University Lodz; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Perugia; CHU de Toulouse	Lupton, MK (corresponding author), Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, London WC2R 2LS, England.	michelle.lupton@kcl.ac.uk	Powell, John F/G-4412-2011; Hunter, Gillian/A-1952-2015; Mecocci, Patrizia/W-2116-2019	Powell, John F/0000-0001-6124-439X; Mecocci, Patrizia/0000-0003-0729-5246; Tsolaki, Magda/0000-0002-2072-8010; Proitsi, Petroula/0000-0002-2553-6974; Williams, Julie/0000-0002-4069-0259; Pritchard, Megan Ruth/0000-0001-8872-3614; Lovestone, Simon/0000-0003-0473-4565; Harold, Denise/0000-0001-5195-0143; Lupton, Michelle/0000-0002-7274-7299	NIHR Biomedical Research Centre for Mental Health at SLAM; KCL; Medical Research Council; Alzheimer's Research Trust; European Union [HEALTH-F4-2009-242257]; Alzheimers Research UK [ART-RF2007-3] Funding Source: researchfish; Medical Research Council [G0801418B] Funding Source: researchfish	NIHR Biomedical Research Centre for Mental Health at SLAM; KCL; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust; European Union(European Commission); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the NIHR Biomedical Research Centre for Mental Health at SLAM and KCL (http://www.slam.nhs.uk/about-us/biomedical-research-centre/brc-home.aspx). It is also supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) through the PhD Studentship funding and the Alzheimer's Research Trust (http://www.alzheimers-research.org.uk/). This work was also supported by the 7th framework programme of the European Union (ADAMS project, http://www.adams-consortium.eu/, HEALTH-F4-2009-242257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Butler AW, 2009, NEUROBIOL AGING, V30, P1037, DOI 10.1016/j.neurobiolaging.2009.03.013; Confaloni A, 2003, NEUROSCI LETT, V353, P61, DOI 10.1016/j.neulet.2003.09.007; Cousin E, 2003, NEUROSCI LETT, V353, P153, DOI 10.1016/S0304-3940(03)01105-4; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Deary IJ, 2005, NEUROSCI LETT, V373, P110, DOI 10.1016/j.neulet.2004.09.073; Dermaut B, 2002, AM J HUM GENET, V70, P1568, DOI 10.1086/340732; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Helisalmi S, 2004, NEUROLOGY, V63, P173, DOI 10.1212/01.WNL.0000133153.98139.4E; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li Z, 2009, EUR J NEUROSCI, V30, P1831, DOI 10.1111/j.1460-9568.2009.06942.x; LOVESTONE S, ANN N Y ACAD SCI, V1180, P36; Ma ZH, 2009, NEUROSCI LETT, V458, P136, DOI 10.1016/j.neulet.2009.04.048; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitsui J, 2010, J HUM GENET, V55, P448, DOI 10.1038/jhg.2010.46; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Orlacchio A, 2004, NEUROSCI LETT, V363, P49, DOI 10.1016/j.neulet.2004.03.044; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Prabhu S, 2009, GENOME RES, V19, P1254, DOI 10.1101/gr.088559.108; PROITSI P, 2009, NEUROBIOL AGING; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Wang T, 2010, GENET EPIDEMIOL, V34, P492, DOI 10.1002/gepi.20502; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	36	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17298	10.1371/journal.pone.0017298	http://dx.doi.org/10.1371/journal.pone.0017298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364883	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000287764100042
J	Suzuki, SW; Onodera, J; Ohsumi, Y				Suzuki, Sho W.; Onodera, Jun; Ohsumi, Yoshinori			Starvation Induced Cell Death in Autophagy-Defective Yeast Mutants Is Caused by Mitochondria Dysfunction	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; PROTEIN; DEGRADATION; MAINTENANCE; MITOPHAGY; RESPIRATION; VACUOLE; ATG32; GENE	Autophagy is a highly-conserved cellular degradation and recycling system that is essential for cell survival during nutrient starvation. The loss of viability had been used as an initial screen to identify autophagy-defective (atg) mutants of the yeast Saccharomyces cerevisiae, but the mechanism of cell death in these mutants has remained unclear. When cells grown in a rich medium were transferred to a synthetic nitrogen starvation media, secreted metabolites lowered the extracellular pH below 3.0 and autophagy-defective mutants mostly died. We found that buffering of the starvation medium dramatically restored the viability of atg mutants. In response to starvation, wild-type (WT) cells were able to upregulate components of the respiratory pathway and ROS (reactive oxygen species) scavenging enzymes, but atg mutants lacked this synthetic capacity. Consequently, autophagy-defective mutants accumulated the high level of ROS, leading to deficient respiratory function, resulting in the loss of mitochondria DNA (mtDNA). We also showed that mtDNA deficient cells are subject to cell death under low pH starvation conditions. Taken together, under starvation conditions non-selective autophagy, rather than mitophagy, plays an essential role in preventing ROS accumulation, and thus in maintaining mitochondria function. The failure of response to starvation is the major cause of cell death in atg mutants.	[Suzuki, Sho W.; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan; [Suzuki, Sho W.] Tokyo Inst Technol, Grad Sch Biosci, Yokohama, Kanagawa 227, Japan; [Onodera, Jun; Ohsumi, Yoshinori] Natl Inst Basic Biol, Dept Cell Biol, Mol Cell Biol Div, Okazaki, Aichi 444, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Suzuki, SW (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 227, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166; Suzuki, Sho/0000-0002-6563-5387	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; COHEN G, 1985, MOL GEN GENET, V200, P74, DOI 10.1007/BF00383315; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; HALL RM, 1977, MOL BIOL REP, V3, P443, DOI 10.1007/BF00808386; HARTIG A, 1986, EUR J BIOCHEM, V160, P487, DOI 10.1111/j.1432-1033.1986.tb10065.x; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kuma A, 2010, SEMIN CELL DEV BIOL, V21, P683, DOI 10.1016/j.semcdb.2010.03.002; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	28	114	126	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17412	10.1371/journal.pone.0017412	http://dx.doi.org/10.1371/journal.pone.0017412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364763	gold, Green Published, Green Submitted			2022-12-25	WOS:000287764100058
J	Vernon, AC; Crum, WR; Johansson, SM; Modo, M				Vernon, Anthony C.; Crum, William R.; Johansson, Saga M.; Modo, Michel			Evolution of Extra-Nigral Damage Predicts Behavioural Deficits in a Rat Proteasome Inhibitor Model of Parkinson's Disease	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; NEURON DEGENERATION; ALPHA-SYNUCLEIN; BRAIN ATROPHY; MOUSE MODEL; MESENCEPHALIC CULTURES; COGNITIVE IMPAIRMENT; INTRALAMINAR NUCLEI; HUNTINGTONS-DISEASE; ALZHEIMER-DISEASE	Establishing the neurological basis of behavioural dysfunction is key to provide a better understanding of Parkinson's disease (PD) and facilitate development of effective novel therapies. For this, the relationships between longitudinal structural brain changes associated with motor behaviour were determined in a rat model of PD and validated by postmortem immunohistochemistry. Rats bearing a nigrostriatal lesion induced by infusion of the proteasome inhibitor lactacystin into the left-medial forebrain bundle and saline-injected controls underwent magnetic resonance imaging (MRI) at baseline (prior to surgery) and 1, 3 and 5 weeks post-surgery with concomitant motor assessments consisting of forelimb grip strength, accelerating rotarod, and apormorphine-induced rotation. Lactacystin-injected rats developed early motor deficits alongside decreased ipsilateral cortical volumes, specifically thinning of the primary motor (M1) and somatosensory cortices and lateral ventricle hypertrophy (as determined by manual segmentation and deformation-based morphometry). Although sustained, motor dysfunction and nigrostriatal damage were maximal by 1 week post-surgery. Additional volume decreases in the ipsilateral ventral midbrain; corpus striatum and thalamus were only evident by week 3 and 5. Whilst cortical MRI volume changes best predicted the degree of motor impairment, post-mortem tyrosine hydroxylase immunoreactivity in the striatum was a better predictor of motor behaviour overall, with the notable exception of performance in the accelerating rotarod, in which, M1 cortical thickness remained the best predictor. These results highlight the importance of identifying extra-nigral regions of damage that impact on behavioural dysfunction from damage to the nigrostriatal system.	[Vernon, Anthony C.; Johansson, Saga M.; Modo, Michel] Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, Dept Neurosci, London WC2R 2LS, England; [Crum, William R.] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Vernon, AC (corresponding author), Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, Dept Neurosci, London WC2R 2LS, England.	mike.modo@kcl.ac.uk	Crum, William R/C-4891-2008; Modo, Mike/A-5995-2011; Modo, Michel/E-5170-2012	Crum, William R/0000-0001-9369-2197; Modo, Michel/0000-0003-4436-735X; Vernon, Anthony/0000-0001-7305-1069	Edmund J. Safra Foundation; NIHR Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Wellcome Trust; EPSRC [WT 088641/Z/09/Z]	Edmund J. Safra Foundation; NIHR Biomedical Research Centre for Mental Health at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Edmund J. Safra Foundation funded this study (www.edmondjsafra.org/). W.R. Crum acknowledges support from the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, and the King's College London Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC (WT 088641/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBUTHNOTT G, 1971, BRAIN RES, V27, P406, DOI 10.1016/0006-8993(71)90272-1; Aymerich MS, 2006, EUR J NEUROSCI, V23, P2099, DOI 10.1111/j.1460-9568.2006.04741.x; Bacci JJ, 2004, J NEUROPATH EXP NEUR, V63, P20, DOI 10.1093/jnen/63.1.20; BAGLIO F, 2009, NEUROBIOL AGING; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Borghammer P, 2010, EUR J NEUROL, V17, P314, DOI 10.1111/j.1468-1331.2009.02807.x; Boska MD, 2007, NEUROBIOL DIS, V26, P590, DOI 10.1016/j.nbd.2007.02.010; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brooks D, 2009, BRAIN RES BULL, V78, P97, DOI 10.1016/j.brainresbull.2008.08.014; Brownell AL, 2003, NEUROIMAGE, V20, P1064, DOI 10.1016/S1053-8119(03)00348-3; Burton EJ, 2005, MOVEMENT DISORD, V20, P1571, DOI 10.1002/mds.20652; CENCI MA, 1993, EUR J NEUROSCI, V5, P1062, DOI 10.1111/j.1460-9568.1993.tb00959.x; Crum WR, 2005, PHYS MED BIOL, V50, P5153, DOI 10.1088/0031-9155/50/21/014; Dalaker TO, 2010, MOVEMENT DISORD, V25, P629, DOI 10.1002/mds.22867; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Debeir T, 2005, EXP NEUROL, V193, P444, DOI 10.1016/j.expneurol.2005.01.007; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Deutch AY, 2006, J NEURAL TRANSM-SUPP, P67; Dunnett SB, 1998, EXP NEUROL, V154, P31, DOI 10.1006/exnr.1998.6926; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Guzman R, 2000, J NEUROSCI METH, V97, P77, DOI 10.1016/S0165-0270(00)00172-2; Halliday GM, 2005, BRAIN, V128, P2272, DOI 10.1093/brain/awh596; Henderson JM, 2000, ANN NEUROL, V47, P345, DOI 10.1002/1531-8249(200003)47:3<345::AID-ANA10>3.3.CO;2-M; Henderson JM, 2000, BRAIN, V123, P1410, DOI 10.1093/brain/123.7.1410; Hou ZY, 2010, J CLIN NEUROSCI, V17, P628, DOI 10.1016/j.jocn.2009.07.101; Ibarretxe-Bilbao N, 2010, J NEUROL NEUROSUR PS, V81, P650, DOI 10.1136/jnnp.2009.179655; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; Jenkins BG, 2004, J NEUROSCI, V24, P9553, DOI 10.1523/JNEUROSCI.1558-04.2004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; Junque C, 2005, MOVEMENT DISORD, V20, P540, DOI 10.1002/mds.20371; Kassubek J, 2002, NEUROSCI LETT, V323, P29, DOI 10.1016/S0304-3940(02)00111-8; Kondoh T, 2005, EXP NEUROL, V192, P194, DOI 10.1016/j.expneurol.2004.12.016; Kostic VS, 2010, NEUROLOGY, V75, P857, DOI 10.1212/WNL.0b013e3181f11c1d; Lauwers E, 2007, NEUROBIOL AGING, V28, P248, DOI 10.1016/j.neurobiolaging.2005.12.005; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lewis MM, 2009, EUR J NEUROL, V16, P475, DOI 10.1111/j.1468-1331.2008.02430.x; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Lyoo CH, 2010, MOVEMENT DISORD, V25, P496, DOI 10.1002/mds.22975; MacInnes N, 2008, J NEURAL TRANSM, V115, P869, DOI 10.1007/s00702-008-0027-6; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Martin WRW, 2009, MOVEMENT DISORD, V24, P1949, DOI 10.1002/mds.22680; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Miwa H, 2005, NEUROSCI LETT, V380, P93, DOI 10.1016/j.neulet.2005.01.024; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Moraschi M, 2010, MAGN RESON IMAGING, V28, P1152, DOI 10.1016/j.mri.2010.03.025; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Orieux G, 2000, NEUROSCIENCE, V97, P79, DOI 10.1016/S0306-4522(00)00011-7; Pavese N, 2009, BBA-MOL BASIS DIS, V1792, P722, DOI 10.1016/j.bbadis.2008.10.003; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pedersen KM, 2005, MOVEMENT DISORD, V20, P164, DOI 10.1002/mds.20289; Pelled G, 2002, EUR J NEUROSCI, V15, P389, DOI 10.1046/j.0953-816x.2001.01866.x; Pelled G, 2005, EUR J NEUROSCI, V21, P2227, DOI 10.1111/j.1460-9568.2005.04035.x; Pelled G, 2007, J MAGN RESON IMAGING, V26, P863, DOI 10.1002/jmri.21051; Peran P, 2010, BRAIN; PRODOEHL J, 2010, MOV DISORD; Reaney SH, 2006, EXP NEUROL, V202, P434, DOI 10.1016/j.expneurol.2006.07.010; Recchia A, 2008, NEUROBIOL DIS, V30, P8, DOI 10.1016/j.nbd.2007.11.002; REIJNDERS JS, 2010, MOV DISORD; Ren QG, 2009, J MOL NEUROSCI, V38, P57, DOI 10.1007/s12031-008-9161-8; Ren QG, 2009, NEUROCHEM RES, V34, P859, DOI 10.1007/s11064-008-9830-6; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P12, DOI 10.1016/j.nbd.2008.09.017; Saywell W, 2006, BIOCHEM BIOPH RES CO, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Sedahat K, 2009, BRAIN RES, V1271, P83, DOI 10.1016/j.brainres.2009.03.026; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; Tam CWC, 2005, NEUROLOGY, V64, P861, DOI 10.1212/01.WNL.0000153070.82309.D4; Tessa C, 2010, EXP NEUROL, V224, P299, DOI 10.1016/j.expneurol.2010.04.005; Van Camp N, 2010, MAGN RESON MATER PHY, V23, P65, DOI 10.1007/s10334-010-0198-7; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; van Vlieta SAM, 2008, BRAIN RES, V1189, P219, DOI 10.1016/j.brainres.2007.10.059; Vernon AC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-1; Wang HD, 2008, NEUROPSYCHOPHARMACOL, V33, P1276, DOI 10.1038/sj.npp.1301521; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wolf OT, 2002, BRAIN RES, V934, P87, DOI 10.1016/S0006-8993(02)02363-6; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x; Zhang X, 2005, BIOCHEM BIOPH RES CO, V333, P544, DOI 10.1016/j.bbrc.2005.05.150; Zhang ZM, 2006, NEUROIMAGE, V33, P636, DOI 10.1016/j.neuroimage.2006.07.004; Zhu W, 2007, FASEB J, V21, P3835, DOI 10.1096/fj.07-8386com	87	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17269	10.1371/journal.pone.0017269	http://dx.doi.org/10.1371/journal.pone.0017269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364887	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100038
J	Blainey, PC; Mosier, AC; Potanina, A; Francis, CA; Quake, SR				Blainey, Paul C.; Mosier, Annika C.; Potanina, Anastasia; Francis, Christopher A.; Quake, Stephen R.			Genome of a Low-Salinity Ammonia-Oxidizing Archaeon Determined by Single-Cell and Metagenomic Analysis	PLOS ONE			English	Article							PACIFIC SUBTROPICAL GYRE; MARINE CRENARCHAEOTA; NITRIFYING ARCHAEA; RELATIVE ABUNDANCE; PROKARYOTIC CELLS; NORTH-ATLANTIC; WATER MASSES; BACTERIA; OCEAN; DIVERSITY	Ammonia-oxidizing archaea (AOA) are thought to be among the most abundant microorganisms on Earth and may significantly impact the global nitrogen and carbon cycles. We sequenced the genome of AOA in an enrichment culture from low-salinity sediments in San Francisco Bay using single-cell and metagenomic genome sequence data. Five single cells were isolated inside an integrated microfluidic device using laser tweezers, the cells' genomic DNA was amplified by multiple displacement amplification (MDA) in 50 nL volumes and then sequenced by high-throughput DNA pyrosequencing. This microscopy-based approach to single-cell genomics minimizes contamination and allows correlation of high-resolution cell images with genomic sequences. Statistical properties of coverage across the five single cells, in combination with the contrasting properties of the metagenomic dataset allowed the assembly of a high-quality draft genome. The genome of this AOA, which we designate Candidatus Nitrosoarchaeum limnia SFB1,is similar to 1.77 Mb with >2100 genes and a G+C content of 32%. Across the entire genome, the average nucleotide identity to Nitrosopumilus maritimus, the only AOA in pure culture, is similar to 70%, suggesting this AOA represents a new genus of Crenarchaeota. Phylogenetically, the 16S rRNA and ammonia monooxygenase subunit A (amoA) genes of this AOA are most closely related to sequences reported from a wide variety of freshwater ecosystems. Like N. maritimus, the low-salinity AOA genome appears to have an ammonia oxidation pathway distinct from ammonia oxidizing bacteria (AOB). In contrast to other described AOA, these low-salinity AOA appear to be motile, based on the presence of numerous motility-and chemotaxis-associated genes in the genome. This genome data will be used to inform targeted physiological and metabolic studies of this novel group of AOA, which may ultimately advance our understanding of AOA metabolism and their impacts on the global carbon and nitrogen cycles.	[Blainey, Paul C.; Potanina, Anastasia; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA; [Mosier, Annika C.; Francis, Christopher A.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Blainey, PC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA.	caf@stanford.edu; quake@stanford.edu	t, lf/AAJ-4924-2020	Francis, Christopher/0000-0001-7557-631X; Mosier, Annika/0000-0001-5333-4854; Blainey, Paul/0000-0002-4889-8783	National Science Foundation [MCB-0604270, OCE-0847266]; NIH [5R01HG004863-02]; EPA STAR; Division Of Ocean Sciences [0847266] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004863] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA STAR(United States Environmental Protection Agency); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by National Science Foundation Grants MCB-0604270 and OCE-0847266 (to C. A. F.), NIH Director's Pioneer Award and NIH 5R01HG004863-02 (to S. R. Q.) and an EPA STAR Graduate Fellowship (to A. C. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1992, APPL ENVIRON MICROB, V58, P3007, DOI 10.1128/AEM.58.9.3007-3011.1992; Arp DJ, 2002, ARCH MICROBIOL, V178, P250, DOI 10.1007/s00203-002-0452-0; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Beman JM, 2010, ENVIRON MICROBIOL, V12, P1282, DOI 10.1111/j.1462-2920.2010.02172.x; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Buckley DH, 1998, APPL ENVIRON MICROB, V64, P4333; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burton SAQ, 2001, APPL ENVIRON MICROB, V67, P2952, DOI 10.1128/AEM.67.7.2952-2957.2001; Church MJ, 2010, ENVIRON MICROBIOL, V12, P679, DOI 10.1111/j.1462-2920.2009.02108.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; HOOPER A, 2005, EUROPEAN J BIOCH, V141, P565; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kemnitz D, 2007, FEMS MICROBIOL ECOL, V60, P442, DOI 10.1111/j.1574-6941.2007.00310.x; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495, DOI 10.4319/lo.2007.52.2.0495; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo X, 2007, J BACTERIOL, V189, P403, DOI 10.1128/JB.01246-06; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Maddison WP, 2000, J THEOR BIOL, V202, P195, DOI 10.1006/jtbi.1999.1050; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Moin NS, 2009, APPL ENVIRON MICROB, V75, P7461, DOI 10.1128/AEM.01001-09; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Pernthaler Annelie, 2007, Methods Mol Biol, V353, P153; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sandaa RA, 1999, APPL ENVIRON MICROB, V65, P3293; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stahl D.A., 1991, SEQUENCING HYBRIDIZA, P205; Teira E, 2006, LIMNOL OCEANOGR, V51, P2131, DOI 10.4319/lo.2006.51.5.2131; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	69	233	248	3	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16626	10.1371/journal.pone.0016626	http://dx.doi.org/10.1371/journal.pone.0016626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364937	Green Published, gold, Green Submitted			2022-12-25	WOS:000287656600009
J	Koch, N; Zacharias, M; Konig, A; Temme, S; Neumann, J; Springer, S				Koch, Norbert; Zacharias, Martin; Koenig, Angelika; Temme, Sebastian; Neumann, Juergen; Springer, Sebastian			Stoichiometry of HLA Class II-Invariant Chain Oligomers	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSMEMBRANE DOMAIN; TRANSPORT-PROPERTIES; ESCHERICHIA-COLI; CELL-SURFACE; IA-ANTIGENS; DR-BETA; MOLECULES; RECEPTOR; BINDING	Background: The HLA gene complex encodes three class II isotypes, DR, DQ, and DP. HLA class II molecules are peptide receptors that present antigens for recognition by T lymphocytes. In antigen presenting cells, the assembly of matched alpha and beta subunits to heterodimers is chaperoned by invariant chain (Ii). Ii forms a homotrimer with three binding sites for class II heterodimers. The current model of class II and Ii structure states that three alpha beta heterodimers bind to an Ii trimer. Methology/Principal Findings: We have now analyzed the composition and size of the complexes of class II and Ii using epitope tagged class II subunits and density gradient experiments. We show here that class II-Ii oligomers consist of one class II heterodimer associated with one Ii trimer, such that the DR, DQ and DP isotypes are contained within separate complexes with Ii. Conclusion/Significance: We propose a structural model of the class II-Ii oligomer and speculate that the pentameric class II-Ii complex is bent towards the cell membrane, inhibiting the binding of additional class II heterodimers to Ii.	[Koch, Norbert; Koenig, Angelika; Temme, Sebastian; Neumann, Juergen] Univ Bonn, Inst Genet, Div Immunobiol, D-5300 Bonn, Germany; [Zacharias, Martin] Tech Univ Munich, Dept Phys, D-8000 Munich, Germany; [Springer, Sebastian] Jacobs Univ Bremen, Mol Life Sci Ctr, Bremen, Germany	University of Bonn; Technical University of Munich; University of Munich; Jacobs University	Koch, N (corresponding author), Univ Bonn, Inst Genet, Div Immunobiol, D-5300 Bonn, Germany.	norbert.koch@uni-bonn.de	Springer, Sebastian/AAJ-7036-2021	Springer, Sebastian/0000-0002-5527-6149	Deutsche Forschungsgemeinschaft [Ko 810/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft Ko 810/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TE, 1983, IMMUNOLOGY, V50, P613; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ARNESON LS, 1995, J CELL BIOL, V129, P1217, DOI 10.1083/jcb.129.5.1217; ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; Ashman JB, 1999, J IMMUNOL, V163, P2704; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castellino F, 2001, EUR J IMMUNOL, V31, P841, DOI 10.1002/1521-4141(200103)31:3<841::AID-IMMU841>3.0.CO;2-D; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Dixon AM, 2006, BIOCHEMISTRY-US, V45, P5228, DOI 10.1021/bi052112e; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GRAF L, 1985, MOL IMMUNOL, V22, P1371, DOI 10.1016/0161-5890(85)90059-8; Gruneberg U, 1997, HUM IMMUNOL, V53, P34, DOI 10.1016/S0198-8859(97)00025-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hayes SM, 2006, J EXP MED, V203, P47, DOI 10.1084/jem.20051886; Hofmann MW, 1999, J BIOL CHEM, V274, P36153, DOI 10.1074/jbc.274.51.36153; JASANOFF A, 1995, P NATL ACAD SCI USA, V92, P9900, DOI 10.1073/pnas.92.21.9900; Jasanoff A, 1998, EMBO J, V17, P6812, DOI 10.1093/emboj/17.23.6812; Jasanoff A, 1999, IMMUNITY, V10, P761, DOI 10.1016/S1074-7613(00)80075-8; JONES PP, 1978, J EXP MED, V148, P925, DOI 10.1084/jem.148.4.925; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; KOCH N, 1986, J BIOL CHEM, V261, P3434; Koch N, 2007, TRENDS BIOCHEM SCI, V32, P532, DOI 10.1016/j.tibs.2007.09.007; KOCH S, 1987, J IMMUNOL METHODS, V103, P211, DOI 10.1016/0022-1759(87)90292-4; LAMB CA, 1992, J IMMUNOL, V148, P3478; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Lennon-Dumenil AM, 2001, EMBO J, V20, P4055, DOI 10.1093/emboj/20.15.4055; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MARKS MS, 1995, J BIOL CHEM, V270, P10475, DOI 10.1074/jbc.270.18.10475; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; Mitra AK, 2004, CURR BIOL, V14, P718, DOI 10.1016/j.cub.2004.04.004; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Neumann J, 2005, J IMMUNOL METHODS, V301, P66, DOI 10.1016/j.jim.2005.03.014; Neumann J, 2001, J BIOL CHEM, V276, P13469, DOI 10.1074/jbc.M010629200; Neumann J, 2006, J CELL SCI, V119, P4207, DOI 10.1242/jcs.03177; Nordeng TW, 2002, MOL BIOL CELL, V13, P1846, DOI 10.1091/mbc.01-10-0478; PARK SJ, 1995, P NATL ACAD SCI USA, V92, P11289, DOI 10.1073/pnas.92.24.11289; PESANDO JM, 1986, J IMMUNOL, V136, P4311; POLLET RJ, 1981, J BIOL CHEM, V256, P2118; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Rodionov DG, 2002, J BIOL CHEM, V277, P47436, DOI 10.1074/jbc.M207149200; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Siebenkotten IM, 1998, J IMMUNOL, V160, P3355; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; SUNG E, 1981, MOL IMMUNOL, V18, P899, DOI 10.1016/0161-5890(81)90013-4; Verreck FAW, 2001, EUR J IMMUNOL, V31, P1029, DOI 10.1002/1521-4141(200104)31:4<1029::AID-IMMU1029>3.0.CO;2-Q; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787; Ye LL, 2008, J IMMUNOL, V181, P2572, DOI 10.4049/jimmunol.181.4.2572; Zhong GM, 1996, J EXP MED, V184, P2061, DOI 10.1084/jem.184.5.2061	58	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17257	10.1371/journal.pone.0017257	http://dx.doi.org/10.1371/journal.pone.0017257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364959	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600037
J	Bonilla, C; Hooker, S; Mason, T; Bock, CH; Kittles, RA				Bonilla, Carolina; Hooker, Stanley; Mason, Tshela; Bock, Cathryn H.; Kittles, Rick A.			Prostate Cancer Susceptibility Loci Identified on Chromosome 12 in African Americans	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GENE POLYMORPHISMS; RISK; ASSOCIATION; VARIANTS; LINKAGE; EXPRESSION; CYP27B1; CYP24A1; PAR-4	Prostate cancer (PCa) is a complex disease that disproportionately affects African Americans and other individuals of African descent. A number of regions across the genome have been associated to PCa, most of them with moderate effects. A few studies have reported chromosomal changes on 12p and 12q that occur during the onset and development of PCa but to date no consistent association of the disease with chromosome 12 polymorphic variation has been identified. In order to unravel genetic risk factors that underlie PCa health disparities we investigated chromosome 12 using ancestry informative markers (AIMs), which allow us to distinguish genomic regions of European or West African origin, and tested them for association with PCa. Additional SNPs were genotyped in those areas where significant signals of association were detected. The strongest signal was discovered at the SNP rs12827748, located upstream of the PAWR gene, a tumor suppressor, which is amply expressed in the prostate. The most frequent allele in Europeans was the risk allele among African Americans. We also examined vitamin D related genes, VDR and CYP27B1, and found a significant association of PCa with the TaqI polymorphism (rs731236) in the former. Although our results warrant further investigation we have uncovered a genetic susceptibility factor for PCa in a likely candidate by means of an approach that takes advantage of the differential contribution of parental groups to an admixed population.	[Bonilla, Carolina] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hooker, Stanley; Kittles, Rick A.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Mason, Tshela] Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; [Bock, Cathryn H.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA	University of Bristol; University of Chicago; Howard University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Bonilla, C (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	C.Bonilla@bristol.ac.uk	Bonilla, Carolina/U-9263-2018	Bonilla, Carolina/0000-0002-9972-6383; Bock, Cathryn/0000-0002-8696-768X; Kittles, Rick/0000-0002-5004-4437	US Department of Defense [W81XWH-06-1-0066]	US Department of Defense(United States Department of Defense)	CB was a recipient of US Department of Defense-Congressionally Directed Medical Research Program grant no. W81XWH-06-1-0066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarasu K, 2009, J CLIN IMMUNOL, V29, P196, DOI 10.1007/s10875-008-9234-z; Andersson P, 2006, EUR J CANCER, V42, P2833, DOI 10.1016/j.ejca.2006.06.030; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berndt SI, 2006, J UROLOGY, V175, P1613, DOI 10.1016/S0022-5347(05)00958-4; Chen L, 2009, CANCER EPIDEM BIOMAR, V18, P2874, DOI 10.1158/1055-9965.EPI-09-0544; Coassin S, 2010, ATHEROSCLEROSIS, V209, P321, DOI 10.1016/j.atherosclerosis.2009.10.026; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fernandez-Marcos PJ, 2009, P NATL ACAD SCI USA, V106, P12962, DOI 10.1073/pnas.0813055106; Gsur A, 2002, PROSTATE, V51, P30, DOI 10.1002/pros.10064; Hawkins GA, 2002, PROSTATE, V53, P175, DOI 10.1002/pros.10144; Hernandez W, 2007, CARCINOGENESIS, V28, P2154, DOI 10.1093/carcin/bgm190; Holick CN, 2007, CANCER EPIDEM BIOMAR, V16, P1990, DOI 10.1158/1055-9965.EPI-07-0487; Ingles SA, 1998, CANCER RES, V58, P1620; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reddy S, 2003, CANCER METAST REV, V22, P83, DOI 10.1023/A:1022216119066; Roff A, 2008, J STEROID BIOCHEM, V112, P47, DOI 10.1016/j.jsbmb.2008.08.009; Schaid DJ, 2007, HUM GENET, V121, P729, DOI 10.1007/s00439-007-0368-5; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Taylor JA, 1996, CANCER RES, V56, P4108; Whitman EJ, 2010, CANCER EPIDEM BIOMAR, V19, P1, DOI 10.1158/1055-9965.EPI-08-1111; Yin M, 2009, INT J CLIN EXP MED, V2, P159; Zapata-Benavides P, 2009, ARCH MED RES, V40, P595, DOI 10.1016/j.arcmed.2009.08.007	27	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16044	10.1371/journal.pone.0016044	http://dx.doi.org/10.1371/journal.pone.0016044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358824	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700015
J	Pena, SDJ; Di Pietro, G; Fuchshuber-Moraes, M; Genro, JP; Hutz, MH; Kehdy, FDG; Kohlrausch, F; Magno, LAV; Montenegro, RC; Moraes, MO; de Moraes, MEA; de Moraes, MR; Ojopi, EB; Perini, JA; Racciopi, C; Ribeiro-dos-Santos, AKC; Rios-Santos, F; Romano-Silva, MA; Sortica, VA; Suarez-Kurtz, G				Pena, Sergio D. J.; Di Pietro, Giuliano; Fuchshuber-Moraes, Mateus; Genro, Julia Pasqualini; Hutz, Mara H.; Gomes Kehdy, Fernanda de Souza; Kohlrausch, Fabiana; Viana Magno, Luiz Alexandre; Montenegro, Raquel Carvalho; Moraes, Manoel Odorico; Amaral de Moraes, Maria Elisabete; de Moraes, Milene Raiol; Ojopi, Elida B.; Perini, Jamila A.; Racciopi, Clarice; Campos Ribeiro-dos-Santos, Andrea Kely; Rios-Santos, Fabricio; Romano-Silva, Marco A.; Sortica, Vinicius A.; Suarez-Kurtz, Guilherme			The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected	PLOS ONE			English	Article							COLOR; POLYMORPHISMS; DIVERSITY; VKORC1; WARFARIN; IMPACT	Based on pre-DNA racial/color methodology, clinical and pharmacological trials have traditionally considered the different geographical regions of Brazil as being very heterogeneous. We wished to ascertain how such diversity of regional color categories correlated with ancestry. Using a panel of 40 validated ancestry-informative insertion-deletion DNA polymorphisms we estimated individually the European, African and Amerindian ancestry components of 934 self-categorized White, Brown or Black Brazilians from the four most populous regions of the Country. We unraveled great ancestral diversity between and within the different regions. Especially, color categories in the northern part of Brazil diverged significantly in their ancestry proportions from their counterparts in the southern part of the Country, indicating that diverse regional semantics were being used in the self-classification as White, Brown or Black. To circumvent these regional subjective differences in color perception, we estimated the general ancestry proportions of each of the four regions in a form independent of color considerations. For that, we multiplied the proportions of a given ancestry in a given color category by the official census information about the proportion of that color category in the specific region, to arrive at a "total ancestry" estimate. Once such a calculation was performed, there emerged a much higher level of uniformity than previously expected. In all regions studied, the European ancestry was predominant, with proportions ranging from 60.6% in the Northeast to 77.7% in the South. We propose that the immigration of six million Europeans to Brazil in the 19(th) and 20(th) centuries - a phenomenon described and intended as the "whitening of Brazil" -is in large part responsible for dissipating previous ancestry dissimilarities that reflected region-specific population histories. These findings, of both clinical and sociological importance for Brazil, should also be relevant to other countries with ancestrally admixed populations.	[Pena, Sergio D. J.; Gomes Kehdy, Fernanda de Souza; Racciopi, Clarice] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Di Pietro, Giuliano; Rios-Santos, Fabricio] Univ Estadual Santa Cruz, Dept Ciencias Saude, Ilheus, Brazil; [Fuchshuber-Moraes, Mateus; Kohlrausch, Fabiana; Perini, Jamila A.; Suarez-Kurtz, Guilherme] Inst Nacl Canc, Coordenacao Pesquisa Div Farmacol, Rio De Janeiro, Brazil; [Genro, Julia Pasqualini; Hutz, Mara H.; Sortica, Vinicius A.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Viana Magno, Luiz Alexandre; Romano-Silva, Marco A.] Univ Fed Minas Gerais, INCT MM, Lab Neurociencia, Fac Med, Belo Horizonte, MG, Brazil; [Montenegro, Raquel Carvalho; Moraes, Manoel Odorico; Amaral de Moraes, Maria Elisabete] Univ Fed Ceara, Unidade Farmacol Clin, Dept Fisiol & Farmacol, Fac Med, Fortaleza, Ceara, Brazil; [Amaral de Moraes, Maria Elisabete; Campos Ribeiro-dos-Santos, Andrea Kely] Fed Univ Para, Lab Genet Humana & Med, Guama, Brazil; [Ojopi, Elida B.] Univ Sao Paulo, Fac Med, Lab Neurociencias, Inst Psiquiatria, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual de Santa Cruz; National Cancer Institute (Inca); Universidade Federal do Rio Grande do Sul; Universidade Federal de Minas Gerais; Universidade Federal do Ceara; Universidade Federal do Para; Universidade de Sao Paulo	Pena, SDJ (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	spena@dcc.ufmg.br	Suarez-Kurtz, Guilherme/J-6648-2012; Romano-Silva, Marco Aurelio/A-1790-2008; Hutz, Mara H/I-4070-2012; Ojopi, Elida Benquique/A-6773-2012; Rios-Santos, Fabricio/E-5930-2011; Magno, Luiz Alexandre V./AAJ-9839-2021; Santos, Ândrea Ribeiro dos/B-6061-2013; Kohlrausch, Fabiana/AEQ-7448-2022; Genro, Julia/J-4795-2015; Sortica, Vinicius A/G-5772-2017; Magno, Alexandre/B-1552-2010; Montenegro, Raquel/I-1260-2013; Kohlrausch, Fabiana/H-1989-2012; Romano-Silva, Marco Aurelio/T-8321-2019; Suarez-Kurtz, Guilherme/P-4620-2019; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019	Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Ojopi, Elida Benquique/0000-0001-5824-5199; Rios-Santos, Fabricio/0000-0001-7151-1631; Magno, Luiz Alexandre V./0000-0003-3693-1897; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Kohlrausch, Fabiana/0000-0001-5992-2905; Sortica, Vinicius A/0000-0001-6185-0832; Magno, Alexandre/0000-0003-3693-1897; Montenegro, Raquel/0000-0002-3861-293X; Kohlrausch, Fabiana/0000-0001-5992-2905; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Hutz, Mara/0000-0002-9146-1229; Kehdy, Fernanda/0000-0001-8964-9049; Di Pietro, Giuliano/0000-0001-9753-222X	Financiadora de Estudos e Projetos (FINEP) of Brazil [01.08.0123.00]	Financiadora de Estudos e Projetos (FINEP) of Brazil(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by the Financiadora de Estudos e Projetos (FINEP) of Brazil, by contract 01.08.0123.00 to the Rede Nacional de Farmacogenetica/-genomica - REFARGEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; [Anonymous], 1999, NOVOS ESTUD-CEBRAP; Bastos JL, 2009, CAD SAUDE PUBLICA, V25, P2111, DOI 10.1590/S0102-311X2009001000003; Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Cann HM, 2002, SCIENCE, V296, P261; Carvalho-Silva DR, 2006, GENETICA, V126, P251, DOI 10.1007/s10709-005-1454-z; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; Costa S, 2006, EST AFRO ASIAT, V28, P47; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; dos Santos SA, 2002, LAT AM PERSPECT, V29, P61, DOI 10.1177/0094582X0202900104; Graham DJ, 2000, EARTH SURF PROC LAND, V25, P1473, DOI 10.1002/1096-9837(200012)25:13&lt;1473::AID-ESP158&gt;3.0.CO;2-C; Harris Marvin., 1980, PATTERNS RACE AM; Harris Marvin, 1963, SOCIOLOGIA, V25, P203; IBGE, 2012, BRAS 500 AN POV; IBGE, 2003, EST SEC 20; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jonas DE, 2009, TRENDS PHARMACOL SCI, V30, P375, DOI 10.1016/j.tips.2009.05.001; KLEIN HS, 1992, J SOC HIST, V25, P505, DOI 10.1353/jsh/25.3.505; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Manly BFJ, 1997, RANDOMIZATION BOOTST; Nobles M, 2000, AM J PUBLIC HEALTH, V90, P1738, DOI 10.2105/AJPH.90.11.1738; Osorio R.G, 2003, SISTEMA CLASSIFICATO; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026; Petruccelli JL, 2001, EST AFRO ASIAT, V23, P5; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; PRADO Paulo, 1981, RETRATO BRASIL ENSAI; Pritchard JK, 2000, GENETICS, V155, P945; Ribeiro D., 1995, POVO BRASILEIRO FORM; Salzano FM, 1970, STUDY BRAZILIAN POPU; Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532; Seyferth G, 1986, CIENCIA HOJE, P54; Seyferth Giralda, 1985, REV MUS PAULISTA, V30, P81; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Suarez-Kurtz G, 2006, CURR DRUG TARGETS, V7, P1649, DOI 10.2174/138945006779025392; Suarez-Kurtz G, 2007, PHARMACOGENOMICS, V8, P1299, DOI 10.2217/14622416.8.10.1299; Suarez-Kurtz G, 2010, PHARMACOGENOMICS, V11, P1257, DOI 10.2217/PGS.10.89; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Talbot J, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-87; Telles EE, 2002, ETHNIC RACIAL STUD, V25, P415, DOI 10.1080/01419870252932133; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727	43	406	423	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17063	10.1371/journal.pone.0017063	http://dx.doi.org/10.1371/journal.pone.0017063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359226	Green Submitted, Green Published, gold			2022-12-25	WOS:000287392700041
J	Gutierrez, O; Berciano, MT; Lafarga, M; Fernandez-Luna, JL				Gutierrez, Olga; Berciano, Maria T.; Lafarga, Miguel; Fernandez-Luna, Jose L.			A Novel Pathway of TEF Regulation Mediated by MicroRNA-125b Contributes to the Control of Actin Distribution and Cell Shape in Fibroblasts	PLOS ONE			English	Article							RHO-GTPASES; P53; APOPTOSIS; LEUKEMIA; GENES; DIFFERENTIATION; EXPRESSION; PROTEINS; DYNAMICS; LINES	Background: Thyrotroph embryonic factor (TEF), a member of the PAR bZIP family of transcriptional regulators, has been involved in neurotransmitter homeostasis, amino acid metabolism, and regulation of apoptotic proteins. In spite of its relevance, nothing is known about the regulation of TEF. Principal Findings: p53-dependent genotoxic agents have been shown to be much more harmful for PAR bZIP-deficient mice as compared to wild type animals. Here we demonstrate that TEF expression is controlled by p53 through upregulation of microRNA-125b, as determined by both regulating the activity of p53 and transfecting cells with microRNA-125b precursors. We also describe a novel role for TEF in controlling actin distribution and cell shape in mouse fibroblasts. Lack of TEF is accompanied by dramatic increase of cell area and decrease of elongation (bipolarity) and dispersion (multipolarity). Staining of actin cytoskeleton also showed that TEF (-/-) cells are characterized by appearance of circumferential actin bundles and disappearance of straight fibers. Interestingly, transfection of TEF (-/-) fibroblasts with TEF induced a wild type-like phenotype. Consistent with our previous findings, transfection of wild type fibroblasts with miR-125b promoted a TEF (-/-)-like phenotype, and a similar but weaker effect was observed following exogenous expression of p53. Conclusions/Significance: These findings provide the first evidence of TEF regulation, through a miR-125b-mediated pathway, and describes a novel role of TEF in the maintenance of cell shape in fibroblasts.	[Gutierrez, Olga; Fernandez-Luna, Jose L.] Hosp Univ Marques de Valdecilla, Unidad Genet Mol, Inst Formac & Invest Marques de Valdecilla, Serv Cantabro Salud, Santander, Spain; [Berciano, Maria T.; Lafarga, Miguel] Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Gutierrez, O (corresponding author), Hosp Univ Marques de Valdecilla, Unidad Genet Mol, Inst Formac & Invest Marques de Valdecilla, Serv Cantabro Salud, Santander, Spain.	fluna@humv.es	Xie, Huangming/B-2260-2012	Lafarga, Miguel/0000-0003-3402-1152; Berciano, Maria T./0000-0002-8225-6995	Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) [RD06/0020/0074, PI070196]; Fundacion Marques de Valdecilla [API08/01]	Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marques de Valdecilla(Instituto de Salud Carlos III)	Funding: This work was supported by Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) grant RD06/0020/0074 (Red Tematica de Investigacion Cooperativa en Cancer), PI070196, and Accion Transversal del Cancer 2008, and grant API08/01 from Fundacion Marques de Valdecilla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Benito A, 1996, BLOOD, V87, P3837, DOI 10.1182/blood.V87.9.3837.bloodjournal8793837; Benito A, 2006, J BIOL CHEM, V281, P38351, DOI 10.1074/jbc.M607004200; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; GEFEN N, LEUKEMIA, V24, P89; Gloushankova N, 1997, ONCOGENE, V15, P2985, DOI 10.1038/sj.onc.1201483; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hong M, 1999, CANCER RES, V59, P2847; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; KHATIB ZA, 1994, GENOMICS, V23, P344, DOI 10.1006/geno.1994.1510; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; LEUNG AK, MOL CELL, V40, P205; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Rizzo MG, 1998, BRIT J CANCER, V77, P1429, DOI 10.1038/bjc.1998.236; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Wang PY, 2010, MOL CELL BIOCHEM, V339, P163, DOI 10.1007/s11010-009-0380-2; Wittmann T, 2001, J CELL SCI, V114, P3795; Xie SY, 2010, ONCOL REP, V23, P1693, DOI 10.3892/or_00000813; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17169	10.1371/journal.pone.0017169	http://dx.doi.org/10.1371/journal.pone.0017169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347262	gold, Green Published			2022-12-25	WOS:000287364500037
J	Sultana, R; Tanneeru, K; Guruprasad, L				Sultana, Rafiya; Tanneeru, Karunakar; Guruprasad, Lalitha			The PE-PPE Domain in Mycobacterium Reveals a Serine alpha/beta Hydrolase Fold and Function: An In-Silico Analysis	PLOS ONE			English	Article							CUTINASE-LIKE PROTEINS; GAP PENALTIES; TUBERCULOSIS; PURIFICATION; SEQUENCE; TRIACYLGLYCEROL; EXPRESSION; FAMILY; LIPASE; IDENTIFICATION	The PE and PPE proteins first reported in the genome sequence of Mycobacterium tuberculosis strain H37Rv are now identified in all mycobacterial species. The PE-PPE domain (Pfam ID: PF08237) is a 225 amino acid residue conserved region located towards the C-terminus of some PE and PPE proteins and hypothetical proteins. Our in-silico sequence analysis revealed that this domain is present in all Mycobacteria, some Rhodococcus and Nocardia farcinica genomes. This domain comprises a pentapeptide sequence motif GxSxG/S at the N-terminus and conserved amino acid residues Ser, Asp and His that constitute a catalytic triad characteristic of lipase, esterase and cutinase activity. The fold prediction and comparative modeling of the 3-D structure of the PE-PPE domain revealed a "serine alpha/beta hydrolase'' structure with a central beta-sheet flanked by alpha-helices on either side. The structure comprises a lid insertion with a closed structure conformation and has a solvent inaccessible active site. The oxyanion hole that stabilizes the negative charge on the tetrahedral intermediate has been identified. Our findings add to the growing list of serine hydrolases in mycobacterium, which are essential for the maintenance of their impermeable cell wall and virulence. These results provide the directions for the design of experiments to establish the function of PE and PPE proteins.	[Sultana, Rafiya; Tanneeru, Karunakar; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Sultana, R (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	lgpsc@uohyd.ernet.in	Tanneeru, Karunakar/C-8200-2019; Tanneeru, Karunakar/C-8946-2016	Tanneeru, PhD, FICS, Dr. Karunakar/0000-0002-9250-6476	CSIR, New Delhi India; Council of Scientific and Industrial Research	CSIR, New Delhi India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The students Ms. Rafiya Sultana and Mr. Karunakar Tanneeru received fellowships from CSIR, New Delhi India. This funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RS and KT thank Council of Scientific and Industrial Research for providing research fellowship. The authors thank CMSD, University of Hyderabad for the computational facility.	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brod FCA, 2010, MOL BIOTECHNOL, V44, P242, DOI 10.1007/s12033-009-9232-2; Brod FCA, 2010, MOL BIOTECHNOL, V44, P110, DOI 10.1007/s12033-009-9218-0; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; du Plessis EM, 2010, CURR MICROBIOL, V60, P248, DOI 10.1007/s00284-009-9533-5; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fett WF, 1999, J APPL MICROBIOL, V86, P561, DOI 10.1046/j.1365-2672.1999.00690.x; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Ilinkin I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-71; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN TS, 1980, PHYSIOL PLANT PATHOL, V17, P1, DOI 10.1016/0048-4059(80)90002-8; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Narayana Y, 2007, CLIN VACCINE IMMUNOL, V14, P1334, DOI 10.1128/CVI.00181-07; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Park IH, 2009, J MICROBIOL BIOTECHN, V19, P128, DOI 10.4014/jmb.0802.130; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; SEBASTIAN J, 1988, ARCH BIOCHEM BIOPHYS, V263, P77, DOI 10.1016/0003-9861(88)90615-7; SEBASTIAN J, 1987, J BACTERIOL, V169, P131, DOI 10.1128/jb.169.1.131-136.1987; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SIMONE GD, 2004, J BIOL CHEM, V279, P6815; Singh G, 2010, CRIT REV MICROBIOL, V36, P259, DOI 10.3109/1040841X.2010.482923; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421	43	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16745	10.1371/journal.pone.0016745	http://dx.doi.org/10.1371/journal.pone.0016745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347309	Green Published, Green Submitted, gold			2022-12-25	WOS:000287363000016
J	Sriwilaijaroen, N; Kondo, S; Yagi, H; Takemae, N; Saito, T; Hiramatsu, H; Kato, K; Suzuki, Y				Sriwilaijaroen, Nongluk; Kondo, Sachiko; Yagi, Hirokazu; Takemae, Nobuhiro; Saito, Takehiko; Hiramatsu, Hiroaki; Kato, Koichi; Suzuki, Yasuo			N-Glycans from Porcine Trachea and Lung: Predominant NeuAc alpha 2-6Gal Could Be a Selective Pressure for Influenza Variants in Favor of Human-Type Receptor	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; GLYCOLYLNEURAMINIC ACID; BINDING PROPERTIES; VIRUS-INFECTION; MOLECULAR-BASIS; H5N1 INFLUENZA; HOST-RANGE; A VIRUSES; ORIGIN; CELLS	It is known that pigs acted as "mixing vessels" for genesis of a new reassortant influenza strain responsible for pandemic H1N1 2009. However, the host factors driving the evolution of a reassorted virus in pigs to 'jump species' resulting in a human outbreak remain unclear. N-glycans derived from the porcine respiratory tract were enzymatically released, fluorescent labeled with 2-aminopyridine, separated according to charge, size and hydrophobicity, and structurally identified by a two-dimensional (size and hydrophobicity) HPLC mapping technique and MALDI-TOF mass spectrometry before and after exo-glycosidase digestion. We found a 3-, 5-, and 13-fold increases in NeuAc alpha 2-6, a preferable human influenza receptor, over NeuAc alpha 2-3, an avian influenza receptor, from upper and lower parts of the porcine trachea towards the porcine lung, a major target organ for swine virus replication. The large proportion of NeuAc alpha 2-6 may exert selective pressure for selection of influenza variants with altered receptor preference for this human-type alpha 2-6 receptor, a crucial first step for generating a human pandemic.	[Sriwilaijaroen, Nongluk] Thammasat Univ, Fac Med, Pathum Thani, Thailand; [Sriwilaijaroen, Nongluk; Hiramatsu, Hiroaki; Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Aichi, Japan; [Kondo, Sachiko; Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Aichi, Japan; [Kondo, Sachiko; Kato, Koichi] GLYENCE Co Ltd, Aichi, Japan; [Takemae, Nobuhiro; Saito, Takehiko] Thailand Japan Zoonot Dis Collaborat Ctr, Bangkok, Thailand; [Takemae, Nobuhiro; Saito, Takehiko] Natl Agr & Food Res Org NARO, Res Team Zoonot Dis, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan; [Kato, Koichi] Inst Mol Sci, Aichi, Japan; [Kato, Koichi] Natl Inst Natl Sci, Okazaki Inst Integrat Biosci, Aichi, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Tokyo 112, Japan; [Suzuki, Yasuo] Univ Shizuoka, Sch Pharmaceut Sci, Global COE Program Innovat Human Sci, Shizuoka 4228526, Japan	Thammasat University; Chubu University; Nagoya City University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Ochanomizu University; University of Shizuoka	Sriwilaijaroen, N (corresponding author), Thammasat Univ, Fac Med, Rangsit Campus, Pathum Thani, Thailand.	suzukiy@isc.chubu.ac.jp	Saito, Takehiko/AFM-3038-2022; Yagi, Hirokazu/ABH-6151-2020	Yasuo, Suzuki/0000-0003-3518-5642; Sriwilaijaroen, Nongluk/0000-0001-7351-6102; Kato, Koichi/0000-0001-7187-9612; Yagi, Hirokazu/0000-0001-9296-0225	Ministry of Education, Culture, Sports, Science and Technology, Japan [20390028]; Health and Labor Science Research Grants, Japan; Grants-in-Aid for Scientific Research [22790076] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Science Research Grants, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant-in-aid (20390028) for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by Health and Labor Science Research Grants, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although GLYENCE Co., Ltd., did not provide direct financial support, it can be considered as an indirect funder for this study. SK and KK are an employee and an advisory director, respectively, of GLYENCE Co., Ltd., Therefore GLYENCE Co., Ltd., played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bewley CA, 2008, NAT BIOTECHNOL, V26, P60, DOI 10.1038/nbt0108-60; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; FABLET C, 2010, VET MICROBI IN PRESS; Gambaryan AS, 2005, VIRUS RES, V114, P15, DOI 10.1016/j.virusres.2005.05.005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gibbs MJ, 2006, NATURE, V440, pE8, DOI 10.1038/nature04823; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; HUSSEINI RH, 1983, J GEN VIROL, V64, P589, DOI 10.1099/0022-1317-64-3-589; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Olsen CW, 2006, DIS SWINE, V9, P469; Roberts Bryan, 2008, P3, DOI 10.1007/978-0-387-75722-3_1; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Sriwilaijaroen N, 2009, GLYCOCONJUGATE J, V26, P433, DOI 10.1007/s10719-008-9193-x; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Takahashi N, 2008, EXPT GLYCOSCIENCE GL, P7, DOI DOI 10.1007/978-4-431-77924-72; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034	39	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16302	10.1371/journal.pone.0016302	http://dx.doi.org/10.1371/journal.pone.0016302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347401	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700015
J	Valero, J; Espana, J; Parra-Damas, A; Martin, E; Rodriguez-Alvarez, J; Saura, CA				Valero, Jorge; Espana, Judit; Parra-Damas, Arnaldo; Martin, Elsa; Rodriguez-Alvarez, Jose; Saura, Carlos A.			Short-Term Environmental Enrichment Rescues Adult Neurogenesis and Memory Deficits in APP(Sw,Ind) Transgenic Mice	PLOS ONE			English	Article							DENTATE GRANULE CELLS; AMYLOID-BETA PROTEIN; ALZHEIMERS-DISEASE; MOUSE MODEL; HIPPOCAMPAL NEUROGENESIS; NEUROPSYCHOLOGICAL REHABILITATION; PHYSICAL-ACTIVITY; OLFACTORY-BULB; SHOLL ANALYSIS; NEURONS	Epidemiological studies indicate that intellectual activity prevents or delays the onset of Alzheimer's disease (AD). Similarly, cognitive stimulation using environmental enrichment (EE), which increases adult neurogenesis and functional integration of newborn neurons into neural circuits of the hippocampus, protects against memory decline in transgenic mouse models of AD, but the mechanisms involved are poorly understood. To study the therapeutic benefits of cognitive stimulation in AD we examined the effects of EE in hippocampal neurogenesis and memory in a transgenic mouse model of AD expressing the human mutant beta-amyloid (A beta) precursor protein (APP(Sw,Ind)). By using molecular markers of new generated neurons (bromodeoxiuridine, NeuN and doublecortin), we found reduced neurogenesis and decreased dendritic length and projections of doublecortin-expressing cells of the dentate gyrus in young APP(Sw,Ind) transgenic mice. Moreover, we detected a lower number of mature neurons (NeuN positive) in the granular cell layer and a reduced volume of the dentate gyrus that could be due to a sustained decrease in the incorporation of new generated neurons. We found that short-term EE for 7 weeks efficiently ameliorates early hippocampal-dependent spatial learning and memory deficits in APP(Sw,Ind) transgenic mice. The cognitive benefits of enrichment in APP(Sw,Ind) transgenic mice were associated with increased number, dendritic length and projections to the CA3 region of the most mature adult newborn neurons. By contrast, A beta levels and the total number of neurons in the dentate gyrus were unchanged by EE in APP(Sw,Ind) mice. These results suggest that promoting the survival and maturation of adult generated newborn neurons in the hippocampus may contribute to cognitive benefits in AD mouse models.	[Valero, Jorge; Espana, Judit; Parra-Damas, Arnaldo; Martin, Elsa; Rodriguez-Alvarez, Jose; Saura, Carlos A.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain	Autonomous University of Barcelona; CIBERNED	Valero, J (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain.	carlos.saura@uab.es	Valero, Jorge/I-4478-2013; Rodriguez-Alvarez, Jose/F-8403-2011; Valero, Jorge/AAG-8053-2019; Saura, Carlos A/AFM-9239-2022; Saura, Carlos A/D-2727-2011; Parra-Damas, Arnaldo/A-8629-2018	Valero, Jorge/0000-0001-6072-3313; Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Valero, Jorge/0000-0001-6072-3313; Saura, Carlos A/0000-0003-3692-5657; Parra-Damas, Arnaldo/0000-0001-5683-060X	Ministerio de Ciencia e Innovacion [SAF2007-64115, SAF2010-20925, CB06/05/0042]; European Commission [200611]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF2007-64115, SAF2010-20925 and CIBERNED CB06/05/0042) and the 7th Framework Programme of the European Commission (MEMOSAD project, Grant 200611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrisqueta-Gomez J, 2004, ARQ NEURO-PSIQUIAT, V62, P778, DOI 10.1590/S0004-282X2004000500007; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Anderton BH, 1998, PROG NEUROBIOL, V55, P595, DOI 10.1016/S0301-0082(98)00022-7; Avila R, 2004, BRAZ J MED BIOL RES, V37, P1721, DOI 10.1590/S0100-879X2004001100018; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Berardi N, 2007, J ALZHEIMERS DIS, V11, P359; CABALKA LM, 1992, NEUROBIOL AGING, V13, P283, DOI 10.1016/0197-4580(92)90041-U; Catlow BJ, 2009, BRAIN RES, V1256, P173, DOI 10.1016/j.brainres.2008.12.028; Clare L, 2002, NEUROPSYCHOLOGY, V16, P538, DOI 10.1037//0894-4105.16.4.538; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cotel MC, 2012, NEUROBIOL AGING, V33, P96, DOI 10.1016/j.neurobiolaging.2010.02.012; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dong SZ, 2007, EUR J NEUROSCI, V26, P101, DOI 10.1111/j.1460-9568.2007.05641.x; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Espana J, 2010, J NEUROSCI, V30, P9402, DOI 10.1523/JNEUROSCI.2154-10.2010; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; FRIEDLAND RP, 1993, NEUROLOGY, V43, P246, DOI 10.1212/WNL.43.2.246; Gan L, 2008, NEUROBIOL DIS, V29, P71, DOI 10.1016/j.nbd.2007.08.002; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gomez C, 2005, J CHEM NEUROANAT, V29, P238, DOI 10.1016/j.jchemneu.2005.01.005; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hastings NB, 2001, CLIN NEUROSCI RES, V1, P175, DOI 10.1016/S1566-2772(01)00003-2; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Ide Y, 2008, EUR J NEUROSCI, V28, P2381, DOI 10.1111/j.1460-9568.2008.06548.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; JURASKA JM, 1985, BRAIN RES, V333, P73, DOI 10.1016/0006-8993(85)90125-8; Kaneko N, 2009, NEUROSCI RES, V63, P155, DOI 10.1016/j.neures.2008.12.001; Kee N, 2007, NAT PROTOC, V2, P3033, DOI 10.1038/nprot.2007.415; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LAZAROV O, 2009, EXP NEUROL; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Li S, 2008, LIFE SCI, V82, P934, DOI 10.1016/j.lfs.2008.02.010; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Milosevic NT, 2007, J THEOR BIOL, V245, P130, DOI 10.1016/j.jtbi.2006.09.022; MIROCHNIC S, 2009, HIPPOCAMPUS; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Petreanu L, 2002, J NEUROSCI, V22, P6106; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Ristanovic D, 2006, J NEUROSCI METH, V158, P212, DOI 10.1016/j.jneumeth.2006.05.030; SCHAEFFER EL, 2009, PROG NEUROPSYCHOPHAR; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Su Y, 1998, J NEUROSCI RES, V53, P177, DOI 10.1002/(SICI)1097-4547(19980715)53:2<177::AID-JNR6>3.0.CO;2-4; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Valero J, 2007, DEV NEUROBIOL, V67, P839, DOI 10.1002/dneu.20352; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Wu CC, 2004, P NATL ACAD SCI USA, V101, P7141, DOI 10.1073/pnas.0402147101; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	84	69	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16832	10.1371/journal.pone.0016832	http://dx.doi.org/10.1371/journal.pone.0016832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347380	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700040
J	Koch, CM; Suschek, CV; Lin, QO; Bork, S; Goergens, M; Joussen, S; Pallua, N; Ho, AD; Zenke, M; Wagner, W				Koch, Carmen M.; Suschek, Christoph V.; Lin, Qiong; Bork, Simone; Goergens, Maria; Joussen, Sylvia; Pallua, Norbert; Ho, Anthony D.; Zenke, Martin; Wagner, Wolfgang			Specific Age-Associated DNA Methylation Changes in Human Dermal Fibroblasts	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; GENE-EXPRESSION; STEM-CELLS; DIFFERENTIATION; CULTURE; SKIN; INK4/ARF; CANCER; TISSUE; SITE	Epigenetic modifications of cytosine residues in the DNA play a critical role for cellular differentiation and potentially also for aging. In mesenchymal stromal cells (MSC) from human bone marrow we have previously demonstrated age-associated methylation changes at specific CpG-sites of developmental genes. In continuation of this work, we have now isolated human dermal fibroblasts from young (<23 years) and elderly donors (>60 years) for comparison of their DNA methylation profiles using the Infinium HumanMethylation27 assay. In contrast to MSC, fibroblasts could not be induced towards adipogenic, osteogenic and chondrogenic lineage and this is reflected by highly significant differences between the two cell types: 766 CpG sites were hyper-methylated and 752 CpG sites were hypo-methylated in fibroblasts in comparison to MSC. Strikingly, global DNA methylation profiles of fibroblasts from the same dermal region clustered closely together indicating that fibroblasts maintain positional memory even after in vitro culture. 75 CpG sites were more than 15% differentially methylated in fibroblasts upon aging. Very high hyper-methylation was observed in the aged group within the INK4A/ARF/INK4b locus and this was validated by pyrosequencing. Age-associated DNA methylation changes were related in fibroblasts and MSC but they were often regulated in opposite directions between the two cell types. In contrast, long-term culture associated changes were very consistent in fibroblasts and MSC. Epigenetic modifications at specific CpG sites support the notion that aging represents a coordinated developmental mechanism that seems to be regulated in a cell type specific manner.	[Koch, Carmen M.; Lin, Qiong; Joussen, Sylvia; Zenke, Martin; Wagner, Wolfgang] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Sch Med, Aachen, Germany; [Suschek, Christoph V.; Goergens, Maria; Pallua, Norbert] Rhein Westfal TH Aachen, Dept Plast & Reconstruct Surg, Burn Ctr, Sch Med, Aachen, Germany; [Bork, Simone; Ho, Anthony D.] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Bork, Simone] Heidelberg Acad Sci & Humanities, Heidelberg, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; Ruprecht Karls University Heidelberg	Koch, CM (corresponding author), Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Sch Med, Aachen, Germany.	wwagner@ukaachen.de	Lin, Qiong/J-6880-2015	Lin, Qiong/0000-0002-7964-6191; Wagner, Wolfgang/0000-0002-1971-3217; Ho, Anthony D./0000-0002-1656-0833	Heidelberg Academy of Sciences (WIN-Kolleg); German Ministry of Education and Research (BMBF); German federal and state governments; Faculty of Medicine, RWTH Aachen; Stem Cell Network North Rhine Westphalia	Heidelberg Academy of Sciences (WIN-Kolleg); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German federal and state governments; Faculty of Medicine, RWTH Aachen; Stem Cell Network North Rhine Westphalia	This work was supported by the Heidelberg Academy of Sciences (WIN-Kolleg), by the German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine" (CB-HERMES), by the excellence initiative of the German federal and state governments, by the START-Program of the Faculty of Medicine, RWTH Aachen and by the Stem Cell Network North Rhine Westphalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2010, AGING-US, V2, P93, DOI 10.18632/aging.100121; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Boukamp P, 2005, CURR MOL MED, V5, P171, DOI 10.2174/1566524053586644; BROTMAN HF, 1977, J EXP ZOOL, V200, P243, DOI 10.1002/jez.1402000206; Cappellesso-Fleury S, 2010, J CLIN IMMUNOL, V30, P607, DOI 10.1007/s10875-010-9415-4; Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen FG, 2007, J CELL SCI, V120, P2875, DOI 10.1242/jcs.03478; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; HORN P, 2010, CYTOTHERAPY IN PRESS; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; JINTARIDTH P, 2010, PHYSL GENOMICS; Junker JPE, 2010, CELLS TISSUES ORGANS, V191, P105, DOI 10.1159/000232157; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; KUAN PF, 2010, BIOINFORMAT IN PRESS; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; MUNOZNAJAR UM, 2010, EPIGENETIC CONTROL A; Murgatroyd C, 2010, AGING-US, V2, P107; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schallmoser K, 2010, HAEMATOL-HEMATOL J, V95, P867, DOI 10.3324/haematol.2009.011692; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; So KJ, 2006, CANCER SCI, V97, P1155, DOI 10.1111/j.1349-7006.2006.00302.x; TABIN CJ, 1992, DEVELOPMENT, V116, P289; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; WILSON VL, 1987, J BIOL CHEM, V262, P9948; WILSON VL, 1983, SCIENCE, V220, P1054; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	62	98	102	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16679	10.1371/journal.pone.0016679	http://dx.doi.org/10.1371/journal.pone.0016679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347436	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600015
J	Liu, HJ; Niu, AR; Chen, SE; Li, YP				Liu, Huijie; Niu, Airu; Chen, Shuen-Ei; Li, Yi-Ping			beta 3-Integrin mediates satellite cell differentiation in regenerating mouse muscle	FASEB JOURNAL			English	Article						myogenic gene expression; myoblast migration; myoblast fusion; focal adhesion; Rac1	ALPHA-V-BETA-3 INTEGRIN; RHO-FAMILY; MYOGENESIS; ACTIVATION; EXPRESSION; REGULATORS; SARCOMERE; MYOBLASTS; ADHESION; GTPASES	Skeletal muscle satellite cells can sense various forms of environmental cues and initiate coordinated signaling that activates myogenesis. Although this process involves cellular membrane receptor integrins, the role of integrins in myogenesis is not well defined. Here, we report a regulatory role of beta 3-integrin, which was previously thought not expressed in muscle, in the initiation of satellite cell differentiation. Undetected in normal muscle, beta 3-integrin expression in mouse hindlimb muscles is induced dramatically from 1 to 3 d after injury by cardiotoxin. The source of beta 3-integrin expression is found to be activated satellite cells. Proliferating C2C12 myoblasts also express beta 3-integrin, which is further up-regulated transiently on differentiation. Knockdown of beta 3-integrin expression attenuates Rac1 activity, impairs myogenic gene expression, and disrupts focal adhesion formation and actin organization, resulting in impaired myoblast migration and myotube formation. Conversely, overexpression of constitutively active Rac1 rescues myotube formation. In addition, a beta 3-integrin-neutralizing antibody similarly blocked myotube formation. Comparing with wild-type littermates, myogenic gene expression and muscle regeneration in cardiotoxin-injured beta 3-integrin-null mice are impaired, as indicated by depressed expression of myogenic markers and morphological disparities. Thus, beta 3-integrin is a mediator of satellite cell differentiation in regenerating muscle.-Liu, H., Niu, A., Chen, S.-E., Li, Y.-P. beta 3-Integrin mediates satellite cell differentiation in regenerating mouse muscle. FASEB J. 25, 1914-1921 (2011). www.fasebj.org	[Liu, Huijie; Niu, Airu; Li, Yi-Ping] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Chen, Shuen-Ei] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Li, YP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	yi-ping.li@uth.tmc.edu	Chen, Shuen-Ei/AAE-3574-2019; Chen, Shuen-Ei/B-2341-2019; Li, Yi-Ping/ABF-9245-2020	Chen, Shuen-Ei/0000-0003-1737-2591; 	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR049022]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049022] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01 AR049022 to Y.-P.L.	Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Blaschuk KL, 1997, DEV BIOL, V184, P266, DOI 10.1006/dbio.1997.8527; Bryan BA, 2005, CELL MOL LIFE SCI, V62, P1547, DOI 10.1007/s00018-005-5029-z; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; GULLBERG D, 1998, FRONT BIOSCI, V3, P1039; Hirsch E, 1998, J CELL SCI, V111, P2397; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Konttinen YT, 2004, RHEUMATOL INT, V24, P333, DOI 10.1007/s00296-003-0379-z; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Nodari A, 2007, J CELL BIOL, V177, P1063, DOI 10.1083/jcb.200610014; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Silver Frederick H, 2003, Crit Rev Biomed Eng, V31, P255, DOI 10.1615/CritRevBiomedEng.v31.i4.10; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wei L, 2000, AM J PHYSIOL-HEART C, V278, pH1736, DOI 10.1152/ajpheart.2000.278.6.H1736; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372	21	47	49	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1914	1921		10.1096/fj.10-170449	http://dx.doi.org/10.1096/fj.10-170449			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21350117	Green Published, Bronze			2022-12-25	WOS:000291023800015
J	MacManus, CF; Campbell, EL; Keely, S; Burgess, A; Kominsky, DJ; Colgan, SP				MacManus, Christopher F.; Campbell, Eric L.; Keely, Simon; Burgess, Adrianne; Kominsky, Douglas J.; Colgan, Sean P.			Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization	FASEB JOURNAL			English	Article						endothelia; epithelia; hypoxia; inflammation; mucosa	SMOOTH-MUSCLE-CELLS; EXPERIMENTAL COLITIS; MURINE MODEL; IN-VITRO; HYPOXIA; INDUCTION; PROTEINS; RECEPTOR; HYDROXYLATION; EXPRESSION	In intact mucosal tissues, epithelial cells are anatomically positioned in proximity to a number of subepithelial cell types, including endothelia. A number of recent studies have suggested that imbalances between energy supply and demand can result in "inflammatory hypoxia." Given these associations, we hypothesized that endothelial-derived, hypoxia-inducible mediators might influence epithelial function. Guided by cDNA microarray analysis of human microvascular endothelial cells (HMEC-1 line) subjected to hypoxia (pO(2) 20 torr, 8 h), we identified adrenomedullin (ADM) as a prominent hypoxia-inducible factor (HIF) that acts on epithelial cells through cell surface receptors. We assessed the functional ability for exogenous ADM to signal in human intestinal Caco2 cells in vitro by demonstrating a dose-dependent induction of Erk1/2phosphorylation. Further analysis revealed that ADM deneddylates cullin-2 (Cul2), whose action has been demonstrated to control the activity of HIF. Caco2 cells stably expressing a hypoxic response element (HRE)-driven luciferase promoter confirmed that ADM activates the HIF signaling pathway. Extensions of these studies revealed an increase in canonical HIF-1-dependent genes following stimulation with ADM. To define physiological relevance, we investigated the effect of ADM in a DSS model of murine colitis. Administration of ADM resulted in reduced inflammatory indices and less severe histological inflammation compared to vehicle controls. Analysis of tissue and serum cytokines showed a marked and significant inhibition of colitis-associated TNF-alpha, IL-1 beta, and KC. Analysis of circulating ADM demonstrated an increase in serum ADM in murine models of colitis. Taken together, these results identify ADM as an endogenously generated vascular mediator that functions as a mucosal protective factor through fine tuning of HIF activity.-MacManus, C.F., Campbell, E.L., Keely, S., Burgess, A., Kominsky, D.J., Colgan, S.P. Antiinflammatory actions of adrenomedullin through fine tuning of HIF stabilization. FASEB J. 25, 1856-1864 (2011). www.fasebj.org	[MacManus, Christopher F.; Campbell, Eric L.; Keely, Simon; Burgess, Adrianne; Kominsky, Douglas J.; Colgan, Sean P.] Univ Colorado, Hlth Sci Ctr, Mucosal Inflammat Program, Aurora, CO 80045 USA; [MacManus, Christopher F.; Campbell, Eric L.; Keely, Simon; Burgess, Adrianne; Colgan, Sean P.] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA; [Kominsky, Douglas J.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol & Perioperat Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Colgan, SP (corresponding author), Univ Colorado, Hlth Sci Ctr, Mucosal Inflammat Program, 12700 E 19th Ave, Aurora, CO 80045 USA.	sean.colgan@ucdenver.edu	Keely, Simon/AAV-9973-2020; Campbell, Eric/N-5357-2015	Keely, Simon/0000-0002-1248-9590; Campbell, Eric/0000-0003-0744-6577	U.S. National Institutes of Health [DK50189, DE016191, HL60569]; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050189, R37DK050189, R01DK050189] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants DK50189, DE016191, and HL60569 and by grants from the Crohn's and Colitis Foundation of America. The authors declare no financial interests in any of the work submitted here.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Andreis PG, 2000, ENDOCRINOLOGY, V141, P2098, DOI 10.1210/en.141.6.2098; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Cueille C, 2005, BIOCHEM BIOPH RES CO, V326, P23, DOI 10.1016/j.bbrc.2004.10.205; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Eltzschig HK, 2009, EXPERT OPIN THER TAR, V13, P1267, DOI 10.1517/14728220903241666; Gonzalez-Rey E, 2006, GUT, V55, P824, DOI 10.1136/gut.2005.084525; Gonzalez-Rey E, 2007, AM J PATHOL, V170, P263, DOI 10.2353/ajpath.2007.060596; Hatoum OA, 2003, AM J PHYSIOL-HEART C, V285, pH1791, DOI 10.1152/ajpheart.00552.2003; Hirota SA, 2010, GASTROENTEROLOGY, V139, P259, DOI 10.1053/j.gastro.2010.03.045; Iwasaki H, 2001, ENDOCRINOLOGY, V142, P564, DOI 10.1210/en.142.2.564; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2009, FASEB J, V23, P1338, DOI 10.1096/fj.08-125344; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kruschewski M, 2001, DIGEST DIS SCI, V46, P2336, DOI 10.1023/A:1012334727509; Kuwasako K, 2004, PEPTIDES, V25, P2003, DOI 10.1016/j.peptides.2004.06.002; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Mikus P, 2005, SEMIN CELL DEV BIOL, V16, P462, DOI 10.1016/j.semcdb.2005.03.002; Mittra S, 2006, AM J PHYSIOL-HEART C, V290, pH1842, DOI 10.1152/ajpheart.00388.2005; Miyashita K, 2003, FEBS LETT, V544, P86, DOI 10.1016/S0014-5793(03)00484-8; Nakayama M, 1998, BIOCHEM BIOPH RES CO, V243, P514, DOI 10.1006/bbrc.1998.8131; Nikitenko LL, 2003, FASEB J, V17, P1499, DOI 10.1096/fj.02-0993fje; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; Qi T, 2010, BRIT J PHARMACOL, V159, P1059, DOI 10.1111/j.1476-5381.2009.00541.x; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Shichiri M, 2003, REGUL PEPTIDES, V112, P167, DOI 10.1016/S0167-0115(03)00036-3; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Talero E, 2008, PEPTIDES, V29, P2001, DOI 10.1016/j.peptides.2008.07.013; Temmesfeld-Wollbruck B, 2009, AM J PHYSIOL-GASTR L, V297, pG43, DOI 10.1152/ajpgi.90532.2008; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhao L, 1996, AM J PHYSIOL-HEART C, V271, pH622, DOI 10.1152/ajpheart.1996.271.2.H622; Zudaire E, 2006, J LEUKOCYTE BIOL, V80, P237, DOI 10.1189/jlb.0206123	40	37	38	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2011	25	6					1856	1864		10.1096/fj.10-170316	http://dx.doi.org/10.1096/fj.10-170316			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21350119	Green Published			2022-12-25	WOS:000291023800009
J	Mitra, S; Lee, JS; Cantrell, M; Van den Berg, CL				Mitra, Shreya; Lee, Ju-Seog; Cantrell, Michael; Van den Berg, Carla Lynn			c-Jun N-terminal Kinase 2 (JNK2) Enhances Cell Migration through Epidermal Growth Factor Substrate 8 (EPS8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; FACTOR RECEPTOR; BREAST-CANCER; NH2-TERMINAL KINASE; PANCREATIC-CANCER; DORSAL RUFFLES; EXPRESSION; RAC; MOTILITY; TRANSFORMATION	Membrane-bound receptors induce biochemical signals to remodel the actin cytoskeleton and mediate cell motility. In association with receptor tyrosine kinases, several downstream mitogen-induced kinases facilitate cell migration. Here, we show a role for c-Jun N-terminal kinase 2 (JNK2) in promoting mammary cancer cell migration through inhibition of epidermal growth factor substrate 8 (EPS8) expression, a key regulator of EGF receptor (R) signaling and trafficking. Using jnk2(-/-) mice, we found that EPS8 expression is higher in polyoma middle T antigen (PyVMT)jnk2(-/-) mammary tumors and jnk2(-/-) mammary glands compared with the respective jnk2(-/-) controls. The inverse relationship between the jnk2 and eps8 expression was also associated with cancer progression in that patients with basal-type breast tumors expressing high jnk2 and low eps8 experienced poor disease-free survival. In mammary tumor cell lines, the absence of jnk2 greatly reduces cell migration that is rescued by EPS8 knockdown. Subsequent studies show that JNK2 enhances formation of the EPS8-Abi-1-Sos-1 complex to augment EGFR activation of Akt and ERK, whereas the absence of JNK2 promotes ESP8/RN-Tre association to inhibit endocytotic trafficking of the EGFR. Together, these studies unveil a critical role for JNK2 and EPS8 in receptor tyrosine kinase signaling and trafficking to convey distinctly different effects on cell migration.	[Mitra, Shreya; Van den Berg, Carla Lynn] Univ Texas Austin, Coll Pharm, Div Pharmacol Toxicol, Austin, TX 78712 USA; [Mitra, Shreya; Van den Berg, Carla Lynn] Univ Texas Austin, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Cantrell, Michael] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mitra, Shreya; Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Div Canc Med, Houston, TX 77054 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Van den Berg, CL (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol Toxicol, Austin, TX 78712 USA.	cvandenberg@mail.utexas.edu	Lee, Ju-Seog/X-1786-2018	Lee, Ju-Seog/0000-0002-5666-9753	National Institutes of Health [CA 100238]; NATIONAL CANCER INSTITUTE [R01CA100238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 100238 (to C. L. V. D. B.).	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Bost F, 1999, MOL CELL BIOL, V19, P1938; Chen NY, 2001, CANCER RES, V61, P3908; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Disanza A, 2009, MOL ONCOL, V3, P280, DOI 10.1016/j.molonc.2009.05.008; Dreskin SC, 2001, J IMMUNOL, V166, P5646, DOI 10.4049/jimmunol.166.9.5646; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gallo R, 1997, ONCOGENE, V15, P1929, DOI 10.1038/sj.onc.1201344; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Inobe M, 1999, BIOCHEM BIOPH RES CO, V266, P216, DOI 10.1006/bbrc.1999.1782; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Joslin EJ, 2007, J CELL SCI, V120, P3688, DOI 10.1242/jcs.010488; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu PS, 2010, ONCOGENE, V29, P3977, DOI 10.1038/onc.2010.144; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; Matoskova B, 1996, ONCOGENE, V12, P2679; MATOSKOVA B, 1995, MOL CELL BIOL, V15, P3805; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tang J, 2003, BIOCHEM BIOPH RES CO, V312, P930, DOI 10.1016/j.bbrc.2003.11.016; Teranishi F, 2009, CANCER SCI, V100, P770, DOI 10.1111/j.1349-7006.2009.01084.x; Tomshine JC, 2009, J BIOL CHEM, V284, P26331, DOI 10.1074/jbc.M109.033514; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Tsuiki H, 2003, CANCER RES, V63, P250; Wang X, 2010, HUM PATHOL, V41, P401, DOI 10.1016/j.humpath.2009.08.018; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Welsch T, 2007, CANCER LETT, V255, P205, DOI 10.1016/j.canlet.2007.04.008; Weston CR, 2003, GENE DEV, V17, P1271, DOI 10.1101/gad.1087303; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Xu M, 2009, ENDOCRINOLOGY, V150, P2064, DOI 10.1210/en.2008-1265; Yamazaki T, 2002, J CELL SCI, V115, P1791; YANG SS, 1995, J BIOL CHEM, V270, P18212, DOI 10.1074/jbc.270.31.18212; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083	68	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15287	15297		10.1074/jbc.M109.094441	http://dx.doi.org/10.1074/jbc.M109.094441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357683	hybrid, Green Published			2022-12-25	WOS:000289788300060
J	Shi, SJ; Ghosh, DD; Okumura, S; Carattino, MD; Kashlan, OB; Sheng, SH; Kleyman, TR				Shi, Shujie; Ghosh, D. Dipon; Okumura, Sora; Carattino, Marcelo D.; Kashlan, Ossama B.; Sheng, Shaohu; Kleyman, Thomas R.			Base of the Thumb Domain Modulates Epithelial Sodium Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; GAMMA-SUBUNIT; FURIN; ENAC; INHIBITION; ACTIVATION; RESIDUES; PEPTIDE	The activity of the epithelial sodium channel (ENaC) is modulated by multiple external factors, including proteases, cations, anions and shear stress. The resolved crystal structure of acid-sensing ion channel 1 (ASIC1), a structurally related ion channel, and mutagenesis studies suggest that the large extracellular region is involved in recognizing external signals that regulate channel gating. The thumb domain in the extracellular region of ASIC1 has a cylinder-like structure with a loop at its base that is in proximity to the tract connecting the extracellular region to the transmembrane domains. This loop has been proposed to have a role in transmitting proton-induced conformational changes within the extracellular region to the gate. We examined whether loops at the base of the thumb domains within ENaC subunits have a similar role in transmitting conformational changes induced by external Na+ and shear stress. Mutations at selected sites within this loop in each of the subunits altered channel responses to both external Na+ and shear stress. The most robust changes were observed at the site adjacent to a conserved Tyr residue. In the context of channels that have a low open probability due to retention of an inhibitory tract, mutations in the loop activated channels in a subunit-specific manner. Our data suggest that this loop has a role in modulating channel gating in response to external stimuli, and are consistent with the hypothesis that external signals trigger movements within the extracellular regions of ENaC subunits that are transmitted to the channel gate.	[Sheng, Shaohu] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Ghosh, D. Dipon] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Sheng, SH (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S929 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	shaohu@pitt.edu	Shi, Shujie/D-4999-2012; Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702; Ghosh, D. Dipon/0000-0001-6391-5767	National Institutes of Health [R01 DK051391, R01 DK054354, R01 ES014701, K01 DK078734, P30 DK079307]; American Heart Association; Howard Hughes Medical Institute; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054354, R01DK051391, P30DK079307, K01DK078734, R37DK051391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Grants R01 DK051391, R01 DK054354, R01 ES014701, K01 DK078734, and P30 DK079307 from the National Institutes of Health.; Supported by a postdoctoral fellowship award from the American Heart Association.; Supported by the Howard Hughes Medical Institute Undergraduate Science Education Program.; Supported by a Carl W. Gottschalk Award from the American Society of Nephrology.	Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2007, AM J PHYSIOL-RENAL, V293, pF316, DOI 10.1152/ajprenal.00455.2006; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2008, EPITHELIAL SODIUM CH; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963	25	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14753	14761		10.1074/jbc.M110.191734	http://dx.doi.org/10.1074/jbc.M110.191734			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367859	Green Published, hybrid			2022-12-25	WOS:000289788300004
J	Wollert, T; Patel, A; Lee, YL; Provance, DW; Vought, VE; Cosgrove, MS; Mercer, JA; Langford, GM				Woellert, Torsten; Patel, Anamika; Lee, Ying-Lung; Provance, D. William, Jr.; Vought, Valarie E.; Cosgrove, Michael S.; Mercer, John A.; Langford, George M.			Myosin5a Tail Associates Directly with Rab3A-containing Compartments in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RAB3A; SYNAPTIC VESICLES; MELANOSOME TRANSPORT; SECRETORY GRANULES; AXONAL-TRANSPORT; PURKINJE-CELLS; ACTIVE ZONE; F-ACTIN; VA; IDENTIFICATION	Myosin-Va (Myo5a) is a motor protein associated with synaptic vesicles (SVs) but the mechanism by which it interacts has not yet been identified. A potential class of binding partners are Rab GTPases and Rab3A is known to associate with SVs and is involved in SV trafficking. We performed experiments to determine whether Rab3A interacts with Myo5a and whether it is required for transport of neuronal vesicles. In vitro motility assays performed with axoplasm from the squid giant axon showed a requirement for a Rab GTPase in Myo5a-dependent vesicle transport. Furthermore, mouse recombinant Myo5a tail revealed that it associated with Rab3A in rat brain synaptosomal preparations in vitro and the association was confirmed by immunofluorescence imaging of primary neurons isolated from the frontal cortex of mouse brains. Synaptosomal Rab3A was retained on recombinant GST-tagged Myo5a tail affinity columns in a GTP-dependent manner. Finally, the direct interaction of Myo5a and Rab3A was determined by sedimentation velocity analytical ultracentrifugation using recombinant mouse Myo5a tail and human Rab3A. When both proteins were incubated in the presence of 1 mM GTP gamma S, Myo5a tail and Rab3A formed a complex and a direct interaction was observed. Further analysis revealed that GTP-bound Rab3A interacts with both the monomeric and dimeric species of the Myo5a tail. However, the interaction between Myo5a tail and nucleotide-free Rab3A did not occur. Thus, our results show that Myo5a and Rab3A are direct binding partners and interact on SVs and that the Myo5a/Rab3A complex is involved in transport of neuronal vesicles.	[Woellert, Torsten; Patel, Anamika; Vought, Valarie E.; Cosgrove, Michael S.; Langford, George M.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Woellert, Torsten; Lee, Ying-Lung; Langford, George M.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Woellert, Torsten; Langford, George M.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Provance, D. William, Jr.; Mercer, John A.] McLaughlin Res Inst, Great Falls, MT 59405 USA	Syracuse University; Dartmouth College; Marine Biological Laboratory - Woods Hole; McLaughlin Research Institute for Biomedical Sciences, Inc.	Langford, GM (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	glangfor@syr.edu	Provance, David W/D-5294-2013; Idn, Inct/J-8385-2013	Provance, David W/0000-0002-9824-0672; Woellert, Torsten/0000-0002-3814-9623; Mercer, John/0000-0003-0307-4438; Langford, George/0000-0001-9737-2182	National Institutes of Health [CA140522, GM066901, TW007220]; NSF [MCB-0517303]; FOGARTY INTERNATIONAL CENTER [R03TW007220] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA140522 (to M. S. C.), GM066901, and TW007220 (to J. A. M. and D. W. P.) and NSF Grant MCB-0517303 (to G. M. L.).	Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; BRONDYK WH, 1995, MOL CELL BIOL, V15, P1137; Brown JR, 2004, J NEUROBIOL, V58, P175, DOI 10.1002/neu.10317; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHIN GJ, 1992, BRAIN RES, V571, P89, DOI 10.1016/0006-8993(92)90512-8; Chou JH, 2000, J BIOL CHEM, V275, P9433, DOI 10.1074/jbc.275.13.9433; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; DekkerOhno K, 1996, BRAIN RES, V714, P226, DOI 10.1016/0006-8993(95)01560-4; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Eichler TW, 2006, BIOCHEM SOC T, V34, P671, DOI 10.1042/BST0340671; Evans LL, 1998, J CELL SCI, V111, P2055; FISCHER V, 1991, NATURE, V349, P79; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Giovedi S, 2004, J BIOL CHEM, V279, P43760, DOI 10.1074/jbc.M403293200; Gramowski A, 2006, EUR J NEUROSCI, V24, P455, DOI 10.1111/j.1460-9568.2006.04892.x; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Leenders AGM, 2001, MOL BIOL CELL, V12, P3095, DOI 10.1091/mbc.12.10.3095; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; MANI F, 1994, BRAZ J MED BIOL RES, V27, P2639; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Roland JT, 2009, J BIOL CHEM, V284, P1213, DOI 10.1074/jbc.M805957200; Rose SD, 2003, J NEUROCHEM, V85, P287, DOI 10.1046/j.1471-4159.2003.01649.x; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Schlamp CL, 1996, EXP EYE RES, V63, P613, DOI 10.1006/exer.1996.0155; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; STAHL B, 1994, J BIOL CHEM, V269, P24770; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; Tabb JS, 1998, J CELL SCI, V111, P3221; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760	65	24	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14352	14361		10.1074/jbc.M110.187286	http://dx.doi.org/10.1074/jbc.M110.187286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349835	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000289556200057
J	Chung, H; Suh, EK; Han, IO; Oh, ES				Chung, Heesung; Suh, Eun-Kyung; Han, Inn-Oc; Oh, Eok-Soo			Keratinocyte-derived Laminin-332 Promotes Adhesion and Migration in Melanocytes and Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BAND ULTRAVIOLET-B; CELL-MIGRATION; BASEMENT-MEMBRANE; INTEGRIN RECEPTORS; ALPHA-3-BETA-1; EXPRESSION; INVASION; MATRIX; GAMMA-2-CHAIN	Melanocytes are highly motile cells that play an integral role in basic skin physiological processes such as wound healing and proper skin pigmentation. It has been postulated that surrounding keratinocytes contribute to melanocyte migration, but underlying mechanisms remain rather vague so far. In this study, we set out to analyze the specific potential contribution of keratinocyte components to melanocytes and melanoma cell migration-related processes. Our studies revealed that A375 human melanoma cell attachment, spreading, and migration are interestingly better supported by HaCaT keratinocyte extracellular matrix (ECM) than by self-derived A375 ECM. Moreover, HaCaT ECM caused increased integrin alpha 6 expression, adhesion-mediated focal adhesion kinase phosphorylation, and focal adhesion formations. Similar effects were confirmed in human melanocytes. Furthermore, we found that keratinocyte-derived soluble factors did not appear to significantly contribute to these processes. Specific extrinsic factors that promoted melanoma migration were attributed to keratinocyte-derived laminin-332, whereas alternative ECM component such as laminin-111 and fibronectin functions appeared to have insignificant contributions. Taken together, these studies implicate extrinsic laminin-332 in promoting the high mobility property and perhaps invasiveness inherently characteristic of, and that are the menace of, melanocytes and melanomas, respectively.	[Chung, Heesung; Suh, Eun-Kyung; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Chung, Heesung; Suh, Eun-Kyung; Oh, Eok-Soo] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Han, Inn-Oc] Inha Univ, Coll Med, Dept Physiol & Biophys, Inchon 402751, South Korea	Ewha Womans University; Ewha Womans University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	OhES@ewha.ac.kr			Ministry of Education, Science and Technology [2009-0071381]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 2009-0071381 (to E.-S.O.).	CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; D'Alessio S, 2008, J CELL SCI, V121, P3922, DOI 10.1242/jcs.037549; Danen EHJ, 1996, EUR J CELL BIOL, V70, P69; DiPersio CM, 2000, J CELL SCI, V113, P3051; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; Eves P, 2003, CLIN EXP METASTAS, V20, P685, DOI 10.1023/B:CLIN.0000006824.41376.b0; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Fitsialos G, 2008, J CELL SCI, V121, P2992, DOI 10.1242/jcs.029256; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Gilles C, 2001, J CELL SCI, V114, P2967; Haass NK, 2004, J MOL HISTOL, V35, P309; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; Hoogduijn MJ, 2004, EXP CELL RES, V294, P60, DOI 10.1016/j.yexcr.2003.11.007; Joshi PG, 2007, PIGM CELL RES, V20, P380, DOI 10.1111/j.1600-0749.2007.00397.x; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Leng J, 1999, J BIOL CHEM, V274, P37855, DOI 10.1074/jbc.274.53.37855; Li YH, 2006, INT J MOL MED, V18, P713; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Ogura Y, 2008, BRIT J DERMATOL, V159, P49, DOI 10.1111/j.1365-2133.2008.08576.x; OIKAWA Y, 2010, EXP CELL RE IN PRESS; Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2; Rodeck U, 1997, J CELL SCI, V110, P113; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Scherschun L, 2001, J AM ACAD DERMATOL, V44, P999, DOI 10.1067/mjd.2001.114752; Scott GA, 1999, EXP DERMATOL, V8, P212, DOI 10.1111/j.1600-0625.1999.tb00373.x; Tsuji T, 2002, CLIN EXP METASTAS, V19, P127, DOI 10.1023/A:1014573204062; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; ZAMBRUNO G, 1993, J CELL SCI, V105, P179; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhu N, 2004, BRIT J CANCER, V90, P1457, DOI 10.1038/sj.bjc.6601698; Zhu NW, 2002, J INVEST DERMATOL, V119, P1165, DOI 10.1046/j.1523-1747.2002.19516.x	37	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13438	13447		10.1074/jbc.M110.166751	http://dx.doi.org/10.1074/jbc.M110.166751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349841	hybrid, Green Published			2022-12-25	WOS:000289282200064
J	Dierssen, M; Arque, G; McDonald, J; Andreu, N; Martinez-Cue, C; Florez, J; Fillat, C				Dierssen, Mara; Arque, Gloria; McDonald, Jerome; Andreu, Nuria; Martinez-Cue, Carmen; Florez, Jesus; Fillat, Cristina			Behavioral Characterization of a Mouse Model Overexpressing DSCR1/RCAN1	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOWN-SYNDROME; TS65DN MICE; B-CHAIN; CALCINEURIN; MEMORY; INHIBITOR; RCAN1; DSCR1; EXPRESSION	DSCR1/RCAN1 is a chromosome 21 gene found to be overexpressed in the brains of Down syndrome (DS) and postulated as a good candidate to contribute to mental disability. However, even though Rcan1 knockout mice have pronounced spatial learning and memory deficits, the possible deleterious effects of its overexpression in DS are not well understood. We have generated a transgenic mouse model overexpressing DSCR1/RCAN1 in the brain and analyzed the effect of RCAN1 overexpression on cognitive function. TgRCAN1 mice present a marked disruption of the learning process in a visuo-spatial learning task. However, no significant differences were observed in the performance of the memory phase of the test (removal session) nor in a step-down passive avoidance task, thus suggesting that once learning has been established, the animals are able to consolidate the information in the longer term.	[Dierssen, Mara; Arque, Gloria; McDonald, Jerome; Andreu, Nuria; Fillat, Cristina] Barcelona Biomed Res Pk PRBB, Ctr Genom Regulat CRG, Genes & Dis Program, Barcelona, Catalonia, Spain; [Dierssen, Mara; Arque, Gloria; McDonald, Jerome; Andreu, Nuria; Fillat, Cristina] CIBER Enfermedades Raras CIBERER, Barcelona, Catalonia, Spain; [Martinez-Cue, Carmen; Florez, Jesus] Univ Cantabria, Fac Med, Dept Physiol & Pharmacol, E-39005 Santander, Spain; [Florez, Jesus] Fdn Iberoamer Down21, Fdn Sindrome Down Cantabria, Santander, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de Cantabria	Dierssen, M (corresponding author), Barcelona Biomed Res Pk PRBB, Ctr Genom Regulat CRG, Genes & Dis Program, Barcelona, Catalonia, Spain.	mara.dierssen@crg.es	Arque, Gloria/AHD-3561-2022; Arque, Gloria/AAT-7266-2020; Dierssen, Mara/G-3552-2015; Fillat, Cristina/ABH-1674-2020; Andreu, Nuria/H-2576-2015; Cue, Carmen Martinez/AAA-2850-2019	Arque, Gloria/0000-0002-8039-3726; Dierssen, Mara/0000-0003-0853-6865; Andreu, Nuria/0000-0003-1999-8483; Fillat, Cristina/0000-0002-0801-3338; Martinez-Cue, Carmen/0000-0002-2137-1156	DURSI [09 2009SGR1313, SGR091527]; FIS [PI 082038, PI041559]; Marato TV3; Jerome Lejeune; Reina Sofia; Areces Foundations; EU [LSHG-CT-2006-037627, CureFXS E-Rare: EU/FIS PS09102673];  [FCT-08-0782];  [SAF2007-60827];  [SAF2010-16427];  [SAF2007-31093-E]	DURSI; FIS(Instituto de Salud Carlos III); Marato TV3; Jerome Lejeune; Reina Sofia; Areces Foundations; EU(European Commission); ; ; ; 	The laboratories of MD and CF are supported by DURSI (Grups consolidats 09 2009SGR1313, SGR091527). This work was supported by FCT-08-0782, SAF2007-60827, SAF2010-16427, SAF2007-31093-E, FIS (PI 082038, PI041559), Marato TV3, Jerome Lejeune, Reina Sofia and Areces Foundations and EU (LSHG-CT-2006-037627; CureFXS E-Rare: EU/FIS PS09102673). The CIBER of Enfermedades Raras is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Casas C, 2001, MECH DEVELOP, V101, P289, DOI 10.1016/S0925-4773(00)00583-9; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; DIERSSEN M, 1992, BRAIN RES, V586, P117, DOI 10.1016/0006-8993(92)91379-S; Dierssen M, 2002, PHARMACOL BIOCHEM BE, V73, P19, DOI 10.1016/S0091-3057(02)00792-X; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Guimera J, 1997, GENOMICS, V45, P59, DOI 10.1006/geno.1997.4861; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Ikegami S, 2000, NEUROSCIENCE, V98, P637, DOI 10.1016/S0306-4522(00)00161-5; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Mitchell AN, 2007, ARCH BIOCHEM BIOPHYS, V467, P185, DOI 10.1016/j.abb.2007.08.030; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SUN X, J BIOL CHEM; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445	24	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17010	10.1371/journal.pone.0017010	http://dx.doi.org/10.1371/journal.pone.0017010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364922	Green Published, gold			2022-12-25	WOS:000287764100017
J	Li, JL; Dohna, HZ; Cardona, CJ; Miller, J; Carpenter, TE				Li, Jinling; Dohna, Heinrich Zu; Cardona, Carol J.; Miller, Joy; Carpenter, Tim E.			Emergence and Genetic Variation of Neuraminidase Stalk Deletions in Avian Influenza Viruses	PLOS ONE			English	Article							A VIRUS; SOUTHERN CHINA; HONG-KONG; HEMAGGLUTININ GLYCOSYLATION; INTERSPECIES TRANSMISSION; SEQUENCE-ANALYSIS; DOMESTIC POULTRY; HUMAN INFECTION; WILD BIRDS; H5N1	When avian influenza viruses (AIVs) are transmitted from their reservoir hosts (wild waterfowl and shorebirds) to domestic bird species, they undergo genetic changes that have been linked to higher virulence and broader host range. Common genetic AIV modifications in viral proteins of poultry isolates are deletions in the stalk region of the neuraminidase (NA) and additions of glycosylation sites on the hemagglutinin (HA). Even though these NA deletion mutations occur in several AIV subtypes, they have not been analyzed comprehensively. In this study, 4,920 NA nucleotide sequences, 5,596 HA nucleotide and 4,702 HA amino acid sequences were analyzed to elucidate the widespread emergence of NA stalk deletions in gallinaceous hosts, the genetic polymorphism of the deletion patterns and association between the stalk deletions in NA and amino acid variants in HA. Forty-seven different NA stalk deletion patterns were identified in six NA subtypes, N1-N3 and N5-N7. An analysis that controlled for phylogenetic dependence due to shared ancestry showed that NA stalk deletions are statistically correlated with gallinaceous hosts and certain amino acid features on the HA protein. Those HA features included five glycosylation sites, one insertion and one deletion. The correlations between NA stalk deletions and HA features are HA-NA-subtype-specific. Our results demonstrate that stalk deletions in the NA proteins of AIV are relatively common. Understanding the NA stalk deletion and related HA features may be important for vaccine and drug development and could be useful in establishing effective early detection and warning systems for the poultry industry.	[Li, Jinling; Dohna, Heinrich Zu; Carpenter, Tim E.] Univ Calif Davis, Ctr Anim Dis Modeling & Surveillance, Davis, CA 95616 USA; [Cardona, Carol J.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Miller, Joy] Natl Ctr Med Intelligence, Ft Detrick, MD USA	University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities	Li, JL (corresponding author), Univ Calif Davis, Ctr Anim Dis Modeling & Surveillance, Davis, CA 95616 USA.	tecarpenter@ucdavis.edu			National Center for Medical Intelligence through United States Department of Agriculture [2009-39556-20244]	National Center for Medical Intelligence through United States Department of Agriculture	National Center for Medical Intelligence through United States Department of Agriculture grant #2009-39556-20244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent SJ, 1999, VIROLOGY, V263, P323, DOI 10.1006/viro.1999.9931; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; BLOK J, 1982, VIROLOGY, V118, P229, DOI 10.1016/0042-6822(82)90337-3; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Campitelli L, 2004, VIROLOGY, V323, P24, DOI 10.1016/j.virol.2004.02.015; CAPPUCCI DT, 1985, AVIAN DIS, V29, P1195, DOI 10.2307/1590473; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; Capua I, 2000, AVIAN PATHOL, V29, P537, DOI 10.1080/03079450020016779; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Cauthen AN, 2000, J VIROL, V74, P6592, DOI 10.1128/JVI.74.14.6592-6599.2000; Cheung CL, 2007, J VIROL, V81, P10402, DOI 10.1128/JVI.01157-07; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Di Trani L, 2004, AVIAN DIS, V48, P376, DOI 10.1637/7088; Dunn PA, 2003, AVIAN DIS, V47, P812, DOI 10.1637/0005-2086-47.s3.812; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELS MC, 1985, VIROLOGY, V142, P241, DOI 10.1016/0042-6822(85)90332-0; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kinde H, 2003, AVIAN DIS, V47, P1214, DOI 10.1637/0005-2086-47.s3.1214; Lee CW, 2004, AVIAN PATHOL, V33, P288, DOI 10.1080/0307945042000203407; Lee MS, 2006, AVIAN DIS, V50, P561, DOI 10.1637/7640-050106R.1; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li JL, 2010, VIRUS RES, V147, P40, DOI 10.1016/j.virusres.2009.10.002; Li JL, 2010, GENOMICS, V95, P29, DOI 10.1016/j.ygeno.2009.09.005; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Li Y, 2006, ARCH VIROL, V151, P1615, DOI 10.1007/s00705-006-0738-7; LIU CG, 1993, VIROLOGY, V194, P403, DOI 10.1006/viro.1993.1276; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Liu JH, 2003, AVIAN PATHOL, V32, P551, DOI 10.1080/0307-9450310001596728; Liu JH, 2003, VIRUS GENES, V27, P197, DOI 10.1023/A:1025736829103; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Marangon S, 2003, AVIAN DIS, V47, P1006, DOI 10.1637/0005-2086-47.s3.1006; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Okamatsu M, 2007, VET MICROBIOL, V124, P35, DOI 10.1016/j.vetmic.2007.04.025; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; PARADISE E, 2006, ANAL PHYLOGENETICS; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; *REAM RDC, 2009, LANG ENV STAT COMP 2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Skehel J, 2009, BIOLOGICALS, V37, P177, DOI 10.1016/j.biologicals.2009.02.012; Sorrell EM, 2007, AVIAN DIS, V51, P264, DOI 10.1637/7538-032906R.1; Spackman E, 2003, J VIROL, V77, P13399, DOI 10.1128/JVI.77.24.13399-13402.2003; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tsukamoto K, 2009, J CLIN MICROBIOL, V47, P2301, DOI 10.1128/JCM.02366-08; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Woolcock PR, 2003, AVIAN DIS, V47, P872, DOI 10.1637/0005-2086-47.s3.872; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09; Zhou NN, 1999, J VIROL, V73, P3366, DOI 10.1128/JVI.73.4.3366-3374.1999	70	74	82	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14722	10.1371/journal.pone.0014722	http://dx.doi.org/10.1371/journal.pone.0014722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373190	Green Published, gold, Green Submitted			2022-12-25	WOS:000287657500006
J	Tanabe, Y; Shitara, T; Kashino, Y; Hara, Y; Kudoh, S				Tanabe, Yukiko; Shitara, Tomofumi; Kashino, Yasuhiro; Hara, Yoshiaki; Kudoh, Sakae			Utilizing the Effective Xanthophyll Cycle for Blooming of Ochromonas smithii and O. itoi (Chrysophyceae) on the Snow Surface	PLOS ONE			English	Article							LIGHT-HARVESTING FUNCTION; IN-VIVO; CAROTENOIDS; ALGAE; PHOTOINHIBITION; INACTIVATION; CHLOROMONAS; VOLVOCALES; PIGMENT	Snow algae inhabit unique environments such as alpine and high latitudes, and can grow and bloom with visualizing on snow or glacier during spring-summer. The chrysophytes Ochromonas smithii and Ochromonas itoi are dominant in yellow-colored snow patches in mountainous heavy snow areas from late May to early June. It is considered to be effective utilizing the xanthophyll cycle and holding sunscreen pigments as protective system for snow algae blooming in the vulnerable environment such as low temperature and nutrients, and strong light, however the study on the photoprotection of chrysophytes snow algae has not been shown. To dissolve how the chrysophytes snow algae can grow and bloom under such an extreme environment, we studied with the object of light which is one point of significance to this problem. We collected the yellow snows and measured photosynthetically active radiation at Mt. Gassan in May 2008 when the bloom occurred, then tried to establish unialgal cultures of O. smithii and O. itoi, and examined their photosynthetic properties by a PAM chlorophyll fluorometer and analyzed the pigment compositions before and after illumination with high-light intensities to investigate the working xanthophyll cycle. This experimental study using unialgal cultures revealed that both O. smithii and O. itoi utilize only the efficient violaxanthin cycle for photoprotection as a dissipation system of surplus energy under prolonged high-light stress, although they possess chlorophyll c with diadinoxanthin.	[Tanabe, Yukiko; Kudoh, Sakae] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Shitara, Tomofumi] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 990, Japan; [Kashino, Yasuhiro] Univ Hyogo, Grad Sch Life Sci, Hyogo, Japan; [Hara, Yoshiaki] Yamagata Univ, Fac Sci, Dept Biol, Yamagata 990, Japan; [Kudoh, Sakae] Grad Univ Adv Studies SOKENDAI, Dept Polar Sci, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Yamagata University; University of Hyogo; Yamagata University; Graduate University for Advanced Studies - Japan	Tanabe, Y (corresponding author), Natl Inst Polar Res, Tachikawa, Tokyo, Japan.	ukko@nipr.ac.jp			Japan Society for the Promotion of Science [21810035]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	21810035, Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1998, PHOTOSYNTH RES, V56, P1, DOI 10.1023/A:1005946808488; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BIDIGARE RR, 1993, J PHYCOL, V29, P427, DOI 10.1111/j.1529-8817.1993.tb00143.x; Britton G., 1999, PHOTOCHEMISTRY CAROT; Cox E.R., 1980, PHYTOFLAGELLATES, P61; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Elster H.J., 1968, BINNENGEWASSER, V24; FALKOWSKI PG, 1997, AQUATIC PHOTOSYNTHET; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; FUKUSHIMA H, 1963, J YOKOHAMA MUNICIP C, V43, P1; Harker M, 1999, EUR J PHYCOL, V34, P35, DOI 10.1080/09670269910001736062; HIRANO M, 1965, MONOGRAPHIAE BIOL, V15, P127; Hoham Ronald W., 2001, P168; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; Hoham RW, 2001, SNOW ECOLOGY INTERDI, P166; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kashino Yasuhiro, 2003, Phycological Research, V51, P168, DOI 10.1111/j.1440-1835.2003.tb00184.x; Kohshima S, 1984, GLACIAL STUDIES LANG, P91; Kol E, 1963, ANN HIST NAT MUS NAT, V55, P155; Koyama Y, 1996, PHOTOCHEM PHOTOBIOL, V63, P243, DOI 10.1111/j.1751-1097.1996.tb03021.x; Kudoh S., 2003, POLAR BIOSCI, V16, P86; LICHTLE C, 1995, J PHYCOL, V31, P380, DOI 10.1111/j.0022-3646.1995.00380.x; Ling HU, 1998, POLAR BIOL, V20, P320, DOI 10.1007/s003000050309; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2001, PLANTA, V212, P382, DOI 10.1007/s004250000403; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; McMinn A, 2004, J MAR BIOL ASSOC UK, V84, P865, DOI 10.1017/S0025315404010112h; Muller T, 1998, POLAR BIOL, V20, P14, DOI 10.1007/s003000050272; OLAIZOLA M, 1994, PHOTOSYNTH RES, V41, P357, DOI 10.1007/BF00019413; Owens T. G., 1994, PHOTOINHIBITION PHOT, P95; Remias D, 2005, EUR J PHYCOL, V40, P259, DOI 10.1080/09670260500202148; SAPOZHNIKOV DI, 1957, DOKL AKAD NAUK SSSR+, V113, P465; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Sonoike K, 1996, PLANT CELL PHYSIOL, V37, P239, DOI 10.1093/oxfordjournals.pcp.a028938; STRANSKY H, 1970, ARCH MIKROBIOL, V73, P315, DOI 10.1007/BF00412298; TANAKA K, 1982, PLANT CELL PHYSIOL, V23, P1009; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; YAMAMOTO HY, 1972, BIOCHIM BIOPHYS ACTA, V267, P538, DOI 10.1016/0005-2728(72)90182-X; YAMAMOTO HY, 1996, OXYGENIC PHOTOSYNTHE, P539, DOI DOI 10.1007/0-306-48127-8_30	43	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14690	10.1371/journal.pone.0014690	http://dx.doi.org/10.1371/journal.pone.0014690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373183	Green Published, Green Submitted, gold			2022-12-25	WOS:000287657500001
J	Mostowy, R; Kouyos, RD; Fouchet, D; Bonhoeffer, S				Mostowy, Rafal; Kouyos, Roger D.; Fouchet, David; Bonhoeffer, Sebastian			The Role of Recombination for the Coevolutionary Dynamics of HIV and the Immune Response	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; IN-VIVO; ANTIRETROVIRAL THERAPY; GENETIC-RECOMBINATION; PERIPHERAL-BLOOD; ESCAPE MUTATIONS; DRUG-RESISTANCE; CELL RESPONSES; DECAY KINETICS	The evolutionary implications of recombination in HIV remain not fully understood. A plausible effect could be an enhancement of immune escape from cytotoxic T lymphocytes (CTLs). In order to test this hypothesis, we constructed a population dynamic model of immune escape in HIV and examined the viral-immune dynamics with and without recombination. Our model shows that recombination (i) increases the genetic diversity of the viral population, (ii) accelerates the emergence of escape mutations with and without compensatory mutations, and (iii) accelerates the acquisition of immune escape mutations in the early stage of viral infection. We see a particularly strong impact of recombination in systems with broad, non-immunodominant CTL responses. Overall, our study argues for the importance of recombination in HIV in allowing the virus to adapt to changing selective pressures as imposed by the immune system and shows that the effect of recombination depends on the immunodominance pattern of effector T cell responses.	[Mostowy, Rafal; Kouyos, Roger D.; Bonhoeffer, Sebastian] ETH, Inst Integrat Biol, Zurich, Switzerland; [Fouchet, David] Univ Lyon, Villeurbanne, France	Swiss Federal Institutes of Technology Domain; ETH Zurich	Mostowy, R (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	rafal.mostowy@env.ethz.ch	Bonhoeffer, Sebastian/A-2735-2008; Kouyos, Roger/G-6226-2014; Kouyos, Roger/ABB-2291-2021	Bonhoeffer, Sebastian/0000-0001-8052-3925; Kouyos, Roger/0000-0002-9220-8348; Kouyos, Roger/0000-0002-9220-8348	Swiss National Foundation [3100A0-116408]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	Funding: This work was supported by Swiss National Foundation grant number 3100A0-116408 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Althaus CL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000103; Althaus CL, 2005, J VIROL, V79, P13572, DOI 10.1128/JVI.79.21.13572-13578.2005; An Wenfeng, 2002, AIDS Reviews, V4, P195; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Asquith B, 2005, J GEN VIROL, V86, P1515, DOI 10.1099/vir.0.80766-0; Asquith B, 2007, P NATL ACAD SCI USA, V104, P6365, DOI 10.1073/pnas.0700666104; BELL G, 1982, MASTERPIECE NATUE EV; Benaroch P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-29; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Bonhoeffer S, 2003, TRENDS MICROBIOL, V11, P499, DOI 10.1016/j.tim.2003.09.002; Bonhoeffer S, 1997, J VIROL, V71, P3275, DOI 10.1128/JVI.71.4.3275-3278.1997; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Bretscher MT, 2004, BIOESSAYS, V26, P180, DOI 10.1002/bies.10386; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Chen JB, 2006, J VIROL, V80, P9651, DOI 10.1128/JVI.00936-06; Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004; De Boer RJ, 2007, J VIROL, V81, P2838, DOI 10.1128/JVI.01914-06; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; Fraser C, 2005, J ROY SOC INTERFACE, V2, P489, DOI 10.1098/rsif.2005.0064; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Graw F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000466; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HAMILTON WD, 1976, Q REV BIOL, V51, P407; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Josefsson L, 2010, ANTIVIR THER, V15, pA41; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kouyos RD, 2009, EPIDEMICS-NETH, V1, P58, DOI 10.1016/j.epidem.2008.11.001; Kuwata T, 1997, J VIROL, V71, P7088, DOI 10.1128/JVI.71.9.7088-7091.1997; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Lopez M, 2007, CURR MOL MED, V7, P446; Mandl JN, 2007, J VIROL, V81, P11982, DOI 10.1128/JVI.00946-07; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Muller V, 2001, P ROY SOC B-BIOL SCI, V268, P235, DOI 10.1098/rspb.2000.1358; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Petravic J, 2008, J VIROL, V82, P11589, DOI 10.1128/JVI.01596-08; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; QUINONESMATEU M, 1999, AIDS REV, V1, P89; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Salathe M, 2008, TRENDS ECOL EVOL, V23, P439, DOI 10.1016/j.tree.2008.04.010; SEGEL LA, 1988, B MATH BIOL, V50, P579, DOI 10.1007/BF02460092; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Vijay NNV, 2008, J GEN VIROL, V89, P1467, DOI 10.1099/vir.0.83668-0; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wooley DP, 1997, J VIROL, V71, P9650, DOI 10.1128/JVI.71.12.9650-9653.1997; Yates A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001301	71	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16052	10.1371/journal.pone.0016052	http://dx.doi.org/10.1371/journal.pone.0016052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364750	Green Submitted, Green Published, gold			2022-12-25	WOS:000287482800004
J	Horby, P; Pham, QT; Hens, N; Nguyen, TTY; Le, QM; Dang, DT; Nguyen, ML; Nguyen, TH; Alexander, N; Edmunds, WJ; Tran, ND; Fox, A; Nguyen, TH				Horby, Peter; Pham Quang Thai; Hens, Niel; Nguyen Thi Thu Yen; Le Quynh Mai; Dang Dinh Thoang; Nguyen Manh Linh; Nguyen Thu Huong; Alexander, Neal; Edmunds, W. John; Tran Nhu Duong; Fox, Annette; Nguyen Tran Hien			Social Contact Patterns in Vietnam and Implications for the Control of Infectious Diseases	PLOS ONE			English	Article							INFLUENZA-A; TRANSMISSION; SPREAD; MODEL; PARAMETERS; AGENTS	Background: The spread of infectious diseases from person to person is determined by the frequency and nature of contacts between infected and susceptible members of the population. Although there is a long history of using mathematical models to understand these transmission dynamics, there are still remarkably little empirical data on contact behaviors with which to parameterize these models. Even starker is the almost complete absence of data from developing countries. We sought to address this knowledge gap by conducting a household based social contact diary in rural Vietnam. Methods and Findings: A diary based survey of social contact patterns was conducted in a household-structured community cohort in North Vietnam in 2007. We used generalized estimating equations to model the number of contacts while taking into account the household sampling design, and used weighting to balance the household size and age distribution towards the Vietnamese population. We recorded 6675 contacts from 865 participants in 264 different households and found that mixing patterns were assortative by age but were more homogenous than observed in a recent European study. We also observed that physical contacts were more concentrated in the home setting in Vietnam than in Europe but the overall level of physical contact was lower. A model of individual versus household vaccination strategies revealed no difference between strategies in the impact on R(0). Conclusions and Significance: This work is the first to estimate contact patterns relevant to the spread of infections transmitted from person to person by non-sexual routes in a developing country setting. The results show interesting similarities and differences from European data and demonstrate the importance of context specific data.	[Horby, Peter; Fox, Annette] Oxford Univ Clin Res Unit, Hanoi, Vietnam; [Horby, Peter; Fox, Annette] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Pham Quang Thai; Nguyen Thi Thu Yen; Le Quynh Mai; Nguyen Manh Linh; Nguyen Thu Huong; Tran Nhu Duong; Nguyen Tran Hien] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Hens, Niel] Hasselt Univ, Diepenbeek, Belgium; [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modeling Infect Dis, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Dang Dinh Thoang] Ha Nam Ctr Prevent Med, Ha Nam, Vietnam; [Alexander, Neal; Edmunds, W. John] London Sch Hyg & Epidemiol, London, England	University of Oxford; National Institute of Hygiene & Epidemiology (NIHE); Hasselt University; University of Antwerp; University of London; London School of Hygiene & Tropical Medicine	Horby, P (corresponding author), Oxford Univ Clin Res Unit, Hanoi, Vietnam.	peter.horby@gmail.com	Hens, Niel/M-4445-2017; Horby, Peter/D-1585-2013; Quang, Thai Pham/Z-2770-2019	Hens, Niel/0000-0003-1881-0637; Quang, Thai Pham/0000-0002-3796-6162; Nguyen, Thi Thu Huong/0000-0002-9441-3660; Fox, Annette/0000-0002-0565-7146; Horby, Peter/0000-0002-9822-1586	Wellcome Trust UK [081613/Z/06/Z, 077078/Z/05/Z]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) [060081]; IAP research network of the Belgian Government (Belgian Science Policy) [P6/03]; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust UK(Wellcome Trust); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IAP research network of the Belgian Government (Belgian Science Policy)(Belgian Federal Science Policy Office); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust UK (grants 081613/Z/06/Z and 077078/Z/05/Z). NH gratefully acknowledges financial support from "SIMID", a strategic basic research project funded by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT), project number 060081 and by the IAP research network number P6/03 of the Belgian Government (Belgian Science Policy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Ball F, 2008, MATH BIOSCI, V212, P69, DOI 10.1016/j.mbs.2008.01.001; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; BERGLUND B, 1967, ACTA PAEDIATR SCAND, V56, P395, DOI 10.1111/j.1651-2227.1967.tb15398.x; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; CPHCSC, 2010, 2009 VIETNAM POPULAT; Diekmann O, 2000, MATH METHODOLOGY INF; Duerr HP, 2007, EPIDEMIOL INFECT, V135, P1124, DOI 10.1017/S0950268807007959; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Goeyvaerts N, 2011, BIOSTATISTICS, V12, P283, DOI 10.1093/biostatistics/kxq059; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lowen A., 2009, PLOS CURR; MCCAW JM, BMC INFECT DIS, V10, P166; MONTO AS, 1971, AM J EPIDEMIOL, V94, P280, DOI 10.1093/oxfordjournals.aje.a121321; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Pellis L, 2009, J R SOC INTERFACE, V6, P979, DOI 10.1098/rsif.2008.0493; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	25	105	107	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16965	10.1371/journal.pone.0016965	http://dx.doi.org/10.1371/journal.pone.0016965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347264	Green Published, gold, Green Accepted			2022-12-25	WOS:000287367600026
J	Caetano-Lopes, J; Lopes, A; Rodrigues, A; Fernandes, D; Perpetuo, IP; Monjardino, T; Lucas, R; Monteiro, J; Konttinen, YT; Canhao, H; Fonseca, JE				Caetano-Lopes, Joana; Lopes, Ana; Rodrigues, Ana; Fernandes, Diana; Perpetuo, Ines P.; Monjardino, Teresa; Lucas, Raquel; Monteiro, Jacinto; Konttinen, Yrjo T.; Canhao, Helena; Fonseca, Joao E.			Upregulation of Inflammatory Genes and Downregulation of Sclerostin Gene Expression Are Key Elements in the Early Phase of Fragility Fracture Healing	PLOS ONE			English	Article							BONE-FORMATION; INCREASES; REPAIR; ADULT; RATS; AGE	Background: Fracture healing is orchestrated by a specific set of events that culminates in the repair of bone and reachievement of its biomechanical properties. The aim of our work was to study the sequence of gene expression events involved in inflammation and bone remodeling occurring in the early phases of callus formation in osteoporotic patients. Methodology/Principal Findings: Fifty-six patients submitted to hip replacement surgery after a low-energy hip fracture were enrolled in this study. The patients were grouped according to the time interval between fracture and surgery: bone collected within 3 days after fracture (n = 13); between the 4(th) and 7(th) day (n = 33); and after one week from the fracture (n = 10). Inflammation- and bone metabolism-related genes were assessed at the fracture site. The expression of pro-inflammatory cytokines was increased in the first days after fracture. The genes responsible for bone formation and resorption were upregulated one week after fracture. The increase in RANKL expression occurred just before that, between the 4(th)-7(th) days after fracture. Sclerostin expression diminished during the first days after fracture. Conclusions: The expression of inflammation-related genes, especially IL-6, is highest at the very first days after fracture but from day 4 onwards there is a shift towards bone remodeling genes, suggesting that the inflammatory phase triggers bone healing. We propose that an initial inflammatory stimulus and a decrease in sclerostin-related effects are the key components in fracture healing. In osteoporotic patients, cellular machinery seems to adequately react to the inflammatory stimulus, therefore local promotion of these events might constitute a promising medical intervention to accelerate fracture healing.	[Caetano-Lopes, Joana; Lopes, Ana; Rodrigues, Ana; Fernandes, Diana; Perpetuo, Ines P.; Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Fac Med, Rheumatol Res Unit, Inst Mol Med, P-1699 Lisbon, Portugal; [Rodrigues, Ana; Canhao, Helena; Fonseca, Joao E.] Hosp Santa Maria, Serv Reumatol & Doencas Osseas Metab, Lisbon, Portugal; [Monjardino, Teresa; Lucas, Raquel] Univ Porto, Sch Med, Dept Hyg & Epidemiol, P-4100 Oporto, Portugal; [Monjardino, Teresa; Lucas, Raquel] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal; [Monteiro, Jacinto] Hosp Santa Maria, Dept Orthopaed, Lisbon, Portugal; [Konttinen, Yrjo T.] Univ Helsinki, Dept Med, Helsinki, Finland; [Konttinen, Yrjo T.] ORTON Orthopaed Hosp, Invalid Fdn, Helsinki, Finland; [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere, Finland	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Universidade do Porto; Universidade do Porto; Universidade de Lisboa; Hospital Santa Maria; University of Helsinki; Coxa Hospital for Joint Replacement	Caetano-Lopes, J (corresponding author), Univ Lisbon, Fac Med, Rheumatol Res Unit, Inst Mol Med, P-1699 Lisbon, Portugal.	jefonseca@netcabo.pt	Monjardino, Teresa/H-5399-2019; Canhao, Helena/C-9611-2018; Fernandes, Diana/D-5916-2011; Rodrigues, Ana/GYQ-6273-2022; IP, Perpétuo/F-3643-2011; Caetano-Lopes, Joana/J-9345-2012	Monjardino, Teresa/0000-0003-4944-3366; Canhao, Helena/0000-0003-1894-4870; Fernandes, Diana/0000-0002-1015-3946; IP, Perpétuo/0000-0001-7671-2539; Caetano-Lopes, Joana/0000-0003-0310-4641; Canhao, Helena/0000-0002-3239-2809; Fonseca, Joao/0000-0003-1432-3671; Lucas, Raquel/0000-0002-4408-8134; Rodrigues, Ana Maria/0000-0003-2046-8017; Monteiro, Jacinto Manuel de Melo Oliveira/0000-0002-4067-200X	Portuguese Foundation of Science and Technology (Fundacao para a Ciencia e Tecnologia) [PTDC/SAU-BEB/65992/2006, SFRH/BD/36825/2007]	Portuguese Foundation of Science and Technology (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology)	This work was supported by two grants from the Portuguese Foundation of Science and Technology (Fundacao para a Ciencia e Tecnologia)(PTDC/SAU-BEB/65992/2006, SFRH/BD/36825/2007). (www.fct.mctes.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Dean DB, 2010, J ANAT IN PRESS; Desai BJ, 2003, J ORTHOP TRAUMA, V17, P689, DOI 10.1097/00005131-200311000-00005; Egyhazi S, 2004, CLIN CHEM, V50, P975, DOI 10.1373/clinchem.2003.027102; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014; Giannoudis PV, 2007, INJURY, V38, pS1, DOI 10.1016/j.injury.2007.02.004; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ikegami Shota, 2009, Orthop Rev (Pavia), V1, pe21, DOI 10.4081/or.2009.e21; Ireland D, 2003, METH MOLEC MED, V80, P433; Ivaska KK, 2007, J BONE MINER RES, V22, P1155, DOI 10.1359/JBMR.070505; Khan Safdar N, 2008, HSS J, V4, P149, DOI 10.1007/s11420-008-9087-2; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; LYRITIS G, 1976, ACTA ORTHOP SCAND, V47, P264, DOI 10.3109/17453677608991988; Marzona L, 2009, CLIN CASES MINER BON, V6, P159; Meyer RA, 2006, J ORTHOP RES, V24, P1933, DOI 10.1002/jor.20124; Nikolaou VS, 2009, INJURY, V40, P663, DOI 10.1016/j.injury.2008.10.035; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Schell H, 2006, BONE, V38, P547, DOI 10.1016/j.bone.2005.09.018; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	29	34	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16947	10.1371/journal.pone.0016947	http://dx.doi.org/10.1371/journal.pone.0016947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347301	Green Published, Green Submitted, gold			2022-12-25	WOS:000287364500014
J	Davis, JL; Dumont, ER; Strait, DS; Grosse, IR				Davis, Julian L.; Dumont, Elizabeth R.; Strait, David S.; Grosse, Ian R.			An Efficient Method of Modeling Material Properties Using a Thermal Diffusion Analogy: An Example Based on Craniofacial Bone	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; ELASTIC PROPERTIES; CRANIAL MECHANICS; CORTICAL BONE; LIZARD SKULL; BIOMECHANICS; MORPHOLOGY; PERFORMANCE; ALLOMETRY; EVOLUTION	The ability to incorporate detailed geometry into finite element models has allowed researchers to investigate the influence of morphology on performance aspects of skeletal components. This advance has also allowed researchers to explore the effect of different material models, ranging from simple (e.g., isotropic) to complex (e.g., orthotropic), on the response of bone. However, bone's complicated geometry makes it difficult to incorporate complex material models into finite element models of bone. This difficulty is due to variation in the spatial orientation of material properties throughout bone. Our analysis addresses this problem by taking full advantage of a finite element program's ability to solve thermal-structural problems. Using a linear relationship between temperature and modulus, we seeded specific nodes of the finite element model with temperatures. We then used thermal diffusion to propagate the modulus throughout the finite element model. Finally, we solved for the mechanical response of the finite element model to the applied loads and constraints. We found that using the thermal diffusion analogy to control the modulus of bone throughout its structure provides a simple and effective method of spatially varying modulus. Results compare favorably against both experimental data and results from an FE model that incorporated a complex (orthotropic) material model. This method presented will allow researchers the ability to easily incorporate more material property data into their finite element models in an effort to improve the model's accuracy.	[Davis, Julian L.] Univ So Indiana, Dept Engn, Evansville, IN 47712 USA; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Strait, David S.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA; [Grosse, Ian R.] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA	University Southern Indiana; University of Massachusetts System; University of Massachusetts Amherst; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Massachusetts System; University of Massachusetts Amherst	Davis, JL (corresponding author), Univ So Indiana, Dept Engn, 8600 Univ Blvd, Evansville, IN 47712 USA.	jldavis2@usi.edu	D, Betsy/ABD-1855-2020	Davis, Julian/0000-0003-4109-3904	National Science Foundation [NSF-DBI 0743460, NSF-BCS 0725078, NSF-BCS 0725126]; Div Of Biological Infrastructure [0743460] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (www.nsf.gov) grants NSF-DBI 0743460 to ERD and IRG, NSF-BCS 0725078 to IRG, and NSF-BCS 0725126 to DSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; CLATTENBURG R, 1975, J BIOMED MATER RES, V9, P169; Currey J.D., 2002, BONES STRUCTURE MECH; Currey J, 2009, CLIN ORTHOP RELAT R, V467, P1948, DOI 10.1007/s11999-009-0784-z; Davidson SRH, 2000, MED ENG PHYS, V22, P741, DOI 10.1016/S1350-4533(01)00003-0; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; El-Brawany M. A., 2009, Journal of Medical Engineering & Technology, V33, P249, DOI 10.1080/03091900802451265; Helgason B, 2008, MED ENG PHYS, V30, P444, DOI 10.1016/j.medengphy.2007.05.006; INCROPERA FP, 1996, INTRO HEAT TRANSFER, P801; Kim H. D., 1992, Biomimetics, V1, P293; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Moazen M, 2008, J ANAT, V213, P499, DOI 10.1111/j.1469-7580.2008.00980.x; Moazen M, 2008, J BIOMECH, V41, P1274, DOI 10.1016/j.jbiomech.2008.01.012; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; Rapoff AJ, 2008, AM J PHYS ANTHROPOL, V135, P100, DOI 10.1002/ajpa.20714; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rayfield EJ, 2008, PALEOBIOLOGY, V34, P494, DOI 10.1666/07006.1; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Strait DS, 2007, J HUM EVOL, V52, P585, DOI 10.1016/j.jhevol.2006.11.019; Strait DS, 2010, ANAT REC, V293, P583, DOI 10.1002/ar.21122; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait David S., 2008, P173, DOI 10.1007/978-0-387-76585-3_9; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Wachter NJ, 2002, BONE, V31, P90, DOI 10.1016/S8756-3282(02)00779-2; Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P402, DOI 10.1002/ajpa.20438; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594	42	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17004	10.1371/journal.pone.0017004	http://dx.doi.org/10.1371/journal.pone.0017004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347288	gold, Green Published			2022-12-25	WOS:000287364500020
J	Gervasi, MG; Osycka-Salut, C; Caballero, J; Vazquez-Levin, M; Pereyra, E; Billi, S; Franchi, A; Perez-Martinez, S				Gracia Gervasi, Maria; Osycka-Salut, Claudia; Caballero, Julieta; Vazquez-Levin, Monica; Pereyra, Elba; Billi, Silvia; Franchi, Ana; Perez-Martinez, Silvina			Anandamide Capacitates Bull Spermatozoa through CB1 and TRPV1 Activation	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; BOVINE SPERM; ACROSOME REACTION; MOUSE SPERMATOZOA; ENDOCANNABINOID SYSTEM; SELECTIVE ANTAGONIST; OVIDUCT; RECEPTOR; RELEASE; HEPARIN	Anandamide (AEA), a major endocannabinoid, binds to cannabinoid and vanilloid receptors (CB1, CB2 and TRPV1) and affects many reproductive functions. Nanomolar levels of anandamide are found in reproductive fluids including mid-cycle oviductal fluid. Previously, we found that R(+)-methanandamide, an anandamide analogue, induces sperm releasing from bovine oviductal epithelium and the CB1 antagonist, SR141716A, reversed this effect. Since sperm detachment may be due to surface remodeling brought about by capacitation, the aim of this paper was to investigate whether anandamide at physiological concentrations could act as a capacitating agent in bull spermatozoa. We demonstrated that at nanomolar concentrations R(+)-methanandamide or anandamide induced bull sperm capacitation, whereas SR141716A and capsazepine (a TRPV1 antagonist) inhibited this induction. Previous studies indicate that mammalian spermatozoa possess the enzymatic machinery to produce and degrade their own AEA via the actions of the AEA-synthesizing phospholipase D and the fatty acid amide hydrolase (FAAH) respectively. Our results indicated that, URB597, a potent inhibitor of the FAAH, produced effects on bovine sperm capacitation similar to those elicited by exogenous AEA suggesting that this process is normally regulated by an endogenous tone. We also investigated whether anandamide is involved in bovine heparin-capacitated spermatozoa, since heparin is a known capacitating agent of bovine sperm. When the spermatozoa were incubated in the presence of R(+)-methanandamide and heparin, the percentage of capacitated spermatozoa was similar to that in the presence of R(+)-methanandamide alone. The pre-incubation with CB1 or TRPV1 antagonists inhibited heparin-induced sperm capacitation; moreover the activity of FAAH was 30% lower in heparin-capacitated spermatozoa as compared to control conditions. This suggests that heparin may increase endogenous anandamide levels. Our findings indicate that anandamide induces sperm capacitation through the activation of CB1 and TRPV1 receptors and could be involved in the same molecular pathway as heparin in bovines.	[Gracia Gervasi, Maria; Osycka-Salut, Claudia; Pereyra, Elba; Franchi, Ana; Perez-Martinez, Silvina] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Med, Ctr Estudios Farmacol & Bot, Buenos Aires, DF, Argentina; [Caballero, Julieta; Vazquez-Levin, Monica] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Billi, Silvia] Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Gervasi, MG (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Med, Ctr Estudios Farmacol & Bot, Buenos Aires, DF, Argentina.	perezms@fmed.uba.ar	osycka-salut, claudia elena/AAG-3441-2020	osycka-salut, claudia elena/0000-0002-8033-5155; Caballero, Julieta/0000-0002-5466-3614; Gervasi, Maria Gracia/0000-0002-5468-2700	National Research Council (CONICET)-Argentina [PIP 112-200801-02204]; FONCyT-Argentina [BID 1728 OC/AR PICT2004-20207]	National Research Council (CONICET)-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT-Argentina(FONCyT)	This work was supported by National Research Council (CONICET)-Argentina (PIP 112-200801-02204) to AF and SPM and by FONCyT-Argentina (BID 1728 OC/AR PICT2004-20207) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirregoitia E, 2010, FERTIL STERIL, V93, P1378, DOI 10.1016/j.fertnstert.2009.01.153; ANDERSON SH, 1994, BIOL REPROD, V51, P795, DOI 10.1095/biolreprod51.4.795; Aquila S, 2009, J CELL PHYSIOL, V221, P147, DOI 10.1002/jcp.21837; Battista N, 2008, MOL CELL ENDOCRINOL, V286, pS17, DOI 10.1016/j.mce.2008.01.010; Bergqvist AS, 2007, ZYGOTE, V15, P225, DOI 10.1017/S0967199407004182; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALVO L, 1989, FERTIL STERIL, V52, P1048; CHIAN RC, 1995, BIOL REPROD, V52, P156, DOI 10.1095/biolreprod52.1.156; CHIAN RC, 1995, MOL REPROD DEV, V42, P318, DOI 10.1002/mrd.1080420309; CROSS NL, 1986, GAMETE RES, V15, P213, DOI 10.1002/mrd.1120150303; De Jonge C, 2005, HUM REPROD UPDATE, V11, P205, DOI 10.1093/humupd/dmi010; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; FRASER LR, 1995, MOL REPROD DEV, V40, P233, DOI 10.1002/mrd.1080400213; FUKUI Y, 1990, THERIOGENOLOGY, V34, P579, DOI 10.1016/0093-691X(90)90013-J; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; HANDROW RR, 1989, J EXP ZOOL, V252, P174, DOI 10.1002/jez.1402520209; Harper M. J. K., 1994, PHYSL REPROD, V1, P123; Herrero MB, 1999, BIOL REPROD, V61, P575, DOI 10.1095/biolreprod61.3.575; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; KALAB P, 1994, J BIOL CHEM, V269, P3810; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MA, 1987, FERTIL STERIL, V48, P649; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; O'Flaherty C, 2004, BBA-GEN SUBJECTS, V1674, P215, DOI 10.1016/j.bbagen.2004.06.020; Palmer SL, 2002, CHEM PHYS LIPIDS, V121, P3, DOI 10.1016/S0009-3084(02)00143-3; PARRISH JJ, 1989, BIOL REPROD, V41, P683, DOI 10.1095/biolreprod41.4.683; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P525, DOI 10.1071/RD07170; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rodriguez PC, 2005, ANIM REPROD SCI, V85, P231, DOI 10.1016/j.anireprosci.2004.05.018; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Rossato M, 2005, J CLIN ENDOCR METAB, V90, P984, DOI 10.1210/jc.2004-1287; Schuel H, 2005, BIOL REPROD, V73, P1078, DOI 10.1095/biolreprod.105.043273; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; SMITH TT, 1991, J REPROD FERTIL, V91, P567, DOI 10.1530/jrf.0.0910567; Sugiura T, 1997, J BIOCHEM-TOKYO, V122, P890; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Sun XF, 2009, BIOL REPROD, V80, P235, DOI 10.1095/biolreprod.108.072736; Talevi R, 2001, BIOL REPROD, V64, P491, DOI 10.1095/biolreprod64.2.491; Talevi R, 2007, BIOL REPROD, V76, P728, DOI 10.1095/biolreprod.106.056028; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang H, 2006, J CLIN INVEST, V116, P2122, DOI 10.1172/JCI28621; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; WARD CR, 1984, DEV BIOL, V104, P287, DOI 10.1016/0012-1606(84)90084-8; Yanagimachi R., 1994, P189	58	50	52	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16993	10.1371/journal.pone.0016993	http://dx.doi.org/10.1371/journal.pone.0016993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347292	gold, Green Published, Green Submitted			2022-12-25	WOS:000287364500018
J	Hii, YL; Rocklov, J; Ng, N				Hii, Yien Ling; Rocklov, Joacim; Ng, Nawi			Short Term Effects of Weather on Hand, Foot and Mouth Disease	PLOS ONE			English	Article							ENTEROVIRUS-71; HERPANGINA; SINGAPORE; SURVIVAL; EPIDEMIC; TAIWAN	Background: Hand, foot, and mouth disease (HFMD) outbreaks leading to clinical and fatal complications have increased since late 1990s; especially in the Asia Pacific Region. Outbreaks of HFMD peaks in the warmer season of the year, but the underlying factors for this annual pattern and the reasons to the recent upsurge trend have not yet been established. This study analyzed the effect of short-term changes in weather on the incidence of HFMD in Singapore. Methods: The relative risks between weekly HFMD cases and temperature and rainfall were estimated for the period 20012008 using time series Poisson regression models allowing for over-dispersion. Smoothing was used to allow non-linear relationship between weather and weekly HFMD cases, and to adjust for seasonality and long-term time trend. Additionally, autocorrelation was controlled and weather was allowed to have a lagged effect on HFMD incidence up to 2 weeks. Results: Weekly temperature and rainfall showed statistically significant association with HFMD incidence at time lag of 1-2 weeks. Every 1 degrees C increases in maximum temperature above 32 degrees C elevated the risk of HFMD incidence by 36% (95% CI = 1.341-1.389). Simultaneously, one mm increase of weekly cumulative rainfall below 75 mm increased the risk of HFMD by 0.3% (CI = 1.002-1.003). While above 75 mm the effect was opposite and each mm increases of rainfall decreased the incidence by 0.5% (CI = 0.995-0.996). We also found that a difference between minimum and maximum temperature greater than 7 degrees C elevated the risk of HFMD by 41% (CI = 1.388-1.439). Conclusion: Our findings suggest a strong association between HFMD and weather. However, the exact reason for the association is yet to be studied. Information on maximum temperature above 32 degrees C and moderate rainfall precede HFMD incidence could help to control and curb the up-surging trend of HFMD.	[Hii, Yien Ling; Rocklov, Joacim; Ng, Nawi] Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Umea, Sweden	Umea University	Hii, YL (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Umea, Sweden.	yienling.hii@epiph.umu.se	Ng, Nawi/F-8373-2011	Ng, Nawi/0000-0003-0556-1483; Lai, Shengjie/0000-0001-9781-8148; Rocklov, Joacim/0000-0003-4030-0449	FAS; Swedish Council for Working Life and Social Research [2006-1512]	FAS; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was undertaken within the Umea Centre for Global Health Research at Umea University, with support from FAS, the Swedish Council for Working Life and Social Research (grant no: 2006-1512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [Anonymous], 2009, KEY ANN IND; CDC, 2008, HAND FOOT MOUTH DIS; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P629; Chan KP, 2003, EMERG INFECT DIS, V9, P78; GOH KT, 2004, GUIDE INFECT DIS PUB; HAGIWARA A, 1983, J GEN VIROL, V64, P491, DOI 10.1099/0022-1317-64-2-499; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Khetsuriani N, 2006, ENTEROVIRUS SURVEILL, P1; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kung CM, 2007, J MED VIROL, V79, P60, DOI 10.1002/jmv.20761; Malaysia MoH, 2009, INC NOT COMM DIS MAL; MCGEADY ML, 1979, APPL ENVIRON MICROB, V37, P972, DOI 10.1128/AEM.37.5.972-977.1979; Ministry of Health Singapore, 2008, EPIDEMIOL NEWS B, V34, P63; NICD, 2008, HAND FOOT MOUTH DIS; NOAA, 2008, NNDC CLIM DAT ONL; Rajtar B, 2008, ANN AGR ENV MED, V15, P199; RDCT, 2009, R LANG ENV STAT COMP; Salo RJ, 1976, EFFECT ACID PH SALTS; Singapore MoH, 2004, GUID INF DIS PUBL HL; Singapore MoH, 2009, WEEKL INF DIS B; Urashima M, 2003, JPN J INFECT DIS, V56, P48; [WHO WPRO], 2010, COMM DIS SURV RESP M; [WHO WPRO], 2010, OV HAND FOOT MOUTH D; WHO/WPRO, 2010, COMM DIS SURV RESP R; WHO/ WPRO, 2010, TRENDS STAT COMM DIS; WPRO/WHO, 2009, HAND FOOT MOUTH DIS; YEAGER JG, 1979, APPL ENVIRON MICROB, V38, P694, DOI 10.1128/AEM.38.4.694-701.1979	29	154	168	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16796	10.1371/journal.pone.0016796	http://dx.doi.org/10.1371/journal.pone.0016796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347303	Green Submitted, gold, Green Published			2022-12-25	WOS:000287364500006
J	Preyer, M; Vigneri, P; Wang, JYJ				Preyer, Martin; Vigneri, Paolo; Wang, Jean Y. J.			Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; COIL OLIGOMERIZATION DOMAIN; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; C-ABL; PHOSPHORYLATION PATHWAYS; PHILADELPHIA-CHROMOSOME; INHIBITOR STI571; STRUCTURAL BASIS; POSITIVE CELLS	Background: The constitutively activated BCR-ABL tyrosine kinase of chronic myeloid leukemia (CML) is localized exclusively to the cytoplasm despite the three nuclear localization signals (NLS) in the ABL portion of this fusion protein. The NLS function of BCR-ABL is re-activated by a kinase inhibitor, imatinib, and in a kinase-defective BCR-ABL mutant. The mechanism of this kinase-dependent inhibition of the NLS function is not understood. Methodology/Principal Findings: By examining the subcellular localization of mutant BCR-ABL proteins under conditions of imatinib and/or leptomycin B treatment to inhibit nuclear export, we have found that mutations of three specific tyrosines (Y232, Y253, Y257, according to ABL-1a numbering) in the kinase domain can inhibit the NLS function of kinase-proficient and kinase-defective BCR-ABL. Interestingly, binding of imatinib to the kinase-defective tyrosine-mutant restored the NLS function, suggesting that the kinase domain conformation induced by imatinib-binding is critical to the re-activation of the NLS function. The C-terminal region of ABL contains an F-actin binding domain (FABD). We examined the subcellular localization of several FABD-mutants and found that this domain is also required for the activated kinase to inhibit the NLS function; however, the binding to F-actin per se is not important. Furthermore, we found that some of the C-terminal deletions reduced the kinase sensitivity to imatinib. Conclusions/Significance: Results from this study suggest that an autophosphorylation-dependent kinase conformation together with the C-terminal region including the FABD imposes a blockade of the BCR-ABL NLS function. Conversely, conformation of the C-terminal region including the FABD can influence the binding affinity of imatinib for the kinase domain. Elucidating the structural interactions among the kinase domain, the NLS region and the FABD may therefore provide insights on the design of next generation BCR-ABL inhibitors for the treatment of CML.	Univ Calif San Diego, Sch Med, Dept Med, Div Hematol Oncol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Preyer, M (corresponding author), Salk Inst Biol Studies, Genet Lab, La Jolla, CA USA.	jywang@ucsd.edu	Vigneri, Paolo G/K-8504-2016	Vigneri, Paolo G/0000-0002-5943-6066	National Institutes of Health, USA [CA-043054]; NATIONAL CANCER INSTITUTE [R01CA043054, R37CA043054] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by the National Institutes of Health, USA, CA-043054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; DALEY GQ, 1992, MOL CELL BIOL, V12, P1864, DOI 10.1128/MCB.12.4.1864; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2005, MOL CELL, V19, P461, DOI 10.1016/j.molcel.2005.06.030; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; LINDGREN V, 1977, NATURE, V266, P744, DOI 10.1038/266744a0; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553, DOI 10.1128/MCB.11.3.1553; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skourides PA, 1999, ONCOGENE, V18, P1165, DOI 10.1038/sj.onc.1202407; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Steen H, 2003, MOL CELL PROTEOMICS, V2, P138, DOI 10.1074/mcp.M300001-MCP200; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Taylor CM, 2005, BIOCHEMISTRY-US, V44, P16246, DOI 10.1021/bi051493t; Van Etten RA, 2003, CURR BIOL, V13, pR608, DOI 10.1016/S0960-9822(03)00528-1; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; Vella V, 2003, J BIOL CHEM, V278, P25151, DOI 10.1074/jbc.M301962200; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; WELCH PJ, 1995, MOL CELL BIOL, V15, P5542; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; WETZLER M, 1993, J CLIN INVEST, V92, P1925, DOI 10.1172/JCI116786; Wiesner S, 2005, J BIOMOL NMR, V32, P335, DOI 10.1007/s10858-005-8868-x; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Zhang XW, 2001, MOL CELL BIOL, V21, P840, DOI 10.1128/MCB.21.3.840-853.2001; Zhao X, 2002, NAT STRUCT BIOL, V9, P117	43	33	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17020	10.1371/journal.pone.0017020	http://dx.doi.org/10.1371/journal.pone.0017020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347248	gold, Green Published			2022-12-25	WOS:000287364500023
J	Jin, ZB; Okamoto, S; Osakada, F; Homma, K; Assawachananont, J; Hirami, Y; Iwata, T; Takahashi, M				Jin, Zi-Bing; Okamoto, Satoshi; Osakada, Fumitaka; Homma, Kohei; Assawachananont, Juthaporn; Hirami, Yasuhiko; Iwata, Takeshi; Takahashi, Masayo			Modeling Retinal Degeneration Using Patient-Specific Induced Pluripotent Stem Cells	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; GENERATION; MOUSE	Retinitis pigmentosa (RP) is the most common inherited human eye disease resulting in night blindness and visual defects. It is well known that the disease is caused by rod photoreceptor degeneration; however, it remains incurable, due to the unavailability of disease-specific human photoreceptor cells for use in mechanistic studies and drug screening. We obtained fibroblast cells from five RP patients with distinct mutations in the RP1, RP9, PRPH2 or RHO gene, and generated patient-specific induced pluripotent stem (iPS) cells by ectopic expression of four key reprogramming factors. We differentiated the iPS cells into rod photoreceptor cells, which had been lost in the patients, and found that they exhibited suitable immunocytochemical features and electrophysiological properties. Interestingly, the number of the patient-derived rod cells with distinct mutations decreased in vitro; cells derived from patients with a specific mutation expressed markers for oxidation or endoplasmic reticulum stress, and exhibited different responses to vitamin E than had been observed in clinical trials. Overall, patient-derived rod cells recapitulated the disease phenotype and expressed markers of cellular stresses. Our results demonstrate that the use of patient-derived iPS cells will help to elucidate the pathogenic mechanisms caused by genetic mutations in RP.	[Jin, Zi-Bing; Okamoto, Satoshi; Homma, Kohei; Assawachananont, Juthaporn; Hirami, Yasuhiko; Takahashi, Masayo] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Jin, Zi-Bing] Hosp Eye, Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China; [Osakada, Fumitaka] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Takahashi, Masayo] Kyoto Univ, Ctr iPS Res & Applicat, Kyoto, Japan	RIKEN; Wenzhou Medical University; Salk Institute; Kyoto University	Jin, ZB (corresponding author), RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan.	mretina@cdb.riken.jp	Jin, Zi-Bing/AAE-4106-2019; Okamoto, Satoshi/F-7309-2013; Jin, Zi-Bing/J-6810-2014; Homma, Kohei/AAF-6716-2021	Jin, Zi-Bing/0000-0003-0515-698X; Okamoto, Satoshi/0000-0003-4071-9696; Jin, Zi-Bing/0000-0003-0515-698X; Homma, Kohei/0000-0002-6253-8047; Osakada, Fumitaka/0000-0002-9078-1458	Ministry of Health, Labour and Welfare, Japan [H21-Nanchi-Ippan-216]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the grant from the Ministry of Health, Labour and Welfare, Japan (#H21-Nanchi-Ippan-216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van Helden YGJ, 2009, CARCINOGENESIS, V30, P2070, DOI 10.1093/carcin/bgp186; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; Weleber R.G., 2006, RETINA, P395; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	15	171	184	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17084	10.1371/journal.pone.0017084	http://dx.doi.org/10.1371/journal.pone.0017084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347327	Green Published, gold, Green Submitted			2022-12-25	WOS:000287363000037
J	Chaves, SR; Rosenblum, JS				Chaves, Susana R.; Rosenblum, Jonathan S.			Efficient Nuclear Transport of Structurally Disturbed Cargo: Mutations in a Cargo Protein Switch Its Cognate Karyopherin	PLOS ONE			English	Article							TRANSFER-RNA MATURATION; LA PROTEIN; IMPORT PATHWAY; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-PROTEINS; BINDING-PROTEINS; YEAST; CHAPERONES; LOCALIZATION; AUTOANTIGEN	The Karyopherin (Kap) family of nuclear transport receptors enables trafficking of proteins to and from the nucleus in a precise, regulated manner. Individual members function in overlapping pathways, while simultaneously being very specific for their main cargoes. The details of this apparent contradiction and rules governing pathway preference remain to be further elucidated. S. cerevisiae Lhp1 is an abundant protein that functions as an RNA chaperone in a variety of biologically important processes. It localizes almost exclusively to the nucleus and is imported by Kap108. We show that mutation of 3 of the 275 residues in Lhp1 alters its import pathway to a Kap121-dependent process. This mutant does not retain wild-type function and is bound by several chaperones. We propose that Kap121 also acts as a chaperone, one that can act as a genetic buffer by transporting mutated proteins to the nucleus.	[Chaves, Susana R.] Univ Minho, Dept Biol, Ctr Mol & Environm Biol, Braga, Portugal; [Rosenblum, Jonathan S.] Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Universidade do Minho; Howard Hughes Medical Institute; Rockefeller University	Chaves, SR (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal.	suchaves@bio.uminho.pt	Chaves, Susana R/H-8786-2013	Chaves, Susana R/0000-0002-6004-9872; Rosenblum, Jonathan/0000-0002-7318-0896	PRAXIS XXI, Portugal	PRAXIS XXI, Portugal	S.R. Chaves was supported in part by PRAXIS XXI, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; ALSPAUGH MA, 1975, J CLIN INVEST, V55, P1067, DOI 10.1172/JCI108007; AUSUBEL FM, 1996, CURRENT PROTOCOLS MO, V2; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chaves SR, 2001, J BIOL CHEM, V276, P17712, DOI 10.1074/jbc.M010760200; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Delahodde A, 2001, MOL MICROBIOL, V39, P304, DOI 10.1046/j.1365-2958.2001.02182.x; Gharahdaghi F, 1996, ANAL BIOCHEM, V233, P94, DOI 10.1006/abio.1996.0012; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HOFFMAN DW, 1991, P NATL ACAD SCI USA, V88, P2495, DOI 10.1073/pnas.88.6.2495; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Marchetti MA, 2000, J CELL SCI, V113, P899; MATTIOLI M, 1974, ARTHRITIS RHEUM-US, V17, P421, DOI 10.1002/art.1780170413; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; MUKAI H, 1993, GENE, V132, P57; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rosenblum JS, 1998, J CELL BIOL, V143, P887, DOI 10.1083/jcb.143.4.887; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Schaper S, 2005, J CELL SCI, V118, P1473, DOI 10.1242/jcs.01739; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Simons FHM, 1996, EXP CELL RES, V224, P224, DOI 10.1006/excr.1996.0132; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Van Horn DJ, 1997, RNA, V3, P1434; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Xue DH, 2000, EMBO J, V19, P1650, DOI 10.1093/emboj/19.7.1650; YOO CJ, 1994, MOL CELL BIOL, V14, P5412, DOI 10.1128/MCB.14.8.5412; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16846	10.1371/journal.pone.0016846	http://dx.doi.org/10.1371/journal.pone.0016846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347375	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700043
J	Legendre, CM; Charpentier-Cote, C; Drouin, R; Bouffard, C				Legendre, Claire-Marie; Charpentier-Cote, Catherine; Drouin, Regen; Bouffard, Chantal			Neurofibromatosis Type 1 and the "Elephant Man's" Disease: The Confusion Persists: An Ethnographic Study	PLOS ONE			English	Article							PROTEUS-SYNDROME; CHILDREN; ADOLESCENTS; CHALLENGES; GUIDELINES; MANAGEMENT; SELF; CARE	Background: During informal interviews in the course of an ethnographic study on intergenerational dialogue between individuals with neurofibromatosis and their parents, many members of Canadian neurofibromatosis associations stated they continue to be told the condition that afflicts them or their children is the "elephant man's" disease. Today, even though well established clinical criteria make it possible to diagnose and differentiate the two diseases, the confusion between NF1 and the disease of Joseph Merrick, the "elephant man", persists in both media representations and those of physicians. The objective of this article is to document the persistence of this confusion, to identify the factors that contribute to it, and to identify its impact on the well being of individuals with NF1. Methodology: Preliminary stages of an ethnographic study. Principal Findings: Our findings show that some reference sources, past medical training, and print and online news media have all contributed to the persistence of the association between NF1 and the disease of Joseph Merrick, the "elephant man". Our observations suggest that this misconception can have negative medical, social, and psychological impacts on patients and their families and thus increase the burden of the disease. Conclusions: Changes of attitude regarding medical teaching and the media could lead to definitively clearing up the confusion.	[Legendre, Claire-Marie; Charpentier-Cote, Catherine; Drouin, Regen; Bouffard, Chantal] Univ Sherbrooke, Div Genet, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Legendre, CM (corresponding author), Univ Sherbrooke, Div Genet, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada.	claire-marie.legendre@usherbrooke.ca			Association de la Neurofibromatose du Quebec (ANFQ); Foundation of Stars Children's Health Research; Fonds de Recherche en Sante du Quebec (FRSQ) [16378]	Association de la Neurofibromatose du Quebec (ANFQ); Foundation of Stars Children's Health Research; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	The work underlying this article was supported by the Association de la Neurofibromatose du Quebec (ANFQ) (http://www.anfq.org/), the Foundation of Stars Children's Health Research, and the Fonds de Recherche en Sante du Quebec (FRSQ) (file number: 16378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLON J, 1995, SOC SCI MED, V40, P1481, DOI 10.1016/0277-9536(94)00356-X; Ablon J, 2000, AM J MED GENET, V93, P136, DOI 10.1002/1096-8628(20000717)93:2<136::AID-AJMG11>3.0.CO;2-L; ALLEN P, 2009, SEVERELY BURNED MAN, V30; Barton B, 2007, CHILD CARE HLTH DEV, V33, P401, DOI 10.1111/j.1365-2214.2006.00717.x; Barton B, 2004, DEV MED CHILD NEUROL, V46, P553, DOI 10.1017/S0012162204000921; Belzeaux R, 2006, PRESSE MED, V35, P277, DOI 10.1016/S0755-4982(06)74570-5; Biesecker L, 2006, EUR J HUM GENET, V14, P1151, DOI 10.1038/sj.ejhg.5201638; Biesecker LG, 2001, JAMA-J AM MED ASSOC, V285, P2240, DOI 10.1001/jama.285.17.2240; BIESECKER LG, 2005, MANAGEMENT GENETIC S, P449; CAREY J, 1988, NEUROFIBROMATOSIS NE, V10, P1; CASSIDY SB, 2005, MANAGEMENT GENETIC S, V17; CASTLENAU B, 2009, WORLDS 1 HANDS FACE; CHILDS D, 2007, 3 FACE TRANSPLANT SI; COHEN MJ, 1987, P GREENWOOD GENET, V6, P6; COHEN MM, 1993, AM J MED GENET, V47, P645, DOI 10.1002/ajmg.1320470514; COHEN MM, 1988, NEUROFIBROMATOSIS, V1, P21; CUTTING L, 2004, LDRP, V19, P11; Descheemaeker MJ, 2005, J INTELL DISABIL RES, V49, P33, DOI 10.1111/j.1365-2788.2005.00660.x; Dupuis A, 2005, J PEDIATR-US, V147, P312, DOI 10.1016/j.jpeds.2005.06.043; DURAND M, 2007, GREFFE TOUTE IMAGE D; ECHKENAZI A, 2007, DEUXIEME GREFFE VISA; Eichenfield LF, 1997, J AM ACAD DERMATOL, V37, P625, DOI 10.1016/S0190-9622(97)70182-8; ENGEL J, 1989, NY TIMES; Ferner RE, 2007, EUR J HUM GENET, V15, P131, DOI 10.1038/sj.ejhg.5201676; Fisch GS, 2007, AM J MED GENET A, V143A, P2478, DOI 10.1002/ajmg.a.31915; FLOYD A, 1987, ELEPHANT WOMAN SOC B, V69, P3; FRIEND T, 1990, US TODAY; FRIEND T, 1989, US TODAY; GAGNERFRENETTE L, 2001, NEUROFIBROMATOSIS EL; Goldberg Y, 1996, CLIN PEDIATR, V35, P545, DOI 10.1177/000992289603501101; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Hammersley M, 1994, ETHNOGRAPHY PRINCIPL; Hart L, 2005, NURSE PRACT, V30, P38, DOI 10.1097/00006205-200506000-00007; HOSTAMISLIGIL G, 1989, NEUROFIBROMATOSIS, V2, P2; Krab LC, 2008, J CHILD NEUROL, V23, P1002, DOI 10.1177/0883073808316366; MERRICK J, 1988, WHAT ELEPHANT MAN RE; MONTAGU A, 1979, ELEPHANT MAN STUDY H; Morse RP, 1999, ARCH NEUROL-CHICAGO, V56, P364, DOI 10.1001/archneur.56.3.364; *NIH CONS DEV C ST, 1988, ARCH NEUROL-CHICAGO, V45, P4; Parkes W. F., 1909, BRIT J DERMATOL, V21, P3; Patenaude AF, 2003, J PEDIATR PSYCHOL, V28, P135, DOI 10.1093/jpepsy/28.2.135; PELE L, 2009, TROISIEME GREFFE VIS; Pinson S, 2002, ARCH PEDIATRIE, V9, P49, DOI 10.1016/S0929-693X(01)00695-9; Radtke Heather B, 2007, J Genet Couns, V16, P387, DOI 10.1007/s10897-007-9101-8; RAI GS, 1981, J AM GERIATR SOC, V29, P45, DOI 10.1111/j.1532-5415.1981.tb02395.x; Redmann Carolyn, 2007, J Fam Health Care, V17, P95; ROBERTGNANSIA E, 2005, SYNDROME PROTEE ORPH; ROSENFELD A, 1988, INSIDE ELEPHANT MAN; SAUVEUR CD, 2008, MAINTENANT JE VIS CO; SEASHORE MR, 1995, PEDIATRICS, V96, P368; SEWARD G, 1986, BMJ-BRIT MED J, V293, P1; TIBBLES JAR, 1986, BRIT MED J, V293, P683, DOI 10.1136/bmj.293.6548.683; Turner J, 2007, AM J MED GENET A, V143A, P2089, DOI 10.1002/ajmg.a.31904; WATT N, 2008, TRANSFORMED FACE TRA; Weber FP, 1909, BRIT J DERMATOL, V21, P49; Williams PG, 1998, J AUTISM DEV DISORD, V28, P567, DOI 10.1023/A:1026012414193; WILLIAMSON D, 1991, TELEGRAM GAZETTE; Wolkenstein P, 2003, ARCH DERMATOL, V139, P103, DOI 10.1001/archderm.139.1.103; Wolkenstein P, 2001, ARCH DERMATOL, V137, P1421, DOI 10.1001/archderm.137.11.1421; Zaroff CM, 2005, EPILEPSY BEHAV, V7, P133, DOI 10.1016/j.yebeh.2005.05.012; 1990, SCI NEWS, V138, P1	61	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16409	10.1371/journal.pone.0016409	http://dx.doi.org/10.1371/journal.pone.0016409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347399	gold, Green Published, Green Submitted			2022-12-25	WOS:000287361700016
J	Ruggiero, D; Dalmasso, C; Nutile, T; Sorice, R; Dionisi, L; Aversano, M; Broet, P; Leutenegger, AL; Bourgain, C; Ciullo, M				Ruggiero, Daniela; Dalmasso, Cyril; Nutile, Teresa; Sorice, Rossella; Dionisi, Laura; Aversano, Mario; Broeet, Philippe; Leutenegger, Anne-Louise; Bourgain, Catherine; Ciullo, Marina			Genetics of VEGF Serum Variation in Human Isolated Populations of Cilento: Importance of VEGF Polymorphisms	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRAIT LINKAGE ANALYSIS; GENERAL PEDIGREES; CANCER; DISEQUILIBRIUM; EXPRESSION; LOCUS; SUSCEPTIBILITY; IDENTIFICATION; ANGIOGENESIS	Vascular Endothelial Growth Factor (VEGF) is the main player in angiogenesis. Because of its crucial role in this process, the study of the genetic factors controlling VEGF variability may be of particular interest for many angiogenesis-associated diseases. Although some polymorphisms in the VEGF gene have been associated with a susceptibility to several disorders, no genome-wide search on VEGF serum levels has been reported so far. We carried out a genome-wide linkage analysis in three isolated populations and we detected a strong linkage between VEGF serum levels and the 6p21.1 VEGF region in all samples. A new locus on chromosome 3p26.3 significantly linked to VEGF serum levels was also detected in a combined population sample. A sequencing of the gene followed by an association study identified three common single nucleotide polymorphisms (SNPs) influencing VEGF serum levels in one population (Campora), two already reported in the literature (rs3025039, rs25648) and one new signal (rs3025020). A fourth SNP (rs41282644) was found to affect VEGF serum levels in another population (Cardile). All the identified SNPs contribute to the related population linkages (35% of the linkage explained in Campora and 15% in Cardile). Interestingly, none of the SNPs influencing VEGF serum levels in one population was found to be associated in the two other populations. These results allow us to exclude the hypothesis that the common variants located in the exons, intron-exon junctions, promoter and regulative regions of the VEGF gene may have a causal effect on the VEGF variation. The data support the alternative hypothesis of a multiple rare variant model, possibly consisting in distinct variants in different populations, influencing VEGF serum levels.	[Ruggiero, Daniela; Nutile, Teresa; Sorice, Rossella; Dionisi, Laura; Aversano, Mario; Ciullo, Marina] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Dalmasso, Cyril; Broeet, Philippe; Bourgain, Catherine] Univ Paris 11, INSERM, U669, Villejuif, France; [Leutenegger, Anne-Louise] INSERM, U946, Paris, France; [Leutenegger, Anne-Louise] Univ Paris Diderot, UMR S946, Paris, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Ruggiero, D (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy.	ciullo@igb.cnr.it	ruggiero, daniela/K-5638-2016; Ciullo, Marina/AAE-3041-2020; Leutenegger, Anne-Louise/B-5597-2009; Bourgain, Catherine/L-1505-2017	ruggiero, daniela/0000-0003-3898-7827; Ciullo, Marina/0000-0002-9621-9984; Leutenegger, Anne-Louise/0000-0002-1302-4357; Bourgain, Catherine/0000-0002-6761-0140; BROET, PHILIPPE/0000-0001-9122-2810; NUTILE, TERESA/0000-0001-7062-8352	EU [Vasoplus-037254]; Italian Ministry of Universities [FIRB -RBIN064YAT]; Assessorato Ricerca Regione Campania; Ente Parco Nazionale del Cilento e Vallo di Diano; Fondazione Banco di Napoli	EU(European Commission); Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); Assessorato Ricerca Regione Campania(Regione Campania); Ente Parco Nazionale del Cilento e Vallo di Diano; Fondazione Banco di Napoli	This work was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano and the Fondazione Banco di Napoli to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Balasubramanian SP, 2007, INT J CANCER, V121, P1009, DOI 10.1002/ijc.22772; Bellenguez C, 2009, GENET EPIDEMIOL, V33, P207, DOI 10.1002/gepi.20371; Ciullo M, 2006, HUM MOL GENET, V15, P1735, DOI 10.1093/hmg/ddl097; Ciullo M, 2008, DIABETES, V57, P783, DOI 10.2337/db07-0970; Colonna V, 2007, HUM HERED, V64, P123, DOI 10.1159/000101964; Colonna V, 2009, EUR J HUM GENET, V17, P1635, DOI 10.1038/ejhg.2009.97; Dalmasso Cyril, 2007, BMC Proc, V1 Suppl 1, pS141; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Falchi M, 2004, AM J HUM GENET, V75, P1015, DOI 10.1086/426155; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Goddard KAB, 1999, GENET EPIDEMIOL, V17, pS575; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Hansen TF, 2010, J CANCER RES CLIN, V136, P751, DOI 10.1007/s00432-009-0714-1; Jain L, 2009, MOL CANCER THER, V8, P2496, DOI 10.1158/1535-7163.MCT-09-0302; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Krippl P, 2003, INT J CANCER, V106, P468, DOI 10.1002/ijc.11238; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin CC, 2003, UROLOGY, V62, P374, DOI 10.1016/S0090-4295(03)00268-1; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pantsulaia I, 2004, CYTOKINE, V27, P152, DOI 10.1016/j.cyto.2004.04.005; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; SIERVO M, 2010, J INTERNAL MED  0623; SPIEGELHALTER D, WINBUGS USER MANUAL; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710	34	54	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16982	10.1371/journal.pone.0016982	http://dx.doi.org/10.1371/journal.pone.0016982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347390	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700060
J	Zhang, JX; Xu, XY; Rao, NV; Argyle, B; McCoard, L; Rusho, WJ; Kennedy, TP; Prestwich, GD; Krueger, G				Zhang, Jianxing; Xu, Xiaoyu; Rao, Narayanam V.; Argyle, Brian; McCoard, Lindsi; Rusho, William J.; Kennedy, Thomas P.; Prestwich, Glenn D.; Krueger, Gerald			Novel Sulfated Polysaccharides Disrupt Cathelicidins, Inhibit RAGE and Reduce Cutaneous Inflammation in a Mouse Model of Rosacea	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; GLYCATION END-PRODUCTS; HUMAN-SKIN; TRANSDERMAL DELIVERY; CELL RECRUITMENT; RECEPTOR RAGE; IN-VITRO; PENETRATION; PERMEATION; ABSORPTION	Background: Rosacea is a common disfiguring skin disease of primarily Caucasians characterized by central erythema of the face, with telangiectatic blood vessels, papules and pustules, and can produce skin thickening, especially on the nose of men, creating rhinophyma. Rosacea can also produce dry, itchy eyes with irritation of the lids, keratitis and corneal scarring. The cause of rosacea has been proposed as over-production of the cationic cathelicidin peptide LL-37. Methodology/Principal Findings: We tested a new class of non-anticoagulant sulfated anionic polysaccharides, semisynthetic glycosaminoglycan ethers (SAGEs) on key elements of the pathogenic pathway leading to rosacea. SAGEs were anti-inflammatory at ng/ml, including inhibition of polymorphonuclear leukocyte (PMN) proteases, P-selectin, and interaction of the receptor for advanced glycation end-products (RAGE) with four representative ligands. SAGEs bound LL-37 and inhibited interleukin-8 production induced by LL-37 in cultured human keratinocytes. When mixed with LL-37 before injection, SAGEs prevented the erythema and PMN infiltration produced by direct intradermal injection of LL-37 into mouse skin. Topical application of a 1% (w/w) SAGE emollient to overlying injected skin also reduced erythema and PMN infiltration from intradermal LL-37. Conclusions: Anionic polysaccharides, exemplified by SAGEs, offer potential as novel mechanism-based therapies for rosacea and by extension other LL-37-mediated and RAGE-ligand driven skin diseases.	[Zhang, Jianxing; Xu, Xiaoyu; Argyle, Brian; McCoard, Lindsi; Prestwich, Glenn D.] Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT 84112 USA; [Zhang, Jianxing; Xu, Xiaoyu; Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Rao, Narayanam V.; Kennedy, Thomas P.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Rusho, William J.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA; [Krueger, Gerald] Univ Utah, Dept Dermatol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zhang, JX (corresponding author), Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT 84112 USA.	tkennedy@mail.mcg.edu			State of Utah to GlycoMira LLC; Center for Therapeutic Biomaterials; Utah Center of Excellence; NIH [R43 AR057281]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR057281] Funding Source: NIH RePORTER	State of Utah to GlycoMira LLC; Center for Therapeutic Biomaterials; Utah Center of Excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Centers of Excellence grant from the State of Utah to GlycoMira LLC, by the Center for Therapeutic Biomaterials, also a Utah Center of Excellence, and by NIH grant R43 AR057281 to Drs. Zhang, Prestwich and Kennedy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; BARKER RL, 1991, J CLIN INVEST, V88, P798, DOI 10.1172/JCI115379; Betz G, 2001, INT J PHARM, V228, P147, DOI 10.1016/S0378-5173(01)00832-8; Bevins CL, 2007, NAT MED, V13, P904, DOI 10.1038/nm0807-904; BONINA FP, 1994, INT J PHARMACEUT, V102, P19, DOI 10.1016/0378-5173(94)90035-3; BOSSHARD E, 1985, FOOD CHEM TOXICOL, V23, P149, DOI 10.1016/0278-6915(85)90007-9; Bralley EE, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-1; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; DEMOERLOOSE P, 1992, BLOOD COAGUL FIBRIN, V3, P827, DOI 10.1097/00001721-199212000-00040; Elewski BE, 2011, J EUR ACAD DERMATOL, V25, P188, DOI 10.1111/j.1468-3083.2010.03751.x; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; FRYER AD, 1992, J CLIN INVEST, V90, P2292, DOI 10.1172/JCI116116; Fuellen G, 2003, TRENDS IMMUNOL, V24, P622, DOI 10.1016/j.it.2003.10.004; Karande P, 2004, NAT BIOTECHNOL, V22, P192, DOI 10.1038/nbt928; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lanke SSS, 2009, INT J PHARMACEUT, V365, P26, DOI 10.1016/j.ijpharm.2008.08.028; Lohwasser C, 2006, J INVEST DERMATOL, V126, P291, DOI 10.1038/sj.jid.5700070; Meingassner JG, 2005, EXP DERMATOL, V14, P752, DOI 10.1111/j.1600-0625.2005.00354.x; Mitragotri S, 2001, PHARMACEUT RES, V18, P1151, DOI 10.1023/A:1010979010907; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Ogata M, 1997, INFECT IMMUN, V65, P2160, DOI 10.1128/IAI.65.6.2160-2167.1997; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Pacini S, 2006, PHARM RES-DORDR, V23, P114, DOI 10.1007/s11095-005-8923-z; Parisel C, 2003, J BIOMED MATER RES A, V67A, P517, DOI 10.1002/jbm.a.10085; PARK H, 2010, J BIOL CHEM, DOI DOI 10.1074/JBC.M110/169276; Powell FC, 2005, NEW ENGL J MED, V352, P793, DOI 10.1056/NEJMcp042829; PRESTWICH G, 2010, Patent No. 7855187; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; SCHAEFER H, 1976, PHARMAZIE, V31, P251; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHRAVEN E, 1973, ARZNEIMITTEL-FORSCH, V23, P274; SILVERBERG M, 1980, J BIOL CHEM, V255, P7281; Song YK, 2006, BIOMATERIALS, V27, P271, DOI 10.1016/j.biomaterials.2005.05.097; STUTTGEN G, 1990, ARZNEIMITTEL-FORSCH, V40-1, P484; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yamasaki K, 2008, EUR J DERMATOL, V18, P11; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; YOUNG JM, 1984, J INVEST DERMATOL, V82, P367, DOI 10.1111/1523-1747.ep12260709; ZESCH A, 1976, ARZNEIMITTEL-FORSCH, V26, P1365; ZIMMERMANN RE, 1982, THERAPIEWOCHE, V32, P6157	50	51	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16658	10.1371/journal.pone.0016658	http://dx.doi.org/10.1371/journal.pone.0016658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347371	Green Submitted, Green Published, gold			2022-12-25	WOS:000287361700025
J	Ghosh, A; Chawla-Sarkar, M; Stuehr, DJ				Ghosh, Arnab; Chawla-Sarkar, Mamta; Stuehr, Dennis J.			Hsp90 interacts with inducible NO synthase client protein in its heme-free state and then drives heme insertion by an ATP-dependent process	FASEB JOURNAL			English	Article						heme-deficient; heme-replete; chaperone; cytokines; cardiovascular	NITRIC-OXIDE SYNTHASE; HEAT-SHOCK-PROTEIN; CHAPERONE MACHINERY; DIMERIZATION INHIBITORS; PROTEOLYTIC DEGRADATION; SUPEROXIDE GENERATION; SUBUNIT DIMERIZATION; MOLECULAR CHAPERONE; ENDOTHELIAL-CELLS; ABC TRANSPORTER	Maturation of NOS enzymes requires that they incorporate heme to become active, but how this cellular process occurs is unclear. We investigated a role for chaperone heat shock protein 90 (hsp90) in enabling heme insertion into the cytokine-inducible mouse NOS. We used macrophage cell line RAW 264.7 and human embryonic kidney HEK293T cells and studied insertion of native heme during iNOS expression and insertion of exogenous heme into preformed apo-iNOS. Pulldown experiments showed that the hsp90-iNOS complex was present in cells, but the extent of their association was inversely related to iNOS heme content. Hsp90 was primarily associated with apo-iNOS monomer and was associated 11-fold less with heme-containing iNOS monomer or dimer in cells. Kinetic studies showed that hsp90 dissociation occurred coincident with cellular heme insertion into apo-iNOS (0.8 h(-1)). The hsp90 inhibitor radicicol or coexpression of an ATPase-defective hsp90 blocked heme insertion into apo-iNOS by 90 and 75%, respectively. The ATPase activity of hsp90 was not required for complex formation with iNOS but was essential for heme insertion to occur. We conclude that hsp90 plays a primary role in maturation of iNOS protein by interacting with the apoenzyme in cells and then driving heme insertion in an ATP-dependent manner.-Ghosh, A., Chawla-Sarkar, M., Stuehr, D. J. Hsp90 interacts with inducible NO synthase client protein in its heme-free state and then drives heme insertion by an ATP-dependent process. FASEB J. 25, 2049-2060 (2011). www.fasebj.org	[Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, India	Cleveland Clinic Foundation; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol NC22, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org		GHOSH, ARNAB/0000-0002-7498-1994	U.S. National Institutes of Health [CA53914, GM51491, HL076491]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. W. Sessa and A. Papapetropoulos for providing hsp90 constructs. This work was supported by U.S. National Institutes of Health grants CA53914, GM51491, and HL076491 (to D.J.S.).	Albakri QA, 1996, J BIOL CHEM, V271, P5414, DOI 10.1074/jbc.271.10.5414; Antonova G, 2007, CLIN HEMORHEOL MICRO, V37, P19; Aschner JL, 2009, AM J PHYSIOL-LUNG C, V296, pL555, DOI 10.1152/ajplung.90456.2008; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Bender AT, 2000, J BIOL CHEM, V275, P26018, DOI 10.1074/jbc.275.34.26018; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Billecke SS, 2004, J BIOL CHEM, V279, P30252, DOI 10.1074/jbc.M403864200; Blasko E, 2002, J BIOL CHEM, V277, P295, DOI 10.1074/jbc.M105691200; Burkhard KA, 2008, BIOCHEMISTRY-US, V47, P7977, DOI 10.1021/bi801005u; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Clapp KM, 2010, J BIOL CHEM, V285, P33642, DOI 10.1074/jbc.M110.159178; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; Fairchild TA, 2001, J BIOL CHEM, V276, P26674, DOI 10.1074/jbc.M103647200; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Hemmens B, 1998, BIOCHEM J, V332, P337, DOI 10.1042/bj3320337; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Kolodziejski PJ, 2004, P NATL ACAD SCI USA, V101, P18141, DOI 10.1073/pnas.0406711102; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; Panda K, 2005, P NATL ACAD SCI USA, V102, P10117, DOI 10.1073/pnas.0408972102; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pant K, 2005, J MOL BIOL, V352, P932, DOI 10.1016/j.jmb.2005.07.070; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; Porter JR, 2010, CURR OPIN CHEM BIOL, V14, P412, DOI 10.1016/j.cbpa.2010.03.019; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Prodromou C, 2009, CURR TOP MED CHEM, V9, P1352, DOI 10.2174/156802609789895656; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Sennequier N, 1999, J BIOL CHEM, V274, P930, DOI 10.1074/jbc.274.2.930; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Song Y, 2002, BIOCHEMISTRY-US, V41, P10616, DOI 10.1021/bi026060u; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Vaughan CK, 2010, NAT STRUCT MOL BIOL, V17, P1400, DOI 10.1038/nsmb1210-1400; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Walerych D, 2010, J BIOL CHEM, V285, P32020, DOI 10.1074/jbc.M110.112110; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200	55	52	52	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					2049	2060		10.1096/fj.10-180554	http://dx.doi.org/10.1096/fj.10-180554			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21357526	Green Published			2022-12-25	WOS:000291023800027
J	Wang, R; Wang, ZX; Yang, JS; Pan, X; De, W; Chen, LB				Wang, R.; Wang, Z-X; Yang, J-S; Pan, X.; De, W.; Chen, L-B			MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)	ONCOGENE			English	Article						microRNA; non-small cell lung cancer; miR-451; RAB14	EXPRESSION; GROWTH; RNA; RESISTANCE; PATTERNS; MIR-451	Accumulating evidence suggests that microRNAs (miRNAs) are important gene regulators, which can have critical roles in diverse biological processes including tumorigenesis. In this study, we analyzed the miRNA expression profiles in non-small cell lung carcinoma (NSCLC) by use of a miRNA microarray platform and identified 40 differentially expressed miRNAs. We showed that miRNA (miR)-451 was the most downregulated in NSCLC tissues. The expression level of miR-451 was found to be significantly correlated with tumor differentiation, pathological stage and lymph-node metastasis. Moreover, low miR-451 expression level was also correlated with shorter overall survival of NSCLC patients (P<0.001). Ectopic miR-451 expression significantly suppressed the in vitro proliferation and colony formation of NSCLC cells and the development of tumors in nude mice by enhancing apoptosis, which might be associated with inactivation of Akt signaling pathway. Interestingly, ectopic miR-451 expression could significantly inhibit RAB14 protein expression and decrease a luciferase-reporter activity containing the RAB14 3'-untranslated region (UTR). In addition,, RNA interference silencing of RAB14 gene could recapitulate the tumor suppressor function of miR-451, whereas restoration of RAB14 expression could partially attenuate the tumor suppressor function of miR-451 in NSCLC cells. Furthermore, we also showed that strong positive immunoreactivity of RAB14 protein was significantly associated with downregulation of miR-451 (P = 0.01). These findings suggest that miR-451 regulates survival of NSCLC cells partially through the downregulation of RAB14. Therefore, targeting with the miR-451/RAB14 interaction might serve as a novel therapeutic application to treat NSCLC patients. Oncogene (2011) 30, 2644-2658; doi:10.1038/onc.2010.642; published online 28 February 2011	[Wang, R.; Chen, L-B] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China; [Wang, Z-X; Pan, X.] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing 210002, Jiangsu, Peoples R China; [Yang, J-S] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Oncol, Nanjing 210002, Jiangsu, Peoples R China; [Yang, J-S; De, W.] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing 210002, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Chen, LB (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, 315 Zhongshan E Rd, Nanjing 210002, Jiangsu, Peoples R China.	dewei_nanjing@yahoo.com.cn; chenlongbang@yeah.net			National Science Foundation of China (NSFC) [30872979, 30901440, 30973477]; National Natural Science Foundation of China [30973477, BK2010590]; Medical Science Development Subject in Science and Technology Project of Nanjing [ZKX08017, YKK08091]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science Development Subject in Science and Technology Project of Nanjing	We acknowledge the excellent technical support and sincere help of the Functional Genomics and Bioinformatics cores of Harbin Medical University, and the Animal Resources Center of School of Medicine, Nanjing University. We thank Zhang Ai-Ping and Cao Lei for assistance with obtaining tissue samples, Huang Gui-Chun for assistance with BALB/c athymic node mouse, and Xu Lin-Yong for assistance with statistical analysis. This study was supported by the National Science Foundation of China (NSFC 30872979, 30901440, and 30973477), the National Natural Science Foundation of China (No. 30973477 and BK2010590), and the Medical Science Development Subject in Science and Technology Project of Nanjing (Grant No. ZKX08017 and YKK08091).	Agarwal R, 2009, TRAFFIC, V10, P1561, DOI 10.1111/j.1600-0854.2009.00969.x; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Brognard J, 2001, CANCER RES, V61, P3986; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chaudhuri K, 2007, DNA CELL BIOL, V26, P321, DOI 10.1089/dna.2006.0549; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Gordeladze JO, 2009, ACTA PHARMACOL SIN, V30, P1369, DOI 10.1038/aps.2009.143; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hu Z, 2005, CLIN CANCER RES, V11, P4646, DOI 10.1158/1078-0432.CCR-04-2013; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ju XL, 2009, PEDIATR HEMAT ONCOL, V26, P1, DOI 10.1080/08880010802378338; Kardassis D, 2009, FEBS J, V276, P2947, DOI 10.1111/j.1742-4658.2009.07031.x; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Skaftnesmo KO, 2007, CURR PHARM BIOTECHNO, V8, P320, DOI 10.2174/138920107783018390; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yang F, 2000, J INVEST DERMATOL, V114, P157, DOI 10.1046/j.1523-1747.2000.00836.x; Yokoi S, 2003, CANCER SCI, V94, P344, DOI 10.1111/j.1349-7006.2003.tb01444.x; Yousef GM, 2008, BIOL CHEM, V389, P689, DOI 10.1515/BC.2008.068; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang HC, 2009, LIFE SCI J, V6, P71; Zhang SZ, 2005, MOL CANCER THER, V4, P1577, DOI 10.1158/1535-7163.MCT-05-0106; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	38	264	290	0	54	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	23					2644	2658		10.1038/onc.2010.642	http://dx.doi.org/10.1038/onc.2010.642			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778CV	21358675				2022-12-25	WOS:000291677800005
J	Davies, JS; Klein, DC; Carter, DA				Davies, Jeff S.; Klein, David C.; Carter, David A.			Selective Genomic Targeting by FRA-2/FOSL2 Transcription Factor REGULATION OF THE Rgs4 GENE IS MEDIATED BY A VARIANT ACTIVATOR PROTEIN 1 (AP-1) PROMOTER SEQUENCE/CREB-BINDING PROTEIN (CBP) MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-RESPONSE-ELEMENT; ARYLALKYLAMINE N-ACETYLTRANSFERASE; RAT PINEAL-GLAND; CIRCADIAN EXPRESSION; C-JUN; GENE-EXPRESSION; PC12 CELLS; RGS4 POLYMORPHISMS; DYNAMIC EXPRESSION; ANTIGEN-2 FRA-2	FRA-2/FOSL2 is a basic region-leucine zipper motif transcription factor that is widely expressed in mammalian tissues. The functional repertoire of this factor is unclear, partly due to a lack of knowledge of genomic sequences that are targeted. Here, we identified novel, functional FRA-2 targets across the genome through expression profile analysis in a knockdown transgenic rat. In this model, a nocturnal rhythm of pineal gland FRA-2 is suppressed by a genetically encoded, dominant negative mutant protein. Bioinformatic analysis of validated sets of FRA-2-regulated and -nonregulated genes revealed that the FRA-2 regulon is limited by genomic target selection rules that, in general, transcend core cis-sequence identity. However, one variant AP-1related (AP-1R) sequence was common to a subset of regulated genes. The functional activity and protein binding partners of a candidate AP-1R sequence were determined for a novel FRA-2-repressed gene, Rgs4. FRA-2 protein preferentially associated with a proximal Rgs4 AP-1R sequence as demonstrated by ex vivo ChIP and in vitro EMSA analysis; moreover, transcriptional repression was blocked by mutation of the AP-1R sequence, where as mutation of an upstream consensus AP-1 family sequence did not affect Rgs4 expression. Nocturnal changes in protein complexes at the Rgs4 AP-1R sequence are associated with FRA-2-dependent dismissal of the co-activator, CBP; this provides a mechanistic basis for Rgs4 gene repression. These studies have also provided functional insight into selective genomic targeting by FRA-2, highlighting discordance between predicted and actual targets. Future studies should address FRA-2-Rgs4 interactions in other systems, including the brain, where FRA-2 function is poorly understood.	[Davies, Jeff S.; Carter, David A.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Klein, David C.] NICHD, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	Cardiff University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Carter, DA (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	carterda@cardiff.ac.uk	Davies, Jeffrey S/K-1400-2019; Carter, David/A-4479-2010; Klein, David C./C-1331-2009	Davies, Jeffrey S/0000-0002-4234-0033; Carter, David/0000-0002-8419-3975; Klein, David/0000-0002-1792-5806	National Institutes of Health; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836, ZIAHD008838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (to D. C. K.). This work was also supported by the Wellcome Trust (to J. D. and D. A. C.).	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Baler R, 1999, BIOL CELL, V91, P699, DOI 10.1016/S0248-4900(00)88533-0; BALER R, 1995, J BIOL CHEM, V270, P27319, DOI 10.1074/jbc.270.45.27319; Benkoussa M, 2002, MOL CELL BIOL, V22, P4522, DOI 10.1128/MCB.22.13.4522-4534.2002; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Burke Z, 1999, J NEUROCHEM, V73, P1343, DOI 10.1046/j.1471-4159.1999.0731343.x; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CARTER DA, 1992, MOL BRAIN RES, V16, P111, DOI 10.1016/0169-328X(92)90200-U; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chik CL, 2007, ENDOCRINOLOGY, V148, P3523, DOI 10.1210/en.2007-0166; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Chowdari KV, 2008, SCHIZOPHRENIA BULL, V34, P118, DOI 10.1093/schbul/sbm042; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Ding L, 2007, GENE, V401, P46, DOI 10.1016/j.gene.2007.07.002; Ebert PJ, 2006, NEUROSCIENCE, V142, P1145, DOI 10.1016/j.neuroscience.2006.08.011; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Engel L, 2005, NEUROSCIENCE, V132, P511, DOI 10.1016/j.neuroscience.2004.12.014; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Flammer JR, 2006, BIOCHEMISTRY-US, V45, P9615, DOI 10.1021/bi052521a; Gaildrat P, 2005, J BIOL CHEM, V280, P16851, DOI 10.1074/jbc.M414587200; Grillet N, 2003, J NEUROSCI, V23, P10613; Guberman AS, 2003, J BIOL CHEM, V278, P2317, DOI 10.1074/jbc.M205057200; Guillaumond F, 2000, J NEUROCHEM, V75, P1398, DOI 10.1046/j.1471-4159.2000.0751398.x; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Ho AK, 2007, ENDOCRINOLOGY, V148, P4592, DOI 10.1210/en.2007-0578; Hu WH, 2008, BIOCHEM J, V412, P35, DOI 10.1042/BJ20080042; Humphries A, 2004, J NEUROCHEM, V91, P946, DOI 10.1111/j.1471-4159.2004.02777.x; Iwamoto T, 2005, CYTOTECHNOLOGY, V47, P107, DOI 10.1007/s10616-005-3763-6; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KONRADI C, 1993, P NATL ACAD SCI USA, V90, P7005, DOI 10.1073/pnas.90.15.7005; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lapidot M, 2008, PLOS GENET, V4; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Liu WH, 2006, P NATL ACAD SCI USA, V103, P18338, DOI 10.1073/pnas.0604560103; Maronde E, 1999, J NEUROSCI, V19, P3326; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Poirier G. L., 2008, Thalamus & Related Systems, V4, P59, DOI 10.1017/S1472928808000368; RYSECK RP, 1991, ONCOGENE, V6, P533; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Seldeen KL, 2009, BIOCHEMISTRY-US, V48, P1975, DOI 10.1021/bi802068s; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith M, 2001, MOL CELL BIOL, V21, P3704, DOI 10.1128/MCB.21.11.3704-3713.2001; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun H, 2006, NUCLEIC ACIDS RES, V34, pD98, DOI 10.1093/nar/gkj096; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; TAMOTSU S, 1995, CELL TISSUE RES, V282, P219, DOI 10.1007/s004410050474; Taymans JM, 2003, J NEUROCHEM, V84, P1118, DOI 10.1046/j.1471-4159.2003.01610.x; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Van Loo P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r66; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Yang JQ, 2010, J BIOL CHEM, V285, P29760, DOI 10.1074/jbc.M110.121459; Yivgi-Ohana N, 2009, ENDOCRINOLOGY, V150, P977, DOI 10.1210/en.2008-0541; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhang DS, 2005, NEUROPSYCHOPHARMACOL, V30, P1443, DOI 10.1038/sj.npp.1300680; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhou HM, 2005, DNA RES, V12, P139, DOI 10.1093/dnares/12.2.139	77	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15227	15239		10.1074/jbc.M110.201996	http://dx.doi.org/10.1074/jbc.M110.201996			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21367864	Green Published, hybrid			2022-12-25	WOS:000289788300054
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			GINS and Sld3 Compete with One Another for Mcm2-7 and Cdc45 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; BUDDING YEAST; ATP-HYDROLYSIS; S-PHASE; PHOSPHORYLATION; COMPLEX; HELICASE; ASSOCIATION; PROGRESSION; CDC7-DBF4	Sld3 is essential for the initiation of DNA replication, but Sld3 does not travel with a replication fork. GINS binds to Cdc45 and Mcm2-7 to form the replication fork helicase in eukaryotes. We purified Sld3, Cdc45, GINS, and Mcm2-7 and studied their interaction and assembly into complexes. Sld3 binds tightly to Cdc45 in the presence or absence of cyclin-dependent kinase activity. Furthermore, Sld3 binds tightly to the Mcm2-7 complex, and a ternary complex forms among Cdc45, Mcm2-7, and Sld3, with a 1:1:1 stoichiometry (CMS complex). GINS binds directly to Mcm2-7, and GINS competes with Sld3 for Mcm2-7 binding. GINS also binds directly to Cdc45, and GINS competes with Sld3 for Cdc45 binding. Cdc45, Mcm2-7, and GINS form a ternary complex with a stoichiometry of 1:1:1 (CMG complex). Size exclusion data reveal that when Sld3, Cdc45, Mcm2-7, and GINS are added together, the result is a mixture of CMS and CMG complexes. The data suggest that GINS and Sld3 compete with one another for Mcm2-7 and Cdc45 binding. Our results are consistent with a model wherein GINS trades places with Sld3 at a replication origin, contributing to the activation of the replication fork helicase.	[Bruck, Irina; Kaplan, Daniel L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, DL (corresponding author), VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	kaplan@vanderbilt.edu		Kaplan, Daniel/0000-0003-2760-7745	Vanderbilt University; American Cancer Society [RSG-08-124-01-CCG]	Vanderbilt University; American Cancer Society(American Cancer Society)	This work was supported by a Vanderbilt University Discovery grant (to D. L. K.) and American Cancer Society Research Scholar Grant RSG-08-124-01-CCG (to D. L. K.).	Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	29	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14157	14167		10.1074/jbc.M111.218305	http://dx.doi.org/10.1074/jbc.M111.218305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362622	Green Published, hybrid			2022-12-25	WOS:000289556200039
J	Chiang, NY; Hsiao, CC; Huang, YS; Chen, HY; Hsieh, IJ; Chang, GW; Lin, HH				Chiang, Nien-Yi; Hsiao, Cheng-Chih; Huang, Yi-Shu; Chen, Hsin-Yi; Hsieh, I-Ju; Chang, Gin-Wen; Lin, Hsi-Hsien			Disease-associated GPR56 Mutations Cause Bilateral Frontoparietal Polymicrogyria via Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CELL-ADHESION; TUMOR-GROWTH; EXPRESSION; ROLES; CLEAVAGE; MOTIF; GPCR; TG2	Loss-of-function mutations in the gene encoding G protein-coupled receptor 56 (GPR56) lead to bilateral frontoparietal polymicrogyria (BFPP), an autosomal recessive disorder affecting brain development. The GPR56 receptor is a member of the adhesion-GPCR family characterized by the chimeric composition of a long ectodomain (ECD), a GPCR proteolysis site (GPS), and a seven-pass transmembrane (7TM) moiety. Interestingly, all identified BFPP-associated missense mutations are located within the extracellular region of GPR56 including the ECD, GPS, and the extracellular loops of 7TM. In the present study, a detailed molecular and functional analysis of the wild-type GPR56 and BFPP-associated point mutants shows that individual GPR56 mutants most likely cause BFPP via different combination of multiple mechanisms. These include reduced surface receptor expression, loss of GPS proteolysis, reduced receptor shedding, inability to interact with a novel protein ligand, and differential distribution of the 7TM moiety in lipid rafts. These results provide novel insights into the cellular functions of GPR56 receptor and reveal molecular mechanisms whereby GPR56 mutations induce BFPP.	[Chiang, Nien-Yi; Huang, Yi-Shu; Hsieh, I-Ju] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Hsiao, Cheng-Chih; Chen, Hsin-Yi; Chang, Gin-Wen; Lin, Hsi-Hsien] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University	Lin, HH (corresponding author), 259 Wen Hwa 1st Rd, Tao Yuan, Taiwan.	hhlin@mail.cgu.edu.tw	LIN, Hsi-Hsien/N-1488-2015; Huang, I-Shu/S-9341-2017	Hsiao, Cheng-Chih/0000-0003-3572-1046; Huang, I-Shu/0000-0001-8770-9298	National Science Council, Taiwan [NSC96-2628-B-182-030-MY2, NSC98-2320-B-182-028-MY3]; Chang Gung Memorial Hospital [CMRPD170013, CMRPD160383]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by Grants from National Science Council, Taiwan (NSC96-2628-B-182-030-MY2 and NSC98-2320-B-182-028-MY3) and Chang Gung Memorial Hospital (CMRPD170013 and CMRPD160383) (to H.-H.L.).	Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Borgatti R, 2009, CLIN GENET, V76, P573, DOI 10.1111/j.1399-0004.2009.01262.x; DAAKA Y, 2004, SCI STKE, pRE2; Davies JQ, 2007, J BIOL CHEM, V282, P27343, DOI 10.1074/jbc.M704096200; Della Chiesa M, 2010, INT IMMUNOL, V22, P91, DOI 10.1093/intimm/dxp116; Druey KM, 2009, IMMUNOL RES, V43, P62, DOI 10.1007/s12026-008-8050-0; Hsiao CC, 2009, FEBS LETT, V583, P3285, DOI 10.1016/j.febslet.2009.09.001; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Ke N, 2008, BIOCHEM BIOPH RES CO, V366, P314, DOI 10.1016/j.bbrc.2007.11.071; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Lin HH, 2005, BIOTECHNIQUES, V38, P696, DOI 10.2144/05385BM03; Liu M, 1999, GENOMICS, V55, P296, DOI 10.1006/geno.1998.5644; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Silva JP, 2009, J BIOL CHEM, V284, P6495, DOI 10.1074/jbc.M806979200; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Stacey M, 2000, TRENDS BIOCHEM SCI, V25, P284, DOI 10.1016/S0968-0004(00)01583-8; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Xu L, 2007, CELL CYCLE, V6, P160, DOI 10.4161/cc.6.2.3760; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zendman AJW, 1999, FEBS LETT, V446, P292, DOI 10.1016/S0014-5793(99)00230-6	29	56	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14215	14225		10.1074/jbc.M110.183830	http://dx.doi.org/10.1074/jbc.M110.183830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349848	Green Published, hybrid			2022-12-25	WOS:000289556200045
J	He, T; Hong, SY; Huang, L; Xue, WH; Yu, ZH; Kwon, H; Kirk, M; Ding, SJ; Su, KH; Zhang, ZX				He, Ti; Hong, Sang Yong; Huang, Lin; Xue, Weihua; Yu, Zhihong; Kwon, Hyoung; Kirk, Marion; Ding, Shi-jian; Su, Kaihong; Zhang, Zhixin			Histone Acetyltransferase p300 Acetylates Pax5 and Strongly Enhances Pax5-mediated Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL-DEVELOPMENT; C-TERMINAL DOMAIN; HEAVY-CHAIN GENE; DNA-BINDING; SEQUENCE RECOGNITION; PAIRED DOMAIN; TARGET GENES; AMINO-ACIDS; BSAP PAX-5; PROTEINS	Pax5/B cell lineage specific activator protein (BSAP) is a B lineage-specific regulator that controls the B lineage-specific gene expression program and immunoglobulin gene V-H to DJ(H) recombination. Despite extensive studies on its multiple functions, little is known about how the activity of Pax5 is regulated. Here, we show that co-expression of histone acetyltransferase E1A binding protein p300 dramatically enhances Pax5-mediated transcriptional activation. The p300-mediated enhancement is dependent on its intrinsic histone acetyltransferase activity. Moreover, p300 interacts with the C terminus of Pax5 and acetylates multiple lysine residues within the paired box DNA binding domain of Pax5. Mutations of lysine residues 67 and 87/89 to alanine within Pax5 abolish p300-mediated enhancement of Pax5-induced Luc-CD19 reporter expression in HEK293 cells and prevent Pax5 to activate endogenous Cd19 and Blnk expression in Pax5(-/-) murine pro B cells. These results uncover a novel level of regulation of Pax5 function by p300-mediated acetylation.	[Hong, Sang Yong; Huang, Lin; Xue, Weihua; Ding, Shi-jian; Su, Kaihong; Zhang, Zhixin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [He, Ti; Hong, Sang Yong] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Yu, Zhihong] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kirk, Marion] Univ Alabama Birmingham, Ctr Comprehens Canc, Mass Spectrometry Shared Facil, Birmingham, AL 35294 USA; [Kwon, Hyoung] Swarthmore Coll, Swarthmore, PA 19081 USA; [Su, Kaihong] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Ding, Shi-jian] Univ Nebraska Med Ctr, Mass Spectrometry & Prote Core Facil, Omaha, NE 68198 USA; [Su, Kaihong; Zhang, Zhixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Swarthmore College; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Zhang, ZX (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, LTC11706A, Omaha, NE 68198 USA.	zhangj@unmc.edu		Zhang, Zhixin/0000-0003-3924-1082	National Institutes of Health [AR048592, AI073174, AI074948, AI076475]; University of Alabama at Birmingham; University of Nebraska Medical Center; Eppley Cancer Institute; National Center for Research Resources (NCRR) Shared Instrumentation [S10 RR13795]; University of Alabama at Birmingham Health Services Foundation; Nebraska Research Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076475, R21AI073174, R01AI074948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham; University of Nebraska Medical Center; Eppley Cancer Institute; National Center for Research Resources (NCRR) Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Alabama at Birmingham Health Services Foundation; Nebraska Research Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR048592, AI073174, AI074948, and AI076475 (to Z. Z.). This work was also supported by funding from the University of Alabama at Birmingham and the University of Nebraska Medical Center and the Eppley Cancer Institute (to Z. Z.). Purchase of the Q-TOF mass spectrometer in the Shared Facility came from funds provided by the National Center for Research Resources (NCRR) Shared Instrumentation Grants S10 RR13795 and the University of Alabama at Birmingham Health Services Foundation General Endowment Fund (Water/Micromass Q-TOF). The Mass Spectrometry and Proteomics Core Facility at the University of Nebraska Medical Center is supported by the Nebraska Research Initiative.	Barlev NA, 2003, MOL CELL BIOL, V23, P6944, DOI 10.1128/MCB.23.19.6944-6957.2003; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Bradney C, 2003, J BIOL CHEM, V278, P2370, DOI 10.1074/jbc.M211464200; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Cobaleda C, 2008, CURR OPIN IMMUNOL, V20, P139, DOI 10.1016/j.coi.2008.03.017; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Eberhard D, 1999, CANCER RES, V59, p1716S; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Fitzsimmons D, 2001, NUCLEIC ACIDS RES, V29, P4154, DOI 10.1093/nar/29.20.4154; Fuxa M, 2007, J IMMUNOL, V178, P8221, DOI 10.4049/jimmunol.178.12.8221-a; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hayakawa F, 2008, J BIOL CHEM, V283, P24420, DOI 10.1074/jbc.M802217200; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hsu LY, 2004, J EXP MED, V199, P825, DOI 10.1084/jem.20032249; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Liu ZJ, 2010, J IMMUNOL, V184, P244, DOI 10.4049/jimmunol.0902324; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2008, NEW ENGL J MED, V358, P82, DOI 10.1056/NEJMcibr0707112; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	45	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14137	14145		10.1074/jbc.M110.176289	http://dx.doi.org/10.1074/jbc.M110.176289			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357426	hybrid, Green Published			2022-12-25	WOS:000289556200037
J	Song, PH; Groos, S; Riederer, B; Feng, Z; Krabbenhoft, A; Manns, MP; Smolka, A; Hagen, SJ; Neusch, C; Seidler, U				Song, Penghong; Groos, Stephanie; Riederer, Brigitte; Feng, Zhe; Krabbenhoeft, Anja; Manns, Michael P.; Smolka, Adam; Hagen, Susan J.; Neusch, Clemens; Seidler, Ursula			Kir4.1 Channel Expression Is Essential for Parietal Cell Control of Acid Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIR2.1 K+ CHANNELS; GASTRIC-MUCOSA; POTASSIUM CHANNELS; OXYNTIC CELLS; MEMBRANE; EZRIN; ENDOCYTOSIS; SUBUNIT; ATPASE; MICE	Kir4.1 channels were found to colocalize with the H+/K+ ATPase throughout the parietal cell (PC) acid secretory cycle. This study was undertaken to explore their functional role. Acid secretory rates, electrophysiological parameters, PC ultrastructure, and gene and protein expression were determined in gastric mucosae of 7-8-day-old Kir4.1-deficient mice and WT littermates. Kir4.1(-/-) mucosa secreted significantly more acid and initiated secretion significantly faster than WT mucosa. No change in PC number but a relative up-regulation of H+/K+ ATPase gene and protein expression (but not of other PC ion transporters) was observed. Electron microscopy revealed fully fused canalicular membranes and a lack of tubulovesicles in resting state Kir4.1(-/-) PCs, suggesting that Kir4.1 ablation may also interfere with tubulovesicle endocytosis. The role of this inward rectifier in the PC apical membrane may therefore be to balance between K+ loss via KCNQ1/KCNE2 and K+ reabsorption by the slow turnover of the H+/K+-ATPase, with consequences for K+ reabsorption, inhibition of acid secretion, and membrane recycling. Our results demonstrate that Kir4.1 channels are involved in the control of acid secretion and suggest that they may also affect secretory membrane recycling. The regulation of gastric acid secretion requires	[Song, Penghong; Riederer, Brigitte; Feng, Zhe; Krabbenhoeft, Anja; Manns, Michael P.; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Groos, Stephanie] Hannover Med Sch, Dept Anat 1, D-30625 Hannover, Germany; [Smolka, Adam] Med Univ S Carolina, Dept Med, Charleston, SC 29403 USA; [Hagen, Susan J.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA; [Neusch, Clemens] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany	Hannover Medical School; Hannover Medical School; Medical University of South Carolina; Harvard University; Beth Israel Deaconess Medical Center; University of Gottingen	Seidler, U (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	seidler.ursula@mh-hannover.de	Seidler, Ursula/HII-8049-2022	Seidler, Ursula/0000-0002-9600-2769	Deutsche Forschungsgemeinschaft [Se460/9-5, Se460/9-6]; Lower Saxony Ministry of Science and Education; Volkswagen Vorab Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lower Saxony Ministry of Science and Education; Volkswagen Vorab Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Sachbeihilfe Se460/9-5 and Se460/9-6 and by the Lower Saxony Ministry of Science and Education and the Volkswagen Vorab Stiftung (to U. S.).	Agnew BJ, 1999, J CELL SCI, V112, P2639; CLAUSEN C, 1982, SCIENCE, V217, P448, DOI 10.1126/science.217.4558.448; CLAUSEN C, 1983, BIOPHYS J, V41, P167, DOI 10.1016/S0006-3495(83)84417-8; CourtoisCoutry N, 1997, CELL, V90, P501, DOI 10.1016/S0092-8674(00)80510-3; CUPPOLETTI J, 1984, J BIOL CHEM, V259, P4952; DEBELLIS L, 1990, AM J PHYSIOL, V258, pG631, DOI 10.1152/ajpgi.1990.258.4.G631; DEBELLIS L, 1992, PFLUG ARCH EUR J PHY, V422, P253, DOI 10.1007/BF00376210; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Forte JG, 2004, AM J PHYSIOL-CELL PH, V286, pC478, DOI 10.1152/ajpcell.00531.2003; Forte JG, 2010, ANNU REV PHYSIOL, V72, P273, DOI 10.1146/annurev-physiol-021909-135744; FORTE TM, 1977, GASTROENTEROLOGY, V73, P941; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; HANZEL D, 1991, EMBO J, V10, P2363, DOI 10.1002/j.1460-2075.1991.tb07775.x; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Jain RN, 2008, J CLIN INVEST, V118, P2459, DOI 10.1172/JCI33569; Kaufhold MA, 2008, GASTROENTEROLOGY, V134, P1058, DOI 10.1053/j.gastro.2008.01.033; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Lambrecht NWG, 2005, PHYSIOL GENOMICS, V21, P81, DOI 10.1152/physiolgenomics.00212.2004; Malinowska DH, 2004, AM J PHYSIOL-CELL PH, V286, pC495, DOI 10.1152/ajpcell.00386.2003; MANGEAT P, 1990, BIOL CELL, V69, P223, DOI 10.1016/0248-4900(90)90349-8; McDaniel N, 2005, AM J PHYSIOL-GASTR L, V289, pG550, DOI 10.1152/ajpgi.00095.2005; Neusch C, 2003, CELL TISSUE RES, V311, P131, DOI 10.1007/s00441-002-0669-x; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Nguyen NV, 2004, GASTROENTEROLOGY, V127, P145, DOI 10.1053/j.gastro.2004.04.016; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Ostrowski J, 1994, J Physiol Pharmacol, V45, P351; Ostrowski J, 1991, J Physiol Pharmacol, V42, P367; Pagliocca A, 2008, EXP PHYSIOL, V93, P1174, DOI 10.1113/expphysiol.2008.042648; PETTITT JM, 1993, IMMUNOL CELL BIOL, V71, P191, DOI 10.1038/icb.1993.21; Raiteri L, 2007, J NEUROCHEM, V103, P952, DOI 10.1111/j.1471-4159.2007.04784.x; Reimann F, 1999, CURR OPIN CELL BIOL, V11, P503, DOI 10.1016/S0955-0674(99)80073-8; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schubert ML, 2009, CURR OPIN GASTROEN, V25, P529, DOI 10.1097/MOG.0b013e328331b62a; Smith RM, 2002, TRAFFIC, V3, P397, DOI 10.1034/j.1600-0854.2002.30603.x; Song PH, 2009, J PHYSIOL-LONDON, V587, P3955, DOI 10.1113/jphysiol.2009.173302; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Thevenod F, 2002, AM J PHYSIOL-CELL PH, V283, pC651, DOI 10.1152/ajpcell.00600.2001; TSUNODA Y, 1987, FEBS LETT, V222, P149, DOI 10.1016/0014-5793(87)80209-0; UEDA S, 1989, BIOCHIM BIOPHYS ACTA, V1012, P254, DOI 10.1016/0167-4889(89)90105-5; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	46	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14120	14128		10.1074/jbc.M110.151191	http://dx.doi.org/10.1074/jbc.M110.151191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21367857	Green Published, hybrid			2022-12-25	WOS:000289556200035
J	Zeng, Y; He, YN; Yang, F; Mooney, SM; Getzenberg, RH; Orban, J; Kulkarni, P				Zeng, Yu; He, Yanan; Yang, Fan; Mooney, Steven M.; Getzenberg, Robert H.; Orban, John; Kulkarni, Prakash			The Cancer/Testis Antigen Prostate-associated Gene 4 (PAGE4) Is a Highly Intrinsically Disordered Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-TESTIS ANTIGEN; BREAST-CANCER; CONFERS RESISTANCE; ANDROGEN RECEPTOR; CELL-LINES; EXPRESSION; SEQUENCE; BINDING; OVEREXPRESSION; ACETYLATION	The cancer/testis antigens (CTAs) are an important group of heterogeneous proteins that are predominantly expressed in the testis in the normal human adult but are aberrantly expressed in several types of cancers. Prostate-associated gene 4 (PAGE4) is a member of the CT-X family of CTAs that in addition to testis, is highly expressed in the fetal prostate, and may also play an important role both in benign and malignant prostate diseases. However, the function of this gene remains poorly understood. Here, we show that PAGE4 is a highly (100%) intrinsically disordered protein (IDP). The primary protein sequence conforms to the features of a typical IDP sequence and the secondary structure prediction algorithm metaPrDOS strongly supported this prediction. Furthermore, SDS-gel electrophoresis and analytical size exclusion chromatography of the recombinant protein revealed an anomalous behavior characteristic of IDPs. UV circular dichroism (CD) and NMR spectroscopy confirmed that PAGE4 is indeed a highly disordered protein. In further bioinformatic analysis, the PredictNLS algorithm uncovered a potential nuclear localization signal, whereas the algorithm DBS-Pred returned a 99.1% probability that PAGE4 is a DNA-binding protein. Consistent with this prediction, biochemical experiments showed that PAGE4 preferentially binds a GC-rich sequence. Silencing PAGE4 expression induced cell death via apoptosis and in mice carrying PCa xenografts, siRNA-mediated knockdown of the PAGE4 mRNA attenuated tumor growth in vivo. Furthermore, overexpressing PAGE4 protected cells from stress-induced death. To our knowledge, PAGE4 is the first example of a CTA that is an IDP with an anti-apoptotic function.	[Zeng, Yu; Mooney, Steven M.; Getzenberg, Robert H.; Kulkarni, Prakash] Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Zeng, Yu; Mooney, Steven M.; Getzenberg, Robert H.; Kulkarni, Prakash] Johns Hopkins Univ, Sch Med, George OBrien Urol Res Ctr, Baltimore, MD 21287 USA; [Getzenberg, Robert H.; Kulkarni, Prakash] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [He, Yanan; Orban, John] Univ Maryland, Dept Chem & Biochem, Rockville, MD 20850 USA; [Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Yang, Fan] CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; California Institute of Technology	Kulkarni, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, 600 N Wolfe St,105B Marburg, Baltimore, MD 21287 USA.	pkulkar4@jhmi.edu	Zhu, Ren-Yuan/V-8966-2019; Yang, Fan/GYU-4249-2022	Zhu, Ren-Yuan/0000-0003-3091-7461; 	National Institutes of Health, NCI [SPORE 2P50CA058236-16]; NIDDK [P50DK082998]; Patrick C. Walsh Prostate Cancer Research Fund; American Urological Association [RS-10-1-508]; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK082998] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Patrick C. Walsh Prostate Cancer Research Fund; American Urological Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant SPORE 2P50CA058236-16 from the NCI, O'Brien Grant P50DK082998 from the NIDDK, and the Patrick C. Walsh Prostate Cancer Research Fund.; Supported by American Urological Association Grant RS-10-1-508.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ajiro M, 2009, INT J ONCOL, V35, P673, DOI 10.3892/ijo_00000379; Andrade Valeria C C, 2008, Cancer Immun, V8, P2; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; Cokol M, 2008, EMBO REP, V9, DOI 10.1038/sj.embor.7401143; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Iavarone C, 2002, MOL CANCER THER, V1, P329; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Kanehira M, 2007, CANCER RES, V67, P3276, DOI 10.1158/0008-5472.CAN-06-3748; Kasuga C, 2008, J NEUROS-PEDIATR, V1, P305, DOI 10.3171/PED/2008/1/4/305; Kim Y, 2010, J BIOL CHEM, V285, P25957, DOI 10.1074/jbc.M109.095950; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Mooney SM, 2010, J BIOL CHEM, V285, P30443, DOI 10.1074/jbc.M110.143792; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Nallur GN, 1996, P NATL ACAD SCI USA, V93, P1184, DOI 10.1073/pnas.93.3.1184; Napoletano C, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.019; Pflug BR, 1999, PROSTATE, V40, P269, DOI 10.1002/(SICI)1097-0045(19990901)40:4<269::AID-PROS9>3.0.CO;2-6; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Prakash K, 2002, P NATL ACAD SCI USA, V99, P7598, DOI 10.1073/pnas.112191399; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Suyama T, 2010, PROSTATE, V70, P1778, DOI 10.1002/pros.21214; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Velazquez Elsa F, 2007, Cancer Immun, V7, P11; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zeng Y, 2006, INT J ONCOL, V28, P421; Zeng Y, 2009, J CELL BIOCHEM, V107, P179, DOI 10.1002/jcb.22114	45	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13985	13994		10.1074/jbc.M110.210765	http://dx.doi.org/10.1074/jbc.M110.210765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357425	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000289556200021
J	Rapanelli, M; Frick, LR; Zanutto, BS				Rapanelli, Maximiliano; Romina Frick, Luciana; Silvano Zanutto, Bonifacio			Learning an Operant Conditioning Task Differentially Induces Gliogenesis in the Medial Prefrontal Cortex and Neurogenesis in the Hippocampus	PLOS ONE			English	Article							GENERATED GRANULE CELLS; ENHANCED SYNAPTIC PLASTICITY; RAT DENTATE GYRUS; ADULT NEUROGENESIS; SPATIAL MEMORY; VOLUNTARY EXERCISE; NEURAL-NETWORKS; AGED RATS; NEURONS; PROLIFERATION	Circuit modification associated with learning and memory involves multiple events, including the addition and remotion of newborn cells trough adulthood. Adult neurogenesis and gliogenesis were mainly described in models of voluntary exercise, enriched environments, spatial learning and memory task; nevertheless, it is unknown whether it is a common mechanism among different learning paradigms, like reward dependent tasks. Therefore, we evaluated cell proliferation, neurogenesis, astrogliogenesis, survival and neuronal maturation in the medial prefrontal cortex (mPFC) and the hippocampus (HIPP) during learning an operant conditioning task. This was performed by using endogenous markers of cell proliferation, and a bromodeoxiuridine (BrdU) injection schedule in two different phases of learning. Learning an operant conditioning is divided in two phases: a first phase when animals were considered incompletely trained (IT, animals that were learning the task) when they performed between 50% and 65% of the responses, and a second phase when animals were considered trained (Tr, animals that completely learned the task) when they reached 100% of the responses with a latency time lower than 5 seconds. We found that learning an operant conditioning task promoted cell proliferation in both phases of learning in the mPFC and HIPP. Additionally, the results presented showed that astrogliogenesis was induced in the medial prefrontal cortex (mPFC) in both phases, however, the first phase promoted survival of these new born astrocytes. On the other hand, an increased number of new born immature neurons was observed in the HIPP only in the first phase of learning, whereas, decreased values were observed in the second phase. Finally, we found that neuronal maturation was induced only during the first phase. This study shows for the first time that learning a reward-dependent task, like the operant conditioning, promotes neurogenesis, astrogliogenesis, survival and neuronal maturation depending on the learning phase in the mPFC-HIPP circuit.	[Rapanelli, Maximiliano; Romina Frick, Luciana; Silvano Zanutto, Bonifacio] IBYME CONICET, Lab Biol Comportamiento, Buenos Aires, DF, Argentina; [Silvano Zanutto, Bonifacio] Univ Buenos Aires, Fac Ingn, Inst Ingn Biomed, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Rapanelli, M (corresponding author), IBYME CONICET, Lab Biol Comportamiento, Buenos Aires, DF, Argentina.	mrapanelli@ibyme.conicet.gov.ar	rapanelli, maximiliano/P-3141-2016	rapanelli, maximiliano/0000-0001-7329-2364	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2006 2485]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-02851]; Universidad de Buenos Aires [I027]; Sigma Xi [G200803150637]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Sigma Xi	Funding: This study was funded by Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2006 2485), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 112-200801-02851), Universidad de Buenos Aires (I027) and Sigma Xi (G200803150637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Chun SK, 2006, NEUROBIOL LEARN MEM, V86, P322, DOI 10.1016/j.nlm.2006.05.005; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kelly MP, 2003, J NEUROSCI, V23, P6443; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Madsen TM, 2005, NEUROPSYCHOPHARMACOL, V30, P27, DOI 10.1038/sj.npp.1300565; Mandyam CD, 2007, J NEUROSCI, V27, P11442, DOI 10.1523/JNEUROSCI.2505-07.2007; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Paixao S, 2010, CURR OPIN NEUROBIOL, V20, P466, DOI 10.1016/j.conb.2010.04.008; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rapanelli M, 2009, NEUROSCIENCE, V163, P1031, DOI 10.1016/j.neuroscience.2009.07.037; Rapanelli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008656; Rapanelli M, 2010, J NEUROCHEM, V113, P725, DOI 10.1111/j.1471-4159.2010.06640.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Van Kampen JM, 2004, EUR J NEUROSCI, V19, P2377, DOI 10.1111/j.0953-816X.2004.03342.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	54	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e14713	10.1371/journal.pone.0014713	http://dx.doi.org/10.1371/journal.pone.0014713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723CC	21364751	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482800003
J	Delputte, PL; Van Gorp, H; Favoreel, HW; Hoebeke, I; Delrue, I; Dewerchin, H; Verdonck, F; Verhasselt, B; Cox, E; Nauwynck, HJ				Delputte, Peter L.; Van Gorp, Hanne; Favoreel, Herman W.; Hoebeke, Inge; Delrue, Iris; Dewerchin, Hannah; Verdonck, Frank; Verhasselt, Bruno; Cox, Eric; Nauwynck, Hans J.			Porcine Sialoadhesin (CD169/Siglec-1) Is an Endocytic Receptor that Allows Targeted Delivery of Toxins and Antigens to Macrophages	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; ACID-BINDING-RECEPTOR; LIPID RAFT ASSOCIATION; SIALIC-ACID; PSEUDORABIES VIRUS; ALVEOLAR MACROPHAGES; MEDIATED ENDOCYTOSIS; B-CELL; MONOCLONAL-ANTIBODIES; TISSUE MACROPHAGES	Sialoadhesin is exclusively expressed on specific subpopulations of macrophages. Since sialoadhesin-positive macrophages are involved in inflammatory autoimmune diseases, such as multiple sclerosis, and potentially in the generation of immune responses, targeted delivery of drugs, toxins or antigens via sialoadhesin-specific immunoconjugates may prove a useful therapeutic strategy. Originally, sialoadhesin was characterized as a lymphocyte adhesion molecule, though recently its involvement in internalization of sialic acid carrying pathogens was shown, suggesting that sialoadhesin is an endocytic receptor. In this report, we show that porcine sialoadhesin-specific antibodies and F(ab')(2) fragments trigger sialoadhesin internalization, both in primary porcine macrophages and in cells expressing recombinant porcine sialoadhesin. Using chemical inhibitors, double immunofluorescence stainings and dominant-negative constructs, porcine sialoadhesin internalization was shown to be clathrin-and Eps15-dependent and to result in targeting to early endosomes but not lysosomes. Besides characterizing the sialoadhesin endocytosis mechanism, two sialoadhesin-specific immunoconjugates were evaluated. We observed that porcine sialoadhesin-specific immunotoxins efficiently kill sialoadhesin-expressing macrophages. Furthermore, porcine sialoadhesin-specific albumin immunoconjugates were shown to be internalized in macrophages and immunization with these immunoconjugates resulted in a rapid and robust induction of albumin-specific antibodies, this compared to immunization with albumin alone. Together, these data expand sialoadhesin functionality and show that it can function as an endocytic receptor, a feature that cannot only be misused by sialic acid carrying pathogens, but that may also be used for specific targeting of toxins or antigens to sialoadhesin-expressing macrophages.	[Delputte, Peter L.; Van Gorp, Hanne; Favoreel, Herman W.; Hoebeke, Inge; Delrue, Iris; Dewerchin, Hannah; Nauwynck, Hans J.] Univ Ghent, Fac Vet Med, Virol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Favoreel, Herman W.; Verdonck, Frank; Cox, Eric] Univ Ghent, Fac Vet Med, Immunol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Verhasselt, Bruno] Univ Ghent, Fac Med & Hlth Sci, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Delputte, PL (corresponding author), Ablynx NV, Zwijnaarde, Belgium.	Peter.Delputte@Ugent.be; Hanne.VanGorp@Ugent.be; Hans.Nauwynck@Ugent.be	Delputte, Peter/A-1062-2008; Favoreel, Herman W/H-8712-2013	Delputte, Peter/0000-0003-3972-616X; Favoreel, Herman W/0000-0003-4993-6857; Verhasselt, Bruno/0000-0002-4645-1144; Dewerchin, Hannah/0000-0002-0059-6751; Nauwynck, Hans/0000-0001-5470-0713; Cox, Eric/0000-0003-4281-2990	fund for scientific research (FWO Vlaanderen); Ghent University; Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - SBO) [80046]	fund for scientific research (FWO Vlaanderen)(FWO); Ghent University(Ghent University); Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - SBO)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	L. Delputte was supported with a post-doctoral fellowship of the fund for scientific research (FWO Vlaanderen) (www.fwo.be). H. Van Gorp was financially supported by a post-doctoral grant from the Special Research Fund of Ghent University. This research was further supported by the Industrial Research Fund (IOF) of Ghent University (www.techtransfer.ugent.be) and the Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - SBO 80046) (www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audran R, 1995, J IMMUNOL METHODS, V188, P147, DOI 10.1016/0022-1759(95)00213-8; Backer R, 2010, P NATL ACAD SCI USA, V107, P216, DOI 10.1073/pnas.0909541107; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Bernstein ID, 2002, CLIN LYMPHOMA, V2, pS9, DOI 10.3816/CLM.2002.s.002; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Chan CHT, 1998, J BIOL CHEM, V273, P27809, DOI 10.1074/jbc.273.43.27809; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1995, J CLIN INVEST, V95, P635, DOI 10.1172/JCI117708; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; CROCKER PR, 1986, J EXP MED, V164, P1862, DOI 10.1084/jem.164.6.1862; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Delputte PL, 2007, J VIROL, V81, P9546, DOI 10.1128/JVI.00569-07; Delputte PL, 2005, J GEN VIROL, V86, P1441, DOI 10.1099/vir.0.80675-0; Delputte PL, 2004, J VIROL, V78, P8094, DOI 10.1128/JVI.78.15.8094-8101.2004; Deputte PL, 2006, ADV EXP MED BIOL, V581, P247; DesplanqueS AS, 2007, VIROLOGY, V362, P60, DOI 10.1016/j.virol.2006.12.018; Dewerchin HL, 2008, J GEN VIROL, V89, P2731, DOI 10.1099/vir.0.2008/002212-0; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Duan XB, 1998, J VIROL, V72, P4520, DOI 10.1128/JVI.72.5.4520-4523.1998; Ducreux J, 2009, BIOCONJUGATE CHEM, V20, P295, DOI 10.1021/bc800390g; Favoreel HW, 2004, J VIROL, V78, P5279, DOI 10.1128/JVI.78.10.5279-5287.2004; Foussias G, 2000, BIOCHEM BIOPH RES CO, V278, P775, DOI 10.1006/bbrc.2000.3866; Geenen K, 2005, J GEN VIROL, V86, P1251, DOI 10.1099/vir.0.80760-0; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Herrera L, 2000, LEUKEMIA, V14, P853, DOI 10.1038/sj.leu.2401779; Ikezumi Y, 2005, NEPHROL DIAL TRANSPL, V20, P2704, DOI 10.1093/ndt/gfi105; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jiang HR, 2006, J IMMUNOL, V177, P2258, DOI 10.4049/jimmunol.177.4.2258; John BJ, 2003, J IMMUNOL, V170, P3534, DOI 10.4049/jimmunol.170.7.3534; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Keler T, 2007, ONCOGENE, V26, P3758, DOI 10.1038/sj.onc.1210375; Kirchberger S, 2005, J IMMUNOL, V175, P1145, DOI 10.4049/jimmunol.175.2.1145; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Kratzer R, 2010, J IMMUNOL, V184, P6855, DOI 10.4049/jimmunol.0902555; Mansfield E, 1997, BLOOD, V90, P2020, DOI 10.1182/blood.V90.5.2020; Monteiro VG, 2005, PARASITOL RES, V97, P380, DOI 10.1007/s00436-005-1460-1; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nath D, 1999, IMMUNOLOGY, V98, P213; NAUWYNCK HJ, 1995, ARCH VIROL, V140, P1137, DOI 10.1007/BF01315422; Newton DL, 2001, BLOOD, V97, P528, DOI 10.1182/blood.V97.2.528; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Pagano L, 2007, ONCOGENE, V26, P3679, DOI 10.1038/sj.onc.1210364; Perry DG, 1999, J IMMUNOL, V162, P380; PESCOVITZ MD, 1984, J IMMUNOL, V133, P368; PHONPHOK Y, 1991, FEBS LETT, V281, P188, DOI 10.1016/0014-5793(91)80390-O; Raveh D, 1998, J LEUKOCYTE BIOL, V64, P108, DOI 10.1002/jlb.64.1.108; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Revilla C, 2009, VET RES, V40, DOI 10.1051/vetres:2008052; Schadee-Eestermans IL, 2000, IMMUNOBIOLOGY, V202, P309, DOI 10.1016/S0171-2985(00)80036-4; SHAN DM, 1995, J IMMUNOL, V154, P4466; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; Thrush GR, 1996, ANNU REV IMMUNOL, V14, P49, DOI 10.1146/annurev.immunol.14.1.49; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Van der Stede Y, 2001, VACCINE, V19, P1870, DOI 10.1016/S0264-410X(00)00440-0; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; VANDENBERG TK, 1992, J EXP MED, V176, P647, DOI 10.1084/jem.176.3.647; Vanderheijden N, 2003, J VIROL, V77, P8207, DOI 10.1128/JVI.77.15.8207-8215.2003; Verdonck F, 2005, J CONTROL RELEASE, V104, P243, DOI 10.1016/j.jconrel.2005.02.007; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wilson DS, 2002, J IMMUNOL METHODS, V260, P29, DOI 10.1016/S0022-1759(01)00514-2; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	72	63	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16827	10.1371/journal.pone.0016827	http://dx.doi.org/10.1371/journal.pone.0016827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359217	Green Published, Green Submitted, gold			2022-12-25	WOS:000287392700025
J	Martinez, M; Brezun, JM; Xerri, C				Martinez, Marina; Brezun, Jean-Michel; Xerri, Christian			Sensorimotor Experience Influences Recovery of Forelimb Abilities but Not Tissue Loss after Focal Cortical Compression in Adult Rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PRIMARY SOMATOSENSORY CORTEX; ENRICHED ENVIRONMENT; SPINAL-CORD; CEREBRAL-CORTEX; VESTIBULAR COMPENSATION; BEHAVIORAL RECOVERY; CUTANEOUS INPUTS; MOTOR; LOCOMOTION	Sensorimotor activity has been shown to play a key role in functional outcome after extensive brain damage. This study was aimed at assessing the influence of sensorimotor experience through subject-environment interactions on the time course of both lesion and gliosis volumes as well as on the recovery of forelimb sensorimotor abilities following focal cortical injury. The lesion consisted of a cortical compression targeting the forepaw representational area within the primary somatosensory cortex of adult rats. After the cortical lesion, rats were randomly subjected to various postlesion conditions: unilateral C5-C6 dorsal root transection depriving the contralateral cortex from forepaw somatosensory inputs, standard housing or an enriched environment promoting sensorimotor experience and social interactions. Behavioral tests were used to assess forelimb placement during locomotion, forelimb-use asymmetry, and forepaw tactile sensitivity. For each group, the time course of tissue loss was described and the gliosis volume over the first postoperative month was evaluated using an unbiased stereological method. Consistent with previous studies, recovery of behavioral abilities was found to depend on post-injury experience. Indeed, increased sensorimotor activity initiated early in an enriched environment induced a rapid and more complete behavioral recovery compared with standard housing. In contrast, severe deprivation of peripheral sensory inputs led to a delayed and only partial sensorimotor recovery. The dorsal rhizotomy was found to increase the perilesional gliosis in comparison to standard or enriched environments. These findings provide further evidence that early sensory experience has a beneficial influence on the onset and time course of functional recovery after focal brain injury.	[Martinez, Marina; Brezun, Jean-Michel; Xerri, Christian] Univ Provence, CNRS, UMR 6149, IFR 131, Marseilles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Martinez, M (corresponding author), Univ Provence, CNRS, UMR 6149, IFR 131, Pole 3 C, Marseilles, France.	christian.xerri@univ-provence.fr	Martínez Filgueira, Marina/GZG-8145-2022	Martinez, Marina/0000-0002-3294-3017	Ministere de l'Enseignement Superieur et de la Recherche; CNRS	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from Ministere de l'Enseignement Superieur et de la Recherche and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriat AM, 2006, BRAIN RES, V1109, P183, DOI 10.1016/j.brainres.2006.06.035; Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3625, DOI 10.1152/jn.00496.2003; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; CASTRO AJ, 1977, PHYSIOL BEHAV, V18, P605, DOI 10.1016/0031-9384(77)90059-2; Chen JR, 2004, J NEUROTRAUM, V21, P1640, DOI 10.1089/0897715042441729; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Coq JO, 1999, EXP BRAIN RES, V129, P518, DOI 10.1007/s002210050922; Coyle DE, 1998, GLIA, V23, P75; DOETSCH GS, 1990, EXP NEUROL, V108, P162, DOI 10.1016/0014-4886(90)90024-M; Frigon A, 2006, BIOL CYBERN, V95, P607, DOI 10.1007/s00422-006-0129-x; GOLDBERGER ME, 1974, J COMP NEUROL, V158, P37, DOI 10.1002/cne.901580104; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; HELGREN ME, 1993, EXP NEUROL, V123, P17, DOI 10.1006/exnr.1993.1137; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ibrahim AG, 2009, EXP NEUROL, V215, P142, DOI 10.1016/j.expneurol.2008.09.023; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Keiner S, 2008, GLIA, V56, P516, DOI 10.1002/glia.20632; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Komitova M, 2006, EXP NEUROL, V199, P113, DOI 10.1016/j.expneurol.2005.12.007; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Liu L, 1998, GLIA, V23, P221, DOI 10.1002/(SICI)1098-1136(199807)23:3<221::AID-GLIA5>3.3.CO;2-Z; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Martinez M, 2010, EXP NEUROL, V221, P186, DOI 10.1016/j.expneurol.2009.10.022; Martinez M, 2009, EUR J NEUROSCI, V30, P2356, DOI 10.1111/j.1460-9568.2009.07019.x; Martinez M, 2009, J NEUROTRAUM, V26, P1043, DOI 10.1089/neu.2008.0717; Metz GA, 2005, BEHAV BRAIN RES, V162, P71, DOI 10.1016/j.bbr.2005.03.002; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Napieralski JA, 1998, EXP NEUROL, V154, P80, DOI 10.1006/exnr.1998.6893; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Soblosky JS, 1997, J NEUROSCI METH, V78, P75, DOI 10.1016/S0165-0270(97)00131-3; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Webb AA, 2003, EUR J NEUROSCI, V18, P412, DOI 10.1046/j.1460-9568.2003.02768.x; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; ZennouAzogui Y, 1996, BEHAV BRAIN RES, V74, P65, DOI 10.1016/0166-4328(95)00142-5; ZENNOUAZOGUI Y, 1995, RESTOR NEUROL NEUROS, V7, P235, DOI 10.3233/RNN-1994-7406	56	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16726	10.1371/journal.pone.0016726	http://dx.doi.org/10.1371/journal.pone.0016726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359230	Green Published, Green Submitted, gold			2022-12-25	WOS:000287392700022
J	Sarachana, T; Xu, MY; Wu, RC; Hu, VW				Sarachana, Tewarit; Xu, Minyi; Wu, Ray-Chang; Hu, Valerie W.			Sex Hormones in Autism: Androgens and Estrogens Differentially and Reciprocally Regulate RORA, a Novel Candidate Gene for Autism	PLOS ONE			English	Article							FETAL TESTOSTERONE; EXPRESSION; ALPHA; EXPLORATION; PATTERNS; PROMO	Autism, a pervasive neurodevelopmental disorder manifested by deficits in social behavior and interpersonal communication, and by stereotyped, repetitive behaviors, is inexplicably biased towards males by a ratio of,4: 1, with no clear understanding of whether or how the sex hormones may play a role in autism susceptibility. Here, we show that male and female hormones differentially regulate the expression of a novel autism candidate gene, retinoic acid-related orphan receptor-alpha (RORA) in a neuronal cell line, SH-SY5Y. In addition, we demonstrate that RORA transcriptionally regulates aromatase, an enzyme that converts testosterone to estrogen. We further show that aromatase protein is significantly reduced in the frontal cortex of autistic subjects relative to sex-and age-matched controls, and is strongly correlated with RORA protein levels in the brain. These results indicate that RORA has the potential to be under both negative and positive feedback regulation by male and female hormones, respectively, through one of its transcriptional targets, aromatase, and further suggest a mechanism for introducing sex bias in autism.	[Sarachana, Tewarit; Xu, Minyi; Wu, Ray-Chang; Hu, Valerie W.] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Sarachana, T (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmvwh@gwumc.edu	Wu, Ray-chang/X-2018-2019	Hu, Valerie/0000-0002-3357-0777	Autism Speaks [2381]; National Center for Research Resources [S10RR025565]; Office of the Commission on Higher Education of the Royal Thai Government, Thailand; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER	Autism Speaks; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Commission on Higher Education of the Royal Thai Government, Thailand(Office of Higher Education Commission (OHEC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: The project described was supported in part by a grant from Autism Speaks Grant # 2381 (VWH), by a joint intramural GWU and Clinical and Translational Science Institute-Children's National Award for development of Novel Clinical and Translational Methodologies (VWH), and by Award Number S10RR025565 from the National Center for Research Resources (P.I.: Anastas Popratiloff, Ph.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. TS is a predoctoral student in the Institute for Biomedical Sciences at The George Washington University, who is supported by a Higher Educational Strategic Scholarship for Frontier Research from the Office of the Commission on Higher Education of the Royal Thai Government, Thailand. This work is part of his dissertation research to be presented in partial fulfillment of the requirements for the Ph.D. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Auyeung B, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-11; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Boukhtouche F, 2006, J NEUROCHEM, V96, P1778, DOI 10.1111/j.1471-4159.2006.03708.x; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chura LR, 2010, PSYCHONEUROENDOCRINO, V35, P122, DOI 10.1016/j.psyneuen.2009.09.009; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Doulazmi M, 1999, J COMP NEUROL, V411, P267; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gold DA, 2007, BRAIN RES, V1140, P19, DOI 10.1016/j.brainres.2005.11.080; GOODALL G, 1987, BEHAV NEURAL BIOL, V47, P307, DOI 10.1016/S0163-1047(87)90422-5; Hadj-Sahraoui N, 2001, DEV BRAIN RES, V126, P201, DOI 10.1016/S0165-3806(01)00095-5; Harding HP, 1997, MOL ENDOCRINOL, V11, P1737, DOI 10.1210/me.11.11.1737; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Lalonde R, 2008, NEUROBIOL LEARN MEM, V90, P472, DOI 10.1016/j.nlm.2008.05.004; LALONDE R, 1987, PHYSIOL BEHAV, V41, P115, DOI 10.1016/0031-9384(87)90139-9; LALONDE R, 1987, J NEUROGENET, V4, P285, DOI 10.3109/01677068709102349; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; VOLKMAR FR, 1994, AM J PSYCHIAT, V151, P1361	26	143	145	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17116	10.1371/journal.pone.0017116	http://dx.doi.org/10.1371/journal.pone.0017116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359227	Green Submitted, Green Published, gold			2022-12-25	WOS:000287392700051
J	Hammelmann, V; Zong, XG; Hofmann, F; Michalakis, S; Biel, M				Hammelmann, Verena; Zong, Xiangang; Hofmann, Franz; Michalakis, Stylianos; Biel, Martin			The cGMP-Dependent Protein Kinase II Is an Inhibitory Modulator of the Hyperpolarization-Activated HCN2 Channel	PLOS ONE			English	Article							PYRAMIDAL NEURONS; CATION CHANNELS; PHYSIOLOGICAL-FUNCTION; INTEGRATIVE PROPERTIES; PACEMAKER CHANNELS; CYCLIC-NUCLEOTIDES; NITRIC-OXIDE; MICE LACKING; MOUSE-BRAIN; LOCALIZATION	Opening of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels is facilitated by direct binding of cyclic nucleotides to a cyclic nucleotide-binding domain (CNBD) in the C-terminus. Here, we show for the first time that in the HCN2 channel cGMP can also exert an inhibitory effect on gating via cGMP-dependent protein kinase II (cGKII)-mediated phosphorylation. Using coimmunoprecipitation and immunohistochemistry we demonstrate that cGKII and HCN2 interact and colocalize with each other upon heterologous expression as well as in native mouse brain. We identify the proximal C-terminus of HCN2 as binding region of cGKII and show that cGKII phosphorylates HCN2 at a specific serine residue (S641) in the C-terminal end of the CNBD. The cGKII shifts the voltage-dependence of HCN2 activation to 2-5 mV more negative voltages and, hence, counteracts the stimulatory effect of cGMP on gating. The inhibitory cGMP effect can be either abolished by mutation of the phosphorylation site in HCN2 or by impairing the catalytic domain of cGKII. By contrast, the inhibitory effect is preserved in a HCN2 mutant carrying a CNBD deficient for cGMP binding. Our data suggest that bidirectional regulation of HCN2 gating by cGMP contributes to cellular fine-tuning of HCN channel activity.	[Hammelmann, Verena; Zong, Xiangang; Michalakis, Stylianos; Biel, Martin] Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany; [Hammelmann, Verena; Zong, Xiangang; Michalakis, Stylianos; Biel, Martin] Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany; [Hofmann, Franz] Tech Univ Munich, Forschergrp Carvas 923, Munich, Germany	University of Munich; University of Munich; Technical University of Munich	Hammelmann, V (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany.	mbiel@cup.uni-muenchen.de	Michalakis, Stylianos/W-2094-2018; Biel, Martin/G-1175-2014; Michalakis, Stylianos/M-4677-2019	Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238	Deutsche Forschungsgemeinschaft (DFG); Sonderforschungsbereich 870 [SFB 870]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sonderforschungsbereich 870	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Sonderforschungsbereich 870 (SFB 870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; CHANG F, 1991, J PHYSIOL-LONDON, V440, P367, DOI 10.1113/jphysiol.1991.sp018713; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; DEHOOP MJ, 1994, CELL BIOL LAB HDB, P154; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Liao ZD, 2010, J GEN PHYSIOL, V136, P247, DOI 10.1085/jgp.201010488; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Magee JC, 1998, J NEUROSCI, V18, P7613; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Musialek P, 1997, CIRC RES, V81, P60, DOI 10.1161/01.RES.81.1.60; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; PAPE HC, 1992, NEURON, V9, P441, DOI 10.1016/0896-6273(92)90182-D; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Taylor MK, 2000, J BIOL CHEM, V275, P28053; UHLER MD, 1993, J BIOL CHEM, V268, P13586; Vaandrager AB, 1996, J BIOL CHEM, V271, P7025, DOI 10.1074/jbc.271.12.7025; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Werner C, 2004, EUR J NEUROSCI, V20, P3498, DOI 10.1111/j.1460-9568.2004.03793.x; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; XU X, 2010, J BIOL CHEM; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	40	9	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17078	10.1371/journal.pone.0017078	http://dx.doi.org/10.1371/journal.pone.0017078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347269	Green Published, gold, Green Submitted			2022-12-25	WOS:000287367600035
J	Li, B; Zheng, YW; Sano, Y; Taniguchi, H				Li, Bin; Zheng, Yun-Wen; Sano, Yuuki; Taniguchi, Hideki			Evidence for Mesenchymal-Epithelial Transition Associated with Mouse Hepatic Stem Cell Differentiation	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; PROGENITOR CELLS; PRECURSOR CELLS; LIVER FIBROSIS; VIMENTIN; CARCINOMA; EXPRESSION; GROWTH; HEPATOCYTES; CANCER	Mesenchymal-epithelial transition events are related to embryonic development, tissue construction, and wound healing. Stem cells are involved in all of these processes, at least in part. However, the direct evidence of mesenchymal-epithelial transition associated with stem cells is unclear. To determine whether mesenchymal-epithelial transition occurs in liver development and/or the differentiation process of hepatic stem cells in vitro, we analyzed a variety of murine liver tissues from embryonic day 11.5 to adults and the colonies derived from hepatic stem/progenitor cells isolated with flow cytometry. The results of gene expression, immunohistochemistry and Western blot showed that as liver develops, the expression of epithelial markers such as Cytokeratin18 and E-cadherin increase, while expression of mesenchymal markers such as vimentin and N-cadherin decreased. On the other hand, in freshly isolated hepatic stem cells, the majority of cells (65.0%) co-express epithelial and mesenchymal markers; this proportion is significantly higher than observed in hematopoietic cells, non-hematopoietic cells and non-stem cell fractions. Likewise, in stem cell-derived colonies cultured over time, upregulation of epithelial genes (Cytokeratin-18 and E-cadherin) occurred simultaneously with downregulation of mesenchymal genes (vimentin and Snail1). Furthermore, in the fetal liver, vimentin-positive cells in the non-hematopoietic fraction had distinct proliferative activity and expressed early the hepatic lineage marker alpha-fetoprotein. Conclusion: Hepatic stem cells co-express mesenchymal and epithelial markers; the mesenchymal-epithelial transition occurred in both liver development and differentiation of hepatic stem/progenitor cells in vitro. Besides as a mesenchymal marker, vimentin is a novel indicator for cell proliferative activity and undifferentiated status in liver cells.	[Li, Bin; Zheng, Yun-Wen; Sano, Yuuki; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan	Yokohama City University	Li, B (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan.	rtanigu@med.yokohama-cu.ac.jp	Li, Bin/P-8992-2015; Zheng, Yun-Wen/R-2874-2019	Li, Bin/0000-0002-4884-6967; Zheng, Yun-Wen/0000-0001-9002-3190	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Japan Science and Technology Agency (JST) [62890004];  [18591421];  [19390340];  [20591531];  [21249071]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); ; ; ; 	Supported by Grants-in-Aid (18591421, 19390340, 20591531 and 21249071) and the 21st Century Center of Excellence (COE) program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan and the grants from Strategic Promotion of Innovative Research and Development (S-innovation, 62890004) from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Eckes B, 2000, J CELL SCI, V113, P2455; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Goldring K, 2002, J PATHOL, V197, P457, DOI 10.1002/path.1157; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ikegami T, 2007, CELLS TISSUES ORGANS, V185, P213, DOI 10.1159/000101322; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; KONG D, PLOS ONE, V5; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; LANE EB, 1983, NATURE, V303, P701, DOI 10.1038/303701a0; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MENDEZ MG, 1838, FASEB J, V24, P1838; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morton RA, 2007, MOL CELL ENDOCRINOL, V270, P87, DOI 10.1016/j.mce.2007.02.005; Nakaya Y, 2008, DEV GROWTH DIFFER, V50, P755, DOI 10.1111/j.1440-169X.2008.01070.x; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Nitta T, 2008, HEPATOLOGY, V48, P909, DOI 10.1002/hep.22397; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Park MY, 2007, INT J ONCOL, V31, P1309; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Price J, 2001, CURR OPIN NEUROBIOL, V11, P564, DOI 10.1016/S0959-4388(00)00250-6; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Seeberger KL, 2009, LAB INVEST, V89, P110, DOI 10.1038/labinvest.2008.122; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; STENGER AM, 1992, MOL BRAIN RES, V13, P273, DOI 10.1016/0169-328X(92)90036-B; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tommasi S, 2007, CURR PHARM DESIGN, V13, P3279, DOI 10.2174/138161207782360663; VENETIANER A, 1983, NATURE, V305, P730, DOI 10.1038/305730a0; Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071; Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188, DOI 10.1152/ajpcell.2000.279.1.C188; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zheng YW, 2000, TRANSPLANT P, V32, P2372, DOI 10.1016/S0041-1345(00)01704-8	52	50	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17092	10.1371/journal.pone.0017092	http://dx.doi.org/10.1371/journal.pone.0017092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347296	Green Published, gold, Green Submitted			2022-12-25	WOS:000287364500025
J	Chang, TC; Yang, Y; Yasue, H; Bharti, AK; Retzel, EF; Liu, WS				Chang, Ti-Cheng; Yang, Yang; Yasue, Hiroshi; Bharti, Arvind K.; Retzel, Ernest F.; Liu, Wan-Sheng			The Expansion of the PRAME Gene Family in Eutheria	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; MULTIPLE ALIGNMENTS; ANTIGEN; EVOLUTIONARY; EXPRESSION; SOFTWARE; MELANOMA; SEQUENCE; TSPY; CHROMOSOME	The PRAME gene family belongs to the group of cancer/testis genes whose expression is restricted primarily to the testis and a variety of cancers. The expansion of this gene family as a result of gene duplication has been observed in primates and rodents. We analyzed the PRAME gene family in Eutheria and discovered a novel Y-linked PRAME gene family in bovine, PRAMEY, which underwent amplification after a lineage-specific, autosome-to-Y transposition. Phylogenetic analyses revealed two major evolutionary clades. Clade I containing the amplified PRAMEYs and the unamplified autosomal homologs in cattle and other eutherians is under stronger functional constraints; whereas, Clade II containing the amplified autosomal PRAMEs is under positive selection. Deep-sequencing analysis indicated that eight of the identified 16 PRAMEY loci are active transcriptionally. Compared to the bovine autosomal PRAME that is expressed predominantly in testis, the PRAMEY gene family is expressed exclusively in testis and is up-regulated during testicular maturation. Furthermore, the sense RNA of PRAMEY is expressed specifically whereas the antisense RNA is expressed predominantly in spermatids. This study revealed that the expansion of the PRAME family occurred in both autosomes and sex chromosomes in a lineage-dependent manner. Differential selection forces have shaped the evolution and function of the PRAME family. The positive selection observed on the autosomal PRAMEs (Clade II) may result in their functional diversification in immunity and reproduction. Conversely, selective constraints have operated on the expanded PRAMEYs to preserve their essential function in spermatogenesis.	[Chang, Ti-Cheng; Yang, Yang; Liu, Wan-Sheng] Penn State Univ, Coll Agr Sci, Ctr Reprod Biol & Hlth, Dept Dairy & Anim Sci, University Pk, PA 16802 USA; [Chang, Ti-Cheng; Liu, Wan-Sheng] Penn State Univ, Integrat Biosci Program, Huck Inst Life Sci, University Pk, PA 16802 USA; [Yasue, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Bharti, Arvind K.; Retzel, Ernest F.] Natl Ctr Genome Resources, Santa Fe, NM USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute of Agrobiological Sciences - Japan; National Center for Genome Resources (NCGR)	Chang, TC (corresponding author), Penn State Univ, Coll Agr Sci, Ctr Reprod Biol & Hlth, Dept Dairy & Anim Sci, University Pk, PA 16802 USA.	wul12@psu.edu	Chang, Ti-Cheng/HHS-7370-2022; Chang, Ti-Cheng/N-3252-2018; Yang, Yang/M-3310-2015		USDA-CSREES [2005-35205-18653, 2010-65205-20362]; Pennsylvania State University	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Pennsylvania State University	This work was supported by grants from USDA-CSREES (No. 2005-35205-18653 and No. 2010-65205-20362) and start-up funds from the Pennsylvania State University to Liu, W-S. http://www.csrees.usda.gov/fo/funding.cfm, http://www.psu.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Bronson RA, 1999, J REPROD IMMUNOL, V45, P159; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Del Mastro R G, 1997, Methods Mol Biol, V68, P183; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Epping MT, 2006, CANCER RES, V66, P10639, DOI 10.1158/0008-5472.CAN-06-2522; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gunn SR, 2009, LEUKEMIA RES, V33, P1276, DOI 10.1016/j.leukres.2008.10.010; HUGHES JF, 2010, NATURE; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; ISAHAKIA MA, 1988, BIOL REPROD, V39, P889, DOI 10.1095/biolreprod39.4.889; JAKUBICZKA S, 1993, GENOMICS, V17, P732, DOI 10.1006/geno.1993.1394; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kawano R, 2009, J CLIN EXP HEMATOP, V49, P1, DOI 10.3960/jslrt.49.1; Kiuchi S, 2006, CYTOGENET GENOME RES, V115, P51, DOI 10.1159/000094801; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu WS, 2009, CYTOGENET GENOME RES, V126, P318, DOI 10.1159/000266168; Liu WS, 2002, MAMM GENOME, V13, P320, DOI 10.1007/s00335-001-2133-8; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lu JC, 2008, EXPERT REV CLIN IMMU, V4, P113, DOI 10.1586/1744666X.4.1.113; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McCarthy N, 2005, NAT REV CANCER, V5, P839, DOI 10.1038/nrc1747; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Minami N, 2003, BIOL REPROD, V69, P1736, DOI 10.1095/biolreprod.103.018051; Nelson Peter T, 2007, Cancer Immun, V7, P1; Ono T, 2001, P NATL ACAD SCI USA, V98, P3282, DOI 10.1073/pnas.041625098; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; Peikert T, 2006, CANCER RES, V66, P4693, DOI 10.1158/0008-5472.CAN-05-3327; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J., 2001, MOL CLONING; Sawyer S, 1999, GENECONV COMPUTER PA; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Vodicka R, 2007, REPROD BIOMED ONLINE, V14, P579, DOI 10.1016/S1472-6483(10)61049-8; Wang A, 2008, ANIM GENET, V39, P207, DOI 10.1111/j.1365-2052.2008.01706.x; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang Yang, 2011, BMC Genomics, V12, P13, DOI 10.1186/1471-2164-12-13; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; TAXONOMY COMMON TREE	60	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16867	10.1371/journal.pone.0016867	http://dx.doi.org/10.1371/journal.pone.0016867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347312	Green Published, Green Submitted, gold			2022-12-25	WOS:000287363000021
J	Poyatos, JF				Poyatos, Juan F.			The Balance of Weak and Strong Interactions in Genetic Networks	PLOS ONE			English	Article							EPISTASIS; RECONSTRUCTION; CONSERVATION	Genetic interactions are being quantitatively characterized in a comprehensive way in several model organisms. These data are then globally represented in terms of genetic networks. How are interaction strengths distributed in these networks? And what type of functional organization of the underlying genomic systems is revealed by such distribution patterns? Here, I found that weak interactions are important for the structure of genetic buffering between signaling pathways in Caenorhabditis elegans, and that the strength of the association between two genes correlates with the number of common interactors they exhibit. I also determined that this network includes genetic cascades balancing weak and strong links, and that its hubs act as particularly strong genetic modifiers; both patterns also identified in Saccharomyces cerevisae networks. In yeast, I further showed a relation, although weak, between interaction strengths and some phenotypic/evolutionary features of the corresponding target genes. Overall, this work demonstrates a non-random organization of interaction strengths in genetic networks, a feature common to other complex networks, and that could reflect in this context how genetic variation is eventually influencing the phenotype.	[Poyatos, Juan F.] CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain; [Poyatos, Juan F.] Univ Oslo, CEES, Dept Biol, Oslo, Norway	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oslo	Poyatos, JF (corresponding author), CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain.	jpoyatos@cnb.csic.es			Ministerio de Ciencia, Tecnologia e Innovacion (Spain) [BFU2008-03632/BMC]; Research Mobility Programme; Abel Extraordinary Chair	Ministerio de Ciencia, Tecnologia e Innovacion (Spain); Research Mobility Programme; Abel Extraordinary Chair	This work was partially supported by Ministerio de Ciencia, Tecnologia e Innovacion (Spain) Grant BFU2008-03632/BMC and Research Mobility Programme, and also by the Abel Extraordinary Chair under the NILS Mobility Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Carter GW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000347; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Csermely P, 2004, TRENDS BIOCHEM SCI, V29, P331, DOI 10.1016/j.tibs.2004.05.004; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Gao H, 2010, GENETICS, V184, P827, DOI 10.1534/genetics.109.111120; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V149, P1167; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Simon H. A, 1962, P AM PHILOS SOC, V106, P467, DOI [DOI 10.1080/14759550302804, DOI 10.2307/985254]; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e14598	10.1371/journal.pone.0014598	http://dx.doi.org/10.1371/journal.pone.0014598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347355	gold, Green Published, Green Submitted			2022-12-25	WOS:000287363000001
J	Nudds, RL; Kaiser, GW; Dyke, GJ				Nudds, Robert L.; Kaiser, Gary W.; Dyke, Gareth J.			Scaling of Avian Primary Feather Length	PLOS ONE			English	Article							FLIGHT; KINEMATICS; ANATOMY; BIRDS	The evolution of the avian wing has long fascinated biologists, yet almost no work includes the length of primary feathers in consideration of overall wing length variation. Here we show that the length of the longest primary feather (f(prim)) contributing to overall wing length scales with negative allometry against total arm (ta = humerus+ulna+manus). The scaling exponent varied slightly, although not significantly so, depending on whether a species level analysis was used or phylogeny was controlled for using independent contrasts: f(prim) proportional to ta(0.78-0.82). The scaling exponent was not significantly different from that predicted (0.86) by earlier work. It appears that there is a general trend for the primary feathers of birds to contribute proportionally less, and ta proportionally more, to overall wingspan as this dimension increases. Wingspan in birds is constrained close to mass (M-1/3) because of optimisation for lift production, which limits opportunities for exterior morphological change. Within the wing, variations in underlying bone and feather lengths nevertheless may, in altering the joint positions, permit a range of different flight styles by facilitating variation in upstroke kinematics.	[Nudds, Robert L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Kaiser, Gary W.] Royal British Columbia Museum, Victoria, BC, Canada; [Dyke, Gareth J.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University of Manchester; University College Dublin	Nudds, RL (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Robert.Nudds@manchester.ac.uk	Bond, Alexander L/A-3786-2010; Dyke, Gareth/AAJ-9320-2020	Dyke, Gareth/0000-0002-8390-7817				DIAL KP, 1991, J MORPHOL, V207, P327, DOI 10.1002/jmor.1052070309; Greenewalt C.H., 1975, Transactions of the American Philosophical Society, V65, P1, DOI 10.2307/1006161; Greenewalt C. H., 1962, Smithsonian Miscellaneous Collections, V144, P1; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; Norberg U., 1990, VERTEBRATE FLIGHT ME; Nudds RL, 2007, J ZOOL, V272, P218, DOI 10.1111/j.1469-7998.2006.00261.x; Nudds RL, 2007, J AVIAN BIOL, V38, P515, DOI 10.1111/j.0908-8857.2007.03913.x; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Rayner Jeremy M. V., 1988, V5, P1; RAYNER JMV, 1985, J ZOOL, V206, P415; RICKER WE, 1973, J FISH RES BOARD CAN, V30, P409, DOI 10.1139/f73-072; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Sokal R. R., 2012, BIOMETRY; Tobalske BW, 2007, J EXP BIOL, V210, P2368, DOI 10.1242/jeb.005686; Worcester SE, 1996, J ZOOL, V239, P609, DOI 10.1111/j.1469-7998.1996.tb05947.x	18	26	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e15665	10.1371/journal.pone.0015665	http://dx.doi.org/10.1371/journal.pone.0015665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347413	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000287361700009
J	Correia, MAS; Mazumder, K; Bras, JLA; Firbank, SJ; Zhu, YP; Lewis, RJ; York, WS; Fontes, CMGA; Gilbert, HJ				Correia, Marcia A. S.; Mazumder, Koushik; Bras, Joana L. A.; Firbank, Susan J.; Zhu, Yanping; Lewis, Richard J.; York, William S.; Fontes, Carlos M. G. A.; Gilbert, Harry J.			Structure and Function of an Arabinoxylan-specific Xylanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; CELL-WALL DEGRADATION; LIGAND-BINDING; H-1-NMR SPECTROSCOPY; COMPLEX; OLIGOSACCHARIDES; BIOCHEMISTRY; REFINEMENT; SEQUENCE; DOMAINS	The enzymatic degradation of plant cell walls plays a central role in the carbon cycle and is of increasing environmental and industrial significance. The enzymes that catalyze this process include xylanases that degrade xylan, a beta-1,4-xylose polymer that is decorated with various sugars. Although xylanases efficiently hydrolyze unsubstituted xylans, these enzymes are unable to access highly decorated forms of the polysaccharide, such as arabinoxylans that contain arabinofuranose decorations. Here, we show that a Clostridium thermocellum enzyme, designated CtXyl5A, hydrolyzes arabinoxylans but does not attack unsubstituted xylans. Analysis of the reaction products generated by CtXyl5A showed that all the oligosaccharides contain an O3 arabinose linked to the reducing endxylose. The crystal structure of the catalytic module(CtGH5) of CtXyl5A, appended to a family 6 noncatalytic carbohydrate-binding module (CtCBM6), showed that CtGH5 displays a canonical (alpha/beta)(8)-barrel fold with the substrate binding cleft running along the surface of the protein. The catalytic apparatus is housed in the center of the cleft. Adjacent to the -1 subsite is a pocket that could accommodate an L-arabinofuranose-linked alpha-1,3 to the active site xylose, which is likely to function as a key specificity determinant. CtCBM6, which adopts a beta-sandwich fold, recognizes the termini of xylo-and gluco-configured oligosaccharides, consistent with the pocket topology displayed by the ligand-binding site. In contrast to typical modular glycoside hydrolases, there is an extensive hydrophobic interface between CtGH5 and CtCBM6, and thus the two modules cannot function as independent entities.	[Correia, Marcia A. S.; Bras, Joana L. A.; Fontes, Carlos M. G. A.] Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, P-1300477 Lisbon, Portugal; [Firbank, Susan J.; Zhu, Yanping; Lewis, Richard J.; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Mazumder, Koushik; Zhu, Yanping; York, William S.; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Universidade de Lisboa; Newcastle University - UK; University System of Georgia; University of Georgia	Fontes, CMGA (corresponding author), Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.utl.pt; h.j.gilbert@newcastle.ac.uk	Correia, Márcia/D-2077-2013	Correia, Márcia/0000-0003-0636-8095; Bras, Joana/0000-0002-1141-5530; lewis, richard/0000-0003-2641-8643; Fontes, Carlos/0000-0002-1219-9753	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/BIAPRO/69732/2006]; Office of Biological and Environmental Research in the Department of Energy Office of Science; Department of Energy [DE-FG02-96ER20220];  [SFRH/BD/16731/2004]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Office of Biological and Environmental Research in the Department of Energy Office of Science; Department of Energy(United States Department of Energy (DOE)); 	This work was supported by Grants PTDC/BIAPRO/69732/2006 from Fundacao para a Ciencia e Tecnologia (Portugal) and SFRH/BD/16731/2004 (to M. A. S. C.), Bioenergy Science Center, United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science, and Department of Energy Grant DE-FG02-96ER20220.	Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brett CT, 1996, PHYSL BIOCH PLANT CE; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1989, ANAL CARBOHYDRATES G, P157; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, DATA COLLECTION PROC, P114; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GRUPPEN H, 1992, CARBOHYD RES, V233, P45, DOI 10.1016/S0008-6215(00)90919-4; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; HOFFMANN RA, 1991, CARBOHYD RES, V221, P63, DOI 10.1016/0008-6215(91)80049-S; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mazumder K, 2010, CARBOHYD RES, V345, P2183, DOI 10.1016/j.carres.2010.07.034; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; MONTANIER CY, 2011, J BIOL CHEM IN PRESS, V286; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Pires VMR, 2004, J BIOL CHEM, V279, P21560, DOI 10.1074/jbc.M401599200; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Williams SJ, 2000, J AM CHEM SOC, V122, P4229, DOI 10.1021/ja0002870; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035	48	61	68	2	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22510	22520		10.1074/jbc.M110.217315	http://dx.doi.org/10.1074/jbc.M110.217315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21378160	Green Published, hybrid			2022-12-25	WOS:000291719900059
J	Peterson, AW; Pendrak, ML; Roberts, DD				Peterson, Alexander W.; Pendrak, Michael L.; Roberts, David D.			ATP Binding to Hemoglobin Response Gene 1 Protein Is Necessary for Regulation of the Mating Type Locus in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANOMALOUS ELECTROPHORETIC BEHAVIOR; ADENYLATE KINASE; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-BINDING; ACIDIC PROTEIN; P-LOOP; YEAST; CHROMATOGRAPHY; MOTIF	HBR1 (hemoglobin response gene 1) is an essential gene in Candida albicans that positively regulates mating type locus MTL alpha gene expression and thereby regulates cell type-specific developmental genes. Hbr1p contains a phosphate-binding loop (P-loop), a highly conserved motif characteristic of ATP-and GTP-binding proteins. Recombinant Hbr1p was isolated in an oligomeric state that specifically bound ATP with K-d similar to 2 mu M. ATP but not ADP, AMP, GTP, or dATP specifically protected Hbr1p from proteolysis by trypsin. Site-directed mutagenesis of the highly conserved P-loop lysine (K22Q) and the less conserved glycine (G19S) decreased the binding affinity for soluble ATP and ATP immobilized through its gamma-phosphate. ATP bound somewhat more avidly than ATP gamma S to wild type and mutant Hbr1p. Although Hbr1p exhibits sequence motifs characteristic of adenylate kinases, and adenylate kinase and ATPase activities have been reported for the apparent human ortholog of Hbr1p, assays for adenylate kinase activity, autophosphorylation, and ATPase activity proved negative. Overexpression of wild type but not the mutant forms of Hbr1p restored MTl alpha 2 expression in an HBR1/hbr1 mutant, indicating that ATP binding to the P-loop is necessary for this function of Hbr1p.	[Peterson, Alexander W.; Pendrak, Michael L.; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10,Rm 2A33,10 Ctr Dr, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008	Roberts, David D./0000-0002-2481-2981	National Institutes of Health through the National Cancer Institute Center for Cancer Research [ZIA SC 009173]; NATIONAL CANCER INSTITUTE [ZIASC009173] Funding Source: NIH RePORTER	National Institutes of Health through the National Cancer Institute Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health through the National Cancer Institute Center for Cancer Research Intramural Research Program, ZIA SC 009173.	ADAMS A, 1998, METHODS YEAST GENETI, P99; ADAMS LD, 2004, CURR PROTOC MOL BIOL, V14, P11; Alves VS, 2004, BIOCHEM BIOPH RES CO, V314, P229, DOI 10.1016/j.bbrc.2003.12.086; BEGG GE, 1999, CURRENT PROTOC PROTE, V10, P11; Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; DUNN B, 1992, CURR PROTOC MOL BIOL, V13, P11; Garcia-Ortega L, 2005, ELECTROPHORESIS, V26, P3407, DOI 10.1002/elps.200500261; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Juhnke H, 2000, MOL MICROBIOL, V35, P936, DOI 10.1046/j.1365-2958.2000.01768.x; Krell T, 1998, J MOL BIOL, V278, P983, DOI 10.1006/jmbi.1998.1755; Kvaal C, 1999, INFECT IMMUN, V67, P6652; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Meng G, 2008, BIOCHEMISTRY-MOSCOW+, V73, P38, DOI 10.1134/S0006297908010057; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; MOORE RE, 2000, CURRENT PROTOC PROTE, V10, P11; ODA Y, 1981, J BIOCHEM-TOKYO, V89, P285, DOI 10.1093/oxfordjournals.jbchem.a133192; ODDS FC, 1988, CANDIDA CANDIDOSIS, P206; Pendrak ML, 2004, EUKARYOT CELL, V3, P764, DOI 10.1128/EC.3.3.764-775.2004; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Ramakrishnan C, 2002, PROTEIN ENG, V15, P783, DOI 10.1093/protein/15.10.783; RANDERATH K, 1964, J CHROMATOGR, V16, P111, DOI 10.1016/S0021-9673(01)82445-6; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7451, DOI 10.1021/bi00484a014; Ren H, 2005, P NATL ACAD SCI USA, V102, P303, DOI 10.1073/pnas.0407459102; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Santama N, 2005, J BIOL CHEM, V280, P36429, DOI 10.1074/jbc.M501982200; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SHERMAN F, 1991, P3; SOLL DR, 1992, CLIN MICROBIOL REV, V5, P183, DOI 10.1128/CMR.5.2.183-203.1992; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; STONE KL, 2004, CURRENT PROTOC PROTE, V13, P1; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WILLIAMS A, 1998, CURR PROTOC MOL BIOL, V10, P11; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhai RT, 2006, FEBS LETT, V580, P3811, DOI 10.1016/j.febslet.2006.05.074; Zhang JF, 2010, CELL MOL LIFE SCI, V67, P1907, DOI 10.1007/s00018-010-0301-2	45	1	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13914	13924		10.1074/jbc.M110.180190	http://dx.doi.org/10.1074/jbc.M110.180190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372131	Green Published, hybrid			2022-12-25	WOS:000289556200014
J	Project, E; Nachliel, E; Gutman, M				Project, Elad; Nachliel, Esther; Gutman, Menachem			The Dynamics of Ca2+ Ions within the Solvation Shell of Calbindin D9k	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; MOLECULAR-DYNAMICS; SURFACE-CHARGES; FORCE-FIELD; SIMULATIONS; CALMODULIN; TRANSITION; GROMACS; MODELS; WATER	The encounter of a Ca2+ ion with a protein and its subsequent binding to specific binding sites is an intricate process that cannot be fully elucidated from experimental observations. We have applied Molecular Dynamics to study this process with atomistic details, using Calbindin D9k (CaB) as a model protein. The simulations show that in most of the time the Ca2+ ion spends within the Debye radius of CaB, it is being detained at the 1st and 2nd solvation shells. While being detained near the protein, the diffusion coefficient of the ion is significantly reduced. However, due to the relatively long period of detainment, the ion can scan an appreciable surface of the protein. The enhanced propagation of the ion on the surface has a functional role: significantly increasing the ability of the ion to scan the protein's surface before being dispersed to the bulk. The contribution of this mechanism to Ca2+ binding becomes significant at low ion concentrations, where the intervals between successive encounters with the protein are getting longer. The efficiency of the surface diffusion is affected by the distribution of charges on the protein's surface. Comparison of the Ca2+ binding dynamics in CaB and its E60D mutant reveals that in the wild type (WT) protein the carboxylate of E60 function as a preferred landing-site for the Ca2+ arriving from the bulk, followed by delivering it to the final binding site. Replacement of the glutamate by aspartate significantly reduced the ability to transfer Ca2+ ions from D60 to the final binding site, explaining the observed decrement in the affinity of the mutated protein to Ca2+.	[Project, Elad; Nachliel, Esther; Gutman, Menachem] Tel Aviv Univ, Laser Lab Fast React, IL-69978 Tel Aviv, Israel	Tel Aviv University	Project, E (corresponding author), Tel Aviv Univ, Laser Lab Fast React, IL-69978 Tel Aviv, Israel.	me@hemi.tau.ac.il						Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cox B.G., 1992, COORDINATION TRANSPO; DASILVA ACR, 1991, TRENDS BIOCHEM SCI, V16, P53, DOI 10.1016/0968-0004(91)90024-P; David R. L., 2010, CRC HDB CHEM PHYS; Eigen M., 1963, PURE APPL CHEM, V6, P97, DOI [10.1351/pac196306010097, DOI 10.1351/PAC196306010097]; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; FORSEN S, 1993, ACCOUNTS CHEM RES, V26, P7, DOI 10.1021/ar00025a002; Friedman R, 2005, BIOPHYS J, V89, P768, DOI 10.1529/biophysj.105.058917; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida H, 2002, BIOCHEMISTRY-US, V41, P15536, DOI 10.1021/bi020330r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Komeiji Y, 2002, FEBS LETT, V521, P133, DOI 10.1016/S0014-5793(02)02853-3; Kordel J, 1997, J BIOMOL NMR, V10, P231, DOI 10.1023/A:1018383102870; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kuntz I D Jr, 1974, Adv Protein Chem, V28, P239, DOI 10.1016/S0065-3233(08)60232-6; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LINSE S, 1988, NATURE, V335, P651, DOI 10.1038/335651a0; LINSE S, 1994, BIOCHEMISTRY-US, V33, P12478, DOI 10.1021/bi00207a015; MARCUS Y, 1985, ION SOLVATION; MARTIN SR, 1990, BIOCHEMISTRY-US, V29, P4188, DOI 10.1021/bi00469a023; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Paquin R, 2008, J AM CHEM SOC, V130, P15805, DOI 10.1021/ja803794g; PATARGIAS GN, J CHEM PHYS, V132; Project E, 2008, J COMPUT CHEM, V29, P1163, DOI 10.1002/jcc.20876; Project E, 2006, BIOPHYS J, V90, P3842, DOI 10.1529/biophysj.105.077792; Project E, 2010, J COMPUT CHEM, V31, P1864, DOI 10.1002/jcc.21473; Robinson R.A., 1959, ELECTROLYTE SOLUTION, DOI DOI 10.1073?PNAS.0305836101; SEATON BA, 1985, BIOCHEMISTRY-US, V24, P6740, DOI 10.1021/bi00345a002; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; SZEBENYI DME, 1986, J BIOL CHEM, V261, P8761; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VENABLE RM, 1988, BIOPOLYMERS, V27, P1001, DOI 10.1002/bip.360270609; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; [No title captured]	44	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e14718	10.1371/journal.pone.0014718	http://dx.doi.org/10.1371/journal.pone.0014718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364983	gold, Green Published, Green Submitted			2022-12-25	WOS:000287656600002
J	Stohl, EA; Gruenig, MC; Cox, MM; Seifert, HS				Stohl, Elizabeth A.; Gruenig, Marielle C.; Cox, Michael M.; Seifert, H. Steven			Purification and Characterization of the RecA Protein from Neisseria gonorrhoeae	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; PILIN-ANTIGENIC-VARIATION; ESCHERICHIA-COLI; BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; DEINOCOCCUS-RADIODURANS; ATP HYDROLYSIS; ERROR-PRONE; STABLE COMPLEXES; BRANCH MIGRATION	The strict human pathogen Neisseria gonorrhoeae is the only causative agent of the sexually transmitted infection gonorrhea. The recA gene from N. gonorrhoeae is essential for DNA repair, natural DNA transformation, and pilin antigenic variation, all processes that are important for the pathogenesis and persistence of N. gonorrhoeae in the human population. To understand the biochemical features of N. gonorrhoeae RecA (RecA(Ng)), we overexpressed and purified the RecA(Ng) and SSBNg proteins and compared their activities to those of the well-characterized E. coli RecA and SSB proteins in vitro. We observed that RecA(Ng) promoted more strand exchange at early time points than RecA(Ec) through DNA homologous substrates, and exhibited the highest ATPase activity of any RecA protein characterized to date. Further analysis of this robust ATPase activity revealed that RecA(Ng) is more efficient at displacing SSB from ssDNA and that RecA(Ng) shows higher ATPase activity during strand exchange than RecA(Ec). Using substrates created to mimic the cellular processes of DNA transformation and pilin antigenic variation we observed that RecA(Ec) catalyzed more strand exchange through a 100 bp heterologous insert, but that RecA(Ng) catalyzed more strand exchange through regions of microheterology. Together, these data suggest that the processes of ATP hydrolysis and DNA strand exchange may be coupled differently in RecA(Ng) than in RecA(Ec). This difference may explain the unusually high ATPase activity observed for RecA(Ng) with the strand exchange activity between RecA(Ng) and RecA(Ec) being more similar.	[Stohl, Elizabeth A.; Seifert, H. Steven] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Gruenig, Marielle C.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Northwestern University; Feinberg School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Stohl, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	e-stohl@northwestern.edu			National Institutes of Health [GM32335, U19 AI01448-16]; Dr. James Chieh-Hsia Mao and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship;  [R01 AI044239];  [R01 AI033493]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001448, R01AI044239, R01AI033493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. James Chieh-Hsia Mao and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (http://www.nih.gov). Work in the Seifert lab was supported by R01 AI044239 and R01 AI033493 to H.S.S. Work in the Cox lab was supported by NIH grant GM32335 to M.M.C. Additionally, EAS was partially supported by NIH grant U19 AI01448-16, and M.C.G. was partially supported by the Dr. James Chieh-Hsia Mao and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Baitin DM, 2003, J MOL BIOL, V328, P1, DOI 10.1016/S0022-2836(03)00242-0; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Britt RL, 2010, J BIOL CHEM, V285, P3211, DOI 10.1074/jbc.M109.028951; CAMPBELL LA, 1984, J BACTERIOL, V160, P288, DOI 10.1128/JB.160.1.288-293.1984; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1982, J BIOL CHEM, V257, P8523; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; FYFE JAM, 1990, GENE, V93, P151, DOI 10.1016/0378-1119(90)90151-G; Ganesh N, 2003, BIOCHEMISTRY-US, V42, P7216, DOI 10.1021/bi0340548; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOODMAN SD, 1991, J BACTERIOL, V173, P5921, DOI 10.1128/jb.173.18.5921-5923.1991; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; Gruenig MC, 2010, J BIOL CHEM, V285, P37188, DOI 10.1074/jbc.M110.171967; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Helm RA, 2009, J BACTERIOL, V191, P5613, DOI 10.1128/JB.00535-09; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; JAIN SK, 1994, J BIOL CHEM, V269, P20653; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; KATO R, 1993, J BIOCHEM-TOKYO, V114, P926, DOI 10.1093/oxfordjournals.jbchem.a124278; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; Kline KA, 2005, J BACTERIOL, V187, P5347, DOI 10.1128/JB.187.15.5347-5355.2005; Kline KA, 2005, J BACTERIOL, V187, P2903, DOI 10.1128/JB.187.8.2903-2907.2005; Kline KA, 2003, MOL MICROBIOL, V50, P3, DOI 10.1046/j.1365-2958.2003.03679.x; KOOMEY JM, 1987, J BACTERIOL, V169, P790, DOI 10.1128/jb.169.2.790-795.1987; KOOMEY M, 1987, GENETICS, V117, P391; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOVETT CM, 1985, J BIOL CHEM, V260, P3305; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; Mehr IJ, 2000, GENETICS, V154, P523; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILLER RV, 1990, ANNU REV MICROBIOL, V44, P365; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; PIERRE A, 1983, J BIOL CHEM, V258, P2870; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SCHOOK POP, 2010, MOL MICROBIOL; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Seifert HS, 1997, GENE, V188, P215, DOI 10.1016/S0378-1119(96)00810-4; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; SEIFERT HS, 1994, J CLIN INVEST, V93, P2744, DOI 10.1172/JCI117290; Shan Q, 1997, J BIOL CHEM, V272, P11063; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; Skaar EP, 2002, J BACTERIOL, V184, P919, DOI 10.1128/jb.184.4.919-927.2002; SPRATT BG, 1989, P NATL ACAD SCI USA, V86, P8988, DOI 10.1073/pnas.86.22.8988; Steffen SE, 2000, ARCH BIOCHEM BIOPHYS, V382, P303, DOI 10.1006/abbi.2000.2029; Steffen SE, 2001, ARCH BIOCHEM BIOPHYS, V388, P165, DOI 10.1006/abbi.2001.2286; Stohl EA, 2002, MICROBIOL-SGM, V148, P1821, DOI 10.1099/00221287-148-6-1821; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; Stohl EA, 2006, J BACTERIOL, V188, P7645, DOI 10.1128/JB.00801-06	76	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17101	10.1371/journal.pone.0017101	http://dx.doi.org/10.1371/journal.pone.0017101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359151	gold, Green Submitted, Green Published			2022-12-25	WOS:000287482300029
J	Lehen'kyi, V; Raphael, M; Oulidi, A; Flourakis, M; Khalimonchyk, S; Kondratskyi, A; Gordienko, DV; Mauroy, B; Bonnal, JL; Skryma, R; Prevarskaya, N				Lehen'kyi, V'yacheslav; Raphael, Maylis; Oulidi, Agathe; Flourakis, Matthieu; Khalimonchyk, Sergii; Kondratskyi, Artem; Gordienko, Dmitri V.; Mauroy, Brigitte; Bonnal, Jean-Lois; Skryma, Roman; Prevarskaya, Natalia			TRPV6 Determines the Effect of Vitamin D3 on Prostate Cancer Cell Growth	PLOS ONE			English	Article							1 ALPHA,25-DIHYDROXYVITAMIN D-3; OPERATED CA2+ CHANNELS; 1,25-DIHYDROXYVITAMIN D-3; ANDROGEN RECEPTOR; LNCAP CELLS; SIGNALING PATHWAY; EPITHELIAL-CELLS; MESSENGER-RNA; MUSCLE-CELLS; PROLIFERATION	Despite remarkable advances in the therapy and prevention of prostate cancer it is still the second cause of death from cancer in industrialized countries. Many therapies initially shown to be beneficial for the patients were abandoned due to the high drug resistance and the evolution rate of the tumors. One of the prospective therapeutical agents even used in the first stage clinical trials, 1,25-dihydroxyvitamin D3, was shown to be either unpredictable or inefficient in many cases. We have already shown that TRPV6 calcium channel, which is the direct target of 1,25-dihydroxyvitamin D3 receptor, positively controls prostate cancer proliferation and apoptosis resistance (Lehen'kyi et al., Oncogene, 2007). However, how the known 1,25-dihydroxyvitamin D3 antiproliferative effects may be compatible with the upregulation of pro-oncogenic TRPV6 channel remains a mystery. Here we demonstrate that in low steroid conditions 1,25-dihydroxyvitamin D3 upregulates the expression of TRPV6, enchances the proliferation by increasing the number of cells entering into S-phase. We show that these pro-proliferative effects of 1,25-dihydroxyvitamin D3 are directly mediated via the overexpression of TRPV6 channel which increases calcium uptake into LNCaP cells. The apoptosis resistance of androgen-dependent LNCaP cells conferred by TRPV6 channel is drastically inversed when 1,25-dihydroxyvitamin D3 effects were combined with the successful TRPV6 knockdown. In addition, the use of androgen-deficient DU-145 and androgen-insensitive LNCaP C4-2 cell lines allowed to suggest that the ability of 1,25-dihydroxyvitamin D3 to induce the expression of TRPV6 channel is a crucial determinant of the success or failure of 1,25-dihydroxyvitamin D3-based therapies.	[Lehen'kyi, V'yacheslav; Raphael, Maylis; Oulidi, Agathe; Flourakis, Matthieu; Khalimonchyk, Sergii; Kondratskyi, Artem; Skryma, Roman; Prevarskaya, Natalia] Equipe Labellise Ligue Natl Canc, INSERM, U1003, Villeneuve Dascq, France; [Lehen'kyi, V'yacheslav; Raphael, Maylis; Oulidi, Agathe; Flourakis, Matthieu; Khalimonchyk, Sergii; Kondratskyi, Artem; Skryma, Roman; Prevarskaya, Natalia] Univ Sci & Technol Lille, Villeneuve Dascq, France; [Gordienko, Dmitri V.] St Georges Univ London, Div Basic Med Sci, London, England; [Mauroy, Brigitte; Bonnal, Jean-Lois] Univ Catholique Lille, Serv Urol, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; St Georges University London; Universite Catholique de Lille	Lehen'kyi, V (corresponding author), Equipe Labellise Ligue Natl Canc, INSERM, U1003, Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr	Bonnal, Jean-Louis JLB/U-9025-2018; LEHEN'KYI, V'yacheslav/AAJ-6008-2020	LEHEN'KYI, V'yacheslav/0000-0003-0806-8766; Prevarskaya, natacha/0000-0003-0316-197X; Flourakis, Matthieu/0000-0002-5366-9125; Kondratskyi, Artem/0000-0003-3290-0524; Gordienko, Dmitri (Dmytro)/0000-0002-4118-9976	Institut National de la Sante et de la Recherche Medicale (INSERM), Ministere de l'Education Nationale et Ligue Nationale Contre le Cancer	Institut National de la Sante et de la Recherche Medicale (INSERM), Ministere de l'Education Nationale et Ligue Nationale Contre le Cancer(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), Ministere de l'Education Nationale et Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Banwell CM, 2003, RECENT RESULTS CANC, V164, P83; Bodding M, 2003, J BIOL CHEM, V278, P50872, DOI 10.1074/jbc.M308800200; Buitrago CG, 2003, J BIOL CHEM, V278, P2199, DOI 10.1074/jbc.M205732200; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHESKIS B, 1995, MOL ENDOCRINOL, V9, P1814, DOI 10.1210/me.9.12.1814; Cooperberg MR, 2005, J CLIN ONCOL, V23, P8146, DOI 10.1200/JCO.2005.02.9751; Eelen G, 2004, J BONE MINER RES, V19, P133, DOI 10.1359/JBMR.0301204; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Gache C, 1999, BREAST CANCER RES TR, V55, P29, DOI 10.1023/A:1006163418479; Gavrilov V, 2005, ANTICANCER RES, V25, P3425; Gniadecki R, 1996, J INVEST DERMATOL, V106, P1212, DOI 10.1111/1523-1747.ep12348498; Gniadecki R, 1996, J INVEST DERMATOL, V106, P510, DOI 10.1111/1523-1747.ep12343866; GRAUER A, 1995, BIOCHEM BIOPH RES CO, V213, P922, DOI 10.1006/bbrc.1995.2217; Haverstick DM, 2000, CANCER RES, V60, P1002; Hsieh TC, 1996, BIOCHEM BIOPH RES CO, V223, P141, DOI 10.1006/bbrc.1996.0859; Hsieh TC, 1997, BIOCHEM BIOPH RES CO, V235, P539, DOI 10.1006/bbrc.1997.6838; KOH E, 1988, LIFE SCI, V42, P215, DOI 10.1016/0024-3205(88)90685-6; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Krishnan AV, 2003, J CELL BIOCHEM, V88, P363, DOI 10.1002/jcb.10334; Krohn K, 2003, CALCIFIED TISSUE INT, V73, P400, DOI 10.1007/s00223-002-2160-9; Lam JS, 2006, J UROLOGY, V175, P27, DOI 10.1016/S0022-5347(05)00034-0; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lou YR, 2004, J STEROID BIOCHEM, V92, P317, DOI 10.1016/j.jsbmb.2004.10.007; Martin JL, 2000, ENDOCRINOLOGY, V141, P2401, DOI 10.1210/en.141.7.2401; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Peehl DM, 2004, J STEROID BIOCHEM, V92, P307, DOI 10.1016/j.jsbmb.2004.10.006; Peng JB, 2001, BIOCHEM BIOPH RES CO, V282, P729, DOI 10.1006/bbrc.2001.4638; Rashid SF, 2001, STEROIDS, V66, P433, DOI 10.1016/S0039-128X(00)00203-8; Skryma R, 2000, J PHYSIOL-LONDON, V527, P71, DOI 10.1111/j.1469-7793.2000.00071.x; So A, 2005, WORLD J UROL, V23, P1, DOI 10.1007/s00345-004-0473-1; Swami S, 2005, MOL CELL ENDOCRINOL, V241, P49, DOI 10.1016/j.mce.2005.05.001; Tischler AS, 1996, TOXICOL APPL PHARM, V140, P115, DOI 10.1006/taap.1996.0204; van Abel M, 2003, AM J PHYSIOL-GASTR L, V285, pG78, DOI 10.1152/ajpgi.00036.2003; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Vanden Abeele F, 2003, CELL CALCIUM, V33, P357, DOI 10.1016/S0143-4160(03)00049-6; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Wiers KM, 1997, CANCER IMMUNOL IMMUN, V44, P97, DOI 10.1007/s002620050361; Wissenbach U, 2004, BIOCHEM BIOPH RES CO, V322, P1359, DOI 10.1016/j.bbrc.2004.08.042; Yamauchi D, 2005, BIOCHEM BIOPH RES CO, V331, P1353, DOI 10.1016/j.bbrc.2005.04.053; Zhao XY, 1997, ENDOCRINOLOGY, V138, P3290, DOI 10.1210/en.138.8.3290	43	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16856	10.1371/journal.pone.0016856	http://dx.doi.org/10.1371/journal.pone.0016856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347289	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000287364500010
J	Zhao, TN; De Graaff, E; Breedveld, GJ; Loda, A; Severijnen, LA; Wouters, CH; Verheijen, FW; Dekker, MCJ; Montagna, P; Willemsen, R; Oostra, BA; Bonifati, V				Zhao, Tianna; De Graaff, Esther; Breedveld, Guido J.; Loda, Agnese; Severijnen, Lies-Anne; Wouters, Cokkie H.; Verheijen, Frans W.; Dekker, Marieke C. J.; Montagna, Pasquale; Willemsen, Rob; Oostra, Ben A.; Bonifati, Vincenzo			Loss of Nuclear Activity of the FBXO7 Protein in Patients with Parkinsonian-Pyramidal Syndrome (PARK15)	PLOS ONE			English	Article							F-BOX PROTEINS; FUNCTIONAL DOMAINS; DISEASE; FAMILY; IDENTIFICATION; INHIBITOR; MUTATIONS	Mutations in the F-box only protein 7 gene (FBXO7) cause PARK15, an autosomal recessive neurodegenerative disease presenting with severe levodopa-responsive parkinsonism and pyramidal disturbances. Understanding the PARK15 pathogenesis might thus provide clues on the mechanisms of maintenance of brain dopaminergic neurons, the same which are lost in Parkinson's disease. The protein(s) encoded by FBXO7 remain very poorly characterized. Here, we show that two protein isoforms are expressed from the FBXO7 gene in normal human cells. The isoform 1 is more abundant, particularly in primary skin fibroblasts. Both isoforms are undetectable in cell lines from the PARK15 patient of an Italian family; the isoform 1 is undetectable and the isoform 2 is severely decreased in the patients from a Dutch PARK15 family. In human cell lines and mouse primary neurons, the endogenous or over-expressed, wild type FBXO7 isoform 1 displays mostly a diffuse nuclear localization. An intact N-terminus is needed for the nuclear FBXO7 localization, as N-terminal modification by PARK15-linked missense mutation, or N-terminus tag leads to cytoplasmic mislocalization. Furthermore, the N-terminus of wild type FBXO7 (but not of mutant FBXO7) is able to confer nuclear localization to profilin (a cytoplasmic protein). Our data also suggest that overexpressed mutant FBXO7 proteins (T22M, R378G and R498X) have decreased stability compared to their wild type counterpart. In human brain, FBXO7 immunoreactivity was highest in the nuclei of neurons throughout the cerebral cortex, intermediate in the globus pallidum and the substantia nigra, and lowest in the hippocampus and cerebellum. In conclusion, the common cellular abnormality found in the PARK15 patients from the Dutch and Italian families is the depletion of the FBXO7 isoform 1, which normally localizes in the cell nucleus. The activity of FBXO7 in the nucleus appears therefore crucial for the maintenance of brain neurons and the pathogenesis of PARK15.	[Zhao, Tianna; De Graaff, Esther; Breedveld, Guido J.; Loda, Agnese; Severijnen, Lies-Anne; Wouters, Cokkie H.; Verheijen, Frans W.; Willemsen, Rob; Oostra, Ben A.; Bonifati, Vincenzo] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Dekker, Marieke C. J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Montagna, Pasquale] Univ Bologna, Dept Neurol, Bologna, Italy	Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Bologna	Zhao, TN (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	v.bonifati@erasmusmc.nl	de Graaff, Esther/D-3287-2011	Loda, Agnese/0000-0001-8109-128X; Wouters, Carine/0000-0002-6426-8845	Erasmus MC Rotterdam (Erasmus Fellowship); Netherlands Organization for Scientific Research (NWO)	Erasmus MC Rotterdam (Erasmus Fellowship); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Erasmus MC Rotterdam (Erasmus Fellowship), and the Netherlands Organization for Scientific Research (NWO, VIDI grant) to VB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2009, PARKINSONISM RELAT D, V15, P721, DOI 10.1016/j.parkreldis.2009.09.010; Bonifati V, 2010, ENCY MOVEMENT DISORD, V3, P392; Bonifati V, 2007, PARKINSONISM RELAT D, V13, pS233, DOI 10.1016/S1353-8020(08)70008-7; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Levenga J, 2009, NEUROBIOL DIS, V35, P241, DOI 10.1016/j.nbd.2009.05.004; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	23	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16983	10.1371/journal.pone.0016983	http://dx.doi.org/10.1371/journal.pone.0016983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347293	Green Submitted, Green Published, gold			2022-12-25	WOS:000287364500017
J	Piganeau, G; Eyre-Walker, A; Grimsley, N; Moreau, H				Piganeau, Gwenael; Eyre-Walker, Adam; Grimsley, Nigel; Moreau, Herve			How and Why DNA Barcodes Underestimate the Diversity of Microbial Eukaryotes	PLOS ONE			English	Article							18S RDNA SEQUENCES; MOLECULAR EVOLUTION; POLYMORPHISM; PLANKTON; ECOLOGY	Background: Because many picoplanktonic eukaryotic species cannot currently be maintained in culture, direct sequencing of PCR-amplified 18S ribosomal gene DNA fragments from filtered sea-water has been successfully used to investigate the astounding diversity of these organisms. The recognition of many novel planktonic organisms is thus based solely on their 18S rDNA sequence. However, a species delimited by its 18S rDNA sequence might contain many cryptic species, which are highly differentiated in their protein coding sequences. Principal Findings: Here, we investigate the issue of species identification from one gene to the whole genome sequence. Using 52 whole genome DNA sequences, we estimated the global genetic divergence in protein coding genes between organisms from different lineages and compared this to their ribosomal gene sequence divergences. We show that this relationship between proteome divergence and 18S divergence is lineage dependant. Unicellular lineages have especially low 18S divergences relative to their protein sequence divergences, suggesting that 18S ribosomal genes are too conservative to assess planktonic eukaryotic diversity. We provide an explanation for this lineage dependency, which suggests that most species with large effective population sizes will show far less divergence in 18S than protein coding sequences. Conclusions: There is therefore a trade-off between using genes that are easy to amplify in all species, but which by their nature are highly conserved and underestimate the true number of species, and using genes that give a better description of the number of species, but which are more difficult to amplify. We have shown that this trade-off differs between unicellular and multicellular organisms as a likely consequence of differences in effective population sizes. We anticipate that biodiversity of microbial eukaryotic species is underestimated and that numerous "cryptic species'' will become discernable with the future acquisition of genomic and metagenomic sequences.	[Piganeau, Gwenael; Grimsley, Nigel; Moreau, Herve] Univ Paris 06, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Piganeau, Gwenael; Grimsley, Nigel; Moreau, Herve] CNRS, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Sussex	Piganeau, G (corresponding author), Univ Paris 06, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France.	gwenael.piganeau@obs-banyuls.fr	Piganeau, Gwenael V/C-7600-2011; Eyre-Walker, Adam/G-6216-2011; Grimsley, Nigel/O-1359-2015	Piganeau, Gwenael V/0000-0002-9992-4187; Eyre-Walker, Adam/0000-0001-5527-8729; Grimsley, Nigel/0000-0001-9323-417X	European Community [254619];  [AAP-FRB2009-PICOPOP]	European Community(European Commission); 	This study was funded by the European Community's 7th Framework program FP7 under grant agreement no254619 and the AAP-FRB2009-PICOPOP (http://www.fondationbiodiversite.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; COYNE J, 2010, SPECIATION; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gourbiere S, 2010, EVOLUTION, V64, P1, DOI 10.1111/j.1558-5646.2009.00844.x; Jancek S, 2008, MOL BIOL EVOL, V25, P2293, DOI 10.1093/molbev/msn168; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Piganeau G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r5; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Viprey M, 2008, ENVIRON MICROBIOL, V10, P1804, DOI 10.1111/j.1462-2920.2008.01602.x; Welch JJ, 2008, J MOL EVOL, V67, P418, DOI 10.1007/s00239-008-9146-9; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	25	45	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16342	10.1371/journal.pone.0016342	http://dx.doi.org/10.1371/journal.pone.0016342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347361	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000287363000008
J	Sawyer, I; Smillie, SJ; Bodkin, JV; Fernandes, E; O'Byrne, KT; Brain, SD				Sawyer, Iain; Smillie, Sarah-Jane; Bodkin, Jennifer V.; Fernandes, Elizabeth; O'Byrne, Kevin T.; Brain, Susan D.			The Vasoactive Potential of Kisspeptin-10 in the Peripheral Vasculature	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; HORMONE; KISS-1; GENE; RAT; DECAPEPTIDE; ACTIVATION; MECHANISMS; PREGNANCY; HISTAMINE	Splice products of the Kiss1 protein (kisspeptins) have been shown to be involved in a diverse range of functions, including puberty, metastasis and vasoconstriction in large human arteries. Circulating Kisspeptin-10 (Kp-10) plasma levels are low in normal individuals but are elevated during various disease states as well as pregnancy. Here, we investigated the potential of Kp-10, the shortest biologically active kisspeptin, to influence microvascular effects, concentrating on the cutaneous vasculature. Kp-10 caused a dose-dependent increase in oedema formation (0.3-10nmol/injection site), assessed by Evans Blue albumin dye extravasation, in the dorsal skin of CD1 mice. Oedema formation was shown to be inhibited by the histamine H-1 receptor antagonist mepyramine. The response was characterised by a ring of pallor at the injection site in keeping with vasoconstrictor activity. Therefore, changes in dorsal skin blood flow were assessed by clearance of intradermally injected (99m)technetium. Kp-10 was found to significantly reduce clearance, in keeping with decreased blood flow and providing further evidence for vasoconstrictor activity. The decreased clearance was partially inhibited by co-treatment with the cyclo-oxygenase inhibitor indomethacin. Finally evidence for the kisspeptin receptor gene (Kiss1R), but not the kisspeptin peptide gene (Kiss1), mRNA expression was observed in heart, aorta and kidney samples from normal and angiotensin II induced hypertensive mice, with similar mRNA levels observed in each. We have evidence for two peripheral vasoactive roles for kisspeptin-10. Firstly, plasma extravasation indicative of ability to induce oedema formation and secondly decreased peripheral blood flow, indicating microvascular constriction. Thus Kp-10 has vasoactive properties in the peripheral microvasculature.	[Sawyer, Iain; Smillie, Sarah-Jane; Bodkin, Jennifer V.; Fernandes, Elizabeth; Brain, Susan D.] Kings Coll London, British Heart Fdn Ctr, Vasc Biol Sect, Div Cardiovasc, London WC2R 2LS, England; [O'Byrne, Kevin T.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Sawyer, I (corresponding author), Kings Coll London, Sch Med, Dept Cardiol, London WC2R 2LS, England.	sue.brain@kcl.ac.uk	Brain, Susan/L-3681-2013; Fernandes, Elizabeth S./Q-7276-2019; Fernandes, Elizabeth S/J-9397-2012	Fernandes, Elizabeth S./0000-0002-0567-2514; Brain, Susan/0000-0002-9684-8342	British Heart Foundation; Biotechnology and Biological Sciences Research Council; British Pharmacological Society; Higher Education Funding Council for England; Knowledge Transfer Network; Medical Research Council; Scottish Funding Council; Biotechnology and Biological Sciences Research Council [BB/F007396/1, BB/E527098/1] Funding Source: researchfish; BBSRC [BB/F007396/1, BB/E527098/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Pharmacological Society; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Knowledge Transfer Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	These studies were supported by the British Heart Foundation and a Capacity Building Award in Integrative Mammalian Biology funded by the Biotechnology and Biological Sciences Research Council, British Pharmacological Society, Higher Education Funding Council for England, Knowledge Transfer Network, Medical Research Council, and Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2009, PRENATAL DIAG, V29, P982, DOI 10.1002/pd.2328; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; BRAIN SD, 1988, BRIT J PHARMACOL, V95, P1005, DOI 10.1111/j.1476-5381.1988.tb11731.x; BRAIN SD, 1985, BRIT J PHARMACOL, V86, P855, DOI 10.1111/j.1476-5381.1985.tb11107.x; BRAIN SD, 2005, BRIT J PHARMACOL, V147, pS202; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Bytautiene E, 2008, REPROD SCI, V15, P26, DOI 10.1177/1933719107309645; Cao T, 1999, AM J PHYSIOL-REG I, V277, pR476, DOI 10.1152/ajpregu.1999.277.2.R476; CAROLE AO, 2005, J ALLERGY CLIN IMMUN, V115, P1162; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; Cho SG, 2009, J CELL BIOCHEM, V107, P1139, DOI 10.1002/jcb.22216; Curtis AE, 2010, AM J PHYSIOL-ENDOC M, V298, pE296, DOI 10.1152/ajpendo.00426.2009; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Kim S, 2000, PHARMACOL REV, V52, P11; Kobayashi T, 2010, BIOORGAN MED CHEM, V18, P3841, DOI 10.1016/j.bmc.2010.04.036; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Liang LH, 2009, HYPERTENSION, V54, P1254, DOI 10.1161/HYPERTENSIONAHA.109.129783; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; Mead EJ, 2007, ENDOCRINOLOGY, V148, P140, DOI 10.1210/en.2006-0818; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Nijher GMK, 2010, BRIT J CLIN PHARMACO, V70, P674, DOI 10.1111/j.1365-2125.2010.03746.x; OWEN DAA, 1984, AGENTS ACTIONS, V14, P39, DOI 10.1007/BF01966830; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; REPKE H, 1987, J PHARMACOL EXP THER, V243, P317; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Santic R, 2007, P NATL ACAD SCI USA, V104, P10217, DOI 10.1073/pnas.0608585104; Schmidhuber SM, 2007, J INVEST DERMATOL, V127, P716, DOI 10.1038/sj.jid.5700569; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1007/BF02253465; Wei JF, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-21; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066	42	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14671	10.1371/journal.pone.0014671	http://dx.doi.org/10.1371/journal.pone.0014671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347414	Green Submitted, Green Published, gold			2022-12-25	WOS:000287361700005
J	Cristea, S; Gregory, PD; Urnov, FD; Cost, GJ				Cristea, Sandra; Gregory, Philip D.; Urnov, Fyodor D.; Cost, Gregory J.			Dissection of Splicing Regulation at an Endogenous Locus by Zinc-Finger Nuclease-Mediated Gene Editing	PLOS ONE			English	Article							II TRANSCRIPTION; MUTATIONS; CELLS; SITE	Sequences governing RNA splicing are difficult to study in situ due to the great difficulty of traditional targeted mutagenesis. Zinc-finger nuclease (ZFN) technology allows for the rapid and efficient introduction of site-specific mutations into mammalian chromosomes. Using a ZFN pair along with a donor plasmid to manipulate the outcomes of DNA repair, we introduced several discrete, targeted mutations into the fourth intron of the endogenous BAX gene in Chinese hamster ovary cells. Putative lariat branch points, the polypyrimidine tract, and the splice acceptor site were targeted. We recovered numerous otherwise isogenic clones carrying the intended mutations and analyzed the effect of each on BAX pre-mRNA splicing. Mutation of one of three possible branch points, the polypyrimidine tract, and the splice acceptor site all caused exclusion of exon five from BAX mRNA. Interestingly, these exon-skipping mutations allowed usage of cryptic splice acceptor sites within intron four. These data demonstrate that ZFN-mediated gene editing is a highly effective tool for dissection of pre-mRNA splicing regulatory sequences in their endogenous context.	[Cristea, Sandra; Gregory, Philip D.; Urnov, Fyodor D.; Cost, Gregory J.] Sangamo BioSci, Richmond, CA 94804 USA	Sangamo Therapeutics, Inc.	Cristea, S (corresponding author), Sangamo BioSci, Richmond, CA 94804 USA.	gcost@sangamo.com		Gregory, Philip/0000-0001-9249-2468; Cost, Gregory/0000-0002-8509-4653	Sangamo BioSciences	Sangamo BioSciences	This work was funded by Sangamo BioSciences. As the authors are employees of Sangamo BioSciences, the funders designed the study, collected and analyzed the data, decided to publish it, and prepared the manuscript.	Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CHEN IT, 1993, MOL CELL BIOL, V13, P289, DOI 10.1128/MCB.13.1.289; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; DEKELVER RC, 2010, GENOME RES; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Hicks MJ, 2006, PLOS BIOL, V4, P943, DOI 10.1371/journal.pbio.0040147; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; HORNIG H, 1986, NATURE, V324, P589, DOI 10.1038/324589a0; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Malphettes L, 2010, BIOTECHNOL BIOENG, V106, P774, DOI 10.1002/bit.22751; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; RUSKIN B, 1985, CELL, V41, P833, DOI 10.1016/S0092-8674(85)80064-7; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Schwartz S, 2009, NUCLEIC ACIDS RES, V37, pW189, DOI 10.1093/nar/gkp320; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556	34	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16961	10.1371/journal.pone.0016961	http://dx.doi.org/10.1371/journal.pone.0016961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347446	gold, Green Submitted, Green Published			2022-12-25	WOS:000287077600036
J	Ke, Z; Yip, SP; Li, L; Zheng, XX; Tong, KY				Ke, Zheng; Yip, Shea Ping; Li, Le; Zheng, Xiao-Xiang; Tong, Kai-Yu			The Effects of Voluntary, Involuntary, and Forced Exercises on Brain-Derived Neurotrophic Factor and Motor Function Recovery: A Rat Brain Ischemia Model	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ELECTRICAL-STIMULATION; STROKE; BDNF; HIPPOCAMPUS; TREADMILL; INJURY; PLASTICITY; MOVEMENT; DEFICITS	Background: Stroke rehabilitation with different exercise paradigms has been investigated, but which one is more effective in facilitating motor recovery and up-regulating brain neurotrophic factor (BDNF) after brain ischemia would be interesting to clinicians and patients. Voluntary exercise, forced exercise, and involuntary muscle movement caused by functional electrical stimulation (FES) have been individually demonstrated effective as stroke rehabilitation intervention. The aim of this study was to investigate the effects of these three common interventions on brain BDNF changes and motor recovery levels using a rat ischemic stroke model. Methodology/Principal Findings: One hundred and seventeen Sprague-Dawley rats were randomly distributed into four groups: Control (Con), Voluntary exercise of wheel running (V-Ex), Forced exercise of treadmill running (F-Ex), and Involuntary exercise of FES (I-Ex) with implanted electrodes placed in two hind limb muscles on the affected side to mimic gait-like walking pattern during stimulation. Ischemic stroke was induced in all rats with the middle cerebral artery occlusion/reperfusion model and fifty-seven rats had motor deficits after stroke. Twenty-four hours after reperfusion, rats were arranged to their intervention programs. De Ryck's behavioral test was conducted daily during the 7-day intervention as an evaluation tool of motor recovery. Serum corticosterone concentration and BDNF levels in the hippocampus, striatum, and cortex were measured after the rats were sacrificed. V-Ex had significantly better motor recovery in the behavioral test. V-Ex also had significantly higher hippocampal BDNF concentration than F-Ex and Con. F-Ex had significantly higher serum corticosterone level than other groups. Conclusion/Significance: Voluntary exercise is the most effective intervention in upregulating the hippocampal BDNF level, and facilitating motor recovery. Rats that exercised voluntarily also showed less corticosterone stress response than other groups. The results also suggested that the forced exercise group was the least preferred intervention with high stress, low brain BDNF levels and less motor recovery.	[Ke, Zheng; Yip, Shea Ping; Li, Le; Tong, Kai-Yu] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Zheng, Xiao-Xiang] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310003, Zhejiang, Peoples R China	Hong Kong Polytechnic University; Zhejiang University	Ke, Z (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.	k.y.tong@polyu.edu.hk	Li, Le/N-1841-2019; Yip, Shea Ping/A-1185-2016; Tong, Raymond Kai-yu/C-3546-2009	Li, Le/0000-0002-9340-9061; Yip, Shea Ping/0000-0002-2170-8185; Tong, Raymond Kai-yu/0000-0003-4375-653X	Research Grants Council of the Hong Kong Special Administrative Region, China [PolyU5633/07M]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council of the Hong Kong Special Administrative Region, China (grant no. PolyU5633/07M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada L, 2003, ARCH PHYS MED REHAB, V84, P1486, DOI 10.1016/S0003-9993(03)00349-6; Arida RM, 2004, NEUROSCI LETT, V364, P135, DOI 10.1016/j.neulet.2004.03.086; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Brown DA, 2007, J APPL PHYSIOL, V103, P1979, DOI 10.1152/japplphysiol.00706.2007; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Carro E, 2000, J NEUROSCI, V20, P2926; Cechetti F, 2008, BRAIN RES, V1188, P182, DOI 10.1016/j.brainres.2007.10.012; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Hayes K, 2008, ACTA NEUROPATHOL, V115, P289, DOI 10.1007/s00401-008-0340-z; Hendriksen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011943; Huang AM, 2006, J NEURAL TRANSM, V113, P803, DOI 10.1007/s00702-005-0359-4; Johnston ANB, 2001, MOL BRAIN RES, V88, P26, DOI 10.1016/S0169-328X(01)00016-X; Leung LY, 2006, NEUROSCI LETT, V397, P135, DOI 10.1016/j.neulet.2005.12.006; Li DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006673; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Park BR, 2004, NEUROSCI RES COMMUN, V34, P10, DOI 10.1002/nrc.10101; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Shoval G, 2005, EUR NEUROPSYCHOPHARM, V15, P319, DOI 10.1016/j.euroneuro.2004.12.005; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Yan TB, 2005, STROKE, V36, P80, DOI 10.1161/01.STR.0000149623.24906.63; Yanagita S, 2007, LIFE SCI, V80, P356, DOI 10.1016/j.lfs.2006.09.027; Yang YR, 2003, CAN J NEUROL SCI, V30, P252, DOI 10.1017/S0317167100002687	32	188	209	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16643	10.1371/journal.pone.0016643	http://dx.doi.org/10.1371/journal.pone.0016643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347437	Green Submitted, gold, Green Published			2022-12-25	WOS:000287077600011
J	Luciano, AA; Yu, HY; Jackson, LW; Wolfe, LA; Bernstein, HB				Luciano, Angel A.; Yu, Haiyan; Jackson, Leila W.; Wolfe, Lisa A.; Bernstein, Helene B.			Preterm Labor and Chorioamnionitis Are Associated with Neonatal T Cell Activation	PLOS ONE			English	Article							MICROBIAL INVASION; INFECTION; FETAL; PARTURITION; TERM; MEMBRANES; INFANTS; RUPTURE	Background: Preterm parturition is characterized by innate immune activation and increased proinflammatory cytokine levels. This well established association leads us to hypothesize that preterm delivery is also associated with neonatal T lymphocyte activation and maturation. Methodology/Principal Findings: Cord blood samples were obtained following term, preterm, and deliveries complicated by clinical chorioamnionitis. Activation marker expression was quantitated by flow cytometric analysis. Infants born following preterm delivery demonstrated enhanced CD4(+) T lymphocyte activation, as determined by CD25 (Term 9.72% vs. Preterm 17.67%, p = 0.0001), HLA-DR (Term 0.91% vs. Preterm 1.92%, p = 0.0012), and CD69 expression (Term 0.38% vs. Preterm 1.20%, p = 0.0003). Neonates delivered following clinical chorioamnionitis also demonstrated increased T cell activation. Preterm neonates had an increased frequency of CD45RO(+) T cells. Conclusion/Significance: Preterm parturition is associated with neonatal CD4(+) T cell activation, and an increased frequency of CD45RO(+) T cells. These findings support the concept that activation of the fetal adaptive immune system in utero is closely associated with preterm labor.	[Luciano, Angel A.] Univ S Florida, Coll Med, Dept Pediat, Div Neonatol, Tampa, FL 33612 USA; [Luciano, Angel A.] USF Childrens Res Inst, St Petersburg, FL USA; [Yu, Haiyan; Wolfe, Lisa A.; Bernstein, Helene B.] Case Western Reserve Univ, Sch Med, Dept Reprod Biol,Med Ctr, Dept Obstet & Gynecol,MacDonald Womens Hosp,Univ, Cleveland, OH 44106 USA; [Yu, Haiyan] Sichuan Univ, Dept Obstet & Gynecol, W China Univ Hosp 2, Chengdu 610064, Peoples R China; [Jackson, Leila W.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	State University System of Florida; University of South Florida; Case Western Reserve University; Sichuan University; Case Western Reserve University	Luciano, AA (corresponding author), Univ S Florida, Coll Med, Dept Pediat, Div Neonatol, Tampa, FL 33612 USA.	hbb22@case.edu			American Cancer Society [RSG-07-070-01-LIB]	American Cancer Society(American Cancer Society)	This study was supported by the American Cancer Society Grant #RSG-07-070-01-LIB. The American Cancer Society had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, Int J Gynaecol Obstet, V63, P75; Athayde N, 2000, AM J OBSTET GYNECOL, V182, P135, DOI 10.1016/S0002-9378(00)70502-3; Bernstein HB, 2002, AM J OBSTET GYNECOL, V187, P1283, DOI 10.1067/mob.2002.126978; BERRY SM, 1995, AM J OBSTET GYNECOL, V173, P1315, DOI 10.1016/0002-9378(95)91378-5; Bruning T, 1997, CLIN EXP IMMUNOL, V107, P306, DOI 10.1111/j.1365-2249.1997.268-ce1165.x; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Esplin MS, 2005, J MATERN-FETAL NEO M, V17, P365, DOI 10.1080/14767050500141329; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; GRAVETT MG, 1994, AM J OBSTET GYNECOL, V171, P1660, DOI 10.1016/0002-9378(94)90418-9; HACK M, 1993, NEW ENGL J MED, V329, P1649, DOI 10.1056/NEJM199311253292210; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Kenyon S, 2004, OBSTET GYNECOL, V104, P1051, DOI 10.1097/01.AOG.0000143268.36682.21; Kim SK, 2009, J PERINAT MED, V37, P543, DOI 10.1515/JPM.2009.106; Matsuda Y, 2010, MICROBIOL IMMUNOL, V54, P38, DOI 10.1111/j.1348-0421.2009.00181.x; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; Peoples JD, 2009, AM J PERINAT, V26, P647, DOI 10.1055/s-0029-1220788; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1576, DOI 10.1016/0002-9378(92)91636-O; ROMERO R, 1988, SEMIN PERINATOL, V12, P262; ROMERO R, 1994, AM J REPROD IMMUNOL, V32, P108, DOI 10.1111/j.1600-0897.1994.tb01101.x; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SAITO S, 1993, CYTOKINE, V5, P81, DOI 10.1016/1043-4666(93)90027-3; Stavitsky AB, 2007, MOL IMMUNOL, V44, P2787, DOI 10.1016/j.molimm.2007.01.011; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85	25	41	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16698	10.1371/journal.pone.0016698	http://dx.doi.org/10.1371/journal.pone.0016698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347427	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600019
J	Sagili, RR; Pankiw, T; Metz, BN				Sagili, Ramesh R.; Pankiw, Tanya; Metz, Bradley N.			Division of Labor Associated with Brood Rearing in the Honey Bee: How Does It Translate to Colony Fitness?	PLOS ONE			English	Article							PHEROMONE; HYMENOPTERA; GROWTH; APIDAE	Division of labor is a striking feature observed in honey bees and many other social insects. Division of labor has been claimed to benefit fitness. In honey bees, the adult work force may be viewed as divided between non-foraging hive bees that rear brood and maintain the nest, and foragers that collect food outside the nest. Honey bee brood pheromone is a larval pheromone that serves as an excellent empirical tool to manipulate foraging behaviors and thus division of labor in the honey bee. Here we use two different doses of brood pheromone to alter the foraging stimulus environment, thus changing demographics of colony division of labor, to demonstrate how division of labor associated with brood rearing affects colony growth rate. We examine the effects of these different doses of brood pheromone on individual foraging ontogeny and specialization, colony level foraging behavior, and individual glandular protein synthesis. Low brood pheromone treatment colonies exhibited significantly higher foraging population, decreased age of first foraging and greater foraging effort, resulting in greater colony growth compared to other treatments. This study demonstrates how division of labor associated with brood rearing affects honey bee colony growth rate, a token of fitness.	[Sagili, Ramesh R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Pankiw, Tanya; Metz, Bradley N.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Oregon State University; Texas A&M University System; Texas A&M University College Station	Sagili, RR (corresponding author), Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA.	sagilir@hort.oregonstate.edu			USDA/NRI [2004-35302-15031]; Texas Honey Bee Legislative Initiative	USDA/NRI(United States Department of Agriculture (USDA)); Texas Honey Bee Legislative Initiative	This research was supported by grants from the USDA/NRI 2004-35302-15031 to T. Pankiw, as well as support from the Texas Honey Bee Legislative Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PD, 1998, SURVIVAL ANAL USING, P111; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; CAMAZINE S, 1993, BEHAV ECOL SOCIOBIOL, V32, P265, DOI 10.1007/BF00166516; ECKERT CD, 1994, OECOLOGIA, V97, P248, DOI 10.1007/BF00323157; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; GARY NE, 1987, ANN ENTOMOL SOC AM, V80, P664, DOI 10.1093/aesa/80.5.664; GIRAY T, 1994, BEHAV ECOL SOCIOBIOL, V35, P13, DOI 10.1007/BF00167054; JEFFREE EP, 1957, J ECON ENTOMOL, V50, P211, DOI 10.1093/jee/50.2.211; LE CONTE Y, 1994, NATURWISSENSCHAFTEN, V81, P462, DOI 10.1007/BF01136651; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Oster G.F., 1978, Monographs in Population Biology, pi; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Pankiw T, 2004, NATURWISSENSCHAFTEN, V91, P575, DOI 10.1007/s00114-004-0568-y; Pankiw T, 2001, BEHAV ECOL SOCIOBIOL, V49, P206, DOI 10.1007/s002650000282; Pankiw T, 2004, NATURWISSENSCHAFTEN, V91, P178, DOI 10.1007/s00114-004-0506-z; Pankiw T, 2002, ANN ENTOMOL SOC AM, V95, P761, DOI 10.1603/0013-8746(2002)095[0761:PFRTBP]2.0.CO;2; Pankiw T, 2007, J INSECT BEHAV, V20, P173, DOI 10.1007/s10905-007-9071-6; Pankiw T, 2008, J ECON ENTOMOL, V101, P1749, DOI 10.1603/0022-0493-101.6.1749; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Sagili RR, 2009, J INSECT BEHAV, V22, P339, DOI 10.1007/s10905-009-9176-1; Sagili RR, 2005, J INSECT PHYSIOL, V51, P953, DOI 10.1016/j.jinsphys.2005.04.003; Schmickl T, 2003, INSECT SOC, V50, P174, DOI 10.1007/s00040-003-0644-x; SEELEY TD, 1991, ETHOLOGY, V87, P284; Sokal R. R., 2012, BIOMETRY; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; WILSON EO, 1987, J ANIM ECOL, V56, P1, DOI 10.2307/4795; WINSTON ML, 1987, BIOL HONEY BEE, P48	30	27	27	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16785	10.1371/journal.pone.0016785	http://dx.doi.org/10.1371/journal.pone.0016785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347428	Green Submitted, Green Published, gold			2022-12-25	WOS:000287077600027
J	Borroni, V; Barrantes, FJ				Borroni, Virginia; Barrantes, Francisco J.			Cholesterol Modulates the Rate and Mechanism of Acetylcholine Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROMUSCULAR-JUNCTION; PHOSPHOLIPASE-D; LIPID RAFTS; POSTSYNAPTIC APPARATUS; DOWNSTREAM ACTIVATION; ACTIN POLYMERIZATION; MEMBRANE CHOLESTEROL; ANTIGENIC MODULATION; PHOSPHATIDIC-ACID; ENDOCYTIC PATHWAY	Stability of the nicotinic acetylcholine receptor (AChR) at the cell surface is key to the correct functioning of the cholinergic synapse. Cholesterol (Chol) is necessary for homeostasis of AChR levels at the plasmalemma and for ion translocation. Here we characterize the endocytic pathway followed by muscle-type AChR in Chol-depleted cells (Chol(-)). Under such conditions, the AChR is internalized by a ligand-, clathrin-, and dynamin-independent mechanism. Expression of a dominant negative form of the small GTPase Rac1, Rac1N17, abolishes receptor endocytosis. Unlike the endocytic pathway in control CHO cells (1), accelerated AChR internalization proceeds even upon disruption of the actin cytoskeleton. Under Chol(-) conditions, AChR internalization is furthermore found to require the activity of Arf6 and its effectors Rac1 and phospholipase D. The Arf6-dependent mechanism may constitute the default endocytic pathway followed by the AChR in the absence of external ligands, membrane Chol levels acting as a key homeostatic regulator of cell surface receptor levels.	[Borroni, Virginia; Barrantes, Francisco J.] Inst Invest Bioquim Bahia Blanca, UNESCO Chair Biophys & Mol Neurobiol, Bahia Blanca, Buenos Aires, Argentina		Barrantes, FJ (corresponding author), Inst Invest Bioquim Bahia Blanca, UNESCO Chair Biophys & Mol Neurobiol, C Carrindanga Km 7,B8000FWB, Bahia Blanca, Buenos Aires, Argentina.	rtfjb1@criba.edu.ar	; Barrantes, Francisco J./HCH-0258-2022	Borroni, Virginia/0000-0002-6007-0006; Barrantes, Francisco J./0000-0002-4745-681X	Ministry of Science and Technology [PICT 01-12790, 5-20155]; Argentine Scientific Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 6367]; Philip Morris USA Inc.; Philip Morris International	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Argentine Scientific Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Philip Morris USA Inc.; Philip Morris International	This work was supported in part by Ministry of Science and Technology Grants PICT 01-12790 and 5-20155, Argentine Scientific Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas) Grant PIP 6367, Philip Morris USA Inc., and Philip Morris International (to F.J.B.).	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; APPEL SH, 1977, P NATL ACAD SCI USA, V74, P2130, DOI 10.1073/pnas.74.5.2130; Bach AS, 2010, MOL BIOL CELL, V21, P2412, DOI 10.1091/mbc.E09-12-1063; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Banks GB, 2003, J NEUROCYTOL, V32, P709, DOI 10.1023/B:NEUR.0000020619.24681.2b; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Barrantes FJ, 2003, CURR OPIN DRUG DISC, V6, P620; Barrantes FJ, 2007, J NEUROCHEM, V103, P72, DOI 10.1111/j.1471-4159.2007.04719.x; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobeszko M, 2004, BIOCHEM BIOPH RES CO, V317, P689, DOI 10.1016/j.bbrc.2004.03.105; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Bruneau E, 2007, J BIOL CHEM, V282, P9932, DOI 10.1074/jbc.M608714200; Bruneau EG, 2008, CURR BIOL, V18, P109, DOI 10.1016/j.cub.2007.12.029; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Chen XL, 2003, J PHARMACOL EXP THER, V305, P573, DOI 10.1124/jpet.102.047894; Christian AE, 1997, J LIPID RES, V38, P2264; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P44, DOI 10.1016/0005-2736(74)90331-9; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Diaz O, 2005, J IMMUNOL, V175, P8077, DOI 10.4049/jimmunol.175.12.8077; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; ENGEL AG, 1982, CIBA F SYMP, V90, P197; FONG TM, 1987, BIOCHEMISTRY-US, V26, P3871, DOI 10.1021/bi00387a020; Gervasio OL, 2007, DEV BIOL, V305, P262, DOI 10.1016/j.ydbio.2007.02.008; Grimmer S, 2002, J CELL SCI, V115, P2953; HEINEMANN S, 1977, P NATL ACAD SCI USA, V74, P3090, DOI 10.1073/pnas.74.7.3090; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; John PAS, 2001, J NEUROBIOL, V49, P212, DOI 10.1002/neu.1076; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; LINDSTROM J, 1979, MUSCLE NERVE, V2, P173, DOI 10.1002/mus.880020304; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nakanishi M, 2001, CELL BIOL INT, V25, P971, DOI 10.1006/cbir.2001.0750; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; PEDICONI MF, 1992, LIPIDS, V27, P669, DOI 10.1007/BF02536022; Phillips WD, 1997, MOL CELL NEUROSCI, V10, P16, DOI 10.1006/mcne.1997.0634; PORTER S, 1985, BIOCHEMISTRY-US, V24, P425, DOI 10.1021/bi00323a028; PORTER S, 1983, J BIOL CHEM, V258, P34; Radhakrishna H, 1999, J CELL SCI, V112, P855; Roccamo AM, 1999, EUR J NEUROSCI, V11, P1615, DOI 10.1046/j.1460-9568.1999.00574.x; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stetzkowski-Marden F, 2006, J MOL NEUROSCI, V30, P37, DOI 10.1385/JMN:30:1:37; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; TZARTOS SJ, 1986, J IMMUNOL, V136, P3231; Wang ZZ, 1999, J NEUROSCI, V19, P1998; Wenz JJ, 2005, BIOCHEMISTRY-US, V44, P398, DOI 10.1021/bi048026g; Wenz Jorge J, 2008, PMC Biophys, V1, P6, DOI 10.1186/1757-5036-1-6; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; YANG SF, 1967, J BIOL CHEM, V242, P477; Zhu D, 2006, J NEUROSCI, V26, P4841, DOI 10.1523/JNEUROSCI.2807-05.2006; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	71	42	43	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17122	17132		10.1074/jbc.M110.211870	http://dx.doi.org/10.1074/jbc.M110.211870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21357688	hybrid, Green Published			2022-12-25	WOS:000290301900062
J	King, C; Sarvetnick, N				King, Cecile; Sarvetnick, Nora			The Incidence of Type-1 Diabetes in NOD Mice Is Modulated by Restricted Flora Not Germ-Free Conditions	PLOS ONE			English	Article							VIRUS-INFECTION; MELLITUS IDDM; T-CELLS; PREVENTION; MOUSE; ADJUVANT; BACTERIA; INSULIN; AUTOIMMUNITY; MATURATION	In the NOD mouse, the incidence of type-1 diabetes is thought to be influenced by the degree of cleanliness of the mouse colony. Studies collectively demonstrate that exposure to bacterial antigen or infection in the neonatal period prevents diabetes [1,2,3,4,5,6,7,8,9,10], supporting the notion that immunostimulation can benefit the maturation of the postnatal immune system [11]. A widely accepted extrapolation from this data has been the notion that NOD mice maintained under germ-free conditions have an increased incidence of diabetes. However, evidence supporting this influential concept is surprisingly limited [12]. In this study, we demonstrate that the incidence of diabetes in female NOD mice remained unchanged under germ-free conditions. By contrast, a spontaneous monoculture with a gram-positive aerobic spore-forming rod delayed the onset and reduced the incidence of diabetes. These findings challenge the view that germ-free NOD mice have increased diabetes incidence and demonstrate that modulation of intestinal microbiota can prevent the development of type-1 diabetes.	[King, Cecile; Sarvetnick, Nora] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	King, C (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Dept Immunol, Darlinghurst, NSW 2010, Australia.	c.king@garvan.org.au	King, Cecile/Q-9794-2019	King, Cecile/0000-0003-2193-2563	NIH [DK54063]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH/DK54063 and Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam C, 2010, DIABETES, V59, P2237, DOI 10.2337/db10-0147; Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; CRABBE PA, 1970, LAB INVEST, V22, P448; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; ELLIOTT RB, 1988, DIABETOLOGIA, V31, P62; GLAISTER JR, 1973, INT ARCH ALLER A IMM, V45, P719, DOI 10.1159/000231071; Gombert JM, 1996, CR ACAD SCI III-VIE, V319, P125; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; HOLT PG, 1995, PEDIAT ALLERG IMM-UK, V6, P59, DOI 10.1111/j.1399-3038.1995.tb00261.x; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; HUDSON JA, 1964, P SOC EXP BIOL MED, V116, P628; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; MACLAREN N, 1989, DIABETES, V38, P534, DOI 10.2337/diabetes.38.4.534; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martins TC, 1996, J AUTOIMMUN, V9, P501, DOI 10.1006/jaut.1996.0067; Martins TC, 1999, CLIN EXP IMMUNOL, V115, P248, DOI 10.1046/j.1365-2249.1999.00781.x; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Mueller DB, 2009, ANN NUTR METAB, V54, P208, DOI 10.1159/000220416; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Qin HY, 1997, J AUTOIMMUN, V10, P271, DOI 10.1006/jaut.1997.0136; Ramiya VK, 1996, J AUTOIMMUN, V9, P349, DOI 10.1006/jaut.1996.0047; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Sai P, 1996, DIABETES METAB, V22, P341; SATOH J, 1988, DIABETES, V37, P1188, DOI 10.2337/diabetes.37.9.1188; SHEHADEH NN, 1993, J AUTOIMMUN, V6, P291, DOI 10.1006/jaut.1993.1025; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; WILBERZ S, 1991, DIABETOLOGIA, V34, P2, DOI 10.1007/BF00404016	30	114	123	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17049	10.1371/journal.pone.0017049	http://dx.doi.org/10.1371/journal.pone.0017049			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364875	Green Published, gold, Green Submitted			2022-12-25	WOS:000287764100022
J	Labroussaa, F; Dubrana, MP; Arricau-Bouvery, N; Beven, L; Saillard, C				Labroussaa, Fabien; Dubrana, Marie-Pierre; Arricau-Bouvery, Nathalie; Beven, Laure; Saillard, Colette			Involvement of a Minimal Actin-Binding Region of Spiroplasma citri Phosphoglycerate Kinase in Spiroplasma Transmission by Its Leafhopper Vector	PLOS ONE			English	Article							CIRCULIFER-HAEMATOCEPS; INSECT TRANSMISSIBILITY; MYCOPLASMA-PNEUMONIAE; IN-VITRO; PROTEIN; SPIRALIN; CELLS; PLANT; PATHOGENICITY; DEHYDROGENASE	Background: Spiroplasma citri is a wall-less bacterium that colonizes phloem vessels of a large number of host plants. Leafhopper vectors transmit S. citri in a propagative and circulative manner, involving colonization and multiplication of bacteria in various insect organs. Previously we reported that phosphoglycerate kinase (PGK), the well-known glycolytic enzyme, bound to leafhopper actin and was unexpectedly implicated in the internalization process of S. citri into Circulifer haematoceps cells. Methodology/Principal Findings: In an attempt to identify the actin-interacting regions of PGK, several overlapping PGK truncations were generated. Binding assays, using the truncations as probes on insect protein blots, revealed that the actin-binding region of PGK was located on the truncated peptide designated PGK-FL5 containing amino acids 49-154. To investigate the role of PGK-FL5-actin interaction, competitive spiroplasma attachment and internalization assays, in which His6-tagged PGK-FL5 was added to Ciha-1 cells prior to infection with S. citri, were performed. No effect on the efficiency of attachment of S. citri to leafhopper cells was observed while internalization was drastically reduced. The in vivo effect of PGK-FL5 was confirmed by competitive experimental transmission assays as injection of PGK-FL5 into S. citri infected leafhoppers significantly affected spiroplasmal transmission. Conclusion: These results suggest that S. citri transmission by its insect vector is correlated to PGK ability to bind actin.	[Labroussaa, Fabien] INRA, Villenave Dornon, France; Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux	Labroussaa, F (corresponding author), INRA, Villenave Dornon, France.	saillard@bordeaux.inra.fr	Labroussaa, Fabien/AAN-2833-2021; Beven, Laure/Q-1096-2018	Labroussaa, Fabien/0000-0002-8712-3024; Beven, Laure/0000-0003-4407-3255; Arricau-Bouvery, Nathalie/0000-0001-9505-4834	INRA; Universite Victor Segalen Bordeaux 2; Ministere de l'Enseignement et de la Recherche	INRA; Universite Victor Segalen Bordeaux 2; Ministere de l'Enseignement et de la Recherche	This work was supported with funding from INRA and Universite Victor Segalen Bordeaux 2. F.L. was supported by a Ph.D. fellowship from the Ministere de l'Enseignement et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar E, 2004, ARCH MICROBIOL, V181, P97, DOI 10.1007/s00203-003-0630-8; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Berho N, 2006, MICROBIOL-SGM, V152, P873, DOI 10.1099/mic.0.28541-0; Berho N, 2006, MICROBIOL-SGM, V152, P2703, DOI 10.1099/mic.0.29085-0; Boutareaud A, 2004, APPL ENVIRON MICROB, V70, P3960, DOI 10.1128/AEM.70.7.3960-3967.2004; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; DALLO SF, 1990, INFECT IMMUN, V58, P4163, DOI 10.1128/IAI.58.12.4163-4165.1990; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Duret S, 2003, APPL ENVIRON MICROB, V69, P6225, DOI 10.1128/AEM.69.10.6225-6234.2003; DURET S, 2009, MICROBIOLOGY; Fletcher J, 1998, PHYTOPATHOLOGY, V88, P1351, DOI 10.1094/PHYTO.1998.88.12.1351; Foissac X, 1996, J BACTERIOL, V178, P2934, DOI 10.1128/jb.178.10.2934-2940.1996; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Killiny N, 2006, MICROBIOL-SGM, V152, P1221, DOI 10.1099/mic.0.28602-0; Killiny N, 2005, PHYTOPATHOLOGY, V95, P541, DOI 10.1094/PHYTO-95-0541; Kwon MO, 1999, PHYTOPATHOLOGY, V89, P1144, DOI 10.1094/PHYTO.1999.89.12.1144; Labroussaa F, 2010, APPL ENVIRON MICROB, V76, P1879, DOI 10.1128/AEM.02384-09; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Ozbek E, 2003, J INVERTEBR PATHOL, V82, P167, DOI 10.1016/S0022-2011(03)00031-4; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; SAGLIO P, 1973, INT J SYST BACTERIOL, V23, P191, DOI 10.1099/00207713-23-3-191; SAGLIO P, 1971, CR ACAD SCI D NAT, V272, P1387; SHERMAN MA, 1990, J BIOL CHEM, V265, P10659; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; VIGNAULT JC, 1980, CR ACAD SCI D NAT, V290, P775; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	29	14	15	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17357	10.1371/journal.pone.0017357	http://dx.doi.org/10.1371/journal.pone.0017357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364953	Green Submitted, Green Published, gold			2022-12-25	WOS:000287656600043
J	Esbjornsson, J; Mild, M; Mansson, F; Norrgren, H; Medstrand, P				Esbjornsson, Joakim; Mild, Mattias; Mansson, Fredrik; Norrgren, Hans; Medstrand, Patrik			HIV-1 Molecular Epidemiology in Guinea-Bissau, West Africa: Origin, Demography and Migrations	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUBTYPE-C; OCCUPATIONAL COHORT; SEQUENCE ALIGNMENT; DUAL INFECTIONS; CIVIL-WAR; TYPE-1; PREVALENCE; RECOMBINANT; INFERENCE	The HIV-1 epidemic in West Africa has been dominated by subtype A and the recombinant form CRF02_AG. Little is known about the origins and the evolutionary history of HIV-1 in this region. We employed Maximum likelihood and Bayesian methods in combination with temporal and spatial information to reconstruct the HIV-1 subtype distribution, demographic history and migration patterns over time in Guinea-Bissau, West Africa. We found that CRF02_AG and subsubtype A3 were the dominant forms of HIV-1 in Guinea-Bissau and that they were introduced into the country on at least six different occasions between 1976 and 1981. These estimates also corresponded well with the first reported HIV-1 cases in Guinea-Bissau. Migration analyses suggested that (1) the HIV-1 epidemic started in the capital Bissau and then dispersed into more rural areas, and (2) the epidemic in Guinea-Bissau was connected to both Cameroon and Mali. This is the first study that describes the HIV-1 molecular epidemiology in a West African country by combining the results of subtype distribution with analyses of epidemic origin and epidemiological linkage between locations. The multiple introductions of HIV-1 into Guinea-Bissau, during a short time-period of five years, coincided with and were likely influenced by the major immigration wave into the country that followed the end of the independence war (1963-1974).	[Esbjornsson, Joakim; Medstrand, Patrik] Lund Univ, Dept Expt Med Sci, Sect Mol Virol, Lund, Sweden; [Mild, Mattias] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden; [Mild, Mattias] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden; [Mansson, Fredrik] Lund Univ, Dept Clin Sci, Infect Dis Res Unit, Malmo, Sweden; [Norrgren, Hans] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden	Lund University; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Lund University; Lund University	Esbjornsson, J (corresponding author), Lund Univ, Dept Expt Med Sci, Sect Mol Virol, Lund, Sweden.	joakim.esbjornsson@med.lu.se		Norrgren, Hans/0000-0001-5780-530X; Esbjornsson, Joakim/0000-0002-3822-4953; Esbjornsson, Joakim/0000-0002-6088-7796	Swedish Research Council; Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); Crafoord Foundation, Lund, Sweden; Royal Physiographic Society, Lund, Sweden; Lars Hierta Memorial Foundation, Stockholm, Sweden; Konsul Thure Carlsson Fund for Medical Research, Lund, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); Crafoord Foundation, Lund, Sweden; Royal Physiographic Society, Lund, Sweden; Lars Hierta Memorial Foundation, Stockholm, Sweden; Konsul Thure Carlsson Fund for Medical Research, Lund, Sweden	Funding: This work was supported by The Swedish Research Council; The Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); The Crafoord Foundation, Lund, Sweden; The Royal Physiographic Society, Lund, Sweden; The Lars Hierta Memorial Foundation, Stockholm, Sweden and Konsul Thure Carlsson Fund for Medical Research, Lund, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2000, ARCH INTERN MED, V160, P3286, DOI 10.1001/archinte.160.21.3286; Andersson S, 1999, VIROLOGY, V262, P312, DOI 10.1006/viro.1999.9867; [Anonymous], 2008, EP FACT SHEET HIV AI; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CHABAL P, 1983, CAN J AFR STUD, V17, P189, DOI 10.2307/484213; Cham F, 2000, AIDS RES HUM RETROV, V16, P1915, DOI 10.1089/08892220050195874; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; FULTZ PN, 1988, AIDS, V2, P129, DOI 10.1097/00002030-198804000-00010; Galetto R, 2004, J BIOL CHEM, V279, P36625, DOI 10.1074/jbc.M405476200; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KANKI PJ, 1987, SCIENCE, V236, P827, DOI 10.1126/science.3033826; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Konings FAJ, 2006, J MED VIROL, V78, P523, DOI 10.1002/jmv.20572; Leitner T, 1996, AIDS RES HUM RETROV, V12, P1595, DOI 10.1089/aid.1996.12.1595; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lewis PO, 1998, MOL BIOL EVOL, V15, P277, DOI 10.1093/oxfordjournals.molbev.a025924; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Mansson F, 2007, SEX TRANSM INFECT, V83, P463, DOI 10.1136/sti.2007.025353; Mansson F, 2009, AIDS, V23, P1575, DOI 10.1097/QAD.0b013e32832cedfb; Meloni ST, 2004, J VIROL, V78, P12455, DOI 10.1128/JVI.78.22.12455-12461.2004; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; Mild M, 2007, J VIROL, V81, P3369, DOI 10.1128/JVI.01295-06; Montavon C, 2000, J ACQ IMMUN DEF SYND, V23, P363; Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40; Nkengasong JN, 2000, J ACQ IMMUN DEF SYND, V23, P430; Norrgren H, 1999, AIDS, V13, P701, DOI 10.1097/00002030-199904160-00011; NORRGREN H, 1995, J ACQ IMMUN DEF SYND, V9, P422, DOI 10.1097/00042560-199508000-00014; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Quinn TC, 1998, BIOMED RES REP, P327; Rambaut A., 2007, TRACER V1 5; RAMBAUT A, 2005, TREE STAT CALC TOOL, P2005; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Schierup M H, 2000, Genetics, V156, P879; Seo TK, 2002, BIOINFORMATICS, V18, P115, DOI 10.1093/bioinformatics/18.1.115; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; SWOFFORD DL, 2003, PAUP SUNDERLANDMASSA; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toure-Kane C, 2000, AIDS RES HUM RETROV, V16, P603, DOI 10.1089/088922200309025; VANTIENEN C, 2009, J ACQUIR IMMUNE DEFI; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI; LOS ALAMOS SEQUENCE	57	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17025	10.1371/journal.pone.0017025	http://dx.doi.org/10.1371/journal.pone.0017025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365013	Green Published, gold, Green Submitted			2022-12-25	WOS:000287482800025
J	Kimura, RH; Jones, DS; Jiang, L; Miao, Z; Cheng, Z; Cochran, JR				Kimura, Richard H.; Jones, Douglas S.; Jiang, Lei; Miao, Zheng; Cheng, Zhen; Cochran, Jennifer R.			Functional Mutation of Multiple Solvent-Exposed Loops in the Ecballium elaterium Trypsin Inhibitor-II Cystine Knot Miniprotein	PLOS ONE			English	Article							CANCER ALPHA(V)-INTEGRIN EXPRESSION; SMALL-ANIMAL PET; INTEGRIN ALPHA(V)BETA(3); STRUCTURAL SCAFFOLD; TUMOR ANGIOGENESIS; SURFACE DISPLAY; RGD PEPTIDES; IN-VIVO; BINDING; ALPHA-V-BETA-3	Background: The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops. Methodology/Principal Findings: Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to alpha(v)beta(5) and alpha(v)beta(5) integrins with affinities in the low nanomolar range, but bound weakly to the related integrins alpha(5)beta(1) and alpha(iib)beta(3). In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to alpha(v)beta(3) and alpha(v)beta(5) integrins. A Cu-64 radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was similar to 3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys. Conclusions/Significance: We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop.	[Kimura, Richard H.; Jiang, Lei; Miao, Zheng; Cheng, Zhen] Stanford Univ, Dept Radiol, MIPS, Canc Ctr,Bio X Program, Stanford, CA 94305 USA; [Jones, Douglas S.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Ctr Canc, Bio X Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Kimura, RH (corresponding author), Stanford Univ, Dept Radiol, MIPS, Canc Ctr,Bio X Program, Stanford, CA 94305 USA.	zcheng@stanford.edu; jennifer.cochran@stanford.edu	miao, zheng/A-8851-2012; Cheng, Zhen/K-2843-2012	Cheng, Zhen/0000-0001-8177-9463; Jones, Douglas/0000-0002-8456-6073	Stanford Molecular Imaging Scholars postdoctoral fellowship [R25 CA118681]; National Cancer Institute (NCI) [5R01 CA119053]; NCI In Vivo Cellular and Molecular Imaging Center (ICMIC) [P50 CA114747]; Edward Mallinckrodt Jr. Foundation; NATIONAL CANCER INSTITUTE [R25CA118681, P50CA114747, R01CA119053] Funding Source: NIH RePORTER	Stanford Molecular Imaging Scholars postdoctoral fellowship; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI In Vivo Cellular and Molecular Imaging Center (ICMIC); Edward Mallinckrodt Jr. Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported, in part, by a Stanford Molecular Imaging Scholars postdoctoral fellowship R25 CA118681 (to R.H.K), the National Cancer Institute (NCI) 5R01 CA119053 (to Z.C.), NCI In Vivo Cellular and Molecular Imaging Center (ICMIC) P50 CA114747, and a Faculty Scholar Award from the Edward Mallinckrodt Jr. Foundation (J.R.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Beer AJ, 2008, CANCER METAST REV, V27, P631, DOI 10.1007/s10555-008-9158-3; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Boy RG, 2010, MOL IMAGING BIOL, V12, P377, DOI 10.1007/s11307-009-0287-z; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Bruning A, 2003, GENE THER, V10, P198, DOI 10.1038/sj.gt.3301887; Cai W, 2005, BIOTECHNIQUES, V39, pS6, DOI DOI 10.2144/000112091; Cai WB, 2008, CURR PHARM DESIGN, V14, P2943, DOI 10.2174/138161208786404308; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen XY, 2004, BIOCONJUGATE CHEM, V15, P41, DOI 10.1021/bc0300403; Chen XY, 2004, MOL IMAGING BIOL, V6, P350, DOI 10.1016/j.mibio.2004.06.004; Cheng Z, 2005, BIOCONJUGATE CHEM, V16, P1433, DOI 10.1021/bc0501698; Cheng Z, 2008, J NUCL MED, V49, P804, DOI 10.2967/jnumed.107.047381; Cheng Z, 2010, MOL IMAGING BIOL, V12, P316, DOI 10.1007/s11307-009-0256-6; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; Cochran JR, 2000, CHEM BIOL, V7, P683, DOI 10.1016/S1074-5521(00)00019-3; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; FAVEL A, 1989, INT J PEPT PROT RES, V33, P202; HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4; Haubner R, 1997, ANGEW CHEM INT EDIT, V36, P1375; Haubner R, 2006, EUR J NUCL MED MOL I, V33, pS54, DOI 10.1007/s00259-006-0136-0; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hilpert K, 2003, J BIOL CHEM, V278, P24986, DOI 10.1074/jbc.M212152200; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jiang L, 2010, J NUCL MED, V51, P251, DOI 10.2967/jnumed.109.069831; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kimura RH, 2010, BIOCONJUGATE CHEM, V21, P436, DOI 10.1021/bc9003102; Kimura RH, 2009, PROTEINS, V77, P359, DOI 10.1002/prot.22441; Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Kolmar H, 2010, EXPERT REV MOL DIAGN, V10, P361, DOI 10.1586/ERM.10.15; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Krause S, 2007, FEBS J, V274, P86, DOI 10.1111/j.1742-4658.2006.05567.x; Lahti JL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000499; Lee S, 2010, BIOCHEMISTRY-US, V49, P1364, DOI 10.1021/bi901135x; Li ZB, 2007, J NUCL MED, V48, P1162, DOI 10.2967/jnumed.107.039859; Liu S, 2006, MOL PHARMACEUT, V3, P472, DOI 10.1021/mp060049x; Liu S, 2009, BIOCONJUGATE CHEM, V20, P2199, DOI 10.1021/bc900167c; Miao Z., 2010, AMINO ACIDS; Miao Z, 2009, BIOCONJUGATE CHEM, V20, P2342, DOI 10.1021/bc900361g; Nielsen CH, 2010, CANCER RES, V70, P9022, DOI 10.1158/0008-5472.CAN-10-1338; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Reiss S, 2006, PLATELETS, V17, P153, DOI 10.1080/09537100500436663; Richards J, 2003, J MOL BIOL, V326, P1475, DOI 10.1016/S0022-2836(03)00082-2; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Schottelius M, 2009, ACCOUNTS CHEM RES, V42, P969, DOI 10.1021/ar800243b; Shi JY, 2009, BIOCONJUGATE CHEM, V20, P750, DOI 10.1021/bc800455p; Silverman AP, 2011, J MOL RECOGNIT, V24, P127, DOI 10.1002/jmr.1036; Silverman AP, 2009, J MOL BIOL, V385, P1064, DOI 10.1016/j.jmb.2008.11.004; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Swers JS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh030; Tolmachev V, 2009, EUR J NUCL MED MOL I, V36, P692, DOI 10.1007/s00259-008-1003-y; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Wentzel A, 1999, J BIOL CHEM, V274, P21037, DOI 10.1074/jbc.274.30.21037; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007; Wu Y, 2005, J NUCL MED, V46, P1707; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724; Zhang XZ, 2006, J NUCL MED, V47, P113	62	34	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16112	10.1371/journal.pone.0016112	http://dx.doi.org/10.1371/journal.pone.0016112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364742	gold, Green Submitted, Green Published			2022-12-25	WOS:000287482800005
J	Petravic, J; Davenport, MP				Petravic, Janka; Davenport, Miles P.			Simian-Human Immunodeficiency Infection - Is the Course Set in the Acute Phase?	PLOS ONE			English	Article							T-CELL RESPONSES; CD8-T-CELL MEMORY; VIRAL REPLICATION; VIRUS-INFECTIONS; CD4-T-CELL HELP; RHESUS-MONKEYS; HIV-INFECTION; VACCINATION; DYNAMICS; LOAD	Identifying early predictors of infection outcome is important for the clinical management of HIV infection, and both viral load and CD4+ T cell level have been found to be useful predictors of subsequent disease progression. Very high viral load or extensively depleted CD4+ T cells in the acute phase often result in failure of immune control, and a fast progression to AIDS. It is usually assumed that extensive loss of CD4+ T cells in the acute phase of HIV infection prevents the establishment of robust T cell help required for virus control in the chronic phase. We tested this hypothesis using viral load and CD4+ T cell number of SHIV-infected rhesus macaques. In acute infection, the lowest level of CD4+ T cells was a good predictor of later survival; animals having less than 3.3% of baseline CD4+ T cells progressed to severe disease, while animals with more than 3.3% of baseline CD4+ T cells experienced CD4+ T cell recovery. However, it is unclear if the disease progression was caused by early depletion, or was simply a result of a higher susceptibility of an animal to infection. We derived a simple relationship between the expected number of CD4+ T cells in the acute and chronic phases for a constant level of host susceptibility or resistance. We found that in most cases, the depletion of CD4+ T cells in chronic infection was consistent with the prediction from the acute CD4+ T cell loss. However, the animals with less than 3.3% of baseline CD4 T cells in the acute phase were approximately 20% more depleted late in the infection than expected based on constant level of virus control. This suggests that severe acute CD4 depletion indeed impairs the immune response.	[Petravic, Janka; Davenport, Miles P.] Univ New S Wales, Complex Syst Biol Grp, Ctr Vasc Res, Sydney, NSW, Australia	University of New South Wales Sydney	Petravic, J (corresponding author), Univ New S Wales, Complex Syst Biol Grp, Ctr Vasc Res, Sydney, NSW, Australia.	m.davenport@unsw.edu.au	Petravic, Janka/AAD-9192-2020	Petravic, Janka/0000-0002-2263-2776; Davenport, Miles/0000-0002-4751-1831	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC)	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Davenport MP, 2007, IMMUNOL REV, V216, P164; Davenport MP, 2006, JAIDS-J ACQ IMM DEF, V41, P259, DOI 10.1097/01.qai.0000199232.31340.d3; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Horton H, 2002, J VIROL, V76, P7187, DOI 10.1128/JVI.76.14.7187-7202.2002; Igarashi T, 2003, J VIROL, V77, P10829, DOI 10.1128/JVI.77.20.10829-10840.2003; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Motulski H, 1995, INTUITIVE BIOSTATIST; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Petravic J, 2008, J VIROL, V82, P11589, DOI 10.1128/JVI.01596-08; Regoes RR, 2002, J VIROL, V76, P2573, DOI 10.1128/jvi.76.5.2573-2578.2002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Zhang L, 2004, J VIROL, V78, P5520, DOI 10.1128/JVI.78.10.5520-5522.2004; Zhang ZQ, 2004, VIROLOGY, V320, P75, DOI 10.1016/j.virol.2003.11.017	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17180	10.1371/journal.pone.0017180	http://dx.doi.org/10.1371/journal.pone.0017180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359149	Green Submitted, gold, Green Published			2022-12-25	WOS:000287482300034
J	Rao, MV; Mohan, PS; Kumar, A; Yuan, AD; Montagna, L; Campbell, J; Veeranna; Espreafico, EM; Julien, JP; Nixon, RA				Rao, Mala V.; Mohan, Panaiyur S.; Kumar, Asok; Yuan, Aidong; Montagna, Lee; Campbell, Jabbar; Veeranna; Espreafico, Enilza M.; Julien, Jean P.; Nixon, Ralph A.			The Myosin Va Head Domain Binds to the Neurofilament-L Rod and Modulates Endoplasmic Reticulum (ER) Content and Distribution within Axons	PLOS ONE			English	Article							IN-VIVO; INTERMEDIATE-FILAMENTS; TRANSPORT; ACTIN; CALMODULIN; MOTOR; LOCALIZATION; CYTOSKELETON; MELANOSOMES; PROTEINS	The neurofilament light subunit (NF-L) binds to myosin Va (Myo Va) in neurons but the sites of interaction and functional significance are not clear. We show by deletion analysis that motor domain of Myo Va binds to the NF-L rod domain that forms the NF backbone. Loss of NF-L and Myo Va binding from axons significantly reduces the axonal content of ER, and redistributes ER to the periphery of axon. Our data are consistent with a novel function for NFs as a scaffold in axons for maintaining the content and proper distribution of vesicular organelles, mediated in part by Myo Va. Based on observations that the Myo Va motor domain binds to intermediate filament (IF) proteins of several classes, Myo Va interactions with IFs may serve similar roles in organizing organelle topography in different cell types.	[Rao, Mala V.; Mohan, Panaiyur S.; Kumar, Asok; Yuan, Aidong; Montagna, Lee; Campbell, Jabbar; Veeranna; Nixon, Ralph A.] NYU, Nathan Kline Inst, Sch Med, Orangeburg, NY 10962 USA; [Rao, Mala V.; Mohan, Panaiyur S.; Yuan, Aidong; Veeranna; Nixon, Ralph A.] NYU, Dept Psychiat, Sch Med, Orangeburg, NY USA; [Nixon, Ralph A.] NYU, Dept Cell Biol, Sch Med, Orangeburg, NY USA; [Espreafico, Enilza M.] Dept Cellular & Mol Biol, Sao Paulo, Brazil; [Espreafico, Enilza M.] Dept Pathogenic Bioagents, Sao Paulo, Brazil; [Julien, Jean P.] Univ Laval, Mol Endocrinol Lab, Dept Anat & Physiol, CHU Laval,Ctr Rech, Quebec City, PQ, Canada	Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; Laval University	Rao, MV (corresponding author), NYU, Nathan Kline Inst, Sch Med, Orangeburg, NY 10962 USA.	nixon@nki.rfmh.org	Espreafico, Enilza/O-3053-2016; Espreafico, Enilza/AAW-4658-2021	Espreafico, Enilza/0000-0002-7552-4234; Espreafico, Enilza/0000-0002-7552-4234; Rao, Mala/0000-0001-7985-2414	NIH/NIA [A605604]; NATIONAL INSTITUTE ON AGING [R01AG005604] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is funded by the grant from NIH/NIA A605604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Chang W, 2008, RNA, V14, P491, DOI 10.1261/rna.665008; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; DZANDU JK, 1988, ANAL BIOCHEM, V174, P157, DOI 10.1016/0003-2697(88)90531-3; ENGLE LJ, 1994, GENOMICS, V19, P407, DOI 10.1006/geno.1994.1088; Erber A, 1998, J MOL EVOL, V47, P751, DOI 10.1007/PL00006434; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Evans LL, 1998, J CELL SCI, V111, P2055; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; Jung CH, 2004, J NEUROSCI, V24, P9486, DOI 10.1523/JNEUROSCI.1665-04.2004; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; LEWIS SA, 1986, MOL CELL BIOL, V6, P1529, DOI 10.1128/MCB.6.5.1529; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; MOORE KJ, 1988, P NATL ACAD SCI USA, V85, P8131, DOI 10.1073/pnas.85.21.8131; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; Oliver TN, 1999, CELL MOL LIFE SCI, V56, P243, DOI 10.1007/s000180050426; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Perkins GA, 2008, J STRUCT BIOL, V161, P469, DOI 10.1016/j.jsb.2007.10.005; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Rao MV, 2002, J CELL BIOL, V159, P279, DOI 10.1083/JCB.200205062; Rodriguez OC, 2002, J CELL SCI, V115, P991; Schmidt Stephen D., 2004, V299, P267; Slepchenko BM, 2007, J CELL BIOL, V179, P635, DOI 10.1083/jcb.200705146; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; TIMAR J, 1993, CELL MOTIL CYTOSKEL, V26, P49, DOI 10.1002/cm.970260106; TOKUTAKE S, 1983, ANAL BIOCHEM, V135, P102, DOI 10.1016/0003-2697(83)90736-4; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Wu XF, 1997, J CELL SCI, V110, P847; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Yuan AD, 2003, J NEUROSCI, V23, P9452; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Yuan AD, 2009, J NEUROSCI, V29, P11316, DOI 10.1523/JNEUROSCI.1942-09.2009; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	52	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17087	10.1371/journal.pone.0017087	http://dx.doi.org/10.1371/journal.pone.0017087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359212	gold, Green Published			2022-12-25	WOS:000287392700047
J	Gess, B; Sevimli, S; Strecker, JK; Young, P; Schabitz, WR				Gess, Burkhard; Sevimli, Sevgi; Strecker, Jan-Kolja; Young, Peter; Schaebitz, Wolf-Ruediger			Sodium-Dependent Vitamin C Transporter 2 (SVCT2) Expression and Activity in Brain Capillary Endothelial Cells after Transient Ischemia in Mice	PLOS ONE			English	Article							ASCORBIC-ACID TRANSPORT; CEREBRAL-ARTERY OCCLUSION; DEHYDROASCORBIC ACID; OXIDATIVE STRESS; RAT-BRAIN; GLUCOSE TRANSPORTERS; INFLAMMATORY CELLS; HUMAN-NEUTROPHILS; OXIDIZED FORM; STROKE	Expression and transport activity of Sodium-dependent Vitamin C Transporter 2 (SVCT2) was shown in various tissues and organs. Vitamin C was shown to be cerebroprotective in several animal models of stroke. Data on expression, localization and transport activity of SVCT2 after cerebral ischemia, however, has been scarce so far. Thus, we studied the expression of SVCT2 after middle cerebral artery occlusion (MCAO) in mice by immunohistochemistry. We found an upregulation of SVCT2 after stroke. Co-stainings with Occludin, Von-Willebrand Factor and CD34 demonstrated localization of SVCT2 in brain capillary endothelial cells in the ischemic area after stroke. Time-course analyses of SVCT2 expression by immunohistochemistry and western blots showed upregulation in the subacute phase of 2-5 days. Radioactive uptake assays using 14 C-labelled ascorbic acid showed a significant increase of ascorbic acid uptake into the brain after stroke. Taken together, these results provide evidence for the expression and transport activity of SVCT2 in brain capillary endothelial cells after transient ischemia in mice. These results may lead to the development of novel neuroprotective strategies in stroke therapy.	[Gess, Burkhard; Sevimli, Sevgi; Strecker, Jan-Kolja; Young, Peter; Schaebitz, Wolf-Ruediger] Univ Clin Muenster, Dept Neurol, Munster, Germany; [Schaebitz, Wolf-Ruediger] Evangel Klinikum Bethel, Bielefeld, Germany	University of Munster; Evangelical Hospital Bethel (EvKB) - House Gilead I	Gess, B (corresponding author), Univ Clin Muenster, Dept Neurol, Munster, Germany.	gess@uni-muenster.de			Innovative Medizinische Forschung (IMF), Munster (IMF) [I-GE 111002]; Deutsche Forschungsgemeinschaft (DFG) [GE 2249/1-1]	Innovative Medizinische Forschung (IMF), Munster (IMF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding: This work was funded by Innovative Medizinische Forschung (IMF), Munster (IMF grant nr.: I-GE 111002; http://campus.uni-muenster.de/imf_start.html) and Deutsche Forschungsgemeinschaft (DFG, grant nr.: GE 2249/1-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 1997, J CLIN INVEST, V100, P2842, DOI 10.1172/JCI119832; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Angelow S, 2003, BRAIN RES, V988, P105, DOI 10.1016/S0006-8993(03)03350-X; Avshalumov MV, 2004, NEURON GLIA BIOL, V1, P365, DOI 10.1017/S1740925X05000311; Berger UV, 2003, J NEUROCHEM, V86, P896, DOI 10.1046/j.1471-4159.2003.01891.x; BIGLEY R, 1983, DIABETES, V32, P545, DOI 10.2337/diabetes.32.6.545; Caprile T, 2009, J NEUROCHEM, V108, P563, DOI 10.1111/j.1471-4159.2008.05788.x; Castro M, 2001, J NEUROCHEM, V78, P815, DOI 10.1046/j.1471-4159.2001.00461.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; Garcia MDL, 2005, GLIA, V50, P32, DOI 10.1002/glia.20133; Gess B, 2010, GLIA, V58, P287, DOI 10.1002/glia.20923; Gieseg SP, 2009, FRONT BIOSCI-LANDMRK, V14, P1230, DOI 10.2741/3305; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Henry PT, 1998, ACTA NEUROCHIR, V140, P977, DOI 10.1007/s007010050201; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hosoya K, 2004, INVEST OPHTH VIS SCI, V45, P1232, DOI 10.1167/iovs.03-0505; Huang J, 2001, P NATL ACAD SCI USA, V98, P11720, DOI 10.1073/pnas.171325998; Huang JJ, 2006, BRAIN RES, V1097, P52, DOI 10.1016/j.brainres.2006.04.047; Ishida H, 2006, AM J HYPERTENS, V19, P33, DOI 10.1016/j.amjhyper.2005.06.023; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Mack WJ, 2006, NEUROSURGERY, V59, P383, DOI 10.1227/01.NEU.0000223496.96945.A7; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Miller AA, 2010, CLIN SCI, V119, P1, DOI 10.1042/CS20090649; Mun GH, 2006, J NEUROSCI RES, V83, P919, DOI 10.1002/jnr.20751; Qiao H, 2008, BRAIN RES, V1208, P79, DOI 10.1016/j.brainres.2008.02.102; Qiao H, 2009, BIOFACTORS, V35, P306, DOI 10.1002/biof.43; Qiu S, 2007, J NEUROSCI RES, V85, P1046, DOI 10.1002/jnr.21204; Rebec GV, 2003, NEUROREPORT, V14, P1263, DOI 10.1097/00001756-200307010-00015; Rogalewski A, 2008, NERVENARZT, V79, P218, DOI 10.1007/s00115-007-2386-x; Rosales-Corral S, 2003, J PINEAL RES, V35, P80, DOI 10.1034/j.1600-079X.2003.00057.x; Rutkowski M, 2004, Z NATURFORSCH C, V59, P762; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Schorah CJ, 1996, AM J CLIN NUTR, V63, P760, DOI 10.1093/ajcn/63.5.760; Sevimli S, 2009, EXP NEUROL, V217, P328, DOI 10.1016/j.expneurol.2009.03.018; Smith AR, 2002, FASEB J, V16, P1102, DOI 10.1096/fj.01-0825fje; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Spector R, 2009, J NEUROCHEM, V111, P315, DOI 10.1111/j.1471-4159.2009.06326.x; Stevens SL, 2002, BRAIN RES, V932, P110, DOI 10.1016/S0006-8993(02)02292-8; Takanaga H, 2004, PFLUG ARCH EUR J PHY, V447, P677, DOI 10.1007/s00424-003-1104-1; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; van Gijn J, 1998, LANCET, V352, pSIII23; WAGNER GC, 1986, NEUROPHARMACOLOGY, V25, P559, DOI 10.1016/0028-3908(86)90184-X; WASHKO P, 1989, J BIOL CHEM, V264, P18996; WELCH RW, 1995, J BIOL CHEM, V270, P12584, DOI 10.1074/jbc.270.21.12584; Wong CHY, 2008, CURR MED CHEM, V15, P1; Zhang WW, 2009, CHINESE MED J-PEKING, V122, P1996, DOI 10.3760/cma.j.issn.0366-6999.2009.17.007; Ziylan YZ, 2006, INT J NEUROSCI, V116, P25, DOI 10.1080/00207450690962262	50	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17139	10.1371/journal.pone.0017139	http://dx.doi.org/10.1371/journal.pone.0017139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347255	gold, Green Published, Green Submitted			2022-12-25	WOS:000287364500033
J	Liuzza, MT; Candidi, M; Aglioti, SM				Liuzza, Marco Tullio; Candidi, Matteo; Aglioti, Salvatore Maria			Do Not Resonate with Actions: Sentence Polarity Modulates Cortico-Spinal Excitability during Action-Related Sentence Reading	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; PARKINSONS-DISEASE; NEURON DISEASE; ACTION WORDS; TIME-COURSE; LANGUAGE; VERB; FACILITATION; BRAIN	Background: Theories of embodied language suggest that the motor system is differentially called into action when processing motor-related versus abstract content words or sentences. It has been recently shown that processing negative polarity action-related sentences modulates neural activity of premotor and motor cortices. Methods and Findings: We sought to determine whether reading negative polarity sentences brought about differential modulation of cortico-spinal motor excitability depending on processing hand-action related or abstract sentences. Facilitatory paired-pulses Transcranial Magnetic Stimulation (pp-TMS) was applied to the primary motor representation of the right-hand and the recorded amplitude of induced motor-evoked potentials (MEP) was used to index M1 activity during passive reading of either hand-action related or abstract content sentences presented in both negative and affirmative polarity. Results showed that the cortico-spinal excitability was affected by sentence polarity only in the hand-action related condition. Indeed, in keeping with previous TMS studies, reading positive polarity, hand action-related sentences suppressed cortico-spinal reactivity. This effect was absent when reading hand action-related negative polarity sentences. Moreover, no modulation of cortico-spinal reactivity was associated with either negative or positive polarity abstract sentences. Conclusions: Our results indicate that grammatical cues prompting motor negation reduce the cortico-spinal suppression associated with affirmative action sentences reading and thus suggest that motor simulative processes underlying the embodiment may involve even syntactic features of language.	[Liuzza, Marco Tullio; Candidi, Matteo; Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Liuzza, Marco Tullio; Candidi, Matteo; Aglioti, Salvatore Maria] Fdn Santa Lucia, IRCCS, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Liuzza, MT (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	matteo.candidi@uniroma1.it	Liuzza, Marco Tullio/A-9967-2012; Aglioti, Salvatore M/E-9829-2012; Candidi, Matteo/K-9245-2016	Liuzza, Marco Tullio/0000-0001-6708-1253; CANDIDI, MATTEO/0000-0001-8201-7954; Aglioti, Salvatore Maria/0000-0001-8175-7563	Istituto Italiano di Tecnologia (IIT) SEED [21538]; European FP7 grant Tango; European Commission [249858]	Istituto Italiano di Tecnologia (IIT) SEED; European FP7 grant Tango; European Commission(European CommissionEuropean Commission Joint Research Centre)	S.M.A. was funded by the Istituto Italiano di Tecnologia (IIT) SEED (Prot. Num. 21538) and the European FP7 grant Tango. The project Tango acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: 249858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bak TH, 2004, BRAIN LANG, V89, P354, DOI 10.1016/S0093-934X(03)00357-2; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; Barsalou LW, 1999, BEHAV BRAIN SCI, V22; Bergen B, 2010, BRAIN LANG, V112, P150, DOI 10.1016/j.bandl.2009.07.002; Borghi AM, 2004, MEM COGNITION, V32, P863, DOI 10.3758/BF03196865; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; BRIGGS G G, 1975, Cortex, V11, P230; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Bufalari I, 2010, BIOL PSYCHOL, V85, P283, DOI 10.1016/j.biopsycho.2010.07.015; Candidi M, 2010, CEREB CORTEX, V20, P2832, DOI 10.1093/cercor/bhq033; Candidi M, 2010, EUR J NEUROSCI, V32, P677, DOI 10.1111/j.1460-9568.2010.07305.x; Carpenter PA, 1999, NEUROIMAGE, V10, P216, DOI 10.1006/nimg.1999.0465; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; DANIELE A, 1994, NEUROPSYCHOLOGIA, V32, P1325, DOI 10.1016/0028-3932(94)00066-2; Davis C, 2010, NEUROCASE, V16, P259, DOI 10.1080/13554790903456183; Di Lazzaro V, 2001, J PHYSIOL-LONDON, V537, P1047, DOI 10.1113/jphysiol.2001.012572; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fodor J, 1983, MODULARITY MIND; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2008, CURR BIOL, V18, pR290, DOI 10.1016/j.cub.2008.02.036; Hasegawa M, 2002, NEUROIMAGE, V15, P647, DOI 10.1006/nimg.2001.1001; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Kaup B., 2005, P ANN M COGN SCI SOC, V27, P1114; Kaup B, 2007, Q J EXP PSYCHOL, V60, P976, DOI 10.1080/17470210600823512; Kaup B, 2006, J PRAGMATICS, V38, P1033, DOI 10.1016/j.pragma.2005.09.012; KERTESZ A, 1984, NEUROLOGY, V34, P40, DOI 10.1212/WNL.34.1.40; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lakoff George., 1999, PHILOS FLESH EMBODIE; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; PAPAGNO C, 1993, J NEUROL NEUROSUR PS, V56, P286, DOI 10.1136/jnnp.56.3.286; Papeo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004508; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; Pecher D., 2005, GROUNDING COGNITION; Peran P, 2009, CORTEX, V45, P960, DOI 10.1016/j.cortex.2009.02.019; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P307, DOI 10.1017/S0140525X99511825; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rodriguez-Ferreiro J, 2009, NEUROPSYCHOLOGIA, V47, P3271, DOI 10.1016/j.neuropsychologia.2009.07.007; Romani M, 2005, NEUROIMAGE, V26, P755, DOI 10.1016/j.neuroimage.2005.02.027; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Silveri MC, 2007, NEUROPSYCHOLOGIA, V45, P2570, DOI 10.1016/j.neuropsychologia.2007.03.014; Taylor LJ, 2008, Q J EXP PSYCHOL, V61, P896, DOI 10.1080/17470210701625519; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tettamanti M, 2008, NEUROIMAGE, V43, P358, DOI 10.1016/j.neuroimage.2008.08.004; Tomasino B, 2010, NEUROSCIENCE, V169, P246, DOI 10.1016/j.neuroscience.2010.04.039; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 2010, BRAIN LANG, V112, P143, DOI 10.1016/j.bandl.2008.11.004	65	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16855	10.1371/journal.pone.0016855	http://dx.doi.org/10.1371/journal.pone.0016855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721OO	21347305	Green Published, Green Submitted, gold			2022-12-25	WOS:000287364500009
J	Deng, MY; Lam, S; Meyer, U; Feldon, J; Li, Q; Wei, R; Luk, L; Chua, SE; Sham, P; Wang, Y; McAlonan, GM				Deng, Michelle Y.; Lam, Sylvia; Meyer, Urs; Feldon, Joram; Li, Qi; Wei, Ran; Luk, Lawrence; Chua, Siew Eng; Sham, Pak; Wang, Yu; McAlonan, Grainne Mary			Frontal-Subcortical Protein Expression following Prenatal Exposure to Maternal Inflammation	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; AUTISM SPECTRUM DISORDERS; PREFRONTAL CORTEX; WHITE-MATTER; INFLUENZA EPIDEMICS; SIGNALING PATHWAYS; MOLECULAR EVIDENCE; SCHIZOPHRENIA; BRAIN; INFECTION	Background: Maternal immune activation (MIA) during prenatal life is a risk factor for neurodevelopmental disorders including schizophrenia and autism. Such conditions are associated with alterations in fronto-subcortical circuits, but their molecular basis is far from clear. Methodology/Principal Findings: Using two-dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry, with targeted western blot analyses for confirmation, we investigated the impact of MIA on the prefrontal and striatal proteome from an established MIA mouse model generated in C57B6 mice, by administering the viral analogue PolyI:C or saline vehicle (control) intravenously on gestation day (GD) 9. In striatum, 11 proteins were up-regulated and 4 proteins were down-regulated in the PolyI: C mice, while 10 proteins were up-regulated and 7 proteins down-regulated in prefrontal cortex (PFC). These were proteins involved in the mitogen-activated protein kinase (MAPK) signaling pathway, oxidation and auto-immune targets, including dual specificity mitogen-activated protein kinase kinase 1 (MEK), eukaryotic initiation factor (eIF) 4A-II, creatine kinase (CK)-B, L-lactate dehydrogenase (LDH)-B, WD repeat-containing protein and NADH dehydrogenase in the striatum; and guanine nucleotide-binding protein (G-protein), 14-3-3 protein, alpha-enolase, olfactory maker protein and heat shock proteins (HSP) 60, and 90-beta in the PFC. Conclusions/Significance: This data fits with emerging evidence for disruption of critical converging intracellular pathways involving MAPK pathways in neurodevelopmental conditions and it shows considerable overlap with protein pathways identified by genetic modeling and clinical post-mortem studies. This has implications for understanding causality and may offer potential biomarkers and novel treatment targets for neurodevelopmental conditions.	[Deng, Michelle Y.; Lam, Sylvia; Li, Qi; Wei, Ran; Chua, Siew Eng; Sham, Pak; McAlonan, Grainne Mary] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Meyer, Urs; Feldon, Joram] Swiss Fed Inst Technol Zurich ETH, Neurobiol & Behav Lab, Schwerzenbach, Switzerland; [Luk, Lawrence] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Chua, Siew Eng; Sham, Pak; McAlonan, Grainne Mary] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu] Univ Hong Kong, Dept Pharmacol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Deng, MY (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	mcalonan@hkucc.hku.hk	wei, wei/HHR-8613-2022; Meyer, Urs/C-4602-2016; Wei, ran/GXF-3452-2022; McAlonan, Grainne/G-1541-2011	Meyer, Urs/0000-0001-7244-0345; wang, yu/0000-0001-8697-2940; McAlonan, Grainne/0000-0002-4466-2343	Swiss Federal Institute of Technology (ETH) Zurich [1107/03]; Swiss National Science Foundation [3100AO-100309, 3100A0-116719]; NARSAD Distinguished Investigator Award; University of Hong Kong; Hong Kong Research Grants Council	Swiss Federal Institute of Technology (ETH) Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NARSAD Distinguished Investigator Award(NARSAD); University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council)	JF and UM received financial support from the Swiss Federal Institute of Technology (ETH) Zurich (grant-1107/03) and the Swiss National Science Foundation (grant 3100AO-100309 and grant 3100A0-116719). JF holds a 2009 NARSAD Distinguished Investigator Award. GMA was funded by a University of Hong Kong Award and holds a General Research Fund from the Hong Kong Research Grants Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; BEHAN A, 2008, MOL PSYCHIAT; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Berry-Kravis E, 2004, MENT RETARD DEV D R, V10, P42, DOI 10.1002/mrdd.20007; Bronchud MH, 2008, PRINCIPLES MOL ONCOL; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Cheung V, 2008, PSYCHOL MED, V38, P877, DOI 10.1017/S0033291707001808; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Clark D, 2006, MOL PSYCHIATR, V11, P459, DOI 10.1038/sj.mp.4001806; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; Fountoulakis M, 2005, J CHROMATOGR B, V819, P115, DOI 10.1016/j.jchromb.2005.01.037; Fumagalli F, 2006, MOL PHARMACOL, V69, P1366, DOI 10.1124/mol.105.019828; Hans A, 2004, FASEB J, V18, P863, DOI 10.1096/fj.03-0764fje; Hazlett EA, 2008, NEUROIMAGE, V42, P1164, DOI 10.1016/j.neuroimage.2008.05.039; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Iwazaki T, 2007, PROTEOMICS, V7, P1131, DOI 10.1002/pmic.200600595; Iwazaki T, 2006, BRAIN RES, V1097, P19, DOI 10.1016/j.brainres.2006.04.052; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; Kim JJ, 2001, SCHIZOPHR RES, V52, P127, DOI 10.1016/S0920-9964(00)00091-8; Kumari V, 2003, PSYCHIAT RES-NEUROIM, V122, P99, DOI 10.1016/s0925-4927(02)00123-3; Kyosseva SV, 1999, BIOL PSYCHIAT, V46, P689, DOI 10.1016/S0006-3223(99)00104-3; LEUNG M, 2009, SCHIZOPHR B; Li Q, 2010, NEUROIMAGE, V52, P1, DOI 10.1016/j.neuroimage.2010.04.015; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Martins-De-Souza D, 2009, EUR ARCH PSY CLIN N, V259, P151, DOI 10.1007/s00406-008-0847-2; Marx CE, 2001, BIOL PSYCHIAT, V50, P743, DOI 10.1016/S0006-3223(01)01209-4; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; MEYER U, 2009, NEUROSCI BIOBEHAV RE; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Meyer U, 2010, PROG NEUROBIOL, V90, P285, DOI 10.1016/j.pneurobio.2009.10.018; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Min WW, 2009, NEUROPHARMACOLOGY, V56, P463, DOI 10.1016/j.neuropharm.2008.09.017; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Muller N, 2006, NEUROTOX RES, V10, P131; Nesvaderani M, 2009, AUST NZ J PSYCHIAT, V43, P310, DOI 10.1080/00048670902721103; NEVESPEREIRA M, 2009, J MED GENET; Novikova SI, 2006, NEUROBIOL DIS, V23, P61, DOI 10.1016/j.nbd.2006.02.002; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Paulson L, 2004, PROTEOMICS, V4, P819, DOI 10.1002/pmic.200300622; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prabakaran S, 2007, J PROTEOME RES, V6, P141, DOI 10.1021/pr060308a; Roncada P, 2009, J NEUROCHEM, V108, P611, DOI 10.1111/j.1471-4159.2008.05806.x; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; SHAM PC, 1992, BRIT J PSYCHIAT, V160, P461, DOI 10.1192/bjp.160.4.461; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith Stephen E. P., 2009, P111, DOI 10.1007/978-0-387-84851-8_7; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Suginta W, 2001, BIOCHEM J, V359, P55, DOI 10.1042/0264-6021:3590055; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; Tannu NS, 2006, NAT PROTOC, V1, P1732, DOI 10.1038/nprot.2006.256; Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004; To MD, 2005, CELL CYCLE, V4, P1185, DOI 10.4161/cc.4.9.2039; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Vercauteren FGG, 2007, PROTEOMICS, V7, P3569, DOI 10.1002/pmic.200700379; Wang XF, 2003, BIOL PSYCHIAT, V53, P361, DOI 10.1016/S0006-3223(02)01972-8; Wang Y, 2007, MOL ENDOCRINOL, V21, P972, DOI 10.1210/me.2006-0249; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Winter C, 2009, INT J NEUROPSYCHOPH, V12, P513, DOI 10.1017/S1461145708009206; Yuskaitis CJ, 2010, BIOCHEM PHARMACOL, V79, P632, DOI 10.1016/j.bcp.2009.09.023; Zhao BY, 1998, J NEUROSCI RES, V52, P7, DOI 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I	74	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16638	10.1371/journal.pone.0016638	http://dx.doi.org/10.1371/journal.pone.0016638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347362	Green Submitted, Green Published, gold			2022-12-25	WOS:000287363000011
J	Drini, M; Wong, NC; Scott, HS; Craig, JM; Dobrovic, A; Hewitt, CA; Dow, C; Young, JP; Jenkins, MA; Saffery, R; Macrae, FA				Drini, Musa; Wong, Nicholas C.; Scott, Hamish S.; Craig, Jeffrey M.; Dobrovic, Alexander; Hewitt, Chelsee A.; Dow, Christofer; Young, Joanne P.; Jenkins, Mark A.; Saffery, Richard; Macrae, Finlay A.			Investigating the Potential Role of Genetic and Epigenetic Variation of DNA Methyltransferase Genes in Hyperplastic Polyposis Syndrome	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; GENOME-WIDE ASSOCIATION; DE-NOVO METHYLATION; COLORECTAL-CANCER; SERRATED POLYPS; INITIAL-CHARACTERIZATION; KRAS MUTATIONS; BRAF MUTATION; BREAST-CANCER; DNMT3B	Background: Hyperplastic Polyposis Syndrome (HPS) is a condition associated with multiple serrated polyps, and an increased risk of colorectal cancer (CRC). At least half of CRCs arising in HPS show a CpG island methylator phenotype (CIMP), potentially linked to aberrant DNA methyltransferase (DNMT) activity. CIMP is associated with methylation of tumor suppressor genes including regulators of DNA mismatch repair (such as MLH1, MGMT), and negative regulators of Wnt signaling (such as WIF1). In this study, we investigated the potential for interaction of genetic and epigenetic variation in DNMT genes, in the aetiology of HPS. Methods: We utilized high resolution melting (HRM) analysis to screen 45 cases with HPS for novel sequence variants in DNMT1, DNMT3A, DNMT3B, and DNMT3L. 21 polyps from 13 patients were screened for BRAF and KRAS mutations, with assessment of promoter methylation in the DNMT1, DNMT3A, DNMT3B, DNMT3L MLH1, MGMT, and WIF1 gene promoters. Results: No pathologic germline mutations were observed in any DNA-methyltransferase gene. However, the T allele of rs62106244 (intron 10 of DNMT1 gene) was over-represented in cases with HPS (p<0.01) compared with population controls. The DNMT1, DNMT3A and DNMT3B promoters were unmethylated in all instances. Interestingly, the DNMT3L promoter showed low levels of methylation in polyps and normal colonic mucosa relative to matched disease free cells with methylation level negatively correlated to expression level in normal colonic tissue. DNMT3L promoter hypomethylation was more often found in polyps harbouring KRAS mutations (p = 0.0053). BRAF mutations were common (11 out of 21 polyps), whilst KRAS mutations were identified in 4 of 21 polyps. Conclusions: Genetic or epigenetic alterations in DNMT genes do not appear to be associated with HPS, but further investigation of genetic variation at rs62106244 is justified given the high frequency of the minor allele in this case series.	[Drini, Musa; Macrae, Finlay A.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Drini, Musa] Canberra Hosp, Dept Gastroenterol & Hepatol, Garran, ACT, Australia; [Wong, Nicholas C.; Craig, Jeffrey M.; Saffery, Richard] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Scott, Hamish S.] Inst Med & Vet Sci, Adelaide, SA 5000, Australia; [Dobrovic, Alexander; Hewitt, Chelsee A.] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Dobrovic, Alexander] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Young, Joanne P.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Jenkins, Mark A.] Univ Melbourne, Sch Populat Hlth, MEGA Epidemiol, Carlton, Vic 3053, Australia	Royal Melbourne Hospital; University of Melbourne; Australian National University; Canberra Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Institute Medical & Veterinary Science Australia; Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Melbourne	Drini, M (corresponding author), Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia.	musa.drini@act.gov.au	Young, Joanne P/B-9981-2011; Scott, Hamish/B-2122-2009; Wong, Nick Wong/AAF-8627-2021; Craig, Jeffrey M/B-3484-2012; Jenkins, Mark/P-7803-2015; Young, Joanne P/H-7774-2014; Saffery, Richard/GLS-1976-2022	Scott, Hamish/0000-0002-5813-631X; Wong, Nick Wong/0000-0003-4393-7541; Craig, Jeffrey M/0000-0003-3979-7849; Jenkins, Mark/0000-0002-8964-6160; Saffery, Richard/0000-0002-9510-4181; Young, Joanne/0000-0002-1514-1522; Dobrovic, Alexander/0000-0003-3414-112X; Hewitt, Chelsee/0000-0001-7472-6128	Hicks Foundation	Hicks Foundation	Hicks Foundation supported MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Aapola U, 2001, CYTOGENET CELL GENET, V92, P122, DOI 10.1159/000056881; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; BENHATTAR J, 1993, GASTROENTEROLOGY, V104, P1044, DOI 10.1016/0016-5085(93)90272-E; Bestor TH, 1998, AM J HUM GENET, V62, P1269, DOI 10.1086/301891; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Burt R, 2000, WHO INT CLASSIFICATI, P135; Carvajal-Carmona LG, 2007, J PATHOL, V212, P378, DOI 10.1002/path.2187; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Chan AOO, 2002, AM J PATHOL, V160, P529, DOI 10.1016/S0002-9440(10)64872-9; Chan TL, 2003, CANCER RES, V63, P4878; Chow E, 2006, GASTROENTEROLOGY, V131, P30, DOI 10.1053/j.gastro.2006.03.046; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Ehrich M., 2006, INTRO EPITYPER QUANT; ELMAARRI O, 2009, HUM MOL GENET, V26, P26; Flynn J, 1996, BIOCHEMISTRY-US, V35, P7308, DOI 10.1021/bi9600512; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gokul G, 2007, EPIGENETICS-US, V2, P80, DOI 10.4161/epi.2.2.3692; Gokul G, 2009, EPIGENETICS-US, V4, P322, DOI 10.4161/epi.4.5.9239; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P146, DOI 10.1309/87BD0C6UCGUG126J; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; IBRAHIM AE, 2010, GUT; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JPJ, 2005, GASTROENTEROLOGY, V129, P1121, DOI 10.1053/j.gastro.2005.07.040; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kanai Y, 1996, JPN J CANCER RES, V87, P1210, DOI 10.1111/j.1349-7006.1996.tb03135.x; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Minoo P, 2007, J PATHOL, V212, P124, DOI 10.1002/path.2160; Montgomery KG, 2004, BREAST CANCER RES, V6, pR390, DOI 10.1186/bcr807; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; O'Brien MJ, 2004, AM J SURG PATHOL, V28, P423, DOI 10.1097/00000478-200404000-00001; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Park BL, 2004, J HUM GENET, V49, P642, DOI 10.1007/s10038-004-0192-x; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; STEGER G, 1994, NUCLEIC ACIDS RES, V22, P2760, DOI 10.1093/nar/22.14.2760; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; van Rijnsoever M, 2002, GUT, V51, P797, DOI 10.1136/gut.51.6.797; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wong NC, 2008, BIOTECHNIQUES, V45, P423, DOI 10.2144/000112945; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Yang S, 2004, AM J SURG PATHOL, V28, P1452, DOI 10.1097/01.pas.0000141404.56839.6a	66	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16831	10.1371/journal.pone.0016831	http://dx.doi.org/10.1371/journal.pone.0016831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347319	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000287363000019
J	Dunstan, AJ; Ward, PD; Marshall, NJ				Dunstan, Andrew J.; Ward, Peter D.; Marshall, N. Justin			Nautilus pompilius Life History and Demographics at the Osprey Reef Seamount, Coral Sea, Australia	PLOS ONE			English	Article							CHAMBER FORMATION; GROWTH; FIJI; MACROMPHALUS; CEPHALOPODA; PHILIPPINES; BELAUENSIS; LONGEVITY; BIOLOGY; HABITAT	Nautiloids are the subject of speculation as to their threatened status arising from the impacts of targeted fishing for the ornamental shell market. Life history knowledge is essential to understand the susceptibility of this group to overfishing and to the instigation of management frameworks. This study provides a comprehensive insight into the life of Nautilus in the wild. At Osprey Reef from 1998-2008, trapping for Nautilus was conducted on 354 occasions, with 2460 individuals of one species, Nautilus pompilius, captured and 247 individuals recaptured. Baited remote underwater video systems (BRUVS) were deployed on 15 occasions and six remotely operated vehicle (ROV) dives from 100-800 m were conducted to record Nautilus presence and behavior. Maturity, sex and size data were recorded, while measurements of recaptured individuals allowed estimation of growth rates to maturity, and longevity beyond maturity. We found sexual dimorphism in size at maturity (males: 131.9 +/- SD = 2.6 mm; females: 118.9 +/- 7.5 mm shell diameter) in a population dominated by mature individuals (58%). Mean growth rates of 15 immature recaptured animals were 0.061 +/- 0.023 mm day(-1) resulting in an estimate of around 15.5 years to maturation. Recaptures of mature animals after five years provide evidence of a lifespan exceeding 20 years. Juvenile Nautilus pompilius feeding behavior was recorded for the first time within the same depth range (200-610 m) as adults. Our results provide strong evidence of a K-selected life history for Nautilus from a detailed study of a 'closed' wild population. In conjunction with population size and density estimates established for the Osprey Reef Nautilus, this work allows calculations for sustainable catch and provides mechanisms to extrapolate these findings to other extant nautiloid populations (Nautilus and Allonautilus spp.) throughout the Indo-Pacific.	[Dunstan, Andrew J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Ward, Peter D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Washington; University of Washington Seattle; University of Queensland	Dunstan, AJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	andy.dunstan@gmail.com		Marshall, Justin/0000-0001-9006-6713	Undersea Explorer; University of Queensland; Australian Research Council [ID LP0775179]	Undersea Explorer; University of Queensland(University of Queensland); Australian Research Council(Australian Research Council)	This work was funded by Undersea Explorer, University of Queensland and Australian Research Council Linkage Projects: Project ID LP0775179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J. M., 2010, NAUTILUS BIOL PALEOB, P373; Arnold JM, 1990, J CEPHALOPOD BIOL, V2, P1; COCHRAN JK, 1984, NATURE, V308, P725, DOI 10.1038/308725a0; Commission ISS, 2001, IUCN RED LIST CAT CR; DAVIS RA, 1973, J PALEONTOL, V47, P925; DENTON EJ, 1966, J MAR BIOL ASSOC UK, V46, P723, DOI 10.1017/S0025315400033440; DUNSTAN A, 2010, FISHERIES R IN PRESS; DUNSTAN A, 2010, PLOS ONE IN PRESS; EICHLER R, 1966, SCIENCE, V153, P734, DOI 10.1126/science.153.3737.734; Hamada T., 1987, NAUTILUS BIOL PALEOB, P579; HAVEN N, 1977, MAR BIOL, V42, P177, DOI 10.1007/BF00391570; Hayasaka S, 1983, 1 KAG U RES CTR S PA; KANIE Y, 1979, Venus the Japanese Journal of Malacology, V38, P129; Landman N.H., 2010, NAUTILUS BIOL PALEOB, P401, DOI DOI 10.1007/978-90-481-3299-7_28; LANDMAN NH, 1988, EARTH PLANET SC LETT, V89, P28, DOI 10.1016/0012-821X(88)90030-1; LANDMAN NH, 1989, MAR BIOL, V102, P65, DOI 10.1007/BF00391324; Landman NH, 2001, VELIGER, V44, P333; LANDMAN NH, 1994, PALEOBIOLOGY, V20, P40, DOI 10.1017/S009483730001112X; Martin A.W., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V156, P207; OBA T, 1992, MAR BIOL, V113, P211; OKUBO S, 1995, VELIGER, V38, P192; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; SAUNDERS WB, 1989, NAUTILUS, V103, P99; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1987, NAUTILUS, V101, P188; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; TANABE K, 1990, MALACOLOGIA, V31, P297; Tanabe K., 1985, KAGOSHIMA U RES CTR, V4, P38; Ward P.D., 1987, NATURAL HIST NAUTILU, P267; WARD PD, 1983, NATURE, V304, P57, DOI 10.1038/304057a0; WARD PD, 1980, VELIGER, V22, P259; WARD PD, 1985, PALEOBIOLOGY, V11, P438, DOI 10.1017/S0094837300011726; Westermann B, 2004, J EXP ZOOL PART A, V301A, P930, DOI 10.1002/jez.a.116; WOODRUFF DS, 2010, NAUTILUS PALEOBIOLOG; WRAY CG, 1995, PALEOBIOLOGY, V21, P220, DOI 10.1017/S009483730001321X	36	21	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16312	10.1371/journal.pone.0016312	http://dx.doi.org/10.1371/journal.pone.0016312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347356	Green Published, gold, Green Submitted			2022-12-25	WOS:000287363000007
J	Akunuru, S; Palumbo, J; Zhai, QJ; Zheng, Y				Akunuru, Shailaja; Palumbo, Joseph; Zhai, Qihui James; Zheng, Yi			Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SIDE POPULATION; PROSPECTIVE IDENTIFICATION; MICROENVIRONMENT; RESISTANCE; KINASE; GROWTH; TUMORS	The cancer stem cell (CSC) theory predicts that a small fraction of cancer cells possess unique self-renewal activity and mediate tumor initiation and propagation. However, the molecular mechanisms involved in CSC regulation remains unclear, impinging on effective targeting of CSCs in cancer therapy. Here we have investigated the hypothesis that Rac1, a Rho GTPase implicated in cancer cell proliferation and invasion, is critical for tumor initiation and metastasis of human non-small cell lung adenocarcinoma (NSCLA). Rac1 knockdown by shRNA suppressed the tumorigenic activities of human NSCLA cell lines and primary patient NSCLA specimens, including effects on invasion, proliferation, anchorage-independent growth, sphere formation and lung colonization. Isolated side population (SP) cells representing putative CSCs from human NSCLA cells contained elevated levels of Rac1-GTP, enhanced in vitro migration, invasion, increased in vivo tumor initiating and lung colonizing activities in xenografted mice. However, CSC activity was also detected within the non-SP population, suggesting the importance of therapeutic targeting of all cells within a tumor. Further, pharmacological or shRNA targeting of Rac1 inhibited the tumorigenic activities of both SP and non-SP NSCLA cells. These studies indicate that Rac1 represents a useful target in NSCLA, and its blockade may have therapeutic value in suppressing CSC proliferation and metastasis.	[Akunuru, Shailaja; Zheng, Yi] Univ Cincinnati, Div Expt Hematol & Canc Biol, Cincinnati, OH 45221 USA; [Akunuru, Shailaja; Zheng, Yi] Univ Cincinnati, Mol Dev Biol Program, Cincinnati, OH USA; [Palumbo, Joseph] Univ Cincinnati, Childrens Hosp Res Fdn, Div Hematol & Oncol, Cincinnati, OH USA; [Zhai, Qihui James] Univ Cincinnati, Dept Pathol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Univ Cincinnati, Div Expt Hematol & Canc Biol, Cincinnati, OH 45221 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIH [R01 CA141341, T32 HL091805]; NATIONAL CANCER INSTITUTE [R01CA141341, T32CA117846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091805] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH R01 CA141341 and T32 HL091805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dirks P, 2010, NATURE, V466, P40, DOI 10.1038/466040a; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A., 2010, ONCOGENE; FUCHS O, 2010, CURR MOL PHARM; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Melendez J, 2004, J BIOL CHEM, V279, P53516, DOI 10.1074/jbc.M408475200; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stengel KR, 2008, CELL CYCLE, V7, DOI 10.4161/cc.7.8.5737; Todaro M, 2008, CELL CYCLE, V7, P309, DOI 10.4161/cc.7.3.5389; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	37	47	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16951	10.1371/journal.pone.0016951	http://dx.doi.org/10.1371/journal.pone.0016951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347385	Green Published, Green Submitted, gold			2022-12-25	WOS:000287361700057
J	Pakhomova, ON; Gregory, BW; Khorokhorina, VA; Bowman, AM; Xiao, S; Pakhomov, AG				Pakhomova, Olga N.; Gregory, Betsy W.; Khorokhorina, Vera A.; Bowman, Angela M.; Xiao, Shu; Pakhomov, Andrei G.			Electroporation-Induced Electrosensitization	PLOS ONE			English	Article							ELECTRIC-FIELD THERAPY; PLASMA-MEMBRANE; IRREVERSIBLE ELECTROPORATION; REPETITION FREQUENCY; HIGH-INTENSITY; GENE-TRANSFER; ELECTROCHEMOTHERAPY; CELLS; PULSES; TUMORS	Background: Electroporation is a method of disrupting the integrity of cell membrane by electric pulses (EPs). Electrical modeling is widely employed to explain and study electroporation, but even most advanced models show limited predictive power. No studies have accounted for the biological consequences of electroporation as a factor that alters the cell's susceptibility to forthcoming EPs. Methodology/Principal Findings: We focused first on the role of EP rate for membrane permeabilization and lethal effects in mammalian cells. The rate was varied from 0.001 to 2,000 Hz while keeping other parameters constant (2 to 3,750 pulses of 60-ns to 9-mu s duration, 1.8 to 13.3 kV/cm). The efficiency of all EP treatments was minimal at high rates and started to increase gradually when the rate decreased below a certain value. Although this value ranged widely (0.1-500 Hz), it always corresponded to the overall treatment duration near 10 s. We further found that longer exposures were more efficient irrespective of the EP rate, and that splitting a high-rate EP train in two fractions with 1-5 min delay enhanced the effects severalfold. Conclusions/Significance: For varied experimental conditions, EPs triggered a delayed and gradual sensitization to EPs. When a portion of a multi-pulse exposure was delivered to already sensitized cells, the overall effect markedly increased. Because of the sensitization, the lethality in EP-treated cells could be increased from 0 to 90% simply by increasing the exposure duration, or the exposure dose could be reduced twofold without reducing the effect. Many applications of electroporation can benefit from accounting for sensitization, by organizing the exposure either to maximize sensitization (e.g., for sterilization) or, for other applications, to completely or partially avoid it. In particular, harmful side effects of electroporation-based therapies (electrochemotherapy, gene therapies, tumor ablation) include convulsions, pain, heart fibrillation, and thermal damage. Sensitization can potentially be employed to reduce these side effects while preserving or increasing therapeutic efficiency.	[Pakhomova, Olga N.; Gregory, Betsy W.; Khorokhorina, Vera A.; Bowman, Angela M.; Xiao, Shu; Pakhomov, Andrei G.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA; [Xiao, Shu] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA	Old Dominion University; Old Dominion University	Pakhomova, ON (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.	andrei@pakhomov.net		Pakhomov, Andrei/0000-0003-3816-3860	National Cancer Institute [R01CA125482]; National Institute of General Medical Sciences [R01GM088303]; NATIONAL CANCER INSTITUTE [R01CA125482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088303] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by R01CA125482 from the National Cancer Institute and R01GM088303 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Andre FM, 2008, HUM GENE THER, V19, P1261, DOI 10.1089/hgt.2008.060; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; Bilska AO, 2000, BIOELECTROCHEMISTRY, V51, P133, DOI 10.1016/S0302-4598(00)00066-0; Bonnafous P, 1999, BBA-BIOMEMBRANES, V1461, P123, DOI 10.1016/S0005-2736(99)00154-6; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; El-Hag AH, 2006, IEEE T PLASMA SCI, V34, P1412, DOI 10.1109/TPS.2006.878382; Escoffre JM, 2009, MOL BIOTECHNOL, V41, P286, DOI 10.1007/s12033-008-9121-0; Esser AT, 2010, BIOPHYS J, V98, P2506, DOI 10.1016/j.bpj.2010.02.035; Faurie C, 2010, J GENE MED, V12, P117, DOI 10.1002/jgm.1414; Heller LC, 2010, CURR GENE THER, V10, P312; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jayaram SH, 2004, IEEE T IND APPL, V40, P1489, DOI 10.1109/TIA.2004.836134; JIANG N, 2010, BIOELECTROMAGNETICS; Kennedy SM, 2008, BIOPHYS J, V94, P5018, DOI 10.1529/biophysj.106.103218; KINOSITA K, 1977, NATURE, V268, P438, DOI 10.1038/268438a0; Lebar Alenka Macek, 2002, IEEE Trans Nanobioscience, V1, P116, DOI 10.1109/TNB.2003.809464; Lebovka N., 2010, ADV ELECTROPORATION, P463; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Miklavcic D, 2005, BIOELECTROCHEMISTRY, V65, P121, DOI 10.1016/j.bioelechem.2004.07.004; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Mir LM, 2009, MOL BIOTECHNOL, V43, P167, DOI 10.1007/s12033-009-9192-6; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; Neumann E., 1989, ELECTROPORATION ELEC; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov A.G., 2010, ADV ELECTROPORATION, P178; Pakhomov AG, 2004, IEEE T PLASMA SCI, V32, P1579, DOI 10.1109/TPS.2004.831773; Pakhomov AG, 2010, ADV ELECTROPORATION; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pucihar G, 2002, BIOELECTROCHEMISTRY, V57, P167, DOI 10.1016/S1567-5394(02)00116-0; Raeisi E, 2010, J MEMBRANE BIOL, V236, P163, DOI 10.1007/s00232-010-9288-8; Rubinsky B, 2010, SER BIOMED ENG, P1, DOI 10.1007/978-3-642-05420-4; Rubinsky J, 2008, J UROLOGY, V180, P2668, DOI 10.1016/j.juro.2008.08.003; Sack M, 2010, IEEE T PLASMA SCI, V38, P1928, DOI 10.1109/TPS.2010.2050073; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Schoenbach KH, 2009, IEEE T DIELECT EL IN, V16, P1224, DOI 10.1109/TDEI.2009.5293932; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2010, J MEMBRANE BIOL, V236, P155, DOI 10.1007/s00232-010-9268-z; Teissie J, 2002, BIOELECTROCHEMISTRY, V55, P107, DOI 10.1016/S1567-5394(01)00138-4; Terpitz U, 2008, BBA-BIOMEMBRANES, V1778, P1493, DOI 10.1016/j.bbamem.2008.03.015; Tiwari JK, 2010, PLANT CELL TISS ORG, V103, P175, DOI 10.1007/s11240-010-9765-x; TSONG TY, 1991, BIOPHYS J, V60, P297, DOI 10.1016/S0006-3495(91)82054-9; Vernhes MC, 1999, BIOELECTROCH BIOENER, V48, P17, DOI 10.1016/S0302-4598(98)00239-6; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007966; Walker K, 2006, BIOELECTROMAGNETICS, V27, P221, DOI 10.1002/bem.20200; Yang XJ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-53; Zupanic A, 2007, NEOPLASMA, V54, P246	53	72	73	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e17100	10.1371/journal.pone.0017100	http://dx.doi.org/10.1371/journal.pone.0017100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347394	Green Submitted, gold, Green Published			2022-12-25	WOS:000287361700066
J	McDonald, JU; Cortini, A; Rosas, M; Fossati-Jimack, L; Ling, GS; Lewis, KJ; Dewitt, S; Liddiard, K; Brown, GD; Jones, SA; Hallett, MB; Botto, M; Taylor, PR				McDonald, Jacqueline U.; Cortini, Andrea; Rosas, Marcela; Fossati-Jimack, Liliane; Ling, Guang Sheng; Lewis, Kimberley J.; Dewitt, Sharon; Liddiard, Kate; Brown, Gordon D.; Jones, Simon A.; Hallett, Maurice B.; Botto, Marina; Taylor, Philip R.			In vivo functional analysis and genetic modification of in vitro-derived mouse neutrophils	FASEB JOURNAL			English	Article						inflammation; animal models; conditional immortalization	BETA-GLUCAN RECEPTOR; EX-VIVO; DECTIN-1; INFLAMMATION; MACROPHAGES; PHAGOCYTOSIS; RECOGNITION; EXPRESSION; CELLS	Mature neutrophils are notoriously short-lived immune cells that cannot be genetically manipulated. Analysis of gene function therefore requires genetically modified animals, which is expensive, time-consuming, and costly in animal life. Analysis of gene function in neutrophils in a physiologically relevant context thus represents a significant problem in the field. We sought to overcome this obstruction in the field by developing a strategy for the analysis of gene function in neutrophils in a physiologically relevant context. Here, we demonstrate the functional relevance of in vitro conditional-Hoxb8 immortalized precursor-derived neutrophils. In vitro-derived neutrophils functionally resembled primary neutrophils, but critically, neutrophils generated in this way can be adoptively transferred into live animals and tracked during inflammatory responses using single-cell analysis to define functional attributes. We have validated this approach using CD11b-deficient neutrophils and replicated the key findings observed in gene-targeted animals and in naturally CD11b-deficient humans. Furthermore, we show that by retroviral transduction, one can generate stable alterations in the precursor cell lines and thus a continuous supply of functionally altered neutrophils. This novel technological advance offers for the first time the possibility of applying higher-throughput genetic modification and in vivo functional analysis to the neutrophil-lineage.-McDonald, J. U., Cortini, A., Rosas, M., Fossati-Jimack, L., Ling, G. S., Lewis, K. J., Dewitt, S., Liddiard, K., Brown, G. D., Jones, S. A., Hallett, M. B., Botto, M., Taylor, P. R. In vivo functional analysis and genetic modification of in vitro-derived mouse neutrophils. FASEB J. 25, 1972-1982 (2011). www.fasebj.org	[McDonald, Jacqueline U.; Rosas, Marcela; Liddiard, Kate; Jones, Simon A.; Taylor, Philip R.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Lewis, Kimberley J.; Dewitt, Sharon; Hallett, Maurice B.] Cardiff Univ, Sch Med, Dept Surg, Cardiff CF14 4XN, S Glam, Wales; [Cortini, Andrea; Fossati-Jimack, Liliane; Ling, Guang Sheng; Botto, Marina] Univ London Imperial Coll Sci Technol & Med, Ctr Complement & Inflammat Res, Div Immunol & Inflammat, London, England; [Brown, Gordon D.] Univ Aberdeen, Sect Infect & Immun, Inst Med Sci, Aberdeen, Scotland	Cardiff University; Cardiff University; Imperial College London; University of Aberdeen	Taylor, PR (corresponding author), Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Tenovus Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	taylorpr@cf.ac.uk	brown, gordon/B-4249-2012; Hallett, Maurice/I-6866-2012; Rosas Nexticapa, Marcela/HGU-1088-2022; Jones, Simon Arnett/Q-7017-2018	Hallett, Maurice/0000-0001-8197-834X; Taylor, Philip/0000-0003-0163-1421; Dewitt, Sharon/0000-0001-8169-8241; brown, gordon/0000-0002-0287-5383; Jones, Simon Arnett/0000-0001-7297-9711	MRC; Wellcome Trust; Medical Research Council [G0601617] Funding Source: researchfish; MRC [G0601617] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	P.R.T. is a Medical Research Council (MRC; UK) Senior Non-Clinical Fellow (G0601617). J.U.M. and K.J.L. are the recipients of MRC-funded Ph.D. studentships. S.D. was funded by the Wellcome Trust. All work with animals was conducted in accordance with institutional and UK Home Office guidelines. The authors thank the staff of their institutional animal facilities for the care of the animals used in these studies. The authors also thank Prof. Ian Sabroe for his critical review of the manuscript.	Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Dewitt S, 2003, J CELL SCI, V116, P2857, DOI 10.1242/jcs.00499; Dewitt S, 2002, J CELL BIOL, V159, P181, DOI 10.1083/jcb.200206089; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Heinsbroek SEM, 2006, J IMMUNOL, V176, P5513, DOI 10.4049/jimmunol.176.9.5513; Kitamura T, 1998, INT J HEMATOL, V67, P351; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nuzzi PA, 2007, MOL BIOL CELL, V18, P795, DOI 10.1091/mbc.E06-09-0876; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865	20	28	28	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2011	25	6					1972	1982		10.1096/fj.10-178517	http://dx.doi.org/10.1096/fj.10-178517			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21368104				2022-12-25	WOS:000291023800020
J	Montanuy, I; Alejo, A; Alcami, A				Montanuy, Imma; Alejo, Ali; Alcami, Antonio			Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses	FASEB JOURNAL			English	Article						immune evasion; cytokine; smallpox; innate immunity	VACCINIA VIRUS; HEPARAN-SULFATE; ALPHA/BETA INTERFERON; ECTROMELIA-VIRUS; HUMAN MONKEYPOX; A27L PROTEIN; MICE LACKING; PROTEOGLYCANS; RECEPTOR; INHIBITION	Eradication of smallpox was accomplished 30 yr ago, but poxviral infections still represent a public health concern due to the potential release of variola virus or the emergence of zoonotic poxviruses, such as monkeypox virus. A critical determinant of poxvirus virulence is the inhibition of interferons (IFNs) by the virus-encoded type I IFN-binding protein (IFN alpha/beta BP). This immunomodulatory protein is secreted and has the unique property of interacting with the cell surface in order to prevent IFN-mediated antiviral responses. However, the mechanism of its attachment to the cell surface remains unknown. Using surface plasmon resonance and cell-binding assays, we report that the IFN alpha/beta BP from vaccinia virus, the smallpox vaccine, interacts with cell surface glycosaminoglycans (GAGs). Analysis of the contribution of different regions of the protein to cell surface binding demonstrated that clusters of basic residues in the first immunoglobulin domain mediate GAG interactions. Furthermore, mutation of the GAG-interaction motifs does not affect its IFN-binding and -blocking capacity. Functional conservation of GAG-binding sites is demonstrated for the IFN alpha/beta BP from variola and monkeypox viruses, extending our understanding of immune modulation by the most virulent human poxviruses. These results are relevant for the design of improved vaccines and intervention strategies.-Montanuy, I., Alejo, A., Alcami, A. Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses. FASEB J. 25, 1960-1971 (2011). www.fasebj.org	[Montanuy, Imma; Alcami, Antonio] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Montanuy, Imma; Alcami, Antonio] Univ Autonoma Madrid, Madrid, Spain; [Alejo, Ali] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain; [Alcami, Antonio] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Alcami, A (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, 1 Campus Cantoblanco, Madrid 28049, Spain.	aalcami@cbm.uam.es	Alcami, Antonio/F-8512-2015; Alejo, Ali/AAF-1477-2020	Alcami, Antonio/0000-0002-3333-6016; Alejo, Ali/0000-0002-1613-6063; Montanuy Sellart, Inmaculada/0000-0001-9743-112X	U.S. National Institute of Allergy and Infectious Diseases [U54AI057160-07]; Wellcome Trust; Comunidad de Madrid; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank members of the laboratory for helpful suggestions and R. Martin for technical assistance. This work was supported by U.S. National Institute of Allergy and Infectious Diseases grant U54AI057160-07 to the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases and grants from the Wellcome Trust and Comunidad de Madrid.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Copeland R, 2008, BIOCHEMISTRY-US, V47, P5774, DOI 10.1021/bi800205t; de Marco MDF, 2010, FASEB J, V24, P1479, DOI 10.1096/fj.09-144733; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Golden JW, 2010, CLIN VACCINE IMMUNOL, V17, P1656, DOI 10.1128/CVI.00235-10; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Huang JY, 2007, P NATL ACAD SCI USA, V104, P9822, DOI 10.1073/pnas.0610352104; KARUPIAH G, 1993, J VIROL, V67, P4214, DOI 10.1128/JVI.67.7.4214-4226.1993; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Liszewski MK, 2008, J IMMUNOL, V181, P4199, DOI 10.4049/jimmunol.181.6.4199; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; MORIKAWA S, 1993, VIROLOGY, V193, P753, DOI 10.1006/viro.1993.1184; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; RODRIGUEZ JR, 1991, VIROLOGY, V185, P929, DOI 10.1016/0042-6822(91)90575-V; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Sambrook J, 2001, MOL CLONING LAB MANU; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Shih PC, 2009, J BIOL CHEM, V284, P36535, DOI 10.1074/jbc.M109.037267; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511; Smith GL, 2002, NAT REV IMMUNOL, V2, P521, DOI 10.1038/nri845; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Urbinati C, 2004, FEBS LETT, V568, P171, DOI 10.1016/j.febslet.2004.05.033; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Xiang Y, 2003, J VIROL, V77, P2623, DOI 10.1128/JVI.77.4.2623-2630.2003; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	53	33	34	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1960	1971		10.1096/fj.10-177188	http://dx.doi.org/10.1096/fj.10-177188			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21372110	Green Published			2022-12-25	WOS:000291023800019
J	Gerken, TA; Jamison, O; Perrine, CL; Collette, JC; Moinova, H; Ravi, L; Markowitz, SD; Shen, W; Patel, H; Tabak, LA				Gerken, Thomas A.; Jamison, Oliver; Perrine, Cynthia L.; Collette, Jeremy C.; Moinova, Helen; Ravi, Lakshmeswari; Markowitz, Sanford D.; Shen, Wei; Patel, Himatkumar; Tabak, Lawrence A.			Emerging Paradigms for the Initiation of Mucin-type Protein O-Glycosylation by the Polypeptide GalNAc Transferase Family of Glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE ACCEPTOR PREFERENCES; ALPHA-D-GALACTOSAMINE; N-TERMINAL RESIDUES; UDP-GALNAC; LECTIN DOMAINS; SWISS-MODEL; P-SELECTIN; ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; DROSOPHILA DEVELOPMENT; LINKED GLYCOSYLATION	Mammalian mucin-type O-glycosylation is initiated by a large family of similar to 20 UDP-GalNAc: polypeptide alpha-N-acetyl-galactosaminyltransferases (ppGalNAc Ts) that transfer alpha-GalNAc from UDP-GalNAc to Ser and Thr residues of polypeptide acceptors. Characterizing the peptide substrate specificity of each isoform is critical to understanding their properties, biological roles, and significance. Presently, only the specificities of ppGalNAc T1, T2, and T10 and the fly orthologues of T1 and T2 have been systematically characterized utilizing random peptide substrates. We now extend these studies to ppGalNAc T3, T5, and T12, transferases variously associated with human disease. Our results reveal several common features; the most striking is the similar pattern of enhancements for the three residues C-terminal to the site of glycosylation for those transferases that contain a common conserved Trp. In contrast, residues N-terminal to the site of glycosylation show a wide range of isoform-specific enhancements, with elevated preferences for Pro, Val, and Tyr being the most common at the -1 position. Further analysis reveals that the ratio of positive (Arg, Lys, and His) to negative (Asp and Glu) charged residue enhancements varied among transferases, thus further modulating substrate preference in an isoform-specific manner. By utilizing the obtained transferase-specific preferences, the glycosylation patterns of the ppGalNAc Ts against a series of peptide substrates could roughly be reproduced, demonstrating the potential for predicting isoform-specific glycosylation. We conclude that each ppGalNAc T isoform may be uniquely sensitive to pep-tide sequence and overall charge, which together dictates the substrate sites that will be glycosylated.	[Gerken, Thomas A.; Jamison, Oliver; Collette, Jeremy C.] Case Western Reserve Univ, WA Bernbaum Ctr Cyst Fibrosis Res, Dept Pediat, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Dept Biochem, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Gerken, Thomas A.; Perrine, Cynthia L.] Case Western Reserve Univ, Dept Chem, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Moinova, Helen; Ravi, Lakshmeswari; Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Shen, Wei; Patel, Himatkumar; Tabak, Lawrence A.] NIDDK, Sect Biol Chem, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gerken, TA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, BRB 823,2109 Adelbert Rd, Cleveland, OH 44104 USA.	txg2@cwru.edu	shen, wei/F-7816-2012		National Institutes of Health from the NCI [CA78834, P30-CA43703, CA130901]; NIDDK; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK070012] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA78834 (to T. A. G.), P30-CA43703, and CA130901 (to S. D. M.) from the NCI and NIDDK intramural program grant (to L. A. T.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2010, GLYCOCONJUGATE J, V27, P435, DOI 10.1007/s10719-010-9290-5; BROCKHAUSEN I, 2007, COMPREHENSIVE GLYCOS, V3, P33; Brockhausen I, 2009, BBA-GEN SUBJECTS, V1790, P1244, DOI 10.1016/j.bbagen.2009.05.020; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; ELHAMMER AP, 1993, J BIOL CHEM, V268, P10029; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P7736, DOI 10.1074/jbc.M111690200; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Guo JM, 2004, ONCOLOGY-BASEL, V67, P271, DOI 10.1159/000081328; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; HAGEN FK, 1995, GLYCOCONJUGATE J, V12, P901, DOI 10.1007/BF00731252; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kato K, 2010, GLYCOCONJUGATE J, V27, P267, DOI 10.1007/s10719-009-9275-4; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lee SH, 2010, J BIOL CHEM, V285, P37683, DOI 10.1074/jbc.M110.162735; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Mardberg K, 2004, GLYCOBIOLOGY, V14, P571, DOI 10.1093/glycob/cwh075; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Nakamura N, 2005, BIOL PHARM BULL, V28, P429, DOI 10.1248/bpb.28.429; Nehrke K, 1996, J BIOL CHEM, V271, P7061, DOI 10.1074/jbc.271.12.7061; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Perrine C, 2009, GLYCOBIOLOGY, V19, P321, DOI 10.1093/glycob/cwn143; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Simmons AD, 1999, HUM MOL GENET, V8, P2155, DOI 10.1093/hmg/8.12.2155; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walmsley AR, 2003, GLYCOBIOLOGY, V13, P641, DOI 10.1093/glycob/cwg080; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xia LJ, 2003, BLOOD, V101, P552, DOI 10.1182/blood-2001-11-0036; Zhang LP, 2010, J BIOL CHEM, V285, P34477, DOI 10.1074/jbc.M110.133561; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	76	114	115	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14493	14507		10.1074/jbc.M111.218701	http://dx.doi.org/10.1074/jbc.M111.218701			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349845	Green Published, hybrid			2022-12-25	WOS:000289556200070
J	Devigne, C; Broly, P; Deneubourg, JL				Devigne, Cedric; Broly, Pierre; Deneubourg, Jean-Louis			Individual Preferences and Social Interactions Determine the Aggregation of Woodlice	PLOS ONE			English	Article							ANT LASIUS-NIGER; TERRESTRIAL ISOPODS ISOPODA; COLLECTIVE DECISION-MAKING; PORCELLIO-SCABER; ANIMAL AGGREGATIONS; FOOD RECRUITMENT; BEHAVIOR; WATER; ONISCIDEA; PATTERNS	Background: The aggregation of woodlice in dark and moist places is considered an adaptation to land life and most studies are focused on its functionality or on the behavioural mechanisms related to the individual's response to abiotic factors. Until now, no clear experimental demonstration was available about aggregation resulting from inter-attraction between conspecifics. Methodology/Main Findings: We present the dynamics of aggregation, not previously described in detail in literature, as being independent of the experimental conditions: homogeneous and heterogeneous environments with identical or different shelters. Indeed whatever these conditions, the aggregation is very quick. In less than 10 minutes more than 50% of woodlice were aggregated in several small groups in the homogeneous environment or under shelters in the heterogeneous environment. After this fast aggregation, woodlice progressively moved into a single aggregate or under one shelter. Conclusions/Significance: Here we show for the first time that aggregation in woodlice implies a strong social component and results from a trade-off between individual preferences and inter-attraction between individuals. Moreover, our results reveal that the response to the heterogeneities affects only the location of the aggregates and not the level of aggregation, and demonstrate the strong inter-attraction between conspecifics which can outweigh individual preferences. This inter-attraction can lead to situations that could seem sub-optimal.	[Devigne, Cedric; Broly, Pierre] Univ Lille Nord France, Lille, France; [Devigne, Cedric; Broly, Pierre] UCLille, FLST, Lab Environm & Sante, Lille, France; [Deneubourg, Jean-Louis] Univ Libre Bruxelles, Brussels, Belgium	Universite de Lille - ISITE; Universite de Lille; Universite Libre de Bruxelles	Devigne, C (corresponding author), Univ Lille Nord France, Lille, France.	cedric.devigne@icl-lille.fr	Devigne, Cedric/C-2438-2016	Devigne, Cedric/0000-0002-3168-6207	Catholic University of Lille	Catholic University of Lille	This study has been carried out with support from the Catholic University of Lille in the framework of the fund-raising campaign "Ensemble Innovons". This financial help generally allows the authors to buy small materials and pay students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CH, 1918, J EXP ZOOL, V27, P193, DOI 10.1002/jez.1400270204; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALIKHAN M, 1995, TERRESTRIAL ISOPOD B; Allee W.C, 1931, ANIMAL AGGREGATION S; Allee WC, 1926, J EXP ZOOL, V45, P255, DOI 10.1002/jez.1400450108; Allee WC, 1929, ECOLOGY, V10, P14, DOI 10.2307/1940510; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; [Anonymous], 1993, EVOLUTIONARY BIOL LA; BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; Bell W. J., 2007, COCKROACHES ECOLOGY; Brockett BFT, 2005, EUR J SOIL BIOL, V41, P123, DOI 10.1016/j.ejsobi.2005.09.004; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; CAREFOOT TH, 1993, COMP BIOCHEM PHYS A, V106, P413, DOI 10.1016/0300-9629(93)90235-V; Colasurdo N, 2005, J INSECT BEHAV, V18, P77, DOI 10.1007/s10905-005-9348-6; Costa J., 2006, OTHER INSECT SOC; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Deneubourg JL, 2002, BIOL BULL-US, V202, P262, DOI 10.2307/1543477; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; DENEUBOURG JL, 1987, EUR J OPER RES, V30, P168, DOI 10.1016/0377-2217(87)90093-2; Depickere S, 2008, J INSECT PHYSIOL, V54, P1349, DOI 10.1016/j.jinsphys.2008.07.013; Devigne C, 2006, INSECT SOC, V53, P46, DOI 10.1007/s00040-005-0834-9; Devigne C, 2004, ANIM BEHAV, V67, P1023, DOI 10.1016/j.anbehav.2003.09.012; Devigne Cedric, 2005, Acta Zoologica Sinica, V51, P161; Duffy J. E., 2007, EVOLUTIONARY ECOLOGY; Dugatkin L.A., 1997, COOPERATION ANIMALS; EBISUNO T, 1982, APPL ENTOMOL ZOOL, V17, P584, DOI 10.1303/aez.17.584; EDNEY EB, 1968, AM ZOOL, V8, P309; FARR JA, 1978, B MAR SCI, V28, P659; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; FRIEDLANDER CP, 1965, ANIM BEHAV, V13, P342, DOI 10.1016/0003-3472(65)90054-0; FRIEDLANDER CP, 1964, ANIM BEHAV, V12, P164, DOI 10.1016/0003-3472(64)90118-6; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; GANTER PF, 1984, ECOLOGY, V65, P438, DOI 10.2307/1941406; Giraldeau L.A., 2000, MG BEH ECOL; Giraldeau Luc-Alain, 1997, P42; Glass EV, 1998, EXP APPL ACAROL, V22, P31, DOI 10.1023/A:1006081323887; Greenaway P, 1998, ISR J ZOOL, V44, P473; Gunn DL, 1937, J EXP BIOL, V14, P178; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; HAMNER WM, 1986, LIMNOL OCEANOGR, V31, P171, DOI 10.4319/lo.1986.31.1.0171; Hartline HK, 1923, J GEN PHYSIOL, V6, P137, DOI 10.1085/jgp.6.2.137; Hassall M, 2010, BEHAVIOUR, V147, P151, DOI 10.1163/000579509X12512861455834; Hendrickx F, 2003, ENVIRON POLLUT, V121, P87, DOI 10.1016/S0269-7491(02)00203-8; Holldobler B., 2009, SUPERORGANISM; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Jeanson R, 2004, ANIM BEHAV, V67, P531, DOI 10.1016/j.anbehav.2003.06.013; Jeanson R, 2007, AM NAT, V170, P47, DOI 10.1086/518570; Jeanson Raphael, 2009, P460; Kaufman BZ, 1996, ZOOL ZH, V75, P188; Krebs JR., 1997, BEHAV ECOLOGY EVOLUT; KUENEN D. J., 1963, ENTOMOL EXPTL ET APPL, V6, P133; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; Linsenmair Karl Eduard, 2007, P339; Linsenmair KE, 1984, S ZOOL SOC LONDON, V53, P423; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; Nicolis SC, 2008, J THEOR BIOL, V254, P580, DOI 10.1016/j.jtbi.2008.06.028; Nicolis SC, 1999, J THEOR BIOL, V198, P575, DOI 10.1006/jtbi.1999.0934; Paoletti MG, 1999, AGR ECOSYST ENVIRON, V74, P157, DOI 10.1016/S0167-8809(99)00035-3; Peters MI, 2006, ETHOLOGY, V112, P521, DOI 10.1111/j.1439-0310.2005.01197.x; Planque R, 2007, BEHAV ECOL SOCIOBIOL, V61, P347, DOI 10.1007/s00265-006-0263-4; RABAUD ETIENNE, 1929, BULL BIOL FRANCE ET BELGIQUE, V63, P377; Scherkenbeck J, 1999, J CHEM ECOL, V25, P1105, DOI 10.1023/A:1020885926578; Schmalfuss Helmut, 2003, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V654, P1; Sempo G, 2009, ETHOLOGY, V115, P1150, DOI 10.1111/j.1439-0310.2009.01699.x; Sorensen FF, 1997, ENVIRON TOXICOL CHEM, V16, P685, DOI [10.1897/1551-5028(1997)016&lt;0685:ALBIWO&gt;2.3.CO;2, 10.1002/etc.5620160412]; Stocker S, 1999, MATH BIOSCI, V156, P167, DOI 10.1016/S0025-5564(98)10065-2; STYRON CE, 1967, AM MIDL NAT, V78, P389, DOI 10.2307/2485238; STYRON CE, 1968, ECOLOGY, V49, P629, DOI 10.2307/1935528; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sutton S., 1972, WOODLICE; TAKEDA N, 1984, S ZOOL SOC LOND, V53, P381; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; Thiel Martin, 2007, P3; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; WARBURG MR, 1964, ANIM BEHAV, V12, P175, DOI 10.1016/0003-3472(64)90119-8; WARBURG MR, 1968, AM ZOOL, V8, P545; WIESER W, 1969, OECOLOGIA, V3, P390, DOI 10.1007/BF00390384; WRIGHT JC, 1990, J EXP BIOL, V154, P13; Yoder JA, 1997, PHYSIOL ENTOMOL, V22, P79, DOI 10.1111/j.1365-3032.1997.tb01143.x; Yoder Jay A., 2002, Journal of Cave and Karst Studies, V64, P140; Zimmer M, 2005, J CHEM ECOL, V31, P1933, DOI 10.1007/s10886-005-5935-4; Zimmer M, 1996, EUR J SOIL BIOL, V32, P141; Zimmer M, 2002, BIOL REV, V77, P455, DOI 10.1017/S1464793102005912; Zimmer M, 2002, FUNCT ECOL, V16, P596, DOI 10.1046/j.1365-2435.2002.00669.x; [No title captured]; [No title captured]	88	48	48	17	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17389	10.1371/journal.pone.0017389	http://dx.doi.org/10.1371/journal.pone.0017389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364761	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100051
J	Iwamori, T; Lin, YN; Ma, L; Iwamori, N; Matzuk, MM				Iwamori, Tokuko; Lin, Yi-Nan; Ma, Lang; Iwamori, Naoki; Matzuk, Martin M.			Identification and Characterization of RBM44 as a Novel Intercellular Bridge Protein	PLOS ONE			English	Article							GERM-CELL DEVELOPMENT; GENE-EXPRESSION; ESCRT MACHINERY; MICE DEFICIENT; CYTOKINESIS; FERTILITY; SPERMATOGENESIS; DIFFERENTIATION; COMPLEX; ABSENCE	Intercellular bridges are evolutionarily conserved structures that connect differentiating germ cells. We previously reported the identification of TEX14 as the first essential intercellular bridge protein, the demonstration that intercellular bridges are required for male fertility, and the finding that intercellular bridges utilize components of the cytokinesis machinery to form. Herein, we report the identification of RNA binding motif protein 44 ( RBM44) as a novel germ cell intercellular bridge protein. RBM44 was identified by proteomic analysis after intercellular bridge enrichment using TEX14 as a marker protein. RBM44 is highly conserved between mouse and human and contains an RNA recognition motif of unknown function. RBM44 mRNA is enriched in testis, and immunofluorescence confirms that RBM44 is an intercellular bridge component. However, RBM44 only partially localizes to TEX14-positive intercellular bridges. RBM44 is expressed most highly in pachytene and secondary spermatocytes, but disappears abruptly in spermatids. We discovered that RBM44 interacts with itself and TEX14 using yeast two-hybrid, mammalian two-hybrid, and immunoprecipitation. To define the in vivo function of RBM44, we generated a targeted deletion of Rbm44 in mice. Rbm44 null male mice produce somewhat increased sperm, and show enhanced fertility of unknown etiology. Thus, although RBM44 localizes to intercellular bridges during meiosis, RBM44 is not required for fertility in contrast to TEX14.	[Iwamori, Tokuko; Lin, Yi-Nan; Ma, Lang; Iwamori, Naoki; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Lin, Yi-Nan; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Iwamori, T (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mmatzuk@bcm.tmc.edu			National Institutes of Health [R01HD057880, U01HD060496]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060496] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work has been supported in part by National Institutes of Health grants R01HD057880 and U01HD060496 (to M. M. M.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chennathukuzhi V, 2003, MOL CELL BIOL, V23, P6419, DOI 10.1128/MCB.23.18.6419-6434.2003; Dev A, 2007, MOL REPROD DEV, V74, P1456, DOI 10.1002/mrd.20742; DREYFUSS G, 1988, J CELL BIOL, V106, P1419, DOI 10.1083/jcb.106.5.1419; Edson MA, 2010, ENDOCRINOLOGY, V151, P358, DOI 10.1210/en.2009-0760; ERICKSON RP, 1973, NATURE-NEW BIOL, V243, P210, DOI 10.1038/newbio243210a0; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Guo GQ, 2004, J THEOR BIOL, V229, P139, DOI 10.1016/j.jtbi.2004.03.010; HUCKINS C, 1978, ANAT REC, V192, P529, DOI 10.1002/ar.1091920407; IWAMORI T, 2010, MOL CELL BIOL; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee KH, 2006, EMBO J, V25, P4263, DOI 10.1038/sj.emboj.7601304; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; REN HP, 1991, AM J ANAT, V192, P121, DOI 10.1002/aja.1001920203; Roy A, 2007, FASEB J, V21, P1013, DOI 10.1096/fj.06-7035com; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	30	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17066	10.1371/journal.pone.0017066	http://dx.doi.org/10.1371/journal.pone.0017066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364893	gold, Green Submitted, Green Published			2022-12-25	WOS:000287764100025
J	Tian, YH; Hou, Y; Zhou, XA; Cheng, HH; Zhou, RJ				Tian, Yihao; Hou, Yu; Zhou, Xiang; Cheng, Hanhua; Zhou, Rongjia			Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation	PLOS ONE			English	Article							MICROTUBULE STABILITY; PROTEIN; TUMORIGENESIS; PROGRESSION; APOPTOSIS; ISOFORM; GROWTH	Oncogenes and tumor suppressors work in concert to regulate cell growth or death, which is a pair of antagonist factors for regulation of tumorigenesis. Here we show promoter characteristic of tumor suppressor RASSF1A, which revealed a p53 binding site in the distal and a GC-rich region in the proximal promoter region of RASSF1A, in despite of TATA box-less. The GC-rich region, which is similar to 300 bp upstream from the RASSF1A ATG, showed the strongest promoter activity in an assay of RASSF1A-driving GFP expression. Methylation analysis of the CpG island showed that 78.57% of the GC sties were methylated in testis tumor samples compared with methylation-less in normal testis. Hypermethylation of the GC-rich region is associated with RASSF1A silencing in human testis tumors. In addition, electrophoretic mobility shift assay indicated that p53 protein bound to the RASSF1A promoter. Further chromatin immunoprecipitation confirmed p53 binding to the RASSF1A. Moreover, p53 binding to the promoter down-regulated RASSF1A expression. These results suggest that p53 protein specifically binds to the RASSF1A promoter and inhibits its expression. Our results provide new insight into the mechanism of action of tumor suppressors and may be a starting point for development of new approaches to cancer treatment.	[Tian, Yihao] Wuhan Univ, Dept Genet, Coll Life Sci, Wuhan 430072, Peoples R China; Wuhan Univ, Ctr Dev Biol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Tian, YH (corresponding author), Wuhan Univ, Dept Genet, Coll Life Sci, Wuhan 430072, Peoples R China.	hhcheng@whu.edu.cn; rjzhou@whu.edu.cn	Zhou, Rongjia/G-4660-2013; Zhou, Rongjia/N-9739-2019	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009	National Natural Science Foundation of China; National Key Basic Research project [2006CB102103]; Key Transgenic New Organism Project [2009ZX08009-148B]; Program of Wuhan Subject Chief Scientist; 111 project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research project(National Basic Research Program of China); Key Transgenic New Organism Project; Program of Wuhan Subject Chief Scientist; 111 project(Ministry of Education, China - 111 Project)	Funding was provided by the National Natural Science Foundation of China, the National Key Basic Research project (2006CB102103), the Key Transgenic New Organism Project (2009ZX08009-148B), Program of Wuhan Subject Chief Scientist, and the 111 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRUCH J, 2008, J BIOL CHEM; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Calvisi DF, 2009, CANCER RES, V69, P4629, DOI 10.1158/0008-5472.CAN-08-3672; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Lusher ME, 2002, CANCER RES, V62, P5906; OKOROKOV AL, 2009, CURR OPIN STRUCT BIO; RICHTER AM, 2009, BIOCH BIOPHYS ACTA; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tommasi S, 2005, CANCER RES, V65, P92; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	32	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17017	10.1371/journal.pone.0017017	http://dx.doi.org/10.1371/journal.pone.0017017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364923	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100019
J	Roodenburg, AJC; Schlatmann, A; Dotsch-Klerk, M; Daamen, R; Dong, J; Guarro, M; Stergiou, M; Sayed, N; Ronoh, E; Jansen, L; Seidell, JC				Roodenburg, Annet J. C.; Schlatmann, Anke; Doetsch-Klerk, Mariska; Daamen, Robert; Dong, Jie; Guarro, Marta; Stergiou, Margarita; Sayed, Nazeeia; Ronoh, Eunice; Jansen, Leon; Seidell, Jacob C.			Potential Effects of Nutrient Profiles on Nutrient Intakes in the Netherlands, Greece, Spain, USA, Israel, China and South-Africa	PLOS ONE			English	Article							NUTRITIONAL QUALITY; FOOD-CONSUMPTION; VALIDATION; SCHEMES; DIET; TOOL	Introduction: Nutrient profiling is defined as the science of categorising foods based on their nutrient composition. Choices Programme is a nutrient profile system with criteria that determine whether foods are eligible to carry a "option" stamp. The Daily Menu Method which has been developed to evaluate these criteria is described here. This simulates the change in calculated nutrient intakes which would be the result of consumers changing their diets in favour food products that comply with the criteria. Methods: Average intakes of energy, trans fatty acids (TFA), saturated fatty acids (SAFA), sodium, added sugar and were derived from dietary intake studies and food consumption surveys of 7 countries: The Netherlands, Greece, Spain, USA, Israel, China and South Africa. For each of the key nutrients, these average intakes were translated into three Daily Menus per country. Average intakes based on these three menus were compared with average intakes from Choices Daily Menus. To compose the Choices Menus, foods from the Typical Menus that did not comply with the criteria were replaced with foods that did comply and are available on the market. Results: Comparison of intakes from the Choices Menus with the survey data showed that calculated intakes of SAFA, TFA, sodium and added sugar were reduced. Fibre intakes were increased. The size of the effect differed per Conclusion: The Daily Menu Method is a useful means to predict the potential effects of nutrient profiles such as Choices criteria, on daily nutrient intakes. The method can be applied internationally and confirms that the criteria of Choices Programme are in line with the aim of the programme: to improve nutrient intakes in the direction of recommendations.	[Roodenburg, Annet J. C.; Seidell, Jacob C.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Roodenburg, Annet J. C.; Doetsch-Klerk, Mariska; Daamen, Robert] Unilever Res Labs, Vlaardingen, Netherlands; [Schlatmann, Anke] Unilever Benelux, Rotterdam, Netherlands; [Dong, Jie] Unilever Discover, Shanghai, Peoples R China; [Guarro, Marta] Unilever Spain, Barcelona, Spain; [Stergiou, Margarita] Unilever Greece, Athens, Greece; [Sayed, Nazeeia] Unilever S Africa, Durban, South Africa; [Ronoh, Eunice] Unilever Israel, Tel Aviv, Israel; [Jansen, Leon] Choices Int Fdn, Brussels, Belgium	Vrije Universiteit Amsterdam; Unilever; Unilever; Unilever; Unilever; Unilever; Unilever; Unilever	Roodenburg, AJC (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.	annet.roodenburg@falw.vu.nl	seidell, jacob/AAF-5362-2019; seidell, jacob c/N-7427-2013; jansen, leon/W-9159-2019	seidell, jacob/0000-0002-9262-9062; 	Netherlands Organisation for Scientific Research (NWO) [018.003.012]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The preparation of this manuscript study was supported by a grant (018.003.012) from the Netherlands Organisation for Scientific Research (NWO). Website: http://www.nwo.nl/. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Regarding the authors: AR is seconded to VU University Amsterdam and employed by Unilever. The authors AR, AS, RD, JD, MG, MS, NS, ER, MDK are employed by Unilever.	Arambepola C, 2008, PUBLIC HEALTH NUTR, V11, P371, DOI 10.1017/S1368980007000377; Azais-Braesco V, 2006, PUBLIC HEALTH NUTR, V9, P613, DOI 10.1079/PHN2006966; BEYERS T, 1998, NUTR EPIDEMIOLOGY, P347; Charlton KE, 2005, NUTRITION, V21, P39, DOI 10.1016/j.nut.2004.09.007; Committee on Medical Aspects of Food Policy, 1991, REP HLTH SOC SUBJ; *CONS NAC AL COM E, 1997, REC ED AL POP PORT R; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; Drewnowski A, 2005, AM J CLIN NUTR, V82, P721, DOI 10.1093/ajcn/82.4.721; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; *DTSCH GES ERN OST, 2000, REF NAHRST 2000; EC, 2007, OFFICIAL J EUROPEA L, VL12, P3; FAO/WHO Consultation, 2003, WHO TECHN REP SER, V916; Farran A., 2004, FOOD COMPOSITION TAB; *FOOD NUTR SERV PU, 2008, ISR NUTR DAT BINAT; *FOOD STAND AG, 2003, NAT DIET NUTR SURV A, V2; Food Standards Agency, 2002, MCCANCE WIDD COMP FO; Fulgoni VL, 2009, J NUTR, V139, P1549, DOI 10.3945/jn.108.101360; Garsetti M, 2007, EUR J NUTR, V46, P15, DOI 10.1007/s00394-007-2002-7; *HEA, 1994, BAL GOOD HLTH; *HLTH COUNC NETH, 2006, PUBL HLGH COUNC NETH; Hulshof KFAM, 1999, EUR J CLIN NUTR, V53, P143, DOI 10.1038/sj.ejcn.1600692; *ISR CTR DIS CONTR, 2001, MABAT 1 ISR HLTH N 2; JANSEN L, 2007, VOEDING NU, V4, P21; Labouze E, 2007, PUBLIC HEALTH NUTR, V10, P690, DOI 10.1017/S1368980007382505; *LIVSM NAT FOOD AD, 2009, KEYH SYMB; Luzzi A. F., 2001, Public Health Nutrition, V4, P437; MacIntyre UE, 2002, NUTR RES, V22, P239, DOI 10.1016/S0271-5317(01)00392-X; Mammas I, 2004, INT J FOOD SCI NUTR, V55, P17, DOI 10.1080/09637480310001642448; *MIN AGR PESC AL P, 2008, AL ESP 2006 EST COMM; *MIN HLTH MIN SCI, 2008, NUTR HLTH STAT CHIN; *MRC, 2002, FOODF 3 FOOD COMP AN; Naska A, 2005, ARCH HELL MED, V22, P259; *NAT AC I MED, 2002, DIET REF INT CARB FI; *NAT HEART FDN NZ, 2002, PICK TICK FOOD INF P; Nijman CAJ, 2007, EUR J CLIN NUTR, V61, P461, DOI 10.1038/sj.ejcn.1602548; OTERO ML, 2000, CARDIOVASC RISK FACT, V9, P319; Quinio C, 2007, EUR J NUTR, V46, P37, DOI 10.1007/s00394-007-2005-4; Rayner M, 2005, NUTR PROFILES APPL C; Rayner M., 2005, FINAL REPORT; Roodenburg AJC, 2009, NUTR BULL, V34, P318, DOI 10.1111/j.1467-3010.2009.01767.x; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P337, DOI 10.1017/S1368980007666671; Steyn NP, 2003, PUBLIC HEALTH NUTR, V6, P631, DOI 10.1079/PHN2003482; *STICHT NED VOED, 2006, NEVO FOOD COMP DAT; Townsend MS, 2010, AM J CLIN NUTR, V91, p1109S, DOI 10.3945/ajcn.2010.28450F; TRICHOPOULOU A, 2007, COMPOSITION TABLES F; United States Department of Agriculture ARS [USDA] USDA Nutrient Data Laboratory., 2008, USDA NAT NUTR DAT ST; *USDA, 2005, USDA DAT ADD SUG CON; *USDA, 1993, USDA DAT FATT AC CON; Van Raaij J, 2008, PUBLIC HEALTH NUTR, V12, P1; *VOED, 1998, ZO EET RESULTATEN VO; Volatier JL, 2007, EUR J NUTR, V46, P29, DOI 10.1007/s00394-007-2004-5; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Waxman Amalia, 2004, Food and Nutrition Bulletin, V25, P292; WRIGHT JD, 2003, CDC ADV DATA VITAL H, V334; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605	56	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14721	10.1371/journal.pone.0014721	http://dx.doi.org/10.1371/journal.pone.0014721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373186	Green Published, gold			2022-12-25	WOS:000287657500005
J	Behnisch, T; YuanXiang, P; Bethge, P; Parvez, S; Chen, Y; Yu, J; Karpova, A; Frey, JU; Mikhaylova, M; Kreutz, MR				Behnisch, Thomas; YuanXiang, PingAn; Bethge, Philipp; Parvez, Suhel; Chen, Ying; Yu, Jin; Karpova, Anna; Frey, Julietta U.; Mikhaylova, Marina; Kreutz, Michael R.			Nuclear Translocation of Jacob in Hippocampal Neurons after Stimuli Inducing Long-Term Potentiation but Not Long-Term Depression	PLOS ONE			English	Article							NMDA RECEPTORS; SUBUNIT COMPOSITION; IMPORTIN-ALPHA; CREB SHUTOFF; LTP; SYNAPSE; EXPRESSION; PLASTICITY; ACTIVATION; INHIBITOR	Background: In recent years a number of potential synapto-nuclear protein messengers have been characterized that are thought to be involved in plasticity-related gene expression, and that have the capacity of importin-mediated and activity-dependent nuclear import. However, there is a surprising paucity of data showing the nuclear import of such proteins in cellular models of learning and memory. Only recently it was found that the transcription factor cyclic AMP response element binding protein 2 (CREB2) transits to the nucleus during long-term depression (LTD), but not during long-term potentiation (LTP) of synaptic transmission in hippocampal primary neurons. Jacob is another messenger that couples NMDA-receptor-activity to nuclear gene expression. We therefore aimed to study whether Jacob accumulates in the nucleus in physiological relevant models of activity-dependent synaptic plasticity. Methodology/Principal Findings: We have analyzed the dynamics of Jacob's nuclear import following induction of NMDA-receptor dependent LTP or LTD at Schaffer collateral-CA1 synapses in rat hippocampal slices. Using time-lapse imaging of neurons expressing a Jacob-Green-Fluorescent-Protein we found that Jacob rapidly translocates from dendrites to the nucleus already during the tetanization period of LTP, but not after induction of LTD. Immunocytochemical stainings confirmed the nuclear accumulation of endogenous Jacob in comparison to apical dendrites after induction of LTP but not LTD. Complementary findings were obtained after induction of NMDA-receptor dependent chemical LTP and LTD in hippocampal primary neurons. However, in accordance with previous studies, high concentrations of NMDA and glycine as well as specific activation of extrasynaptic NMDA-receptors resembling pathological conditions induce an even more profound increase of nuclear Jacob levels. Conclusions/Significance: Taken together, these findings suggest that the two major forms of NMDA-receptor dependent synaptic plasticity, LTP and LTD, elicit the transition of different synapto-nuclear messengers albeit in both cases importin-mediated retrograde transport and NMDA-receptor activation is required.	[Behnisch, Thomas; YuanXiang, PingAn; Chen, Ying; Yu, Jin] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Behnisch, Thomas] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Bethge, Philipp; Karpova, Anna; Mikhaylova, Marina; Kreutz, Michael R.] Leibniz Inst Neurobiol, Project Grp Neuroplast, Magdeburg, Germany; [Parvez, Suhel; Frey, Julietta U.] Leibniz Inst Neurobiol, Dept Neurophysiol, Magdeburg, Germany; [Parvez, Suhel] Hamdard Univ, Dept Toxicol, New Delhi, India	Fudan University; Fudan University; Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Jamia Hamdard University	Behnisch, T (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.	behnish@fudan.edu.cn	YUANXIANG, PingAn/AAF-1662-2019; Mikhaylova, Marina/AAM-4368-2020; Behnisch, Thomas/G-3688-2018; Parvez, Suhel/E-6778-2010	YUANXIANG, PingAn/0000-0002-3746-3282; Mikhaylova, Marina/0000-0001-7646-1346; Behnisch, Thomas/0000-0002-7842-3252; Parvez, Suhel/0000-0002-6318-6506	NSFC [30870795, 30970920]; DFG [SFB779, TPB8]; CBBS/Land Saxony-Anhalt/EU [C1-TP4]; DIP grant; DZNE; Schram Foundation	NSFC(National Natural Science Foundation of China (NSFC)); DFG(German Research Foundation (DFG)); CBBS/Land Saxony-Anhalt/EU(European Commission); DIP grant; DZNE; Schram Foundation	This work was supported by NSFC grants (30870795, 30970920) to T. B. and by the DFG (SFB779, TPB8 to M. R. K.), the CBBS/Land Saxony-Anhalt/EU (C1-TP4 to M. R. K.), DIP grant, the DZNE (to M. R. K.), and the Schram Foundation (to M. R. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; Cai F, 2010, NEUROSCIENCE, V169, P1520, DOI 10.1016/j.neuroscience.2010.06.032; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P301; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Fagerlund R, 2008, CELL SIGNAL, V20, P1442, DOI 10.1016/j.cellsig.2008.03.012; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frey S, 2008, PROG BRAIN RES, V169, P117, DOI 10.1016/S0079-6123(07)00007-6; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Goslin K., 1991, CULTURING NERVE CELL, P251; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hosokawa K, 2008, NEUROSCIENCE, V157, P864, DOI 10.1016/j.neuroscience.2008.09.045; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kindler S, 2009, J BIOL CHEM, V284, P25431, DOI 10.1074/jbc.M109.022137; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kollen M, 2008, NEUROSCIENCE, V154, P1308, DOI 10.1016/j.neuroscience.2008.04.045; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Leutgeb JK, 2003, J NEUROSCI METH, V130, P19, DOI 10.1016/S0165-0270(03)00228-0; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; RONICKE R, 2010, NEUROBIOL AGING 0202; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	39	37	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17276	10.1371/journal.pone.0017276	http://dx.doi.org/10.1371/journal.pone.0017276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364755	gold, Green Submitted, Green Published			2022-12-25	WOS:000287482800042
J	Campbell-Smith, G; Campbell-Smith, M; Singleton, I; Linkie, M				Campbell-Smith, Gail; Campbell-Smith, Miran; Singleton, Ian; Linkie, Matthew			Apes in Space: Saving an Imperilled Orangutan Population in Sumatra	PLOS ONE			English	Article							KIBALE NATIONAL-PARK; RANGING BEHAVIOR; FOREST EDGE; CROP; CONFLICT; ELEPHANT; PEOPLE; CONSTRAINTS; PERCEPTIONS; ATTITUDES	Deforestation rates in Sumatra are amongst the highest in the tropics. Lowland forests, which support the highest densities of orangutans, are particularly vulnerable to clearance and fragmentation because they are highly accessible. Consequently, many orangutans will, in the future, live in strictly or partially isolated populations. Whilst orangutans have been extensively studied in primary forests, their response to living in human-dominated landscapes remains poorly known, despite it being essential for their future management. Here, we focus on an isolated group of critically endangered Sumatran orangutans (Pongo abelii) that co-exist with farmers in a mixed agroforest system consisting of degraded natural forest, smallholder (predominantly rubber) farms and oil palm plantations. Over 24 months we conducted the first ever spatial assessment of orangutan habitat use in the human-transformed landscape of Batang Serangan, North Sumatra. From 1,204 independent crop-raiding incidents recorded, orangutans showed strong foraging preference for mixed farmland/degraded forest habitat over oil palm patches. The core home range areas of the eight adult orangutans encompassed only 14% of the available study area. Monthly home range sizes averaged 423 ha (+/- 139, SD) for males, and 131 +/- 46 ha for females, and were positively influenced by wild and cultivated fruit presence, and by crop consumption. The average daily distance travelled was similar for both adult males (868 m +/- 350, SD) and females (866 m +/- 195), but increased when orangutans raided crops. These findings show that orangutans can survive, demographically, in certain types of degraded landscapes, foraging on a mixture of crops and wild fruits. However, the poor quality habitat offered to orangutans by oil palm plantations, in terms of low food availability and as a barrier to female movements, is cause for concern since this is the land use type that is most rapidly replacing the preferred forest habitat across both Sumatran and Bornean orangutan ranges.	[Campbell-Smith, Gail; Linkie, Matthew] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Campbell-Smith, Miran] Orangutan Informat Ctr, Human Orangutan Conflict & Mitigat Programme, Medan, North Sumatra, Indonesia; [Singleton, Ian] PanEco Fdn, Sumatran Orangutan Conservat Programme, Medan, North Sumatra, Indonesia; [Linkie, Matthew] Fauna & Flora Int, Cambridge, England	University of Kent	Campbell-Smith, G (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	primatelass@gmail.com			United States Fish and Wildlife Service [31221208, 31221435]; G Campbell-Smith by Born Free Foundation; Humane Society International; PanEco; People's Trust for Endangered Species; Orangutan Republik Education Initiative; Orangutan Foundation; Primate Society of Great Britain; Borneo Orangutan Society-Canada; SeaWorld and Bush Gardens Conservation Fund	United States Fish and Wildlife Service(US Fish & Wildlife Service); G Campbell-Smith by Born Free Foundation; Humane Society International; PanEco; People's Trust for Endangered Species; Orangutan Republik Education Initiative; Orangutan Foundation; Primate Society of Great Britain; Borneo Orangutan Society-Canada; SeaWorld and Bush Gardens Conservation Fund	Funding: This specific study was supported by the United States Fish and Wildlife Service Great Ape Conservation Fund through grants # 31221208 and # 31221435 held by N Leader-Williams at the Durrell Institute of Conservation and Ecology, University of Kent, and by funds awarded to G Campbell-Smith by Born Free Foundation, Humane Society International, SeaWorld and Bush Gardens Conservation Fund, PanEco, People's Trust for Endangered Species, Orangutan Republik Education Initiative, Orangutan Foundation, Primate Society of Great Britain and Borneo Orangutan Society-Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Atmoko Sri Suci Utami, 2009, P225; Buij R, 2002, BIOL CONSERV, V107, P83, DOI 10.1016/S0006-3207(02)00048-4; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Clements GR, 2010, CONSERV BIOL, V24, P1437, DOI 10.1111/j.1523-1739.2010.01584.x; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; Ganas J, 2005, BEHAV ECOL SOCIOBIOL, V58, P277, DOI 10.1007/s00265-005-0920-z; Grueter CC, 2009, PRIMATES, V50, P81, DOI 10.1007/s10329-008-0113-2; Harrison ME, 2010, INT J PRIMATOL, V31, P585, DOI 10.1007/s10764-010-9415-5; HARRISON ME, 2008, AM J PRIMATOL, V70, P1; Heiduck S, 2002, ORYX, V36, P133, DOI 10.1017/S0030605302000200; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Hoare, 1999, STANDARDISED DATA CO; Hockings K., 2009, BEST PRACTICE GUIDEL; Hockings KJ, 2009, AM J PRIMATOL, V71, P636, DOI 10.1002/ajp.20698; Husson Simon J., 2009, P77; Jackson TR, 2008, ORYX, V42, P83, DOI 10.1017/S0030605308001117; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Lahm S., 1996, PACHYDERM, V21, P69; Lee P. C., 2005, COMMENSALISM CONFLIC, V4, P1, DOI DOI 10.1002/047001539X.CH1; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Marchal V., 2009, PRIMATE CONSERVATION, V24, P107; Marshall Andrew J., 2009, P311; Matsuda I, 2009, INT J PRIMATOL, V30, P313, DOI 10.1007/s10764-009-9344-3; Meijaard E, 2007, CURR BIOL, V17, pR540, DOI 10.1016/j.cub.2007.05.016; MORROGHBERNARD HC, 2002, ORANGUTAN DATA COLLE; Nantha HS, 2009, BIODIVERS CONSERV, V18, P487, DOI 10.1007/s10531-008-9512-3; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; NEWMARK WD, 1993, BIOL CONSERV, V63, P177, DOI 10.1016/0006-3207(93)90507-W; Nyhus PJ, 2000, ORYX, V34, P262, DOI 10.1017/S0030605300031331; Ostro LET, 1999, J WILDLIFE MANAGE, V63, P748, DOI 10.2307/3802665; Parker GE, 2006, ORYX, V40, P343, DOI 10.1017/S0030605306000822; Reynolds V, 2006, BUDONGO FOREST PROJE, V7, P4; Saj TL, 2001, AFR J ECOL, V39, P195, DOI 10.1046/j.0141-6707.2000.00299.x; Singleton I, 2001, INT J PRIMATOL, V22, P877, DOI 10.1023/A:1012033919441; Singleton I, 2000, THESIS U KENT CANTER THESIS U KENT CANTER; Singleton Ian, 2009, P205; Sitati NW, 2005, J APPL ECOL, V42, P1175, DOI 10.1111/j.1365-2664.2005.01091.x; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Stephens D.W., 1986, pi; STRUM SC, 1994, REV ECOL-TERRE VIE, V49, P295; SUKUMAR R, 1990, J TROP ECOL, V6, P33, DOI 10.1017/S0266467400004004; Thouless Chris R., 1994, Oryx, V28, P119; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wartmann FM, 2010, PRIMATES, V51, P119, DOI 10.1007/s10329-009-0186-6; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	52	47	47	5	217	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17210	10.1371/journal.pone.0017210	http://dx.doi.org/10.1371/journal.pone.0017210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21364732	Green Submitted, Green Published, gold			2022-12-25	WOS:000287392700059
J	Wuchty, S; Arjona, D; Li, AG; Kotliarov, Y; Walling, J; Ahn, S; Zhang, A; Maric, D; Anolik, R; Zenklusen, JC; Fine, HA				Wuchty, Stefan; Arjona, Dolores; Li, Aiguo; Kotliarov, Yuri; Walling, Jennifer; Ahn, Susie; Zhang, Alice; Maric, Dragan; Anolik, Rachel; Zenklusen, Jean Claude; Fine, Howard A.			Prediction of Associations between microRNAs and Gene Expression in Glioma Biology	PLOS ONE			English	Article							MESSENGER-RNAS; REVEALS; AMPLIFICATION; GLIOBLASTOMA; REGIONS; MIRNAS; TUMORS; SITES; WEE1; SET	Despite progress in the determination of miR interactions, their regulatory role in cancer is only beginning to be unraveled. Utilizing gene expression data from 27 glioblastoma samples we found that the mere knowledge of physical interactions between specific mRNAs and miRs can be used to determine associated regulatory interactions, allowing us to identify 626 associated interactions, involving 128 miRs that putatively modulate the expression of 246 mRNAs. Experimentally determining the expression of miRs, we found an over-representation of over(under)-expressed miRs with various predicted mRNA target sequences. Such significantly associated miRs that putatively bind over-expressed genes strongly tend to have binding sites nearby the 3'UTR of the corresponding mRNAs, suggesting that the presence of the miRs near the translation stop site may be a factor in their regulatory ability. Our analysis predicted a significant association between miR-128 and the protein kinase WEE1, which we subsequently validated experimentally by showing that the over-expression of the naturally under-expressed miR-128 in glioma cells resulted in the inhibition of WEE1 in glioblastoma cells.	[Wuchty, Stefan] NINDS, Neurooncol Branch, NCI, Natl Ctr Biotechnol Informat,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wuchty, S (corresponding author), NINDS, Neurooncol Branch, NCI, Natl Ctr Biotechnol Informat,NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hfine@mail.nih.gov	Kotliarov, Yuri/B-6938-2017	Kotliarov, Yuri/0000-0002-6558-8883	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010840, ZIABC011101, ZIABC010839, ZIABC011099, ZIABC011100, ZICBC011086, ZIABC011102, ZIASC010100] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjona D, 2005, NEUROPATH APPL NEURO, V31, P384, DOI 10.1111/j.1365-2990.2005.00653.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI, 1995, J ROY STAT SOC, V57, P89; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Gonzalez-Gomez P, 2003, INT J ONCOL, V22, P601; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Zhang JX, 2010, INT J ONCOL, V36, P913, DOI 10.3892/ijo_00000570; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	53	59	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14681	10.1371/journal.pone.0014681	http://dx.doi.org/10.1371/journal.pone.0014681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358821	Green Published, Green Submitted, gold			2022-12-25	WOS:000287392700003
J	Yew, JY; Dreisewerd, K; de Oliveira, CC; Etges, WJ				Yew, Joanne Y.; Dreisewerd, Klaus; de Oliveira, Cassia Cardoso; Etges, William J.			Male-Specific Transfer and Fine Scale Spatial Differences of Newly Identified Cuticular Hydrocarbons and Triacylglycerides in a Drosophila Species Pair	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; CACTOPHILIC DROSOPHILA; PREMATING ISOLATION; EPICUTICULAR HYDROCARBONS; REPRODUCTIVE ISOLATION; ISOLATED POPULATIONS; SEXUAL ISOLATION; INCIPIENT SPECIATION; STENOCEREUS-GUMMOSUS; MOJAVENSIS CLUSTER	We analyzed epicuticular hydrocarbon variation in geographically isolated populations of D. mojavensis cultured on different rearing substrates and a sibling species, D. arizonae, with ultraviolet laser desorption/ionization mass spectrometry (UV-LDI MS). Different body parts, i.e. legs, proboscis, and abdomens, of both species showed qualitatively similar hydrocarbon profiles consisting mainly of long-chain monoenes, dienes, trienes, and tetraenes. However, D. arizonae had higher amounts of most hydrocarbons than D. mojavensis and females of both species exhibited greater hydrocarbon amounts than males. Hydrocarbon profiles of D. mojavensis populations were significantly influenced by sex and rearing substrates, and differed between body parts. Lab food-reared flies had lower amounts of most hydrocarbons than flies reared on fermenting cactus substrates. We discovered 48 male-and species-specific hydrocarbons ranging in size from C-22 to C-50 in the male anogenital region of both species, most not described before. These included several oxygen-containing hydrocarbons in addition to high intensity signals corresponding to putative triacylglycerides, amounts of which were influenced by larval rearing substrates. Some of these compounds were transferred to female cuticles in high amounts during copulation. This is the first study showing that triacylglycerides may be a separate class of courtship-related signaling molecules in drosophilids. This study also extends the kind and number of epicuticular hydrocarbons in these species and emphasizes the role of larval ecology in influencing amounts of these compounds, many of which mediate courtship success within and between species.	[Yew, Joanne Y.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Yew, Joanne Y.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yew, Joanne Y.; Dreisewerd, Klaus] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [de Oliveira, Cassia Cardoso; Etges, William J.] Univ Arkansas, Dept Biol Sci, Program Ecol & Evolutionary Biol, Fayetteville, AR 72701 USA	National University of Singapore; National University of Singapore; University of Munster; University of Arkansas System; University of Arkansas Fayetteville	Yew, JY (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	wetges@uark.edu	Dreisewerd, Klaus/K-3884-2015; Yew, Joanne/D-6562-2014	Dreisewerd, Klaus/0000-0002-7619-808X; 	National Science Foundations [NSF EF-0723930]; Alexander von Humboldt Foundation; Singapore National Research Foundation [RF001-363]	National Science Foundations(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Singapore National Research Foundation(National Research Foundation, Singapore)	National Science Foundations grant NSF EF-0723930, http://www.nsf.gov; Alexander von Humboldt Foundation, no grant number; Singapore National Research Foundation RF001-363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN SM, 1991, INT J SYST BACTERIOL, V41, P197, DOI 10.1099/00207713-41-2-197; ALONSOPIMENTEL H, 1992, J INSECT BEHAV, V5, P131, DOI 10.1007/BF01049164; Atchison J., 1986, STAT ANAL COMPOSITIO; Barker J.S.F., 1982, ECOLOGICAL GENETICS; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; BRAZNER JC, 1993, EVOL ECOL, V7, P605, DOI 10.1007/BF01237824; Byrne BC, 1999, THESIS U LEICESTER L; Capy P, 2000, HEREDITY, V84, P468, DOI 10.1046/j.1365-2540.2000.00711.x; CARLSON DA, 1989, ANAL CHEM, V61, P1564, DOI 10.1021/ac00189a019; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; COYNE JA, 1995, P NATL ACAD SCI USA, V92, P9505, DOI 10.1073/pnas.92.21.9505; Cvacka J, 2006, J CHEM ECOL, V32, P409, DOI 10.1007/s10886-005-9008-5; Dreisewerd K, 2005, ANAL CHEM, V77, P4098, DOI 10.1021/ac048373w; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Etges WJ, 2008, J EVOLUTION BIOL, V21, P1641, DOI 10.1111/j.1420-9101.2008.01601.x; Etges WJ, 2006, J CHEM ECOL, V32, P2629, DOI 10.1007/s10886-006-9187-8; Etges WJ, 2006, ANIM BEHAV, V71, P1205, DOI 10.1016/j.anbehav.2005.11.006; Etges WJ, 2010, EVOLUTION, V64, P3549, DOI 10.1111/j.1558-5646.2010.01096.x; Etges WJ, 2009, EVOLUTION, V63, P1712, DOI 10.1111/j.1558-5646.2009.00661.x; Etges William J., 1999, P164; Etges WJ, 2001, J CHEM ECOL, V27, P2125, DOI 10.1023/A:1012203222876; ETGES WJ, 1987, OECOLOGIA, V71, P375, DOI 10.1007/BF00378710; ETGES WJ, 1992, EVOLUTION, V46, P1945, DOI [10.2307/2410042, 10.1111/j.1558-5646.1992.tb01180.x]; Etges WJ, 2001, AM NAT, V158, P585, DOI 10.1086/323587; Everaerts C, 2010, ANIM BEHAV, V79, P1135, DOI 10.1016/j.anbehav.2010.02.013; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; FELLOWS DP, 1972, ECOLOGY, V53, P850, DOI 10.2307/1934300; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FOGLEMAN JC, 1981, P NATL ACAD SCI-BIOL, V78, P4435, DOI 10.1073/pnas.78.7.4435; FOGLEMAN JC, 1989, APPL ENVIRON MICROB, V55, P100, DOI 10.1128/AEM.55.1.100-105.1989; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Heed W.G., 1986, P311; Heed W.B., 1982, P65; Heed W. B., 1978, ECOLOGICAL GENETICS, P109, DOI DOI 10.1007/978-1-4612-6330-2; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JACKSON LL, 1974, INSECT BIOCHEM, V4, P369, DOI 10.1016/0020-1790(74)90074-2; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Jennings JH, 2010, EVOLUTION, V64, P587, DOI 10.1111/j.1558-5646.2009.00834.x; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; MARKOW TA, 1983, EVOLUTION, V37, P649, DOI 10.1111/j.1558-5646.1983.tb05585.x; Mas F, 2005, J CHEM ECOL, V31, P2747, DOI 10.1007/s10886-005-7570-5; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Mori K, 2010, TETRAHEDRON, V66, P7161, DOI 10.1016/j.tet.2010.06.080; RUIZ A, 1988, J ANIM ECOL, V57, P237, DOI 10.2307/4775; RUIZ A, 1990, J HERED, V81, P30, DOI 10.1093/oxfordjournals.jhered.a110922; SAS-Institute, 2004, SAS STAT 9 1 2; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Starmer W.T., 1982, P159; STARMER WT, 1982, MICROBIAL ECOL, V8, P71, DOI 10.1007/BF02011463; STARMER WT, 1990, EVOL BIOL, V24, P253; Stennett MD, 1997, J CHEM ECOL, V23, P2803, DOI 10.1023/A:1022519228346; TAYLOR BJ, 1989, J NEUROGENET, V5, P193, DOI 10.3109/01677068909066208; TOOLSON EC, 1990, ANN ENTOMOL SOC AM, V83, P1165, DOI 10.1093/aesa/83.6.1165; Wasserman Marvin, 1992, P455; Xu A, 2002, CELL TISSUE RES, V307, P381, DOI 10.1007/s00441-002-0524-0; Yew JY, 2008, P NATL ACAD SCI USA, V105, P7135, DOI 10.1073/pnas.0802692105; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	61	33	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16898	10.1371/journal.pone.0016898	http://dx.doi.org/10.1371/journal.pone.0016898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21369358	gold, Green Submitted, Green Published			2022-12-25	WOS:000287367600022
J	Ohta, H; Arai, S; Akita, K; Ohta, T; Fukuda, S				Ohta, Hitomi; Arai, Shigeyuki; Akita, Kenji; Ohta, Tsunetaka; Fukuda, Shigeharu			Neurotrophic Effects of a Cyanine Dye via the PI3K-Akt Pathway: Attenuation of Motor Discoordination and Neurodegeneration in an Ataxic Animal Model	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PC12 CELLS; NEURITE OUTGROWTH; CEREBRAL-ISCHEMIA; PURKINJE-CELLS; PROTEIN-KINASE; FACTOR-I; BRAIN; RECEPTOR; NEURONS	Background: Neurotrophic factors may be future therapeutic agents for neurodegenerative disease. In the screening of biologically active molecules for neurotrophic potency, we found that a photosensitizing cyanine dye, NK-4, had remarkable neurotrophic activities and was a potent radical scavenger. Methodology/Principal Findings: In this study, we evaluated the effect of NK-4 on the protection of neurons against oxidative damage and investigated the associated intracellular signaling pathways. Subsequently, we evaluated the effect of NK-4 in an animal model of neurodegeneration. In vitro, NK-4 showed dose-dependent protection of PC12 cells from toxicity induced by oxidative stress caused by hydrogen peroxide (H2O2) or 6-hydroxydopamine (6-OHDA). Comparison of extracellular signal-regulated kinase signaling pathways between treatment with NK-4 and nerve growth factor (NGF) using K252a, an inhibitor of the NGF receptor TrkA, revealed that NK-4 activity occurs independently of NGF receptors. LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor, blocked the protective effect of NK-4, and NK-4 caused activation of Akt/protein kinase B, a downstream effector of PI3K. These results suggest that the neuroprotective effects of NK-4 are mediated by the PI3K-Akt signaling pathway. NK-4 treatment also attenuated stress-induced activation of SAPK/JNK, which suggests that NK-4 activates a survival signaling pathway and inhibits stress-activated apoptotic pathways independently of the TrkA receptor in neuronal cells. In vivo, administration of NK-4 improved motor coordination in genetic ataxic hamsters, as assessed by rota-rod testing. Histological analysis showed that cerebellar atrophy was significantly attenuated by NK-4 treatment. Notably, the Purkinje cell count in the treated group was threefold higher than that in the vehicle group. Conclusions/Significance: These results suggest that NK-4 is a potential agent for therapy for neurodegenerative disorders based on the activation of survival signaling pathways.	[Ohta, Hitomi; Arai, Shigeyuki; Akita, Kenji; Ohta, Tsunetaka; Fukuda, Shigeharu] Hayashibara Biochem Labs Inc, Res Ctr, Inst Biomed, Okayama, Japan	Hayashibara Biochemical Laboratories, Inc.	Ohta, H (corresponding author), Hayashibara Biochem Labs Inc, Res Ctr, Inst Biomed, Okayama, Japan.	htmohta@hayashibara.co.jp			Hayashibara Biochemical Laboratories Inc.	Hayashibara Biochemical Laboratories Inc.	Funding: Funding for this study was provided by Hayashibara Biochemical Laboratories Inc. The authors are employees of Hayashibara Biochemical Laboratories Inc., and they participated in study design, data collection, decision to publish and preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akita K, 2007, J NEUROGENET, V21, P19, DOI 10.1080/01677060600843316; Akita K, 2009, CEREBELLUM, V8, P202, DOI 10.1007/s12311-009-0113-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barski JJ, 2003, J NEUROSCI, V23, P3469; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; BERG MM, 1992, J BIOL CHEM, V267, P13; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Carrascosa C, 2004, BIOMATERIALS, V25, P707, DOI 10.1016/S0142-9612(03)00562-3; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Culmsee C, 2002, NEUROSCIENCE, V115, P1089, DOI 10.1016/S0306-4522(02)00539-0; Dago L, 2002, J NEUROCHEM, V81, P17, DOI 10.1046/j.1471-4159.2002.00803.x; de Warrenburg BPC, 2005, MOVEMENT DISORD, V20, P497, DOI 10.1002/mds.20375; Fernandez AM, 1998, P NATL ACAD SCI USA, V95, P1253, DOI 10.1073/pnas.95.3.1253; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121; Florez-McClure ML, 2004, J NEUROSCI, V24, P4498, DOI 10.1523/JNEUROSCI.5744-03.2004; Fonnum F, 2004, J NEUROCHEM, V88, P513, DOI 10.1046/j.1471-4159.2003.02211.x; Fonnum F, 2000, TOXICOL LETT, V112, P9, DOI 10.1016/S0378-4274(99)00246-5; GIAVAZZI R, 1986, CANCER RES, V46, P1928; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; Halliwell B, 1999, FREE RADIC BIOL MED, V3, P146; Halliwell B, 1999, FREE RADIC BIOL MED, V3, P170; Halliwell B., 1999, FREE RADICALS BIOL M, V3, P140; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ishihara M, 2007, IN VIVO, V21, P163; Kim Y, 2004, MOL CELLS, V18, P353; Koya-Miyata S, 2010, BIOL PHARM BULL, V33, P1872, DOI 10.1248/bpb.33.1872; Kunikata T, 2002, BIOL PHARM BULL, V25, P1018, DOI 10.1248/bpb.25.1018; LEVI A, 1988, MOL NEUROBIOL, V2, P201, DOI 10.1007/BF02935346; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Malek RL, 1999, J BIOL CHEM, V274, P35499, DOI 10.1074/jbc.274.50.35499; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; MENDEZ JS, 1975, J NEUROSURG, V42, P166, DOI 10.3171/jns.1975.42.2.0166; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Mironov SL, 2009, J PHYSIOL-LONDON, V587, P2473, DOI 10.1113/jphysiol.2009.169805; Mito K, 1996, J MED ENG TECHNOL, V20, P121, DOI 10.3109/03091909609008390; Mito Keiichiro, 1996, Frontiers of Medical and Biological Engineering, V7, P81; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; SHAFER TJ, 1991, NEUROTOXICOLOGY, V12, P473; Shimoke K, 1999, DEV BRAIN RES, V112, P245, DOI 10.1016/S0165-3806(98)00172-2; Spedding M, 2008, NOVART FDN SYMP, V289, P222, DOI [DOI 10.1002/9780470751251.CH18, DOI 10.1002/SERIES1767]; Ushio C, 2009, BIOMED RES-TOKYO, V30, P365, DOI 10.2220/biomedres.30.365; Weeks BS, 2007, MED SCI MONITOR, V13, pBR51; Welsh JP, 2002, ADV NEUROL, V89, P331; Yoo Young Mi, 2003, Neurosurg Focus, V15, pECP1; Zhang LL, 2000, J NEUROSCI RES, V59, P489, DOI 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9; Zhou XH, 2003, BIOL PHARM BULL, V26, P341	56	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17137	10.1371/journal.pone.0017137	http://dx.doi.org/10.1371/journal.pone.0017137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347252	gold, Green Submitted, Green Published			2022-12-25	WOS:000287364500032
J	Tanturli, M; Giuntoli, S; Barbetti, V; Rovida, E; Dello Sbarba, P				Tanturli, Michele; Giuntoli, Serena; Barbetti, Valentina; Rovida, Elisabetta; Dello Sbarba, Persio			Hypoxia Selects Bortezomib-Resistant Stem Cells of Chronic Myeloid Leukemia	PLOS ONE			English	Article							BONE-MARROW-CELLS; APOPTOSIS; PROGENITORS	We previously demonstrated that severe hypoxia inhibits growth of Chronic Myeloid Leukemia (CML) cells and selects stem cells where BCR/Abl(protein) is suppressed, although mRNA is not, so that hypoxia-selected stem cells, while remaining leukemic, are independent of BCR/Abl signaling and thereby refractory to Imatinib-mesylate. The main target of this study was to address the effects of the proteasome inhibitor Bortezomib (BZ) on the maintenance of stem or progenitor cells in hypoxic primary cultures (LC1), by determining the capacity of LC1 cells to repopulate normoxic secondary cultures (LC2) and the kinetics of this repopulation. Unselected K562 cells from day-2 hypoxic LC1 repopulated LC2 with rapid, progenitor-type kinetics; this repopulation was suppressed by BZ addition to LC1 at time 0, but completely resistant to day-1 BZ, indicating that progenitors require some time to adapt to stand hypoxia. K562 cells selected in hypoxic day-7 LC1 repopulated LC2 with stem-type kinetics, which was largely resistant to BZ added at either time 0 or day 1, indicating that hypoxia-selectable stem cells are BZ-resistant per se, i.e. before their selection. Furthermore, these cells were completely resistant to day-6 BZ, i.e. after selection. On the other hand, hypoxia-selected stem cells from CD34-positive cells of blast-crisis CML patients appeared completely resistant to either time-0 or day-1 BZ. To exploit in vitro the capacity of CML cells to adapt to hypoxia enabled to detect a subset of BZ-resistant leukemia stem cells, a finding of particular relevance in light of the fact that our experimental system mimics the physiologically hypoxic environment of bone marrow niches where leukemia stem cells most likely home and sustain minimal residual disease in vivo. This suggests the use of BZ as an enhanced strategy to control CML. in particular to prevent relapse of disease, to be considered with caution and to need further deepening.	[Tanturli, Michele] Univ Florence, Dipartimento Patol & Oncol Sperimentali, Florence, Italy; Ist Toscano Tumori, Florence, Italy	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Tanturli, M (corresponding author), Univ Florence, Dipartimento Patol & Oncol Sperimentali, Florence, Italy.	persio@unifi.it	Rovida, Elisabetta/F-3565-2015; Dello Sbarba, Persio/AAX-9887-2020	Rovida, Elisabetta/0000-0002-5949-3239; Tanturli, Michele/0000-0002-2642-1706	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG5220]; Associazione Italiana per la lotta contro le Leucemie e i Linfomi (AIL, sezione di Prato), Fondazione Cassa di Risparmio di Volterra; Federazione Italiana per la Ricerca sul Cancro (FIRC); Istituto Toscano Tumori (ITT)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la lotta contro le Leucemie e i Linfomi (AIL, sezione di Prato), Fondazione Cassa di Risparmio di Volterra(Fondazione AIRC per la ricerca sul cancro); Federazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori (ITT)	This work was supported by grants from Istituto Toscano Tumori (ITT), Associazione Italiana per la Ricerca sul Cancro (AIRC; contract # IG5220) and Associazione Italiana per la lotta contro le Leucemie e i Linfomi (AIL, sezione di Prato), Fondazione Cassa di Risparmio di Volterra. VB was supported by Federazione Italiana per la Ricerca sul Cancro (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albero MP, 2010, ONCOGENE, V29, P3276, DOI 10.1038/onc.2010.81; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Cipolleschi MG, 2000, LEUKEMIA, V14, P735, DOI 10.1038/sj.leu.2401744; DELLOSBARBA P, 1987, EXP HEMATOL, V15, P137; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Giuntoli S, 2006, LEUKEMIA, V20, P1291, DOI 10.1038/sj.leu.2404224; Giuntoli S, 2007, STEM CELLS, V25, P1119, DOI 10.1634/stemcells.2006-0637; Giuntoli S, 2011, HAEMATOL-HEMATOL J, V96, P204, DOI 10.3324/haematol.2010.029082; Heaney NB, 2010, BLOOD, V115, P2241, DOI 10.1182/blood-2008-06-164582; Ivanovic Z, 2002, EXP HEMATOL, V30, P67, DOI 10.1016/S0301-472X(01)00765-2; Jagani Z, 2009, CANCER RES, V69, P6546, DOI 10.1158/0008-5472.CAN-09-0605; Olivotto M, 2008, CELL CYCLE, V7, P176, DOI 10.4161/cc.7.2.5315; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104	13	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17008	10.1371/journal.pone.0017008	http://dx.doi.org/10.1371/journal.pone.0017008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347297	Green Published, Green Submitted, gold			2022-12-25	WOS:000287364500021
J	Vuohelainen, T; Ojala, R; Virtanen, A; Korhonen, P; Luukkaala, T; Holm, P; Tammela, O				Vuohelainen, Tuomo; Ojala, Riitta; Virtanen, Anita; Korhonen, Paivi; Luukkaala, Tiina; Holm, Paivi; Tammela, Outi			Decreased Free Water Clearance Is Associated with Worse Respiratory Outcomes in Premature Infants	PLOS ONE			English	Article							ANTI-DIURETIC HORMONE; ATRIAL-NATRIURETIC-PEPTIDE; BRONCHOPULMONARY DYSPLASIA; MECHANICAL VENTILATION; DISTRESS SYNDROME; NEONATAL-PERIOD; VASOPRESSIN; HOMEOSTASIS; EXCRETION; PRESSURE	Objective: The goal was to elucidate predictors of decreased free water clearance (DFWC) in very low birth weight (VLBW) infants. We hypothesized that DFWC and fluid retention are linked to the severity of pulmonary problems and prolonged respiratory support, especially to nCPAP treatment. Methods: The investigation was carried out at Tampere University Hospital between 2001 and 2006. The study population comprised 74 VLBW infants born at 29.21 (24.57-34.14) weeks of gestation. Median birth weight was 1175 (575-1490) grams. We measured plasma and urine osmolality and 24-hour urine volume to calculate free water clearance (FWC) for each infant. If FWC was less than 30 ml/kg/day the infant was classified as having DFWC. Results: There were 38 (51.4%) infants with DFWC in the study population. The median duration of the observed DFT period was 14 (4-44) days. The gestational age at birth was lower for DFWC infants compared to infants with normal FWC (NFWC), 28.29 (24.57-32.86) vs. 30.00 (25.57-34.14) weeks (p = 0.001). DFWC infants also needed longer ventilator treatment, 2 (0-23) vs. 0.50 (0-23) days (p = 0.046), nCPAP treatment 30 (0-100) vs. 3 (0-41) days (p < 0.0001) and longer oxygen supplementation 47 (0-163) vs. 22 (0-74) days (p = 0.011) than NFWC infants. All values presented here are medians with ranges. Conclusions: DFWC appears to be frequently connected with exacerbation and prolongation of pulmonary problems in VLBW infants. Cautious fluid administration seems to be indicated in VLBW infants with prolonged respiratory problems and DFWC.	[Vuohelainen, Tuomo; Ojala, Riitta; Virtanen, Anita; Korhonen, Paivi; Tammela, Outi] Univ Tampere, Paediat Res Ctr, FIN-33101 Tampere, Finland; [Vuohelainen, Tuomo; Ojala, Riitta; Virtanen, Anita; Korhonen, Paivi; Tammela, Outi] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Vuohelainen, Tuomo; Ojala, Riitta; Korhonen, Paivi; Tammela, Outi] Tampere Univ Hosp, Dept Paediat, Tampere, Finland; [Luukkaala, Tiina] Pirkanmaa Hosp Dist, Ctr Sci, Tampere, Finland; [Holm, Paivi] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital	Vuohelainen, T (corresponding author), Univ Tampere, Paediat Res Ctr, FIN-33101 Tampere, Finland.	tuomo.vuohelainen@fimnet.fi		Luukkaala, Tiina/0000-0003-4636-9586; Korhonen, Paivi/0000-0002-1747-5526	Tampere University Hospital [9K130, 9L102]	Tampere University Hospital	This study was financially supported by the Competitive Research Funding of the Tampere University Hospital (Grants 9K130 and 9L102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell EF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000503.pub2; BENFIELD GFA, 1982, THORAX, V37, P147, DOI 10.1136/thx.37.2.147; Das Bibhuti B., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P43; DAWSON KP, 1983, THORAX, V38, P589, DOI 10.1136/thx.38.8.589; FRASS M, 1993, CRIT CARE MED, V21, P343, DOI 10.1097/00003246-199303000-00009; HAZINSKI TA, 1988, PEDIATR RES, V23, P86, DOI 10.1203/00006450-198801000-00019; HEMMER M, 1980, ANESTHESIOLOGY, V52, P395, DOI 10.1097/00000542-198005000-00004; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kobr J, 2010, PHYSIOL RES, V59, P545, DOI 10.33549/physiolres.931752; KOJIMA T, 1990, PEDIATR RES, V27, P260, DOI 10.1203/00006450-199003000-00011; Laughon MM, 2009, SEMIN FETAL NEONAT M, V14, P374, DOI 10.1016/j.siny.2009.08.002; MANNING PT, 1985, SCIENCE, V229, P395, DOI 10.1126/science.2990050; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Pihkala J, 1989, Duodecim, V105, P1540; RAO M, 1986, AM J DIS CHILD, V140, P825, DOI 10.1001/archpedi.1986.02140220107045; RONCONI M, 1995, J PERINAT MED, V23, P307, DOI 10.1515/jpme.1995.23.4.307; ROSSAINT R, 1993, J APPL PHYSIOL, V75, P2484, DOI 10.1152/jappl.1993.75.6.2484; SHENNAN AT, 1988, PEDIATRICS, V82, P527; SPITZER AR, 1981, J PEDIATR-US, V98, P476, DOI 10.1016/S0022-3476(81)80728-7; Swischuk LE, 1996, PEDIATR RADIOL, V26, P508, DOI 10.1007/BF01372230; TAMMELA OKT, 1992, ACTA PAEDIATR, V81, P207, DOI 10.1111/j.1651-2227.1992.tb12205.x; TAMMELA OKT, 1995, EUR J PEDIATR, V154, pS15, DOI 10.1007/BF02155106; Tkacova R, 1997, J AM COLL CARDIOL, V30, P739, DOI 10.1016/S0735-1097(97)00199-X; Vuohelainen T, 2008, ACTA PAEDIATR, V97, P904, DOI 10.1111/j.1651-2227.2008.00809.x; Vuohelainen T, 2007, PEDIATR RES, V62, P106, DOI 10.1203/PDR.0b013e3180674d92; VUORI A, 1982, INT J CLIN PHARM TH, V20, P488; WIRIYATHIAN S, 1986, PEDIATR RES, V20, P103, DOI 10.1203/00006450-198602000-00001	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16995	10.1371/journal.pone.0016995	http://dx.doi.org/10.1371/journal.pone.0016995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347330	gold, Green Published, Green Submitted			2022-12-25	WOS:000287363000029
J	Brenner, K; Arnold, FH				Brenner, Katie; Arnold, Frances H.			Self-Organization, Layered Structure, and Aggregation Enhance Persistence of a Synthetic Biofilm Consortium	PLOS ONE			English	Article							EVOLUTIONARY PERSPECTIVE; SPATIAL STRUCTURE; COMMUNICATION; COMMUNITY; SELECTION; BACTERIA; MICROORGANISMS; POPULATIONS; COMPETITION; BEHAVIOR	Microbial consortia constitute a majority of the earth's biomass, but little is known about how these cooperating communities persist despite competition among community members. Theory suggests that non-random spatial structures contribute to the persistence of mixed communities; when particular structures form, they may provide associated community members with a growth advantage over unassociated members. If true, this has implications for the rise and persistence of multi-cellular organisms. However, this theory is difficult to study because we rarely observe initial instances of non-random physical structure in natural populations. Using two engineered strains of Escherichia coli that constitute a synthetic symbiotic microbial consortium, we fortuitously observed such spatial self-organization. This consortium forms a biofilm and, after several days, adopts a defined layered structure that is associated with two unexpected, measurable growth advantages. First, the consortium cannot successfully colonize a new, downstream environment until it self-organizes in the initial environment; in other words, the structure enhances the ability of the consortium to survive environmental disruptions. Second, when the layered structure forms in downstream environments the consortium accumulates significantly more biomass than it did in the initial environment; in other words, the structure enhances the global productivity of the consortium. We also observed that the layered structure only assembles in downstream environments that are colonized by aggregates from a previous, structured community. These results demonstrate roles for self-organization and aggregation in persistence of multi-cellular communities, and also illustrate a role for the techniques of synthetic biology in elucidating fundamental biological principles.	[Brenner, Katie; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Brenner, K (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu		Arnold, Frances H./0000-0002-4027-364X	National Institutes of Health [1-R01-CA118486]; NATIONAL CANCER INSTITUTE [R01CA118486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the National Institutes of Health grant 1-R01-CA118486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Johnson CR, 2002, TRENDS ECOL EVOL, V17, P83, DOI 10.1016/S0169-5347(01)02385-0; Johnson CR, 2002, P ROY SOC B-BIOL SCI, V269, P655, DOI 10.1098/rspb.2001.1948; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Lion S, 2008, ECOL LETT, V11, P277, DOI 10.1111/j.1461-0248.2007.01132.x; Millstein RL, 2006, BRIT J PHILOS SCI, V57, P627, DOI 10.1093/bjps/axl025; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Pesci EC, 1997, TRENDS MICROBIOL, V5, P132, DOI 10.1016/S0966-842X(97)01008-1; RICHAUD C, 1984, J BIOL CHEM, V259, P4824; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Urban MC, 2006, ECOLOGY, V87, P1616, DOI 10.1890/0012-9658(2006)87[1616:EMTAEP]2.0.CO;2; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Wingreen NS, 2006, PLOS BIOL, V4, P1486, DOI 10.1371/journal.pbio.0040299	35	52	54	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16791	10.1371/journal.pone.0016791	http://dx.doi.org/10.1371/journal.pone.0016791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347422	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000287361700033
J	Streit, AK; Netter, MF; Kempf, F; Walecki, M; Rinne, S; Bollepalli, MK; Preisig-Muller, R; Renigunta, V; Daut, J; Baukrowitz, T; Sansom, MSP; Stansfeld, PJ; Decher, N				Streit, Anne K.; Netter, Michael F.; Kempf, Franca; Walecki, Magdalena; Rinne, Susanne; Bollepalli, Murali K.; Preisig-Mueller, Regina; Renigunta, Vijay; Daut, Juergen; Baukrowitz, Thomas; Sansom, Mark S. P.; Stansfeld, Phillip J.; Decher, Niels			A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKGROUND K+ CHANNEL; MOLECULAR-BASIS; PH; BINDING; ION; INACTIVATION; SELECTIVITY; CISAPRIDE; MEMBER; HERG	Two-pore domain potassium (K-2P) channels play a key role in setting the membrane potential of excitable cells. Despite their role as putative targets for drugs and general anesthetics, little is known about the structure and the drug binding site of K-2P channels. We describe A1899 as a potent and highly selective blocker of the K-2P channel TASK-1. As A1899 acts as an open-channel blocker and binds to residues forming the wall of the central cavity, the drug was used to further our understanding of the channel pore. Using alanine mutagenesis screens, we have identified residues in both pore loops, the M2 and M4 segments, and the halothane response element to form the drug binding site of TASK-1. Our experimental data were used to validate a K-2P open-pore homology model of TASK-1, providing structural insights for future rational design of drugs targeting K-2P channels.	[Streit, Anne K.; Netter, Michael F.; Kempf, Franca; Walecki, Magdalena; Rinne, Susanne; Decher, Niels] Univ Marburg, Inst Physiol & Pathophysiol, Vegetat Physiol Grp, D-35037 Marburg, Germany; [Bollepalli, Murali K.] Univ Jena, Inst Physiol 2, D-07743 Jena, Germany; [Preisig-Mueller, Regina; Renigunta, Vijay; Daut, Juergen] Univ Marburg, Inst Physiol & Pathophysiol, Cardiovasc Cell Physiol Grp, D-35037 Marburg, Germany; [Baukrowitz, Thomas] Univ Kiel, Inst Physiol, D-24118 Kiel, Germany; [Sansom, Mark S. P.; Stansfeld, Phillip J.] Univ Oxford, Struct Bioinformat & Computat Biochem Unit, Dept Biochem, Oxford OX1 3QU, England	Philipps University Marburg; Friedrich Schiller University of Jena; Philipps University Marburg; University of Kiel; University of Oxford	Decher, N (corresponding author), Deutschhausstr 1-2, D-35037 Marburg, Germany.	decher@staff.uni-marburg.de	Decher, Niels/AAF-5002-2020; Stansfeld, Phill/C-6213-2011; Sansom, Mark S.P./C-5157-2009; Stansfeld, Phillip James/AAA-9228-2020	Stansfeld, Phill/0000-0001-8800-7669; Sansom, Mark S.P./0000-0001-6360-7959; Stansfeld, Phillip James/0000-0001-8800-7669; Baukrowitz, Thomas/0000-0003-4562-0505	Kempkes Stiftung [12/08]; Deutsche Forschungsgemeinschaft [BA-1793/5-1, DE-1482/3-1, DE-1482/2-1]; Wellcome Trust	Kempkes Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Kempkes Stiftung Grant 12/08 (to N.D.) and by Deutsche Forschungsgemeinschaft Grants BA-1793/5-1 (to T.B.), DE-1482/3-1 (to N.D. and J.D.), and DE-1482/2-1 (to N.D.).; Supported by the Wellcome Trust.	ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Ashmole I, 2001, PFLUG ARCH EUR J PHY, V442, P828, DOI 10.1007/s004240100620; Barrows B, 2009, CHANNELS, V3, P239; Bruhova I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-5; Budde T, 2008, PFLUG ARCH EUR J PHY, V456, P1061, DOI 10.1007/s00424-008-0482-9; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; Czirjak G, 2000, MOL ENDOCRINOL, V14, P863, DOI 10.1210/me.14.6.863; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; Decher N, 2006, MOL PHARMACOL, V70, P1204, DOI 10.1124/mol.106.026203; Dilmac N, 2004, MOL PHARMACOL, V66, P1236, DOI 10.1124/mol.104.000893; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Meadows HJ, 2001, NEUROPHARMACOLOGY, V40, P551, DOI 10.1016/S0028-3908(00)00189-1; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Putzke C, 2007, CARDIOVASC RES, V75, P59, DOI 10.1016/j.cardiores.2007.02.025; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Strutz-Seebohm N, 2007, CELL PHYSIOL BIOCHEM, V20, P791, DOI 10.1159/000110439; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Treptow W, 2010, J AM CHEM SOC, V132, P8145, DOI 10.1021/ja102191s	29	66	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13977	13984		10.1074/jbc.M111.227884	http://dx.doi.org/10.1074/jbc.M111.227884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21362619	Green Published, hybrid			2022-12-25	WOS:000289556200020
J	Leuner, K; Kraus, M; Woelfle, U; Beschmann, H; Harteneck, C; Boehncke, WH; Schempp, CM; Muller, WE				Leuner, Kristina; Kraus, Margarethe; Woelfle, Ute; Beschmann, Heike; Harteneck, Christian; Boehncke, Wolf-Henning; Schempp, Christoph M.; Mueller, Walter E.			Reduced TRPC Channel Expression in Psoriatic Keratinocytes Is Associated with Impaired Differentiation and Enhanced Proliferation	PLOS ONE			English	Article							CALCIUM-INDUCED DIFFERENTIATION; HUMAN GINGIVAL KERATINOCYTES; SENSING RECEPTOR; POTENTIAL ROLE; SKIN; ACTIVATION; DISEASE; CELLS	Psoriasis is a characteristic inflammatory and scaly skin condition with typical histopathological features including increased proliferation and hampered differentiation of keratinocytes. The activation of innate and adaptive inflammatory cellular immune responses is considered to be the main trigger factor of the epidermal changes in psoriatic skin. However, the molecular players that are involved in enhanced proliferation and impaired differentiation of psoriatic keratinocytes are only partly understood. One important factor that regulates differentiation on the cellular level is Ca(2+). In normal epidermis, a Ca(2+) gradient exists that is disturbed in psoriatic plaques, favoring impaired keratinocyte proliferation. Several TRPC channels such as TRPC1, TRPC4, or TRPC6 are key proteins in the regulation of high [Ca(2+)] ex induced differentiation. Here, we investigated if TRPC channel function is impaired in psoriasis using calcium imaging, RT-PCR, western blot analysis and immunohistochemical staining of skin biopsies. We demonstrated substantial defects in Ca(2+) influx in psoriatic keratinocytes in response to high extracellular Ca(2+) levels, associated with a downregulation of all TRPC channels investigated, including TRPC6 channels. As TRPC6 channel activation can partially overcome this Ca(2+) entry defect, specific TRPC channel activators may be potential new drug candidates for the topical treatment of psoriasis.	[Leuner, Kristina; Kraus, Margarethe; Mueller, Walter E.] Goethe Univ Frankfurt, Inst Pharmacol, Bioctr Niederursel, Frankfurt, Germany; [Woelfle, Ute; Schempp, Christoph M.] Univ Med Ctr, Dept Dermatol, Freiburg, Germany; [Beschmann, Heike; Boehncke, Wolf-Henning] Goethe Univ Frankfurt, Dept Dermatol, Frankfurt, Germany; [Harteneck, Christian] Univ Tubingen, Inst Pharmacol & Toxicol, Tubingen, Germany; [Harteneck, Christian] Univ Tubingen, Interfac Ctr Pharmacogenom & Drug Res, Tubingen, Germany	Goethe University Frankfurt; University of Freiburg; Goethe University Frankfurt; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Leuner, K (corresponding author), Goethe Univ Frankfurt, Inst Pharmacol, Bioctr Niederursel, Frankfurt, Germany.	Leuner@em.uni-frankfurt.de	Wölfle, Ute/AAG-6972-2021; Friedland, Kristina/G-4651-2015	Wölfle, Ute/0000-0003-0093-560X; Friedland, Kristina/0000-0001-8603-5957; Muller, Werner E.G./0000-0002-8223-3689	Cassella-med GmbH & Co. KG, Cologne, Germany	Cassella-med GmbH & Co. KG, Cologne, Germany	This study was supported by Cassella-med GmbH & Co. KG, Cologne, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; W.E. Muller and C.M. Schempp received research grants from Cassella-med GmbH & Co. KG, Cologne, Germany. This does not alter the authors' adherence to all PLoS ONE policies of sharing.	Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Beck B, 2008, CELL CALCIUM, V43, P492, DOI 10.1016/j.ceca.2007.08.005; Beck B, 2006, J INVEST DERMATOL, V126, P1982, DOI 10.1038/sj.jid.5700352; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Cai SW, 2006, PFLUG ARCH EUR J PHY, V452, P43, DOI 10.1007/s00424-005-0001-1; Cai SW, 2005, J DERMATOL SCI, V40, P21, DOI 10.1016/j.jdermsci.2005.06.005; Fatherazi S, 2007, PFLUG ARCH EUR J PHY, V453, P879, DOI 10.1007/s00424-006-0156-4; GERDES J, 1984, J IMMUNOL, V133, P1710; HANCOCK GE, 1988, J EXP MED, V168, P1395, DOI 10.1084/jem.168.4.1395; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; JONES KT, 1994, EXP CELL RES, V210, P71, DOI 10.1006/excr.1994.1011; Karvonen SL, 2000, J INVEST DERMATOL, V114, P693, DOI 10.1046/j.1523-1747.2000.00926.x; KRUEGER GG, 1981, J CLIN INVEST, V68, P1548, DOI 10.1172/JCI110409; Leuner K, 2010, MOL PHARMACOL, V77, P368, DOI 10.1124/mol.109.057513; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Montell C, 2006, CHEM SENSES, V31, pA45; Muller M, 2008, J BIOL CHEM, V283, P33942, DOI 10.1074/jbc.M801844200; OLANIRAN AK, 1995, ARCH DERMATOL RES, V287, P231, DOI 10.1007/BF01105071; Pani B, 2008, CELL MOL LIFE SCI, V65, P205, DOI 10.1007/s00018-007-7397-z; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Tschachler E, 2007, CLIN DERMATOL, V25, P589, DOI 10.1016/j.clindermatol.2007.09.021; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Woelfle U, 2010, J INVEST DERMATOL, V130, P113, DOI 10.1038/jid.2009.248; Wolk K, 2007, EXP DERMATOL, V16, P234; Wolk K, 2006, J INVEST DERMATOL, V126, P122; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227	32	55	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e14716	10.1371/journal.pone.0014716	http://dx.doi.org/10.1371/journal.pone.0014716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364982	gold, Green Published, Green Submitted			2022-12-25	WOS:000287656600001
J	Zehendner, CM; Librizzi, L; de Curtis, M; Kuhlmann, CRW; Luhmann, HJ				Zehendner, Christoph M.; Librizzi, Laura; de Curtis, Marco; Kuhlmann, Christoph R. W.; Luhmann, Heiko J.			Caspase-3 Contributes to ZO-1 and Cl-5 Tight-Junction Disruption in Rapid Anoxic Neurovascular Unit Damage	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; FOCAL ISCHEMIA; NEURONAL DEATH; MOUSE MODEL; PERMEABILITY; EXPRESSION; VESSELS; REPERFUSION; INHIBITION	Background: Tight-junction (TJ) protein degradation is a decisive step in hypoxic blood-brain barrier (BBB) breakdown in stroke. In this study we elucidated the impact of acute cerebral ischemia on TJ protein arrangement and the role of the apoptotic effector protease caspase-3 in this context. Methodology/Principal Findings: We used an in vitro model of the neurovascular unit and the guinea pig whole brain preparation to analyze with immunohistochemical methods the BBB properties and neurovascular integrity. In both methodological approaches we observed rapid TJ protein disruptions after 30 min of oxygen and glucose deprivation or middle cerebral artery occlusion, which were accompanied by strong caspase-3 activation in brain endothelial cells (BEC). Surprisingly only few DNA-fragmentations were detected with TUNEL stainings in BEC. Z-DEVD-fmk, an irreversible caspase-3 inhibitor, partly blocked TJ disruptions and was protective on trans-endothelial electrical resistance. Conclusions/Significance: Our data provide evidence that caspase-3 is rapidly activated during acute cerebral ischemia predominantly without triggering DNA-fragmentation in BEC. Further we detected fast TJ protein disruptions which could be partly blocked by caspase-3 inhibition with Z-DEVD-fmk. We suggest that the basis for clinically relevant BBB breakdown in form of TJ disruptions is initiated within minutes during ischemia and that caspase-3 contributes to this process.	[Zehendner, Christoph M.; Kuhlmann, Christoph R. W.; Luhmann, Heiko J.] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, D-6500 Mainz, Germany; [Librizzi, Laura; de Curtis, Marco] Fdn Ist Neurol Carlo Besta, Unit Expt Neurophysiol & Epileptol, Milan, Italy	Johannes Gutenberg University of Mainz; IRCCS Istituto Neurologico Besta	Zehendner, CM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Saarstr 21, D-6500 Mainz, Germany.	luhmann@uni-mainz.de	de Curtis, Marco M/J-8704-2016; Librizzi, Laura/J-7889-2016; Luhmann, Heiko J./N-8797-2019	de Curtis, Marco M/0000-0001-7443-6737; Librizzi, Laura/0000-0002-2741-4452; Luhmann, Heiko J./0000-0002-7934-8661; de Curtis, Marco/0000-0002-5608-929X	neuroscience graduate school at the University Medical Center of the Johannes Gutenberg University of Mainz [DFG GRK 1044]; TALIAN HEALTH MINISTRY; FONDAZIONE CARIPLO [2005.1208/10.4963]; EC [LSH-CT-2006-037315]	neuroscience graduate school at the University Medical Center of the Johannes Gutenberg University of Mainz; TALIAN HEALTH MINISTRY; FONDAZIONE CARIPLO(Fondazione Cariplo); EC(European CommissionEuropean Commission Joint Research Centre)	CMZ was supported by the neuroscience graduate school at the University Medical Center of the Johannes Gutenberg University of Mainz (DFG GRK 1044). LL and MdC were supported by the ITALIAN HEALTH MINISTRY and by a FONDAZIONE CARIPLO grant 2005.1208/10.4963. HJL and MdC receive funding by the EC (LSH-CT-2006-037315, EPICURE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bendfeldt K, 2007, J NEUROSCI, V27, P3260, DOI 10.1523/JNEUROSCI.4033-06.2007; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; Brillault J, 2002, J NEUROCHEM, V83, P807, DOI 10.1046/j.1471-4159.2002.01186.x; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Chen J, 1998, J NEUROSCI, V18, P4914; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; de Curtis M, 1998, BRAIN RES PROTOC, V3, P221, DOI 10.1016/S1385-299X(98)00044-0; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Garnier P, 2004, EUR J NEUROSCI, V20, P937, DOI 10.1111/j.1460-9568.2004.03551.x; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gerriets T, 2009, J NEUROSURG, V111, P1036, DOI 10.3171/2009.3.JNS081040; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Kuhlmann CRW, 2009, NEUROSCI LETT, V449, P168, DOI 10.1016/j.neulet.2008.10.096; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lee SR, 2004, J CEREBR BLOOD F MET, V24, P720, DOI 10.1097/01.WCB.0000122747.72175.47; Li H, 2000, STROKE, V31, P176, DOI 10.1161/01.STR.31.1.176; LLINAS R, 1981, FED PROC, V40, P2240; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; MUHLETHALER M, 1993, EUR J NEUROSCI, V5, P915, DOI 10.1111/j.1460-9568.1993.tb00942.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pastori C, 2007, EXP NEUROL, V204, P95, DOI 10.1016/j.expneurol.2006.09.023; Rosell A, 2008, NEUROSCI LETT, V430, P1, DOI 10.1016/j.neulet.2007.05.006; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Wang ZY, 2009, FREE RADICAL BIO MED, V46, P1032, DOI 10.1016/j.freeradbiomed.2008.11.027; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yenari MA, 2006, STROKE, V37, P1087, DOI 10.1161/01.STR.0000206281.77178.ac; Zehendner CM, 2009, J CEREBR BLOOD F MET, V29, P1879, DOI 10.1038/jcbfm.2009.103; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	67	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16760	10.1371/journal.pone.0016760	http://dx.doi.org/10.1371/journal.pone.0016760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364989	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600017
J	Saraiva, VB; Silva, LD; Ferreira-DaSilva, CT; da Silva, JL; Teixeira-Ferreira, A; Perales, J; Souza, MC; Henriques, MD; Caruso-Neves, C; Pinheiro, AAD				Saraiva, Victor Barbosa; Silva, Leandro de Souza; Ferreira-DaSilva, Claudio Teixeira; da Silva-Filho, Joao Luiz; Teixeira-Ferreira, Andre; Perales, Jonas; Souza, Mariana Conceicao; Henriques, Maria das Gracas; Caruso-Neves, Celso; de Sa Pinheiro, Ana Acacia			Impairment of the Plasmodium falciparum Erythrocytic Cycle Induced by Angiotensin Peptides	PLOS ONE			English	Article							MALARIAL INFECTION; NA+-ATPASE; RECEPTOR; PARASITES; SYSTEM; CELLS; INVASION; KINASES; CULTURE; BLOOD	Plasmodium falciparum causes the most serious complications of malaria and is a public health problem worldwide with over 2 million deaths each year. The erythrocyte invasion mechanisms by Plasmodium sp. have been well described, however the physiological aspects involving host components in this process are still poorly understood. Here, we provide evidence for the role of renin-angiotensin system (RAS) components in reducing erythrocyte invasion by P. falciparum. Angiotensin II (Ang II) reduced erythrocyte invasion in an enriched schizont culture of P. falciparum in a dose-dependent manner. Using mass spectroscopy, we showed that Ang II was metabolized by erythrocytes to Ang IV and Ang-(1-7). Parasite infection decreased Ang-(1-7) and completely abolished Ang IV formation. Similar to Ang II, Ang-(1-7) decreased the level of infection in an A779 (specific antagonist of Ang-(1-7) receptor, MAS)-sensitive manner. 10(-7) M PD123319, an AT(2) receptor antagonist, partially reversed the effects of Ang-(1-7) and Ang II. However, 10(-6) M losartan, an antagonist of the AT(1) receptor, had no effect. Gs protein is a crucial player in the Plasmodium falciparum blood cycle and angiotensin peptides can modulate protein kinase A (PKA) activity; 10(-8) M Ang II or 10(-8) M Ang-(1-7) inhibited this activity in erythrocytes by 60% and this effect was reversed by 10(-7) M A779. 10(-6) M dibutyryl-cAMP increased the level of infection and 10(-7) M PKA inhibitor decreased the level of infection by 30%. These results indicate that the effect of Ang-(1-7) on P. falciparum blood stage involves a MAS-mediated PKA inhibition. Our results indicate a crucial role for Ang II conversion into Ang-(1-7) in controlling the erythrocytic cycle of the malaria parasite, adding new functions to peptides initially described to be involved in the regulation of vascular tonus.	[Saraiva, Victor Barbosa] Inst Fed Educ Ciencia & Tecnol Fluminense, Cabo Frio, Brazil; [Silva, Leandro de Souza; Ferreira-DaSilva, Claudio Teixeira; da Silva-Filho, Joao Luiz; Caruso-Neves, Celso; de Sa Pinheiro, Ana Acacia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Teixeira-Ferreira, Andre; Perales, Jonas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Teixeira-Ferreira, Andre; Perales, Jonas] Rede Proteom Rio de Janeiro, Rio De Janeiro, Brazil; [Souza, Mariana Conceicao; Henriques, Maria das Gracas] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos, Rio De Janeiro, Brazil; [Caruso-Neves, Celso] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, Brazil; [de Sa Pinheiro, Ana Acacia] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Pesquisa Translac Saude & Ambiente Regi, Rio De Janeiro, Brazil	Instituto Federal Fluminense; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Saraiva, VB (corresponding author), Inst Fed Educ Ciencia & Tecnol Fluminense, Cabo Frio, Brazil.	acacia@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Souza, Mariana/GQQ-6648-2022; Henriques, Maria das Graças M O/G-2998-2013; Silva-Filho, João Luiz/I-5704-2016; Fisiologia, Ciencias Biologicas/C-2407-2012; Sila, Leandro/B-1381-2018; Souza, Mariana/C-1677-2015	Caruso-Neves, Celso/0000-0002-2415-7753; Henriques, Maria das Graças M O/0000-0003-3065-0541; Silva-Filho, João Luiz/0000-0003-4762-2205; Sila, Leandro/0000-0001-8720-0088; Barbosa, Victor/0000-0002-9130-8902; Souza, Mariana/0000-0002-6933-9227; Pinheiro, Ana Acacia/0000-0002-3894-1645	World Health Organization [A51005]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [Pronex/FAPERJ E-26/110.562/2010, Pronex/FAPERJ E-26/110.551/2010, APQ1/FAPERJ E-26/110.792/2009, JCNE/FAPERJ E-26/101.450/2010]	World Health Organization(World Health Organization); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by World Health Organization grant (ID. A51005) and by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (Pronex/FAPERJ E-26/110.562/2010, Pronex/FAPERJ E-26/110.551/2010, APQ1/FAPERJ E-26/110.792/2009, JCNE/FAPERJ E-26/101.450/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SP, 2010, AM J PHYSIOL-HEART C, V298, pH587, DOI 10.1152/ajpheart.00975.2009; Al-Qattan KK, 2006, ANAT HISTOL EMBRYOL, V35, P130, DOI 10.1111/j.1439-0264.2005.00649.x; Cerutti C, 1999, MEM I OSWALDO CRUZ, V94, P803, DOI 10.1590/S0074-02761999000600017; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; De Souza AM, 2004, REGUL PEPTIDES, V120, P167, DOI 10.1016/j.regpep.2004.03.005; Dhangadamajhi G, 2010, INFECT GENET EVOL, V10, P337, DOI 10.1016/j.meegid.2010.01.009; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010; Filtz TM, 2004, EUR J PHARMACOL, V502, P11, DOI 10.1016/j.ejphar.2004.08.030; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Haldar K, 2001, CURR OPIN HEMATOL, V8, P92, DOI 10.1097/00062752-200103000-00006; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; KNIGHT A, 1982, T ROY SOC TROP MED H, V76, P503, DOI 10.1016/0035-9203(82)90150-X; Kumar R, 2007, TRENDS ENDOCRIN MET, V18, P208, DOI 10.1016/j.tem.2007.05.001; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lara LD, 2006, BIOCHEM J, V395, P183, DOI 10.1042/BJ20051455; Lara LS, 2010, ARCH BIOCHEM BIOPHYS, V496, P117, DOI 10.1016/j.abb.2010.02.005; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maciel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003296; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Maia J.C., 1983, GENES ANTIGENS PARAS, P144; McDonough AA, 2010, AM J PHYSIOL-REG I, V298, pR851, DOI 10.1152/ajpregu.00002.2010; Merckx A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040019; MONNOT C, 1991, MOL ENDOCRINOL, V5, P1477, DOI 10.1210/mend-5-10-1477; Murphy SC, 2004, BLOOD, V103, P1920, DOI 10.1182/blood-2003-09-3165; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nussberger J, 2001, CLIN CHEM, V47, P726; Rega A., 1979, CATION FLUX BIOMEMBR, P67; Ruiz-Ortega M, 2001, HYPERTENSION, V38, P1382, DOI 10.1161/hy1201.100589; Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Shao Y, 2008, ACTA PHARMACOL SIN, V29, P829, DOI 10.1111/j.1745-7254.2008.00812.x; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Suganuma T, 2005, CLIN CANCER RES, V11, P2686, DOI 10.1158/1078-0432.CCR-04-1946; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vlahakos DV, 2010, AM J KIDNEY DIS, V56, P558, DOI 10.1053/j.ajkd.2009.12.042	38	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17174	10.1371/journal.pone.0017174	http://dx.doi.org/10.1371/journal.pone.0017174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364758	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000287482800030
J	Croitoru-Lamoury, J; Lamoury, FMJ; Caristo, M; Suzuki, K; Walker, D; Takikawa, O; Taylor, R; Brew, BJ				Croitoru-Lamoury, Juliana; Lamoury, Francois M. J.; Caristo, Michael; Suzuki, Kazuo; Walker, David; Takikawa, Osamu; Taylor, Rosanne; Brew, Bruce J.			Interferon-gamma Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO)	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NEURAL PRECURSOR CELLS; L-TRYPTOPHAN TRANSPORT; MARROW STROMAL CELLS; CD4(+) T-CELLS; IMMUNE-RESPONSE; DENDRITIC CELLS; 2,3-DIOXYGENASE ACTIVITY; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS	The kynurenine pathway (KP) of tryptophan metabolism is linked to antimicrobial activity and modulation of immune responses but its role in stem cell biology is unknown. We show that human and mouse mesenchymal and neural stem cells (MSCs and NSCs) express the complete KP, including indoleamine 2,3 dioxygenase 1 (IDO) and IDO2, that it is highly regulated by type I (IFN-beta) and II interferons (IFN-gamma), and that its transcriptional modulation depends on the type of interferon, cell type and species. IFN-gamma inhibited proliferation and altered human and mouse MSC neural, adipocytic and osteocytic differentiation via the activation of IDO. A functional KP present in MSCs, NSCs and perhaps other stem cell types offers novel therapeutic opportunities for optimisation of stem cell proliferation and differentiation.	[Croitoru-Lamoury, Juliana; Lamoury, Francois M. J.; Caristo, Michael; Suzuki, Kazuo; Brew, Bruce J.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Walker, David] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Takikawa, Osamu] Natl Ctr Geriatr & Gerontol, Lab Radiat Safety, Natl Inst Longev Sci, Morioka, Iwate, Japan; [Taylor, Rosanne] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	St Vincents Hospital Sydney; St Vincents Hospital Sydney; Monash University; National Center for Geriatrics & Gerontology; University of Sydney	Croitoru-Lamoury, J (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	j.lamoury@amr.org.au	McLean, Emma/F-4616-2012; Brew, Bruce/J-6513-2012	Suzuki, Kazuo/0000-0002-2531-794X; brew, bruce/0000-0003-0622-1392	National and Health Medical Research Council (NHMRC); St. Vincent's Clinic Foundation, Sydney; University of New South Wales, Sydney, Australia	National and Health Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); St. Vincent's Clinic Foundation, Sydney; University of New South Wales, Sydney, Australia	This work was supported by National and Health Medical Research Council (NHMRC), St. Vincent's Clinic Foundation, Sydney, University of New South Wales, Sydney, Australia and MS Research Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhani A, 2005, EUR J NEUROL, V12, P625, DOI 10.1111/j.1468-1331.2005.01041.x; Austin C, 2009, AMINO ACIDS, V36, P99, DOI 10.1007/s00726-008-0037-6; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; BARISH ME, 1991, DEV BIOL, V144, P412, DOI 10.1016/0012-1606(91)90433-4; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Boasso A, 2005, BLOOD, V105, P1574, DOI 10.1182/blood-2004-06-2089; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Costantino G, 2009, EXPERT OPIN THER TAR, V13, P247, DOI [10.1517/14728220802665734, 10.1517/14728220802665734 ]; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Di Pucchio T, 2010, EXPERT OPIN THER PAT, V20, P229, DOI 10.1517/13543770903512974; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; HEYES MP, 1991, ANN NEUROL, V29, P202, DOI 10.1002/ana.410290215; Hill M, 2007, EUR J IMMUNOL, V37, P3054, DOI 10.1002/eji.200636704; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Kahler David J, 2009, Handb Exp Pharmacol, P165, DOI 10.1007/978-3-540-71029-5_8; Kanai M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-8; Kaper T, 2007, PLOS BIOL, V5, P2201, DOI 10.1371/journal.pbio.0050257; Kudo Y, 2001, J PHYSIOL-LONDON, V531, P417, DOI 10.1111/j.1469-7793.2001.0417i.x; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Kwidzinski E, 2007, J MOL MED, V85, P1351, DOI 10.1007/s00109-007-0229-7; Lamoury FMJ, 2006, CYTOTHERAPY, V8, P228, DOI 10.1080/14653240600735875; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Lu CY, 2010, BIOCHEMISTRY-US, V49, P5028, DOI 10.1021/bi1005078; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Makar TK, 2008, J NEUROIMMUNOL, V196, P67, DOI 10.1016/j.jneuroim.2008.02.014; Manuelpillai U, 2005, AM J OBSTET GYNECOL, V192, P280, DOI 10.1016/j.ajog.2004.06.090; Matysiak M, 2008, J NEUROIMMUNOL, V193, P12, DOI 10.1016/j.jneuroim.2007.07.025; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2009, NEUROSCI LETT, V456, P101, DOI 10.1016/j.neulet.2008.03.097; Puccetti P, 2007, EUR J IMMUNOL, V37, P876, DOI 10.1002/eji.200737184; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Song SJ, 2007, STEM CELLS DEV, V16, P747, DOI 10.1089/scd.2007.0027; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; Takikawa O, 1999, ADV EXP MED BIOL, V467, P553; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Travers MT, 2004, BBA-BIOMEMBRANES, V1661, P106, DOI 10.1016/j.bbamem.2003.12.004; Tyndall A, 2009, CURR OPIN HEMATOL, V16, P285, DOI 10.1097/MOH.0b013e32832aacb3; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vamos E, 2009, J NEUROL SCI; Walker DW, 1999, PEDIATR RES, V45, P820, DOI 10.1203/00006450-199906000-00007; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yadav MC, 2007, GLIA, V55, P1385, DOI 10.1002/glia.20544; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007	63	158	168	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14698	10.1371/journal.pone.0014698	http://dx.doi.org/10.1371/journal.pone.0014698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359206	gold, Green Submitted, Green Published			2022-12-25	WOS:000287392700011
J	Folkers, ME; Delker, DA; Maxwell, CI; Nelson, CA; Schwartz, JJ; Nix, DA; Hagedorn, CH				Folkers, Milan E.; Delker, Don A.; Maxwell, Christopher I.; Nelson, Cassie A.; Schwartz, Jason J.; Nix, David A.; Hagedorn, Curt H.			ENCODE Tiling Array Analysis Identifies Differentially Expressed Annotated and Novel 5 ' Capped RNAs in Hepatitis C Infected Liver	PLOS ONE			English	Article							SIGNALING PATHWAYS; GENETIC-VARIATION; INTERFERON-ALPHA; MESSENGER-RNA; IN-VIVO; VIRUS; PREDICTION; SIGNATURE; AFFINITY; FIBROSIS	Microarray studies of chronic hepatitis C infection have provided valuable information regarding the host response to viral infection. However, recent studies of the human transcriptome indicate pervasive transcription in previously unannotated regions of the genome and that many RNA transcripts have short or lack 3' poly(A) ends. We hypothesized that using ENCODE tiling arrays (1% of the genome) in combination with affinity purifying Pol II RNAs by their unique 5' m(7) GpppN cap would identify previously undescribed annotated and unannotated genes that are differentially expressed in liver during hepatitis C virus (HCV) infection. Both 5'-capped and poly(A)+ populations of RNA were analyzed using ENCODE tiling arrays. Sixty-four annotated genes were significantly increased in HCV cirrhotic as compared to control liver; twenty-seven (42%) of these genes were identified only by analyzing 5' capped RNA. Thirty-one annotated genes were significantly decreased; sixteen (50%) of these were identified only by analyzing 5' capped RNA. Bioinformatic analysis showed that capped RNA produced more consistent results, provided a more extensive expression profile of intronic regions and identified upregulated Pol II transcriptionally active regions in unannotated areas of the genome in HCV cirrhotic liver. Two of these regions were verified by PCR and RACE analysis. qPCR analysis of liver biopsy specimens demonstrated that these unannotated transcripts, as well as IRF1, TRIM22 and MET, were also upregulated in hepatitis C with mild inflammation and no fibrosis. The analysis of 5' capped RNA in combination with ENCODE tiling arrays provides additional gene expression information and identifies novel upregulated Pol II transcripts not previously described in HCV infected liver. This approach, particularly when combined with new RNA sequencing technologies, should also be useful in further defining Pol II transcripts differentially regulated in specific disease states and in studying RNAs regulated by changes in pre-mRNA splicing or 3' polyadenylation status.	[Folkers, Milan E.; Delker, Don A.; Maxwell, Christopher I.; Nelson, Cassie A.; Hagedorn, Curt H.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Delker, Don A.; Maxwell, Christopher I.; Nix, David A.; Hagedorn, Curt H.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Schwartz, Jason J.] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Hagedorn, Curt H.] Univ Utah, Dept Expt Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Folkers, ME (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	curt.hagedorn@hsc.utah.edu			National Institutes of Healths [CA063640, T32CA093247]; NATIONAL CANCER INSTITUTE [R55CA063640, R01CA063640, T32CA093247] Funding Source: NIH RePORTER	National Institutes of Healths(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Healths grant CA063640 (CHH). C. Maxwell was supported by a NIH Multidisciplinary Cancer Research Training Program T32CA093247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Bajak Edyta Z., 2008, V419, P147, DOI 10.1007/978-1-59745-033-1_10; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Chang CC, 2009, J IMMUNOL, V182, P5208, DOI 10.4049/jimmunol.0804048; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dill MT, 2010, GASTROENTEROLOGY; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Friedland DE, 2005, BIOCHEMISTRY-US, V44, P4546, DOI 10.1021/bi047645m; Gao Bo, 2009, HEPATOLOGY NA, V9999; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hayashida K, 2005, CLIN GASTROENTEROL H, V3, P1253, DOI 10.1016/S1542-3565(05)00412-X; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Helt GA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-266; Honda M, 2006, HEPATOLOGY, V44, P1122, DOI 10.1002/hep.21383; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Kanazawa N, 2004, J VIROL, V78, P9713, DOI 10.1128/JVI.78.18.9713-9720.2004; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kikuchi K, 2009, NUCLEIC ACIDS RES, V37, P4987, DOI 10.1093/nar/gkp426; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Lederer SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-98; Li Ke, 2002, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V16, P351; Mas VR, 2010, MOL MED, V16, P287, DOI 10.2119/molmed.2009.00165; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Peng J, 2005, RNA, V11, P1131, DOI 10.1261/rna.2470905; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Rassenti LZ, 2008, BLOOD, V112, P1923, DOI 10.1182/blood-2007-05-092882; Richter JD, 2008, CELL, V132, P335, DOI 10.1016/j.cell.2008.01.024; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Smith MW, 2006, GASTROENTEROLOGY, V130, P179, DOI 10.1053/j.gastro.2005.08.015; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Spivak-Kroizman T, 2002, FEBS LETT, V516, P9, DOI 10.1016/S0014-5793(02)02445-6; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vlad G, 2003, HUM IMMUNOL, V64, P483, DOI 10.1016/S0198-8859(03)00040-5; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weber M, 2005, CIRC RES, V96, P1161, DOI 10.1161/01.RES.0000170651.72198.fa; Wietzke-Braun P, 2006, EUR J GASTROEN HEPAT, V18, P991, DOI 10.1097/01.meg.0000224478.89545.76; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	69	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14697	10.1371/journal.pone.0014697	http://dx.doi.org/10.1371/journal.pone.0014697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359205	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700010
J	Skovgaard, D; Kjaer, A; Heinemeier, KM; Brandt-Larsen, M; Madsen, J; Kjaer, M				Skovgaard, Dorthe; Kjaer, Andreas; Heinemeier, Katja Maria; Brandt-Larsen, Malene; Madsen, Jacob; Kjaer, Michael			Use of Cis-[F-18]Fluoro-Proline for Assessment of Exercise-Related Collagen Synthesis in Musculoskeletal Connective Tissue	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; POSITRON-EMISSION-TOMOGRAPHY; SKELETAL-MUSCLE; GROWTH-FACTORS; RAT MUSCLE; TENDON; BONE; PET; METABOLISM; EXPRESSION	Protein turnover in collagen rich tissue is influenced by exercise, but can only with difficulty be studied in vivo due to use of invasive procedure. The present study was done to investigate the possibility of applying the PET-tracer, cis-[F-18]fluoro-proline (cis-Fpro), for non-invasive assessment of collagen synthesis in rat musculoskeletal tissues at rest and following short-term (3 days) treadmill running. Musculoskeletal collagen synthesis was studied in rats at rest and 24 h post-exercise. At each session, rats were PET scanned at two time points following injection of cis-FPro: (60 and 240 min p.i). SUV were calculated for Achilles tendon, calf muscle and tibial bone. The PET-derived results were compared to mRNA expression of collagen type I and III. Tibial bone had the highest SUV that increased significantly (p<0.001) from the early (60 min) to the late (240 min) PET scan, while SUV in tendon and muscle decreased (p<0.001). Exercise had no influence on SUV, which was contradicted by an increased gene expression of collagen type I and III in muscle and tendon. The clearly, visible uptake of cis-Fpro in the collagen-rich musculoskeletal tissues is promising for multi-tissue studies in vivo. The tissue-specific differences with the highest basal uptake in bone are in accordance with earlier studies relying on tissue incorporation of isotopic-labelled proline. A possible explanation of the failure to demonstrate enhanced collagen synthesis following exercise, despite augmented collagen type I and III transcription, is that SUV calculations are not sensitive enough to detect minor changes in collagen synthesis. Further studies including kinetic compartment modeling must be performed to establish whether cis-Fpro can be used for non-invasive in-vivo assessment of exercise-induced changes in musculoskeletal collagen synthesis.	[Skovgaard, Dorthe; Heinemeier, Katja Maria; Kjaer, Michael] Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med Copenhagen, Copenhagen, Denmark; [Skovgaard, Dorthe; Kjaer, Andreas; Heinemeier, Katja Maria; Kjaer, Michael] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Skovgaard, Dorthe; Brandt-Larsen, Malene; Madsen, Jacob] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen	Skovgaard, D (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med Copenhagen, Copenhagen, Denmark.	dskovgaard@dadlnet.dk	Kjaer, Michael/W-6842-2019; Kjaer, Andreas/E-8932-2015	Kjaer, Michael/0000-0002-4582-8755; Kjaer, Andreas/0000-0002-2706-5547	Danish Medical Research Council; Danish National Advanced Technology Foundation; Novo Nordisk Foundation, Danish Rheumatism Association, Team Denmark [R38-A270, 33241979-06]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Advanced Technology Foundation; Novo Nordisk Foundation, Danish Rheumatism Association, Team Denmark(Novo Nordisk Foundation)	This work was supported by the Danish Medical Research Council, the Danish National Advanced Technology Foundation, the Novo Nordisk Foundation, Danish Rheumatism Association: R38-A270, Team Denmark: 33241979-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asola M, 2008, KIDNEY INT, V73, pS131, DOI 10.1038/sj.ki.5002614; Asola MR, 2002, EUR J NUCL MED MOL I, V29, P1485, DOI 10.1007/s00259-002-0921-3; Babraj J, 2002, BIOCHEM SOC T, V30, P61, DOI 10.1042/bst0300061; Babraj JA, 2005, AM J PHYSIOL-ENDOC M, V289, pE864, DOI 10.1152/ajpendo.00243.2005; Babraj JA, 2005, J BONE MINER RES, V20, P930, DOI 10.1359/JBMR.050201; BOOTH FW, 1972, MED SCI SPORT EXER, V4, P230; Carter EA, 1999, J TRAUMA, V47, P341, DOI 10.1097/00005373-199908000-00021; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; de Boer JR, 2003, J NUCL MED, V44, P341; Fischman AJ, 1998, P NATL ACAD SCI USA, V95, P12793, DOI 10.1073/pnas.95.22.12793; Haaparanta M, 2003, LIFE SCI, V73, P1437, DOI 10.1016/S0024-3205(03)00470-3; Hamacher K, 1999, J LABELLED COMPD RAD, V42, P1135; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Hsu HB, 1996, P NATL ACAD SCI USA, V93, P1841, DOI 10.1073/pnas.93.5.1841; Jones Hazel A, 2005, Toxicol Appl Pharmacol, V207, P230, DOI 10.1016/j.taap.2005.02.027; Kim J, 2006, J NUCL MED, V47, P330; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Lavalaye J, 2008, MOL IMAGING BIOL; Mackey AL, 2008, CONNECT TISSUE RES, V49, P165, DOI 10.1080/03008200802151672; McAnulty RJ, 2005, METH MOLEC MED, V117, P189; Meyer PT, 2006, EUR J NUCL MED MOL I, V33, P948, DOI 10.1007/s00259-006-0121-7; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; REDDY GK, 1992, CALCIFIED TISSUE INT, V50, P320, DOI 10.1007/BF00301629; SKOVGAARD D, 2010, MOL IMAGING BIOL, P52235; Smith K, 2007, CURR OPIN CLIN NUTR, V10, P582, DOI 10.1097/MCO.0b013e328285d858; Stoffels G, 2008, NUCL MED BIOL, V35, P895, DOI 10.1016/j.nucmedbio.2008.08.003; SUOMINEN H, 1980, ACTA PHYSIOL SCAND, V108, P17, DOI 10.1111/j.1748-1716.1980.tb06495.x; TAKEUCHI T, 1969, BIOCHIM BIOPHYS ACTA, V175, P142, DOI 10.1016/0005-2795(69)90153-6; UITTO J, 1977, ARCH BIOCHEM BIOPHYS, V181, P293, DOI 10.1016/0003-9861(77)90507-0; VIDEMAN T, 1981, BIOCHEM J, V200, P435, DOI 10.1042/bj2000435; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Wackerhage H, 2006, J ANAT, V208, P451, DOI 10.1111/j.1469-7580.2006.00544.x; Wallace WE, 2002, J NUCL MED, V43, P413; Warner SE, 2006, CALCIFIED TISSUE INT, V79, P395, DOI 10.1007/s00223-005-0293-3; Wester HJ, 1999, NUCL MED BIOL, V26, P259, DOI 10.1016/S0969-8051(98)00107-3; Zimny M, 2002, NUCL MED COMMUN, V23, P695, DOI 10.1097/00006231-200207000-00015	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16678	10.1371/journal.pone.0016678	http://dx.doi.org/10.1371/journal.pone.0016678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347251	gold, Green Published, Green Submitted			2022-12-25	WOS:000287364500003
J	Srichai, MB; Colleta, H; Gewin, L; Matrisian, L; Abel, TW; Koshikawa, N; Seiki, M; Pozzi, A; Harris, RC; Zent, R				Srichai, Manakan B.; Colleta, Heloisa; Gewin, Leslie; Matrisian, Linsey; Abel, Ty W.; Koshikawa, Naohiko; Seiki, Motoharu; Pozzi, Ambra; Harris, Raymond C.; Zent, Roy			Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) Modulates Water Homeostasis in Mice	PLOS ONE			English	Article							RENAL DEVELOPMENT; TRANSGENIC MICE; KIDNEY-DISEASE; EXPRESSION; CANCER; CELLS	MT4-MMP is a membrane-type metalloproteinase (MMP) anchored to the membrane by a glycosyl-phosphatidylinositol (GPI) motif. GPI-type MT-MMPs (MT4- and MT6-MMP) are related to other MT-MMPs, but their physiological substrates and functions in vivo have yet to be identified. In this manuscript we show that MT4-MMP is expressed early in kidney development, as well as in the adult kidney, where the highest levels of expression are found in the papilla. MT4-MMP null mice had minimal renal developmental abnormalities, with a minor branching morphogenesis defect in early embryonic kidney development and slightly dysmorphic collecting ducts in adult mice. Interestingly, MT4-MMP null mice had higher baseline urine osmolarities relative to wild type controls, but these animals were able to concentrate and dilute their urines normally. However, MT4-MMP-null mice had decreased daily water intake and daily urine output, consistent with primary hypodipsia. MT4-MMP was shown to be expressed in areas of the hypothalamus considered important for regulating thirst. Thus, our results show that although MT4-MMP is expressed in the kidney, this metalloproteinase does not play a major role in renal development or function; however it does appear to modify the neural stimuli that modulate thirst.	[Srichai, Manakan B.; Pozzi, Ambra; Harris, Raymond C.; Zent, Roy] Vet Adm Hosp, Dept Med, Nashville, TN USA; [Srichai, Manakan B.; Colleta, Heloisa; Gewin, Leslie; Matrisian, Linsey; Pozzi, Ambra; Harris, Raymond C.; Zent, Roy] Vanderbilt Univ, Div Nephrol, Dept Med, Med Ctr, Nashville, TN USA; [Abel, Ty W.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Dept Canc Biol, Med Ctr, Nashville, TN USA; [Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tokyo	Srichai, MB (corresponding author), Vet Adm Hosp, Dept Med, Nashville, TN USA.	roy.zent@vanderbilt.edu	Seiki, Motoharu/K-9443-2015; Koshikawa, Naohiko/S-7306-2017	Koshikawa, Naohiko/0000-0002-4539-888X	NIH [DK075594, DK083187, DK62794]; NIDDK; AHA; Veterans Affairs; National Kidney Foundation; Grants-in-Aid for Scientific Research [22591762] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062794, R01DK083187, P30DK079341, R01DK075594] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); Veterans Affairs(US Department of Veterans Affairs); National Kidney Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: The work was funded by NIH Grants DK075594, DK083187, DK62794 and the George O'Brien Center Grant from NIDDK. The studies were performed from funds from these three RO1 grants to RZ and RCH. In addition much of the phenotyping was done by the renal physiology core of the George O'Brien Center Grant; American Heart Association, established investigator award (RZ). RZ has a career award from the AHA. Funding also came from Veterans Affairs, Career Development Award (MBS) and Merit awards (RZ, AP, RCH). All these investigators hold positions at the VA and thus were partially funded by the VA to do these studies; funding also came from the National Kidney Foundation Fellowship Award (LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle S, 2007, DEV DYNAM, V236, P2321, DOI 10.1002/dvdy.21242; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Chabottaux V, 2006, CANCER RES, V66, P5165, DOI 10.1158/0008-5472.CAN-05-3012; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Ermolli M, 2003, TRANSPL IMMUNOL, V11, P137, DOI 10.1016/S0966-3274(02)00150-8; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Godley LA, 1996, GENE DEV, V10, P836, DOI 10.1101/gad.10.7.836; Haas CS, 2004, CONNECT TISSUE RES, V45, P73, DOI 10.1080/03008200490442644; HUSTED RF, 1988, AM J PHYSIOL, V255, pF1160, DOI 10.1152/ajprenal.1988.255.6.F1160; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Lelongt B, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_9.28; Lelongt B, 1997, J CELL BIOL, V136, P1363, DOI 10.1083/jcb.136.6.1363; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Puente XS, 1996, CANCER RES, V56, P944; Riggins KS, 2010, EXP CELL RES, V316, P2993, DOI 10.1016/j.yexcr.2010.08.003; Rikimaru A, 2007, GENES CELLS, V12, P1091, DOI 10.1111/j.1365-2443.2007.01110.x; ROBERTSON GL, 1982, AM J MED, V72, P339, DOI 10.1016/0002-9343(82)90825-7; Ronco P, 2007, SEMIN NEPHROL, V27, P352, DOI 10.1016/j.semnephrol.2007.02.006; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sewards TV, 2003, BRAIN RES REV, V42, P243, DOI 10.1016/S0165-0173(03)00175-9; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Srichai MB, 2008, J AM SOC NEPHROL, V19, P1538, DOI 10.1681/ASN.2007101101; Wang XH, 2010, AM J PHYSIOL-RENAL, V299, pF973, DOI 10.1152/ajprenal.00216.2010; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	26	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17099	10.1371/journal.pone.0017099	http://dx.doi.org/10.1371/journal.pone.0017099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347258	Green Published, gold, Green Submitted			2022-12-25	WOS:000287364500028
J	Buchheim, MA; Keller, A; Koetschan, C; Forster, F; Merget, B; Wolf, M				Buchheim, Mark A.; Keller, Alexander; Koetschan, Christian; Foerster, Frank; Merget, Benjamin; Wolf, Matthias			Internal Transcribed Spacer 2 (nu ITS2 rRNA) Sequence-Structure Phylogenetics: Towards an Automated Reconstruction of the Green Algal Tree of Life	PLOS ONE			English	Article							COLONIAL VOLVOCALES CHLOROPHYTA; SECONDARY STRUCTURE; NUCLEAR RDNA; DNA BARCODES; DASYCLADALES CHLOROPHYTA; MOLECULAR SYSTEMATICS; GENE-SEQUENCES; LAND PLANTS; 18S RDNA; EVOLUTION	Background: Chloroplast-encoded genes (matK and rbcL) have been formally proposed for use in DNA barcoding efforts targeting embryophytes. Extending such a protocol to chlorophytan green algae, though, is fraught with problems including non homology (matK) and heterogeneity that prevents the creation of a universal PCR toolkit (rbcL). Some have advocated the use of the nuclear-encoded, internal transcribed spacer two (ITS2) as an alternative to the traditional chloroplast markers. However, the ITS2 is broadly perceived to be insufficiently conserved or to be confounded by introgression or biparental inheritance patterns, precluding its broad use in phylogenetic reconstruction or as a DNA barcode. A growing body of evidence has shown that simultaneous analysis of nucleotide data with secondary structure information can overcome at least some of the limitations of ITS2. The goal of this investigation was to assess the feasibility of an automated, sequence-structure approach for analysis of IT2 data from a large sampling of phylum Chlorophyta. Methodology/Principal Findings: Sequences and secondary structures from 591 chlorophycean, 741 trebouxiophycean and 938 ulvophycean algae, all obtained from the ITS2 Database, were aligned using a sequence structure-specific scoring matrix. Phylogenetic relationships were reconstructed by Profile Neighbor-Joining coupled with a sequence structure-specific, general time reversible substitution model. Results from analyses of the ITS2 data were robust at multiple nodes and showed considerable congruence with results from published phylogenetic analyses. Conclusions/Significance: Our observations on the power of automated, sequence-structure analyses of ITS2 to reconstruct phylum-level phylogenies of the green algae validate this approach to assessing diversity for large sets of chlorophytan taxa. Moreover, our results indicate that objections to the use of ITS2 for DNA barcoding should be weighed against the utility of an automated, data analysis approach with demonstrated power to reconstruct evolutionary patterns for highly divergent lineages.	[Buchheim, Mark A.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; [Buchheim, Mark A.] Univ Tulsa, Mervin Bovaird Inst Mol Biol & Biotechnol, Tulsa, OK 74104 USA; [Keller, Alexander; Koetschan, Christian; Foerster, Frank; Merget, Benjamin; Wolf, Matthias] Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany	University of Tulsa; University of Tulsa; University of Wurzburg	Buchheim, MA (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	mark-buchheim@utulsa.edu	Keller, Alexander/D-1221-2009; Wolf, Matthias/A-5580-2008; Förster, Frank/A-2181-2010	Keller, Alexander/0000-0001-5716-3634; Wolf, Matthias/0000-0003-2004-1806; Förster, Frank/0000-0003-4166-5423	Deutsche Forschungsgemeinschaft [Mu-2831/1-1]; National Science Foundation [MCB-0132083, DEB-0129030]; BIGGS Graduate School, Bavaria, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); BIGGS Graduate School, Bavaria, Germany	Financial support for this study was provided by the Deutsche Forschungsgemeinschaft (Mu-2831/1-1 to MW) and the National Science Foundation (MCB-0132083 and DEB-0129030 to MAB). AK was supported by the BIGGS Graduate School, Bavaria, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 1999, PLANT BIOLOGY, V1, P418, DOI 10.1111/j.1438-8677.1999.tb00724.x; Angeler DG, 1999, J PHYCOL, V35, P815, DOI 10.1046/j.1529-8817.1999.3540815.x; Angeler DG, 1998, BIOLOGIA, V53, P567; Arnheim N., 1983, P38; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; BAKKER FT, 1995, J MOL EVOL, V40, P640, DOI 10.1007/BF00160512; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Buchheim M, 2005, J PHYCOL, V41, P1039, DOI 10.1111/j.1529-8817.2005.00129.x; BUCHHEIM MA, 1992, J PHYCOL, V28, P362, DOI 10.1111/j.0022-3646.1992.00362.x; Buchheim MA, 2002, J PHYCOL, V38, P376, DOI 10.1046/j.1529-8817.2002.01145.x; BUCHHEIM MA, 1991, BIOSYSTEMS, V25, P85, DOI 10.1016/0303-2647(91)90015-D; Buchheim MA, 1997, J PHYCOL, V33, P1024, DOI 10.1111/j.0022-3646.1997.01024.x; Buchheim MA, 1997, J PHYCOL, V33, P286, DOI 10.1111/j.0022-3646.1997.00286.x; Buchheim MA, 2001, J PHYCOL, V37, P819, DOI 10.1046/j.1529-8817.2001.00162.x; Buchheim MA, 1996, MOL PHYLOGENET EVOL, V5, P391, DOI 10.1006/mpev.1996.0034; Buchheim MA, 2010, J PHYCOL, V46, P1038, DOI 10.1111/j.1529-8817.2010.00886.x; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; CHASE MW, 2009, SCI ONLINE; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coat G, 1998, EUR J PHYCOL, V33, P81, DOI 10.1017/S0967026297001455; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Coleman AW, 2001, J PHYCOL, V37, P836, DOI 10.1046/j.1529-8817.2001.01043.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Durand C, 2002, J EVOLUTION BIOL, V15, P122, DOI 10.1046/j.1420-9101.2002.00370.x; Ebach MC, 2005, BIOSCIENCE, V55, P822; EDLIND TD, 1990, GENE, V96, P289, DOI 10.1016/0378-1119(90)90266-T; Engelmann JC, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2008.02199.x; Fabry S, 1999, J MOL EVOL, V48, P94, DOI 10.1007/PL00006449; Fama P, 2000, EUR J PHYCOL, V35, P349, DOI 10.1080/09670260010001735951; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Friedl T, 1996, PHYCOLOGIA, V35, P456, DOI 10.2216/i0031-8884-35-5-456.1; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Gile GH, 2010, J PHYCOL, V46, P743, DOI 10.1111/j.1529-8817.2010.00851.x; Harpke D, 2008, BOTANY, V86, P300, DOI 10.1139/B07-134; Harpke D, 2006, MOL PHYLOGENET EVOL, V41, P579, DOI 10.1016/j.ympev.2006.05.036; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hegewald E, 2003, PLANT SYST EVOL, V241, P185, DOI 10.1007/s00606-003-0061-7; Hegewald E., 2000, ALGOL STUD, V100, P29, DOI DOI 10.1127/algol_stud/100/2000/29; Hegewald E, 2010, PHYCOLOGIA, V49, P325, DOI 10.2216/09-61.1; Hepperle D, 2000, J PHYCOL, V36, P590, DOI 10.1046/j.1529-8817.2000.99184.x; Hershkovitz MA, 1996, MOL BIOL EVOL, V13, P1276, DOI 10.1093/oxfordjournals.molbev.a025693; Holdrege C, 2006, BIOSCIENCE, V56, P93; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Jakupciak JP, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2009.02632.x; Kapraun DF, 1998, PHYCOLOGIA, V37, P176, DOI 10.2216/i0031-8884-37-3-176.1; KAPRAUN DF, 1993, PHYCOLOGIA, V32, P1, DOI 10.2216/i0031-8884-32-1-1.1; Kapraun Donald F., 1994, Cryptogamic Botany, V4, P410; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Keller A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-218; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Krienitz L, 2004, PHYCOLOGIA, V43, P529, DOI 10.2216/i0031-8884-43-5-529.1; Krienitz L, 2003, BIOLOGIA, V58, P437; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ledford H, 2008, NATURE, V451, P616, DOI 10.1038/451616b; Leliaert F, 2003, EUR J PHYCOL, V38, P233, DOI 10.1080/1364253031000136376; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Lewis LA, 2004, J PHYCOL, V40, P1127, DOI 10.1111/j.1529-8817.2004.03235.x; Loughnane CJ, 2008, PHYCOLOGIA, V47, P416, DOI 10.2216/PH07-61.1; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; McManus HA, 2005, PHYCOLOGIA, V44, P582, DOI 10.2216/0031-8884(2005)44[582:MPMVAC]2.0.CO;2; Mei Hong, 2007, Acta Hydrobiologica Sinica, V31, P492; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; Nakazawa AS, 2004, PHYCOLOGIA, V43, P711, DOI 10.2216/i0031-8884-43-6-711.1; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nozaki H, 1999, J PHYCOL, V35, P104, DOI 10.1046/j.1529-8817.1999.3510104.x; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; Nozaki H, 2003, BIOLOGIA, V58, P425; Nozaki H, 1995, J PHYCOL, V31, P970, DOI 10.1111/j.0022-3646.1995.00970.x; Nozaki H, 2003, MOL PHYLOGENET EVOL, V29, P58, DOI 10.1016/S1055-7903(03)00089-7; Nozaki Hisayoshi, 2001, Phycologia, V40, P37; Pillmann A, 1997, EUR J PHYCOL, V32, P379, DOI 10.1017/S0967026297001352; Pocock T, 2004, J PHYCOL, V40, P1138, DOI 10.1111/j.1529-8817.2004.04060.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Rahmann S, 2006, ADV DATA MINING TECH, P104; Rambaut A, 2009, FIGTREE V1 2 3; Sanders ER, 2003, AM J BOT, V90, P628, DOI 10.3732/ajb.90.4.628; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Smith VS, 2005, SYST BIOL, V54, P841, DOI 10.1080/10635150500354894; TURMEL M, 2002, COMPLETE CHLOROPLAST; van Hannen EJ, 2002, EUR J PHYCOL, V37, P203, DOI 10.1017/S096702620200361X; Verbruggen H, 2005, MOL PHYLOGENET EVOL, V37, P789, DOI 10.1016/j.ympev.2005.06.015; Wheeler QD, 2005, CLADISTICS, V21, P405, DOI 10.1111/j.1096-0031.2005.00075.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wiemers M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-300; WILL KW, 2005, SYSTEMATIC BIOL, V54; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wolf M, 2003, BIOLOGIA, V58, P433; Wolf M, 2003, BIOLOGIA, V58, P759; Wolf M, 2002, PLANT SYST EVOL, V230, P161, DOI 10.1007/s006060200002; WOLF M, 2009, SCIENCE         1210; Wolf M., 2002, ARCH HYDROBIOL S, V104, P59; Wolf M, 2008, BIOINFORMATICS, V24, P2401, DOI 10.1093/bioinformatics/btn453; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Zechman FW, 2003, J PHYCOL, V39, P819, DOI 10.1046/j.1529-8817.2003.02183.x; Zimmer EA, 1980, P NATL ACAD SCI USA, V77, P2518	115	67	72	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16931	10.1371/journal.pone.0016931	http://dx.doi.org/10.1371/journal.pone.0016931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347329	Green Published, gold			2022-12-25	WOS:000287363000023
J	Momozawa, Y; Deffontaine, V; Louis, E; Medrano, JF				Momozawa, Yukihide; Deffontaine, Valerie; Louis, Edouard; Medrano, Juan F.			Characterization of Bacteria in Biopsies of Colon and Stools by High Throughput Sequencing of the V2 Region of Bacterial 16S rRNA Gene in Human	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; MICROBIOME	Background: The characterization of the human intestinal microflora and their interactions with the host have been identified as key components in the study of intestinal disorders such as inflammatory bowel diseases. High-throughput sequencing has enabled culture-independent studies to deeply analyze bacteria in the gut. It is possible with this technology to systematically analyze links between microbes and the genetic constitution of the host, such as DNA polymorphisms and methylation, and gene expression. Methods and Findings: In this study the V2 region of the bacterial 16S ribosomal RNA (rRNA) gene using 454 pyrosequencing from seven anatomic regions of human colon and two types of stool specimens were analyzed. The study examined the number of reads needed to ascertain differences between samples, the effect of DNA extraction procedures and PCR reproducibility, and differences between biopsies and stools in order to design a large scale systematic analysis of gut microbes. It was shown (1) that sequence coverage lower than 1,000 reads influenced quantitative and qualitative differences between samples measured by UniFrac distances. Distances between samples became stable after 1,000 reads. (2) Difference of extracted bacteria was observed between the two DNA extraction methods. In particular, Firmicutes Bacilli were not extracted well by one method. (3) Quantitative and qualitative difference in bacteria from ileum to rectum colon were not observed, but there was a significant positive trend between distances within colon and quantitative differences. Between sample type, biopsies or stools, quantitative and qualitative differences were observed. Conclusions: Results of human colonic bacteria analyzed using high-throughput sequencing were highly dependent on the experimental design, especially the number of sequence reads, DNA extraction method, and sample type.	[Momozawa, Yukihide; Deffontaine, Valerie] Univ Liege, GIGA Res, Unit Anim Genom, Liege, Belgium; [Momozawa, Yukihide; Deffontaine, Valerie] Univ Liege, Fac Vet Med, Liege, Belgium; [Louis, Edouard] Univ Liege, GIGA Res, Unit Hepatol & Gastroenterol, Dept Clin Sci, Liege, Belgium; [Louis, Edouard] Univ Liege, Fac Med, Liege, Belgium; [Louis, Edouard] Univ Liege, CHU Liege, Liege, Belgium; [Medrano, Juan F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of California System; University of California Davis	Momozawa, Y (corresponding author), Univ Liege, GIGA Res, Unit Anim Genom, Liege, Belgium.	Yukihide.Momozawa@guest.ulg.ac.be	Momozawa, Yukihide/N-6453-2015		Fonds National de la Recherche Scientifique (FNRS) [830107]; GIGA-Crohn [315422]; Walloon region; Forem Formations program	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); GIGA-Crohn; Walloon region; Forem Formations program	This project was supported by the Fonds National de la Recherche Scientifique (FNRS) - Region Wallonne program IP-SEQ-Groupe Interdisciplinaire de Genoproteomique Appliquee (GIGA) (Convention no830107) and by the Region Wallonne program GIGA-Crohn (Convention no315422). VD is supported by the Walloon region and Forem Formations program (Portefeuille GIGA2 BioIndustry Support - Volet IP-SEQ). EL is a senior research associate from the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Varaljay VA, 2010, APPL ENVIRON MICROB, V76, P609, DOI 10.1128/AEM.01258-09; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	19	78	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16952	10.1371/journal.pone.0016952	http://dx.doi.org/10.1371/journal.pone.0016952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347324	Green Published, Green Submitted, gold			2022-12-25	WOS:000287363000024
J	Krymskaya, VP; Snow, J; Cesarone, G; Khavin, I; Goncharov, DA; Lim, PN; Veasey, SC; Ihida-Stansbury, K; Jones, PL; Goncharova, EA				Krymskaya, Vera P.; Snow, Jennifer; Cesarone, Gregory; Khavin, Irene; Goncharov, Dmitry A.; Lim, Poay N.; Veasey, Sigrid C.; Ihida-Stansbury, Kaori; Jones, Peter L.; Goncharova, Elena A.			mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia	FASEB JOURNAL			English	Article						pulmonary hypertension; mTORC1; mTORC2; rictor; Akt	MAMMALIAN TARGET; RAPAMYCIN MTOR; LYMPHANGIOLEIOMYOMATOSIS LAM; IN-VITRO; ACTIVATION; PHOSPHORYLATION; HYPERTENSION; PROMOTES; GROWTH; METFORMIN	Pulmonary arterial vascular smooth muscle (PAVSM) cell proliferation is a key pathophysiological component of vascular remodeling in pulmonary arterial hypertension (PAH) for which cellular and molecular mechanisms are poorly understood. The goal of our study was to determine the role of mammalian target of rapamycin (mTOR) in PAVSM cell proliferation, a major pathological manifestation of vascular remodeling in PAH. Our data demonstrate that chronic hypoxia promoted mTOR(Ser-2481) phosphorylation, an indicator of mTOR intrinsic catalytic activity, mTORC1-specific S6 and mTORC2-specific Akt (Ser-473) phosphorylation, and proliferation of human and rat PAVSM cells that was inhibited by siRNA mTOR. PAVSM cells derived from rats exposed to chronic hypoxia (VSM-H cells) retained increased mTOR(Ser-2481), S6, Akt (Ser-473) phosphorylation, and DNA synthesis compared to cells from normoxia-exposed rats. Suppression of mTORC2 signaling with siRNA rictor, or inhibition of mTORC1 signaling with rapamycin and metformin, while having little effect on other complex activities, inhibited VSM-H and chronic hypoxia-induced human and rat PAVSM cell proliferation. Collectively, our data demonstrate that up-regulation of mTOR activity and activation of both mTORC1 and mTORC2 are required for PAVSM cell proliferation induced by in vitro and in vivo chronic hypoxia and suggest that mTOR may serve as a potential therapeutic target to inhibit vascular remodeling in PAH.-Krymskaya, V. P., Snow, J., Cesarone, G., Khavin, I., Goncharov, D. A., Lim, P. N., Veasey, S. C., Ihida-Stansbury, K., Jones, P. L., Goncharova, E. A. mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia. FASEB J. 25, 1922-1933 (2011). www.fasebj.org	[Goncharova, Elena A.] Univ Penn, Translat Res Labs, Pulm Allergy & Crit Care Div, Dept Med, Philadelphia, PA 19104 USA; [Krymskaya, Vera P.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Krymskaya, Vera P.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Veasey, Sigrid C.] Univ Penn, Ctr Sleep & Resp Neurobiol, Dept Med, Philadelphia, PA 19104 USA; [Ihida-Stansbury, Kaori; Jones, Peter L.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Goncharova, EA (corresponding author), Univ Penn, Translat Res Labs, Pulm Allergy & Crit Care Div, Dept Med, Rm 1214,125 S 31st St, Philadelphia, PA 19104 USA.	goncharo@mail.med.upenn.edu		Jones, Peter Lloyd/0000-0003-1445-4081	Gilead Science Research Scholars grant; U.S. National Institutes of Health (NIH)/National Heart Lung and Blood Institute [2R01HL071106, R01HL090829, LAM07-001, NIH HL080492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080492, R01HL090829, R01HL071106] Funding Source: NIH RePORTER	Gilead Science Research Scholars grant(Gilead Sciences); U.S. National Institutes of Health (NIH)/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Andrew Eszterhas for critical reading of the manuscript. This work was supported by a Gilead Science Research Scholars grant (E.G.) and in part by U.S. National Institutes of Health (NIH)/National Heart Lung and Blood Institute grants 2R01HL071106 (V.P.K.), R01HL090829 (V.P.K.), LAM07-001 (E.G.), and NIH HL080492 (S.C.V). E.G. is a Parker B. Francis Fellow in Pulmonary Research.	Agard C, 2009, BRIT J PHARMACOL, V158, P1285, DOI 10.1111/j.1476-5381.2009.00445.x; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Barst RJ, 2005, J CLIN INVEST, V115, P2691, DOI 10.1172/JCI26593; Chen B, 2009, AM J PHYSIOL-LUNG C, V297, pL1151, DOI 10.1152/ajplung.00183.2009; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cogo A, 2003, J APPL PHYSIOL, V94, P1403, DOI 10.1152/japplphysiol.00363.2002; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Fraser KL, 1999, CHEST, V115, P1321, DOI 10.1378/chest.115.5.1321; Gerasimovskaya EV, 2005, J APPL PHYSIOL, V98, P722, DOI 10.1152/japplphysiol.00715.2004; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Goncharova EA, 2002, AM J PHYSIOL-LUNG C, V283, pL354, DOI 10.1152/ajplung.00010.2002; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2008, J CELL BIOCHEM, V103, P369, DOI 10.1002/jcb.21419; Goncharova EA, 2009, MOL PHARMACOL, V76, P766, DOI 10.1124/mol.109.057042; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Ihida-Stansbury K, 2006, AM J PHYSIOL-LUNG C, V291, pL694, DOI 10.1152/ajplung.00119.2006; Incalzi RA, 1999, CIRCULATION, V99, P1600, DOI 10.1161/01.CIR.99.12.1600; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; Kirtane AJ, 2007, CARDIOVASC DRUG REV, V25, P316, DOI 10.1111/j.1527-3466.2007.00024.x; Krymskaya VP, 2009, CELL CYCLE, V8, P403, DOI 10.4161/cc.8.3.7555; Krymskaya VP, 2004, FASEB J, V18, P428, DOI 10.1096/fj.04-2869fje; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li WM, 2007, CIRC RES, V100, P79, DOI 10.1161/01.RES.0000253094.03023.3f; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; MacEachern PR, 2004, CHEST, V126, p978S, DOI 10.1378/chest.126.4_MeetingAbstracts.978S; MARTI HH, 1994, PFLUG ARCH EUR J PHY, V429, P216, DOI 10.1007/BF00374315; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Paddenberg R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-15; Pak O, 2007, EUR RESPIR J, V30, P364, DOI 10.1183/09031936.00128706; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; PAUL RJ, 1989, ANNU REV PHYSIOL, V51, P331, DOI 10.1146/annurev.physiol.51.1.331; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Roulin D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-57; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833	50	81	86	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1922	1933		10.1096/fj.10-175018	http://dx.doi.org/10.1096/fj.10-175018			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21368105	Green Published			2022-12-25	WOS:000291023800016
J	Yang, M; Lim, Y; Li, XJ; Zhong, JH; Zhou, XF				Yang, Miao; Lim, Yoon; Li, Xiaojiang; Zhong, Jin-Hua; Zhou, Xin-Fu			Precursor of Brain-derived Neurotrophic Factor (proBDNF) Forms a Complex with Huntingtin-associated Protein-1 (HAP1) and Sortilin That Modulates proBDNF Trafficking, Degradation, and Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT SECRETION; PRIMARY SENSORY NEURONS; CENTRAL-NERVOUS-SYSTEM; TRANS-GOLGI NETWORK; INTRACELLULAR TRAFFICKING; VAL66MET POLYMORPHISM; HIPPOCAMPAL-NEURONS; RETROGRADE TRANSPORT; CARBOXYPEPTIDASE-E; MUTANT HUNTINGTIN	proBDNF, a precursor of brain-derived neurotrophic factor (BDNF), is anterogradely transported and released from nerve terminals, but the mechanism underlying this process remains unclear. In this study, we report that proBDNF forms a complex with Huntingtin associated protein-1 (HAP1) and sortilin, which plays an important role in proBDNF intracellular trafficking and stabilization. The interaction of proBDNF with both HAP1A and sortilin in co-transfected HEK293 cells is confirmed by both fluorescence resonance energy transfer and co-immunoprecipitation. The frequent co-localization (>90%) of endogenous HAP1, sortilin, and proBDNF is also found in cultured cortical neurons. Mapping studies using GST pulldown and competition assays has defined the interacting region of HAP1 with proBDNF within amino acids 371-445 and the binding sequences of proBDNF to HAP1 between amino acids 65 and 90. Fluorescence recovery after photobleaching confirms the defective movement of proBDNF-containing vesicles in neurites of HAP1(-/-) neurons, which can be partially restored by reintroducing HAP1 cDNA into the neurons. However, the effect is significantly increased by simultaneously reintroducing both HAP1 and sortilin. proBDNF and HAP1 are highly co-localized with organelle markers for the Golgi network, microtubules, molecular motor, or endosomes in normal neurons, but this co-localization is reduced in HAP1(-/-) neurons. Co-immunoprecipitation and Western blot showed that sortilin stabilizes the proBDNF.HAP1 complex in co-transfected HEK293 cells, helping to prevent proBDNF degradation. Furthermore, the complex facilitates furin cleavage to release mature BDNF.	[Yang, Miao; Lim, Yoon; Zhong, Jin-Hua; Zhou, Xin-Fu] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Yang, Miao; Lim, Yoon; Zhong, Jin-Hua; Zhou, Xin-Fu] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia; [Li, Xiaojiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Flinders University South Australia; Flinders University South Australia; Emory University	Zhou, XF (corresponding author), Flinders Univ S Australia, Dept Human Physiol, GPO Box 2100, Adelaide, SA 5001, Australia.	Xin-fu.zhou@flinders.edu.au	Zhou, Xiaofang/C-6169-2013; zhou, xin-fu/G-6643-2011; zhou, xin-fu/F-4119-2013	Zhou, Xiaofang/0000-0001-6343-1455; zhou, xin-fu/0000-0002-8687-0175; Lim, Yoon/0000-0003-1110-1969	National Health and Medical Research Council [375110, 488022]; NATIONAL INSTITUTE ON AGING [R01AG019206] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was supported by National Health and Medical Research Council Grants 375110 and 488022.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Butowt R, 2001, J NEUROSCI, V21, P8915, DOI 10.1523/JNEUROSCI.21-22-08915.2001; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; del Toro D, 2006, J NEUROSCI, V26, P12748, DOI 10.1523/JNEUROSCI.3873-06.2006; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gutekunst CA, 2003, J HISTOCHEM CYTOCHEM, V51, P841, DOI 10.1177/002215540305100615; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Haubensak W, 1998, J CELL SCI, V111, P1483; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Hilgenberg L. G., 2007, J VIS EXP, V10, p[562, 1]; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J BIOL CHEM, V273, P19220, DOI 10.1074/jbc.273.30.19220; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Momose Y, 2002, ANN NEUROL, V51, P133, DOI 10.1002/ana.10079; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Park JJ, 2008, MOL CELL NEUROSCI, V39, P63, DOI 10.1016/j.mcn.2008.05.016; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rong JA, 2007, J BIOL CHEM, V282, P4748, DOI 10.1074/jbc.M609057200; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; von Bartheld CS, 2001, MOL NEUROBIOL, V24, P1, DOI 10.1385/MN:24:1-3:001; Wang H, 2006, EUR J NEUROSCI, V24, P2444, DOI 10.1111/j.1460-9568.2006.05138.x; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Wu LLY, 2010, J BIOL CHEM, V285, P5614, DOI 10.1074/jbc.M109.073197; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	73	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.195347	http://dx.doi.org/10.1074/jbc.M110.195347			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21357693	hybrid, Green Published			2022-12-25	WOS:000290022800066
J	Kawai, M; Breggia, AC; DeMambro, VE; Shen, XC; Canalis, E; Bouxsein, ML; Beamer, WG; Clemmons, DR; Rosen, CJ				Kawai, Masanobu; Breggia, Anne C.; DeMambro, Victoria E.; Shen, Xinchun; Canalis, Ernesto; Bouxsein, Mary L.; Beamer, Wesley G.; Clemmons, David R.; Rosen, Clifford J.			The Heparin-binding Domain of IGFBP-2 Has Insulin-like Growth Factor Binding-independent Biologic Activity in the Growing Skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; BETA-CATENIN; FACTOR-I; TRANSGENIC MICE; IGF-I; TRANSCRIPTIONAL ACTIVITY; EXTRACELLULAR-MATRIX; PROSTATE-CANCER; BONE TURNOVER; STEM-CELLS	Insulin-like growth factor-binding protein 2 (IGFBP-2) is a member of a family of six highly conserved IGFBPs that are carriers for the insulin-like growth factors (IGFs). IGFBP-2 levels rise during rapid neonatal growth and at the time of peak bone acquisition. In contrast, Igfbp2(-/-) mice have low bone mass accompanied by reduced osteoblast numbers, low bone formation rates, and increased PTEN expression. In the current study, we postulated that IGFBP-2 increased bone mass partly through the activity of its heparin-binding domain (HBD). We synthesized a HBD peptide specific for IGFBP-2 and demonstrated in vitro that it rescued the mineralization phenotype of Igfbp2(-/-) bone marrow stromal cells and calvarial osteoblasts. Consistent with its cellular actions, the HBD peptide ex vivo stimulated metacarpal periosteal expansion. Furthermore, administration of HBD peptide to Igfbp2(-/-) mice increased osteoblast number, suppressed marrow adipogenesis, restored trabecular bone mass, and reduced bone resorption. Skeletal rescue in the Igfbp2-/- mice was characterized by reduced PTEN expression followed by enhanced Akt phosphorylation in response to IGF-I and increased beta-catenin signaling through two mechanisms: 1) stimulation of its cytosolic accumulation and 2) increased phosphorylation of serine 552. We conclude that the HBD peptide of IGFBP-2 has anabolic activity by activating IGF-I/Akt and beta-catenin signaling pathways. These data support a growing body of evidence that IGFBP-2 is not just a transport protein but rather that it functions coordinately with IGF-I to stimulate growth and skeletal acquisition.	[Kawai, Masanobu; Breggia, Anne C.; DeMambro, Victoria E.; Rosen, Clifford J.] Maine Med Ctr, Res Inst, Ctr Clin & Translat Res, Scarborough, ME 04074 USA; [Kawai, Masanobu] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi Ku, Osaka 5941101, Japan; [Kawai, Masanobu] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Shen, Xinchun; Clemmons, David R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA; [Bouxsein, Mary L.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Beamer, Wesley G.] Jackson Lab, Bar Harbor, ME 04609 USA	Maine Medical Center; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Saint Francis Hospital & Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Jackson Laboratory	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, Ctr Clin & Translat Res, 81 Res Dr, Scarborough, ME 04074 USA.	ROSENC@mmc.org		Kawai, Masanobu/0000-0003-4466-1559	National Institutes of Health [AR021707]; National Institutes of Arthritis, Musculoskeletal, and Skin Disorders [AR153853]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Arthritis, Musculoskeletal, and Skin Disorders	This work was supported, in whole or in part, by National Institutes of Health Grant AR021707 (to E. C.) and National Institutes of Arthritis, Musculoskeletal, and Skin Disorders Grant AR153853 (to C. J. R.).	Amin S, 2007, J BONE MINER RES, V22, P799, DOI 10.1359/JBMR.070306; Arai T, 1996, ENDOCRINOLOGY, V137, P4571, DOI 10.1210/en.137.11.4571; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; COHEN P, 1993, J CLIN ENDOCR METAB, V76, P1031, DOI 10.1210/jc.76.4.1031; Conover CA, 2002, GROWTH HORM IGF RES, V12, P178, DOI 10.1016/S1096-6374(02)00044-8; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Duan CM, 1999, P NATL ACAD SCI USA, V96, P15274, DOI 10.1073/pnas.96.26.15274; Eckstein F, 2002, ANAT EMBRYOL, V206, P139, DOI 10.1007/s00429-002-0282-5; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Hoeflich A, 2001, ENDOCRINOLOGY, V142, P1889, DOI 10.1210/en.142.5.1889; Hu DL, 2009, J AM GERIATR SOC, V57, P1213, DOI 10.1111/j.1532-5415.2009.02318.x; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kawai M, 2009, PEDIATR NEPHROL, V24, P1277, DOI 10.1007/s00467-008-1040-6; Khosla S, 1998, J CLIN INVEST, V101, P2165, DOI 10.1172/JCI1111; Levitt RJ, 2005, BIOCHEM BIOPH RES CO, V336, P1056, DOI 10.1016/j.bbrc.2005.08.229; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Maile LA, 2008, J CELL BIOCHEM, V105, P437, DOI 10.1002/jcb.21841; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Palermo C, 2004, AM J PHYSIOL-ENDOC M, V286, pE648, DOI 10.1152/ajpendo.00049.2003; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Russo VC, 1999, ENDOCRINOLOGY, V140, P3082, DOI 10.1210/en.140.7.3082; Russo VC, 1997, ENDOCRINOLOGY, V138, P4858, DOI 10.1210/en.138.11.4858; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Shoba LNN, 2003, J CELL BIOCHEM, V88, P1247, DOI 10.1002/jcb.10474; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Wang YM, 2006, J BONE MINER RES, V21, P1350, DOI 10.1359/JBMR.060610; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Wood TL, 2000, MOL ENDOCRINOL, V14, P1472, DOI 10.1210/me.14.9.1472; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674	47	41	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14670	14680		10.1074/jbc.M110.193334	http://dx.doi.org/10.1074/jbc.M110.193334			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21372140	Green Published, hybrid			2022-12-25	WOS:000289556200086
J	Nishimura, M; Yamamoto, H; Yoshida, T; Seimiya, M; Sawabe, Y; Matsushita, K; Umemura, H; Sogawa, K; Takizawa, H; Yokosuka, O; Nomura, F				Nishimura, Motoi; Yamamoto, Haruna; Yoshida, Toshihiko; Seimiya, Masanori; Sawabe, Yuji; Matsushita, Kazuyuki; Umemura, Hiroshi; Sogawa, Kazuyuki; Takizawa, Hirotaka; Yokosuka, Osamu; Nomura, Fumio			Decreases in the Serum VLDL-TG/Non-VLDL-TG Ratio from Early Stages of Chronic Hepatitis C: Alterations in TG-Rich Lipoprotein Levels	PLOS ONE			English	Article							LIPASE DEFICIENCY; DENSITY-LIPOPROTEIN; LIVER-DISEASE; VIRUS; METABOLISM; STEATOSIS; DIAGNOSIS; ABNORMALITIES; ASSAY	Background: The liver secretes very-low-density lipoproteins (VLDLs) and plays a key role in lipid metabolism. Plasma total triglyceride (TG) level variations have been studied in patients with hepatitis C virus (HCV)-related chronic hepatitis (CH-C). However, the results of these studies are variable. A homogenous assay protocol was recently proposed to directly measure the TG content in VLDL (VLDL-TG) and VLDL remnants. Methodology/Principal Findings: Using the assay protocol, we determined serum VLDL-TG levels in 69 fasting patients with biopsy-proven HCV-related chronic liver disease and 50 healthy subjects. Patients were classified into stages F0-F4 using the 5-point Desmet scale. Serum total TG levels in patients with non-cirrhotic (F1-F3) CH-C did not demonstrate significant differences compared with healthy subjects, but serum VLDL-TG levels did demonstrate significant differences. Mean serum VLDL-TG levels tended to decrease with disease progression from F1 to F4 (cirrhosis). Compared with healthy subjects, serum non-VLDL-TG levels significantly increased in patients with stages F2 and F3 CH-C; however, we observed no significant difference in patients with liver cirrhosis. Furthermore, the serum VLDL-TG/non-VLDL-TG ratio, when taken, demonstrated a significant decrease in patients with CH-C from the mildest stage F1 onward. Conclusions/Significance: The decrease in serum VLDL-TG levels was attenuated by increase in non-VLDL-TG levels in patients with non-cirrhotic CH-C, resulting in comparable total TG levels. Results of previous studies though variable, were confirmed to have a logical basis. The decrease in the serum VLDL-TG/non-VLDL-TG ratio as early as stage F1 demonstrated TG metabolic alterations in early stages of CH-C for the first time. The involvement of TG metabolism in CH-C pathogenesis has been established in experimental animals, while conventional TG measurements are generally considered as poor indicators of CH-C progression in clinical practice. The serum VLDL-TG/non-VLDL-TG ratio, which focuses on TG metabolic alterations, may be an early indicator of CH-C.	[Nishimura, Motoi; Yamamoto, Haruna; Matsushita, Kazuyuki; Umemura, Hiroshi; Nomura, Fumio] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan; [Nishimura, Motoi; Yamamoto, Haruna; Yoshida, Toshihiko; Seimiya, Masanori; Sawabe, Yuji; Matsushita, Kazuyuki; Umemura, Hiroshi; Nomura, Fumio] Chiba Univ Hosp, Div Lab Med, Chiba, Japan; [Nishimura, Motoi; Matsushita, Kazuyuki; Sogawa, Kazuyuki; Nomura, Fumio] Chiba Univ Hosp, Clin Prote Res Ctr, Chiba, Japan; [Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Takizawa, Hirotaka] Kashiwado Mem Fdn, Kashiwado Clin, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University	Nishimura, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan.	ZXA03460@nifty.ne.jp	Matsushita, Kazuyuki/AAJ-5380-2020	Matsushita, Kazuyuki/0000-0001-6742-0761	Japanese government [KAKENHI 21790531]	Japanese government	This work was supported by Grant-in-Aid for Scientific Research of Japanese government (KAKENHI 21790531, http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connelly PW, 1999, CLIN CHIM ACTA, V286, P243, DOI 10.1016/S0009-8981(99)00105-9; CONNELLY PW, 1990, ARTERIOSCLEROSIS, V10, P40, DOI 10.1161/01.ATV.10.1.40; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fujiwara K, 2006, LIVER INT, V26, P520, DOI 10.1111/j.1478-3231.2006.01263.x; Fujiwara K, 2008, J GASTROENTEROL, V43, P951, DOI 10.1007/s00535-008-2254-x; GOLDBERG IJ, 1985, METABOLISM, V34, P832, DOI 10.1016/0026-0495(85)90107-6; HEGELE RA, 1993, ARTERIOSCLER THROMB, V13, P720, DOI 10.1161/01.ATV.13.5.720; HIRAOKA H, 1993, HEPATOLOGY, V18, P103, DOI 10.1016/0270-9139(93)90513-M; Hsu CS, 2008, HEPATOL INT, V2, P250, DOI 10.1007/s12072-008-9064-3; KLOSE G, 1977, EUR J CLIN INVEST, V7, P557, DOI 10.1111/j.1365-2362.1977.tb01651.x; MCINTYRE N, 1978, GUT, V19, P526, DOI 10.1136/gut.19.6.526; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; OHNO O, 1997, J CLIN MICROBIOL, V35, P201; Okada M, 2005, CLIN CHEM, V51, P1804, DOI 10.1373/clinchem.2005.049304; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Petit JM, 2003, AM J GASTROENTEROL, V98, P1150, DOI 10.1016/S0002-9270(03)00106-0; Ruel IL, 2003, J LIPID RES, V44, P1508, DOI 10.1194/jlr.M200479-JLR200; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; SHIRAI K, 1981, BIOCHEM BIOPH RES CO, V100, P591, DOI 10.1016/S0006-291X(81)80217-3; Siagris D, 2006, J VIRAL HEPATITIS, V13, P56, DOI 10.1111/j.1365-2893.2005.00655.x; SIMMONDS P, 1993, J GEN VIROL, V74, P661, DOI 10.1099/0022-1317-74-4-661; Takase H, 2005, ATHEROSCLEROSIS, V180, P197, DOI 10.1016/j.atherosclerosis.2004.11.020; TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; TSUKIYAMAKOHARA K, 1993, VIROLOGY, V192, P430, DOI 10.1006/viro.1993.1058	26	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17309	10.1371/journal.pone.0017309	http://dx.doi.org/10.1371/journal.pone.0017309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364889	gold, Green Published, Green Submitted			2022-12-25	WOS:000287764100043
J	Tricker, E; Arvand, A; Kwan, R; Chen, GY; Gallagher, E; Cheng, G				Tricker, Erin; Arvand, Afsane; Kwan, Raymond; Chen, Gordon Y.; Gallagher, Ewen; Cheng, Genhong			Apoptosis Induced by Cytoskeletal Disruption Requires Distinct Domains of MEKK1	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; E3 UBIQUITIN LIGASE; INDUCED CELL-DEATH; JNK ACTIVATION; GENE DISRUPTION; UBIQUITYLATION; VINBLASTINE; PATHWAYS; BINDING; PROLIFERATION	MEKK1 is a mitogen-activated protein kinase kinase kinase (MAP3K) that activates the MAPK JNK and is required for microtubule inhibitor-induced apoptosis in B cells. Here, we find that apoptosis induced by actin disruption via cytochalasin D and by the protein phosphatase 1/2A inhibitor okadaic acid also requires MEKK1 activation. To elucidate the functional requirements for activation of the MEKK1-dependent apoptotic pathway, we created mutations within MEKK1. MEKK1-deficient cells were complemented with MEKK1 containing mutations in either the ubiquitin interacting motif (UIM), plant homeodomain (PHD), caspase cleavage site or the kinase domain at near endogenous levels of expression and tested for their sensitivity to each drug. We found that both the kinase activity and the PHD domain of MEKK1 are required for JNK activation and efficient induction of apoptosis by drugs causing cytoskeletal disruption. Furthermore, we discovered that modification of MEKK1 and its localization depends on the integrity of the PHD.	[Tricker, Erin; Arvand, Afsane; Kwan, Raymond; Chen, Gordon Y.; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Gallagher, Ewen] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Arvand, Afsane] Mt St Marys Coll, Dept Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles; Imperial College London	Tricker, E (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	gcheng@mednet.ucla.edu			National Institutes of Health [R01 CA100210]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grant R01 CA100210 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau RM, 2007, CELL SIGNAL, V19, P139, DOI 10.1016/j.cellsig.2006.05.030; BOUDREAU RT, 2007, EXP MOL PATHOL; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Cardoso F, 2009, JNCI-J NATL CANCER I, V101, P1174, DOI 10.1093/jnci/djp235; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chao JI, 2006, MOL PHARMACOL, V69, P154, DOI 10.1124/mol.105.015503; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chu R, 2009, BIOCHEM PHARMACOL, V78, P241, DOI 10.1016/j.bcp.2009.04.005; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Deak JC, 1997, BIOCHEM J, V322, P185, DOI 10.1042/bj3220185; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Giannini AL, 2008, BIOCHEM J, V410, P101, DOI 10.1042/BJ20070995; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; KAN Z, NATURE, V466, P869; Kolomeichuk SN, 2008, FEBS J, V275, P1889, DOI 10.1111/j.1742-4658.2008.06349.x; Kolomeichuk SN, 2008, MOL PHARMACOL, V73, P128, DOI 10.1124/mol.108.039750; Kwan R, 2001, MOL CELL BIOL, V21, P7183, DOI 10.1128/MCB.21.21.7183-7190.2001; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; ROWINSKY EK, 1991, PHARMACOL THERAPEUT, V52, P35, DOI 10.1016/0163-7258(91)90086-2; Schlesinger Thomas K., 1998, Frontiers in Bioscience, V3, pD1181; Schlesinger TK, 2002, J BIOL CHEM, V277, P10283, DOI 10.1074/jbc.M106885200; Strnad P, 2001, CELL TISSUE RES, V306, P277, DOI 10.1007/s004410100455; Suria H, 1999, LIFE SCI, V65, P2697, DOI 10.1016/S0024-3205(99)00538-X; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; White SR, 2001, AM J RESP CELL MOL, V24, P282, DOI 10.1165/ajrcmb.24.3.3995; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Witowsky JA, 2003, J BIOL CHEM, V278, P1403, DOI 10.1074/jbc.C200616200; XIA Y, 2006, MOL CELL BIOL; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; ZHAO B, 2007, PP2A REGULATES UPSTR	39	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17310	10.1371/journal.pone.0017310	http://dx.doi.org/10.1371/journal.pone.0017310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364884	Green Submitted, Green Published, gold			2022-12-25	WOS:000287764100044
J	Aguado-Llera, D; Martinez-Gomez, AI; Prieto, J; Marenchino, M; Traverso, JA; Gomez, J; Chueca, A; Neira, JL				Aguado-Llera, David; Isabel Martinez-Gomez, Ana; Prieto, Jesus; Marenchino, Marco; Angel Traverso, Jose; Gomez, Javier; Chueca, Ana; Neira, Jose L.			The Conformational Stability and Biophysical Properties of the Eukaryotic Thioredoxins of Pisum Sativum Are Not Family-Conserved	PLOS ONE			English	Article							H-TYPE THIOREDOXINS; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURES; PLASTIDIAL THIOREDOXINS; PROTEIN-STRUCTURE; MOLTEN GLOBULE; IDENTIFICATION; ARABIDOPSIS; SYSTEM; NMR	Thioredoxins (TRXs) are ubiquitous proteins involved in redox processes. About forty genes encode TRX or TRX-related proteins in plants, grouped in different families according to their subcellular localization. For instance, the h-type TRXs are located in cytoplasm or mitochondria, whereas f-type TRXs have a plastidial origin, although both types of proteins have an eukaryotic origin as opposed to other TRXs. Herein, we study the conformational and the biophysical features of TRXh1, TRXh2 and TRXf from Pisum sativum. The modelled structures of the three proteins show the well-known TRX fold. While sharing similar pH-denaturations features, the chemical and thermal stabilities are different, being PsTRXh1 (Pisum sativum thioredoxin h1) the most stable isoform; moreover, the three proteins follow a three-state denaturation model, during the chemical-denaturations. These differences in the thermal-and chemical-denaturations result from changes, in a broad sense, of the several ASAs (accessible surface areas) of the proteins. Thus, although a strong relationship can be found between the primary amino acid sequence and the structure among TRXs, that between the residue sequence and the conformational stability and biophysical properties is not. We discuss how these differences in the biophysical properties of TRXs determine their unique functions in pea, and we show how residues involved in the biophysical features described (pH-titrations, dimerizations and chemical-denaturations) belong to regions involved in interaction with other proteins. Our results suggest that the sequence demands of protein-protein function are relatively rigid, with different protein-binding pockets (some in common) for each of the three proteins, but the demands of structure and conformational stability per se (as long as there is a maintained core), are less so.	[Aguado-Llera, David; Gomez, Javier; Neira, Jose L.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain; [Isabel Martinez-Gomez, Ana] Univ Almeria, Dept Quim Fis Bioquim & Quim Inorgan, Almeria, Spain; [Prieto, Jesus; Marenchino, Marco] CNIO, Dept Biol Estruct & Biocomp, Madrid, Spain; [Angel Traverso, Jose; Chueca, Ana] CSIC, Estn Expt Zaidin, Dept Bioquim Biol Celular & Mol Plantas, Granada, Spain; [Neira, Jose L.] Biocomputat & Complex Syst Phys Inst, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; Universidad de Almeria; Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Aguado-Llera, D (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain.	jlneira@umh.es	Neira, Jose/ABF-4210-2021; Gomez, Javier/N-9820-2013; Traverso, Jose/B-4342-2008; Llera, David Aguado/A-4349-2017; Traverso, Jose A./I-6038-2014	Gomez, Javier/0000-0001-9612-5075; Traverso, Jose/0000-0003-2519-5185; Llera, David Aguado/0000-0002-8333-2857; Neira, Jose Luis/0000-0002-4933-0428; Traverso, Jose A./0000-0003-4623-6118	Junta de Andalucia, Spain [CVI 154]; Spanish Research Council (CSIC); Spanish Ministerio de Ciencia e Innovacion (MCINN) [SAF2008-05742-C02-01]; Generalitat Valenciana (GV) [ACOMP/2010/114]; Spanish MCINN [SAF2008-05742-C02-01, CSD-2008-00005]; FIPSE Foundation [Exp. 36557/06]	Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); Spanish Research Council (CSIC); Spanish Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana (GV)(Center for Forestry Research & Experimentation (CIEF)); Spanish MCINN(Spanish Government); FIPSE Foundation	This work was supported by Junta de Andalucia, Spain (grant no. CVI 154) to AC. JAT was supported by the program JAE-DOC 2009 from the Spanish Research Council (CSIC). The work of JG was supported by Projects SAF2008-05742-C02-01 from the Spanish Ministerio de Ciencia e Innovacion (MCINN) and Generalitat Valenciana (GV) (ACOMP/2010/114). The work of JLN was supported by Projects SAF2008-05742-C02-01 and CSD-2008-00005 from the Spanish MCINN, FIPSE Foundation (Exp. 36557/06) and GV (ACOMP/2010/114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1967, J BIOL CHEM, V242, P3026; ALBERTS B, 1994, MOL BIOL CELL, P630; ANGLISTER J, 1993, J BIOMOL NMR, V3, P121; Atkins P., 2006, PHYS CHEM; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; BARAJASLOPEZ J, 2007, PLANT PHYIOSL, V145, P945; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Buchanan BB, 1997, P NATL ACAD SCI USA, V94, P5372, DOI 10.1073/pnas.94.10.5372; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Capitani G, 2000, J MOL BIOL, V302, P135, DOI 10.1006/jmbi.2000.4006; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coudevylle N, 2005, BIOCHEMISTRY-US, V44, P2001, DOI 10.1021/bi047816n; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FLORENCIO FJ, 1988, ARCH BIOCHEM BIOPHYS, V266, P496, DOI 10.1016/0003-9861(88)90282-2; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gronenborn AM, 1999, PROTEIN SCI, V8, P426; HARDING SE, 1997, PROTEIN STRUCTURE PR, P219; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Issakidis-Bourguet E, 2001, PLANT J, V25, P127, DOI 10.1046/j.0960-7412.2000.00943.x; Itzhaki LS, 1997, J MOL BIOL, V270, P89, DOI 10.1006/jmbi.1997.1049; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LANGSETMO K, 1989, BIOCHEMISTRY-US, V28, P3211, DOI 10.1021/bi00434a015; Laue T.M., 1992, COMPUTER AIDED INTER; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lopez-Redondo ML, 2010, FEBS LETT, V584, P989, DOI 10.1016/j.febslet.2010.01.043; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maeda K, 2008, PROTEIN SCI, V17, P1015, DOI 10.1110/ps.083460308; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Meyer Y, 2006, PHOTOSYNTH RES, V89, P179, DOI 10.1007/s11120-006-9095-3; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Montrichard F, 2003, PLANT PHYSIOL, V132, P1707, DOI 10.1104/pp.102.019562; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Mottonen JM, 2009, PROTEINS, V75, P610, DOI 10.1002/prot.22273; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Neira JL, 2001, BIOCHEMISTRY-US, V40, P15246, DOI 10.1021/bi011186x; Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681; Pedroso I, 2002, BIOCHEMISTRY-US, V41, P9873, DOI 10.1021/bi025742e; Perez-Jimenez R, 2009, NAT STRUCT MOL BIOL, V16, P890, DOI 10.1038/nsmb.1627; Pettifer S, 2009, BIOINFORMATICS, V25, P2090, DOI 10.1093/bioinformatics/btp329; Privalov Peter L., 1992, P83; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Richardson JM, 2000, BIOCHEMISTRY-US, V39, P11154, DOI 10.1021/bi000610b; Royer C A, 1995, Methods Mol Biol, V40, P65; Sahrawy M, 1996, J MOL EVOL, V42, P422; Sahrawy M, 1997, J MOL BIOL, V269, P623, DOI 10.1006/jmbi.1997.1054; Schmid F. Z., 1997, PROTEIN STRUCTURE PR, P261; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; SOULIE JM, 1985, EUR J BIOCHEM, V152, P565, DOI 10.1111/j.1432-1033.1985.tb09232.x; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; Traverso JA, 2008, J EXP BOT, V59, P1267, DOI 10.1093/jxb/ern037; Traverso JA, 2007, PLANT PHYSIOL, V143, P300, DOI 10.1104/pp.106.089524; Traverso JA, 2007, PLANT SIGNAL BEHAV, V2, P426, DOI 10.4161/psb.2.5.4419; Traverso JA, 2010, J PLANT PHYSIOL, V167, P423, DOI 10.1016/j.jplph.2009.10.017; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Wani AH, 2006, BIOCHEMISTRY-US, V45, P11226, DOI 10.1021/bi060647h; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WISHART DS, 1993, BIOCHIM BIOPHYS ACTA, V1164, P36, DOI 10.1016/0167-4838(93)90109-5; WOLLMAN EE, 1988, J BIOL CHEM, V263, P15506; WOODY RW, 1995, METHOD ENZYMOL, V246, P34	82	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17068	10.1371/journal.pone.0017068	http://dx.doi.org/10.1371/journal.pone.0017068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364950	Green Submitted, gold, Green Published			2022-12-25	WOS:000287656600029
J	Gromova, P; Rubin, BP; An, T; Erneux, C; Vanderwinden, JM				Gromova, Petra; Rubin, Brian P.; An Thys; Erneux, Christophe; Vanderwinden, Jean-Marie			Neurotensin Receptor 1 Is Expressed in Gastrointestinal Stromal Tumors but Not in Interstitial Cells of Cajal	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; KINASE-C-THETA; IMATINIB MESYLATE; POTENTIAL ROLE; HUMAN-PLASMA; KIT K641E; IN-VITRO; GENE; CANCER; ACTIVATION	Gastrointestinal stromal tumors (GIST) are thought to derive from the interstitial cells of Cajal (ICC) or an ICC precursor. Oncogenic mutations of the KIT or PDGFRA receptor tyrosine kinases are present in the majority of GIST, leading to ligand-independent activation of the intracellular signal transduction pathways. We previously investigated the gene expression profile in the murine Kit(K641E) GIST model and identified Ntsr1 mRNA, encoding the Neurotensin receptor 1, amongst the upregulated genes. Here we characterized Ntsr1 mRNA and protein expression in the murine Kit(K641E) GIST model and in tissue microarrays of human GIST. Ntsr1 mRNA upregulation in Kit(K641E) animals was confirmed by quantitative PCR. Ntsr1 immunoreactivity was not detected in the Kit positive ICC of WT mice, but was present in the Kit positive hyperplasia of Kit(K641E) mice. In the normal human gut, NTSR1 immunoreactivity was detected in myenteric neurons but not in KIT positive ICC. Two independent tissue microarrays, including a total of 97 GIST, revealed NTSR1 immunoreactivity in all specimens, including the KIT negative GIST with PDGFRA mutation. NTSR1 immunoreactivity exhibited nuclear, cytoplasmic or mixed patterns, which might relate to variable levels of NTSR1 activation. As studies using radio-labeled NTSR1 ligand analogues for whole body tumor imaging and for targeted therapeutic interventions have already been reported, this study opens new perspectives for similar approaches in GIST.	[Gromova, Petra; An Thys; Vanderwinden, Jean-Marie] Univ Libre Brussels, Fac Med, Neurophysiol Lab, Brussels, Belgium; [Rubin, Brian P.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Rubin, Brian P.] Taussig Canc Ctr, Cleveland, OH USA; [Erneux, Christophe] Univ Libre Brussels, Fac Med, IRIBHM, Brussels, Belgium	Universite Libre de Bruxelles; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Universite Libre de Bruxelles	Gromova, P (corresponding author), Univ Libre Brussels, Fac Med, Neurophysiol Lab, Brussels, Belgium.	jmvdwin@ulb.ac.be	Gener, Petra/AAD-5770-2019	Thys, An/0000-0002-6838-312X; Gener, Petra/0000-0002-2250-570X	National Fund for Scientific Research (Belgium) [7.4.558.07.F, 7.4.529.08.F]; Fonds de la Recherche Scientifique Medicale [3.4.571.07.F]; Belgian State Policy; Life Raft Group	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian State Policy; Life Raft Group	Funding: National Fund for Scientific Research (Belgium) http://www2.frs-fnrs.be/, Televie grant 7.4.558.07.F, jointly to JMV and CE. National Fund for Scientific Research (Belgium), Fonds de la Recherche Scientifique Medicale grant 3.4.571.07.F to JMV. National Fund for Scientific Research (Belgium), Grant 7.4.529.08.F and Belgian State Policy http://www.belspo.be/belspo/home/port_en.stm PAIP (P6/28) to CE. BPR is funded by a generous grant from The Life Raft Group http://www.liferaftgroup.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; BLACKBURN AM, 1979, J ENDOCRINOL, V83, P175, DOI 10.1677/joe.0.0830175; Blay P, 2004, CLIN CANCER RES, V10, P4089, DOI 10.1158/1078-0432.CCR-04-0630; Buchegger F, 2003, J NUCL MED, V44, P1649; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Demetri GD, 2007, J NATL COMPR CANC S2, V5, pS30; Dong ZZ, 1998, AM J PHYSIOL-GASTR L, V274, pG535, DOI 10.1152/ajpgi.1998.274.3.G535; Duensing A, 2004, CANCER RES, V64, P5127, DOI 10.1158/0008-5472.CAN-04-0559; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Fletcher CDM, 2002, INT J SURG PATHOL, V10, P81, DOI 10.1177/106689690201000201; Garcia-Garayoa E, 2009, EUR J NUCL MED MOL I, V36, P37, DOI 10.1007/s00259-008-0894-y; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Gromova P, 2009, J CELL MOL MED, V13, P1536, DOI 10.1111/j.1582-4934.2009.00768.x; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jager PL, 2004, NUCL MED COMMUN, V25, P433, DOI 10.1097/00006231-200405000-00002; Kitamura Y, 2008, J GASTROENTEROL, V43, P499, DOI 10.1007/s00535-008-2200-y; LEONG MTM, 2004, J BIOL CHEM, V279, P12636; LEONG MTM, 2004, J HISTOCHEM CYTOCHEM, V52, P335; Liegl-Atzwanger B, 2010, VIRCHOWS ARCH, V456, P111, DOI 10.1007/s00428-010-0891-y; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; Medeiros F, 2004, AM J SURG PATHOL, V28, P889, DOI 10.1097/00000478-200407000-00007; Meggiato T, 1996, TUMORI, V82, P592, DOI 10.1177/030089169608200616; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Parkkila S, 2010, MODERN PATHOL, V23, P743, DOI 10.1038/modpathol.2009.189; Prior JO, 2009, J CLIN ONCOL, V27, P439, DOI 10.1200/JCO.2008.17.2742; Reubi JC, 1999, INT J CANCER, V82, P213, DOI 10.1002/(SICI)1097-0215(19990719)82:2<213::AID-IJC11>3.0.CO;2-8; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Shankar S, 2005, RADIOLOGY, V235, P892, DOI 10.1148/radiol.2353040332; SHAW C, 1983, REGUL PEPTIDES, V7, P145, DOI 10.1016/0167-0115(83)90306-3; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; THEODORSSONNORHEIM E, 1983, GASTROENTEROLOGY, V85, P881; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Van den Abbeele AD, 2002, EUR J CANCER, V38, pS60, DOI 10.1016/S0959-8049(02)80604-9; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8	40	14	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e14710	10.1371/journal.pone.0014710	http://dx.doi.org/10.1371/journal.pone.0014710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364741	Green Published, gold, Green Submitted			2022-12-25	WOS:000287482800002
J	Poninska, J; Samolinski, B; Tomaszewska, A; Raciborski, F; Samel-Kowalik, P; Walkiewicz, A; Lipiec, A; Piekarska, B; Komorowski, J; Krzych-Falta, E; Namyslowski, A; Borowicz, J; Kostrzewa, G; Majewski, S; Ploski, R				Poninska, Joanna; Samolinski, Boleslaw; Tomaszewska, Aneta; Raciborski, Filip; Samel-Kowalik, Piotr; Walkiewicz, Artur; Lipiec, Agnieszka; Piekarska, Barbara; Komorowski, Jaroslaw; Krzych-Falta, Edyta; Namyslowski, Andrzej; Borowicz, Jacek; Kostrzewa, Grazyna; Majewski, Slawomir; Ploski, Rafal			Filaggrin Gene Defects Are Independent Risk Factors for Atopic Asthma in a Polish Population: A Study in ECAP Cohort	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; EARLY-ONSET; ICHTHYOSIS VULGARIS; ALLERGIC RHINITIS; DERMATITIS; ECZEMA; PREDISPOSE; METAANALYSIS; PREVALENT; VARIANTS	Background: FLG null variants of which 2282del4 and R501X are the most frequent in Caucasians are established risk factors for atopic dermatitis (AD) with an effect probably mediated through impairment of epidermal barrier. Among subjects with AD FLG defects are also consistently associated with asthma and allergic rhinitis (AR) but it is less clear to what extent these associations are also present independently from skin disease. The aim of the present study was to evaluate the role of 2282del4 and R501X in predisposing to these allergic phenotypes in a Polish population. Methodology: 2282del4 and R501X were typed among 3,802 participants of the Epidemiology of Allergic Diseases in Poland (ECAP) survey, a cross-sectional population-based study using ECRHS II and ISAAC questionnaires, and ambulatory examination. Principal Findings: The FLG null variants were associated with AD (OR = 2.01, CI: 1.20-3.36, P = 0.007), allergic rhinitis (in particular persistent form, OR = 1.69, CI: 1.12-2.54, P = 0.011), and asthma (in particular atopic asthma, OR = 2.22, CI: 1.24-3.96, P = 0.006). Association with atopic asthma (but not persistent allergic rhinitis) was also present in the absence of AD, (OR = 2.02, CI: 1.07-3.81, P = 0.027) as well as in the absence of AD and history of broadly defined inflammatory skin disease (OR = 2.30, CI: 1.07-4.93, P = 0.03). Association to atopic asthma would have not been found if diagnosis was made by questionnaire only (OR = 1.15, CI: 0.58-2.32, P = 0.8). We did not observe an association between FLG variants and allergic sensitizations (P = 0.8) or total IgE. (P = 0.6). Conclusions/Significance: In a Polish population FLG 2282del4 and R501X carriage increases risk for development of AD and atopic asthma (also in the absence of AD or history thereof). This suggests that interventions aimed at restoring epidermal barrier may have a general role in asthma prophylaxis/treatment.	[Poninska, Joanna; Kostrzewa, Grazyna; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Samolinski, Boleslaw; Tomaszewska, Aneta; Raciborski, Filip; Samel-Kowalik, Piotr; Walkiewicz, Artur; Lipiec, Agnieszka; Piekarska, Barbara; Komorowski, Jaroslaw; Krzych-Falta, Edyta; Namyslowski, Andrzej; Borowicz, Jacek] Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland; [Majewski, Slawomir] Med Univ Warsaw, Dept Dermatol & Venereol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw	Poninska, J (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl	Piekarska, Barbara/AAJ-7354-2020; Tomaszewska, Aneta/X-8906-2018; Lipiec, Agnieszka/X-7523-2018; Samel-Kowalik, Piotr/M-3239-2018	Piekarska, Barbara/0000-0002-6800-7781; Tomaszewska, Aneta/0000-0001-6730-6352; Lipiec, Agnieszka/0000-0003-3037-2326; Samel-Kowalik, Piotr/0000-0002-9047-0414; Ploski, Rafal/0000-0001-6286-5526; Raciborski, Filip/0000-0003-0562-0260; Poninska, Joanna/0000-0002-0890-611X; Krzych-Falta, Edyta/0000-0002-9857-7136	Polish Ministry of Science and Higher Education, Ministry of Health [6P052005C/06572]; Warsaw Medical University [1WY/NK1W/2009]	Polish Ministry of Science and Higher Education, Ministry of Health; Warsaw Medical University	Funding: The work was financed by grants from Polish Ministry of Science and Higher Education, Ministry of Health grant nr 6P052005C/06572, and Warsaw Medical University grant nr 1WY/NK1W/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER JNW, 2006, J INVEST DERMATOL, V127, P654; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Bonnelykke K, 2010, PEDIAT ALLERG IMM-UK, V21, P954, DOI 10.1111/j.1399-3038.2010.01073.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Brown SJ, 2008, J INVEST DERMATOL, V128, P1591, DOI 10.1038/sj.jid.5701206; DEBELIC M, 1996, MANUALE ALLERGOLOGIC, V4; Global Initiative for Asthma, 2009, GLOB STRAT ASTHM MAN; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; JOHANSSON GOS, 1998, CLIN WORKSH IGE ANT; Kulig M, 2000, J ALLERGY CLIN IMMUN, V105, P274, DOI 10.1016/S0091-6749(00)90076-9; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mueller-Malesinska M, 2001, J AUDIOLOGICAL MED, V10, P136; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stemmler S, 2007, J INVEST DERMATOL, V127, P722, DOI 10.1038/sj.jid.5700579; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Weidinger S, 2007, J INVEST DERMATOL, V127, P724, DOI 10.1038/sj.jid.5700630	24	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16933	10.1371/journal.pone.0016933	http://dx.doi.org/10.1371/journal.pone.0016933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365004	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482800021
J	Messaoud, Y; Chen, HYH				Messaoud, Yassine; Chen, Han Y. H.			The Influence of Recent Climate Change on Tree Height Growth Differs with Species and Spatial Environment	PLOS ONE			English	Article							TREMBLING ASPEN; BLACK SPRUCE; SITE INDEX; BRITISH-COLUMBIA; FAGUS-SYLVATICA; RADIAL GROWTH; WHITE SPRUCE; ATMOSPHERIC CO2; CARBON-DIOXIDE; DOUGLAS-FIR	Tree growth has been reported to increase in response to recent global climate change in controlled and semi-controlled experiments, but few studies have reported response of tree growth to increased temperature and atmospheric carbon dioxide (CO2) concentration in natural environments. This study addresses how recent global climate change has affected height growth of trembling aspen (Populus tremuloides Michx) and black spruce (Picea mariana Mill B. S.) in their natural environments. We sampled 145 stands dominated by aspen and 82 dominated by spruce over the entire range of their distributions in British Columbia, Canada. These stands were established naturally after fire between the 19(th) and 20(th) centuries. Height growth was quantified as total heights of sampled dominant and co-dominant trees at breast-height age of 50 years. We assessed the relationships between 50-year height growth and environmental factors at both spatial and temporal scales. We also tested whether the tree growth associated with global climate change differed with spatial environment (latitude, longitude and elevation). As expected, height growth of both species was positively related to temperature variables at the regional scale and with soil moisture and nutrient availability at the local scale. While height growth of trembling aspen was not significantly related to any of the temporal variables we examined, that of black spruce increased significantly with stand establishment date, the anomaly of the average maximum summer temperature between May-August, and atmospheric CO2 concentration, but not with the Palmer Drought Severity Index. Furthermore, the increase of spruce height growth associated with recent climate change was higher in the western than in eastern part of British Columbia. This study demonstrates that the response of height growth to recent climate change, i.e., increasing temperature and atmospheric CO2 concentration, did not only differ with tree species, but also their growing spatial environment.	[Messaoud, Yassine; Chen, Han Y. H.] Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada	Lakehead University	Messaoud, Y (corresponding author), Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada.	hchen1@lakeheadu.ca	Chen, Han YH/A-1359-2008	Chen, Han YH/0000-0001-9477-5541	Natural Sciences and Engineering Research Council of Canada [DG283336-09]; Ontario Early Researcher Award	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	Natural Sciences and Engineering Research Council of Canada (DG283336-09) and an Ontario Early Researcher Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, SPECIAL REPORT SERIE; Asshoff R, 2006, GLOBAL CHANGE BIOL, V12, P848, DOI 10.1111/j.1365-2486.2006.01133.x; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Bradley KL, 2007, TRENDS ECOL EVOL, V22, P538, DOI 10.1016/j.tree.2007.08.005; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Chen HYH, 2002, CAN J FOREST RES, V32, P112, DOI 10.1139/x01-179; Chen HYH, 1998, FOREST ECOL MANAG, V102, P157, DOI 10.1016/S0378-1127(97)00154-0; Chen HYH, 1998, CAN J FOREST RES, V28, P1743, DOI 10.1139/cjfr-28-12-1743; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Dai A, 1999, J CLIMATE, V12, P2451, DOI [10.1175/1520-0442(1999)012<2451:EOCSMP>2.0.CO;2, 10.1175/1520-0442(1999)012&lt;2451:EOCSMP&gt;2.0.CO;2]; DYER ME, 1987, FOREST SCI, V33, P3; Fantin N, 2002, CAN J FOREST RES, V32, P1478, DOI [10.1139/x02-053, 10.1139/X02-053]; Fries A, 1998, SCAND J FOREST RES, V13, P128, DOI 10.1080/02827589809382969; Gifford RM, 2004, NEW PHYTOL, V163, P221, DOI 10.1111/j.1469-8137.2004.01133.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GRAUMLICH LJ, 1991, ECOLOGY, V72, P1, DOI 10.2307/1938895; Green RN, 1994, HDB MINISTRY FORESTS; Hamann A, 2005, AGR FOREST METEOROL, V128, P211, DOI 10.1016/j.agrformet.2004.10.004; Hamel B, 2004, FOREST ECOL MANAG, V191, P239, DOI 10.1016/j.foreco.2003.12.004; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Howell CD, 2007, STAT METHODS PSYCHOL; KELLOMAKI S, 1994, FOREST ECOL MANAG, V65, P201, DOI 10.1016/0378-1127(94)90171-6; Klinka K, 2003, FOREST ECOL MANAG, V175, P521, DOI 10.1016/S0378-1127(02)00184-6; Klinka K, 1996, FOREST CHRON, V72, P193, DOI 10.5558/tfc72193-2; Klinka K., 2000, DISTRIBUTION SYNOPSI; Koutavas A, 2008, DENDROCHRONOLOGIA, V26, P13, DOI 10.1016/j.dendro.2007.06.001; Kozlowski TT., 1997, GROWTH CONTROL WOODY; LAMARCHE VC, 1984, SCIENCE, V225, P1019, DOI 10.1126/science.225.4666.1019; Lapointe-Garant MP, 2010, GLOBAL CHANGE BIOL, V16, P2039, DOI 10.1111/j.1365-2486.2009.02048.x; Leonelli G, 2008, CAN J FOREST RES, V38, P1211, DOI 10.1139/X07-227; Loehle C, 2000, CAN J FOREST RES, V30, P1632, DOI 10.1139/cjfr-30-10-1632; Luckman BH, 2005, CLIM DYNAM, V24, P131, DOI 10.1007/s00382-004-0511-0; Luttmerding H. A., 1990, DESCRIBING ECOSYSTEM; Miller J.H., 1990, SILVICS N AM, P461; Miyamoto Y, 2010, FOREST ECOL MANAG, V259, P514, DOI 10.1016/j.foreco.2009.11.008; MONSERUD RA, 1984, FOREST SCI, V30, P943; Moore DJP, 2006, GLOBAL CHANGE BIOL, V12, P1367, DOI 10.1111/j.1365-2486.2006.01189.x; Nigh GD, 2004, FOREST SCI, V50, P659; Nigh GD, 2002, FOREST CHRON, V78, P306, DOI 10.5558/tfc78306-2; Nigh GD, 2006, CLIMATIC CHANGE, V76, P321, DOI 10.1007/s10584-005-9041-y; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Pinno BD, 2009, FOREST ECOL MANAG, V257, P782, DOI 10.1016/j.foreco.2008.09.058; Pinto PE, 2008, FOREST ECOL MANAG, V255, P619, DOI 10.1016/j.foreco.2007.09.031; Piovesan G, 2008, GLOBAL CHANGE BIOL, V14, P1265, DOI 10.1111/j.1365-2486.2008.01570.x; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Seynave I, 2008, J BIOGEOGR, V35, P1851, DOI 10.1111/j.1365-2699.2008.01930.x; Soule PT, 2006, NEW PHYTOL, V171, P379, DOI 10.1111/j.1469-8137.2006.01746.x; Srur AM, 2008, REV CHIL HIST NAT, V81, P239; SYSTAT, 2007, SYST 12 WIND; Viereck L. A., 2007, ALASKA TREES SHRUBS, V2nd; Voelker SL, 2006, ECOL MONOGR, V76, P549, DOI 10.1890/0012-9615(2006)076[0549:HCGEDW]2.0.CO;2; Wang GG, 2006, GLOBAL CHANGE BIOL, V12, P601, DOI 10.1111/j.1365-2486.2006.01098.x; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Wirth C, 2008, ECOL MONOGR, V78, P489, DOI 10.1890/07-0074.1	57	36	38	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14691	10.1371/journal.pone.0014691	http://dx.doi.org/10.1371/journal.pone.0014691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358817	gold, Green Submitted, Green Published			2022-12-25	WOS:000287392700006
J	Miyagi, M; Wan, Q; Ahmad, MF; Gokulrangan, G; Tomechko, SE; Bennett, B; Dealwis, C				Miyagi, Masaru; Wan, Qun; Ahmad, Md. Faiz; Gokulrangan, Giridharan; Tomechko, Sara E.; Bennett, Brad; Dealwis, Chris			Histidine Hydrogen-Deuterium Exchange Mass Spectrometry for Probing the Microenvironment of Histidine Residues in Dihydrofolate Reductase	PLOS ONE			English	Article							MAGNETIC-RESONANCE; CRYSTAL-STRUCTURE; PK(A) VALUES; METHOTREXATE; CATALYSIS; PROTEINS; KINETICS; NETWORK; MOTIONS; PROTONS	Background: Histidine Hydrogen-Deuterium Exchange Mass Spectrometry (His-HDX-MS) determines the HDX rates at the imidazole C(2)-hydrogen of histidine residues. This method provides not only the HDX rates but also the pK(a) values of histidine imidazole rings. His-HDX-MS was used to probe the microenvironment of histidine residues of E. coli dihydrofolate reductase (DHFR), an enzyme proposed to undergo multiple conformational changes during catalysis. Methodology/Principal Findings: Using His-HDX-MS, the pK(a) values and the half-lives (t(1/2)) of HDX reactions of five histidine residues of apo-DHFR, DHFR in complex with methotrexate (DHFR-MTX), DHFR in complex with MTX and NADPH (DHFR-MTX-NADPH), and DHFR in complex with folate and NADP(+) (DHFR-folate-NADP+) were determined. The results showed that the two parameters (pK(a) and t(1/2)) are sensitive to the changes of the microenvironment around the histidine residues. Although four of the five histidine residues are located far from the active site, ligand binding affected their pK(a), t(1/)2 or both. This is consistent with previous observations of ligand binding-induced distal conformational changes on DHFR. Most of the observed pK(a) and t(1/2) changes could be rationalized using the X-ray structures of apo-DHFR, DHFR-MTX-NADPH, and DHFR-folate-NADP+. The availability of the neutron diffraction structure of DHFR-MTX enabled us to compare the protonation states of histidine imidazole rings. Conclusions/Significance: Our results demonstrate the usefulness of His-HDX-MS in probing the microenvironments of histidine residues within proteins.	[Miyagi, Masaru; Gokulrangan, Giridharan; Tomechko, Sara E.; Dealwis, Chris] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Miyagi, Masaru; Wan, Qun; Ahmad, Md. Faiz; Bennett, Brad; Dealwis, Chris] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Miyagi, M (corresponding author), Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.	masaru.miyagi@case.edu; chris.dealwis@case.edu		Wan, Qun/0000-0002-8309-0341	National Institutes of Health (NIH) [P30EY-11373]; Case Western Reserve University; Cleveland Foundation; Department of Defense (DOD) Laboratory Directed Research and Development [20070131ER]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; Cleveland Foundation; Department of Defense (DOD) Laboratory Directed Research and Development(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health (NIH) grant P30EY-11373 (Visual Sciences Research Center of Case Western Reserve University) and funds from Case Western Reserve University and the Cleveland Foundation. QW and CD were funded by a Department of Defense (DOD) Laboratory Directed Research and Development award (20070131ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Amyes TL, 2004, J AM CHEM SOC, V126, P4366, DOI 10.1021/ja039890j; Barlin G. B., 1972, ELUCIDATION ORGANI 1, P611; Bennett B, 2006, P NATL ACAD SCI USA, V103, P18493, DOI 10.1073/pnas.0604977103; Bennett BC, 2008, ACTA CRYSTALLOGR D, V64, P764, DOI 10.1107/S0907444908012845; Bennett BC, 2007, J MED CHEM, V50, P4374, DOI 10.1021/jm070319v; Bennett BC, 2009, J STRUCT BIOL, V166, P162, DOI 10.1016/j.jsb.2009.01.001; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Harris T M, 1965, Chem Ind, V41, P1728; Horiuchi Y, 2010, BBA-PROTEINS PROTEOM, V1804, P846, DOI 10.1016/j.bbapap.2009.12.011; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; LODOWSKI DT, 2010, BIOCHEMISTRY; Markley J. L., 1973, P INT C STABLE ISOT, V1st, P103; MARTIN RB, 1963, SCIENCE, V139, P1198, DOI 10.1126/science.139.3560.1198; MATTHEWS DA, 1977, SCIENCE, V197, P452, DOI 10.1126/science.17920; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miyagi M, 2008, ANAL CHEM, V80, P6481, DOI 10.1021/ac8009643; Niimura N, 2004, CELL BIOCHEM BIOPHYS, V40, P351, DOI 10.1385/CBB:40:3:351; POE M, 1979, J BIOL CHEM, V254, P8143; Rajagopalan PTR, 2002, P NATL ACAD SCI USA, V99, P13481, DOI 10.1073/pnas.172501499; SACHS DH, 1971, J BIOL CHEM, V246, P6576; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; VAUGHAN JD, 1970, J ORG CHEM, V35, P1141, DOI 10.1021/jo00829a062; Wimalasena DS, 2010, BIOCHEMISTRY-US, V49, P6973, DOI 10.1021/bi100647z; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102; WYETH P, 1980, BIOCHEMISTRY-US, V19, P2608, DOI 10.1021/bi00553a012; Yamamoto T, 2004, J BIOCHEM, V135, P663, DOI 10.1093/jb/mvh080; Yamamoto T, 2004, J BIOCHEM, V135, P17, DOI 10.1093/jb/mvh002	31	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17055	10.1371/journal.pone.0017055	http://dx.doi.org/10.1371/journal.pone.0017055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359214	gold, Green Submitted, Green Published			2022-12-25	WOS:000287392700040
J	Kilpelainen, M; Nurminen, L; Donner, K				Kilpelainen, Markku; Nurminen, Lauri; Donner, Kristian			Effects of Mean Luminance Changes on Human Contrast Perception: Contrast Dependence, Time-Course and Spatial Specificity	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; PRIMARY VISUAL-CORTEX; NATURAL IMAGES; LIGHT-ADAPTATION; BACKGROUND LUMINANCE; EYE-MOVEMENTS; CONE VISION; RESPONSES; BRIGHTNESS; DYNAMICS	Background: When we are viewing natural scenes, every saccade abruptly changes both the mean luminance and the contrast structure falling on any given retinal location. Thus it would be useful if the two were independently encoded by the visual system, even when they change simultaneously. Recordings from single neurons in the cat visual system have suggested that contrast information may be quite independently represented in neural responses to simultaneous changes in contrast and luminance. Here we test to what extent this is true in human perception. Methodology/Principal Findings: Small contrast stimuli were presented together with a 7-fold upward or downward step of mean luminance (between 185 and 1295 Td, corresponding to 14 and 98 cd/m(2)), either simultaneously or with various delays (50-800 ms). The perceived contrast of the target under the different conditions was measured with an adaptive staircase method. Over the contrast range 0.1-0.45, mainly subtractive attenuation was found. Perceived contrast decreased by 0.052 +/- 0.021 (N = 3) when target onset was simultaneous with the luminance increase. The attenuation subsided within 400 ms, and even faster after luminance decreases, where the effect was also smaller. The main results were robust against differences in target types and the size of the field over which luminance changed. Conclusions/Significance: Perceived contrast is attenuated mainly by a subtractive term when coincident with a luminance change. The effect is of ecologically relevant magnitude and duration; in other words, strict contrast constancy must often fail during normal human visual behaviour. Still, the relative robustness of the contrast signal is remarkable in view of the limited dynamic response range of retinal cones. We propose a conceptual model for how early retinal signalling may allow this.	[Kilpelainen, Markku] Univ Helsinki, Dept Behav Sci, Helsinki, Finland; [Nurminen, Lauri] Aalto Univ, Sch Sci & Technol, Brain Res Unit, Low Temp Lab, Espoo, Finland; [Donner, Kristian] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki; Aalto University; University of Helsinki	Kilpelainen, M (corresponding author), Univ Helsinki, Dept Behav Sci, Helsinki, Finland.	markku.kilpelainen@helsinki.fi	Kilpeläinen, Markku/C-7613-2011; Kilpeläinen, Markku/AAF-3420-2021	Kilpeläinen, Markku/0000-0002-4112-7548; Kilpeläinen, Markku/0000-0002-4112-7548; Donner, Kristian/0000-0001-7833-4236; Nurminen, Lauri/0000-0001-7480-7059	Finnish Graduate School of Psychology; Finnish Graduate School of Neuroscience; Academy of Finland [128081]	Finnish Graduate School of Psychology; Finnish Graduate School of Neuroscience; Academy of Finland(Academy of Finland)	Markku Kilpelainen was funded by the Finnish Graduate School of Psychology (www.gspsy.fi). Lauri Nurminen was funded by the Finnish Graduate School of Neuroscience (www.brain-mind.fi). Kristian Donner was supported by a research grant 128081 from the Academy of Finland (www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Baker DH, 2009, P NATL ACAD SCI USA, V106, P5436, DOI 10.1073/pnas.0812860106; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BOWEN RW, 1989, VISION RES, V29, P1501, DOI 10.1016/0042-6989(89)90134-X; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; DeMarco PJ, 2000, VISION RES, V40, P1907, DOI 10.1016/S0042-6989(00)00033-X; Djupsund K, 1996, VISION RES, V36, P3253, DOI 10.1016/0042-6989(96)00021-1; DONNER K, 1989, VISUAL NEUROSCI, V3, P39, DOI 10.1017/S0952523800012499; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Freeman DK, 2010, J NEUROPHYSIOL, V104, P704, DOI 10.1152/jn.00767.2009; Friedburg C, 2001, J PHYSIOL-LONDON, V534, P217, DOI 10.1111/j.1469-7793.2001.t01-1-00217.x; Garcia-Perez MA, 2010, J SENS STUD, V25, P876, DOI 10.1111/j.1745-459X.2010.00310.x; Geisler WS, 2007, J NEUROSCI, V27, P5063, DOI 10.1523/JNEUROSCI.0835-07.2007; GEISLER WS, 1978, VISION RES, V18, P279, DOI 10.1016/0042-6989(78)90162-1; HAYHOE MM, 1987, VISION RES, V27, P1981, DOI 10.1016/0042-6989(87)90062-9; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; Heikkinen H, 2009, VISION RES, V49, P1717, DOI 10.1016/j.visres.2009.03.024; HOOD DC, 1993, VISUAL NEUROSCI, V10, P857, DOI 10.1017/S0952523800006076; KAERNBACH C, 1990, J ACOUST SOC AM, V88, P2645, DOI 10.1121/1.399985; Kagan I, 2008, J VISION, V8, DOI 10.1167/8.14.19; Kilpelainen M, 2007, VISION RES, V47, P3298, DOI 10.1016/j.visres.2007.09.008; KRAUSKOPF J, 1980, VISION RES, V20, P671, DOI 10.1016/0042-6989(80)90091-7; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lee B, 1996, VISION RES, V36, P2159, DOI 10.1016/0042-6989(95)00271-5; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; Lindgren JT, 2008, J VISION, V8, DOI 10.1167/8.12.6; Ludwig CJH, 2005, J NEUROSCI, V25, P9907, DOI 10.1523/JNEUROSCI.2197-05.2005; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Muller JR, 2001, J NEUROSCI, V21, P6978, DOI 10.1523/JNEUROSCI.21-17-06978.2001; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; PELI E, 1995, J OPT SOC AM A, V12, P817, DOI 10.1364/JOSAA.12.000817; PELI E, 1991, J OPT SOC AM A, V8, P1352, DOI 10.1364/JOSAA.8.001352; PELLI DG, 1985, J OPT SOC AM A, V2, pP89; Poot L, 1997, J OPT SOC AM A, V14, P2499, DOI 10.1364/JOSAA.14.002499; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Saarela TP, 2008, J VISION, V8, DOI 10.1167/8.3.23; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; STEVENS JC, 1963, J OPT SOC AM, V53, P375, DOI 10.1364/JOSA.53.000375; Stevenson IH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009206; Summers RJ, 2009, VISION RES, V49, P1894, DOI 10.1016/j.visres.2009.04.027; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Webb BS, 2005, J NEUROSCI, V25, P11666, DOI 10.1523/JNEUROSCI.3414-05.2005; WESTHEIMER G, 1967, J PHYSIOL-LONDON, V190, P139, DOI 10.1113/jphysiol.1967.sp008198; WHITTLE P, 1969, VISION RES, V9, P1095, DOI 10.1016/0042-6989(69)90050-9; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17200	10.1371/journal.pone.0017200	http://dx.doi.org/10.1371/journal.pone.0017200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347246	Green Submitted, Green Published, gold			2022-12-25	WOS:000287369200027
J	Fernandez-Mazuecos, M; Vargas, P				Fernandez-Mazuecos, Mario; Vargas, Pablo			Genetically Depauperate in the Continent but Rich in Oceanic Islands: Cistus monspeliensis (Cistaceae) in the Canary Islands	PLOS ONE			English	Article							TROPICAL WETLAND TREE; OLEA-EUROPAEA L.; DNA POLYMORPHISM; POPULATIONS; DIVERSITY; EVOLUTION; PHYLOGEOGRAPHY; COLONIZATION; MAINLAND; PATTERNS	Background: Population genetic theory holds that oceanic island populations are expected to have lower levels of genetic variation than their mainland counterparts, due to founder effect after island colonization from the continent. Cistus monspeliensis (Cistaceae) is distributed in both the Canary Islands and the Mediterranean region. Numerous phylogenetic results obtained in the last years allow performing further phylogeographic analyses in Cistus. Methodology/Principal Findings: We analyzed sequences from multiple plastid DNA regions in 47 populations of Cistus monspeliensis from the Canary Islands (21 populations) and the Mediterranean basin (26 populations). The time-calibrated phylogeny and phylogeographic analyses yielded the following results: (1) a single, ancestral haplotype is distributed across the Mediterranean, whereas 10 haplotypes in the Canary Islands; (2) four haplotype lineages are present in the Canarian Islands; (3) multiple colonization events across the archipelago are inferred; (4) the earliest split of intraspecific lineages occurred in the Early to Middle Pleistocene (< 930,000 years BP). Conclusions/Significance: The contrasting pattern of cpDNA variation is best explained by genetic bottlenecks in the Mediterranean during Quaternary glaciations, while the Canarian archipelago acted as a refugium of high levels of genetic diversity. Active colonization across the Canarian islands is supported not only by the distribution of C. monspeliensis in five of the seven islands, but also by our phylogeographic reconstruction in which unrelated haplotypes are present on the same island. Widespread distribution of thermophilous habitats on every island, as those found throughout the Mediterranean, has likely been responsible for the successful colonization of C. monspeliensis, despite the absence of a long-distance dispersal mechanism. This is the first example of a plant species with higher genetic variation among oceanic island populations than among those of the continent.	[Fernandez-Mazuecos, Mario; Vargas, Pablo] CSIC, Real Jardin Bot, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Fernandez-Mazuecos, M (corresponding author), CSIC, Real Jardin Bot, Madrid, Spain.	mfmazuecos@rjb.csic.es	Fernández-Mazuecos, Mario/F-9699-2011	Fernández-Mazuecos, Mario/0000-0003-4027-6477	Spanish Direccion General de Investigacion Cientifica y Tecnica (DGICYT) [CGL2005-06017-C02]	Spanish Direccion General de Investigacion Cientifica y Tecnica (DGICYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research on continental plants has been supported by the Spanish Direccion General de Investigacion Cientifica y Tecnica (DGICYT) through project CGL2005-06017-C02 and a PhD scholarship to M.F.-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; ANCOCHEA E, 1990, J VOLCANOL GEOTH RES, V44, P231, DOI 10.1016/0377-0273(90)90019-C; Baldwin B. G., 1998, MOL SYSTEMATICS PLAN, P410, DOI DOI 10.1007/978-1-4615-5419-6_14; Bloomquist EW, 2010, TRENDS ECOL EVOL, V25, P626, DOI 10.1016/j.tree.2010.08.010; Bramwell D., 1976, Monographiae Biologicae, V30, P207; Bramwell D., 2001, FLORES SILVESTRES IS, V4; Carine MA, 2005, TAXON, V54, P895, DOI 10.2307/25065476; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Carracedo J. C., 2002, GEOLOGY SPAIN, P439, DOI DOI 10.1144/GOSPP; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Chiang YC, 2006, MOL ECOL, V15, P765, DOI 10.1111/j.1365-294X.2005.02833.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cox C.B., 2010, BIOGEOGRAPHY ECOLOGI; CRONK QCB, 1992, BIOL J LINN SOC, V46, P91, DOI 10.1111/j.1095-8312.1992.tb00852.x; Del Arco M, 2004, LISTA ESPECIES SILVE, P99; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Drummond A. J., 2010, GENEIOUS V4 8; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Fernandez-Mazuecos M, 2010, MOL ECOL, V19, P1381, DOI 10.1111/j.1365-294X.2010.04549.x; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Garcia-Verdugo C, 2009, MOL ECOL, V18, P454, DOI 10.1111/j.1365-294X.2008.04027.x; Garcia-Verdugo C, 2010, BOT J LINN SOC, V162, P54, DOI 10.1111/j.1095-8339.2009.01013.x; Gomez A, 2003, THEOR APPL GENET, V107, P1123, DOI 10.1007/s00122-003-1320-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guzman B, 2005, MOL PHYLOGENET EVOL, V37, P644, DOI 10.1016/j.ympev.2005.04.026; Guzman B, 2010, PERSPECT PLANT ECOL, V12, P163, DOI 10.1016/j.ppees.2009.09.002; Guzman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006362; Guzman B, 2009, J BIOGEOGR, V36, P954, DOI 10.1111/j.1365-2699.2008.02040.x; Hansen A, 1993, FLORA MACARONESIA CH; Hedderson TA, 2006, J BRYOL, V28, P283, DOI 10.1179/174328206X136287; Hess J, 2000, MOL ECOL, V9, P857, DOI 10.1046/j.1365-294x.2000.00942.x; Hudson RR, 2000, GENETICS, V155, P2011; INOUE K, 1990, AM J BOT, V77, P1440, DOI 10.2307/2444754; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marrero A, 2008, BOT MACARONESICA, V27, P73; Matsumura S, 2009, MOL PHYLOGENET EVOL, V53, P1032, DOI 10.1016/j.ympev.2009.06.011; Medail F, 1999, PLANT ECOL, V140, P221, DOI 10.1023/A:1009775327616; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Nei M., 1987, MOL EVOLUTIONARY GEN; Nepokroeff M, 2003, SYST BIOL, V52, P820, DOI 10.1080/10635150390251072; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; Pineiro R, 2007, MOL ECOL, V16, P2155, DOI 10.1111/j.1365-294X.2007.03280.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER VER 1 4; Richardson JE, 2003, EVOLUTION, V57, P816; Rivera-Ocasio E, 2002, MOL ECOL, V11, P675, DOI 10.1046/j.1365-294X.2002.01476.x; Rivera-Ocasio E, 2006, CONSERV GENET, V7, P251, DOI 10.1007/s10592-005-9022-8; Rodriguez-Sanchez F, 2009, J BIOGEOGR, V36, P1270, DOI 10.1111/j.1365-2699.2009.02091.x; Shepherd LD, 2009, J BIOGEOGR, V36, P1972, DOI 10.1111/j.1365-2699.2009.02120.x; Short MJ, 1994, FLORA MADEIRA, P226; Silvertown J, 2004, J ECOL, V92, P168, DOI 10.1111/j.1365-2745.2004.00853.x; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Sunding P., 1979, PLANTS ISLANDS, P13; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Takayama K, 2005, MOL ECOL, V14, P1059, DOI 10.1111/j.1365-294X.2005.02462.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TSUMURA Y, 1993, CAN J FOREST RES, V23, P859, DOI 10.1139/x93-112; Vargas P, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P297, DOI 10.1007/1-4020-4904-8_11; Vendramin GG, 2008, EVOLUTION, V62, P680, DOI 10.1111/j.1558-5646.2007.00294.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY	68	46	47	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17172	10.1371/journal.pone.0017172	http://dx.doi.org/10.1371/journal.pone.0017172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347265	Green Published, gold, Green Submitted			2022-12-25	WOS:000287367600040
J	Romero, A; Estevez-Calvar, N; Dios, S; Figueras, A; Novoa, B				Romero, Alejandro; Estevez-Calvar, Noelia; Dios, Sonia; Figueras, Antonio; Novoa, Beatriz			New Insights into the Apoptotic Process in Mollusks: Characterization of Caspase Genes in Mytilus galloprovincialis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; VIRUS-INFECTION; BIVALVE MOLLUSKS; CYTOCHROME-C; ACTIVATION; MUSSELS; OYSTER; MECHANISMS; EXPRESSION; RECEPTORS	Apoptosis is an essential biological process in the development and maintenance of immune system homeostasis. Caspase proteins constitute the core of the apoptotic machinery and can be categorized as either initiators or effectors of apoptosis. Although the genes encoding caspase proteins have been described in vertebrates and in almost all invertebrate phyla, there are few reports describing the initiator and executioner caspases or the modulation of their expression by different stimuli in different apoptotic pathways in bivalves. In the present work, we characterized two initiator and four executioner caspases in the mussel Mytilus galloprovincialis. Both initiators and executioners showed structural features that make them different from other caspase proteins already described. Evaluation of the genes' tissue expression patterns revealed extremely high expression levels within the gland and gills, where the apoptotic process is highly active due to the clearance of damaged cells. Hemocytes also showed high expression values, probably due to of the role of apoptosis in the defense against pathogens. To understand the mechanisms of caspase gene regulation, hemocytes were treated with UV-light, environmental pollutants and pathogen-associated molecular patterns (PAMPs) and apoptosis was evaluated by microscopy, flow cytometry and qPCR techniques. Our results suggest that the apoptotic process could be tightly regulated in bivalve mollusks by overexpression/suppression of caspase genes; additionally, there is evidence of caspase-specific responses to pathogens and pollutants. The apoptotic process in mollusks has a similar complexity to that of vertebrates, but presents unique features that may be related to recurrent exposure to environmental changes, pollutants and pathogens imposed by their sedentary nature.	[Romero, Alejandro; Estevez-Calvar, Noelia; Dios, Sonia; Figueras, Antonio; Novoa, Beatriz] CSIC, Inst Invest Marinas, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Romero, A (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	virus@iim.csic.es	Dios, Sonia/M-4201-2018; Figueras, Antonio/B-5133-2015; Novoa, Beatriz/K-3785-2014; Romero, Alejandro/R-4565-2019; Figueras, Antonio/AAB-8921-2019	Dios, Sonia/0000-0002-2126-991X; Figueras, Antonio/0000-0002-0617-0030; Romero, Alejandro/0000-0002-9343-3352; Figueras, Antonio/0000-0002-0617-0030; Novoa, Beatriz/0000-0003-4888-8419	EU from the Spanish Ministerio de Ciencia e Innovacion [FOOD-CT-2005-007103, AGL2008-05111/ACU]	EU from the Spanish Ministerio de Ciencia e Innovacion	This work was funded by the EU Integrated Project FOOD-CT-2005-007103 and AGL2008-05111/ACU from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen HL, 2005, J CLIN INVEST, V115, P2875, DOI 10.1172/JCI25365; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; Baccarani E. M., 1998, DIS AQUAT ORGAN, V32, P145; Baier-Anderson C, 2000, ENVIRON RES, V83, P72, DOI 10.1006/enrs.1999.4033; Barsiene Janina, 2008, Ekologija, V54, P44; Best SM, 2004, VIROLOGY, V320, P191, DOI 10.1016/j.virol.2003.11.025; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bridgham JT, 2003, CELL DEATH DIFFER, V10, P19, DOI 10.1038/sj.cdd.4401174; Buckland-Nicks J, 2005, J EXP ZOOL PART A, V303A, P723, DOI 10.1002/jez.a.207; Chang CC, 2008, FISH SHELLFISH IMMUN, V25, P672, DOI 10.1016/j.fsi.2008.09.004; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COLES JA, 1995, DIS AQUAT ORGAN, V22, P59, DOI 10.3354/dao022059; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; Dyrynda EA, 2000, MAR ECOL PROG SER, V206, P155, DOI 10.3354/meps206155; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Farris J. L, 2006, FRESHWATER BIVALVE E; FIGUERAS AJ, 1991, AQUACULTURE, V99, P17, DOI 10.1016/0044-8486(91)90285-F; Gagnaire B, 2006, CELL BIOL TOXICOL, V22, P1, DOI 10.1007/s10565-006-0011-6; Garcia-Garcia E, 2008, DEV COMP IMMUNOL, V32, P637, DOI 10.1016/j.dci.2007.10.004; Gifondorwa DJ, 2006, BIOL BULL-US, V210, P109, DOI 10.2307/4134600; HALE J, 1996, EUR J BIOCHEM, V236, P1; Ho PK, 2005, FEBS J, V272, P5436, DOI 10.1111/j.1742-4658.2005.04966.x; Huang WB, 2010, FISH SHELLFISH IMMUN, V28, P587, DOI 10.1016/j.fsi.2009.12.016; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koyama AH, 2003, INT REV IMMUNOL, V22, P341, DOI 10.1080/08830180305210; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lancellotti Marcelo, 2006, Brazilian Journal of Morphological Sciences, V23, P75; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lynch M, 1999, EVOLUTION, V53, P319, DOI [10.2307/2640769, 10.1111/j.1558-5646.1999.tb03768.x]; MOORE MN, 1978, J CONSEIL, V38, P6; Muzio M, 1998, INT J CLIN LAB RES, V28, P141, DOI 10.1007/s005990050035; NAIMO TJ, 1995, ECOTOXICOLOGY, V4, P341, DOI 10.1007/BF00118870; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; PIPE RK, 1995, FISH SHELLFISH IMMUN, V5, P581, DOI 10.1016/S1050-4648(95)80043-3; PROTA G, 1994, EUR J CANCER, V30A, P553, DOI 10.1016/0959-8049(94)90438-3; Reis MIR, 2007, MOL IMMUNOL, V44, P774, DOI 10.1016/j.molimm.2006.04.028; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Robertson AJ, 2006, DEV BIOL, V300, P321, DOI 10.1016/j.ydbio.2006.08.053; ROBLEDO JAF, 1994, DIS AQUAT ORGAN, V18, P203, DOI 10.3354/dao018203; Sakata S, 2007, GENE, V396, P134, DOI 10.1016/j.gene.2007.03.010; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Sunila I, 2003, DIS AQUAT ORGAN, V56, P163, DOI 10.3354/dao056163; Terahara K, 2008, CURR PHARM DESIGN, V14, P131, DOI 10.2174/138161208783378725; Tittel JN, 2000, GENOME BIOL, V1, P1; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vernooy SY, 2000, J CELL BIOL, V150, pF69, DOI 10.1083/jcb.150.2.F69; Villalba A, 1997, DIS AQUAT ORGAN, V31, P127, DOI 10.3354/dao031127; Wang KJ, 2008, DEV COMP IMMUNOL, V32, P1326, DOI 10.1016/j.dci.2008.04.007; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Wiens M, 2003, BBA-MOL CELL RES, V1593, P179, DOI 10.1016/S0167-4889(02)00388-9; Williams Trevor, 2009, Virologica Sinica, V24, P295, DOI 10.1007/s12250-009-3060-1; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wolbers F, 2004, APOPTOSIS, V9, P385, DOI 10.1023/B:APPT.0000025816.16399.7a; Wootton EC, 2003, AQUAT TOXICOL, V65, P13, DOI 10.1016/S0166-445X(03)00098-5; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191; Zorita I, 2007, ENVIRON POLLUT, V148, P236, DOI 10.1016/j.envpol.2006.10.022	64	82	87	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17003	10.1371/journal.pone.0017003	http://dx.doi.org/10.1371/journal.pone.0017003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347300	Green Published, gold			2022-12-25	WOS:000287364500019
J	Anchelin, M; Murcia, L; Alcaraz-Perez, F; Garcia-Navarro, EM; Cayuela, ML				Anchelin, Monique; Murcia, Laura; Alcaraz-Perez, Francisca; Garcia-Navarro, Esther M.; Cayuela, Maria L.			Behaviour of Telomere and Telomerase during Aging and Regeneration in Zebrafish	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE GENE; REPEAT AMPLIFICATION PROTOCOL; STEM-CELL BEHAVIOR; GRADUAL SENESCENCE; CATALYTIC SUBUNIT; TERMINAL TRANSFERASE; ADULT ZEBRAFISH; HUMAN-DISEASE; C-MYC; LENGTH	Telomere length and telomerase activity are important factors in the pathobiology of human diseases. Age-related diseases and premature aging syndromes are characterized by short telomeres, which can compromise cell viability, whereas tumour cells can prevent telomere loss by aberrantly upregulating telomerase. The zebrafish (Danio rerio) offers multiple experimental manipulation advantages over other vertebrate models and, therefore, it has been recently considered as a potential model for aging, cancer, and regeneration studies. However, it has only partially been exploited to shed light on these fundamental biological processes. The aim of this study was, therefore, to investigate telomere length and telomerase expression and activity in different strains of zebrafish obtained from different stock centres to determine whether they undergo any changes during aging and regeneration. We found that although both telomerase expression and telomere length increased from embryo to adulthood stages, they drastically declined in aged fish despite telomerase activity was detected in different tissues of old fish. In addition, we observed a weaker upregulation of telomerase expression in regenerating fins of old fish, which well correlates with their impaired regeneration capacity. Strikingly, telomeres were elongated or maintained during the fin regeneration process at all ages and after repeated amputations, likely to support high cell proliferation rates. We conclude that the expression of telomerase and telomere length are closely related during the entire life cycle of the fish and that these two parameters can be used as biomarkers of aging in zebrafish. Our results also reveal a direct relationship between the expression of telomerase, telomere length and the efficiency of tissue regeneration.	[Anchelin, Monique; Murcia, Laura; Alcaraz-Perez, Francisca; Garcia-Navarro, Esther M.; Cayuela, Maria L.] Univ Hosp Virgen de la Arrixaca, CIBERehd, Dept Surg, Telomerase Aging & Canc Grp,Res Unit, Murcia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca	Anchelin, M (corresponding author), Univ Hosp Virgen de la Arrixaca, CIBERehd, Dept Surg, Telomerase Aging & Canc Grp,Res Unit, Murcia, Spain.	marial.cayuela@carm.es	Murcia, Laura/AAD-7100-2021	Murcia, Laura/0000-0001-7768-0989; Alcaraz Perez, Francisca/0000-0003-1802-4943	Spanish Ministry of Science and Innovation [05/0087, PIO6/00369]; Regional Government of Murcia, Spain (CARM) [08760/PI/08]; University of Murcia; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, Spain; RED RTICC [RD07/0020/0023]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Murcia, Spain (CARM); University of Murcia; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, Spain; RED RTICC	This work was supported by the Spanish Ministry of Science and Innovation (grants 05/0087 and PIO6/00369), Fundacion Seneca from the Regional Government of Murcia, Spain (CARM, grant 08760/PI/08), University of Murcia (fellowships to FA-P), Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, Spain (short-fellowships to MA) and RED RTICC (RD07/0020/0023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCARAZPEREZ F, 2008, BMC BIOTECHNOL, P8; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brittijn SA, 2009, INT J DEV BIOL, V53, P835, DOI 10.1387/ijdb.082615sb; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Canela Andres, 2007, Methods Mol Biol, V371, P45; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Cayuela ML, 2005, EMBO REP, V6, P268, DOI 10.1038/sj.embor.7400359; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Du HY, 2007, AGING CELL, V6, P689, DOI 10.1111/j.1474-9726.2007.00324.x; Elmore LW, 2008, EXP BIOL MED, V233, P958, DOI 10.3181/0712-RM-345; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Gerhard GS, 2007, AGEING RES REV, V6, P64, DOI 10.1016/j.arr.2007.02.007; Gerhard GS, 2002, AGING CELL, V1, P104, DOI 10.1046/j.1474-9728.2002.00012.x; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; HIYAMA E, 1995, NAT MED, V1, P249, DOI 10.1038/nm0395-249; HIYAMA K, 1995, ONCOGENE, V10, P937; Horikawa I, 1999, CANCER RES, V59, P826; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lau BWM, 2008, J MOL NEUROSCI, V34, P63, DOI 10.1007/s12031-007-0072-x; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Liu JP, 2006, CELL RES, V16, P809, DOI 10.1038/sj.cr.7310098; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Lund TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007688; Mason PJ, 2004, CELL CYCLE, V3, P1127; McChesney PA, 2005, ZEBRAFISH, V1, P349, DOI 10.1089/zeb.2005.1.349; PERICUESTA E, 2006, REPROD BIOL ENDOCRIN, V3; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Reimschuessel R, 2001, ILAR J, V42, P285; Rowlerson A, 1997, CELL TISSUE RES, V289, P311, DOI 10.1007/s004410050878; Takakura M, 1999, CANCER RES, V59, P551; TSAI SB, AGING CELL, V6, P209; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Wright WE, 1996, DEV GENET, V18, P173; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	63	101	104	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16955	10.1371/journal.pone.0016955	http://dx.doi.org/10.1371/journal.pone.0016955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347393	gold, Green Submitted, Green Published			2022-12-25	WOS:000287361700058
J	Ruz, M; Moser, A; Webster, K				Ruz, Maria; Moser, Anna; Webster, Kristin			Social Expectations Bias Decision-Making in Uncertain Inter-Personal Situations	PLOS ONE			English	Article							ULTIMATUM GAME; NEURAL SYSTEMS; AUTOMATICITY; INFORMATION; BEHAVIOR; WORDS; TRUST; NORMS; FACE	Understanding the role that social cues have on interpersonal choice, and their susceptibility to contextual effects, is of core importance to models of social decision-making. Language, on the other hand, is one of the main means of communication during social interactions in our culture. The present experiments tested whether positive and negative linguistic descriptions of alleged partners in a modified Ultimatum Game biased decisions made to the same set of offers, and whether the contextual uncertainty of the game modulated this biasing effect. The results showed that in an uncertain context, the same offers were accepted with higher probability when they were preceded by positive rather than by negative valenced trait-words. Participants also accepted fair offers with higher probability than unfair offers, but this effect did not interact with the valence of the social descriptive words. In addition, the speed of the decision was affected by valence: acceptance choices were faster when they followed a positive adjective, whereas rejection responses were faster after a negative-valenced word. However, these effects were highly reduced when the uncertainty was eliminated from the game. This suggests that positive and negative relevant social information can bias decisions made to the same pieces of evidence during interpersonal interactions, but that this mainly takes place when the uncertainty associated with the choices is high.	[Ruz, Maria; Moser, Anna] Univ Granada, Dept Expt Psychol, Granada, Spain; [Webster, Kristin] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of Granada; Brown University	Ruz, M (corresponding author), Univ Granada, Dept Expt Psychol, Granada, Spain.	mruz@ugr.es	Ruz, Maria/G-1668-2016	Ruz, Maria/0000-0003-1733-5715	Spanish Ministry of Science and Innovation (MICINN) [RYC-2008-03008]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Research presented in this paper was supported by the Spanish Ministry of Science and Innovation (MICINN) through a Ramon y Cajal Research Fellowship granted to MR (ref. RYC-2008-03008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade EB, 2007, PSYCHOL SCI, V18, P668, DOI 10.1111/j.1467-9280.2007.01956.x; [Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Asch S.E., 1951, ORG INFLUENCE PROCES, V58, P295; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Damasio A.R., 1994, DESCARTES ERROR EMOT; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DEDREU CKW, 2007, HDB BASIC PRINCIPLES, P608; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Grieve PG, 1999, PERS SOC PSYCHOL B, V25, P926, DOI 10.1177/01461672992511002; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Hewstone M., 1996, STEREOTYPES STEREOTY; Higgins E. T., 1989, UNINTENDED THOUGHT; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kucera F., 1967, COMPUTATIONAL ANAL P; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; OLSON JM, 1996, EXPENTANCIES; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Reid SA, 2005, PERS SOC PSYCHOL B, V31, P804, DOI 10.1177/0146167204271708; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Ruz M, 2005, J COGNITIVE NEUROSCI, V17, P768, DOI 10.1162/0898929053747685; Ruz M, 2011, NEUROIMAGE, V54, P1685, DOI 10.1016/j.neuroimage.2010.08.039; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; SCHACHTER S, 1985, J ECON BEHAV ORGAN, V6, P339, DOI 10.1016/0167-2681(85)90003-4; Scharlemann JPW, 2001, J ECON PSYCHOL, V22, P617, DOI 10.1016/S0167-4870(01)00059-9; SEMIN GR, 1991, EUROPEAN REV SOCIAL, P1; Smith JR, 2007, BRIT J SOC PSYCHOL, V46, P769, DOI 10.1348/014466606X164439; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Van Kleef GA, 2010, ADV EXP SOC PSYCHOL, V42, P45, DOI 10.1016/S0065-2601(10)42002-X; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	43	14	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e15762	10.1371/journal.pone.0015762	http://dx.doi.org/10.1371/journal.pone.0015762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347404	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700010
J	Wang, MY; Spinetti, G; Monticone, RE; Zhang, J; Wu, J; Jiang, LQ; Khazan, B; Telljohann, R; Lakatta, EG				Wang, Mingyi; Spinetti, Gaia; Monticone, Robert E.; Zhang, Jing; Wu, James; Jiang, Liqun; Khazan, Benjamin; Telljohann, Richard; Lakatta, Edward G.			A Local Proinflammatory Signalling Loop Facilitates Adverse Age-Associated Arterial Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; MATRIX-METALLOPROTEINASE; ANGIOTENSIN-II; TGF-BETA; INVASION; EXPRESSION; DISEASE; MCP-1; ATHEROSCLEROSIS	Background: The coincidence of vascular smooth muscle cells (VSMC) infiltration and collagen deposition within a diffusely thickened intima is a salient feature of central arterial wall inflammation that accompanies advancing age. However, the molecular mechanisms involved remain undefined. Methodology/Principal Findings: Immunostaining and immunoblotting of rat aortae demonstrate that a triad of proinflammatory molecules, MCP-1, TGF-beta 1, and MMP-2 increases within the aortic wall with aging. Exposure of VSMC isolated from 8-mo-old rats (young) to MCP-1 effects, via CCR-2 signaling, both an increase in TGF-beta 1 activity, up to levels of untreated VSMC from 30-mo-old (old) rats, and a concurrent increase in MMP-2 activation. Furthermore, exposure of young VSMC to TGF-beta 1 increases levels of MCP-1, and MMP-2 activation, to levels of untreated VSMC from old rats. This autocatalytic signaling loop that enhances collagen production and invasiveness of VSMC is effectively suppressed by si-MCP-1, a CCR2 antagonist, or MMP-2 inhibition. Conclusions/Significance: Threshold levels of MCP-1, MMP-2, or TGF-beta 1 activity trigger a feed-forward signaling mechanism that is implicated in the initiation and progression of adverse age-associated arterial wall remodeling. Intervention that suppressed this signaling loop may potentially retard age-associated adverse arterial remodeling.	[Wang, Mingyi; Spinetti, Gaia; Monticone, Robert E.; Zhang, Jing; Wu, James; Jiang, Liqun; Khazan, Benjamin; Telljohann, Richard; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; [Spinetti, Gaia] MultiMed IRCCS, Milan, Italy	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); IRCCS Multimedica	Wang, MY (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.	mingyiw@grc.nia.nih.gov	Wang, Mingyi/L-8370-2017; Telljohann, Richard/ABF-1207-2021; Spinetti, Gaia/T-8245-2018; Lakatta, Edward G/AAL-1447-2020	Wang, Mingyi/0000-0001-6412-369X; Spinetti, Gaia/0000-0001-7996-6809; Lakatta, Edward/0000-0002-4772-0035	National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000240] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Fu ZM, 2009, CIRC RES, V104, P1337, DOI 10.1161/CIRCRESAHA.108.187088; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gressner OA, 2008, J CELL MOL MED, V12, P2717, DOI 10.1111/j.1582-4934.2008.00260.x; Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014; Jenkins GM, 1998, CIRCULATION, V97, P82, DOI 10.1161/01.CIR.97.1.82; Jiang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002231; Joner M, 2007, ARTERIOSCL THROM VAS, V27, P182, DOI 10.1161/01.ATV.0000251021.28725.e8; Lakatta EG, 2009, MED CLIN N AM, V93, P583, DOI 10.1016/j.mcna.2009.02.008; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Nagai Y, 1998, CIRCULATION, V98, P1504, DOI 10.1161/01.CIR.98.15.1504; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Palumbo R, 2000, CIRCULATION, V102, P225, DOI 10.1161/01.CIR.102.2.225; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Raymond J, 2005, J VASC INTERV RADIOL, V16, P1355, DOI 10.1097/01.RVI.0000171693.68581.96; Redondo S, 2007, CYTOKINE GROWTH F R, V18, P279, DOI 10.1016/j.cytogfr.2007.04.005; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roth-Eichhorn S, 1998, HEPATOLOGY, V28, P1588, DOI 10.1002/hep.510280619; Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08; STARY HC, 1991, EUR HEART J SUPPL, P3; VIRMANI R, 1991, AM J PATHOL, V139, P1119; Virmani R, 1998, Semin Interv Cardiol, V3, P163; Wang M, 2006, ARTERIOSCL THROM VAS, V26, pE83; Wang M, 2002, HYPERTENSION, V39, P865, DOI 10.1161/01.HYP.0000014506.13322.66; WANG M, 2006, HDB HYPERTENSION, V23, P137; Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409; Wang MY, 2010, CURR OPIN NEPHROL HY, V19, P201, DOI 10.1097/MNH.0b013e3283361c0b; Wang MY, 2005, AM J PATHOL, V167, P1429, DOI 10.1016/S0002-9440(10)61229-1; Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45	30	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16653	10.1371/journal.pone.0016653	http://dx.doi.org/10.1371/journal.pone.0016653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347430	gold, Green Published, Green Submitted			2022-12-25	WOS:000287077600012
J	Roe, JS; Kim, HR; Hwang, IY; Cho, EJ; Youn, HD				Roe, J-S; Kim, H-R; Hwang, I-Y; Cho, E-J; Youn, H-D			von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage	ONCOGENE			English	Article						von Hippel-Lindau; Skp2; DNA damage; renal cell carcinoma; tumorigenesis	RENAL-CELL CARCINOMA; HYPOXIA-INDUCIBLE FACTOR-1; CYCLIN-DEPENDENT KINASES; TUMOR-SUPPRESSOR; PROLYL HYDROXYLATION; TISSUE MICROARRAY; MOLECULAR-BASIS; INHIBITOR P27; TARGET GENE; HIF-ALPHA	Germline mutations in the von Hippel-Lindau (VHL) tumor suppressor gene cause VHL disease, a rare and autosomal-dominant genetic syndrome. Because VHL protein (pVHL) is the master regulator of hypoxia-inducible factor alpha (HIF alpha), the most prominent feature of VHL disease is the deregulation of HIF alpha proteins. However, the precise mechanism by which the loss of pVHL function contributes to tumorigenesis is not fully understood. Here, we show that pVHL destabilizes the F-box protein Skp2, a chief component of Skp, Cullin, F-box-containing complex that promotes DNA synthesis in the S phase. The beta-domain of pVHL interacts with Skp2, stimulating proteasome-dependent Skp2 degradation, but the destabilization of Skp2 does not depend on the E3 ubiquitin ligase activity of pVHL. Notably, the generation of DNA damage induces Skp2 degradation, which is attenuated by the suppression of endogenous pVHL expression. One possible mechanism of pVHL-dependent Skp2 degradation entails the antagonizing of Akt-mediated Skp2 phosphorylation, which maintains Skp2 stability. Reintroduction of VHL into VHL-null renal cell carcinoma (RCC) cells decreased Skp2 levels and restored DNA damage-dependent Skp2 degradation. These results identify the tumor suppressor function of pVHL in delaying the S-phase progression to inhibit cell proliferation on DNA damage. Clinically, this report explains as to why Skp2 accumulates abnormally in RCC tissues. Oncogene (2011) 30, 3127-3138; doi:10.1038/onc.2011.40; published online 28 February 2011	[Roe, J-S; Kim, H-R; Hwang, I-Y; Youn, H-D] Seoul Natl Univ, Coll Med, Natl Res Lab Metab Checkpoint, Dept Biomed Sci,Canc Res Inst, Seoul 110799, South Korea; [Roe, J-S; Kim, H-R; Hwang, I-Y; Youn, H-D] Seoul Natl Univ, Coll Med, Natl Res Lab Metab Checkpoint, Dept Biochem & Mol Biol,Canc Res Inst, Seoul 110799, South Korea; [Cho, E-J] Sungkyunkwan Univ, Coll Pharm, Natl Res Lab Chromatin Dynam, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU)	Youn, HD (corresponding author), Seoul Natl Univ, Coll Med, Natl Res Lab Metab Checkpoint, Dept Biomed Sci,Canc Res Inst, 28 Yongon Dong, Seoul 110799, South Korea.	hdyoun@snu.ac.kr	Hwang, Inyoung/AAS-3325-2021; Cho, Eun-Jung/AAR-1785-2020; Youn, Hong-Duk/J-2774-2012	Hwang, Inyoung/0000-0002-4633-3658; Cho, Eun-Jung/0000-0002-6610-5329; Roe, Jae-Seok/0000-0002-9994-3062	Korea government (MEST) [0720460, A090281, NRF-2010-0018896, A080181, S2-2008-000-00400-1]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare (0720460), the Korea Healthcare Technology R&D Project (A090281), and National Research Foundation Grant (NRF-2010-0018896) to H-DY, a grant from the Korea Healthcare R&D Project (A080181) to E-JC and by the Korea Student Aid Foundation (KOSAF) grant, funded by the Korea government (MEST) (S2-2008-000-00400-1) to JSR. We thank Dr B Bruene (Johann Wolfgang Goethe-University) and Dr DS Lim (KAIST) for invaluable materials.	Balasubramanian S, 1999, ONCOGENE, V18, P1297, DOI 10.1038/sj.onc.1202417; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cohen HT, 1999, CURR OPIN NEPHROL HY, V8, P325, DOI 10.1097/00041552-199905000-00008; Cuadrado M, 2009, CANCER RES, V69, P8726, DOI 10.1158/0008-5472.CAN-09-0729; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feng X, 2009, ONCOGENE, V28, P3320, DOI 10.1038/onc.2009.185; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; He G, 2006, BRIT J CANCER, V95, P1514, DOI 10.1038/sj.bjc.6603448; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Ishizaki H, 2007, PATHOL INT, V57, P672, DOI 10.1111/j.1440-1827.2007.02156.x; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kawasaki T, 1999, ONCOL REP, V6, P329; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Kim M, 1998, BIOCHEM BIOPH RES CO, V253, P672, DOI 10.1006/bbrc.1998.9839; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Lam JS, 2005, UROLOGY, V66, P1, DOI 10.1016/j.urology.2005.06.112; Langner C, 2004, VIRCHOWS ARCH, V445, P631, DOI 10.1007/s00428-004-1121-2; Leonardi E, 2009, FEBS LETT, V583, P3704, DOI 10.1016/j.febslet.2009.10.070; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu Z, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-51; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Lowe Scott W., 1995, Current Opinion in Oncology, V7, P547, DOI 10.1097/00001622-199511000-00013; Maher ER, 2004, CURR MOL MED, V4, P833, DOI 10.2174/1566524043359827; MAHER ER, 1991, J MED GENET, V28, P443, DOI 10.1136/jmg.28.7.443; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mizutani Y, 2007, INT J ONCOL, V30, P919; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nho Richard Seonghun, 2003, Prog Cell Cycle Res, V5, P249; Nyhan MJ, 2008, BIOCHEM SOC T, V36, P472, DOI 10.1042/BST0360472; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Osipov V, 2002, APPL IMMUNOHISTO M M, V10, P344, DOI 10.1097/00022744-200212000-00010; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Vikhanskaya F, 1996, EXP CELL RES, V227, P380, DOI 10.1006/excr.1996.0288; Vivo C, 2003, BRIT J CANCER, V88, P388, DOI 10.1038/sj.bjc.6600736; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wykoff CC, 2004, BRIT J CANCER, V90, P1235, DOI 10.1038/sj.bjc.6601657; Zhou H, 2004, TOXICOL APPL PHARM, V200, P111, DOI 10.1016/j.taap.2004.04.003	52	22	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	28					3127	3138		10.1038/onc.2011.40	http://dx.doi.org/10.1038/onc.2011.40			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	792FQ	21358672				2022-12-25	WOS:000292726300002
J	Jung, T; Gross, W; Zoller, M				Jung, Thorsten; Gross, Wolfgang; Zoeller, Margot			CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; PREMETASTATIC NICHE; INVASIVE GROWTH; CARCINOMA-CELLS; RAT-TUMOR; HYALURONAN; CANCER	Tumor progression requires a crosstalk with the tumor surrounding, where the tumor matrix plays an essential role. We recently reported that only the matrix delivered by a CD44v6-competent (ASML(wt)), but not that of a CD44v6-deficient (ASML-CD44v(kd)) rat pancreatic adenocarcinoma line supports metastasis formation. We here describe that this matrix provides an important feedback toward the tumor cell and that CD44v6 accounts for orchestrating signals received from the matrix. ASML(wt) cells contain more hyaluronan synthase-3 and secrete higher amounts of > 50 kDa HA than ASML-CD44v(kd) cells, which secrete more hyaluronidase. Only the ASML(wt)-matrix supports migration and apoptosis resistance, which both can be initiated via CD44v6, c-Met, and alpha 6 beta 4 ligand binding and proceed via FAK, PI3K/Akt, and MAPK activation, respectively. However, c-Met-and alpha 6 beta 4-initiated signaling are strongly augmented by the association with CD44v6 as only very weak effects are observed in CD44v6-deficient cells. The same CD44v6-dependent convergence of motility-and apoptosis resistance-related signals also accounts for human tumor lines. Thus, CD44v6 promotes motility and apoptosis resistance via its involvement in assembling a matrix that, in turn, triggers activation of signaling cascades, which proceeds, independent of the initiating receptor-ligand interaction, in a concerted action via CD44v6.	[Jung, Thorsten; Zoeller, Margot] Univ Hosp Surg, Dept Tumor Cell Biol, D-69120 Heidelberg, Germany; [Gross, Wolfgang] Heidelberg Univ, Dept Expt Surg, D-69120 Heidelberg, Germany; [Zoeller, Margot] German Canc Res Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Zoller, M (corresponding author), Univ Hosp Surg, Dept Tumor Cell Biol, Neuenheimer Feld 365, D-69120 Heidelberg, Germany.	margot.zoeller@uni-heidelberg.de		Gross, Wolfgang/0000-0002-5431-7594	DFG [SPP1190]; NCT	DFG(German Research Foundation (DFG)); NCT	This work was supported by the DFG/SPP1190 and NCT (to M. Z.).	Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Berdiaki A, 2009, BBA-GEN SUBJECTS, V1790, P1258, DOI 10.1016/j.bbagen.2009.06.013; Bertotti A, 2003, TRENDS BIOCHEM SCI, V28, P527, DOI 10.1016/j.tibs.2003.09.001; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; da Costa CA, 2007, CURR MOL MED, V7, P650, DOI 10.2174/156652407782564426; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Foger N, 2000, EUR J IMMUNOL, V30, P2888; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hill A, 2006, CANCER LETT, V237, P1, DOI 10.1016/j.canlet.2005.05.006; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Klosek SK, 2009, BIOCHEM BIOPH RES CO, V379, P1097, DOI 10.1016/j.bbrc.2009.01.023; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Kobayashi H, 2002, INT J CANCER, V102, P379, DOI 10.1002/ijc.10710; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Lamontagne CA, 2008, EXP CELL RES, V314, P227, DOI 10.1016/j.yexcr.2007.07.013; Lee KH, 2008, CLIN EXP METASTAS, V25, P89, DOI 10.1007/s10585-007-9106-6; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; Marhaba R, 2004, J MOL HISTOL, V35, P211; MATZKU S, 1983, INVAS METAST, V3, P109; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Nie Daotai, 2010, Front Biosci (Schol Ed), V2, P184; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pucci S, 2009, ADV CANCER RES, V105, P93, DOI 10.1016/S0065-230X(09)05006-4; RUDY W, 1993, CANCER RES, V53, P1262; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; STERN M, 1992, MATRIX, V12, P397, DOI 10.1016/S0934-8832(11)80036-3; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2008, SEMIN CANCER BIOL, V18, P238, DOI 10.1016/j.semcancer.2008.03.014; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tsang TY, 2008, APOPTOSIS, V13, P1135, DOI 10.1007/s10495-008-0241-6; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yu Q, 2004, CLIN EXP METASTAS, V21, P235, DOI 10.1023/B:CLIN.0000037705.25256.d3; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	70	63	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.208421	http://dx.doi.org/10.1074/jbc.M110.208421			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21372142	Green Published, hybrid			2022-12-25	WOS:000290022800027
J	Nag, S; Sarkar, B; Bandyopadhyay, A; Sahoo, B; Sreenivasan, VKA; Kombrabail, M; Muralidharan, C; Maiti, S				Nag, Suman; Sarkar, Bidyut; Bandyopadhyay, Arkarup; Sahoo, Bankanidhi; Sreenivasan, Varun K. A.; Kombrabail, Mamata; Muralidharan, Chandrakesan; Maiti, Sudipta			Nature of the Amyloid-beta Monomer and the Monomer-Oligomer Equilibrium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPAIR SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; PHYSIOLOGICAL CONCENTRATIONS; PROTEIN OLIGOMERIZATION; ENERGY-TRANSFER; CELL-MEMBRANES; FLUORESCENCE; PEPTIDE; DYNAMICS; SPECTROSCOPY	The monomer to oligomer transition initiates the aggregation and pathogenic transformation of Alzheimer amyloid-beta (A beta) peptide. However, the monomeric state of this aggregation-prone peptide has remained beyond the reach of most experimental techniques, and a quantitative understanding of this transition is yet to emerge. Here, we employ single-molecule level fluorescence tools to characterize the monomeric state and the monomer-oligomer transition at physiological concentrations in buffers mimicking the cerebrospinal fluid (CSF). Our measurements show that the monomer has a hydrodynamic radius of 0.9 +/- 0.1 nm, which confirms the prediction made by some of the in silico studies. Surprisingly, at equilibrium, both A beta(40) and A beta(42) remain predominantly monomeric up to 3 mu M, above which it forms large aggregates. This concentration is much higher than the estimated concentrations in the CSF of either normal or diseased brains. If A beta oligomers are present in the CSF and are the key agents in Alzheimer pathology, as is generally believed, then these must be released in the CSF as preformed entities. Although the oligomers are thermodynamically unstable, we find that a large kinetic barrier, which is mostly entropic in origin, strongly impedes their dissociation. Thermodynamic principles therefore allow the development of a pharmacological agent that can catalytically convert metastable oligomers into nontoxic monomers.	[Nag, Suman; Sarkar, Bidyut; Bandyopadhyay, Arkarup; Sahoo, Bankanidhi; Sreenivasan, Varun K. A.; Kombrabail, Mamata; Muralidharan, Chandrakesan; Maiti, Sudipta] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Maiti, S (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, 1 Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	maiti@tifr.res.in	Sreenivasan, Varun/D-9646-2014; Sreenivasan, Varun/C-4967-2012; Sahoo, Bankanidhi/C-2295-2017	Sarkar, Bidyut/0000-0001-5023-7581; Maiti, Sudipta/0000-0002-6540-7472; Bandyopadhyay, Arkarup/0000-0003-1979-857X; Sahoo, Bankanidhi/0000-0002-3633-1616; Sreenivasan, Varun/0000-0002-8667-8394				ARBELOA FL, 1989, J LUMIN, V44, P105, DOI 10.1016/0022-2313(89)90027-6; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bjerke Maria, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/986310; Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Garai K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2822322; Garcia-Ruiz JM, 2003, J STRUCT BIOL, V142, P22, DOI 10.1016/S1047-8477(03)00035-2; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HARAN G, 1992, P NATL ACAD SCI USA, V89, P11764, DOI 10.1073/pnas.89.24.11764; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kuo YM, 1999, BIOCHEM BIOPH RES CO, V257, P787, DOI 10.1006/bbrc.1999.0552; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li XF, 2006, CELL BIOCHEM BIOPHYS, V46, P123, DOI 10.1385/CBB:46:2:123; LUBIENSKI MJ, 1994, BIOCHEMISTRY-US, V33, P8866, DOI 10.1021/bi00196a003; Massi F, 2001, BIOPHYS J, V80, P31, DOI 10.1016/S0006-3495(01)75993-0; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Nag S, 2010, BIOPHYS J, V99, P1969, DOI 10.1016/j.bpj.2010.07.020; Santos AN, 2007, J ALZHEIMERS DIS, V11, P117; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Raffa DF, 2007, J PHYS CHEM B, V111, P3789, DOI 10.1021/jp0689621; Ramreddy T, 2007, J PHYS CHEM B, V111, P5757, DOI 10.1021/jp068818f; Sahoo B, 2009, BIOPHYS J, V97, P1454, DOI 10.1016/j.bpj.2009.05.055; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Sengupta P, 2002, METHODS, V27, P374, DOI 10.1016/S1046-2023(02)00096-8; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang Y, 2010, J PHYS CHEM B, V114, P7112, DOI 10.1021/jp101496y; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002	45	133	136	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13827	13833		10.1074/jbc.M110.199885	http://dx.doi.org/10.1074/jbc.M110.199885			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349839	Green Published, hybrid			2022-12-25	WOS:000289556200005
J	Harrison, F; Buckling, A				Harrison, Freya; Buckling, Angus			Wider Access to Genotypic Space Facilitates Loss of Cooperation in a Bacterial Mutator	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; PATHOGENIC BACTERIA; SIDEROPHORE PRODUCTION; EVOLUTION; VIRULENCE; RATES; ADAPTATION; HYPERMUTABILITY	Understanding the ecological, evolutionary and genetic factors that affect the expression of cooperative behaviours is a topic of wide biological significance. On a practical level, this field of research is useful because many pathogenic microbes rely on the cooperative production of public goods (such as nutrient scavenging molecules, toxins and biofilm matrix components) in order to exploit their hosts. Understanding the evolutionary dynamics of cooperation is particularly relevant when considering long-term, chronic infections where there is significant potential for intra-host evolution. The impact of responses to non-social selection pressures on social evolution is arguably an under-examined area. In this paper, we consider how the evolution of a non-social trait - hypermutability - affects the cooperative production of iron-scavenging siderophores by the opportunistic human pathogen Pseudomonas aeruginosa. We confirm an earlier prediction that hypermutability accelerates the breakdown of cooperation due to increased sampling of genotypic space, allowing mutator lineages to generate non-cooperative genotypes with the ability to persist at high frequency and dominate populations. This may represent a novel cost of hypermutability.	[Harrison, Freya; Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Harrison, F (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	freya.harrison@zoo.ox.ac.uk		Buckling, Angus/0000-0003-1170-4604	Royal Society; University of Oxford; Magdalen College, Oxford	Royal Society(Royal Society of London); University of Oxford; Magdalen College, Oxford	This work was funded by the Royal Society (grant awarded to AB) and by the University of Oxford (Newton-Abraham studentship awarded to FH). FH is currently supported by a Fellowship by Examination at Magdalen College, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedau MA, 2003, BIOSYSTEMS, V69, P143, DOI 10.1016/S0303-2647(02)00137-5; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; CORNELIS P, 2002, ENV MICROBIOL, V4; de Visser JAGM, 2002, MICROBIOL-SGM, V148, P1247, DOI 10.1099/00221287-148-5-1247; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; FRANK SA, 1994, P ROY SOC B-BIOL SCI, V258, P153, DOI 10.1098/rspb.1994.0156; Funchain P, 2000, GENETICS, V154, P959; Giraud A, 2002, ANTIMICROB AGENTS CH, V46, P863, DOI 10.1128/AAC.46.3.863-865.2002; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harrison F, 2005, CURR BIOL, V15, P1968, DOI 10.1016/j.cub.2005.09.048; HARRISON F, 2009, FRONT BIOSCI S, V1, P250; Harrison F, 2007, P ROY SOC B-BIOL SCI, V274, P1341, DOI 10.1098/rspb.2006.0408; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Harrison F, 2009, ISME J, V3, P632, DOI 10.1038/ismej.2009.9; HAUSER AR, SEVERE INFECT CAUSED; Jiricny N, 2010, J EVOLUTION BIOL, V23, P738, DOI 10.1111/j.1420-9101.2010.01939.x; Kummerli R, 2009, P ROY SOC B-BIOL SCI, V276, P3531, DOI 10.1098/rspb.2009.0861; Kummerli R, 2009, EVOLUTION, V63, P939, DOI 10.1111/j.1558-5646.2008.00548.x; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Nyilasi Ildiko, 2005, Acta Microbiologica et Immunologica Hungarica, V52, P185, DOI 10.1556/AMicr.52.2005.2.4; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; Racey D, 2010, EVOLUTION, V64, P515, DOI 10.1111/j.1558-5646.2009.00821.x; Rainey PB, 1999, CURR BIOL, V9, pR371, DOI 10.1016/S0960-9822(99)80230-9; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Schaaff F, 2002, ANTIMICROB AGENTS CH, V46, P3540, DOI 10.1128/AAC.46.11.3540-3548.2002; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, TRENDS MICROBIOL, V5, P427, DOI 10.1016/S0966-842X(97)01157-8; Tenaillon O, 1999, GENETICS, V152, P485; TROBNER W, 1984, MOL GEN GENET, V198, P177, DOI 10.1007/BF00328720; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; WANDERSMAN C, 2004, ANN REV MICROBIOL, V58; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209	42	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17254	10.1371/journal.pone.0017254	http://dx.doi.org/10.1371/journal.pone.0017254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364773	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100036
J	Leduc, F; Faucher, D; Nkoma, GB; Gregoire, MC; Arguin, M; Wellinger, RJ; Boissonneault, G				Leduc, Frederic; Faucher, David; Nkoma, Genevieve Bikond; Gregoire, Marie-Chantal; Arguin, Melina; Wellinger, Raymund J.; Boissonneault, Guylain			Genome-Wide Mapping of DNA Strand Breaks	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; CHROMATIN; REPAIR; YEAST; ACTIVATION; ORIGIN; DAMAGE; ASSAY; H2AX	Determination of cellular DNA damage has so far been limited to global assessment of genome integrity whereas nucleotide-level mapping has been restricted to specific loci by the use of specific primers. Therefore, only limited DNA sequences can be studied and novel regions of genomic instability can hardly be discovered. Using a well-characterized yeast model, we describe a straightforward strategy to map genome-wide DNA strand breaks without compromising nucleotide-level resolution. This technique, termed "damaged DNA immunoprecipitation'' (dDIP), uses immunoprecipitation and the terminal deoxynucleotidyl transferase-mediated dUTP-biotin end-labeling (TUNEL) to capture DNA at break sites. When used in combination with microarray or next-generation sequencing technologies, dDIP will allow researchers to map genome-wide DNA strand breaks as well as other types of DNA damage and to establish a clear profiling of altered genes and/or intergenic sequences in various experimental conditions. This mapping technique could find several applications for instance in the study of aging, genotoxic drug screening, cancer, meiosis, radiation and oxidative DNA damage.	[Leduc, Frederic; Nkoma, Genevieve Bikond; Gregoire, Marie-Chantal; Arguin, Melina; Boissonneault, Guylain] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada; [Faucher, David; Wellinger, Raymund J.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Leduc, F (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada.	guylain.boissonneault@usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759; Gregoire, Marie-Chantal/0000-0002-2478-1716; Boissonneault, Guylain/0000-0003-4755-3473	Canadian Institutes of Health Research [MOP-93781]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research (grant #MOP-93781) to G.B. (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brachmann CB, 1998, YEAST, V14, P115; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Conconi A, 2005, MOL CELL BIOL, V25, P9773, DOI 10.1128/MCB.25.22.9773-9783.2005; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Gradzka I, 2005, DNA REPAIR, V4, P1129, DOI 10.1016/j.dnarep.2005.06.001; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Leduc F, 2008, BIOL REPROD, V78, P324, DOI 10.1095/biolreprod.107.064162; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Maniatis T., 1982, MOL CLONING LAB MANU; Pfeifer GP, 1998, TOXICOL LETT, V103, P447, DOI 10.1016/S0378-4274(98)00337-3; RAGHURAMAN MK, 1994, GENE DEV, V8, P554, DOI 10.1101/gad.8.5.554; SCHMITZ GG, 1991, ANAL BIOCHEM, V192, P222, DOI 10.1016/0003-2697(91)90212-C; SHIBATA Y, 2009, MAPPING REGULATORY E; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057	22	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17353	10.1371/journal.pone.0017353	http://dx.doi.org/10.1371/journal.pone.0017353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364894	Green Submitted, gold, Green Published			2022-12-25	WOS:000287764100049
J	Yamanoue, Y; Miya, M; Doi, H; Mabuchi, K; Sakai, H; Nishida, M				Yamanoue, Yusuke; Miya, Masaki; Doi, Hiroyuki; Mabuchi, Kohji; Sakai, Harumi; Nishida, Mutsumi			Multiple Invasions into Freshwater by Pufferfishes (Teleostei: Tetraodontidae): A Mitogenomic Perspective	PLOS ONE			English	Article							PHYLOGENETIC TREE SELECTION; MITOCHONDRIAL-DNA SEQUENCES; MIDDLE MAGDALENA VALLEY; GONDWANA LIFE RAFTS; MARINE INCURSIONS; DIVERGENCE TIME; NORTHWESTERN AMAZONIA; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; EASTERN CORDILLERA	Pufferfishes of the Family Tetraodontidae are the most speciose group in the Order Tetraodontiformes and mainly inhabit coastal waters along continents. Although no members of other tetraodontiform families have fully discarded their marine lives, approximately 30 tetraodontid species spend their entire lives in freshwaters in disjunct tropical regions of South America, Central Africa, and Southeast Asia. To investigate the interrelationships of tetraodontid pufferfishes and thereby elucidate the evolutionary origins of their freshwater habitats, we performed phylogenetic analysis based on whole mitochondrial genome sequences from 50 tetraodontid species and closely related species (including 31 newly determined sequences). The resulting phylogenies reveal that the family is composed of four major lineages and that freshwater species from the different continents are independently nested in two of the four lineages. A monophyletic origin of the use of freshwater habitats was statistically rejected, and ancestral habitat reconstruction on the resulting tree demonstrates that tetraodontids independently entered freshwater habitats in different continents at least three times. Relaxed molecular-clock Bayesian divergence time estimation suggests that the timing of these invasions differs between continents, occurring at 0-10 million years ago (MA) in South America, 17-38 MA in Central Africa, and 48-78 MA in Southeast Asia. These timings are congruent with geological events that could facilitate adaptation to freshwater habitats in each continent.	[Yamanoue, Yusuke; Mabuchi, Kohji; Nishida, Mutsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Miya, Masaki] Nat Hist Museum & Inst, Chiba, Japan; [Doi, Hiroyuki] Shimonoseki Marine Sci Museum Kaikyokan, Yamaguchi, Japan; [Sakai, Harumi] Natl Fisheries Univ, Dept Appl Aquabiol, Yamaguchi, Japan	University of Tokyo; Japan Fisheries Research & Education Agency (FRA)	Yamanoue, Y (corresponding author), Univ Tokyo, Fisheries Lab, Shizuoka, Japan.	yamanouey@yahoo.co.jp	Miya, Masaki/O-2664-2019	Miya, Masaki/0000-0002-9791-9886	Japan Society for the Promotion of Science [19207007, 22370035, 22770079]; Nippon Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nippon Foundation(Nippon Foundation)	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (19207007, 22370035, 22770079), and the Nippon Foundation-Hadal Environmental Science Education Program (HADEEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 1996, J MOL EVOL, V42, P459; Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Beadle LC., 1974, INLAND WATERS AFRICA; BECK RA, 1995, NATURE, V373, P55, DOI 10.1038/373055a0; Benton M.J., 1993, FOSSIL RECORD; Benton M.J., 2005, VERTEBRATE PALAEONTO; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Berra TM, 2007, FRESHWATER FISH DIST; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; Briggs JC, 2003, SYST BIOL, V52, P548, DOI 10.1080/10635150390218385; Cazier EC, 1997, AAPG BULL, V81, P1332; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; COOPER MA, 1995, AAPG BULL, V79, P1421; CrnogoracJurcevic T, 1997, GENOMICS, V41, P177, DOI 10.1006/geno.1997.4646; DEKKERS W J, 1975, Bijdragen tot de Dierkunde, V45, P87; Ebert K., 2001, PUFFERS FRESH BRACKI; Fraser-Brunner A., 1943, Annals & Magazine of Natural History Series 11, V10, P1; Froese R, 2010, FISHBASE VERSION 03; Giresse P, 2005, J AFR EARTH SCI, V43, P301, DOI 10.1016/j.jafrearsci.2005.07.009; GRAY J, 1988, PALAEOGEOGR PALAEOCL, V62, P1, DOI 10.1016/0031-0182(88)90054-5; Guiraud R, 2005, J AFR EARTH SCI, V43, P83, DOI 10.1016/j.jafrearsci.2005.07.017; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; Holcroft NI, 2005, MOL PHYLOGENET EVOL, V34, P525, DOI 10.1016/j.ympev.2004.11.003; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Hoorn C, 2006, PALAIOS, V21, P197, DOI 10.2110/palo.2005.p05-131; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V112, P187, DOI 10.1016/0031-0182(94)90074-4; Horton BK, 2002, GEOL SOC AM BULL, V114, P771, DOI 10.1130/0016-7606(2002)114<0771:PESSIN>2.0.CO;2; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Hutchinson G. E., 1957, TREATISE LIMNOLOGY, VI; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Kato Akira, 2005, BMC Physiol, V5, P18, DOI 10.1186/1472-6793-5-18; Kullander SO, 2003, CHECK LIST FRESHWATE; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Kumazawa Y, 2000, MOL BIOL EVOL, V17, P1869, DOI 10.1093/oxfordjournals.molbev.a026288; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Kumazawa Y, 2004, ENDOCYT CELL RES, V15, P136; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Li X, 2006, ICHTHYOL RES, V53, P148, DOI 10.1007/s10228-005-0321-3; Little C, 1990, TERRESTRIAL INVASION; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Loytynoja A, 2003, BIOINFORMATICS, V19, P1505, DOI 10.1093/bioinformatics/btg193; Maddison WP, 2017, MESQUITE MODULAR SYS; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Monks N., 2006, BRACKISH WATER FISHE, P252; Monsch KA, 1998, PALAEOGEOGR PALAEOCL, V143, P31, DOI 10.1016/S0031-0182(98)00064-9; Nelson JS, 1984, FISHES WORLD; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Remane A, 1971, BIOL BRACKISH WATER; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SENOU H, 1989, FRESHWATER FISHES JA, P674; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Sparks JS, 2005, SYST BIOL, V54, P158, DOI 10.1080/10635150590906019; Sparks JS, 2004, MOL PHYLOGENET EVOL, V30, P599, DOI 10.1016/S1055-7903(03)00225-2; Stamatakis A, 2010, BIOINFORMATICS, V26, pi132, DOI 10.1093/bioinformatics/btq205; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tyler James C., 2002, Studi e Ricerche sui Giacimenti Terziari di Bolca, V9, P47; TYLER JAMES C., 1964, PROC ACAD NATUR SCI PHILADELPHIA, V116, P119; TYLER JC, 1992, P BIOL SOC WASH, V105, P462; Tyler JC, 1996, SMITHSONIAN CONTRIBU, V82, P1, DOI DOI 10.5479/SI.00810266.82.1; Tyler JC, 1980, NOAA TECHNICAL REPOR, V434, P1, DOI DOI 10.5962/BHL.TITLE.63022; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Vonhof HB, 2003, GEOL SOC AM BULL, V115, P983, DOI 10.1130/B25058.1; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wilson AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001979; Winterbottom R., 1974, Smithsonian Contributions to Zoology, VNo. 155, P1; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yamanoue Y, 2009, MOL BIOL EVOL, V26, P623, DOI 10.1093/molbev/msn283; Yamanoue Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-212; Yang Z, 2008, J APPL ICHTHYOL, V24, P569, DOI 10.1111/j.1439-0426.2008.01071.x; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YUAN CM, 1986, FRESHWATER FISHES JI, P255; Zhang KJ, 2002, GEOL J, V37, P217, DOI 10.1002/gj.911; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	95	62	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17410	10.1371/journal.pone.0017410	http://dx.doi.org/10.1371/journal.pone.0017410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364898	Green Published, Green Submitted, gold			2022-12-25	WOS:000287764100056
J	Pietropaolo, S; Guilleminot, A; Martin, B; D'Amato, FR; Crusio, WE				Pietropaolo, Susanna; Guilleminot, Aurelie; Martin, Benoit; D'Amato, Francesca R.; Crusio, Wim E.			Genetic-Background Modulation of Core and Variable Autistic-Like Symptoms in Fmr1 Knock-Out Mice	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; ACOUSTIC STARTLE REFLEX; PERVASIVE DEVELOPMENTAL DISORDERS; MOUSE MODEL; PREPULSE INHIBITION; BEHAVIORAL-PHENOTYPE; AUDIOGENIC-SEIZURES; MENTAL-RETARDATION; SOCIAL-ISOLATION; YOUNG-CHILDREN	Background: No animal models of autism spectrum disorders (ASD) with good construct validity are currently available; using genetic models of pathologies characterized by ASD-like deficits, but with known causes, may be therefore a promising strategy. The Fmr1-KO mouse is an example of this approach, modeling Fragile X syndrome, a well-known genetic disorder presenting ASD symptoms. The Fmr1-KO is available on different genetic backgrounds (FVB versus C57BL/6), which may explain some of the conflicting results that have been obtained with these mutants up till now. Methods: Fmr1 KO and their wild-type littermates on both the FVB and C57BL/6 genetic backgrounds were examined on a battery of tests modeling the clinical symptoms of ASD, including the triad of core symptoms (alterations in social interaction and communication, presence of repetitive behaviors), as well as the secondary symptoms (disturbances in sensori-motor reactivity and in circadian patterns of activity, epileptic events). Results: Fmr1-KO mice displayed autistic-like core symptoms of altered social interaction and occurrence of repetitive behaviors with additional hyperactivity. The genetic background modulated the effects of the Fmr1 deletion and it appears that the C57BL/6 background may be more suitable for further research on core autistic-like symptoms. Conclusions: The Fmr1-mouse line does not recapitulate all of the main core and secondary ASD symptoms, but still can be useful to elucidate the neurobiological mechanisms underlying specific ASD-like endophenotypes.	[Pietropaolo, Susanna; Crusio, Wim E.] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Talence, France; [Pietropaolo, Susanna; Crusio, Wim E.] CNRS, UMR 5287, Talence, France; [Guilleminot, Aurelie; Martin, Benoit] INSERM, U642, Lab Traitement Signal & Image, Rennes, France; [Guilleminot, Aurelie; Martin, Benoit] Univ Rennes 1, LTSI, Rennes, France; [D'Amato, Francesca R.] Italian Natl Res Council CNR, Inst Neurosci, Rome, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Pietropaolo, S (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Talence, France.	wim_crusio@yahoo.com	Crusio, Wim/ABD-5214-2021; Crusio, Wim/ABE-1287-2021; Crusio, Wim/A-7070-2008	Crusio, Wim/0000-0001-6638-202X; Crusio, Wim/0000-0001-6638-202X; D'Amato, Francesca/0000-0002-4577-4574; pietropaolo, susanna/0000-0002-8993-1922	March of Dimes [12-FY05-1198]; Conseil Regional d'Aquitaine, CNRS; University of Bordeaux 1; INSERM; University of Rennes 1; CNRS-CNR [23779]	March of Dimes(March of Dimes); Conseil Regional d'Aquitaine, CNRS; University of Bordeaux 1; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Rennes 1; CNRS-CNR(Consiglio Nazionale delle Ricerche (CNR)Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the March of Dimes (12-FY05-1198), Conseil Regional d'Aquitaine, CNRS, and the University of Bordeaux 1 to Wim E. Crusio. Aurelie Guilleminot and Benoit Martin were supported by grants from INSERM and the University of Rennes 1. Susanna Pietropaolo, Francesca D'Amato, and Wim E. Crusio were supported by the bilateral grant CNRS-CNR 2010 (#23779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STATMAN MENT D; Bailey DB, 1998, J AUTISM DEV DISORD, V28, P499; Bailey DB, 2001, J AUTISM DEV DISORD, V31, P165; BAKKER CE, 1994, CELL, V78, P23; Baranek GT, 2002, J AUTISM DEV DISORD, V32, P397, DOI 10.1023/A:1020541906063; Belzung C., 2005, DRUG DISC TODAY DIS, V2, P93, DOI DOI 10.1016/J.DDMOD.2005.05.004; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Brock M., 2010, J INTELLECT DISABIL; Brodkin ES, 1997, J CHILD ADOL PSYCHOP, V7, P109, DOI 10.1089/cap.1997.7.109; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Csomor PA, 2005, BEHAV BRAIN RES, V162, P256, DOI 10.1016/j.bbr.2005.03.020; Csomor PA, 2008, BEHAV NEUROSCI, V122, P885, DOI 10.1037/0735-7044.122.4.885; DAmato FR, 1996, NEUROBIOL LEARN MEM, V65, P9, DOI 10.1006/nlme.1996.0002; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; Dominick KC, 2007, RES DEV DISABIL, V28, P145, DOI 10.1016/j.ridd.2006.02.003; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; GEYER M, 1998, CURRENT PROTOCOLS NE; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Horrigan JP, 1997, J AUTISM DEV DISORD, V27, P313, DOI 10.1023/A:1025854532079; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ivanco TL, 2002, HIPPOCAMPUS, V12, P47, DOI 10.1002/hipo.10004; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; LIU ZH, INT J NEUROPSYCHOPHA, P1; Loesch DZ, 2007, NEUROSCI BIOBEHAV R, V31, P315, DOI 10.1016/j.neubiorev.2006.09.007; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Mineur YS, 2002, HIPPOCAMPUS, V12, P39, DOI 10.1002/hipo.10005; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muris P, 1998, J ANXIETY DISORD, V12, P387, DOI 10.1016/S0887-6185(98)00022-X; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Pacey LKK, 2009, MOL PHARMACOL, V76, P18, DOI 10.1124/mol.109.056127; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P505, DOI 10.1037/0735-7044.122.3.505; Pietropaolo S, 2008, PSYCHOPHARMACOLOGY, V197, P613, DOI 10.1007/s00213-008-1081-3; Pietropaolo S, 2009, BEHAV GENET, V39, P623, DOI 10.1007/s10519-009-9291-y; Polimeni MA, 2005, J INTELL DISABIL RES, V49, P260, DOI 10.1111/j.1365-2788.2005.00642.x; Qin M, 2005, NEUROSCIENCE, V135, P999, DOI 10.1016/j.neuroscience.2005.06.081; Qiu LF, 2009, CEREB CORTEX, V19, P1504, DOI 10.1093/cercor/bhn163; Radde R, 2008, EUR J NUCL MED MOL I, V35, pS70, DOI 10.1007/s00259-007-0704-y; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schreier HA, 1998, J CHILD ADOL PSYCHOP, V8, P49, DOI 10.1089/cap.1998.8.49; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Spivak B, 2004, NEUROPSYCHOBIOLOGY, V50, P157, DOI 10.1159/000079108; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Symons FJ, 2003, AM J MED GENET A, V118A, P115, DOI 10.1002/ajmg.a.10078; TERRANOVA ML, 1993, DEV PSYCHOBIOL, V26, P467, DOI 10.1002/dev.420260805; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; Ventura R, 2004, BEHAV PHARMACOL, V15, P433, DOI 10.1097/00008877-200409000-00018; VERGNES M, 1982, NEUROSCI LETT, V33, P97, DOI 10.1016/0304-3940(82)90136-7; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Williams PG, 2004, J SLEEP RES, V13, P265; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yan QJ, 2004, GENES BRAIN BEHAV, V3, P337, DOI 10.1111/j.1601-183X.2004.00087.x; Yee BK, 2005, BEHAV BRAIN RES, V163, P265, DOI 10.1016/j.bbr.2005.05.013; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P1865, DOI 10.1038/sj.npp.1300480; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P240, DOI 10.1038/sj.npp.1300323; YUHAS J, 2010, J AUTISM DEV DISORD; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zupan B, 2008, NEUROPSYCHOPHARMACOL, V33, P2667, DOI 10.1038/sj.npp.1301651	80	110	113	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17073	10.1371/journal.pone.0017073	http://dx.doi.org/10.1371/journal.pone.0017073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364941	gold, Green Published, Green Submitted			2022-12-25	WOS:000287656600030
J	Zeng, L; Das, S; Burne, RA				Zeng, Lin; Das, Satarupa; Burne, Robert A.			Genetic Analysis of the Functions and Interactions of Components of the LevQRST Signal Transduction Complex of Streptococcus mutans	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; FRUCTAN HYDROLASE GENE; GRAM-POSITIVE BACTERIA; BETA-D-FRUCTOSIDASE; PHOSPHOTRANSFERASE SYSTEM; HISTIDINE KINASES; MULTIPLE SUGAR; EXPRESSION; MUTAGENESIS; METABOLISM	Transcription of the genes for a fructan hydrolase (fruA) and a fructose/mannose sugar: phosphotransferase permease (levDEFG) in Streptococcus mutans is activated by a four-component regulatory system consisting of a histidine kinase (LevS), a response regulator (LevR) and two carbohydrate-binding proteins (LevQT). The expression of the fruA and levD operons was at baseline in a levQ mutant and substantially decreased in a levT null mutant, with lower expression with the cognate inducers fructose or mannose, but slightly higher expression in glucose or galactose. A strain expressing levQ with two point mutations (E170A/F292S) did not require inducers to activate gene expression and displayed altered levD expression when growing on various carbohydrates, including cellobiose. Linker-scanning (LS) mutagenesis was used to generate three libraries of mutants of levQ, levS and levT that displayed various levels of altered substrate specificity and of fruA/levD gene expression. The data support that LevQ and LevT are intimately involved in the sensing of carbohydrate signals, and that LevQ appears to be required for the integrity of the signal transduction complex, apparently by interacting with the sensor kinase LevS.	[Zeng, Lin; Das, Satarupa; Burne, Robert A.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Zeng, L (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	lzeng@dental.ufl.edu	Zeng, Lin/L-5931-2019	Zeng, Lin/0000-0002-9269-2707; Burne, Robert/0000-0002-4234-0316	National Institute of Dental and Craniofacial Research, United States of America [RO1 DE12236]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012236] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant RO1 DE12236 from the National Institute of Dental and Craniofacial Research, United States of America (http://www.nidcr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Barrett JF, 1998, P NATL ACAD SCI USA, V95, P5317, DOI 10.1073/pnas.95.9.5317; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Burne RA, 1996, J DENT RES, V75, P1572, DOI 10.1177/00220345960750080801; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; BURNE RA, 1987, J BACTERIOL, V169, P4507, DOI 10.1128/jb.169.10.4507-4517.1987; BURNE RA, 1992, INFECT IMMUN, V60, P4621, DOI 10.1128/IAI.60.11.4621-4632.1992; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cha R S, 1992, PCR Methods Appl, V2, P14; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Faustoferri RC, 1998, PLASMID, V40, P247, DOI 10.1006/plas.1998.1371; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; MUNRO C, 1991, INFECT IMMUN, V59, P2316, DOI 10.1128/IAI.59.7.2316-2323.1991; Poquet I, 1998, J BACTERIOL, V180, P1904, DOI 10.1128/JB.180.7.1904-1912.1998; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; ROSEY EL, 1992, J BACTERIOL, V174, P6159, DOI 10.1128/JB.174.19.6159-6170.1992; Rozen R, 2001, FEMS MICROBIOL LETT, V195, P205, DOI 10.1016/S0378-1097(01)00009-X; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Sambrook J, 2001, MOL CLONING LAB MANU; Shaw W V, 1975, Methods Enzymol, V43, P737; Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105; Tetsch L, 2009, MOL MICROBIOL, V73, P982, DOI 10.1111/j.1365-2958.2009.06847.x; VANHOUTE J, 1994, J DENT RES, V73, P1727, DOI 10.1177/00220345940730110801; Wen ZT, 2001, FEMS MICROBIOL LETT, V205, P337, DOI 10.1111/j.1574-6968.2001.tb10969.x; Zeng L, 2008, MOL MICROBIOL, V70, P197, DOI 10.1111/j.1365-2958.2008.06403.x; Zeng L, 2006, MOL MICROBIOL, V62, P187, DOI 10.1111/j.1365-2958.2006.05359.x; Zeng L, 2010, J BACTERIOL, V192, P2434, DOI 10.1128/JB.01624-09; Zeng L, 2010, MOL MICROBIOL, V75, P1145, DOI 10.1111/j.1365-2958.2009.07029.x; Zeng L, 2009, J BACTERIOL, V191, P2153, DOI 10.1128/JB.01641-08; Zuobi-Hasona Kheir, 2008, V425, P287, DOI 10.1007/978-1-60327-210-0_23	34	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17335	10.1371/journal.pone.0017335	http://dx.doi.org/10.1371/journal.pone.0017335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364902	Green Submitted, Green Published, gold			2022-12-25	WOS:000287656600040
J	Nacke, H; Thurmer, A; Wollherr, A; Will, C; Hodac, L; Herold, N; Schoning, I; Schrumpf, M; Daniel, R				Nacke, Heiko; Thuermer, Andrea; Wollherr, Antje; Will, Christiane; Hodac, Ladislav; Herold, Nadine; Schoening, Ingo; Schrumpf, Marion; Daniel, Rolf			Pyrosequencing-Based Assessment of Bacterial Community Structure Along Different Management Types in German Forest and Grassland Soils	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; FUNGAL COMMUNITIES; PH GRADIENT; GEN.-NOV.; DIVERSITY; ACTINOBACTERIA; SEQUENCES; MEMBERS; PHYLUM	Background: Soil bacteria are important drivers for nearly all biogeochemical cycles in terrestrial ecosystems and participate in most nutrient transformations in soil. In contrast to the importance of soil bacteria for ecosystem functioning, we understand little how different management types affect the soil bacterial community composition. Methodology/Principal Findings: We used pyrosequencing-based analysis of the V2-V3 16S rRNA gene region to identify changes in bacterial diversity and community structure in nine forest and nine grassland soils from the Schwabische Alb that covered six different management types. The dataset comprised 598,962 sequences that were affiliated to the domain Bacteria. The number of classified sequences per sample ranged from 23,515 to 39,259. Bacterial diversity was more phylum rich in grassland soils than in forest soils. The dominant taxonomic groups across all samples (>1% of all sequences) were Acidobacteria, Alphaproteobacteria, Actinobacteria, Betaproteobacteria, Deltaproteobacteria, Gammaproteobacteria, and Firmicutes. Significant variations in relative abundances of bacterial phyla and proteobacterial classes, including Actinobacteria, Firmicutes, Verrucomicrobia, Cyanobacteria, Gemmatimonadetes and Alphaproteobacteria, between the land use types forest and grassland were observed. At the genus level, significant differences were also recorded for the dominant genera Phenylobacter, Bacillus, Kribbella, Streptomyces, Agromyces, and Defluviicoccus. In addition, soil bacterial community structure showed significant differences between beech and spruce forest soils. The relative abundances of bacterial groups at different taxonomic levels correlated with soil pH, but little or no relationships to management type and other soil properties were found. Conclusions/Significance: Soil bacterial community composition and diversity of the six analyzed management types showed significant differences between the land use types grassland and forest. Furthermore, bacterial community structure was largely driven by tree species and soil pH.	[Nacke, Heiko; Will, Christiane; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany; [Thuermer, Andrea; Wollherr, Antje; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, Gottingen, Germany; [Herold, Nadine; Schrumpf, Marion] Max Planck Inst Biogeochem, Jena, Germany; [Schoening, Ingo] Univ Jena, Inst Ecol, Jena, Germany	University of Gottingen; University of Gottingen; Max Planck Society; Friedrich Schiller University of Jena	Nacke, H (corresponding author), Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany.	rdaniel@gwdg.de	Schrumpf, Marion/C-1671-2013; Hodac, Ladislav/AAP-7284-2021; Hodac, Ladislav/A-4072-2014; Daniel, Rolf/AAQ-5933-2021; Schöning, Ingo/D-3341-2009; Herold, Nadine/I-7996-2013	Hodac, Ladislav/0000-0002-6885-1317; Daniel, Rolf/0000-0002-8646-7925; Schöning, Ingo/0000-0002-9830-5026; Schrumpf, Marion/0000-0003-4219-4125; Nacke, Heiko/0000-0001-6169-6169	DFG [1374, DA 374/4-1]	DFG(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (DA 374/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Anandham R, 2011, INT J SYST EVOL MICR, V61, P392, DOI 10.1099/ijs.0.022012-0; Anderson RC, 2000, INT J SYST EVOL MICR, V50, P633, DOI 10.1099/00207713-50-2-633; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Brady N. C., 2007, NATURE PROPERTIES SO; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2007, VET MICROBIOL, V121, P299, DOI 10.1016/j.vetmic.2006.12.006; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; FAO, 2006, GUID SOIL DESCR; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Hackl E, 2004, APPL ENVIRON MICROB, V70, P5057, DOI 10.1128/AEM.70.9.5057-5065.2004; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; JimenezSalgado T, 1997, APPL ENVIRON MICROB, V63, P3676, DOI 10.1128/AEM.63.9.3676-3683.1997; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; McCaig AE, 2001, APPL ENVIRON MICROB, V67, P4554, DOI 10.1128/AEM.67.10.4554-4559.2001; Morales SE, 2009, APPL ENVIRON MICROB, V75, P668, DOI 10.1128/AEM.01757-08; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Nusslein K, 1999, APPL ENVIRON MICROB, V65, P3622; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sait M, 2006, APPL ENVIRON MICROB, V72, P1852, DOI 10.1128/AEM.72.3.1852-1857.2006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmalenberger A, 2001, APPL ENVIRON MICROB, V67, P3557, DOI 10.1128/AEM.67.8.3557-3563.2001; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Shannon CE, 1949, MD COMPUT, V14, P306; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weon HY, 2009, INT J SYST EVOL MICR, V59, P1685, DOI 10.1099/ijs.0.004838-0; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Xie CH, 2005, INT J SYST EVOL MICR, V55, P753, DOI 10.1099/ijs.0.63377-0	54	390	442	5	282	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17000	10.1371/journal.pone.0017000	http://dx.doi.org/10.1371/journal.pone.0017000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359220	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700035
J	Jiang, WQ; Nguyen, A; Cao, Y; Chang, ACM; Reddel, RR				Jiang, Wei-Qin; Nguyen, Akira; Cao, Ying; Chang, Andy C. -M.; Reddel, Roger R.			HP1-Mediated Formation of Alternative Lengthening of Telomeres-Associated PML Bodies Requires HIRA but Not ASF1a	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA BODIES; FRAUMENI SYNDROME FIBROBLASTS; NUCLEOSOME ASSEMBLY PATHWAY; PRIMARY HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; HETEROCHROMATIN FOCI; DNA-SYNTHESIS; HP1 PROTEINS; MRE11/RAD50/NBS1 COMPLEX	Approximately 10% of cancers use recombination-mediated Alternative Lengthening of Telomeres (ALT) instead of telomerase to prevent telomere shortening. A characteristic of cells that utilize ALT is the presence of ALT-associated PML nuclear bodies (APBs) containing (TTAGGG)n DNA, telomere binding proteins, DNA recombination proteins, and heterochromatin protein 1 (HP1). The function of APBs is unknown and it is possible that they are functionally heterogeneous. Most ALT cells lack functional p53, and restoration of the p53/p21 pathway in these cells results in growth arrest/senescence and a substantial increase in the number of large APBs that is dependent on two HP1 isoforms, HP1 alpha and HP1 gamma. Here we investigated the mechanism of HP1-mediated APB formation, and found that histone chaperones, HIRA and ASF1a, are present in APBs following activation of the p53/p21 pathway in ALT cells. HIRA and ASF1a were also found to colocalize inside PML bodies in normal fibroblasts approaching senescence, providing evidence for the existence of a senescence-associated ASF1a/HIRA complex inside PML bodies, consistent with a role for these proteins in induction of senescence in both normal and ALT cells. Moreover, knockdown of HIRA but not ASF1a significantly reduced p53-mediated induction of large APBs, with a concomitant reduction of large HP1 foci. We conclude that HIRA, in addition to its physical and functional association with ASF1a, plays a unique, ASF1a-independent role, which is required for the localization of HP1 to PML bodies and thus for APB formation.	[Jiang, Wei-Qin; Nguyen, Akira; Cao, Ying; Chang, Andy C. -M.; Reddel, Roger R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia; [Jiang, Wei-Qin; Nguyen, Akira; Cao, Ying; Chang, Andy C. -M.; Reddel, Roger R.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney	Jiang, WQ (corresponding author), Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia.	rreddel@cmri.org.au	Reddel, Roger R/A-6635-2014	Reddel, Roger R/0000-0002-6302-6107	Cancer Council New South Wales [PG 06-04]; National Health and Medical Research Council of Australia [633265]	Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Program Grant PG 06-04 from Cancer Council New South Wales (www.cancercouncil.com.au) and project grant ID 633265 from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brachner A, 2006, CANCER RES, V66, P3584, DOI 10.1158/0008-5472.CAN-05-2839; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fan Q, 2009, NUCLEIC ACIDS RES, V37, P1740, DOI 10.1093/nar/gkn995; Fasching CL, 2005, CANCER RES, V65, P2722, DOI 10.1158/0008-5472.CAN-04-2881; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Grobelny JV, 2000, J CELL SCI, V113, P4577; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Harborth J, 2001, J CELL SCI, V114, P4557; Henson JD, 2005, CLIN CANCER RES, V11, P217; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Jiang WQ, 2007, ONCOGENE, V26, P4635, DOI 10.1038/sj.onc.1210260; Jiang WQ, 2009, J CELL BIOL, V185, P797, DOI 10.1083/jcb.200810084; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; MACLEAN K, 1994, ONCOGENE, V9, P719; Marciniak RA, 2005, CANCER RES, V65, P2730, DOI 10.1158/0008-5472.CAN-04-2888; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; Moran-Jones K, 2005, NUCLEIC ACIDS RES, V33, P486, DOI 10.1093/nar/gki203; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Nabetani A, 2004, J BIOL CHEM, V279, P25849, DOI 10.1074/jbc.M312652200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; ROGAN EM, 1995, MOL CELL BIOL, V15, P4745; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Singer MS, 1998, GENETICS, V150, P613; Slatter T, 2010, AM J PATHOL, V177, P2694, DOI 10.2353/ajpath.2010.100468; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Toouli CD, 2002, ONCOGENE, V21, P128, DOI 10.1038/sj.onc.1205014; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2003, J BIOL CHEM, V278, P35660, DOI 10.1074/jbc.M303549200; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Wu GK, 2003, CANCER RES, V63, P2589; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Yeager TR, 1999, CANCER RES, V59, P4175; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, CELL CYCLE, V6, P784, DOI 10.4161/cc.6.7.4079; Zhang RG, 2007, MOL CELL BIOL, V27, P949, DOI 10.1128/MCB.01639-06; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	69	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17036	10.1371/journal.pone.0017036	http://dx.doi.org/10.1371/journal.pone.0017036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347226	Green Published, Green Submitted, gold			2022-12-25	WOS:000287369200014
J	Charland, KM; Brownstein, JS; Verma, A; Brien, S; Buckeridge, DL				Charland, Katia M.; Brownstein, John S.; Verma, Aman; Brien, Stephanie; Buckeridge, David L.			Socio-Economic Disparities in the Burden of Seasonal Influenza: The Effect of Social and Material Deprivation on Rates of Influenza Infection	PLOS ONE			English	Article							ACUTE RESPIRATORY-INFECTIONS; HOSPITAL ADMISSION; HEALTH; CHILDREN; DISEASE; SURVEILLANCE; MORTALITY; SYSTEM; AGE	Background: There is little empirical evidence in support of a relationship between rates of influenza infection and level of material deprivation (i.e., lack of access to goods and services) and social deprivation (i.e. lack of social cohesion and support). Method: Using validated population-level indices of material and social deprivation and medical billing claims for outpatient clinic and emergency department visits for influenza from 1996 to 2006, we assessed the relationship between neighbourhood rates of influenza and neighbourhood levels of deprivation using Bayesian ecological regression models. Then, by pooling data from neighbourhoods in the top decile (i.e., most deprived) and the bottom decile, we compared rates in the most deprived populations to the least deprived populations using age-and sex-standardized rate ratios. Results: Deprivation scores ranged from one to five with five representing the highest level of deprivation. We found a 21% reduction in rates for every 1 unit increase in social deprivation score (rate ratio [RR] 0.79, 95% Credible Interval [CrI] 0.66, 0.97). There was little evidence of a meaningful linear relationship with material deprivation (RR 1.06, 95% CrI 0.93, 1.24). However, relative to neighbourhoods with deprivation scores in the bottom decile, those in the top decile (i. e., most materially deprived) had substantially higher rates (RR 2.02, 95% Confidence Interval 1.99, 2.05). Conclusion: Though it is hypothesized that social and material deprivation increase risk of acute respiratory infection, we found decreasing healthcare utilization rates for influenza with increasing social deprivation. This finding may be explained by the fewer social contacts and, thus, fewer influenza exposure opportunities of the socially deprived. Though there was no evidence of a linear relationship with material deprivation, when comparing the least to the most materially deprived populations, we observed higher rates in the most materially deprived populations.	[Charland, Katia M.; Brownstein, John S.] Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Charland, Katia M.; Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Charland, Katia M.; Brownstein, John S.; Verma, Aman; Brien, Stephanie; Buckeridge, David L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Buckeridge, David L.] Montreal Publ Hlth Dept, Off Surveillance & Epidemiol, Montreal, PQ, Canada	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; McGill University	Charland, KM (corresponding author), Childrens Hosp, Childrens Hosp Informat Program, 300 Longwood Ave, Boston, MA 02115 USA.	katia.charland@mcgill.ca	Verma, Aman/D-5550-2014; Thompson, Ross/D-7996-2013; Austin, Jeremy/F-8729-2010; Owen, Kylie/K-9400-2015; Gershwin, Lisa-ann/N-6392-2015	Verma, Aman/0000-0001-7436-1325; Thompson, Ross/0000-0002-5287-2455; Robb, Kate/0000-0002-7038-3612; Austin, Jeremy/0000-0003-4244-2942; Owen, Kylie/0000-0002-8986-482X; Gershwin, Lisa-ann/0000-0003-1254-725X	National Institute of Allergy and Infectious Diseases [R21AI073591-01]; National Library of Medicine, National Institutes of Health [R21LM009263-01]; Canadian Institutes of Health Research [PAN-83152, CAT 86857]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073591] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM009263] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institute of Allergy and Infectious Diseases [R21AI073591-01], the National Library of Medicine, National Institutes of Health [R21LM009263-01], and the Canadian Institutes of Health Research [PAN-83152, CAT 86857]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2008, SOC SCI MED, V66, P691, DOI 10.1016/j.socscimed.2007.10.011; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Cadieux G, 2008, HEALTH SERV RES, V43, P2223, DOI 10.1111/j.1475-6773.2008.00873.x; Cardoso MRA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-19; Carpenter KM, 2010, ANN BEHAV MED, V39, P79, DOI 10.1007/s12160-010-9160-1; Christakis N. A., 2010, PLOS ONE, V5; Cohen F, 2007, PSYCHOSOM MED, V69, P225, DOI 10.1097/PSY.0b013e31803139a6; Crighton EJ, 2007, SOC SCI MED, V64, P1636, DOI 10.1016/j.socscimed.2006.12.001; Feldman PJ, 2004, ANN BEHAV MED, V27, P91, DOI 10.1207/s15324796abm2702_3; Glynn AN, 2008, J ROY STAT SOC A STA, V171, P179; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; Hawker JI, 2003, RESP MED, V97, P1219, DOI 10.1016/S0954-6111(03)00252-X; Jackson C, 2006, STAT MED, V25, P2136, DOI 10.1002/sim.2370; Jackson CH, 2008, SOC SCI MED, V67, P1995, DOI 10.1016/j.socscimed.2008.09.041; Jordan R, 2006, RESP MED, V100, P1282, DOI 10.1016/j.rmed.2005.10.014; Jordan RE, 2008, BRIT J GEN PRACT, V58, P400, DOI 10.3399/bjgp08X302682; Kaler SG, 2008, ANN NY ACAD SCI, V1136, P28, DOI 10.1196/annals.1425.035; Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Pampalon R, 2000, Chronic Dis Can, V21, P104; Philibert MD, 2007, SOC SCI MED, V64, P1651, DOI 10.1016/j.socscimed.2006.12.010; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; SPIEGELHELTER DJ, 2002, WINBUGS BAYESIAN INF; STONE AA, ARCH INTERN MED, V170, P570; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008	28	40	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17207	10.1371/journal.pone.0017207	http://dx.doi.org/10.1371/journal.pone.0017207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723BX	21359150	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300040
J	Li, W; Zhu, S; Li, JH; Huang, Y; Zhou, RR; Fan, XG; Yang, HA; Gong, X; Eissa, NT; Jahnen-Dechent, W; Wang, P; Tracey, KJ; Sama, AE; Wang, HC				Li, Wei; Zhu, Shu; Li, Jianhua; Huang, Yan; Zhou, Rongrong; Fan, Xuegong; Yang, Huan; Gong, Xing; Eissa, N. Tony; Jahnen-Dechent, Willi; Wang, Ping; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao			A Hepatic Protein, Fetuin-A, Occupies a Protective Role in Lethal Systemic Inflammation	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; HUMAN ALPHA-2-HS GLYCOPROTEIN; ACUTE-PHASE PROTEIN; IFN-GAMMA; EXPERIMENTAL SEPSIS; BOVINE FETUIN; APOPTOTIC CELLS; TYROSINE KINASE; HMGB1 RELEASE; BACTERIAL-DNA	Background: A liver-derived protein, fetuin-A, was first purified from calf fetal serum in 1944, but its potential role in lethal systemic inflammation was previously unknown. This study aims to delineate the molecular mechanisms underlying the regulation of hepatic fetuin-A expression during lethal systemic inflammation (LSI), and investigated whether alterations of fetuin-A levels affect animal survival, and influence systemic accumulation of a late mediator, HMGB1. Methods and Findings: LSI was induced by endotoxemia or cecal ligation and puncture (CLP) in fetuin-A knock-out or wildtype mice, and animal survival rates were compared. Murine peritoneal macrophages were challenged with exogenous (endotoxin) or endogenous (IFN-gamma) stimuli in the absence or presence of fetuin-A, and HMGB1 expression and release was assessed. Circulating fetuin-A levels were decreased in a time-dependent manner, starting between 26 h, reaching a nadir around 24-48 h, and returning towards base-line approximately 72 h post onset of endotoxemia or sepsis. These dynamic changes were mirrored by an early cytokine IFN-gamma-mediated inhibition (up to 50-70%) of hepatic fetuin-A expression. Disruption of fetuin-A expression rendered animals more susceptible to LSI, whereas supplementation of fetuin-A (20100 mg/kg) dose-dependently increased animal survival rates. The protection was associated with a significant reduction in systemic HMGB1 accumulation in vivo, and parallel inhibition of IFN-gamma or LPS-induced HMGB1 release in vitro. Conclusions: These experimental data suggest that fetuin-A is protective against lethal systemic inflammation partly by inhibiting active HMGB1 release.	[Li, Wei; Zhu, Shu; Li, Jianhua; Huang, Yan; Zhou, Rongrong; Yang, Huan; Wang, Ping; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Li, Wei; Zhu, Shu; Sama, Andrew E.; Wang, Haichao] N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA; [Huang, Yan; Zhou, Rongrong; Fan, Xuegong] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Gong, Xing; Eissa, N. Tony] Baylor Coll Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA; [Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Dept Biomed Engn, Biointerface Lab, Aachen, Germany	Northwell Health; Northwell Health; North Shore University Hospital; Central South University; Baylor College of Medicine; RWTH Aachen University; RWTH Aachen University Hospital	Li, W (corresponding author), Feinstein Inst Med Res, Manhasset, NY 11030 USA.	hwang@nshs.edu	Wang, Haichao/AAU-2237-2021; Jahnen-Dechent, Willi/A-7608-2011	Wang, Haichao/0000-0002-0211-9000; Wang, Ping/0000-0002-1557-0394; Jahnen-Dechent, Willi/0000-0003-1315-4407; Li, Wei/0000-0002-7941-7022; Tracey, Kevin J/0000-0003-1884-6314	National Institute of General Medical Sciences [R01GM063075, R01GM070817]; National Center for Complementary & Integrative Health [R01AT005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062508, R01GM070817, R01GM063075] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (R01GM063075 and R01GM070817 to HW.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chmiela M, 1997, GUT, V40, P20, DOI 10.1136/gut.40.1.20; CHRISTIE DL, 1987, FEBS LETT, V214, P45, DOI 10.1016/0014-5793(87)80010-8; DAVEAU M, 1988, FEBS LETT, V241, P191, DOI 10.1016/0014-5793(88)81059-7; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Deriy LV, 2002, SHOCK, V17, P312, DOI 10.1097/00024382-200204000-00013; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Dubreuil JD, 2002, MICROBIOL MOL BIOL R, V66, P617, DOI 10.1128/MMBR.66.4.617-629.2002; DZIEGIELEWSKA KM, 1992, J COMP PHYSIOL B, V162, P168, DOI 10.1007/BF00398343; Dziegielewska KM, 1998, IMMUNOL LETT, V60, P31, DOI 10.1016/S0165-2478(97)00126-0; Dziegielewska KM, 1995, FETUIN, P1; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; HAASEMANN M, 1991, BIOCHEM J, V274, P899, DOI 10.1042/bj2740899; HEINZEL FP, 1990, J IMMUNOL, V145, P2920; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Lord JM, 2003, CLIN SCI, V105, P267, DOI 10.1042/CS20030177; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; OHNISHI T, 1993, J BONE MINER RES, V8, P367; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Su X, 2008, BBA-MOL CELL RES, V1783, P1623, DOI 10.1016/j.bbamcr.2008.04.009; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tang DL, 2009, AM J RESP CELL MOL, V41, P651, DOI 10.1165/rcmb.2008-0119OC; Tuttolomondo A, 2010, ATHEROSCLEROSIS, V208, P290, DOI 10.1016/j.atherosclerosis.2009.07.032; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Wang Haichao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000884; Wang HC, 2006, J NUTR, V136, P360, DOI 10.1093/jn/136.2.360; Wang HC, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(05)62030-2; Wang HC, 2004, NAT MED, V10, P124, DOI 10.1038/nm0204-124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang SL, 2002, ANN SURG, V236, P625, DOI 10.1097/00000658-200211000-00013; Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062	57	262	275	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16945	10.1371/journal.pone.0016945	http://dx.doi.org/10.1371/journal.pone.0016945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347455	gold, Green Submitted, Green Published			2022-12-25	WOS:000287077600035
J	Zhou, XH; Wong, LL; Karakoti, AS; Seal, S; McGinnis, JF				Zhou, Xiaohong; Wong, Lily L.; Karakoti, Ajay S.; Seal, Sudipta; McGinnis, James F.			Nanoceria Inhibit the Development and Promote the Regression of Pathologic Retinal Neovascularization in the Vldlr Knockout Mouse	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; NADPH OXIDASE; SUBRETINAL NEOVASCULARIZATION; PHOTORECEPTOR DEGENERATION; PIGMENT EPITHELIUM; MODEL; MICE; PROTECTION; INJURY	Many neurodegenerative diseases are known to occur and progress because of oxidative stress, the presence of reactive oxygen species (ROS) in excess of the cellular defensive capabilities. Age related macular degeneration (AMD), diabetic retinopathy (DR) and inherited retinal degeneration share oxidative stress as a common node upstream of the blinding effects of these diseases. Knockout of the Vldlr gene results in a mouse that develops intraretinal and subretinal neovascular lesions within the first month of age and is an excellent model for a form of AMD called retinal angiomatous proliferation (RAP). Cerium oxide nanoparticles (nanoceria) catalytically scavenge ROS by mimicking the activities of superoxide dismutase and catalase. A single intravitreal injection of nanoceria into the Vldlr-/- eye was shown to inhibit: the rise in ROS in the Vldlr-/- retina, increases in vascular endothelial growth factor (VEGF) in the photoreceptor layer, and the formation of intraretinal and subretinal neovascular lesions. Of more therapeutic interest, injection of nanoceria into older mice (postnatal day 28) resulted in the regression of existing vascular lesions indicating that the pathologic neovessels require the continual production of excessive ROS. Our data demonstrate the unique ability of nanoceria to prevent downstream effects of oxidative stress in vivo and support their therapeutic potential for treatment of neurodegenerative diseases such as AMD and DR.	[Zhou, Xiaohong; Wong, Lily L.; Karakoti, Ajay S.; Seal, Sudipta; McGinnis, James F.] Univ Oklahoma, Coll Med, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK 73190 USA; [Karakoti, Ajay S.; Seal, Sudipta] Univ Cent Florida, Adv Mat Proc Anal Ctr, Mech Mat Aerosp Engn Nanosci & Technol Ctr, Orlando, FL 32816 USA; [McGinnis, James F.] Oklahoma Ctr Neurosci, Dept Ophthalmol & Cell Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University System of Florida; University of Central Florida	Zhou, XH (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab, Boston, MA 02115 USA.	lily-wong@ouhsc.edu; james-mcginnis@ouhsc.edu	Seal, Sudipta/A-7698-2012; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AGI-8160-2022; Karakoti, Ajay/AAY-5886-2020; Liu, Zhanjiang/R-9633-2019; Wong, Li Lian/AAG-5568-2020; Wong, Lily/D-7737-2011	Wong, Li Lian/0000-0001-9045-4556; Wong, Lily/0000-0003-0569-3398; Na-Nakorn, Uthairat/0000-0002-0804-3561; KARAKOTI, AJAY/0000-0001-9081-2325	NIH [P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724]; FFB [C-NP-0707-0404-UOK08]; NSF [CBET-0708172]; OCAST [HR06-075]; Presbyterian Health Foundation; Research to Prevent Blindness; RPB; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018306, P30EY012190, R01EY018724] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FFB; NSF(National Science Foundation (NSF)); OCAST; Presbyterian Health Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RPB; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from: NIH: P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724; FFB (http://www.blindness.org/): C-NP-0707-0404-UOK08; NSF: CBET-0708172; OCAST(http://www.ok.gov/ocast/Programs/Oklahoma_Health_Research_(OHR)/index.html): HR06-075, and unrestricted funds from Presbyterian Health Foundation (http://www.phfokc.com/research.htm) and Research to Prevent Blindness (http://www.rpbusa.org/rpb/) (RPB). JFM is a recipient of an RPB Senior Scientific Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L P, 1997, Curr Opin Ophthalmol, V8, P19; Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bhatti MT, 2006, CURR NEUROL NEUROSCI, V6, P403, DOI 10.1007/s11910-996-0021-z; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Butler D, 2006, ANTIOXID REDOX SIGN, V8, P185, DOI 10.1089/ars.2006.8.185; Cao W, 2000, J NEUROSCI RES, V60, P195, DOI 10.1002/(SICI)1097-4547(20000415)60:2<195::AID-JNR8>3.0.CO;2-7; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; FRIED R, 1975, J NEUROCHEM, V24, P433, DOI 10.1111/j.1471-4159.1975.tb07658.x; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hogg R, 2004, CURR EYE RES, V29, P387, DOI 10.1080/02713680490517890; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Kaluzny J J, 1996, Klin Oczna, V98, P145; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x; Korystov YN, 2007, RADIAT RES, V168, P226, DOI 10.1667/RR0925.1; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Lodi F, 2006, EUR J PHARMACOL, V544, P97, DOI 10.1016/j.ejphar.2006.06.028; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; OLIVEIRA CR, 1994, ANN NY ACAD SCI, V738, P130; Onyango Isaac G., 2006, Current Alzheimer Research, V3, P339, DOI 10.2174/156720506778249489; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Poon HF, 2004, J GERONTOL A-BIOL, V59, P478; Sacca SC, 2009, MUTAT RES-FUND MOL M, V667, P98, DOI 10.1016/j.mrfmmm.2008.11.002; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; STERNBERG P, 1993, INVEST OPHTH VIS SCI, V34, P3661; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; van Reyk DM, 2003, REDOX REP, V8, P187, DOI 10.1179/135100003225002673; Wu MY, 2008, INVEST OPHTH VIS SCI, V49, P2679, DOI 10.1167/iovs.07-1440; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200; Zhou XH, 2007, DEV NEUROBIOL, V67, P603, DOI 10.1002/dneu.20373	50	163	173	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16733	10.1371/journal.pone.0016733	http://dx.doi.org/10.1371/journal.pone.0016733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21423623	Green Published, Green Submitted, gold			2022-12-25	WOS:000287656600014
J	Hofherr, SE; Adams, KE; Chen, CY; May, S; Weaver, EA; Barry, MA				Hofherr, Sean E.; Adams, Kristen E.; Chen, Christopher Y.; May, Shannon; Weaver, Eric A.; Barry, Michael A.			Real-Time Dynamic Imaging of Virus Distribution In Vivo	PLOS ONE			English	Article							GENE DELIVERY; ADENOVIRUS; TOXICITY; VECTORS; THERAPY	The distribution of viruses and gene therapy vectors is difficult to assess in a living organism. For instance, trafficking in murine models can usually only be assessed after sacrificing the animal for tissue sectioning or extraction. These assays are laborious requiring whole animal sectioning to ascertain tissue localization. They also obviate the ability to perform longitudinal or kinetic studies in one animal. To track viruses after systemic infection, we have labeled adenoviruses with a near-infrared (NIR) fluorophore and imaged these after intravenous injection in mice. Imaging was able to track and quantitate virus particles entering the jugular vein simultaneous with injection, appearing in the heart within 500 milliseconds, distributing in the bloodstream and throughout the animal within 7 seconds, and that the bulk of virus distribution was essentially complete within 3 minutes. These data provide the first in vivo real-time tracking of the rapid initial events of systemic virus infection.	[Hofherr, Sean E.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Chen, Christopher Y.; May, Shannon; Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Div Infect Dis, Translat Immunovirol & Biodef Program, Dept Internal Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Mayo Grad Sch, Dept Mol Med, Dept Immunol, Rochester, MN USA; [Adams, Kristen E.] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Health Science Center Houston	Hofherr, SE (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	mab@mayo.edu	Chen, Christopher/B-8141-2012	Chen, Christopher/0000-0003-2726-3989; Davies, Benjamin/0000-0003-3623-600X	Muscular Dystrophy Association; N.I.H. [R01-CA136945]; NATIONAL CANCER INSTITUTE [R01CA136945] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to M.A.B. from the Muscular Dystrophy Association and the N.I.H. (R01-CA136945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; Barry MA, 2009, CURR OPIN MOL THER, V11, P411; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; Dubensky TW, 2002, CANCER CELL, V1, P307, DOI 10.1016/S1535-6108(02)00062-4; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Ottobrini L, 2008, EUR J NUCL MED MOL I, V35, P365, DOI 10.1007/s00259-007-0578-z; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Ray P, 2003, CANCER RES, V63, P1160; Reynolds PN, 2000, MOL THER, V2, P562, DOI 10.1006/mthe.2000.0205; Shashkova EV, 2008, CANCER RES, V68, P5896, DOI 10.1158/0008-5472.CAN-08-0488; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059	13	202	206	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17076	10.1371/journal.pone.0017076	http://dx.doi.org/10.1371/journal.pone.0017076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347236	gold, Green Published, Green Submitted			2022-12-25	WOS:000287369200018
J	Vandevenne, P; Lebrun, M; El Mjiyad, N; Ote, I; Di Valentin, E; Habraken, Y; Dortu, E; Piette, J; Sadzot-Delvaux, C				Vandevenne, Patricia; Lebrun, Marielle; El Mjiyad, Nadia; Ote, Isabelle; Di Valentin, Emmanuel; Habraken, Yvette; Dortu, Estelle; Piette, Jacques; Sadzot-Delvaux, Catherine			The Varicella-Zoster Virus ORF47 Kinase Interferes with Host Innate Immune Response by Inhibiting the Activation of IRF3	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NF-KAPPA-B; DOUBLE-STRANDED-RNA; TRANSCRIPTIONAL REGULATORY PROTEIN; ANTIVIRAL RESPONSE; GENE-EXPRESSION; I INTERFERON; VIRAL REPLICATION; STIMULATED GENES; SERINE KINASE	The innate immune response constitutes the first line of host defence that limits viral spread and plays an important role in the activation of adaptive immune response. Viral components are recognized by specific host pathogen recognition receptors triggering the activation of IRF3. IRF3, along with NF-kappa B, is a key regulator of IFN-beta expression. Until now, the role of IRF3 in the activation of the innate immune response during Varicella-Zoster Virus (VZV) infection has been poorly studied. In this work, we demonstrated for the first time that VZV rapidly induces an atypical phosphorylation of IRF3 that is inhibitory since it prevents subsequent IRF3 homodimerization and induction of target genes. Using a mutant virus unable to express the viral kinase ORF47p, we demonstrated that (i) IRF3 slower-migrating form disappears; (ii) IRF3 is phosphorylated on serine 396 again and recovers the ability to form homodimers; (iii) amounts of IRF3 target genes such as IFN-beta and ISG15 mRNA are greater than in cells infected with the wild-type virus; and (iv) IRF3 physically interacts with ORF47p. These data led us to hypothesize that the viral kinase ORF47p is involved in the atypical phosphorylation of IRF3 during VZV infection, which prevents its homodimerization and subsequent induction of target genes such as IFN-beta and ISG15.	[Vandevenne, Patricia; Lebrun, Marielle; Ote, Isabelle; Di Valentin, Emmanuel; Habraken, Yvette; Piette, Jacques; Sadzot-Delvaux, Catherine] Univ Liege, GIGA Res, Lab Virol & Immunol, Liege, Belgium; [El Mjiyad, Nadia] Inst Invest Biomed Bellvitge IDIBELL, Lab Mol Oncol LOM, Barcelona, Spain; [Dortu, Estelle] Univ Liege, Dept Pathol, Liege, Belgium	University of Liege; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Liege	Vandevenne, P (corresponding author), Univ Liege, GIGA Res, Lab Virol & Immunol, Liege, Belgium.	csadzot@ulg.ac.be	Lebrun, Marielle/GVT-8895-2022	Di Valentin, Emmanuel/0000-0002-5287-7950; Lobsiger, Christian/0000-0002-4313-010X; Cleveland, Don/0000-0002-1934-3682	Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium); "Fonds National pour la Recherche Scientifique" (FNRS); Interuniversity Attraction Poles (IAP) Programme [IAP6/18]	Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium); "Fonds National pour la Recherche Scientifique" (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles (IAP) Programme(Belgian Federal Science Policy Office)	The work was supported by the "Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium), and The "Fonds National pour la Recherche Scientifique" (FNRS). This paper also presents research results of the IAP6/18, funded by the Interuniversity Attraction Poles (IAP) Programme, initiated by the Belgian State, Science Policy Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Abendroth A, 2001, J VIROL, V75, P4878, DOI 10.1128/JVI.75.10.4878-4888.2001; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Boehme KW, 2004, J VIROL, V78, P1202, DOI 10.1128/JVI.78.3.1202-1211.2004; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Eisfeld AJ, 2006, J VIROL, V80, P1710, DOI 10.1128/JVI.80.4.1710-1723.2006; El Mjiyad N, 2007, J VIROL, V81, P13092, DOI 10.1128/JVI.01378-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; HEINEMAN TC, 1995, J VIROL, V69, P7367, DOI 10.1128/JVI.69.11.7367-7370.1995; Heineman TC, 1996, J VIROL, V70, P7312, DOI 10.1128/JVI.70.10.7312-7317.1996; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu HL, 2005, VIROLOGY, V337, P304, DOI 10.1016/j.virol.2005.04.024; Hwang SM, 2009, CELL HOST MICROBE, V5, P166, DOI 10.1016/j.chom.2008.12.013; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jones JO, 2006, J VIROL, V80, P5113, DOI 10.1128/JVI.01956-05; Kennedy PGE, 2001, VIROLOGY, V289, P218, DOI 10.1006/viro.2001.1173; Kenyon T. K., 2003, Journal of Medical Virology, V70, pS95, DOI 10.1002/jmv.10329; Kenyon TK, 2002, J VIROL, V76, P10980, DOI 10.1128/JVI.76.21.10980-10993.2002; Kenyon TK, 2001, J VIROL, V75, P8854, DOI 10.1128/JVI.75.18.8854-8858.2001; Kinchington PR, 2000, J VIROL, V74, P2265, DOI 10.1128/JVI.74.5.2265-2277.2000; KINCHINGTON PR, 1999, FRONTIERS BIOSCIENCE, V4; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Moffat JF, 1998, P NATL ACAD SCI USA, V95, P11969, DOI 10.1073/pnas.95.20.11969; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; NG TI, 1994, J VIROL, V68, P1350, DOI 10.1128/JVI.68.3.1350-1359.1994; NIKKELS AF, 1993, VIRCHOWS ARCH A, V422, P121, DOI 10.1007/BF01607163; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reddy SM, 1998, J VIROL, V72, P8083, DOI 10.1128/JVI.72.10.8083-8088.1998; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Schaap A, 2005, J VIROL, V79, P12921, DOI 10.1128/JVI.79.20.12921-12933.2005; Sen N, 2010, J VIROL, V84, P9240, DOI 10.1128/JVI.01147-10; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shibaki T, 2001, J INTERF CYTOK RES, V21, P279, DOI 10.1089/107999001300177466; SMITH RF, 1989, J VIROL, V63, P450, DOI 10.1128/JVI.63.1.450-455.1989; Spengler M, 2001, ARCH VIR S, V17, P71; STEVENSON D, 1994, J GEN VIROL, V75, P317, DOI 10.1099/0022-1317-75-2-317; Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Taylor RT, 2006, J VIROL, V80, P920, DOI 10.1128/JVI.80.2.920-928.2006; Taylor RT, 2005, J VIROL, V79, P3873, DOI 10.1128/JVI.79.6.3873-3877.2005; VANDEVENNE P, 2010, BIOCH PHARM; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304	65	95	97	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16870	10.1371/journal.pone.0016870	http://dx.doi.org/10.1371/journal.pone.0016870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347389	gold, Green Published, Green Submitted			2022-12-25	WOS:000287361700047
J	Wong, LL; Peatman, E; Lu, JG; Kucuktas, H; He, SP; Zhou, CJ; Na-nakorn, U; Liu, ZJ				Wong, Li Lian; Peatman, Eric; Lu, Jianguo; Kucuktas, Huseyin; He, Shunping; Zhou, Chuanjiang; Na-nakorn, Uthairat; Liu, Zhanjiang			DNA Barcoding of Catfish: Species Authentication and Phylogenetic Assessment	PLOS ONE			English	Article							SILURIFORMES; SEQUENCE; TUNA	As the global market for fisheries and aquaculture products expands, mislabeling of these products has become a growing concern in the food safety arena. Molecular species identification techniques hold the potential for rapid, accurate assessment of proper labeling. Here we developed and evaluated DNA barcodes for use in differentiating United States domestic and imported catfish species. First, we sequenced 651 base-pair barcodes from the cytochrome oxidase I (COI) gene from individuals of 9 species (and an Ictalurid hybrid) of domestic and imported catfish in accordance with standard DNA barcoding protocols. These included domestic Ictalurid catfish, and representative imported species from the families of Clariidae and Pangasiidae. Alignment of individual sequences from within a given species revealed highly consistent barcodes (98% similarity on average). These alignments allowed the development and analyses of consensus barcode sequences for each species and comparison with limited sequences in public databases (GenBank and Barcode of Life Data Systems). Validation tests carried out in blinded studies and with commercially purchased catfish samples (both frozen and fresh) revealed the reliability of DNA barcoding for differentiating between these catfish species. The developed protocols and consensus barcodes are valuable resources as increasing market and governmental scrutiny is placed on catfish and other fisheries and aquaculture products labeling in the United States.	[Wong, Li Lian; Peatman, Eric; Lu, Jianguo; Kucuktas, Huseyin; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Auburn, AL 36849 USA; [He, Shunping; Zhou, Chuanjiang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Zhou, Chuanjiang] Southwest Univ, Sch Life Sci, Chongqing, Peoples R China; [Na-nakorn, Uthairat] Kasetsart Univ, Fac Fisheries, Dept Aquaculture, Bangkok, Thailand	Auburn University System; Auburn University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Southwest University - China; Kasetsart University	Wong, LL (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Seal, Sudipta/A-7698-2012; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AGI-8160-2022; Karakoti, Ajay/AAY-5886-2020; Liu, Zhanjiang/R-9633-2019; Wong, Li Lian/AAG-5568-2020; Wong, Lily/D-7737-2011	Wong, Li Lian/0000-0001-9045-4556; Wong, Lily/0000-0003-0569-3398; Na-Nakorn, Uthairat/0000-0002-0804-3561; KARAKOTI, AJAY/0000-0001-9081-2325	USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP) [2009-35205-05101]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018306, P30EY012190, R01EY018724] Funding Source: NIH RePORTER	USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP)(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This project was supported in part by a grant from USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP award # 2009-35205-05101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BOONBRAHM M, 1977, EXPT HYBRIDIZATION F; Botti S, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-60; COSTA FO, 2007, GENOMICS SOC POLICY, V3, P29, DOI DOI 10.1186/1746-5354-3-2-29; DAWNAY NR, 2007, VALIDATION IN PRESS; DONSAKUL T, 1989, P 27 KAS U C JAN 30, P421; Dugan KA, 2002, J FORENSIC SCI, V47, P811; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferraris Carl J. Jr., 1999, Proceedings of the California Academy of Sciences, V51, P1; *FISH BOL, 2010, FISH BARC LIF IN CAM; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GARCIAFRANCO M, 1993, THESIS TOKYO U FISHE; HANSON T, CATFISH DATABASE USD; Hardman M, 2005, MOL PHYLOGENET EVOL, V37, P700, DOI 10.1016/j.ympev.2005.04.029; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jondeung A, 2007, GENE, V387, P49, DOI 10.1016/j.gene.2006.08.001; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LEGRANDE WH, 1981, COPEIA, P33; Liu Z, 1998, MOL GEN GENET, V258, P260, DOI 10.1007/s004380050730; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Na-Nakorn U, 2002, J FISH BIOL, V60, P1051, DOI [10.1111/j.1095-8649.2002.tb02428.x, 10.1006/jfbi.2002.1906]; NEI M, 2000, MOL EVOLUTION PHYLOG; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SMITH EG, 2002, CAMBODIAN J AGR; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Teugels GG, 1999, CYBIUM, V23, P285; *USDA, 2002, CATF PROD; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005	35	163	173	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17812	10.1371/journal.pone.0017812	http://dx.doi.org/10.1371/journal.pone.0017812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423623	Green Submitted, Green Published, gold			2022-12-25	WOS:000288513900034
J	Yu, DX; Yu, ZJ; Sun, Q; Sun, LA; Li, HX; Song, J; Mi, M; Wu, HY; Lu, L; Liu, C; Zhang, G; Hu, FB; Lin, X				Yu, Danxia; Yu, Zhijie; Sun, Qi; Sun, Liang; Li, Huaixing; Song, Jun; Mi, Ming; Wu, Hongyu; Lu, Ling; Liu, Chen; Zhang, Geng; Hu, Frank B.; Lin, Xu			Effects of Body Fat on the Associations of High-Molecular-Weight Adiponectin, Leptin and Soluble Leptin Receptor with Metabolic Syndrome in Chinese	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RISK-FACTORS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; OBESITY; WOMEN; SENSITIVITY; HEALTH; ADIPOCYTOKINES	Background: Little is known regarding the associations between high-molecular-weight (HMW-) adiponectin, leptin and soluble leptin receptor (sOB-R) and metabolic syndrome (MetS) in Chinese. Also few studies elucidate the effects of inflammation and body fat mass on the relations. Methods: Plasma HMW-adiponectin, leptin and sOB-R were measured among 1055 Chinese men and women (35 similar to 54 yrs). Whole body and trunk fat mass were determined by Dual-energy X-ray absorptiometry. MetS was defined by the updated NCEP/ATPIII criterion for Asian-Americans. Results: HMW-adiponectin was inversely associated with MetS in multivariate model including fat mass index (FMI), inflammatory markers, leptin and sOB-R (OR in the highest quartile =0.30, 95%CI 0.18 similar to 0.50, P<.0001). Plasma sOB-R was also inversely associated with MetS independent of body fatness and inflammatory markers, whereas the association was somewhat attenuated after adjusting HMW-adiponectin (OR for the highest quartile =0.78, 95%CI 0.47 similar to 1.32, P = 0.15). In contrast, leptin was associated with increased odds of MetS independent of inflammatory markers, HMW-adiponectin, and sOB-R (OR for the highest quartile =2.64, 95%CI 1.35 similar to 5.18, P = 0.006), although further adjustment for FMI abolished this association. Conclusions: HMW-adiponectin exhibited strong inverse associations with MetS independent of body composition, inflammation, leptin and sOB-R; while the associations of leptin and sOB-R were largely explained by fat mass or HMW-adiponectin, respectively.	[Yu, Danxia; Yu, Zhijie; Sun, Liang; Li, Huaixing; Wu, Hongyu; Lu, Ling; Liu, Chen; Zhang, Geng; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Song, Jun; Mi, Ming] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard T.H. Chan School of Public Health; Shanghai Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health	Yu, DX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	xlin@sibs.ac.cn		Sun, Xinli/0000-0002-6592-6168; Yu, Danxia/0000-0002-1710-9382; Wang, Guo-Liang/0000-0001-8877-3064	Chinese Academy of Sciences [KSCX2-YW-R-116, KSCX2-EW-R-10]; Ministry of Science and Technology of China [2008DFA31960, 2009AA022704, 2011CB504002]; National Natural Science Foundation of China [30930081, 81021002]; Shanghai Institutes [SIBS2008006]; Unilever Corporate Research	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes; Unilever Corporate Research(Unilever)	This study was supported by grant from the Chinese Academy of Sciences (KSCX2-YW-R-116, KSCX2-EW-R-10); the Ministry of Science and Technology of China (2008DFA31960, 863 Program 2009AA022704, 973 program 2011CB504002); the National Natural Science Foundation of China (30930081, 81021002); the Chief Scientist Program of Shanghai Institutes and (SIBS2008006). Dr. Qi Sun was supported by a postdoctoral fellowship from the Unilever Corporate Research before September 2010. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; *COMM IR, 2009, GUID DAT PROC AN INT; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Franks PW, 2005, OBES RES, V13, P1476, DOI 10.1038/oby.2005.178; Furler SM, 2006, OBESITY, V14, P228, DOI 10.1038/oby.2006.29; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Ingelsson E, 2008, J CLIN ENDOCR METAB, V93, P3149, DOI 10.1210/jc.2008-0207; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koska J, 2008, AM J CLIN NUTR, V87, P295, DOI 10.1093/ajcn/87.2.295; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Oh DK, 2007, DIABETES OBES METAB, V9, P282, DOI 10.1111/j.1463-1326.2006.00610.x; Sepilian VP, 2006, FERTIL STERIL, V85, P1441, DOI 10.1016/j.fertnstert.2005.10.038; Shimamura M, 2004, BIOCHEM BIOPH RES CO, V322, P1080, DOI 10.1016/j.bbrc.2004.08.024; Soderberg S, 2007, INT J OBESITY, V31, P1126, DOI 10.1038/sj.ijo.0803561; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; SUN Q, 2009, LEPTIN SOLUBLE LEPTI, V59, P611; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Ukkola O, 2007, METABOLISM, V56, P1221, DOI 10.1016/j.metabol.2007.04.019; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Wang J, 2008, OBESITY, V16, P172, DOI 10.1038/oby.2007.42; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Yu ZJ, 2009, CIRCULATION, V119, P2969, DOI 10.1161/CIRCULATIONAHA.108.833574; Zhai F, 2006, NUTR HLTH STATUS CHI; Zhuo Q, 2009, DIABETES RES CLIN PR, V84, P27, DOI 10.1016/j.diabres.2008.12.019	41	66	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16818	10.1371/journal.pone.0016818	http://dx.doi.org/10.1371/journal.pone.0016818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347230	gold, Green Submitted, Green Published			2022-12-25	WOS:000287369200008
J	Taylor, AM; Reby, D; McComb, K				Taylor, Anna M.; Reby, David; McComb, Karen			Cross Modal Perception of Body Size in Domestic Dogs (Canis familiaris)	PLOS ONE			English	Article							VOCAL-TRACT RESONANCES; RED DEER; INDIVIDUAL RECOGNITION; PHONETIC INFORMATION; RHESUS MACAQUES; MONKEYS; VOICE; CHIMPANZEE; MACACA; DISCRIMINATION	While the perception of size-related acoustic variation in animal vocalisations is well documented, little attention has been given to how this information might be integrated with corresponding visual information. Using a cross-modal design, we tested the ability of domestic dogs to match growls resynthesised to be typical of either a large or a small dog to size-matched models. Subjects looked at the size-matched model significantly more often and for a significantly longer duration than at the incorrect model, showing that they have the ability to relate information about body size from the acoustic domain to the appropriate visual category. Our study suggests that the perceptual and cognitive mechanisms at the basis of size assessment in mammals have a multisensory nature, and calls for further investigations of the multimodal processing of size information across animal species.	[Taylor, Anna M.; Reby, David; McComb, Karen] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Sussex	Taylor, AM (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	anna.magdalena.taylor@gmail.com	reby, david/A-4227-2013	Goldingay, Ross/0000-0002-6684-9299; Reby, David/0000-0001-9261-1711; Walker, Faith/0000-0001-8435-4452	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was entirely funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship to author AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Adachi I, 2007, BEHAV PROCESS, V74, P27, DOI 10.1016/j.beproc.2006.09.004; [Anonymous], SPORTST VERS 5 4 48; BAUER HR, 1983, PSYCHOL REC, V33, P161, DOI 10.1007/BF03394834; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Evans TA, 2005, J EXP PSYCHOL ANIM B, V31, P399, DOI 10.1037/0097-7403.31.4.399; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch WT, 2000, ETHOLOGY, V106, P559, DOI 10.1046/j.1439-0310.2000.00572.x; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Gil-Da-Costa R, 2004, P NATL ACAD SCI USA, V101, P17516, DOI 10.1073/pnas.0408077101; Izumi A, 2004, ANIM COGN, V7, P179, DOI 10.1007/s10071-004-0212-4; Johnston RE, 2008, J COMP PSYCHOL, V122, P121, DOI 10.1037/0735-7036.122.2.121; Jordan KE, 2008, COGNITION, V108, P617, DOI 10.1016/j.cognition.2008.05.006; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; Miller E.H., 1991, P128; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Riede T, 1999, J EXP BIOL, V202, P2859; SCHMIDTNIELSEN K, 1975, J EXP ZOOL, V194, P287, DOI 10.1002/jez.1401940120; SINNOTT JM, 1991, J ACOUST SOC AM, V89, P2421, DOI 10.1121/1.400974; SINNOTT JM, 1989, J ACOUST SOC AM, V86, P557, DOI 10.1121/1.398235; SOMMERS MS, 1992, J ACOUST SOC AM, V91, P3499, DOI 10.1121/1.402839; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; Taylor AM, 2008, J ACOUST SOC AM, V123, P2903, DOI 10.1121/1.2896962; Taylor AM, 2009, ETHOLOGY, V115, P905, DOI 10.1111/j.1439-0310.2009.01681.x; WILSON EO, 1972, SCI AM, V227, P52, DOI 10.1038/scientificamerican0972-52	36	54	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17069	10.1371/journal.pone.0017069	http://dx.doi.org/10.1371/journal.pone.0017069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	22053200	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000287392700043
